Citrus Sinensis ID: 041830

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------470-------480-------490-------500-------510-------520-------530-------540-------550-------560-------570-------580-------590-------600
Protein Sequence
MATTLITHQLYCRAASAALFLFICSLVSYSLGQNNNLPNCDTNSSADVSGYRCSGSQYQCGTFAILRTNSYYSSLFNLSFYLGLNRFVIARANGFSADTEFLPKDQPLLIPIDCKCNNNGGFFQADLTKTTIKGESFYSIAQSLEGLTTCGAIKERNPSVSPWDLDDKARLQVPLRCACPSSSENLPETRILVSYPVGEGDTVSGLAAKFNTTPAAIIAANNKSLEGFKPEDLLAFTSILIPLNGEPVLAPLAKPHDPNLHVPETNYSIPDITPPKKKSKMLKVGAYIALSGAVVGGCIAIAAVVIVILLKKKKQQSPMISHKDCRDVELQQLSASVRTTSDKKVSFEGSQSTIEGQIIDTAEQHKRLLESYSIEDLRRATEKFNSSNRIEGAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDEGSVWLSEKIKSILQAE
Secondary Structure (PSIPRED)
ccccHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccHHcccccccccHHHHHHHHcccHHHHHHHcccccccccccccccEEEEEEccccccccEEEEEEEEEccccccHHHHHHHcccccHHHHHHHHcccccccccccccEEEEEEEcccccccccccccccEEEEEccccccHHHHHHHccccHHHHHHHcccccccccccccccccEEEEcccccccccccccccccccccccccccccccccccccccccccEEEEEHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccHHHHHcccccccccccccccccccccccccccccHHHHHcccccEEEHHHHHHHHHccccccccccEEEEEEEcccEEEEEEcccHHHHHHHHHHHHHHccccccccccEEEEccccccEEEEEEEcccccHHHHccccccccccccccccccccHHHHHHHHHHHHHHHHHHHcccccccEEcccccccccccccccEEEcccccccccccccccccccccccccccccccEEEHHHHHHHHHHccccccccccccccccHHHHHHHHHHHcc
Secondary Structure Prediction (SSPRO)
ccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccccccccccEEEccccccccEEEEEEcccccccHHHHHHHHcccHHHHHccccccccccccccccEEEEEEEccccccccEEEEcEEEEEcccccHHHHHHHHcccHHHHHHHHHccccccccccccccEEEEEEcccccccccccccEEEEEEEEcccccccEccccccccccEEEEccccccccccccccccccccEcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEEHHHHHHHHccccHcccccEEEEEEEEcccEEEEEEccccccHHHHHHHHHHHHHcccccEEEEEEEEcccccEEEEEEEcccccHHHHHcccccccccccccccccccHHHHHHHHHHHHHHHHHHHHcccccEEEcccccccEEEccccccEEccccHHHccccccccHHHHHccccccccccHHHHHHHHHHHHHccccccccccccccHHHHHHHHHHHHHccc
Coil and Loop (DISEMBL)
MATTLITHQLYCRAASAALFLFICSLVSYslgqnnnlpncdtnssadvsgyrcsgsqyqcgtFAILRTNSYYSSLFNLSFYLGLNRFVIARangfsadteflpkdqpllipidckcnnnggffqadltkttikgeSFYSIAQSLEglttcgaikernpsvspwdlddkarlqvplrcacpsssenlpetrilvsypvgegdtvsglaakfnttpAAIIAANnkslegfkpedlLAFTSiliplngepvlaplakphdpnlhvpetnysipditppkkkskmlKVGAYIALSGAVVGGCIAIAAVVIVILLKKkkqqspmishkdcRDVELQQLSAsvrttsdkkvsfegsqstiegQIIDTAEQHKRLLESYSIEDLRRATEKfnssnriegavyhgrlngknlaiKRTEHEVITKLEMQLVQHATHHHPNIVRLLgtcltdgphsfLVFEYAkngslkdwlhgglamKNQFIASCYCFLTWSQRLRICLDVAMALQYMHhvmnpsyvhrniksrnifldeefnarvgnfgmarcvnddtespqfystnpaswsmgiDIFAYGIVLLEVlsgqtpinrprkkdegsVWLSEKIKSILQAE
Flexible Loop (DISEMBL)
MATTLITHQLYCRAASAALFLFICSLVSYSLGQNNNLPNCDTNSSADVSGYRCSGSQYQCGTFAILRTNSYYSSLFNLSFYLGLNRFVIARANGFSADTEFLPKDQPLLIPIDCKCNNNGGFFQADLTKTTIKGESFYSIAQSLEGLTTCGAIkernpsvspwdldDKARLQVPLRCacpsssenlpetRILVSYPVGEGDTVSGLAAKFNTTPAAIIAANNKSLEGFKPEDLLAFTSILIPLNGEPVLAPLAKPHDPNLHVPETNYSIPDITPPKKKSKMLKVGAYIALSGAVVGGCIAIAAVVIVILLKKKKQQSPMISHKDCRDVELQQLsasvrttsdkkvsfegsqstiegqiiDTAEQHKRLLESYSIEDLrratekfnssnriegavyhgrlngknlAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVlsgqtpinrprkkdegsvwlsekiksilqae
Low Complexity Region (SEG)
MATTLITHQLYCRAASAALFLFICSLVSYSLGQNNNLPNCDTNSSADVSGYRCSGSQYQCGTFAILRTnsyysslfnlsfylglnRFVIARANGFSADTEFLPKDQPLLIPIDCKCNNNGGFFQADLTKTTIKGESFYSIAQSLEGLTTCGAIKERNPSVSPWDLDDKARLQVPLRCACPSSSENLPETRILVSYPVGEGDTVSGLAAKFNTTPaaiiaannKSLEGFKPEDLLAFTSILIPLNGEPVLAPLAKPHDPNLHVPETNYSIPDITPPKKKSKMLKVGAYIALSgavvggciaiaavviviLLKKKKQQSPMISHKDCRDVELQQLSASVRTTSDKKVSFEGSQSTIEGQIIDTAEQHKRLLESYSIEDLRRATEKFNSSNRIEGAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDEGSVWLSEKIKSILQAE
Disordered region (IsUnstruct)
***TLITHQLYCRAASAALFLFICSLVSYSLGQNNNLPNCDTNSSADVSGYRCSGSQYQCGTFAILRTNSYYSSLFNLSFYLGLNRFVIARANGFSADTEFLPKDQPLLIPIDCKCNNNGGFFQADLTKTTIKGESFYSIAQSLEGLTTCGAIKERNPSVSPWDLDDKARLQVPLRCACP******PETRILVSYPVGEGDTVSGLAAKFNTTPAAIIAANNKSLEGFKPEDLLAFTSILIPLNGEPVLAPLA***************************MLKVGAYIALSGAVVGGCIAIAAVVIVILLK*****************************************************************************RIEGAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSG****************************
Disordered Region (DISOPRED)
*******HQLYCRAASAALFLFICSLVSYSLGQNNN***C***SSADVSGYRCSGSQYQCGTFAILRTNSYYSSLFNLSFYLGLNRFVIARANGFSADTEFLPKDQPLLIPIDCKCNNNGGFFQADLTKTTIKGESFYSIAQSLEGLTTCGAIKERNPSVSPWDLDDKARLQVPLRCACPSSSENLPETRILVSYPVGEGDTVSGLAAKFNTTPAAIIAANNKSLEGFKPEDLLAFTSILIPLN*******************************************IALSGAVVGGCIAIAAVVIVILL*********************************************************LLESYSIEDLRRATEKFNSSNRIEGAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKN**IASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPI**********VWLSEKIKSIL***
Disordered Region (DISEMBL)
MATTLITHQLYCRAASAALFLFICSLVSYSLGQNNNLPNCDTNSSADVSGYRCSGSQYQCGTFAILRTNSYYSSLFNLSFYLGLNRFVIARANGFSADTEFLPKDQPLLIPIDCKCNNNGGFFQADLTKTTIKGESFYSIAQSLEGLTTCGAIKERNPSVSPWDLDDKARLQVPLRCACPSSSENLPETRILVSYPVGEGDTVSGLAAKFNTTPAAIIAANNKSLEGFKPEDLLAFTSILIPLNGEPVLAPLAKPHDPNLHVPETNYSIPDITPPKKKSKMLKVGAYIALSGAVVGGCIAIAAVVIVILLKK**********KDCRDVELQQLSAS**************QSTIEGQIIDTAEQHKRLLESYSIEDLRRATEKFNSSNRIEGAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPI***********WLSEKIKSILQAE
Disordered Region (DISPRO)
*ATTLITHQLYCRAASAALFLFICSLVSYSLGQNNNLPNCDTNSSADVSGYRCSGSQYQCGTFAILRTNSYYSSLFNLSFYLGLNRFVIARANGFSADTEFLPKDQPLLIPIDCKCNNNGGFFQADLTKTTIKGESFYSIAQSLEGLTTCGAIKERNPSVSPWDLDDKARLQVPLRCACPSSSENLPETRILVSYPVGEGDTVSGLAAKFNTTPAAIIAANNKSLEGFKPEDLLAFTSILIPLNGEPVLAPLAKP**************************LKVGAYIALSGAVVGGCIAIAAVVIVILLKKKK***********************************************AEQHKRLLESYSIEDLRRATEKFNSSNRIEGAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDEGSVWLSEKIKSILQ**
Transmembrane Helix (TMHMM)
oooooooooHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiHHHHHHHHHHHHHHHHHHHHHHHHHooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooHHHHHHHHHHHHHHHHHHHHHHHHHHHiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MATTLITHQLYCRAASAALFLFICSLVSYSLGQNNNLPNCDTNSSADVSGYRCSGSQYQCGTFAILRTNSYYSSLFNLSFYLGLNRFVIARANGFSADTEFLPKDQPLLIPIDCKCNNNGGFFQADLTKTTIKGESFYSIAQSLEGLTTCGAIKERNPSVSPWDLDDKARLQVPLRCACPSSSENLPETRILVSYPVGEGDTVSGLAAKFNTTPAAIIAANNKSLEGFKPEDLLAFTSILIPLNGEPVLAPLAKPHDPNLHVPETNYSIPDITPPKKKSKMLKVGAYIALSGAVVGGCIAIAAVVIVILLKKKKQQSPMISHKDCRDVELQQLSASVRTTSDKKVSFEGSQSTIEGQIIDTAEQHKRLLESYSIEDLRRATEKFNSSNRIEGAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDEGSVWLSEKIKSILQAE
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	600	2.2.26 [Sep-21-2011]
Q9SGI7	654	Protein LYK2 OS=Arabidops	yes	no	0.79	0.724	0.452	1e-119
O64825	612	LysM domain receptor-like	no	no	0.863	0.846	0.290	5e-54
O22808	664	Protein LYK5 OS=Arabidops	no	no	0.886	0.801	0.294	7e-53
A8R7E6	617	Chitin elicitor receptor	no	no	0.726	0.706	0.266	2e-37
Q9LRP3	467	Probable receptor-like pr	no	no	0.353	0.453	0.328	8e-33
D7UPN3	605	Chitin elicitor receptor	no	no	0.671	0.666	0.252	2e-31
Q9SJG2	494	Probable receptor-like pr	no	no	0.343	0.417	0.347	5e-31
Q8LEB6	484	Probable receptor-like pr	no	no	0.353	0.438	0.328	7e-31
Q6R2J8	703	Protein STRUBBELIG-RECEPT	no	no	0.61	0.520	0.286	8e-31
Q9LT96	946	Probable leucine-rich rep	no	no	0.323	0.205	0.326	8e-29

>sp|Q9SGI7|LYK2_ARATH Protein LYK2 OS=Arabidopsis thaliana GN=LYK2 PE=2 SV=1

 Score =  428 bits (1100), Expect = e-119,   Method: Compositional matrix adjust.
 Identities = 244/539 (45%), Positives = 337/539 (62%), Gaps = 65/539 (12%)

Query: 50  GYRCSGSQYQCGTFAILRTNSYYSSLFNLSFYLGLNRFVIARANGFSADTEFLPKDQPLL 109
           GY C  +  +C TFAILR    + SL +LS +LGL+           AD E++PK Q LL
Sbjct: 47  GYVCHSNLQKCHTFAILRAKPPFYSLSDLSRHLGLD-----------ADDEYVPKGQLLL 95

Query: 110 IPIDCKCNNNGGFFQADLTKTTIKGESFYSIAQSLEGLTTCGAIKERNPSVSPWDLDDKA 169
           IPI+C+CN  G  ++A L K  +KG++F S++QSL+GLTTC +I+E+NP +S   L D  
Sbjct: 96  IPIECRCN--GSIYEASLIKNCVKGDTFRSVSQSLQGLTTCLSIREKNPHISEDKLGDNI 153

Query: 170 RLQVPLRCACPSSSENLPETRILVSYPVGEGDTVSGLAAKFNTTPAAIIAANNKSLEGFK 229
           +L++ +RC+CP   E +     LV+YPVG  D+VS LA +FNTT  AI++ANNKS     
Sbjct: 154 KLRLAIRCSCPQ--EGVSNASFLVTYPVGVRDSVSSLAVRFNTTEDAIVSANNKSG---- 207

Query: 230 PEDLLAFTSILIPLNGEPVLAPLAKPHDPNLHVPETNYSIPDITPPKKKSKMLKVGAYIA 289
                     ++PL  +P L PL        H PE   S       KK+SKM      IA
Sbjct: 208 ----------VVPL--KPALIPLD-------HKPEKQGSRKRNPSKKKRSKM---KLMIA 245

Query: 290 LSGAVVGGCIAIAAVVIVILLKKKKQQSPMISHK--DCRDVELQQLSASVRTTSDKKVSF 347
           +S A+ G C  +  +V   L  KK+ Q    + K    +D E +QLS S+RTTSDKK+SF
Sbjct: 246 VSSAIAGVCGLVTLMVFGYLHWKKETQIQTQTQKWISNKDPETRQLSLSIRTTSDKKISF 305

Query: 348 EGSQSTIEGQIID------TAEQHKRLLESYSIEDLRRATEKFNSSNRIEGAVYHGRLNG 401
           EGSQ   +G I+D      T    K +LE Y+ E+L +ATE F+SSN I+G+VY G L G
Sbjct: 306 EGSQ---DGSILDSHNTVGTTTPRKPVLEIYAFEELEKATENFSSSNHIKGSVYFGSLKG 362

Query: 402 KNLAIKRTEHEVITKLEMQLVQHATHHHP-NIVRLLGTCLTD-GPHSFLVFEYAKNGSLK 459
           K+LAIK+   + + + +  L+   +H++  N++R+LGTC  +    S+LVFEYA+NGSL 
Sbjct: 363 KDLAIKQVNADEMKRFDFGLLNDQSHYYNHNVIRVLGTCFREIDQDSYLVFEYARNGSLW 422

Query: 460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFL 519
           DW+   LA+KNQFI SCYCFL W QR++IC DVA+AL+YMH +   +YVH NIKSRNIFL
Sbjct: 423 DWIQNKLAIKNQFIESCYCFLAWKQRIKICHDVAIALKYMHRI---NYVHGNIKSRNIFL 479

Query: 520 DEEFNARVGNFGMARCVNDDTESPQFY---STNPASWSMGIDIFAYGIVLLEVLSGQTP 575
           +E+   +VGNFGM++CV ++  + +     S +PAS     DIFAYGI+++EVLSGQTP
Sbjct: 480 NEDLRGKVGNFGMSKCVTNELATEENLIESSLSPAS-----DIFAYGIIVMEVLSGQTP 533

May recognize microbe-derived N-acetylglucosamine (NAG)-containing ligands.
Arabidopsis thaliana (taxid: 3702)

>sp|O64825|LYK4_ARATH LysM domain receptor-like kinase 4 OS=Arabidopsis thaliana GN=LYK4 PE=1 SV=1

 Score =  212 bits (540), Expect = 5e-54,   Method: Compositional matrix adjust.
 Identities = 172/592 (29%), Positives = 299/592 (50%), Gaps = 74/592 (12%)

Query: 19  LFLFICSLVSYSLGQNN----NLPNCD-TNSSADVSGYRCSGSQYQCGTFAILRTNSYYS 73
           L   + SL S++  Q      +  +C  ++++  V GY C+G    C  + I R+   +S
Sbjct: 9   LVFILLSLSSFATAQQPYVGISTTDCSVSDNTTSVFGYSCNGLNKTCQAYVIFRSTPSFS 68

Query: 74  SLFNLSFYLGLNRFVIARANGFSADTEFLPKDQPLLIPIDCKCNNNGGFFQADLTKTTIK 133
           ++ ++S    ++  +++  N  S  T F P  Q ++IP+ C C  +    Q+++T T   
Sbjct: 69  TVTSISSLFSVDPSLVSSLNDASPSTSF-PSGQQVIIPLTCSCTGDDS--QSNITYTIQP 125

Query: 134 GESFYSIA-QSLEGLTTCGAIKERNPSVSPWDLDDKARLQVPLRCACPSSSE-NLPETRI 191
            +S+++IA  +L+GL+TC A+ ++N +VS   L    R+ VP+RCACP++ + N    + 
Sbjct: 126 NDSYFAIANDTLQGLSTCQALAKQN-NVSSQSLFPGMRIVVPIRCACPTAKQINEDGVKY 184

Query: 192 LVSYPVGEGDTVSGLAAKFNTTPAAIIAANNKSLEGFKPEDLLAFTSILIPLNGEP--VL 249
           L+SY V   DT++ ++ +F    +  + AN  S   F+  ++  FT+ILIPL   P    
Sbjct: 185 LMSYTVVFEDTIAIISDRFGVETSKTLKANEMS---FENSEVFPFTTILIPLVNPPANTN 241

Query: 250 APLAKPHDPNLHVPETNYSIPDITPPKKKSKMLKVGAYIALSGAVVGGCIAIAAVVIVIL 309
           + +  P  P           PD    KKK+ +       AL+G V+GG + ++ +   I 
Sbjct: 242 SLIPPPPPPPPQSVSPPPLSPDGRKSKKKTWVY------ALAG-VLGGALVLSVIGAAIF 294

Query: 310 -LKKKKQQSPMISHKDCRDVELQQLSASVRTTSDKKVSFEGSQSTIEGQIIDTAEQHKRL 368
            L KKK ++           + Q+ + ++        SF G +  +  Q  D  +    +
Sbjct: 295 CLSKKKTKT-----------QTQEETGNLD-------SFMGKKPPMSDQEFDPLDGLSGM 336

Query: 369 ----LESYSIEDLRRATEKFNSSNRIEGAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQH 424
               L+ Y   +L+ AT  F SS+ I G+ Y G++NG    IK+ E     ++ +     
Sbjct: 337 VVESLKVYKFHELQSATSDFTSSSSIGGSGYIGKINGDGAMIKKIEGNASEEVNLL---- 392

Query: 425 ATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQ 484
           +  +H NI+RL G C  +G   +LV+E+A NGSL +W+H           +    L+ +Q
Sbjct: 393 SKLNHLNIIRLSGFCFHEGDW-YLVYEHASNGSLSEWIH-----------TTKSLLSLTQ 440

Query: 485 RLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD----- 539
           +L+I LD+A  L Y+H+  +P YVHR++ S N+FLD EF A++G+ G AR   +D     
Sbjct: 441 KLQIALDIATGLNYLHNFADPPYVHRDLNSNNVFLDLEFRAKIGSLGSARSTTEDFVLTK 500

Query: 540 -TESPQFYSTNPASWSMG-----IDIFAYGIVLLEVLSGQTPINRPRKKDEG 585
             E  + Y   P     G     +D++A+G+VLLE+++G+      ++ DEG
Sbjct: 501 HVEGTRGY-LAPEYLEHGLVSTKLDVYAFGVVLLEIVTGKEASELKKEIDEG 551

Lysin motif (LysM) receptor kinase that functions as a cell surface receptor in chitin elicitor (chitooligosaccharides) signaling leading to innate immunity. Recognizes microbe-derived N-acetylglucosamine (NAG)-containing ligands. Involved in the resistance to the pathogenic fungus Alternaria brassicicola and to the bacterial pathogen the bacterial pathogen Pseudomonas syringae pv tomato DC3000, probably by sensing microbe-associated molecular pattern (MAMP) and pathogen-associated molecular patterns (PAMP). May play a role in detecting peptidoglycans (e.g. PGNs) during bacterial growth.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|O22808|LYK5_ARATH Protein LYK5 OS=Arabidopsis thaliana GN=LYK5 PE=1 SV=1

 Score =  209 bits (531), Expect = 7e-53,   Method: Compositional matrix adjust.
 Identities = 173/587 (29%), Positives = 286/587 (48%), Gaps = 55/587 (9%)

Query: 14  AASAALFLFICSLVSYSLGQ----NNNLPNCDTNSSADVS-GYRCSGSQYQCGTFAILRT 68
           A S  LFL +   VS +  Q    NN+   C+     +++ G+ C+G    C ++    +
Sbjct: 8   ALSVTLFLLLFFAVSPAKAQQPYVNNHQLACEVRVYDNITNGFTCNGPP-SCRSYLTFWS 66

Query: 69  NSYYSSLFNLSFYLGLNRFVIARANGFSADTEFLPKDQPLLIPIDCKCNNNGGFFQADLT 128
              Y++  +++  L ++   I   N     T  +P  + ++IP +C C+++ G F     
Sbjct: 67  QPPYNTADSIAKLLNVSAAEIQSINNLPTATTRIPTRELVVIPANCSCSSSSGGFYQHNA 126

Query: 129 KTTIKG----ESFYSIAQ-SLEGLTTCGAIKERNPSVSPWDLDDKARLQVPLRCACPSSS 183
              + G    E+++S+A  + + L+TC A+  +N       L     L VPLRCACP++ 
Sbjct: 127 TYNLSGNRGDETYFSVANDTYQALSTCQAMMSQN-RYGERQLTPGLNLLVPLRCACPTAK 185

Query: 184 ENLPETRILVSYPVGEGDTVSGLAAKFNTTPAAIIAANNKSLEGFKPEDLLAFTSILIPL 243
           +     + L++Y V  GD++SG+A  FN+T AAI   N         +++  FT +L+PL
Sbjct: 186 QTTAGFKYLLTYLVAMGDSISGIAEMFNSTSAAITEGNE-----LTSDNIFFFTPVLVPL 240

Query: 244 NGEPVLAPLAKPHDPNLHVPETNYSIPDITPPKKKSKMLKVGAYIALSGAVVGGCIAIAA 303
             EP    ++    P   V     +  D  PP   S    +   I +   ++     +A 
Sbjct: 241 TTEPTKIVISPSPPPPPVVATPPQTPVD--PPGSSSSHKWIYIGIGIGAGLLLLLSILAL 298

Query: 304 VVIVILLKKKKQQSPMISHKDCRDVELQQLSASVRTTSDKKVSFEGSQSTIEGQIIDTAE 363
                  KKK   S +       D   +Q   S+ TT+  + S + S S+    +    E
Sbjct: 299 CFYKRRSKKKSLPSSLPEENKLFDSSTKQ---SIPTTTTTQWSIDLSNSSEAFGLKSAIE 355

Query: 364 QHKRLLESYSIEDLRRATEKFNSSNRIEGAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQ 423
                L  Y   DL+ AT  F+  NRI+G+VY   +NG + A+K  + +V +  E+ L++
Sbjct: 356 S----LTLYRFNDLQSATSNFSDENRIKGSVYRATINGDDAAVKVIKGDVSSS-EINLLK 410

Query: 424 HATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWS 483
               +H NI+RL G C+ +G  S+LVFEY++NGS+ DWLH          +S    LTW 
Sbjct: 411 KL--NHSNIIRLSGFCIREGT-SYLVFEYSENGSISDWLH----------SSGKKSLTWK 457

Query: 484 QRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---- 539
           QR+ I  DVA AL Y+H+ + P ++H+N++S NI LD  F A++ NFG+AR +++     
Sbjct: 458 QRVEIARDVAEALDYLHNYITPPHIHKNLESTNILLDSNFRAKIANFGVARILDEGDLDL 517

Query: 540 -----TESPQFYSTNPASWSMGI-----DIFAYGIVLLEVLSGQTPI 576
                 E  Q Y   P     G+     D+FA+G+ +LE+LSG+  +
Sbjct: 518 QLTRHVEGTQGYLA-PEYVENGVITSKLDVFAFGVAVLELLSGREAV 563

May recognize microbe-derived N-acetylglucosamine (NAG)-containing ligands.

Arabidopsis thaliana (taxid: 3702)

>sp|A8R7E6|CERK1_ARATH Chitin elicitor receptor kinase 1 OS=Arabidopsis thaliana GN=CERK1 PE=1 SV=1

 Score =  157 bits (397), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 134/502 (26%), Positives = 232/502 (46%), Gaps = 66/502 (13%)

Query: 89  IARANGFSADTEFLPKDQPLLIPIDCKCNNNGGFFQADLTKTTIKGESFYSIAQS-LEGL 147
           I R N    D + +     +L+P  C+C   G F   + + +  + +++  +A S    L
Sbjct: 66  ILRYNSNIKDKDRIQMGSRVLVPFPCECQP-GDFLGHNFSYSVRQEDTYERVAISNYANL 124

Query: 148 TTCGAIKERNPSVSPWDLDDKARLQVPLRCACPSSSENLPETRILVSYPVGEGDTVSGLA 207
           TT  +++ RNP     ++   A L V + C+C   S +  +  + V+YP+   D++S +A
Sbjct: 125 TTMESLQARNP-FPATNIPLSATLNVLVNCSCGDESVS-KDFGLFVTYPLRPEDSLSSIA 182

Query: 208 AKFNTTPAAIIAANNKSLEGFKPEDLLAFTSILIPLNGEPVLAPLAKPHDPNLHVPETNY 267
            + +   A I+   N  +  F   + + +    +P              DPN        
Sbjct: 183 -RSSGVSADILQRYNPGVN-FNSGNGIVY----VP------------GRDPN-------- 216

Query: 268 SIPDITPPKKKSKMLKVGAYIALSGAVVGGCIAIAAVVIVILLKKKKQQSPMISHKDCRD 327
                 PP K SK   VGA + ++G V+G  +A+  ++ ++    +K +S   S      
Sbjct: 217 ---GAFPPFKSSKQDGVGAGV-IAGIVIGVIVALLLILFIVYYAYRKNKSKGDSFSSSIP 272

Query: 328 VELQQLSASVRTTSDKKVSFEGSQSTIEGQIIDTAEQHKRLLESYSIEDLRRATEKFNSS 387
           +  +   AS  +     +   G    I    +D + +       +S+E+L +AT+ FN S
Sbjct: 273 LSTKADHASSTSLQSGGLGGAGVSPGIAAISVDKSVE-------FSLEELAKATDNFNLS 325

Query: 388 NRIE----GAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDG 443
            +I     GAVY+  L G+  AIK+ + E   +   +L      HH N+VRL+G C+   
Sbjct: 326 FKIGQGGFGAVYYAELRGEKAAIKKMDMEASKQFLAELKVLTRVHHVNLVRLIGYCVEG- 384

Query: 444 PHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM 503
              FLV+EY +NG+L   LHG          S    L W++R++I LD A  L+Y+H   
Sbjct: 385 -SLFLVYEYVENGNLGQHLHG----------SGREPLPWTKRVQIALDSARGLEYIHEHT 433

Query: 504 NPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQ-----FYSTNP----ASWS 554
            P YVHR+IKS NI +D++F A+V +FG+ +       + +     F    P       S
Sbjct: 434 VPVYVHRDIKSANILIDQKFRAKVADFGLTKLTEVGGSATRGAMGTFGYMAPETVYGEVS 493

Query: 555 MGIDIFAYGIVLLEVLSGQTPI 576
             +D++A+G+VL E++S +  +
Sbjct: 494 AKVDVYAFGVVLYELISAKGAV 515

Lysin motif (LysM) receptor kinase that functions as a cell surface receptor in chitin elicitor (chitooligosaccharides) signaling leading to innate immunity toward both biotic and abiotic stresses (e.g. tolerance to salinity, heavy-metal stresses, and Botrytis cinerea infection). Recognizes microbe-derived N-acetylglucosamine (NAG)-containing ligands. Involved in the resistance to pathogenic fungi Alternaria brassicicola and Erysiphe cichoracearum, probably by sensing microbe-associated molecular patterns (MAMP) and pathogen-associated molecular patterns (PAMP). Plays an essential role in detecting peptidoglycans (e.g. PGNs) and restricting bacterial growth. Target of the bacterial type III effector E3-ligase protein hopAB2/avrPtoB of Pseudomonas syringae pv. tomato DC3000 that mediates ubiquitination and subsequent proteolysis, thus blocking all defense responses by suppressing PAMP-triggered immunity (PTI).

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9LRP3|Y3174_ARATH Probable receptor-like protein kinase At3g17420 OS=Arabidopsis thaliana GN=At3g17420 PE=1 SV=1

 Score =  142 bits (358), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 82/250 (32%), Positives = 140/250 (56%), Gaps = 38/250 (15%)

Query: 372 YSIEDLRRATEKFNSSNRI----EGAVYHGRLNGKN-LAIKRT-----EHEVITKLEMQL 421
           +++ DL+ AT  F+  + I     G VYHG L  K  +A+K+      + +   ++E++ 
Sbjct: 142 FTLRDLQLATNHFSKESIIGDGGYGVVYHGTLTNKTPVAVKKLLNNPGQADKDFRVEVEA 201

Query: 422 VQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLT 481
           + H    H N+VRLLG C+ +G H  LV+EY  NG+L+ WLHG +  K          LT
Sbjct: 202 IGHV--RHKNLVRLLGYCV-EGTHRMLVYEYMNNGNLEQWLHGDMIHKGH--------LT 250

Query: 482 WSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE 541
           W  R+++ +  A AL Y+H  + P  VHR+IKS NI +D+ F+A++ +FG+A+ +  D+ 
Sbjct: 251 WEARIKVLVGTAKALAYLHEAIEPKVVHRDIKSSNILMDDNFDAKLSDFGLAKLLGADSN 310

Query: 542 -------------SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDEGSVW 588
                        +P++   N    +   D+++YG+VLLE ++G+ P++  R K+E  V 
Sbjct: 311 YVSTRVMGTFGYVAPEY--ANSGLLNEKSDVYSYGVVLLEAITGRYPVDYARPKEE--VH 366

Query: 589 LSEKIKSILQ 598
           + E +K ++Q
Sbjct: 367 MVEWLKLMVQ 376

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|D7UPN3|CERK1_ORYSJ Chitin elicitor receptor kinase 1 OS=Oryza sativa subsp. japonica GN=CERK1 PE=1 SV=1

 Score =  137 bits (345), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 126/499 (25%), Positives = 223/499 (44%), Gaps = 96/499 (19%)

Query: 108 LLIPIDCKC---------NNNGGFFQADLTKTTIKGESFYSIAQSLEGLTTCGAIKERNP 158
           +L+P  C C             G     L      G+++ ++A +   LTT   ++  N 
Sbjct: 81  VLVPFPCSCLGLPAAPASTFLAGAIPYPLPLPRGGGDTYDAVAANYADLTTAAWLEATNA 140

Query: 159 SVSPWDLDDKARLQVPLRCACPSSSENLPETRILVSYPVGEGDTVSGLAAKFN-TTPA-- 215
                      R+ V + C+C     + P   + ++YP+ +G+T+  +AA++  ++PA  
Sbjct: 141 YPPGRIPGGDGRVNVTINCSCGDERVS-PRYGLFLTYPLWDGETLESVAAQYGFSSPAEM 199

Query: 216 AIIAANNKSLEGFKPEDLLAFTSILIPLNGEPVLAPLAKPHDPNLHVPETNYSIPDITPP 275
            +I   N  + G   + +     + IP+             DPN      +Y       P
Sbjct: 200 ELIRRYNPGMGGVSGKGI-----VFIPVK------------DPN-----GSYH------P 231

Query: 276 KKKSKMLKVGAYIALSGAVVGGCIAIAAVVIVILLKKKKQQSPMISHKDCRDVELQQLSA 335
            K   M    +  A++G V+  CIAI  V I +++   +                Q+   
Sbjct: 232 LKSGGMGNSLSGGAIAGIVI-ACIAIFIVAIWLIIMFYR---------------WQKFRK 275

Query: 336 SVRTTSDKKVSFEGSQSTIEGQIIDTAEQHKRLLESYSIEDLRRATEKFNSSNRIE---- 391
           +    S ++ S     S  EG  ++      R +E +S E++  AT+ F+  ++I     
Sbjct: 276 ATSRPSPEETSHLDDASQAEGIKVE------RSIE-FSYEEIFNATQGFSMEHKIGQGGF 328

Query: 392 GAVYHGRLNGKNLAIKRTEHEVITKL--EMQLVQHATHHHPNIVRLLGTCLTDGPHSFLV 449
           G+VY+  L G+  AIK+   +   +   E++++ H   HH N+VRL+G C+ +    FLV
Sbjct: 329 GSVYYAELRGEKTAIKKMGMQATQEFLAELKVLTHV--HHLNLVRLIGYCVEN--CLFLV 384

Query: 450 FEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVH 509
           +E+  NG+L   L            + Y  L+W+ R++I LD A  L+Y+H  + P YVH
Sbjct: 385 YEFIDNGNLSQHLQ----------RTGYAPLSWATRVQIALDSARGLEYLHEHVVPVYVH 434

Query: 510 RNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQF-------YSTNPASWSMG-----I 557
           R+IKS NI LD++F A++ +FG+A+     + S          +   P     G     +
Sbjct: 435 RDIKSANILLDKDFRAKIADFGLAKLTEVGSMSQSLSTRVAGTFGYMPPEARYGEVSPKV 494

Query: 558 DIFAYGIVLLEVLSGQTPI 576
           D++A+G+VL E+LS +  I
Sbjct: 495 DVYAFGVVLYELLSAKQAI 513

Plays an essential role in detecting peptidoglycans (e.g. PGNs) and restricting bacterial growth. Recognizes microbe-derived N-acetylglucosamine (NAG)-containing ligands (By similarity). Lysin motif (LysM) receptor kinase required as a cell surface receptor for chitin elicitor (chitooligosaccharides) signaling leading to innate immunity in response to both biotic and abiotic stresses. Involved in the resistance to pathogenic fungi, probably by sensing microbe-associated molecular patterns (MAMP) and pathogen-associated molecular patterns (PAMP).

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SJG2|Y2296_ARATH Probable receptor-like protein kinase At2g42960 OS=Arabidopsis thaliana GN=At2g42960 PE=3 SV=1

 Score =  136 bits (342), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 84/242 (34%), Positives = 137/242 (56%), Gaps = 36/242 (14%)

Query: 372 YSIEDLRRATEKFNSSNRIE----GAVYHGRL-NGKNLAIKRT-----EHEVITKLEMQL 421
           +++ DL  AT +F   N +     G VY G+L NG  +A+K+      + E   ++E++ 
Sbjct: 171 FTLRDLELATNRFAPVNVLGEGGYGVVYRGKLVNGTEVAVKKLLNNLGQAEKEFRVEVEA 230

Query: 422 VQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLT 481
           + H    H N+VRLLG C+ +G H  LV+EY  +G+L+ WLHG  AM+       +  LT
Sbjct: 231 IGHV--RHKNLVRLLGYCI-EGVHRMLVYEYVNSGNLEQWLHG--AMRQ------HGNLT 279

Query: 482 WSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE 541
           W  R++I    A AL Y+H  + P  VHR+IK+ NI +D+EFNA++ +FG+A+ + D  E
Sbjct: 280 WEARMKIITGTAQALAYLHEAIEPKVVHRDIKASNILIDDEFNAKLSDFGLAKLL-DSGE 338

Query: 542 S-------PQFYSTNPASWSMGI-----DIFAYGIVLLEVLSGQTPINRPRKKDEGSV-- 587
           S         F    P   + G+     DI+++G++LLE ++G+ P++  R  +E ++  
Sbjct: 339 SHITTRVMGTFGYVAPEYANTGLLNEKSDIYSFGVLLLEAITGRDPVDYGRPANEVNLVE 398

Query: 588 WL 589
           WL
Sbjct: 399 WL 400

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q8LEB6|Y5185_ARATH Probable receptor-like protein kinase At5g18500 OS=Arabidopsis thaliana GN=At5g18500 PE=1 SV=1

 Score =  135 bits (341), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 82/250 (32%), Positives = 139/250 (55%), Gaps = 38/250 (15%)

Query: 372 YSIEDLRRATEKFNSSNRIE----GAVYHGRL-NGKNLAIKR-----TEHEVITKLEMQL 421
           +++ DL+ AT +F+  N I     G VY G L NG  +A+K+      + +   ++E++ 
Sbjct: 154 FTLRDLQMATNQFSRDNIIGDGGYGVVYRGNLVNGTPVAVKKLLNNLGQADKDFRVEVEA 213

Query: 422 VQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLT 481
           + H    H N+VRLLG C+ +G    LV+EY  NG+L+ WL G     NQ     + +LT
Sbjct: 214 IGHV--RHKNLVRLLGYCM-EGTQRMLVYEYVNNGNLEQWLRG----DNQ----NHEYLT 262

Query: 482 WSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE 541
           W  R++I +  A AL Y+H  + P  VHR+IKS NI +D++FN+++ +FG+A+ +  D  
Sbjct: 263 WEARVKILIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDKFNSKISDFGLAKLLGADKS 322

Query: 542 -------------SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDEGSVW 588
                        +P++   N    +   D++++G+VLLE ++G+ P++  R   E  V 
Sbjct: 323 FITTRVMGTFGYVAPEY--ANSGLLNEKSDVYSFGVVLLEAITGRYPVDYARPPPE--VH 378

Query: 589 LSEKIKSILQ 598
           L E +K ++Q
Sbjct: 379 LVEWLKMMVQ 388

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q6R2J8|SRF8_ARATH Protein STRUBBELIG-RECEPTOR FAMILY 8 OS=Arabidopsis thaliana GN=SRF8 PE=2 SV=1

 Score =  135 bits (340), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 129/450 (28%), Positives = 203/450 (45%), Gaps = 84/450 (18%)

Query: 198 GEGDTVSGLAAKFNTTPAAIIAANNKSLEGFKPEDLLAFTSILIPLNGEPVLAPLAKPHD 257
           G  D +SGL       P   +   N    G  P++L +  +++   N    +    +P  
Sbjct: 205 GSIDVLSGL-------PLKTLNVANNHFNGSIPKELSSIQTLIYDGNSFDNVPASPQPER 257

Query: 258 PNLHVPETNYSIPDITPPKKKSKMLKVGAYIALSGAVVGGCI-------AIAAVVIVILL 310
           P      +    P I   +K S   K      LSG VV G +        I A+V+ + L
Sbjct: 258 PGKKETPSGSKKPKIGSEEKSSDSGK-----GLSGGVVTGIVFGSLFVAGIIALVLYLCL 312

Query: 311 KKKKQQSPMISHKDCRDVEL-------QQLSASVRTTSD------KKVSFE-----GSQS 352
            KKK++    +    R + L       +Q   SV + +D      +KV+ +     GS S
Sbjct: 313 HKKKRKVRGSTRASQRSLPLSGTPEVQEQRVKSVASVADLKSSPAEKVTVDRVMKNGSIS 372

Query: 353 TIEGQIIDTAEQHKRLLESYSIEDLRRATEKFNSSNRIE----GAVYHGRL-NGKNLAIK 407
            I   I  TA Q       Y++  L+ AT  F+  N I     G VY     NGK +AIK
Sbjct: 373 RIRSPI--TASQ-------YTVSSLQVATNSFSQENIIGEGSLGRVYRAEFPNGKIMAIK 423

Query: 408 RTEHEVITKLE----MQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL 462
           + ++  ++  E    ++ V + +   HPNIV L G C   G    LV+EY  NG+L D L
Sbjct: 424 KIDNAALSLQEEDNFLEAVSNMSRLRHPNIVPLAGYCTEHG-QRLLVYEYVGNGNLDDTL 482

Query: 463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEE 522
           H                LTW+ R+++ L  A AL+Y+H V  PS VHRN KS NI LDEE
Sbjct: 483 HTN--------DDRSMNLTWNARVKVALGTAKALEYLHEVCLPSIVHRNFKSANILLDEE 534

Query: 523 FNARVGNFGMARCVNDDTE--------------SPQFYSTNPASWSMGIDIFAYGIVLLE 568
            N  + + G+A  +  +TE              +P+F  +    +++  D++ +G+V+LE
Sbjct: 535 LNPHLSDSGLA-ALTPNTERQVSTQVVGSFGYSAPEFALS--GIYTVKSDVYTFGVVMLE 591

Query: 569 VLSGQTPINRPRKKDEGSV--WLSEKIKSI 596
           +L+G+ P++  R + E S+  W + ++  I
Sbjct: 592 LLTGRKPLDSSRTRAEQSLVRWATPQLHDI 621

Arabidopsis thaliana (taxid: 3702)

>sp|Q9LT96|Y5977_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g49770 OS=Arabidopsis thaliana GN=At5g49770 PE=2 SV=1

 Score =  129 bits (323), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 76/233 (32%), Positives = 126/233 (54%), Gaps = 39/233 (16%)

Query: 370 ESYSIEDLRRATEKFNSSNRIEGAVYHGRL-----NGKNLAIKRTEHEVIT-----KLEM 419
           ++++ E+L + T  F+ +N + G  Y         NG+ +AIKR +   +      K E+
Sbjct: 620 KAFTFEELSKCTNNFSDANDVGGGGYGQVYKGTLPNGQVIAIKRAQQGSMQGAFEFKTEI 679

Query: 420 QLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCF 479
           +L+     HH N+V+LLG C  D     LV+EY  NGSL+D L G   +K          
Sbjct: 680 ELLSRV--HHKNVVKLLGFCF-DQKEQMLVYEYIPNGSLRDGLSGKNGVK---------- 726

Query: 480 LTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD 539
           L W++RL+I L     L Y+H + +P  +HR++KS NI LDE   A+V +FG+++ V D 
Sbjct: 727 LDWTRRLKIALGSGKGLAYLHELADPPIIHRDVKSNNILLDEHLTAKVADFGLSKLVGDP 786

Query: 540 TES--------------PQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR 578
            ++              P++Y TN    +   D++ +G+V+LE+L+G++PI+R
Sbjct: 787 EKAHVTTQVKGTMGYLDPEYYMTN--QLTEKSDVYGFGVVMLELLTGKSPIDR 837

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	600
224060233	680	predicted protein [Populus trichocarpa]	0.95	0.838	0.678	0.0
255536947	681	ATP binding protein, putative [Ricinus c	0.926	0.816	0.674	0.0
225452136	675	PREDICTED: uncharacterized protein LOC10	0.943	0.838	0.661	0.0
296090235	672	unnamed protein product [Vitis vinifera]	0.906	0.809	0.648	0.0
356570127	684	PREDICTED: putative proline-rich recepto	0.953	0.836	0.625	0.0
290490586	672	LysM type receptor kinase [Lotus japonic	0.933	0.833	0.628	0.0
449442042	684	PREDICTED: protein STRUBBELIG-RECEPTOR F	0.968	0.849	0.590	0.0
15232204	654	protein kinase domain-containing protein	0.79	0.724	0.452	1e-117
297828564	640	kinase family protein [Arabidopsis lyrat	0.813	0.762	0.433	1e-115
449448550	639	PREDICTED: probable receptor protein kin	0.898	0.843	0.303	1e-62

>gi|224060233|ref|XP_002300098.1| predicted protein [Populus trichocarpa] gi|222847356|gb|EEE84903.1| predicted protein [Populus trichocarpa]

 Score =  817 bits (2111), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 407/600 (67%), Positives = 485/600 (80%), Gaps = 30/600 (5%)

Query: 17  AALFLFICSLVSYSLGQNNNLPNCDTNSSADVSGYRCS--GSQYQCGTFAILRTNSYYSS 74
           A  F+ IC LVS +LGQN  L +C T +S D SGY C+  G Q QC TFAIL T+SY+SS
Sbjct: 14  AFAFILICLLVS-ALGQN--LLSCQT-TSPDASGYHCNSNGLQDQCKTFAILHTSSYFSS 69

Query: 75  LFNLSFYLGLNRFVIARANGFSADTEFLPKDQPLLIPIDCKCNNNGGFFQADLTKTTIKG 134
           L NLSFYLGL+RFVIA  NGFSA+TEFLPKDQPLLIPIDCKCN  GGFFQA +TKTTIKG
Sbjct: 70  LSNLSFYLGLDRFVIAATNGFSANTEFLPKDQPLLIPIDCKCN--GGFFQALVTKTTIKG 127

Query: 135 ESFYSIAQSLEGLTTCGAIKERNPSVSPWDLDDKARLQVPLRCACPSSSENLPETRILVS 194
           ESFYSI++SLEGLTTC AI+E+NP +SP +L+ K +LQVPLRCACPSS+E +  TR+L+S
Sbjct: 128 ESFYSISKSLEGLTTCKAIREKNPGISPENLNGKVQLQVPLRCACPSSTEVILATRLLLS 187

Query: 195 YPVGEGDTVSGLAAKFNTTPAAIIAANNKSLEGFKPEDLLAFTSILIPLNGEPVLAPLAK 254
           YPV  GDT+S LA KFNTTP AI +ANN+SL  FKP  L+  TS+LIPL G+P L PLAK
Sbjct: 188 YPVSAGDTISNLAIKFNTTPEAITSANNRSLTTFKPTSLVPLTSLLIPLGGKPTLGPLAK 247

Query: 255 PHDPNLHVPETNYSIPDITPPKKKSKMLKVGAYIALSGAVVGGCIAIAAVVIVILLKKKK 314
           P++PNLH+P +  S+P I P KK+SKM ++G YIA++GAVVG  IAIAA  +VI LKKKK
Sbjct: 248 PNEPNLHIPAS--SLPVINPHKKRSKMWRIGVYIAVTGAVVGVSIAIAAAFLVIQLKKKK 305

Query: 315 QQSPMISHKDCRDVELQQLSASVRTTSDKKVSFEGSQSTIEGQIIDTAEQHKRLLESYSI 374
           Q   ++S +   D ELQQLS SVRTTSDKKVSF+ SQ+  + QI DT    K  +E+Y++
Sbjct: 306 Q---VLSKE--ADTELQQLSLSVRTTSDKKVSFDDSQNHFDSQITDTTPG-KVFVETYTV 359

Query: 375 EDLRRATEKFNSSNRIEGAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVR 434
           E+L+RATE FNSSN+IEG+VYHGRLNGKNLAIKR + E I+K+E+ L Q ATHHHPNI+R
Sbjct: 360 EELKRATEDFNSSNQIEGSVYHGRLNGKNLAIKRVQPETISKVELGLFQDATHHHPNIIR 419

Query: 435 LLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAM 494
           ++GTCL++GP SFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTW+QRL+ICLDVA+
Sbjct: 420 VVGTCLSEGPDSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWNQRLKICLDVAV 479

Query: 495 ALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASWS 554
           ALQYMHH+M+PSYVHRNIKSRNIFLDEEFNA++GNFGMA CV DDT+ P F STNPASWS
Sbjct: 480 ALQYMHHIMHPSYVHRNIKSRNIFLDEEFNAKIGNFGMAGCVEDDTKEPDFNSTNPASWS 539

Query: 555 MG--------------IDIFAYGIVLLEVLSGQTPINRPRKKDEGSVWLSEKIKSILQAE 600
           +G               DIF++G+VL+EVLSGQTPI RP    EGS+WLS+KIKSIL +E
Sbjct: 540 LGYLAPEAHQGVVSSSTDIFSFGVVLMEVLSGQTPITRPNDNGEGSIWLSKKIKSILLSE 599

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255536947|ref|XP_002509540.1| ATP binding protein, putative [Ricinus communis] gi|223549439|gb|EEF50927.1| ATP binding protein, putative [Ricinus communis]

 Score =  783 bits (2021), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 393/583 (67%), Positives = 468/583 (80%), Gaps = 27/583 (4%)

Query: 36  NLPNCDTNSSADVSGYRCS--GSQYQCGTFAILRTNSYYSSLFNLSFYLGLNRFVIARAN 93
           NL +C+T +S D SGYRC+  GSQ  C TFAIL TNSY+SSL NLSFYLG NRFVIA AN
Sbjct: 28  NLLSCET-TSPDASGYRCNINGSQDHCKTFAILSTNSYFSSLSNLSFYLGFNRFVIAEAN 86

Query: 94  GFSADTEFLPKDQPLLIPIDCKCNNNGGFFQADLTKTTIKGESFYSIAQSLEGLTTCGAI 153
           GFSADTEFLPKDQPLLIPIDCKCN  G FF+A++TKTTIKGE+FY IA+SLEGLTTC AI
Sbjct: 87  GFSADTEFLPKDQPLLIPIDCKCN--GNFFRAEVTKTTIKGENFYGIAESLEGLTTCKAI 144

Query: 154 KERNPSVSPWDLDDKARLQVPLRCACPSSSENLPETRILVSYPVGEGDTVSGLAAKFNTT 213
           +E N  VSPW+L DKARL VPLRCACPSSS+    TR L+SYPV EGDT+S +A KFNTT
Sbjct: 145 QENNLGVSPWNLADKARLLVPLRCACPSSSQVTLATRFLLSYPVSEGDTISNIAIKFNTT 204

Query: 214 PAAIIAANNKSLEGFKPEDLLAFTSILIPLNGEPVLAPLAKPHDPNLHVPETNYSIPDIT 273
           P AII+ANN+SL  FKPE+L+   S+LIPLN EP L  LAKP +PN   P    SIP I 
Sbjct: 205 PEAIISANNRSLANFKPENLVPLASLLIPLNREPALGSLAKPREPN--SPFRESSIPVIN 262

Query: 274 PPKKKSKMLKVGAYIALSGAVVGGCIAIAAVVIVILLKKKKQQSPMISHKDCRDVELQQL 333
           P KKKSKM  +G YIA++G VVG  IAI A  +++ LKKKK+Q+     KD  D ELQQL
Sbjct: 263 PHKKKSKMWMIGVYIAVTGVVVGATIAIVAAFLIVQLKKKKKQN---LSKD-GDPELQQL 318

Query: 334 SASVRTTSDKKVSFEGSQSTIEGQIIDTAEQHKRLL-ESYSIEDLRRATEKFNSSNRIEG 392
           S SVRTTS+KKVSFEGSQ  ++ QIIDT  +++++L E+Y++E+LR+ATE F+SS+ I+G
Sbjct: 319 SLSVRTTSEKKVSFEGSQQDLDNQIIDTTPRNRKVLVENYTVEELRKATEDFSSSSLIDG 378

Query: 393 AVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEY 452
           +VY+GRLNGKNLAIKRT+ E I+K++    Q+ATHHHPNI+RLLGTCL++G  SFLVFEY
Sbjct: 379 SVYYGRLNGKNLAIKRTKSETISKIDFSHFQNATHHHPNIIRLLGTCLSEGSDSFLVFEY 438

Query: 453 AKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNI 512
           AKNGSLKDWLHGGLAMKNQFIASCYCFLTW+QRL+ICLDVA+ALQYMHH+MNPSYVHRN+
Sbjct: 439 AKNGSLKDWLHGGLAMKNQFIASCYCFLTWNQRLKICLDVAVALQYMHHIMNPSYVHRNV 498

Query: 513 KSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASWSMG---------------I 557
           KSRNIFLDEEFNA++GNFGMARC+  DT++ + +STNP+SWS+G               I
Sbjct: 499 KSRNIFLDEEFNAKIGNFGMARCIEGDTQNTEIHSTNPSSWSLGYLAPEYIHQGIVSPCI 558

Query: 558 DIFAYGIVLLEVLSGQTPINRPRKKDEGSVWLSEKIKSILQAE 600
           DIFA+G+VLLEVLSG+ PI RP  K E S  LSEK+KSIL +E
Sbjct: 559 DIFAFGVVLLEVLSGKRPITRPDNKGEESNLLSEKMKSILSSE 601

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225452136|ref|XP_002263070.1| PREDICTED: uncharacterized protein LOC100264694 [Vitis vinifera]

 Score =  771 bits (1992), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 397/600 (66%), Positives = 463/600 (77%), Gaps = 34/600 (5%)

Query: 18  ALFLFICSLVSYSLGQNNNLPNCDTNSSADVSGYRCSG--SQYQCGTFAILRTNSYYSSL 75
           ALFLFI   VS +LGQ+  L +C+T SS D SGY C+G  SQ QCGTFA+LRTNSYYSSL
Sbjct: 12  ALFLFILVFVS-TLGQS--LLSCET-SSRDASGYYCNGNGSQKQCGTFALLRTNSYYSSL 67

Query: 76  FNLSFYLGLNRFVIARANGFSADTEFLPKDQPLLIPIDCKCNNNGGFFQADLTKTTIKGE 135
           FNLSFYLG++RF+IA ANGFSADTE LP + PLLIPI+CKC    GFFQA+LTKTTI+GE
Sbjct: 68  FNLSFYLGIDRFLIAEANGFSADTELLPYNLPLLIPIECKCK--AGFFQAELTKTTIEGE 125

Query: 136 SFYSIAQSLEGLTTCGAIKERNPSVSPWDLDDKARLQVPLRCACPSSSENLPETRILVSY 195
           SF+ IA+SLEGLTTC AI+ERNPS+ PW L DK RL +PLRCACPSSSE + ET++L+SY
Sbjct: 126 SFFGIAESLEGLTTCKAIRERNPSIQPWGLADKVRLLIPLRCACPSSSELIQETKLLLSY 185

Query: 196 PVGEGDTVSGLAAKFNTTPAAIIAANNKSLEGFKPEDLLAFTSILIPLNGEPVLAPLAKP 255
           PV EGDTV  LA KFNTT  AII+ANN+S    +   L   +S+LIPL  +P L   AKP
Sbjct: 186 PVSEGDTVPSLAFKFNTTSEAIISANNRSGATLRLGSLAPVSSLLIPLRDKPTLGSPAKP 245

Query: 256 HDPNLHVPETNYSIPDITPPKKKSKMLKVGAYIALSGAVVGGCIAIAAVVIVILLKKKKQ 315
            +PNL +P T  SIP I P KKK+KM K+G YIA+SG  VG  +AIAA V+VI  K+KKQ
Sbjct: 246 REPNLGLPAT--SIPVINPHKKKTKMWKIGVYIAVSGVAVGASVAIAAAVLVIHWKRKKQ 303

Query: 316 QSPMISHKDCRDVELQQLSASVRTTSDKKVSFEGSQSTIEGQIIDTAEQHKRLLESYSIE 375
            +  +      DVELQQL  SVRTTS+KKVSFEGSQ  I+ QIID+   HK ++E+Y++ 
Sbjct: 304 NAYKMG-----DVELQQLGLSVRTTSEKKVSFEGSQDPID-QIIDST-PHKIVVETYTML 356

Query: 376 DLRRATEKFNSSNRIEGAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRL 435
           +LR+ATE FNSSN IEG+V+HGRLNGKNLAIK T  E I+K+E  L   A HHHPNI+RL
Sbjct: 357 ELRKATEDFNSSNLIEGSVFHGRLNGKNLAIKHTHPEAISKIEFGLFHDAIHHHPNIMRL 416

Query: 436 LGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMA 495
           LGTCL +GP S+L+FEYAKNGSLKDWLHGGLAMK+QFIASCYCFLTW+QRLRICLDVAMA
Sbjct: 417 LGTCLNEGPDSYLIFEYAKNGSLKDWLHGGLAMKSQFIASCYCFLTWNQRLRICLDVAMA 476

Query: 496 LQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASWSM 555
           LQYMHH+M+P YVHRNIKSRNIFLDEEFNA++GNFGMARC  DD E  Q YST  ASWS 
Sbjct: 477 LQYMHHIMHPCYVHRNIKSRNIFLDEEFNAKIGNFGMARCFEDDAEDSQPYST--ASWSK 534

Query: 556 G---------------IDIFAYGIVLLEVLSGQTPINRPRKKDEGSVWLSEKIKSILQAE 600
           G               +DIFAYG+VLLEVLSG+TPI R   K  G VWL EKIKSIL +E
Sbjct: 535 GYLAPEYLHQGIISPTLDIFAYGVVLLEVLSGKTPITRADDKGGGRVWLPEKIKSILGSE 594

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|296090235|emb|CBI40054.3| unnamed protein product [Vitis vinifera]

 Score =  741 bits (1913), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 389/600 (64%), Positives = 451/600 (75%), Gaps = 56/600 (9%)

Query: 18  ALFLFICSLVSYSLGQNNNLPNCDTNSSADVSGYRCSG--SQYQCGTFAILRTNSYYSSL 75
           ALFLFI   VS +LGQ+  L +C+T SS D SGY C+G  SQ QCGTFA+LRTNSYYSSL
Sbjct: 12  ALFLFILVFVS-TLGQS--LLSCET-SSRDASGYYCNGNGSQKQCGTFALLRTNSYYSSL 67

Query: 76  FNLSFYLGLNRFVIARANGFSADTEFLPKDQPLLIPIDCKCNNNGGFFQADLTKTTIKGE 135
           FNLSFYLG++RF+IA ANGFSADTE LP + PLLIPI+CKC    GFFQA+LTKTTI+GE
Sbjct: 68  FNLSFYLGIDRFLIAEANGFSADTELLPYNLPLLIPIECKCK--AGFFQAELTKTTIEGE 125

Query: 136 SFYSIAQSLEGLTTCGAIKERNPSVSPWDLDDKARLQVPLRCACPSSSENLPETRILVSY 195
           SF+ IA+SLEGLTTC AI+ERNPS+ PW L DK RL +PLRCACPSSSE + ET++L+SY
Sbjct: 126 SFFGIAESLEGLTTCKAIRERNPSIQPWGLADKVRLLIPLRCACPSSSELIQETKLLLSY 185

Query: 196 PVGEGDTVSGLAAKFNTTPAAIIAANNKSLEGFKPEDLLAFTSILIPLNGEPVLAPLAKP 255
           PV EGDTV  LA KFNTT  AII+ANN+S    +   L                AP    
Sbjct: 186 PVSEGDTVPSLAFKFNTTSEAIISANNRSGATLRLGSL----------------AP---- 225

Query: 256 HDPNLHVPETNYSIPDITPPKKKSKMLKVGAYIALSGAVVGGCIAIAAVVIVILLKKKKQ 315
             PNL +P T  SIP I P KKK+KM K+G YIA+SG  VG  +AIAA V+VI  K+KKQ
Sbjct: 226 --PNLGLPAT--SIPVINPHKKKTKMWKIGVYIAVSGVAVGASVAIAAAVLVIHWKRKKQ 281

Query: 316 QSPMISHKDCRDVELQQLSASVRTTSDKKVSFEGSQSTIEGQIIDTAEQHKRLLESYSIE 375
            +  +      DVELQQL  SVRTTS+KKVSFEGSQ  I+ QIID+   HK ++E+Y++ 
Sbjct: 282 NAYKMG-----DVELQQLGLSVRTTSEKKVSFEGSQDPID-QIIDST-PHKIVVETYTML 334

Query: 376 DLRRATEKFNSSNRIEGAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRL 435
           +LR+ATE FNSSN IEG+V+HGRLNGKNLAIK T  E I+K+E  L   A HHHPNI+RL
Sbjct: 335 ELRKATEDFNSSNLIEGSVFHGRLNGKNLAIKHTHPEAISKIEFGLFHDAIHHHPNIMRL 394

Query: 436 LGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMA 495
           LGTCL +GP S+L+FEYAKNGSLKDWLHGGLAMK+QFIASCYCFLTW+QRLRICLDVAMA
Sbjct: 395 LGTCLNEGPDSYLIFEYAKNGSLKDWLHGGLAMKSQFIASCYCFLTWNQRLRICLDVAMA 454

Query: 496 LQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASWSM 555
           LQYMHH+M+P YVHRNIKSRNIFLDEEFNA++GNFGMARC  DD E  Q YST  ASWS 
Sbjct: 455 LQYMHHIMHPCYVHRNIKSRNIFLDEEFNAKIGNFGMARCFEDDAEDSQPYST--ASWSK 512

Query: 556 G---------------IDIFAYGIVLLEVLSGQTPINRPRKKDEGSVWLSEKIKSILQAE 600
           G               +DIFAYG+VLLEVLSG+TPI R   K  G VWL EKIKSIL +E
Sbjct: 513 GYLAPEYLHQGIISPTLDIFAYGVVLLEVLSGKTPITRADDKGGGRVWLPEKIKSILGSE 572

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356570127|ref|XP_003553242.1| PREDICTED: putative proline-rich receptor-like protein kinase PERK11-like [Glycine max] gi|148362066|gb|ABQ59611.1| LYK10 [Glycine max]

 Score =  738 bits (1905), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 385/616 (62%), Positives = 465/616 (75%), Gaps = 44/616 (7%)

Query: 10  LYCRAASAALFLFICSLVSYSLGQNNNLPNCDTNSSADVSGYRC--SGSQYQCGTFAILR 67
            + +A    L+LF+ SL         +L +C+T +S D SGY C  + SQ QC TFA+  
Sbjct: 5   FHMKALVFFLWLFVPSL-------GKDLLSCET-TSPDASGYHCIENVSQNQCETFALFL 56

Query: 68  TNSYYSSLFNLSFYLGLNRFVIARANGFSADTEFLPKDQPLLIPIDCKCNNNGGFFQADL 127
           TNSYYSSL NL+ YLGLN+FVIA+ANGFSADTEFL +DQPLL+PI CKC   GGF QA+L
Sbjct: 57  TNSYYSSLSNLTSYLGLNKFVIAQANGFSADTEFLSQDQPLLVPIHCKCI--GGFSQAEL 114

Query: 128 TKTTIKGESFYSIAQSLEGLTTCGAIKERNPSVSPWDLDDKARLQVPLRCACPSSSENLP 187
           TKTT+KGESFY IAQSLEGLTTC AI++ NP VSPW+LDDK RL VPLRC+CP SS+  P
Sbjct: 115 TKTTVKGESFYGIAQSLEGLTTCKAIRDNNPGVSPWNLDDKVRLVVPLRCSCPFSSQVRP 174

Query: 188 ETRILVSYPVGEGDTVSGLAAKFNTTPAAIIAANNKSLEGFKPEDLLA-FTSILIPLNGE 246
           + ++L+SYPV EGDT+S LA+KFN T  AI+ ANN S +G +    LA FTSILIPLNG+
Sbjct: 175 QPKLLLSYPVSEGDTISNLASKFNITKEAIVYANNISSQGLRTRSSLAPFTSILIPLNGK 234

Query: 247 PVLAPLAKPHDPNLHVPETNYSIPDITPPKKKSKMLKVGAYIALSGAVVGGCIAIAAVVI 306
           P++ PL KP +P+     T  SIP +T P KKS M K    I L+G  +G CIA AA   
Sbjct: 235 PIIGPLVKPKEPDSGNQTT--SIP-VTSPHKKSPMWKTELCIGLAGVALGVCIAFAAAFF 291

Query: 307 VILLKKKKQQSPMISHKDCR--DVELQQLSASVRTTS--DKKVSFEGSQSTIEGQIIDTA 362
            I LK KK++        C+  D+ELQ L+ SVRTTS  DKKVSFEGSQ  ++ +I+D A
Sbjct: 292 FIRLKHKKEE-----ENSCKEGDLELQYLNQSVRTTSTSDKKVSFEGSQDALDVKIVD-A 345

Query: 363 EQHKRLLESYSIEDLRRATEKFNSSNRIEGAVYHGRLNGKNLAIKRTEHEVITKLEMQLV 422
              K LL++Y+IED+R+ATE F+SSN IEG+VYHGRLNGKN+AIK T+ EV++K+++ L 
Sbjct: 346 LPRKLLLDTYTIEDVRKATEDFSSSNHIEGSVYHGRLNGKNMAIKGTKAEVVSKIDLGLF 405

Query: 423 QHATHHHPNIVRLLGTCLTDGPH---SFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCF 479
             A HHHPNI+RLLGT + +G     SFLVFEYAKNGSLKDWLHGGLA+KNQFIASCYCF
Sbjct: 406 HDALHHHPNILRLLGTSMLEGEQQEESFLVFEYAKNGSLKDWLHGGLAIKNQFIASCYCF 465

Query: 480 LTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD 539
           LTWSQRLRICLDVA ALQYMHHVMNPSYVHRN+KSRNIFLDEEF A++GNFGMA CV +D
Sbjct: 466 LTWSQRLRICLDVAGALQYMHHVMNPSYVHRNVKSRNIFLDEEFGAKIGNFGMAGCVEND 525

Query: 540 TESPQFYSTNPASWSMG---------------IDIFAYGIVLLEVLSGQTPINRPRKKDE 584
           TE PQFYSTNPASWS+G               +DIFAYG+VLLEVLSGQTPI+RP +K E
Sbjct: 526 TEDPQFYSTNPASWSLGYLAPEYVHQGVISPSVDIFAYGVVLLEVLSGQTPISRPNEKGE 585

Query: 585 GSVWLSEKIKSILQAE 600
           GS+WL++KI+SIL +E
Sbjct: 586 GSIWLTDKIRSILVSE 601

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|290490586|dbj|BAI79280.1| LysM type receptor kinase [Lotus japonicus]

 Score =  729 bits (1883), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 383/609 (62%), Positives = 462/609 (75%), Gaps = 49/609 (8%)

Query: 17  AALFLFICSLVSYSLGQNNNLPNCDTNSSADVSGY-----RCSGSQYQCGTFAILRTNSY 71
            AL  F+C LV  SLG+N  L  C+T S  D SGY     + S S   CGTFA+  TNS+
Sbjct: 10  GALVFFLCFLVP-SLGKN--LLTCETTSPYDASGYYHCNEKVSHSLSHCGTFALFLTNSH 66

Query: 72  YSSLFNLSFYLGLNRFVIARANGFSADTEFLPKDQPLLIPIDCKCNNNGGFFQADLTKTT 131
           Y SL NL+FYLGLNRFVIA ANGFSA+TEFLP++ PLLIPIDC+C   G FFQA+LTKTT
Sbjct: 67  YPSLSNLTFYLGLNRFVIAEANGFSAETEFLPQNHPLLIPIDCRCK--GEFFQAELTKTT 124

Query: 132 IKGESFYSIAQSLEGLTTCGAIKERNPSVSPWDLDDKARLQVPLRCACPSSSENLPETRI 191
           IKGESFYSIA+SLEGLTTC AI+E NP VSPW+LDD  RL +PLRCACP SSE     RI
Sbjct: 125 IKGESFYSIAESLEGLTTCKAIRENNPDVSPWNLDDNLRLIIPLRCACPFSSE----PRI 180

Query: 192 LVSYPVGEGDTVSGLAAKFNTTPAAIIAANNKSLEGFKPEDLLAFTSILIPLNGEPVLAP 251
           L+SY V EGDT+S LA+KFN T  AI++ANN SLEG  P+ L  FTSILIPLNG+P+  P
Sbjct: 181 LLSYIVREGDTISNLASKFNITKEAIVSANNISLEGLGPKKLAPFTSILIPLNGKPIFGP 240

Query: 252 LAKPHDPNLHVPETNYSIPDITPPKKKSKMLKVGAYIALSGAVVGGCIAIAAVVIVILLK 311
           LAKP +PN   P T        P  KKS M K   YIAL+G  +G  IA AA   VI LK
Sbjct: 241 LAKPMEPNSSFPTTR------IPTHKKSAMWKTELYIALAGVAIGVFIAFAAAFFVIRLK 294

Query: 312 KKKQQSPMISHKDCRDVELQQLSASVRTT--SDKKVSFEGSQSTIEGQIIDTAEQHKRLL 369
           +KK +    S K+ RD+ELQ L+ SVRTT  SDKK+SFEGSQ T++G+++DT   +K LL
Sbjct: 295 QKKVKEN--SSKE-RDMELQYLNQSVRTTTTSDKKISFEGSQDTLDGKMVDT---NKMLL 348

Query: 370 ESYSIEDLRRATEKFNSSNRIEGAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHAT-HH 428
           E+Y++ED+R+ATE F+SSN+IEG+V+HGRL GK++AIKRT+ E+++K+++ L  +++ HH
Sbjct: 349 ETYTVEDMRKATEDFSSSNQIEGSVFHGRLKGKDIAIKRTKTEMVSKIDLSLFHYSSLHH 408

Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HPNI+ +LGTCL +GP S+LV EYAKNGSLKDWLHGGLA+KNQFIASCYCFL WSQRLRI
Sbjct: 409 HPNILGVLGTCLLEGPESYLVLEYAKNGSLKDWLHGGLAIKNQFIASCYCFLNWSQRLRI 468

Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV-ND-DTESPQFY 546
           CLD+A AL+YMHHVMNPSYVHRN+KSRNIF+DEEF A++GNFG   CV ND DTE P FY
Sbjct: 469 CLDIANALKYMHHVMNPSYVHRNVKSRNIFIDEEFGAKIGNFG---CVENDYDTEDPHFY 525

Query: 547 STNPASWSMG---------------IDIFAYGIVLLEVLSGQTPINRPRKKDEGSVWLSE 591
           STNPASWS+G               IDIFAYG+VLLEVL+GQTPI+R   K EGSVWL+E
Sbjct: 526 STNPASWSLGYLAPEYVHQGVISPSIDIFAYGVVLLEVLTGQTPISRTNDKGEGSVWLTE 585

Query: 592 KIKSILQAE 600
           K++S L +E
Sbjct: 586 KVRSTLVSE 594

Source: Lotus japonicus

Species: Lotus japonicus

Genus: Lotus

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449442042|ref|XP_004138791.1| PREDICTED: protein STRUBBELIG-RECEPTOR FAMILY 8-like [Cucumis sativus] gi|449490385|ref|XP_004158590.1| PREDICTED: protein STRUBBELIG-RECEPTOR FAMILY 8-like [Cucumis sativus]

 Score =  724 bits (1869), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 362/613 (59%), Positives = 461/613 (75%), Gaps = 32/613 (5%)

Query: 5   LITHQLYCRAASAALFLFICSLVSYSLGQNNNLPNCDTNSSADVSGYRCSGSQ--YQCGT 62
           ++ + L+ R     L LFI  LVS + G+++   +CD+  S +  G+ C+G +   QCGT
Sbjct: 3   IVINVLFLRT----LVLFIW-LVSSAFGESS--LSCDSMLS-NAFGFHCNGKETLMQCGT 54

Query: 63  FAILRTNSYYSSLFNLSFYLGLNRFVIARANGFSADTEFLPKDQPLLIPIDCKCNNNGGF 122
           FA+L  NS +SSLFNLS+YLG+N+F IA  NGFSADT+FLPK+QPLLIPI+CKCN  G F
Sbjct: 55  FAVLFANSEFSSLFNLSYYLGINQFAIAEINGFSADTKFLPKNQPLLIPIECKCN--GSF 112

Query: 123 FQADLTKTTIKGESFYSIAQSLEGLTTCGAIKERNPSVSPWDLDDKARLQVPLRCACPSS 182
           F A+LTKT+IKGESFYSIA+SLEGLTTC AIKE+NP VSPW L D  RL +P+RC CPSS
Sbjct: 113 FLAELTKTSIKGESFYSIAESLEGLTTCKAIKEKNPGVSPWGLRDSIRLLIPMRCGCPSS 172

Query: 183 SENLPETRILVSYPVGEGDTVSGLAAKFNTTPAAIIAANNKSLEGFKPEDLLAFTSILIP 242
               P+ R+L+SYPV +GDT+  LA  FNTTP +II AN++SL  FKP+ L+ F+++LIP
Sbjct: 173 YAGGPKPRLLISYPVRQGDTIFNLATNFNTTPESIITANSRSLSTFKPQSLVPFSTLLIP 232

Query: 243 LNGEPVLAPLAKPHDPNLHVPETNYSIPDITPPKKKSKMLKVGAYIALSGAVVGGCIAIA 302
           +NG+P+L   AKP  PNLH+P T  SIP I P K K+KML +G YIA+   ++G CIA  
Sbjct: 233 VNGKPILGSFAKPKQPNLHLPST--SIPTINPHKNKAKMLHLGVYIAVGVTILGVCIAAI 290

Query: 303 AVVIVILLKKKKQQSPMISHKDCRDVELQQLSASVRTTSDKKVSFEGSQSTIEGQIIDTA 362
              +VI LKK KQ+    S+++  D+ELQQLS S+RT SDKK SFEGSQ T +  ++++ 
Sbjct: 291 TYFLVIKLKKDKQKKTQKSYEERGDMELQQLSLSIRTASDKKFSFEGSQDTFDSHLLES- 349

Query: 363 EQHKRLLESYSIEDLRRATEKFNSSNRIEGAVYHGRLNGKNLAIKRTEHEVITKLEMQLV 422
              K L+  Y++E++R+ATE FN +N+IEG++Y GRLNGKN+AIKRTE+E I+K+E  L+
Sbjct: 350 NASKMLISMYTVEEIRKATENFNPTNQIEGSMYQGRLNGKNMAIKRTENETISKIEFNLL 409

Query: 423 QHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTW 482
                 HP+I+RLLG CLT+ P SFLVFEYAKNGSLKDWLHGGLAMKNQFI SCYCFLTW
Sbjct: 410 HEI--KHPSILRLLGICLTEDPDSFLVFEYAKNGSLKDWLHGGLAMKNQFIISCYCFLTW 467

Query: 483 SQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTES 542
           SQRL ICLDVA  LQ+MHHVM P YVHRNIKSRNIFLDE+FNAR+GNFG+A+CV +D E 
Sbjct: 468 SQRLHICLDVAAGLQHMHHVMKPVYVHRNIKSRNIFLDEDFNARIGNFGLAKCVQNDIED 527

Query: 543 PQFYSTNPASWSMG---------------IDIFAYGIVLLEVLSGQTPINRPRKKDEGSV 587
           P+  S+NPASWS+G               IDIFAYG++LLEVLSG+TPI +P    EGSV
Sbjct: 528 PKLCSSNPASWSLGYLAPEYIHQGIISPTIDIFAYGVILLEVLSGKTPITKPNADGEGSV 587

Query: 588 WLSEKIKSILQAE 600
            L+EKIK+I++++
Sbjct: 588 RLTEKIKTIMESD 600

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15232204|ref|NP_186833.1| protein kinase domain-containing protein [Arabidopsis thaliana] gi|75337203|sp|Q9SGI7.1|LYK2_ARATH RecName: Full=Protein LYK2; AltName: Full=LysM domain receptor-like kinase 2; AltName: Full=LysM-containing receptor-like kinase 2; Flags: Precursor gi|6091745|gb|AAF03457.1|AC010797_33 putative protein kinase [Arabidopsis thaliana] gi|332640202|gb|AEE73723.1| protein kinase domain-containing protein [Arabidopsis thaliana]

 Score =  428 bits (1100), Expect = e-117,   Method: Compositional matrix adjust.
 Identities = 244/539 (45%), Positives = 337/539 (62%), Gaps = 65/539 (12%)

Query: 50  GYRCSGSQYQCGTFAILRTNSYYSSLFNLSFYLGLNRFVIARANGFSADTEFLPKDQPLL 109
           GY C  +  +C TFAILR    + SL +LS +LGL+           AD E++PK Q LL
Sbjct: 47  GYVCHSNLQKCHTFAILRAKPPFYSLSDLSRHLGLD-----------ADDEYVPKGQLLL 95

Query: 110 IPIDCKCNNNGGFFQADLTKTTIKGESFYSIAQSLEGLTTCGAIKERNPSVSPWDLDDKA 169
           IPI+C+CN  G  ++A L K  +KG++F S++QSL+GLTTC +I+E+NP +S   L D  
Sbjct: 96  IPIECRCN--GSIYEASLIKNCVKGDTFRSVSQSLQGLTTCLSIREKNPHISEDKLGDNI 153

Query: 170 RLQVPLRCACPSSSENLPETRILVSYPVGEGDTVSGLAAKFNTTPAAIIAANNKSLEGFK 229
           +L++ +RC+CP   E +     LV+YPVG  D+VS LA +FNTT  AI++ANNKS     
Sbjct: 154 KLRLAIRCSCPQ--EGVSNASFLVTYPVGVRDSVSSLAVRFNTTEDAIVSANNKSG---- 207

Query: 230 PEDLLAFTSILIPLNGEPVLAPLAKPHDPNLHVPETNYSIPDITPPKKKSKMLKVGAYIA 289
                     ++PL  +P L PL        H PE   S       KK+SKM      IA
Sbjct: 208 ----------VVPL--KPALIPLD-------HKPEKQGSRKRNPSKKKRSKM---KLMIA 245

Query: 290 LSGAVVGGCIAIAAVVIVILLKKKKQQSPMISHK--DCRDVELQQLSASVRTTSDKKVSF 347
           +S A+ G C  +  +V   L  KK+ Q    + K    +D E +QLS S+RTTSDKK+SF
Sbjct: 246 VSSAIAGVCGLVTLMVFGYLHWKKETQIQTQTQKWISNKDPETRQLSLSIRTTSDKKISF 305

Query: 348 EGSQSTIEGQIID------TAEQHKRLLESYSIEDLRRATEKFNSSNRIEGAVYHGRLNG 401
           EGSQ   +G I+D      T    K +LE Y+ E+L +ATE F+SSN I+G+VY G L G
Sbjct: 306 EGSQ---DGSILDSHNTVGTTTPRKPVLEIYAFEELEKATENFSSSNHIKGSVYFGSLKG 362

Query: 402 KNLAIKRTEHEVITKLEMQLVQHATHHHP-NIVRLLGTCLTD-GPHSFLVFEYAKNGSLK 459
           K+LAIK+   + + + +  L+   +H++  N++R+LGTC  +    S+LVFEYA+NGSL 
Sbjct: 363 KDLAIKQVNADEMKRFDFGLLNDQSHYYNHNVIRVLGTCFREIDQDSYLVFEYARNGSLW 422

Query: 460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFL 519
           DW+   LA+KNQFI SCYCFL W QR++IC DVA+AL+YMH +   +YVH NIKSRNIFL
Sbjct: 423 DWIQNKLAIKNQFIESCYCFLAWKQRIKICHDVAIALKYMHRI---NYVHGNIKSRNIFL 479

Query: 520 DEEFNARVGNFGMARCVNDDTESPQFY---STNPASWSMGIDIFAYGIVLLEVLSGQTP 575
           +E+   +VGNFGM++CV ++  + +     S +PAS     DIFAYGI+++EVLSGQTP
Sbjct: 480 NEDLRGKVGNFGMSKCVTNELATEENLIESSLSPAS-----DIFAYGIIVMEVLSGQTP 533

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297828564|ref|XP_002882164.1| kinase family protein [Arabidopsis lyrata subsp. lyrata] gi|297328004|gb|EFH58423.1| kinase family protein [Arabidopsis lyrata subsp. lyrata]

 Score =  422 bits (1084), Expect = e-115,   Method: Compositional matrix adjust.
 Identities = 239/551 (43%), Positives = 345/551 (62%), Gaps = 63/551 (11%)

Query: 38  PNCDTNSSADVSGYRCSGSQYQCGTFAILRTNSYYSSLFNLSFYLGLNRFVIARANGFSA 97
           P  +    A   GY C  +  +C TFAILR  S ++S+ NLS++LGL+           A
Sbjct: 36  PVQEEEEEASSFGYVCHSNLQKCHTFAILRAKSPFNSISNLSYHLGLDT---------EA 86

Query: 98  DTEFLPKDQPLLIPIDCKCNNNGGFFQADLTKTTIKGESFYSIAQSLEGLTTCGAIKERN 157
           D EF+ + Q LLIP++C+CN  G  ++A+L KT +KG++F S++QSL+GLT+C +I+E+N
Sbjct: 87  D-EFVLQGQLLLIPVECRCN--GSIYEANLIKTCVKGDTFRSVSQSLQGLTSCLSIREKN 143

Query: 158 PSVSPWDLDDKARLQVPLRCACPSSSENLPETRILVSYPVGEGDTVSGLAAKFNTTPAAI 217
           P +S   + D  +L++ +RC+CP   E +  T  LV+YPVG  D+V+ LA +FNTT  AI
Sbjct: 144 PDISEDKIGDNVKLRLAIRCSCPQ--EGVSNTSFLVTYPVGVRDSVTSLAVRFNTTEDAI 201

Query: 218 IAANNKSLEGFKPEDLLAFTSILIPLNGEPVLAPLAKPHDPNLHVPETNYSIPDITPPKK 277
           ++ANNKS               ++PL  +P L PL        H PE   +     P K+
Sbjct: 202 VSANNKSG--------------VVPL--KPALIPLD-------HKPEKPENRQKRKPSKE 238

Query: 278 KSKMLKVGAYIALSGAVVGGCIAIAAVVIVILLKKKKQQSPMISHK--DCRDVELQQLSA 335
           K   +K+   IA+S A+ G    +  +V   L  KK+ Q    + K    +D E +QLS 
Sbjct: 239 KRSKMKL--MIAVSSAIAGVFGLVTLMVFGYLHWKKETQMQTQTQKWISNKDPETRQLSL 296

Query: 336 SVRTTSDKKVSFEGSQSTIEGQIID------TAEQHKRLLESYSIEDLRRATEKFNSSNR 389
           S+RTTSDKK+SFEGSQ   +G I+D      T    K +LE Y+ E+L +ATE F+SSN 
Sbjct: 297 SIRTTSDKKISFEGSQ---DGSILDSHNTVGTTTPRKPVLEMYAFEELEKATENFSSSNH 353

Query: 390 IEGAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATHHHP-NIVRLLGTCLTD-GPHSF 447
           I+G+VY G L GK+LAIK+   + + + +  L+   +H++  N++R+LGTC  +    S+
Sbjct: 354 IKGSVYFGSLKGKDLAIKQVSADAVKRFDFGLLNDQSHYYNHNLIRVLGTCFPEIDQDSY 413

Query: 448 LVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSY 507
           LVFEYA+NGSL DW+   LA+KNQFI SCYCFL W QR++IC DVA+AL+YMH +   +Y
Sbjct: 414 LVFEYARNGSLWDWIQNKLAIKNQFIESCYCFLAWKQRIKICHDVAIALKYMHRI---NY 470

Query: 508 VHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFY---STNPASWSMGIDIFAYGI 564
           VH NIKSRNIFL+E+   +VGNFGM++C+ ++  + +     S +PAS     D+FAYGI
Sbjct: 471 VHGNIKSRNIFLNEDLRGKVGNFGMSKCLTNELATEENLIEGSLSPAS-----DVFAYGI 525

Query: 565 VLLEVLSGQTP 575
           +++EVLSGQTP
Sbjct: 526 IVMEVLSGQTP 536

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449448550|ref|XP_004142029.1| PREDICTED: probable receptor protein kinase TMK1-like [Cucumis sativus]

 Score =  247 bits (630), Expect = 1e-62,   Method: Compositional matrix adjust.
 Identities = 181/597 (30%), Positives = 314/597 (52%), Gaps = 58/597 (9%)

Query: 16  SAALFLFICSLVSYSLGQNNNLPNCD-TNSSADVSGYRCSGSQYQCGTFAILRTNSYYSS 74
           +A+LF F   +VS      +   +C  T+ S    GY C+     C +F   R+ S ++S
Sbjct: 10  TASLFCFFSFIVSQQPYAGSTTADCAVTHRSTGNLGYFCNTPNRNCHSFLTFRSRSPFNS 69

Query: 75  LFNLSFYLGLNRFVIARANGFSADTEFLPKDQPLLIPIDCKCNNNGGFFQADLTKTTIKG 134
           + +++  LG +   ++R N  +A   F P D+ +L+P  C C+  G FFQ++++ TT  G
Sbjct: 70  VSSIATLLGSDPSELSRVNSVNASATF-PPDKLVLVPTTCSCS--GQFFQSNVSFTTRTG 126

Query: 135 ESFYSIA-QSLEGLTTCGAIKERNPSVSPWDLDDKARLQVPLRCACPSSSENLPETRILV 193
           +S++ IA ++L+GL+TC ++  +NP+VS   +    R+ VPLRCACP+ ++       L+
Sbjct: 127 DSYFVIANETLQGLSTCQSLISQNPNVSVTSIKGGERILVPLRCACPTKNQTDMGFNYLL 186

Query: 194 SYPVGEGDTVSGLAAKFNTTPAAI-IAANNKSLEGFKPEDLLAFTSILIPLNGEPVLAPL 252
           SY V  GDTV  +A  F +  A + I  +   L+G     +  FT++LIPL  EP    +
Sbjct: 187 SYLVVFGDTVFDIAQIFESFGADMGIILDANELQG--SSFVNPFTTLLIPLKTEPSSTGM 244

Query: 253 AKPHDPNLHVPETNYSIPDITPPKKKSKMLKVGAYIALSGAVVGGCIA-IAAVVIVILLK 311
               + N   P         +P  K++ +     YI ++        A I AVV    ++
Sbjct: 245 K---ERNSSPPPPPSLPTSPSPASKRTWV-----YILVAVVGGVVLAAVIGAVVFFACVR 296

Query: 312 KKKQQSPMISHKDCRDVELQQLSASVRTTSDKKVSFEGSQSTIEGQIIDTAEQHKRLLES 371
           K+K+++      +   +E+     S   TS+KK+  +G  S+I    I +  Q    +++
Sbjct: 297 KRKKKT------EHTPIEIDSFE-STEKTSEKKL--DGDSSSITLDSISSVVQS---VKA 344

Query: 372 YSIEDLRRATEKFNSSNRIEGAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATHHHPN 431
           Y+ ++L+ AT+ F+S++ I+G+VYHG +NG + AIK+   +V  ++ +        +H N
Sbjct: 345 YTFKELQDATDNFSSTHLIKGSVYHGTINGDSAAIKKMNGDVSKQINLL----NKTNHTN 400

Query: 432 IVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLD 491
           ++RL G C  +G H +LVFEYA  G L DW+    +  ++F       LTW+QR++I +D
Sbjct: 401 LIRLSGVCFEEG-HWYLVFEYAAKGVLSDWIDSNGSNNDRF-------LTWTQRIQIAVD 452

Query: 492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPA 551
           VA  L Y+H   NP +VH+++K  NI LD++F  ++ NF +AR      E  +F  T   
Sbjct: 453 VATGLNYLHSFTNPPHVHKDLKMDNILLDDDFRGKISNFSLARSAG--WEEGEFTLTMHI 510

Query: 552 SWSMG---------------IDIFAYGIVLLEVLSGQTPINRPRKKDEGSVWLSEKI 593
             + G               +D++++GI+++E+L+G+      RK++     L EK+
Sbjct: 511 VGTRGYMAPEYLENGLVSTKLDVYSFGILIIEMLTGKEVSELHRKENLQLTDLLEKV 567

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	600
TAIR|locus:2082359	654	LYK2 "LysM-containing receptor	0.541	0.496	0.445	4.1e-102
TAIR|locus:2050987	664	LYK5 "LysM-containing receptor	0.361	0.326	0.375	1.5e-63
TAIR|locus:2049029	612	LYK4 "LysM-containing receptor	0.371	0.364	0.341	7.9e-53
TAIR|locus:2093591	467	GPK1 "glyoxysomal protein kina	0.356	0.458	0.338	6.9e-32
TAIR|locus:2012325	466	AT1G09440 [Arabidopsis thalian	0.416	0.536	0.320	5.5e-31
TAIR|locus:2027559	492	AT1G56720 [Arabidopsis thalian	0.348	0.424	0.343	1.1e-30
TAIR|locus:2089860	617	CERK1 "chitin elicitor recepto	0.316	0.307	0.353	4.1e-30
TAIR|locus:2077730	512	AT3G59110 [Arabidopsis thalian	0.343	0.402	0.338	5.7e-29
TAIR|locus:2045620	494	AT2G42960 [Arabidopsis thalian	0.343	0.417	0.338	2.1e-28
TAIR|locus:2146203	484	AT5G18500 [Arabidopsis thalian	0.356	0.442	0.334	5.1e-28

TAIR|locus:2082359 LYK2 "LysM-containing receptor-like kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 687 (246.9 bits), Expect = 4.1e-102, Sum P(2) = 4.1e-102
 Identities = 154/346 (44%), Positives = 214/346 (61%)

Query:   240 LIPLNGEPVLAPLAKPHDPNLHVPETNYSIPDITPPKKKSKMLKVGAYIALSXXXXXXXX 299
             ++  N +  + PL     P  H PE   S     P KKK   +K+   IA+S        
Sbjct:   199 IVSANNKSGVVPLKPALIPLDHKPEKQGSRKR-NPSKKKRSKMKL--MIAVSSAIAGVCG 255

Query:   300 XXXXXXXXXLLKKKKQQSPMISHK--DCRDVELQQLSASVRTTSDKKVSFEGSQSTIEGQ 357
                      L  KK+ Q    + K    +D E +QLS S+RTTSDKK+SFEGSQ   +G 
Sbjct:   256 LVTLMVFGYLHWKKETQIQTQTQKWISNKDPETRQLSLSIRTTSDKKISFEGSQ---DGS 312

Query:   358 IID------TAEQHKRLLESYSIEDLRRATEKFNSSNRIEGAVYHGRLNGKNLAIKRTEH 411
             I+D      T    K +LE Y+ E+L +ATE F+SSN I+G+VY G L GK+LAIK+   
Sbjct:   313 ILDSHNTVGTTTPRKPVLEIYAFEELEKATENFSSSNHIKGSVYFGSLKGKDLAIKQVNA 372

Query:   412 EVITKLEMQLVQHATHHHP-NIVRLLGTCLTD-GPHSFLVFEYAKNGSLKDWLHGGLAMK 469
             + + + +  L+   +H++  N++R+LGTC  +    S+LVFEYA+NGSL DW+   LA+K
Sbjct:   373 DEMKRFDFGLLNDQSHYYNHNVIRVLGTCFREIDQDSYLVFEYARNGSLWDWIQNKLAIK 432

Query:   470 NQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGN 529
             NQFI SCYCFL W QR++IC DVA+AL+YMH +   +YVH NIKSRNIFL+E+   +VGN
Sbjct:   433 NQFIESCYCFLAWKQRIKICHDVAIALKYMHRI---NYVHGNIKSRNIFLNEDLRGKVGN 489

Query:   530 FGMARCVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTP 575
             FGM++CV ++  + +  +   +S S   DIFAYGI+++EVLSGQTP
Sbjct:   490 FGMSKCVTNELATEE--NLIESSLSPASDIFAYGIIVMEVLSGQTP 533

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2050987 LYK5 "LysM-containing receptor-like kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 386 (140.9 bits), Expect = 1.5e-63, Sum P(2) = 1.5e-63
 Identities = 93/248 (37%), Positives = 142/248 (57%)

Query:   369 LESYSIEDLRRATEKFNSSNRIEGAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATHH 428
             L  Y   DL+ AT  F+  NRI+G+VY   +NG + A+K  + +V +  E+ L++    +
Sbjct:   357 LTLYRFNDLQSATSNFSDENRIKGSVYRATINGDDAAVKVIKGDVSSS-EINLLKKL--N 413

Query:   429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
             H NI+RL G C+ +G  S+LVFEY++NGS+ DWLH     K+         LTW QR+ I
Sbjct:   414 HSNIIRLSGFCIREGT-SYLVFEYSENGSISDWLHSS-GKKS---------LTWKQRVEI 462

Query:   489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--------- 539
               DVA AL Y+H+ + P ++H+N++S NI LD  F A++ NFG+AR +++          
Sbjct:   463 ARDVAEALDYLHNYITPPHIHKNLESTNILLDSNFRAKIANFGVARILDEGDLDLQLTRH 522

Query:   540 TESPQFYSTNPASWSMGI-----DIFAYGIVLLEVLSGQTPINRPRKKD-EGSV-WLSEK 592
              E  Q Y   P     G+     D+FA+G+ +LE+LSG+  +   +KK+ E  V  L + 
Sbjct:   523 VEGTQGYLA-PEYVENGVITSKLDVFAFGVAVLELLSGREAVTIHKKKEGEEEVEMLCKV 581

Query:   593 IKSILQAE 600
             I S+L  E
Sbjct:   582 INSVLGGE 589

GO:0005576 "extracellular region" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=IDA

GO:0010200 "response to chitin" evidence=RCA

GO:0008061 "chitin binding" evidence=IDA

GO:0071323 "cellular response to chitin" evidence=IEP

TAIR|locus:2049029 LYK4 "LysM-containing receptor-like kinase 4" [Arabidopsis thaliana (taxid:3702)]

 Score = 336 (123.3 bits), Expect = 7.9e-53, Sum P(2) = 7.9e-53
 Identities = 87/255 (34%), Positives = 137/255 (53%)

Query:   346 SFEGSQSTIEGQIIDTAEQHKRLL-ES---YSIEDLRRATEKFNSSNRIEGAVYHGRLNG 401
             SF G +  +  Q  D  +    ++ ES   Y   +L+ AT  F SS+ I G+ Y G++NG
Sbjct:   314 SFMGKKPPMSDQEFDPLDGLSGMVVESLKVYKFHELQSATSDFTSSSSIGGSGYIGKING 373

Query:   402 KNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW 461
                 IK+ E       E+ L+     +H NI+RL G C  +G   +LV+E+A NGSL +W
Sbjct:   374 DGAMIKKIEGNASE--EVNLLSKL--NHLNIIRLSGFCFHEGDW-YLVYEHASNGSLSEW 428

Query:   462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE 521
             +H     K+         L+ +Q+L+I LD+A  L Y+H+  +P YVHR++ S N+FLD 
Sbjct:   429 IH---TTKS--------LLSLTQKLQIALDIATGLNYLHNFADPPYVHRDLNSNNVFLDL 477

Query:   522 EFNARVGNFGMARCVNDD------TESPQFYSTNPASWSMGI-----DIFAYGIVLLEVL 570
             EF A++G+ G AR   +D       E  + Y   P     G+     D++A+G+VLLE++
Sbjct:   478 EFRAKIGSLGSARSTTEDFVLTKHVEGTRGYLA-PEYLEHGLVSTKLDVYAFGVVLLEIV 536

Query:   571 SGQTPINRPRKKDEG 585
             +G+      ++ DEG
Sbjct:   537 TGKEASELKKEIDEG 551

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=IDA

GO:0008061 "chitin binding" evidence=IDA

GO:0045087 "innate immune response" evidence=IMP

GO:0071219 "cellular response to molecule of bacterial origin" evidence=IEP

GO:0071323 "cellular response to chitin" evidence=IEP

TAIR|locus:2093591 GPK1 "glyoxysomal protein kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 353 (129.3 bits), Expect = 6.9e-32, P = 6.9e-32
 Identities = 84/248 (33%), Positives = 141/248 (56%)

Query:   372 YSIEDLRRATEKFNSSNRIE----GAVYHGRLNGKN-LAIKRT-----EHEVITKLEMQL 421
             +++ DL+ AT  F+  + I     G VYHG L  K  +A+K+      + +   ++E++ 
Sbjct:   142 FTLRDLQLATNHFSKESIIGDGGYGVVYHGTLTNKTPVAVKKLLNNPGQADKDFRVEVEA 201

Query:   422 VQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLT 481
             + H    H N+VRLLG C+ +G H  LV+EY  NG+L+ WLHG +  K          LT
Sbjct:   202 IGHV--RHKNLVRLLGYCV-EGTHRMLVYEYMNNGNLEQWLHGDMIHKGH--------LT 250

Query:   482 WSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE 541
             W  R+++ +  A AL Y+H  + P  VHR+IKS NI +D+ F+A++ +FG+A+ +  D+ 
Sbjct:   251 WEARIKVLVGTAKALAYLHEAIEPKVVHRDIKSSNILMDDNFDAKLSDFGLAKLLGADSN 310

Query:   542 --SPQFYST----NPASWSMGI-----DIFAYGIVLLEVLSGQTPINRPRKKDEGSVWLS 590
               S +   T     P   + G+     D+++YG+VLLE ++G+ P++  R K+E  V + 
Sbjct:   311 YVSTRVMGTFGYVAPEYANSGLLNEKSDVYSYGVVLLEAITGRYPVDYARPKEE--VHMV 368

Query:   591 EKIKSILQ 598
             E +K ++Q
Sbjct:   369 EWLKLMVQ 376

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009506 "plasmodesma" evidence=IDA

GO:0009735 "response to cytokinin stimulus" evidence=RCA

GO:0043161 "proteasomal ubiquitin-dependent protein catabolic process" evidence=RCA

GO:0043248 "proteasome assembly" evidence=RCA

GO:0048767 "root hair elongation" evidence=RCA

GO:0051788 "response to misfolded protein" evidence=RCA

TAIR|locus:2012325 AT1G09440 [Arabidopsis thaliana (taxid:3702)]

 Score = 345 (126.5 bits), Expect = 5.5e-31, P = 5.5e-31
 Identities = 91/284 (32%), Positives = 149/284 (52%)

Query:   333 LSASVRTTSDKKVSFEGSQSTIEGQIIDTAEQHKRLLESYSIEDLRRATEKFNSSNRIE- 391
             L  + R+TS        S S + G      E H      +++ DL  AT +F+  N I  
Sbjct:   110 LCVANRSTSSLYEMATPSPSPLSG----LPESHLGWGHWFTLRDLEIATNRFSKENVIGE 165

Query:   392 ---GAVYHGRL-NGKNLAIKRT-EHEVITKLEMQLVQHATHH--HPNIVRLLGTCLTDGP 444
                G VY G L NG  +A+K+   H    + E ++   A  H  H N+VRLLG C+ +G 
Sbjct:   166 GGYGVVYRGELVNGSLVAVKKILNHLGQAEKEFRVEVDAIGHVRHKNLVRLLGYCI-EGT 224

Query:   445 HSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMN 504
             +  LV+EY  NG+L++WLHG  AMK+      + +LTW  R+++    + AL Y+H  + 
Sbjct:   225 NRILVYEYMNNGNLEEWLHG--AMKH------HGYLTWEARMKVLTGTSKALAYLHEAIE 276

Query:   505 PSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQ------FYSTNPASWSMGI- 557
             P  VHR+IKS NI +D+ FNA++ +FG+A+ + D            F    P   + G+ 
Sbjct:   277 PKVVHRDIKSSNILIDDRFNAKISDFGLAKLLGDGKSHVTTRVMGTFGYVAPEYANTGLL 336

Query:   558 ----DIFAYGIVLLEVLSGQTPINRPRKKDEGSV--WLSEKIKS 595
                 D++++G+++LE ++G+ P++  R  +E ++  WL   + S
Sbjct:   337 NEKSDVYSFGVLVLEAITGRDPVDYARPANEVNLVEWLKMMVGS 380

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009832 "plant-type cell wall biogenesis" evidence=RCA

GO:0010413 "glucuronoxylan metabolic process" evidence=RCA

GO:0045492 "xylan biosynthetic process" evidence=RCA

TAIR|locus:2027559 AT1G56720 [Arabidopsis thaliana (taxid:3702)]

 Score = 344 (126.2 bits), Expect = 1.1e-30, Sum P(2) = 1.1e-30
 Identities = 82/239 (34%), Positives = 135/239 (56%)

Query:   372 YSIEDLRRATEKFNSSNRIE----GAVYHGRL-NGKNLAIKRTEHEV-ITKLEMQLVQHA 425
             +++ DL  AT +F+  N I     G VY G L NG  +A+K+  +++   + E ++   A
Sbjct:   167 FTLRDLETATNRFSKENVIGEGGYGVVYRGELMNGTPVAVKKILNQLGQAEKEFRVEVDA 226

Query:   426 THH--HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWS 483
               H  H N+VRLLG C+ +G H  LV+EY  NG+L+ WLHG  AM+       + +LTW 
Sbjct:   227 IGHVRHKNLVRLLGYCI-EGTHRILVYEYVNNGNLEQWLHG--AMRQ------HGYLTWE 277

Query:   484 QRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESP 543
              R+++ +  + AL Y+H  + P  VHR+IKS NI +++EFNA+V +FG+A+ +       
Sbjct:   278 ARMKVLIGTSKALAYLHEAIEPKVVHRDIKSSNILINDEFNAKVSDFGLAKLLGAGKSHV 337

Query:   544 Q------FYSTNPASWSMGI-----DIFAYGIVLLEVLSGQTPINRPRKKDEGSV--WL 589
                    F    P   + G+     D++++G+VLLE ++G+ P++  R   E ++  WL
Sbjct:   338 TTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRDPVDYGRPAHEVNLVDWL 396

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2089860 CERK1 "chitin elicitor receptor kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 302 (111.4 bits), Expect = 4.1e-30, Sum P(2) = 4.1e-30
 Identities = 76/215 (35%), Positives = 120/215 (55%)

Query:   372 YSIEDLRRATEKFNSSNRIE----GAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATH 427
             +S+E+L +AT+ FN S +I     GAVY+  L G+  AIK+ + E   +   +L      
Sbjct:   310 FSLEELAKATDNFNLSFKIGQGGFGAVYYAELRGEKAAIKKMDMEASKQFLAELKVLTRV 369

Query:   428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLR 487
             HH N+VRL+G C+ +G   FLV+EY +NG+L   LHG               L W++R++
Sbjct:   370 HHVNLVRLIGYCV-EGS-LFLVYEYVENGNLGQHLHGSGREP----------LPWTKRVQ 417

Query:   488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQ--- 544
             I LD A  L+Y+H    P YVHR+IKS NI +D++F A+V +FG+ +       + +   
Sbjct:   418 IALDSARGLEYIHEHTVPVYVHRDIKSANILIDQKFRAKVADFGLTKLTEVGGSATRGAM 477

Query:   545 --FYSTNPASW----SMGIDIFAYGIVLLEVLSGQ 573
               F    P +     S  +D++A+G+VL E++S +
Sbjct:   478 GTFGYMAPETVYGEVSAKVDVYAFGVVLYELISAK 512

GO:0005576 "extracellular region" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=IDA

GO:0019199 "transmembrane receptor protein kinase activity" evidence=IMP;IDA

GO:0032491 "detection of molecule of fungal origin" evidence=IEP;IMP

GO:0035556 "intracellular signal transduction" evidence=RCA;IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009817 "defense response to fungus, incompatible interaction" evidence=IMP

GO:0010200 "response to chitin" evidence=RCA;IMP

GO:0005515 "protein binding" evidence=IPI

GO:0002752 "cell surface pattern recognition receptor signaling pathway" evidence=IDA

GO:0042742 "defense response to bacterium" evidence=IDA

GO:0008061 "chitin binding" evidence=IDA

GO:2001080 "chitosan binding" evidence=IDA

GO:0032499 "detection of peptidoglycan" evidence=IMP

GO:0045087 "innate immune response" evidence=IMP

GO:0002679 "respiratory burst involved in defense response" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031347 "regulation of defense response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0042803 "protein homodimerization activity" evidence=IDA

GO:0071219 "cellular response to molecule of bacterial origin" evidence=IEP

GO:0071323 "cellular response to chitin" evidence=IEP

TAIR|locus:2077730 AT3G59110 [Arabidopsis thaliana (taxid:3702)]

 Score = 342 (125.4 bits), Expect = 5.7e-29, P = 5.7e-29
 Identities = 82/242 (33%), Positives = 140/242 (57%)

Query:   372 YSIEDLRRATEKFNSSNRIE----GAVYHGRL-NGKNLAIKRT-----EHEVITKLEMQL 421
             +++ DL+ AT +F + N I     G VY GRL NG ++A+K+      + E   ++E++ 
Sbjct:   178 FTLRDLQLATNRFAAENVIGEGGYGVVYKGRLINGNDVAVKKLLNNLGQAEKEFRVEVEA 237

Query:   422 VQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLT 481
             + H    H N+VRLLG C+ +G +  LV+EY  +G+L+ WLHG +  ++         LT
Sbjct:   238 IGHV--RHKNLVRLLGYCI-EGVNRMLVYEYVNSGNLEQWLHGAMGKQST--------LT 286

Query:   482 WSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE 541
             W  R++I +  A AL Y+H  + P  VHR+IK+ NI +D++FNA++ +FG+A+ + D  E
Sbjct:   287 WEARMKILVGTAQALAYLHEAIEPKVVHRDIKASNILIDDDFNAKLSDFGLAKLL-DSGE 345

Query:   542 SP-------QFYSTNPASWSMGI-----DIFAYGIVLLEVLSGQTPINRPRKKDEGSV-- 587
             S         F    P   + G+     DI+++G++LLE ++G+ P++  R  +E ++  
Sbjct:   346 SHITTRVMGTFGYVAPEYANTGLLNEKSDIYSFGVLLLETITGRDPVDYERPANEVNLVE 405

Query:   588 WL 589
             WL
Sbjct:   406 WL 407

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005886 "plasma membrane" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0009506 "plasmodesma" evidence=IDA

TAIR|locus:2045620 AT2G42960 [Arabidopsis thaliana (taxid:3702)]

 Score = 336 (123.3 bits), Expect = 2.1e-28, P = 2.1e-28
 Identities = 82/242 (33%), Positives = 134/242 (55%)

Query:   372 YSIEDLRRATEKFNSSNRIE----GAVYHGRL-NGKNLAIKRT-----EHEVITKLEMQL 421
             +++ DL  AT +F   N +     G VY G+L NG  +A+K+      + E   ++E++ 
Sbjct:   171 FTLRDLELATNRFAPVNVLGEGGYGVVYRGKLVNGTEVAVKKLLNNLGQAEKEFRVEVEA 230

Query:   422 VQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLT 481
             + H    H N+VRLLG C+ +G H  LV+EY  +G+L+ WLHG +             LT
Sbjct:   231 IGHV--RHKNLVRLLGYCI-EGVHRMLVYEYVNSGNLEQWLHGAMRQHGN--------LT 279

Query:   482 WSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE 541
             W  R++I    A AL Y+H  + P  VHR+IK+ NI +D+EFNA++ +FG+A+ + D  E
Sbjct:   280 WEARMKIITGTAQALAYLHEAIEPKVVHRDIKASNILIDDEFNAKLSDFGLAKLL-DSGE 338

Query:   542 SP-------QFYSTNPASWSMGI-----DIFAYGIVLLEVLSGQTPINRPRKKDEGSV-- 587
             S         F    P   + G+     DI+++G++LLE ++G+ P++  R  +E ++  
Sbjct:   339 SHITTRVMGTFGYVAPEYANTGLLNEKSDIYSFGVLLLEAITGRDPVDYGRPANEVNLVE 398

Query:   588 WL 589
             WL
Sbjct:   399 WL 400

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009507 "chloroplast" evidence=ISM

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2146203 AT5G18500 [Arabidopsis thaliana (taxid:3702)]

 Score = 332 (121.9 bits), Expect = 5.1e-28, P = 5.1e-28
 Identities = 83/248 (33%), Positives = 140/248 (56%)

Query:   372 YSIEDLRRATEKFNSSNRIE----GAVYHGRL-NGKNLAIKRT-----EHEVITKLEMQL 421
             +++ DL+ AT +F+  N I     G VY G L NG  +A+K+      + +   ++E++ 
Sbjct:   154 FTLRDLQMATNQFSRDNIIGDGGYGVVYRGNLVNGTPVAVKKLLNNLGQADKDFRVEVEA 213

Query:   422 VQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLT 481
             + H    H N+VRLLG C+ +G    LV+EY  NG+L+ WL G     NQ     + +LT
Sbjct:   214 IGHV--RHKNLVRLLGYCM-EGTQRMLVYEYVNNGNLEQWLRGD----NQN----HEYLT 262

Query:   482 WSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE 541
             W  R++I +  A AL Y+H  + P  VHR+IKS NI +D++FN+++ +FG+A+ +  D  
Sbjct:   263 WEARVKILIGTAKALAYLHEAIEPKVVHRDIKSSNILIDDKFNSKISDFGLAKLLGADKS 322

Query:   542 --SPQFYST----NPASWSMGI-----DIFAYGIVLLEVLSGQTPINRPRKKDEGSVWLS 590
               + +   T     P   + G+     D++++G+VLLE ++G+ P++  R   E  V L 
Sbjct:   323 FITTRVMGTFGYVAPEYANSGLLNEKSDVYSFGVVLLEAITGRYPVDYARPPPE--VHLV 380

Query:   591 EKIKSILQ 598
             E +K ++Q
Sbjct:   381 EWLKMMVQ 388

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0030003 "cellular cation homeostasis" evidence=RCA

GO:0070838 "divalent metal ion transport" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

No EC number assignment, probably not an enzyme!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: grail3.0017002501 hypothetical protein (680 aa) (Populus trichocarpa)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	600
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	3e-34
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-34
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	9e-32
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	1e-29
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	3e-27
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	4e-25
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	7e-25
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	6e-20
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-19
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-18
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	2e-16
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	7e-16
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	7e-16
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	9e-16
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	1e-15
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-15
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-15
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	5e-15
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	8e-15
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-14
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	2e-14
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-14
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-14
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	3e-14
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	4e-14
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	5e-14
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	6e-14
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	7e-14
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	1e-13
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	1e-13
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	2e-13
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	2e-13
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-13
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-13
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-13
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-13
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	3e-13
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-13
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	6e-13
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	7e-13
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	8e-13
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-12
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	1e-12
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	1e-12
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	2e-12
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	2e-12
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-12
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	3e-12
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	3e-12
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	5e-12
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	7e-12
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	7e-12
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	8e-12
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-11
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-11
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	2e-11
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	2e-11
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	3e-11
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	3e-11
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	4e-11
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	4e-11
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-11
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	5e-11
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	6e-11
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	7e-11
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	8e-11
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	3e-10
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	3e-10
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	3e-10
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	4e-10
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	4e-10
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	4e-10
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	5e-10
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	5e-10
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	6e-10
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	7e-10
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	8e-10
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	8e-10
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	8e-10
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	9e-10
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	1e-09
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	2e-09
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	3e-09
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-09
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	3e-09
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	3e-09
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	4e-09
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	4e-09
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	6e-09
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	7e-09
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	8e-09
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-08
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-08
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-08
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	2e-08
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	4e-08
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	4e-08
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	4e-08
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	4e-08
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	5e-08
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	5e-08
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	5e-08
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	5e-08
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	7e-08
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	9e-08
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	9e-08
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-07
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	1e-07
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	1e-07
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	1e-07
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	1e-07
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-07
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-07
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	2e-07
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-07
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-07
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	3e-07
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-07
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	3e-07
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	3e-07
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	3e-07
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	4e-07
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	4e-07
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-07
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	4e-07
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	5e-07
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	5e-07
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	6e-07
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	6e-07
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	8e-07
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	8e-07
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	8e-07
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	9e-07
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-06
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	1e-06
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	2e-06
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	2e-06
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-06
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-06
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-06
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-06
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	2e-06
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-06
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-06
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	3e-06
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-06
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	3e-06
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	4e-06
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-06
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	4e-06
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	6e-06
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	7e-06
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	7e-06
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	9e-06
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	9e-06
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-05
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	1e-05
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-05
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	1e-05
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	1e-05
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-05
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	2e-05
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	2e-05
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	2e-05
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-05
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	3e-05
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-05
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	4e-05
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	5e-05
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	6e-05
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	6e-05
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	6e-05
pfam01476	43	pfam01476, LysM, LysM domain	7e-05
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	7e-05
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	8e-05
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	8e-05
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	1e-04
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-04
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	2e-04
cd00118	45	cd00118, LysM, Lysine Motif is a small domain invo	2e-04
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-04
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-04
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	2e-04
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-04
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	3e-04
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	3e-04
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-04
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	5e-04
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	6e-04
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	7e-04
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	8e-04
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	0.001
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	0.001
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	0.001
smart00257	44	smart00257, LysM, Lysin motif	0.001
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	0.001
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	0.001
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	0.001
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	0.001
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	0.001
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	0.002
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	0.002
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	0.002
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	0.002
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	0.002
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	0.002
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	0.002
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	0.002
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	0.003
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	0.003
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	0.003
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	0.003
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	0.003
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	0.004
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	0.004

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  130 bits (329), Expect = 3e-34
 Identities = 53/211 (25%), Positives = 96/211 (45%), Gaps = 47/211 (22%)

Query: 392 GAVYHGRLNGKNL------AIKRTEHEVITKLEMQLVQHATH----HHPNIVRLLGTCLT 441
           G VY G+L GK        A+K  + +   +   + ++ A       HPN+V+LLG C  
Sbjct: 13  GEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNVVKLLGVCTE 72

Query: 442 DGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHH 501
           + P  ++V EY + G L  +L      KN+        L+ S  L   L +A  ++Y+  
Sbjct: 73  EEPL-YIVMEYMEGGDLLSYLR-----KNR------PKLSLSDLLSFALQIARGMEYLES 120

Query: 502 VMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDT----------------ESPQF 545
             N  ++HR++ +RN  + E    ++ +FG++R + DD                 ES + 
Sbjct: 121 -KN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKE 177

Query: 546 YSTNPASWSMGIDIFAYGIVLLEVLS-GQTP 575
                 S     D++++G++L E+ + G+ P
Sbjct: 178 GKFTSKS-----DVWSFGVLLWEIFTLGEQP 203

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  130 bits (329), Expect = 3e-34
 Identities = 52/211 (24%), Positives = 93/211 (44%), Gaps = 46/211 (21%)

Query: 392 GAVYHGRLNGKNL------AIKRTEHEVITKLEMQLVQHATH----HHPNIVRLLGTCLT 441
           G VY G L GK        A+K  + +   +   + ++ A       HPNIV+LLG C  
Sbjct: 13  GEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVKLLGVCTE 72

Query: 442 DGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHH 501
           + P   +V EY   G L D+L      + + +       + S  L   L +A  ++Y+  
Sbjct: 73  EEPL-MIVMEYMPGGDLLDYLR---KNRPKEL-------SLSDLLSFALQIARGMEYLES 121

Query: 502 VMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDT----------------ESPQF 545
             N  ++HR++ +RN  + E    ++ +FG++R + DD                 ES + 
Sbjct: 122 -KN--FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAPESLKE 178

Query: 546 YSTNPASWSMGIDIFAYGIVLLEVLS-GQTP 575
                 S     D++++G++L E+ + G+ P
Sbjct: 179 GKFTSKS-----DVWSFGVLLWEIFTLGEEP 204

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  123 bits (311), Expect = 9e-32
 Identities = 59/217 (27%), Positives = 98/217 (45%), Gaps = 46/217 (21%)

Query: 391 EGA---VYHGRLNGKNL-----AIKR----TEHEVITKL--EMQLVQHATHHHPNIVRLL 436
           EGA   VY G+L GK+      A+K        E       E ++++     HPN+VRLL
Sbjct: 5   EGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL--GHPNVVRLL 62

Query: 437 GTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMAL 496
           G C  + P  +LV EY + G L D+L     +      S    L+    L   + +A  +
Sbjct: 63  GVCTEEEPL-YLVLEYMEGGDLLDYLRKSRPVFPSPEKST---LSLKDLLSFAIQIAKGM 118

Query: 497 QYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN-----PA 551
           +Y+       +VHR++ +RN  + E+   ++ +FG++R    D     +Y        P 
Sbjct: 119 EYLASK---KFVHRDLAARNCLVGEDLVVKISDFGLSR----DVYDDDYYRKKTGGKLPI 171

Query: 552 SWSM-------GI-----DIFAYGIVLLEVLS-GQTP 575
            W M       GI     D++++G++L E+ + G TP
Sbjct: 172 RW-MAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATP 207

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  117 bits (295), Expect = 1e-29
 Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 52/214 (24%)

Query: 392 GAVYHGRLNGKNL------AIKR----TEHEVITKL--EMQLVQHATHHHPNIVRLLGTC 439
           G VY G L G         A+K        E   +   E  +++     HPNIVRLLG C
Sbjct: 13  GEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKL--SHPNIVRLLGVC 70

Query: 440 LTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYM 499
               P  ++V EY   G L D+L        +        LT    L++ L +A  ++Y+
Sbjct: 71  TQGEPL-YIVTEYMPGGDLLDFLR---KHGEK--------LTLKDLLQMALQIAKGMEYL 118

Query: 500 HHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDT-----------------ES 542
               N  +VHR++ +RN  + E    ++ +FG++R + +D                  ES
Sbjct: 119 ES-KN--FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPES 175

Query: 543 PQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTP 575
            +       S     D++++G++L E+ + G+ P
Sbjct: 176 LKDGKFTSKS-----DVWSFGVLLWEIFTLGEQP 204

Length = 258

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  109 bits (274), Expect = 3e-27
 Identities = 54/195 (27%), Positives = 87/195 (44%), Gaps = 33/195 (16%)

Query: 392 GAVYHGR--LNGKNLAIKRTEHEVITKLEMQL---VQHATH-HHPNIVRLLGTCLTDGPH 445
           G VY  R    GK +AIK  + E  + L  +L   ++     +HPNIV+L G    +   
Sbjct: 7   GTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHL 66

Query: 446 SFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNP 505
            +LV EY + GSLKD            +      L+  + LRI L +   L+Y+H     
Sbjct: 67  -YLVMEYCEGGSLKD-----------LLKENEGKLSEDEILRILLQILEGLEYLHSN--- 111

Query: 506 SYVHRNIKSRNIFLDE-EFNARVGNFGMARCVNDDTESPQFYSTNPA-----------SW 553
             +HR++K  NI LD      ++ +FG+++ +  D    +     PA            +
Sbjct: 112 GIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYY 171

Query: 554 SMGIDIFAYGIVLLE 568
           S   DI++ G++L E
Sbjct: 172 SEKSDIWSLGVILYE 186

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  104 bits (262), Expect = 4e-25
 Identities = 52/209 (24%), Positives = 87/209 (41%), Gaps = 48/209 (22%)

Query: 392 GAVYHGRL--NGKNLAIKRTEHEVITKLEMQLVQ-----HATHHHPNIVRLLGTCLTDGP 444
           G VY  +    GK +A+K  +       + Q  +          HPNIVRL+     D  
Sbjct: 13  GTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAF-EDKD 71

Query: 445 HSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMN 504
           H +LV EY + G L D+L            S    L+  +  +I L +   L+Y+H    
Sbjct: 72  HLYLVMEYCEGGDLFDYL------------SRGGPLSEDEAKKIALQILRGLEYLHSN-- 117

Query: 505 PSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESP------------------QFY 546
              +HR++K  NI LDE    ++ +FG+A+ +   + S                     Y
Sbjct: 118 -GIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGY 176

Query: 547 STNPASWSMGIDIFAYGIVLLEVLSGQTP 575
                     +D+++ G++L E+L+G+ P
Sbjct: 177 GP-------KVDVWSLGVILYELLTGKPP 198

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  103 bits (260), Expect = 7e-25
 Identities = 54/201 (26%), Positives = 93/201 (46%), Gaps = 35/201 (17%)

Query: 392 GAVYHGR--LNGKNLAIKRTEHEVITKLEMQLVQ----HATHHHPNIVRLLGTCLTDGPH 445
           G VY  R    GK +AIK  + + I K   ++++         HPNIVRL      +   
Sbjct: 13  GKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDED-K 71

Query: 446 SFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNP 505
            +LV EY + G L D L                 L+  +       +  AL+Y+H     
Sbjct: 72  LYLVMEYCEGGDLFDLLKK------------RGRLSEDEARFYLRQILSALEYLHS-KG- 117

Query: 506 SYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------SPQFYSTNP-----ASWS 554
             VHR++K  NI LDE+ + ++ +FG+AR ++   +      +P++ +  P       + 
Sbjct: 118 -IVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMA--PEVLLGKGYG 174

Query: 555 MGIDIFAYGIVLLEVLSGQTP 575
             +DI++ G++L E+L+G+ P
Sbjct: 175 KAVDIWSLGVILYELLTGKPP 195

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 89.4 bits (222), Expect = 6e-20
 Identities = 60/208 (28%), Positives = 99/208 (47%), Gaps = 42/208 (20%)

Query: 392 GAVYHGRLNGK-NLAIKR------TEHEVI--TKLEMQLVQHATHHHPNIVRLLGTCLTD 442
           G V+ G+  GK ++AIK       +E + I   K+ M+L       HPN+V+L G C   
Sbjct: 18  GVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKL------SHPNLVQLYGVCTKQ 71

Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
            P  F+V EY  NG L ++L      K +              L +C DV  A++Y+   
Sbjct: 72  RP-IFIVTEYMANGCLLNYLR---ERKGKLGTE--------WLLDMCSDVCEAMEYLE-- 117

Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW--------- 553
            +  ++HR++ +RN  + E+   +V +FG+AR V DD  +    +  P  W         
Sbjct: 118 -SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYS 176

Query: 554 --SMGIDIFAYGIVLLEVLS-GQTPINR 578
             S   D++++G+++ EV S G+ P  R
Sbjct: 177 RFSSKSDVWSFGVLMWEVFSEGKMPYER 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 88.2 bits (219), Expect = 2e-19
 Identities = 60/212 (28%), Positives = 98/212 (46%), Gaps = 54/212 (25%)

Query: 392 GAVYHGRLNGKNLAIKRT------------EHEVITKLEMQLVQHATHHHPNIVRLLGTC 439
           G V  G   G+ +A+K              E  V+T L           HPN+V+LLG  
Sbjct: 20  GDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLR----------HPNLVQLLGVV 69

Query: 440 LTDGPHSFLVFEYAKNGSLKDWLHG-GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQY 498
           L   P  ++V EY   GSL D+L   G A+           +T +Q+L   LDV   ++Y
Sbjct: 70  LQGNP-LYIVTEYMAKGSLVDYLRSRGRAV-----------ITLAQQLGFALDVCEGMEY 117

Query: 499 MHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW----- 553
           +      ++VHR++ +RN+ + E+  A+V +FG+A+  +   +S +     P  W     
Sbjct: 118 LE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKL----PVKWTAPEA 170

Query: 554 ------SMGIDIFAYGIVLLEVLS-GQTPINR 578
                 S   D++++GI+L E+ S G+ P  R
Sbjct: 171 LREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 202

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 84.9 bits (210), Expect = 2e-18
 Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 42/208 (20%)

Query: 392 GAVYHGRLNGK-NLAIKR------TEHEVI--TKLEMQLVQHATHHHPNIVRLLGTCLTD 442
           G V +G+  G+ ++AIK       +E E I   K+ M+L       H  +V+L G C   
Sbjct: 18  GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKL------SHEKLVQLYGVCTKQ 71

Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
            P  ++V EY  NG L ++L                    SQ L +C DV   + Y+   
Sbjct: 72  RP-IYIVTEYMSNGCLLNYLREHGKR-----------FQPSQLLEMCKDVCEGMAYLE-- 117

Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW--------- 553
            +  ++HR++ +RN  +D++   +V +FG++R V DD  +    S  P  W         
Sbjct: 118 -SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYS 176

Query: 554 --SMGIDIFAYGIVLLEVLS-GQTPINR 578
             S   D++A+G+++ EV S G+ P  R
Sbjct: 177 KFSSKSDVWAFGVLMWEVYSLGKMPYER 204

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score = 79.5 bits (197), Expect = 2e-16
 Identities = 40/162 (24%), Positives = 72/162 (44%), Gaps = 30/162 (18%)

Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLR 487
           +HPNI++   +    G    +V EYA  G L         +K Q            Q L 
Sbjct: 57  NHPNIIKYYESFEEKG-KLCIVMEYADGGDLSQ------KIKKQ--KKEGKPFPEEQILD 107

Query: 488 ICLDVAMALQYMH--HVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---- 541
             + + +AL+Y+H   ++     HR+IK +NIFL      ++G+FG+++ ++   +    
Sbjct: 108 WFVQLCLALKYLHSRKIL-----HRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKT 162

Query: 542 --------SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTP 575
                   SP+     P ++    DI++ G VL E+ + + P
Sbjct: 163 VVGTPYYLSPELCQNKPYNYK--SDIWSLGCVLYELCTLKHP 202

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 77.8 bits (192), Expect = 7e-16
 Identities = 49/206 (23%), Positives = 89/206 (43%), Gaps = 42/206 (20%)

Query: 392 GAVYHGRLN------GKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLT 441
           G V   R +      G+ +A+K   H       +  E ++    T  H NIV+  G C  
Sbjct: 18  GKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEK 77

Query: 442 DGPHSF-LVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH 500
            G  S  L+ EY  +GSL+D+L      ++Q        +   + L     +   + Y+ 
Sbjct: 78  PGGRSLRLIMEYLPSGSLRDYLQR---HRDQ--------INLKRLLLFSSQICKGMDYLG 126

Query: 501 HVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARC---------VNDDTESPQF-YSTNP 550
              +  Y+HR++ +RNI ++ E   ++ +FG+A+          V +  ESP F Y+  P
Sbjct: 127 ---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYA--P 181

Query: 551 ASWSMGI-----DIFAYGIVLLEVLS 571
                       D++++G+ L E+ +
Sbjct: 182 ECLRTSKFSSASDVWSFGVTLYELFT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score = 77.2 bits (191), Expect = 7e-16
 Identities = 52/207 (25%), Positives = 88/207 (42%), Gaps = 47/207 (22%)

Query: 392 GAVY--HGRLNGKNLAIKRTEHEVITKLEMQLVQHATHH---HPNIVRLLGTCLTDGPHS 446
           G VY    +  GK +AIK  + E   K E  + +        HPNIV+  G+ L      
Sbjct: 14  GEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKD-EL 72

Query: 447 FLVFEYAKNGSLKDWLHG-GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH--HVM 503
           ++V E+   GSLKD L      +    IA  Y          +C ++   L+Y+H   ++
Sbjct: 73  WIVMEFCSGGSLKDLLKSTNQTLTESQIA--Y----------VCKELLKGLEYLHSNGII 120

Query: 504 NPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------SPQFYS---------T 548
                HR+IK+ NI L  +   ++ +FG++  ++D         +P + +          
Sbjct: 121 -----HRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYD 175

Query: 549 NPASWSMGIDIFAYGIVLLEVLSGQTP 575
             A      DI++ GI  +E+  G+ P
Sbjct: 176 YKA------DIWSLGITAIELAEGKPP 196

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 77.3 bits (190), Expect = 9e-16
 Identities = 58/193 (30%), Positives = 102/193 (52%), Gaps = 24/193 (12%)

Query: 392 GAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVF 450
           GAV  G   G+ +A+K  + +V  +  ++     T  HH N+VRLLG  L +G +  +V 
Sbjct: 20  GAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNGLY--IVM 77

Query: 451 EYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHR 510
           E    G+L ++L      + + + S        Q L+  LDVA   + M ++ +   VHR
Sbjct: 78  ELMSKGNLVNFLR----TRGRALVSV------IQLLQFSLDVA---EGMEYLESKKLVHR 124

Query: 511 NIKSRNIFLDEEFNARVGNFGMARCVN---DDTESPQFYSTNPA----SWSMGIDIFAYG 563
           ++ +RNI + E+  A+V +FG+AR  +   D+++ P  ++   A     +S   D+++YG
Sbjct: 125 DLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYG 184

Query: 564 IVLLEVLS-GQTP 575
           ++L EV S G+ P
Sbjct: 185 VLLWEVFSYGRAP 197

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 76.9 bits (189), Expect = 1e-15
 Identities = 58/205 (28%), Positives = 96/205 (46%), Gaps = 42/205 (20%)

Query: 392 GAVYHGR-LNGKNLAIKR------TEHEVITKLE--MQLVQHATHHHPNIVRLLGTCLTD 442
           G V+ G  L  + +AIK       +E + I + +  M+L       HP +V+L G C   
Sbjct: 18  GLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKL------SHPKLVQLYGVCTER 71

Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
            P   LVFE+ ++G L D+L    A + +F             L +CLDV   + Y+   
Sbjct: 72  SP-ICLVFEFMEHGCLSDYLR---AQRGKFSQETL--------LGMCLDVCEGMAYLE-- 117

Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW--------- 553
            + + +HR++ +RN  + E    +V +FGM R V DD  +    +  P  W         
Sbjct: 118 -SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFS 176

Query: 554 --SMGIDIFAYGIVLLEVLS-GQTP 575
             S   D++++G+++ EV S G+TP
Sbjct: 177 KYSSKSDVWSFGVLMWEVFSEGKTP 201

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score = 77.3 bits (191), Expect = 1e-15
 Identities = 60/238 (25%), Positives = 104/238 (43%), Gaps = 47/238 (19%)

Query: 362 AEQHKRLLESYSIEDLRRATEKFNSSNRI-EGA---VYHG--RLNGKNLAIK----RTEH 411
            E+ K  L+    E   R  E + +  +I EGA   VY    R  GK +AIK    R ++
Sbjct: 1   EEELKAALKDIVSEGDPR--ELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQN 58

Query: 412 EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQ 471
           + +   E+ +++     HPNIV    + L      ++V EY   GSL D           
Sbjct: 59  KELIINEILIMK--DCKHPNIVDYYDSYLVGD-ELWVVMEYMDGGSLTD----------- 104

Query: 472 FIASCYCFLTWSQRLRICLDVAMALQYMH--HVMNPSYVHRNIKSRNIFLDEEFNARVGN 529
            I   +  +   Q   +C +V   L+Y+H  +V+     HR+IKS NI L ++ + ++ +
Sbjct: 105 IITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVI-----HRDIKSDNILLSKDGSVKLAD 159

Query: 530 FGMARCVNDDTE------------SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTP 575
           FG A  +  +              +P+        +   +DI++ GI+ +E+  G+ P
Sbjct: 160 FGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKD--YGPKVDIWSLGIMCIEMAEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 76.7 bits (189), Expect = 2e-15
 Identities = 61/216 (28%), Positives = 95/216 (43%), Gaps = 49/216 (22%)

Query: 392 GAVYHGRLNGKN-------LAIK--RTEHEVITKLEMQ--LVQHATHHHPNIVRLLGTCL 440
           G VY G L G N       +AIK  +   E   + E +      +   HPNIV LLG C 
Sbjct: 19  GKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCT 78

Query: 441 TDGPHSFLVFEYAKNGSLKDWL-------HGGLAMKNQFIASCYCFLTWSQRLRICLDVA 493
            + P   L FEY  +G L ++L         G    ++ + S    L  S  L I + +A
Sbjct: 79  KEQPTCML-FEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSS---LDCSDFLHIAIQIA 134

Query: 494 MALQYM--HHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFY----- 546
             ++Y+  HH     +VHR++ +RN  + E    ++ +FG++R    D  S  +Y     
Sbjct: 135 AGMEYLSSHH-----FVHRDLAARNCLVGEGLTVKISDFGLSR----DIYSADYYRVQSK 185

Query: 547 STNPASW-----------SMGIDIFAYGIVLLEVLS 571
           S  P  W           +   DI+++G+VL E+ S
Sbjct: 186 SLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score = 74.9 bits (185), Expect = 5e-15
 Identities = 50/207 (24%), Positives = 84/207 (40%), Gaps = 41/207 (19%)

Query: 392 GAVYHG--RLNGKNLAIKRTE-----HEVITKL--EMQLVQHATHHHPNIVRLLGTCLTD 442
           G+VY    +  G+ +A+K  E      E +  L  E++++    H  PNIVR  G+   +
Sbjct: 14  GSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQH--PNIVRYYGSERDE 71

Query: 443 GPHSFLVF-EYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHH 501
             ++  +F EY   GSL   L     +    I   Y              +   L Y+H 
Sbjct: 72  EKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRK-YTR-----------QILEGLAYLH- 118

Query: 502 VMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN--PASW------ 553
             +   VHR+IK  NI +D +   ++ +FG A+ + D        S    P  W      
Sbjct: 119 --SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPY-WMAPEVI 175

Query: 554 -----SMGIDIFAYGIVLLEVLSGQTP 575
                    DI++ G  ++E+ +G+ P
Sbjct: 176 RGEEYGRAADIWSLGCTVIEMATGKPP 202

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 74.4 bits (183), Expect = 8e-15
 Identities = 58/207 (28%), Positives = 96/207 (46%), Gaps = 43/207 (20%)

Query: 392 GAVYHGRLNGK-NLAIKRTEHEVITKLEMQLVQHAT----HHHPNIVRLLGTCLTDGPHS 446
           G VY G L G   +A+K     +   L+ + +Q A     + HPNIV+L+G C+   P  
Sbjct: 9   GDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQP-I 67

Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           ++V E    GSL  +L      KN+        LT  + L++ LD A  ++Y+    + +
Sbjct: 68  YIVMELVPGGSLLTFLRKK---KNR--------LTVKKLLQMSLDAAAGMEYLE---SKN 113

Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN------PASW------- 553
            +HR++ +RN  + E    ++ +FGM+R      E    Y+ +      P  W       
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSR-----EEEGGIYTVSDGLKQIPIKWTAPEALN 168

Query: 554 ----SMGIDIFAYGIVLLEVLS-GQTP 575
               +   D+++YGI+L E  S G TP
Sbjct: 169 YGRYTSESDVWSYGILLWETFSLGDTP 195

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 74.5 bits (184), Expect = 1e-14
 Identities = 59/210 (28%), Positives = 93/210 (44%), Gaps = 46/210 (21%)

Query: 392 GAVYHGR--LNGKNLAIK--RTEHE----VITKL-EMQLVQHATHHHPNIVRLLGTCLTD 442
           G VY  R    G+ +A+K  R E+E     IT + E++L+Q     HPNIVRL     + 
Sbjct: 13  GQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKL--RHPNIVRLKEIVTSK 70

Query: 443 GPHS-FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHH 501
           G  S ++VFEY  +  L      GL    +         T SQ       +   LQY+H 
Sbjct: 71  GKGSIYMVFEYMDH-DLT-----GLLDSPEVK------FTESQIKCYMKQLLEGLQYLH- 117

Query: 502 VMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN---------P-- 550
             +   +HR+IK  NI ++ +   ++ +FG+AR       +   Y TN         P  
Sbjct: 118 --SNGILHRDIKGSNILINNDGVLKLADFGLARPYTK--RNSADY-TNRVITLWYRPPEL 172

Query: 551 ----ASWSMGIDIFAYGIVLLEVLSGQTPI 576
                 +   +D+++ G +L E+  G+ PI
Sbjct: 173 LLGATRYGPEVDMWSVGCILAELFLGK-PI 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 73.7 bits (181), Expect = 2e-14
 Identities = 58/213 (27%), Positives = 98/213 (46%), Gaps = 48/213 (22%)

Query: 392 GAVYHGRL---NGKNL--AIKR----TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTD 442
           G VYHG L   +G+ +  A+K     T+ E + +   + +      HPN++ LLG CL  
Sbjct: 9   GCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPS 68

Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
                +V  Y K+G L+            FI S     T    +   L VA  ++Y+   
Sbjct: 69  EGSPLVVLPYMKHGDLR-----------NFIRSETHNPTVKDLIGFGLQVAKGMEYL--- 114

Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN-------PASWSM 555
            +  +VHR++ +RN  LDE F  +V +FG+AR + D     ++YS +       P  W M
Sbjct: 115 ASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDK----EYYSVHNHTGAKLPVKW-M 169

Query: 556 GI------------DIFAYGIVLLEVLS-GQTP 575
            +            D++++G++L E+++ G  P
Sbjct: 170 ALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 202

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 73.6 bits (181), Expect = 2e-14
 Identities = 49/172 (28%), Positives = 82/172 (47%), Gaps = 31/172 (18%)

Query: 425 ATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL--HGGLAMKNQFIASCYCFLTW 482
               H NIV+  G C T+G    +VFEY ++G L  +L  HG  A   +   S    LT 
Sbjct: 63  TNFQHENIVKFYGVC-TEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTL 121

Query: 483 SQRLRICLDVAMALQYM--HHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDT 540
           SQ L+I + +A  + Y+   H     +VHR++ +RN  +  +   ++G+FGM+R    D 
Sbjct: 122 SQLLQIAVQIASGMVYLASQH-----FVHRDLATRNCLVGYDLVVKIGDFGMSR----DV 172

Query: 541 ESPQFYSTN-----PASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
            +  +Y        P  W           +   D++++G+VL E+ + G+ P
Sbjct: 173 YTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 73.1 bits (180), Expect = 3e-14
 Identities = 61/211 (28%), Positives = 100/211 (47%), Gaps = 47/211 (22%)

Query: 392 GAVYHGRLN--GKN---LAIKRTEHEVITKLEMQLVQHAT----HHHPNIVRLLGTCLTD 442
           G V  GRL   GK    +AIK  +     K  +  +  A+      HPNI+RL G     
Sbjct: 18  GEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS 77

Query: 443 GPHSFLVFEYAKNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH 500
            P   ++ EY +NGSL  +L  + G     +F        T  Q + +   +A  ++Y+ 
Sbjct: 78  RPV-MIITEYMENGSLDKFLRENDG-----KF--------TVGQLVGMLRGIASGMKYLS 123

Query: 501 HVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN----PASW--- 553
             MN  YVHR++ +RNI ++     +V +FG++R   +D+E+   Y+T     P  W   
Sbjct: 124 E-MN--YVHRDLAARNILVNSNLVCKVSDFGLSR-RLEDSEAT--YTTKGGKIPIRWTAP 177

Query: 554 --------SMGIDIFAYGIVLLEVLS-GQTP 575
                   +   D++++GIV+ EV+S G+ P
Sbjct: 178 EAIAYRKFTSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 73.0 bits (179), Expect = 3e-14
 Identities = 51/165 (30%), Positives = 82/165 (49%), Gaps = 37/165 (22%)

Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRL 486
           HPNI+ L G  +T      +V EY +NGSL  +L  H G     QF        T  Q +
Sbjct: 64  HPNIIHLEGV-VTKSKPVMIVTEYMENGSLDAFLRKHDG-----QF--------TVIQLV 109

Query: 487 RICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFY 546
            +   +A  ++Y+  +    YVHR++ +RNI ++     +V +FG++R + DD E+   Y
Sbjct: 110 GMLRGIASGMKYLSDM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA--Y 164

Query: 547 STN----PASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
           +T     P  W           +   D+++YGIV+ EV+S G+ P
Sbjct: 165 TTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERP 209

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 72.3 bits (177), Expect = 4e-14
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 30/205 (14%)

Query: 392 GAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVF 450
           G V  G   G  +A+K  +++   +  +      T   H N+V+LLG  + +    ++V 
Sbjct: 20  GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79

Query: 451 EYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHR 510
           EY   GSL D+L      + + +    C L +S      LDV  A++Y+      ++VHR
Sbjct: 80  EYMAKGSLVDYLRS----RGRSVLGGDCLLKFS------LDVCEAMEYLE---ANNFVHR 126

Query: 511 NIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SMGIDI 559
           ++ +RN+ + E+  A+V +FG+ +    +  S Q     P  W           S   D+
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 182

Query: 560 FAYGIVLLEVLS-GQTPINRPRKKD 583
           +++GI+L E+ S G+ P  R   KD
Sbjct: 183 WSFGILLWEIYSFGRVPYPRIPLKD 207

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 72.0 bits (177), Expect = 5e-14
 Identities = 52/193 (26%), Positives = 79/193 (40%), Gaps = 37/193 (19%)

Query: 402 KNLAIK--RTEHEVITKLEM---QLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNG 456
             +A+K  + EH    K E      V     H P IVRL+G C   G    LV E A  G
Sbjct: 24  VEVAVKTLKQEHIAAGKKEFLREASVMAQLDH-PCIVRLIGVCK--GEPLMLVMELAPLG 80

Query: 457 SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRN 516
            L  +L      K + I         S    +   VAM + Y+       +VHR++ +RN
Sbjct: 81  PLLKYL-----KKRREIPV-------SDLKELAHQVAMGMAYLESK---HFVHRDLAARN 125

Query: 517 IFLDEEFNARVGNFGMARCVNDDTESPQFYSTN--PASW-----------SMGIDIFAYG 563
           + L     A++ +FGM+R +   ++  +  +    P  W           S   D+++YG
Sbjct: 126 VLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYG 185

Query: 564 IVLLEVLS-GQTP 575
           + L E  S G  P
Sbjct: 186 VTLWEAFSYGAKP 198

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 72.7 bits (178), Expect = 6e-14
 Identities = 49/165 (29%), Positives = 81/165 (49%), Gaps = 24/165 (14%)

Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQ----FIASCYCFLTWS 483
           HHPNI+ LLG C   G + +L  EYA +G+L D+L     ++         S    L+  
Sbjct: 66  HHPNIINLLGACEHRG-YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 124

Query: 484 QRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESP 543
           Q L    DVA  + Y+       ++HR++ +RNI + E + A++ +FG++R    +    
Sbjct: 125 QLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVK 179

Query: 544 QFYSTNPASWSMGI------------DIFAYGIVLLEVLS-GQTP 575
           +     P  W M I            D+++YG++L E++S G TP
Sbjct: 180 KTMGRLPVRW-MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 223

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 71.6 bits (176), Expect = 7e-14
 Identities = 42/191 (21%), Positives = 81/191 (42%), Gaps = 33/191 (17%)

Query: 403 NLAIKRTEHEVITKLEMQLVQHATH----HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSL 458
            +A+K  + + ++ +    ++ A       H N++RL G  LT      +V E A  GSL
Sbjct: 25  PVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHP--LMMVTELAPLGSL 82

Query: 459 KDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIF 518
            D L                    S      + +A  ++Y+    +  ++HR++ +RNI 
Sbjct: 83  LDRLR----------KDALGHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNIL 129

Query: 519 LDEEFNARVGNFGMARC--VNDDTESPQFYSTNPASW-----------SMGIDIFAYGIV 565
           L  +   ++G+FG+ R    N+D    + +   P +W           S   D++ +G+ 
Sbjct: 130 LASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVT 189

Query: 566 LLEVLS-GQTP 575
           L E+ + G+ P
Sbjct: 190 LWEMFTYGEEP 200

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 71.5 bits (176), Expect = 1e-13
 Identities = 47/231 (20%), Positives = 91/231 (39%), Gaps = 71/231 (30%)

Query: 392 GAVYHGRL--NGKNLAIKRTEHEVITKL-EMQLVQ------HATHHHPNIVRLLGT---- 438
             V   +     K  AIK  +   + K  +++ V+         + HP I++L  T    
Sbjct: 15  STVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE 74

Query: 439 -CLTDGPHSFLVFEYAKNGSLKDWLH--GGLAMKN-QFIASCYCFLTWSQRLRICLDVAM 494
             L      + V EYA NG L  ++   G L  K  +F A+               ++ +
Sbjct: 75  ENL------YFVLEYAPNGELLQYIRKYGSLDEKCTRFYAA---------------EILL 113

Query: 495 ALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDT-------------E 541
           AL+Y+H   +   +HR++K  NI LD++ + ++ +FG A+ ++ ++              
Sbjct: 114 ALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170

Query: 542 SPQFYSTNPAS-----------------WSMGIDIFAYGIVLLEVLSGQTP 575
             +      AS                      D++A G ++ ++L+G+ P
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 39/186 (20%)

Query: 410 EHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM- 468
           E EV+ KL          HHPNI+ LLG C   G + ++  EYA  G+L D+L     + 
Sbjct: 52  ELEVLCKL---------GHHPNIINLLGACENRG-YLYIAIEYAPYGNLLDFLRKSRVLE 101

Query: 469 ------KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEE 522
                 K    AS    LT  Q L+   DVA  +QY+       ++HR++ +RN+ + E 
Sbjct: 102 TDPAFAKEHGTAST---LTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGEN 155

Query: 523 FNARVGNFGMARCVNDDTESPQFYSTNPASWSMGI------------DIFAYGIVLLEVL 570
             +++ +FG++R   ++    +     P  W M I            D++++G++L E++
Sbjct: 156 LASKIADFGLSR--GEEVYVKKTMGRLPVRW-MAIESLNYSVYTTKSDVWSFGVLLWEIV 212

Query: 571 S-GQTP 575
           S G TP
Sbjct: 213 SLGGTP 218

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 71.0 bits (174), Expect = 2e-13
 Identities = 42/180 (23%), Positives = 82/180 (45%), Gaps = 26/180 (14%)

Query: 407 KRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGL 466
           K  +  + ++   +L       H N+VRLLG C    PH +++ EY   G LK +L    
Sbjct: 45  KTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPH-YMILEYTDLGDLKQFL---R 100

Query: 467 AMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNAR 526
           A K++        L+  Q++ +C  +A+    M H+ N  +VHR++ +RN  +  +   +
Sbjct: 101 ATKSKDEKLKPPPLSTKQKVALCTQIALG---MDHLSNARFVHRDLAARNCLVSSQREVK 157

Query: 527 VGNFGMARCVNDDTESPQFYSTN----PASW-----------SMGIDIFAYGIVLLEVLS 571
           V    +++    D  + ++Y       P  W           S   D++++G+++ EV +
Sbjct: 158 VSLLSLSK----DVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 70.4 bits (173), Expect = 2e-13
 Identities = 41/160 (25%), Positives = 77/160 (48%), Gaps = 26/160 (16%)

Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLR 487
            H  +V+L   C ++    ++V EY   GSL D+L  G   K          L   Q + 
Sbjct: 59  RHDKLVQLYAVC-SEEEPIYIVTEYMSKGSLLDFLKSGEGKK----------LRLPQLVD 107

Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYS 547
           +   +A  + Y+    N  Y+HR++ +RNI + E    ++ +FG+AR + DD  + +  +
Sbjct: 108 MAAQIAEGMAYLES-RN--YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGA 164

Query: 548 TNPASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
             P  W           ++  D++++GI+L E+++ G+ P
Sbjct: 165 KFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVP 204

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 70.6 bits (173), Expect = 2e-13
 Identities = 48/213 (22%), Positives = 100/213 (46%), Gaps = 39/213 (18%)

Query: 392 GAVYHGRLNGKN-----LAIKRTEHEVITKLEMQ-LVQHAT----HHHPNIVRLLGTCLT 441
           G+V  G+L+  +     +A+K  + ++ T  E++  +  A       HPN+++L+G C  
Sbjct: 13  GSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFE 72

Query: 442 DG-----PHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMAL 496
                  P   ++  + K+G L  +L   L  +   +      L     L+  +D+A+ +
Sbjct: 73  ASSLQKIPKPMVILPFMKHGDLHSFL---LYSR---LGGLPEKLPLQTLLKFMVDIALGM 126

Query: 497 QYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV-NDDTESPQFYSTNPASWSM 555
           +Y+    N +++HR++ +RN  L E+    V +FG+++ + + D       +  P  W +
Sbjct: 127 EYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKW-I 182

Query: 556 GI------------DIFAYGIVLLEVLS-GQTP 575
            I            D++A+G+ + E+ + GQTP
Sbjct: 183 AIESLADRVYTSKSDVWAFGVTMWEIATRGQTP 215

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 56/215 (26%), Positives = 85/215 (39%), Gaps = 44/215 (20%)

Query: 392 GAVYHGRLNGKNLAIKRTEHEVITKLE-----------MQLVQHATHHHPNIVRLLGTCL 440
           G VY G   G++      +  V T  E           M+ +  +  +H NIVRL+G   
Sbjct: 20  GEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSF 79

Query: 441 TDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH 500
              P  F++ E    G LK +L        +  +     LT    L    DVA   +Y+ 
Sbjct: 80  ERLPR-FILLELMAGGDLKSFLRENRPRPERPSS-----LTMKDLLFCARDVAKGCKYLE 133

Query: 501 HVMNPSYVHRNIKSRNIFLDEEFNARV---GNFGMARCVNDDTESPQFYSTN-----PAS 552
                 ++HR+I +RN  L  +   RV    +FGMAR    D     +Y        P  
Sbjct: 134 ---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR----DIYRASYYRKGGRAMLPIK 186

Query: 553 WSM------GI-----DIFAYGIVLLEVLS-GQTP 575
           W        GI     D++++G++L E+ S G  P
Sbjct: 187 WMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMP 221

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 70.5 bits (173), Expect = 2e-13
 Identities = 49/199 (24%), Positives = 94/199 (47%), Gaps = 37/199 (18%)

Query: 402 KNLAIKRTEHEV---ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSL 458
           K L    TE ++   ++++EM  +      H NI+ LLG C  +GP  ++V EYA +G+L
Sbjct: 48  KMLKDDATEKDLSDLVSEMEMMKM---IGKHKNIINLLGVCTQEGP-LYVVVEYAAHGNL 103

Query: 459 KDWL--HGGLAMKNQFIASCYCFLTWSQR--LRICLDVAMALQYMHHVMNPSYVHRNIKS 514
           +D+L                    T +Q+  +     VA  ++++    +   +HR++ +
Sbjct: 104 RDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFL---ASKKCIHRDLAA 160

Query: 515 RNIFLDEEFNARVGNFGMARCVNDDTESPQFY--STN---PASWSMGI------------ 557
           RN+ + E+   ++ +FG+AR    D     +Y  +TN   P  W M              
Sbjct: 161 RNVLVTEDHVMKIADFGLAR----DIHHIDYYRKTTNGRLPVKW-MAPEALFDRVYTHQS 215

Query: 558 DIFAYGIVLLEVLS-GQTP 575
           D++++G++L E+ + G +P
Sbjct: 216 DVWSFGVLLWEIFTLGGSP 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score = 71.7 bits (174), Expect = 2e-13
 Identities = 61/234 (26%), Positives = 100/234 (42%), Gaps = 45/234 (19%)

Query: 392 GAVYHGRLNGKNLAIKRTEHEVITKL--------EMQLVQHATHHHPNIVRLLGTCLTDG 443
           G VY  R   K +A+K    ++ +K         E+Q++    +H PNIV+L      +G
Sbjct: 14  GEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILAS-LNHPPNIVKLYDFFQDEG 71

Query: 444 PHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM 503
              +LV EY   GSL+D L                 L+ S+ L I   +  AL+Y+H   
Sbjct: 72  -SLYLVMEYVDGGSLEDLLKKI---------GRKGPLSESEALFILAQILSALEYLHSK- 120

Query: 504 NPSYVHRNIKSRNIFLDEE-FNARVGNFGMARCVND-DTESPQFYSTNPASWSMG----- 556
               +HR+IK  NI LD +    ++ +FG+A+ + D  + S      + +  + G     
Sbjct: 121 --GIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPE 178

Query: 557 -------------IDIFAYGIVLLEVLSGQTPINRPRKKDEGSVWLSEKIKSIL 597
                         DI++ GI L E+L+G  P     +K+  +   + KI   L
Sbjct: 179 VLLGLSLAYASSSSDIWSLGITLYELLTGLPP--FEGEKNSSATSQTLKIILEL 230

Length = 384

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 70.2 bits (172), Expect = 3e-13
 Identities = 46/169 (27%), Positives = 75/169 (44%), Gaps = 34/169 (20%)

Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG-------GLAMKNQFIASC---YC 478
           HPNIV+LLG C    P   L+FEY   G L ++L          L+        C     
Sbjct: 67  HPNIVKLLGVCAVGKPMC-LLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPL 125

Query: 479 FLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND 538
            L+ +++L I   VA  + Y+       +VHR++ +RN  + E    ++ +FG++R    
Sbjct: 126 PLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIADFGLSR---- 178

Query: 539 DTESPQFYSTN-----PASW-----------SMGIDIFAYGIVLLEVLS 571
           +  S  +Y  +     P  W           +   D++AYG+VL E+ S
Sbjct: 179 NIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 50/168 (29%), Positives = 81/168 (48%), Gaps = 30/168 (17%)

Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM-------KNQFIASCYCFL 480
           HHPNI+ LLG C   G + +L  EYA +G+L D+L     +            AS    L
Sbjct: 54  HHPNIINLLGACEHRG-YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTAST---L 109

Query: 481 TWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDT 540
           +  Q L    DVA  + Y+       ++HR++ +RNI + E + A++ +FG++R    + 
Sbjct: 110 SSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR--GQEV 164

Query: 541 ESPQFYSTNPASWSMGI------------DIFAYGIVLLEVLS-GQTP 575
              +     P  W M I            D+++YG++L E++S G TP
Sbjct: 165 YVKKTMGRLPVRW-MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 211

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 69.1 bits (169), Expect = 6e-13
 Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 38/204 (18%)

Query: 392 GAVYHG--RLNGKNLAIKRTEHEVITKLEMQLVQHATH---HHPNIVRLLGTCLTDGPHS 446
           G VY G  +     +A+K T  E   ++E  L + A      HPN+V+LLG C T  P  
Sbjct: 20  GEVYEGVWKKYSLTVAVK-TLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-TREPPF 77

Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQY---MHHVM 503
           +++ E+   G+L D+L                     Q +   + + MA Q    M ++ 
Sbjct: 78  YIITEFMTYGNLLDYLRE----------------CNRQEVNAVVLLYMATQISSAMEYLE 121

Query: 504 NPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW---------- 553
             +++HR++ +RN  + E    +V +FG++R +  DT +    +  P  W          
Sbjct: 122 KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 181

Query: 554 -SMGIDIFAYGIVLLEVLS-GQTP 575
            S+  D++A+G++L E+ + G +P
Sbjct: 182 FSIKSDVWAFGVLLWEIATYGMSP 205

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 68.7 bits (168), Expect = 7e-13
 Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 40/209 (19%)

Query: 392 GAVYHGRLN--GKN---LAIKRTEHEVITKLEMQLVQHAT----HHHPNIVRLLGTCLTD 442
           G V  GRL   GK    +AIK  +     K     +  A+      HPNI+ L G     
Sbjct: 18  GEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS 77

Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
            P   ++ E+ +NG+L  +L        QF        T  Q + +   +A  ++Y+  +
Sbjct: 78  RP-VMIITEFMENGALDSFLRQN---DGQF--------TVIQLVGMLRGIAAGMKYLSEM 125

Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYST----NPASWSM--- 555
              +YVHR++ +RNI ++     +V +FG++R + DDT  P + S+     P  W+    
Sbjct: 126 ---NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182

Query: 556 --------GIDIFAYGIVLLEVLS-GQTP 575
                     D+++YGIV+ EV+S G+ P
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVMSYGERP 211

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score = 68.4 bits (168), Expect = 8e-13
 Identities = 47/184 (25%), Positives = 77/184 (41%), Gaps = 32/184 (17%)

Query: 428 HHPNIVRLLGTCLTDGPHS-FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYC---FLTWS 483
            HPNIVR     +     + ++V EY + G L            Q I  C     ++   
Sbjct: 57  KHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLA-----------QLIQKCKKERKYIEEE 105

Query: 484 QRLRICLDVAMALQYMHHVMNPSYV--HRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE 541
              RI   + +AL   H+  +P     HR++K  NIFLD   N ++G+FG+A+ +  D+ 
Sbjct: 106 FIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS 165

Query: 542 SPQFYSTNPASWSMGI----------DIFAYGIVLLEVLSGQTPINRPRKKDEGSVWLSE 591
             + Y   P   S             DI++ G ++ E+ +   P    R + +    L+ 
Sbjct: 166 FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFT-ARNQLQ----LAS 220

Query: 592 KIKS 595
           KIK 
Sbjct: 221 KIKE 224

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 68.5 bits (168), Expect = 1e-12
 Identities = 36/159 (22%), Positives = 69/159 (43%), Gaps = 19/159 (11%)

Query: 430 PNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRIC 489
            ++VRLLG   T G  + +V E    G LK +L                  T  + +++ 
Sbjct: 69  HHVVRLLGVVST-GQPTLVVMELMAKGDLKSYLRS--RRPEAENNPGLGPPTLQKFIQMA 125

Query: 490 LDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND-DTESPQFYST 548
            ++A  + Y+       +VHR++ +RN  + E+   ++G+FGM R + + D         
Sbjct: 126 AEIADGMAYLAAK---KFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGL 182

Query: 549 NPASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
            P  W           +   D++++G+VL E+ +  + P
Sbjct: 183 LPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQP 221

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 68.6 bits (168), Expect = 1e-12
 Identities = 52/195 (26%), Positives = 92/195 (47%), Gaps = 45/195 (23%)

Query: 401 GKNLAIKRTEH---EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSF-LVFEYAKNG 456
           G+ +A+K+ +H   E +   E ++    +  H NIV+  G C + G  +  LV EY   G
Sbjct: 33  GEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYG 92

Query: 457 SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQY-------MHHVMNPSYVH 509
           SL+D+L                     Q+ R  LD    L Y       M ++ +  YVH
Sbjct: 93  SLRDYL---------------------QKHRERLDHRKLLLYASQICKGMEYLGSKRYVH 131

Query: 510 RNIKSRNIFLDEEFNARVGNFGMARCVNDDT---------ESPQFY----STNPASWSMG 556
           R++ +RNI ++ E   ++G+FG+ + +  D          ESP F+    S   + +S+ 
Sbjct: 132 RDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVA 191

Query: 557 IDIFAYGIVLLEVLS 571
            D++++G+VL E+ +
Sbjct: 192 SDVWSFGVVLYELFT 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 52/211 (24%), Positives = 100/211 (47%), Gaps = 36/211 (17%)

Query: 392 GAVYHGRLNGKN----LAIKRTEHEVITKLEMQ-----LVQHATHHHPNIVRLLGTCLTD 442
           G+V  G+LN  +    +A+K  +  + T+ EM+      V      HPN++RL+G CL  
Sbjct: 13  GSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQT 72

Query: 443 G-----PHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQ 497
                 P   ++  + K+G L  +L   L  +   +  C  +L     ++   D+A  ++
Sbjct: 73  VESEGYPSPVVILPFMKHGDLHSFL---LYSR---LGDCPQYLPTQMLVKFMTDIASGME 126

Query: 498 YMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV-NDDTESPQFYSTNPASW--- 553
           Y+    + S++HR++ +RN  L+E  N  V +FG+++ + N D       +  P  W   
Sbjct: 127 YLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183

Query: 554 --------SMGIDIFAYGIVLLEVLS-GQTP 575
                   +   D++++G+ + E+ + GQTP
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEIATRGQTP 214

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 51/205 (24%), Positives = 93/205 (45%), Gaps = 41/205 (20%)

Query: 392 GAVYHG--RLNGKNLAIKRTEHEVITKLEMQLVQHATH-----HHPNIVRLLGTCLTDGP 444
           G VY G     G  +AIK+   E I +  ++ +           HPNIV+ +G  +    
Sbjct: 14  GVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIG-SIETSD 72

Query: 445 HSFLVFEYAKNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
             +++ EYA+NGSL+  +   G      + + + Y +    Q L+        L Y+H  
Sbjct: 73  SLYIILEYAENGSLRQIIKKFGPF---PESLVAVYVY----QVLQ-------GLAYLH-- 116

Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTES------------PQFYSTNP 550
                +HR+IK+ NI   ++   ++ +FG+A  +ND ++             P+    + 
Sbjct: 117 -EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSG 175

Query: 551 ASWSMGIDIFAYGIVLLEVLSGQTP 575
           AS +   DI++ G  ++E+L+G  P
Sbjct: 176 ASTAS--DIWSLGCTVIELLTGNPP 198

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 67.6 bits (165), Expect = 2e-12
 Identities = 48/171 (28%), Positives = 82/171 (47%), Gaps = 30/171 (17%)

Query: 426 THHHPNIVRLLGTCLTDGPHSF-LVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQ 484
           T +H NIV+  G C   G     L+ EY   GSL+D+L      K++        L  +Q
Sbjct: 62  TLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLP-----KHK--------LNLAQ 108

Query: 485 RLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARC--------- 535
            L     +   + Y+H   +  Y+HR++ +RN+ LD +   ++G+FG+A+          
Sbjct: 109 LLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR 165

Query: 536 VNDDTESPQF-YST---NPASWSMGIDIFAYGIVLLEVLSGQTPINRPRKK 582
           V +D +SP F Y+        +S   D++++G+ L E+L+       P KK
Sbjct: 166 VREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKK 216

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 66.8 bits (163), Expect = 3e-12
 Identities = 42/159 (26%), Positives = 70/159 (44%), Gaps = 28/159 (17%)

Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
              I+R       D     +V EYA+NG L   L                 L   Q  R 
Sbjct: 58  SSYIIRYY-ESFLDKGKLNIVMEYAENGDLHKLLKMQRGRP----------LPEDQVWRF 106

Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------- 541
            + + + L ++H   +   +HR+IKS N+FLD   N ++G+ G+A+ ++D+T        
Sbjct: 107 FIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVG 163

Query: 542 -----SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTP 575
                SP+     P  ++   D++A G+VL E  +G+ P
Sbjct: 164 TPYYLSPELCEDKP--YNEKSDVWALGVVLYECCTGKHP 200

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 66.8 bits (163), Expect = 3e-12
 Identities = 46/178 (25%), Positives = 81/178 (45%), Gaps = 37/178 (20%)

Query: 410 EHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMK 469
           E +V+ KL           HP +V+L G C    P  ++V E+ +NG L ++L      +
Sbjct: 49  EAKVMMKLS----------HPKLVQLYGVCTQQKP-LYIVTEFMENGCLLNYLR-----Q 92

Query: 470 NQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGN 529
            Q   S    L+      +C DV   ++Y+      S++HR++ +RN  +      +V +
Sbjct: 93  RQGKLSKDMLLS------MCQDVCEGMEYLER---NSFIHRDLAARNCLVSSTGVVKVSD 143

Query: 530 FGMARCVNDDTESPQFYSTNPASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
           FGM R V DD  +    +  P  W           S   D++++G+++ EV + G+ P
Sbjct: 144 FGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMP 201

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 66.9 bits (163), Expect = 3e-12
 Identities = 51/179 (28%), Positives = 83/179 (46%), Gaps = 32/179 (17%)

Query: 418 EMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL--HGGLA--MKNQFI 473
           E +L+    H H  IVR  G C T+G    +VFEY ++G L  +L  HG  A  +     
Sbjct: 57  EAELLTVLQHQH--IVRFYGVC-TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGED 113

Query: 474 ASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA 533
            +    LT  Q L I   +A  + Y+  +    +VHR++ +RN  + +    ++G+FGM+
Sbjct: 114 VAP-GQLTLGQMLAIASQIASGMVYLASL---HFVHRDLATRNCLVGQGLVVKIGDFGMS 169

Query: 534 RCVNDDTESPQFYSTN-----PASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
           R    D  S  +Y        P  W           +   DI+++G+VL E+ + G+ P
Sbjct: 170 R----DIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQP 224

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 66.9 bits (163), Expect = 5e-12
 Identities = 44/161 (27%), Positives = 77/161 (47%), Gaps = 23/161 (14%)

Query: 430 PNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG-----GLAMKNQFIASCYCFLT--W 482
           PNI+RLLG C+ + P   ++ EY +NG L  +L            N  +   +C     +
Sbjct: 79  PNIIRLLGVCVDEDPLC-MITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISY 137

Query: 483 SQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV-NDDTE 541
           S  L + L +A  ++Y+  +   ++VHR++ +RN  + E    ++ +FGM+R +   D  
Sbjct: 138 SSLLHVALQIASGMKYLSSL---NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYY 194

Query: 542 SPQFYSTNPASWS------MG-----IDIFAYGIVLLEVLS 571
             Q  +  P  W       MG      D++A+G+ L E+L 
Sbjct: 195 RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILM 235

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 65.9 bits (161), Expect = 7e-12
 Identities = 54/205 (26%), Positives = 93/205 (45%), Gaps = 39/205 (19%)

Query: 392 GAVYHGR--LNGKNLAIK-----RTEHEV--ITKLEMQLVQHATHHH-PNIVRLLGTCLT 441
           GAVY G+    G+ +A+K       + +V  I + E+ L+        PNI +  G    
Sbjct: 15  GAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQR-EVALLSQLRQSQPPNITKYYG-SYL 72

Query: 442 DGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHH 501
            GP  +++ EYA+ GS++        MK   IA  Y  +       I  +V +AL+Y+H 
Sbjct: 73  KGPRLWIIMEYAEGGSVRT------LMKAGPIAEKYISV-------IIREVLVALKYIHK 119

Query: 502 VMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNP----------- 550
           V     +HR+IK+ NI +    N ++ +FG+A  +N ++     +   P           
Sbjct: 120 V---GVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEG 176

Query: 551 ASWSMGIDIFAYGIVLLEVLSGQTP 575
             +    DI++ GI + E+ +G  P
Sbjct: 177 KYYDTKADIWSLGITIYEMATGNPP 201

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 65.6 bits (160), Expect = 7e-12
 Identities = 48/172 (27%), Positives = 78/172 (45%), Gaps = 41/172 (23%)

Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HPNIV+LLG CL + P   ++ E  + G L  +L      +          LT  + L I
Sbjct: 58  HPNIVKLLGVCLLNEPQY-IIMELMEGGDLLSYLRDARVERFG-----PPLLTLKELLDI 111

Query: 489 CLDVAMA---LQYMHHVMNPSYVHRNIKSRNIFLDEEFNAR-----VGNFGMARCVNDDT 540
           CLDVA     L+ MH      ++HR++ +RN  + E+         +G+FG+AR    D 
Sbjct: 112 CLDVAKGCVYLEQMH------FIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR----DI 161

Query: 541 ESPQFYSTN-----PASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
               +Y        P  W           +   D++++G+++ E+L+ GQ P
Sbjct: 162 YKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQP 213

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 65.8 bits (160), Expect = 8e-12
 Identities = 56/211 (26%), Positives = 99/211 (46%), Gaps = 46/211 (21%)

Query: 392 GAVYHG--RLNGKN---LAIKRTEHEVITKLEMQLVQHAT----HHHPNIVRLLGTCLTD 442
           G V+ G  ++ G+    +AIK  +     K     +  A+      H NI+RL G  +T 
Sbjct: 19  GEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGV-VTK 77

Query: 443 GPHSFLVFEYAKNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH 500
              + ++ EY +NG+L  +L  H G     Q +            LR    +A  ++Y+ 
Sbjct: 78  FKPAMIITEYMENGALDKYLRDHDGEFSSYQLVG----------MLR---GIAAGMKYLS 124

Query: 501 HVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN----PASWSM- 555
              + +YVHR++ +RNI ++     +V +FG++R + DD E    Y+T+    P  W+  
Sbjct: 125 ---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGT--YTTSGGKIPIRWTAP 179

Query: 556 ----------GIDIFAYGIVLLEVLS-GQTP 575
                       D++++GIV+ EV+S G+ P
Sbjct: 180 EAIAYRKFTSASDVWSFGIVMWEVMSFGERP 210

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 50/196 (25%), Positives = 89/196 (45%), Gaps = 31/196 (15%)

Query: 392 GAVYHGRLNGKN-LAIKRTEHEVITKLEMQLVQHA----THHHPNIVRLLGTCLTDGPHS 446
           G V+ G L  K  +A+K  + ++  +L+++ +  A     + HPNIV+L+G C    P  
Sbjct: 9   GEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQP-I 67

Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           ++V E    G    +L      K++        L   Q ++  LD A  + Y+    + +
Sbjct: 68  YIVMELVPGGDFLSFLR---KKKDE--------LKTKQLVKFALDAAAGMAYLE---SKN 113

Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SM 555
            +HR++ +RN  + E    ++ +FGM+R  +D   S       P  W           S 
Sbjct: 114 CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSS 173

Query: 556 GIDIFAYGIVLLEVLS 571
             D+++YGI+L E  S
Sbjct: 174 ESDVWSYGILLWETFS 189

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 50/209 (23%), Positives = 91/209 (43%), Gaps = 49/209 (23%)

Query: 392 GAVYHGRLNGKN-LAIKR------------TEHEVITKLEMQLVQHATHHHPNIVRLLGT 438
           G V+ G  N    +A+K              E +++ KL           HP +++L   
Sbjct: 20  GEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKL----------RHPKLIQLYAV 69

Query: 439 CLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQY 498
           C T     ++V E  K GSL ++L GG              L   Q + +   VA  + Y
Sbjct: 70  C-TLEEPIYIVTELMKYGSLLEYLQGGAGRA----------LKLPQLIDMAAQVASGMAY 118

Query: 499 MHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW----- 553
           +      +Y+HR++ +RN+ + E    +V +FG+AR + +D    +  +  P  W     
Sbjct: 119 LE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEA 175

Query: 554 ------SMGIDIFAYGIVLLEVLS-GQTP 575
                 S+  D++++GI+L E+++ G+ P
Sbjct: 176 ALYNRFSIKSDVWSFGILLTEIVTYGRMP 204

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 64.4 bits (157), Expect = 2e-11
 Identities = 47/206 (22%), Positives = 90/206 (43%), Gaps = 43/206 (20%)

Query: 392 GAVYHGR-LNGKNLAIKRTEHEVITKL-----EMQLVQHATHHHPNIVRLLGTCLTDGPH 445
           G V+ G   N   +AIK  + + + K      E+Q ++     H +++ L   C    P 
Sbjct: 20  GEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRL--RHKHLISLFAVCSVGEPV 77

Query: 446 SFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNP 505
            +++ E  + GSL  +L      +          L  +  + +   VA  + Y+      
Sbjct: 78  -YIITELMEKGSLLAFL-RSPEGQV---------LPVASLIDMACQVAEGMAYLE---EQ 123

Query: 506 SYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN----PASW-------- 553
           + +HR++ +RNI + E+   +V +FG+AR + +D      Y ++    P  W        
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKED-----VYLSSDKKIPYKWTAPEAASH 178

Query: 554 ---SMGIDIFAYGIVLLEVLS-GQTP 575
              S   D++++GI+L E+ + GQ P
Sbjct: 179 GTFSTKSDVWSFGILLYEMFTYGQVP 204

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 65.4 bits (159), Expect = 2e-11
 Identities = 50/194 (25%), Positives = 82/194 (42%), Gaps = 55/194 (28%)

Query: 407 KRTEHEVI-------TKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK 459
           K  EH VI       T  E  +++   H  P+I++L GT           F Y K   L 
Sbjct: 115 KTCEHVVIKAGQRGGTATEAHILRAINH--PSIIQLKGT-----------FTYNKFTCL- 160

Query: 460 DWLHGGLAMKNQFIASCYCFLTWSQRLRIC------LDVAMALQYMHHVMNPSYVHRNIK 513
                   +  ++    YC+L   + + IC        V  A+QY+H       +HR+IK
Sbjct: 161 --------ILPRYKTDLYCYLAAKRNIAICDILAIERSVLRAIQYLH---ENRIIHRDIK 209

Query: 514 SRNIFLDEEFNARVGNFGMARCVNDD--------------TESPQFYSTNPASWSMGIDI 559
           + NIF++   +  +G+FG A C   D              T +P+  + +P  +   +DI
Sbjct: 210 AENIFINHPGDVCLGDFGAA-CFPVDINANKYYGWAGTIATNAPELLARDP--YGPAVDI 266

Query: 560 FAYGIVLLEVLSGQ 573
           ++ GIVL E+ +  
Sbjct: 267 WSAGIVLFEMATCH 280

Length = 391

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 64.6 bits (157), Expect = 3e-11
 Identities = 46/181 (25%), Positives = 86/181 (47%), Gaps = 27/181 (14%)

Query: 418 EMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIAS-- 475
           E  L++   H  P++++L G C  DGP   L+ EYAK GSL+ +L     +   ++ S  
Sbjct: 53  EFNLLKQVNH--PHVIKLYGACSQDGP-LLLIVEYAKYGSLRSFLRESRKVGPSYLGSDG 109

Query: 476 ----CYCFLTWSQRLRICLDVAMALQY---MHHVMNPSYVHRNIKSRNIFLDEEFNARVG 528
                Y      + L +   ++ A Q    M ++     VHR++ +RN+ + E    ++ 
Sbjct: 110 NRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKIS 169

Query: 529 NFGMARCV-NDDTESPQFYSTNPASWSMGI------------DIFAYGIVLLEVLS-GQT 574
           +FG++R V  +D+   +     P  W M I            D++++G++L E+++ G  
Sbjct: 170 DFGLSRDVYEEDSYVKRSKGRIPVKW-MAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 228

Query: 575 P 575
           P
Sbjct: 229 P 229

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 64.4 bits (157), Expect = 3e-11
 Identities = 48/185 (25%), Positives = 83/185 (44%), Gaps = 29/185 (15%)

Query: 406 IKRTEHEVITKLEMQLVQHATH--HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH 463
           +K T H    +  M  ++  +H  +H NIV LLG C   GP   ++ EY   G L ++L 
Sbjct: 73  LKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGP-ILVITEYCCYGDLLNFLR 131

Query: 464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEF 523
                + +       FLT    L     VA   + M  + + + +HR++ +RN+ L    
Sbjct: 132 -----RKR-----ESFLTLEDLLSFSYQVA---KGMAFLASKNCIHRDLAARNVLLTHGK 178

Query: 524 NARVGNFGMARCVNDDTESPQFYSTN-PASW-----------SMGIDIFAYGIVLLEVLS 571
             ++ +FG+AR + +D+      +   P  W           +   D+++YGI+L E+ S
Sbjct: 179 IVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Query: 572 -GQTP 575
            G  P
Sbjct: 239 LGSNP 243

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 64.2 bits (156), Expect = 4e-11
 Identities = 39/156 (25%), Positives = 82/156 (52%), Gaps = 18/156 (11%)

Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQF-IASCYCFLTWSQRLR 487
           +PNI+RLLG C++D P   ++ EY +NG L  +L     +++ F  A+    ++ +  L 
Sbjct: 76  NPNIIRLLGVCVSDDPLC-MITEYMENGDLNQFL-SQREIESTFTHANNIPSVSIANLLY 133

Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV-NDDTESPQFY 546
           + + +A  ++Y+  +   ++VHR++ +RN  +   +  ++ +FGM+R + + D    Q  
Sbjct: 134 MAVQIASGMKYLASL---NFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGR 190

Query: 547 STNPASW-----------SMGIDIFAYGIVLLEVLS 571
           +  P  W           +   D++A+G+ L E+ +
Sbjct: 191 AVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 63.8 bits (156), Expect = 4e-11
 Identities = 43/160 (26%), Positives = 69/160 (43%), Gaps = 35/160 (21%)

Query: 392 GAVYHGRL--NGKNLAIK----RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPH 445
           G VY  R    G+ +AIK      + E   K E  +++  ++H PNI    G  +   P 
Sbjct: 20  GKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNH-PNIATFYGAFIKKNPP 78

Query: 446 S-----FLVFEYAKNGSLKDWLHG----GLAMKNQFIASCYCFLTWSQRLRICLDVAMAL 496
                 +LV E    GS+ D + G    G  +K ++IA  Y          I  +    L
Sbjct: 79  GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIA--Y----------ILRETLRGL 126

Query: 497 QYMH--HVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR 534
            Y+H   V+     HR+IK +NI L +    ++ +FG++ 
Sbjct: 127 AYLHENKVI-----HRDIKGQNILLTKNAEVKLVDFGVSA 161

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 63.8 bits (155), Expect = 4e-11
 Identities = 47/195 (24%), Positives = 94/195 (48%), Gaps = 36/195 (18%)

Query: 397 GRLNGKNLAIK------RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSF-LV 449
           G   G+ +A+K         H    K E++++++   +H NIV+  G C  DG +   L+
Sbjct: 29  GDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNL--YHENIVKYKGICTEDGGNGIKLI 86

Query: 450 FEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVH 509
            E+  +GSLK++L       N             Q+L+  + +   + Y+    +  YVH
Sbjct: 87  MEFLPSGSLKEYLPRNKNKIN-----------LKQQLKYAVQICKGMDYLG---SRQYVH 132

Query: 510 RNIKSRNIFLDEEFNARVGNFGMARC---------VNDDTESPQFYSTNP----ASWSMG 556
           R++ +RN+ ++ E   ++G+FG+ +          V DD +SP F+        + + + 
Sbjct: 133 RDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIA 192

Query: 557 IDIFAYGIVLLEVLS 571
            D++++G+ L E+L+
Sbjct: 193 SDVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 63.5 bits (155), Expect = 5e-11
 Identities = 33/108 (30%), Positives = 58/108 (53%), Gaps = 9/108 (8%)

Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRL 486
            PNI RLLG C  D P   ++ EY +NG L  +L  H     +   +A     L++S  L
Sbjct: 78  DPNIARLLGVCTVD-PPLCMIMEYMENGDLNQFLQKH---VAETSGLACNSKSLSFSTLL 133

Query: 487 RICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR 534
            +   +A  ++Y+   +N  +VHR++ +RN  + + +  ++ +FGM+R
Sbjct: 134 YMATQIASGMRYLES-LN--FVHRDLATRNCLVGKNYTIKIADFGMSR 178

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 63.4 bits (154), Expect = 6e-11
 Identities = 37/154 (24%), Positives = 77/154 (50%), Gaps = 17/154 (11%)

Query: 430 PNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRIC 489
           PNI+RLL  C+T  P   ++ EY +NG L  +L      +     +    +++S  + + 
Sbjct: 79  PNIIRLLAVCITSDPLC-MITEYMENGDLNQFL-SRHEPQEAAEKADVVTISYSTLIFMA 136

Query: 490 LDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV-NDDTESPQFYST 548
             +A  ++Y+  +   ++VHR++ +RN  + + +  ++ +FGM+R + + D    Q  + 
Sbjct: 137 TQIASGMKYLSSL---NFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAV 193

Query: 549 NPASW-----------SMGIDIFAYGIVLLEVLS 571
            P  W           +   D++A+G+ L E+L+
Sbjct: 194 LPIRWMSWESILLGKFTTASDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 63.2 bits (153), Expect = 7e-11
 Identities = 52/181 (28%), Positives = 84/181 (46%), Gaps = 38/181 (20%)

Query: 418 EMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL--HGG----LAMKNQ 471
           E +L+ +  H H  IV+  G C+   P   +VFEY K+G L  +L  HG     +A  N+
Sbjct: 57  EAELLTNLQHEH--IVKFYGVCVEGDP-LIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNR 113

Query: 472 FIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFG 531
                   LT SQ L I   +A  + Y+    +  +VHR++ +RN  + E    ++G+FG
Sbjct: 114 PAE-----LTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFG 165

Query: 532 MARCVNDDTESPQFYSTN-----PASW-----------SMGIDIFAYGIVLLEVLS-GQT 574
           M+R    D  S  +Y        P  W           +   D+++ G+VL E+ + G+ 
Sbjct: 166 MSR----DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQ 221

Query: 575 P 575
           P
Sbjct: 222 P 222

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 63.1 bits (153), Expect = 8e-11
 Identities = 51/180 (28%), Positives = 83/180 (46%), Gaps = 33/180 (18%)

Query: 418 EMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL--HGGLAM---KNQF 472
           E +L+ +  H H  IV+  G C  DG    +VFEY K+G L  +L  HG  AM     Q 
Sbjct: 57  EAELLTNLQHEH--IVKFYGVCG-DGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQP 113

Query: 473 IASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGM 532
             +    L  SQ L I   +A  + Y+    +  +VHR++ +RN  +      ++G+FGM
Sbjct: 114 RQA-KGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGM 169

Query: 533 ARCVNDDTESPQFYSTN-----PASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
           +R    D  S  +Y        P  W           +   D++++G++L E+ + G+ P
Sbjct: 170 SR----DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 225

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 61.2 bits (148), Expect = 3e-10
 Identities = 55/216 (25%), Positives = 95/216 (43%), Gaps = 49/216 (22%)

Query: 392 GAVYHGRLNG-------KNLAIKRTEHEVITKLEMQLVQHATH----HHPNIVRLLGTCL 440
           G VY G L G       + +AIK  + +    L  +    A       HPNIV LLG   
Sbjct: 19  GKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVT 78

Query: 441 TDGPHSFLVFEYAKNGSLKDWL-----HG--GLAMKNQFIASCYCFLTWSQRLRICLDVA 493
            + P S ++F Y  +  L ++L     H   G    ++ + S    L  +  + I   +A
Sbjct: 79  KEQPLS-MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKST---LEPADFVHIVTQIA 134

Query: 494 MALQYM--HHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFY----- 546
             ++++  HHV     VH+++ +RN+ + ++ N ++ + G+ R    +  +  +Y     
Sbjct: 135 AGMEFLSSHHV-----VHKDLATRNVLVFDKLNVKISDLGLFR----EVYAADYYKLMGN 185

Query: 547 STNPASW-----------SMGIDIFAYGIVLLEVLS 571
           S  P  W           S+  DI++YG+VL EV S
Sbjct: 186 SLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 61.2 bits (148), Expect = 3e-10
 Identities = 45/164 (27%), Positives = 77/164 (46%), Gaps = 21/164 (12%)

Query: 425 ATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL-----HGGLAMKNQFIASCYCF 479
           A  HHPNIV LLG    + P   L FEY   G L ++L     H  +   +    +    
Sbjct: 62  AELHHPNIVCLLGVVTQEQPVCML-FEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSS 120

Query: 480 LTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV-ND 538
           L     L I + +A  ++Y+    +  +VH+++ +RNI + E+ + ++ + G++R + + 
Sbjct: 121 LDHGDFLHIAIQIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSA 177

Query: 539 DTESPQFYSTNPASW-----------SMGIDIFAYGIVLLEVLS 571
           D    Q  S  P  W           S   DI+++G+VL E+ S
Sbjct: 178 DYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 61.2 bits (148), Expect = 3e-10
 Identities = 55/224 (24%), Positives = 104/224 (46%), Gaps = 43/224 (19%)

Query: 400 NGKNLAIKRTEHEVITKLEM---QLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNG 456
            GK +A+K+ +     + E+   ++V    +HH N+V +  + L  G   ++V E+ + G
Sbjct: 46  TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLV-GDELWVVMEFLEGG 104

Query: 457 SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRN 516
           +L D +     M  + IA+            +CL V  AL Y+H   N   +HR+IKS +
Sbjct: 105 ALTD-IVTHTRMNEEQIAT------------VCLSVLRALSYLH---NQGVIHRDIKSDS 148

Query: 517 IFLDEEFNARVGNFGMARCVNDDTE------------SPQFYSTNPASWSMGIDIFAYGI 564
           I L  +   ++ +FG    V+ +              +P+  S  P  +   +DI++ GI
Sbjct: 149 ILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLP--YGTEVDIWSLGI 206

Query: 565 VLLEVLSGQTP-INRP------RKKDEGSVWLSE--KIKSILQA 599
           +++E++ G+ P  N P      R +D     + +  K+ S+L+ 
Sbjct: 207 MVIEMIDGEPPYFNEPPLQAMRRIRDNLPPRVKDSHKVSSVLRG 250

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 61.2 bits (148), Expect = 4e-10
 Identities = 49/198 (24%), Positives = 98/198 (49%), Gaps = 38/198 (19%)

Query: 402 KNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW 461
           K+ A ++   ++I+++EM  +      H NI+ LLG C  DGP  +++ EYA  G+L+++
Sbjct: 59  KSDATEKDLSDLISEMEMMKM---IGKHKNIINLLGACTQDGP-LYVIVEYASKGNLREY 114

Query: 462 LHGGLAMKNQFIASCYC-------FLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKS 514
           L    A +   +  CY         L++   +     VA  ++Y+    +   +HR++ +
Sbjct: 115 LR---ARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 168

Query: 515 RNIFLDEEFNARVGNFGMARCVNDDTESPQFY--STN---PASW-----------SMGID 558
           RN+ + E+   ++ +FG+AR    D     +Y  +TN   P  W           +   D
Sbjct: 169 RNVLVTEDNVMKIADFGLAR----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 224

Query: 559 IFAYGIVLLEVLS-GQTP 575
           ++++G++L E+ + G +P
Sbjct: 225 VWSFGVLLWEIFTLGGSP 242

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 60.4 bits (146), Expect = 4e-10
 Identities = 51/205 (24%), Positives = 94/205 (45%), Gaps = 38/205 (18%)

Query: 392 GAVYHGRLNGKN--LAIKRTEHEVITKLEMQLVQHA----THHHPNIVRLLGTCLTDGPH 445
           G V+ GRL   N  +A+K     +   L+ + +Q A     + HPNIVRL+G C    P 
Sbjct: 9   GEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP- 67

Query: 446 SFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNP 505
            ++V E  + G   D+L         F+ +    L   + +++  + A  ++Y+    + 
Sbjct: 68  IYIVMELVQGG---DFL--------TFLRTEGPRLKVKELIQMVENAAAGMEYLE---SK 113

Query: 506 SYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTES--------------PQFYSTNPA 551
             +HR++ +RN  + E+   ++ +FGM+R   D   +              P+  + N  
Sbjct: 114 HCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPE--ALNYG 171

Query: 552 SWSMGIDIFAYGIVLLEVLS-GQTP 575
            +S   D++++GI+L E  S G  P
Sbjct: 172 RYSSESDVWSFGILLWEAFSLGAVP 196

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 60.5 bits (147), Expect = 4e-10
 Identities = 45/197 (22%), Positives = 88/197 (44%), Gaps = 36/197 (18%)

Query: 393 AVYHGRLNGK-NLAIKRTEHEVITKLEMQLVQHA----THHHPNIVRLLGTCLTDGPHSF 447
            VY    N K  +A+K  ++     +  + +Q A       HP+IV+L+G   T+ P  +
Sbjct: 25  GVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVI-TENP-VW 82

Query: 448 LVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSY 507
           +V E A  G L+ +L      K          L  +  +     ++ AL Y+       +
Sbjct: 83  IVMELAPLGELRSYLQ---VNKYS--------LDLASLILYSYQLSTALAYLESK---RF 128

Query: 508 VHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE-------------SPQFYSTNPASWS 554
           VHR+I +RN+ +      ++G+FG++R + D++              +P+  S N   ++
Sbjct: 129 VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPE--SINFRRFT 186

Query: 555 MGIDIFAYGIVLLEVLS 571
              D++ +G+ + E+L 
Sbjct: 187 SASDVWMFGVCMWEILM 203

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 60.5 bits (147), Expect = 5e-10
 Identities = 41/161 (25%), Positives = 76/161 (47%), Gaps = 31/161 (19%)

Query: 427 HHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRL 486
           + HPNIV +  + L  G   ++V E+ + G+L D +     M  + IA+           
Sbjct: 73  YQHPNIVEMYSSYLV-GDELWVVMEFLEGGALTDIVTHT-RMNEEQIAT----------- 119

Query: 487 RICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE----- 541
            +CL V  AL ++H       +HR+IKS +I L  +   ++ +FG    V+ +       
Sbjct: 120 -VCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSL 175

Query: 542 -------SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTP 575
                  +P+  S  P  +   +DI++ GI+++E++ G+ P
Sbjct: 176 VGTPYWMAPEVISRLP--YGTEVDIWSLGIMVIEMVDGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 62.2 bits (151), Expect = 5e-10
 Identities = 60/242 (24%), Positives = 115/242 (47%), Gaps = 34/242 (14%)

Query: 343 KKVSFEGSQSTIEGQIIDTAEQHKRLLESYSIEDLRRATEKFNS-SNRIEGAVYHGRL-- 399
           K+V  E    T E Q  D+     ++ +S +I D+  + ++ N  S   +GA Y G+   
Sbjct: 661 KRV--ENEDGTWELQFFDS-----KVSKSITINDILSSLKEENVISRGKKGASYKGKSIK 713

Query: 400 NGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK 459
           NG    +K   ++V +    ++       HPNIV+L+G C ++   ++L+ EY +  +L 
Sbjct: 714 NGMQFVVKEI-NDVNSIPSSEIADMGKLQHPNIVKLIGLCRSE-KGAYLIHEYIEGKNLS 771

Query: 460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFL 519
           + L                 L+W +R +I + +A AL+++H   +P+ V  N+    I +
Sbjct: 772 EVLRN---------------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIII 816

Query: 520 D--EEFNARVGNFGMARCVNDDTESPQFYSTNPASWSMGI----DIFAYGIVLLEVLSGQ 573
           D  +E + R+   G+  C +        Y       +  I    DI+ +G++L+E+L+G+
Sbjct: 817 DGKDEPHLRLSLPGLL-CTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGK 875

Query: 574 TP 575
           +P
Sbjct: 876 SP 877

Length = 968

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 59.6 bits (145), Expect = 6e-10
 Identities = 49/200 (24%), Positives = 89/200 (44%), Gaps = 34/200 (17%)

Query: 392 GAVYHG--RLNGKNLAIK----RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPH 445
           G+VY    +  G+ +AIK      + + I K E+ +++      P IV+  G+   +   
Sbjct: 17  GSVYKAIHKETGQVVAIKVVPVEEDLQEIIK-EISILKQC--DSPYIVKYYGSYFKNT-D 72

Query: 446 SFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNP 505
            ++V EY   GS+ D       MK          LT  +   I       L+Y+H   + 
Sbjct: 73  LWIVMEYCGAGSVSD------IMK-----ITNKTLTEEEIAAILYQTLKGLEYLH---SN 118

Query: 506 SYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE-------SPQFYS---TNPASWSM 555
             +HR+IK+ NI L+EE  A++ +FG++  + D          +P + +        ++ 
Sbjct: 119 KKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNN 178

Query: 556 GIDIFAYGIVLLEVLSGQTP 575
             DI++ GI  +E+  G+ P
Sbjct: 179 KADIWSLGITAIEMAEGKPP 198

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score = 59.7 bits (145), Expect = 7e-10
 Identities = 52/206 (25%), Positives = 86/206 (41%), Gaps = 40/206 (19%)

Query: 392 GAVYHG--RLNGKNLAIK--------RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLT 441
           G+VY G    +G   A+K        +T  E + +LE ++   +   HPNIV+ LGT   
Sbjct: 14  GSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTERE 73

Query: 442 DGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHH 501
           +      + E    GSL   L    +     I      L   Q L       + L+Y+H 
Sbjct: 74  EDNLYIFL-ELVPGGSLAKLLKKYGSFPEPVIR-----LYTRQIL-------LGLEYLH- 119

Query: 502 VMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQF------------YSTN 549
             + + VHR+IK  NI +D     ++ +FGMA+ V + + +  F                
Sbjct: 120 --DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQG 177

Query: 550 PASWSMGIDIFAYGIVLLEVLSGQTP 575
               +   DI++ G  +LE+ +G+ P
Sbjct: 178 GYGLA--ADIWSLGCTVLEMATGKPP 201

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 60.2 bits (147), Expect = 8e-10
 Identities = 45/203 (22%), Positives = 88/203 (43%), Gaps = 47/203 (23%)

Query: 399 LNGKNLAIKR----TEHEVITK--L-EMQLVQHATHHHPNIVRLLGTCLTDGPHSF---- 447
             G+ +AIK+     +  +  K  L E++L++H    H NI+ LL       P  F    
Sbjct: 23  RTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL--RHENIIGLLDILRPPSPEDFNDVY 80

Query: 448 LVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH--HVMNP 505
           +V E  +   L   +     + +  I     +  + Q LR        L+Y+H  +V   
Sbjct: 81  IVTELMET-DLHKVIKSPQPLTDDHI----QYFLY-QILR-------GLKYLHSANV--- 124

Query: 506 SYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYS--------------TNPA 551
             +HR++K  NI ++   + ++ +FG+AR V+ D +   F +               + +
Sbjct: 125 --IHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSS 182

Query: 552 SWSMGIDIFAYGIVLLEVLSGQT 574
            ++  IDI++ G +  E+L+ + 
Sbjct: 183 RYTKAIDIWSVGCIFAELLTRKP 205

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 59.7 bits (145), Expect = 8e-10
 Identities = 51/221 (23%), Positives = 95/221 (42%), Gaps = 58/221 (26%)

Query: 392 GAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATH----------------HHPNIVRL 435
           G +++G L  +       E EV  K    +  HA+                  H NI+ +
Sbjct: 20  GRIFYGILIDEKPG---KEEEVFVK---TVKDHASEIQVTLLLQESCLLYGLSHQNILPI 73

Query: 436 LGTCLTDGPHSFLVFEYAKNGSLKDWLHGG-LAMKNQFIASCYCFLTWSQRLRICLDVAM 494
           L  C+ DG   F+++ Y   G+LK +L    L   N   A     L+  Q + + + +A 
Sbjct: 74  LHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQA-----LSTQQLVHMAIQIAC 128

Query: 495 ALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR--------CVNDDTESP--- 543
            + Y+H       +H++I +RN  +DEE   ++ +  ++R        C+ D+   P   
Sbjct: 129 GMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKW 185

Query: 544 --------QFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTP 575
                   + YS+         D++++G++L E+++ GQTP
Sbjct: 186 MALESLVNKEYSS-------ASDVWSFGVLLWELMTLGQTP 219

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 60.4 bits (146), Expect = 8e-10
 Identities = 51/196 (26%), Positives = 95/196 (48%), Gaps = 34/196 (17%)

Query: 402 KNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW 461
           K+ A  +   ++++++EM         H NI+ LLG C  DGP   LV EYA  G+L+++
Sbjct: 53  KDDATDKDLSDLVSEMEMM---KMIGKHKNIINLLGACTQDGPLYVLV-EYASKGNLREY 108

Query: 462 LHGGL--AMKNQFIASCYC---FLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRN 516
           L       M   F  +C      LT+   +     VA  ++Y+    +   +HR++ +RN
Sbjct: 109 LRARRPPGMDYSF-DTCKLPEEQLTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARN 164

Query: 517 IFLDEEFNARVGNFGMARCVNDDTESPQFY--STN---PASW-----------SMGIDIF 560
           + + E+   ++ +FG+AR    D  +  +Y  +TN   P  W           +   D++
Sbjct: 165 VLVTEDNVMKIADFGLAR----DVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 220

Query: 561 AYGIVLLEVLS-GQTP 575
           ++G++L E+ + G +P
Sbjct: 221 SFGVLLWEIFTLGGSP 236

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 59.5 bits (144), Expect = 9e-10
 Identities = 40/160 (25%), Positives = 82/160 (51%), Gaps = 27/160 (16%)

Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLR 487
            HP +VRL    +T  P  +++ EY +NGSL D+L     +K          LT ++ + 
Sbjct: 59  QHPRLVRLYAV-VTQEP-IYIITEYMENGSLVDFLKTPEGIK----------LTINKLID 106

Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYS 547
           +   +A  + ++    N  Y+HR++++ NI + E    ++ +FG+AR + D+  + +  +
Sbjct: 107 MAAQIAEGMAFIE-RKN--YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGA 163

Query: 548 TNPASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
             P  W           ++  D++++GI+L E+++ G+ P
Sbjct: 164 KFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 47/163 (28%), Positives = 74/163 (45%), Gaps = 35/163 (21%)

Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           H  IVRLLG C   G    LV + +  GSL D +      +++        L W      
Sbjct: 68  HAYIVRLLGIC--PGASLQLVTQLSPLGSLLDHVR-----QHRDSLDPQRLLNW------ 114

Query: 489 CLDVAMALQYMH-HVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYS 547
           C+ +A  + Y+  H M    VHRN+ +RNI L  +   ++ +FG+A  +  D +   FYS
Sbjct: 115 CVQIAKGMYYLEEHRM----VHRNLAARNILLKSDSIVQIADFGVADLLYPD-DKKYFYS 169

Query: 548 --TNPASWSMGI------------DIFAYGIVLLEVLS-GQTP 575
               P  W M +            D+++YG+ + E++S G  P
Sbjct: 170 EHKTPIKW-MALESILFGRYTHQSDVWSYGVTVWEMMSYGAEP 211

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 58.8 bits (142), Expect = 2e-09
 Identities = 43/175 (24%), Positives = 84/175 (48%), Gaps = 22/175 (12%)

Query: 418 EMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG----GLAMKNQFI 473
           EM+L++     H NI+ LLG C  +GP  +++ EYA  G+L+++L      G        
Sbjct: 67  EMELMK-LIGKHKNIINLLGVCTQEGP-LYVIVEYAAKGNLREFLRARRPPGPDYTFDIT 124

Query: 474 ASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA 533
                 L++   +     VA  ++Y+    +   +HR++ +RN+ + E+   ++ +FG+A
Sbjct: 125 KVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGLA 181

Query: 534 RCVND-DTESPQFYSTNPASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
           R V+D D          P  W           +   D++++GI++ E+ + G +P
Sbjct: 182 RGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSP 236

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 58.5 bits (141), Expect = 3e-09
 Identities = 44/196 (22%), Positives = 92/196 (46%), Gaps = 34/196 (17%)

Query: 402 KNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW 461
           K+ A ++   ++++++EM         H NI+ LLG C  DGP  +++ EYA  G+L+++
Sbjct: 56  KDDATEKDLSDLVSEMEMM---KMIGKHKNIINLLGACTQDGP-LYVIVEYASKGNLREY 111

Query: 462 LHGGLAMKNQFIASCYCF---------LTWSQRLRICLDVAMALQYMHHVMNPSYVHRNI 512
           L        +     Y +         +T+   +     VA  ++Y+    +   +HR++
Sbjct: 112 LRARRPPGME-----YSYDIARVPDEQMTFKDLVSCTYQVARGMEYL---ASQKCIHRDL 163

Query: 513 KSRNIFLDEEFNARVGNFGMARCVND-DTESPQFYSTNPASW-----------SMGIDIF 560
            +RN+ + E    ++ +FG+AR VN+ D          P  W           +   D++
Sbjct: 164 AARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVW 223

Query: 561 AYGIVLLEVLS-GQTP 575
           ++G+++ E+ + G +P
Sbjct: 224 SFGVLMWEIFTLGGSP 239

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 58.7 bits (143), Expect = 3e-09
 Identities = 45/178 (25%), Positives = 80/178 (44%), Gaps = 62/178 (34%)

Query: 427 HHHPNIVRLLGTCLTDGPHS-FLVFEYA--------KNGSLKDWLHGGLAMKNQFIASCY 477
             HPNIV+LL     +     +LVFEY         +   L+D +H       ++I   Y
Sbjct: 64  GDHPNIVKLLNVIKAENDKDIYLVFEYMETDLHAVIRANILED-VH------KRYIM--Y 114

Query: 478 CFLTWSQRLRICLDVAMALQYMH--HVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARC 535
                 Q L+       AL+Y+H  +V     +HR++K  NI L+ +   ++ +FG+AR 
Sbjct: 115 ------QLLK-------ALKYIHSGNV-----IHRDLKPSNILLNSDCRVKLADFGLARS 156

Query: 536 VNDDTESPQFYSTNPA--------------------SWSMGIDIFAYGIVLLEVLSGQ 573
           +++  E+P+    NP                      ++ G+D+++ G +L E+L G+
Sbjct: 157 LSELEENPE----NPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGK 210

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 58.0 bits (140), Expect = 3e-09
 Identities = 43/203 (21%), Positives = 95/203 (46%), Gaps = 40/203 (19%)

Query: 400 NGKNLAIKRTEHEVITKLEM-QLVQHATH----HHPNIVRLLGTCL---TDG--PHSFLV 449
           + + +A+K  + ++ +  ++ + ++ A       HPN+++L+G  L     G  P   ++
Sbjct: 26  SFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVI 85

Query: 450 FEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVH 509
             + K+G L  +L      +  F       L     +R  +D+A  ++Y+    + +++H
Sbjct: 86  LPFMKHGDLHTFLLMSRIGEEPFT------LPLQTLVRFMIDIASGMEYLS---SKNFIH 136

Query: 510 RNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFY-----STNPASW----------- 553
           R++ +RN  L+E     V +FG+++ +     S  +Y     S  P  W           
Sbjct: 137 RDLAARNCMLNENMTVCVADFGLSKKI----YSGDYYRQGCASKLPVKWLALESLADNVY 192

Query: 554 SMGIDIFAYGIVLLEVLS-GQTP 575
           +   D++A+G+ + E+++ GQTP
Sbjct: 193 TTHSDVWAFGVTMWEIMTRGQTP 215

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 51/183 (27%), Positives = 87/183 (47%), Gaps = 43/183 (23%)

Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL---HGG 465
           ++ EVI   +M+        HPNIV    +   +G   F+V EY   G L   +    G 
Sbjct: 46  SKKEVILLAKMK--------HPNIVTFFASFQENG-RLFIVMEYCDGGDLMKRINRQRGV 96

Query: 466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEE-FN 524
           L  ++Q        L+W       + +++ L+++H   +   +HR+IKS+NIFL +    
Sbjct: 97  LFSEDQI-------LSWF------VQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMV 140

Query: 525 ARVGNFGMARCVNDDTE------------SPQFYSTNPASWSMGIDIFAYGIVLLEVLSG 572
           A++G+FG+AR +ND  E            SP+     P  ++   DI++ G VL E+ + 
Sbjct: 141 AKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRP--YNNKTDIWSLGCVLYELCTL 198

Query: 573 QTP 575
           + P
Sbjct: 199 KHP 201

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 57.7 bits (139), Expect = 4e-09
 Identities = 56/217 (25%), Positives = 98/217 (45%), Gaps = 44/217 (20%)

Query: 390 IEGAVYHGRLNGKNLAIK--RTEHEVITKLEMQLVQHATHH--HPNIVRLLGTCLTDGPH 445
           ++  VY  R    ++AIK  + E+E   + EM       H   +P IVR++G C  +   
Sbjct: 11  VKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVC--EAEA 68

Query: 446 SFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNP 505
             LV E A  G L           N+F++     +T S  + +   V+M ++Y+      
Sbjct: 69  LMLVMEMASGGPL-----------NKFLSGKKDEITVSNVVELMHQVSMGMKYLE---GK 114

Query: 506 SYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN-----PASW------- 553
           ++VHR++ +RN+ L  +  A++ +FG+++ +  D     +Y        P  W       
Sbjct: 115 NFVHRDLAARNVLLVNQHYAKISDFGLSKALGADD---SYYKARSAGKWPLKWYAPECIN 171

Query: 554 ----SMGIDIFAYGIVLLEVLS-GQTPINRPRKKDEG 585
               S   D+++YGI + E  S GQ    +P KK +G
Sbjct: 172 FRKFSSRSDVWSYGITMWEAFSYGQ----KPYKKMKG 204

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score = 57.7 bits (140), Expect = 4e-09
 Identities = 49/217 (22%), Positives = 86/217 (39%), Gaps = 57/217 (26%)

Query: 389 RI-EGAVYHG-------RLNGKNLAIKR---------TEHEVITKLE-MQLVQHATHHHP 430
           RI EGA  HG       R  G+ +A+K+           ++ + +++ +Q  QH     P
Sbjct: 7   RIGEGA--HGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQH-----P 59

Query: 431 NIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICL 490
            +V+LL      G    LV EY     L + L                 L  +Q      
Sbjct: 60  YVVKLLDV-FPHGSGFVLVMEYMP-SDLSEVLR-----------DEERPLPEAQVKSYMR 106

Query: 491 DVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNP 550
            +   + YMH       +HR++K  N+ +  +   ++ +FG+AR  +++      YS   
Sbjct: 107 MLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL--YSHQV 161

Query: 551 AS-WSM-------------GIDIFAYGIVLLEVLSGQ 573
           A+ W               G+D++A G +  E+L+G 
Sbjct: 162 ATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGS 198

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 57.2 bits (138), Expect = 6e-09
 Identities = 29/110 (26%), Positives = 54/110 (49%), Gaps = 17/110 (15%)

Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQR--- 485
           HPN+++ LG C+   P+  LV E+   G LK++L     M  Q           +Q+   
Sbjct: 54  HPNVLQCLGQCIESIPY-LLVLEFCPLGDLKNYLRSNRGMVAQM----------AQKDVL 102

Query: 486 LRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARC 535
            R+  +VA  L ++H      ++H ++  RN  L  + + ++G++G+A  
Sbjct: 103 QRMACEVASGLLWLHQA---DFIHSDLALRNCQLTADLSVKIGDYGLALE 149

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 56.6 bits (136), Expect = 7e-09
 Identities = 55/211 (26%), Positives = 99/211 (46%), Gaps = 44/211 (20%)

Query: 392 GAVYHGRLNGKN-LAIKRTEHEVITK----LEMQLVQHATHHHPNIVRLLGTCLTDGPHS 446
           G V+ G  NG   +AIK  +   ++      E Q+++   H    +V+L    +++ P  
Sbjct: 20  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE--KLVQLYAV-VSEEP-I 75

Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQY---MHHVM 503
           ++V EY   GSL D+L G                   + LR+   V MA Q    M +V 
Sbjct: 76  YIVTEYMSKGSLLDFLKG----------------EMGKYLRLPQLVDMAAQIASGMAYVE 119

Query: 504 NPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW---------- 553
             +YVHR++++ NI + E    +V +FG+AR + D+  + +  +  P  W          
Sbjct: 120 RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 179

Query: 554 -SMGIDIFAYGIVLLEVLS-GQTP----INR 578
            ++  D++++GI+L E+ + G+ P    +NR
Sbjct: 180 FTIKSDVWSFGILLTELTTKGRVPYPGMVNR 210

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 56.3 bits (136), Expect = 8e-09
 Identities = 42/166 (25%), Positives = 71/166 (42%), Gaps = 34/166 (20%)

Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           H ++V+L G C+ D   + +V EY K G L  +LH     KN                  
Sbjct: 60  HKHLVKLYGVCVRDE--NIMVEEYVKFGPLDVFLH---REKNNVSLHWK----------- 103

Query: 489 CLDVAMALQY-MHHVMNPSYVHRNIKSRNIFL----DEEFN---ARVGNFGMARCVNDDT 540
            LDVA  L   +H++ +   VH N+  +NI +      E      ++ + G+   V    
Sbjct: 104 -LDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSRE 162

Query: 541 E--------SPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPIN 577
           E        +P+      AS ++  D +++G  LLE+ S G+ P++
Sbjct: 163 ERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLS 208

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 43/169 (25%), Positives = 78/169 (46%), Gaps = 31/169 (18%)

Query: 418 EMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCY 477
           E +++Q    +HP +V L  +   D  + +LV +    G L+   H  L+ K +F     
Sbjct: 50  ERRILQEL--NHPFLVNLWYS-FQDEENMYLVVDLLLGGDLR--YH--LSQKVKFSEE-- 100

Query: 478 CFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN 537
                  +  IC ++ +AL+Y+H   +   +HR+IK  NI LDE+ +  + +F +A  V 
Sbjct: 101 -----QVKFWIC-EIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVT 151

Query: 538 DDTES-----------PQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTP 575
            DT +           P+        +S+ +D ++ G+   E L G+ P
Sbjct: 152 PDTLTTSTSGTPGYMAPEVLCR--QGYSVAVDWWSLGVTAYECLRGKRP 198

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 55.9 bits (135), Expect = 2e-08
 Identities = 47/212 (22%), Positives = 92/212 (43%), Gaps = 49/212 (23%)

Query: 392 GAVYHG--RLNGKN----LAIKRTEHEVITKLEMQLVQH----ATHHHPNIVRLLGTCLT 441
           G VY G     G+     +AIK    E   K   +++      A+  HP++VRLLG CL+
Sbjct: 21  GTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS 80

Query: 442 DGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQY--M 499
                 L+ +    G L D++       ++        L W      C+ +A  + Y   
Sbjct: 81  --SQVQLITQLMPLGCLLDYVR-----NHKDNIGSQYLLNW------CVQIAKGMSYLEE 127

Query: 500 HHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN---PASWSMG 556
             +     VHR++ +RN+ +    + ++ +FG+A+ +  D +  ++++     P  W M 
Sbjct: 128 KRL-----VHRDLAARNVLVKTPQHVKITDFGLAKLL--DVDEKEYHAEGGKVPIKW-MA 179

Query: 557 I------------DIFAYGIVLLEVLS-GQTP 575
           +            D+++YG+ + E+++ G  P
Sbjct: 180 LESILHRIYTHKSDVWSYGVTVWELMTFGAKP 211

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 47/198 (23%), Positives = 92/198 (46%), Gaps = 35/198 (17%)

Query: 398 RLNGKNLAIKRTEHEVITKLEM---QLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAK 454
           + +GK +A+K+ +     + E+   ++V    + H N+V +  + L  G   ++V E+ +
Sbjct: 42  KSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-GDELWVVMEFLE 100

Query: 455 NGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKS 514
            G+L D +     M  + IA+            +CL V  AL  +H       +HR+IKS
Sbjct: 101 GGALTD-IVTHTRMNEEQIAA------------VCLAVLKALSVLH---AQGVIHRDIKS 144

Query: 515 RNIFLDEEFNARVGNFGMARCVNDDTE------------SPQFYSTNPASWSMGIDIFAY 562
            +I L  +   ++ +FG    V+ +              +P+  S  P  +   +DI++ 
Sbjct: 145 DSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLP--YGPEVDIWSL 202

Query: 563 GIVLLEVLSGQTP-INRP 579
           GI+++E++ G+ P  N P
Sbjct: 203 GIMVIEMVDGEPPYFNEP 220

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score = 55.2 bits (134), Expect = 2e-08
 Identities = 40/180 (22%), Positives = 81/180 (45%), Gaps = 28/180 (15%)

Query: 406 IKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGG 465
           I + +    T  E  ++     +HP IV+L     T+    +LV EYA  G L  + H  
Sbjct: 31  IIKRKEVEHTLTERNILSRI--NHPFIVKLHYAFQTEE-KLYLVLEYAPGGEL--FSH-- 83

Query: 466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNA 525
                  ++    F     R     ++ +AL+Y+H   +   ++R++K  NI LD + + 
Sbjct: 84  -------LSKEGRFSEERARFYAA-EIVLALEYLH---SLGIIYRDLKPENILLDADGHI 132

Query: 526 RVGNFGMARCVNDDTESPQFYSTNP----------ASWSMGIDIFAYGIVLLEVLSGQTP 575
           ++ +FG+A+ ++ +      +   P            +   +D ++ G++L E+L+G+ P
Sbjct: 133 KLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 54.9 bits (133), Expect = 4e-08
 Identities = 48/197 (24%), Positives = 85/197 (43%), Gaps = 45/197 (22%)

Query: 400 NGKNLAIKRTEHEVITKLEMQLVQHATH---------HHPNIVRLLGTCLTDGPHSFLVF 450
           +GK  A+K      I  ++++ V+H             HP +V L G+   D  + +LV 
Sbjct: 25  SGKYYALKILSKAKI--VKLKQVEH-VLNEKRILQSIRHPFLVNLYGS-FQDDSNLYLVM 80

Query: 451 EYAKNGSLKDWLHGGLAMKN---QFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSY 507
           EY   G L   L           +F A+                V +AL+Y+H +     
Sbjct: 81  EYVPGGELFSHLRKSGRFPEPVARFYAA---------------QVVLALEYLHSL---DI 122

Query: 508 VHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTES----PQFYSTNP-----ASWSMGID 558
           V+R++K  N+ LD +   ++ +FG A+ V   T +    P++ +  P       +   +D
Sbjct: 123 VYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLCGTPEYLA--PEIILSKGYGKAVD 180

Query: 559 IFAYGIVLLEVLSGQTP 575
            +A GI++ E+L+G  P
Sbjct: 181 WWALGILIYEMLAGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 55.1 bits (132), Expect = 4e-08
 Identities = 39/159 (24%), Positives = 75/159 (47%), Gaps = 28/159 (17%)

Query: 425 ATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQ 484
           A+  HP++VRLLG CL+  P   LV +   +G L D++H     +++        L W  
Sbjct: 64  ASMDHPHLVRLLGVCLS--PTIQLVTQLMPHGCLLDYVH-----EHKDNIGSQLLLNW-- 114

Query: 485 RLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN-DDTESP 543
               C+ +A  + Y+        VHR++ +RN+ +    + ++ +FG+AR +  D+ E  
Sbjct: 115 ----CVQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN 167

Query: 544 QFYSTNPASW-----------SMGIDIFAYGIVLLEVLS 571
                 P  W           +   D+++YG+ + E+++
Sbjct: 168 ADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 206

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 54.5 bits (131), Expect = 4e-08
 Identities = 49/188 (26%), Positives = 87/188 (46%), Gaps = 42/188 (22%)

Query: 398 RLNGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGS 457
           +++ K     R E  V++ ++          HPNIV+   +   +G + ++V +Y + G 
Sbjct: 37  KMSPKEREESRKEVAVLSNMK----------HPNIVQYQESFEENG-NLYIVMDYCEGGD 85

Query: 458 LKDWLHG--GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSR 515
           L   ++   G+      I      L W   ++ICL        + HV +   +HR+IKS+
Sbjct: 86  LYKKINAQRGVLFPEDQI------LDWF--VQICLA-------LKHVHDRKILHRDIKSQ 130

Query: 516 NIFLDEEFNARVGNFGMARCVNDDTE------------SPQFYSTNPASWSMGIDIFAYG 563
           NIFL ++   ++G+FG+AR +N   E            SP+     P  ++   DI+A G
Sbjct: 131 NIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRP--YNNKSDIWALG 188

Query: 564 IVLLEVLS 571
            VL E+ +
Sbjct: 189 CVLYEMCT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 54.4 bits (132), Expect = 4e-08
 Identities = 38/164 (23%), Positives = 69/164 (42%), Gaps = 41/164 (25%)

Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLR 487
            HPNIV+LL    T+    +LVFEY     LK           +++      L+ +    
Sbjct: 56  KHPNIVKLLDVIHTER-KLYLVFEYCDM-DLK-----------KYLDKRPGPLSPNLIKS 102

Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR--CVNDDTESP-- 543
           I   +   L Y H       +HR++K +NI ++ +   ++ +FG+AR   +   T +   
Sbjct: 103 IMYQLLRGLAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEV 159

Query: 544 --------------QFYSTNPASWSMGIDIFAYGIVLLEVLSGQ 573
                         + YST        +DI++ G +  E+++G+
Sbjct: 160 VTLWYRAPEILLGSKHYST-------AVDIWSVGCIFAEMITGK 196

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 54.0 bits (130), Expect = 5e-08
 Identities = 39/163 (23%), Positives = 69/163 (42%), Gaps = 24/163 (14%)

Query: 425 ATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQ 484
           A+ +HPNI+      L DG    +V EYA  G L   +      +            W  
Sbjct: 54  ASVNHPNIISYKEAFL-DGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQ----EIW-- 106

Query: 485 RLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---TE 541
             RI + +   LQ +H       +HR++KS NI L      ++G+ G+++ +  +   T+
Sbjct: 107 --RIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQ 161

Query: 542 -------SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
                  +P+ +   P S+    DI++ G +L E+ +   P  
Sbjct: 162 IGTPHYMAPEVWKGRPYSYKS--DIWSLGCLLYEMATFAPPFE 202

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 54.3 bits (131), Expect = 5e-08
 Identities = 52/172 (30%), Positives = 80/172 (46%), Gaps = 35/172 (20%)

Query: 379 RATEKFNSSNRI-EGA---VYHGR--LNGKNLAIK--RTEHE----VITKL-EMQLVQHA 425
           R+  +F   NRI EG    VY  R   +G+ +A+K  R ++E     I+ L E+ L+ + 
Sbjct: 4   RSVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNL 63

Query: 426 THHHPNIVRLLGTCLTDGPHS-FLVFEYAKN--GSLKDWLHGGLAMKNQFIASCYCFLTW 482
              HPNIV L    +     S FLV EY +    SL D       M   F        + 
Sbjct: 64  --RHPNIVELKEVVVGKHLDSIFLVMEYCEQDLASLLD------NMPTPF--------SE 107

Query: 483 SQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR 534
           SQ   + L +   LQY+H       +HR++K  N+ L ++   ++ +FG+AR
Sbjct: 108 SQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLAR 156

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 53.9 bits (129), Expect = 5e-08
 Identities = 39/165 (23%), Positives = 78/165 (47%), Gaps = 32/165 (19%)

Query: 426 THHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL---HGGLAMKNQFIASCYCFLTW 482
           T  H  +VRL      + P  +++ EY   GSL D+L    GG  +  + I         
Sbjct: 57  TLQHDKLVRLYAVVTKEEP-IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFS------ 109

Query: 483 SQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDT-- 540
                     A   + M ++   +Y+HR++++ N+ + E    ++ +FG+AR + D+   
Sbjct: 110 ----------AQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159

Query: 541 --ESPQF-------YSTNPASWSMGIDIFAYGIVLLEVLS-GQTP 575
             E  +F        + N  S+++  D++++GI+L E+++ G+ P
Sbjct: 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIP 204

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 53.8 bits (129), Expect = 5e-08
 Identities = 47/159 (29%), Positives = 69/159 (43%), Gaps = 28/159 (17%)

Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSL--KDWLHGGLAMKNQFIASCYCFLTWSQRL 486
           HPNIV    +   DG H ++V EY   G L  K  L  G       I      L W   +
Sbjct: 57  HPNIVAFKESFEADG-HLYIVMEYCDGGDLMQKIKLQRGKLFPEDTI------LQWF--V 107

Query: 487 RICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-----TE 541
           ++CL V        H+     +HR+IKS+NIFL +    ++G+FG AR +        T 
Sbjct: 108 QMCLGV-------QHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTY 160

Query: 542 SPQFYSTNPASW-----SMGIDIFAYGIVLLEVLSGQTP 575
               Y   P  W     +   DI++ G +L E+ + + P
Sbjct: 161 VGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHP 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 53.5 bits (129), Expect = 7e-08
 Identities = 42/151 (27%), Positives = 68/151 (45%), Gaps = 28/151 (18%)

Query: 392 GAVYHGR--LNGKNLAIK------RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDG 443
           G VY  R    G+ +AIK        + E+I + E+ +++   H  PNIV   G+ L   
Sbjct: 17  GDVYKARDIATGELVAIKVIKLEPGDDFEIIQQ-EISMLKECRH--PNIVAYFGSYLRRD 73

Query: 444 PHSFLVFEYAKNGSLKDWLH-GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
              ++V EY   GSL+D        +    IA  Y          +C +    L Y+H  
Sbjct: 74  -KLWIVMEYCGGGSLQDIYQVTRGPLSELQIA--Y----------VCRETLKGLAYLHET 120

Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMA 533
                +HR+IK  NI L E+ + ++ +FG++
Sbjct: 121 ---GKIHRDIKGANILLTEDGDVKLADFGVS 148

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score = 53.5 bits (129), Expect = 9e-08
 Identities = 47/217 (21%), Positives = 82/217 (37%), Gaps = 58/217 (26%)

Query: 392 GAVYHGRLNGKNLAIKRTEHEVITKLEMQLV--QHATH-------------HHPNIVRLL 436
           G VY         A+     E++   E+++      T               HPN+V+  
Sbjct: 14  GKVY--------TAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65

Query: 437 GTCLTDGPHSFLVF-EYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMA 495
           G  +        +F EY   G+L++ L  G  +    I          +   + L   +A
Sbjct: 66  GVEVHR--EKVYIFMEYCSGGTLEELLEHGRILDEHVI----------RVYTLQLLEGLA 113

Query: 496 LQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE-------------- 541
             + H +     VHR+IK  NIFLD     ++G+FG A  + ++T               
Sbjct: 114 YLHSHGI-----VHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPA 168

Query: 542 --SPQFYSTNPASWSMG-IDIFAYGIVLLEVLSGQTP 575
             +P+  +           DI++ G V+LE+ +G+ P
Sbjct: 169 YMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 53.3 bits (128), Expect = 9e-08
 Identities = 48/199 (24%), Positives = 84/199 (42%), Gaps = 47/199 (23%)

Query: 397 GRLNGKNLAIKRTEHEVITKLEMQLVQHATH-----HHPNIVRLLGTCLTDGPHSFLVFE 451
            + + K + IK+   E +TK E    Q+         HPNI+      L D     +V E
Sbjct: 21  RKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDK-ALMIVME 79

Query: 452 YAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQY-------MHHVMN 504
           YA  G+L +++                     +R    LD    L +       +HHV  
Sbjct: 80  YAPGGTLAEYIQ--------------------KRCNSLLDEDTILHFFVQILLALHHVHT 119

Query: 505 PSYVHRNIKSRNIFLDEEFN-ARVGNFGMARCVNDDTE-----------SPQFYSTNPAS 552
              +HR++K++NI LD+     ++G+FG+++ ++  ++           SP+     P  
Sbjct: 120 KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKP-- 177

Query: 553 WSMGIDIFAYGIVLLEVLS 571
           ++   DI+A G VL E+ S
Sbjct: 178 YNQKSDIWALGCVLYELAS 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 53.5 bits (129), Expect = 1e-07
 Identities = 40/161 (24%), Positives = 77/161 (47%), Gaps = 28/161 (17%)

Query: 398 RLNGKNLAIKRTEH--EVITKL-----EMQLVQHATHHHPNIVRLLGTCLT---DGPHSF 447
             +GK +AIK+  H  +V T       E+++++H    H NI+ +         D    +
Sbjct: 27  TRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRH--FKHDNIIAIRDILRPPGADFKDVY 84

Query: 448 LVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSY 507
           +V +  ++  L   +H    +  + I   Y FL   Q LR        L+Y+H   + + 
Sbjct: 85  VVMDLMES-DLHHIIHSDQPLTEEHI--RY-FL--YQLLR-------GLKYIH---SANV 128

Query: 508 VHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYST 548
           +HR++K  N+ ++E+   R+G+FGMAR ++      +++ T
Sbjct: 129 IHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMT 169

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 53.0 bits (127), Expect = 1e-07
 Identities = 39/161 (24%), Positives = 75/161 (46%), Gaps = 31/161 (19%)

Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           +P IVR++G C  +     LV E A+ G L  +L      KN+ +       T      +
Sbjct: 55  NPYIVRMIGIC--EAESWMLVMELAELGPLNKFLQ-----KNKHV-------TEKNITEL 100

Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYST 548
              V+M ++Y+      ++VHR++ +RN+ L  +  A++ +FG+++ +  D    +  + 
Sbjct: 101 VHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTH 157

Query: 549 N--PASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
              P  W           S   D++++G+++ E  S GQ P
Sbjct: 158 GKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKP 198

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 53.6 bits (128), Expect = 1e-07
 Identities = 47/188 (25%), Positives = 83/188 (44%), Gaps = 30/188 (15%)

Query: 401 GKNLAIKRTEHEVITKLEM---QLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGS 457
           G+ +AIK+   +   K E+   +++      +PNIV  L + L  G   F+V EY   GS
Sbjct: 44  GQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLV-GDELFVVMEYLAGGS 102

Query: 458 LKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNI 517
           L D +      + Q  A C          R CL    AL+++H       +HR+IKS N+
Sbjct: 103 LTDVVTETCMDEAQIAAVC----------RECLQ---ALEFLH---ANQVIHRDIKSDNV 146

Query: 518 FLDEEFNARVGNFGMARCVNDDTESPQFYSTNP----------ASWSMGIDIFAYGIVLL 567
            L  + + ++ +FG    +  +          P           ++   +DI++ GI+ +
Sbjct: 147 LLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAI 206

Query: 568 EVLSGQTP 575
           E++ G+ P
Sbjct: 207 EMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 53.0 bits (128), Expect = 1e-07
 Identities = 48/211 (22%), Positives = 86/211 (40%), Gaps = 37/211 (17%)

Query: 392 GAVY---HGRLNGKNLAIKRTEHEVITKLEMQLVQ--HATHH--HPNIVRLLGTCLTDGP 444
           G VY   H +  GK  A+K+   +   +   QL++          P +V+  G    +G 
Sbjct: 15  GVVYKVRH-KPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGE 73

Query: 445 HSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMN 504
            S +V EY   GSL D L     +    +A             I   +   L Y+H   +
Sbjct: 74  IS-IVLEYMDGGSLADLLKKVGKIPEPVLAY------------IARQILKGLDYLHTKRH 120

Query: 505 PSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------------SPQFYSTNPAS 552
              +HR+IK  N+ ++ +   ++ +FG+++ + +  +            SP+       S
Sbjct: 121 --IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPE--RIQGES 176

Query: 553 WSMGIDIFAYGIVLLEVLSGQTPINRPRKKD 583
           +S   DI++ G+ LLE   G+ P   P +  
Sbjct: 177 YSYAADIWSLGLTLLECALGKFPFLPPGQPS 207

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 53.0 bits (128), Expect = 1e-07
 Identities = 41/151 (27%), Positives = 65/151 (43%), Gaps = 29/151 (19%)

Query: 392 GAVYHGRLNGKN--LAIK-------RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTD 442
           G VY       N  +AIK         E E I + E+Q +  +    P I +  G     
Sbjct: 15  GEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQ-EIQFL--SQCRSPYITKYYG-SFLK 70

Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
           G   +++ EY   GS  D L  G  +   +IA             I  +V + L+Y+H  
Sbjct: 71  GSKLWIIMEYCGGGSCLDLLKPG-KLDETYIAF------------ILREVLLGLEYLH-- 115

Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMA 533
                +HR+IK+ NI L EE + ++ +FG++
Sbjct: 116 -EEGKIHRDIKAANILLSEEGDVKLADFGVS 145

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 53.0 bits (127), Expect = 2e-07
 Identities = 54/208 (25%), Positives = 94/208 (45%), Gaps = 41/208 (19%)

Query: 392 GAVYHGRLNGKN--LAIKRTEHEVI--------TKLEMQLVQHATHHHPNIVRLLGTCLT 441
           G V+   L G N   AIK  + +V+        T +E +++  A   HP +  L  T  T
Sbjct: 9   GKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLTHLYCTFQT 67

Query: 442 DGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHH 501
              + F V EY         L+GG  M +  I SC+ F    +      ++   LQ++H 
Sbjct: 68  K-ENLFFVMEY---------LNGGDLMFH--IQSCHKF-DLPRATFYAAEIICGLQFLH- 113

Query: 502 VMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR------------CVNDDTESPQFYSTN 549
             +   V+R++K  NI LD + + ++ +FGM +            C   D  +P+     
Sbjct: 114 --SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQ 171

Query: 550 PASWSMGIDIFAYGIVLLEVLSGQTPIN 577
             + S  +D +++G++L E+L GQ+P +
Sbjct: 172 KYNTS--VDWWSFGVLLYEMLIGQSPFH 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 52.9 bits (127), Expect = 2e-07
 Identities = 52/204 (25%), Positives = 92/204 (45%), Gaps = 37/204 (18%)

Query: 392 GAVYHGRLNGKN--LAIKRTEHEVI--------TKLEMQLVQHATHHHPNIVRLLGTCLT 441
           G V    L G N   AIK  + +V+        T +E +++  A  H P +  L  T  T
Sbjct: 9   GKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEH-PFLTHLFCTFQT 67

Query: 442 DGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHH 501
              H F V EY         L+GG  M +  I S   F     R     ++   LQ++H 
Sbjct: 68  K-EHLFFVMEY---------LNGGDLMFH--IQSSGRFDEARARFYAA-EIICGLQFLH- 113

Query: 502 VMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARC-VNDDTESPQFYST---------NPA 551
                 ++R++K  N+ LD++ + ++ +FGM +  +N + ++  F  T            
Sbjct: 114 --KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQ 171

Query: 552 SWSMGIDIFAYGIVLLEVLSGQTP 575
            ++  +D +++G++L E+L GQ+P
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSP 195

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 52.8 bits (126), Expect = 2e-07
 Identities = 54/226 (23%), Positives = 102/226 (45%), Gaps = 33/226 (14%)

Query: 366 KRLLESYSIEDLRRATEKFNSSNR-IEGAVYHGR--LNGKNLAIKRTEHEVITKLEM--- 419
           ++L    S+ D ++   +F    +   G VY       G+ +AI++   +   K E+   
Sbjct: 7   EKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN 66

Query: 420 QLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCF 479
           +++    + +PNIV  L + L  G   ++V EY   GSL D +      + Q  A C   
Sbjct: 67  EILVMRENKNPNIVNYLDSYLV-GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVC--- 122

Query: 480 LTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGM-ARCVND 538
                  R CL    AL+++H   +   +HR+IKS NI L  + + ++ +FG  A+   +
Sbjct: 123 -------RECLQ---ALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169

Query: 539 DTESPQFYST---------NPASWSMGIDIFAYGIVLLEVLSGQTP 575
            ++      T            ++   +DI++ GI+ +E++ G+ P
Sbjct: 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 51.9 bits (124), Expect = 3e-07
 Identities = 61/220 (27%), Positives = 97/220 (44%), Gaps = 50/220 (22%)

Query: 388 NRIEGAVYHGR--LNGKNLAIK-----RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCL 440
           N   G VY GR    G+  AIK       E E I KLE+ +++  +HH  NI    G  +
Sbjct: 26  NGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEI-KLEINMLKKYSHHR-NIATYYGAFI 83

Query: 441 TDGP-----HSFLVFEYAKNGSLKDWLHG--GLAMKNQFIASCYCFLTWSQRLRICLDVA 493
              P       +LV E+   GS+ D +    G A+K  +IA             IC ++ 
Sbjct: 84  KKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAY------------ICREIL 131

Query: 494 MALQYMH--HVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA----RCV---NDDTESPQ 544
             L ++H   V     +HR+IK +N+ L E    ++ +FG++    R V   N    +P 
Sbjct: 132 RGLAHLHAHKV-----IHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPY 186

Query: 545 FYS-------TNP-ASWSMGIDIFAYGIVLLEVLSGQTPI 576
           + +        NP A++    DI++ GI  +E+  G  P+
Sbjct: 187 WMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 52.1 bits (125), Expect = 3e-07
 Identities = 45/185 (24%), Positives = 80/185 (43%), Gaps = 44/185 (23%)

Query: 406 IKRTEH-----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD 460
           +K+ +H      V+ ++           HP I+RL  T   D    +++ EY   G L  
Sbjct: 42  LKQEQHVHNEKRVLKEVS----------HPFIIRLFWT-EHDQRFLYMLMEYVPGGELFS 90

Query: 461 WLHGGLAMKNQ---FIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNI 517
           +L       N    F AS               ++  AL+Y+H   +   V+R++K  NI
Sbjct: 91  YLRNSGRFSNSTGLFYAS---------------EIVCALEYLH---SKEIVYRDLKPENI 132

Query: 518 FLDEEFNARVGNFGMARCVNDDT----ESPQFY---STNPASWSMGIDIFAYGIVLLEVL 570
            LD+E + ++ +FG A+ + D T     +P++           +  +D +A GI++ E+L
Sbjct: 133 LLDKEGHIKLTDFGFAKKLRDRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEML 192

Query: 571 SGQTP 575
            G  P
Sbjct: 193 VGYPP 197

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 52.1 bits (125), Expect = 3e-07
 Identities = 53/236 (22%), Positives = 97/236 (41%), Gaps = 51/236 (21%)

Query: 396 HGRLNGKNLAIK-RTEHEVITKLEMQLVQHATHH--------HPNIVRLLGTCLTDGPHS 446
             +  G+  AIK   + E+   L+M+ VQH            HP IV ++ +   D    
Sbjct: 38  KHKGTGEYYAIKCLKKREI---LKMKQVQHVAQEKSILMELSHPFIVNMMCS-FQDENRV 93

Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           + + E+   G L   L       N  +A  Y             ++ +A +Y+H   +  
Sbjct: 94  YFLLEFVVGGELFTHLRKAGRFPND-VAKFYH-----------AELVLAFEYLH---SKD 138

Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDT----ESPQFYSTNPASWSMG----ID 558
            ++R++K  N+ LD + + +V +FG A+ V D T     +P++ +      S G    +D
Sbjct: 139 IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFTLCGTPEYLAPEVIQ-SKGHGKAVD 197

Query: 559 IFAYGIVLLEVLSG------QTPINRPRKKDEGSV----WLSEK----IKSILQAE 600
            +  G++L E ++G       TP     K   G +    W   +    +K +LQ +
Sbjct: 198 WWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPNWFDGRARDLVKGLLQTD 253

Length = 329

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 51.5 bits (123), Expect = 3e-07
 Identities = 47/194 (24%), Positives = 85/194 (43%), Gaps = 42/194 (21%)

Query: 398 RLNGKNLAIKRTEHEVITKLEMQLVQHATH-----HHPNIVRLLGTCLTDGPHSFLVFEY 452
           R +GK   IK+      ++ E +  +          HPNIV    +   +    ++V  +
Sbjct: 22  RTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGF 81

Query: 453 AKNGSLKDWLH---GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH--HVMNPSY 507
            + G L   L    G L  +NQ +        W       + +AMALQY+H  H++    
Sbjct: 82  CEGGDLYHKLKEQKGKLLPENQVV-------EWF------VQIAMALQYLHEKHIL---- 124

Query: 508 VHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------------SPQFYSTNPASWSM 555
            HR++K++N+FL      +VG+ G+AR + +  +            SP+ +S  P ++  
Sbjct: 125 -HRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKS 183

Query: 556 GIDIFAYGIVLLEV 569
             D++A G  + E+
Sbjct: 184 --DVWALGCCVYEM 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 52.0 bits (124), Expect = 3e-07
 Identities = 54/226 (23%), Positives = 98/226 (43%), Gaps = 33/226 (14%)

Query: 366 KRLLESYSIEDLRRATEKFNSSNR-IEGAVYHGR--LNGKNLAIKRTEHEVITKLEM--- 419
           ++L    S+ D ++   +F    +   G VY       G+ +AIK+   +   K E+   
Sbjct: 6   EKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIIN 65

Query: 420 QLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCF 479
           +++    + +PNIV  L + L  G   ++V EY   GSL D +      + Q  A C   
Sbjct: 66  EILVMRENKNPNIVNYLDSYLV-GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVC--- 121

Query: 480 LTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD 539
                  R CL    AL ++H   +   +HR+IKS NI L  + + ++ +FG    +  +
Sbjct: 122 -------RECLQ---ALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168

Query: 540 TESPQFYSTNP----------ASWSMGIDIFAYGIVLLEVLSGQTP 575
                     P           ++   +DI++ GI+ +E++ G+ P
Sbjct: 169 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 52.0 bits (125), Expect = 3e-07
 Identities = 42/161 (26%), Positives = 69/161 (42%), Gaps = 35/161 (21%)

Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGL--AMKNQFIASCYCFLTWSQRL 486
           HP +V L   C     H   V EYA  G L   +H  +    +  F A+C          
Sbjct: 61  HPFLVNLFA-CFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFYAAC---------- 109

Query: 487 RICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND----DTES 542
                V + LQY+H       V+R++K  N+ LD E   ++ +FG+  C       D  S
Sbjct: 110 -----VVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGL--CKEGMGFGDRTS 159

Query: 543 -----PQFYSTN---PASWSMGIDIFAYGIVLLEVLSGQTP 575
                P+F +       S++  +D +  G+++ E+L G++P
Sbjct: 160 TFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESP 200

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 47/208 (22%), Positives = 90/208 (43%), Gaps = 43/208 (20%)

Query: 392 GAVYHGRLNG-------KNLAIKRTEHEVITKLEMQLVQHAT-------HHHPNIVRLLG 437
           G VY G   G         +AIK        +  ++ +  A+       HH   +VRLLG
Sbjct: 20  GMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH---VVRLLG 76

Query: 438 TCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQ 497
             ++ G  + ++ E    G LK +L   L  + +         +  + +++  ++A  + 
Sbjct: 77  V-VSQGQPTLVIMELMTRGDLKSYLRS-LRPEMEN-NPVQAPPSLKKMIQMAGEIADGMA 133

Query: 498 YMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYS---------- 547
           Y++      +VHR++ +RN  + E+F  ++G+FGM R    D     +Y           
Sbjct: 134 YLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPVR 186

Query: 548 -TNPASWSMGI-----DIFAYGIVLLEV 569
             +P S   G+     D++++G+VL E+
Sbjct: 187 WMSPESLKDGVFTTYSDVWSFGVVLWEI 214

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 51.7 bits (124), Expect = 4e-07
 Identities = 41/173 (23%), Positives = 74/173 (42%), Gaps = 34/173 (19%)

Query: 418 EMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVF-EYAKNGSLKDWLHGGLAMKNQFIASC 476
           E++ ++     H NIV+ LG           +F EY   GS+   L        +F    
Sbjct: 58  EIETLKDL--DHLNIVQYLG--FETTEEYLSIFLEYVPGGSIGSCLR----TYGRFEEQL 109

Query: 477 YCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV 536
             F T  Q L         L Y+H   +   +HR++K+ N+ +D +   ++ +FG+++  
Sbjct: 110 VRFFT-EQVLE-------GLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKS 158

Query: 537 -----NDDTES---------PQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTP 575
                ND   S         P+   +    +S  +DI++ G V+LE+ +G+ P
Sbjct: 159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 51.5 bits (123), Expect = 4e-07
 Identities = 35/141 (24%), Positives = 68/141 (48%), Gaps = 25/141 (17%)

Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           ++V EY   GSL D+L  G              L     + +   VA  + Y+   MN  
Sbjct: 76  YIVTEYMSKGSLLDFLKDGEGR----------ALKLPNLVDMAAQVAAGMAYIER-MN-- 122

Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SM 555
           Y+HR+++S NI + +    ++ +FG+AR + D+  + +  +  P  W           ++
Sbjct: 123 YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182

Query: 556 GIDIFAYGIVLLEVLS-GQTP 575
             D++++GI+L E+++ G+ P
Sbjct: 183 KSDVWSFGILLTELVTKGRVP 203

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 51.3 bits (123), Expect = 4e-07
 Identities = 40/156 (25%), Positives = 67/156 (42%), Gaps = 30/156 (19%)

Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL---HGGLAMKNQFIASCYCFLTWSQ 484
            HPNI+      + D     +  EYA  G+L D +    G L  +   +   Y F   S 
Sbjct: 57  QHPNIIAYYNHFMDDNT-LLIEMEYANGGTLYDKIVRQKGQLFEEEMVLW--YLFQIVS- 112

Query: 485 RLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQ 544
                     A+ Y+H       +HR+IK+ NIFL +    ++G+FG+++ +  +    +
Sbjct: 113 ----------AVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE 159

Query: 545 F-----YSTNP-----ASWSMGIDIFAYGIVLLEVL 570
                 Y  +P       ++   DI+A G VL E+L
Sbjct: 160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELL 195

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 51.5 bits (123), Expect = 4e-07
 Identities = 43/165 (26%), Positives = 74/165 (44%), Gaps = 39/165 (23%)

Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRL 486
           H NIVRL G  +T G    +V EY  NG+L  +L  H G              L   Q +
Sbjct: 65  HSNIVRLEGV-ITRGNTMMIVTEYMSNGALDSFLRKHEGQ-------------LVAGQLM 110

Query: 487 RICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFY 546
            +   +A  ++Y+  +    YVH+ + +  + ++ +   ++  F   R   D +E+   Y
Sbjct: 111 GMLPGLASGMKYLSEM---GYVHKGLAAHKVLVNSDLVCKISGFR--RLQEDKSEA--IY 163

Query: 547 ST----NPASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
           +T    +P  W           S   D++++GIV+ EV+S G+ P
Sbjct: 164 TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERP 208

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 51.3 bits (123), Expect = 5e-07
 Identities = 47/157 (29%), Positives = 71/157 (45%), Gaps = 34/157 (21%)

Query: 392 GAVY--HGRLNGKNLAIKR---------TEHEVIT-KLEMQLVQHATHHHPNIVRLLGTC 439
           G VY  +    G+ LA+K+         T+ EV   + E+QL++     H  IV+  G C
Sbjct: 16  GRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLK--NLQHERIVQYYG-C 72

Query: 440 LTDGPHSFLVFEYAKNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQ 497
           L D     +  EY   GS+KD L  +G L    + +   Y      Q L         ++
Sbjct: 73  LRDDETLSIFMEYMPGGSVKDQLKAYGAL---TETVTRKYTR----QILE-------GVE 118

Query: 498 YMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR 534
           Y+H  M    VHR+IK  NI  D   N ++G+FG ++
Sbjct: 119 YLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASK 152

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 51.4 bits (124), Expect = 5e-07
 Identities = 38/163 (23%), Positives = 66/163 (40%), Gaps = 37/163 (22%)

Query: 427 HHHPNIVRLLGTCLTDGPHSFLVFEYAKN---GSLKDWLHGGLAMKNQFIASCYCFLTWS 483
           + HPNIV+L      +    + VFEY +      +KD    G       I S        
Sbjct: 55  NEHPNIVKLKEVFREND-ELYFVFEYMEGNLYQLMKD--RKGKPFSESVIRS-------- 103

Query: 484 QRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESP 543
               I   +   L ++H      + HR++K  N+ +      ++ +FG+AR +      P
Sbjct: 104 ----IIYQILQGLAHIHKH---GFFHRDLKPENLLVSGPEVVKIADFGLAREIR---SRP 153

Query: 544 QF--Y-STN----P------ASWSMGIDIFAYGIVLLEVLSGQ 573
            +  Y ST     P       S+S  +DI+A G ++ E+ + +
Sbjct: 154 PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 51.0 bits (122), Expect = 6e-07
 Identities = 30/112 (26%), Positives = 51/112 (45%), Gaps = 26/112 (23%)

Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK------DWLHG-GLAMKNQFIASCYCFL 480
            HPNI++ LG C+   P+  LVFEY + G LK       W       +  Q         
Sbjct: 53  QHPNILQCLGQCVEAIPY-LLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ--------- 102

Query: 481 TWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGM 532
                 R+  ++A  + +MH     +++H ++  RN FL  +   +VG++G+
Sbjct: 103 ------RMACEIAAGVTHMHKH---NFLHSDLALRNCFLTSDLTVKVGDYGI 145

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 50.9 bits (121), Expect = 6e-07
 Identities = 55/217 (25%), Positives = 94/217 (43%), Gaps = 44/217 (20%)

Query: 388 NRIEGAVYHGR--LNGKNLAIK----RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLT 441
           N   G VY GR    G+  AIK      + E   K E+ +++  +HH  NI    G  + 
Sbjct: 16  NGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHR-NIATYYGAFIK 74

Query: 442 DGP-----HSFLVFEYAKNGSLKDWLHG--GLAMKNQFIASCYCFLTWSQRLRICLDVAM 494
             P       +LV E+   GS+ D +    G  +K ++IA             IC ++  
Sbjct: 75  KNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY------------ICREILR 122

Query: 495 ALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA----RCV---NDDTESPQFYS 547
            L ++H       +HR+IK +N+ L E    ++ +FG++    R V   N    +P + +
Sbjct: 123 GLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMA 179

Query: 548 -------TNP-ASWSMGIDIFAYGIVLLEVLSGQTPI 576
                   NP A++    D+++ GI  +E+  G  P+
Sbjct: 180 PEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 50.4 bits (120), Expect = 8e-07
 Identities = 38/161 (23%), Positives = 77/161 (47%), Gaps = 29/161 (18%)

Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLR 487
            H  +V+L    +T  P  +++ E+   GSL D+L      K              Q L 
Sbjct: 59  QHDKLVKL-HAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSK--------------QPLP 102

Query: 488 ICLDV-AMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDT----ES 542
             +D  A   + M  +   +Y+HR++++ NI +      ++ +FG+AR + D+     E 
Sbjct: 103 KLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG 162

Query: 543 PQF-------YSTNPASWSMGIDIFAYGIVLLEVLS-GQTP 575
            +F        + N  S+++  D++++GI+L+E+++ G+ P
Sbjct: 163 AKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 50.4 bits (121), Expect = 8e-07
 Identities = 49/215 (22%), Positives = 88/215 (40%), Gaps = 33/215 (15%)

Query: 394 VYHGRLNGKNLAIKRTEHEVITKLEMQLVQ-----HATHHHPNIVRLLGTCLTDGPHSFL 448
           V H R  GK +A+K    E+   ++ Q+++     H  +  P IV   G    +G    +
Sbjct: 20  VLH-RPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNS-PYIVGFYGAFYNNG-DISI 76

Query: 449 VFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYV 508
             EY   GSL   L        + I             +I + V   L Y+H       +
Sbjct: 77  CMEYMDGGSLDKILKEVQGRIPERILG-----------KIAVAVLKGLTYLHEKHK--II 123

Query: 509 HRNIKSRNIFLDEEFNARVGNFGMA-RCVNDDTESPQFYST---------NPASWSMGID 558
           HR++K  NI ++     ++ +FG++ + VN   ++  F  T             +S+  D
Sbjct: 124 HRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT--FVGTSSYMAPERIQGNDYSVKSD 181

Query: 559 IFAYGIVLLEVLSGQTPINRPRKKDEGSVWLSEKI 593
           I++ G+ L+E+ +G+ P        +G   L + I
Sbjct: 182 IWSLGLSLIELATGRFPYPPENDPPDGIFELLQYI 216

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 51.0 bits (122), Expect = 8e-07
 Identities = 40/176 (22%), Positives = 78/176 (44%), Gaps = 47/176 (26%)

Query: 415 TKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIA 474
           T +E  L+Q+  H  P+++R+  T L  G  + +V  +                   + +
Sbjct: 104 TLIEAMLLQNVNH--PSVIRMKDT-LVSGAITCMVLPH-------------------YSS 141

Query: 475 SCYCFLTWSQRLRICLDVAM--------ALQYMHHVMNPSYVHRNIKSRNIFLDEEFNAR 526
             Y +LT   R  + +D A+         L+Y+H       +HR++K+ NIF+++     
Sbjct: 142 DLYTYLTKRSR-PLPIDQALIIEKQILEGLRYLHAQ---RIIHRDVKTENIFINDVDQVC 197

Query: 527 VGNFGMARC-VND----------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLS 571
           +G+ G A+  V            +T +P+  +     ++   DI++ GIVL E+L+
Sbjct: 198 IGDLGAAQFPVVAPAFLGLAGTVETNAPEVLAR--DKYNSKADIWSAGIVLFEMLA 251

Length = 357

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 50.4 bits (120), Expect = 9e-07
 Identities = 35/148 (23%), Positives = 73/148 (49%), Gaps = 29/148 (19%)

Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           ++V E+   GSL D+L  G             +L   Q + +   +A  + Y+   MN  
Sbjct: 76  YIVTEFMGKGSLLDFLKEGDGK----------YLKLPQLVDMAAQIADGMAYIER-MN-- 122

Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SM 555
           Y+HR++++ NI + +    ++ +FG+AR + D+  + +  +  P  W           ++
Sbjct: 123 YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 182

Query: 556 GIDIFAYGIVLLEVLS-GQTP----INR 578
             D++++GI+L E+++ G+ P    +NR
Sbjct: 183 KSDVWSFGILLTELVTKGRVPYPGMVNR 210

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 50.3 bits (121), Expect = 1e-06
 Identities = 45/174 (25%), Positives = 80/174 (45%), Gaps = 39/174 (22%)

Query: 379 RATEKFNSSNRIE----GAVYHGR--LNGKNLAIKRTEHE------VITKL-EMQLVQHA 425
           R+ +++   NRIE    G VY  R    G+ +A+K+ + E       IT L E+ ++   
Sbjct: 2   RSVDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKL 61

Query: 426 THHHPNIVRL----LGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQF-IASCYCFL 480
              HPNIV +    +G+ L      ++V EY ++  LK  +     MK  F  +   C +
Sbjct: 62  --QHPNIVTVKEVVVGSNLD---KIYMVMEYVEH-DLKSLME---TMKQPFLQSEVKCLM 112

Query: 481 TWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR 534
              Q L         + ++H       +HR++K+ N+ L+     ++ +FG+AR
Sbjct: 113 L--QLLS-------GVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAR 154

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score = 50.0 bits (120), Expect = 1e-06
 Identities = 49/195 (25%), Positives = 81/195 (41%), Gaps = 51/195 (26%)

Query: 405 AIK----RTEHEVITKL---EMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGS 457
           AIK      + E + K    E+++++     H NIV L       G   +LVFEY +  +
Sbjct: 30  AIKKFKESEDDEDVKKTALREVKVLRQL--RHENIVNLKEAFRRKG-RLYLVFEYVER-T 85

Query: 458 LKDWLH---GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH-HVMNPSYVHRNIK 513
           L + L    GGL      + S      W Q L+       A+ Y H H +    +HR+IK
Sbjct: 86  LLELLEASPGGLPP--DAVRSY----IW-QLLQ-------AIAYCHSHNI----IHRDIK 127

Query: 514 SRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN---------------PASWSMGID 558
             NI + E    ++ +FG AR +      P    T+                 ++   +D
Sbjct: 128 PENILVSESGVLKLCDFGFARAL---RARPASPLTDYVATRWYRAPELLVGDTNYGKPVD 184

Query: 559 IFAYGIVLLEVLSGQ 573
           ++A G ++ E+L G+
Sbjct: 185 VWAIGCIMAELLDGE 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 50.0 bits (119), Expect = 2e-06
 Identities = 44/191 (23%), Positives = 87/191 (45%), Gaps = 34/191 (17%)

Query: 400 NGKNLAIKRTEHEVITKLEM---QLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNG 456
           +G+ +A+K  +     + E+   ++V    + H N+V +  + L  G   +++ E+ + G
Sbjct: 45  SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLV-GEELWVLMEFLQGG 103

Query: 457 SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRN 516
           +L D            I S    L   Q   +C  V  AL Y+H   +   +HR+IKS +
Sbjct: 104 ALTD------------IVS-QTRLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDS 147

Query: 517 IFLDEEFNARVGNFGMARCVNDDTE------------SPQFYSTNPASWSMGIDIFAYGI 564
           I L  +   ++ +FG    ++ D              +P+  S  P  +   +DI++ GI
Sbjct: 148 ILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTP--YGTEVDIWSLGI 205

Query: 565 VLLEVLSGQTP 575
           +++E++ G+ P
Sbjct: 206 MVIEMVDGEPP 216

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 51.0 bits (122), Expect = 2e-06
 Identities = 55/207 (26%), Positives = 80/207 (38%), Gaps = 64/207 (30%)

Query: 409 TEHEVITKL-----------------EMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFE 451
           T HEV  KL                 E  L   A  +HPNIV LL +        F VFE
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALC--ARLYHPNIVALLDSGEAPPGLLFAVFE 59

Query: 452 YAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRN 511
           Y    +L++ L    A            L   +  R+ L V  AL   H   N   VHR+
Sbjct: 60  YVPGRTLREVLAADGA------------LPAGETGRLMLQVLDALACAH---NQGIVHRD 104

Query: 512 IKSRNIFL---DEEFNARVGNFGMARCVND-----------DTE---SPQFYS------- 547
           +K +NI +       +A+V +FG+   +              TE   +P + +       
Sbjct: 105 LKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGE 164

Query: 548 -TNPASWSMGIDIFAYGIVLLEVLSGQ 573
              P S     D++A+G++ LE L+GQ
Sbjct: 165 PVTPNS-----DLYAWGLIFLECLTGQ 186

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 49.7 bits (118), Expect = 2e-06
 Identities = 48/200 (24%), Positives = 87/200 (43%), Gaps = 33/200 (16%)

Query: 392 GAVYHGRLNGKN--LAIKRTEHEV----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPH 445
           G VY G  N     +AIK  + E     I  ++ ++   +    P I R  G+ L  G  
Sbjct: 18  GEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLK-GTK 76

Query: 446 SFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNP 505
            +++ EY   GS  D L  G  ++  +IA+            I  ++   L Y+H   + 
Sbjct: 77  LWIIMEYLGGGSALDLLKPG-PLEETYIAT------------ILREILKGLDYLH---SE 120

Query: 506 SYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNP----------ASWSM 555
             +HR+IK+ N+ L E+ + ++ +FG+A  + D       +   P          +++  
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDF 180

Query: 556 GIDIFAYGIVLLEVLSGQTP 575
             DI++ GI  +E+  G+ P
Sbjct: 181 KADIWSLGITAIELAKGEPP 200

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 41/160 (25%), Positives = 73/160 (45%), Gaps = 31/160 (19%)

Query: 430 PNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRIC 489
           P + RLLG CLT      LV +    G L D++      +N+        L W      C
Sbjct: 69  PYVCRLLGICLTSTVQ--LVTQLMPYGCLLDYVR-----ENKDRIGSQDLLNW------C 115

Query: 490 LDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN-DDTESPQFYST 548
           + +A  + Y+  V     VHR++ +RN+ +    + ++ +FG+AR ++ D+TE       
Sbjct: 116 VQIAKGMSYLEEV---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGK 172

Query: 549 NPASWSMGI------------DIFAYGIVLLEVLS-GQTP 575
            P  W M +            D+++YG+ + E+++ G  P
Sbjct: 173 VPIKW-MALESILHRRFTHQSDVWSYGVTVWELMTFGAKP 211

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 49.3 bits (117), Expect = 2e-06
 Identities = 53/200 (26%), Positives = 87/200 (43%), Gaps = 43/200 (21%)

Query: 401 GKNLAIKR---------TEHEV-ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFL-- 448
           G+ LA+K+         T  EV   + E+QL+++  H    IV+  G CL D     L  
Sbjct: 27  GRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHER--IVQYYG-CLRDPMERTLSI 83

Query: 449 VFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYV 508
             E+   GS+KD L              Y  LT +   +    +   + Y+H  M    V
Sbjct: 84  FMEHMPGGSIKDQLKS------------YGALTENVTRKYTRQILEGVSYLHSNM---IV 128

Query: 509 HRNIKSRNIFLDEEFNARVGNFGMAR-----CVNDD-----TESPQFYSTNPAS---WSM 555
           HR+IK  NI  D   N ++G+FG ++     C++       T +P + S    S   +  
Sbjct: 129 HRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGR 188

Query: 556 GIDIFAYGIVLLEVLSGQTP 575
             DI++ G  ++E+L+ + P
Sbjct: 189 KADIWSVGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 49.8 bits (119), Expect = 2e-06
 Identities = 34/117 (29%), Positives = 57/117 (48%), Gaps = 20/117 (17%)

Query: 495 ALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFY------ST 548
           AL Y+H       +HR++K+ NIFLDE  NA +G+FG A  ++   ++PQ Y       T
Sbjct: 197 ALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLET 253

Query: 549 NPA------SWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDEGSVWLSEKIKSILQA 599
           N         +    DI++ G+VL E+      +   + K   S     +++SI++ 
Sbjct: 254 NSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSS-----QLRSIIRC 305

Length = 392

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score = 49.2 bits (118), Expect = 2e-06
 Identities = 51/210 (24%), Positives = 84/210 (40%), Gaps = 54/210 (25%)

Query: 392 GAVYHGR--LNGKNLAIK----RTEHEVITKL---EMQLVQHATHHHPNIVRLLGTCLTD 442
           G VY  R  L G+ +AIK    R E E I K    E++L++    +HPNI++LL      
Sbjct: 13  GVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKEL--NHPNIIKLLDV-FRH 69

Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRL----RICLDVAMALQY 498
               +LVFE+                        Y  +   QR      I   +   LQ 
Sbjct: 70  KGDLYLVFEFMD-------------------TDLYKLIKDRQRGLPESLIKSYLYQLLQG 110

Query: 499 MHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPAS------ 552
           +    +   +HR++K  N+ ++ E   ++ +FG+AR       SP    T+         
Sbjct: 111 LAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFG----SPVRPYTHYVVTRWYRA 166

Query: 553 ---------WSMGIDIFAYGIVLLEVLSGQ 573
                    +S  +DI++ G +  E+LS +
Sbjct: 167 PELLLGDKGYSTPVDIWSVGCIFAELLSRR 196

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 49.2 bits (117), Expect = 3e-06
 Identities = 40/155 (25%), Positives = 69/155 (44%), Gaps = 28/155 (18%)

Query: 392 GAVY--HGRLNGKNLAIKRTE--HEVITKLEMQL-VQHATHHHPNIVRLLGTC----LTD 442
           G V+    + NG   A+K  +  H++  ++E +  +  A   HPN+V+  G      + +
Sbjct: 32  GKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91

Query: 443 GPHSFLVFEYAKNGSLKDWLHG----GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQY 498
           G   +LV E    GS+ D + G    G  M+   IA             I  +  M LQ+
Sbjct: 92  GDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAY------------ILHEALMGLQH 139

Query: 499 MHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA 533
           +H       +HR++K  NI L  E   ++ +FG++
Sbjct: 140 LH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVS 171

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 49.1 bits (117), Expect = 3e-06
 Identities = 35/131 (26%), Positives = 62/131 (47%), Gaps = 27/131 (20%)

Query: 491 DVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR------------CVND 538
           +V +AL ++H       ++R++K  NI LD E + ++ +FGM +            C   
Sbjct: 104 EVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTP 160

Query: 539 DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKD--EG--------SVW 588
           D  +P+         S  +D +A G+++ E+++GQ P     + D  E          VW
Sbjct: 161 DYIAPEILQELEYGPS--VDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVW 218

Query: 589 LSEKIKSILQA 599
           LS++  SIL+A
Sbjct: 219 LSKEAVSILKA 229

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 48.7 bits (116), Expect = 3e-06
 Identities = 25/108 (23%), Positives = 48/108 (44%), Gaps = 10/108 (9%)

Query: 487 RICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFY 546
           R C   A  +  + H+     ++R++K  N+ LD + N R+ + G+A  + D     + Y
Sbjct: 98  RACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGY 157

Query: 547 STNPA----------SWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDE 584
           +  P            +   +D FA G+ L E+++ + P     +K E
Sbjct: 158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE 205

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 48.5 bits (115), Expect = 3e-06
 Identities = 47/173 (27%), Positives = 78/173 (45%), Gaps = 33/173 (19%)

Query: 418 EMQLVQHATHHHPNIVRLLGTCLTD-GPHSFLVF-EYAKNGSLKDWLHGGLAMKNQFIAS 475
           E+QL+++  H    IV+  G CL D    +  +F EY   GS+KD L             
Sbjct: 54  EIQLLKNLQHER--IVQYYG-CLRDRAEKTLTIFMEYMPGGSVKDQLKA----------- 99

Query: 476 CYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR- 534
            Y  LT S   +    +   + Y+H  M    VHR+IK  NI  D   N ++G+FG ++ 
Sbjct: 100 -YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155

Query: 535 ----CVNDD-----TESPQFYSTNPAS---WSMGIDIFAYGIVLLEVLSGQTP 575
               C++       T +P + S    S   +    D+++ G  ++E+L+ + P
Sbjct: 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPP 208

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 48.7 bits (116), Expect = 3e-06
 Identities = 50/190 (26%), Positives = 86/190 (45%), Gaps = 34/190 (17%)

Query: 401 GKNLAIKRTEHEVITKLEM---QLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGS 457
           G+ +AIK+   +   K E+   +++    + HPNIV  L + L  G   ++V EY   GS
Sbjct: 44  GQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLV-GDELWVVMEYLAGGS 102

Query: 458 LKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNI 517
           L D +      + Q  A C          R CL    AL+++H   +   +HR+IKS NI
Sbjct: 103 LTDVVTETCMDEGQIAAVC----------RECLQ---ALEFLH---SNQVIHRDIKSDNI 146

Query: 518 FLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASWSMG------------IDIFAYGIV 565
            L  + + ++ +FG   C     E  +  +     + M             +DI++ GI+
Sbjct: 147 LLGMDGSVKLTDFGF--CAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIM 204

Query: 566 LLEVLSGQTP 575
            +E++ G+ P
Sbjct: 205 AIEMVEGEPP 214

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 48.8 bits (116), Expect = 4e-06
 Identities = 25/99 (25%), Positives = 52/99 (52%), Gaps = 17/99 (17%)

Query: 491 DVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR------------CVND 538
           ++++ L ++H       ++R++K  N+ LD E + ++ +FGM +            C   
Sbjct: 109 EISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTP 165

Query: 539 DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
           D  +P+  +  P  +   +D +AYG++L E+L+GQ P +
Sbjct: 166 DYIAPEIIAYQP--YGKSVDWWAYGVLLYEMLAGQPPFD 202

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 48.5 bits (115), Expect = 4e-06
 Identities = 45/146 (30%), Positives = 65/146 (44%), Gaps = 30/146 (20%)

Query: 401 GKNLAIKR---------TEHEV-ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFL-V 449
           G+ LA+K+         T  EV   + E+QL++     H  IV+  G CL D     L +
Sbjct: 27  GRELAVKQVPFDPDSQETSKEVNALECEIQLLK--NLRHDRIVQYYG-CLRDPEEKKLSI 83

Query: 450 F-EYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYV 508
           F EY   GS+KD L              Y  LT +   R    +   + Y+H  M    V
Sbjct: 84  FVEYMPGGSIKDQLKA------------YGALTENVTRRYTRQILQGVSYLHSNM---IV 128

Query: 509 HRNIKSRNIFLDEEFNARVGNFGMAR 534
           HR+IK  NI  D   N ++G+FG ++
Sbjct: 129 HRDIKGANILRDSAGNVKLGDFGASK 154

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 48.3 bits (115), Expect = 4e-06
 Identities = 50/216 (23%), Positives = 96/216 (44%), Gaps = 50/216 (23%)

Query: 392 GAVYHG--RLNGKNLAIKRTEHEVIT--------------KLEMQLVQHATHHHPNIVRL 435
           G+VY G    +G+ +A+K+ E   ++                E+ L++     H NIV+ 
Sbjct: 14  GSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL--QHENIVQY 71

Query: 436 LGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMA 495
           LG    D  H  +  EY   GS+   L+   A +   + +   F+   Q L+        
Sbjct: 72  LG-SSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRN---FV--RQILK-------G 118

Query: 496 LQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPA---- 551
           L Y+H   N   +HR+IK  NI +D +   ++ +FG+++ +  ++ S +     P+    
Sbjct: 119 LNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGS 175

Query: 552 ------------SWSMGIDIFAYGIVLLEVLSGQTP 575
                       S++   DI++ G +++E+L+G+ P
Sbjct: 176 VFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 48.1 bits (115), Expect = 6e-06
 Identities = 47/199 (23%), Positives = 82/199 (41%), Gaps = 52/199 (26%)

Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKN---QFIASCYCFLTWSQR 485
           HP + +L  +C       F V EY   G L   +           +F A+          
Sbjct: 55  HPFLTQLH-SCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAE--------- 104

Query: 486 LRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR----------- 534
                 + + LQ++H       ++R++K  N+ LD E + ++ +FGM +           
Sbjct: 105 ------IVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTST 155

Query: 535 -CVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDEGSV------ 587
            C   D  +P+  S  P  +   +D +A G++L E+L+GQ+P       DE  +      
Sbjct: 156 FCGTPDYIAPEILSYQP--YGPAVDWWALGVLLYEMLAGQSPFE---GDDEDELFQSILE 210

Query: 588 -------WLSEKIKSILQA 599
                  WLS++ KSIL++
Sbjct: 211 DEVRYPRWLSKEAKSILKS 229

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 48.1 bits (114), Expect = 7e-06
 Identities = 48/208 (23%), Positives = 87/208 (41%), Gaps = 41/208 (19%)

Query: 392 GAVYHGRLN--GKNL----AIKRTEHEVITKLEMQLVQHA----THHHPNIVRLLGTCLT 441
           G VY G     G+ +    AIK        K   +++  A    +  +P++ RLLG CLT
Sbjct: 21  GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 80

Query: 442 DGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHH 501
                 L+ +    G L D++          I S Y  L W      C+ +A  + Y+  
Sbjct: 81  STVQ--LITQLMPFGCLLDYVR----EHKDNIGSQY-LLNW------CVQIAKGMNYLE- 126

Query: 502 VMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN-PASWSMGI--- 557
                 VHR++ +RN+ +    + ++ +FG+A+ +  D +         P  W M +   
Sbjct: 127 --ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKW-MALESI 183

Query: 558 ---------DIFAYGIVLLEVLS-GQTP 575
                    D+++YG+ + E+++ G  P
Sbjct: 184 LHRIYTHQSDVWSYGVTVWELMTFGSKP 211

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 47.5 bits (113), Expect = 7e-06
 Identities = 53/206 (25%), Positives = 86/206 (41%), Gaps = 39/206 (18%)

Query: 392 GAVYHGR--LNGKNLAIKR---TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHS 446
           G VY  R       +AIK     +   +  L  ++  H+   H NIV+ LG+   +G   
Sbjct: 22  GIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENG--F 79

Query: 447 FLVF-EYAKNGSLKDWLH---GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
           F +F E    GSL   L    G L    Q I     F T  Q L         L+Y+H  
Sbjct: 80  FKIFMEQVPGGSLSALLRSKWGPLKDNEQTII----FYT-KQILE-------GLKYLH-- 125

Query: 503 MNPSYVHRNIKSRNIFLDEEFNA-RVGNFGMAR---CVNDDTES---------PQFYSTN 549
            +   VHR+IK  N+ ++      ++ +FG ++    +N  TE+         P+     
Sbjct: 126 -DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKG 184

Query: 550 PASWSMGIDIFAYGIVLLEVLSGQTP 575
           P  +    DI++ G  ++E+ +G+ P
Sbjct: 185 PRGYGAPADIWSLGCTIVEMATGKPP 210

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 47.7 bits (114), Expect = 9e-06
 Identities = 43/218 (19%), Positives = 81/218 (37%), Gaps = 44/218 (20%)

Query: 385 NSSNRIEGAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQ---HATHH--HPNIVRLLGTC 439
              + +   +   +     +A+K+   +  +K +++L+Q     +    HPNI+  + T 
Sbjct: 9   CFEDLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYV-TS 67

Query: 440 LTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICL---DVAMAL 496
                  ++V      GS +D L      K  F             L I     DV  AL
Sbjct: 68  FIVDSELYVVSPLMAYGSCEDLL------KTHF---PEGL----PELAIAFILKDVLNAL 114

Query: 497 QYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA----------RCVNDDTE----- 541
            Y+H      ++HR++K+ +I L  +    +     +          R V+D  +     
Sbjct: 115 DYIHSK---GFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKN 171

Query: 542 ----SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTP 575
               SP+    N   ++   DI++ GI   E+ +G  P
Sbjct: 172 LPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 47.7 bits (113), Expect = 9e-06
 Identities = 25/97 (25%), Positives = 52/97 (53%), Gaps = 17/97 (17%)

Query: 491 DVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR------------CVND 538
           ++A+ L ++H   +   ++R++K  N+ LD E + ++ +FGM +            C   
Sbjct: 109 EIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTP 165

Query: 539 DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTP 575
           D  +P+  +  P  +   +D +A+G++L E+L+GQ P
Sbjct: 166 DYIAPEIIAYQP--YGKSVDWWAFGVLLYEMLAGQAP 200

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 47.1 bits (112), Expect = 1e-05
 Identities = 47/172 (27%), Positives = 78/172 (45%), Gaps = 39/172 (22%)

Query: 392 GAVYHGR--LNGKNLAIK--RTEHEV----ITKL-EMQLVQHATHHHPNIVRLLGTCLTD 442
           G VY  R    G+ +A+K  R ++E     IT + E+++++    +H NIV L    +TD
Sbjct: 21  GQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQL--NHRNIVNLK-EIVTD 77

Query: 443 GPHS----------FLVFEYAKNGSLKDWLHGGLAMKN-QFIASCYCFLTWSQRLRICLD 491
              +          +LVFEY  +  L   L  GL   +   I S          ++  L+
Sbjct: 78  KQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSF---------MKQLLE 127

Query: 492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESP 543
               L Y H     +++HR+IK  NI L+ +   ++ +FG+AR  N +   P
Sbjct: 128 ---GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRP 173

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 47.2 bits (112), Expect = 1e-05
 Identities = 50/204 (24%), Positives = 80/204 (39%), Gaps = 42/204 (20%)

Query: 398 RLNGKNLAIKRTEHEVITKLEMQLVQHATH-----HHPNIVRLLGTCLTDGPHSFLVFEY 452
           +  G+ + ++R   E  T   +  +Q   H     +HPNIV    T + D    ++V  +
Sbjct: 22  KPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN-ELWVVTSF 80

Query: 453 AKNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHR 510
              GS KD +  H    M    IA             I   V  AL Y+HH+    YVHR
Sbjct: 81  MAYGSAKDLICTHFMDGMSELAIAY------------ILQGVLKALDYIHHM---GYVHR 125

Query: 511 NIKSRNIFLDEE----FNARVGNFGM------ARCVNDDTE---------SPQFYSTNPA 551
           ++K+ +I +  +     +    N  M       R V+D  +         SP+    N  
Sbjct: 126 SVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQ 185

Query: 552 SWSMGIDIFAYGIVLLEVLSGQTP 575
            +    DI++ GI   E+ +G  P
Sbjct: 186 GYDAKSDIYSVGITACELANGHVP 209

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 47.0 bits (112), Expect = 1e-05
 Identities = 39/160 (24%), Positives = 69/160 (43%), Gaps = 24/160 (15%)

Query: 428 HHPNIVRLLGTCLTDGPHSF-LVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQR- 485
             P IV+  G  L +   S  +  EY + GSL D ++  +  +   I          ++ 
Sbjct: 57  KSPYIVKYYGAFLDESSSSIGIAMEYCEGGSL-DSIYKKVKKRGGRI---------GEKV 106

Query: 486 -LRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA-RCVN--DDTE 541
             +I   V   L Y+H   +   +HR+IK  NI L  +   ++ +FG++   VN    T 
Sbjct: 107 LGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTF 163

Query: 542 SPQFYSTNP-----ASWSMGIDIFAYGIVLLEVLSGQTPI 576
           +   +   P       +S+  D+++ G+ LLEV   + P 
Sbjct: 164 TGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 46.7 bits (111), Expect = 1e-05
 Identities = 58/205 (28%), Positives = 93/205 (45%), Gaps = 61/205 (29%)

Query: 392 GAVYHGR--LNGKNLAIKR----TEHEVITKL---EMQLVQHATHHHPNIVRLLGTCLTD 442
           G VY  R  L G+ +A+K+    TE E +      E+ L++   H  PNIV+LL     D
Sbjct: 14  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNH--PNIVKLL-----D 66

Query: 443 GPHS----FLVFEYAKNGSLKDWLH----GGLAMKNQFIASCYCFLTWSQRLRICLDVAM 494
             H+    +LVFE+  +  LK ++      G+ +    I S Y F    Q L+      +
Sbjct: 67  VIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPL--PLIKS-YLF----QLLQ-----GL 113

Query: 495 ALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARC------------VNDDTES 542
           A  + H V+     HR++K +N+ ++ E   ++ +FG+AR             V     +
Sbjct: 114 AFCHSHRVL-----HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRA 168

Query: 543 PQ------FYSTNPASWSMGIDIFA 561
           P+      +YST    WS+G  IFA
Sbjct: 169 PEILLGCKYYSTAVDIWSLGC-IFA 192

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 46.8 bits (111), Expect = 1e-05
 Identities = 40/186 (21%), Positives = 70/186 (37%), Gaps = 31/186 (16%)

Query: 407 KRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGL 466
              + EV+  L  ++   A  +HP+I+R+LG    D  H  L  E+   GS+   L    
Sbjct: 40  SSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDS-HFNLFVEWMAGGSVSHLLSKYG 98

Query: 467 AMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEE-FNA 525
           A K   I            +     +   L Y+H       +HR++K  N+ +D      
Sbjct: 99  AFKEAVI------------INYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRL 143

Query: 526 RVGNFGMARCVNDDTESP-----QFYST---------NPASWSMGIDIFAYGIVLLEVLS 571
           R+ +FG A  +            Q   T             +    D+++ G V++E+ +
Sbjct: 144 RIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMAT 203

Query: 572 GQTPIN 577
            + P N
Sbjct: 204 AKPPWN 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 46.3 bits (110), Expect = 2e-05
 Identities = 45/209 (21%), Positives = 83/209 (39%), Gaps = 47/209 (22%)

Query: 392 GAVY--HGRLNGKNLAIKR-------TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTD 442
           G+VY    R  G   AIK         +++V      + +       P + +L  +    
Sbjct: 10  GSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYS-FQS 68

Query: 443 GPHSFLVFEYAKNGSLKDWLH--GGLAMK--NQFIASCYCFLTWSQRLRICLDVAMALQY 498
             + +LV EY   G     +   GGL      Q+IA                +V + ++ 
Sbjct: 69  KDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIA----------------EVVLGVED 112

Query: 499 MHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYST----NPASWS 554
           +H       +HR+IK  N+ +D+  + ++ +FG++R      E+ +F  T     P +  
Sbjct: 113 LH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNG---LENKKFVGTPDYLAPETI- 165

Query: 555 MGI------DIFAYGIVLLEVLSGQTPIN 577
           +G+      D ++ G V+ E L G  P +
Sbjct: 166 LGVGDDKMSDWWSLGCVIFEFLFGYPPFH 194

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 43/174 (24%), Positives = 76/174 (43%), Gaps = 37/174 (21%)

Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           H ++V   G C+  G  S +V EY K GSL  +L      KN+ + +    ++W      
Sbjct: 58  HKHLVLNYGVCVC-GDESIMVQEYVKFGSLDTYLK-----KNKNLIN----ISWK----- 102

Query: 489 CLDVAMALQY-MHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYS 547
            L+VA  L + +H + +    H N+ ++N+ L  E + + GN    + ++D   S     
Sbjct: 103 -LEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIK-LSDPGISITVLP 160

Query: 548 ----------------TNPASWSMGIDIFAYGIVLLEVLSGQT-PIN--RPRKK 582
                            NP + S+  D +++G  L E+ SG   P++    +KK
Sbjct: 161 KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK 214

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 46.7 bits (111), Expect = 2e-05
 Identities = 47/203 (23%), Positives = 90/203 (44%), Gaps = 46/203 (22%)

Query: 398 RLNGKNLAIKRTEHEVITKL--------EMQLVQHATHHHPNIVRLLGTCLTDGPHSF-- 447
              G+ +AIK+  ++V   +        E++L++     HP+IV +    L      F  
Sbjct: 22  THTGEKVAIKKI-NDVFEHVSDATRILREIKLLRLL--RHPDIVEIKHIMLPPSRREFKD 78

Query: 448 --LVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNP 505
             +VFE  ++      LH  +   +      + F  + Q LR       AL+Y+H     
Sbjct: 79  IYVVFELMESD-----LHQVIKANDDLTPEHHQFFLY-QLLR-------ALKYIH---TA 122

Query: 506 SYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPAS------------- 552
           +  HR++K +NI  + +   ++ +FG+AR   +DT +  F++   A+             
Sbjct: 123 NVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFF 182

Query: 553 --WSMGIDIFAYGIVLLEVLSGQ 573
             ++  IDI++ G +  EVL+G+
Sbjct: 183 SKYTPAIDIWSIGCIFAEVLTGK 205

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 46.1 bits (109), Expect = 2e-05
 Identities = 42/172 (24%), Positives = 78/172 (45%), Gaps = 32/172 (18%)

Query: 418 EMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG--GLAMKNQFIAS 475
           E  +++  T HH  +VRLLG  ++ G  + +V E   +G LK +L      A  N     
Sbjct: 59  EASVMKGFTCHH--VVRLLGV-VSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 115

Query: 476 CYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARC 535
                T  + +++  ++A  + Y++      +VHR++ +RN  +  +F  ++G+FGM R 
Sbjct: 116 P----TLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR- 167

Query: 536 VNDDTESPQFYSTN-----PASW-----------SMGIDIFAYGIVLLEVLS 571
              D     +Y        P  W           +   D++++G+VL E+ S
Sbjct: 168 ---DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 45.8 bits (108), Expect = 3e-05
 Identities = 51/221 (23%), Positives = 85/221 (38%), Gaps = 38/221 (17%)

Query: 378 RRATEKFNSSNRI----EGAVYHGR-LNGKNLA----IKRTEHEVITKLEMQLVQHATHH 428
           R   E F    RI     G VY  R +N   LA    IK    E    ++ +++      
Sbjct: 5   RNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCK 64

Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           H NIV   G+ L      ++  E+   GSL+D  H                L+ SQ   +
Sbjct: 65  HSNIVAYFGSYLRRD-KLWICMEFCGGGSLQDIYH------------VTGPLSESQIAYV 111

Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYST 548
             +    L Y+H   +   +HR+IK  NI L +  + ++ +FG++  +       + +  
Sbjct: 112 SRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIG 168

Query: 549 NP-------------ASWSMGIDIFAYGIVLLEVLSGQTPI 576
            P               ++   DI+A GI  +E+   Q P+
Sbjct: 169 TPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 45.6 bits (108), Expect = 3e-05
 Identities = 23/93 (24%), Positives = 43/93 (46%), Gaps = 10/93 (10%)

Query: 499 MHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN--------- 549
           + H+     V+R++K  N+ LD+  N R+ + G+A  +    +      T          
Sbjct: 108 LEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQ 167

Query: 550 PASWSMGIDIFAYGIVLLEVLSGQTPINRPRKK 582
              +   +D FA G  L E+++G++P  R RK+
Sbjct: 168 GEVYDFSVDWFALGCTLYEMIAGRSPF-RQRKE 199

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 45.9 bits (109), Expect = 3e-05
 Identities = 25/97 (25%), Positives = 52/97 (53%), Gaps = 17/97 (17%)

Query: 491 DVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR------------CVND 538
           ++A+ L ++H   +   ++R++K  N+ LD E + ++ +FGM +            C   
Sbjct: 109 EIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTP 165

Query: 539 DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTP 575
           D  +P+  +  P  +   +D +A+G++L E+L+GQ P
Sbjct: 166 DYIAPEIIAYQP--YGKSVDWWAFGVLLYEMLAGQPP 200

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 45.6 bits (108), Expect = 4e-05
 Identities = 43/191 (22%), Positives = 90/191 (47%), Gaps = 28/191 (14%)

Query: 413 VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQF 472
           V TK+E  ++     +HP IV+L     T+G   +L+ ++ + G L   L          
Sbjct: 43  VRTKMERDILAEV--NHPFIVKLHYAFQTEG-KLYLILDFLRGGDLFTRL---------- 89

Query: 473 IASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGM 532
             S     T         ++A+AL ++H +     ++R++K  NI LDEE + ++ +FG+
Sbjct: 90  --SKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGHIKLTDFGL 144

Query: 533 AR-CVNDDTESPQFYST---------NPASWSMGIDIFAYGIVLLEVLSGQTPINRPRKK 582
           ++  ++ + ++  F  T         N    +   D +++G+++ E+L+G  P     +K
Sbjct: 145 SKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK 204

Query: 583 DEGSVWLSEKI 593
           +  ++ L  K+
Sbjct: 205 ETMTMILKAKL 215

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 45.3 bits (107), Expect = 5e-05
 Identities = 43/195 (22%), Positives = 76/195 (38%), Gaps = 40/195 (20%)

Query: 427 HHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRL 486
            +HP + +L   C       F V E+   G L    H  +    +F  +   F       
Sbjct: 53  RNHPFLTQLY-CCFQTPDRLFFVMEFVNGGDLM--FH--IQKSRRFDEARARFYA----- 102

Query: 487 RICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR------------ 534
               ++  AL ++H   +   ++R++K  N+ LD E + ++ +FGM +            
Sbjct: 103 ---AEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTF 156

Query: 535 CVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRK--------KDE-- 584
           C   D  +P+        +   +D +A G++L E+L G  P     +         DE  
Sbjct: 157 CGTPDYIAPEILQE--MLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVV 214

Query: 585 GSVWLSEKIKSILQA 599
              WLS+    IL+A
Sbjct: 215 YPTWLSQDAVDILKA 229

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 45.2 bits (107), Expect = 6e-05
 Identities = 45/159 (28%), Positives = 69/159 (43%), Gaps = 34/159 (21%)

Query: 392 GAVYHGR--LNGKNLAIKRTEH---------EVITKLEMQLVQHATHHHPNIVRLLGTCL 440
           GAVY  R     + +AIK+  +         + I K E++ +Q     HPN +   G  L
Sbjct: 29  GAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIK-EVRFLQ--QLRHPNTIEYKGCYL 85

Query: 441 TDGPHSFLVFEYAKNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQY 498
            +   ++LV EY   GS  D L  H    ++   IA+            IC      L Y
Sbjct: 86  REHT-AWLVMEYCL-GSASDILEVHKK-PLQEVEIAA------------ICHGALQGLAY 130

Query: 499 MHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN 537
           +H   +   +HR+IK+ NI L E    ++ +FG A  V+
Sbjct: 131 LH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVS 166

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 44.7 bits (106), Expect = 6e-05
 Identities = 52/235 (22%), Positives = 98/235 (41%), Gaps = 48/235 (20%)

Query: 367 RLLESYSIEDLRRATEKFNSSNRIEGAVYHGRLNGKNLAIK-----RTEHEVITKL---E 418
           + +ES  I+       K N  N I    Y G  N K + I+        H+V+  +   E
Sbjct: 13  KCIESDDIDKYTSVLIKENDQNSI----YKGIFNNKEVIIRTFKKFHKGHKVLIDITENE 68

Query: 419 MQLVQHATHHHPNIVRLLGTCL---TDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIAS 475
           ++ ++    +  NI+++ G  +    D P   L+ EY   G L++ L      K +    
Sbjct: 69  IKNLRRIDSN--NILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL-----DKEKD--- 118

Query: 476 CYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARC 535
               L++  +L + +D    L  ++   N  Y  +N+ S +  + E +  ++   G+ + 
Sbjct: 119 ----LSFKTKLDMAIDCCKGLYNLYKYTNKPY--KNLTSVSFLVTENYKLKIICHGLEKI 172

Query: 536 VNDDTESPQFYSTNPA---SWSMGIDIFA----------YGIVLLEVLSGQTPIN 577
           ++    SP F + N     S+ M  DIF+           G+VL E+ +G+ P  
Sbjct: 173 LS----SPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE 223

Length = 283

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 45.6 bits (108), Expect = 6e-05
 Identities = 30/91 (32%), Positives = 46/91 (50%), Gaps = 12/91 (13%)

Query: 499 MHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGM----ARCVNDD---TESPQFYSTNPA 551
           +HHV +   +HR+IKS NI L      ++G+FG     A  V+DD   T     Y   P 
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPE 215

Query: 552 SW-----SMGIDIFAYGIVLLEVLSGQTPIN 577
            W     S   D+F+ G++L E+L+ + P +
Sbjct: 216 IWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246

Length = 496

>gnl|CDD|144899 pfam01476, LysM, LysM domain

 Score = 40.1 bits (95), Expect = 7e-05
 Identities = 12/48 (25%), Positives = 20/48 (41%), Gaps = 5/48 (10%)

Query: 195 YPVGEGDTVSGLAAKFNTTPAAIIAANNKSLEGFKPEDLLAFTSILIP 242
           Y V +GDT+S +A ++  T   +   N          +L     + IP
Sbjct: 1   YTVKKGDTLSSIAKRYGITVEELAELNG-----LSSPNLYVGQKLKIP 43

The LysM (lysin motif) domain is about 40 residues long. It is found in a variety of enzymes involved in bacterial cell wall degradation. This domain may have a general peptidoglycan binding function. The structure of this domain is known. Length = 43

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 44.5 bits (105), Expect = 7e-05
 Identities = 31/148 (20%), Positives = 64/148 (43%), Gaps = 16/148 (10%)

Query: 392 GAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHA----THHHPNIVRLLGTCLTDGPHSF 447
           G V  G      + +K        + +M+ ++ A    +  H N+++ LG C    P+  
Sbjct: 14  GEVNSG-YTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPY-L 71

Query: 448 LVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSY 507
           LV E+   G LK +L      +           T  QR+    ++A+ L ++H     ++
Sbjct: 72  LVMEFCPLGDLKGYLRSCRKAELM-----TPDPTTLQRM--ACEIALGLLHLH---KNNF 121

Query: 508 VHRNIKSRNIFLDEEFNARVGNFGMARC 535
           +H ++  RN  L  +   ++G++G++  
Sbjct: 122 IHSDLALRNCLLTADLTVKIGDYGLSHN 149

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 44.8 bits (106), Expect = 8e-05
 Identities = 28/122 (22%), Positives = 59/122 (48%), Gaps = 25/122 (20%)

Query: 468 MKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLD-EEFNAR 526
           ++   ++  +  L   Q LR        L+Y+H   + + +HR++K  N+F++ E+   +
Sbjct: 106 LEQGPLSEEHARLFMYQLLR-------GLKYIH---SANVLHRDLKPANVFINTEDLVLK 155

Query: 527 VGNFGMARCVNDDTESPQFYSTN--------------PASWSMGIDIFAYGIVLLEVLSG 572
           +G+FG+AR V+       + S                P +++  ID++A G +  E+L+G
Sbjct: 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTG 215

Query: 573 QT 574
           + 
Sbjct: 216 KP 217

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 44.3 bits (104), Expect = 8e-05
 Identities = 40/184 (21%), Positives = 77/184 (41%), Gaps = 28/184 (15%)

Query: 402 KNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW 461
           K + ++  E E I  ++ ++   +    P + +  G+ L D    +++ EY   GS  D 
Sbjct: 35  KIIDLEEAEDE-IEDIQQEITVLSQCDSPYVTKYYGSYLKD-TKLWIIMEYLGGGSALDL 92

Query: 462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE 521
           L  G              L  +Q   I  ++   L Y+H   +   +HR+IK+ N+ L E
Sbjct: 93  LEPGP-------------LDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSE 136

Query: 522 EFNARVGNFGMARCVNDDTESPQFYSTNP----------ASWSMGIDIFAYGIVLLEVLS 571
               ++ +FG+A  + D       +   P          +++    DI++ GI  +E+  
Sbjct: 137 HGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAK 196

Query: 572 GQTP 575
           G+ P
Sbjct: 197 GEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 44.3 bits (104), Expect = 1e-04
 Identities = 48/205 (23%), Positives = 83/205 (40%), Gaps = 38/205 (18%)

Query: 392 GAVYHGR--LNGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGP 444
           G VY  R    G+  A+K  + E      + + E+ +V+   H   NIV   G+ L+   
Sbjct: 23  GDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHC--NIVAYFGSYLSR-E 79

Query: 445 HSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMN 504
             ++  EY   GSL+D  H    +    IA             +C +    L Y+H   +
Sbjct: 80  KLWICMEYCGGGSLQDIYHVTGPLSELQIAY------------VCRETLQGLAYLH---S 124

Query: 505 PSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNP-------------A 551
              +HR+IK  NI L +  + ++ +FG+A  +       + +   P              
Sbjct: 125 KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNG 184

Query: 552 SWSMGIDIFAYGIVLLEVLSGQTPI 576
            ++   DI+A GI  +E+   Q P+
Sbjct: 185 GYNQLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 44.2 bits (105), Expect = 1e-04
 Identities = 40/180 (22%), Positives = 68/180 (37%), Gaps = 64/180 (35%)

Query: 428 HHPNIVRLLGTCLTDGPHS-FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTW-SQR 485
            H N+V L+   L     S +L+F+YA++    D                   + +  Q 
Sbjct: 60  KHENVVSLVEVFLEHADKSVYLLFDYAEH----DLWQ---------------IIKFHRQA 100

Query: 486 LRICLDVAM----------ALQYMH--HVMNPSYVHRNIKSRNIFLDEEFNAR----VGN 529
            R+ +  +M           + Y+H   V+     HR++K  NI +  E   R    +G+
Sbjct: 101 KRVSIPPSMVKSLLWQILNGVHYLHSNWVL-----HRDLKPANILVMGEGPERGVVKIGD 155

Query: 530 FGMARCVNDDTESP--QFYSTNP---ASWS------MG-------IDIFAYGIVLLEVLS 571
            G+AR  N    +P       +P     W       +G       IDI+A G +  E+L+
Sbjct: 156 LGLARLFN----APLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 43.5 bits (103), Expect = 2e-04
 Identities = 59/205 (28%), Positives = 87/205 (42%), Gaps = 49/205 (23%)

Query: 394 VYHGR--LNGKNLAIK--RTEHEVITKL----EMQLVQHATHHHPNIVRLLGTCLTDGPH 445
           VY GR  L G+ +A+K  R EHE         E  L++     H NIV L     T    
Sbjct: 21  VYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLK--DLKHANIVTLHDIIHTKKTL 78

Query: 446 SFLVFEYAKNGSLK---DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
           +  VFEY     LK   D   GGL+M N      + F    Q LR        L Y H  
Sbjct: 79  TL-VFEYLDT-DLKQYMDDCGGGLSMHN---VRLFLF----QLLR-------GLAYCHQ- 121

Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARC--VNDDTESPQ----FY--------ST 548
                +HR++K +N+ + E    ++ +FG+AR   V   T S +    +Y        ST
Sbjct: 122 --RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGST 179

Query: 549 NPASWSMGIDIFAYGIVLLEVLSGQ 573
               +S  +D++  G +  E+ +G+
Sbjct: 180 E---YSTSLDMWGVGCIFYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|212030 cd00118, LysM, Lysine Motif is a small domain involved in binding peptidoglycan

 Score = 39.0 bits (92), Expect = 2e-04
 Identities = 11/30 (36%), Positives = 16/30 (53%)

Query: 193 VSYPVGEGDTVSGLAAKFNTTPAAIIAANN 222
            +Y V  GDT+  +A K+  T   + AAN 
Sbjct: 1   KTYTVKPGDTLWSIAKKYGVTVEELAAANP 30

LysM, a small globular domain with approximately 40 amino acids, is a widespread protein module involved in binding peptidoglycan in bacteria and chitin in eukaryotes. The domain was originally identified in enzymes that degrade bacterial cell walls, but proteins involved in many other biological functions also contain this domain. It has been reported that the LysM domain functions as a signal for specific plant-bacteria recognition in bacterial pathogenesis. Many of these enzymes are modular and are composed of catalytic units linked to one or several repeats of LysM domains. LysM domains are found in bacteria and eukaryotes. Length = 45

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 40/184 (21%), Positives = 81/184 (44%), Gaps = 28/184 (15%)

Query: 402 KNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW 461
           K + ++  E E I  ++ ++   +    P + +  G+ L  G   +++ EY   GS  D 
Sbjct: 35  KIIDLEEAEDE-IEDIQQEITVLSQCDSPYVTKYYGSYLK-GTKLWIIMEYLGGGSALDL 92

Query: 462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE 521
           L  G   + Q IA+            +  ++   L Y+H   +   +HR+IK+ N+ L E
Sbjct: 93  LRAGPFDEFQ-IAT------------MLKEILKGLDYLH---SEKKIHRDIKAANVLLSE 136

Query: 522 EFNARVGNFGMARCVNDDTESPQFYSTNP----------ASWSMGIDIFAYGIVLLEVLS 571
           + + ++ +FG+A  + D       +   P          +++    DI++ GI  +E+  
Sbjct: 137 QGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAK 196

Query: 572 GQTP 575
           G+ P
Sbjct: 197 GEPP 200

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 43.7 bits (103), Expect = 2e-04
 Identities = 42/152 (27%), Positives = 69/152 (45%), Gaps = 26/152 (17%)

Query: 392 GAVYHGR--LNGKNLAIKRTEH-EVITKLEMQLVQH-----ATHHHPNIVRLLGTCLTDG 443
           G VY GR   N K  A+K  +  ++I K  +  VQ      A    P IV L  + L   
Sbjct: 18  GKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYS-LQSA 76

Query: 444 PHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH-HV 502
            + +LV EY   G +K  LH             Y +      ++   +VA+AL Y+H H 
Sbjct: 77  NNVYLVMEYLIGGDVKSLLH------------IYGYFDEEMAVKYISEVALALDYLHRH- 123

Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR 534
                +HR++K  N+ +  E + ++ +FG+++
Sbjct: 124 ---GIIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 48/208 (23%), Positives = 90/208 (43%), Gaps = 41/208 (19%)

Query: 392 GAVYHGRLNGKN--LAIKRTEHEVI--------TKLEMQLVQHATHHHPNIVRLLGTCLT 441
           G V    L GK    A+K  + +V+        T +E +++  A  + P +  L  T  T
Sbjct: 9   GKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWEN-PFLTHLYCTFQT 67

Query: 442 DGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHH 501
              H F V E+   G L    H  +  K +F      F           ++   LQ++H 
Sbjct: 68  K-EHLFFVMEFLNGGDLM--FH--IQDKGRFDLYRATFYA--------AEIVCGLQFLH- 113

Query: 502 VMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR------------CVNDDTESPQFYSTN 549
             +   ++R++K  N+ LD + + ++ +FGM +            C   D  +P+     
Sbjct: 114 --SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGL 171

Query: 550 PASWSMGIDIFAYGIVLLEVLSGQTPIN 577
             ++S  +D +++G++L E+L GQ+P +
Sbjct: 172 KYTFS--VDWWSFGVLLYEMLIGQSPFH 197

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 43.1 bits (101), Expect = 3e-04
 Identities = 40/192 (20%), Positives = 82/192 (42%), Gaps = 37/192 (19%)

Query: 405 AIKRTEHEVITKLE-MQLVQHATH------HHPNIVRLLGTCLTDGPHSFLVFEYAKNGS 457
           A+K  + E++   E +  VQ   H      +HP +V L  +C       F V EY   G 
Sbjct: 24  AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL-HSCFQTESRLFFVIEYVNGGD 82

Query: 458 LKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNI 517
           L   +     +  +  A  Y             ++++AL Y+H       ++R++K  N+
Sbjct: 83  LMFHMQRQRKLPEEH-ARFYS-----------AEISLALNYLHE---RGIIYRDLKLDNV 127

Query: 518 FLDEEFNARVGNFGMAR------------CVNDDTESPQFYSTNPASWSMGIDIFAYGIV 565
            LD E + ++ ++GM +            C   +  +P+        +   +D +A G++
Sbjct: 128 LLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGE--DYGFSVDWWALGVL 185

Query: 566 LLEVLSGQTPIN 577
           + E+++G++P +
Sbjct: 186 MFEMMAGRSPFD 197

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 42.7 bits (101), Expect = 3e-04
 Identities = 48/207 (23%), Positives = 90/207 (43%), Gaps = 56/207 (27%)

Query: 400 NGKNLAIKRTEHEVITKLEMQLVQHATH-----HHPNIVR-----LLGTCLTDGPHSFLV 449
           N + +AIKR + E   +  +  ++         +HPN+V+     ++G  L      +LV
Sbjct: 25  NNEKVAIKRIDLEK-CQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDEL------WLV 77

Query: 450 FEYAKNGSLKDWL-----HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMN 504
             Y   GSL D +      GGL   ++ I +            +  +V   L+Y+H   +
Sbjct: 78  MPYLSGGSLLDIMKSSYPRGGL---DEAIIAT-----------VLKEVLKGLEYLH---S 120

Query: 505 PSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQ-----FYSTNP--------- 550
              +HR+IK+ NI L E+ + ++ +FG++  + D  +  +     F  T P         
Sbjct: 121 NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGT-PCWMAPEVME 179

Query: 551 --ASWSMGIDIFAYGIVLLEVLSGQTP 575
               +    DI+++GI  +E+ +G  P
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAP 206

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 42.7 bits (100), Expect = 3e-04
 Identities = 27/108 (25%), Positives = 52/108 (48%), Gaps = 16/108 (14%)

Query: 491 DVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE--------- 541
           ++ + L++MH   N   V+R++K  NI LDE  + R+ + G+A C     +         
Sbjct: 105 EIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHG 160

Query: 542 --SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDEGSV 587
             +P+      A +    D F+ G +L ++L G +P  + + KD+  +
Sbjct: 161 YMAPEVLQKGTA-YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 207

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 42.2 bits (99), Expect = 4e-04
 Identities = 25/93 (26%), Positives = 47/93 (50%), Gaps = 9/93 (9%)

Query: 499 MHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN--------- 549
           + H+ +   V+R++K  N+ LD++ N R+ + G+A  + D     Q   TN         
Sbjct: 108 ILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILK 167

Query: 550 PASWSMGIDIFAYGIVLLEVLSGQTPINRPRKK 582
              +S  +D FA G  + E+++G+TP    ++K
Sbjct: 168 EEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEK 200

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 41.9 bits (99), Expect = 5e-04
 Identities = 58/203 (28%), Positives = 88/203 (43%), Gaps = 57/203 (28%)

Query: 392 GAVYHGR--LNGKNLAIK--RTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTD 442
           G VY  R  L G+ +A+K  R E E          E+ L++    +HPNIVRLL     D
Sbjct: 13  GVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKEL--NHPNIVRLL-----D 65

Query: 443 GPHS----FLVFEYAKNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMAL 496
             HS    +LVFE+  +  LK ++       +    I S   +L   Q L+      +A 
Sbjct: 66  VVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKS---YL--YQLLQ-----GIAY 114

Query: 497 QYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------------SPQ 544
            + H V+     HR++K +N+ +D E   ++ +FG+AR                   +P+
Sbjct: 115 CHSHRVL-----HRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPE 169

Query: 545 ------FYSTNPASWSMGIDIFA 561
                  YST    WS+G  IFA
Sbjct: 170 ILLGSRQYSTPVDIWSIGC-IFA 191

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 41.7 bits (98), Expect = 6e-04
 Identities = 46/210 (21%), Positives = 84/210 (40%), Gaps = 47/210 (22%)

Query: 392 GAVY--HGRLNGKNLAIKRTEHEVITKLEMQLVQ---HATHHHPNIVRLLGTCLTDGPHS 446
           G VY    +  G   A K  + E   +LE  +V+    +   HPNIV L      +    
Sbjct: 19  GKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYE-NKL 77

Query: 447 FLVFEYAKNGSLKDWL----HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
           +++ E+   G+L   +     G               LT  Q   +C  +  AL ++H  
Sbjct: 78  WILIEFCDGGALDSIMLELERG---------------LTEPQIRYVCRQMLEALNFLH-- 120

Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGM-ARCVNDDTESPQF---------------- 545
            +   +HR++K+ NI L  + + ++ +FG+ A+  +   +   F                
Sbjct: 121 -SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACET 179

Query: 546 YSTNPASWSMGIDIFAYGIVLLEVLSGQTP 575
           +  NP  +    DI++ GI L+E+   + P
Sbjct: 180 FKDNPYDYK--ADIWSLGITLIELAQMEPP 207

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 41.6 bits (97), Expect = 7e-04
 Identities = 50/205 (24%), Positives = 89/205 (43%), Gaps = 39/205 (19%)

Query: 392 GAVYHGR--LNGKNLAIKRTEH---------EVITKLEMQLVQHATHHHPNIVRLLGTCL 440
           GAVY  R   N + +AIK+  +         + I K E++ +Q     HPN ++  G C 
Sbjct: 29  GAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIK-EVRFLQKL--RHPNTIQYRG-CY 84

Query: 441 TDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH 500
                ++LV EY   GS  D L      K              Q + I      ALQ + 
Sbjct: 85  LREHTAWLVMEYCL-GSASDLLE---VHKKPL-----------QEVEIAAVTHGALQGLA 129

Query: 501 HVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV---NDDTESPQFY------STNPA 551
           ++ + + +HR++K+ NI L E    ++G+FG A  +   N    +P +       + +  
Sbjct: 130 YLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXFVGTPYWMAPEVILAMDEG 189

Query: 552 SWSMGIDIFAYGIVLLEVLSGQTPI 576
            +   +D+++ GI  +E+   + P+
Sbjct: 190 QYDGKVDVWSLGITCIELAERKPPL 214

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 41.4 bits (98), Expect = 8e-04
 Identities = 44/212 (20%), Positives = 86/212 (40%), Gaps = 50/212 (23%)

Query: 392 GAVYHGR--LNGKNLAIK--RTEHEVITK--------LEMQLVQHATHHHPNIVRLLGTC 439
             VY  R    G+ +AIK  +       K         E++L+Q     HPNI+ LL   
Sbjct: 14  AVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQEL--KHPNIIGLLDVF 71

Query: 440 LTDGPHSFLVFEYAKNGSLKDWLHGGLAM--KNQFIASCYCFLTWSQRLRICLDVAMALQ 497
                 + LVFE+         +   L    K++ I      LT +      L   M L+
Sbjct: 72  GHKSNIN-LVFEF---------METDLEKVIKDKSI-----VLTPADIKSYML---MTLR 113

Query: 498 YMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR-CVNDDTE-SPQ----------- 544
            + ++ +   +HR++K  N+ +  +   ++ +FG+AR   + + + + Q           
Sbjct: 114 GLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPEL 173

Query: 545 FYSTNPASWSMGIDIFAYGIVLLEVLSGQTPI 576
            +      + +G+D+++ G +  E+L  + P 
Sbjct: 174 LFGAR--HYGVGVDMWSVGCIFAELLL-RVPF 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 41.3 bits (97), Expect = 0.001
 Identities = 21/104 (20%), Positives = 50/104 (48%), Gaps = 19/104 (18%)

Query: 487 RICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFG--------MARCVND 538
           +I + +  AL+Y+H     S +HR++K  N+ ++     ++ +FG        +A+ +  
Sbjct: 107 KIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTI-- 162

Query: 539 DTESPQFYS-------TNPASWSMGIDIFAYGIVLLEVLSGQTP 575
           D     + +        N   + +  D+++ GI ++E+ +G+ P
Sbjct: 163 DAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFP 206

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 41.1 bits (96), Expect = 0.001
 Identities = 43/190 (22%), Positives = 77/190 (40%), Gaps = 49/190 (25%)

Query: 407 KRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGL 466
           K TEH   T+ E Q+++H     P +V L     TD     L+ +Y   G L        
Sbjct: 46  KTTEH---TRTERQVLEH-IRQSPFLVTLHYAFQTD-TKLHLILDYINGGEL-------- 92

Query: 467 AMKNQFIASCYCFLTWSQRLRICL--------DVAMALQYMHHVMNPSYVHRNIKSRNIF 518
                       F   SQR R           ++ +AL+++H +     ++R+IK  NI 
Sbjct: 93  ------------FTHLSQRERFKEQEVQIYSGEIVLALEHLHKL---GIIYRDIKLENIL 137

Query: 519 LDEEFNARVGNFGMAR-CVNDDTE------------SPQFYSTNPASWSMGIDIFAYGIV 565
           LD   +  + +FG+++    D+ E            +P             +D ++ G++
Sbjct: 138 LDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVL 197

Query: 566 LLEVLSGQTP 575
           + E+L+G +P
Sbjct: 198 MYELLTGASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score = 41.1 bits (97), Expect = 0.001
 Identities = 48/221 (21%), Positives = 82/221 (37%), Gaps = 60/221 (27%)

Query: 392 GAVYHGR--LNGKNLAIKRTEHEVITKLEMQ---LVQHATH--------HHPNIVRLLGT 438
           G V+  +    G   AIK     VI K +M     V               P +V+L   
Sbjct: 7   GRVFLAKKKSTGDIYAIK-----VIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-Y 60

Query: 439 CLTDGPHSFLVFEYAKNGSLKDWLH--GGL--AMKNQFIASCYCFLTWSQRLRICLDVAM 494
                 + +LV EY   G L   L   G L   +   +IA                ++ +
Sbjct: 61  SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIA----------------EIVL 104

Query: 495 ALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR---------CVNDDTESPQF 545
           AL+Y+H   +   +HR++K  NI +D   + ++ +FG+++           +D+ E  + 
Sbjct: 105 ALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRI 161

Query: 546 YST---------NPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
             T              S  +D ++ G +L E L G  P +
Sbjct: 162 VGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFH 202

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|197609 smart00257, LysM, Lysin motif

 Score = 36.7 bits (86), Expect = 0.001
 Identities = 12/47 (25%), Positives = 24/47 (51%), Gaps = 4/47 (8%)

Query: 195 YPVGEGDTVSGLAAKFNTTPAAIIAANNKSLEGFKPEDLLAFTSILI 241
           Y V +GDT+S +A ++  + + ++  NN       P++L     + I
Sbjct: 2   YTVKKGDTLSSIARRYGISVSDLLELNN----ILDPDNLQVGQKLKI 44

Length = 44

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 35/168 (20%), Positives = 66/168 (39%), Gaps = 30/168 (17%)

Query: 428 HHPNIVRLLGTCLTD----GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWS 483
           +HPN+V+  G         G   +LV E    GS+ + + G L    +   +   ++ + 
Sbjct: 77  NHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYG 136

Query: 484 QRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGM------ARCVN 537
                      AL  + H+ N   +HR++K  NI L  E   ++ +FG+       R   
Sbjct: 137 -----------ALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRR 185

Query: 538 DDTESPQFY---------STNPASWSMGIDIFAYGIVLLEVLSGQTPI 576
           + +    F+              S+    D+++ GI  +E+  G  P+
Sbjct: 186 NTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 40.7 bits (95), Expect = 0.001
 Identities = 59/223 (26%), Positives = 91/223 (40%), Gaps = 54/223 (24%)

Query: 380 ATEKFNSSNRIEGA---VYHG--RLNGKNLAIK----RTEHEV-ITKL-EMQLVQHATHH 428
           AT   N     EG+   VY G  R+NG+ +A+K    +TE  V  T + E  L++   H 
Sbjct: 4   ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKH- 62

Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIA-------SCYCFLT 481
             NIV L     T    +F VFEY         +H  LA   Q++             L 
Sbjct: 63  -ANIVLLHDIIHTKETLTF-VFEY---------MHTDLA---QYMIQHPGGLHPYNVRLF 108

Query: 482 WSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR-----CV 536
             Q LR        L Y+H       +HR++K +N+ +      ++ +FG+AR       
Sbjct: 109 MFQLLR-------GLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ 158

Query: 537 NDDTESPQFYSTNP------ASWSMGIDIFAYGIVLLEVLSGQ 573
              +E    +   P        +S  +DI+  G + +E+L GQ
Sbjct: 159 TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQ 201

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 40.5 bits (95), Expect = 0.001
 Identities = 41/183 (22%), Positives = 79/183 (43%), Gaps = 35/183 (19%)

Query: 407 KRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGL 466
           K  EH   T+ E Q+++      P +V L     TD     L+ +Y   G L  + H  L
Sbjct: 46  KTAEH---TRTERQVLEA-VRRCPFLVTLHYAFQTDT-KLHLILDYVNGGEL--FTH--L 96

Query: 467 AMKNQFIASCYCFLTWSQRLRICL-DVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNA 525
             +  F  S          +R+ + ++ +AL ++H +     ++R+IK  NI LD E + 
Sbjct: 97  YQREHFTES---------EVRVYIAEIVLALDHLHQL---GIIYRDIKLENILLDSEGHV 144

Query: 526 RVGNFGMARCVNDDTE-------------SPQFYSTNPASWSMGIDIFAYGIVLLEVLSG 572
            + +FG+++    + E             +P+            +D ++ G++  E+L+G
Sbjct: 145 VLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204

Query: 573 QTP 575
            +P
Sbjct: 205 ASP 207

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 40.6 bits (95), Expect = 0.001
 Identities = 27/106 (25%), Positives = 48/106 (45%), Gaps = 11/106 (10%)

Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HPNIVR   T   +    ++V +  +   L +  +     K +F         W+  +++
Sbjct: 68  HPNIVRYYKT-FLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEE----RIWNIFVQM 122

Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR 534
            L    AL+Y+H       VHR++   NI L E+    + +FG+A+
Sbjct: 123 VL----ALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLAK 162

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 40.8 bits (95), Expect = 0.001
 Identities = 52/204 (25%), Positives = 87/204 (42%), Gaps = 35/204 (17%)

Query: 392 GAVYHG--RLNGKNLAIKRTEHEVITKLEMQLVQ---HATHHHPNIVRLLGTCLTDGPHS 446
           G VY    +  G   A K  E +   +LE  +V+    AT +HP IV+LLG    DG   
Sbjct: 26  GKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLW 85

Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
            ++ E+   G++   +   L +           LT  Q   IC  +  ALQY+H   +  
Sbjct: 86  IMI-EFCPGGAVDAIM---LELDRG--------LTEPQIQVICRQMLEALQYLH---SMK 130

Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGM-ARCVNDDTESPQFYST--------------NPA 551
            +HR++K+ N+ L  + + ++ +FG+ A+ V        F  T                 
Sbjct: 131 IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDT 190

Query: 552 SWSMGIDIFAYGIVLLEVLSGQTP 575
            +    DI++ GI L+E+   + P
Sbjct: 191 PYDYKADIWSLGITLIEMAQIEPP 214

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 40.3 bits (95), Expect = 0.002
 Identities = 38/161 (23%), Positives = 69/161 (42%), Gaps = 33/161 (20%)

Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKN---QFIASCYCFLTWSQ 484
           +HP IV+L  T   D  + +++ EY   G L   L           +F  +C        
Sbjct: 51  NHPFIVKLYRT-FKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIAC-------- 101

Query: 485 RLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQ 544
                  V +A +Y+H   N   ++R++K  N+ LD     ++ +FG A+ +    ++  
Sbjct: 102 -------VVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWT 151

Query: 545 FYSTNP----------ASWSMGIDIFAYGIVLLEVLSGQTP 575
           F  T P            +   +D ++ GI+L E+L+G+ P
Sbjct: 152 FCGT-PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPP 191

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 40.8 bits (95), Expect = 0.002
 Identities = 48/197 (24%), Positives = 83/197 (42%), Gaps = 35/197 (17%)

Query: 394 VYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYA 453
           VY  +L  K   IKR++     + E  ++  A  + P +V+L      D  + ++V EY 
Sbjct: 70  VYAMKLLSKFEMIKRSDSAFFWE-ERDIMAFA--NSPWVVQLF-CAFQDDKYLYMVMEYM 125

Query: 454 KNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIK 513
             G L +       M N  +        W++      +V +AL  +H +     +HR++K
Sbjct: 126 PGGDLVN------LMSNYDVPE-----KWAKFY--TAEVVLALDAIHSM---GLIHRDVK 169

Query: 514 SRNIFLDEEFNARVGNF---------GMARC----VNDDTESPQFYSTNPASWSMG--ID 558
             N+ LD+  + ++ +F         GM RC       D  SP+   +       G   D
Sbjct: 170 PDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECD 229

Query: 559 IFAYGIVLLEVLSGQTP 575
            ++ G+ L E+L G TP
Sbjct: 230 WWSVGVFLFEMLVGDTP 246

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 40.3 bits (94), Expect = 0.002
 Identities = 28/104 (26%), Positives = 51/104 (49%), Gaps = 14/104 (13%)

Query: 491 DVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN- 549
           ++ + L++MH   N   V+R++K  NI LDE  + R+ + G+A C     +      T+ 
Sbjct: 105 EIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHG 160

Query: 550 ---PASWSMGI------DIFAYGIVLLEVLSGQTPINRPRKKDE 584
              P     G+      D F+ G +L ++L G +P  + + KD+
Sbjct: 161 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 40.4 bits (94), Expect = 0.002
 Identities = 22/88 (25%), Positives = 51/88 (57%), Gaps = 11/88 (12%)

Query: 495 ALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQFYST--- 548
            L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + ++Y     
Sbjct: 132 GLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEI 188

Query: 549 --NPASWSMGIDIFAYGIVLLEVLSGQT 574
             N   ++  +DI++ G ++ E+L+G+T
Sbjct: 189 MLNWMHYNQTVDIWSVGCIMAELLTGRT 216

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 40.4 bits (94), Expect = 0.002
 Identities = 55/202 (27%), Positives = 92/202 (45%), Gaps = 43/202 (21%)

Query: 394 VYHGR--LNGKNLAIK--RTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPH 445
           V+ GR  L    +A+K  R EHE         E+ L+++  H   NIV L     T+   
Sbjct: 21  VFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKH--ANIVTLHDIIHTERCL 78

Query: 446 SFLVFEYAKNGSLKDWL-HGG--LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
           + LVFEY  +  LK +L + G  ++M N  I   + F    Q LR        L Y H  
Sbjct: 79  T-LVFEYLDS-DLKQYLDNCGNLMSMHNVKI---FMF----QLLR-------GLSYCHK- 121

Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTES-----------PQFYSTNPA 551
                +HR++K +N+ ++E+   ++ +FG+AR  +  T++           P        
Sbjct: 122 --RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGST 179

Query: 552 SWSMGIDIFAYGIVLLEVLSGQ 573
            +S  ID++  G +L E+ +G+
Sbjct: 180 EYSTPIDMWGVGCILYEMATGR 201

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 40.3 bits (95), Expect = 0.002
 Identities = 46/170 (27%), Positives = 70/170 (41%), Gaps = 54/170 (31%)

Query: 392 GAVYHGR--LNGKNLAIKR----TEHEVI---TKLEMQLVQHATHH-HPNIVRLLGTCLT 441
           G VY  R    G+ +A+K+       E I   T  E+ L++      HPNIVRLL  C  
Sbjct: 13  GTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVC-- 70

Query: 442 DGPHS------FLVFEYAKNGSLKDW-LHGGLAMKNQFIASC---------YCFLTWSQR 485
            GP +       LVFE+       D  L         +++ C            L   Q 
Sbjct: 71  HGPRTDRELKLTLVFEHV------DQDLA-------TYLSKCPKPGLPPETIKDLMR-QL 116

Query: 486 LRICLDVAMALQYMH-HVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR 534
           LR        + ++H H      VHR++K +NI +  +   ++ +FG+AR
Sbjct: 117 LR-------GVDFLHSH----RIVHRDLKPQNILVTSDGQVKIADFGLAR 155

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 40.0 bits (93), Expect = 0.002
 Identities = 35/158 (22%), Positives = 73/158 (46%), Gaps = 22/158 (13%)

Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLR 487
           +HPN+++ L + + D   + +V E A  G L   +      + + I        W   ++
Sbjct: 60  NHPNVIKYLDSFIEDNELN-IVLELADAGDLSQMIKY-FKKQKRLIPE---RTVWKYFVQ 114

Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------ 541
           +C     A+++MH   +   +HR+IK  N+F+      ++G+ G+ R  +  T       
Sbjct: 115 LC----SAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLV 167

Query: 542 -SPQFYS---TNPASWSMGIDIFAYGIVLLEVLSGQTP 575
            +P + S    +   ++   DI++ G +L E+ + Q+P
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSP 205

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 40.1 bits (94), Expect = 0.002
 Identities = 41/193 (21%), Positives = 82/193 (42%), Gaps = 40/193 (20%)

Query: 401 GKNLAIKR----TEHEVITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKN 455
           G+ +AIK+     + +++ K+ M+ ++      H N+V L+          +LVFE+  +
Sbjct: 26  GQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVF-RRKKRLYLVFEFVDH 84

Query: 456 GSLKDWLH--GGLAMKNQFIASCYCFLTWSQRLRICL-DVAMALQYMHHVMNPSYVHRNI 512
             L D      GL                  R+R  L  +   +++ H   + + +HR+I
Sbjct: 85  TVLDDLEKYPNGLD---------------ESRVRKYLFQILRGIEFCH---SHNIIHRDI 126

Query: 513 KSRNIFLDEEFNARVGNFGMARCVNDDTES------------PQFYSTNPASWSMGIDIF 560
           K  NI + +    ++ +FG AR +    E             P+    +   +   +DI+
Sbjct: 127 KPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDT-KYGRAVDIW 185

Query: 561 AYGIVLLEVLSGQ 573
           A G ++ E+L+G+
Sbjct: 186 AVGCLVTEMLTGE 198

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 40.1 bits (93), Expect = 0.003
 Identities = 31/117 (26%), Positives = 53/117 (45%), Gaps = 20/117 (17%)

Query: 480 LTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD 539
           L    R  I   +  A++Y+H   +   +HR+IK  NIFL+ +    +G+FG A     +
Sbjct: 265 LLKQTR-AIMKQLLCAVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKE 320

Query: 540 -------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQ-TPINRPRKK 582
                        T SP+  + +   +    DI++ G++LL++LS    PI     K
Sbjct: 321 REAFDYGWVGTVATNSPEILAGD--GYCEITDIWSCGLILLDMLSHDFCPIGDGGGK 375

Length = 501

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 39.7 bits (93), Expect = 0.003
 Identities = 37/159 (23%), Positives = 71/159 (44%), Gaps = 39/159 (24%)

Query: 392 GAVYHGR--LNGKNLAIKR----TEHEVITKL---EMQLVQHATHHHPNIVRLLGTCLTD 442
           G VY GR    G+ +A+K+    +E E +      E+ L++     HPNIV L    + +
Sbjct: 14  GVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKEL--QHPNIVCLQDVLMQE 71

Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
               +L+FE+  +  LK +L      K Q+                 +D  +   Y++ +
Sbjct: 72  -SRLYLIFEFL-SMDLKKYLDS--LPKGQY-----------------MDAELVKSYLYQI 110

Query: 503 MNPSY-------VHRNIKSRNIFLDEEFNARVGNFGMAR 534
           +           +HR++K +N+ +D +   ++ +FG+AR
Sbjct: 111 LQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLAR 149

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 39.6 bits (92), Expect = 0.003
 Identities = 26/93 (27%), Positives = 42/93 (45%), Gaps = 16/93 (17%)

Query: 499 MHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--------TESPQFYST-- 548
           +H +    YVHR+IK  N+ LD   + R+ +FG    +N D          +P + S   
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEI 174

Query: 549 -NPASWSMG-----IDIFAYGIVLLEVLSGQTP 575
                  MG      D ++ G+ + E+L G+TP
Sbjct: 175 LQAMEDGMGKYGPECDWWSLGVCMYEMLYGETP 207

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 39.8 bits (93), Expect = 0.003
 Identities = 29/103 (28%), Positives = 54/103 (52%), Gaps = 16/103 (15%)

Query: 486 LRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR-CVNDDTESPQ 544
           LR    VA   Q M  + + + +HR++ +RN+ L +   A++ +FG+AR  +ND     +
Sbjct: 215 LRFSSQVA---QGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271

Query: 545 FYSTNPASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
             +  P  W           ++  D+++YGI+L E+ S G++P
Sbjct: 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSP 314

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 39.4 bits (92), Expect = 0.003
 Identities = 48/207 (23%), Positives = 91/207 (43%), Gaps = 38/207 (18%)

Query: 396 HGRLNGKNLAIKRTEHEVI---------TKLEMQLVQHATHHHPNIVRLLGTCLTDGPHS 446
            G   GK  A+K  +   I         TK E  +++     HP IV L+    T G   
Sbjct: 19  TGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAV--KHPFIVDLIYAFQTGG-KL 75

Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           +L+ EY   G L  ++H  L  +  F+    CF           ++++AL+++H      
Sbjct: 76  YLILEYLSGGEL--FMH--LEREGIFMEDTACFYL--------SEISLALEHLHQQ---G 120

Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMAR-CVNDDTESPQFYST---------NPASWSMG 556
            ++R++K  NI LD + + ++ +FG+ +  +++ T +  F  T           +     
Sbjct: 121 IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKA 180

Query: 557 IDIFAYGIVLLEVLSGQTPIN-RPRKK 582
           +D ++ G ++ ++L+G  P     RKK
Sbjct: 181 VDWWSLGALMYDMLTGAPPFTAENRKK 207

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 39.1 bits (91), Expect = 0.004
 Identities = 55/216 (25%), Positives = 90/216 (41%), Gaps = 43/216 (19%)

Query: 392 GAVYHGRLN-GKNLAIKR----TEHEVITKLEMQLVQH-----ATHHHPNIVRLLGTCLT 441
           G VY G  N G+ +A+K+    T + +  + E + +Q       +  H NIV+ LGTCL 
Sbjct: 14  GTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLD 73

Query: 442 DGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHH 501
           D   S  + E+   GS+   L+             +C  T     +  LD    + Y+H 
Sbjct: 74  DNTISIFM-EFVPGGSISSILN----RFGPLPEPVFCKYT-----KQILD---GVAYLH- 119

Query: 502 VMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN----DDTESPQFYSTNPASWSMG- 556
             N   VHR+IK  N+ L      ++ +FG AR +       T S    S +   + M  
Sbjct: 120 --NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAP 177

Query: 557 -----------IDIFAYGIVLLEVLSGQTPI-NRPR 580
                       DI++ G  + E+ +G+ P+ +  R
Sbjct: 178 EVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDR 213

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 39.3 bits (91), Expect = 0.004
 Identities = 22/86 (25%), Positives = 49/86 (56%), Gaps = 11/86 (12%)

Query: 496 LQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQFYST---- 548
           L+Y+H   +   +HR++K  N+ ++E+   R+ +FG+AR  +D+     + ++Y      
Sbjct: 131 LKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATRWYRAPEIM 187

Query: 549 -NPASWSMGIDIFAYGIVLLEVLSGQ 573
            N   ++  +DI++ G ++ E+L G+
Sbjct: 188 LNWMHYNQTVDIWSVGCIMAELLKGK 213

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	600
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.97
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	99.97
KOG3653	534	consensus Transforming growth factor beta/activin	99.97
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	99.97
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	99.97
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	99.97
KOG2052	513	consensus Activin A type IB receptor, serine/threo	99.97
KOG0598	357	consensus Ribosomal protein S6 kinase and related	99.97
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	99.97
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	99.97
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	99.97
PHA02988	283	hypothetical protein; Provisional	99.97
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	99.97
KOG0661	538	consensus MAPK related serine/threonine protein ki	99.97
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	99.97
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	99.97
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	99.97
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	99.96
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	99.96
KOG0198	313	consensus MEKK and related serine/threonine protei	99.96
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	99.96
KOG0583	370	consensus Serine/threonine protein kinase [Signal	99.96
KOG0578	550	consensus p21-activated serine/threonine protein k	99.96
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	99.96
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	99.96
KOG0582	516	consensus Ste20-like serine/threonine protein kina	99.96
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	99.96
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	99.96
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	99.96
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	99.96
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	99.96
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	99.96
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	99.96
PTZ00263	329	protein kinase A catalytic subunit; Provisional	99.96
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	99.96
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	99.96
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	99.96
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	99.96
KOG0611	668	consensus Predicted serine/threonine protein kinas	99.96
KOG0694	694	consensus Serine/threonine protein kinase [Signal	99.96
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	99.96
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	99.96
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	99.96
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	99.96
KOG0605	550	consensus NDR and related serine/threonine kinases	99.96
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	99.96
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	99.95
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	99.95
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	99.95
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	99.95
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	99.95
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	99.95
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	99.95
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	99.95
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	99.95
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	99.95
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	99.95
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	99.95
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	99.95
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	99.95
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	99.95
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	99.95
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	99.95
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	99.95
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	99.95
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	99.95
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	99.95
PLN00034	353	mitogen-activated protein kinase kinase; Provision	99.95
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	99.95
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	99.95
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	99.95
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	99.95
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	99.95
KOG1989	738	consensus ARK protein kinase family [Signal transd	99.95
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	99.95
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	99.95
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	99.95
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	99.95
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	99.95
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	99.95
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	99.95
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	99.95
PHA03211	461	serine/threonine kinase US3; Provisional	99.95
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	99.95
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	99.95
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	99.95
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	99.95
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	99.95
PTZ00267	478	NIMA-related protein kinase; Provisional	99.95
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	99.95
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	99.95
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	99.95
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	99.95
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	99.95
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	99.95
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	99.95
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	99.95
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	99.95
PHA03212	391	serine/threonine kinase US3; Provisional	99.94
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	99.94
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	99.94
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	99.94
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	99.94
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	99.94
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	99.94
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	99.94
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	99.94
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	99.94
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	99.94
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	99.94
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.94
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	99.94
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	99.94
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	99.94
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	99.94
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.94
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	99.94
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	99.94
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	99.94
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	99.94
KOG0610	459	consensus Putative serine/threonine protein kinase	99.94
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	99.94
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	99.94
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.94
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	99.94
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	99.94
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	99.94
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	99.94
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	99.94
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	99.94
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	99.94
PTZ00283	496	serine/threonine protein kinase; Provisional	99.94
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	99.94
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.94
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	99.94
PTZ00036	440	glycogen synthase kinase; Provisional	99.94
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	99.94
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	99.94
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	99.94
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	99.94
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	99.94
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	99.94
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	99.94
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	99.94
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	99.94
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.94
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	99.94
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	99.94
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	99.94
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	99.94
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	99.94
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	99.94
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	99.94
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	99.94
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	99.94
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	99.94
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	99.94
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	99.94
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	99.94
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	99.93
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	99.93
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	99.93
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	99.93
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	99.93
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.93
PHA03207	392	serine/threonine kinase US3; Provisional	99.93
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	99.93
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	99.93
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	99.93
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	99.93
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	99.93
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	99.93
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	99.93
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	99.93
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	99.93
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	99.93
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.93
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	99.93
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	99.93
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	99.93
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	99.93
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	99.93
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	99.93
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	99.93
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.93
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	99.93
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	99.93
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.93
PTZ00266	1021	NIMA-related protein kinase; Provisional	99.93
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	99.93
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.93
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	99.93
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.93
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	99.93
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	99.93
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.93
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.93
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	99.93
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	99.93
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	99.93
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	99.93
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	99.93
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	99.93
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	99.93
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	99.93
KOG4717	864	consensus Serine/threonine protein kinase [Signal	99.93
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	99.93
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	99.93
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	99.93
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.93
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	99.93
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.93
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	99.93
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	99.93
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.93
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.93
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.93
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	99.93
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	99.93
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	99.93
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	99.93
KOG0607	463	consensus MAP kinase-interacting kinase and relate	99.93
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	99.93
KOG0589	426	consensus Serine/threonine protein kinase [General	99.93
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.93
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.93
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	99.93
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	99.93
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	99.93
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	99.93
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	99.93
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	99.93
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	99.93
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	99.93
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	99.93
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	99.93
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	99.93
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	99.93
PTZ00284	467	protein kinase; Provisional	99.93
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	99.93
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	99.93
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	99.93
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	99.93
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.93
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	99.93
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	99.93
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	99.93
KOG0584	632	consensus Serine/threonine protein kinase [General	99.93
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	99.93
PHA03209	357	serine/threonine kinase US3; Provisional	99.93
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	99.93
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	99.93
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	99.93
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	99.93
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	99.93
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	99.93
KOG0586	596	consensus Serine/threonine protein kinase [General	99.93
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	99.93
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	99.93
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	99.93
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.93
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	99.93
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	99.93
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	99.93
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	99.93
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	99.93
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	99.93
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.93
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	99.93
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	99.93
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	99.93
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	99.93
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	99.92
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	99.92
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	99.92
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	99.92
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	99.92
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	99.92
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.92
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	99.92
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	99.92
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	99.92
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	99.92
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.92
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.92
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	99.92
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	99.92
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	99.92
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	99.92
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	99.92
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	99.92
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.92
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	99.92
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	99.92
KOG0201	467	consensus Serine/threonine protein kinase [Signal	99.92
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	99.92
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	99.92
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	99.92
KOG0577	948	consensus Serine/threonine protein kinase [Signal	99.92
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	99.92
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	99.92
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	99.92
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	99.92
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	99.92
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	99.92
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	99.92
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	99.92
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	99.92
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	99.92
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	99.92
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.92
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	99.92
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	99.92
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	99.92
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	99.92
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.92
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	99.92
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	99.92
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	99.92
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	99.92
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.91
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	99.91
PTZ00024	335	cyclin-dependent protein kinase; Provisional	99.91
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	99.91
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.91
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	99.91
PLN00009	294	cyclin-dependent kinase A; Provisional	99.91
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.91
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	99.91
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	99.91
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	99.91
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	99.91
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	99.91
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	99.91
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	99.91
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	99.91
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	99.91
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	99.91
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	99.91
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	99.91
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	99.91
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	99.91
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	99.91
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	99.91
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	99.91
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.9
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	99.9
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	99.9
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	99.9
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	99.9
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	99.9
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	99.9
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	99.9
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	99.9
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	99.9
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	99.9
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	99.89
PHA02882	294	putative serine/threonine kinase; Provisional	99.89
PHA03210	501	serine/threonine kinase US3; Provisional	99.89
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	99.89
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	99.89
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	99.89
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	99.89
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	99.89
KOG0690	516	consensus Serine/threonine protein kinase [Signal	99.89
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	99.89
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	99.89
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	99.89
KOG0696	683	consensus Serine/threonine protein kinase [Signal	99.88
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.88
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.88
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.88
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	99.88
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.88
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.88
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	99.87
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.87
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.87
KOG0596	677	consensus Dual specificity; serine/threonine and t	99.87
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.86
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	99.86
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.86
KOG1152	772	consensus Signal transduction serine/threonine kin	99.85
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.84
PRK06347	592	autolysin; Reviewed	99.83
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.83
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.82
KOG0695	593	consensus Serine/threonine protein kinase [Signal	99.82
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	99.82
PRK06347	592	autolysin; Reviewed	99.8
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.78
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.76
PLN00181	793	protein SPA1-RELATED; Provisional	99.76
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.76
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.73
PRK10783	456	mltD membrane-bound lytic murein transglycosylase	99.73
PRK09188	365	serine/threonine protein kinase; Provisional	99.69
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.68
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.67
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.66
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.66
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.66
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.65
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.63
PRK10345	210	hypothetical protein; Provisional	99.6
PRK12274	218	serine/threonine protein kinase; Provisional	99.6
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.58
PRK10783	456	mltD membrane-bound lytic murein transglycosylase	99.57
PRK14879	211	serine/threonine protein kinase; Provisional	99.57
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.53
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.48
smart00090	237	RIO RIO-like kinase.	99.48
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.47
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.46
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.45
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.44
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.41
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.38
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.37
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.37
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.36
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.32
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.29
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.28
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.26
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.26
PRK13914	481	invasion associated secreted endopeptidase; Provis	99.2
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.07
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.04
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.02
KOG1243	690	consensus Protein kinase [General function predict	99.01
PF01476	44	LysM: LysM domain; InterPro: IPR018392 This domain	99.0
KOG1266	458	consensus Protein kinase [Signal transduction mech	98.96
PRK13914	481	invasion associated secreted endopeptidase; Provis	98.94
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	98.86
COG1388	124	LytE FOG: LysM repeat [Cell envelope biogenesis, o	98.81
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.71
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	98.69
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.68
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	98.68
KOG0590	601	consensus Checkpoint kinase and related serine/thr	98.62
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.6
PRK14125	103	cell division suppressor protein YneA; Provisional	98.6
KOG3087	229	consensus Serine/threonine protein kinase [General	98.59
TIGR02899	44	spore_safA spore coat assembly protein SafA. in wh	98.5
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.49
cd00118	46	LysM Lysin domain, found in a variety of enzymes i	98.46
PF01476	44	LysM: LysM domain; InterPro: IPR018392 This domain	98.44
PRK10871	319	nlpD lipoprotein NlpD; Provisional	98.43
PRK14125	103	cell division suppressor protein YneA; Provisional	98.4
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.2
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.17
TIGR02907	338	spore_VI_D stage VI sporulation protein D. SpoVID,	98.16
COG1388	124	LytE FOG: LysM repeat [Cell envelope biogenesis, o	98.16
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.13
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	98.12
COG3858	423	Predicted glycosyl hydrolase [General function pre	98.11
smart00257	44	LysM Lysin motif.	98.11
PRK09902	216	hypothetical protein; Provisional	98.06
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	98.02
PRK11198	147	LysM domain/BON superfamily protein; Provisional	98.02
KOG0606	1205	consensus Microtubule-associated serine/threonine	98.01
KOG1235	538	consensus Predicted unusual protein kinase [Genera	97.92
TIGR02899	44	spore_safA spore coat assembly protein SafA. in wh	97.88
COG0478	304	RIO-like serine/threonine protein kinase fused to	97.79
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	97.74
cd00118	46	LysM Lysin domain, found in a variety of enzymes i	97.74
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	97.73
TIGR02907	338	spore_VI_D stage VI sporulation protein D. SpoVID,	97.67
PRK10871	319	nlpD lipoprotein NlpD; Provisional	97.5
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	97.47
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.46
COG3858	423	Predicted glycosyl hydrolase [General function pre	97.45
PF01636	239	APH: Phosphotransferase enzyme family This family	97.2
KOG2137	700	consensus Protein kinase [Signal transduction mech	97.15
smart00257	44	LysM Lysin motif.	97.06
COG4248	637	Uncharacterized protein with protein kinase and he	97.04
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.03
COG1652	269	XkdP Uncharacterized protein containing LysM domai	97.01
PLN02876	822	acyl-CoA dehydrogenase	96.89
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	96.73
PRK11198	147	LysM domain/BON superfamily protein; Provisional	96.66
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	96.64
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	96.63
PRK10593	297	hypothetical protein; Provisional	96.38
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	96.32
TIGR03505	74	FimV_core FimV N-terminal domain. This region is f	96.31
PRK10260	306	L,D-transpeptidase; Provisional	96.27
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	96.26
PRK10190	310	L,D-transpeptidase; Provisional	96.2

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-41  Score=354.51  Aligned_cols=217  Identities=40%  Similarity=0.707  Sum_probs=182.1

Q ss_pred             hccccCHHHHHHHHhccCCCCcee----EEEEEEEE-CCeEEEEEEcchhH---HHHHHHHHHHHHhCCCCceeeeeeEE
Q 041830          368 LLESYSIEDLRRATEKFNSSNRIE----GAVYHGRL-NGKNLAIKRTEHEV---ITKLEMQLVQHATHHHPNIVRLLGTC  439 (600)
Q Consensus       368 ~~~~~~~~el~~~t~~f~~~~~~~----G~Vy~g~~-~g~~vAvK~~~~~~---~~~~e~ei~~~~~l~HpNIv~l~g~~  439 (600)
                      ....|++.|+.+||++|+.++.+|    |.||+|.+ +|..||||++....   ..+|..|+..+.+++|||+|+|+|||
T Consensus        61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC  140 (361)
T KOG1187|consen   61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC  140 (361)
T ss_pred             CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence            456799999999999999888775    89999999 55899999987643   35699999999999999999999999


Q ss_pred             eccCCceEEEEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEe
Q 041830          440 LTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFL  519 (600)
Q Consensus       440 ~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl  519 (600)
                      .+.+.+.+||||||++|+|.++|+....          .+|+|.+|++|+.++|+||+|||+...++|+|||||++||||
T Consensus       141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~----------~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILL  210 (361)
T KOG1187|consen  141 LEGGEHRLLVYEYMPNGSLEDHLHGKKG----------EPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILL  210 (361)
T ss_pred             ecCCceEEEEEEccCCCCHHHHhCCCCC----------CCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeE
Confidence            8765358999999999999999987542          159999999999999999999999877899999999999999


Q ss_pred             CCCCcEEEEeccCccccCC-------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCCCCCccc
Q 041830          520 DEEFNARVGNFGMARCVND-------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDEGS  586 (600)
Q Consensus       520 d~~~~~kI~DFGla~~~~~-------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~~~~~~  586 (600)
                      |+++++||+|||+|+....             .+.+||+..+  ...+.++|||||||+|+||+||+.|.+.....+.  
T Consensus       211 D~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~--g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~--  286 (361)
T KOG1187|consen  211 DEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYAST--GKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGE--  286 (361)
T ss_pred             CCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhcc--CCcCcccccccchHHHHHHHhCCcccCCCCCccc--
Confidence            9999999999999976653             1235666655  4568899999999999999999999886552222  


Q ss_pred             hhHHHHHHhhhh
Q 041830          587 VWLSEKIKSILQ  598 (600)
Q Consensus       587 ~~l~~~~~~~l~  598 (600)
                      ..+.+|.+..++
T Consensus       287 ~~l~~w~~~~~~  298 (361)
T KOG1187|consen  287 LSLVEWAKPLLE  298 (361)
T ss_pred             ccHHHHHHHHHH
Confidence            235666555544

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-36  Score=302.01  Aligned_cols=175  Identities=27%  Similarity=0.495  Sum_probs=152.3

Q ss_pred             CCceeEEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHH
Q 041830          387 SNRIEGAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       387 ~~~~~G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~  459 (600)
                      +.|.++.||+|++  ++..||||.+...     ..+.++.||.+++.++|||||+|+++++.+ +.+|||||||.+|||.
T Consensus        19 G~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~-~~i~lVMEyC~gGDLs   97 (429)
T KOG0595|consen   19 GSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDD-DFIYLVMEYCNGGDLS   97 (429)
T ss_pred             cCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecC-CeEEEEEEeCCCCCHH
Confidence            5556699999999  7899999987654     345678999999999999999999998666 4999999999999999


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC------CcEEEEeccCc
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEE------FNARVGNFGMA  533 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~------~~~kI~DFGla  533 (600)
                      +||+..+            .+++.....++.|+|.||++||   +++||||||||.||||+..      -.+||+|||+|
T Consensus        98 ~yi~~~~------------~l~e~t~r~Fm~QLA~alq~L~---~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA  162 (429)
T KOG0595|consen   98 DYIRRRG------------RLPEATARHFMQQLASALQFLH---ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA  162 (429)
T ss_pred             HHHHHcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence            9998764            2899999999999999999999   7899999999999999764      46899999999


Q ss_pred             cccCCCC-----------CCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          534 RCVNDDT-----------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       534 ~~~~~~~-----------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                      |.+....           ++||+...  ..|+.|+|+||.|+||||+++|+.||...
T Consensus       163 R~L~~~~~a~tlcGSplYMAPEV~~~--~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~  217 (429)
T KOG0595|consen  163 RFLQPGSMAETLCGSPLYMAPEVIMS--QQYDAKADLWSIGTILYQCLTGKPPFDAE  217 (429)
T ss_pred             hhCCchhHHHHhhCCccccCHHHHHh--ccccchhhHHHHHHHHHHHHhCCCCcccc
Confidence            9876443           46666654  67899999999999999999999999843

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=309.73  Aligned_cols=181  Identities=29%  Similarity=0.491  Sum_probs=154.3

Q ss_pred             CCceeEEEEEEEECCeE-EEEEEcchhH-----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          387 SNRIEGAVYHGRLNGKN-LAIKRTEHEV-----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       387 ~~~~~G~Vy~g~~~g~~-vAvK~~~~~~-----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      +.|.+|.||+|.|.|+. ||||++....     .+.+.+|+..+..++|||||+|+|+|.+....+.||||||++|+|.+
T Consensus        50 G~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~  129 (362)
T KOG0192|consen   50 GSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSV  129 (362)
T ss_pred             ccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHH
Confidence            34445999999999998 9999986533     45789999999999999999999998655325899999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCC-ceecCCCCCCEEeCCCC-cEEEEeccCccccCC
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS-YVHRNIKSRNIFLDEEF-NARVGNFGMARCVND  538 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivHrDLk~~NILld~~~-~~kI~DFGla~~~~~  538 (600)
                      +|+....          ..|++..+++++.|||+||.|||+   .+ |||||||++|||++.++ ++||+|||+++....
T Consensus       130 ~l~~~~~----------~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~  196 (362)
T KOG0192|consen  130 LLHKKRK----------RKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVI  196 (362)
T ss_pred             HHhhccc----------CCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecc
Confidence            9987411          459999999999999999999994   45 99999999999999997 999999999975542


Q ss_pred             ------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          539 ------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       539 ------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                                  .+++||.+......++.++|||||||+||||+||+.||....
T Consensus       197 ~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~  250 (362)
T KOG0192|consen  197 SKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLA  250 (362)
T ss_pred             ccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCC
Confidence                        134788776434568999999999999999999999997644

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-34  Score=289.40  Aligned_cols=189  Identities=27%  Similarity=0.402  Sum_probs=160.0

Q ss_pred             cCHHHHHHHHhccCCCCceeEEEEEEEE--CCeEEEEEEc----chhHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCc
Q 041830          372 YSIEDLRRATEKFNSSNRIEGAVYHGRL--NGKNLAIKRT----EHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPH  445 (600)
Q Consensus       372 ~~~~el~~~t~~f~~~~~~~G~Vy~g~~--~g~~vAvK~~----~~~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~  445 (600)
                      .+..|+++...   .+.|.+|.||++++  +++.+|+|.+    +....+++.+|+.++....|||||+++|.|+.++..
T Consensus        76 i~~~dle~~~~---lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~  152 (364)
T KOG0581|consen   76 ISLSDLERLGV---LGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEE  152 (364)
T ss_pred             cCHHHhhhhhh---cccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCce
Confidence            55666655432   24555699999999  6999999997    445567889999999999999999999999877645


Q ss_pred             eEEEEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcE
Q 041830          446 SFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNA  525 (600)
Q Consensus       446 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~  525 (600)
                      ..|+||||.+|||.+++....            .+++...-+|+.+|++||.|||+  .++||||||||+|||++.+|.+
T Consensus       153 isI~mEYMDgGSLd~~~k~~g------------~i~E~~L~~ia~~VL~GL~YLh~--~~~IIHRDIKPsNlLvNskGeV  218 (364)
T KOG0581|consen  153 ISICMEYMDGGSLDDILKRVG------------RIPEPVLGKIARAVLRGLSYLHE--ERKIIHRDIKPSNLLVNSKGEV  218 (364)
T ss_pred             EEeehhhcCCCCHHHHHhhcC------------CCCHHHHHHHHHHHHHHHHHHhh--ccCeeeccCCHHHeeeccCCCE
Confidence            999999999999999997643            28899999999999999999996  3799999999999999999999


Q ss_pred             EEEeccCccccC----------CCCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          526 RVGNFGMARCVN----------DDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       526 kI~DFGla~~~~----------~~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                      ||+|||.++.+.          ..+++||...+  ..|+.++||||||+.++|+.+|+.||...
T Consensus       219 KicDFGVS~~lvnS~a~tfvGT~~YMsPERi~g--~~Ys~~sDIWSLGLsllE~a~GrfP~~~~  280 (364)
T KOG0581|consen  219 KICDFGVSGILVNSIANTFVGTSAYMSPERISG--ESYSVKSDIWSLGLSLLELAIGRFPYPPP  280 (364)
T ss_pred             EeccccccHHhhhhhcccccccccccChhhhcC--CcCCcccceecccHHHHHHhhCCCCCCCc
Confidence            999999987543          23456777666  46788899999999999999999999875

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-35  Score=306.76  Aligned_cols=178  Identities=26%  Similarity=0.534  Sum_probs=151.9

Q ss_pred             CCceeEEEEEEEECCe-EEEEEEcchhH--HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          387 SNRIEGAVYHGRLNGK-NLAIKRTEHEV--ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       387 ~~~~~G~Vy~g~~~g~-~vAvK~~~~~~--~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      +.|.+|.||.|.++|. .||+|.++...  .+.|.+|+.+|++++|+|||+++|+|..++ .+|||||||++|+|.+||+
T Consensus       215 G~G~FG~V~~g~~~~~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~-piyIVtE~m~~GsLl~yLr  293 (468)
T KOG0197|consen  215 GSGQFGEVWLGKWNGSTKVAVKTIKEGSMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE-PIYIVTEYMPKGSLLDYLR  293 (468)
T ss_pred             cCCccceEEEEEEcCCCcccceEEeccccChhHHHHHHHHHHhCcccCeEEEEEEEecCC-ceEEEEEecccCcHHHHhh
Confidence            4444599999999887 89999987643  256889999999999999999999997664 7999999999999999998


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCCC---
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDT---  540 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~~---  540 (600)
                      ....          ..+...+.+.++.|||+||+||+   +.++|||||.++||||+++..+||+||||||....+.   
T Consensus       294 ~~~~----------~~l~~~~Ll~~a~qIaeGM~YLe---s~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~  360 (468)
T KOG0197|consen  294 TREG----------GLLNLPQLLDFAAQIAEGMAYLE---SKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTA  360 (468)
T ss_pred             hcCC----------CccchHHHHHHHHHHHHHHHHHH---hCCccchhhhhhheeeccCceEEEcccccccccCCCceee
Confidence            7332          34889999999999999999999   7799999999999999999999999999999654432   


Q ss_pred             ----------CCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCCC
Q 041830          541 ----------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRPR  580 (600)
Q Consensus       541 ----------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~~  580 (600)
                                .+||.+..  ..++.+||||||||+||||+| |+.||....
T Consensus       361 ~~~~kfPIkWtAPEa~~~--~~FS~kSDVWSFGVlL~E~fT~G~~py~~ms  409 (468)
T KOG0197|consen  361 SEGGKFPIKWTAPEALNY--GKFSSKSDVWSFGVLLWELFTYGRVPYPGMS  409 (468)
T ss_pred             cCCCCCCceecCHHHHhh--CCcccccceeehhhhHHHHhccCCCCCCCCC
Confidence                      24554443  457889999999999999999 999987644

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=2.6e-34  Score=312.90  Aligned_cols=190  Identities=25%  Similarity=0.467  Sum_probs=153.5

Q ss_pred             CCceeEEEEEEEECC-------eEEEEEEcchhH----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCC
Q 041830          387 SNRIEGAVYHGRLNG-------KNLAIKRTEHEV----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKN  455 (600)
Q Consensus       387 ~~~~~G~Vy~g~~~g-------~~vAvK~~~~~~----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~  455 (600)
                      +.+.+|+||+|+..|       ..||||.++++.    ..+|++|+..+..++|||||+|+|+|..+ +..++|+|||.+
T Consensus       495 GegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~-~P~~MvFEYm~~  573 (774)
T KOG1026|consen  495 GEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREG-DPLCMVFEYMDH  573 (774)
T ss_pred             cCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccC-CeeEEEEEeccc
Confidence            344459999998733       469999987643    45799999999999999999999999765 589999999999


Q ss_pred             CCHHHHHhcCcCccccc-ccc-cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCc
Q 041830          456 GSLKDWLHGGLAMKNQF-IAS-CYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA  533 (600)
Q Consensus       456 GsL~~~L~~~~~~~~~~-~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla  533 (600)
                      |||.+||+...+..... .+. .+.+|+..+.+.||.|||.||.||-   +..+|||||..+|+||.++..+||+||||+
T Consensus       574 GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs---~~~FVHRDLATRNCLVge~l~VKIsDfGLs  650 (774)
T KOG1026|consen  574 GDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLS---SHHFVHRDLATRNCLVGENLVVKISDFGLS  650 (774)
T ss_pred             ccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHH---hCcccccchhhhhceeccceEEEecccccc
Confidence            99999998654321111 011 1345999999999999999999998   678999999999999999999999999999


Q ss_pred             cccCCC--------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCCCCC
Q 041830          534 RCVNDD--------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRPRKK  582 (600)
Q Consensus       534 ~~~~~~--------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~~~~  582 (600)
                      |..-..              +++||...-  .++|.+||||||||||||++| |+.||....++
T Consensus       651 RdiYssDYYk~~~~t~lPIRWMppEsIly--~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~  712 (774)
T KOG1026|consen  651 RDIYSSDYYKVRGNTLLPIRWMPPESILY--GKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ  712 (774)
T ss_pred             hhhhhhhhhcccCCceeeeecCCHHHhhc--CcccchhhhhhhhhhhhhhhccccCcccccchH
Confidence            854221              123443333  467999999999999999999 99999876554

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.2e-33  Score=287.15  Aligned_cols=181  Identities=24%  Similarity=0.387  Sum_probs=154.8

Q ss_pred             CCceeEEEEEEEE--CCeEEEEEEcchhH-----HHHHHHHHHHHHhCCCCceeeeeeEEecc-CCceEEEEeecCCCCH
Q 041830          387 SNRIEGAVYHGRL--NGKNLAIKRTEHEV-----ITKLEMQLVQHATHHHPNIVRLLGTCLTD-GPHSFLVFEYAKNGSL  458 (600)
Q Consensus       387 ~~~~~G~Vy~g~~--~g~~vAvK~~~~~~-----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~-~~~~~LV~Ey~~~GsL  458 (600)
                      +.|.+|.||+++.  +|+.||+|+++.+.     ..-..+||.+++++.||||++|.+..... +..+|||+|||++ ||
T Consensus       126 GeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL  204 (560)
T KOG0600|consen  126 GEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DL  204 (560)
T ss_pred             cCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-hh
Confidence            5566799999998  89999999976544     23457999999999999999999997765 4489999999998 89


Q ss_pred             HHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC
Q 041830          459 KDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND  538 (600)
Q Consensus       459 ~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~  538 (600)
                      .-++....           ..|++.++..+++|++.||+|+|   ..+|+|||||.+|||||.+|.+||+|||||++...
T Consensus       205 ~GLl~~p~-----------vkft~~qIKc~mkQLl~Gl~~cH---~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~  270 (560)
T KOG0600|consen  205 SGLLSSPG-----------VKFTEPQIKCYMKQLLEGLEYCH---SRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTP  270 (560)
T ss_pred             hhhhcCCC-----------cccChHHHHHHHHHHHHHHHHHh---hcCeeeccccccceEEcCCCCEEeccccceeeccC
Confidence            88887543           34899999999999999999999   78999999999999999999999999999997655


Q ss_pred             CCC-------------CCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCCCCC
Q 041830          539 DTE-------------SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKD  583 (600)
Q Consensus       539 ~~~-------------~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~~~  583 (600)
                      ...             +||++.+. ..|+.++|+||.||||.||++|++.|....+.+
T Consensus       271 ~~~~~~T~rVvTLWYRpPELLLG~-t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEve  327 (560)
T KOG0600|consen  271 SGSAPYTSRVVTLWYRPPELLLGA-TSYGTAVDLWSVGCILAELFLGKPILQGRTEVE  327 (560)
T ss_pred             CCCcccccceEEeeccChHHhcCC-cccccceeehhhhHHHHHHHcCCCCcCCccHHH
Confidence            432             46666553 678999999999999999999999998765543

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=7.9e-34  Score=303.28  Aligned_cols=198  Identities=29%  Similarity=0.504  Sum_probs=157.4

Q ss_pred             hhccccCHHHHHHHHhccCCC-------------CceeEEEEEEEE--CC---eEEEEEEcchhH----HHHHHHHHHHH
Q 041830          367 RLLESYSIEDLRRATEKFNSS-------------NRIEGAVYHGRL--NG---KNLAIKRTEHEV----ITKLEMQLVQH  424 (600)
Q Consensus       367 ~~~~~~~~~el~~~t~~f~~~-------------~~~~G~Vy~g~~--~g---~~vAvK~~~~~~----~~~~e~ei~~~  424 (600)
                      .....+++||--+|..+|..+             .|-+|.||+|++  .|   ..||||.++...    +.+|..|.-+|
T Consensus       605 ~YiDP~TYEDPnqAvreFakEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIM  684 (996)
T KOG0196|consen  605 TYIDPHTYEDPNQAVREFAKEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIM  684 (996)
T ss_pred             eecCCccccCccHHHHHhhhhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhc
Confidence            344556666666666555321             122399999998  34   469999997633    34677888899


Q ss_pred             HhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 041830          425 ATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMN  504 (600)
Q Consensus       425 ~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~  504 (600)
                      .+++||||++|.|+. +.....+||+|||+||+|+.||+.+..           .+++.|...+.++||.||.||.   +
T Consensus       685 GQFdHPNIIrLEGVV-Tks~PvMIiTEyMENGsLDsFLR~~DG-----------qftviQLVgMLrGIAsGMkYLs---d  749 (996)
T KOG0196|consen  685 GQFDHPNIIRLEGVV-TKSKPVMIITEYMENGSLDSFLRQNDG-----------QFTVIQLVGMLRGIASGMKYLS---D  749 (996)
T ss_pred             ccCCCCcEEEEEEEE-ecCceeEEEhhhhhCCcHHHHHhhcCC-----------ceEeehHHHHHHHHHHHhHHHh---h
Confidence            999999999999995 566688999999999999999987652           2899999999999999999999   6


Q ss_pred             CCceecCCCCCCEEeCCCCcEEEEeccCccccCCCCC---------------CCcccccCCCCCCccCchHHHHHHHHHH
Q 041830          505 PSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---------------SPQFYSTNPASWSMGIDIFAYGIVLLEV  569 (600)
Q Consensus       505 ~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~~~---------------~pe~~~~~~~~~t~~sDVwSfGvvL~EL  569 (600)
                      .++|||||.++|||++.+..+||+|||++|.+.++..               +||...  ...+|.++|||||||||||+
T Consensus       750 m~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa--~RKFTsASDVWSyGIVmWEV  827 (996)
T KOG0196|consen  750 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIA--YRKFTSASDVWSYGIVMWEV  827 (996)
T ss_pred             cCchhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhh--hcccCchhhccccceEEEEe
Confidence            6999999999999999999999999999998865542               122211  13457789999999999999


Q ss_pred             Hh-CCCCCCCCCC
Q 041830          570 LS-GQTPINRPRK  581 (600)
Q Consensus       570 lt-G~~Pf~~~~~  581 (600)
                      ++ |..||..-.+
T Consensus       828 mSyGERPYWdmSN  840 (996)
T KOG0196|consen  828 MSYGERPYWDMSN  840 (996)
T ss_pred             cccCCCcccccch
Confidence            88 9999975443

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.3e-32  Score=287.44  Aligned_cols=178  Identities=26%  Similarity=0.474  Sum_probs=153.2

Q ss_pred             ccCCCCceeEEEEEEEE--CCeEEEEEEcch------hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecC
Q 041830          383 KFNSSNRIEGAVYHGRL--NGKNLAIKRTEH------EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAK  454 (600)
Q Consensus       383 ~f~~~~~~~G~Vy~g~~--~g~~vAvK~~~~------~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~  454 (600)
                      .|.+++++ ..+|+++.  +|+.||+|++.+      ...++...||.+++.++|||||+|++++. +.++.|||.|+|+
T Consensus        24 ~~LGkGgF-A~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FE-Ds~nVYivLELC~  101 (592)
T KOG0575|consen   24 RFLGKGGF-ARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFE-DSNNVYIVLELCH  101 (592)
T ss_pred             eeeccCcc-eEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEee-cCCceEEEEEecC
Confidence            34555554 89999988  799999999765      33457889999999999999999999964 5569999999999


Q ss_pred             CCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCcc
Q 041830          455 NGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR  534 (600)
Q Consensus       455 ~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~  534 (600)
                      +|+|.+++++.            .+|++.++..+.+||+.||.|||   +.+|+|||||-.|+||+++.++||+|||||.
T Consensus       102 ~~sL~el~Krr------------k~ltEpEary~l~QIv~GlkYLH---~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt  166 (592)
T KOG0575|consen  102 RGSLMELLKRR------------KPLTEPEARYFLRQIVEGLKYLH---SLGIIHRDLKLGNLFLNENMNVKIGDFGLAT  166 (592)
T ss_pred             CccHHHHHHhc------------CCCCcHHHHHHHHHHHHHHHHHH---hcCceecccchhheeecCcCcEEecccceee
Confidence            99999999843            34999999999999999999999   7799999999999999999999999999998


Q ss_pred             ccCCC------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          535 CVNDD------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       535 ~~~~~------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                      .+..+            +-+||+...  ..++..+||||+|||||-|+.|++||...
T Consensus       167 ~le~~~Erk~TlCGTPNYIAPEVl~k--~gHsfEvDiWSlGcvmYtLL~G~PPFetk  221 (592)
T KOG0575|consen  167 QLEYDGERKKTLCGTPNYIAPEVLNK--SGHSFEVDIWSLGCVMYTLLVGRPPFETK  221 (592)
T ss_pred             eecCcccccceecCCCcccChhHhcc--CCCCCchhhhhhhhHHHhhhhCCCCcccc
Confidence            76533            225666653  56788999999999999999999999764

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=8.6e-33  Score=285.80  Aligned_cols=187  Identities=26%  Similarity=0.507  Sum_probs=155.4

Q ss_pred             ccccCHHHHHHHHhccCCCCceeEEEEEEEECCeEEEEEEcchhHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEE
Q 041830          369 LESYSIEDLRRATEKFNSSNRIEGAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFL  448 (600)
Q Consensus       369 ~~~~~~~el~~~t~~f~~~~~~~G~Vy~g~~~g~~vAvK~~~~~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~L  448 (600)
                      .....|+++....  +. +.+..|.||.|++.++.||||+++.-.    |.+|..+++++||||+.|.|+|... +-++|
T Consensus       118 ~WeiPFe~IsELe--Wl-GSGaQGAVF~Grl~netVAVKKV~elk----ETdIKHLRkLkH~NII~FkGVCtqs-PcyCI  189 (904)
T KOG4721|consen  118 LWEIPFEEISELE--WL-GSGAQGAVFLGRLHNETVAVKKVRELK----ETDIKHLRKLKHPNIITFKGVCTQS-PCYCI  189 (904)
T ss_pred             hccCCHHHhhhhh--hh-ccCcccceeeeeccCceehhHHHhhhh----hhhHHHHHhccCcceeeEeeeecCC-ceeEE
Confidence            3455666654432  22 344559999999999999999876543    7889999999999999999999654 58899


Q ss_pred             EEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEE
Q 041830          449 VFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVG  528 (600)
Q Consensus       449 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~  528 (600)
                      |||||+.|-|...|+..+.            +.......+..+||.||.|||   .+.|||||||+-||||..+..+||+
T Consensus       190 iMEfCa~GqL~~VLka~~~------------itp~llv~Wsk~IA~GM~YLH---~hKIIHRDLKSPNiLIs~~d~VKIs  254 (904)
T KOG4721|consen  190 IMEFCAQGQLYEVLKAGRP------------ITPSLLVDWSKGIAGGMNYLH---LHKIIHRDLKSPNILISYDDVVKIS  254 (904)
T ss_pred             eeeccccccHHHHHhccCc------------cCHHHHHHHHHHhhhhhHHHH---HhhHhhhccCCCceEeeccceEEec
Confidence            9999999999999987653            677788899999999999999   5689999999999999999999999


Q ss_pred             eccCccccCC-----------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          529 NFGMARCVND-----------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       529 DFGla~~~~~-----------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                      |||.++....           .+++||+...++  .+.++||||||||||||+||..||...+
T Consensus       255 DFGTS~e~~~~STkMSFaGTVaWMAPEvIrneP--csEKVDIwSfGVVLWEmLT~EiPYkdVd  315 (904)
T KOG4721|consen  255 DFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEP--CSEKVDIWSFGVVLWEMLTGEIPYKDVD  315 (904)
T ss_pred             cccchHhhhhhhhhhhhhhhHhhhCHHHhhcCC--cccccceehhHHHHHHHHhcCCCccccc
Confidence            9999875432           345788776644  5789999999999999999999997543

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.97  E-value=1.8e-30  Score=308.84  Aligned_cols=169  Identities=25%  Similarity=0.545  Sum_probs=141.1

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcCc
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM  468 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~  468 (600)
                      .|.||+|+.  +|..||||+++.... ..+.|+..+.+++|||||+++|+|.++. ..|+||||+++|+|.++++.    
T Consensus       703 ~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~l~~l~HpnIv~~~~~~~~~~-~~~lv~Ey~~~g~L~~~l~~----  776 (968)
T PLN00113        703 KGASYKGKSIKNGMQFVVKEINDVNS-IPSSEIADMGKLQHPNIVKLIGLCRSEK-GAYLIHEYIEGKNLSEVLRN----  776 (968)
T ss_pred             CeeEEEEEECCCCcEEEEEEccCCcc-ccHHHHHHHhhCCCCCcceEEEEEEcCC-CCEEEEeCCCCCcHHHHHhc----
Confidence            499999997  789999999865432 2245677888999999999999987664 78999999999999999952    


Q ss_pred             ccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC--------CCC
Q 041830          469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN--------DDT  540 (600)
Q Consensus       469 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~--------~~~  540 (600)
                                 ++|.++.+|+.|+++||+|||+..+++++||||||+||+++.++..++. ||.+....        ..+
T Consensus       777 -----------l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~~~~~~t~~y  844 (968)
T PLN00113        777 -----------LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISSAY  844 (968)
T ss_pred             -----------CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccCCCccccccc
Confidence                       8999999999999999999997667799999999999999999988876 66554321        234


Q ss_pred             CCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          541 ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       541 ~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                      .+||+...  ..++.++|||||||++|||+||+.||+..
T Consensus       845 ~aPE~~~~--~~~~~~sDv~S~Gvvl~el~tg~~p~~~~  881 (968)
T PLN00113        845 VAPETRET--KDITEKSDIYGFGLILIELLTGKSPADAE  881 (968)
T ss_pred             cCcccccC--CCCCcccchhhHHHHHHHHHhCCCCCCcc
Confidence            57777654  45788999999999999999999999643

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=9.1e-32  Score=270.32  Aligned_cols=178  Identities=25%  Similarity=0.388  Sum_probs=146.3

Q ss_pred             CCceeEEEEEEEE--CCeEEEEEEcchhHH----------HHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecC
Q 041830          387 SNRIEGAVYHGRL--NGKNLAIKRTEHEVI----------TKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAK  454 (600)
Q Consensus       387 ~~~~~G~Vy~g~~--~g~~vAvK~~~~~~~----------~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~  454 (600)
                      +.|.+|.|-.|.-  +|+.||||.+.....          ...++|+.+|++++|||||++.+++..+ +..||||||++
T Consensus       181 GsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~-ds~YmVlE~v~  259 (475)
T KOG0615|consen  181 GSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVP-DSSYMVLEYVE  259 (475)
T ss_pred             cCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecC-CceEEEEEEec
Confidence            3344589998877  899999998765331          1346899999999999999999997555 47899999999


Q ss_pred             CCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC---CcEEEEecc
Q 041830          455 NGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEE---FNARVGNFG  531 (600)
Q Consensus       455 ~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~---~~~kI~DFG  531 (600)
                      +|+|.+++-.+..            +.+..-..+++|++.|+.|||   +.+|+||||||+|||+..+   ..+||+|||
T Consensus       260 GGeLfd~vv~nk~------------l~ed~~K~~f~Qll~avkYLH---~~GI~HRDiKPeNILl~~~~e~~llKItDFG  324 (475)
T KOG0615|consen  260 GGELFDKVVANKY------------LREDLGKLLFKQLLTAVKYLH---SQGIIHRDIKPENILLSNDAEDCLLKITDFG  324 (475)
T ss_pred             CccHHHHHHhccc------------cccchhHHHHHHHHHHHHHHH---HcCcccccCCcceEEeccCCcceEEEecccc
Confidence            9999999976653            666667889999999999999   7799999999999999655   889999999


Q ss_pred             CccccC-----------CCCCCCcccccCCCCCC-ccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          532 MARCVN-----------DDTESPQFYSTNPASWS-MGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       532 la~~~~-----------~~~~~pe~~~~~~~~~t-~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                      +|+...           +.+-+||+.......++ .++|+||+|||||-+++|.+||....
T Consensus       325 lAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~  385 (475)
T KOG0615|consen  325 LAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEY  385 (475)
T ss_pred             hhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCccccc
Confidence            998653           23346777766544444 48999999999999999999997644

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.97  E-value=1e-30  Score=266.76  Aligned_cols=172  Identities=26%  Similarity=0.450  Sum_probs=140.8

Q ss_pred             eEEEEEEEECCeEEEEEEcchhHHHH--HHHHHHHHHhCCCCceeeeeeEEeccCC----ceEEEEeecCCCCHHHHHhc
Q 041830          391 EGAVYHGRLNGKNLAIKRTEHEVITK--LEMQLVQHATHHHPNIVRLLGTCLTDGP----HSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       391 ~G~Vy~g~~~g~~vAvK~~~~~~~~~--~e~ei~~~~~l~HpNIv~l~g~~~~~~~----~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      +|.||+|.++++.||||++.....+.  .|++|..+-.+.|+||++|+++- +.++    ++|||+||.++|+|.+||..
T Consensus       223 fg~V~KaqL~~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~e-kr~t~~~~eywLVt~fh~kGsL~dyL~~  301 (534)
T KOG3653|consen  223 FGCVWKAQLDNRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAE-KRGTADRMEYWLVTEFHPKGSLCDYLKA  301 (534)
T ss_pred             cceeehhhccCceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchh-ccCCccccceeEEeeeccCCcHHHHHHh
Confidence            39999999999999999998766554  46667777788999999999984 3333    78999999999999999987


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhc------CCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV------MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND  538 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~------~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~  538 (600)
                      +.             ++|....+|+..+++||+|||+.      ++++|+|||||++||||..|+++.|+|||+|..+..
T Consensus       302 nt-------------isw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p  368 (534)
T KOG3653|consen  302 NT-------------ISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEP  368 (534)
T ss_pred             cc-------------ccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecC
Confidence            54             89999999999999999999964      367899999999999999999999999999986653


Q ss_pred             CC--------------CCCcccccCCC----CCCccCchHHHHHHHHHHHhCCCCC
Q 041830          539 DT--------------ESPQFYSTNPA----SWSMGIDIFAYGIVLLEVLSGQTPI  576 (600)
Q Consensus       539 ~~--------------~~pe~~~~~~~----~~t~~sDVwSfGvvL~ELltG~~Pf  576 (600)
                      ..              ++||++.+.-.    ..-.+.||||+|.|||||+++-.-+
T Consensus       369 ~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~  424 (534)
T KOG3653|consen  369 GKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDA  424 (534)
T ss_pred             CCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccc
Confidence            32              35665544211    1113479999999999999975544

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=1.9e-31  Score=300.34  Aligned_cols=185  Identities=28%  Similarity=0.523  Sum_probs=154.1

Q ss_pred             CCceeEEEEEEEE---CCe----EEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCC
Q 041830          387 SNRIEGAVYHGRL---NGK----NLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKN  455 (600)
Q Consensus       387 ~~~~~G~Vy~g~~---~g~----~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~  455 (600)
                      +.+.+|.||+|.+   +|.    .||||.+++.    ...+|.+|...|.+++|||||+++|+|++.+ ..+|++|||++
T Consensus       701 G~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~-~~~i~leyM~g  779 (1025)
T KOG1095|consen  701 GKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSG-PPLILLEYMEG  779 (1025)
T ss_pred             ccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCC-CcEEEehhccc
Confidence            4445599999998   343    4999988653    3457889999999999999999999999864 78999999999


Q ss_pred             CCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccc
Q 041830          456 GSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARC  535 (600)
Q Consensus       456 GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~  535 (600)
                      |+|..||++.+....+     ...|+..+.+.++.|||+|+.||+   +.++|||||..+|+||+.+..+||+||||||.
T Consensus       780 GDL~sflr~~r~~~~~-----~~~L~~~dLl~~a~dvA~G~~YLe---~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArD  851 (1025)
T KOG1095|consen  780 GDLLSFLRESRPAPFQ-----PSNLSMRDLLAFALDVAKGMNYLE---SKHFVHRDLAARNCLLDERRVVKIADFGLARD  851 (1025)
T ss_pred             CcHHHHHHhcccccCC-----CCCCCHHHHHHHHHHHhhhhHHHH---hCCCcCcchhhhheeecccCcEEEcccchhHh
Confidence            9999999987643221     255999999999999999999999   77999999999999999999999999999993


Q ss_pred             cC-C-------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCCCCC
Q 041830          536 VN-D-------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRPRKK  582 (600)
Q Consensus       536 ~~-~-------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~~~~  582 (600)
                      +- .             .+++||.+..  ..++.++|||||||+|||++| |..||...++.
T Consensus       852 iy~~~yyr~~~~a~lPvkWm~PEsl~d--~iFtskSDvWsFGVllWEifslG~~PY~~~~n~  911 (1025)
T KOG1095|consen  852 IYDKDYYRKHGEAMLPVKWMPPESLKD--GIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNF  911 (1025)
T ss_pred             hhhchheeccCccccceecCCHHHHhh--cccccccchhhhHHHHHHHHhCCCCCCCCcchH
Confidence            32 1             1234565554  567999999999999999999 99999865543

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=99.97  E-value=1.7e-30  Score=269.24  Aligned_cols=186  Identities=25%  Similarity=0.403  Sum_probs=145.7

Q ss_pred             ccccCHHHHHHHHhccCCCCceeEEEEEEEE--CCeEEEEEEcchhHHH------HHHHHHHHHHhC-CCCceeeeeeEE
Q 041830          369 LESYSIEDLRRATEKFNSSNRIEGAVYHGRL--NGKNLAIKRTEHEVIT------KLEMQLVQHATH-HHPNIVRLLGTC  439 (600)
Q Consensus       369 ~~~~~~~el~~~t~~f~~~~~~~G~Vy~g~~--~g~~vAvK~~~~~~~~------~~e~ei~~~~~l-~HpNIv~l~g~~  439 (600)
                      ...|.|+++.        +.|.+.+|++++.  +++.||||++.+...-      -..+|-..|..+ .||.|++|+-.+
T Consensus        72 ~~DF~Fg~~l--------GeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TF  143 (604)
T KOG0592|consen   72 PNDFKFGKIL--------GEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTF  143 (604)
T ss_pred             hhhcchhhee--------ccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEe
Confidence            3456665542        3444589999987  7999999998765432      123344444444 799999999886


Q ss_pred             eccCCceEEEEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEe
Q 041830          440 LTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFL  519 (600)
Q Consensus       440 ~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl  519 (600)
                      .++ ..+|+|+||+++|+|.++|+..+.            |++.....++.+|+.||+|||   +.+||||||||+||||
T Consensus       144 QD~-~sLYFvLe~A~nGdll~~i~K~Gs------------fde~caR~YAAeIldAleylH---~~GIIHRDlKPENILL  207 (604)
T KOG0592|consen  144 QDE-ESLYFVLEYAPNGDLLDLIKKYGS------------FDETCARFYAAEILDALEYLH---SNGIIHRDLKPENILL  207 (604)
T ss_pred             ecc-cceEEEEEecCCCcHHHHHHHhCc------------chHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeE
Confidence            544 589999999999999999987542            888889999999999999999   7899999999999999


Q ss_pred             CCCCcEEEEeccCccccCCCCC-------------------------CCcccccCCCCCCccCchHHHHHHHHHHHhCCC
Q 041830          520 DEEFNARVGNFGMARCVNDDTE-------------------------SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQT  574 (600)
Q Consensus       520 d~~~~~kI~DFGla~~~~~~~~-------------------------~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~  574 (600)
                      |+|+++||.|||-|+.+.+...                         +||++..  ...+.++|+|+|||+||+|+.|++
T Consensus       208 d~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~--~~~~~~sDiWAlGCilyQmlaG~P  285 (604)
T KOG0592|consen  208 DKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLND--SPAGPSSDLWALGCILYQMLAGQP  285 (604)
T ss_pred             cCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcC--CCCCcccchHHHHHHHHHHhcCCC
Confidence            9999999999999987654321                         1232222  223567899999999999999999


Q ss_pred             CCCCCC
Q 041830          575 PINRPR  580 (600)
Q Consensus       575 Pf~~~~  580 (600)
                      ||...+
T Consensus       286 PFra~N  291 (604)
T KOG0592|consen  286 PFRAAN  291 (604)
T ss_pred             CCcccc
Confidence            997644

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=7.5e-32  Score=258.65  Aligned_cols=182  Identities=24%  Similarity=0.376  Sum_probs=149.7

Q ss_pred             CCceeEEEEEEEE--CCeEEEEEEcch-----hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCc-eEEEEeecCCCCH
Q 041830          387 SNRIEGAVYHGRL--NGKNLAIKRTEH-----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPH-SFLVFEYAKNGSL  458 (600)
Q Consensus       387 ~~~~~G~Vy~g~~--~g~~vAvK~~~~-----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~-~~LV~Ey~~~GsL  458 (600)
                      ++|-+|.||++..  +|..+|.|.+.-     ...+....|+..+++++|||||+++++.+.++.+ ++||||||.+|+|
T Consensus        28 G~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDL  107 (375)
T KOG0591|consen   28 GRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDL  107 (375)
T ss_pred             cCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCH
Confidence            4455599999977  899999998653     3335567899999999999999999965554445 8999999999999


Q ss_pred             HHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCC--ceecCCCCCCEEeCCCCcEEEEeccCcccc
Q 041830          459 KDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS--YVHRNIKSRNIFLDEEFNARVGNFGMARCV  536 (600)
Q Consensus       459 ~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDLk~~NILld~~~~~kI~DFGla~~~  536 (600)
                      .+.++..+..+        ..+++..++++..|+++||.++|... ++  |.||||||.||+|+.+|.+|++|||+++.+
T Consensus       108 sqmIk~~K~qk--------r~ipE~~Vwk~f~QL~~AL~~cH~~~-~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen  108 SQMIKHFKKQK--------RLIPEKTVWKYFVQLCRALYHCHSKI-PRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHHHHHHHhcc--------ccCchHHHHHHHHHHHHHHHHHhccc-cccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            99997644221        44899999999999999999999532 44  899999999999999999999999999977


Q ss_pred             CCCC------------CCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          537 NDDT------------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       537 ~~~~------------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                      ....            ++||....  ..|+.++||||+||++|||+.-++||.+.
T Consensus       179 ~s~~tfA~S~VGTPyYMSPE~i~~--~~Y~~kSDiWslGCllyEMcaL~~PF~g~  231 (375)
T KOG0591|consen  179 SSKTTFAHSLVGTPYYMSPERIHE--SGYNFKSDIWSLGCLLYEMCALQSPFYGD  231 (375)
T ss_pred             cchhHHHHhhcCCCcccCHHHHhc--CCCCcchhHHHHHHHHHHHHhcCCCcccc
Confidence            5443            23444333  56899999999999999999999999764

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=3.9e-31  Score=267.97  Aligned_cols=168  Identities=27%  Similarity=0.429  Sum_probs=136.6

Q ss_pred             eEEEEEEEECCeEEEEEEcch--hHHHHHHHHHHHHHhCCCCceeeeeeEEeccC---CceEEEEeecCCCCHHHHHhcC
Q 041830          391 EGAVYHGRLNGKNLAIKRTEH--EVITKLEMQLVQHATHHHPNIVRLLGTCLTDG---PHSFLVFEYAKNGSLKDWLHGG  465 (600)
Q Consensus       391 ~G~Vy~g~~~g~~vAvK~~~~--~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~---~~~~LV~Ey~~~GsL~~~L~~~  465 (600)
                      +|.||+|+|.|+.||||.+..  +.....|.||..-..++|+||+.|++.-..+.   .++|||+||.++|||+|||.+.
T Consensus       224 yGEVwrG~wrGe~VAVKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r~  303 (513)
T KOG2052|consen  224 FGEVWRGRWRGEDVAVKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNRN  303 (513)
T ss_pred             ccceeeccccCCceEEEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhhc
Confidence            499999999999999999753  44456688999888999999999999865443   2579999999999999999763


Q ss_pred             cCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-
Q 041830          466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV-----MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-  539 (600)
Q Consensus       466 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-  539 (600)
                                   .++....++++..+|.||+|||..     .++.|.|||||++|||+.+++.+.|+|+|||...... 
T Consensus       304 -------------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t  370 (513)
T KOG2052|consen  304 -------------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDT  370 (513)
T ss_pred             -------------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccC
Confidence                         389999999999999999999954     2678999999999999999999999999999644332 


Q ss_pred             ---------------CCCCcccccCC----CCCCccCchHHHHHHHHHHHh
Q 041830          540 ---------------TESPQFYSTNP----ASWSMGIDIFAYGIVLLEVLS  571 (600)
Q Consensus       540 ---------------~~~pe~~~~~~----~~~t~~sDVwSfGvvL~ELlt  571 (600)
                                     +++||++...-    ..--..+||||||.||||+.-
T Consensus       371 ~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar  421 (513)
T KOG2052|consen  371 DTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR  421 (513)
T ss_pred             CcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence                           23555543310    111234799999999999875

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=99.97  E-value=1.4e-30  Score=260.07  Aligned_cols=175  Identities=23%  Similarity=0.385  Sum_probs=146.3

Q ss_pred             CceeEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHH
Q 041830          388 NRIEGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       388 ~~~~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~  459 (600)
                      .|.+|.||..+-  +++.+|+|.+++..      ......|..++..++||.||++.-.+ ++...+|||+||+.||.|.
T Consensus        35 kG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysF-Qt~~kLylVld~~~GGeLf  113 (357)
T KOG0598|consen   35 KGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSF-QTEEKLYLVLDYLNGGELF  113 (357)
T ss_pred             ccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEec-ccCCeEEEEEeccCCccHH
Confidence            344499999987  78999999987643      23456777888889999999998665 4556899999999999999


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC--
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN--  537 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~--  537 (600)
                      .+|.+.+.            +++....-++..|+.||.|||   +.+||||||||+|||||.+|+++|+|||+++...  
T Consensus       114 ~hL~~eg~------------F~E~~arfYlaEi~lAL~~LH---~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~  178 (357)
T KOG0598|consen  114 YHLQREGR------------FSEDRARFYLAEIVLALGYLH---SKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD  178 (357)
T ss_pred             HHHHhcCC------------cchhHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence            99986542            888888889999999999999   7899999999999999999999999999998432  


Q ss_pred             ----------CCCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          538 ----------DDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       538 ----------~~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                                ..+.+||+...  ..|+..+|.||+||++|||++|.+||...+
T Consensus       179 ~~~t~tfcGT~eYmAPEil~~--~gy~~~vDWWsLGillYeML~G~pPF~~~~  229 (357)
T KOG0598|consen  179 GDATRTFCGTPEYMAPEILLG--KGYDKAVDWWSLGILLYEMLTGKPPFYAED  229 (357)
T ss_pred             CCccccccCCccccChHHHhc--CCCCcccchHhHHHHHHHHhhCCCCCcCcc
Confidence                      22345665554  478899999999999999999999997644

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=99.97  E-value=1.8e-30  Score=272.02  Aligned_cols=187  Identities=25%  Similarity=0.489  Sum_probs=153.9

Q ss_pred             ccCHHHHHHHHhccCCCCceeEEEEEEEECCeEEEEEEcch-----hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCc
Q 041830          371 SYSIEDLRRATEKFNSSNRIEGAVYHGRLNGKNLAIKRTEH-----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPH  445 (600)
Q Consensus       371 ~~~~~el~~~t~~f~~~~~~~G~Vy~g~~~g~~vAvK~~~~-----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~  445 (600)
                      ...++|+......   +.|-+|+||+|+|.|+ ||||.++.     +..+.|..|+..+++-+|.||+-|.|+|..+  .
T Consensus       388 eIp~~ev~l~~rI---GsGsFGtV~Rg~whGd-VAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p--~  461 (678)
T KOG0193|consen  388 EIPPEEVLLGERI---GSGSFGTVYRGRWHGD-VAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNP--P  461 (678)
T ss_pred             ccCHHHhhcccee---ccccccceeecccccc-eEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCC--c
Confidence            3445555444322   3333499999999885 89998754     4456789999999999999999999999765  4


Q ss_pred             eEEEEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcE
Q 041830          446 SFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNA  525 (600)
Q Consensus       446 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~  525 (600)
                      ..||+.+|++-+|+.+||-.+           ..|...+.+.|++|||+||.|||   .++|||||||+.||++++++.+
T Consensus       462 ~AIiTqwCeGsSLY~hlHv~e-----------tkfdm~~~idIAqQiaqGM~YLH---AK~IIHrDLKSnNIFl~~~~kV  527 (678)
T KOG0193|consen  462 LAIITQWCEGSSLYTHLHVQE-----------TKFDMNTTIDIAQQIAQGMDYLH---AKNIIHRDLKSNNIFLHEDLKV  527 (678)
T ss_pred             eeeeehhccCchhhhhccchh-----------hhhhHHHHHHHHHHHHHhhhhhh---hhhhhhhhccccceEEccCCcE
Confidence            599999999999999998654           33889999999999999999999   8899999999999999999999


Q ss_pred             EEEeccCccccCC--------------CCCCCccccc-CCCCCCccCchHHHHHHHHHHHhCCCCCC
Q 041830          526 RVGNFGMARCVND--------------DTESPQFYST-NPASWSMGIDIFAYGIVLLEVLSGQTPIN  577 (600)
Q Consensus       526 kI~DFGla~~~~~--------------~~~~pe~~~~-~~~~~t~~sDVwSfGvvL~ELltG~~Pf~  577 (600)
                      ||+|||++..-..              -+.+||+... +...|++.+||||||+|+|||+||..||.
T Consensus       528 kIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys  594 (678)
T KOG0193|consen  528 KIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS  594 (678)
T ss_pred             EEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC
Confidence            9999999853210              1236776543 45678999999999999999999999998

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.97  E-value=7.5e-31  Score=277.47  Aligned_cols=177  Identities=29%  Similarity=0.539  Sum_probs=150.5

Q ss_pred             CCceeEEEEEEEE---CC--eE-EEEEEcch------hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecC
Q 041830          387 SNRIEGAVYHGRL---NG--KN-LAIKRTEH------EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAK  454 (600)
Q Consensus       387 ~~~~~G~Vy~g~~---~g--~~-vAvK~~~~------~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~  454 (600)
                      +.|.+|.||+|++   ++  .. ||||..+.      +...++..|.+.|.+++|||||+|+|++..+. .+|||||+|+
T Consensus       166 GeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~-Pl~ivmEl~~  244 (474)
T KOG0194|consen  166 GEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEE-PLMLVMELCN  244 (474)
T ss_pred             ecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCC-ccEEEEEecC
Confidence            4555699999998   22  23 89998773      34457788999999999999999999987664 8999999999


Q ss_pred             CCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCcc
Q 041830          455 NGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR  534 (600)
Q Consensus       455 ~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~  534 (600)
                      ||+|.++|+...           ..++..++++++.++|+||+|||   +.+++||||.++|+|++.++.+||+|||+++
T Consensus       245 gGsL~~~L~k~~-----------~~v~~~ek~~~~~~AA~Gl~YLh---~k~~IHRDIAARNcL~~~~~~vKISDFGLs~  310 (474)
T KOG0194|consen  245 GGSLDDYLKKNK-----------KSLPTLEKLRFCYDAARGLEYLH---SKNCIHRDIAARNCLYSKKGVVKISDFGLSR  310 (474)
T ss_pred             CCcHHHHHHhCC-----------CCCCHHHHHHHHHHHHhHHHHHH---HCCCcchhHhHHHheecCCCeEEeCcccccc
Confidence            999999998764           23899999999999999999999   7799999999999999999999999999998


Q ss_pred             ccCC------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCCC
Q 041830          535 CVND------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRPR  580 (600)
Q Consensus       535 ~~~~------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~~  580 (600)
                      ....            .+.+||...+  ..++.++|||||||++||+++ |..||....
T Consensus       311 ~~~~~~~~~~~~klPirWLAPEtl~~--~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~  367 (474)
T KOG0194|consen  311 AGSQYVMKKFLKKLPIRWLAPETLNT--GIFSFKTDVWSFGVLLWEIFENGAEPYPGMK  367 (474)
T ss_pred             CCcceeeccccccCcceecChhhhcc--CccccccchhheeeeEEeeeccCCCCCCCCC
Confidence            6531            2235777666  378999999999999999999 889997644

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=99.97  E-value=2.5e-30  Score=250.09  Aligned_cols=177  Identities=22%  Similarity=0.407  Sum_probs=149.2

Q ss_pred             CCceeEEEEEEEE--CCeEEEEEEcchhHH------HHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCH
Q 041830          387 SNRIEGAVYHGRL--NGKNLAIKRTEHEVI------TKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSL  458 (600)
Q Consensus       387 ~~~~~G~Vy~g~~--~g~~vAvK~~~~~~~------~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL  458 (600)
                      +.|.+|.|...+.  +|..+|+|.++.+..      +....|..++..+.||+++++.+.+.+. ..+||||||.++|.|
T Consensus        53 GtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~-~~lymvmeyv~GGEl  131 (355)
T KOG0616|consen   53 GTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDN-SNLYMVMEYVPGGEL  131 (355)
T ss_pred             ccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccC-CeEEEEEeccCCccH
Confidence            3344599998887  789999999876543      3345677888889999999999997554 599999999999999


Q ss_pred             HHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC
Q 041830          459 KDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND  538 (600)
Q Consensus       459 ~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~  538 (600)
                      ..+|++.++            +++....-++.+|+.||+|||   +..|++|||||+|||||.+|.+||.|||+|+.+..
T Consensus       132 FS~Lrk~~r------------F~e~~arFYAAeivlAleylH---~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~  196 (355)
T KOG0616|consen  132 FSYLRKSGR------------FSEPHARFYAAEIVLALEYLH---SLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG  196 (355)
T ss_pred             HHHHHhcCC------------CCchhHHHHHHHHHHHHHHHH---hcCeeeccCChHHeeeccCCcEEEEeccceEEecC
Confidence            999987543            889999999999999999999   67999999999999999999999999999986643


Q ss_pred             C---------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCCC
Q 041830          539 D---------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRK  581 (600)
Q Consensus       539 ~---------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~  581 (600)
                      .         +.+||...+  ..+..++|.|||||++|||+.|.+||...+.
T Consensus       197 rT~TlCGTPeYLAPEii~s--k~ynkavDWWalGVLIYEMlaG~pPF~~~~~  246 (355)
T KOG0616|consen  197 RTWTLCGTPEYLAPEIIQS--KGYNKAVDWWALGVLIYEMLAGYPPFYDDNP  246 (355)
T ss_pred             cEEEecCCccccChHHhhc--CCCCcchhHHHHHHHHHHHHcCCCCCcCCCh
Confidence            3         335555554  4577889999999999999999999987554

>PHA02988 hypothetical protein; Provisional

Probab=99.97  E-value=4.3e-30  Score=262.78  Aligned_cols=196  Identities=19%  Similarity=0.351  Sum_probs=154.6

Q ss_pred             cccCHHHHHHHHhccCCCCceeEEEEEEEECCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEec--
Q 041830          370 ESYSIEDLRRATEKFNSSNRIEGAVYHGRLNGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLT--  441 (600)
Q Consensus       370 ~~~~~~el~~~t~~f~~~~~~~G~Vy~g~~~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~--  441 (600)
                      +..+.+++.........+++ .|.||+|+++|+.||||+++...      .+.+.+|+..+.+++||||++++|++.+  
T Consensus        13 ~~i~~~~i~~~~~~~i~~g~-~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~   91 (283)
T PHA02988         13 KCIESDDIDKYTSVLIKEND-QNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIV   91 (283)
T ss_pred             eecCHHHcCCCCCeEEeeCC-ceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecc
Confidence            33455555333222222222 38999999999999999986422      3456789999999999999999999865  


Q ss_pred             c-CCceEEEEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC
Q 041830          442 D-GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLD  520 (600)
Q Consensus       442 ~-~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld  520 (600)
                      + ....++||||+++|+|.++++...            .++|.+.++++.+++.||.|||..  .+++||||||+|||++
T Consensus        92 ~~~~~~~lv~Ey~~~g~L~~~l~~~~------------~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~  157 (283)
T PHA02988         92 DDLPRLSLILEYCTRGYLREVLDKEK------------DLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVT  157 (283)
T ss_pred             cCCCceEEEEEeCCCCcHHHHHhhCC------------CCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEEC
Confidence            2 236789999999999999997543            389999999999999999999942  3788999999999999


Q ss_pred             CCCcEEEEeccCccccCC---------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          521 EEFNARVGNFGMARCVND---------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       521 ~~~~~kI~DFGla~~~~~---------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                      +++.+||+|||+++....         .+.+||........++.++|||||||++|||++|+.||...+
T Consensus       158 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~  226 (283)
T PHA02988        158 ENYKLKIICHGLEKILSSPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT  226 (283)
T ss_pred             CCCcEEEcccchHhhhccccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC
Confidence            999999999999875332         223566654433467889999999999999999999997643

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=99.97  E-value=2.9e-30  Score=253.18  Aligned_cols=180  Identities=19%  Similarity=0.319  Sum_probs=151.1

Q ss_pred             CCceeEEEEEEEE--CCeEEEEEEcchhHHH-----HHHHHHHHHHhCCCCceeeeeeEEecc-CCceEEEEeecCCCCH
Q 041830          387 SNRIEGAVYHGRL--NGKNLAIKRTEHEVIT-----KLEMQLVQHATHHHPNIVRLLGTCLTD-GPHSFLVFEYAKNGSL  458 (600)
Q Consensus       387 ~~~~~G~Vy~g~~--~g~~vAvK~~~~~~~~-----~~e~ei~~~~~l~HpNIv~l~g~~~~~-~~~~~LV~Ey~~~GsL  458 (600)
                      +.|.+|.||+|+.  +++.||+|+++.+..+     --.+||.++.+.+|||||.+..+.+.. -+.+|||||||++ ||
T Consensus        85 ~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DL  163 (419)
T KOG0663|consen   85 EEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DL  163 (419)
T ss_pred             ccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hH
Confidence            4455699999998  7899999998775532     236899999999999999999886643 2468999999998 99


Q ss_pred             HHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC
Q 041830          459 KDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND  538 (600)
Q Consensus       459 ~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~  538 (600)
                      ...+..-.           .++...+..-+..|+++|++|||   ..-|+|||||++|+|+...|.+||+|||+||....
T Consensus       164 ksl~d~m~-----------q~F~~~evK~L~~QlL~glk~lH---~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygs  229 (419)
T KOG0663|consen  164 KSLMETMK-----------QPFLPGEVKTLMLQLLRGLKHLH---DNWILHRDLKTSNLLLSHKGILKIADFGLAREYGS  229 (419)
T ss_pred             HHHHHhcc-----------CCCchHHHHHHHHHHHHHHHHHh---hceeEecccchhheeeccCCcEEecccchhhhhcC
Confidence            99987543           35888999999999999999999   66899999999999999999999999999998765


Q ss_pred             CC------------CCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCCCC
Q 041830          539 DT------------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRKK  582 (600)
Q Consensus       539 ~~------------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~~  582 (600)
                      ..            .+||.+... ..|+...|+||+|||+.||+++++-|.+..+.
T Consensus       230 p~k~~T~lVVTLWYRaPELLLG~-~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~  284 (419)
T KOG0663|consen  230 PLKPYTPLVVTLWYRAPELLLGA-KTYSTAVDMWSVGCIFAELLTQKPLFPGKSEI  284 (419)
T ss_pred             CcccCcceEEEeeecCHHHhcCC-cccCcchhhhhHHHHHHHHHhcCCCCCCCchH
Confidence            52            256665543 56889999999999999999999999876544

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.97  E-value=8.3e-31  Score=267.66  Aligned_cols=193  Identities=21%  Similarity=0.344  Sum_probs=158.8

Q ss_pred             CHHHHHHHHhccCCCCceeEEEEEEEE--CCeEEEEEEcchhHHH----HHHHHHHHHHhCC-CCceeeeeeEEeccCCc
Q 041830          373 SIEDLRRATEKFNSSNRIEGAVYHGRL--NGKNLAIKRTEHEVIT----KLEMQLVQHATHH-HPNIVRLLGTCLTDGPH  445 (600)
Q Consensus       373 ~~~el~~~t~~f~~~~~~~G~Vy~g~~--~g~~vAvK~~~~~~~~----~~e~ei~~~~~l~-HpNIv~l~g~~~~~~~~  445 (600)
                      .+.+-....++.  +.|.+|.||+|+-  +|+.||||+|+.....    .-.+|+..++++. |||||+|..++.+....
T Consensus         7 ~~m~RY~~i~kl--GDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~   84 (538)
T KOG0661|consen    7 IFMDRYTVIRKL--GDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI   84 (538)
T ss_pred             hHHHHHHHHHHh--cCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence            344555555554  3445599999987  7999999999874421    2358999999999 99999999997766558


Q ss_pred             eEEEEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcE
Q 041830          446 SFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNA  525 (600)
Q Consensus       446 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~  525 (600)
                      +|+|||||+. +|++.+++.+           ..|++.++..|+.||.+||+|+|   .+++.|||+||+|||+..+..+
T Consensus        85 L~fVfE~Md~-NLYqLmK~R~-----------r~fse~~irnim~QilqGL~hiH---k~GfFHRDlKPENiLi~~~~~i  149 (538)
T KOG0661|consen   85 LYFVFEFMDC-NLYQLMKDRN-----------RLFSESDIRNIMYQILQGLAHIH---KHGFFHRDLKPENILISGNDVI  149 (538)
T ss_pred             EeeeHHhhhh-hHHHHHhhcC-----------CcCCHHHHHHHHHHHHHHHHHHH---hcCcccccCChhheEeccccee
Confidence            9999999976 9999998753           56999999999999999999999   7799999999999999999999


Q ss_pred             EEEeccCccccCCCCC-----------CCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCCCCC
Q 041830          526 RVGNFGMARCVNDDTE-----------SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKD  583 (600)
Q Consensus       526 kI~DFGla~~~~~~~~-----------~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~~~  583 (600)
                      ||+|||+||.+.....           +||++.. ...|+.+.|+||+|||++|+.+-++-|.+.++-+
T Consensus       150 KiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLr-s~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~D  217 (538)
T KOG0661|consen  150 KIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLR-SGYYSSPVDMWAVGCIMAELYSLRPLFPGASEID  217 (538)
T ss_pred             EecccccccccccCCCcchhhhcccccchHHhhh-ccccCCchHHHHHHHHHHHHHHhcccCCCCcHHH
Confidence            9999999998765443           4444433 3567889999999999999999999998766543

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=99.97  E-value=1.2e-30  Score=252.63  Aligned_cols=180  Identities=22%  Similarity=0.331  Sum_probs=147.8

Q ss_pred             CCceeEEEEEEEE--CCeEEEEEEcchh----HH-HHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHH
Q 041830          387 SNRIEGAVYHGRL--NGKNLAIKRTEHE----VI-TKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       387 ~~~~~G~Vy~g~~--~g~~vAvK~~~~~----~~-~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~  459 (600)
                      +.|.+|.||+.+.  +|+.||||++.+.    .+ +-..+||.++++++|||+|.|+.+|... ..++||+|||++ ++.
T Consensus        11 GEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrk-rklhLVFE~~dh-TvL   88 (396)
T KOG0593|consen   11 GEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRK-RKLHLVFEYCDH-TVL   88 (396)
T ss_pred             ccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhc-ceeEEEeeecch-HHH
Confidence            3445699999988  8999999997432    22 3357899999999999999999997655 489999999998 555


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD  539 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~  539 (600)
                      +-|....           ..++...+.+++.|+++|+.|+|   +.+++||||||+|||+..++.+||+|||+||.+...
T Consensus        89 ~eLe~~p-----------~G~~~~~vk~~l~Q~l~ai~~cH---k~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p  154 (396)
T KOG0593|consen   89 HELERYP-----------NGVPSELVKKYLYQLLKAIHFCH---KNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAP  154 (396)
T ss_pred             HHHHhcc-----------CCCCHHHHHHHHHHHHHHhhhhh---hcCeecccCChhheEEecCCcEEeccchhhHhhcCC
Confidence            5554433           23888999999999999999999   779999999999999999999999999999987632


Q ss_pred             C------------CCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCCCCC
Q 041830          540 T------------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKD  583 (600)
Q Consensus       540 ~------------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~~~  583 (600)
                      .            .+||...+. ..|...+||||.||++.||++|.+-|.+.++.+
T Consensus       155 gd~YTDYVATRWYRaPELLvGD-tqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiD  209 (396)
T KOG0593|consen  155 GDNYTDYVATRWYRAPELLVGD-TQYGKPVDIWAIGCVFAELLTGEPLWPGRSDID  209 (396)
T ss_pred             cchhhhhhhhhhccChhhhccc-CcCCCcccchhhhHHHHHHhcCCcCCCCcchHH
Confidence            2            256655443 567888999999999999999999888766553

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=99.97  E-value=4.7e-30  Score=266.72  Aligned_cols=177  Identities=25%  Similarity=0.467  Sum_probs=145.9

Q ss_pred             eeEEEEEEEECC-eEEEEEEcchhH----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          390 IEGAVYHGRLNG-KNLAIKRTEHEV----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       390 ~~G~Vy~g~~~g-~~vAvK~~~~~~----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      -+|.|.....+| ..||||.++.+.    +..|.+|+.+|.+++|||||+|+|+|..+. .+++|+|||++|+|.+||..
T Consensus       550 qFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~De-PicmI~EYmEnGDLnqFl~a  628 (807)
T KOG1094|consen  550 QFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDD-PLCMITEYMENGDLNQFLSA  628 (807)
T ss_pred             ccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCC-chHHHHHHHhcCcHHHHHHh
Confidence            349999998866 899999998754    357889999999999999999999999875 89999999999999999987


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCCC----
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDT----  540 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~~----  540 (600)
                      +...          .+.-...++|+.|||.||+||.   +.++|||||.++|+|+|.++++||+|||++|.+-...    
T Consensus       629 heap----------t~~t~~~vsi~tqiasgmaYLe---s~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~v  695 (807)
T KOG1094|consen  629 HELP----------TAETAPGVSICTQIASGMAYLE---SLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRV  695 (807)
T ss_pred             ccCc----------ccccchhHHHHHHHHHHHHHHH---hhchhhccccccceeecCcccEEecCcccccccccCCceee
Confidence            6431          1345567789999999999999   6699999999999999999999999999999553321    


Q ss_pred             ----------CCCcccccCCCCCCccCchHHHHHHHHHHHh--CCCCCCCCCCC
Q 041830          541 ----------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLS--GQTPINRPRKK  582 (600)
Q Consensus       541 ----------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt--G~~Pf~~~~~~  582 (600)
                                +++|....  ..++.++|||+|||.|||+++  ...||....++
T Consensus       696 qgr~vlpiRwmawEsill--gkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e  747 (807)
T KOG1094|consen  696 QGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE  747 (807)
T ss_pred             ecceeeeeeehhHHHHHh--ccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH
Confidence                      12222222  457899999999999999865  88999765443

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.97  E-value=2.2e-30  Score=273.42  Aligned_cols=170  Identities=26%  Similarity=0.436  Sum_probs=146.4

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      |.|-.|+.  +|+.+|||.+.+..      ...+|+||.+|+.+.||||+++++++. +..++|||.||+++|.|.++|.
T Consensus        26 g~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe-~~~~lylvlEyv~gGELFdylv  104 (786)
T KOG0588|consen   26 GCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWE-NKQHLYLVLEYVPGGELFDYLV  104 (786)
T ss_pred             ceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeec-cCceEEEEEEecCCchhHHHHH
Confidence            88888887  89999999986642      246899999999999999999999964 4469999999999999999997


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC------
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN------  537 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~------  537 (600)
                      ..+            +|++.+..+++.||..|+.|+|   ..+|+||||||+|+|||.+.++||+|||+|..-.      
T Consensus       105 ~kG------------~l~e~eaa~ff~QIi~gv~yCH---~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLe  169 (786)
T KOG0588|consen  105 RKG------------PLPEREAAHFFRQILDGVSYCH---AFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLE  169 (786)
T ss_pred             hhC------------CCCCHHHHHHHHHHHHHHHHHh---hhcceeccCCchhhhhhcccCEeeeccceeecccCCcccc
Confidence            654            3899999999999999999999   6699999999999999999999999999996432      


Q ss_pred             -----CCCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          538 -----DDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       538 -----~~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                           +.+.+||+.++++.. ..++||||.|||||.|+||+.||+.
T Consensus       170 TSCGSPHYA~PEIV~G~pYd-G~~sDVWSCGVILfALLtG~LPFdD  214 (786)
T KOG0588|consen  170 TSCGSPHYAAPEIVSGRPYD-GRPSDVWSCGVILFALLTGKLPFDD  214 (786)
T ss_pred             ccCCCcccCCchhhcCCCCC-CCccccchhHHHHHHHHhCCCCCCC
Confidence                 223456766665433 5679999999999999999999984

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=99.96  E-value=4.1e-30  Score=266.31  Aligned_cols=173  Identities=28%  Similarity=0.440  Sum_probs=147.6

Q ss_pred             CCceeEEEEEEEE--CCeEEEEEEcchhH-----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHH
Q 041830          387 SNRIEGAVYHGRL--NGKNLAIKRTEHEV-----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       387 ~~~~~G~Vy~g~~--~g~~vAvK~~~~~~-----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~  459 (600)
                      +.|..|.||||+-  +++.||+|.+.+..     .+.+.+|+++++.++|||||.++.++... .++|+|+||+.+ +|.
T Consensus        11 G~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~-~~~~vVte~a~g-~L~   88 (808)
T KOG0597|consen   11 GEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETS-AHLWVVTEYAVG-DLF   88 (808)
T ss_pred             cCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhccc-ceEEEEehhhhh-hHH
Confidence            3344599999987  77899999876532     23478899999999999999999997655 599999999986 999


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD  539 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~  539 (600)
                      .+|....            .|+++++..|+.|+..||.|||   +.+|.|||+||.|||++..+.+|++|||+||.+...
T Consensus        89 ~il~~d~------------~lpEe~v~~~a~~LVsaL~yLh---s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~  153 (808)
T KOG0597|consen   89 TILEQDG------------KLPEEQVRAIAYDLVSALYYLH---SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN  153 (808)
T ss_pred             HHHHhcc------------CCCHHHHHHHHHHHHHHHHHHH---hcCcccccCCcceeeecCCCceeechhhhhhhcccC
Confidence            9997654            3999999999999999999999   779999999999999999999999999999976433


Q ss_pred             ------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          540 ------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       540 ------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                                  +++||....  ..|+..+|.||+|||+||+++|++||..
T Consensus       154 t~vltsikGtPlYmAPElv~e--~pyd~~sDlWslGcilYE~~~G~PPF~a  202 (808)
T KOG0597|consen  154 TSVLTSIKGTPLYMAPELVEE--QPYDHTSDLWSLGCILYELYVGQPPFYA  202 (808)
T ss_pred             ceeeeeccCcccccCHHHHcC--CCccchhhHHHHHHHHHHHhcCCCCchH
Confidence                        235666553  5577889999999999999999999953

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=99.96  E-value=1.5e-29  Score=241.36  Aligned_cols=180  Identities=22%  Similarity=0.359  Sum_probs=150.5

Q ss_pred             CCceeEEEEEEEE--CCeEEEEEEcchhHH-----HHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHH
Q 041830          387 SNRIEGAVYHGRL--NGKNLAIKRTEHEVI-----TKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       387 ~~~~~G~Vy~g~~--~g~~vAvK~~~~~~~-----~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~  459 (600)
                      +.|.+|.||+|+.  +|+.||||+++....     -...+||..++.++|+||+.+++++-.. ..+-||+|||+. +|.
T Consensus        11 GEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~-~~l~lVfEfm~t-dLe   88 (318)
T KOG0659|consen   11 GEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHK-SNLSLVFEFMPT-DLE   88 (318)
T ss_pred             cCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCC-CceEEEEEeccc-cHH
Confidence            4455699999998  799999999765332     2357899999999999999999997555 488999999986 999


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD  539 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~  539 (600)
                      ..++...           ..|+..++..++.++++|++|||   .+.|+||||||.|+|+++++.+||+|||+|+.....
T Consensus        89 ~vIkd~~-----------i~l~pa~iK~y~~m~LkGl~y~H---~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p  154 (318)
T KOG0659|consen   89 VVIKDKN-----------IILSPADIKSYMLMTLKGLAYCH---SKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSP  154 (318)
T ss_pred             HHhcccc-----------cccCHHHHHHHHHHHHHHHHHHH---hhhhhcccCCccceEEcCCCcEEeecccchhccCCC
Confidence            9998654           45899999999999999999999   778999999999999999999999999999977543


Q ss_pred             C------------CCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCCCCC
Q 041830          540 T------------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKD  583 (600)
Q Consensus       540 ~------------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~~~  583 (600)
                      .            .+||.+.+. ..|+.++|+||.|||+.||+-|.+-|.+.++.+
T Consensus       155 ~~~~~~~V~TRWYRAPELLfGs-r~Yg~~VDmWavGCI~AELllr~P~fpG~sDid  209 (318)
T KOG0659|consen  155 NRIQTHQVVTRWYRAPELLFGS-RQYGTGVDMWAVGCIFAELLLRVPFFPGDSDID  209 (318)
T ss_pred             CcccccceeeeeccChHHhccc-hhcCCcchhhhHHHHHHHHHccCCCCCCCchHH
Confidence            2            246655442 567889999999999999999887777655543

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.96  E-value=9.3e-30  Score=258.00  Aligned_cols=176  Identities=27%  Similarity=0.396  Sum_probs=145.9

Q ss_pred             CceeEEEEEEEE--CCeEEEEEEcchhH---HHHHHHHHHHHHhCCCCceeeeeeEEeccCC-ceEEEEeecCCCCHHHH
Q 041830          388 NRIEGAVYHGRL--NGKNLAIKRTEHEV---ITKLEMQLVQHATHHHPNIVRLLGTCLTDGP-HSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       388 ~~~~G~Vy~g~~--~g~~vAvK~~~~~~---~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~-~~~LV~Ey~~~GsL~~~  461 (600)
                      .+..|.||.+..  +|+..|||......   .+.+++|+.++.+++|||||+++|....... .+++.|||+++|+|.++
T Consensus        27 ~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~  106 (313)
T KOG0198|consen   27 RGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDL  106 (313)
T ss_pred             CccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHH
Confidence            355599999998  48999999987654   3558999999999999999999997443332 58899999999999999


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC-CCcEEEEeccCccccCC--
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE-EFNARVGNFGMARCVND--  538 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~-~~~~kI~DFGla~~~~~--  538 (600)
                      +.+...           .|++..+.++.+||++||+|||   +++|+|||||++|||++. ++.+||+|||+++....  
T Consensus       107 ~~~~g~-----------~l~E~~v~~ytr~iL~GL~ylH---s~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~  172 (313)
T KOG0198|consen  107 IKRYGG-----------KLPEPLVRRYTRQILEGLAYLH---SKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKG  172 (313)
T ss_pred             HHHcCC-----------CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCcccceEEEeCCCCeEEeccCcccccccccc
Confidence            987541           3999999999999999999999   789999999999999999 79999999999886552  


Q ss_pred             -------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          539 -------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       539 -------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                                   .+.+||.... ......++|||||||++.||+||+.||..
T Consensus       173 ~~~~~~~~~~Gtp~~maPEvi~~-g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~  224 (313)
T KOG0198|consen  173 TKSDSELSVQGTPNYMAPEVIRN-GEVARRESDIWSLGCTVVEMLTGKPPWSE  224 (313)
T ss_pred             ccccccccccCCccccCchhhcC-CCcCCccchhhhcCCEEEeccCCCCcchh
Confidence                         1124555543 11122489999999999999999999976

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=99.96  E-value=3e-30  Score=276.73  Aligned_cols=181  Identities=23%  Similarity=0.442  Sum_probs=149.9

Q ss_pred             cCCCCceeEEEEEEEE--CCe----EEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeec
Q 041830          384 FNSSNRIEGAVYHGRL--NGK----NLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYA  453 (600)
Q Consensus       384 f~~~~~~~G~Vy~g~~--~g~----~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~  453 (600)
                      +..+.+.+|.||+|.|  .|+    +||||.+...    ...++..|...|..++|||++||+|+|..+  .+.||++||
T Consensus       702 kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s--~~qlvtq~m  779 (1177)
T KOG1025|consen  702 KVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLS--TLQLVTQLM  779 (1177)
T ss_pred             ceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccc--hHHHHHHhc
Confidence            3445566699999999  554    5888887542    235677889999999999999999999765  488999999


Q ss_pred             CCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCc
Q 041830          454 KNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA  533 (600)
Q Consensus       454 ~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla  533 (600)
                      +.|+|.+|++.++           ..+.-...+.+..|||+||.|||   +.++|||||.++||||.+-..+||.|||++
T Consensus       780 P~G~LlDyvr~hr-----------~~igsq~lLnw~~QIAkgM~YLe---~qrlVHrdLaaRNVLVksP~hvkitdfgla  845 (1177)
T KOG1025|consen  780 PLGCLLDYVREHR-----------DNIGSQDLLNWCYQIAKGMKYLE---EQRLVHRDLAARNVLVKSPNHVKITDFGLA  845 (1177)
T ss_pred             ccchHHHHHHHhh-----------ccccHHHHHHHHHHHHHHHHHHH---hcchhhhhhhhhheeecCCCeEEEEecchh
Confidence            9999999998866           34778889999999999999999   779999999999999999999999999999


Q ss_pred             cccCCCCCCCccccc--------------CCCCCCccCchHHHHHHHHHHHh-CCCCCCCCCCC
Q 041830          534 RCVNDDTESPQFYST--------------NPASWSMGIDIFAYGIVLLEVLS-GQTPINRPRKK  582 (600)
Q Consensus       534 ~~~~~~~~~pe~~~~--------------~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~~~~  582 (600)
                      +.+..+..  |+...              ....|+.++|||||||.+||++| |..|+++...+
T Consensus       846 ~ll~~d~~--ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~  907 (1177)
T KOG1025|consen  846 KLLAPDEK--EYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAE  907 (1177)
T ss_pred             hccCcccc--cccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHH
Confidence            98765532  22111              23457889999999999999999 99999875443

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=5.8e-29  Score=261.55  Aligned_cols=175  Identities=25%  Similarity=0.426  Sum_probs=147.5

Q ss_pred             ceeEEEEEEEE--CCeEEEEEEcchh--------HHHHHHHHHHHHHhCC-CCceeeeeeEEeccCCceEEEEeecCCCC
Q 041830          389 RIEGAVYHGRL--NGKNLAIKRTEHE--------VITKLEMQLVQHATHH-HPNIVRLLGTCLTDGPHSFLVFEYAKNGS  457 (600)
Q Consensus       389 ~~~G~Vy~g~~--~g~~vAvK~~~~~--------~~~~~e~ei~~~~~l~-HpNIv~l~g~~~~~~~~~~LV~Ey~~~Gs  457 (600)
                      +.+|.|+.|..  +|..||+|.++.+        ..+.+.+|+..++.++ ||||++++.++.... .+|+||||+.+|+
T Consensus        28 GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~-~~~ivmEy~~gGd  106 (370)
T KOG0583|consen   28 GSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT-KIYIVMEYCSGGD  106 (370)
T ss_pred             CCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC-eEEEEEEecCCcc
Confidence            33499999987  7899999976653        2235568999999999 999999999976664 7999999999999


Q ss_pred             HHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC-CcEEEEeccCcccc
Q 041830          458 LKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEE-FNARVGNFGMARCV  536 (600)
Q Consensus       458 L~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~-~~~kI~DFGla~~~  536 (600)
                      |.+++....            .+.+.+...+++|++.|++|+|   +.+|+|||||++|||+|.+ +++||+|||++...
T Consensus       107 L~~~i~~~g------------~l~E~~ar~~F~Qlisav~y~H---~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~  171 (370)
T KOG0583|consen  107 LFDYIVNKG------------RLKEDEARKYFRQLISAVAYCH---SRGIVHRDLKPENILLDGNEGNLKLSDFGLSAIS  171 (370)
T ss_pred             HHHHHHHcC------------CCChHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence            999998733            3888999999999999999999   7799999999999999999 99999999999866


Q ss_pred             C-CC-----------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          537 N-DD-----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       537 ~-~~-----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                      . ..           +.+||.+......-..++||||+||+||-|++|+.||+..
T Consensus       172 ~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~  226 (370)
T KOG0583|consen  172 PGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS  226 (370)
T ss_pred             CCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc
Confidence            2 21           2357776664322357799999999999999999999863

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.8e-29  Score=263.74  Aligned_cols=173  Identities=28%  Similarity=0.501  Sum_probs=147.8

Q ss_pred             CCceeEEEEEEEE--CCeEEEEEEcchhHH---HHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          387 SNRIEGAVYHGRL--NGKNLAIKRTEHEVI---TKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       387 ~~~~~G~Vy~g~~--~g~~vAvK~~~~~~~---~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      +.+..|.||.++-  +++.||||++.....   +-+-.|+..|+..+|+|||+++..++.. +++|+|||||++|+|.+.
T Consensus       282 gqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~-deLWVVMEym~ggsLTDv  360 (550)
T KOG0578|consen  282 GQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG-DELWVVMEYMEGGSLTDV  360 (550)
T ss_pred             ccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhccc-ceeEEEEeecCCCchhhh
Confidence            4444599999987  788999999865432   3456899999999999999999987766 589999999999999999


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--  539 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--  539 (600)
                      +...             .+++.++..|++++++||+|||   ..+|+|||||++|||++.++.+||+|||++..+...  
T Consensus       361 Vt~~-------------~~~E~qIA~Icre~l~aL~fLH---~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~  424 (550)
T KOG0578|consen  361 VTKT-------------RMTEGQIAAICREILQGLKFLH---ARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS  424 (550)
T ss_pred             hhcc-------------cccHHHHHHHHHHHHHHHHHHH---hcceeeeccccceeEeccCCcEEEeeeeeeeccccccC
Confidence            8653             3899999999999999999999   789999999999999999999999999998765432  


Q ss_pred             ----------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          540 ----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       540 ----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                                +++||....  ..|..++||||||++.+||+-|++||-.
T Consensus       425 KR~TmVGTPYWMAPEVvtr--k~YG~KVDIWSLGIMaIEMveGEPPYln  471 (550)
T KOG0578|consen  425 KRSTMVGTPYWMAPEVVTR--KPYGPKVDIWSLGIMAIEMVEGEPPYLN  471 (550)
T ss_pred             ccccccCCCCccchhhhhh--cccCccccchhhhhHHHHHhcCCCCccC
Confidence                      345665544  5678999999999999999999999964

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.1e-29  Score=264.73  Aligned_cols=180  Identities=24%  Similarity=0.487  Sum_probs=151.6

Q ss_pred             CCCCceeEEEEEEEE--CCeEEEEEEcchhHH--HHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          385 NSSNRIEGAVYHGRL--NGKNLAIKRTEHEVI--TKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       385 ~~~~~~~G~Vy~g~~--~g~~vAvK~~~~~~~--~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      ..+++-+|.||.|.|  -.-.||||.++++..  .+|..|...|+.++|||+|+|+|+|..+ ..+|||+|||.+|+|.+
T Consensus       274 KLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~E-pPFYIiTEfM~yGNLLd  352 (1157)
T KOG4278|consen  274 KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHE-PPFYIITEFMCYGNLLD  352 (1157)
T ss_pred             ccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccC-CCeEEEEecccCccHHH
Confidence            344455599999999  356799999988754  5788999999999999999999999766 48999999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCCC
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDT  540 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~~  540 (600)
                      ||++...          ..++--..+.++.||+.||+||.   .+++|||||..+|+|+.++..+||+||||+|++..+.
T Consensus       353 YLRecnr----------~ev~avvLlyMAtQIsSaMeYLE---kknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT  419 (1157)
T KOG4278|consen  353 YLRECNR----------SEVPAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT  419 (1157)
T ss_pred             HHHHhch----------hhcchhHHHHHHHHHHHHHHHHH---HhhhhhhhhhhhhccccccceEEeeccchhhhhcCCc
Confidence            9987553          23666778899999999999999   7899999999999999999999999999999987765


Q ss_pred             C-------------CCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCCC
Q 041830          541 E-------------SPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRPR  580 (600)
Q Consensus       541 ~-------------~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~~  580 (600)
                      +             +||.+.-  ..++.++|||+|||+|||+.| |-.||...+
T Consensus       420 YTAHAGAKFPIKWTAPEsLAy--NtFSiKSDVWAFGVLLWEIATYGMsPYPGid  471 (1157)
T KOG4278|consen  420 YTAHAGAKFPIKWTAPESLAY--NTFSIKSDVWAFGVLLWEIATYGMSPYPGID  471 (1157)
T ss_pred             eecccCccCcccccCcccccc--cccccchhhHHHHHHHHHHHhcCCCCCCCcc
Confidence            4             2332221  235678999999999999998 999997643

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=99.96  E-value=1.6e-28  Score=255.96  Aligned_cols=173  Identities=23%  Similarity=0.342  Sum_probs=144.2

Q ss_pred             eeEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          390 IEGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       390 ~~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      ..|.||+++.  +|+.||+|.++.+.      ...+..|+..+..++||||+++++++..+ ...|+||||+++|+|.++
T Consensus         7 ~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~-~~~~lv~E~~~~~~L~~~   85 (323)
T cd05595           7 TFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-DRLCFVMEYANGGELFFH   85 (323)
T ss_pred             CCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecC-CEEEEEEeCCCCCcHHHH
Confidence            3499999987  68999999986542      23456788889999999999999987655 489999999999999998


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC----
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN----  537 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~----  537 (600)
                      +....            .+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...    
T Consensus        86 l~~~~------------~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  150 (323)
T cd05595          86 LSRER------------VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA  150 (323)
T ss_pred             HHHcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC
Confidence            86543            3899999999999999999999   6799999999999999999999999999886431    


Q ss_pred             --------CCCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          538 --------DDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       538 --------~~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                              ..+.+||....  ..++.++|||||||++|||++|+.||...+
T Consensus       151 ~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~g~~Pf~~~~  199 (323)
T cd05595         151 TMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD  199 (323)
T ss_pred             ccccccCCcCcCCcccccC--CCCCchhchhhhHHHHHHHHhCCCCCCCCC
Confidence                    12235665543  456788999999999999999999997543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=9.9e-29  Score=250.71  Aligned_cols=176  Identities=24%  Similarity=0.397  Sum_probs=151.5

Q ss_pred             ceeEEEEEEEE--CCeEEEEEEcchhH----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          389 RIEGAVYHGRL--NGKNLAIKRTEHEV----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       389 ~~~G~Vy~g~~--~g~~vAvK~~~~~~----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      |..+.||+|+.  .++.||||++.-+.    .+.+.+|+..+..++||||++++..+..+ ..+|+||.||.+||+.+.+
T Consensus        37 G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~-~~LWvVmpfMa~GS~ldIi  115 (516)
T KOG0582|consen   37 GASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVD-SELWVVMPFMAGGSLLDII  115 (516)
T ss_pred             cceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEec-ceeEEeehhhcCCcHHHHH
Confidence            33489999998  78999999986543    35678999999999999999999887666 4899999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCcccc------
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV------  536 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~------  536 (600)
                      +...+          ..+++..+.-|.+++++||.|||   ..+.||||||+.||||+.+|.+||+|||.+..+      
T Consensus       116 k~~~~----------~Gl~E~~Ia~iLre~LkaL~YLH---~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R  182 (516)
T KOG0582|consen  116 KTYYP----------DGLEEASIATILREVLKALDYLH---QNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDR  182 (516)
T ss_pred             HHHcc----------ccccHHHHHHHHHHHHHHHHHHH---hcCceecccccccEEEcCCCcEEEcCceeeeeecccCce
Confidence            86543          34899999999999999999999   679999999999999999999999999976433      


Q ss_pred             ----------CCCCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          537 ----------NDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       537 ----------~~~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                                ...+.+||........|+.|+|||||||...||.+|..||..
T Consensus       183 ~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k  234 (516)
T KOG0582|consen  183 QVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSK  234 (516)
T ss_pred             eeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCccc
Confidence                      223457887666667899999999999999999999999964

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=99.96  E-value=1.2e-28  Score=261.20  Aligned_cols=172  Identities=18%  Similarity=0.319  Sum_probs=143.2

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||+++.  +|+.||+|.++...      ...+..|+..+..++|+||+++++.+.+. ...|+||||+++|+|.+++
T Consensus        14 ~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~-~~~~lv~E~~~gg~L~~~l   92 (363)
T cd05628          14 FGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDK-LNLYLIMEFLPGGDMMTLL   92 (363)
T ss_pred             CEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecC-CeEEEEEcCCCCCcHHHHH
Confidence            499999987  68899999986532      23456788888899999999999997554 5899999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC----
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND----  538 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~----  538 (600)
                      ....            .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....    
T Consensus        93 ~~~~------------~l~~~~~~~~~~qi~~aL~~lH---~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~  157 (363)
T cd05628          93 MKKD------------TLTEEETQFYIAETVLAIDSIH---QLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRT  157 (363)
T ss_pred             HhcC------------CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccc
Confidence            7543            3899999999999999999999   67999999999999999999999999999864321    


Q ss_pred             -------------------------------------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCC
Q 041830          539 -------------------------------------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTP  575 (600)
Q Consensus       539 -------------------------------------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~P  575 (600)
                                                                 .+.+||....  ..++.++|||||||++|||++|+.|
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~~DvwSlGvil~ell~G~~P  235 (363)
T cd05628         158 EFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGYPP  235 (363)
T ss_pred             cccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcC--CCCCCchhhhhhHHHHHHHHhCCCC
Confidence                                                       1224554433  3567889999999999999999999


Q ss_pred             CCCCC
Q 041830          576 INRPR  580 (600)
Q Consensus       576 f~~~~  580 (600)
                      |....
T Consensus       236 f~~~~  240 (363)
T cd05628         236 FCSET  240 (363)
T ss_pred             CCCCC
Confidence            97543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=99.96  E-value=7.6e-30  Score=254.33  Aligned_cols=181  Identities=24%  Similarity=0.346  Sum_probs=143.1

Q ss_pred             CCceeEEEEEEEE--CCeEEEEEEcchhHHHHHHHHHHHHHhCCCCceeeeeeEEeccCC----ceEEEEeecCCCCHHH
Q 041830          387 SNRIEGAVYHGRL--NGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGP----HSFLVFEYAKNGSLKD  460 (600)
Q Consensus       387 ~~~~~G~Vy~g~~--~g~~vAvK~~~~~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~----~~~LV~Ey~~~GsL~~  460 (600)
                      +.|.+|.||+|..  +++.||||+.-.+..-+ .+|+.+|..++|||||+|.-++....+    ...|||||||. +|.+
T Consensus        33 G~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~k-nrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~  110 (364)
T KOG0658|consen   33 GSGSFGVVYQAKLRETEEEVAIKKVLQDKRYK-NRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYR  110 (364)
T ss_pred             eecccceEEEEEEcCCCceeEEEEecCCCCcC-cHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHH
Confidence            3444599999998  67899999875544222 566777778999999999988764332    23589999987 9999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC-CcEEEEeccCccccCCC
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEE-FNARVGNFGMARCVNDD  539 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~-~~~kI~DFGla~~~~~~  539 (600)
                      +++......        ..++...+.-+..|+.+||+|||   +.+|+||||||.|+|+|.+ +.+||||||.|+.+...
T Consensus       111 ~~r~~~~~~--------~~mp~~~iKLYt~Qlfrgl~yLh---~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~  179 (364)
T KOG0658|consen  111 VIRHYTRAN--------QRMPLLEIKLYTYQLFRGLAYLH---SHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG  179 (364)
T ss_pred             HHHHHhhcC--------CCCceeeeHHHHHHHHHHHHHHH---hcCcccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence            998532111        23677778889999999999999   6799999999999999977 89999999999987554


Q ss_pred             CC-----------CCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCCC
Q 041830          540 TE-----------SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRK  581 (600)
Q Consensus       540 ~~-----------~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~  581 (600)
                      ..           +||...+. ..|+.+.||||.|||+.||+-|++-|.+.+.
T Consensus       180 epniSYicSRyYRaPELifga-~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~  231 (364)
T KOG0658|consen  180 EPNISYICSRYYRAPELIFGA-TEYTTSIDIWSAGCVMAELLKGQPLFPGDSS  231 (364)
T ss_pred             CCceeEEEeccccCHHHHcCc-cccCceeEEhhhhHHHHHHhcCCcccCCCCH
Confidence            32           56655543 5789999999999999999999999987543

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.2e-28  Score=252.93  Aligned_cols=172  Identities=25%  Similarity=0.358  Sum_probs=145.0

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||+++.  +|+.||+|.++...      ...+.+|+..+..++||||+++++++.++ ...++||||+++|+|.+++
T Consensus        14 ~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~~   92 (291)
T cd05612          14 FGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQ-RFLYMLMEYVPGGELFSYL   92 (291)
T ss_pred             CeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccC-CeEEEEEeCCCCCCHHHHH
Confidence            499999998  58999999986422      23567889999999999999999987554 5889999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC---
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---  539 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~---  539 (600)
                      +...            .+++.+...++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++.....   
T Consensus        93 ~~~~------------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~~~  157 (291)
T cd05612          93 RNSG------------RFSNSTGLFYASEIVCALEYLH---SKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWT  157 (291)
T ss_pred             HHcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCccc
Confidence            7543            3889999999999999999999   679999999999999999999999999998765322   


Q ss_pred             ------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 ------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 ------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                            ..+||....  ..++.++|||||||++|||++|+.||...+
T Consensus       158 ~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~~l~~g~~pf~~~~  202 (291)
T cd05612         158 LCGTPEYLAPEVIQS--KGHNKAVDWWALGILIYEMLVGYPPFFDDN  202 (291)
T ss_pred             ccCChhhcCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence                  235665543  346788999999999999999999997543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.8e-28  Score=254.28  Aligned_cols=173  Identities=21%  Similarity=0.289  Sum_probs=144.0

Q ss_pred             ceeEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          389 RIEGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       389 ~~~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      |..|.||+++.  +++.||+|.++...      ...+..|+..+..++||||+++++++..+ +..|+||||+++|+|.+
T Consensus         4 G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~g~L~~   82 (312)
T cd05585           4 GSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSP-EKLYLVLAFINGGELFH   82 (312)
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecC-CeEEEEEcCCCCCcHHH
Confidence            33499999998  68899999886432      23456788889999999999999987655 58999999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC--
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND--  538 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~--  538 (600)
                      ++....            .+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....  
T Consensus        83 ~l~~~~------------~~~~~~~~~~~~qi~~~l~~lH---~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~  147 (312)
T cd05585          83 HLQREG------------RFDLSRARFYTAELLCALENLH---KFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD  147 (312)
T ss_pred             HHHhcC------------CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC
Confidence            997543            3899999999999999999999   67999999999999999999999999999875321  


Q ss_pred             ----------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 ----------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 ----------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                .+.+||....  ..++.++|||||||++|||++|+.||...
T Consensus       148 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~el~tg~~pf~~~  196 (312)
T cd05585         148 DKTNTFCGTPEYLAPELLLG--HGYTKAVDWWTLGVLLYEMLTGLPPFYDE  196 (312)
T ss_pred             CccccccCCcccCCHHHHcC--CCCCCccceechhHHHHHHHhCCCCcCCC
Confidence                      1234565543  45678899999999999999999999653

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=99.96  E-value=1.3e-28  Score=256.67  Aligned_cols=173  Identities=23%  Similarity=0.331  Sum_probs=144.3

Q ss_pred             ceeEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          389 RIEGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       389 ~~~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      |..|.||+++.  +|+.||+|.++...      ...+..|+..+..++||||+++++++... ...|+||||+++|+|.+
T Consensus         6 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~   84 (323)
T cd05571           6 GTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTH-DRLCFVMEYANGGELFF   84 (323)
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcC-CEEEEEEeCCCCCcHHH
Confidence            34499999987  78999999986532      23456788889999999999999987655 48999999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC---
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN---  537 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~---  537 (600)
                      ++....            .+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...   
T Consensus        85 ~l~~~~------------~~~~~~~~~~~~qi~~~L~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~  149 (323)
T cd05571          85 HLSRER------------VFSEDRARFYGAEIVSALGYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG  149 (323)
T ss_pred             HHHHcC------------CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC
Confidence            997543            3899999999999999999999   6799999999999999999999999999987431   


Q ss_pred             ---------CCCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          538 ---------DDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       538 ---------~~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                               ..+.+||....  ..++.++|||||||++|||++|+.||...
T Consensus       150 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~Pf~~~  198 (323)
T cd05571         150 ATMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQ  198 (323)
T ss_pred             CcccceecCccccChhhhcC--CCCCccccCcccchhhhhhhcCCCCCCCC
Confidence                     12235665543  45678899999999999999999999653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=99.96  E-value=1.8e-28  Score=256.27  Aligned_cols=172  Identities=22%  Similarity=0.340  Sum_probs=143.7

Q ss_pred             eeEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          390 IEGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       390 ~~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      ..|.||+++.  +|+.||+|.++.+.      ...+.+|+..+..++||||+++++++..+ +..++||||+++|+|.++
T Consensus         7 ~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~Ey~~~g~L~~~   85 (328)
T cd05593           7 TFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTK-DRLCFVMEYVNGGELFFH   85 (328)
T ss_pred             CCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC-CEEEEEEeCCCCCCHHHH
Confidence            3499999987  68999999986532      23456788889999999999999987655 489999999999999999


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC---
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND---  538 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~---  538 (600)
                      +....            .+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....   
T Consensus        86 l~~~~------------~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~  150 (328)
T cd05593          86 LSRER------------VFSEDRTRFYGAEIVSALDYLH---SGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA  150 (328)
T ss_pred             HHhcC------------CCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc
Confidence            86543            3899999999999999999999   67999999999999999999999999999875321   


Q ss_pred             ---------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 ---------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 ---------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                               .+.+||....  ..++.++|||||||++|||++|+.||...
T Consensus       151 ~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~Pf~~~  198 (328)
T cd05593         151 TMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQ  198 (328)
T ss_pred             ccccccCCcCccChhhhcC--CCCCccCCccccchHHHHHhhCCCCCCCC
Confidence                     1234555443  35678899999999999999999999754

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=99.96  E-value=1.2e-28  Score=262.77  Aligned_cols=173  Identities=18%  Similarity=0.305  Sum_probs=142.9

Q ss_pred             eeEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          390 IEGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       390 ~~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      ..|.||+++.  +++.||+|.++...      ...+..|+..+..++||||+++++++.+. +..|+||||+++|+|.++
T Consensus        13 ~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~-~~~~lv~E~~~gg~L~~~   91 (381)
T cd05626          13 AFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDK-DNLYFVMDYIPGGDMMSL   91 (381)
T ss_pred             CCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecC-CEEEEEEecCCCCcHHHH
Confidence            3499999988  68899999986532      23467788889999999999999997655 589999999999999999


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC----
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN----  537 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~----  537 (600)
                      +....            .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...    
T Consensus        92 l~~~~------------~~~e~~~~~~~~qi~~aL~~LH---~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~  156 (381)
T cd05626          92 LIRME------------VFPEVLARFYIAELTLAIESVH---KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN  156 (381)
T ss_pred             HHhcC------------CCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence            97543            3888899999999999999999   6799999999999999999999999999875321    


Q ss_pred             -------------------------------------------------------CCCCCCcccccCCCCCCccCchHHH
Q 041830          538 -------------------------------------------------------DDTESPQFYSTNPASWSMGIDIFAY  562 (600)
Q Consensus       538 -------------------------------------------------------~~~~~pe~~~~~~~~~t~~sDVwSf  562 (600)
                                                                             ..+.+||....  ..++.++|||||
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwSl  234 (381)
T cd05626         157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLR--KGYTQLCDWWSV  234 (381)
T ss_pred             cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcC--CCCCCccceeeh
Confidence                                                                   11224554433  346788999999


Q ss_pred             HHHHHHHHhCCCCCCCCC
Q 041830          563 GIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       563 GvvL~ELltG~~Pf~~~~  580 (600)
                      ||++|||++|+.||...+
T Consensus       235 G~il~elltG~~Pf~~~~  252 (381)
T cd05626         235 GVILFEMLVGQPPFLAPT  252 (381)
T ss_pred             hhHHHHHHhCCCCCcCCC
Confidence            999999999999997644

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=99.96  E-value=3e-28  Score=254.61  Aligned_cols=171  Identities=20%  Similarity=0.361  Sum_probs=144.7

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||+++.  +|+.||+|.++...      ...+..|+..+..++||||+++++++..+ +..|+||||+++|+|.+++
T Consensus        31 ~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l  109 (329)
T PTZ00263         31 FGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDE-NRVYFLLEFVVGGELFTHL  109 (329)
T ss_pred             CeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcC-CEEEEEEcCCCCChHHHHH
Confidence            399999998  68899999886532      23567888999999999999999997655 4899999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC---
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---  539 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~---  539 (600)
                      ....            .+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....   
T Consensus       110 ~~~~------------~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~  174 (329)
T PTZ00263        110 RKAG------------RFPNDVAKFYHAELVLAFEYLH---SKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRTFT  174 (329)
T ss_pred             HHcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCcce
Confidence            7543            3788899999999999999999   679999999999999999999999999999865432   


Q ss_pred             ------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 ------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 ------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                            +.+||....  ..++.++|||||||++|||++|+.||...
T Consensus       175 ~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~  218 (329)
T PTZ00263        175 LCGTPEYLAPEVIQS--KGHGKAVDWWTMGVLLYEFIAGYPPFFDD  218 (329)
T ss_pred             ecCChhhcCHHHHcC--CCCCCcceeechHHHHHHHHcCCCCCCCC
Confidence                  235665544  34678899999999999999999999654

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=99.96  E-value=5.1e-28  Score=247.47  Aligned_cols=174  Identities=20%  Similarity=0.268  Sum_probs=144.6

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhHH------HHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEVI------TKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~~------~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||++..  +|+.||+|.++....      ..+..|+..+..++|+||+++++++..+ +..++||||+++|+|.+++
T Consensus        13 ~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~-~~~~lv~e~~~~g~L~~~~   91 (285)
T cd05631          13 FGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETK-DALCLVLTIMNGGDLKFHI   91 (285)
T ss_pred             CEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccC-CeEEEEEEecCCCcHHHHH
Confidence            399999987  789999998764321      2356788899999999999999987655 4899999999999999888


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC----
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND----  538 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~----  538 (600)
                      .....          ..+++.++..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++....    
T Consensus        92 ~~~~~----------~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  158 (285)
T cd05631          92 YNMGN----------PGFDEQRAIFYAAELCCGLEDLQ---RERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETV  158 (285)
T ss_pred             HhhCC----------CCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCee
Confidence            64321          24899999999999999999999   67999999999999999999999999999875422    


Q ss_pred             -------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          539 -------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       539 -------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                             .+.+||....  ..++.++|||||||++|||++|+.||...+
T Consensus       159 ~~~~g~~~y~aPE~~~~--~~~~~~~DvwslGvil~el~~g~~pf~~~~  205 (285)
T cd05631         159 RGRVGTVGYMAPEVINN--EKYTFSPDWWGLGCLIYEMIQGQSPFRKRK  205 (285)
T ss_pred             cCCCCCCCccCHhhhcC--CCCCcccCchhHHHHHHHHHhCCCCCCCCC
Confidence                   1235666543  457888999999999999999999997644

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=99.96  E-value=2.8e-28  Score=255.94  Aligned_cols=172  Identities=21%  Similarity=0.328  Sum_probs=143.9

Q ss_pred             eEEEEEEEEC---CeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          391 EGAVYHGRLN---GKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       391 ~G~Vy~g~~~---g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      .|.||++...   +..||+|++....      ...+..|+..+..++||||+++++++... ...++||||+++|+|.++
T Consensus        43 ~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-~~~~lv~Ey~~~g~L~~~  121 (340)
T PTZ00426         43 FGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE-SYLYLVLEFVIGGEFFTF  121 (340)
T ss_pred             CeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeC-CEEEEEEeCCCCCcHHHH
Confidence            4999999862   3689999875432      23566788999999999999999998655 489999999999999999


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--  539 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--  539 (600)
                      +....            .+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....  
T Consensus       122 i~~~~------------~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~~~  186 (340)
T PTZ00426        122 LRRNK------------RFPNDVGCFYAAQIVLIFEYLQ---SLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTY  186 (340)
T ss_pred             HHHcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCCcc
Confidence            97643            3889999999999999999999   679999999999999999999999999999765322  


Q ss_pred             -------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 -------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 -------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                             +.+||....  ..++.++|||||||++|||++|+.||...+
T Consensus       187 ~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~ell~G~~Pf~~~~  232 (340)
T PTZ00426        187 TLCGTPEYIAPEILLN--VGHGKAADWWTLGIFIYEILVGCPPFYANE  232 (340)
T ss_pred             eecCChhhcCHHHHhC--CCCCccccccchhhHHHHHhcCCCCCCCCC
Confidence                   235665543  346788999999999999999999997643

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=99.96  E-value=2.2e-28  Score=256.39  Aligned_cols=185  Identities=22%  Similarity=0.375  Sum_probs=144.6

Q ss_pred             eEEEEEEEE-------CCeEEEEEEcchh----HHHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCCH
Q 041830          391 EGAVYHGRL-------NGKNLAIKRTEHE----VITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSL  458 (600)
Q Consensus       391 ~G~Vy~g~~-------~g~~vAvK~~~~~----~~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL  458 (600)
                      .|.||++..       .++.||+|+++..    ....+..|+..+..+ +||||++++|+|...+...+++|||+++|+|
T Consensus        20 fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L   99 (338)
T cd05102          20 FGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNL   99 (338)
T ss_pred             cceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcH
Confidence            499999974       2467999998642    224567888888888 8999999999987665578999999999999


Q ss_pred             HHHHhcCcCcccc--------------------------------------------------cccccccCCCHHHHHHH
Q 041830          459 KDWLHGGLAMKNQ--------------------------------------------------FIASCYCFLTWSQRLRI  488 (600)
Q Consensus       459 ~~~L~~~~~~~~~--------------------------------------------------~~~~~~~~l~~~~~~~i  488 (600)
                      .++++........                                                  .......++++.+++.+
T Consensus       100 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~  179 (338)
T cd05102         100 SNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICY  179 (338)
T ss_pred             HHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHH
Confidence            9999753210000                                                  00001245889999999


Q ss_pred             HHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC--------------CCCCCcccccCCCCCC
Q 041830          489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND--------------DTESPQFYSTNPASWS  554 (600)
Q Consensus       489 ~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~--------------~~~~pe~~~~~~~~~t  554 (600)
                      +.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....              .+.+||....  ..++
T Consensus       180 ~~qi~~aL~~LH---~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~  254 (338)
T cd05102         180 SFQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFD--KVYT  254 (338)
T ss_pred             HHHHHHHHHHHH---HCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhc--CCCC
Confidence            999999999999   67999999999999999999999999999975421              1235665543  4568


Q ss_pred             ccCchHHHHHHHHHHHh-CCCCCCCCC
Q 041830          555 MGIDIFAYGIVLLEVLS-GQTPINRPR  580 (600)
Q Consensus       555 ~~sDVwSfGvvL~ELlt-G~~Pf~~~~  580 (600)
                      .++|||||||+||||++ |+.||....
T Consensus       255 ~~sDiwslG~il~el~~~g~~pf~~~~  281 (338)
T cd05102         255 TQSDVWSFGVLLWEIFSLGASPYPGVQ  281 (338)
T ss_pred             cccCHHHHHHHHHHHHhCCCCCCCCCC
Confidence            88999999999999997 999997643

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=1.3e-28  Score=262.13  Aligned_cols=171  Identities=20%  Similarity=0.311  Sum_probs=141.9

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||+++.  +|+.||||.+....      ...++.|+..+..++||||+++++++.++ ...|+||||+++|+|.+++
T Consensus        14 ~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~-~~~~lv~E~~~gg~L~~~l   92 (377)
T cd05629          14 FGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDA-QYLYLIMEFLPGGDLMTML   92 (377)
T ss_pred             CEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcC-CeeEEEEeCCCCCcHHHHH
Confidence            399999987  78999999875432      23566788888999999999999997655 4899999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC-----
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN-----  537 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~-----  537 (600)
                      ....            .+++.....++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...     
T Consensus        93 ~~~~------------~~~~~~~~~~~~ql~~aL~~LH---~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~  157 (377)
T cd05629          93 IKYD------------TFSEDVTRFYMAECVLAIEAVH---KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDS  157 (377)
T ss_pred             HhcC------------CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence            7543            3888899999999999999999   6799999999999999999999999999985221     


Q ss_pred             ------------------------------------------------------CCCCCCcccccCCCCCCccCchHHHH
Q 041830          538 ------------------------------------------------------DDTESPQFYSTNPASWSMGIDIFAYG  563 (600)
Q Consensus       538 ------------------------------------------------------~~~~~pe~~~~~~~~~t~~sDVwSfG  563 (600)
                                                                            ..+.+||....  ..++.++||||||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG  235 (377)
T cd05629         158 AYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ--QGYGQECDWWSLG  235 (377)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHcc--CCCCCceeeEecc
Confidence                                                                  11234554433  3467889999999


Q ss_pred             HHHHHHHhCCCCCCCC
Q 041830          564 IVLLEVLSGQTPINRP  579 (600)
Q Consensus       564 vvL~ELltG~~Pf~~~  579 (600)
                      |++|||++|+.||...
T Consensus       236 vil~elltG~~Pf~~~  251 (377)
T cd05629         236 AIMFECLIGWPPFCSE  251 (377)
T ss_pred             hhhhhhhcCCCCCCCC
Confidence            9999999999999654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=99.96  E-value=1.1e-28  Score=246.53  Aligned_cols=176  Identities=23%  Similarity=0.439  Sum_probs=149.5

Q ss_pred             CCceeEEEEEEEE--CCeEEEEEEcchhHHH------HHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCH
Q 041830          387 SNRIEGAVYHGRL--NGKNLAIKRTEHEVIT------KLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSL  458 (600)
Q Consensus       387 ~~~~~G~Vy~g~~--~g~~vAvK~~~~~~~~------~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL  458 (600)
                      +.|.+|.|-++..  .|+.||||.++++.++      .+.+||.+|..++||||+.++.++... +.+.|||||..+|.|
T Consensus        62 GkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENk-dKIvivMEYaS~GeL  140 (668)
T KOG0611|consen   62 GKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENK-DKIVIVMEYASGGEL  140 (668)
T ss_pred             cCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCC-ceEEEEEEecCCccH
Confidence            4455689988876  7999999998775543      468899999999999999999997554 589999999999999


Q ss_pred             HHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC
Q 041830          459 KDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND  538 (600)
Q Consensus       459 ~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~  538 (600)
                      ++|+.+.+.            |++.+..++++||..|+.|+|   ..+++|||||-+|||||.++++||+|||++-....
T Consensus       141 YDYiSer~~------------LsErEaRhfFRQIvSAVhYCH---knrVvHRDLKLENILLD~N~NiKIADFGLSNly~~  205 (668)
T KOG0611|consen  141 YDYISERGS------------LSEREARHFFRQIVSAVHYCH---KNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD  205 (668)
T ss_pred             HHHHHHhcc------------ccHHHHHHHHHHHHHHHHHHh---hccceecccchhheeecCCCCeeeeccchhhhhcc
Confidence            999987543            999999999999999999999   77999999999999999999999999999865432


Q ss_pred             C-----------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 D-----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 ~-----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                      .           +.+||+..+.+.. .+.+|-||+||+||.|+.|..||+..
T Consensus       206 ~kfLqTFCGSPLYASPEIvNG~PY~-GPEVDsWsLGvLLYtLVyGtMPFDG~  256 (668)
T KOG0611|consen  206 KKFLQTFCGSPLYASPEIVNGTPYK-GPEVDSWSLGVLLYTLVYGTMPFDGR  256 (668)
T ss_pred             ccHHHHhcCCcccCCccccCCCCCC-CCccchhhHHHHHHHHhhcccccCCc
Confidence            2           2356666655433 56799999999999999999999864

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=8.9e-29  Score=263.29  Aligned_cols=177  Identities=25%  Similarity=0.457  Sum_probs=142.6

Q ss_pred             ceeEEEEEEEE--CCeEEEEEEcchhHH------H--HHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCH
Q 041830          389 RIEGAVYHGRL--NGKNLAIKRTEHEVI------T--KLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSL  458 (600)
Q Consensus       389 ~~~G~Vy~g~~--~g~~vAvK~~~~~~~------~--~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL  458 (600)
                      |-+|.|+.+..  +++.+|||.++++.+      +  ..|+.|..++. +||.++.|+..+.+. +++|.||||+.+|++
T Consensus       379 GsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~-~HPFL~~L~~~fQT~-~~l~fvmey~~Ggdm  456 (694)
T KOG0694|consen  379 GSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELAN-RHPFLVNLFSCFQTK-EHLFFVMEYVAGGDL  456 (694)
T ss_pred             CcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhc-cCCeEeecccccccC-CeEEEEEEecCCCcE
Confidence            33499999998  678999999876432      2  34555666666 799999999886555 599999999999996


Q ss_pred             HHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC
Q 041830          459 KDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND  538 (600)
Q Consensus       459 ~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~  538 (600)
                      ..+.+..             .+++....-++..|+.||.|||   +++||+||||-+|||||.+|.+||+||||++....
T Consensus       457 ~~~~~~~-------------~F~e~rarfyaAev~l~L~fLH---~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~  520 (694)
T KOG0694|consen  457 MHHIHTD-------------VFSEPRARFYAAEVVLGLQFLH---ENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG  520 (694)
T ss_pred             EEEEecc-------------cccHHHHHHHHHHHHHHHHHHH---hcCceeeecchhheEEcccCcEEecccccccccCC
Confidence            6555432             2899999999999999999999   77999999999999999999999999999985431


Q ss_pred             CC-------CCCcccccC---CCCCCccCchHHHHHHHHHHHhCCCCCCCCCCCC
Q 041830          539 DT-------ESPQFYSTN---PASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKD  583 (600)
Q Consensus       539 ~~-------~~pe~~~~~---~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~~~  583 (600)
                      ..       ..|+++.++   ...|+..+|.|||||+||||+.|..||.+.+++|
T Consensus       521 ~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee  575 (694)
T KOG0694|consen  521 QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEE  575 (694)
T ss_pred             CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence            11       134444332   3678999999999999999999999999766554

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=99.96  E-value=2.7e-28  Score=260.22  Aligned_cols=172  Identities=19%  Similarity=0.307  Sum_probs=142.6

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||+++.  +++.||+|.+....      ...+..|+.++..++||||+++++.+.++ ...|+|||||++|+|.+++
T Consensus        14 ~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~-~~~~lv~E~~~gg~L~~~l   92 (382)
T cd05625          14 FGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDK-DNLYFVMDYIPGGDMMSLL   92 (382)
T ss_pred             CEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeC-CEEEEEEeCCCCCcHHHHH
Confidence            499999988  68899999986532      23567788889999999999999997655 4899999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC-----
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN-----  537 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~-----  537 (600)
                      ....            .+++.....++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...     
T Consensus        93 ~~~~------------~~~e~~~~~~~~qi~~al~~lH---~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~  157 (382)
T cd05625          93 IRMG------------IFPEDLARFYIAELTCAVESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (382)
T ss_pred             HhcC------------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccc
Confidence            7542            3788889999999999999999   6799999999999999999999999999974211     


Q ss_pred             ------------------------------------------------------CCCCCCcccccCCCCCCccCchHHHH
Q 041830          538 ------------------------------------------------------DDTESPQFYSTNPASWSMGIDIFAYG  563 (600)
Q Consensus       538 ------------------------------------------------------~~~~~pe~~~~~~~~~t~~sDVwSfG  563 (600)
                                                                            ..+.+||....  ..++.++||||||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwSlG  235 (382)
T cd05625         158 KYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCDWWSVG  235 (382)
T ss_pred             cccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcC--CCCCCeeeEEech
Confidence                                                                  11234555433  3567889999999


Q ss_pred             HHHHHHHhCCCCCCCCC
Q 041830          564 IVLLEVLSGQTPINRPR  580 (600)
Q Consensus       564 vvL~ELltG~~Pf~~~~  580 (600)
                      |+||||++|+.||...+
T Consensus       236 vil~elltG~~Pf~~~~  252 (382)
T cd05625         236 VILYEMLVGQPPFLAQT  252 (382)
T ss_pred             HHHHHHHhCCCCCCCCC
Confidence            99999999999997543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=99.96  E-value=6e-28  Score=252.33  Aligned_cols=170  Identities=21%  Similarity=0.382  Sum_probs=140.8

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      .|.||+++.  +++.||+|.++.+.      ...+..|...+..+ +||||+++++++..+ ...|+||||+++|+|.++
T Consensus         8 ~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~-~~~~lv~e~~~~g~L~~~   86 (329)
T cd05588           8 YAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTE-SRLFFVIEFVSGGDLMFH   86 (329)
T ss_pred             CeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcC-CEEEEEEeCCCCCCHHHH
Confidence            499999988  68899999987532      22355677777666 699999999997655 489999999999999999


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC----
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN----  537 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~----  537 (600)
                      +....            .+++.++..++.|++.||.|||   +.+++||||||+|||++.++.+||+|||+++...    
T Consensus        87 ~~~~~------------~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~  151 (329)
T cd05588          87 MQRQR------------KLPEEHARFYSAEISLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGD  151 (329)
T ss_pred             HHHcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEECcCccccccccCCC
Confidence            86543            3899999999999999999999   6799999999999999999999999999986421    


Q ss_pred             --------CCCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          538 --------DDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       538 --------~~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                              ..+.+||....  ..++.++|||||||++|||++|+.||+.
T Consensus       152 ~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~g~~Pf~~  198 (329)
T cd05588         152 TTSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDI  198 (329)
T ss_pred             ccccccCCccccCHHHHcC--CCCCCccceechHHHHHHHHHCCCCccc
Confidence                    11235665543  4567889999999999999999999964

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=99.96  E-value=2.5e-28  Score=258.68  Aligned_cols=171  Identities=20%  Similarity=0.367  Sum_probs=143.1

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||+++.  +|+.||||.++...      ...+..|+..+..++||||+++++++... ...|+||||+++|+|.+++
T Consensus        14 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~-~~~~lv~E~~~~g~L~~~l   92 (364)
T cd05599          14 FGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDE-NYLYLIMEYLPGGDMMTLL   92 (364)
T ss_pred             CEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcC-CeEEEEECCCCCcHHHHHH
Confidence            399999998  68899999986532      23456788899999999999999997655 5899999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC----
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND----  538 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~----  538 (600)
                      ....            .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+..    
T Consensus        93 ~~~~------------~l~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  157 (364)
T cd05599          93 MKKD------------TFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRT  157 (364)
T ss_pred             HHcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEeecccceeccccccc
Confidence            7543            3899999999999999999999   67999999999999999999999999999864321    


Q ss_pred             ----------------------------------------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhC
Q 041830          539 ----------------------------------------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSG  572 (600)
Q Consensus       539 ----------------------------------------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG  572 (600)
                                                                    ...+||....  ..++.++|||||||++|||++|
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~~G  235 (364)
T cd05599         158 EFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQ--TGYNKECDWWSLGVIMYEMLVG  235 (364)
T ss_pred             cccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcC--CCCCCeeeeecchhHHHHhhcC
Confidence                                                          1234554433  4567889999999999999999


Q ss_pred             CCCCCCC
Q 041830          573 QTPINRP  579 (600)
Q Consensus       573 ~~Pf~~~  579 (600)
                      +.||...
T Consensus       236 ~~Pf~~~  242 (364)
T cd05599         236 YPPFCSD  242 (364)
T ss_pred             CCCCCCC
Confidence            9999754

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=99.96  E-value=3.9e-28  Score=253.28  Aligned_cols=174  Identities=21%  Similarity=0.335  Sum_probs=143.1

Q ss_pred             eeEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          390 IEGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       390 ~~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      ..|.||+++.  +|+.||+|.++.+.      ...+..|+..+..++||||+++++++..+ ...++||||+++|+|.++
T Consensus         7 ~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~-~~~~lv~E~~~~~~L~~~   85 (325)
T cd05594           7 TFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH-DRLCFVMEYANGGELFFH   85 (325)
T ss_pred             CCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcC-CEEEEEEeCCCCCcHHHH
Confidence            3499999987  78999999986532      23456678888889999999999987555 489999999999999999


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC---
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND---  538 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~---  538 (600)
                      +....            .+++.++..++.|++.||.|||+  ..+|+||||||+|||++.++.+||+|||+++....   
T Consensus        86 l~~~~------------~l~~~~~~~~~~qi~~aL~~lH~--~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~  151 (325)
T cd05594          86 LSRER------------VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA  151 (325)
T ss_pred             HHhcC------------CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc
Confidence            86543            38999999999999999999993  25899999999999999999999999999864321   


Q ss_pred             ---------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          539 ---------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       539 ---------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                               .+.+||....  ..++.++|||||||++|||++|+.||...+
T Consensus       152 ~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tG~~Pf~~~~  200 (325)
T cd05594         152 TMKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD  200 (325)
T ss_pred             ccccccCCcccCCHHHHcc--CCCCCccccccccceeeeeccCCCCCCCCC
Confidence                     1235665543  456788999999999999999999996543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=99.96  E-value=5e-28  Score=251.15  Aligned_cols=178  Identities=20%  Similarity=0.329  Sum_probs=142.2

Q ss_pred             CCceeEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCH
Q 041830          387 SNRIEGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSL  458 (600)
Q Consensus       387 ~~~~~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL  458 (600)
                      +.|.+|.||.++-  +|+.+|+|++++..      +.....|-.+|....+|+||+|+-.+ ++.+.+||||||.+||++
T Consensus       150 gkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsF-QD~~~LYLiMEylPGGD~  228 (550)
T KOG0605|consen  150 GKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSF-QDKEYLYLIMEYLPGGDM  228 (550)
T ss_pred             ccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEe-cCCCeeEEEEEecCCccH
Confidence            5556699999976  89999999987633      23344555666667899999999665 555699999999999999


Q ss_pred             HHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC
Q 041830          459 KDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND  538 (600)
Q Consensus       459 ~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~  538 (600)
                      ..+|....            .|++.....++.+.+.|+.-||   ..+++||||||+|+|||..|++||+||||+.-+..
T Consensus       229 mTLL~~~~------------~L~e~~arfYiaE~vlAI~~iH---~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~  293 (550)
T KOG0605|consen  229 MTLLMRKD------------TLTEDWARFYIAETVLAIESIH---QLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDK  293 (550)
T ss_pred             HHHHHhcC------------cCchHHHHHHHHHHHHHHHHHH---HcCcccccCChhheeecCCCCEeeccccccchhhh
Confidence            99997653            4899999999999999999999   77999999999999999999999999999852211


Q ss_pred             C-----------------------------------------------------------CCCCcccccCCCCCCccCch
Q 041830          539 D-----------------------------------------------------------TESPQFYSTNPASWSMGIDI  559 (600)
Q Consensus       539 ~-----------------------------------------------------------~~~pe~~~~~~~~~t~~sDV  559 (600)
                      .                                                           +.+||++..  ..|+..+|.
T Consensus       294 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~--kgY~~~cDw  371 (550)
T KOG0605|consen  294 KHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLG--KGYGKECDW  371 (550)
T ss_pred             hhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhc--CCCCccccH
Confidence            0                                                           001222222  346777999


Q ss_pred             HHHHHHHHHHHhCCCCCCCCCCC
Q 041830          560 FAYGIVLLEVLSGQTPINRPRKK  582 (600)
Q Consensus       560 wSfGvvL~ELltG~~Pf~~~~~~  582 (600)
                      ||+|||||||+.|.+||...+..
T Consensus       372 WSLG~ImyEmLvGyPPF~s~tp~  394 (550)
T KOG0605|consen  372 WSLGCIMYEMLVGYPPFCSETPQ  394 (550)
T ss_pred             HHHHHHHHHHHhCCCCCCCCCHH
Confidence            99999999999999999875544

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=99.96  E-value=1.2e-27  Score=238.88  Aligned_cols=182  Identities=22%  Similarity=0.352  Sum_probs=149.3

Q ss_pred             CCceeEEEEEEEE--CCeEEEEEEcchhHH-----HHHHHHHHHHHhCCCCc-eeeeeeEEeccCC-----ceEEEEeec
Q 041830          387 SNRIEGAVYHGRL--NGKNLAIKRTEHEVI-----TKLEMQLVQHATHHHPN-IVRLLGTCLTDGP-----HSFLVFEYA  453 (600)
Q Consensus       387 ~~~~~G~Vy~g~~--~g~~vAvK~~~~~~~-----~~~e~ei~~~~~l~HpN-Iv~l~g~~~~~~~-----~~~LV~Ey~  453 (600)
                      +.+.+|.||+|+.  +|+.||+|+++-+..     ....+|+..+..++|+| ||+|++++..+..     .++||+||+
T Consensus        20 GeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~   99 (323)
T KOG0594|consen   20 GEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFL   99 (323)
T ss_pred             CCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEee
Confidence            4556799999988  899999998754332     23578999999999999 9999999876543     678999999


Q ss_pred             CCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCc
Q 041830          454 KNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA  533 (600)
Q Consensus       454 ~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla  533 (600)
                      +. +|..++.......        ..++...+..+++|+++||+|||   +++|+||||||.|||+++++.+||+|||+|
T Consensus       100 d~-DL~~ymd~~~~~~--------~g~~~~~ik~~m~Qll~gl~~~H---~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA  167 (323)
T KOG0594|consen  100 DR-DLKKYMDSLPKKP--------QGLPPRLIKSFMRQLLRGLAFLH---SHGILHRDLKPQNLLISSSGVLKLADFGLA  167 (323)
T ss_pred             cc-cHHHHHHhccccc--------cCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCcceEEECCCCcEeeeccchH
Confidence            75 9999997654211        23667889999999999999999   779999999999999999999999999999


Q ss_pred             cccCCCC------------CCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCCC
Q 041830          534 RCVNDDT------------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRK  581 (600)
Q Consensus       534 ~~~~~~~------------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~  581 (600)
                      +...-..            .+||...+. ..|+...|+||+|||+.||++++.-|....+
T Consensus       168 ra~~ip~~~yt~evvTlWYRaPEvLlGs-~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se  226 (323)
T KOG0594|consen  168 RAFSIPMRTYTPEVVTLWYRAPEVLLGS-TSYSTSVDIWSLGCIFAEMFTRRPLFPGDSE  226 (323)
T ss_pred             HHhcCCcccccccEEEeeccCHHHhcCC-CcCCCCcchHhHHHHHHHHHhCCCCCCCCcH
Confidence            8654221            256665543 3588899999999999999999988987654

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=99.95  E-value=2.7e-28  Score=259.66  Aligned_cols=172  Identities=19%  Similarity=0.288  Sum_probs=142.3

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||+++.  +|+.||+|.+....      ...+.+|+..+..++|+||+++++.+.++ +.+|+||||+++|+|.+++
T Consensus        14 ~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~-~~~~lv~E~~~~g~L~~~i   92 (376)
T cd05598          14 FGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDK-DNLYFVMDYIPGGDMMSLL   92 (376)
T ss_pred             CeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcC-CEEEEEEeCCCCCcHHHHH
Confidence            499999987  68899999986432      23466788899999999999999997655 5899999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCcccc------
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV------  536 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~------  536 (600)
                      ....            .+++.....++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||++...      
T Consensus        93 ~~~~------------~~~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~  157 (376)
T cd05598          93 IRLG------------IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  157 (376)
T ss_pred             HhcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccc
Confidence            7543            3788888999999999999999   679999999999999999999999999997421      


Q ss_pred             -------------------------------------------------CCCCCCCcccccCCCCCCccCchHHHHHHHH
Q 041830          537 -------------------------------------------------NDDTESPQFYSTNPASWSMGIDIFAYGIVLL  567 (600)
Q Consensus       537 -------------------------------------------------~~~~~~pe~~~~~~~~~t~~sDVwSfGvvL~  567 (600)
                                                                       ...+.+||....  ..++.++|||||||++|
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvily  235 (376)
T cd05598         158 KYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR--TGYTQLCDWWSVGVILY  235 (376)
T ss_pred             cccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC--CCCCcceeeeeccceee
Confidence                                                             111234554433  34677899999999999


Q ss_pred             HHHhCCCCCCCCC
Q 041830          568 EVLSGQTPINRPR  580 (600)
Q Consensus       568 ELltG~~Pf~~~~  580 (600)
                      ||++|+.||...+
T Consensus       236 ell~G~~Pf~~~~  248 (376)
T cd05598         236 EMLVGQPPFLADT  248 (376)
T ss_pred             ehhhCCCCCCCCC
Confidence            9999999997644

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=5.1e-28  Score=253.18  Aligned_cols=171  Identities=21%  Similarity=0.388  Sum_probs=144.8

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||+++.  +|+.||+|.++...      ...+..|+..+..++||||+++++++... ...|+||||+++|+|.+++
T Consensus        14 ~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-~~~~lv~e~~~g~~L~~~l   92 (333)
T cd05600          14 YGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDD-EYLYLAMEYVPGGDFRTLL   92 (333)
T ss_pred             CeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcC-CEEEEEEeCCCCCCHHHHH
Confidence            499999998  68899999987542      23456788888999999999999997654 5899999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC----
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND----  538 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~----  538 (600)
                      ....            .+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....    
T Consensus        93 ~~~~------------~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~~~~~  157 (333)
T cd05600          93 NNLG------------VLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANS  157 (333)
T ss_pred             HHcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEEEeCcCCcccccccCC
Confidence            7543            3889999999999999999999   67999999999999999999999999999875432    


Q ss_pred             -----CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 -----DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 -----~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                           .+.+||....  ..++.++|||||||++|||++|+.||...
T Consensus       158 ~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~  201 (333)
T cd05600         158 VVGSPDYMAPEVLRG--KGYDFTVDYWSLGCMLYEFLCGFPPFSGS  201 (333)
T ss_pred             cccCccccChhHhcC--CCCCCccceecchHHHhhhhhCCCCCCCC
Confidence                 2345666544  36788899999999999999999999754

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=99.95  E-value=2.1e-27  Score=242.36  Aligned_cols=177  Identities=20%  Similarity=0.273  Sum_probs=143.9

Q ss_pred             ceeEEEEEEEE--CCeEEEEEEcchhHH------HHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          389 RIEGAVYHGRL--NGKNLAIKRTEHEVI------TKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       389 ~~~G~Vy~g~~--~g~~vAvK~~~~~~~------~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      +..|.||++..  +|+.||+|.+.....      ..+..|+..+..++|+||+++.+++..+ ...++||||+++|+|.+
T Consensus         4 G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~g~L~~   82 (280)
T cd05608           4 GGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTK-TDLCLVMTIMNGGDLRY   82 (280)
T ss_pred             CCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCC-CeEEEEEeCCCCCCHHH
Confidence            33499999987  688999999865322      2346788889999999999999887555 47899999999999998


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC--
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND--  538 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~--  538 (600)
                      ++......        ...+++.+++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++....  
T Consensus        83 ~~~~~~~~--------~~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~  151 (280)
T cd05608          83 HIYNVDEE--------NPGFPEPRACFYTAQIISGLEHLH---QRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQ  151 (280)
T ss_pred             HHHhcccc--------CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCC
Confidence            88542211        134899999999999999999999   67999999999999999999999999999875432  


Q ss_pred             ----------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 ----------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 ----------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                ...+||....  ..++.++|||||||++|||++|+.||...
T Consensus       152 ~~~~~~~g~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~pf~~~  200 (280)
T cd05608         152 SKTKGYAGTPGFMAPELLQG--EEYDFSVDYFALGVTLYEMIAARGPFRAR  200 (280)
T ss_pred             ccccccCCCcCccCHHHhcC--CCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence                      1234555543  35677899999999999999999999754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=99.95  E-value=2.5e-28  Score=255.10  Aligned_cols=179  Identities=26%  Similarity=0.535  Sum_probs=150.3

Q ss_pred             CCceeEEEEEEEEC----Ce--EEEEEEcch----hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCC
Q 041830          387 SNRIEGAVYHGRLN----GK--NLAIKRTEH----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNG  456 (600)
Q Consensus       387 ~~~~~G~Vy~g~~~----g~--~vAvK~~~~----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~G  456 (600)
                      +.|.+|.||+|.++    |+  .||||..+.    +..++|..|..+|++++|||||+|+|+|.+.  ..|||||.++-|
T Consensus       398 G~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~--P~WivmEL~~~G  475 (974)
T KOG4257|consen  398 GEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ--PMWIVMELAPLG  475 (974)
T ss_pred             cCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeecc--ceeEEEecccch
Confidence            33445999999983    32  489998765    3456788999999999999999999998643  789999999999


Q ss_pred             CHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCcccc
Q 041830          457 SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV  536 (600)
Q Consensus       457 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~  536 (600)
                      .|++||..+.           ..|+......++.||..+|+|||   +.++|||||..+|||+.....+|++|||++|.+
T Consensus       476 ELr~yLq~nk-----------~sL~l~tL~ly~~Qi~talaYLe---SkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~  541 (974)
T KOG4257|consen  476 ELREYLQQNK-----------DSLPLRTLTLYCYQICTALAYLE---SKRFVHRDIAARNILVSSPQCVKLADFGLSRYL  541 (974)
T ss_pred             hHHHHHHhcc-----------ccchHHHHHHHHHHHHHHHHHHH---hhchhhhhhhhhheeecCcceeeecccchhhhc
Confidence            9999998765           33889999999999999999999   789999999999999999999999999999987


Q ss_pred             CCCCC-------------CCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCCCCCC
Q 041830          537 NDDTE-------------SPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRPRKKD  583 (600)
Q Consensus       537 ~~~~~-------------~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~~~~~  583 (600)
                      ..+..             +||...  -.+++.++|||.|||.|||+++ |..||....+++
T Consensus       542 ed~~yYkaS~~kLPIKWmaPESIN--fRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD  600 (974)
T KOG4257|consen  542 EDDAYYKASRGKLPIKWMAPESIN--FRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD  600 (974)
T ss_pred             cccchhhccccccceeecCccccc--hhcccchhhHHHHHHHHHHHHHhcCCccccccccc
Confidence            65432             344332  2467889999999999999987 999998765543

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=99.95  E-value=9.7e-28  Score=250.78  Aligned_cols=171  Identities=22%  Similarity=0.393  Sum_probs=140.0

Q ss_pred             eeEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          390 IEGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       390 ~~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      ..|.||+++.  +++.||+|.++...      ...+..|+..+..+ +||||+++++++..+ ...++||||+++|+|.+
T Consensus         7 ~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~-~~~~lv~E~~~~~~L~~   85 (329)
T cd05618           7 SYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-SRLFFVIEYVNGGDLMF   85 (329)
T ss_pred             CCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeC-CEEEEEEeCCCCCCHHH
Confidence            3499999988  67899999986532      12345666666554 799999999987655 48999999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC---
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN---  537 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~---  537 (600)
                      ++....            .+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...   
T Consensus        86 ~~~~~~------------~l~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~  150 (329)
T cd05618          86 HMQRQR------------KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG  150 (329)
T ss_pred             HHHHcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC
Confidence            886543            3899999999999999999999   6799999999999999999999999999987431   


Q ss_pred             ---------CCCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          538 ---------DDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       538 ---------~~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                               ..+.+||....  ..++.++|||||||++|||++|+.||..
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~Pf~~  198 (329)
T cd05618         151 DTTSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDI  198 (329)
T ss_pred             CccccccCCccccCHHHHcC--CCCCCccceecccHHHHHHhhCCCCCcc
Confidence                     11235665543  4567889999999999999999999963

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=99.95  E-value=4.4e-28  Score=257.44  Aligned_cols=172  Identities=23%  Similarity=0.302  Sum_probs=142.5

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||+++.  +++.+|+|.++...      ...+.+|+..+..++||||+++++++..+ ...|+||||+++|+|.+++
T Consensus        56 fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~-~~~~lv~Ey~~gg~L~~~l  134 (370)
T cd05621          56 FGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDD-KYLYMVMEYMPGGDLVNLM  134 (370)
T ss_pred             CeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CEEEEEEcCCCCCcHHHHH
Confidence            399999998  68899999876421      23456788888899999999999997655 5899999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC----
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND----  538 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~----  538 (600)
                      ...             .+++.++..++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+++....    
T Consensus       135 ~~~-------------~~~~~~~~~~~~qil~aL~~LH---~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~  198 (370)
T cd05621         135 SNY-------------DVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV  198 (370)
T ss_pred             Hhc-------------CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEEecccceecccCCce
Confidence            643             2788899999999999999999   67999999999999999999999999999875432    


Q ss_pred             ---------CCCCCcccccCC--CCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 ---------DTESPQFYSTNP--ASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 ---------~~~~pe~~~~~~--~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                               .+.+||......  ..++.++|||||||+||||++|+.||...
T Consensus       199 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~  250 (370)
T cd05621         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYAD  250 (370)
T ss_pred             ecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCC
Confidence                     123566554322  23678899999999999999999999754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=99.95  E-value=9.5e-28  Score=249.84  Aligned_cols=174  Identities=22%  Similarity=0.362  Sum_probs=140.6

Q ss_pred             ceeEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCCHH
Q 041830          389 RIEGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       389 ~~~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~  459 (600)
                      +..|.||+++.  +|+.||+|.++.+.      ...+..|...+... +||||+++++++... +..|+||||+++|+|.
T Consensus         6 G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-~~~~iv~Ey~~~g~L~   84 (320)
T cd05590           6 GSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTP-DRLFFVMEFVNGGDLM   84 (320)
T ss_pred             CCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcC-CEEEEEEcCCCCchHH
Confidence            33499999998  68899999986532      12334555555544 699999999987554 5899999999999999


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC-
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND-  538 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~-  538 (600)
                      +++....            .+++.++..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++.... 
T Consensus        85 ~~i~~~~------------~l~~~~~~~~~~ql~~~L~~lH---~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~  149 (320)
T cd05590          85 FHIQKSR------------RFDEARARFYAAEITSALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN  149 (320)
T ss_pred             HHHHHcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC
Confidence            9987543            3889999999999999999999   67999999999999999999999999999875321 


Q ss_pred             -----------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          539 -----------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       539 -----------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                                 .+.+||....  ..++.++|||||||++|||++|+.||...+
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~Pf~~~~  200 (320)
T cd05590         150 GKTTSTFCGTPDYIAPEILQE--MLYGPSVDWWAMGVLLYEMLCGHAPFEAEN  200 (320)
T ss_pred             CCcccccccCccccCHHHHcC--CCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence                       1234565543  456778999999999999999999997643

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=99.95  E-value=8.3e-28  Score=250.55  Aligned_cols=172  Identities=23%  Similarity=0.338  Sum_probs=139.5

Q ss_pred             eeEEEEEEEE--CCeEEEEEEcchhHH------HHHHHHHH-HHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          390 IEGAVYHGRL--NGKNLAIKRTEHEVI------TKLEMQLV-QHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       390 ~~G~Vy~g~~--~g~~vAvK~~~~~~~------~~~e~ei~-~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      ..|.||+++.  +|+.||+|.+.....      ..+..|.. .+..++||||+++++++... +..|+||||+++|+|.+
T Consensus         7 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~g~L~~   85 (323)
T cd05575           7 SFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTA-DKLYFVLDYVNGGELFF   85 (323)
T ss_pred             CCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeC-CEEEEEEcCCCCCCHHH
Confidence            3499999998  789999999865321      12223333 45678999999999987655 48899999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC--
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND--  538 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~--  538 (600)
                      ++....            .+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++....  
T Consensus        86 ~l~~~~------------~~~~~~~~~~~~qi~~~l~~lH---~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~  150 (323)
T cd05575          86 HLQRER------------SFPEPRARFYAAEIASALGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS  150 (323)
T ss_pred             HHHhcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC
Confidence            997543            3889999999999999999999   67999999999999999999999999999864321  


Q ss_pred             ----------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 ----------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 ----------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                .+.+||....  ..++.++|||||||++|||++|+.||...
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~g~~pf~~~  199 (323)
T cd05575         151 KTTSTFCGTPEYLAPEVLRK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSR  199 (323)
T ss_pred             CccccccCChhhcChhhhcC--CCCCccccccccchhhhhhhcCCCCCCCC
Confidence                      1235665543  45678899999999999999999999754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.95  E-value=1.1e-27  Score=244.51  Aligned_cols=198  Identities=27%  Similarity=0.377  Sum_probs=149.7

Q ss_pred             CCceeEEEEEEEE--CCeEEEEEEcchhH-----------------HHHHHHHHHHHHhCCCCceeeeeeEEecc-CCce
Q 041830          387 SNRIEGAVYHGRL--NGKNLAIKRTEHEV-----------------ITKLEMQLVQHATHHHPNIVRLLGTCLTD-GPHS  446 (600)
Q Consensus       387 ~~~~~G~Vy~g~~--~g~~vAvK~~~~~~-----------------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~-~~~~  446 (600)
                      +.|-+|.|-.++.  +|+.||||.+.+..                 .++..+||.+|++++|||||+|+.+--+. .+.+
T Consensus       106 G~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~  185 (576)
T KOG0585|consen  106 GSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPESDKL  185 (576)
T ss_pred             cCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcccCce
Confidence            4455699999987  79999999875422                 13567899999999999999999984321 2468


Q ss_pred             EEEEeecCCCCHHHHHhcCcCcccccccccccC-CCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcE
Q 041830          447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCF-LTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNA  525 (600)
Q Consensus       447 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~  525 (600)
                      |||+|||..|.+... ...            .+ |++.+..++.+++..||+|||   ..+|+||||||+|+||++++++
T Consensus       186 YlVley~s~G~v~w~-p~d------------~~els~~~Ar~ylrDvv~GLEYLH---~QgiiHRDIKPsNLLl~~~g~V  249 (576)
T KOG0585|consen  186 YLVLEYCSKGEVKWC-PPD------------KPELSEQQARKYLRDVVLGLEYLH---YQGIIHRDIKPSNLLLSSDGTV  249 (576)
T ss_pred             EEEEEeccCCccccC-CCC------------cccccHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEEcCCCcE
Confidence            999999999887431 111            23 899999999999999999999   6799999999999999999999


Q ss_pred             EEEeccCccccC-----------------CCCCCCcccccCC--CCCCccCchHHHHHHHHHHHhCCCCCCCCCCC----
Q 041830          526 RVGNFGMARCVN-----------------DDTESPQFYSTNP--ASWSMGIDIFAYGIVLLEVLSGQTPINRPRKK----  582 (600)
Q Consensus       526 kI~DFGla~~~~-----------------~~~~~pe~~~~~~--~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~~----  582 (600)
                      ||+|||.+-...                 +...+||....+.  ..-+.+.||||+||.||-|+-|+.||.....-    
T Consensus       250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~  329 (576)
T KOG0585|consen  250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFD  329 (576)
T ss_pred             EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHH
Confidence            999999876431                 1223566554422  22356689999999999999999999642211    


Q ss_pred             ------------CccchhHHHHHHhhhhcC
Q 041830          583 ------------DEGSVWLSEKIKSILQAE  600 (600)
Q Consensus       583 ------------~~~~~~l~~~~~~~l~~~  600 (600)
                                  .+....+.+.|+++|++|
T Consensus       330 KIvn~pL~fP~~pe~~e~~kDli~~lL~Kd  359 (576)
T KOG0585|consen  330 KIVNDPLEFPENPEINEDLKDLIKRLLEKD  359 (576)
T ss_pred             HHhcCcccCCCcccccHHHHHHHHHHhhcC
Confidence                        112345677777777654

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=99.95  E-value=1.2e-27  Score=249.28  Aligned_cols=172  Identities=22%  Similarity=0.366  Sum_probs=141.9

Q ss_pred             eEEEEEEEE-----CCeEEEEEEcchhHH-------HHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCH
Q 041830          391 EGAVYHGRL-----NGKNLAIKRTEHEVI-------TKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSL  458 (600)
Q Consensus       391 ~G~Vy~g~~-----~g~~vAvK~~~~~~~-------~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL  458 (600)
                      .|.||+++.     .|+.||+|.++....       ..+..|+..+..++||||+++++++..+ ...|+||||+++|+|
T Consensus         9 ~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L   87 (323)
T cd05584           9 YGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTG-GKLYLILEYLSGGEL   87 (323)
T ss_pred             CeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecC-CeEEEEEeCCCCchH
Confidence            499999875     478899999865321       2356788889999999999999997665 489999999999999


Q ss_pred             HHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC
Q 041830          459 KDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND  538 (600)
Q Consensus       459 ~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~  538 (600)
                      .+++....            .+.+.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        88 ~~~~~~~~------------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  152 (323)
T cd05584          88 FMHLEREG------------IFMEDTACFYLSEISLALEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIH  152 (323)
T ss_pred             HHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEeeCcCCeeccc
Confidence            99997543            3788888999999999999999   67999999999999999999999999999864211


Q ss_pred             ------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          539 ------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       539 ------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                                  .+.+||....  ..++.++|||||||++|||++|+.||...+
T Consensus       153 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~pf~~~~  204 (323)
T cd05584         153 EGTVTHTFCGTIEYMAPEILMR--SGHGKAVDWWSLGALMYDMLTGAPPFTAEN  204 (323)
T ss_pred             CCCcccccCCCccccChhhccC--CCCCCcceecccHHHHHHHhcCCCCCCCCC
Confidence                        1235665543  345778999999999999999999997543

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=99.95  E-value=7.7e-28  Score=250.59  Aligned_cols=174  Identities=24%  Similarity=0.348  Sum_probs=140.3

Q ss_pred             ceeEEEEEEEE--CCeEEEEEEcchhHH------HHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCCHH
Q 041830          389 RIEGAVYHGRL--NGKNLAIKRTEHEVI------TKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       389 ~~~G~Vy~g~~--~g~~vAvK~~~~~~~------~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~  459 (600)
                      |..|.||+|+.  +|+.||+|.++.+..      ..+..|...+..+ +||||+++++++..+ ...|+||||+++|+|.
T Consensus         6 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~-~~~~lv~E~~~~~~L~   84 (321)
T cd05591           6 GSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTK-DRLFFVMEYVNGGDLM   84 (321)
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC-CeEEEEEeCCCCCcHH
Confidence            33499999988  578999999865421      2334555555543 799999999997655 4899999999999999


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC-
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND-  538 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~-  538 (600)
                      +++....            .+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.... 
T Consensus        85 ~~l~~~~------------~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~  149 (321)
T cd05591          85 FQIQRSR------------KFDEPRSRFYAAEVTLALMFLH---RHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILN  149 (321)
T ss_pred             HHHHHcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeecccceecccC
Confidence            9987543            3889999999999999999999   67999999999999999999999999999874321 


Q ss_pred             -----------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          539 -----------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       539 -----------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                                 .+.+||....  ..++.++|||||||++|||++|+.||...+
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~tg~~Pf~~~~  200 (321)
T cd05591         150 GVTTTTFCGTPDYIAPEILQE--LEYGPSVDWWALGVLMYEMMAGQPPFEADN  200 (321)
T ss_pred             CccccccccCccccCHHHHcC--CCCCCccceechhHHHHHHhcCCCCCCCCC
Confidence                       1234555433  456788999999999999999999997644

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=99.95  E-value=2.4e-27  Score=247.15  Aligned_cols=171  Identities=25%  Similarity=0.418  Sum_probs=138.3

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHH---HHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQ---HATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~---~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~  459 (600)
                      .|.||++..  +|+.||||.++...      .+.+..|+..   +..++||||+++++++... ...|+||||+++|+|.
T Consensus        12 ~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~-~~~~lv~E~~~~~~L~   90 (324)
T cd05589          12 FGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTE-DHVCFVMEYAAGGDLM   90 (324)
T ss_pred             CEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcC-CEEEEEEcCCCCCcHH
Confidence            489999988  68899999986532      1233344333   3457799999999997554 5899999999999999


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC-
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND-  538 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~-  538 (600)
                      .+++..             .+++.++..++.|++.||.|||   +.+++||||||+|||++.++.+||+|||+++.... 
T Consensus        91 ~~~~~~-------------~l~~~~~~~~~~qi~~al~~lH---~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~  154 (324)
T cd05589          91 MHIHTD-------------VFSEPRAVFYAACVVLGLQYLH---ENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF  154 (324)
T ss_pred             HHhhcC-------------CCCHHHHHHHHHHHHHHHHHHH---hCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence            888642             3899999999999999999999   67999999999999999999999999999864321 


Q ss_pred             -----------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          539 -----------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       539 -----------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                                 .+.+||....  ..++.++|||||||++|||++|+.||...+
T Consensus       155 ~~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~G~~pf~~~~  205 (324)
T cd05589         155 GDRTSTFCGTPEFLAPEVLTE--TSYTRAVDWWGLGVLIYEMLVGESPFPGDD  205 (324)
T ss_pred             CCcccccccCccccCHhHhcC--CCCCcccchhhHHHHHHHHHhCCCCCCCCC
Confidence                       1235665543  356788999999999999999999997543

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=99.95  E-value=1.7e-27  Score=247.54  Aligned_cols=174  Identities=24%  Similarity=0.405  Sum_probs=138.8

Q ss_pred             ceeEEEEEEEE--CCeEEEEEEcchhHH------HHHHHHHHHHH-hCCCCceeeeeeEEeccCCceEEEEeecCCCCHH
Q 041830          389 RIEGAVYHGRL--NGKNLAIKRTEHEVI------TKLEMQLVQHA-THHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       389 ~~~G~Vy~g~~--~g~~vAvK~~~~~~~------~~~e~ei~~~~-~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~  459 (600)
                      |..|.||+++.  +++.||+|.++.+..      .....|...+. ..+||||+++++++... ...++||||+++|+|.
T Consensus         6 G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~-~~~~lv~e~~~gg~L~   84 (316)
T cd05592           6 GSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTK-EHLFFVMEYLNGGDLM   84 (316)
T ss_pred             CCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcC-CEEEEEEcCCCCCcHH
Confidence            33499999998  578899998865421      22233443343 35799999999997554 4899999999999999


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC-
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND-  538 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~-  538 (600)
                      +++....            .+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.... 
T Consensus        85 ~~~~~~~------------~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~  149 (316)
T cd05592          85 FHIQSSG------------RFDEARARFYAAEIICGLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNG  149 (316)
T ss_pred             HHHHHcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCC
Confidence            9987543            3889999999999999999999   67999999999999999999999999999874321 


Q ss_pred             -----------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          539 -----------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       539 -----------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                                 .+.+||....  ..++.++|||||||++|||++|+.||...+
T Consensus       150 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~ell~G~~Pf~~~~  200 (316)
T cd05592         150 EGKASTFCGTPDYIAPEILKG--QKYNESVDWWSFGVLLYEMLIGQSPFHGED  200 (316)
T ss_pred             CCccccccCCccccCHHHHcC--CCCCCcccchhHHHHHHHHHhCCCCCCCCC
Confidence                       1235665543  346788999999999999999999997543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=99.95  E-value=1e-27  Score=254.61  Aligned_cols=172  Identities=22%  Similarity=0.276  Sum_probs=141.9

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||+++.  +|+.||+|.++...      ...+..|+..+..++||||+++++++..+ ...|+||||+++|+|.+++
T Consensus        56 ~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~-~~~~lv~Ey~~gg~L~~~l  134 (370)
T cd05596          56 FGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDD-KYLYMVMEYMPGGDLVNLM  134 (370)
T ss_pred             CEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecC-CEEEEEEcCCCCCcHHHHH
Confidence            389999988  68899999986432      12356788889999999999999987554 5899999999999999998


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC---
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---  539 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~---  539 (600)
                      +..             .+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....   
T Consensus       135 ~~~-------------~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~  198 (370)
T cd05596         135 SNY-------------DIPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV  198 (370)
T ss_pred             Hhc-------------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc
Confidence            653             2788888999999999999999   679999999999999999999999999998754321   


Q ss_pred             ----------CCCCcccccC--CCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 ----------TESPQFYSTN--PASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 ----------~~~pe~~~~~--~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                +.+||.....  ...++.++|||||||++|||++|+.||...
T Consensus       199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~  250 (370)
T cd05596         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD  250 (370)
T ss_pred             cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCC
Confidence                      2245554332  234678899999999999999999999753

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=99.95  E-value=1.2e-27  Score=254.23  Aligned_cols=172  Identities=23%  Similarity=0.302  Sum_probs=142.0

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||+++.  +++.+|+|.++...      ...+.+|+..+..++||||+++++.+..+ ...|+||||+++|+|.+++
T Consensus        56 fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~-~~~~lv~Ey~~gg~L~~~~  134 (371)
T cd05622          56 FGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD-RYLYMVMEYMPGGDLVNLM  134 (371)
T ss_pred             CeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC-CEEEEEEcCCCCCcHHHHH
Confidence            389999988  68899999875422      22356788888889999999999997654 5899999999999999998


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC----
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND----  538 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~----  538 (600)
                      +..             .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....    
T Consensus       135 ~~~-------------~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~  198 (371)
T cd05622         135 SNY-------------DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV  198 (371)
T ss_pred             Hhc-------------CCCHHHHHHHHHHHHHHHHHHH---HCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc
Confidence            643             2788889999999999999999   67999999999999999999999999999875432    


Q ss_pred             ---------CCCCCcccccCC--CCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 ---------DTESPQFYSTNP--ASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 ---------~~~~pe~~~~~~--~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                               ...+||......  ..++.++|||||||++|||++|+.||...
T Consensus       199 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~  250 (371)
T cd05622         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYAD  250 (371)
T ss_pred             cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCC
Confidence                     123566554321  23678899999999999999999999754

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=99.95  E-value=2.2e-27  Score=246.63  Aligned_cols=173  Identities=24%  Similarity=0.400  Sum_probs=140.0

Q ss_pred             eeEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHh-CCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          390 IEGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHAT-HHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       390 ~~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~-l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      ..|.||+++.  +++.||||.++...      ......|...+.. .+||||+++++++.++ ...++||||+++|+|.+
T Consensus         7 ~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~-~~~~lv~ey~~~g~L~~   85 (316)
T cd05619           7 SFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTK-ENLFFVMEYLNGGDLMF   85 (316)
T ss_pred             CCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeC-CEEEEEEeCCCCCcHHH
Confidence            3499999998  57889999987542      1223344444543 5899999999997665 48999999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC---
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN---  537 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~---  537 (600)
                      ++....            .+++.++..++.|++.||.|||   +.+++||||||+|||++.++.+||+|||+++...   
T Consensus        86 ~l~~~~------------~~~~~~~~~~~~qi~~al~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  150 (316)
T cd05619          86 HIQSCH------------KFDLPRATFYAAEIICGLQFLH---SKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD  150 (316)
T ss_pred             HHHHcC------------CCCHHHHHHHHHHHHHHHHHHH---hCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC
Confidence            997532            3889999999999999999999   6799999999999999999999999999986421   


Q ss_pred             ---------CCCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          538 ---------DDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       538 ---------~~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                               ..+.+||....  ..++.++|||||||++|||++|+.||...+
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~G~~pf~~~~  200 (316)
T cd05619         151 AKTCTFCGTPDYIAPEILLG--QKYNTSVDWWSFGVLLYEMLIGQSPFHGHD  200 (316)
T ss_pred             CceeeecCCccccCHHHHcC--CCCCchhhhhhHHHHHHHHHhCCCCCCCCC
Confidence                     12345665543  356788999999999999999999997543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.95  E-value=1.8e-28  Score=230.98  Aligned_cols=174  Identities=25%  Similarity=0.365  Sum_probs=147.4

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhHH------HHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEVI------TKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~~------~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      +|.||.|+.  ++-.||+|++.+...      .++.+|+.+..+++||||++++|++.++ ...||++||.++|+|...|
T Consensus        35 FG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~-~riyLilEya~~gel~k~L  113 (281)
T KOG0580|consen   35 FGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS-KRIYLILEYAPRGELYKDL  113 (281)
T ss_pred             cccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheecc-ceeEEEEEecCCchHHHHH
Confidence            389999998  677899999876543      3577889999999999999999997655 4899999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC----
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND----  538 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~----  538 (600)
                      +..+.          ..+++.....++.|+|.||.|+|   .++++||||||+|+|++.++..||+|||-+.....    
T Consensus       114 ~~~~~----------~~f~e~~~a~Yi~q~A~Al~y~h---~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~~kR~  180 (281)
T KOG0580|consen  114 QEGRM----------KRFDEQRAATYIKQLANALLYCH---LKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSNKRK  180 (281)
T ss_pred             Hhccc----------ccccccchhHHHHHHHHHHHHhc---cCCcccCCCCHHHhccCCCCCeeccCCCceeecCCCCce
Confidence            86543          33788888899999999999999   88999999999999999999999999998764422    


Q ss_pred             ------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          539 ------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       539 ------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                            +..+||....  ..++..+|+|++||+.||++.|.+||....
T Consensus       181 tlcgt~dyl~pEmv~~--~~hd~~Vd~w~lgvl~yeflvg~ppFes~~  226 (281)
T KOG0580|consen  181 TLCGTLDYLPPEMVEG--RGHDKFVDLWSLGVLCYEFLVGLPPFESQS  226 (281)
T ss_pred             eeecccccCCHhhcCC--CCccchhhHHHHHHHHHHHHhcCCchhhhh
Confidence                  2234565544  567888999999999999999999997655

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=99.95  E-value=1.7e-27  Score=249.23  Aligned_cols=173  Identities=23%  Similarity=0.381  Sum_probs=141.9

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEeccC----CceEEEEeecCCCCHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTDG----PHSFLVFEYAKNGSLK  459 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~----~~~~LV~Ey~~~GsL~  459 (600)
                      .|.||+|+.  +|+.||||+++..     ....+.+|+..+..++||||+++++++....    ...|+|||||+ ++|.
T Consensus        13 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~   91 (338)
T cd07859          13 YGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLH   91 (338)
T ss_pred             CeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHH
Confidence            399999987  6899999987642     2235678999999999999999999876432    24799999996 6999


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC-
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND-  538 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~-  538 (600)
                      +++....            .+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.... 
T Consensus        92 ~~l~~~~------------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~  156 (338)
T cd07859          92 QVIKAND------------DLTPEHHQFFLYQLLRALKYIH---TANVFHRDLKPKNILANADCKLKICDFGLARVAFND  156 (338)
T ss_pred             HHHHhcc------------cCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEccCccccccccc
Confidence            9986543            3899999999999999999999   67999999999999999999999999999874321 


Q ss_pred             --------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 --------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 --------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                    .+.+||........++.++|||||||++|||++|+.||...
T Consensus       157 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~  211 (338)
T cd07859         157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK  211 (338)
T ss_pred             cCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence                          12356655433346788899999999999999999999654

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=99.95  E-value=7.9e-28  Score=254.58  Aligned_cols=172  Identities=17%  Similarity=0.320  Sum_probs=142.8

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||+++.  +|+.||+|.++...      ...+..|+..+..++|+||+++++.+..+ ...|+||||+++|+|.+++
T Consensus        14 ~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-~~~~lv~E~~~gg~L~~~l   92 (360)
T cd05627          14 FGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDK-RNLYLIMEFLPGGDMMTLL   92 (360)
T ss_pred             CEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CEEEEEEeCCCCccHHHHH
Confidence            399999988  68899999986432      23456788888899999999999987554 5899999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC----
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND----  538 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~----  538 (600)
                      ....            .+++.....++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....    
T Consensus        93 ~~~~------------~l~~~~~~~~~~qi~~~L~~lH---~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~  157 (360)
T cd05627          93 MKKD------------TLSEEATQFYIAETVLAIDAIH---QLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRT  157 (360)
T ss_pred             HhcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccc
Confidence            7543            3889999999999999999999   67999999999999999999999999999864321    


Q ss_pred             -------------------------------------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCC
Q 041830          539 -------------------------------------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTP  575 (600)
Q Consensus       539 -------------------------------------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~P  575 (600)
                                                                 ...+||....  ..++.++|||||||++|||++|+.|
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyel~tG~~P  235 (360)
T cd05627         158 EFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQ--TGYNKLCDWWSLGVIMYEMLIGYPP  235 (360)
T ss_pred             ccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcC--CCCCCcceeccccceeeecccCCCC
Confidence                                                       1234554433  4567889999999999999999999


Q ss_pred             CCCCC
Q 041830          576 INRPR  580 (600)
Q Consensus       576 f~~~~  580 (600)
                      |....
T Consensus       236 f~~~~  240 (360)
T cd05627         236 FCSET  240 (360)
T ss_pred             CCCCC
Confidence            97543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=99.95  E-value=2.9e-27  Score=246.43  Aligned_cols=172  Identities=22%  Similarity=0.351  Sum_probs=138.3

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhHH------HHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEVI------TKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~~------~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      .|.||+++.  +++.||+|.++.+..      .....|...+... +|++|+++++++... +..|+||||+++|+|.++
T Consensus        13 ~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-~~~~lv~E~~~~g~L~~~   91 (323)
T cd05616          13 FGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTM-DRLYFVMEYVNGGDLMYQ   91 (323)
T ss_pred             CeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecC-CEEEEEEcCCCCCCHHHH
Confidence            499999988  577999999875431      1233444444444 589999999887554 589999999999999999


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC----
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN----  537 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~----  537 (600)
                      +....            .+++.++..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++...    
T Consensus        92 ~~~~~------------~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~  156 (323)
T cd05616          92 IQQVG------------RFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV  156 (323)
T ss_pred             HHHcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCC
Confidence            86543            3889999999999999999999   6799999999999999999999999999987432    


Q ss_pred             --------CCCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          538 --------DDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       538 --------~~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                              ..+.+||....  ..++.++|||||||++|||++|+.||...+
T Consensus       157 ~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~Pf~~~~  205 (323)
T cd05616         157 TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGED  205 (323)
T ss_pred             ccccCCCChhhcCHHHhcC--CCCCCccchhchhHHHHHHHhCCCCCCCCC
Confidence                    11235665544  456888999999999999999999997643

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=99.95  E-value=5.3e-27  Score=238.95  Aligned_cols=173  Identities=23%  Similarity=0.331  Sum_probs=142.8

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhHH------HHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEVI------TKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~~------~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||+++.  +|+.||+|.+.....      .....|+..+..++||||+++++++..+ ...++||||+++|+|.+++
T Consensus         6 ~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~-~~~~lv~e~~~g~~L~~~~   84 (277)
T cd05607           6 FGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESK-THLCLVMSLMNGGDLKYHI   84 (277)
T ss_pred             ceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecC-CeEEEEEecCCCCCHHHHH
Confidence            499999987  689999999864322      2334577888899999999999987554 5899999999999999988


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC----
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND----  538 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~----  538 (600)
                      .....          ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.....    
T Consensus        85 ~~~~~----------~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~  151 (277)
T cd05607          85 YNVGE----------RGLEMERVIHYSAQITCGILHLH---SMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTI  151 (277)
T ss_pred             Hhccc----------cCCCHHHHHHHHHHHHHHHHHHH---HCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCcee
Confidence            65332          34899999999999999999999   67999999999999999999999999999865432    


Q ss_pred             -------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 -------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 -------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                             .+.+||....  ..++.++|||||||++|||++|+.||...
T Consensus       152 ~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGv~l~el~~g~~p~~~~  197 (277)
T cd05607         152 TQRAGTNGYMAPEILKE--EPYSYPVDWFAMGCSIYEMVAGRTPFKDH  197 (277)
T ss_pred             eccCCCCCccCHHHHcc--CCCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence                   2235665544  33788899999999999999999999754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=99.95  E-value=3.1e-27  Score=249.37  Aligned_cols=169  Identities=22%  Similarity=0.349  Sum_probs=137.6

Q ss_pred             eeEEEEEEEE--CCeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          390 IEGAVYHGRL--NGKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       390 ~~G~Vy~g~~--~g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      ..|.||+++.  +|+.||||.+...    ....+.+|+..+..++|+||+++++++..+ ...++||||+++|+|.+.. 
T Consensus        86 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~~-  163 (353)
T PLN00034         86 AGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHN-GEIQVLLEFMDGGSLEGTH-  163 (353)
T ss_pred             CCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccC-CeEEEEEecCCCCcccccc-
Confidence            3499999998  6899999997432    234678899999999999999999997554 4889999999999986421 


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD----  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~----  539 (600)
                                     .+.+..+..++.||+.||+|||   +.+|+|||||++|||+++++.+||+|||+++.....    
T Consensus       164 ---------------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~  225 (353)
T PLN00034        164 ---------------IADEQFLADVARQILSGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPC  225 (353)
T ss_pred             ---------------cCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEcccccceecccccccc
Confidence                           2567788899999999999999   679999999999999999999999999998754321    


Q ss_pred             --------CCCCcccccC---CCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          540 --------TESPQFYSTN---PASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       540 --------~~~pe~~~~~---~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                              +.+||.+...   ....+.++|||||||++|||++|+.||..
T Consensus       226 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~  275 (353)
T PLN00034        226 NSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV  275 (353)
T ss_pred             cccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence                    2356654321   12234579999999999999999999974

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=99.95  E-value=9.4e-28  Score=238.99  Aligned_cols=178  Identities=22%  Similarity=0.379  Sum_probs=147.8

Q ss_pred             CCceeEEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEec----cCCceEEEEeecCC
Q 041830          387 SNRIEGAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLT----DGPHSFLVFEYAKN  455 (600)
Q Consensus       387 ~~~~~G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~----~~~~~~LV~Ey~~~  455 (600)
                      +.|.+|.|+.+..  +|+.||||++...     ..++.-+|+..++.++|+||+.+..+...    +.+..|+|+|+|+ 
T Consensus        31 G~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elMe-  109 (359)
T KOG0660|consen   31 GRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELME-  109 (359)
T ss_pred             cCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHHh-
Confidence            5556699999988  7999999997632     22456789999999999999999999654    2346799999995 


Q ss_pred             CCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccc
Q 041830          456 GSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARC  535 (600)
Q Consensus       456 GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~  535 (600)
                      -+|...++.+.            .|+......+.+|+++||.|+|   +.+++||||||+|+|++.+...||+|||+||.
T Consensus       110 tDL~~iik~~~------------~L~d~H~q~f~YQiLrgLKyiH---SAnViHRDLKPsNll~n~~c~lKI~DFGLAR~  174 (359)
T KOG0660|consen  110 TDLHQIIKSQQ------------DLTDDHAQYFLYQILRGLKYIH---SANVIHRDLKPSNLLLNADCDLKICDFGLARY  174 (359)
T ss_pred             hHHHHHHHcCc------------cccHHHHHHHHHHHHHhcchhh---cccccccccchhheeeccCCCEEeccccceee
Confidence            49999998653            3888999999999999999999   67999999999999999999999999999998


Q ss_pred             cCCC----C----------CCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCCC
Q 041830          536 VNDD----T----------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRK  581 (600)
Q Consensus       536 ~~~~----~----------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~  581 (600)
                      ....    .          .+||.... ...|+.+.||||.||||.||++|++-|.+.+.
T Consensus       175 ~~~~~~~~~mTeYVaTRWYRAPElll~-~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~  233 (359)
T KOG0660|consen  175 LDKFFEDGFMTEYVATRWYRAPELLLN-SSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY  233 (359)
T ss_pred             ccccCcccchhcceeeeeecCHHHHhc-cccccchhhhhhhhHHHHHHHcCCCCCCCCch
Confidence            8531    1          14554432 35689999999999999999999999976543

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=99.95  E-value=2.7e-27  Score=246.05  Aligned_cols=173  Identities=23%  Similarity=0.405  Sum_probs=140.0

Q ss_pred             eeEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHH-hCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          390 IEGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHA-THHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       390 ~~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~-~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      ..|.||+++.  +|+.||+|.++.+.      ......|...+. .++||||+++++++..+ +..|+||||+++|+|.+
T Consensus         7 ~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-~~~~lv~E~~~~g~L~~   85 (316)
T cd05620           7 SFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTK-EHLFFVMEFLNGGDLMF   85 (316)
T ss_pred             CCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeC-CEEEEEECCCCCCcHHH
Confidence            3499999998  68899999987542      123344554444 35899999999997655 48999999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC---
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN---  537 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~---  537 (600)
                      ++....            .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...   
T Consensus        86 ~i~~~~------------~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  150 (316)
T cd05620          86 HIQDKG------------RFDLYRATFYAAEIVCGLQFLH---SKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD  150 (316)
T ss_pred             HHHHcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC
Confidence            987542            3889999999999999999999   6799999999999999999999999999986421   


Q ss_pred             ---------CCCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          538 ---------DDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       538 ---------~~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                               ..+.+||....  ..++.++|||||||++|||++|+.||...+
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~el~~g~~Pf~~~~  200 (316)
T cd05620         151 NRASTFCGTPDYIAPEILQG--LKYTFSVDWWSFGVLLYEMLIGQSPFHGDD  200 (316)
T ss_pred             CceeccCCCcCccCHHHHcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence                     12235666543  456788999999999999999999997543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=99.95  E-value=2.1e-27  Score=247.24  Aligned_cols=172  Identities=22%  Similarity=0.333  Sum_probs=138.6

Q ss_pred             eeEEEEEEEE--CCeEEEEEEcchhHH------HHHHHHHH-HHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          390 IEGAVYHGRL--NGKNLAIKRTEHEVI------TKLEMQLV-QHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       390 ~~G~Vy~g~~--~g~~vAvK~~~~~~~------~~~e~ei~-~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      ..|.||+++.  +|+.||+|.+.....      ..+..|.. .+..++||||+++++++... +..|+||||+++|+|.+
T Consensus         7 ~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~   85 (321)
T cd05603           7 SFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTA-EKLYFVLDYVNGGELFF   85 (321)
T ss_pred             CCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcC-CEEEEEEcCCCCCCHHH
Confidence            3499999998  688999999864321      22333433 46678999999999987554 48999999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC--
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND--  538 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~--  538 (600)
                      ++....            .+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++....  
T Consensus        86 ~l~~~~------------~~~~~~~~~~~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~  150 (321)
T cd05603          86 HLQRER------------CFLEPRARFYAAEVASAIGYLH---SLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE  150 (321)
T ss_pred             HHHHcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC
Confidence            886532            3788889999999999999999   67999999999999999999999999999874311  


Q ss_pred             ----------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 ----------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 ----------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                .+.+||....  ..++.++|||||||++|||++|+.||...
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~  199 (321)
T cd05603         151 ETTSTFCGTPEYLAPEVLRK--EPYDRTVDWWCLGAVLYEMLYGLPPFYSR  199 (321)
T ss_pred             CccccccCCcccCCHHHhcC--CCCCCcCcccccchhhhhhhcCCCCCCCC
Confidence                      1234555443  34678899999999999999999999754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=99.95  E-value=1.7e-27  Score=248.41  Aligned_cols=172  Identities=22%  Similarity=0.328  Sum_probs=139.4

Q ss_pred             eeEEEEEEEE--CCeEEEEEEcchhHH------HHHHHHHH-HHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          390 IEGAVYHGRL--NGKNLAIKRTEHEVI------TKLEMQLV-QHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       390 ~~G~Vy~g~~--~g~~vAvK~~~~~~~------~~~e~ei~-~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      ..|.||+++.  +|+.+|+|.+.....      ..+..|.. .+..++||||+++++++..+ +..|+||||+++|+|..
T Consensus         7 ~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~   85 (325)
T cd05604           7 SFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTT-EKLYFVLDFVNGGELFF   85 (325)
T ss_pred             CCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecC-CEEEEEEcCCCCCCHHH
Confidence            3499999987  689999999865321      22333333 45668999999999987655 48999999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC--
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND--  538 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~--  538 (600)
                      ++....            .+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++....  
T Consensus        86 ~l~~~~------------~~~~~~~~~~~~qi~~al~~lH---~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~  150 (325)
T cd05604          86 HLQRER------------SFPEPRARFYAAEIASALGYLH---SINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS  150 (325)
T ss_pred             HHHHcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC
Confidence            886543            3899999999999999999999   67999999999999999999999999999874321  


Q ss_pred             ----------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 ----------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 ----------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                .+.+||....  ..++.++|||||||++|||++|+.||...
T Consensus       151 ~~~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslG~il~el~~G~~pf~~~  199 (325)
T cd05604         151 DTTTTFCGTPEYLAPEVIRK--QPYDNTVDWWCLGAVLYEMLYGLPPFYCR  199 (325)
T ss_pred             CCcccccCChhhCCHHHHcC--CCCCCcCccccccceehhhhcCCCCCCCC
Confidence                      1234565543  45678899999999999999999999754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=99.95  E-value=2.8e-27  Score=246.81  Aligned_cols=171  Identities=24%  Similarity=0.335  Sum_probs=137.7

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhHH------HHHHHHH-HHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEVI------TKLEMQL-VQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~~------~~~e~ei-~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      .|.||+++.  +++.||+|.+.....      ..+..|. ..+..++||||+++++++..+ +..|+||||+++|+|.++
T Consensus         8 fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~   86 (325)
T cd05602           8 FGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA-DKLYFVLDYINGGELFYH   86 (325)
T ss_pred             CeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcC-CeEEEEEeCCCCCcHHHH
Confidence            499999988  678899999865321      1222232 345678999999999987655 489999999999999999


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC----
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN----  537 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~----  537 (600)
                      +....            .+++.+...++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...    
T Consensus        87 ~~~~~------------~~~~~~~~~~~~qi~~~L~~lH---~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~  151 (325)
T cd05602          87 LQRER------------CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG  151 (325)
T ss_pred             HHhcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC
Confidence            97543            2778888889999999999999   6799999999999999999999999999987431    


Q ss_pred             --------CCCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          538 --------DDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       538 --------~~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                              ..+.+||....  ..++.++|||||||++|||++|+.||...
T Consensus       152 ~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~  199 (325)
T cd05602         152 TTSTFCGTPEYLAPEVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSR  199 (325)
T ss_pred             CcccccCCccccCHHHHcC--CCCCCccccccccHHHHHHhcCCCCCCCC
Confidence                    11235665543  45678899999999999999999999754

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=99.95  E-value=2.1e-27  Score=260.31  Aligned_cols=186  Identities=27%  Similarity=0.403  Sum_probs=147.8

Q ss_pred             hccCCCCceeEEEEEEEE-C-CeEEEEEEcc---hhHHHHHHHHHHHHHhCC-CCceeeeee-EEecc---C--CceEEE
Q 041830          382 EKFNSSNRIEGAVYHGRL-N-GKNLAIKRTE---HEVITKLEMQLVQHATHH-HPNIVRLLG-TCLTD---G--PHSFLV  449 (600)
Q Consensus       382 ~~f~~~~~~~G~Vy~g~~-~-g~~vAvK~~~---~~~~~~~e~ei~~~~~l~-HpNIv~l~g-~~~~~---~--~~~~LV  449 (600)
                      +++..++|+ +.||.+.. . |..||+|++-   +.......+||..|+.+. |+|||.+++ .....   +  -+.+|.
T Consensus        42 ~~vLAEGGF-a~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllL  120 (738)
T KOG1989|consen   42 EKVLAEGGF-AQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLL  120 (738)
T ss_pred             EEEEccCCc-EEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEee
Confidence            344555555 89999999 3 4899999963   334456788999999998 999999999 33221   1  356899


Q ss_pred             EeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEe
Q 041830          450 FEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGN  529 (600)
Q Consensus       450 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~D  529 (600)
                      ||||++|+|-|++.....          ..|++.++++|+.|+++|+++||.. .++|||||||-+||||+.++..||||
T Consensus       121 mEyC~gg~Lvd~mn~Rlq----------~~lte~eVLkIf~dv~~AVa~mH~~-~pPiIHRDLKiENvLls~~g~~KLCD  189 (738)
T KOG1989|consen  121 MEYCKGGSLVDFMNTRLQ----------TRLTEDEVLKIFYDVCEAVAAMHYL-KPPIIHRDLKIENVLLSADGNYKLCD  189 (738)
T ss_pred             hhhccCCcHHHHHHHHHh----------ccCChHHHHHHHHHHHHHHHHHhcC-CCccchhhhhhhheEEcCCCCEEeCc
Confidence            999999999999975432          2399999999999999999999977 88999999999999999999999999


Q ss_pred             ccCccccC---------------------CCCCCCccccc-CCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          530 FGMARCVN---------------------DDTESPQFYST-NPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       530 FGla~~~~---------------------~~~~~pe~~~~-~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                      ||-+....                     ..+.+||.+.. .....++|+||||+||+||-|+-...||...
T Consensus       190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s  261 (738)
T KOG1989|consen  190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES  261 (738)
T ss_pred             ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence            99875321                     11224554332 2344588999999999999999999999753

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=99.95  E-value=3.2e-27  Score=245.62  Aligned_cols=171  Identities=24%  Similarity=0.381  Sum_probs=140.2

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      .|.||+++.  +++.||+|.++...      ...+..|+..+..+ +||||+++++++... ...++||||+++|+|.++
T Consensus         8 ~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~   86 (318)
T cd05570           8 FGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTK-DRLFFVMEYVNGGDLMFH   86 (318)
T ss_pred             CeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcC-CEEEEEEcCCCCCCHHHH
Confidence            499999988  57899999987542      22344566666555 699999999997655 489999999999999999


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC----
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN----  537 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~----  537 (600)
                      +....            .+++.++..++.|++.||.|||   +.+++||||||+|||+++++.+||+|||+++...    
T Consensus        87 ~~~~~------------~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~  151 (318)
T cd05570          87 IQRSG------------RFDEPRARFYAAEIVLGLQFLH---ERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV  151 (318)
T ss_pred             HHHcC------------CCCHHHHHHHHHHHHHHHHHHH---hCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC
Confidence            87543            3899999999999999999999   6799999999999999999999999999986421    


Q ss_pred             --------CCCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          538 --------DDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       538 --------~~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                              ..+.+||....  ..++.++|||||||++|||++|+.||...
T Consensus       152 ~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslGvil~~l~~G~~pf~~~  199 (318)
T cd05570         152 TTSTFCGTPDYIAPEILSY--QPYGPAVDWWALGVLLYEMLAGQSPFEGD  199 (318)
T ss_pred             cccceecCccccCHHHhcC--CCCCcchhhhhHHHHHHHHhhCCCCCCCC
Confidence                    11234665543  45678899999999999999999999754

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=99.95  E-value=4.6e-27  Score=245.84  Aligned_cols=173  Identities=23%  Similarity=0.342  Sum_probs=144.7

Q ss_pred             eeEEEEEEEE--CCeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          390 IEGAVYHGRL--NGKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       390 ~~G~Vy~g~~--~g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      .+|.||+++.  +|..+|+|.++.+    ....+.+|+..+..++||||+++++++..+ +..++||||+++|+|.+++.
T Consensus        17 ~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~   95 (331)
T cd06649          17 NGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-GEISICMEHMDGGSLDQVLK   95 (331)
T ss_pred             CCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-CEEEEEeecCCCCcHHHHHH
Confidence            3499999998  6889999987543    234678899999999999999999998665 48999999999999999997


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC-----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND-----  538 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~-----  538 (600)
                      ...            .+++..+..++.|++.||.|||+  ..+|+||||||+|||++.++.+||+|||+++....     
T Consensus        96 ~~~------------~~~~~~~~~~~~~i~~~l~~lH~--~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  161 (331)
T cd06649          96 EAK------------RIPEEILGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS  161 (331)
T ss_pred             HcC------------CCCHHHHHHHHHHHHHHHHHHhh--cCCEEcCCCChhhEEEcCCCcEEEccCccccccccccccc
Confidence            543            38899999999999999999994  23699999999999999999999999999875422     


Q ss_pred             -----CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 -----DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 -----~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                           .+.+||....  ..++.++|||||||++|||++|+.||...
T Consensus       162 ~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~~~  205 (331)
T cd06649         162 FVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVELAIGRYPIPPP  205 (331)
T ss_pred             CCCCcCcCCHhHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence                 2235665543  34678899999999999999999999653

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=99.95  E-value=3.3e-27  Score=246.51  Aligned_cols=170  Identities=22%  Similarity=0.382  Sum_probs=140.0

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      .|.||+++.  +++.||+|.++.+.      ...+..|+..+..+ +||||+++++++... ...|+||||+++|+|.++
T Consensus         8 ~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~   86 (327)
T cd05617           8 YAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTT-SRLFLVIEYVNGGDLMFH   86 (327)
T ss_pred             CeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeC-CEEEEEEeCCCCCcHHHH
Confidence            499999988  67899999987543      22345666666666 699999999987554 589999999999999998


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC----
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN----  537 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~----  537 (600)
                      +....            .+++.++..++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++...    
T Consensus        87 ~~~~~------------~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~  151 (327)
T cd05617          87 MQRQR------------KLPEEHARFYAAEICIALNFLH---ERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGD  151 (327)
T ss_pred             HHHcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCC
Confidence            86532            3899999999999999999999   6799999999999999999999999999987421    


Q ss_pred             --------CCCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          538 --------DDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       538 --------~~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                              ..+.+||....  ..++.++|||||||+||||++|+.||..
T Consensus       152 ~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~ell~g~~pf~~  198 (327)
T cd05617         152 TTSTFCGTPNYIAPEILRG--EEYGFSVDWWALGVLMFEMMAGRSPFDI  198 (327)
T ss_pred             ceecccCCcccCCHHHHCC--CCCCchheeehhHHHHHHHHhCCCCCCc
Confidence                    11235665543  4567889999999999999999999964

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=99.95  E-value=8.2e-27  Score=243.16  Aligned_cols=172  Identities=22%  Similarity=0.353  Sum_probs=138.5

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCC-ceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHP-NIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~Hp-NIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      .|.||+++.  +++.||+|.++.+.      ...+..|...+..+.|+ +|+++++++... +..|+||||+++|+|.++
T Consensus        13 ~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-~~~~lv~E~~~~g~L~~~   91 (324)
T cd05587          13 FGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM-DRLYFVMEYVNGGDLMYH   91 (324)
T ss_pred             CeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcC-CEEEEEEcCCCCCcHHHH
Confidence            499999988  56789999986532      23445666677777654 578888876544 589999999999999999


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC----
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN----  537 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~----  537 (600)
                      +....            .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++...    
T Consensus        92 ~~~~~------------~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~  156 (324)
T cd05587          92 IQQVG------------KFKEPHAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK  156 (324)
T ss_pred             HHHcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC
Confidence            96543            3889999999999999999999   6799999999999999999999999999986421    


Q ss_pred             --------CCCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          538 --------DDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       538 --------~~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                              ..+.+||....  ..++.++|||||||++|||++|+.||...+
T Consensus       157 ~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~pf~~~~  205 (324)
T cd05587         157 TTRTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGED  205 (324)
T ss_pred             ceeeecCCccccChhhhcC--CCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence                    12335666544  346788999999999999999999997543

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=99.95  E-value=1.3e-27  Score=248.37  Aligned_cols=171  Identities=24%  Similarity=0.407  Sum_probs=142.1

Q ss_pred             eEEEEEEEE-----CCeEEEEEEcchhHH-----HHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          391 EGAVYHGRL-----NGKNLAIKRTEHEVI-----TKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       391 ~G~Vy~g~~-----~g~~vAvK~~~~~~~-----~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      .|.||+++.     +|+.||+|.++....     ..+..|+..+..++||||+++++++..+ ...|+||||+++|+|.+
T Consensus         9 ~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~~~L~~   87 (318)
T cd05582           9 FGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTE-GKLYLILDFLRGGDLFT   87 (318)
T ss_pred             CEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcC-CEEEEEEcCCCCCcHHH
Confidence            489998864     578999999875331     2456788889999999999999997655 48999999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-  539 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-  539 (600)
                      ++....            .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++..... 
T Consensus        88 ~l~~~~------------~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~  152 (318)
T cd05582          88 RLSKEV------------MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE  152 (318)
T ss_pred             HHHHcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC
Confidence            996532            3899999999999999999999   679999999999999999999999999998754322 


Q ss_pred             -----------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 -----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 -----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                 ..+||....  ..++.++|||||||++|||++|+.||...
T Consensus       153 ~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~tg~~p~~~~  201 (318)
T cd05582         153 KKAYSFCGTVEYMAPEVVNR--RGHTQSADWWSFGVLMFEMLTGSLPFQGK  201 (318)
T ss_pred             CceecccCChhhcCHHHHcC--CCCCCccceeccceEeeeeccCCCCCCCC
Confidence                       124554433  34577899999999999999999999754

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=4.6e-27  Score=245.91  Aligned_cols=174  Identities=22%  Similarity=0.277  Sum_probs=142.5

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||+++.  +++.||+|.+....      ...+..|+..+..++|+||+++++++..+ ...|+||||+++|+|.+++
T Consensus        14 ~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~g~~L~~~l   92 (331)
T cd05597          14 FGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDE-NNLYLVMDYYVGGDLLTLL   92 (331)
T ss_pred             CeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecC-CeEEEEEecCCCCcHHHHH
Confidence            499999998  68899999986421      23456778888889999999999987655 5899999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC----
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND----  538 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~----  538 (600)
                      ....           ..+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....    
T Consensus        93 ~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  158 (331)
T cd05597          93 SKFE-----------DRLPEDMARFYLAEMVLAIDSVH---QLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV  158 (331)
T ss_pred             HHhc-----------CCCCHHHHHHHHHHHHHHHHHHH---hCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence            6532           23889999999999999999999   67999999999999999999999999999865422    


Q ss_pred             ---------CCCCCccccc---CCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 ---------DTESPQFYST---NPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 ---------~~~~pe~~~~---~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                               .+.+||....   ....++.++|||||||++|||++|+.||...
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~  211 (331)
T cd05597         159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE  211 (331)
T ss_pred             cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence                     1234555432   1234677899999999999999999999653

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=99.95  E-value=4.4e-27  Score=240.98  Aligned_cols=173  Identities=23%  Similarity=0.368  Sum_probs=141.4

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      .|.||+++.  +++.||+|.++...    ...+.+|+..+..++||||+++++++..+ ...++||||++ |+|.+++..
T Consensus        18 ~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~-~~l~~~l~~   95 (288)
T cd07871          18 YATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTE-RCLTLVFEYLD-SDLKQYLDN   95 (288)
T ss_pred             CEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCC-CeEEEEEeCCC-cCHHHHHHh
Confidence            399999987  68899999875322    23456889999999999999999997655 47899999997 599999865


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-----
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-----  539 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-----  539 (600)
                      ..           ..+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....     
T Consensus        96 ~~-----------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~  161 (288)
T cd07871          96 CG-----------NLMSMHNVKIFMFQLLRGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYS  161 (288)
T ss_pred             cC-----------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCcccc
Confidence            32           23789999999999999999999   679999999999999999999999999998754211     


Q ss_pred             -------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 -------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 -------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                             ..+||.... ...++.++|||||||++|||++|+.||...+
T Consensus       162 ~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~  208 (288)
T cd07871         162 NEVVTLWYRPPDVLLG-STEYSTPIDMWGVGCILYEMATGRPMFPGST  208 (288)
T ss_pred             CceecccccChHHhcC-CcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                   234665432 2346778999999999999999999997543

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.7e-27  Score=250.67  Aligned_cols=172  Identities=24%  Similarity=0.396  Sum_probs=144.3

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||+++.  +|+.||||.++...      ...+..|+..+..++||||+++++++.++ ...++||||+++|+|.+++
T Consensus        14 ~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l   92 (350)
T cd05573          14 FGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDE-EHLYLVMEYMPGGDLMNLL   92 (350)
T ss_pred             cEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecC-CeEEEEEcCCCCCCHHHHH
Confidence            399999998  58999999986532      23567788889999999999999987554 5899999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCCC--
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDT--  540 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~~--  540 (600)
                      ....            .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++......  
T Consensus        93 ~~~~------------~l~~~~~~~i~~qi~~aL~~LH---~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~  157 (350)
T cd05573          93 IRKD------------VFPEETARFYIAELVLALDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDR  157 (350)
T ss_pred             HHcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcc
Confidence            7642            3889999999999999999999   6799999999999999999999999999987543322  


Q ss_pred             ---------------------------------------CCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          541 ---------------------------------------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       541 ---------------------------------------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                                                             .+||....  ..++.++|||||||+||||++|+.||...+
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~Pf~~~~  234 (350)
T cd05573         158 EYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRG--TPYGLECDWWSLGVILYEMLYGFPPFYSDT  234 (350)
T ss_pred             cccccccccccccccccccccccccccccccccccCccccCHHHHcC--CCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence                                                   23444433  356788999999999999999999997543

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>PHA03211 serine/threonine kinase US3; Provisional

Probab=99.95  E-value=5.6e-26  Score=246.58  Aligned_cols=166  Identities=21%  Similarity=0.366  Sum_probs=137.4

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcCcc
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMK  469 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~  469 (600)
                      |.||+++.  .++.||||....   ..+..|+..+..++|+|||++++++...+ ..++|||++. |+|.+++....   
T Consensus       183 G~Vy~a~~~~~~~~vavK~~~~---~~~~~E~~iL~~L~HpnIv~l~~~~~~~~-~~~lv~e~~~-~~L~~~l~~~~---  254 (461)
T PHA03211        183 GCVFESSHPDYPQRVVVKAGWY---ASSVHEARLLRRLSHPAVLALLDVRVVGG-LTCLVLPKYR-SDLYTYLGARL---  254 (461)
T ss_pred             eEEEEEEECCCCCEEEEecccc---cCHHHHHHHHHHCCCCCCCcEEEEEEECC-EEEEEEEccC-CCHHHHHHhcC---
Confidence            89999998  578899996433   23467888899999999999999987654 7899999995 79999886532   


Q ss_pred             cccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC-----------
Q 041830          470 NQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND-----------  538 (600)
Q Consensus       470 ~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~-----------  538 (600)
                              ..++|.+++.|+.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....           
T Consensus       255 --------~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~  323 (461)
T PHA03211        255 --------RPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIA  323 (461)
T ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHH---HCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccC
Confidence                    24899999999999999999999   67999999999999999999999999999875422           


Q ss_pred             ---CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          539 ---DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       539 ---~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                         .+.+||....  ..++.++|||||||+||||++|..|+..
T Consensus       324 GT~~Y~APE~~~~--~~~~~~sDvwSlGviL~El~~g~~~lf~  364 (461)
T PHA03211        324 GTVDTNAPEVLAG--DPYTPSVDIWSAGLVIFEAAVHTASLFS  364 (461)
T ss_pred             CCcCCcCHHHHcC--CCCCchHHHHHHHHHHHHHHHcCCCccc
Confidence               1234555543  3467889999999999999998877644

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=99.95  E-value=1.6e-27  Score=248.99  Aligned_cols=174  Identities=22%  Similarity=0.337  Sum_probs=144.7

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||+++.  +|+.||+|.++...      ...+++|+..+..++|+||+++++++..+ ...++||||+++|+|.+++
T Consensus        14 ~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l   92 (330)
T cd05601          14 FGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDK-DNLYLVMEYQPGGDLLSLL   92 (330)
T ss_pred             CEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecC-CeEEEEECCCCCCCHHHHH
Confidence            399999987  78999999987543      23467788888889999999999987554 5899999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC---
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---  539 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~---  539 (600)
                      +...           ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....   
T Consensus        93 ~~~~-----------~~l~~~~~~~~~~qi~~aL~~lH---~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  158 (330)
T cd05601          93 NRYE-----------DQFDEDMAQFYLAELVLAIHSVH---QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV  158 (330)
T ss_pred             HHhc-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence            7642           23899999999999999999999   679999999999999999999999999998754321   


Q ss_pred             ----------CCCCcccccC----CCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 ----------TESPQFYSTN----PASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 ----------~~~pe~~~~~----~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                +.+||.....    ...++.++|||||||++|||++|+.||...
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~  212 (330)
T cd05601         159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG  212 (330)
T ss_pred             eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC
Confidence                      2346654421    234678899999999999999999999653

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=99.95  E-value=5.4e-27  Score=245.43  Aligned_cols=174  Identities=22%  Similarity=0.273  Sum_probs=142.5

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||+++.  +++.+|+|.+....      ...+..|+..+..++|+||+++++++..+ ...|+||||+++|+|.+++
T Consensus        14 fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv~ey~~~g~L~~~l   92 (332)
T cd05623          14 FGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDE-NNLYLVMDYYVGGDLLTLL   92 (332)
T ss_pred             CeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecC-CEEEEEEeccCCCcHHHHH
Confidence            499999998  57889999985422      12356777788889999999999987655 5899999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC----
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND----  538 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~----  538 (600)
                      +...           ..+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....    
T Consensus        93 ~~~~-----------~~l~~~~~~~~~~qi~~al~~lH---~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~  158 (332)
T cd05623          93 SKFE-----------DRLPEDMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV  158 (332)
T ss_pred             HHhc-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence            7532           23889999999999999999999   67999999999999999999999999999864321    


Q ss_pred             ---------CCCCCccccc---CCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 ---------DTESPQFYST---NPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 ---------~~~~pe~~~~---~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                               .+.+||+...   ....++.++|||||||++|||++|+.||...
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~  211 (332)
T cd05623         159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAE  211 (332)
T ss_pred             eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCC
Confidence                     2235665542   1235678899999999999999999999753

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=99.95  E-value=7.8e-27  Score=243.29  Aligned_cols=172  Identities=23%  Similarity=0.361  Sum_probs=138.2

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhHH------HHHHHHHHHHHhCC-CCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEVI------TKLEMQLVQHATHH-HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~~------~~~e~ei~~~~~l~-HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      .|.||+++.  +|+.||+|.++.+..      ..+..|...+..+. |++|+++++++..+ +..|+||||+++|+|.++
T Consensus        13 ~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~-~~~~lv~Ey~~~g~L~~~   91 (323)
T cd05615          13 FGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTV-DRLYFVMEYVNGGDLMYH   91 (323)
T ss_pred             CeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecC-CEEEEEEcCCCCCcHHHH
Confidence            499999988  688999999865321      23445555565554 57788888876554 489999999999999999


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC----
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN----  537 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~----  537 (600)
                      +....            .+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...    
T Consensus        92 i~~~~------------~l~~~~~~~i~~qi~~al~~lH---~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~  156 (323)
T cd05615          92 IQQVG------------KFKEPQAVFYAAEISVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV  156 (323)
T ss_pred             HHHcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc
Confidence            86543            3899999999999999999999   6799999999999999999999999999987432    


Q ss_pred             --------CCCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          538 --------DDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       538 --------~~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                              ....+||....  ..++.++|||||||++|||++|+.||...+
T Consensus       157 ~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~elltG~~pf~~~~  205 (323)
T cd05615         157 TTRTFCGTPDYIAPEIIAY--QPYGKSVDWWAYGVLLYEMLAGQPPFDGED  205 (323)
T ss_pred             cccCccCCccccCHHHHcC--CCCCCccchhhhHHHHHHHHhCCCCCCCCC
Confidence                    11235665543  346788999999999999999999997643

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=99.95  E-value=5.8e-27  Score=239.46  Aligned_cols=171  Identities=23%  Similarity=0.310  Sum_probs=140.7

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      .|.||+++.  +++.||+|+++..     ....+.+|+..+..++||||+++++++..+ ...++||||++++.+..+..
T Consensus        14 ~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~l~~~~~   92 (287)
T cd07848          14 YGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRR-GKLYLVFEYVEKNMLELLEE   92 (287)
T ss_pred             CEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecC-CEEEEEEecCCCCHHHHHHh
Confidence            489999998  5789999987642     224567789999999999999999997655 48999999999877765543


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD----  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~----  539 (600)
                      ..            ..+++.++..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++.....    
T Consensus        93 ~~------------~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  157 (287)
T cd07848          93 MP------------NGVPPEKVRSYIYQLIKAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN  157 (287)
T ss_pred             cC------------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence            22            23889999999999999999999   679999999999999999999999999998754321    


Q ss_pred             ---------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 ---------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 ---------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                               ..+||....  ..++.++|||||||++|||++|+.||...
T Consensus       158 ~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslGvil~el~~g~~pf~~~  204 (287)
T cd07848         158 YTEYVATRWYRSPELLLG--APYGKAVDMWSVGCILGELSDGQPLFPGE  204 (287)
T ss_pred             ccccccccccCCcHHHcC--CCCCCchhHHhHHHHHHHHHhCCCCCCCC
Confidence                     235665543  34678899999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=99.95  E-value=1.8e-27  Score=240.05  Aligned_cols=173  Identities=29%  Similarity=0.560  Sum_probs=140.3

Q ss_pred             eEEEEEEEEC------CeEEEEEEcch----hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          391 EGAVYHGRLN------GKNLAIKRTEH----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       391 ~G~Vy~g~~~------g~~vAvK~~~~----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      .|.||+|.+.      +..|+||.++.    +...++..|+..+.+++||||++++|+|... ...++|+||+++|+|.+
T Consensus        12 fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~-~~~~lv~e~~~~g~L~~   90 (259)
T PF07714_consen   12 FGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIEN-EPLFLVMEYCPGGSLDD   90 (259)
T ss_dssp             SEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESS-SSEEEEEE--TTEBHHH
T ss_pred             CcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccccccccccccccccc-ccccccccccccccccc
Confidence            3999999997      67899999854    2245778899999999999999999999854 47899999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCCC
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDT  540 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~~  540 (600)
                      +|+....          ..+++.+++.|+.||+.||.|||   +.+++|+||+++||++++++.+||+|||+++......
T Consensus        91 ~L~~~~~----------~~~~~~~~~~i~~~i~~~l~~Lh---~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   91 YLKSKNK----------EPLSEQQRLSIAIQIAEALSYLH---SNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             HHHHTCT----------TTSBHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred             ccccccc----------ccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccccc
Confidence            9987621          34899999999999999999999   5689999999999999999999999999998762111


Q ss_pred             --------------CCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          541 --------------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       541 --------------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                                    .+||....  ..++.++||||||+++|||++ |+.||...
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~--~~~~~ksDVysfG~~l~ei~~~~~~p~~~~  209 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKD--GEYTKKSDVYSFGMLLYEILTLGKFPFSDY  209 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHH--SEESHHHHHHHHHHHHHHHHTTSSGTTTTS
T ss_pred             cccccccccccccccccccccc--cccccccccccccccccccccccccccccc
Confidence                          23444333  336888999999999999999 78998654

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=99.95  E-value=8.9e-27  Score=255.62  Aligned_cols=175  Identities=22%  Similarity=0.347  Sum_probs=142.6

Q ss_pred             eEEEEEEEE--C-CeEEEEEEcchh---HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          391 EGAVYHGRL--N-GKNLAIKRTEHE---VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       391 ~G~Vy~g~~--~-g~~vAvK~~~~~---~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      .|.||++..  + ++.||+|....+   ....+..|+..+..++|||||++++++..+ +..||||||+++|+|.++|+.
T Consensus        80 ~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~-~~~~lv~E~~~gg~L~~~l~~  158 (478)
T PTZ00267         80 TTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSD-DKLLLIMEYGSGGDLNKQIKQ  158 (478)
T ss_pred             CcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEEC-CEEEEEEECCCCCCHHHHHHH
Confidence            389999976  3 678888875332   223567799999999999999999998665 489999999999999999864


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-----
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-----  539 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-----  539 (600)
                      ....        ..++++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....     
T Consensus       159 ~~~~--------~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~  227 (478)
T PTZ00267        159 RLKE--------HLPFQEYEVGLLFYQIVLALDEVH---SRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDV  227 (478)
T ss_pred             HHhc--------cCCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcccccc
Confidence            3210        134889999999999999999999   679999999999999999999999999999764321     


Q ss_pred             ---------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 ---------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 ---------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                               +.+||....  ..++.++|||||||++|||++|+.||...
T Consensus       228 ~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~tg~~Pf~~~  274 (478)
T PTZ00267        228 ASSFCGTPYYLAPELWER--KRYSKKADMWSLGVILYELLTLHRPFKGP  274 (478)
T ss_pred             ccccCCCccccCHhHhCC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence                     224554433  45678899999999999999999999754

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=99.95  E-value=6.6e-27  Score=236.63  Aligned_cols=172  Identities=22%  Similarity=0.358  Sum_probs=141.4

Q ss_pred             eEEEEEEEE-----CCeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          391 EGAVYHGRL-----NGKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       391 ~G~Vy~g~~-----~g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      +|.||+|.+     .+..||+|.++..    ....+++|+..+..++||||++++|++... ...++||||+++|+|.++
T Consensus        18 fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~   96 (266)
T cd05064          18 FGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRG-NTMMIVTEYMSNGALDSF   96 (266)
T ss_pred             CCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecC-CCcEEEEEeCCCCcHHHH
Confidence            399999976     2568999987653    224577899999999999999999997654 589999999999999999


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC---
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND---  538 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~---  538 (600)
                      +....           ..++|.+++.++.|++.||+|||   +.+++||||||+|||++.++.+|++|||.+.....   
T Consensus        97 l~~~~-----------~~l~~~~~~~~~~~i~~al~~lH---~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~  162 (266)
T cd05064          97 LRKHE-----------GQLVAGQLMGMLPGLASGMKYLS---EMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAI  162 (266)
T ss_pred             HHhCC-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCEeeccccHhhEEEcCCCcEEECCCcccccccccch
Confidence            97542           23899999999999999999999   67999999999999999999999999998654311   


Q ss_pred             ----------CCCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          539 ----------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       539 ----------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                                ...+||....  ..++.++|||||||++||+++ |+.||...
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~ell~~g~~p~~~~  212 (266)
T cd05064         163 YTTMSGKSPVLWAAPEAIQY--HHFSSASDVWSFGIVMWEVMSYGERPYWDM  212 (266)
T ss_pred             hcccCCCCceeecCHHHHhh--CCccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence                      1234554433  456788999999999999875 99999754

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=99.95  E-value=8.3e-27  Score=243.86  Aligned_cols=172  Identities=22%  Similarity=0.322  Sum_probs=139.5

Q ss_pred             eEEEEEEEE-----CCeEEEEEEcchhH-------HHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCC
Q 041830          391 EGAVYHGRL-----NGKNLAIKRTEHEV-------ITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGS  457 (600)
Q Consensus       391 ~G~Vy~g~~-----~g~~vAvK~~~~~~-------~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~Gs  457 (600)
                      .|.||+++.     +|+.||+|.++...       .+.+..|+..+..+ +|+||+++++++..+ ...++||||+++|+
T Consensus        13 ~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~-~~~~lv~e~~~~g~   91 (332)
T cd05614          13 YGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTE-AKLHLILDYVSGGE   91 (332)
T ss_pred             CEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecC-CEEEEEEeCCCCCc
Confidence            499999875     57889999876432       12456677778777 499999999887555 48899999999999


Q ss_pred             HHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC
Q 041830          458 LKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN  537 (600)
Q Consensus       458 L~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~  537 (600)
                      |.+++....            .+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        92 L~~~l~~~~------------~~~~~~~~~~~~qi~~~l~~lH---~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~  156 (332)
T cd05614          92 MFTHLYQRD------------NFSEDEVRFYSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (332)
T ss_pred             HHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHeEECCCCCEEEeeCcCCcccc
Confidence            999997543            3899999999999999999999   6799999999999999999999999999987532


Q ss_pred             C-------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          538 D-------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       538 ~-------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                      .             .+.+||.... ...++.++|||||||++|||++|+.||...
T Consensus       157 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~elltg~~pf~~~  210 (332)
T cd05614         157 SEEKERTYSFCGTIEYMAPEIIRG-KGGHGKAVDWWSLGILIFELLTGASPFTLE  210 (332)
T ss_pred             ccCCCccccccCCccccCHHHhcC-CCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence            1             1234555432 233577899999999999999999999643

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=99.95  E-value=2.4e-27  Score=253.07  Aligned_cols=178  Identities=29%  Similarity=0.433  Sum_probs=143.6

Q ss_pred             eeEEEEEEEE--CCeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccC-----CceEEEEeecCCCCH
Q 041830          390 IEGAVYHGRL--NGKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDG-----PHSFLVFEYAKNGSL  458 (600)
Q Consensus       390 ~~G~Vy~g~~--~g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~-----~~~~LV~Ey~~~GsL  458 (600)
                      .+|.||+|+.  +|+.||||.++..    .++..-+|+.++++++|+|||+++|+-.+..     ....+|||||.+|||
T Consensus        25 a~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL  104 (732)
T KOG4250|consen   25 AFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSL  104 (732)
T ss_pred             ccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcH
Confidence            3499999997  8999999987652    2345678999999999999999999843221     245899999999999


Q ss_pred             HHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC--CCC--cEEEEeccCcc
Q 041830          459 KDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLD--EEF--NARVGNFGMAR  534 (600)
Q Consensus       459 ~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld--~~~--~~kI~DFGla~  534 (600)
                      +..|++..+         ...|++.+.+.+..++..||.|||   ..+|+||||||.||++-  +++  .-||+|||.||
T Consensus       105 ~~~L~~PEN---------~~GLpE~e~l~lL~d~~~al~~Lr---En~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar  172 (732)
T KOG4250|consen  105 RKVLNSPEN---------AYGLPESEFLDLLSDLVSALRHLR---ENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR  172 (732)
T ss_pred             HHHhcCccc---------ccCCCHHHHHHHHHHHHHHHHHHH---HcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence            999986543         155999999999999999999999   66999999999999993  334  47999999999


Q ss_pred             ccCCCCC-----------CCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          535 CVNDDTE-----------SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       535 ~~~~~~~-----------~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                      .++.+..           .|+.+.. ...|+..+|.|||||++||.+||..||-...
T Consensus       173 el~d~s~~~S~vGT~~YLhPel~E~-q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~  228 (732)
T KOG4250|consen  173 ELDDNSLFTSLVGTEEYLHPELYER-QKKYTATVDLWSFGVTLYECATGELPFIPFG  228 (732)
T ss_pred             cCCCCCeeeeecCchhhcChHHHhh-ccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence            8876542           2333321 2556778999999999999999999996543

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=99.95  E-value=7.1e-27  Score=241.11  Aligned_cols=172  Identities=22%  Similarity=0.320  Sum_probs=140.6

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      .|.||+++.  +|+.||+|.++...    .....+|+..++.++||||+++++++..+ ...++||||++ ++|.+++..
T Consensus        18 ~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~-~~l~~~~~~   95 (303)
T cd07869          18 YATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTK-ETLTLVFEYVH-TDLCQYMDK   95 (303)
T ss_pred             CEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecC-CeEEEEEECCC-cCHHHHHHh
Confidence            389999998  68899999876422    12456788899999999999999997655 48899999996 688888865


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC------
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND------  538 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~------  538 (600)
                      ..           ..+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....      
T Consensus        96 ~~-----------~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  161 (303)
T cd07869          96 HP-----------GGLHPENVKLFLFQLLRGLSYIH---QRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYS  161 (303)
T ss_pred             CC-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCC
Confidence            43           23888999999999999999999   67999999999999999999999999999864321      


Q ss_pred             ------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 ------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 ------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                            ...+||..... ..++.++|||||||++|||++|+.||...
T Consensus       162 ~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~  207 (303)
T cd07869         162 NEVVTLWYRPPDVLLGS-TEYSTCLDMWGVGCIFVEMIQGVAAFPGM  207 (303)
T ss_pred             CCcccCCCCChHHHcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                  12345654321 34677899999999999999999999754

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=99.95  E-value=1.3e-26  Score=237.03  Aligned_cols=174  Identities=20%  Similarity=0.265  Sum_probs=144.0

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhHH------HHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEVI------TKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~~------~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||++..  +++.||+|.++....      ..+..|+..+..++||||+++++.+..+ +..++||||+++|+|.+++
T Consensus        13 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~~   91 (285)
T cd05605          13 FGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK-DALCLVLTLMNGGDLKFHI   91 (285)
T ss_pred             CeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCC-CeEEEEEeccCCCcHHHHH
Confidence            399999987  688999998865321      2345688889999999999999987554 4899999999999999988


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC---
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---  539 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~---  539 (600)
                      .....          ..+++.++..++.|++.||.|||   +.+++||||||+||++++++.++|+|||+++.....   
T Consensus        92 ~~~~~----------~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  158 (285)
T cd05605          92 YNMGN----------PGFDEERAVFYAAEITCGLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETI  158 (285)
T ss_pred             HhcCc----------CCCCHHHHHHHHHHHHHHHHHHH---HCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCcc
Confidence            65321          24899999999999999999999   669999999999999999999999999998764321   


Q ss_pred             --------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 --------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 --------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                              ..+||....  ..++.++|||||||++|||++|+.||....
T Consensus       159 ~~~~~~~~y~aPE~~~~--~~~~~~~Diws~G~~l~el~~g~~pf~~~~  205 (285)
T cd05605         159 RGRVGTVGYMAPEVVKN--ERYTFSPDWWGLGCLIYEMIEGKSPFRQRK  205 (285)
T ss_pred             ccccCCCCccCcHHhcC--CCCCccccchhHHHHHHHHHHCCCCCCCCc
Confidence                    234665543  456788999999999999999999997643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=99.95  E-value=9.3e-27  Score=241.78  Aligned_cols=171  Identities=23%  Similarity=0.448  Sum_probs=140.3

Q ss_pred             eEEEEEEEE--CCe----EEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          391 EGAVYHGRL--NGK----NLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       391 ~G~Vy~g~~--~g~----~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      .|.||+|++  +|+    .||+|.++..    ....+..|+..+..++||||++++|+|..+  ..++++||+++|+|.+
T Consensus        20 ~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~--~~~~v~e~~~~g~l~~   97 (316)
T cd05108          20 FGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--TVQLITQLMPFGCLLD   97 (316)
T ss_pred             CceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC--CceeeeecCCCCCHHH
Confidence            389999987  444    3899997532    234567788899999999999999998653  5789999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-  539 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-  539 (600)
                      +++...           ..+++..+++++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+++..... 
T Consensus        98 ~l~~~~-----------~~~~~~~~~~~~~qi~~~L~~LH---~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~  163 (316)
T cd05108          98 YVREHK-----------DNIGSQYLLNWCVQIAKGMNYLE---ERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE  163 (316)
T ss_pred             HHHhcc-----------ccCCHHHHHHHHHHHHHHHHHHH---hcCeeccccchhheEecCCCcEEEccccccccccCCC
Confidence            997643           23889999999999999999999   679999999999999999999999999999865321 


Q ss_pred             -------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          540 -------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       540 -------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                                   +.+||....  ..++.++|||||||++|||++ |+.||...
T Consensus       164 ~~~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slGv~l~el~t~g~~p~~~~  215 (316)
T cd05108         164 KEYHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGI  215 (316)
T ss_pred             cceeccCCccceeecChHHhcc--CCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence                         123444332  456788999999999999998 99999653

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=99.95  E-value=1.3e-26  Score=242.58  Aligned_cols=172  Identities=23%  Similarity=0.356  Sum_probs=144.0

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      +|.||++..  +|..+|+|.++.+    ....+.+|+..+..++||||+++++++..+ +..++||||+++|+|.++++.
T Consensus        18 ~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~   96 (333)
T cd06650          18 GGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-GEISICMEHMDGGSLDQVLKK   96 (333)
T ss_pred             CEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEEC-CEEEEEEecCCCCcHHHHHHH
Confidence            499999998  5888999986542    234678899999999999999999998766 489999999999999999975


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC------
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND------  538 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~------  538 (600)
                      ..            .+++.....++.+++.||.|||+  ..+++||||||+|||++.++.+||+|||+++....      
T Consensus        97 ~~------------~~~~~~~~~~~~~l~~~l~~lH~--~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~  162 (333)
T cd06650          97 AG------------RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF  162 (333)
T ss_pred             cC------------CCCHHHHHHHHHHHHHHHHHHHh--cCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhhccccC
Confidence            43            37888999999999999999994  24799999999999999999999999999875421      


Q ss_pred             ----CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 ----DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 ----~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                          .+.+||....  ..++.++|||||||++|||++|+.||...
T Consensus       163 ~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~~  205 (333)
T cd06650         163 VGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAIGRYPIPPP  205 (333)
T ss_pred             CCCccccCHHHhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence                2335666543  34677899999999999999999999754

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=99.95  E-value=6.7e-27  Score=244.64  Aligned_cols=174  Identities=22%  Similarity=0.258  Sum_probs=141.8

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||+++.  +++.||+|.+....      ...+..|+..+..++|+||+++++++..+ +..|+||||+++|+|.+++
T Consensus        14 fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~-~~~~lv~Ey~~gg~L~~~l   92 (331)
T cd05624          14 FGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDE-NYLYLVMDYYVGGDLLTLL   92 (331)
T ss_pred             CeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CEEEEEEeCCCCCcHHHHH
Confidence            399999988  67889999876421      12356677788888999999999997655 5899999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC----
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND----  538 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~----  538 (600)
                      +...           ..+++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....    
T Consensus        93 ~~~~-----------~~l~~~~~~~~~~qi~~~L~~lH---~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  158 (331)
T cd05624          93 SKFE-----------DRLPEDMARFYIAEMVLAIHSIH---QLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV  158 (331)
T ss_pred             HHhc-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence            7532           23889999999999999999999   67999999999999999999999999999865432    


Q ss_pred             ---------CCCCCcccccC---CCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 ---------DTESPQFYSTN---PASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 ---------~~~~pe~~~~~---~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                               .+.+||.....   ...++.++|||||||+||||++|+.||...
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~  211 (331)
T cd05624         159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE  211 (331)
T ss_pred             eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence                     12345554331   124577899999999999999999999653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=99.95  E-value=1.4e-26  Score=239.03  Aligned_cols=183  Identities=23%  Similarity=0.435  Sum_probs=142.4

Q ss_pred             eEEEEEEEE------------------CCeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEE
Q 041830          391 EGAVYHGRL------------------NGKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFL  448 (600)
Q Consensus       391 ~G~Vy~g~~------------------~g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~L  448 (600)
                      .|.||++.+                  ++..||+|.+...    ....+.+|+..+..++||||++++|++... +..++
T Consensus        18 fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~l   96 (304)
T cd05096          18 FGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRLLGVCVDE-DPLCM   96 (304)
T ss_pred             CeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEecC-CceEE
Confidence            499999975                  2346999987542    234677899999999999999999998765 47899


Q ss_pred             EEeecCCCCHHHHHhcCcCccccc-------ccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC
Q 041830          449 VFEYAKNGSLKDWLHGGLAMKNQF-------IASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE  521 (600)
Q Consensus       449 V~Ey~~~GsL~~~L~~~~~~~~~~-------~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~  521 (600)
                      ||||+++|+|.+++..........       .......++|.++++++.|++.||.|||   +.+|+||||||+|||++.
T Consensus        97 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~ivH~dlkp~Nill~~  173 (304)
T cd05096          97 ITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLS---SLNFVHRDLATRNCLVGE  173 (304)
T ss_pred             EEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccccCcchhheEEcC
Confidence            999999999999996532110000       0111234899999999999999999999   668999999999999999


Q ss_pred             CCcEEEEeccCccccCC--------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHh--CCCCCCCC
Q 041830          522 EFNARVGNFGMARCVND--------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLS--GQTPINRP  579 (600)
Q Consensus       522 ~~~~kI~DFGla~~~~~--------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt--G~~Pf~~~  579 (600)
                      ++.+||+|||+++....              .+.+||....  ..++.++||||||+++|||++  +..||...
T Consensus       174 ~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~  245 (304)
T cd05096         174 NLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILM--GKFTTASDVWAFGVTLWEILMLCKEQPYGEL  245 (304)
T ss_pred             CccEEECCCccceecccCceeEecCcCCCCccccCHHHHhc--CCCCchhhhHHHHHHHHHHHHccCCCCCCcC
Confidence            99999999999875422              1234555443  357888999999999999987  56788654

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>PHA03212 serine/threonine kinase US3; Provisional

Probab=99.94  E-value=1.8e-26  Score=246.64  Aligned_cols=168  Identities=25%  Similarity=0.380  Sum_probs=139.9

Q ss_pred             eeEEEEEEEE--CCeEEEEEEcchhHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcC
Q 041830          390 IEGAVYHGRL--NGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLA  467 (600)
Q Consensus       390 ~~G~Vy~g~~--~g~~vAvK~~~~~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~  467 (600)
                      .+|.||++..  +++.||+|....   ..+.+|+..+..++|||||++++++..+ ...++|+|++. ++|.+++.... 
T Consensus       104 ~~g~V~~~~d~~~~~~vaiK~~~~---~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~lv~e~~~-~~L~~~l~~~~-  177 (391)
T PHA03212        104 AEGFAFACIDNKTCEHVVIKAGQR---GGTATEAHILRAINHPSIIQLKGTFTYN-KFTCLILPRYK-TDLYCYLAAKR-  177 (391)
T ss_pred             CCeEEEEEEECCCCCEEEEechhh---hhhHHHHHHHHhCCCCCCCCEeEEEEEC-CeeEEEEecCC-CCHHHHHHhcC-
Confidence            3499999988  688999997653   3457788899999999999999997655 47899999995 78999886543 


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC---------
Q 041830          468 MKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND---------  538 (600)
Q Consensus       468 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~---------  538 (600)
                                 .+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....         
T Consensus       178 -----------~l~~~~~~~i~~qi~~aL~ylH---~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~  243 (391)
T PHA03212        178 -----------NIAICDILAIERSVLRAIQYLH---ENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGW  243 (391)
T ss_pred             -----------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccc
Confidence                       3889999999999999999999   67999999999999999999999999999864311         


Q ss_pred             ----CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 ----DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 ----~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                          .+.+||....  ..++.++|||||||++|||++|+.||...
T Consensus       244 ~gt~~y~aPE~~~~--~~~~~~~DiwSlGvil~elltg~~p~~~~  286 (391)
T PHA03212        244 AGTIATNAPELLAR--DPYGPAVDIWSAGIVLFEMATCHDSLFEK  286 (391)
T ss_pred             cCccCCCChhhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCcCCc
Confidence                1235666544  35788899999999999999999887653

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=99.94  E-value=1.9e-26  Score=230.93  Aligned_cols=172  Identities=26%  Similarity=0.488  Sum_probs=142.4

Q ss_pred             eEEEEEEEE--CCeEEEEEEcch----hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEH----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      .|.||+++.  +|+.+|+|....    +....+..|+..+..++||||++++++|... ...++||||+++++|.++++.
T Consensus         8 ~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~   86 (252)
T cd05084           8 FGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-QPIYIVMELVQGGDFLTFLRT   86 (252)
T ss_pred             CccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCeEEEEeeccCCcHHHHHHh
Confidence            489999988  789999997643    3335678888889999999999999998665 478999999999999999975


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-----
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-----  539 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-----  539 (600)
                      ..           ..++|.+++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++.....     
T Consensus        87 ~~-----------~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  152 (252)
T cd05084          87 EG-----------PRLKVKELIQMVENAAAGMEYLE---SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYAST  152 (252)
T ss_pred             CC-----------CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEEcCCCcEEECccccCccccccccccc
Confidence            32           23899999999999999999999   679999999999999999999999999998753321     


Q ss_pred             ---------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          540 ---------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       540 ---------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                               +.+||....  ..++.++||||||+++|||++ |..||...
T Consensus       153 ~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~e~~~~~~~p~~~~  200 (252)
T cd05084         153 GGMKQIPVKWTAPEALNY--GRYSSESDVWSFGILLWEAFSLGAVPYANL  200 (252)
T ss_pred             CCCCCCceeecCchhhcC--CCCChHHHHHHHHHHHHHHHhCCCCCcccc
Confidence                     224554433  346778999999999999998 89998643

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=99.94  E-value=1.4e-26  Score=234.34  Aligned_cols=181  Identities=20%  Similarity=0.386  Sum_probs=141.0

Q ss_pred             CceeEEEEEEEE-C---CeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHH
Q 041830          388 NRIEGAVYHGRL-N---GKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       388 ~~~~G~Vy~g~~-~---g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~  459 (600)
                      .+.+|.||+|.. +   ...+++|.+...    ....+.+|+..+..++|+||++++|.+... ...++||||+++|+|.
T Consensus         5 ~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~-~~~~lv~e~~~~g~L~   83 (269)
T cd05042           5 NGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIES-IPYLLVLEFCPLGDLK   83 (269)
T ss_pred             ccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCC-CceEEEEEeCCCCcHH
Confidence            344599999976 2   356899976532    223456788888889999999999998655 4789999999999999


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC-
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND-  538 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~-  538 (600)
                      +++........       ..+++...+.++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++.... 
T Consensus        84 ~~l~~~~~~~~-------~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~  153 (269)
T cd05042          84 NYLRSNRGMVA-------QMAQKDVLQRMACEVASGLLWLH---QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPE  153 (269)
T ss_pred             HHHHhcccccc-------ccccHHHHHHHHHHHHHHHHHHH---hcCEecccccHhheEecCCCcEEEeccccccccccc
Confidence            99976542111       22578888999999999999999   67999999999999999999999999999864311 


Q ss_pred             -------------CCCCCcccccC-----CCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          539 -------------DTESPQFYSTN-----PASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       539 -------------~~~~pe~~~~~-----~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                                   ...+||.....     ...++.++|||||||++|||++ |+.||...
T Consensus       154 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~  213 (269)
T cd05042         154 DYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL  213 (269)
T ss_pred             hheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence                         12345554321     2345778999999999999999 78888654

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=99.94  E-value=1.3e-26  Score=246.75  Aligned_cols=183  Identities=24%  Similarity=0.387  Sum_probs=142.3

Q ss_pred             eEEEEEEEE-------CCeEEEEEEcchh----HHHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCCH
Q 041830          391 EGAVYHGRL-------NGKNLAIKRTEHE----VITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSL  458 (600)
Q Consensus       391 ~G~Vy~g~~-------~g~~vAvK~~~~~----~~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL  458 (600)
                      +|.||++++       ++..||||+++..    ..+.+.+|+..+..+ +||||++++|+|... ...++|||||++|+|
T Consensus        48 fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~-~~~~lv~E~~~~g~L  126 (375)
T cd05104          48 FGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVG-GPTLVITEYCCYGDL  126 (375)
T ss_pred             cceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccC-CcceeeehhccCCcH
Confidence            499999974       3457999998642    224567788888888 899999999998655 488999999999999


Q ss_pred             HHHHhcCcCccc---------------------------------------------------------------ccccc
Q 041830          459 KDWLHGGLAMKN---------------------------------------------------------------QFIAS  475 (600)
Q Consensus       459 ~~~L~~~~~~~~---------------------------------------------------------------~~~~~  475 (600)
                      .++++.......                                                               .....
T Consensus       127 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  206 (375)
T cd05104         127 LNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEE  206 (375)
T ss_pred             HHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhc
Confidence            999975321000                                                               00000


Q ss_pred             cccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--------------CC
Q 041830          476 CYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--------------TE  541 (600)
Q Consensus       476 ~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--------------~~  541 (600)
                      ....++|.+++.++.||+.||.|||   +.+++||||||+|||++.++.+||+|||+++.....              +.
T Consensus       207 ~~~~l~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~  283 (375)
T cd05104         207 DELALDTEDLLSFSYQVAKGMSFLA---SKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWM  283 (375)
T ss_pred             cCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCccee
Confidence            1135899999999999999999999   679999999999999999999999999998754321              23


Q ss_pred             CCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          542 SPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       542 ~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                      +||....  ..++.++|||||||++|||++ |+.||...
T Consensus       284 aPE~~~~--~~~~~~sDi~slG~~l~ellt~g~~p~~~~  320 (375)
T cd05104         284 APESIFN--CVYTFESDVWSYGILLWEIFSLGSSPYPGM  320 (375)
T ss_pred             ChhHhcC--CCCCCCCCHHHHHHHHHHHHhcCCCCCCCC
Confidence            4555433  356788999999999999998 89998654

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=99.94  E-value=2.3e-26  Score=240.10  Aligned_cols=173  Identities=24%  Similarity=0.339  Sum_probs=142.6

Q ss_pred             EEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      +.||++..  +|+.||+|+++.+     ....++.|+..++.++||||+++++++..+ +..++||||+++|+|.+++..
T Consensus        14 ~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~-~~~~lv~e~~~~~~l~~~~~~   92 (327)
T cd08227          14 MTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-NELWVVTSFMAYGSAKDLICT   92 (327)
T ss_pred             EEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEEC-CEEEEEEeccCCCcHHHHHHh
Confidence            78999987  7899999998643     223566788888889999999999998766 489999999999999999965


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC-------
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN-------  537 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~-------  537 (600)
                      ...          ..+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.++++||+......       
T Consensus        93 ~~~----------~~l~~~~~~~i~~qi~~~L~~LH---~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~  159 (327)
T cd08227          93 HFM----------DGMSELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLR  159 (327)
T ss_pred             hcc----------CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCChhhEEEecCCcEEEcccchhhcccccccccc
Confidence            321          23899999999999999999999   6799999999999999999999999998643221       


Q ss_pred             ------------CCCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          538 ------------DDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       538 ------------~~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                                  ..+.+||........++.++|||||||++|||++|+.||..
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~  212 (327)
T cd08227         160 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD  212 (327)
T ss_pred             ccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence                        01235666544334578889999999999999999999974

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=5.6e-27  Score=245.00  Aligned_cols=174  Identities=21%  Similarity=0.286  Sum_probs=137.0

Q ss_pred             ceeEEEEEEEE--CCeEEEEEEcchhHH------HHHHHHHHHHHhC---CCCceeeeeeEEeccCCceEEEEeecCCCC
Q 041830          389 RIEGAVYHGRL--NGKNLAIKRTEHEVI------TKLEMQLVQHATH---HHPNIVRLLGTCLTDGPHSFLVFEYAKNGS  457 (600)
Q Consensus       389 ~~~G~Vy~g~~--~g~~vAvK~~~~~~~------~~~e~ei~~~~~l---~HpNIv~l~g~~~~~~~~~~LV~Ey~~~Gs  457 (600)
                      |..|.||+++.  +|+.||+|.+.....      .....|...+...   .||||+++++++..+ ...|+||||+++|+
T Consensus         4 G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~-~~~~lv~e~~~~g~   82 (330)
T cd05586           4 GTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTD-SDLYLVTDYMSGGE   82 (330)
T ss_pred             CCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecC-CeEEEEEcCCCCCh
Confidence            33499999988  689999999865321      1122233333332   699999999987555 58999999999999


Q ss_pred             HHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC
Q 041830          458 LKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN  537 (600)
Q Consensus       458 L~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~  537 (600)
                      |.+++....            .+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        83 L~~~l~~~~------------~~~~~~~~~~~~qil~al~~LH---~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~  147 (330)
T cd05586          83 LFWHLQKEG------------RFSEDRAKFYIAELVLALEHLH---KYDIVYRDLKPENILLDATGHIALCDFGLSKANL  147 (330)
T ss_pred             HHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeEECCCCCEEEecCCcCcCCC
Confidence            999987543            3899999999999999999999   6799999999999999999999999999986431


Q ss_pred             C------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          538 D------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       538 ~------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                      .            .+.+||.... ...++.++|||||||++|||++|+.||...
T Consensus       148 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DvwslGvil~elltG~~Pf~~~  200 (330)
T cd05586         148 TDNKTTNTFCGTTEYLAPEVLLD-EKGYTKHVDFWSLGVLVFEMCCGWSPFYAE  200 (330)
T ss_pred             CCCCCccCccCCccccCHHHHcC-CCCCCCccceeccccEEEEeccCCCCCCCC
Confidence            1            1234555432 234678899999999999999999999754

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=99.94  E-value=2.7e-26  Score=231.01  Aligned_cols=173  Identities=27%  Similarity=0.482  Sum_probs=140.6

Q ss_pred             ceeEEEEEEEE----CCeEEEEEEcchhH----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          389 RIEGAVYHGRL----NGKNLAIKRTEHEV----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       389 ~~~G~Vy~g~~----~g~~vAvK~~~~~~----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      +..|.||+|.+    .+..||+|.+....    .+.+.+|+..+..++||||++++|++. . +..++||||+++|+|.+
T Consensus         6 G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~-~~~~lv~e~~~~~~L~~   83 (257)
T cd05115           6 GNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-A-EALMLVMEMASGGPLNK   83 (257)
T ss_pred             CCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-C-CCeEEEEEeCCCCCHHH
Confidence            33489999977    34579999875432    245778899999999999999999874 3 36899999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-  539 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-  539 (600)
                      ++....           ..+++.++++++.|++.||.|||   +.+++||||||+|||++.++.+||+|||+++..... 
T Consensus        84 ~l~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~  149 (257)
T cd05115          84 FLSGKK-----------DEITVSNVVELMHQVSMGMKYLE---GKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADD  149 (257)
T ss_pred             HHHhCC-----------CCCCHHHHHHHHHHHHHHHHHHH---hcCeeecccchheEEEcCCCcEEeccCCccccccCCc
Confidence            997533           23899999999999999999999   679999999999999999999999999998744221 


Q ss_pred             --------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          540 --------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       540 --------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                                    ..+||....  ..++.++|||||||++|||++ |+.||...
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~  202 (257)
T cd05115         150 SYYKARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGITMWEAFSYGQKPYKKM  202 (257)
T ss_pred             cceeccCCCCCCcccCCHHHHcc--CCCCchhhHHHHHHHHHHHhcCCCCCcCcC
Confidence                          223444332  346778999999999999996 99999754

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=99.94  E-value=2.7e-26  Score=230.53  Aligned_cols=173  Identities=25%  Similarity=0.498  Sum_probs=143.2

Q ss_pred             eeEEEEEEEE-CCeEEEEEEcchhH--HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCc
Q 041830          390 IEGAVYHGRL-NGKNLAIKRTEHEV--ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGL  466 (600)
Q Consensus       390 ~~G~Vy~g~~-~g~~vAvK~~~~~~--~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~  466 (600)
                      ..|.||++.+ ++..+|+|.++...  ...+..|+..+..++||||+++++++..+ ...++||||+++|+|.++++...
T Consensus        16 ~~~~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~iv~e~~~~~~L~~~~~~~~   94 (256)
T cd05114          16 QFGVVHLGKWRAQIKVAIKAINEGAMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQ-KPLYIVTEFMENGCLLNYLRQRQ   94 (256)
T ss_pred             cCceEEEEEeccCceEEEEecccCCccHHHHHHHHHHHHHCCCCCceeEEEEEccC-CCEEEEEEcCCCCcHHHHHHhCc
Confidence            3489999998 55689999876432  34677899999999999999999997655 48899999999999999997533


Q ss_pred             CcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC--------
Q 041830          467 AMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND--------  538 (600)
Q Consensus       467 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~--------  538 (600)
                                 ..++|..++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++....        
T Consensus        95 -----------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~  160 (256)
T cd05114          95 -----------GKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSG  160 (256)
T ss_pred             -----------cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCC
Confidence                       23899999999999999999999   67999999999999999999999999998875421        


Q ss_pred             -----CCCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          539 -----DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       539 -----~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                           ...+||....  ..++.++||||||+++|||++ |+.||...
T Consensus       161 ~~~~~~y~aPE~~~~--~~~~~~~Di~s~G~~l~el~~~g~~p~~~~  205 (256)
T cd05114         161 AKFPVKWSPPEVFNF--SKYSSKSDVWSFGVLMWEVFTEGKMPFEKK  205 (256)
T ss_pred             CCCchhhCChhhccc--CccchhhhhHHHHHHHHHHHcCCCCCCCCC
Confidence                 1224554432  346778999999999999999 99999654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=99.94  E-value=2.4e-26  Score=230.81  Aligned_cols=172  Identities=28%  Similarity=0.517  Sum_probs=145.6

Q ss_pred             EEEEEEEECCeEEEEEEcchhH-HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcCccc
Q 041830          392 GAVYHGRLNGKNLAIKRTEHEV-ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKN  470 (600)
Q Consensus       392 G~Vy~g~~~g~~vAvK~~~~~~-~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~  470 (600)
                      |.||++...|..+|+|..+.+. .+.+..|+..+..++|+|+++++|++..++...++++||+++|+|.++++....   
T Consensus        20 ~~v~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~---   96 (256)
T cd05082          20 GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR---   96 (256)
T ss_pred             CeEEEEEEcCCcEEEEEeCCCchHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCC---
Confidence            8999999999999999886543 345778999999999999999999876665578999999999999999975432   


Q ss_pred             ccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC---------CC
Q 041830          471 QFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---------TE  541 (600)
Q Consensus       471 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~---------~~  541 (600)
                             ..++|..++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++.....         ..
T Consensus        97 -------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~  166 (256)
T cd05082          97 -------SVLGGDCLLKFSLDVCEAMEYLE---ANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT  166 (256)
T ss_pred             -------CCCCHHHHHHHHHHHHHHHHHHH---hCCEeccccchheEEEcCCCcEEecCCccceeccccCCCCccceeec
Confidence                   23889999999999999999999   679999999999999999999999999998754321         23


Q ss_pred             CCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCC
Q 041830          542 SPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINR  578 (600)
Q Consensus       542 ~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~  578 (600)
                      +||....  ..++.++||||||+++|||++ |+.||..
T Consensus       167 aPE~~~~--~~~~~~~Dv~slG~i~~~l~~~g~~p~~~  202 (256)
T cd05082         167 APEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPR  202 (256)
T ss_pred             CHHHHcc--CCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence            4565433  346778999999999999998 9999864

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=99.94  E-value=2.8e-26  Score=231.45  Aligned_cols=172  Identities=24%  Similarity=0.515  Sum_probs=143.9

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH--HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCc
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV--ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGL  466 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~--~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~  466 (600)
                      .|.||++..  +++.||+|.++.+.  ...+..|+..+..++|+||+++++++..+ ...+++|||+++|+|.+++....
T Consensus        19 ~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~   97 (263)
T cd05052          19 YGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-PPFYIITEFMTYGNLLDYLRECN   97 (263)
T ss_pred             cceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCCCCChhheEEEEcCC-CCcEEEEEeCCCCcHHHHHHhCC
Confidence            489999988  58899999986543  24567889999999999999999998665 47899999999999999997543


Q ss_pred             CcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-------
Q 041830          467 AMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-------  539 (600)
Q Consensus       467 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-------  539 (600)
                      .          ..+++..++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++.....       
T Consensus        98 ~----------~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~  164 (263)
T cd05052          98 R----------QEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG  164 (263)
T ss_pred             C----------CCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCcEEeCCCccccccccceeeccCC
Confidence            2          34899999999999999999999   679999999999999999999999999998765322       


Q ss_pred             ------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCC
Q 041830          540 ------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINR  578 (600)
Q Consensus       540 ------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~  578 (600)
                            ..+||....  ..++.++|||||||++|||++ |..||..
T Consensus       165 ~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~t~g~~p~~~  208 (263)
T cd05052         165 AKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPG  208 (263)
T ss_pred             CCCccccCCHHHhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence                  234554433  345778999999999999998 9999864

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=99.94  E-value=2.5e-26  Score=235.11  Aligned_cols=174  Identities=21%  Similarity=0.372  Sum_probs=136.3

Q ss_pred             eEEEEEEEE---CCeEEEEEEcchhH-----HHHHHHHHHHHHh---CCCCceeeeeeEEec----cCCceEEEEeecCC
Q 041830          391 EGAVYHGRL---NGKNLAIKRTEHEV-----ITKLEMQLVQHAT---HHHPNIVRLLGTCLT----DGPHSFLVFEYAKN  455 (600)
Q Consensus       391 ~G~Vy~g~~---~g~~vAvK~~~~~~-----~~~~e~ei~~~~~---l~HpNIv~l~g~~~~----~~~~~~LV~Ey~~~  455 (600)
                      .|.||+++.   +|+.||+|.++...     ...+.+|+..+..   +.||||++++++|..    .....++||||++ 
T Consensus        14 ~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-   92 (290)
T cd07862          14 YGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-   92 (290)
T ss_pred             CeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-
Confidence            499999987   46789999875321     1233445544443   479999999999852    2336899999996 


Q ss_pred             CCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccc
Q 041830          456 GSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARC  535 (600)
Q Consensus       456 GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~  535 (600)
                      ++|.+++.....          ..+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        93 ~~l~~~~~~~~~----------~~~~~~~~~~i~~qi~~aL~~lH---~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~  159 (290)
T cd07862          93 QDLTTYLDKVPE----------PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI  159 (290)
T ss_pred             CCHHHHHHhCCC----------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence            699999875331          33899999999999999999999   67999999999999999999999999999875


Q ss_pred             cCCC-----------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          536 VNDD-----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       536 ~~~~-----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                      ....           +.+||....  ..++.++|||||||++|||++|++||....
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~~f~~~~  213 (290)
T cd07862         160 YSFQMALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSS  213 (290)
T ss_pred             ccCCcccccccccccccChHHHhC--CCCCCccchHHHHHHHHHHHcCCCCcCCCC
Confidence            4321           235665533  456788999999999999999999997643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.94  E-value=6.8e-26  Score=228.10  Aligned_cols=171  Identities=26%  Similarity=0.393  Sum_probs=142.2

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh--------HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE--------VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~--------~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      .|.||++..  +|+.+|+|.+...        ....+++|+..+..++||||+++++++..+ ...++|+||+++++|.+
T Consensus        15 ~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e~~~~~~l~~   93 (263)
T cd06625          15 FGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDD-ETLSIFMEYMPGGSVKD   93 (263)
T ss_pred             ceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccC-CeEEEEEEECCCCcHHH
Confidence            389999987  6899999986431        124577889999999999999999997655 48999999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC--
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND--  538 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~--  538 (600)
                      ++....            .+++..+..++.+++.||.|||   +.+++||||+|+||++++++.+||+|||+++....  
T Consensus        94 ~~~~~~------------~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~  158 (263)
T cd06625          94 QLKAYG------------ALTETVTRKYTRQILEGVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC  158 (263)
T ss_pred             HHHHhC------------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceeccccc
Confidence            987532            3888999999999999999999   67999999999999999999999999999864321  


Q ss_pred             -------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 -------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 -------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                   ...+||....  ..++.++||||||+++|||++|+.||...
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~  210 (263)
T cd06625         159 SSGTGMKSVTGTPYWMSPEVISG--EGYGRKADVWSVGCTVVEMLTEKPPWAEF  210 (263)
T ss_pred             cccccccCCCcCccccCcceecc--CCCCchhhhHHHHHHHHHHHhCCCCcccc
Confidence                         1234555544  33677899999999999999999999653

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.94  E-value=3.8e-26  Score=259.40  Aligned_cols=182  Identities=21%  Similarity=0.296  Sum_probs=144.2

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh------HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE------VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~------~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||+|+.  +|+.||+|+++.+      ..+++.+|+..+..++||||+++++++... +..+++|||+++|+|.+++
T Consensus        15 fG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~-~~lyLVMEY~eGGSL~~lL   93 (932)
T PRK13184         15 MGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDG-DPVYYTMPYIEGYTLKSLL   93 (932)
T ss_pred             CEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeC-CEEEEEEEcCCCCCHHHHH
Confidence            399999988  6899999987542      234577899999999999999999998655 4889999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC-----
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN-----  537 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~-----  537 (600)
                      ....... .........+++.++++++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...     
T Consensus        94 ~s~~~~~-~l~e~~~~~lsv~~iL~I~~QIa~AL~yLH---s~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~  169 (932)
T PRK13184         94 KSVWQKE-SLSKELAEKTSVGAFLSIFHKICATIEYVH---SKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEED  169 (932)
T ss_pred             HHhhhcc-ccchhhhcccCHHHHHHHHHHHHHHHHHHH---HCCccccCCchheEEEcCCCCEEEEecCcceeccccccc
Confidence            7532110 000011134778899999999999999999   6799999999999999999999999999997551     


Q ss_pred             -------------------------CCCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          538 -------------------------DDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       538 -------------------------~~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                               ....+||....  ..++.++|||||||++|||+||+.||...
T Consensus       170 ~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g--~~~S~kSDIWSLGVILyELLTG~~PF~~~  234 (932)
T PRK13184        170 LLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG--VPASESTDIYALGVILYQMLTLSFPYRRK  234 (932)
T ss_pred             ccccccccccccccccccCCCCCCCCCCCCHHHhcC--CCCCcHhHHHHHHHHHHHHHHCCCCCCCc
Confidence                                     11223444333  34678899999999999999999999753

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=99.94  E-value=5e-26  Score=227.95  Aligned_cols=174  Identities=26%  Similarity=0.394  Sum_probs=145.5

Q ss_pred             eEEEEEEEE--CCeEEEEEEcch-----hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEH-----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~-----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      .|.||++..  +|+.|++|.++.     .....+..|+..+..++||||+++++++..+ ...++||||+++++|.++++
T Consensus        13 ~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~   91 (256)
T cd08529          13 FGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDK-GKLNIVMEYAENGDLHKLLK   91 (256)
T ss_pred             CeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccC-CEEEEEEEeCCCCcHHHHHH
Confidence            389999988  689999998653     2334677888889999999999999998665 48899999999999999997


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD----  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~----  539 (600)
                      ....          ..+++.++..++.+++.||.|||   +.+++||||||+||++++++.+||+|||+++.....    
T Consensus        92 ~~~~----------~~~~~~~~~~i~~~l~~al~~lH---~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~  158 (256)
T cd08529          92 MQRG----------RPLPEDQVWRFFIQILLGLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFA  158 (256)
T ss_pred             HhcC----------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchh
Confidence            6421          34899999999999999999999   679999999999999999999999999998754322    


Q ss_pred             --------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 --------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 --------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                              ..+||+...  ..++.++|+||||+++|||++|+.||...+
T Consensus       159 ~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~  205 (256)
T cd08529         159 NTIVGTPYYLSPELCED--KPYNEKSDVWALGVVLYECCTGKHPFDANN  205 (256)
T ss_pred             hccccCccccCHHHhcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence                    224555544  346778999999999999999999997544

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=99.94  E-value=3.1e-26  Score=231.67  Aligned_cols=174  Identities=23%  Similarity=0.386  Sum_probs=142.9

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh---HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcC
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE---VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGG  465 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~---~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~  465 (600)
                      .|.||+|+.  ++..|++|.+...   ..+.+.+|+..+..++|+||++++|++... +..++++||+++++|.++++..
T Consensus        21 ~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~   99 (268)
T cd06624          21 YGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSEN-GFFKIFMEQVPGGSLSALLRSK   99 (268)
T ss_pred             ceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccC-CEEEEEEecCCCCCHHHHHHHh
Confidence            389999987  5778999987543   234677889999999999999999997655 4889999999999999999754


Q ss_pred             cCcccccccccccCC--CHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC-CCcEEEEeccCccccCC----
Q 041830          466 LAMKNQFIASCYCFL--TWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE-EFNARVGNFGMARCVND----  538 (600)
Q Consensus       466 ~~~~~~~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~-~~~~kI~DFGla~~~~~----  538 (600)
                      .           ..+  ++.++..++.|++.||+|||   +.+|+||||||+||+++. ++.+||+|||++.....    
T Consensus       100 ~-----------~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~  165 (268)
T cd06624         100 W-----------GPLKDNEQTIIFYTKQILEGLKYLH---DNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPC  165 (268)
T ss_pred             c-----------ccCCCcHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCc
Confidence            2           124  78888999999999999999   679999999999999986 67999999999865421    


Q ss_pred             --------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 --------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 --------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                              ...+||........++.++||||||+++|||++|+.||...
T Consensus       166 ~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~  214 (268)
T cd06624         166 TETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL  214 (268)
T ss_pred             cccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccc
Confidence                    12356665444445678899999999999999999999753

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=99.94  E-value=2e-26  Score=245.17  Aligned_cols=183  Identities=25%  Similarity=0.384  Sum_probs=142.4

Q ss_pred             eEEEEEEEE--C-----CeEEEEEEcchh----HHHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCCH
Q 041830          391 EGAVYHGRL--N-----GKNLAIKRTEHE----VITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSL  458 (600)
Q Consensus       391 ~G~Vy~g~~--~-----g~~vAvK~~~~~----~~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL  458 (600)
                      +|.||+++.  .     +..||+|+++..    ....+..|+..+..+ +|+|||+++|+|... ...++||||+++|+|
T Consensus        51 fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~-~~~~lv~ey~~~g~L  129 (374)
T cd05106          51 FGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHG-GPVLVITEYCCYGDL  129 (374)
T ss_pred             cccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC-CCeEEeHhhccCCcH
Confidence            499999875  2     247999998642    234567788888888 899999999998665 488999999999999


Q ss_pred             HHHHhcCcCcc----------------------------------------------------------cccccccccCC
Q 041830          459 KDWLHGGLAMK----------------------------------------------------------NQFIASCYCFL  480 (600)
Q Consensus       459 ~~~L~~~~~~~----------------------------------------------------------~~~~~~~~~~l  480 (600)
                      .++++......                                                          ..........+
T Consensus       130 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  209 (374)
T cd05106         130 LNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPL  209 (374)
T ss_pred             HHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccccchhccCCCCCc
Confidence            99996532100                                                          00000112358


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--------------CCCCccc
Q 041830          481 TWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--------------TESPQFY  546 (600)
Q Consensus       481 ~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--------------~~~pe~~  546 (600)
                      ++.++++++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+++.....              +.+||..
T Consensus       210 ~~~~~~~i~~qi~~aL~yLH---~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~  286 (374)
T cd05106         210 DLDDLLRFSSQVAQGMDFLA---SKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESI  286 (374)
T ss_pred             CHHHHHHHHHHHHHHHHHHH---HCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHh
Confidence            99999999999999999999   679999999999999999999999999998754221              2345544


Q ss_pred             ccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          547 STNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       547 ~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                      ..  ..++.++|||||||++|||++ |+.||...
T Consensus       287 ~~--~~~~~~~DvwSlGvil~ellt~G~~Pf~~~  318 (374)
T cd05106         287 FD--CVYTVQSDVWSYGILLWEIFSLGKSPYPGI  318 (374)
T ss_pred             cC--CCCCccccHHHHHHHHHHHHhCCCCCCccc
Confidence            33  457889999999999999997 99999654

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=99.94  E-value=2.9e-26  Score=230.39  Aligned_cols=172  Identities=30%  Similarity=0.526  Sum_probs=141.9

Q ss_pred             eEEEEEEEE-CCeEEEEEEcchhH--HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcC
Q 041830          391 EGAVYHGRL-NGKNLAIKRTEHEV--ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLA  467 (600)
Q Consensus       391 ~G~Vy~g~~-~g~~vAvK~~~~~~--~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~  467 (600)
                      .|.||++.+ .+..+|+|.+....  ...+..|+..+..++||||+++++++... ...++||||+++++|.++++... 
T Consensus        17 ~~~v~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~-   94 (256)
T cd05059          17 FGVVHLGKWRGKIDVAIKMIREGAMSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQ-RPIFIVTEYMANGCLLNYLRERK-   94 (256)
T ss_pred             CceEEEeEecCCccEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEEEEEEEEcCC-CceEEEEecCCCCCHHHHHHhcc-
Confidence            389999988 45689999876432  23567788889999999999999997655 47899999999999999997543 


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--------
Q 041830          468 MKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--------  539 (600)
Q Consensus       468 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--------  539 (600)
                                ..++|..++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++.....        
T Consensus        95 ----------~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~  161 (256)
T cd05059          95 ----------GKLGTEWLLDMCSDVCEAMEYLE---SNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGT  161 (256)
T ss_pred             ----------cCCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHhhEEECCCCcEEECCcccceecccccccccCCC
Confidence                      23899999999999999999999   678999999999999999999999999998754321        


Q ss_pred             -----CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          540 -----TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       540 -----~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                           ..+||....  ..++.++||||||+++|||++ |+.||...
T Consensus       162 ~~~~~y~~Pe~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~  205 (256)
T cd05059         162 KFPVKWAPPEVFDY--SRFSSKSDVWSFGVLMWEVFSEGKMPYERF  205 (256)
T ss_pred             CCCccccCHHHhcc--CCCCchhhHHHHHHHHHHHhccCCCCCCCC
Confidence                 234554433  346778999999999999999 89999654

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.94  E-value=4.2e-26  Score=230.93  Aligned_cols=180  Identities=18%  Similarity=0.350  Sum_probs=141.2

Q ss_pred             ceeEEEEEEEEC----CeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          389 RIEGAVYHGRLN----GKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       389 ~~~G~Vy~g~~~----g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      +..|.||+|++.    +..+|+|.++..    ....+.+|+..+..++||||++++|++.+. ...++||||+++|+|.+
T Consensus         6 G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~g~L~~   84 (269)
T cd05087           6 GWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEV-TPYLLVMEFCPLGDLKG   84 (269)
T ss_pred             cCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC-CCcEEEEECCCCCcHHH
Confidence            334899999873    357999987542    223567788999999999999999997655 47899999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC--
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND--  538 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~--  538 (600)
                      +++.......       ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++....  
T Consensus        85 ~l~~~~~~~~-------~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~  154 (269)
T cd05087          85 YLRSCRKAEL-------MTPDPTTLQRMACEIALGLLHLH---KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKED  154 (269)
T ss_pred             HHHHhhhccc-------ccccHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEECCccccccccCcc
Confidence            9975432110       23678888999999999999999   67999999999999999999999999999864321  


Q ss_pred             ------------CCCCCcccccCC-----CCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          539 ------------DTESPQFYSTNP-----ASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       539 ------------~~~~pe~~~~~~-----~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                                  ...+||......     ..++.++|+||||+++|||++ |+.||...
T Consensus       155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~  213 (269)
T cd05087         155 YYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHL  213 (269)
T ss_pred             eeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCC
Confidence                        123456543211     235778999999999999996 99999654

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=99.94  E-value=9.4e-26  Score=226.79  Aligned_cols=171  Identities=25%  Similarity=0.476  Sum_probs=139.9

Q ss_pred             eeEEEEEEEE----CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          390 IEGAVYHGRL----NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       390 ~~G~Vy~g~~----~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      ..|.||+|.+    +++.+|+|.++.+     ..+.+..|+..+..+.||||++++|++. . +..++||||+++|+|.+
T Consensus         7 ~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~-~~~~lv~e~~~~~~L~~   84 (257)
T cd05116           7 NFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-A-ESWMLVMELAELGPLNK   84 (257)
T ss_pred             CCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-C-CCcEEEEecCCCCcHHH
Confidence            3489999976    5788999987532     2345778888999999999999999974 3 36799999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-  539 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-  539 (600)
                      ++....            .+++..++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++..... 
T Consensus        85 ~l~~~~------------~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~  149 (257)
T cd05116          85 FLQKNK------------HVTEKNITELVHQVSMGMKYLE---ETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADE  149 (257)
T ss_pred             HHHhcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchhhEEEcCCCeEEECCCccccccCCCC
Confidence            996532            3889999999999999999999   679999999999999999999999999998754321 


Q ss_pred             --------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          540 --------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       540 --------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                                    ..+||....  ..++.++|||||||++|||++ |+.||...
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~  202 (257)
T cd05116         150 NYYKAKTHGKWPVKWYAPECMNY--YKFSSKSDVWSFGVLMWEAFSYGQKPYKGM  202 (257)
T ss_pred             CeeeecCCCCCCccccCHhHhcc--CCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence                          123443322  345678999999999999998 99999753

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=99.94  E-value=6.3e-26  Score=232.03  Aligned_cols=174  Identities=21%  Similarity=0.265  Sum_probs=143.9

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||++..  +|+.+|+|.++...      ...+..|+..+..++|+||+++.+.+..+ +..+++|||+++|+|.+++
T Consensus        13 ~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~   91 (285)
T cd05632          13 FGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETK-DALCLVLTIMNGGDLKFHI   91 (285)
T ss_pred             CeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecC-CEEEEEEEeccCccHHHHH
Confidence            499999988  68899999876432      22356788889999999999999887555 4889999999999999988


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC----
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND----  538 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~----  538 (600)
                      .....          ..+++.++..++.|++.||.|||   +.+|+||||||+||++++++.+||+|||+++....    
T Consensus        92 ~~~~~----------~~~~~~~~~~~~~ql~~~l~~lH---~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  158 (285)
T cd05632          92 YNMGN----------PGFEEERALFYAAEILCGLEDLH---RENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESI  158 (285)
T ss_pred             HHhcC----------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcc
Confidence            65321          24899999999999999999999   67999999999999999999999999999865421    


Q ss_pred             -------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          539 -------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       539 -------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                             ...+||....  ..++.++|+|||||++|||++|+.||....
T Consensus       159 ~~~~g~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~P~~~~~  205 (285)
T cd05632         159 RGRVGTVGYMAPEVLNN--QRYTLSPDYWGLGCLIYEMIEGQSPFRGRK  205 (285)
T ss_pred             cCCCCCcCccChHHhcC--CCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence                   2235665543  456788999999999999999999997543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=99.94  E-value=6e-26  Score=228.64  Aligned_cols=173  Identities=26%  Similarity=0.510  Sum_probs=143.7

Q ss_pred             eEEEEEEEE-CCeEEEEEEcchhH--HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcC
Q 041830          391 EGAVYHGRL-NGKNLAIKRTEHEV--ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLA  467 (600)
Q Consensus       391 ~G~Vy~g~~-~g~~vAvK~~~~~~--~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~  467 (600)
                      .|.||+|.. +++.||+|.++...  .+.+.+|+..+..++||||+++++++... +..+++|||+++++|.+++.....
T Consensus        19 ~~~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~   97 (261)
T cd05068          19 FGEVWEGLWNNTTPVAVKTLKPGTMDPKDFLAEAQIMKKLRHPKLIQLYAVCTLE-EPIYIVTELMKYGSLLEYLQGGAG   97 (261)
T ss_pred             CccEEEEEecCCeEEEEEeeCCCcccHHHHHHHHHHHHHCCCCCccceeEEEecC-CCeeeeeecccCCcHHHHHhccCC
Confidence            389999988 56789999986532  34577899999999999999999997655 478999999999999999975431


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--------
Q 041830          468 MKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--------  539 (600)
Q Consensus       468 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--------  539 (600)
                                ..++|.++..++.|++.||.|||   +.+++||||||+||++++++.+||+|||+++.....        
T Consensus        98 ----------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  164 (261)
T cd05068          98 ----------RALKLPQLIDMAAQVASGMAYLE---AQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREGA  164 (261)
T ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccCCC
Confidence                      34899999999999999999999   679999999999999999999999999998754321        


Q ss_pred             -----CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          540 -----TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       540 -----~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                           ..+||....  ..++.++||||||+++|||++ |+.||...
T Consensus       165 ~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~  208 (261)
T cd05068         165 KFPIKWTAPEAALY--NRFSIKSDVWSFGILLTEIVTYGRMPYPGM  208 (261)
T ss_pred             cCceeccCcccccc--CCCCchhhHHHHHHHHHHHHhcCCCCCCCC
Confidence                 224554432  346778999999999999999 99999653

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=99.94  E-value=1e-25  Score=229.10  Aligned_cols=169  Identities=26%  Similarity=0.464  Sum_probs=142.2

Q ss_pred             eEEEEEEEE--CCeEEEEEEcch----hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEH----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      .|.||+|..  +|+.||+|..+.    .....++.|+..+..++||||+++++++..+ ...++||||+++++|.+++..
T Consensus        17 ~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~   95 (277)
T cd06642          17 FGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKG-TKLWIIMEYLGGGSALDLLKP   95 (277)
T ss_pred             CeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccC-CceEEEEEccCCCcHHHHhhc
Confidence            389999987  678999998753    2234678899999999999999999997655 489999999999999999864


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-----
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-----  539 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-----  539 (600)
                      +             .+++.++..++.|++.||.|||   ..+++|+||+|+||++++++.+||+|||+++.....     
T Consensus        96 ~-------------~~~~~~~~~~~~~i~~~l~~lH---~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06642          96 G-------------PLEETYIATILREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             C-------------CCCHHHHHHHHHHHHHHHHHHh---cCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhh
Confidence            2             2889999999999999999999   679999999999999999999999999998754321     


Q ss_pred             -------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          540 -------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       540 -------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                             ..+||....  ..++.++|||||||++|||++|+.||..
T Consensus       160 ~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~  203 (277)
T cd06642         160 TFVGTPFWMAPEVIKQ--SAYDFKADIWSLGITAIELAKGEPPNSD  203 (277)
T ss_pred             cccCcccccCHHHhCc--CCCchhhhHHHHHHHHHHHHhCCCCCcc
Confidence                   234555443  3467789999999999999999999864

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=99.94  E-value=1.1e-25  Score=226.92  Aligned_cols=129  Identities=26%  Similarity=0.340  Sum_probs=111.3

Q ss_pred             EEEEEEEECC--eEEEEEEcchhHH------HHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          392 GAVYHGRLNG--KNLAIKRTEHEVI------TKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       392 G~Vy~g~~~g--~~vAvK~~~~~~~------~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      |+||.+++.|  ..+|+|+++++..      .+.+.|-.++..++||.+..|++.+..+ ...+|+||||+||+|...++
T Consensus        91 G~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~-~~~cl~meyCpGGdL~~Lrq  169 (459)
T KOG0610|consen   91 GTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETD-KYSCLVMEYCPGGDLHSLRQ  169 (459)
T ss_pred             eeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeecc-ceeEEEEecCCCccHHHHHh
Confidence            9999999954  7899999977543      2345566677788999999999997655 48899999999999999887


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCcc
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR  534 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~  534 (600)
                      +...          ..+++..+.-++.+|+-||+|||   -.+||.|||||+||||-++|++-|+||.|+.
T Consensus       170 kQp~----------~~fse~~aRFYaAEvl~ALEYLH---mlGivYRDLKPENILvredGHIMLsDFDLS~  227 (459)
T KOG0610|consen  170 KQPG----------KRFSESAARFYAAEVLLALEYLH---MLGIVYRDLKPENILVREDGHIMLSDFDLSL  227 (459)
T ss_pred             hCCC----------CccchhhHHHHHHHHHHHHHHHH---hhceeeccCCcceeEEecCCcEEeeeccccc
Confidence            6543          34899999999999999999999   5699999999999999999999999999875

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=99.94  E-value=7.5e-26  Score=231.54  Aligned_cols=173  Identities=21%  Similarity=0.276  Sum_probs=143.6

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||++..  +++.||+|.++...      ...+..|+..+..++|+||+++++.+..+ +..++||||+++|+|.+++
T Consensus        13 ~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~g~~L~~~l   91 (285)
T cd05630          13 FGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETK-DALCLVLTLMNGGDLKFHI   91 (285)
T ss_pred             CeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecC-CEEEEEEEecCCCcHHHHH
Confidence            499999988  68899999875432      12345688889999999999999997655 4899999999999999998


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC----
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND----  538 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~----  538 (600)
                      .....          ..+++.+++.++.|++.||.|||   +.+|+||||||+||++++++.++|+|||++.....    
T Consensus        92 ~~~~~----------~~l~~~~~~~~~~qi~~~l~~lH---~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~  158 (285)
T cd05630          92 YHMGE----------AGFEEGRAVFYAAEICCGLEDLH---QERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTI  158 (285)
T ss_pred             HHhcc----------cCCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCccc
Confidence            64321          34899999999999999999999   67999999999999999999999999999865432    


Q ss_pred             -------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 -------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 -------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                             ...+||....  ..++.++|||||||++|||++|+.||...
T Consensus       159 ~~~~g~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~Pf~~~  204 (285)
T cd05630         159 KGRVGTVGYMAPEVVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQR  204 (285)
T ss_pred             cCCCCCccccChHHHcC--CCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence                   1235666543  45678899999999999999999999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=99.94  E-value=4.3e-26  Score=239.14  Aligned_cols=184  Identities=24%  Similarity=0.400  Sum_probs=143.6

Q ss_pred             eEEEEEEEE-------CCeEEEEEEcchh----HHHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCCH
Q 041830          391 EGAVYHGRL-------NGKNLAIKRTEHE----VITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSL  458 (600)
Q Consensus       391 ~G~Vy~g~~-------~g~~vAvK~~~~~----~~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL  458 (600)
                      .|.||++..       +++.||+|+++..    ..+.+..|+..+..+ +|+||++++++|..++..++++|||+++|+|
T Consensus        20 fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L   99 (337)
T cd05054          20 FGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNL   99 (337)
T ss_pred             CceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCH
Confidence            499999975       2468999987532    223456788888888 7999999999987766678999999999999


Q ss_pred             HHHHhcCcCccc----c---------------------------------------------cccccccCCCHHHHHHHH
Q 041830          459 KDWLHGGLAMKN----Q---------------------------------------------FIASCYCFLTWSQRLRIC  489 (600)
Q Consensus       459 ~~~L~~~~~~~~----~---------------------------------------------~~~~~~~~l~~~~~~~i~  489 (600)
                      .+++........    .                                             ........++|.++..++
T Consensus       100 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  179 (337)
T cd05054         100 SNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYS  179 (337)
T ss_pred             HHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHH
Confidence            999964321000    0                                             000001368999999999


Q ss_pred             HHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC--------------CCCCCcccccCCCCCCc
Q 041830          490 LDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND--------------DTESPQFYSTNPASWSM  555 (600)
Q Consensus       490 ~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~--------------~~~~pe~~~~~~~~~t~  555 (600)
                      .||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.+..              .+.+||....  ..++.
T Consensus       180 ~qi~~aL~~lH---~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~  254 (337)
T cd05054         180 FQVARGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFD--KVYTT  254 (337)
T ss_pred             HHHHHHHHHHH---hCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcC--CCCCc
Confidence            99999999999   67999999999999999999999999999976421              1234555443  45788


Q ss_pred             cCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          556 GIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       556 ~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                      ++|||||||+||||++ |+.||...
T Consensus       255 ~~Di~SlGv~l~el~t~g~~p~~~~  279 (337)
T cd05054         255 QSDVWSFGVLLWEIFSLGASPYPGV  279 (337)
T ss_pred             cccHHHHHHHHHHHHHcCCCCCCCC
Confidence            8999999999999998 99999653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.94  E-value=8e-26  Score=230.66  Aligned_cols=171  Identities=27%  Similarity=0.480  Sum_probs=140.2

Q ss_pred             eEEEEEEEE------CCeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccC-CceEEEEeecCCCCHH
Q 041830          391 EGAVYHGRL------NGKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDG-PHSFLVFEYAKNGSLK  459 (600)
Q Consensus       391 ~G~Vy~g~~------~g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~-~~~~LV~Ey~~~GsL~  459 (600)
                      .|.||.+.+      +++.||+|..+..    ....+.+|+..+..++||||+++++++.... ...+++|||+++|+|.
T Consensus        17 ~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~   96 (283)
T cd05080          17 FGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLR   96 (283)
T ss_pred             CcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHH
Confidence            488987653      5678999987643    2345678999999999999999999876542 3578999999999999


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD  539 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~  539 (600)
                      +++...             .++|.++..++.|++.||.|||   +.+++||||||+|||+++++.+||+|||+++.....
T Consensus        97 ~~~~~~-------------~l~~~~~~~i~~~l~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  160 (283)
T cd05080          97 DYLPKH-------------KLNLAQLLLFAQQICEGMAYLH---SQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  160 (283)
T ss_pred             HHHHHc-------------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence            999653             2899999999999999999999   679999999999999999999999999998755321


Q ss_pred             C---------------CCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 T---------------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 ~---------------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                      .               .+||....  ..++.++||||||+++|||++|+.||...
T Consensus       161 ~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~  213 (283)
T cd05080         161 HEYYRVREDGDSPVFWYAVECLKE--NKFSYASDVWSFGVTLYELLTHCDSKQSP  213 (283)
T ss_pred             chhhccCCCCCCCceeeCHhHhcc--cCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence            1               23444332  34678899999999999999999998653

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=99.94  E-value=8.4e-26  Score=232.45  Aligned_cols=171  Identities=25%  Similarity=0.472  Sum_probs=142.2

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH---HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcC
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV---ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGG  465 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~---~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~  465 (600)
                      .|.||+|+.  +|+.|++|.+....   ...+..|+..+..++|+||+++++.+... ...++||||+++|+|.++++..
T Consensus        33 ~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~  111 (296)
T cd06654          33 SGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-DELWVVMEYLAGGSLTDVVTET  111 (296)
T ss_pred             CeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeC-CEEEEeecccCCCCHHHHHHhc
Confidence            489999987  68899999875422   24567788888999999999999997655 4899999999999999998643


Q ss_pred             cCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC------
Q 041830          466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD------  539 (600)
Q Consensus       466 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~------  539 (600)
                                   .+++.++..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++.....      
T Consensus       112 -------------~~~~~~~~~i~~ql~~aL~~LH---~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~  175 (296)
T cd06654         112 -------------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  175 (296)
T ss_pred             -------------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEECccccchhccccccccCc
Confidence                         2789999999999999999999   679999999999999999999999999998653221      


Q ss_pred             ------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 ------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 ------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                            +.+||....  ..++.++|||||||++|||++|+.||....
T Consensus       176 ~~~~~~y~aPE~~~~--~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~  220 (296)
T cd06654         176 MVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNEN  220 (296)
T ss_pred             ccCCccccCHHHHcC--CCCCccchHHHHHHHHHHHHhCCCCCCCCC
Confidence                  224555443  345778999999999999999999996543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=99.94  E-value=5.4e-26  Score=228.84  Aligned_cols=172  Identities=23%  Similarity=0.493  Sum_probs=142.4

Q ss_pred             eEEEEEEEE-CCeEEEEEEcchh--HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcC
Q 041830          391 EGAVYHGRL-NGKNLAIKRTEHE--VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLA  467 (600)
Q Consensus       391 ~G~Vy~g~~-~g~~vAvK~~~~~--~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~  467 (600)
                      .|.||+|.. ++..||+|.+...  ..+.+..|+..+..++|+||+++++++... ...+++|||+++|+|.++++....
T Consensus        19 ~g~v~~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~   97 (261)
T cd05072          19 FGEVWMGYYNNSTKVAVKTLKPGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTKE-EPIYIITEYMAKGSLLDFLKSDEG   97 (261)
T ss_pred             CceEEEEEecCCceEEEEEccCCchhHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-CCcEEEEecCCCCcHHHHHHHhcC
Confidence            389999988 6678999987643  234677888999999999999999987544 578999999999999999975432


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--------
Q 041830          468 MKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--------  539 (600)
Q Consensus       468 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--------  539 (600)
                                ..+++.+++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++.....        
T Consensus        98 ----------~~~~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~  164 (261)
T cd05072          98 ----------GKVLLPKLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGA  164 (261)
T ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEecCCCcEEECCCccceecCCCceeccCCC
Confidence                      33889999999999999999999   679999999999999999999999999999765321        


Q ss_pred             -----CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCC
Q 041830          540 -----TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINR  578 (600)
Q Consensus       540 -----~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~  578 (600)
                           ..+||....  ..++.++|||||||++|||++ |+.||..
T Consensus       165 ~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~  207 (261)
T cd05072         165 KFPIKWTAPEAINF--GSFTIKSDVWSFGILLYEIVTYGKIPYPG  207 (261)
T ss_pred             ccceecCCHHHhcc--CCCChhhhhhhhHHHHHHHHccCCCCCCC
Confidence                 223554433  346778999999999999998 9999964

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=99.94  E-value=5.3e-26  Score=228.69  Aligned_cols=172  Identities=28%  Similarity=0.483  Sum_probs=141.8

Q ss_pred             eEEEEEEEEC-CeEEEEEEcchhH--HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcC
Q 041830          391 EGAVYHGRLN-GKNLAIKRTEHEV--ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLA  467 (600)
Q Consensus       391 ~G~Vy~g~~~-g~~vAvK~~~~~~--~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~  467 (600)
                      .|.||.+++. +..+|+|.++...  ...+..|+..+..++||||+++++++... ...+++|||+++|+|.++++... 
T Consensus        17 ~~~vy~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~l~~~i~~~~-   94 (256)
T cd05113          17 FGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQ-RPIYIVTEYMSNGCLLNYLREHG-   94 (256)
T ss_pred             cceEEEEEecCCCcEEEEEcCCCcccHHHHHHHHHHHhcCCCCCeeeEEEEEccC-CCcEEEEEcCCCCcHHHHHHhcC-
Confidence            4899999884 4469999876533  24577899999999999999999998654 47899999999999999997543 


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--------
Q 041830          468 MKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--------  539 (600)
Q Consensus       468 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--------  539 (600)
                                ..++|.+++.++.||+.||+|||   +.+++|+||||+||+++.++.+||+|||+++.....        
T Consensus        95 ----------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~  161 (256)
T cd05113          95 ----------KRFQPSQLLEMCKDVCEGMAYLE---SKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGS  161 (256)
T ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCC
Confidence                      23899999999999999999999   679999999999999999999999999998754321        


Q ss_pred             -----CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          540 -----TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       540 -----~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                           ..+||....  ..++.++|||||||++|||++ |+.||...
T Consensus       162 ~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l~~l~~~g~~p~~~~  205 (256)
T cd05113         162 KFPVRWSPPEVLLY--SKFSSKSDVWAFGVLMWEVYSLGKMPYERF  205 (256)
T ss_pred             ccChhhCCHHHHhc--CcccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence                 123444332  346778999999999999999 99999654

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=99.94  E-value=2.1e-25  Score=227.50  Aligned_cols=174  Identities=22%  Similarity=0.358  Sum_probs=143.4

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh---HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcC
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE---VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGG  465 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~---~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~  465 (600)
                      .|.||++..  ++..+++|.+...   ....+..|+..+..++||||+++++++..+ ...++|+||+++|+|..++...
T Consensus        18 ~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-~~~~~v~e~~~~~~l~~~~~~~   96 (282)
T cd06643          18 FGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-NNLWILIEFCAGGAVDAVMLEL   96 (282)
T ss_pred             CeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeC-CEEEEEEEecCCCcHHHHHHhc
Confidence            489999998  5788999987542   234567788889999999999999998765 4889999999999999988653


Q ss_pred             cCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC-------
Q 041830          466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND-------  538 (600)
Q Consensus       466 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~-------  538 (600)
                      .           ..++|..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++....       
T Consensus        97 ~-----------~~l~~~~~~~~~~qi~~~L~~LH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~  162 (282)
T cd06643          97 E-----------RPLTEPQIRVVCKQTLEALNYLH---ENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS  162 (282)
T ss_pred             C-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEccCCCEEEcccccccccccccccccc
Confidence            2           34899999999999999999999   67999999999999999999999999999865422       


Q ss_pred             -----CCCCCccccc---CCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 -----DTESPQFYST---NPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 -----~~~~pe~~~~---~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                           .+.+||....   ....++.++|||||||++|||++|+.||...
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~  211 (282)
T cd06643         163 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL  211 (282)
T ss_pred             ccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcccc
Confidence                 1235665432   2234677899999999999999999999753

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=99.94  E-value=6.2e-26  Score=231.27  Aligned_cols=171  Identities=26%  Similarity=0.424  Sum_probs=138.1

Q ss_pred             eEEEEEEEE--CCe----EEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          391 EGAVYHGRL--NGK----NLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       391 ~G~Vy~g~~--~g~----~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      .|.||+|.+  +|+    .+++|.+...    ...+++.|+..+..+.||||++++|++..  ...++++||+++|+|.+
T Consensus        20 ~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~--~~~~~i~e~~~~gsL~~   97 (279)
T cd05111          20 FGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG--ASLQLVTQLSPLGSLLD   97 (279)
T ss_pred             CcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEECC--CccEEEEEeCCCCcHHH
Confidence            389999998  454    4788887532    22456677777888999999999998743  36789999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-  539 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-  539 (600)
                      +++...           ..++|..++.++.||+.||+|||   +.+++||||||+|||+++++.+||+|||+++..... 
T Consensus        98 ~l~~~~-----------~~~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~  163 (279)
T cd05111          98 HVRQHR-----------DSLDPQRLLNWCVQIAKGMYYLE---EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDD  163 (279)
T ss_pred             HHHhcc-----------cCCCHHHHHHHHHHHHHHHHHHH---HCCEeccccCcceEEEcCCCcEEEcCCccceeccCCC
Confidence            997543           24899999999999999999999   678999999999999999999999999999754221 


Q ss_pred             -------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          540 -------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       540 -------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                                   ..+||....  ..++.++|||||||++|||++ |+.||...
T Consensus       164 ~~~~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~el~t~g~~p~~~~  215 (279)
T cd05111         164 KKYFYSEHKTPIKWMALESILF--GRYTHQSDVWSYGVTVWEMMSYGAEPYAGM  215 (279)
T ss_pred             cccccCCCCCcccccCHHHhcc--CCcCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence                         123444332  346788999999999999998 99999654

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=99.94  E-value=1.3e-25  Score=227.37  Aligned_cols=178  Identities=25%  Similarity=0.516  Sum_probs=138.7

Q ss_pred             eeEEEEEEEEC--Ce--EEEEEEcch-----hHHHHHHHHHHHHHhCCCCceeeeeeEEeccC-----CceEEEEeecCC
Q 041830          390 IEGAVYHGRLN--GK--NLAIKRTEH-----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDG-----PHSFLVFEYAKN  455 (600)
Q Consensus       390 ~~G~Vy~g~~~--g~--~vAvK~~~~-----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~-----~~~~LV~Ey~~~  455 (600)
                      ..|.||+|.+.  +.  .+|+|.++.     .....+.+|+..+..++|+||++++++|....     ...+++|||+++
T Consensus        11 ~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~   90 (272)
T cd05075          11 EFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKH   90 (272)
T ss_pred             cCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCC
Confidence            34899999983  32  589998653     22345677888899999999999999886421     246899999999


Q ss_pred             CCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccc
Q 041830          456 GSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARC  535 (600)
Q Consensus       456 GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~  535 (600)
                      |+|.+++...+...      ....++|.....++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++.
T Consensus        91 ~~l~~~~~~~~~~~------~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  161 (272)
T cd05075          91 GDLHSFLLYSRLGD------CPQYLPTQMLVKFMTDIASGMEYLS---SKSFIHRDLAARNCMLNENMNVCVADFGLSKK  161 (272)
T ss_pred             CcHHHHHHHhcccC------CcccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhheEEcCCCCEEECCCCcccc
Confidence            99999985322110      0134899999999999999999999   67999999999999999999999999999886


Q ss_pred             cCCCC--------------CCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCC
Q 041830          536 VNDDT--------------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINR  578 (600)
Q Consensus       536 ~~~~~--------------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~  578 (600)
                      .....              .+||...  ...++.++||||||+++|||++ |+.||..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~pe~~~--~~~~~~~~Di~slG~il~el~~~g~~p~~~  217 (272)
T cd05075         162 IYNGDYYRQGRIAKMPVKWIAIESLA--DRVYTTKSDVWSFGVTMWEIATRGQTPYPG  217 (272)
T ss_pred             cCcccceecCCcccCCcccCCHHHcc--CCCcChHHHHHHHHHHHHHHHcCCCCCCCC
Confidence            53211              1233222  2346778999999999999999 8899965

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=99.94  E-value=1.3e-25  Score=226.13  Aligned_cols=173  Identities=28%  Similarity=0.534  Sum_probs=138.3

Q ss_pred             eeEEEEEEEE-----CCeEEEEEEcch----hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          390 IEGAVYHGRL-----NGKNLAIKRTEH----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       390 ~~G~Vy~g~~-----~g~~vAvK~~~~----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      ..|.||+|.+     .+..+|+|++..    .....+..|+..++.++||||++++++|...+...++++||+++|+|.+
T Consensus         7 ~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~   86 (262)
T cd05058           7 HFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRN   86 (262)
T ss_pred             CCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHH
Confidence            3489999986     235799998743    2234566788888999999999999988755556899999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC--
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND--  538 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~--  538 (600)
                      +++...           ..+++..++.++.|++.||.|||   +.+++||||||+|||+++++.+||+|||+++....  
T Consensus        87 ~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~  152 (262)
T cd05058          87 FIRSET-----------HNPTVKDLIGFGLQVAKGMEYLA---SKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKE  152 (262)
T ss_pred             HHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCccccccccCCc
Confidence            997543           22678888999999999999999   67999999999999999999999999999875421  


Q ss_pred             --------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhC-CCCCCC
Q 041830          539 --------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSG-QTPINR  578 (600)
Q Consensus       539 --------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG-~~Pf~~  578 (600)
                                    ...+||....  ..++.++|||||||++|||++| .+||..
T Consensus       153 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~~~~~  205 (262)
T cd05058         153 YYSVHNHTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPD  205 (262)
T ss_pred             ceeecccccCcCCccccChhHhcc--CccchHHHHHHHHHHHHHHHcCCCCCCCC
Confidence                          1224554433  4567889999999999999995 556643

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=99.94  E-value=4.7e-26  Score=250.47  Aligned_cols=176  Identities=22%  Similarity=0.363  Sum_probs=142.4

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCC-------ceEEEEeecCCC
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGP-------HSFLVFEYAKNG  456 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~-------~~~LV~Ey~~~G  456 (600)
                      +|.||+++.  +|+.||||.++.+     ....++.|+..+..++|+||+++...+.....       .+++||||+++|
T Consensus        45 fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~g  124 (496)
T PTZ00283         45 TGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAG  124 (496)
T ss_pred             CEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCC
Confidence            399999987  7899999987532     23456778888899999999999877643221       368999999999


Q ss_pred             CHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCcccc
Q 041830          457 SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV  536 (600)
Q Consensus       457 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~  536 (600)
                      +|.++++.....        ...+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       125 sL~~~l~~~~~~--------~~~l~e~~~~~i~~qll~aL~~lH---~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~  193 (496)
T PTZ00283        125 DLRQEIKSRAKT--------NRTFREHEAGLLFIQVLLAVHHVH---SKHMIHRDIKSANILLCSNGLVKLGDFGFSKMY  193 (496)
T ss_pred             cHHHHHHHhhcc--------CCCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEeCCCCEEEEecccCeec
Confidence            999999753321        134899999999999999999999   679999999999999999999999999998754


Q ss_pred             CC--------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          537 ND--------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       537 ~~--------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                      ..              .+.+||....  ..++.++|||||||+||||++|+.||...
T Consensus       194 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~s~k~DVwSlGvilyeLltG~~Pf~~~  248 (496)
T PTZ00283        194 AATVSDDVGRTFCGTPYYVAPEIWRR--KPYSKKADMFSLGVLLYELLTLKRPFDGE  248 (496)
T ss_pred             cccccccccccccCCcceeCHHHhCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence            22              1234555543  45788899999999999999999999753

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=99.94  E-value=9.4e-26  Score=233.44  Aligned_cols=172  Identities=23%  Similarity=0.319  Sum_probs=142.9

Q ss_pred             eeEEEEEEEE--CCeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          390 IEGAVYHGRL--NGKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       390 ~~G~Vy~g~~--~g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      .+|.||+++.  +|..+|+|.+..+    ...++..|+..+..++||||+++++++..+ +..++||||+++|+|.++++
T Consensus        13 ~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~ey~~~~~L~~~l~   91 (308)
T cd06615          13 NGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSD-GEISICMEHMDGGSLDQVLK   91 (308)
T ss_pred             CCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-CEEEEEeeccCCCcHHHHHH
Confidence            3489999988  6888999986532    234567899999999999999999998765 48999999999999999997


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC-----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND-----  538 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~-----  538 (600)
                      ...            .+++..+..++.|++.||.|||+  ..+++||||||+|||++.++.+||+|||+++....     
T Consensus        92 ~~~------------~~~~~~~~~~~~~i~~~l~~lH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  157 (308)
T cd06615          92 KAG------------RIPENILGKISIAVLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS  157 (308)
T ss_pred             hcC------------CCCHHHHHHHHHHHHHHHHHHHh--hCCEEECCCChHHEEEecCCcEEEccCCCccccccccccc
Confidence            542            38899999999999999999994  24899999999999999999999999999875432     


Q ss_pred             -----CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          539 -----DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       539 -----~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                           ...+||....  ..++.++|||||||++|||++|+.||..
T Consensus       158 ~~~~~~~~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~p~~~  200 (308)
T cd06615         158 FVGTRSYMSPERLQG--THYTVQSDIWSLGLSLVEMAIGRYPIPP  200 (308)
T ss_pred             CCCCcCccChhHhcC--CCCCccchHHHHHHHHHHHHhCCCCCCC
Confidence                 2234565433  3467789999999999999999999864

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.94  E-value=5.1e-26  Score=228.27  Aligned_cols=175  Identities=23%  Similarity=0.365  Sum_probs=142.7

Q ss_pred             ceeEEEEEEEEC--C----------eEEEEEEcchhH--HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecC
Q 041830          389 RIEGAVYHGRLN--G----------KNLAIKRTEHEV--ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAK  454 (600)
Q Consensus       389 ~~~G~Vy~g~~~--g----------~~vAvK~~~~~~--~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~  454 (600)
                      +.+|.||+|...  +          ..+++|.+....  ...+.+|+..+..++||||++++|++..  ...++||||++
T Consensus         6 G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~lv~e~~~   83 (259)
T cd05037           6 GTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKHLVKLYGVCVR--DENIMVEEYVK   83 (259)
T ss_pred             cccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCCCcchhheeeEEec--CCcEEEEEcCC
Confidence            334899999983  3          248888765433  3567788889999999999999999876  36799999999


Q ss_pred             CCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC-------cEEE
Q 041830          455 NGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEF-------NARV  527 (600)
Q Consensus       455 ~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~-------~~kI  527 (600)
                      +|+|.++++...           ..+++..++.++.|++.||+|||   +.+|+||||||+|||++.++       .+||
T Consensus        84 ~~~L~~~l~~~~-----------~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl  149 (259)
T cd05037          84 FGPLDVFLHREK-----------NNVSLHWKLDVAKQLASALHYLE---DKKLVHGNVCGKNILVARYGLNEGYVPFIKL  149 (259)
T ss_pred             CCcHHHHHHhhc-----------cCCCHHHHHHHHHHHHHHHHHHh---hCCeecccCccceEEEecCccccCCceeEEe
Confidence            999999997643           13899999999999999999999   67999999999999999887       7999


Q ss_pred             EeccCccccCC--------CCCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          528 GNFGMARCVND--------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       528 ~DFGla~~~~~--------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                      +|||+++....        ...+||+.......++.++||||||+++|||++ |..||...
T Consensus       150 ~Dfg~a~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~  210 (259)
T cd05037         150 SDPGIPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL  210 (259)
T ss_pred             CCCCcccccccccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccC
Confidence            99999886422        234567655433456788999999999999999 57888655

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=99.94  E-value=2.5e-25  Score=226.43  Aligned_cols=170  Identities=24%  Similarity=0.441  Sum_probs=142.3

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      .|.||+|..  ++..||+|.++..    ....+..|+..+..+.|+||+++++++..+ ...++||||+++|+|.++++.
T Consensus        17 ~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~i~~   95 (277)
T cd06640          17 FGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKG-TKLWIIMEYLGGGSALDLLRA   95 (277)
T ss_pred             CeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-CEEEEEEecCCCCcHHHHHhc
Confidence            489999987  6889999987632    234577888889999999999999998665 489999999999999999864


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-----
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-----  539 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-----  539 (600)
                      +             .+++.+...++.+++.||+|||   ..+++|+||+|+||+++.++.++|+|||++......     
T Consensus        96 ~-------------~l~~~~~~~~~~~l~~~l~~lh---~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~  159 (277)
T cd06640          96 G-------------PFDEFQIATMLKEILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN  159 (277)
T ss_pred             C-------------CCCHHHHHHHHHHHHHHHHHHH---hCCccCcCCChhhEEEcCCCCEEEcccccceeccCCccccc
Confidence            3             2788999999999999999999   679999999999999999999999999998654321     


Q ss_pred             -------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 -------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 -------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                             ..+||....  ..++.++|||||||++|||++|+.||...
T Consensus       160 ~~~~~~~y~apE~~~~--~~~~~~~Dv~slG~il~el~tg~~p~~~~  204 (277)
T cd06640         160 TFVGTPFWMAPEVIQQ--SAYDSKADIWSLGITAIELAKGEPPNSDM  204 (277)
T ss_pred             cccCcccccCHhHhcc--CCCccHHHHHHHHHHHHHHHHCCCCCCCc
Confidence                   134554433  34677899999999999999999999753

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>PTZ00036 glycogen synthase kinase; Provisional

Probab=99.94  E-value=3.1e-26  Score=248.65  Aligned_cols=176  Identities=19%  Similarity=0.306  Sum_probs=138.2

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhHHHHHHHHHHHHHhCCCCceeeeeeEEecc-------CCceEEEEeecCCCCHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTD-------GPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~-------~~~~~LV~Ey~~~GsL~~~  461 (600)
                      .|.||+|..  +++.||||++..+. ....+|+..+..++|||||++++++...       ...+++||||+++ +|.++
T Consensus        79 fg~Vy~~~~~~~~~~vAiK~i~~~~-~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l~~~  156 (440)
T PTZ00036         79 FGVVYEAICIDTSEKVAIKKVLQDP-QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKY  156 (440)
T ss_pred             CEEEEEEEECCCCCEEEEEEEecCc-chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCc-cHHHH
Confidence            399999988  68899999886543 3346788899999999999999886432       1136799999984 78877


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC-cEEEEeccCccccCCC-
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEF-NARVGNFGMARCVNDD-  539 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~-~~kI~DFGla~~~~~~-  539 (600)
                      +......        ...+++..+..++.|++.||+|||   +.+|+||||||+|||++.++ .+||+|||+++..... 
T Consensus       157 ~~~~~~~--------~~~l~~~~~~~~~~qi~~gL~yLH---~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~  225 (440)
T PTZ00036        157 MKHYARN--------NHALPLFLVKLYSYQLCRALAYIH---SKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ  225 (440)
T ss_pred             HHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCcCHHHEEEcCCCCceeeeccccchhccCCC
Confidence            7542211        134899999999999999999999   67999999999999998665 7999999999754321 


Q ss_pred             ----------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 ----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 ----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                                +.+||.... ...++.++|||||||+||||++|++||....
T Consensus       226 ~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwSlGvil~elltG~~pf~~~~  275 (440)
T PTZ00036        226 RSVSYICSRFYRAPELMLG-ATNYTTHIDLWSLGCIIAEMILGYPIFSGQS  275 (440)
T ss_pred             CcccCCCCcCccCHHHhcC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                      235665432 2357888999999999999999999997643

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=99.94  E-value=1e-25  Score=225.12  Aligned_cols=172  Identities=27%  Similarity=0.485  Sum_probs=142.5

Q ss_pred             eEEEEEEEE-CCeEEEEEEcchhH----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcC
Q 041830          391 EGAVYHGRL-NGKNLAIKRTEHEV----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGG  465 (600)
Q Consensus       391 ~G~Vy~g~~-~g~~vAvK~~~~~~----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~  465 (600)
                      .|.||+|.. ++..+|+|..+...    ...+..|+..+..++||||+++++++...+ ..++||||+++|+|.+++...
T Consensus         8 ~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~~~~~   86 (250)
T cd05085           8 FGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQ-PIYIVMELVPGGDFLSFLRKK   86 (250)
T ss_pred             CceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCC-ccEEEEECCCCCcHHHHHHhc
Confidence            489999987 67889999865422    235677888899999999999999986654 789999999999999998654


Q ss_pred             cCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC------
Q 041830          466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD------  539 (600)
Q Consensus       466 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~------  539 (600)
                      .           ..++|.+++.++.|++.+|.|||   +.+++||||||+||+++.++.+||+|||+++.....      
T Consensus        87 ~-----------~~~~~~~~~~~~~~i~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~  152 (250)
T cd05085          87 K-----------DELKTKQLVKFALDAAAGMAYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSG  152 (250)
T ss_pred             C-----------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccChheEEEcCCCeEEECCCccceeccccccccCC
Confidence            3           23889999999999999999999   679999999999999999999999999998643221      


Q ss_pred             -------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          540 -------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       540 -------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                             ..+||+...  ..++.++||||||+++|||++ |..||...
T Consensus       153 ~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~ll~~~~~~g~~p~~~~  198 (250)
T cd05085         153 LKQIPIKWTAPEALNY--GRYSSESDVWSYGILLWETFSLGVCPYPGM  198 (250)
T ss_pred             CCCCcccccCHHHhcc--CCCCchhHHHHHHHHHHHHhcCCCCCCCCC
Confidence                   234555433  346778999999999999998 99999653

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=99.94  E-value=5.7e-26  Score=241.45  Aligned_cols=173  Identities=19%  Similarity=0.334  Sum_probs=140.9

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEeccC----CceEEEEeecCCCCHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTDG----PHSFLVFEYAKNGSLK  459 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~----~~~~LV~Ey~~~GsL~  459 (600)
                      .|.||++..  +|+.||||++...     ....+.+|+..+..++||||+++++++....    ...|+|+||+. ++|.
T Consensus        13 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~   91 (372)
T cd07853          13 FGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLH   91 (372)
T ss_pred             CEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHH
Confidence            399999987  7899999987542     2245678899999999999999999976442    16799999997 5888


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD  539 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~  539 (600)
                      +++....            .+++.++..++.|++.||.|||   +.+++||||||+|||++.++.+||+|||+++.....
T Consensus        92 ~~~~~~~------------~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~  156 (372)
T cd07853          92 KIIVSPQ------------PLSSDHVKVFLYQILRGLKYLH---SAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPD  156 (372)
T ss_pred             HHHhcCC------------CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHHEEECCCCCEEeccccceeecccC
Confidence            8886432            3899999999999999999999   679999999999999999999999999998754321


Q ss_pred             -------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 -------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 -------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                                   +.+||.... ...++.++|||||||++|||++|+.||...+
T Consensus       157 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~  209 (372)
T cd07853         157 ESKHMTQEVVTQYYRAPEILMG-SRHYTSAVDIWSVGCIFAELLGRRILFQAQS  209 (372)
T ss_pred             ccccCCCCCcCCCcCCHHHHcC-CCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC
Confidence                         234554432 2346788999999999999999999997543

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=99.94  E-value=1.8e-25  Score=223.91  Aligned_cols=172  Identities=26%  Similarity=0.436  Sum_probs=145.7

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH-HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcC
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV-ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLA  467 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~-~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~  467 (600)
                      .|.||+++.  +++.+++|.++... .+.+.+|+..+..++|+||++++|++..+ ...|+++||+++++|.+++.... 
T Consensus        16 ~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~l~~e~~~~~~L~~~l~~~~-   93 (256)
T cd06612          16 YGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCDSPYIVKYYGSYFKN-TDLWIVMEYCGAGSVSDIMKITN-   93 (256)
T ss_pred             CeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC-CcEEEEEecCCCCcHHHHHHhCc-
Confidence            389999998  47899999987543 45778899999999999999999998665 58999999999999999996533 


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCCC-------
Q 041830          468 MKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDT-------  540 (600)
Q Consensus       468 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~~-------  540 (600)
                                ..++|.++..++.|++.||.|||   +.+++||||+|+||++++++.+||+|||++.......       
T Consensus        94 ----------~~l~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  160 (256)
T cd06612          94 ----------KTLTEEEIAAILYQTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI  160 (256)
T ss_pred             ----------cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEECCCCcEEEcccccchhcccCcccccccc
Confidence                      34899999999999999999999   6689999999999999999999999999987653321       


Q ss_pred             -----CCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          541 -----ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       541 -----~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                           .+||....  ..++.++||||||+++|||++|+.||...
T Consensus       161 ~~~~y~~PE~~~~--~~~~~~~Di~s~G~il~~l~~g~~p~~~~  202 (256)
T cd06612         161 GTPFWMAPEVIQE--IGYNNKADIWSLGITAIEMAEGKPPYSDI  202 (256)
T ss_pred             CCccccCHHHHhc--CCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence                 24555433  35678899999999999999999999753

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=99.94  E-value=5e-26  Score=235.49  Aligned_cols=173  Identities=23%  Similarity=0.369  Sum_probs=140.9

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      .|.||+|+.  +++.||+|.++...    ...+.+|+..+..++||||+++++++..+ +..++||||+++ +|.+++..
T Consensus        19 ~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~-~l~~~~~~   96 (309)
T cd07872          19 YATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTD-KSLTLVFEYLDK-DLKQYMDD   96 (309)
T ss_pred             CEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeC-CeEEEEEeCCCC-CHHHHHHh
Confidence            499999987  67889999876422    12456788899999999999999998665 488999999975 89888865


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-----
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-----  539 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-----  539 (600)
                      ..           ..+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....     
T Consensus        97 ~~-----------~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  162 (309)
T cd07872          97 CG-----------NIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYS  162 (309)
T ss_pred             cC-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECccccceecCCCccccc
Confidence            43           23789999999999999999999   679999999999999999999999999998753211     


Q ss_pred             -------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 -------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 -------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                             ..+||.... ...++.++|||||||++|||++|+.||...+
T Consensus       163 ~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~el~tg~~pf~~~~  209 (309)
T cd07872         163 NEVVTLWYRPPDVLLG-SSEYSTQIDMWGVGCIFFEMASGRPLFPGST  209 (309)
T ss_pred             cccccccccCCHHHhC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                   224554432 2346778999999999999999999997543

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=99.94  E-value=4.3e-26  Score=230.88  Aligned_cols=175  Identities=24%  Similarity=0.436  Sum_probs=141.9

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH--HHHHHHHHHHHHhC-CCCceeeeeeEEeccC-----CceEEEEeecCCCCHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV--ITKLEMQLVQHATH-HHPNIVRLLGTCLTDG-----PHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~--~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~-----~~~~LV~Ey~~~GsL~~  460 (600)
                      .|.||+|..  +++.||+|.++...  ...+..|+..+..+ +|+||+++++++....     ...|++|||+++|+|.+
T Consensus        19 ~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~   98 (272)
T cd06637          19 YGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD   98 (272)
T ss_pred             CeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHH
Confidence            499999988  67899999975432  23556777777777 6999999999986432     35799999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-  539 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-  539 (600)
                      ++.....          ..++|..+..++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++..... 
T Consensus        99 ~l~~~~~----------~~l~~~~~~~~~~qi~~~l~~LH---~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~  165 (272)
T cd06637          99 LIKNTKG----------NTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV  165 (272)
T ss_pred             HHHhccC----------CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHEEECCCCCEEEccCCCceeccccc
Confidence            9975332          34899999999999999999999   669999999999999999999999999998754321 


Q ss_pred             -----------CCCCcccccC---CCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          540 -----------TESPQFYSTN---PASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       540 -----------~~~pe~~~~~---~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                                 ..+||+....   ...++.++|||||||++|||++|+.||..
T Consensus       166 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~  218 (272)
T cd06637         166 GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD  218 (272)
T ss_pred             ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence                       2356655421   23567789999999999999999999964

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=99.94  E-value=1e-25  Score=229.88  Aligned_cols=183  Identities=26%  Similarity=0.478  Sum_probs=143.1

Q ss_pred             eEEEEEEEE------CCeEEEEEEcch----hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          391 EGAVYHGRL------NGKNLAIKRTEH----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       391 ~G~Vy~g~~------~g~~vAvK~~~~----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      .|.||+|.+      .+..+++|.++.    +....+++|+..+..++||||+++++++... ...|++|||+++|+|.+
T Consensus        18 ~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~~~L~~   96 (283)
T cd05090          18 FGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQE-QPVCMLFEYLNQGDLHE   96 (283)
T ss_pred             CcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecC-CceEEEEEcCCCCcHHH
Confidence            389999985      457899999863    2234577899999999999999999997655 47899999999999999


Q ss_pred             HHhcCcCccc-----ccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccc
Q 041830          461 WLHGGLAMKN-----QFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARC  535 (600)
Q Consensus       461 ~L~~~~~~~~-----~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~  535 (600)
                      ++........     .........+++.+.+.++.|++.||.|||   +.+++||||||+|||+++++.+||+|||+++.
T Consensus        97 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  173 (283)
T cd05090          97 FLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLS---SHFFVHKDLAARNILIGEQLHVKISDLGLSRE  173 (283)
T ss_pred             HHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hcCeehhccccceEEEcCCCcEEecccccccc
Confidence            9964321000     000001134899999999999999999999   67999999999999999999999999999975


Q ss_pred             cCCC--------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          536 VNDD--------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       536 ~~~~--------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                      ....              +.+||....  ..++.++||||||+++|||++ |..||...
T Consensus       174 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~~g~~p~~~~  230 (283)
T cd05090         174 IYSADYYRVQPKSLLPIRWMPPEAIMY--GKFSSDSDIWSFGVVLWEIFSFGLQPYYGF  230 (283)
T ss_pred             ccCCcceecccCCCccceecChHHhcc--CCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence            4221              234554433  346788999999999999999 99998653

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.94  E-value=8e-26  Score=229.97  Aligned_cols=162  Identities=19%  Similarity=0.285  Sum_probs=129.0

Q ss_pred             EEEEEEcchhHH---HHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcCcccccccccccC
Q 041830          403 NLAIKRTEHEVI---TKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCF  479 (600)
Q Consensus       403 ~vAvK~~~~~~~---~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~  479 (600)
                      .|++|.++....   ..+.+|+..+..++||||++++|+|..+. ..++||||+++|+|..+++...           ..
T Consensus        46 ~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~-~~~lv~ey~~~g~L~~~l~~~~-----------~~  113 (274)
T cd05076          46 RVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGS-ENIMVEEFVEHGPLDVCLRKEK-----------GR  113 (274)
T ss_pred             eEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeEEEEEEeCC-ceEEEEecCCCCcHHHHHHhcC-----------CC
Confidence            589998865432   34556777788899999999999987664 7899999999999999997533           23


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC-------cEEEEeccCccccC--------CCCCCCc
Q 041830          480 LTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEF-------NARVGNFGMARCVN--------DDTESPQ  544 (600)
Q Consensus       480 l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~-------~~kI~DFGla~~~~--------~~~~~pe  544 (600)
                      +++.+++.++.|+++||+|||   +.+|+||||||+|||+++++       .+|++|||++....        ..+.+||
T Consensus       114 ~~~~~~~~i~~qi~~~l~~lH---~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~aPe  190 (274)
T cd05076         114 VPVAWKITVAQQLASALSYLE---DKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSREERVERIPWIAPE  190 (274)
T ss_pred             CCHHHHHHHHHHHHHHHHHHH---cCCccCCCCCcccEEEeccCcccCccceeeecCCccccccccccccccCCcccCch
Confidence            889999999999999999999   67999999999999997643       48999999875432        1233566


Q ss_pred             ccccCCCCCCccCchHHHHHHHHHHH-hCCCCCCCCC
Q 041830          545 FYSTNPASWSMGIDIFAYGIVLLEVL-SGQTPINRPR  580 (600)
Q Consensus       545 ~~~~~~~~~t~~sDVwSfGvvL~ELl-tG~~Pf~~~~  580 (600)
                      ..... ..++.++|||||||++|||+ +|+.||....
T Consensus       191 ~~~~~-~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~  226 (274)
T cd05076         191 CVPGG-NSLSTAADKWSFGTTLLEICFDGEVPLKERT  226 (274)
T ss_pred             hhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence            54332 45678899999999999995 6999997543

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.94  E-value=1.3e-25  Score=226.70  Aligned_cols=174  Identities=23%  Similarity=0.365  Sum_probs=138.6

Q ss_pred             eeEEEEEEEEC--------------CeEEEEEEcchhH---HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEee
Q 041830          390 IEGAVYHGRLN--------------GKNLAIKRTEHEV---ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEY  452 (600)
Q Consensus       390 ~~G~Vy~g~~~--------------g~~vAvK~~~~~~---~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey  452 (600)
                      ..|.||+|++.              ...|++|.++...   ...+.+|+..+..++||||++++|++..+. ..+++|||
T Consensus         7 ~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~-~~~lv~e~   85 (262)
T cd05077           7 TRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDV-ENIMVEEF   85 (262)
T ss_pred             CcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC-CCEEEEec
Confidence            34899999862              2258999876433   235667788888999999999999987654 78999999


Q ss_pred             cCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCc-------E
Q 041830          453 AKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFN-------A  525 (600)
Q Consensus       453 ~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~-------~  525 (600)
                      +++|+|..+++...           ..+++.++++++.||+.||+|||   +.+|+||||||+|||++.++.       +
T Consensus        86 ~~~~~l~~~~~~~~-----------~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nill~~~~~~~~~~~~~  151 (262)
T cd05077          86 VEFGPLDLFMHRKS-----------DVLTTPWKFKVAKQLASALSYLE---DKDLVHGNVCTKNILLAREGIDGECGPFI  151 (262)
T ss_pred             ccCCCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHhh---hCCeECCCCCcccEEEecCCccCCCCcee
Confidence            99999999987533           24899999999999999999999   779999999999999986654       8


Q ss_pred             EEEeccCccccCC--------CCCCCcccccCCCCCCccCchHHHHHHHHHHH-hCCCCCCCC
Q 041830          526 RVGNFGMARCVND--------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVL-SGQTPINRP  579 (600)
Q Consensus       526 kI~DFGla~~~~~--------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELl-tG~~Pf~~~  579 (600)
                      |++|||++.....        .+.+||.... ...++.++|||||||++|||+ +|+.||...
T Consensus       152 ~l~d~g~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~~l~el~~~~~~p~~~~  213 (262)
T cd05077         152 KLSDPGIPITVLSRQECVERIPWIAPECVED-SKNLSIAADKWSFGTTLWEICYNGEIPLKDK  213 (262)
T ss_pred             EeCCCCCCccccCcccccccccccChhhhcC-CCCCCchhHHHHHHHHHHHHHhCCCCCCCCc
Confidence            9999999865432        2345665432 245677899999999999997 588888653

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=99.94  E-value=1.1e-25  Score=227.31  Aligned_cols=172  Identities=27%  Similarity=0.419  Sum_probs=142.0

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh---HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcC
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE---VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGG  465 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~---~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~  465 (600)
                      .|.||+|+.  +|+.||+|..+..   ....++.|+..+..++||||+++++++..+ ...++||||+++|+|.++++..
T Consensus        22 ~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~-~~~~iv~e~~~~~~L~~~~~~~  100 (267)
T cd06646          22 YGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSR-EKLWICMEYCGGGSLQDIYHVT  100 (267)
T ss_pred             CeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeC-CEEEEEEeCCCCCcHHHHHHhc
Confidence            389999997  7889999987542   224567888899999999999999998665 4889999999999999998653


Q ss_pred             cCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC------
Q 041830          466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD------  539 (600)
Q Consensus       466 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~------  539 (600)
                      .            .+++.++..++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.....      
T Consensus       101 ~------------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~  165 (267)
T cd06646         101 G------------PLSELQIAYVCRETLQGLAYLH---SKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS  165 (267)
T ss_pred             C------------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCCEEECcCccceeecccccccCc
Confidence            2            3889999999999999999999   679999999999999999999999999998754321      


Q ss_pred             ------CCCCccccc-CCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          540 ------TESPQFYST-NPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       540 ------~~~pe~~~~-~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                            ..+||.... ....++.++|||||||++|||++|+.||..
T Consensus       166 ~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~  211 (267)
T cd06646         166 FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFD  211 (267)
T ss_pred             cccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccc
Confidence                  224554432 123356789999999999999999999854

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.94  E-value=1.3e-25  Score=225.43  Aligned_cols=173  Identities=30%  Similarity=0.559  Sum_probs=146.3

Q ss_pred             eEEEEEEEECCeEEEEEEcchhH--HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcCc
Q 041830          391 EGAVYHGRLNGKNLAIKRTEHEV--ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM  468 (600)
Q Consensus       391 ~G~Vy~g~~~g~~vAvK~~~~~~--~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~  468 (600)
                      .|.||++...|+.||+|..+...  .+++..|+..+..++|+||+++++++... ...++||||+++++|.++++.... 
T Consensus        19 ~g~v~~~~~~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~-   96 (256)
T cd05039          19 FGDVMLGDYRGQKVAVKCLKDDSTAAQAFLAEASVMTTLRHPNLVQLLGVVLQG-NPLYIVTEYMAKGSLVDYLRSRGR-   96 (256)
T ss_pred             CceEEEEEecCcEEEEEEeccchhHHHHHHHHHHHHHhcCCcceeeeEEEEcCC-CCeEEEEEecCCCcHHHHHHhcCC-
Confidence            38999999999999999987654  34677899999999999999999997654 588999999999999999975431 


Q ss_pred             ccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC---------
Q 041830          469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---------  539 (600)
Q Consensus       469 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~---------  539 (600)
                               ..++|.++..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++.....         
T Consensus        97 ---------~~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  164 (256)
T cd05039          97 ---------AVITLAQQLGFALDVCEGMEYLE---EKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKLPVK  164 (256)
T ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHHH---hCCccchhcccceEEEeCCCCEEEcccccccccccccccCCCccc
Confidence                     24899999999999999999999   679999999999999999999999999998765321         


Q ss_pred             CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          540 TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       540 ~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                      ..+||....  ..++.++||||||+++|||++ |+.||...
T Consensus       165 ~~ape~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~  203 (256)
T cd05039         165 WTAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRI  203 (256)
T ss_pred             ccCchhhcC--CcCCcHHHHHHHHHHHHHHHhcCCCCCCCC
Confidence            234555433  346678999999999999997 99998654

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=99.94  E-value=1.2e-26  Score=221.91  Aligned_cols=170  Identities=26%  Similarity=0.436  Sum_probs=137.1

Q ss_pred             EEEEEEEE--CCeEEEEEEcchh-----------HHHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCC
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHE-----------VITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGS  457 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~-----------~~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~Gs  457 (600)
                      ..|-+...  +|+.+|+|++...           ..+....|+.+++++ .||||+++.+++..+ .+.++|+|.|+.|.
T Consensus        31 s~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~-sF~FlVFdl~prGE  109 (411)
T KOG0599|consen   31 SVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD-AFVFLVFDLMPRGE  109 (411)
T ss_pred             hhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc-chhhhhhhhcccch
Confidence            34444433  6888999986431           122334677777775 499999999997665 48899999999999


Q ss_pred             HHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC
Q 041830          458 LKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN  537 (600)
Q Consensus       458 L~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~  537 (600)
                      |.|+|...            ..|++++..+|++|+..|+.|||   ..+||||||||+|||+|++.++||+|||++..+.
T Consensus       110 LFDyLts~------------VtlSEK~tR~iMrqlfegVeylH---a~~IVHRDLKpENILlddn~~i~isDFGFa~~l~  174 (411)
T KOG0599|consen  110 LFDYLTSK------------VTLSEKETRRIMRQLFEGVEYLH---ARNIVHRDLKPENILLDDNMNIKISDFGFACQLE  174 (411)
T ss_pred             HHHHhhhh------------eeecHHHHHHHHHHHHHHHHHHH---HhhhhhcccChhheeeccccceEEeccceeeccC
Confidence            99999764            34999999999999999999999   7899999999999999999999999999997665


Q ss_pred             CC-----------CCCCccccc----CCCCCCccCchHHHHHHHHHHHhCCCCCC
Q 041830          538 DD-----------TESPQFYST----NPASWSMGIDIFAYGIVLLEVLSGQTPIN  577 (600)
Q Consensus       538 ~~-----------~~~pe~~~~----~~~~~t~~sDVwSfGvvL~ELltG~~Pf~  577 (600)
                      .+           +.+||...-    ....|+..+|.||.||+||.|+.|.+||.
T Consensus       175 ~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw  229 (411)
T KOG0599|consen  175 PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW  229 (411)
T ss_pred             CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh
Confidence            43           234554321    35567888999999999999999999994

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.94  E-value=5e-27  Score=247.70  Aligned_cols=178  Identities=25%  Similarity=0.404  Sum_probs=149.5

Q ss_pred             CCceeEEEEEEEE--CCeEEEEEEcchhH---HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          387 SNRIEGAVYHGRL--NGKNLAIKRTEHEV---ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       387 ~~~~~G~Vy~g~~--~g~~vAvK~~~~~~---~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      +.|.+|.||.|+.  +....|||.+....   .+-+.+||.....++|.|||+++|.|-+++ ++-+.||-.+||||.+.
T Consensus       584 GKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senG-f~kIFMEqVPGGSLSsL  662 (1226)
T KOG4279|consen  584 GKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENG-FFKIFMEQVPGGSLSSL  662 (1226)
T ss_pred             ecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCC-eEEEEeecCCCCcHHHH
Confidence            3445599999998  55678999886543   345788999999999999999999975554 88899999999999999


Q ss_pred             HhcCcCcccccccccccCC--CHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC-CCCcEEEEeccCccccC-
Q 041830          462 LHGGLAMKNQFIASCYCFL--TWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLD-EEFNARVGNFGMARCVN-  537 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld-~~~~~kI~DFGla~~~~-  537 (600)
                      |+...           .+|  .+...-.+.+||++||.|||   +..|||||||-+|||++ -.|.+||+|||.++.+. 
T Consensus       663 LrskW-----------GPlKDNEstm~fYtkQILeGLkYLH---en~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg  728 (1226)
T KOG4279|consen  663 LRSKW-----------GPLKDNESTMNFYTKQILEGLKYLH---ENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG  728 (1226)
T ss_pred             HHhcc-----------CCCccchhHHHHHHHHHHHHhhhhh---hcceeeccccCCcEEEeeccceEEecccccchhhcc
Confidence            98754           235  66777788999999999999   67899999999999996 46899999999887542 


Q ss_pred             -----------CCCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          538 -----------DDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       538 -----------~~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                 ..+++||+....+..|..++|||||||.+.||.||++||.+.
T Consensus       729 inP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~El  781 (1226)
T KOG4279|consen  729 INPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVEL  781 (1226)
T ss_pred             CCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeec
Confidence                       223578888888889999999999999999999999999653

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=99.94  E-value=1e-25  Score=229.34  Aligned_cols=171  Identities=25%  Similarity=0.445  Sum_probs=139.4

Q ss_pred             eeEEEEEEEE--CCe----EEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHH
Q 041830          390 IEGAVYHGRL--NGK----NLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       390 ~~G~Vy~g~~--~g~----~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~  459 (600)
                      ..|.||+|++  +|+    .||+|.++..    ....+..|+..+..+.|+||++++|+|...  ..++++||+++|+|.
T Consensus        19 ~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~l~~~~~~~g~l~   96 (279)
T cd05109          19 AFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLTS--TVQLVTQLMPYGCLL   96 (279)
T ss_pred             CCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC--CcEEEEEcCCCCCHH
Confidence            3499999987  554    4899987532    234567788888899999999999998643  578999999999999


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD  539 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~  539 (600)
                      ++++...           ..+++.+++.++.|++.||+|||   +.+++||||||+|||+++++.+||+|||+++.....
T Consensus        97 ~~l~~~~-----------~~~~~~~~~~~~~qi~~~L~~lH---~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~  162 (279)
T cd05109          97 DYVRENK-----------DRIGSQDLLNWCVQIAKGMSYLE---EVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDID  162 (279)
T ss_pred             HHHhhcc-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCCCceeecccc
Confidence            9997643           23899999999999999999999   679999999999999999999999999998765321


Q ss_pred             --------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCC
Q 041830          540 --------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINR  578 (600)
Q Consensus       540 --------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~  578 (600)
                                    ..+||....  ..++.++|||||||++|||++ |+.||..
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~  214 (279)
T cd05109         163 ETEYHADGGKVPIKWMALESILH--RRFTHQSDVWSYGVTVWELMTFGAKPYDG  214 (279)
T ss_pred             cceeecCCCccchhhCCHHHhcc--CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence                          123444332  346778999999999999998 9999865

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=99.94  E-value=1.2e-25  Score=237.84  Aligned_cols=170  Identities=21%  Similarity=0.335  Sum_probs=138.7

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEeccC-----CceEEEEeecCCCCH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTDG-----PHSFLVFEYAKNGSL  458 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~-----~~~~LV~Ey~~~GsL  458 (600)
                      .|.||++..  +|+.||+|.+...     ....+.+|+..+..++||||+++++++....     ...|+||||+++ +|
T Consensus        34 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l  112 (359)
T cd07876          34 QGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NL  112 (359)
T ss_pred             CEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCc-CH
Confidence            499999987  6899999997532     2345678889999999999999999875432     246999999975 67


Q ss_pred             HHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC
Q 041830          459 KDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND  538 (600)
Q Consensus       459 ~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~  538 (600)
                      .++++.              .+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       113 ~~~~~~--------------~~~~~~~~~~~~qi~~~L~~LH---~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~  175 (359)
T cd07876         113 CQVIHM--------------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACT  175 (359)
T ss_pred             HHHHhc--------------cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEecCCCcccccc
Confidence            766642              2788889999999999999999   67999999999999999999999999999875422


Q ss_pred             -----------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          539 -----------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       539 -----------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                                 .+.+||....  ..++.++|||||||++|||++|+.||...+
T Consensus       176 ~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~tg~~pf~~~~  226 (359)
T cd07876         176 NFMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGELVKGSVIFQGTD  226 (359)
T ss_pred             CccCCCCcccCCCCCchhccC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence                       1335665543  456788999999999999999999997543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=99.94  E-value=8.3e-26  Score=226.79  Aligned_cols=174  Identities=25%  Similarity=0.439  Sum_probs=142.8

Q ss_pred             ceeEEEEEEEEC---C--eEEEEEEcchhH----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHH
Q 041830          389 RIEGAVYHGRLN---G--KNLAIKRTEHEV----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       389 ~~~G~Vy~g~~~---g--~~vAvK~~~~~~----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~  459 (600)
                      +..|.||+|.+.   +  ..||+|.++.+.    .+.+..|+..+.+++||||+++++++..  ...++++||+++|+|.
T Consensus         6 g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~~~~~L~   83 (257)
T cd05040           6 GSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT--HPLMMVTELAPLGSLL   83 (257)
T ss_pred             cCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC--CeEEEEEEecCCCcHH
Confidence            334899999872   2  369999987643    3467889999999999999999999765  5789999999999999


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD  539 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~  539 (600)
                      +++.....          ..++|...+.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++.....
T Consensus        84 ~~l~~~~~----------~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~  150 (257)
T cd05040          84 DRLRKDAL----------GHFLISTLCDYAVQIANGMRYLE---SKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQN  150 (257)
T ss_pred             HHHHhccc----------ccCcHHHHHHHHHHHHHHHHHHH---hCCccccccCcccEEEecCCEEEecccccccccccc
Confidence            99976431          23899999999999999999999   679999999999999999999999999998765331


Q ss_pred             ---------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          540 ---------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       540 ---------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                                     +.+||....  ..++.++||||||+++|||++ |+.||...
T Consensus       151 ~~~~~~~~~~~~~~~y~~pE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~  204 (257)
T cd05040         151 EDHYVMEEHLKVPFAWCAPESLRT--RTFSHASDVWMFGVTLWEMFTYGEEPWAGL  204 (257)
T ss_pred             ccceecccCCCCCceecCHHHhcc--cCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence                           123443322  346778999999999999999 99999643

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=99.94  E-value=1.5e-25  Score=226.35  Aligned_cols=171  Identities=26%  Similarity=0.359  Sum_probs=140.4

Q ss_pred             eEEEEEEEE--CCeEEEEEEcch--------hHHHHHHHHHHHHHhCCCCceeeeeeEEecc-CCceEEEEeecCCCCHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEH--------EVITKLEMQLVQHATHHHPNIVRLLGTCLTD-GPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~--------~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~-~~~~~LV~Ey~~~GsL~  459 (600)
                      .|.||++..  +|+.||+|.+..        .....+++|+..+..++||||+++++++.+. ...++++|||+++|+|.
T Consensus        15 ~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~   94 (265)
T cd06652          15 FGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIK   94 (265)
T ss_pred             ceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHH
Confidence            389999987  688999998642        1234677899999999999999999986543 23578999999999999


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC-
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND-  538 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~-  538 (600)
                      +++....            .+++...++++.+++.||+|||   +.+++|+||||+||+++.++.+||+|||+++.... 
T Consensus        95 ~~l~~~~------------~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~  159 (265)
T cd06652          95 DQLKSYG------------ALTENVTRKYTRQILEGVSYLH---SNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTI  159 (265)
T ss_pred             HHHHHcC------------CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence            9986532            2788899999999999999999   66899999999999999999999999998874321 


Q ss_pred             --------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          539 --------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       539 --------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                                    ...+||....  ..++.++|||||||++|||++|+.||..
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~p~~~  211 (265)
T cd06652         160 CLSGTGMKSVTGTPYWMSPEVISG--EGYGRKADIWSVGCTVVEMLTEKPPWAE  211 (265)
T ss_pred             cccccccccCCCCccccChhhhcC--CCCCcchhHHHHHHHHHHHhhCCCCCCc
Confidence                          1234555433  3467789999999999999999999964

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=99.94  E-value=3.5e-25  Score=227.09  Aligned_cols=174  Identities=26%  Similarity=0.392  Sum_probs=143.7

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh---HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcC
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE---VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGG  465 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~---~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~  465 (600)
                      .|.||+|+.  +|+.+++|.+...   ....+..|+..+..+.||||+++++.+..++ ..++||||+++++|..++...
T Consensus        25 ~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~lv~e~~~~~~l~~~~~~~  103 (292)
T cd06644          25 FGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDG-KLWIMIEFCPGGAVDAIMLEL  103 (292)
T ss_pred             CeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCC-eEEEEEecCCCCcHHHHHHhh
Confidence            499999998  5789999997543   2345677888899999999999999987664 899999999999999887643


Q ss_pred             cCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC-------
Q 041830          466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND-------  538 (600)
Q Consensus       466 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~-------  538 (600)
                      .           ..+++.++..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++.....       
T Consensus       104 ~-----------~~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~  169 (292)
T cd06644         104 D-----------RGLTEPQIQVICRQMLEALQYLH---SMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRRDS  169 (292)
T ss_pred             c-----------CCCCHHHHHHHHHHHHHHHHHHh---cCCeeecCCCcceEEEcCCCCEEEccCccceeccccccccce
Confidence            2           23899999999999999999999   67999999999999999999999999998764321       


Q ss_pred             -----CCCCCccccc---CCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 -----DTESPQFYST---NPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 -----~~~~pe~~~~---~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                           .+.+||+...   ....++.++|||||||++|||++|+.||...
T Consensus       170 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~  218 (292)
T cd06644         170 FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL  218 (292)
T ss_pred             ecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc
Confidence                 1235666532   1234677899999999999999999999653

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=99.94  E-value=1e-25  Score=241.33  Aligned_cols=183  Identities=26%  Similarity=0.375  Sum_probs=141.8

Q ss_pred             eEEEEEEEEC-------CeEEEEEEcchh----HHHHHHHHHHHHHhCC-CCceeeeeeEEeccCCceEEEEeecCCCCH
Q 041830          391 EGAVYHGRLN-------GKNLAIKRTEHE----VITKLEMQLVQHATHH-HPNIVRLLGTCLTDGPHSFLVFEYAKNGSL  458 (600)
Q Consensus       391 ~G~Vy~g~~~-------g~~vAvK~~~~~----~~~~~e~ei~~~~~l~-HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL  458 (600)
                      .|.||+|+..       +..||||+++..    ..+.+..|+..+..+. ||||++++|+|... ...|||||||++|+|
T Consensus        50 fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~-~~~~lv~Ey~~~g~L  128 (400)
T cd05105          50 FGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS-GPIYIITEYCFYGDL  128 (400)
T ss_pred             CceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC-CceEEEEEecCCCcH
Confidence            3999999862       246999998642    2345778999999986 99999999998655 489999999999999


Q ss_pred             HHHHhcCcCccc--------------------------------------------------------------------
Q 041830          459 KDWLHGGLAMKN--------------------------------------------------------------------  470 (600)
Q Consensus       459 ~~~L~~~~~~~~--------------------------------------------------------------------  470 (600)
                      .++|+.......                                                                    
T Consensus       129 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  208 (400)
T cd05105         129 VNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNY  208 (400)
T ss_pred             HHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcc
Confidence            999975321000                                                                    


Q ss_pred             ---------------ccc-cccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCcc
Q 041830          471 ---------------QFI-ASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR  534 (600)
Q Consensus       471 ---------------~~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~  534 (600)
                                     ... ......+++.+++.++.|++.||.|||   +.+++||||||+|||+++++.+||+|||+++
T Consensus       209 ~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivH~dikp~Nill~~~~~~kL~DfGla~  285 (400)
T cd05105         209 DRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLA---SKNCVHRDLAARNVLLAQGKIVKICDFGLAR  285 (400)
T ss_pred             cccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChHhEEEeCCCEEEEEeCCcce
Confidence                           000 000134889999999999999999999   6799999999999999999999999999987


Q ss_pred             ccCCC--------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          535 CVNDD--------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       535 ~~~~~--------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                      .....              ..+||....  ..++.++|||||||++|||++ |..||...
T Consensus       286 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwSlGvil~ellt~g~~P~~~~  343 (400)
T cd05105         286 DIMHDSNYVSKGSTFLPVKWMAPESIFD--NLYTTLSDVWSYGILLWEIFSLGGTPYPGM  343 (400)
T ss_pred             eccccccccccCCcCCCcceEChhhhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence            54221              224554433  346788999999999999997 99998653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=99.94  E-value=1.2e-25  Score=233.14  Aligned_cols=183  Identities=22%  Similarity=0.354  Sum_probs=140.7

Q ss_pred             eeEEEEEEEE----CCeEEEEEEcchhH-HHHHHHHHHHHHhCCCCceeeeeeEEecc-CCceEEEEeecCCCCHHHHHh
Q 041830          390 IEGAVYHGRL----NGKNLAIKRTEHEV-ITKLEMQLVQHATHHHPNIVRLLGTCLTD-GPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       390 ~~G~Vy~g~~----~g~~vAvK~~~~~~-~~~~e~ei~~~~~l~HpNIv~l~g~~~~~-~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      ..|.||+++.    ++..||+|.++... ...+.+|+..+..++||||+++++++... +...++|+||+++ +|.+++.
T Consensus        13 ~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~   91 (317)
T cd07867          13 TYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHIIK   91 (317)
T ss_pred             CCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-cHHHHHH
Confidence            3499999986    34689999886543 23567889999999999999999987643 3467999999975 8888875


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEe----CCCCcEEEEeccCccccCCC
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFL----DEEFNARVGNFGMARCVNDD  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl----d~~~~~kI~DFGla~~~~~~  539 (600)
                      ........   .....+++..+..++.|++.||.|||   +.+|+||||||+|||+    +.++.+||+|||+++.....
T Consensus        92 ~~~~~~~~---~~~~~l~~~~~~~i~~qi~~aL~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~  165 (317)
T cd07867          92 FHRASKAN---KKPMQLPRSMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSP  165 (317)
T ss_pred             hhhccccC---CCCccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCC
Confidence            43211100   01134899999999999999999999   6799999999999999    56689999999999754321


Q ss_pred             ---------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 ---------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 ---------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                                     +.+||.... ...++.++|||||||++|||+||+.||....
T Consensus       166 ~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwSlG~il~el~tg~~~f~~~~  220 (317)
T cd07867         166 LKPLADLDPVVVTFWYRAPELLLG-ARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             cccccccCcceecccccCcHHhcC-CCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence                           234555432 1346778999999999999999999997543

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=99.94  E-value=3.4e-25  Score=223.83  Aligned_cols=171  Identities=28%  Similarity=0.498  Sum_probs=141.1

Q ss_pred             eEEEEEEEEC-----CeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          391 EGAVYHGRLN-----GKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       391 ~G~Vy~g~~~-----g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      .|.||+|++.     ...||||.++..    ....+..|+..+..++||||+++++++... ...+++|||+++|+|.++
T Consensus        17 ~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~iv~e~~~~~~L~~~   95 (266)
T cd05033          17 FGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKS-RPVMIITEYMENGSLDKF   95 (266)
T ss_pred             cceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecC-CceEEEEEcCCCCCHHHH
Confidence            4899999882     347999987542    234567788899999999999999997655 478999999999999999


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC---
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND---  538 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~---  538 (600)
                      +....           ..+++.++++++.|++.||+|||   +.+|+||||||+||++++++.+||+|||+++....   
T Consensus        96 ~~~~~-----------~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~  161 (266)
T cd05033          96 LREND-----------GKFTVGQLVGMLRGIASGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEA  161 (266)
T ss_pred             HHhcc-----------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCCEEECccchhhccccccc
Confidence            97543           23899999999999999999999   67999999999999999999999999999886531   


Q ss_pred             -----------CCCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCC
Q 041830          539 -----------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINR  578 (600)
Q Consensus       539 -----------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~  578 (600)
                                 ...+||....  ..++.++||||||+++|||++ |..||..
T Consensus       162 ~~~~~~~~~~~~y~~Pe~~~~--~~~~~~~Dv~slG~~l~~l~~~g~~p~~~  211 (266)
T cd05033         162 TYTTKGGKIPIRWTAPEAIAY--RKFTSASDVWSFGIVMWEVMSYGERPYWD  211 (266)
T ss_pred             ceeccCCCCCccccChhhhcc--CCCccccchHHHHHHHHHHHccCCCCCCC
Confidence                       1223444432  346778999999999999998 9999854

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=99.94  E-value=8.5e-26  Score=230.22  Aligned_cols=183  Identities=27%  Similarity=0.519  Sum_probs=143.5

Q ss_pred             eEEEEEEEECC-------eEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHH
Q 041830          391 EGAVYHGRLNG-------KNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       391 ~G~Vy~g~~~g-------~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~  459 (600)
                      .|.||+|...+       ..||+|.++..    ....+.+|+..+..++||||+++++++... ...+++|||+++|+|.
T Consensus        18 ~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~-~~~~~~~e~~~~~~L~   96 (283)
T cd05048          18 FGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKE-QPTCMLFEYLAHGDLH   96 (283)
T ss_pred             CCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCC-CceEEEEecCCCCcHH
Confidence            48999998732       56999987542    234577889999999999999999997655 4789999999999999


Q ss_pred             HHHhcCcCcccc-cc---cccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccc
Q 041830          460 DWLHGGLAMKNQ-FI---ASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARC  535 (600)
Q Consensus       460 ~~L~~~~~~~~~-~~---~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~  535 (600)
                      +++......... ..   ......+++.+++.++.|++.||.|||   +.+++||||||+||++++++.+||+|||+++.
T Consensus        97 ~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~  173 (283)
T cd05048          97 EFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLS---SHHFVHRDLAARNCLVGEGLTVKISDFGLSRD  173 (283)
T ss_pred             HHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccccceEEEcCCCcEEECCCcceee
Confidence            999764321110 00   000134899999999999999999999   67999999999999999999999999999875


Q ss_pred             cCC--------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          536 VND--------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       536 ~~~--------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                      ...              ...+||....  ..++.++|||||||++|||++ |..||...
T Consensus       174 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDv~slG~il~el~~~g~~p~~~~  230 (283)
T cd05048         174 IYSADYYRVQSKSLLPVRWMPPEAILY--GKFTTESDIWSFGVVLWEIFSYGLQPYYGF  230 (283)
T ss_pred             ccccccccccCCCcccccccCHHHhcc--CcCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence            421              1234565443  346788999999999999998 99999753

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=99.94  E-value=1.3e-25  Score=233.11  Aligned_cols=185  Identities=21%  Similarity=0.346  Sum_probs=141.9

Q ss_pred             CceeEEEEEEEE----CCeEEEEEEcchhH-HHHHHHHHHHHHhCCCCceeeeeeEEecc-CCceEEEEeecCCCCHHHH
Q 041830          388 NRIEGAVYHGRL----NGKNLAIKRTEHEV-ITKLEMQLVQHATHHHPNIVRLLGTCLTD-GPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       388 ~~~~G~Vy~g~~----~g~~vAvK~~~~~~-~~~~e~ei~~~~~l~HpNIv~l~g~~~~~-~~~~~LV~Ey~~~GsL~~~  461 (600)
                      .|..|.||+++.    +++.||+|.++... .....+|+..+..++||||+++++++... +...+++|||+. ++|.++
T Consensus        11 ~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~   89 (317)
T cd07868          11 RGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHI   89 (317)
T ss_pred             cCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-CCHHHH
Confidence            334499999986    35789999986532 23567889999999999999999987543 346799999996 589888


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEe----CCCCcEEEEeccCccccC
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFL----DEEFNARVGNFGMARCVN  537 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl----d~~~~~kI~DFGla~~~~  537 (600)
                      +.........   .....+++..+..++.|++.||.|||   +.+|+||||||+|||+    +.++.+||+|||+++...
T Consensus        90 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~  163 (317)
T cd07868          90 IKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN  163 (317)
T ss_pred             HHhccccccc---CCcccCCHHHHHHHHHHHHHHHHHHH---hCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccC
Confidence            8643321100   01134899999999999999999999   6799999999999999    456789999999997543


Q ss_pred             CC---------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          538 DD---------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       538 ~~---------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                      ..               +.+||..... ..++.++||||+||++|||++|+.||....
T Consensus       164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~~f~~~~  220 (317)
T cd07868         164 SPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  220 (317)
T ss_pred             CCCccccccCCccccccccCCHHHcCC-CCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence            21               2345554331 346788999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=99.94  E-value=2e-25  Score=225.54  Aligned_cols=172  Identities=26%  Similarity=0.378  Sum_probs=141.8

Q ss_pred             eEEEEEEEE--CCeEEEEEEcch--------hHHHHHHHHHHHHHhCCCCceeeeeeEEecc-CCceEEEEeecCCCCHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEH--------EVITKLEMQLVQHATHHHPNIVRLLGTCLTD-GPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~--------~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~-~~~~~LV~Ey~~~GsL~  459 (600)
                      .|.||++..  +|+.|++|.++.        +....+++|+..+..++||||+++++++... +...++++||+++++|.
T Consensus        15 ~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~   94 (266)
T cd06651          15 FGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVK   94 (266)
T ss_pred             CEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHH
Confidence            389999987  688999998642        1224577889999999999999999987643 34678999999999999


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD  539 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~  539 (600)
                      +++....            .+++.+++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++.....
T Consensus        95 ~~l~~~~------------~l~~~~~~~~~~qi~~~l~~LH---~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd06651          95 DQLKAYG------------ALTESVTRKYTRQILEGMSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTI  159 (266)
T ss_pred             HHHHHcC------------CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCCCccccccc
Confidence            9997542            3889999999999999999999   679999999999999999999999999998754211


Q ss_pred             ---------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 ---------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 ---------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                     ..+||....  ..++.++|||||||++|||++|+.||...
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~i~~el~~g~~pf~~~  212 (266)
T cd06651         160 CMSGTGIRSVTGTPYWMSPEVISG--EGYGRKADVWSLGCTVVEMLTEKPPWAEY  212 (266)
T ss_pred             cccCCccccCCccccccCHHHhCC--CCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence                           124554433  45678899999999999999999999753

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=2.9e-25  Score=226.03  Aligned_cols=174  Identities=22%  Similarity=0.369  Sum_probs=143.6

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh---HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcC
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE---VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGG  465 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~---~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~  465 (600)
                      .|.||++..  ++..+|+|..+..   ..+.+..|+..+..++||||+++++++..+ ...|+||||+++|+|.+++...
T Consensus        18 ~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~   96 (280)
T cd06611          18 FGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYE-NKLWILIEFCDGGALDSIMLEL   96 (280)
T ss_pred             CceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecC-CeEEEEeeccCCCcHHHHHHHh
Confidence            489999988  5889999987532   234577889999999999999999998655 4889999999999999998753


Q ss_pred             cCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC------
Q 041830          466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD------  539 (600)
Q Consensus       466 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~------  539 (600)
                      .           ..+++.++..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++......      
T Consensus        97 ~-----------~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~  162 (280)
T cd06611          97 E-----------RGLTEPQIRYVCRQMLEALNFLH---SHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT  162 (280)
T ss_pred             c-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccce
Confidence            2           34899999999999999999999   669999999999999999999999999987644221      


Q ss_pred             ------CCCCccccc---CCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 ------TESPQFYST---NPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 ------~~~pe~~~~---~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                            ..+||....   ....++.++||||||+++|||++|+.||...
T Consensus       163 ~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~  211 (280)
T cd06611         163 FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL  211 (280)
T ss_pred             eecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC
Confidence                  234555432   1234577899999999999999999999754

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=99.93  E-value=8.9e-26  Score=227.11  Aligned_cols=175  Identities=24%  Similarity=0.469  Sum_probs=145.1

Q ss_pred             eeEEEEEEEE-CCeEEEEEEcchhH---HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcC
Q 041830          390 IEGAVYHGRL-NGKNLAIKRTEHEV---ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGG  465 (600)
Q Consensus       390 ~~G~Vy~g~~-~g~~vAvK~~~~~~---~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~  465 (600)
                      ..|.||+|.. +++.+++|.++...   ...+..|+..+..++|+||+++++++... ...++||||+++|+|.++++..
T Consensus        18 ~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~   96 (261)
T cd05148          18 YFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVG-EPVYIITELMEKGSLLAFLRSP   96 (261)
T ss_pred             CCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecC-CCeEEEEeecccCCHHHHHhcC
Confidence            3489999998 67889999976543   34678889999999999999999997655 4789999999999999999764


Q ss_pred             cCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC------
Q 041830          466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD------  539 (600)
Q Consensus       466 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~------  539 (600)
                      ..          ..+++.++..++.+++.||.|||   +.+++||||||+||+++.++.+||+|||++......      
T Consensus        97 ~~----------~~~~~~~~~~~~~~i~~al~~lH---~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~~  163 (261)
T cd05148          97 EG----------QVLPVASLIDMACQVAEGMAYLE---EQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSD  163 (261)
T ss_pred             CC----------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccCcceEEEcCCceEEEccccchhhcCCccccccC
Confidence            32          34899999999999999999999   678999999999999999999999999998755322      


Q ss_pred             ------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCCC
Q 041830          540 ------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRPR  580 (600)
Q Consensus       540 ------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~~  580 (600)
                            ..+||....  ..++.++||||||+++|||++ |+.||...+
T Consensus       164 ~~~~~~~~~PE~~~~--~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~  209 (261)
T cd05148         164 KKIPYKWTAPEAASH--GTFSTKSDVWSFGILLYEMFTYGQVPYPGMN  209 (261)
T ss_pred             CCCceEecCHHHHcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCcCC
Confidence                  123554433  346778999999999999998 899996543

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=99.93  E-value=1.2e-25  Score=228.68  Aligned_cols=181  Identities=22%  Similarity=0.411  Sum_probs=141.1

Q ss_pred             eEEEEEEEEC-------CeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHH
Q 041830          391 EGAVYHGRLN-------GKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       391 ~G~Vy~g~~~-------g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~  459 (600)
                      .|.||+|...       +..||+|.+...    ...++..|+..+..++||||+++++++... ...++||||+++|+|.
T Consensus        19 ~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~   97 (277)
T cd05062          19 FGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-QPTLVIMELMTRGDLK   97 (277)
T ss_pred             CCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-CCeEEEEecCCCCCHH
Confidence            3899998763       357999987532    223567788888999999999999997544 4889999999999999


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC-
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND-  538 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~-  538 (600)
                      ++++........  ......++|.+++.++.|++.||.|||   +.+++||||||+||++++++.+||+|||+++.... 
T Consensus        98 ~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~  172 (277)
T cd05062          98 SYLRSLRPEMEN--NPVQAPPSLKKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET  172 (277)
T ss_pred             HHHHHcCccccc--cccccCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCcchheEEEcCCCCEEECCCCCccccCCc
Confidence            999753321000  000134789999999999999999999   67999999999999999999999999999864321 


Q ss_pred             -------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          539 -------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       539 -------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                                   .+.+||....  ..++.++|||||||++|||++ |+.||...
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~p~~~~  225 (277)
T cd05062         173 DYYRKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGM  225 (277)
T ss_pred             ceeecCCCCccCHhhcChhHhhc--CCcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence                         1234555433  346788999999999999999 78898654

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=99.93  E-value=3.3e-25  Score=225.44  Aligned_cols=175  Identities=21%  Similarity=0.266  Sum_probs=143.6

Q ss_pred             eeEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          390 IEGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       390 ~~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      ..|.||++..  +|+.+|+|.+....      ...+..|+..+..++||||+++++++... +..|+||||+++++|.++
T Consensus         5 ~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~   83 (277)
T cd05577           5 GFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETK-DDLCLVMTLMNGGDLKYH   83 (277)
T ss_pred             CceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecC-CeEEEEEecCCCCcHHHH
Confidence            3499999987  68999999875422      22345688889999999999999987555 488999999999999999


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC---
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND---  538 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~---  538 (600)
                      +.....          ..+++.+++.++.|++.||.|||   +.+++||||+|+||++++++.+||+|||++.....   
T Consensus        84 l~~~~~----------~~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  150 (277)
T cd05577          84 IYNVGE----------PGFPEARAIFYAAQIICGLEHLH---QRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK  150 (277)
T ss_pred             HHHcCc----------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc
Confidence            975432          24899999999999999999999   67999999999999999999999999998865431   


Q ss_pred             --------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          539 --------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       539 --------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                              ...+||....  ..++.++|||||||++|||++|+.||....
T Consensus       151 ~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~  198 (277)
T cd05577         151 IKGRAGTPGYMAPEVLQG--EVYDFSVDWFALGCTLYEMIAGRSPFRQRK  198 (277)
T ss_pred             cccccCCCCcCCHHHhcC--CCCCchhhhHHHHHHHHHHhhCCCCCCCCc
Confidence                    1234565443  336788999999999999999999996543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=99.93  E-value=1.3e-25  Score=228.47  Aligned_cols=178  Identities=26%  Similarity=0.438  Sum_probs=141.8

Q ss_pred             eEEEEEEEEC-------CeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHH
Q 041830          391 EGAVYHGRLN-------GKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       391 ~G~Vy~g~~~-------g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~  459 (600)
                      .|.||+|.+.       +..||+|..+..    ....+..|+..+..++|+||+++++++.+.+ ..++||||+++|+|.
T Consensus        19 ~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~-~~~lv~e~~~g~~L~   97 (277)
T cd05036          19 FGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERL-PRFILLELMAGGDLK   97 (277)
T ss_pred             CCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC-CcEEEEecCCCCCHH
Confidence            4899999883       467999987532    2235677888899999999999999976654 789999999999999


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC---cEEEEeccCcccc
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEF---NARVGNFGMARCV  536 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~---~~kI~DFGla~~~  536 (600)
                      ++++........     ...++|.++++++.||+.||+|||   +.+++||||||+||+++.++   .+||+|||+++..
T Consensus        98 ~~i~~~~~~~~~-----~~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~  169 (277)
T cd05036          98 SFLRENRPRPER-----PSSLTMKDLLFCARDVAKGCKYLE---ENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDI  169 (277)
T ss_pred             HHHHHhCCCCCC-----CCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccchheEEEeccCCCcceEeccCcccccc
Confidence            999765421110     134899999999999999999999   66899999999999998654   6999999998754


Q ss_pred             CCC--------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          537 NDD--------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       537 ~~~--------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                      ...              ..+||....  ..++.++|||||||++|||++ |+.||...
T Consensus       170 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~~g~~pf~~~  225 (277)
T cd05036         170 YRASYYRKGGRAMLPIKWMPPEAFLD--GIFTSKTDVWSFGVLLWEIFSLGYMPYPGR  225 (277)
T ss_pred             CCccceecCCCCCccHhhCCHHHHhc--CCcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence            211              234555433  447889999999999999997 99999754

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.93  E-value=2.7e-25  Score=224.36  Aligned_cols=172  Identities=25%  Similarity=0.491  Sum_probs=140.5

Q ss_pred             eEEEEEEEE-CCeEEEEEEcchhH--HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcC
Q 041830          391 EGAVYHGRL-NGKNLAIKRTEHEV--ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLA  467 (600)
Q Consensus       391 ~G~Vy~g~~-~g~~vAvK~~~~~~--~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~  467 (600)
                      .|.||+|+. ++..||+|.++...  .+.+.+|+..+..++||||+++++++ .+ ...++||||+++|+|.++++....
T Consensus        19 ~~~v~~~~~~~~~~valK~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~-~~-~~~~lv~e~~~~~~L~~~~~~~~~   96 (262)
T cd05071          19 FGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVV-SE-EPIYIVTEYMSKGSLLDFLKGEMG   96 (262)
T ss_pred             CCcEEEEEecCCceEEEEecccCccCHHHHHHHHHHHHhCCCCCcceEEEEE-CC-CCcEEEEEcCCCCcHHHHHhhccc
Confidence            489999988 44579999987532  34577889999999999999999986 33 367999999999999999975321


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--------
Q 041830          468 MKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--------  539 (600)
Q Consensus       468 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--------  539 (600)
                                ..++|.+++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||.++.....        
T Consensus        97 ----------~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~~~  163 (262)
T cd05071          97 ----------KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA  163 (262)
T ss_pred             ----------cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccCcccEEEcCCCcEEeccCCceeeccccccccccCC
Confidence                      23899999999999999999999   679999999999999999999999999998754321        


Q ss_pred             -----CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          540 -----TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       540 -----~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                           ..+||....  ..++.++||||||+++|||++ |+.||...
T Consensus       164 ~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l~ellt~g~~p~~~~  207 (262)
T cd05071         164 KFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGM  207 (262)
T ss_pred             cccceecCHhHhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence                 123443322  346778999999999999999 88898654

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>PHA03207 serine/threonine kinase US3; Provisional

Probab=99.93  E-value=1.5e-25  Score=240.01  Aligned_cols=172  Identities=25%  Similarity=0.345  Sum_probs=140.6

Q ss_pred             ceeEEEEEEEE----CCeEEEEEEcchhHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          389 RIEGAVYHGRL----NGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       389 ~~~G~Vy~g~~----~g~~vAvK~~~~~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      +.+|.||++..    .+..||+|.+....  ..++|+..+..++||||+++++++..+ ...+++|||+. ++|.+++..
T Consensus       103 G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--~~~~E~~il~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~-~~l~~~l~~  178 (392)
T PHA03207        103 GSEGEVFVCTKHGDEQRKKVIVKAVTGGK--TPGREIDILKTISHRAIINLIHAYRWK-STVCMVMPKYK-CDLFTYVDR  178 (392)
T ss_pred             CCCeEEEEEEEcCCccceeEEEEeccccc--cHHHHHHHHHhcCCCCccceeeeEeeC-CEEEEEehhcC-CCHHHHHHh
Confidence            33499999876    35679999886543  346788889999999999999987655 48899999996 689999843


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-----
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-----  539 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-----  539 (600)
                      .            ..++|.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....     
T Consensus       179 ~------------~~l~~~~~~~i~~ql~~aL~~LH---~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~  243 (392)
T PHA03207        179 S------------GPLPLEQAITIQRRLLEALAYLH---GRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQ  243 (392)
T ss_pred             c------------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEccCccccccCccccccc
Confidence            3            23899999999999999999999   679999999999999999999999999998654321     


Q ss_pred             ---------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCCC
Q 041830          540 ---------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRK  581 (600)
Q Consensus       540 ---------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~  581 (600)
                               +.+||....  ..++.++|||||||++|||++|+.||.....
T Consensus       244 ~~~~~gt~~y~aPE~~~~--~~~~~~~DvwslGvil~el~~g~~pf~~~~~  292 (392)
T PHA03207        244 CYGWSGTLETNSPELLAL--DPYCAKTDIWSAGLVLFEMSVKNVTLFGKQV  292 (392)
T ss_pred             ccccccccCccCHhHhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCCC
Confidence                     124555443  3467889999999999999999999976543

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=2.2e-25  Score=226.21  Aligned_cols=170  Identities=26%  Similarity=0.450  Sum_probs=144.4

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      .|.||+|+.  +|+.||+|.+..+.    ...+..|+..++.++|+||+++++++..+ ...|+|+||+++++|.++++.
T Consensus        14 ~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~   92 (274)
T cd06609          14 FGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKG-SKLWIIMEYCGGGSCLDLLKP   92 (274)
T ss_pred             CeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEEC-CeEEEEEEeeCCCcHHHHHhh
Confidence            389999998  68899999875432    24567888899999999999999997665 589999999999999999975


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-----
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-----  539 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-----  539 (600)
                      .             .+++.++..++.|++.||.|||   +.+++||||+|+||++++++.++|+|||+++.....     
T Consensus        93 ~-------------~~~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~  156 (274)
T cd06609          93 G-------------KLDETYIAFILREVLLGLEYLH---EEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRN  156 (274)
T ss_pred             c-------------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEECCCCCEEEcccccceeecccccccc
Confidence            3             3899999999999999999999   678999999999999999999999999998765432     


Q ss_pred             -------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 -------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 -------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                             ..+||....  ..++.++||||||+++|||++|+.||...
T Consensus       157 ~~~~~~~y~~PE~~~~--~~~~~~sDv~slG~il~~l~tg~~p~~~~  201 (274)
T cd06609         157 TFVGTPFWMAPEVIKQ--SGYDEKADIWSLGITAIELAKGEPPLSDL  201 (274)
T ss_pred             cccCCccccChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence                   234555544  33788899999999999999999999653

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=99.93  E-value=2.1e-25  Score=226.07  Aligned_cols=182  Identities=30%  Similarity=0.554  Sum_probs=140.9

Q ss_pred             eEEEEEEEE--CCe--EEEEEEcch----hHHHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          391 EGAVYHGRL--NGK--NLAIKRTEH----EVITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       391 ~G~Vy~g~~--~g~--~vAvK~~~~----~~~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      .|.||+|+.  +|.  .+++|.++.    +....+..|+..+.++ +||||+++++++..++ ..+++|||+++|+|.++
T Consensus         8 ~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~-~~~lv~e~~~~~~L~~~   86 (270)
T cd05047           8 FGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRG-YLYLAIEYAPHGNLLDF   86 (270)
T ss_pred             CceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCC-CceEEEEeCCCCcHHHH
Confidence            489999998  343  478888763    2234567788888888 7999999999986654 78999999999999999


Q ss_pred             HhcCcCcccc--c--ccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC
Q 041830          462 LHGGLAMKNQ--F--IASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN  537 (600)
Q Consensus       462 L~~~~~~~~~--~--~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~  537 (600)
                      ++........  +  .......+++.+++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++...
T Consensus        87 i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~  163 (270)
T cd05047          87 LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQE  163 (270)
T ss_pred             HHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccccceEEEcCCCeEEECCCCCccccc
Confidence            9764321100  0  0001134899999999999999999999   6799999999999999999999999999985321


Q ss_pred             C-----------CCCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCC
Q 041830          538 D-----------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINR  578 (600)
Q Consensus       538 ~-----------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~  578 (600)
                      .           ...+||+...  ..++.++|||||||++|||++ |+.||..
T Consensus       164 ~~~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~el~~~g~~pf~~  214 (270)
T cd05047         164 VYVKKTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCG  214 (270)
T ss_pred             hhhhccCCCCccccCChHHHcc--CCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence            1           1234555433  346778999999999999997 9999964

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=99.93  E-value=2e-25  Score=225.20  Aligned_cols=171  Identities=27%  Similarity=0.396  Sum_probs=141.5

Q ss_pred             eEEEEEEEE-CCeEEEEEEcchh---------HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          391 EGAVYHGRL-NGKNLAIKRTEHE---------VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       391 ~G~Vy~g~~-~g~~vAvK~~~~~---------~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      .|.||+|.. +|+.+|+|.++..         ....+++|+..+..++|+||+++++++... ...++++||+++|+|.+
T Consensus        13 ~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~   91 (265)
T cd06631          13 YGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDD-NTISIFMEFVPGGSISS   91 (265)
T ss_pred             CeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecC-CeEEEEEecCCCCcHHH
Confidence            489999987 7889999976421         123577888999999999999999998665 58899999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC--
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND--  538 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~--  538 (600)
                      ++.+..            .+++.++..++.|++.||+|||   +.+++|+||+|+||++++++.+||+|||+++....  
T Consensus        92 ~l~~~~------------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~  156 (265)
T cd06631          92 ILNRFG------------PLPEPVFCKYTKQILDGVAYLH---NNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVG  156 (265)
T ss_pred             HHHhcC------------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcc
Confidence            997542            3789999999999999999999   66899999999999999999999999999865321  


Q ss_pred             ----------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 ----------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 ----------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                      ...+||....  ..++.++||||||+++|||++|+.||...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~  211 (265)
T cd06631         157 LHGTHSNMLKSMHGTPYWMAPEVINE--SGYGRKSDIWSIGCTVFEMATGKPPLASM  211 (265)
T ss_pred             ccccccccccccCCCccccChhhhcC--CCCcchhhHHHHHHHHHHHHhCCCccccC
Confidence                            1123554433  34577899999999999999999999653

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=99.93  E-value=2e-25  Score=225.73  Aligned_cols=178  Identities=22%  Similarity=0.465  Sum_probs=140.6

Q ss_pred             eEEEEEEEEC-----CeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCC-----ceEEEEeecCC
Q 041830          391 EGAVYHGRLN-----GKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGP-----HSFLVFEYAKN  455 (600)
Q Consensus       391 ~G~Vy~g~~~-----g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~-----~~~LV~Ey~~~  455 (600)
                      .|.||+|...     +..||+|+++.+     ....+..|+..+..++||||++++|++.....     ..++++||+++
T Consensus        12 ~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~   91 (273)
T cd05035          12 FGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKH   91 (273)
T ss_pred             CceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCC
Confidence            4899999872     367999987642     22456778888999999999999999765431     36899999999


Q ss_pred             CCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccc
Q 041830          456 GSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARC  535 (600)
Q Consensus       456 GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~  535 (600)
                      |+|..++........      ...+++.....++.|++.||.|||   +.+++||||||+||++++++.+||+|||+++.
T Consensus        92 ~~l~~~l~~~~~~~~------~~~~~~~~~~~~~~~i~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  162 (273)
T cd05035          92 GDLHSFLLYSRLGGL------PEKLPLQTLLKFMVDIALGMEYLS---NRNFIHRDLAARNCMLREDMTVCVADFGLSKK  162 (273)
T ss_pred             CCHHHHHHHhhccCC------cccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchheEEECCCCeEEECCccceee
Confidence            999999865331110      134899999999999999999999   67999999999999999999999999999876


Q ss_pred             cCCC--------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          536 VNDD--------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       536 ~~~~--------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                      ....              ..+||....  ..++.++||||||+++|||++ |..||...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~SlG~il~el~~~g~~p~~~~  219 (273)
T cd05035         163 IYSGDYYRQGRIAKMPVKWIAIESLAD--RVYTSKSDVWAFGVTMWEIATRGQTPYPGV  219 (273)
T ss_pred             ccccccccccccccCCccccCHhhccc--CCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence            4321              123443322  446788999999999999999 88998653

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=99.93  E-value=2.8e-25  Score=227.68  Aligned_cols=171  Identities=26%  Similarity=0.403  Sum_probs=143.7

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      |.||++..  +++.+|+|.++...      ...+..|+..+..+.||||+++++++... ...++||||+++|+|.+++.
T Consensus        15 ~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~   93 (290)
T cd05580          15 GRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDD-SNLYLVMEYVPGGELFSHLR   93 (290)
T ss_pred             eEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcC-CeEEEEEecCCCCCHHHHHH
Confidence            89999988  68999999876432      24567788899999999999999997655 58899999999999999997


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD----  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~----  539 (600)
                      ...            .+++.++..++.|++.||.|||   +.+++||||+|+||+++.++.+||+|||+++.....    
T Consensus        94 ~~~------------~l~~~~~~~~~~qil~~l~~lH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~  158 (290)
T cd05580          94 KSG------------RFPEPVARFYAAQVVLALEYLH---SLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTL  158 (290)
T ss_pred             HcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCCCCCC
Confidence            543            3899999999999999999999   679999999999999999999999999998765322    


Q ss_pred             -----CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 -----TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 -----~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                           ..+||....  ..++.++||||||+++|||++|+.||...+
T Consensus       159 ~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~  202 (290)
T cd05580         159 CGTPEYLAPEIILS--KGYGKAVDWWALGILIYEMLAGYPPFFDDN  202 (290)
T ss_pred             CCCccccChhhhcC--CCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence                 234555433  345778999999999999999999997543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=99.93  E-value=3.4e-25  Score=226.91  Aligned_cols=183  Identities=22%  Similarity=0.404  Sum_probs=142.0

Q ss_pred             eEEEEEEEEC-------CeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHH
Q 041830          391 EGAVYHGRLN-------GKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       391 ~G~Vy~g~~~-------g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~  459 (600)
                      .|.||+|...       ...+++|.+...    ....+..|+..+..+.||||+++++.|..+ ...++++||+++|+|.
T Consensus        13 ~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~   91 (290)
T cd05045          13 FGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQD-GPLLLIVEYAKYGSLR   91 (290)
T ss_pred             CcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecC-CCcEEEEEecCCCCHH
Confidence            3899999862       256899986532    234577889999999999999999998655 4789999999999999


Q ss_pred             HHHhcCcCccccc------------ccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEE
Q 041830          460 DWLHGGLAMKNQF------------IASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARV  527 (600)
Q Consensus       460 ~~L~~~~~~~~~~------------~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI  527 (600)
                      +++..........            .......+++.+++.++.|++.||.|||   +.+++||||||+|||+++++.+||
T Consensus        92 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~ivH~dikp~nill~~~~~~kl  168 (290)
T cd05045          92 SFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLA---EMKLVHRDLAARNVLVAEGRKMKI  168 (290)
T ss_pred             HHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHH---HCCeehhhhhhheEEEcCCCcEEe
Confidence            9997543211000            0011245899999999999999999999   679999999999999999999999


Q ss_pred             EeccCccccCCC--------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          528 GNFGMARCVNDD--------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       528 ~DFGla~~~~~~--------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                      +|||+++.....              ..+||....  ..++.++||||||+++|||++ |+.||...
T Consensus       169 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~  233 (290)
T cd05045         169 SDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFD--HIYTTQSDVWSFGVLLWEIVTLGGNPYPGI  233 (290)
T ss_pred             ccccccccccCccchhcccCCCCCccccCHHHHcc--CCcchHhHHHHHHHHHHHHHhcCCCCCCCC
Confidence            999998754211              123444332  346778999999999999999 99999653

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=99.93  E-value=2.3e-25  Score=227.11  Aligned_cols=173  Identities=23%  Similarity=0.363  Sum_probs=142.4

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      .|.||+++.  +|+.||+|++...     ..+.+..|+..+..++|+||+++++++... ...++||||++++.|..+++
T Consensus        14 ~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~~v~e~~~~~~l~~~~~   92 (286)
T cd07847          14 YGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRK-RKLHLVFEYCDHTVLNELEK   92 (286)
T ss_pred             CeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeC-CEEEEEEeccCccHHHHHHh
Confidence            389999998  6899999987532     123467788899999999999999997655 48899999999998888775


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCCC---
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDT---  540 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~~---  540 (600)
                      ...            .++|.+++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++.......   
T Consensus        93 ~~~------------~~~~~~~~~~~~ql~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  157 (286)
T cd07847          93 NPR------------GVPEHLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDY  157 (286)
T ss_pred             CCC------------CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCChhhEEEcCCCcEEECccccceecCCCcccc
Confidence            432            3899999999999999999999   6799999999999999999999999999987653321   


Q ss_pred             ---------CCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          541 ---------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       541 ---------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                               .+||.... ...++.++||||||+++|||++|+.||....
T Consensus       158 ~~~~~~~~~~aPE~~~~-~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~  205 (286)
T cd07847         158 TDYVATRWYRAPELLVG-DTQYGPPVDVWAIGCVFAELLTGQPLWPGKS  205 (286)
T ss_pred             cCcccccccCCHHHHhC-CCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence                     24554432 1346778999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=99.93  E-value=1.6e-25  Score=231.85  Aligned_cols=174  Identities=21%  Similarity=0.314  Sum_probs=142.9

Q ss_pred             EEEEEEEECCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCc
Q 041830          392 GAVYHGRLNGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGL  466 (600)
Q Consensus       392 G~Vy~g~~~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~  466 (600)
                      +.||+++.+|+.||+|++..+     ....++.|+..+..++|+||+++++++..+ ...+++|||+++|+|.++++...
T Consensus        16 v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~-~~~~~~~e~~~~~~l~~~l~~~~   94 (314)
T cd08216          16 VHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVD-SELYVVSPLMAYGSCEDLLKTHF   94 (314)
T ss_pred             EEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecC-CeEEEEEeccCCCCHHHHHHHhc
Confidence            566677678999999987532     335678899999999999999999997655 47899999999999999997543


Q ss_pred             CcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC--------
Q 041830          467 AMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND--------  538 (600)
Q Consensus       467 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~--------  538 (600)
                      .          ..+++.....++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||.+.....        
T Consensus        95 ~----------~~~~~~~~~~~~~~l~~~L~~LH---~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~  161 (314)
T cd08216          95 P----------EGLPELAIAFILKDVLNALDYIH---SKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV  161 (314)
T ss_pred             c----------cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence            2          23888999999999999999999   66999999999999999999999999998753321        


Q ss_pred             -----------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 -----------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 -----------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                 ...+||........++.++|||||||++|||++|+.||...
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~  213 (314)
T cd08216         162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM  213 (314)
T ss_pred             ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence                       12345555443345778899999999999999999999753

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=99.93  E-value=1.8e-25  Score=227.99  Aligned_cols=174  Identities=22%  Similarity=0.384  Sum_probs=142.1

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      .|.||+|+.  +|+.||+|.++..     ....+..|+..+..++||||+++++++..+ ...++||||++ ++|.+++.
T Consensus        13 ~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e~~~-~~l~~~~~   90 (285)
T cd07861          13 YGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQE-SRLYLIFEFLS-MDLKKYLD   90 (285)
T ss_pred             ceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeC-CeEEEEEecCC-CCHHHHHh
Confidence            389999988  6889999987532     124567789999999999999999998665 48899999997 68999886


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC-----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND-----  538 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~-----  538 (600)
                      .....         ..+++.++..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++....     
T Consensus        91 ~~~~~---------~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  158 (285)
T cd07861          91 SLPKG---------QYMDAELVKSYLYQILQGILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY  158 (285)
T ss_pred             cCCCC---------CcCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccc
Confidence            53311         34899999999999999999999   67999999999999999999999999999864421     


Q ss_pred             -------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 -------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 -------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                             ...+||..... ..++.++|||||||++|||+||+.||...
T Consensus       159 ~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~~~~~~  205 (285)
T cd07861         159 THEVVTLWYRAPEVLLGS-PRYSTPVDIWSIGTIFAEMATKKPLFHGD  205 (285)
T ss_pred             cCCcccccccChHHhcCC-CCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence                   12346654332 34577899999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=99.93  E-value=1.4e-25  Score=229.85  Aligned_cols=177  Identities=24%  Similarity=0.372  Sum_probs=141.5

Q ss_pred             EEEEEEEE--CCeEEEEEEcchh--HHHHHHHHHHHHHhC-CCCceeeeeeEEeccC----CceEEEEeecCCCCHHHHH
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHE--VITKLEMQLVQHATH-HHPNIVRLLGTCLTDG----PHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~--~~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~----~~~~LV~Ey~~~GsL~~~L  462 (600)
                      |.||++..  +|+.+|+|.+...  ....++.|+..+..+ +|||++++++++....    ...++||||+++|+|.+++
T Consensus        36 ~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~  115 (291)
T cd06639          36 GKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELV  115 (291)
T ss_pred             eEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHH
Confidence            89999988  6889999987642  224566777777777 7999999999986432    3579999999999999998


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC---
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---  539 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~---  539 (600)
                      +.....        ...++|..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++.....   
T Consensus       116 ~~~~~~--------~~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~  184 (291)
T cd06639         116 KGLLIC--------GQRLDEAMISYILYGALLGLQHLH---NNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR  184 (291)
T ss_pred             HHhhhc--------CCCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEeecccchhccccccc
Confidence            642211        134899999999999999999999   679999999999999999999999999998754321   


Q ss_pred             ---------CCCCcccccCC---CCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 ---------TESPQFYSTNP---ASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 ---------~~~pe~~~~~~---~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                               ..+||......   ..++.++|||||||++|||++|+.||...
T Consensus       185 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~  236 (291)
T cd06639         185 RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM  236 (291)
T ss_pred             ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC
Confidence                     23455543321   23578899999999999999999999754

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.93  E-value=2e-25  Score=227.70  Aligned_cols=171  Identities=26%  Similarity=0.503  Sum_probs=140.1

Q ss_pred             eEEEEEEEE------CCeEEEEEEcchhH---HHHHHHHHHHHHhCCCCceeeeeeEEecc-CCceEEEEeecCCCCHHH
Q 041830          391 EGAVYHGRL------NGKNLAIKRTEHEV---ITKLEMQLVQHATHHHPNIVRLLGTCLTD-GPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       391 ~G~Vy~g~~------~g~~vAvK~~~~~~---~~~~e~ei~~~~~l~HpNIv~l~g~~~~~-~~~~~LV~Ey~~~GsL~~  460 (600)
                      .|.||++..      +++.||+|++....   ...++.|+..+..++||||+++++++... ....++||||+++|+|.+
T Consensus        17 ~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~   96 (284)
T cd05081          17 FGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRD   96 (284)
T ss_pred             CceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHH
Confidence            389999874      47789999976432   34678899999999999999999987643 346799999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-  539 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-  539 (600)
                      ++....           ..++|..+..++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++..... 
T Consensus        97 ~l~~~~-----------~~l~~~~~~~~~~~l~~aL~~LH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~  162 (284)
T cd05081          97 YLQKHR-----------ERLDHRKLLLYASQICKGMEYLG---SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK  162 (284)
T ss_pred             HHHhcC-----------cCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHhhEEECCCCeEEECCCcccccccCCC
Confidence            997543           23899999999999999999999   679999999999999999999999999998865321 


Q ss_pred             --------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCC
Q 041830          540 --------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN  577 (600)
Q Consensus       540 --------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~  577 (600)
                                    ..+||....  ..++.++|||||||++|||++|..|+.
T Consensus       163 ~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~~~~~~  212 (284)
T cd05081         163 EYYKVREPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYSDKSC  212 (284)
T ss_pred             cceeecCCCCCceEeeCHHHhcc--CCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence                          123444332  346778999999999999999877754

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=99.93  E-value=1.9e-25  Score=225.82  Aligned_cols=172  Identities=27%  Similarity=0.492  Sum_probs=140.7

Q ss_pred             eEEEEEEEE--CCe---EEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          391 EGAVYHGRL--NGK---NLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       391 ~G~Vy~g~~--~g~---~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      .|.||+|+.  +++   .+|+|..+..    ....+..|+..+..++|+||+++.+++... ...++||||+++|+|.++
T Consensus        18 ~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~   96 (268)
T cd05063          18 FGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKF-KPAMIITEYMENGALDKY   96 (268)
T ss_pred             CccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccC-CCcEEEEEcCCCCCHHHH
Confidence            389999987  333   7999987543    234567888889999999999999997655 478999999999999999


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--  539 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--  539 (600)
                      ++...           ..+++.++..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++.....  
T Consensus        97 ~~~~~-----------~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~  162 (268)
T cd05063          97 LRDHD-----------GEFSSYQLVGMLRGIAAGMKYLS---DMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE  162 (268)
T ss_pred             HHhcC-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccccchhhEEEcCCCcEEECCCccceecccccc
Confidence            97533           23899999999999999999999   669999999999999999999999999998755321  


Q ss_pred             -------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          540 -------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       540 -------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                                   ..+||....  ..++.++|||||||++|||++ |+.||...
T Consensus       163 ~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~il~ell~~g~~p~~~~  214 (268)
T cd05063         163 GTYTTSGGKIPIRWTAPEAIAY--RKFTSASDVWSFGIVMWEVMSFGERPYWDM  214 (268)
T ss_pred             cceeccCCCcCceecCHHHhhc--CCcChHhHHHHHHHHHHHHHhCCCCCCCcC
Confidence                         223444332  345778999999999999998 99999653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=99.93  E-value=2.4e-25  Score=224.74  Aligned_cols=171  Identities=26%  Similarity=0.460  Sum_probs=141.1

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh------------HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCC
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE------------VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNG  456 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~------------~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~G  456 (600)
                      .|.||+|..  +++.+|+|.+...            ..+.+++|+..+..++||||+++++++..+ ...+++|||++++
T Consensus        13 ~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~   91 (267)
T cd06628          13 FGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDA-DHLNIFLEYVPGG   91 (267)
T ss_pred             CeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeC-CccEEEEEecCCC
Confidence            389999987  6789999976421            123567888999999999999999997665 4889999999999


Q ss_pred             CHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCcccc
Q 041830          457 SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV  536 (600)
Q Consensus       457 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~  536 (600)
                      +|.+++....            .+++.++..++.|++.||+|||   +.+++||||+|+||++++++.+||+|||+++..
T Consensus        92 ~L~~~l~~~~------------~l~~~~~~~~~~~l~~~l~~lH---~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~  156 (267)
T cd06628          92 SVAALLNNYG------------AFEETLVRNFVRQILKGLNYLH---NRGIIHRDIKGANILVDNKGGIKISDFGISKKL  156 (267)
T ss_pred             CHHHHHHhcc------------CccHHHHHHHHHHHHHHHHHHH---hcCcccccCCHHHEEEcCCCCEEecccCCCccc
Confidence            9999997542            3889999999999999999999   669999999999999999999999999998765


Q ss_pred             CCC------------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          537 NDD------------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       537 ~~~------------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                      ...                  ..+||....  ..++.++||||||+++|||++|+.||...
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~  215 (267)
T cd06628         157 EANSLSTKTNGARPSLQGSVFWMAPEVVKQ--TSYTRKADIWSLGCLVVEMLTGKHPFPDC  215 (267)
T ss_pred             ccccccCCccccccccCCCcCccChhHhcc--CCCCchhhhHHHHHHHHHHhhCCCCCCCc
Confidence            421                  123443332  34567899999999999999999999753

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=99.93  E-value=3.5e-25  Score=225.63  Aligned_cols=167  Identities=20%  Similarity=0.350  Sum_probs=139.3

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      .|.||+++.  +++.||+|....+    ....+..|+..+..++||||+++++++..+ +..++||||+++|+|..+.  
T Consensus        14 ~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~l~~~~--   90 (279)
T cd06619          14 GGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVE-NRISICTEFMDGGSLDVYR--   90 (279)
T ss_pred             CeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEEC-CEEEEEEecCCCCChHHhh--
Confidence            489999987  7889999987532    224567788889999999999999998765 4789999999999997652  


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-----
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-----  539 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-----  539 (600)
                                    .+++..+..++.|++.||.|||   +.+++|+||||+|||++.++.+||+|||++......     
T Consensus        91 --------------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~~~~~  153 (279)
T cd06619          91 --------------KIPEHVLGRIAVAVVKGLTYLW---SLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTY  153 (279)
T ss_pred             --------------cCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccccccCC
Confidence                          1678888999999999999999   679999999999999999999999999998754321     


Q ss_pred             -----CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 -----TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 -----~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                           ..+||....  ..++.++||||||+++|||++|+.||...
T Consensus       154 ~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~~pf~~~  196 (279)
T cd06619         154 VGTNAYMAPERISG--EQYGIHSDVWSLGISFMELALGRFPYPQI  196 (279)
T ss_pred             CCChhhcCceeecC--CCCCCcchHHHHHHHHHHHHhCCCCchhh
Confidence                 234665543  35678899999999999999999999653

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=99.93  E-value=1.6e-25  Score=227.66  Aligned_cols=183  Identities=26%  Similarity=0.458  Sum_probs=145.2

Q ss_pred             eEEEEEEEE-C------CeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHH
Q 041830          391 EGAVYHGRL-N------GKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       391 ~G~Vy~g~~-~------g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~  459 (600)
                      .|.||+|.. +      ++.||+|.++..    ..+.+.+|+..+..+.|+||+++++++... ...++||||+++|+|.
T Consensus        18 ~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~   96 (280)
T cd05049          18 FGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEG-DPPIMVFEYMEHGDLN   96 (280)
T ss_pred             CceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecC-CCeEEEEecCCCCCHH
Confidence            389999976 2      367999987542    335678899999999999999999998765 4899999999999999


Q ss_pred             HHHhcCcCccccc--ccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC
Q 041830          460 DWLHGGLAMKNQF--IASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN  537 (600)
Q Consensus       460 ~~L~~~~~~~~~~--~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~  537 (600)
                      ++++.........  .......+++.++..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++...
T Consensus        97 ~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~  173 (280)
T cd05049          97 KFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLA---SQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVY  173 (280)
T ss_pred             HHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHh---hCCeeccccccceEEEcCCCeEEECCcccceecc
Confidence            9997643211000  0111244899999999999999999999   6799999999999999999999999999987432


Q ss_pred             C--------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          538 D--------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       538 ~--------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                      .              ...+||....  ..++.++|||||||++|||++ |+.||...
T Consensus       174 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~e~~~~g~~p~~~~  228 (280)
T cd05049         174 TTDYYRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSFGVVLWEIFTYGKQPWYGL  228 (280)
T ss_pred             cCcceecCCCCcccceecChhhhcc--CCcchhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence            1              1235565443  346788999999999999999 99998653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=99.93  E-value=3.7e-25  Score=224.18  Aligned_cols=175  Identities=21%  Similarity=0.315  Sum_probs=140.2

Q ss_pred             CCceeEEEEEEEE--CCeEEEEEEcchhHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          387 SNRIEGAVYHGRL--NGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       387 ~~~~~G~Vy~g~~--~g~~vAvK~~~~~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      +++..|.||++..  +|+.+|+|..........+.+...+. .+||||+++++.+..++ ..++||||+++|+|.++++.
T Consensus        25 g~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~e~~~~~~~-~~h~~iv~~~~~~~~~~-~~~iv~e~~~~~~L~~~l~~  102 (267)
T PHA03390         25 IDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAIEPMVHQLM-KDNPNFIKLYYSVTTLK-GHVLIMDYIKDGDLFDLLKK  102 (267)
T ss_pred             cCCCceEEEEEEEcCCCcEEEEEEEehhhcchhhHHHHHHh-hcCCCEEEEEEEEecCC-eeEEEEEcCCCCcHHHHHHh
Confidence            3344599999987  68899999987654333333332222 26999999999986654 89999999999999999975


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC-cEEEEeccCccccCCC----
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEF-NARVGNFGMARCVNDD----  539 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~-~~kI~DFGla~~~~~~----  539 (600)
                      ..            .++|.++..++.|+++||.|||   +.+++||||||+||+++.++ .++|+|||+++.....    
T Consensus       103 ~~------------~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~  167 (267)
T PHA03390        103 EG------------KLSEAEVKKIIRQLVEALNDLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD  167 (267)
T ss_pred             cC------------CCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCCccCC
Confidence            42            3899999999999999999999   66899999999999999988 9999999998755432    


Q ss_pred             ----CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 ----TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 ----~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                          ..+||....  ..++.++||||||+++|||++|+.||....
T Consensus       168 ~~~~y~aPE~~~~--~~~~~~~DvwslG~il~~l~~g~~p~~~~~  210 (267)
T PHA03390        168 GTLDYFSPEKIKG--HNYDVSFDWWAVGVLTYELLTGKHPFKEDE  210 (267)
T ss_pred             CCCcccChhhhcC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence                235665544  346778999999999999999999997543

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=99.93  E-value=2.9e-25  Score=229.27  Aligned_cols=171  Identities=23%  Similarity=0.359  Sum_probs=140.7

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||++..  .++.|++|.++...      ...+..|+..+..++||||+++++.+..+ ...++||||+++|+|.+++
T Consensus        14 ~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~g~~L~~~l   92 (305)
T cd05609          14 YGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETK-RHLCMVMEYVEGGDCATLL   92 (305)
T ss_pred             CeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecC-CEEEEEEecCCCCcHHHHH
Confidence            389999988  67899999876532      23456788888999999999999997655 4889999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC-----
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN-----  537 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~-----  537 (600)
                      ....            .+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++...     
T Consensus        93 ~~~~------------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~  157 (305)
T cd05609          93 KNIG------------ALPVDMARMYFAETVLALEYLH---NYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTT  157 (305)
T ss_pred             HHcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccc
Confidence            6542            3899999999999999999999   6799999999999999999999999999986311     


Q ss_pred             ----------------------CCCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          538 ----------------------DDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       538 ----------------------~~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                            ....+||....  ..++.++|+||||+++|||++|+.||...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~vl~el~~g~~pf~~~  219 (305)
T cd05609         158 NLYEGHIEKDTREFLDKQVCGTPEYIAPEVILR--QGYGKPVDWWAMGIILYEFLVGCVPFFGD  219 (305)
T ss_pred             cccccccccchhhccccCCccCccccCchhccC--CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence                                  01223444332  34678899999999999999999999753

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=99.93  E-value=2.8e-25  Score=223.20  Aligned_cols=171  Identities=28%  Similarity=0.471  Sum_probs=140.4

Q ss_pred             eeEEEEEEEE--C---CeEEEEEEcchhH----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          390 IEGAVYHGRL--N---GKNLAIKRTEHEV----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       390 ~~G~Vy~g~~--~---g~~vAvK~~~~~~----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      ..|.||+|++  .   +..+|+|.++.+.    .+.+..|+..+..+.|+||+++++++..  +..++||||+++|+|.+
T Consensus         7 ~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~--~~~~~v~e~~~~~~L~~   84 (257)
T cd05060           7 NFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCKG--EPLMLVMELAPLGPLLK   84 (257)
T ss_pred             CceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEcC--CceEEEEEeCCCCcHHH
Confidence            3499999987  2   2679999876433    2456778889999999999999998643  46899999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-  539 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-  539 (600)
                      ++....            .+++..++.++.|++.||+|||   ..+++||||||+|||++.++.+||+|||+++..... 
T Consensus        85 ~l~~~~------------~~~~~~~~~~~~qi~~~l~~lh---~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~  149 (257)
T cd05060          85 YLKKRR------------EIPVSDLKELAHQVAMGMAYLE---SKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGS  149 (257)
T ss_pred             HHHhCC------------CCCHHHHHHHHHHHHHHHHHHh---hcCeeccCcccceEEEcCCCcEEeccccccceeecCC
Confidence            997543            2899999999999999999999   668999999999999999999999999998754221 


Q ss_pred             --------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          540 --------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       540 --------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                                    ..+||....  ..++.++||||||+++|||++ |+.||...
T Consensus       150 ~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~~~~~g~~p~~~~  202 (257)
T cd05060         150 DYYRATTAGRWPLKWYAPECINY--GKFSSKSDVWSYGVTLWEAFSYGAKPYGEM  202 (257)
T ss_pred             cccccccCccccccccCHHHhcC--CCCCccchHHHHHHHHHHHHcCCCCCcccC
Confidence                          223444432  346778999999999999998 99999754

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.93  E-value=1.8e-25  Score=224.25  Aligned_cols=172  Identities=31%  Similarity=0.535  Sum_probs=143.1

Q ss_pred             eEEEEEEEECCeEEEEEEcchhH-HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcCcc
Q 041830          391 EGAVYHGRLNGKNLAIKRTEHEV-ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMK  469 (600)
Q Consensus       391 ~G~Vy~g~~~g~~vAvK~~~~~~-~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~  469 (600)
                      .|.||++..+++.||+|..+.+. ...+..|+..+..++||||+++++++..+  ..+++|||+++|+|.+++.....  
T Consensus        19 ~g~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--~~~~v~e~~~~~~L~~~l~~~~~--   94 (254)
T cd05083          19 FGAVLQGEYTGQKVAVKNIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHN--GLYIVMELMSKGNLVNFLRTRGR--   94 (254)
T ss_pred             CCceEecccCCCceEEEeecCcchHHHHHHHHHHHHhCCCCCcCeEEEEEcCC--CcEEEEECCCCCCHHHHHHhcCc--
Confidence            38999999999999999986542 34567888899999999999999997543  57999999999999999975432  


Q ss_pred             cccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC---------C
Q 041830          470 NQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---------T  540 (600)
Q Consensus       470 ~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~---------~  540 (600)
                              ..+++.+++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++.....         .
T Consensus        95 --------~~~~~~~~~~~~~qi~~al~~lH---~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~y  163 (254)
T cd05083          95 --------ALVSVIQLLQFSLDVAEGMEYLE---SKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVKW  163 (254)
T ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccCcceEEEcCCCcEEECCCccceeccccCCCCCCCcee
Confidence                    23889999999999999999999   679999999999999999999999999998754321         2


Q ss_pred             CCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          541 ESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       541 ~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                      .+||....  ..++.++|+||||+++|||++ |+.||...
T Consensus       164 ~~pe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~  201 (254)
T cd05083         164 TAPEALKH--KKFSSKSDVWSYGVLLWEVFSYGRAPYPKM  201 (254)
T ss_pred             cCHHHhcc--CCcCchhhHHHHHHHHHHHHhCCCCCCccC
Confidence            24554432  356778999999999999998 99999654

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=99.93  E-value=1.8e-25  Score=230.11  Aligned_cols=173  Identities=24%  Similarity=0.424  Sum_probs=142.8

Q ss_pred             CceeEEEEEEEE--CCeEEEEEEcchh---HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          388 NRIEGAVYHGRL--NGKNLAIKRTEHE---VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       388 ~~~~G~Vy~g~~--~g~~vAvK~~~~~---~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .+..|.||++..  +++.||+|.++..   ....+..|+..+..++||||+++++++... +..++++||+++++|.+++
T Consensus        31 ~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-~~~~iv~e~~~~~~L~~~~  109 (297)
T cd06659          31 EGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVG-EELWVLMEFLQGGALTDIV  109 (297)
T ss_pred             CCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeC-CeEEEEEecCCCCCHHHHH
Confidence            334499999987  6899999987532   234567788888999999999999997655 4889999999999999987


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC----
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND----  538 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~----  538 (600)
                      ...             .+++.+++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.....    
T Consensus       110 ~~~-------------~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~  173 (297)
T cd06659         110 SQT-------------RLNEEQIATVCESVLQALCYLH---SQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK  173 (297)
T ss_pred             hhc-------------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHeEEccCCcEEEeechhHhhccccccc
Confidence            542             2889999999999999999999   67999999999999999999999999999864322    


Q ss_pred             --------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 --------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 --------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                              ...+||....  ..++.++|||||||++|||++|+.||...
T Consensus       174 ~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~p~~~~  220 (297)
T cd06659         174 RKSLVGTPYWMAPEVISR--TPYGTEVDIWSLGIMVIEMVDGEPPYFSD  220 (297)
T ss_pred             ccceecCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence                    1234555543  34678899999999999999999999643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=99.93  E-value=2.1e-26  Score=223.85  Aligned_cols=183  Identities=23%  Similarity=0.354  Sum_probs=149.2

Q ss_pred             CCCceeEEEEEEEE---C---CeEEEEEEcchhH-----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecC
Q 041830          386 SSNRIEGAVYHGRL---N---GKNLAIKRTEHEV-----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAK  454 (600)
Q Consensus       386 ~~~~~~G~Vy~g~~---~---g~~vAvK~~~~~~-----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~  454 (600)
                      .+.|.+|.||+++-   +   .+.+|||+++.+.     ....-+|+..++.++||||+.|..++...+...||++||.+
T Consensus        32 Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAE  111 (438)
T KOG0666|consen   32 IGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAE  111 (438)
T ss_pred             ecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhh
Confidence            34555699999965   2   2368999987652     23457899999999999999999998874458999999999


Q ss_pred             CCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC----CcEEEEec
Q 041830          455 NGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEE----FNARVGNF  530 (600)
Q Consensus       455 ~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~----~~~kI~DF  530 (600)
                      + +|.+.++.++....       ..++...+..|..||+.|+.|||   +.=|+||||||.|||+..+    |++||+||
T Consensus       112 h-DL~~II~fHr~~~~-------~~lp~~mvKsilwQil~Gv~YLH---~NWvlHRDLKPaNIlvmgdgperG~VKIaDl  180 (438)
T KOG0666|consen  112 H-DLWHIIKFHRASKA-------KQLPRSMVKSILWQILDGVHYLH---SNWVLHRDLKPANILVMGDGPERGRVKIADL  180 (438)
T ss_pred             h-hHHHHHHHhccchh-------ccCCHHHHHHHHHHHHhhhHHHh---hhheeeccCCcceEEEeccCCccCeeEeecc
Confidence            8 99999977654322       34888999999999999999999   5569999999999999766    99999999


Q ss_pred             cCccccCCCC---------------CCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          531 GMARCVNDDT---------------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       531 Gla~~~~~~~---------------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                      |++|.....-               .+||.+.+. ..||.+.||||.|||+.||+|-++-|...+
T Consensus       181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa-~hYT~AiDvWAiGCIfaElLtl~PlF~g~E  244 (438)
T KOG0666|consen  181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGA-RHYTKAIDVWAIGCIFAELLTLEPLFKGRE  244 (438)
T ss_pred             cHHHHhhccccccccCCceEEEEEecChHHhccc-ccccchhhhHHHHHHHHHHHccCccccchh
Confidence            9999764432               257766553 578999999999999999999998887654

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.93  E-value=2.3e-25  Score=225.43  Aligned_cols=172  Identities=28%  Similarity=0.493  Sum_probs=140.9

Q ss_pred             eEEEEEEEE--CC---eEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          391 EGAVYHGRL--NG---KNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       391 ~G~Vy~g~~--~g---~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      .|.||+|..  +|   ..||||.++..    ....+..|+..+..++||||+++++++..+ ...++||||+++|+|.++
T Consensus        17 ~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~~~lv~e~~~~~~L~~~   95 (269)
T cd05065          17 FGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS-RPVMIITEFMENGALDSF   95 (269)
T ss_pred             CCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCC-CceEEEEecCCCCcHHHH
Confidence            389999987  33   35999997542    234678899999999999999999997554 478999999999999999


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--  539 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--  539 (600)
                      ++...           ..+++.+++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++.....  
T Consensus        96 l~~~~-----------~~~~~~~~~~i~~~l~~al~~lH---~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~  161 (269)
T cd05065          96 LRQND-----------GQFTVIQLVGMLRGIAAGMKYLS---EMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS  161 (269)
T ss_pred             HhhCC-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccChheEEEcCCCcEEECCCccccccccCcc
Confidence            97543           23899999999999999999999   679999999999999999999999999998754321  


Q ss_pred             ---------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          540 ---------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       540 ---------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                                     ..+||....  ..++.++|||||||++|||++ |+.||...
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~DvwslG~~l~e~l~~g~~p~~~~  215 (269)
T cd05065         162 DPTYTSSLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWDM  215 (269)
T ss_pred             ccccccccCCCcceeecCHhHhcc--CcccchhhhhhhHHHHHHHhcCCCCCCCCC
Confidence                           123444332  346778999999999999987 99999653

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=99.93  E-value=1.7e-25  Score=255.07  Aligned_cols=181  Identities=23%  Similarity=0.391  Sum_probs=144.3

Q ss_pred             eEEEEEEEE--CCeEEEEEEcch-----hHHHHHHHHHHHHHhCCCCceeeeeeEEecc-CCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEH-----EVITKLEMQLVQHATHHHPNIVRLLGTCLTD-GPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~-----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~-~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      +|.||+++.  .++.+|+|.+..     .....+..|+.++..++|||||++++++... ...+||||||+++|+|.++|
T Consensus        26 FGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL  105 (1021)
T PTZ00266         26 FGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNI  105 (1021)
T ss_pred             CeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHH
Confidence            399999998  678899998653     2334677899999999999999999987644 34689999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcC----CCCceecCCCCCCEEeCC-----------------
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM----NPSYVHRNIKSRNIFLDE-----------------  521 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~----~~~ivHrDLk~~NILld~-----------------  521 (600)
                      ......        ...+++..++.|+.||+.||.|||...    ..+|+||||||+||||+.                 
T Consensus       106 ~k~~~~--------~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng  177 (1021)
T PTZ00266        106 QKCYKM--------FGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNG  177 (1021)
T ss_pred             HHHhhc--------cCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCC
Confidence            753211        134899999999999999999999532    146999999999999964                 


Q ss_pred             CCcEEEEeccCccccCC-----------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          522 EFNARVGNFGMARCVND-----------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       522 ~~~~kI~DFGla~~~~~-----------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                      ...+||+|||+++....           .+.+||.+......++.++|||||||+||||++|+.||...
T Consensus       178 ~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~  246 (1021)
T PTZ00266        178 RPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKA  246 (1021)
T ss_pred             CCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcC
Confidence            34589999999875431           23457766544455788999999999999999999999753

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=99.93  E-value=3e-25  Score=228.44  Aligned_cols=171  Identities=25%  Similarity=0.466  Sum_probs=142.6

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh---HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcC
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE---VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGG  465 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~---~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~  465 (600)
                      .|.||+|..  +|+.|++|.+...   ....+..|+..+..++||||+++++++... +..++|+||+++|+|.+++...
T Consensus        32 ~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~  110 (296)
T cd06655          32 SGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVG-DELFVVMEYLAGGSLTDVVTET  110 (296)
T ss_pred             CeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecC-ceEEEEEEecCCCcHHHHHHhc
Confidence            389999986  7899999987542   224567788889999999999999997655 5899999999999999998642


Q ss_pred             cCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC------
Q 041830          466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD------  539 (600)
Q Consensus       466 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~------  539 (600)
                                   .+++.+++.++.+++.||+|||   +.+++||||||+||+++.++.+||+|||++......      
T Consensus       111 -------------~l~~~~~~~i~~~l~~al~~LH---~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~  174 (296)
T cd06655         111 -------------CMDEAQIAAVCRECLQALEFLH---ANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST  174 (296)
T ss_pred             -------------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCCC
Confidence                         3899999999999999999999   679999999999999999999999999998754321      


Q ss_pred             ------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 ------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 ------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                            ..+||....  ..++.++|||||||++|||++|+.||...+
T Consensus       175 ~~~~~~y~aPE~~~~--~~~~~~~Dv~slGvil~~lltg~~pf~~~~  219 (296)
T cd06655         175 MVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNEN  219 (296)
T ss_pred             cCCCccccCcchhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence                  124554433  346778999999999999999999997643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.93  E-value=4.9e-25  Score=225.06  Aligned_cols=170  Identities=26%  Similarity=0.517  Sum_probs=139.8

Q ss_pred             eEEEEEEEE------CCeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEecc-CCceEEEEeecCCCCHH
Q 041830          391 EGAVYHGRL------NGKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTD-GPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       391 ~G~Vy~g~~------~g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~-~~~~~LV~Ey~~~GsL~  459 (600)
                      .|.||.+++      ++..||+|.++..    ....+++|+..++.+.||||+++++++... +...++||||+++++|.
T Consensus        17 ~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~   96 (284)
T cd05079          17 FGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLK   96 (284)
T ss_pred             ceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHH
Confidence            489999874      4778999997632    234678899999999999999999998665 24679999999999999


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD  539 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~  539 (600)
                      +++....           ..++|.+++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++.....
T Consensus        97 ~~l~~~~-----------~~~~~~~~~~i~~~i~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~  162 (284)
T cd05079          97 EYLPRNK-----------NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD  162 (284)
T ss_pred             HHHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccchheEEEcCCCCEEECCCccccccccC
Confidence            9996542           23899999999999999999999   679999999999999999999999999998754321


Q ss_pred             ---------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCC
Q 041830          540 ---------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPI  576 (600)
Q Consensus       540 ---------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf  576 (600)
                                     ..+||....  ..++.++||||||+++|||++++.|+
T Consensus       163 ~~~~~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~ellt~~~~~  212 (284)
T cd05079         163 KEYYTVKDDLDSPVFWYAPECLIQ--SKFYIASDVWSFGVTLYELLTYCDSE  212 (284)
T ss_pred             ccceeecCCCCCCccccCHHHhcc--CCCCccccchhhhhhhhhhhcCCCCC
Confidence                           123444332  34677899999999999999987765

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=99.93  E-value=2.3e-25  Score=225.32  Aligned_cols=172  Identities=29%  Similarity=0.487  Sum_probs=140.7

Q ss_pred             eEEEEEEEE--C---CeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          391 EGAVYHGRL--N---GKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       391 ~G~Vy~g~~--~---g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      .|.||+|+.  +   +..+|+|.++..    ....++.|+..+..++||||+++++++..+ +..++||||+++|+|.++
T Consensus        17 ~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~   95 (267)
T cd05066          17 FGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKS-KPVMIVTEYMENGSLDAF   95 (267)
T ss_pred             CCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC-CccEEEEEcCCCCCHHHH
Confidence            389999987  2   337999987542    234678888899999999999999997655 488999999999999999


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--  539 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--  539 (600)
                      +....           ..+++.+++.++.|++.||+|||   +.+++||||||+|||++.++.+|++|||+++.....  
T Consensus        96 ~~~~~-----------~~~~~~~~~~i~~~i~~~l~~lH---~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~  161 (267)
T cd05066          96 LRKHD-----------GQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  161 (267)
T ss_pred             HHhcC-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCEeehhhchhcEEECCCCeEEeCCCCcccccccccc
Confidence            97543           23899999999999999999999   679999999999999999999999999998754321  


Q ss_pred             -------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          540 -------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       540 -------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                                   ..+||....  ..++.++||||||+++||+++ |+.||...
T Consensus       162 ~~~~~~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~l~ell~~g~~p~~~~  213 (267)
T cd05066         162 AAYTTRGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMSYGERPYWEM  213 (267)
T ss_pred             eeeecCCCccceeecCHhHhcc--CccCchhhhHHHHHHHHHHhcCCCCCcccC
Confidence                         123444332  346778999999999999887 99999654

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.93  E-value=2.6e-25  Score=223.92  Aligned_cols=172  Identities=24%  Similarity=0.499  Sum_probs=142.5

Q ss_pred             eEEEEEEEE-CCeEEEEEEcchhH--HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcC
Q 041830          391 EGAVYHGRL-NGKNLAIKRTEHEV--ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLA  467 (600)
Q Consensus       391 ~G~Vy~g~~-~g~~vAvK~~~~~~--~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~  467 (600)
                      .|.||++.. +++.||+|.+....  ...++.|+..+..++|+||+++++++ .+ ...+++|||+++|+|.+++.....
T Consensus        19 ~g~v~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~-~~~~~v~e~~~~~~L~~~~~~~~~   96 (260)
T cd05067          19 FGEVWMGYYNGHTKVAIKSLKQGSMSPEAFLAEANLMKQLQHPRLVRLYAVV-TQ-EPIYIITEYMENGSLVDFLKTPEG   96 (260)
T ss_pred             cceEEeeecCCCceEEEEEecCCCCcHHHHHHHHHHHHhcCCcCeeeEEEEE-cc-CCcEEEEEcCCCCCHHHHHHhcCC
Confidence            489999988 77899999886533  24678899999999999999999985 34 368999999999999999875432


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--------
Q 041830          468 MKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--------  539 (600)
Q Consensus       468 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--------  539 (600)
                                ..+++.++..++.|++.||+|||   +.+++||||||+||++++++.++|+|||+++.....        
T Consensus        97 ----------~~~~~~~~~~i~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~  163 (260)
T cd05067          97 ----------IKLTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGA  163 (260)
T ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccccCC
Confidence                      34899999999999999999999   679999999999999999999999999998754411        


Q ss_pred             -----CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          540 -----TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       540 -----~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                           ..+||....  ..++.++||||||+++|||++ |+.||...
T Consensus       164 ~~~~~y~~pe~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~  207 (260)
T cd05067         164 KFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTYGRIPYPGM  207 (260)
T ss_pred             cccccccCHHHhcc--CCcCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence                 223444332  345778999999999999999 99999754

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.93  E-value=4.3e-26  Score=241.29  Aligned_cols=174  Identities=26%  Similarity=0.499  Sum_probs=145.6

Q ss_pred             CceeEEEEEEEE---CCe--EEEEEEcchhH----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCH
Q 041830          388 NRIEGAVYHGRL---NGK--NLAIKRTEHEV----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSL  458 (600)
Q Consensus       388 ~~~~G~Vy~g~~---~g~--~vAvK~~~~~~----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL  458 (600)
                      .|-+|.|++|.|   .|+  .||||.++.+.    ...|.+|...|.+++|||+|+|||+..+  ....||||.++.|||
T Consensus       120 ~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~--qp~mMV~ELaplGSL  197 (1039)
T KOG0199|consen  120 EGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD--QPAMMVFELAPLGSL  197 (1039)
T ss_pred             CcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc--chhhHHhhhcccchH
Confidence            334599999999   344  58999987643    4578999999999999999999999654  378999999999999


Q ss_pred             HHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC
Q 041830          459 KDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND  538 (600)
Q Consensus       459 ~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~  538 (600)
                      .+.|+....          ..|-......++.|||.||.||.   .+++|||||..+|+||.....+||+||||.|.+..
T Consensus       198 ldrLrka~~----------~~llv~~Lcdya~QiA~aM~YLe---skrlvHRDLAARNlllasprtVKI~DFGLmRaLg~  264 (1039)
T KOG0199|consen  198 LDRLRKAKK----------AILLVSRLCDYAMQIAKAMQYLE---SKRLVHRDLAARNLLLASPRTVKICDFGLMRALGE  264 (1039)
T ss_pred             HHHHhhccc----------cceeHHHHHHHHHHHHHHHHHHh---hhhhhhhhhhhhhheecccceeeeecccceeccCC
Confidence            999987322          34778888999999999999999   78999999999999999999999999999987754


Q ss_pred             CCC---------------CCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCC
Q 041830          539 DTE---------------SPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINR  578 (600)
Q Consensus       539 ~~~---------------~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~  578 (600)
                      ...               +||.+.  +..++.++|||+|||.||||+| |+.||..
T Consensus       265 ned~Yvm~p~rkvPfAWCaPEsLr--h~kFShaSDvWmyGVTiWEMFtyGEePW~G  318 (1039)
T KOG0199|consen  265 NEDMYVMAPQRKVPFAWCAPESLR--HRKFSHASDVWMYGVTIWEMFTYGEEPWVG  318 (1039)
T ss_pred             CCcceEecCCCcCcccccCHhHhc--cccccccchhhhhhhhHHhhhccCCCCCCC
Confidence            332               333332  3567889999999999999999 8999965

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=99.93  E-value=1.7e-25  Score=230.97  Aligned_cols=182  Identities=29%  Similarity=0.518  Sum_probs=140.8

Q ss_pred             eEEEEEEEE--CCe--EEEEEEcchh----HHHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          391 EGAVYHGRL--NGK--NLAIKRTEHE----VITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       391 ~G~Vy~g~~--~g~--~vAvK~~~~~----~~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      .|.||++..  +|.  .+++|.++..    ....+.+|+..+.++ +|+||+++++++..+ ...|+||||+++|+|.++
T Consensus        20 ~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~   98 (303)
T cd05088          20 FGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-GYLYLAIEYAPHGNLLDF   98 (303)
T ss_pred             CceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC-CCceEEEEeCCCCcHHHH
Confidence            499999987  454  4688876542    223567788888888 899999999997655 478999999999999999


Q ss_pred             HhcCcCcccc----cccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC
Q 041830          462 LHGGLAMKNQ----FIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN  537 (600)
Q Consensus       462 L~~~~~~~~~----~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~  537 (600)
                      ++........    ........+++.+++.++.|++.||+|||   +.+++||||||+|||+++++.+||+|||+++...
T Consensus        99 l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~  175 (303)
T cd05088          99 LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQE  175 (303)
T ss_pred             HHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHH---hCCccccccchheEEecCCCcEEeCccccCcccc
Confidence            9764321100    00011134899999999999999999999   6799999999999999999999999999986321


Q ss_pred             C-----------CCCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCC
Q 041830          538 D-----------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINR  578 (600)
Q Consensus       538 ~-----------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~  578 (600)
                      .           ...+||....  ..++.++|||||||++|||+| |..||..
T Consensus       176 ~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~  226 (303)
T cd05088         176 VYVKKTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCG  226 (303)
T ss_pred             hhhhcccCCCcccccCHHHHhc--cCCcccccchhhhhHHHHHHhcCCCCccc
Confidence            1           1234554433  346788999999999999998 9999964

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.93  E-value=2.9e-25  Score=226.05  Aligned_cols=180  Identities=23%  Similarity=0.411  Sum_probs=145.0

Q ss_pred             eEEEEEEEE-C-----CeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          391 EGAVYHGRL-N-----GKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       391 ~G~Vy~g~~-~-----g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      .|.||+|.. .     +..|++|+++..    ....+..|+..+..++|+||++++|++..++...++++||+++|+|.+
T Consensus        19 ~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~   98 (280)
T cd05043          19 FGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKL   98 (280)
T ss_pred             CceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHH
Confidence            389999998 3     578999987542    234567788889999999999999998876667899999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-  539 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-  539 (600)
                      ++........    .....+++.+++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++.+... 
T Consensus        99 ~l~~~~~~~~----~~~~~l~~~~~~~i~~~i~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~  171 (280)
T cd05043          99 FLQQCRLGEA----NNPQALSTQQLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMD  171 (280)
T ss_pred             HHHhcccccc----ccccCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCHhhEEEcCCCcEEECCCCCcccccCCc
Confidence            9975432100    01134899999999999999999999   679999999999999999999999999999754221 


Q ss_pred             -------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          540 -------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       540 -------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                                   ..+||....  ..++.++||||||+++||+++ |+.||...
T Consensus       172 ~~~~~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~  223 (280)
T cd05043         172 YHCLGDNENRPVKWMALESLVN--KEYSSASDVWSFGVLLWELMTLGQTPYVEI  223 (280)
T ss_pred             eEEeCCCCCcchhccCHHHHhc--CCCCchhhHHHhHHHHHHHhcCCCCCcCcC
Confidence                         234554433  346788999999999999999 99999753

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.93  E-value=3e-25  Score=224.07  Aligned_cols=175  Identities=21%  Similarity=0.335  Sum_probs=142.6

Q ss_pred             eEEEEEEEE--CCeEEEEEEcch------hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEH------EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~------~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||+|+.  +|+.||||.++.      +....+..|+..+..++||||+++++++... +..++++||+++|+|.+++
T Consensus        15 ~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~~   93 (267)
T cd08228          15 FSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIED-NELNIVLELADAGDLSQMI   93 (267)
T ss_pred             CeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEEC-CeEEEEEEecCCCcHHHHH
Confidence            389999987  789999997532      2234567889999999999999999997655 4889999999999999998


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC----
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND----  538 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~----  538 (600)
                      ......        ...+++.+++.++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++.....    
T Consensus        94 ~~~~~~--------~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~  162 (267)
T cd08228          94 KYFKKQ--------KRLIPERTVWKYFVQLCSAVEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA  162 (267)
T ss_pred             HHhhhc--------cCCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCCHHHEEEcCCCCEEECccccceeccchhHH
Confidence            642211        134889999999999999999999   67999999999999999999999999999875432    


Q ss_pred             --------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 --------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 --------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                              ...+||....  ..++.++|+||||+++|||++|+.||...
T Consensus       163 ~~~~~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~p~~~~  209 (267)
T cd08228         163 AHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGD  209 (267)
T ss_pred             HhcCCCCccccChhhhcc--CCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence                    1234665543  34567899999999999999999998643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=99.93  E-value=2.6e-25  Score=228.02  Aligned_cols=183  Identities=23%  Similarity=0.410  Sum_probs=143.5

Q ss_pred             eEEEEEEEE-------CCeEEEEEEcchhH---HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          391 EGAVYHGRL-------NGKNLAIKRTEHEV---ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       391 ~G~Vy~g~~-------~g~~vAvK~~~~~~---~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      .|.||+++.       ++..+++|.++...   .+.+++|+..+..++|+||+++++++... ...++||||+++++|.+
T Consensus        18 ~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~   96 (291)
T cd05094          18 FGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDG-DPLIMVFEYMKHGDLNK   96 (291)
T ss_pred             CCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccC-CceEEEEecCCCCcHHH
Confidence            389999975       34569999976543   24578899999999999999999998655 47899999999999999


Q ss_pred             HHhcCcCccccc----ccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCcccc
Q 041830          461 WLHGGLAMKNQF----IASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV  536 (600)
Q Consensus       461 ~L~~~~~~~~~~----~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~  536 (600)
                      +++.........    .......++|.+++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++..
T Consensus        97 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~  173 (291)
T cd05094          97 FLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDV  173 (291)
T ss_pred             HHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEECCCCccccc
Confidence            997643210000    0001123899999999999999999999   779999999999999999999999999998644


Q ss_pred             CCC--------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          537 NDD--------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       537 ~~~--------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                      ...              ..+||....  ..++.++||||||+++|||+| |+.||...
T Consensus       174 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~  229 (291)
T cd05094         174 YSTDYYRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSFGVILWEIFTYGKQPWFQL  229 (291)
T ss_pred             CCCceeecCCCCCcceeecChHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            221              234554433  346778999999999999999 99998653

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=99.93  E-value=3.8e-25  Score=225.61  Aligned_cols=174  Identities=24%  Similarity=0.320  Sum_probs=135.9

Q ss_pred             ceeEEEEEEEE--CCeEEEEEEcchhHH------HHHHHHHH---HHHhCCCCceeeeeeEEeccCCceEEEEeecCCCC
Q 041830          389 RIEGAVYHGRL--NGKNLAIKRTEHEVI------TKLEMQLV---QHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGS  457 (600)
Q Consensus       389 ~~~G~Vy~g~~--~g~~vAvK~~~~~~~------~~~e~ei~---~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~Gs  457 (600)
                      +..|.||++..  +|+.+|+|.++....      ..+..|..   .+...+||||+++++++..+ +..++||||+++|+
T Consensus         5 G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~   83 (279)
T cd05633           5 GGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTP-DKLCFILDLMNGGD   83 (279)
T ss_pred             CCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecC-CeEEEEEecCCCCC
Confidence            33499999988  688999998754211      11222222   22334799999999987655 48899999999999


Q ss_pred             HHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC
Q 041830          458 LKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN  537 (600)
Q Consensus       458 L~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~  537 (600)
                      |.+++....            .++|.++..++.|++.||+|||   +.+++||||||+|||+++++.+||+|||++....
T Consensus        84 L~~~i~~~~------------~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~  148 (279)
T cd05633          84 LHYHLSQHG------------VFSEKEMRFYATEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFS  148 (279)
T ss_pred             HHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCcCCCCCCHHHEEECCCCCEEEccCCcceecc
Confidence            999987542            3899999999999999999999   6789999999999999999999999999986432


Q ss_pred             C----------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          538 D----------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       538 ~----------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                      .          ...+||.... ...++.++|||||||++|||++|+.||...
T Consensus       149 ~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  199 (279)
T cd05633         149 KKKPHASVGTHGYMAPEVLQK-GTAYDSSADWFSLGCMLFKLLRGHSPFRQH  199 (279)
T ss_pred             ccCccCcCCCcCccCHHHhcC-CCCCCchhhhHHHHHHHHHHHhCCCCcCCC
Confidence            1          1234555432 234677899999999999999999999754

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=99.93  E-value=3.7e-25  Score=226.55  Aligned_cols=183  Identities=25%  Similarity=0.418  Sum_probs=143.7

Q ss_pred             eEEEEEEEE-------CCeEEEEEEcchh---HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          391 EGAVYHGRL-------NGKNLAIKRTEHE---VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       391 ~G~Vy~g~~-------~g~~vAvK~~~~~---~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      .|.||++..       ++..+|+|.++..   ....+..|+..+.+++||||+++++++... ...++||||+++|+|.+
T Consensus        18 ~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~   96 (288)
T cd05093          18 FGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG-DPLIMVFEYMKHGDLNK   96 (288)
T ss_pred             CeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecC-CccEEEEEcCCCCCHHH
Confidence            489999974       3456899987642   234678899999999999999999998655 48899999999999999


Q ss_pred             HHhcCcCcccc-cccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC-
Q 041830          461 WLHGGLAMKNQ-FIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND-  538 (600)
Q Consensus       461 ~L~~~~~~~~~-~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~-  538 (600)
                      +++........ ........++|.+++.++.|++.||+|||   +.+++||||||+||++++++.+||+|||+++.... 
T Consensus        97 ~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH---~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  173 (288)
T cd05093          97 FLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYST  173 (288)
T ss_pred             HHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccCcceEEEccCCcEEeccCCccccccCC
Confidence            99754321000 00001134899999999999999999999   67999999999999999999999999999874421 


Q ss_pred             -------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          539 -------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       539 -------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                                   ...+||....  ..++.++|||||||++|||++ |+.||...
T Consensus       174 ~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~sDiwslG~il~~l~t~g~~p~~~~  226 (288)
T cd05093         174 DYYRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSLGVVLWEIFTYGKQPWYQL  226 (288)
T ss_pred             ceeecCCCCCccccccCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence                         1234554433  456778999999999999998 99998654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=99.93  E-value=2.4e-25  Score=229.38  Aligned_cols=173  Identities=23%  Similarity=0.355  Sum_probs=140.9

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      .|.||+++.  +++.||+|.++...    ...+..|+..+..++||||+++++++..+ ...++||||++ ++|.+++..
T Consensus        19 ~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~-~~~~lv~e~~~-~~l~~~l~~   96 (301)
T cd07873          19 YATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE-KSLTLVFEYLD-KDLKQYLDD   96 (301)
T ss_pred             CEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecC-CeEEEEEeccc-cCHHHHHHh
Confidence            489999988  67899999875322    23456788899999999999999998655 48899999997 599998865


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-----
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-----  539 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-----  539 (600)
                      ..           ..+++.++..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++.....     
T Consensus        97 ~~-----------~~~~~~~~~~~~~qi~~aL~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  162 (301)
T cd07873          97 CG-----------NSINMHNVKLFLFQLLRGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYS  162 (301)
T ss_pred             cC-----------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCccc
Confidence            43           23889999999999999999999   679999999999999999999999999998653211     


Q ss_pred             -------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 -------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 -------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                             ..+||.... ...++.++|||||||++|||++|+.||...+
T Consensus       163 ~~~~~~~y~~PE~~~~-~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~  209 (301)
T cd07873         163 NEVVTLWYRPPDILLG-STDYSTQIDMWGVGCIFYEMSTGRPLFPGST  209 (301)
T ss_pred             ccceeecccCcHHHhC-CCCCccHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                   124554332 2346778999999999999999999997543

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=99.93  E-value=2.7e-25  Score=228.77  Aligned_cols=170  Identities=25%  Similarity=0.471  Sum_probs=141.7

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH---HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcC
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV---ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGG  465 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~---~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~  465 (600)
                      .|.||++..  +|+.||+|.+....   ...+..|+..+..++|+||+++++++..+ ...++||||+++++|.+++...
T Consensus        32 ~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~  110 (297)
T cd06656          32 SGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-DELWVVMEYLAGGSLTDVVTET  110 (297)
T ss_pred             CeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CEEEEeecccCCCCHHHHHHhC
Confidence            489999987  78999999875422   24567788889999999999999998655 4889999999999999998642


Q ss_pred             cCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC------
Q 041830          466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD------  539 (600)
Q Consensus       466 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~------  539 (600)
                                   .+++.++..++.+++.||.|||   +.+++||||||+|||++.++.+||+|||++......      
T Consensus       111 -------------~~~~~~~~~~~~~l~~~L~~LH---~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~  174 (297)
T cd06656         111 -------------CMDEGQIAAVCRECLQALDFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  174 (297)
T ss_pred             -------------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCcCc
Confidence                         2789999999999999999999   669999999999999999999999999998754322      


Q ss_pred             ------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 ------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 ------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                            ..+||....  ..++.++|||||||++|||++|+.||...
T Consensus       175 ~~~~~~y~aPE~~~~--~~~~~~~Di~slGvil~~l~tg~~pf~~~  218 (297)
T cd06656         175 MVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNE  218 (297)
T ss_pred             ccCCccccCHHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                  123444433  34577899999999999999999999654

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=99.93  E-value=1.4e-24  Score=220.81  Aligned_cols=170  Identities=26%  Similarity=0.463  Sum_probs=142.1

Q ss_pred             eeEEEEEEEE--CCeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          390 IEGAVYHGRL--NGKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       390 ~~G~Vy~g~~--~g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      ..|.||+|..  +++.+|+|..+..    ....+.+|+..+..++||||+++++++..+ +..++||||+++|+|.+++.
T Consensus        16 ~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~l~~~i~   94 (277)
T cd06641          16 SFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-TKLWIIMEYLGGGSALDLLE   94 (277)
T ss_pred             CCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeC-CeEEEEEEeCCCCcHHHHHh
Confidence            3499999987  6789999986532    224577888899999999999999997655 48899999999999999986


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD----  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~----  539 (600)
                      ..             .+++.++..++.+++.|+.|||   +.+++|+||||+||+++.++.++|+|||+++.....    
T Consensus        95 ~~-------------~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~  158 (277)
T cd06641          95 PG-------------PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKR  158 (277)
T ss_pred             cC-------------CCCHHHHHHHHHHHHHHHHHHc---cCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhh
Confidence            42             2889999999999999999999   679999999999999999999999999998654321    


Q ss_pred             --------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          540 --------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       540 --------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                              ..+||....  ..++.++|+|||||++|||++|+.||..
T Consensus       159 ~~~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~  203 (277)
T cd06641         159 NTFVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELAKGEPPHSE  203 (277)
T ss_pred             ccccCCccccChhhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCc
Confidence                    134555433  3456789999999999999999999964

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=99.93  E-value=8.1e-25  Score=222.99  Aligned_cols=173  Identities=24%  Similarity=0.324  Sum_probs=135.8

Q ss_pred             eeEEEEEEEE--CCeEEEEEEcchhHH------HHHHHH---HHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCH
Q 041830          390 IEGAVYHGRL--NGKNLAIKRTEHEVI------TKLEMQ---LVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSL  458 (600)
Q Consensus       390 ~~G~Vy~g~~--~g~~vAvK~~~~~~~------~~~e~e---i~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL  458 (600)
                      ..|.||+++.  +|+.||+|.+.....      ..+..|   +..+....||||+++++++..+ +..++||||+++|+|
T Consensus         6 ~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~~~~v~e~~~g~~L   84 (278)
T cd05606           6 GFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-DKLSFILDLMNGGDL   84 (278)
T ss_pred             CCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecC-CEEEEEEecCCCCcH
Confidence            3489999987  688999998754211      111112   2233445799999999887554 488999999999999


Q ss_pred             HHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC
Q 041830          459 KDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND  538 (600)
Q Consensus       459 ~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~  538 (600)
                      .+++....            .++|.++..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++....
T Consensus        85 ~~~l~~~~------------~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~  149 (278)
T cd05606          85 HYHLSQHG------------VFSEAEMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSK  149 (278)
T ss_pred             HHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCEEcCCCCHHHEEECCCCCEEEccCcCccccCc
Confidence            99886432            3899999999999999999999   67899999999999999999999999999864422


Q ss_pred             ----------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 ----------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 ----------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                ...+||.... ...++.++|||||||++|||++|+.||...
T Consensus       150 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~  199 (278)
T cd05606         150 KKPHASVGTHGYMAPEVLQK-GVAYDSSADWFSLGCMLFKLLRGHSPFRQH  199 (278)
T ss_pred             cCCcCcCCCcCCcCcHHhcC-CCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence                      1234565443 234678899999999999999999999764

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=99.93  E-value=2.6e-25  Score=227.20  Aligned_cols=173  Identities=23%  Similarity=0.374  Sum_probs=135.9

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH-----HHHHHHHHHHHH---hCCCCceeeeeeEEecc----CCceEEEEeecCCC
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV-----ITKLEMQLVQHA---THHHPNIVRLLGTCLTD----GPHSFLVFEYAKNG  456 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~-----~~~~e~ei~~~~---~l~HpNIv~l~g~~~~~----~~~~~LV~Ey~~~G  456 (600)
                      .|.||+++.  +|+.||+|.++...     .....+|+..+.   .++||||+++++++...    ....+++|||++ +
T Consensus        13 ~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~   91 (288)
T cd07863          13 YGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD-Q   91 (288)
T ss_pred             CeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEcccc-c
Confidence            499999988  68899999875321     112334444443   45799999999987532    235799999998 5


Q ss_pred             CHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCcccc
Q 041830          457 SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV  536 (600)
Q Consensus       457 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~  536 (600)
                      +|.+++.....          ..+++.++..++.|++.||.|||   +.+++||||||+|||++.++.+||+|||+++..
T Consensus        92 ~l~~~~~~~~~----------~~~~~~~~~~~~~qi~~al~~lH---~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~  158 (288)
T cd07863          92 DLRTYLDKVPP----------PGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGQVKLADFGLARIY  158 (288)
T ss_pred             CHHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccCccccc
Confidence            89999875332          23899999999999999999999   679999999999999999999999999998754


Q ss_pred             CCC-----------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          537 NDD-----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       537 ~~~-----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                      ...           ..+||....  ..++.++|||||||++|||++|++||...
T Consensus       159 ~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~~l~~g~~~f~~~  210 (288)
T cd07863         159 SCQMALTPVVVTLWYRAPEVLLQ--STYATPVDMWSVGCIFAEMFRRKPLFCGN  210 (288)
T ss_pred             cCcccCCCccccccccCchHhhC--CCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence            321           235665543  35688899999999999999999999643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.93  E-value=9.6e-26  Score=231.35  Aligned_cols=176  Identities=21%  Similarity=0.348  Sum_probs=144.8

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhHH-----HHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEVI-----TKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~~-----~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      ..|-.+++  +|+.||||.+++...     ..+-.|+..|+.++|||||+||.+. +....+|||+|.=.+|+|.+|+-.
T Consensus        32 AVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEVi-DTQTKlyLiLELGD~GDl~DyImK  110 (864)
T KOG4717|consen   32 AVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVI-DTQTKLYLILELGDGGDLFDYIMK  110 (864)
T ss_pred             ehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehh-cccceEEEEEEecCCchHHHHHHh
Confidence            55655654  899999999876432     3567899999999999999999994 555689999999999999999976


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC-CCCcEEEEeccCccccCCC----
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLD-EEFNARVGNFGMARCVNDD----  539 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld-~~~~~kI~DFGla~~~~~~----  539 (600)
                      +.           ..|.+....+++.||..|+.|+|   ...+|||||||+||.+- +-|-+|+.|||++-...++    
T Consensus       111 He-----------~Gl~E~La~kYF~QI~~AI~YCH---qLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~kL~  176 (864)
T KOG4717|consen  111 HE-----------EGLNEDLAKKYFAQIVHAISYCH---QLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKKLT  176 (864)
T ss_pred             hh-----------ccccHHHHHHHHHHHHHHHHHHh---hhhhhcccCCcceeEEeeecCceEeeeccccccCCCcchhh
Confidence            54           34899999999999999999999   56899999999999885 4588999999998655433    


Q ss_pred             -------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCCCCC
Q 041830          540 -------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKD  583 (600)
Q Consensus       540 -------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~~~  583 (600)
                             +.+||++.+.. .-.+++||||+|||||-|++|+.||+..++.|
T Consensus       177 TsCGSLAYSAPEILLGDs-YDAPAVDiWSLGVILyMLVCGq~PFqeANDSE  226 (864)
T KOG4717|consen  177 TSCGSLAYSAPEILLGDS-YDAPAVDIWSLGVILYMLVCGQPPFQEANDSE  226 (864)
T ss_pred             cccchhhccCchhhhcCc-cCCcchhhhHHHHHHHHHHhCCCccccccchh
Confidence                   23677776632 22467899999999999999999999888775

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=99.93  E-value=4.9e-25  Score=222.63  Aligned_cols=173  Identities=26%  Similarity=0.402  Sum_probs=142.1

Q ss_pred             eeEEEEEEEE--CCeEEEEEEcchhH---HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          390 IEGAVYHGRL--NGKNLAIKRTEHEV---ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       390 ~~G~Vy~g~~--~g~~vAvK~~~~~~---~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      ..|.||+++.  +++.||+|.++...   ...+.+|+..+..++||||+++++.+... ...|++|||+++|+|.+++..
T Consensus        21 ~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~   99 (267)
T cd06645          21 TYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRR-DKLWICMEFCGGGSLQDIYHV   99 (267)
T ss_pred             CCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeC-CEEEEEEeccCCCcHHHHHHh
Confidence            3489999988  68899999876432   23456788889999999999999997655 488999999999999999865


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-----
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-----  539 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-----  539 (600)
                      ..            .+++.+++.++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++......     
T Consensus       100 ~~------------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~  164 (267)
T cd06645         100 TG------------PLSESQIAYVSRETLQGLYYLH---SKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRK  164 (267)
T ss_pred             cC------------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccc
Confidence            32            3899999999999999999999   669999999999999999999999999998644221     


Q ss_pred             -------CCCCccccc-CCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          540 -------TESPQFYST-NPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       540 -------~~~pe~~~~-~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                             ..+||.... ....++.++|||||||++|||++|+.||..
T Consensus       165 ~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~  211 (267)
T cd06645         165 SFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFD  211 (267)
T ss_pred             cccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccc
Confidence                   234555422 123467789999999999999999999854

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=99.93  E-value=6.5e-25  Score=220.17  Aligned_cols=173  Identities=24%  Similarity=0.399  Sum_probs=142.7

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      .|.||++..  +++.+|+|.++..    ..+.+..|+..+..++|+||+++++.+..+ ...+++|||+++|+|.+++..
T Consensus        13 ~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~l~~~~~~   91 (255)
T cd08219          13 FGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEAD-GHLYIVMEYCDGGDLMQKIKL   91 (255)
T ss_pred             CeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEEC-CEEEEEEeeCCCCcHHHHHHh
Confidence            389999987  6889999986432    224567788889999999999999997655 589999999999999999865


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-----
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-----  539 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-----  539 (600)
                      ...          ..+++...+.++.|++.||.|||   +.+++|+||||+||++++++.++++|||+++.....     
T Consensus        92 ~~~----------~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~  158 (255)
T cd08219          92 QRG----------KLFPEDTILQWFVQMCLGVQHIH---EKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYAC  158 (255)
T ss_pred             ccC----------CCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEECCCCcEEEcccCcceeecccccccc
Confidence            332          33789999999999999999999   679999999999999999999999999998755321     


Q ss_pred             -------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 -------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 -------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                             ..+||....  ..++.++|+||||+++|||++|+.||...
T Consensus       159 ~~~~~~~~~aPE~~~~--~~~~~~~Dv~slG~i~~~l~~g~~p~~~~  203 (255)
T cd08219         159 TYVGTPYYVPPEIWEN--MPYNNKSDIWSLGCILYELCTLKHPFQAN  203 (255)
T ss_pred             cccCCccccCHHHHcc--CCcCchhhhhhhchhheehhhccCCCCCC
Confidence                   224554433  34678899999999999999999999754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=99.93  E-value=3.9e-25  Score=225.78  Aligned_cols=177  Identities=21%  Similarity=0.393  Sum_probs=144.0

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      .|.||++..  +|+.||+|.++.+    ....+.+|+..+..++|+||+++++.+..+ ...++||||+++++|.++++.
T Consensus        14 ~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~l~~~~~~   92 (286)
T cd06622          14 YGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIE-GAVYMCMEYMDAGSLDKLYAG   92 (286)
T ss_pred             CeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecC-CeEEEEEeecCCCCHHHHHHh
Confidence            499999998  5899999986532    234567888889999999999999987665 489999999999999999875


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC------
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND------  538 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~------  538 (600)
                      ...         ...+++..+..++.+++.||.|||+  +.+++||||||+||+++.++.+||+|||++.....      
T Consensus        93 ~~~---------~~~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~  161 (286)
T cd06622          93 GVA---------TEGIPEDVLRRITYAVVKGLKFLKE--EHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTN  161 (286)
T ss_pred             ccc---------cCCCCHHHHHHHHHHHHHHHHHHHh--cCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCccccC
Confidence            421         0248999999999999999999994  35899999999999999999999999999865422      


Q ss_pred             ----CCCCCcccccCC----CCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 ----DTESPQFYSTNP----ASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 ----~~~~pe~~~~~~----~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                          ...+||......    ..++.++|+|||||++|||++|+.||...
T Consensus       162 ~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~  210 (286)
T cd06622         162 IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE  210 (286)
T ss_pred             CCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCc
Confidence                123566543321    23577899999999999999999999653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.93  E-value=3.4e-25  Score=232.95  Aligned_cols=186  Identities=24%  Similarity=0.395  Sum_probs=143.2

Q ss_pred             ceeEEEEEEEE-------CCeEEEEEEcchh----HHHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCC
Q 041830          389 RIEGAVYHGRL-------NGKNLAIKRTEHE----VITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNG  456 (600)
Q Consensus       389 ~~~G~Vy~g~~-------~g~~vAvK~~~~~----~~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~G  456 (600)
                      |..|.||++..       +++.||||+++.+    ....+.+|+..+..+ +||||++++++|...+...+++|||+++|
T Consensus        18 G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g   97 (343)
T cd05103          18 GAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG   97 (343)
T ss_pred             CccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCC
Confidence            33499999974       4678999998642    223566788888888 68999999999876666789999999999


Q ss_pred             CHHHHHhcCcCcccc-------------------------------------------------------cccccccCCC
Q 041830          457 SLKDWLHGGLAMKNQ-------------------------------------------------------FIASCYCFLT  481 (600)
Q Consensus       457 sL~~~L~~~~~~~~~-------------------------------------------------------~~~~~~~~l~  481 (600)
                      +|.++++........                                                       ........++
T Consensus        98 ~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  177 (343)
T cd05103          98 NLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLT  177 (343)
T ss_pred             cHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCC
Confidence            999999753210000                                                       0000013478


Q ss_pred             HHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--------------CCCCcccc
Q 041830          482 WSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--------------TESPQFYS  547 (600)
Q Consensus       482 ~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--------------~~~pe~~~  547 (600)
                      |.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....              ..+||...
T Consensus       178 ~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~  254 (343)
T cd05103         178 LEDLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIF  254 (343)
T ss_pred             HHHHHHHHHHHHHHHHHHH---hCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhc
Confidence            9999999999999999999   679999999999999999999999999998754211              22455443


Q ss_pred             cCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          548 TNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       548 ~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                      .  ..++.++||||||+++|||++ |..||...
T Consensus       255 ~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~  285 (343)
T cd05103         255 D--RVYTIQSDVWSFGVLLWEIFSLGASPYPGV  285 (343)
T ss_pred             C--CCCCchhhHHHHHHHHHHHHHCCCCCCCCc
Confidence            2  456788999999999999997 99998653

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=99.93  E-value=5.6e-25  Score=221.57  Aligned_cols=172  Identities=22%  Similarity=0.362  Sum_probs=144.3

Q ss_pred             eEEEEEEEEC--CeEEEEEEcchh------HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRLN--GKNLAIKRTEHE------VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~~--g~~vAvK~~~~~------~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||+++..  ++.+|+|.+...      ..+.+..|+..+..++||||+++++++..+ ...++++||+++|+|.+++
T Consensus         6 ~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l   84 (262)
T cd05572           6 FGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDK-KYIYMLMEYCLGGELWTIL   84 (262)
T ss_pred             ceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcC-CccEEEEecCCCCcHHHHH
Confidence            4899999994  899999987542      224577788888999999999999987554 5889999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC---
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---  539 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~---  539 (600)
                      ++..            .+++.++..++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||+++.....   
T Consensus        85 ~~~~------------~l~~~~~~~~~~~i~~~l~~lH---~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~  149 (262)
T cd05572          85 RDRG------------LFDEYTARFYIACVVLAFEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKT  149 (262)
T ss_pred             hhcC------------CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccccc
Confidence            7643            2889999999999999999999   679999999999999999999999999998865432   


Q ss_pred             --------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 --------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 --------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                              ..+||....  ..++.++|+||||+++|||++|+.||....
T Consensus       150 ~~~~~~~~~~~PE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~  196 (262)
T cd05572         150 WTFCGTPEYVAPEIILN--KGYDFSVDYWSLGILLYELLTGRPPFGEDD  196 (262)
T ss_pred             ccccCCcCccChhHhcC--CCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence                    224554432  346778999999999999999999997654

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.93  E-value=3.7e-25  Score=225.25  Aligned_cols=172  Identities=24%  Similarity=0.460  Sum_probs=141.8

Q ss_pred             eEEEEEEEE--CCe----EEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          391 EGAVYHGRL--NGK----NLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       391 ~G~Vy~g~~--~g~----~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      .|.||+|.+  +|+    .+|+|.++.+    ....+.+|+..+..+.||||++++|+|..  ...++||||+++|+|.+
T Consensus        20 ~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~--~~~~~v~e~~~~g~L~~   97 (279)
T cd05057          20 FGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS--SQVQLITQLMPLGCLLD   97 (279)
T ss_pred             CccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec--CceEEEEecCCCCcHHH
Confidence            389999987  343    5899987543    23467789999999999999999999875  47899999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-  539 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-  539 (600)
                      +++...           ..+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++..... 
T Consensus        98 ~l~~~~-----------~~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~  163 (279)
T cd05057          98 YVRNHK-----------DNIGSQYLLNWCVQIAKGMSYLE---EKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE  163 (279)
T ss_pred             HHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHH---hCCEEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence            997643           23899999999999999999999   679999999999999999999999999999765321 


Q ss_pred             -------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCCC
Q 041830          540 -------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRPR  580 (600)
Q Consensus       540 -------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~~  580 (600)
                                   +.+||....  ..++.++|+||||+++|||++ |+.||....
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~  216 (279)
T cd05057         164 KEYHAEGGKVPIKWMALESILH--RIYTHKSDVWSYGVTVWELMTFGAKPYEGIP  216 (279)
T ss_pred             cceecCCCcccccccCHHHhhc--CCcCchhhHHHHHHHHHHHhcCCCCCCCCCC
Confidence                         223443322  345778999999999999999 999997543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=99.93  E-value=2.8e-25  Score=235.48  Aligned_cols=170  Identities=19%  Similarity=0.330  Sum_probs=138.7

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEeccC-----CceEEEEeecCCCCH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTDG-----PHSFLVFEYAKNGSL  458 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~-----~~~~LV~Ey~~~GsL  458 (600)
                      .|.||++..  .++.||||++...     ....+.+|+..+..++||||+++++++....     ...|+||||+++ +|
T Consensus        37 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l  115 (364)
T cd07875          37 QGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NL  115 (364)
T ss_pred             CeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCCC-CH
Confidence            499999987  6889999997542     2245667888899999999999999865322     246999999975 78


Q ss_pred             HHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC
Q 041830          459 KDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND  538 (600)
Q Consensus       459 ~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~  538 (600)
                      .+++..              .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       116 ~~~~~~--------------~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~  178 (364)
T cd07875         116 CQVIQM--------------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  178 (364)
T ss_pred             HHHHHh--------------cCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEECCCCcEEEEeCCCccccCC
Confidence            777742              2788899999999999999999   67999999999999999999999999999975432


Q ss_pred             C-----------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          539 D-----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       539 ~-----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                      .           +.+||....  ..++.++|||||||++|||++|+.||...+
T Consensus       179 ~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pf~~~~  229 (364)
T cd07875         179 SFMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIKGGVLFPGTD  229 (364)
T ss_pred             CCcccCCcccCCcCCHHHHhC--CCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence            2           235665543  456788999999999999999999997543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=99.93  E-value=4e-25  Score=227.35  Aligned_cols=183  Identities=27%  Similarity=0.458  Sum_probs=140.7

Q ss_pred             eEEEEEEEE--CCe--EEEEEEcchh----HHHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          391 EGAVYHGRL--NGK--NLAIKRTEHE----VITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       391 ~G~Vy~g~~--~g~--~vAvK~~~~~----~~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      .|.||+|..  +|.  .+++|.++..    ....+..|+..+.++ +||||+++++++... ...++++||+++|+|.++
T Consensus        15 ~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~   93 (297)
T cd05089          15 FGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENR-GYLYIAIEYAPYGNLLDF   93 (297)
T ss_pred             cceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccC-CcceEEEEecCCCcHHHH
Confidence            399999987  333  4788887631    224567788888888 799999999997655 478999999999999999


Q ss_pred             HhcCcCcccc----cccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC
Q 041830          462 LHGGLAMKNQ----FIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN  537 (600)
Q Consensus       462 L~~~~~~~~~----~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~  537 (600)
                      ++........    ........+++.+++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||++....
T Consensus        94 l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  170 (297)
T cd05089          94 LRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLS---EKQFIHRDLAARNVLVGENLASKIADFGLSRGEE  170 (297)
T ss_pred             HHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCcCCcceEEECCCCeEEECCcCCCcccc
Confidence            9764321100    00001134899999999999999999999   6799999999999999999999999999986432


Q ss_pred             C-----------CCCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          538 D-----------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       538 ~-----------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                      .           ...+||....  ..++.++|||||||++|||++ |+.||...
T Consensus       171 ~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~il~el~t~g~~pf~~~  222 (297)
T cd05089         171 VYVKKTMGRLPVRWMAIESLNY--SVYTTKSDVWSFGVLLWEIVSLGGTPYCGM  222 (297)
T ss_pred             ceeccCCCCcCccccCchhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence            1           1234554433  346788999999999999998 99999654

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.93  E-value=5e-25  Score=235.95  Aligned_cols=184  Identities=24%  Similarity=0.403  Sum_probs=142.4

Q ss_pred             eeEEEEEEEEC-------CeEEEEEEcchhH----HHHHHHHHHHHHhCC-CCceeeeeeEEeccCCceEEEEeecCCCC
Q 041830          390 IEGAVYHGRLN-------GKNLAIKRTEHEV----ITKLEMQLVQHATHH-HPNIVRLLGTCLTDGPHSFLVFEYAKNGS  457 (600)
Q Consensus       390 ~~G~Vy~g~~~-------g~~vAvK~~~~~~----~~~~e~ei~~~~~l~-HpNIv~l~g~~~~~~~~~~LV~Ey~~~Gs  457 (600)
                      ..|.||++++.       ++.||+|+++...    ...+..|+..+..+. |||||+++|+|...+ ..++||||+++|+
T Consensus        49 ~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~-~~~iv~E~~~~g~  127 (401)
T cd05107          49 AFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGG-PIYIITEYCRYGD  127 (401)
T ss_pred             CceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCC-CcEEEEeccCCCc
Confidence            34999999873       3579999986432    235667888888887 999999999987654 7899999999999


Q ss_pred             HHHHHhcCcCccc-------------------------------------------------------------------
Q 041830          458 LKDWLHGGLAMKN-------------------------------------------------------------------  470 (600)
Q Consensus       458 L~~~L~~~~~~~~-------------------------------------------------------------------  470 (600)
                      |.++++.......                                                                   
T Consensus       128 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  207 (401)
T cd05107         128 LVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESS  207 (401)
T ss_pred             HHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhcc
Confidence            9999976431000                                                                   


Q ss_pred             -------------------ccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEecc
Q 041830          471 -------------------QFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFG  531 (600)
Q Consensus       471 -------------------~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFG  531 (600)
                                         .........++|.+++.++.|++.||+|||   +.+++||||||+|||+++++.+||+|||
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrdlkp~NiLl~~~~~~kL~DfG  284 (401)
T cd05107         208 NYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLA---SKNCVHRDLAARNVLICEGKLVKICDFG  284 (401)
T ss_pred             CcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHh---cCCcCcccCCcceEEEeCCCEEEEEecC
Confidence                               000011235889999999999999999999   6799999999999999999999999999


Q ss_pred             CccccCCC--------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          532 MARCVNDD--------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       532 la~~~~~~--------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                      +++.....              ..+||....  ..++.++|||||||++|||++ |+.||...
T Consensus       285 la~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslGvil~e~l~~g~~P~~~~  345 (401)
T cd05107         285 LARDIMRDSNYISKGSTFLPLKWMAPESIFN--NLYTTLSDVWSFGILLWEIFTLGGTPYPEL  345 (401)
T ss_pred             cceecccccccccCCCcCCCCceeChHHhcC--CCCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence            98754211              123443332  345778999999999999998 89998653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.93  E-value=6.8e-25  Score=221.14  Aligned_cols=175  Identities=21%  Similarity=0.359  Sum_probs=144.0

Q ss_pred             eEEEEEEEE--CCeEEEEEEcch------hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEH------EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~------~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||+|..  +|+.||+|.++.      .....+.+|+..+..++|+||+++++++..+ +..++||||+++|+|.+++
T Consensus        15 ~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l   93 (267)
T cd08224          15 FSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIEN-NELNIVLELADAGDLSRMI   93 (267)
T ss_pred             ceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecC-CeEEEEEecCCCCCHHHHH
Confidence            389999998  689999997642      2234677899999999999999999998665 4889999999999999998


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC---
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---  539 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~---  539 (600)
                      .......        ..+++.+++.++.+++.||.|||   +.+++||||+|+||+++.++.++|+|||+++.....   
T Consensus        94 ~~~~~~~--------~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~~  162 (267)
T cd08224          94 KHFKKQK--------RLIPERTIWKYFVQLCSALEHMH---SKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA  162 (267)
T ss_pred             HHhcccC--------CCcCHHHHHHHHHHHHHHHHHHH---hCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCcc
Confidence            6532111        34899999999999999999999   679999999999999999999999999998754321   


Q ss_pred             ---------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 ---------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 ---------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                               ..+||....  ..++.++|||||||++|||++|+.||...
T Consensus       163 ~~~~~~~~~y~apE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~  209 (267)
T cd08224         163 AHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGD  209 (267)
T ss_pred             cceecCCccccCHHHhcc--CCCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence                     124554432  44677899999999999999999999643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.93  E-value=5e-25  Score=223.14  Aligned_cols=179  Identities=22%  Similarity=0.359  Sum_probs=137.2

Q ss_pred             ceeEEEEEEEE-CC---eEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          389 RIEGAVYHGRL-NG---KNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       389 ~~~G~Vy~g~~-~g---~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      |..|.||+|+. ++   ..+++|.++..    ....+.+|+..+..++||||+++++.|... ...++||||+++|+|.+
T Consensus         6 G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~   84 (268)
T cd05086           6 GWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEA-IPYLLVFEYCELGDLKS   84 (268)
T ss_pred             CcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCC-CccEEEEecCCCCcHHH
Confidence            33489999976 32   34667765432    234567788888889999999999998655 47899999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC---
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN---  537 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~---  537 (600)
                      +++......        ..+++.....++.||+.||+|||   +.+++||||||+|||++.++.+||+|||++....   
T Consensus        85 ~l~~~~~~~--------~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~  153 (268)
T cd05086          85 YLSQEQWHR--------RNSQLLLLQRMACEIAAGVTHMH---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED  153 (268)
T ss_pred             HHHhhhccc--------ccccHHHHHHHHHHHHHHHHHHH---HCCeeccCCccceEEEcCCccEEecccccccccCcch
Confidence            997643210        23677888899999999999999   6689999999999999999999999999875321   


Q ss_pred             -----------CCCCCCcccccC-----CCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          538 -----------DDTESPQFYSTN-----PASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       538 -----------~~~~~pe~~~~~-----~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                                 ..+.+||+....     ...++.++|||||||++|||++ |+.||...
T Consensus       154 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~  212 (268)
T cd05086         154 YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHL  212 (268)
T ss_pred             hhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCC
Confidence                       112356654321     1235678999999999999997 57788643

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=99.93  E-value=7.4e-25  Score=219.74  Aligned_cols=174  Identities=26%  Similarity=0.415  Sum_probs=142.9

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      .|.||++..  +++.||+|++..+     ..+.++.|+..+..++|+|++++++.+.......+++|||+++++|.++++
T Consensus        13 ~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~   92 (257)
T cd08223          13 YGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLK   92 (257)
T ss_pred             CeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHH
Confidence            389999987  6788999987542     223567788889999999999999886544446799999999999999997


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD----  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~----  539 (600)
                      ....          ..+++.+++.++.+++.|++|||   +.+++||||||+||+++.++.++|+|||++......    
T Consensus        93 ~~~~----------~~l~~~~~~~~~~~l~~~l~~lH---~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~  159 (257)
T cd08223          93 EQKG----------KLLPENQVVEWFVQIAMALQYLH---EKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA  159 (257)
T ss_pred             HhcC----------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCchhEEEecCCcEEEecccceEEecccCCcc
Confidence            5332          34899999999999999999999   679999999999999999999999999998754321    


Q ss_pred             --------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 --------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 --------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                              ..+||....  ..++.++||||||+++|||++|+.||...
T Consensus       160 ~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~~~~~~  205 (257)
T cd08223         160 STLIGTPYYMSPELFSN--KPYNYKSDVWALGCCVYEMATLKHAFNAK  205 (257)
T ss_pred             ccccCCcCccChhHhcC--CCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence                    234555433  34677899999999999999999999754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=6.1e-25  Score=220.84  Aligned_cols=175  Identities=27%  Similarity=0.433  Sum_probs=144.7

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh---HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcC
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE---VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGG  465 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~---~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~  465 (600)
                      .|.||++..  +++.+++|.+...   ..+.+..|+..+..++||||++++|++... ...|++|||+++++|.+++...
T Consensus        16 ~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~l~~e~~~~~~l~~~~~~~   94 (262)
T cd06613          16 YGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRR-DKLWIVMEYCGGGSLQDIYQVT   94 (262)
T ss_pred             ceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeC-CEEEEEEeCCCCCcHHHHHHhh
Confidence            389999988  5788999987543   235678889999999999999999997655 4899999999999999998764


Q ss_pred             cCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC------
Q 041830          466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD------  539 (600)
Q Consensus       466 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~------  539 (600)
                      .           ..+++.++..++.|++.||.|||   +.+++|+||||+||++++++.+||+|||++......      
T Consensus        95 ~-----------~~l~~~~~~~~~~ql~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~  160 (262)
T cd06613          95 R-----------GPLSELQIAYVCRETLKGLAYLH---ETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS  160 (262)
T ss_pred             c-----------cCCCHHHHHHHHHHHHHHHHHHH---hCCceecCCChhhEEECCCCCEEECccccchhhhhhhhcccc
Confidence            2           23889999999999999999999   679999999999999999999999999998654321      


Q ss_pred             ------CCCCcccccC-CCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 ------TESPQFYSTN-PASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 ------~~~pe~~~~~-~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                            ..+||..... ...++.++||||||+++|||++|+.||....
T Consensus       161 ~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~  208 (262)
T cd06613         161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH  208 (262)
T ss_pred             ccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence                  2346655432 1256778999999999999999999997543

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=99.93  E-value=4e-25  Score=226.99  Aligned_cols=170  Identities=27%  Similarity=0.471  Sum_probs=141.5

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH---HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcC
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV---ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGG  465 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~---~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~  465 (600)
                      .|.||++..  ++..||||.++...   .+.+..|+..+..++|+||+++++.+... +..++||||+++++|.+++...
T Consensus        35 ~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~  113 (292)
T cd06658          35 TGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVG-DELWVVMEFLEGGALTDIVTHT  113 (292)
T ss_pred             CeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecC-CeEEEEEeCCCCCcHHHHHhcC
Confidence            489999987  68899999875422   24567888889999999999999997655 5889999999999999998542


Q ss_pred             cCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC-------
Q 041830          466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND-------  538 (600)
Q Consensus       466 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~-------  538 (600)
                                   .+++.++..++.+++.||+|||   +.+++||||||+||++++++.+||+|||++.....       
T Consensus       114 -------------~l~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~  177 (292)
T cd06658         114 -------------RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS  177 (292)
T ss_pred             -------------CCCHHHHHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCce
Confidence                         2889999999999999999999   66999999999999999999999999999864321       


Q ss_pred             -----CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 -----DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 -----~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                           .+.+||....  ..++.++||||||+++|||++|+.||...
T Consensus       178 ~~~~~~y~aPE~~~~--~~~~~~~Dv~slGvil~el~~g~~p~~~~  221 (292)
T cd06658         178 LVGTPYWMAPEVISR--LPYGTEVDIWSLGIMVIEMIDGEPPYFNE  221 (292)
T ss_pred             eecCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence                 1234554433  34677899999999999999999999753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=99.93  E-value=1.7e-25  Score=238.25  Aligned_cols=178  Identities=21%  Similarity=0.327  Sum_probs=145.9

Q ss_pred             CCceeEEEEEEEE--CCeEEEEEEcchhH--HHHHHHHHHHHHhCC-C-----CceeeeeeEEeccCCceEEEEeecCCC
Q 041830          387 SNRIEGAVYHGRL--NGKNLAIKRTEHEV--ITKLEMQLVQHATHH-H-----PNIVRLLGTCLTDGPHSFLVFEYAKNG  456 (600)
Q Consensus       387 ~~~~~G~Vy~g~~--~g~~vAvK~~~~~~--~~~~e~ei~~~~~l~-H-----pNIv~l~g~~~~~~~~~~LV~Ey~~~G  456 (600)
                      +.|.+|.|.++..  +++.||||.++.+.  ..+...|+.++..++ |     -|+|++++++...+ +++||+|.++. 
T Consensus       195 GkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~-HlciVfELL~~-  272 (586)
T KOG0667|consen  195 GKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRN-HLCIVFELLST-  272 (586)
T ss_pred             cccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeecccccc-ceeeeehhhhh-
Confidence            3444599999988  78999999987654  234456777777665 3     29999999987664 99999999975 


Q ss_pred             CHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC--CcEEEEeccCcc
Q 041830          457 SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEE--FNARVGNFGMAR  534 (600)
Q Consensus       457 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~--~~~kI~DFGla~  534 (600)
                      +|.++|+.+..          ..|+...+..|+.||+.||.+||   ..+|||+||||+||||.+.  ..+||+|||.+.
T Consensus       273 NLYellK~n~f----------~Glsl~~ir~~~~Qil~~L~~L~---~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc  339 (586)
T KOG0667|consen  273 NLYELLKNNKF----------RGLSLPLVRKFAQQILTALLFLH---ELGIIHCDLKPENILLKDPKRSRIKVIDFGSSC  339 (586)
T ss_pred             hHHHHHHhcCC----------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCChhheeeccCCcCceeEEeccccc
Confidence            99999987653          45999999999999999999999   6799999999999999643  479999999997


Q ss_pred             ccCCCC---------CCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCCC
Q 041830          535 CVNDDT---------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRK  581 (600)
Q Consensus       535 ~~~~~~---------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~  581 (600)
                      ......         .+||++.+  ..|+.+.|+||||||+.||++|.+-|.+.++
T Consensus       340 ~~~q~vytYiQSRfYRAPEVILG--lpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne  393 (586)
T KOG0667|consen  340 FESQRVYTYIQSRFYRAPEVILG--LPYDTAIDMWSLGCILAELFTGEPLFPGDNE  393 (586)
T ss_pred             ccCCcceeeeeccccccchhhcc--CCCCCccceeehhhhHHhHhcCccccCCCCH
Confidence            654432         47888776  6788999999999999999999877876543

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.93  E-value=1.4e-25  Score=218.73  Aligned_cols=190  Identities=21%  Similarity=0.358  Sum_probs=150.0

Q ss_pred             cCHHHHHHHHhccCCCCceeEEEEEEEE--CCeEEEEEEcchh---HHHHHHHHHHHHHhCC-CCceeeeeeEEeccCCc
Q 041830          372 YSIEDLRRATEKFNSSNRIEGAVYHGRL--NGKNLAIKRTEHE---VITKLEMQLVQHATHH-HPNIVRLLGTCLTDGPH  445 (600)
Q Consensus       372 ~~~~el~~~t~~f~~~~~~~G~Vy~g~~--~g~~vAvK~~~~~---~~~~~e~ei~~~~~l~-HpNIv~l~g~~~~~~~~  445 (600)
                      -+|+|+.+.|++..+++-. +.|-..+.  +|.++|||.+++.   .+.+.-+|+.++.+.. |+||+.|+.++.++ ..
T Consensus        73 g~F~d~YkLt~e~LGeGAy-asVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd-~~  150 (463)
T KOG0607|consen   73 GKFEDMYKLTSELLGEGAY-ASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDD-TR  150 (463)
T ss_pred             chHHHHHHhHHHHhcCccc-eeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhccc-ce
Confidence            3588999999998776544 66655543  8999999998653   3355667777777654 99999999997554 58


Q ss_pred             eEEEEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC---
Q 041830          446 SFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEE---  522 (600)
Q Consensus       446 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~---  522 (600)
                      +|||||-|.+|+|..+++...            .+++.+.-++.++|+.||.|||   .++|.||||||+|||-.+.   
T Consensus       151 FYLVfEKm~GGplLshI~~~~------------~F~E~EAs~vvkdia~aLdFlH---~kgIAHRDlKPENiLC~~pn~v  215 (463)
T KOG0607|consen  151 FYLVFEKMRGGPLLSHIQKRK------------HFNEREASRVVKDIASALDFLH---TKGIAHRDLKPENILCESPNKV  215 (463)
T ss_pred             EEEEEecccCchHHHHHHHhh------------hccHHHHHHHHHHHHHHHHHHh---hcCcccccCCccceeecCCCCc
Confidence            999999999999999998654            3899999999999999999999   8899999999999999654   


Q ss_pred             CcEEEEeccCccccCCC-----C--------------CCCccc---ccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          523 FNARVGNFGMARCVNDD-----T--------------ESPQFY---STNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       523 ~~~kI~DFGla~~~~~~-----~--------------~~pe~~---~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                      .-+||+||.++..+...     .              ++||+.   ......|+.++|.||+|||||-|++|.+||..
T Consensus       216 sPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG  293 (463)
T KOG0607|consen  216 SPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVG  293 (463)
T ss_pred             CceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccC
Confidence            34899999987543211     1              123321   11234578889999999999999999999965

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=99.93  E-value=1.3e-24  Score=224.65  Aligned_cols=172  Identities=27%  Similarity=0.406  Sum_probs=141.5

Q ss_pred             eEEEEEEEE--CCeEEEEEEcch------hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEH------EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~------~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||+|+.  +|+.||+|.+..      +....+.+|+..+..++||||++++++|..+ ...|+|+||++ |+|.+++
T Consensus        28 ~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~-g~l~~~~  105 (307)
T cd06607          28 FGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLRE-HTAWLVMEYCL-GSASDIL  105 (307)
T ss_pred             CeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeC-CeEEEEHHhhC-CCHHHHH
Confidence            489999987  689999998753      2224567888889999999999999998765 47899999997 6888877


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC---
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---  539 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~---  539 (600)
                      ....           ..+++.++..++.|++.||.|||   +.+++||||+|+||++++++.+||+|||++......   
T Consensus       106 ~~~~-----------~~l~~~~~~~~~~ql~~~L~~LH---~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~~~~  171 (307)
T cd06607         106 EVHK-----------KPLQEVEIAAICHGALQGLAYLH---SHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPANSF  171 (307)
T ss_pred             HHcc-----------cCCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEECCCCCEEEeecCcceecCCCCCc
Confidence            5432           23899999999999999999999   669999999999999999999999999998755322   


Q ss_pred             -----CCCCccccc-CCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          540 -----TESPQFYST-NPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       540 -----~~~pe~~~~-~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                           +.+||.... ....++.++||||||+++|||++|+.||..
T Consensus       172 ~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~  216 (307)
T cd06607         172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN  216 (307)
T ss_pred             cCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCC
Confidence                 235665432 234567889999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.93  E-value=5.9e-26  Score=236.11  Aligned_cols=178  Identities=22%  Similarity=0.394  Sum_probs=147.5

Q ss_pred             CCceeEEEEEEE--ECCeEEEEEEcchhH-----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHH
Q 041830          387 SNRIEGAVYHGR--LNGKNLAIKRTEHEV-----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       387 ~~~~~G~Vy~g~--~~g~~vAvK~~~~~~-----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~  459 (600)
                      +.+.+|.++..+  .+++.+++|.+....     ....+.|+..+.+++|||||.+.+.++.++...+|||+||+||+|.
T Consensus        13 G~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~   92 (426)
T KOG0589|consen   13 GRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLA   92 (426)
T ss_pred             CccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHH
Confidence            334446665544  478899999865432     2345788889999999999999999877764489999999999999


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD  539 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~  539 (600)
                      +.+...+.          ..++++++++++.|++.|+.|||   +.+|+|||||+.||++..+..+||+|||+|+.+...
T Consensus        93 ~~i~~~k~----------~~f~E~~i~~~~~Q~~~av~ylH---~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   93 QLIKEQKG----------VLFPEERILKWFVQILLAVNYLH---ENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             HHHHHHhh----------ccccHHHHHHHHHHHHHHHHHHH---hhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            99977552          34899999999999999999999   679999999999999999999999999999987655


Q ss_pred             C------------CCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 T------------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 ~------------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                      .            ..||.+..  ..|..++|+||+||++|||++-+++|...
T Consensus       160 ~~~a~tvvGTp~YmcPEil~d--~pYn~KSDiWsLGC~~yEm~~lk~aF~a~  209 (426)
T KOG0589|consen  160 DSLASTVVGTPYYMCPEILSD--IPYNEKSDIWSLGCCLYEMCTLKPAFKAS  209 (426)
T ss_pred             hhhhheecCCCcccCHHHhCC--CCCCccCcchhhcchHHHHHhcccccCcc
Confidence            3            23454444  56889999999999999999999999764

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.93  E-value=3.8e-25  Score=223.32  Aligned_cols=175  Identities=21%  Similarity=0.350  Sum_probs=142.6

Q ss_pred             eEEEEEEEE--CCeEEEEEEcch------hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEH------EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~------~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||++..  +|+.+|||.+..      .....+..|+..+..++||||+++++++..++ ..+++|||+++++|.+++
T Consensus        15 ~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~-~~~~v~e~~~~~~L~~~~   93 (267)
T cd08229          15 FSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDN-ELNIVLELADAGDLSRMI   93 (267)
T ss_pred             CeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCC-eEEEEEEecCCCCHHHHH
Confidence            389999986  789999997643      12245678899999999999999999987654 889999999999999998


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC---
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---  539 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~---  539 (600)
                      +.....        ...++|.+++.++.+++.||.|||   +.+++|+||||+||+++.++.++|+|||++......   
T Consensus        94 ~~~~~~--------~~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~  162 (267)
T cd08229          94 KHFKKQ--------KRLIPEKTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA  162 (267)
T ss_pred             HHhhcc--------CCCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCcc
Confidence            642211        134899999999999999999999   679999999999999999999999999988654321   


Q ss_pred             ---------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 ---------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 ---------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                               ..+||....  ..++.++|+||||+++|||++|+.||...
T Consensus       163 ~~~~~~~~~~~ape~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~  209 (267)
T cd08229         163 AHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGD  209 (267)
T ss_pred             cccccCCcCccCHHHhcC--CCccchhhHHHHHHHHHHHHhCCCCcccc
Confidence                     124554433  34567899999999999999999999643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.93  E-value=8.8e-26  Score=225.33  Aligned_cols=187  Identities=20%  Similarity=0.359  Sum_probs=146.8

Q ss_pred             ceeEEEEEEEEC-------CeEEEEEEcchhH----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCC
Q 041830          389 RIEGAVYHGRLN-------GKNLAIKRTEHEV----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGS  457 (600)
Q Consensus       389 ~~~G~Vy~g~~~-------g~~vAvK~~~~~~----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~Gs  457 (600)
                      |.+|.||+|.|.       .+.|-+|.++...    ...+..|-..+....|||+..+.|++.++....++++.++.-|+
T Consensus       295 GtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gN  374 (563)
T KOG1024|consen  295 GTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGN  374 (563)
T ss_pred             CchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcch
Confidence            345999999772       2346667665533    23456677777888899999999999998888899999999999


Q ss_pred             HHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC
Q 041830          458 LKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN  537 (600)
Q Consensus       458 L~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~  537 (600)
                      |..||...+..+    ..+.+.++-.+...++.|++.||+|||   +.++||.||..+|++||+..++||+|=.++|.+-
T Consensus       375 LK~FL~~Cr~~~----~~~aqtvtt~qlV~masQla~am~hlh---~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLF  447 (563)
T KOG1024|consen  375 LKSFLQICRGDD----PSYAQTVTTIQLVLMASQLAMAMEHLH---NHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLF  447 (563)
T ss_pred             HHHHHHHhccCC----CccccchhHHHHHHHHHHHHHHHHHHH---hcCcccchhhhhcceehhheeEEeccchhccccC
Confidence            999998433211    122355888999999999999999999   7799999999999999999999999999998664


Q ss_pred             CCCC--------------CCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCCCCCCc
Q 041830          538 DDTE--------------SPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRPRKKDE  584 (600)
Q Consensus       538 ~~~~--------------~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~~~~~~  584 (600)
                      +...              ++|...  ...|+.++|||||||+||||+| |+.|+.+.+..|.
T Consensus       448 P~DYhcLGDnEnRPvkWMslEal~--n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm  507 (563)
T KOG1024|consen  448 PGDYHCLGDNENRPVKWMSLEALQ--NSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEM  507 (563)
T ss_pred             cccccccCCCCCCcccccCHHHHh--hhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHH
Confidence            3321              122221  2456888999999999999998 9999987765543

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=99.93  E-value=7.3e-25  Score=223.43  Aligned_cols=183  Identities=25%  Similarity=0.422  Sum_probs=141.7

Q ss_pred             eEEEEEEEEC-------CeEEEEEEcchhH----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHH
Q 041830          391 EGAVYHGRLN-------GKNLAIKRTEHEV----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       391 ~G~Vy~g~~~-------g~~vAvK~~~~~~----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~  459 (600)
                      .|.||+|...       ++.||+|+++...    ...+..|+..+..++||||+++++++...+ ..++++||+++++|.
T Consensus        18 ~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~-~~~~~~e~~~~~~l~   96 (283)
T cd05091          18 FGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQ-PLSMIFSYCSHSDLH   96 (283)
T ss_pred             CCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCC-ceEEEEEcCCCCcHH
Confidence            4899999872       4679999986432    245677888888999999999999986654 789999999999999


Q ss_pred             HHHhcCcCccc----ccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccc
Q 041830          460 DWLHGGLAMKN----QFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARC  535 (600)
Q Consensus       460 ~~L~~~~~~~~----~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~  535 (600)
                      +++........    .........+++..+++++.|++.||.|||   +.+++||||||+||++++++.+||+|||+++.
T Consensus        97 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH---~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  173 (283)
T cd05091          97 EFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLS---SHHVVHKDLATRNVLVFDKLNVKISDLGLFRE  173 (283)
T ss_pred             HHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HcCccccccchhheEecCCCceEecccccccc
Confidence            99864221000    000011134899999999999999999999   67999999999999999999999999999875


Q ss_pred             cCC--------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          536 VND--------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       536 ~~~--------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                      ...              .+.+||....  ..++.++||||||+++|||++ |..||...
T Consensus       174 ~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~  230 (283)
T cd05091         174 VYAADYYKLMGNSLLPIRWMSPEAIMY--GKFSIDSDIWSYGVVLWEVFSYGLQPYCGY  230 (283)
T ss_pred             cccchheeeccCccCCccccCHHHHhc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence            421              1224554432  346778999999999999998 88888653

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=99.93  E-value=3.6e-25  Score=222.34  Aligned_cols=171  Identities=22%  Similarity=0.351  Sum_probs=141.6

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||+++.  +|+.+++|.++.+.      ...+..|+..+..++||||+++++.+... ...|+++||+++++|.+++
T Consensus         6 ~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l   84 (265)
T cd05579           6 YGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGK-KNLYLVMEYLPGGDLASLL   84 (265)
T ss_pred             ceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecC-cEEEEEEecCCCCcHHHHH
Confidence            389999998  48999999876432      24567788889999999999999987554 5889999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC---
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---  539 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~---  539 (600)
                      ++..            .+++.++..++.|++.||+|||   +.+++||||+|+||++++++.+||+|||++......   
T Consensus        85 ~~~~------------~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  149 (265)
T cd05579          85 ENVG------------SLDEDVARIYIAEIVLALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQI  149 (265)
T ss_pred             HHcC------------CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccc
Confidence            7532            3899999999999999999999   679999999999999999999999999998654222   


Q ss_pred             -----------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 -----------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 -----------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                       ..+||....  ..++.++||||||+++|||++|+.||...
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~  204 (265)
T cd05579         150 NLNDDEKEDKRIVGTPDYIAPEVILG--QGHSKTVDWWSLGCILYEFLVGIPPFHGE  204 (265)
T ss_pred             ccccccccccCcccCccccCHHHhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence                             123443332  23577899999999999999999999654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=99.93  E-value=4.7e-25  Score=222.90  Aligned_cols=179  Identities=27%  Similarity=0.514  Sum_probs=142.1

Q ss_pred             eeEEEEEEEECC--------eEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCC
Q 041830          390 IEGAVYHGRLNG--------KNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGS  457 (600)
Q Consensus       390 ~~G~Vy~g~~~g--------~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~Gs  457 (600)
                      ..|.||+|+...        +.+|+|.+...    ....+.+|+..+..++||||+++++++... ...++||||+++|+
T Consensus         7 ~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e~~~~~~   85 (269)
T cd05044           7 AFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLN-EPQYIIMELMEGGD   85 (269)
T ss_pred             cceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCC-CCeEEEEeccCCCc
Confidence            348999998732        57999986542    234677889999999999999999998655 47899999999999


Q ss_pred             HHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC-----cEEEEeccC
Q 041830          458 LKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEF-----NARVGNFGM  532 (600)
Q Consensus       458 L~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~-----~~kI~DFGl  532 (600)
                      |.++++.......     ....++|.+++.++.|++.||+|||   +.+++|+||||+||+++.+.     .+|++|||+
T Consensus        86 L~~~l~~~~~~~~-----~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~  157 (269)
T cd05044          86 LLSYLRDARVERF-----GPPLLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGL  157 (269)
T ss_pred             HHHHHHHhhhccc-----CCccccHHHHHHHHHHHHHHHHHHH---hCCcccCCCChheEEEecCCCCCCcceEECCccc
Confidence            9999975332110     0134899999999999999999999   67899999999999999877     899999999


Q ss_pred             ccccCC--------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          533 ARCVND--------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       533 a~~~~~--------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                      ++....              ...+||....  ..++.++|||||||++|||++ |+.||...
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~ellt~g~~p~~~~  217 (269)
T cd05044         158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLD--GKFTTQSDVWSFGVLMWEILTLGQQPYPAL  217 (269)
T ss_pred             ccccccccccccCcccCCCccccCHHHHcc--CCcccchhHHHHHHHHHHHHHcCCCCCccc
Confidence            864321              1234555443  346788999999999999998 99999653

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=99.93  E-value=5.1e-25  Score=223.01  Aligned_cols=172  Identities=24%  Similarity=0.471  Sum_probs=140.1

Q ss_pred             eEEEEEEEEC-----CeEEEEEEcch----hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          391 EGAVYHGRLN-----GKNLAIKRTEH----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       391 ~G~Vy~g~~~-----g~~vAvK~~~~----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      .|.||+|...     ...|+||....    +..+.+..|+..+..+.||||+++++++..  ...++||||+++|+|.++
T Consensus        19 ~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~--~~~~lv~e~~~~~~L~~~   96 (270)
T cd05056          19 FGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE--NPVWIVMELAPLGELRSY   96 (270)
T ss_pred             ceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC--CCcEEEEEcCCCCcHHHH
Confidence            3899999872     23689998653    233467789999999999999999999753  367899999999999999


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--  539 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--  539 (600)
                      +....           ..+++.+++.++.+++.||.|||   +.+++||||||+||+++.++.+||+|||+++.....  
T Consensus        97 l~~~~-----------~~~~~~~~~~~~~~l~~~l~~lH---~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  162 (270)
T cd05056          97 LQVNK-----------YSLDLASLILYSYQLSTALAYLE---SKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY  162 (270)
T ss_pred             HHhCC-----------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccccChheEEEecCCCeEEccCceeeecccccc
Confidence            97543           23899999999999999999999   679999999999999999999999999998754221  


Q ss_pred             -----------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCCC
Q 041830          540 -----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRPR  580 (600)
Q Consensus       540 -----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~~  580 (600)
                                 ..+||....  ..++.++||||||+++|||++ |+.||....
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~pf~~~~  213 (270)
T cd05056         163 YKASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMLGVKPFQGVK  213 (270)
T ss_pred             eecCCCCccccccChhhhcc--CCCCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence                       224554432  346788999999999999986 999996543

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=99.93  E-value=7.9e-25  Score=224.10  Aligned_cols=172  Identities=22%  Similarity=0.332  Sum_probs=140.1

Q ss_pred             eEEEEEEEE-----CCeEEEEEEcchhH-------HHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCC
Q 041830          391 EGAVYHGRL-----NGKNLAIKRTEHEV-------ITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGS  457 (600)
Q Consensus       391 ~G~Vy~g~~-----~g~~vAvK~~~~~~-------~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~Gs  457 (600)
                      .|.||+++.     +|+.||+|+++...       .+.++.|+..+..+ +|+||+++++.+..+ ...++||||+++++
T Consensus        13 ~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~   91 (290)
T cd05613          13 YGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTD-TKLHLILDYINGGE   91 (290)
T ss_pred             cceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecC-CeEEEEEecCCCCc
Confidence            389999876     67899999986532       23456788888888 599999999886554 47899999999999


Q ss_pred             HHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC
Q 041830          458 LKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN  537 (600)
Q Consensus       458 L~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~  537 (600)
                      |.+++....            .+++.+...++.|++.||.|||   +.+++||||+|+|||++.++.+||+|||+++...
T Consensus        92 L~~~l~~~~------------~l~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~  156 (290)
T cd05613          92 LFTHLSQRE------------RFKEQEVQIYSGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFH  156 (290)
T ss_pred             HHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEECCCCCEEEeeCccceecc
Confidence            999997542            3888999999999999999999   6799999999999999999999999999987543


Q ss_pred             CC-------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          538 DD-------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       538 ~~-------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                      ..             ..+||........++.++||||||+++|||++|+.||..
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~  210 (290)
T cd05613         157 EDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV  210 (290)
T ss_pred             cccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence            21             124555443223456789999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=99.93  E-value=4.7e-25  Score=224.72  Aligned_cols=176  Identities=24%  Similarity=0.427  Sum_probs=141.4

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh--HHHHHHHHHHHHHhC-CCCceeeeeeEEecc-----CCceEEEEeecCCCCHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE--VITKLEMQLVQHATH-HHPNIVRLLGTCLTD-----GPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~--~~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~-----~~~~~LV~Ey~~~GsL~~  460 (600)
                      .|.||+|+.  +++.+|+|.....  ....++.|+..+..+ +|+||+++++++...     +...+++|||+++|+|.+
T Consensus        29 ~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~  108 (282)
T cd06636          29 YGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTD  108 (282)
T ss_pred             CeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHH
Confidence            499999998  6889999987543  224566777777777 699999999997632     346799999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC--
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND--  538 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~--  538 (600)
                      ++.....          ..+++..+..++.|++.||.|||   +.+++||||||+||++++++.+||+|||+++....  
T Consensus       109 ~~~~~~~----------~~~~~~~~~~~~~qi~~al~~LH---~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~  175 (282)
T cd06636         109 LVKNTKG----------NALKEDWIAYICREILRGLAHLH---AHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV  175 (282)
T ss_pred             HHHHccC----------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhccc
Confidence            9975432          23788899999999999999999   67999999999999999999999999999864421  


Q ss_pred             ----------CCCCCcccccC---CCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 ----------DTESPQFYSTN---PASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 ----------~~~~pe~~~~~---~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                ...+||.....   ...++.++|||||||++|||++|+.||...
T Consensus       176 ~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~  229 (282)
T cd06636         176 GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM  229 (282)
T ss_pred             cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcccc
Confidence                      12346654321   235677899999999999999999999653

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=99.93  E-value=5.1e-25  Score=227.32  Aligned_cols=173  Identities=26%  Similarity=0.438  Sum_probs=140.3

Q ss_pred             eEEEEEEEE-------CCeEEEEEEcchh----HHHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCCH
Q 041830          391 EGAVYHGRL-------NGKNLAIKRTEHE----VITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSL  458 (600)
Q Consensus       391 ~G~Vy~g~~-------~g~~vAvK~~~~~----~~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL  458 (600)
                      .|.||++..       .+..||+|.++..    ..+.+..|+..+.++ +||||+++++++... +..+++|||+++|+|
T Consensus        48 ~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L  126 (302)
T cd05055          48 FGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIG-GPILVITEYCCYGDL  126 (302)
T ss_pred             CeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecC-CceEEEEEcCCCCcH
Confidence            389999874       2457999987542    224567888899999 799999999998655 478999999999999


Q ss_pred             HHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC
Q 041830          459 KDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND  538 (600)
Q Consensus       459 ~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~  538 (600)
                      .++++....          ..+++.++..++.|++.||+|||   +.+++|+||||+|||++.++.+|++|||+++....
T Consensus       127 ~~~i~~~~~----------~~l~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~  193 (302)
T cd05055         127 LNFLRRKRE----------SFLTLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMN  193 (302)
T ss_pred             HHHHHhCCC----------CCCCHHHHHHHHHHHHHHHHHHH---HCCeehhhhccceEEEcCCCeEEECCCcccccccC
Confidence            999975432          23899999999999999999999   67999999999999999999999999999875432


Q ss_pred             C--------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          539 D--------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       539 ~--------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                      .              ..+||....  ..++.++|||||||++|||++ |+.||...
T Consensus       194 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslGvil~el~t~g~~p~~~~  247 (302)
T cd05055         194 DSNYVVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGILLWEIFSLGSNPYPGM  247 (302)
T ss_pred             CCceeecCCCCcccccCCHhhhcc--CCCCcHhHHHHHHHHHHHHHhCCCCCcCCC
Confidence            1              223444332  345778999999999999998 99998653

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=99.93  E-value=7.9e-25  Score=221.75  Aligned_cols=171  Identities=25%  Similarity=0.399  Sum_probs=141.5

Q ss_pred             EEEEEEEE--CCeEEEEEEcchh-------------HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCC
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHE-------------VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNG  456 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~-------------~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~G  456 (600)
                      |.||+|..  +|+.+|+|.++..             ..+.+..|+..+..++||||+++++++... +..++||||+++|
T Consensus        15 ~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~   93 (272)
T cd06629          15 GRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTE-EYLSIFLEYVPGG   93 (272)
T ss_pred             eEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccC-CceEEEEecCCCC
Confidence            89999976  6899999986421             113466788889999999999999997654 5889999999999


Q ss_pred             CHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCcccc
Q 041830          457 SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV  536 (600)
Q Consensus       457 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~  536 (600)
                      +|.++++...            .+++.++..++.|++.||.|||   +.+++||||+|+||+++.++.+||+|||+++..
T Consensus        94 ~L~~~l~~~~------------~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~  158 (272)
T cd06629          94 SIGSCLRTYG------------RFEEQLVRFFTEQVLEGLAYLH---SKGILHRDLKADNLLVDADGICKISDFGISKKS  158 (272)
T ss_pred             cHHHHHhhcc------------CCCHHHHHHHHHHHHHHHHHHh---hCCeeecCCChhhEEEcCCCeEEEeeccccccc
Confidence            9999997642            3889999999999999999999   679999999999999999999999999998754


Q ss_pred             CCC--------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          537 NDD--------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       537 ~~~--------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                      ...              ..+||........++.++|+||||+++|||++|+.||..
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~  214 (272)
T cd06629         159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD  214 (272)
T ss_pred             cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcC
Confidence            321              124555443333467889999999999999999999964

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=99.93  E-value=3.6e-25  Score=232.59  Aligned_cols=171  Identities=20%  Similarity=0.343  Sum_probs=139.4

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH-----HHHHHHHHHHHHhCCCCceeeeeeEEeccC-----CceEEEEeecCCCCH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV-----ITKLEMQLVQHATHHHPNIVRLLGTCLTDG-----PHSFLVFEYAKNGSL  458 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~-----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~-----~~~~LV~Ey~~~GsL  458 (600)
                      .|.||++..  +++.||||.+....     ...+.+|+..+..++||||+++++++....     ...|+++|++ +++|
T Consensus        28 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l  106 (343)
T cd07878          28 YGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADL  106 (343)
T ss_pred             CeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCH
Confidence            499999987  67899999976432     234567899999999999999999865321     2468999998 7799


Q ss_pred             HHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC
Q 041830          459 KDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND  538 (600)
Q Consensus       459 ~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~  538 (600)
                      .+++...             .+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       107 ~~~~~~~-------------~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~  170 (343)
T cd07878         107 NNIVKCQ-------------KLSDEHVQFLIYQLLRGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADD  170 (343)
T ss_pred             HHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHH---HCCeecccCChhhEEECCCCCEEEcCCccceecCC
Confidence            9888542             3899999999999999999999   67999999999999999999999999999876533


Q ss_pred             C---------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 D---------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 ~---------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                      .         +.+||.... ...++.++|||||||++|||++|+.||...
T Consensus       171 ~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~  219 (343)
T cd07878         171 EMTGYVATRWYRAPEIMLN-WMHYNQTVDIWSVGCIMAELLKGKALFPGN  219 (343)
T ss_pred             CcCCccccccccCchHhcC-CccCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence            2         235555432 234678899999999999999999999653

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=7.8e-25  Score=221.02  Aligned_cols=172  Identities=26%  Similarity=0.370  Sum_probs=141.1

Q ss_pred             eEEEEEEEE--CCeEEEEEEcch--------hHHHHHHHHHHHHHhCCCCceeeeeeEEecc-CCceEEEEeecCCCCHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEH--------EVITKLEMQLVQHATHHHPNIVRLLGTCLTD-GPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~--------~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~-~~~~~LV~Ey~~~GsL~  459 (600)
                      .|.||++..  +|+.||+|.+..        .....+++|+..+..++|+||+++++++... +...++++||+++++|.
T Consensus        15 ~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~   94 (264)
T cd06653          15 FGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIK   94 (264)
T ss_pred             CeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHH
Confidence            389999987  689999998632        2224677899999999999999999987543 23578999999999999


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC-
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND-  538 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~-  538 (600)
                      +++....            .+++.+.++++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||+++.... 
T Consensus        95 ~~~~~~~------------~l~~~~~~~~~~~i~~al~~LH---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~  159 (264)
T cd06653          95 DQLKAYG------------ALTENVTRRYTRQILQGVSYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTI  159 (264)
T ss_pred             HHHHHcC------------CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECccccccccccc
Confidence            9987532            2789999999999999999999   66899999999999999999999999999875421 


Q ss_pred             --------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 --------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 --------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                    ...+||....  ..++.++|+|||||++|||++|+.||...
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~  212 (264)
T cd06653         160 CMSGTGIKSVTGTPYWMSPEVISG--EGYGRKADVWSVACTVVEMLTEKPPWAEY  212 (264)
T ss_pred             cccCccccccCCcccccCHhhhcC--CCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence                          1124554433  34677899999999999999999999653

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=99.93  E-value=2.5e-25  Score=227.07  Aligned_cols=178  Identities=24%  Similarity=0.384  Sum_probs=141.1

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh--HHHHHHHHHHHHHhC-CCCceeeeeeEEec----cCCceEEEEeecCCCCHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE--VITKLEMQLVQHATH-HHPNIVRLLGTCLT----DGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~--~~~~~e~ei~~~~~l-~HpNIv~l~g~~~~----~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      .|.||+++.  +|+.+|+|..+..  ....++.|+..+..+ +||||+++++++..    .++..++||||+++|+|.++
T Consensus        31 ~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~  110 (286)
T cd06638          31 YGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDL  110 (286)
T ss_pred             CcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHH
Confidence            389999988  6889999987542  224566777778787 69999999998753    33468999999999999999


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--  539 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--  539 (600)
                      ++......        ..+++..+..++.|++.||.|||   +.+++||||||+||++++++.+||+|||+++.....  
T Consensus       111 l~~~~~~~--------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~  179 (286)
T cd06638         111 VKGFLKRG--------ERMEEPIIAYILHEALMGLQHLH---VNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL  179 (286)
T ss_pred             HHHhhccC--------ccccHHHHHHHHHHHHHHHHHHH---hCCccccCCCHHhEEECCCCCEEEccCCceeecccCCC
Confidence            86432110        34889999999999999999999   679999999999999999999999999998754321  


Q ss_pred             ----------CCCCcccccC---CCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 ----------TESPQFYSTN---PASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 ----------~~~pe~~~~~---~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                ..+||.....   ...++.++|||||||++|||++|+.||...
T Consensus       180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~  232 (286)
T cd06638         180 RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL  232 (286)
T ss_pred             ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCC
Confidence                      2245554321   234677899999999999999999998653

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=99.93  E-value=4.2e-25  Score=222.34  Aligned_cols=172  Identities=23%  Similarity=0.471  Sum_probs=141.5

Q ss_pred             eEEEEEEEE-CCeEEEEEEcchhH--HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcC
Q 041830          391 EGAVYHGRL-NGKNLAIKRTEHEV--ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLA  467 (600)
Q Consensus       391 ~G~Vy~g~~-~g~~vAvK~~~~~~--~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~  467 (600)
                      .|.||++.. .+..+|+|.++...  ...+.+|+..+..++|+|++++++++ .+ ...+++|||+++++|.++++....
T Consensus        19 ~~~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~-~~-~~~~lv~e~~~~~~L~~~~~~~~~   96 (260)
T cd05070          19 FGEVWMGTWNGNTKVAVKTLKPGTMSPESFLEEAQIMKKLRHDKLVQLYAVV-SE-EPIYIVTEYMSKGSLLDFLKDGEG   96 (260)
T ss_pred             CceEEEEEecCCceeEEEEecCCCCCHHHHHHHHHHHHhcCCCceEEEEeEE-CC-CCcEEEEEecCCCcHHHHHHhcCC
Confidence            489999987 56789999876532  24677899999999999999999986 34 367999999999999999975431


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--------
Q 041830          468 MKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--------  539 (600)
Q Consensus       468 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--------  539 (600)
                                ..+++.++..++.+++.||+|||   +.+++||||||+||++++++.+||+|||++......        
T Consensus        97 ----------~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~  163 (260)
T cd05070          97 ----------RALKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGA  163 (260)
T ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccccCC
Confidence                      23899999999999999999999   668999999999999999999999999998754321        


Q ss_pred             -----CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          540 -----TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       540 -----~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                           ..+||....  ..++.++||||||+++|||++ |+.||...
T Consensus       164 ~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~~g~~p~~~~  207 (260)
T cd05070         164 KFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELVTKGRVPYPGM  207 (260)
T ss_pred             CCCccccChHHHhc--CCCcchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence                 234554432  346778999999999999999 89999653

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>PTZ00284 protein kinase; Provisional

Probab=99.93  E-value=3.2e-25  Score=242.82  Aligned_cols=173  Identities=16%  Similarity=0.263  Sum_probs=134.2

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh--HHHHHHHHHHHHHhCC------CCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE--VITKLEMQLVQHATHH------HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~--~~~~~e~ei~~~~~l~------HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      +|.||++..  +++.||||+++..  .......|+..+..++      |.+++++++++..+....++|||++ +++|.+
T Consensus       142 fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~  220 (467)
T PTZ00284        142 FGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLD  220 (467)
T ss_pred             CEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-CCCHHH
Confidence            399999987  6889999998542  1223344444444433      5569999998876655789999998 678999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC----------------c
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEF----------------N  524 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~----------------~  524 (600)
                      ++....            .+++.++..|+.||+.||.|||+  +.+|+||||||+|||++.++                .
T Consensus       221 ~l~~~~------------~l~~~~~~~i~~qi~~aL~yLH~--~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~  286 (467)
T PTZ00284        221 WIMKHG------------PFSHRHLAQIIFQTGVALDYFHT--ELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCR  286 (467)
T ss_pred             HHHHcC------------CCCHHHHHHHHHHHHHHHHHHHh--cCCeecCCCCHHHEEEecCCcccccccccccCCCCce
Confidence            886542            38999999999999999999994  24899999999999998665                4


Q ss_pred             EEEEeccCccccC---------CCCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          525 ARVGNFGMARCVN---------DDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       525 ~kI~DFGla~~~~---------~~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                      +||+|||++....         ..+.+||....  ..++.++|||||||++|||++|+.||...+
T Consensus       287 vkl~DfG~~~~~~~~~~~~~gt~~Y~APE~~~~--~~~~~~~DiwSlGvil~elltG~~pf~~~~  349 (467)
T PTZ00284        287 VRICDLGGCCDERHSRTAIVSTRHYRSPEVVLG--LGWMYSTDMWSMGCIIYELYTGKLLYDTHD  349 (467)
T ss_pred             EEECCCCccccCccccccccCCccccCcHHhhc--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999999875321         23446776654  457888999999999999999999997644

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=99.93  E-value=8.8e-27  Score=225.19  Aligned_cols=185  Identities=23%  Similarity=0.383  Sum_probs=154.5

Q ss_pred             HHHHHHHhccCCCCceeEEEEEEEE--CCeEEEEEEcchhH-HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEe
Q 041830          375 EDLRRATEKFNSSNRIEGAVYHGRL--NGKNLAIKRTEHEV-ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFE  451 (600)
Q Consensus       375 ~el~~~t~~f~~~~~~~G~Vy~g~~--~g~~vAvK~~~~~~-~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~E  451 (600)
                      ||+....++..  .+.+|+||++.+  .|+.+|||++..+. .+++.+||.++.+...|++|+++|.++... .+|+|||
T Consensus        32 EEVFDi~~KLG--EGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~s-DLWIVME  108 (502)
T KOG0574|consen   32 EEVFDIVGKLG--EGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHS-DLWIVME  108 (502)
T ss_pred             HHHHHHHHHhc--CCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcCCchhhhhhhhhccCC-ceEeehh
Confidence            44444444443  334599999977  79999999987543 467788999999999999999999988764 8999999


Q ss_pred             ecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEecc
Q 041830          452 YAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFG  531 (600)
Q Consensus       452 y~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFG  531 (600)
                      ||..|++.+.++-.+           .+|++.++-.+.++-++||+|||.   ..-+|||||..||||+.+|.+|++|||
T Consensus       109 YCGAGSiSDI~R~R~-----------K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFG  174 (502)
T KOG0574|consen  109 YCGAGSISDIMRARR-----------KPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFG  174 (502)
T ss_pred             hcCCCcHHHHHHHhc-----------CCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhcc
Confidence            999999999997654           569999999999999999999994   467899999999999999999999999


Q ss_pred             CccccCC------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          532 MARCVND------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       532 la~~~~~------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                      .|..++.            -+.+||+...  ..|..++||||+|+.-.||..|++||..
T Consensus       175 VAGQLTDTMAKRNTVIGTPFWMAPEVI~E--IGY~~~ADIWSLGITaIEMAEG~PPYsD  231 (502)
T KOG0574|consen  175 VAGQLTDTMAKRNTVIGTPFWMAPEVIEE--IGYDTKADIWSLGITAIEMAEGRPPYSD  231 (502)
T ss_pred             ccchhhhhHHhhCccccCcccccHHHHHH--hccchhhhHhhhcchhhhhhcCCCCccc
Confidence            9875532            2345665544  6788899999999999999999999964

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=99.93  E-value=1e-24  Score=218.75  Aligned_cols=173  Identities=23%  Similarity=0.367  Sum_probs=141.5

Q ss_pred             eEEEEEEEE--CCeEEEEEEcch-----hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEH-----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~-----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      .|.||.++.  +++.+++|.+..     .....+.+|+..+++++|+||+++++++.+. ...+++|||+++|+|.+++.
T Consensus        13 ~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~~~~e~~~~~~L~~~~~   91 (256)
T cd08221          13 FGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDD-NTLLIEMEYANGGTLYDKIV   91 (256)
T ss_pred             CceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecC-CeEEEEEEecCCCcHHHHHH
Confidence            376666665  788999997543     2234577899999999999999999998665 48899999999999999997


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCCC---
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDT---  540 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~~---  540 (600)
                      ....          ..+++.++..++.|++.||.|||   +.+++||||+|+||++++++.+||+|||+++......   
T Consensus        92 ~~~~----------~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~  158 (256)
T cd08221          92 RQKG----------QLFEEEMVLWYLFQIVSAVSYIH---KAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA  158 (256)
T ss_pred             hccc----------cCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChHhEEEeCCCCEEECcCcceEEcccccccc
Confidence            5421          24899999999999999999999   6689999999999999999999999999987653322   


Q ss_pred             ---------CCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          541 ---------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       541 ---------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                               .+||....  ..++.++||||||+++|||++|+.||...
T Consensus       159 ~~~~~~~~y~ape~~~~--~~~~~~~Dv~slG~i~~~l~~g~~~~~~~  204 (256)
T cd08221         159 ETVVGTPYYMSPELCQG--VKYNFKSDIWALGCVLYELLTLKRTFDAT  204 (256)
T ss_pred             cccCCCccccCHhhcCC--CCCCCcchhHHHHHHHHHHHHCCCCCCCC
Confidence                     23444432  34677899999999999999999999653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=99.93  E-value=1e-24  Score=222.69  Aligned_cols=173  Identities=21%  Similarity=0.330  Sum_probs=143.7

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      .|.||++..  +|+.||+|.+...    ....+..|+..+..++||||+++++++... ...++||||+++|+|.++++.
T Consensus        18 ~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~   96 (284)
T cd06620          18 GGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNE-NNICMCMEFMDCGSLDRIYKK   96 (284)
T ss_pred             CeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecC-CEEEEEEecCCCCCHHHHHHh
Confidence            499999998  5889999976432    234667888889999999999999998766 489999999999999999875


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC------
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND------  538 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~------  538 (600)
                      ..            .+++.....++.+++.||.|||+  ..+++||||||+||++++++.++|+|||++.....      
T Consensus        97 ~~------------~~~~~~~~~~~~~i~~~l~~LH~--~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~~~~~  162 (284)
T cd06620          97 GG------------PIPVEILGKIAVAVVEGLTYLYN--VHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTF  162 (284)
T ss_pred             cc------------CCCHHHHHHHHHHHHHHHHHHHH--hcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhccCcc
Confidence            32            38999999999999999999995  24799999999999999999999999999864321      


Q ss_pred             ----CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          539 ----DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       539 ----~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                          ...+||....  ..++.++|||||||++|||++|+.||....
T Consensus       163 ~~~~~~~aPE~~~~--~~~~~~~Di~slG~~l~~l~tg~~p~~~~~  206 (284)
T cd06620         163 VGTSTYMSPERIQG--GKYTVKSDVWSLGISIIELALGKFPFAFSN  206 (284)
T ss_pred             ccCcccCCHHHHcc--CCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence                1234665443  356778999999999999999999997544

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=99.93  E-value=3.7e-25  Score=233.61  Aligned_cols=170  Identities=19%  Similarity=0.319  Sum_probs=138.2

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEeccC-----CceEEEEeecCCCCH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTDG-----PHSFLVFEYAKNGSL  458 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~-----~~~~LV~Ey~~~GsL  458 (600)
                      .|.||++..  .++.||||++...     ....+.+|+..+..++||||+++++++....     ...++||||+++ +|
T Consensus        30 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l  108 (355)
T cd07874          30 QGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NL  108 (355)
T ss_pred             CEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cH
Confidence            399999987  6889999987542     2245567888889999999999999875432     246999999975 67


Q ss_pred             HHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC
Q 041830          459 KDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND  538 (600)
Q Consensus       459 ~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~  538 (600)
                      .+++..              .+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       109 ~~~~~~--------------~l~~~~~~~~~~qi~~aL~~LH---~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~  171 (355)
T cd07874         109 CQVIQM--------------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  171 (355)
T ss_pred             HHHHhh--------------cCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEECCCCCEEEeeCcccccCCC
Confidence            777642              2788999999999999999999   67999999999999999999999999999976432


Q ss_pred             C-----------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          539 D-----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       539 ~-----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                      .           ..+||....  ..++.++|||||||++|||++|+.||...+
T Consensus       172 ~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~  222 (355)
T cd07874         172 SFMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRD  222 (355)
T ss_pred             ccccCCccccCCccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            2           234565543  356788999999999999999999997543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.93  E-value=5.9e-25  Score=218.62  Aligned_cols=169  Identities=21%  Similarity=0.268  Sum_probs=137.6

Q ss_pred             eeEEEEEEEE--CCeEEEEEEcchhHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcC
Q 041830          390 IEGAVYHGRL--NGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLA  467 (600)
Q Consensus       390 ~~G~Vy~g~~--~g~~vAvK~~~~~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~  467 (600)
                      ..|.||+++.  +|+.+|+|+++...  ....|...+....||||+++++++... ...+++|||+++|+|.+++.... 
T Consensus         5 ~~~~v~~~~~~~~~~~~~~K~i~~~~--~~~~~~~~~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~-   80 (237)
T cd05576           5 VIDKVLLVMDTRTQQTFILKGLRKSS--EYSRERLTIIPHCVPNMVCLHKYIVSE-DSVFLVLQHAEGGKLWSHISKFL-   80 (237)
T ss_pred             ccceEEEEEEccCCcEEEEEeecchh--hhhhHHHHHHhcCCCceeehhhheecC-CeEEEEEecCCCCCHHHHHHHhc-
Confidence            3488999988  78999999987653  223444555566799999999997655 58899999999999999986532 


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--------
Q 041830          468 MKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--------  539 (600)
Q Consensus       468 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--------  539 (600)
                                 .+++.++..++.|++.||.|||   +.+++||||||+||+++.++.++++|||++......        
T Consensus        81 -----------~l~~~~~~~~~~ql~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~~~~~~~~  146 (237)
T cd05576          81 -----------NIPEECVKRWAAEMVVALDALH---REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSCDGEAVEN  146 (237)
T ss_pred             -----------CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEEcCCCCEEEecccchhccccccccCCcCc
Confidence                       3899999999999999999999   679999999999999999999999999987544321        


Q ss_pred             -CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          540 -TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       540 -~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                       ..+||....  ..++.++||||+|+++|||++|+.||..
T Consensus       147 ~y~aPE~~~~--~~~~~~~DvwslG~il~el~~g~~~~~~  184 (237)
T cd05576         147 MYCAPEVGGI--SEETEACDWWSLGAILFELLTGKTLVEC  184 (237)
T ss_pred             cccCCcccCC--CCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence             235555433  3456789999999999999999988754

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=99.93  E-value=5.3e-25  Score=229.89  Aligned_cols=176  Identities=20%  Similarity=0.301  Sum_probs=143.5

Q ss_pred             eeEEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          390 IEGAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       390 ~~G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      ..|.||+++.  +|+.||+|.+..+     ..+.+++|+..+..++||||+++++++... ...++|+||+.+|+|.+++
T Consensus        12 ~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~~v~e~~~~~~l~~~l   90 (328)
T cd08226          12 NLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTG-SWLWVISPFMAYGSANSLL   90 (328)
T ss_pred             CceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecC-CceEEEEecccCCCHHHHH
Confidence            3489999988  7999999986532     235677888888889999999999998655 4889999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC-----
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN-----  537 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~-----  537 (600)
                      .....          ..+++..+..++.|++.||+|||   +.+++||||||+|||++.++.+|++||+......     
T Consensus        91 ~~~~~----------~~~~~~~~~~~~~qi~~aL~~lH---~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~  157 (328)
T cd08226          91 KTYFP----------EGMSEALIGNILFGALRGLNYLH---QNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQK  157 (328)
T ss_pred             Hhhcc----------cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcc
Confidence            76432          23889999999999999999999   6799999999999999999999999997532110     


Q ss_pred             --------------CCCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          538 --------------DDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       538 --------------~~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                    ..+.+||........++.++|||||||++|||++|+.||...
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~  213 (328)
T cd08226         158 AKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM  213 (328)
T ss_pred             ccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence                          113456665443345678899999999999999999999754

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=99.93  E-value=3.3e-25  Score=227.74  Aligned_cols=172  Identities=22%  Similarity=0.349  Sum_probs=141.0

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH--------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV--------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~--------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      .|.||+|..  +|+.||||.++...        ...+..|+..+..++|+||+++++++..+ +..++||||+ +|+|.+
T Consensus        13 ~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~lv~e~~-~~~L~~   90 (298)
T cd07841          13 YAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHK-SNINLVFEFM-ETDLEK   90 (298)
T ss_pred             ccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecC-CEEEEEEccc-CCCHHH
Confidence            389999987  68899999976432        12456788889999999999999998664 5889999999 899999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-  539 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-  539 (600)
                      +++...           ..+++.+++.++.||++||.|||   +.+++|+||||+||+++.++.+||+|||+++..... 
T Consensus        91 ~i~~~~-----------~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  156 (298)
T cd07841          91 VIKDKS-----------IVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN  156 (298)
T ss_pred             HHhccC-----------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence            997543           13899999999999999999999   679999999999999999999999999998765432 


Q ss_pred             -----------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 -----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 -----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                 ..+||.... ...++.++|||||||++|||++|.+||...
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slG~il~e~~~g~~~~~~~  206 (298)
T cd07841         157 RKMTHQVVTRWYRAPELLFG-ARHYGVGVDMWSVGCIFAELLLRVPFLPGD  206 (298)
T ss_pred             ccccccccceeeeCHHHHhC-CCCCCcHHHHHHHHHHHHHHHcCCccccCC
Confidence                       123444322 234577899999999999999998877643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=99.93  E-value=5.7e-25  Score=221.47  Aligned_cols=172  Identities=23%  Similarity=0.468  Sum_probs=139.9

Q ss_pred             eEEEEEEEE-CCeEEEEEEcchhH--HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcC
Q 041830          391 EGAVYHGRL-NGKNLAIKRTEHEV--ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLA  467 (600)
Q Consensus       391 ~G~Vy~g~~-~g~~vAvK~~~~~~--~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~  467 (600)
                      .|.||++.. .+..+|+|....+.  ...+..|+..+..++|+|++++++++ .. ...+++|||+++|+|.++++....
T Consensus        19 ~~~v~~~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~-~~~~~v~e~~~~~~L~~~~~~~~~   96 (260)
T cd05069          19 FGEVWMGTWNGTTKVAIKTLKPGTMMPEAFLQEAQIMKKLRHDKLVPLYAVV-SE-EPIYIVTEFMGKGSLLDFLKEGDG   96 (260)
T ss_pred             CCeEEEEEEcCCceEEEEEcccCCccHHHHHHHHHHHHhCCCCCeeeEEEEE-cC-CCcEEEEEcCCCCCHHHHHhhCCC
Confidence            489999988 44579999876432  24567889999999999999999986 33 367999999999999999975432


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--------
Q 041830          468 MKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--------  539 (600)
Q Consensus       468 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--------  539 (600)
                                ..++|..+..++.+++.||+|||   +.+++||||||+||++++++.+||+|||+++.....        
T Consensus        97 ----------~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~~~  163 (260)
T cd05069          97 ----------KYLKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGA  163 (260)
T ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccccCCC
Confidence                      34899999999999999999999   668999999999999999999999999998754321        


Q ss_pred             -----CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          540 -----TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       540 -----~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                           ..+||....  ...+.++||||||+++|||++ |+.||...
T Consensus       164 ~~~~~y~~Pe~~~~--~~~~~~~Di~slG~~l~el~t~g~~p~~~~  207 (260)
T cd05069         164 KFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELVTKGRVPYPGM  207 (260)
T ss_pred             ccchhhCCHHHhcc--CCcChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                 123443322  345778999999999999999 99999754

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.93  E-value=6.6e-26  Score=239.35  Aligned_cols=181  Identities=20%  Similarity=0.426  Sum_probs=145.9

Q ss_pred             CCceeEEEEEEEE--CCeEEEEEEcch-------hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCC-ceEEEEeecCCC
Q 041830          387 SNRIEGAVYHGRL--NGKNLAIKRTEH-------EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGP-HSFLVFEYAKNG  456 (600)
Q Consensus       387 ~~~~~G~Vy~g~~--~g~~vAvK~~~~-------~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~-~~~LV~Ey~~~G  456 (600)
                      +.|..-+||+|-.  +|..||--.++.       +..+++-.|+.+++.+.|||||+++.++++..+ .+-+|+|.|..|
T Consensus        49 GrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSG  128 (632)
T KOG0584|consen   49 GRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSG  128 (632)
T ss_pred             ccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCC
Confidence            4444578999987  677776432221       223567889999999999999999999775432 467999999999


Q ss_pred             CHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC-CcEEEEeccCccc
Q 041830          457 SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEE-FNARVGNFGMARC  535 (600)
Q Consensus       457 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~-~~~kI~DFGla~~  535 (600)
                      +|+.|+++.+.            ++.+....+++||++||.|||+. .++|+|||||.+||+|+.+ |.+||+|+|||..
T Consensus       129 tLr~Y~kk~~~------------vn~kaik~W~RQILkGL~yLHs~-~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl  195 (632)
T KOG0584|consen  129 TLREYRKKHRR------------VNIKAIKSWCRQILKGLVYLHSQ-DPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATL  195 (632)
T ss_pred             cHHHHHHHhcc------------CCHHHHHHHHHHHHHHhhhhhcC-CCCccccccccceEEEcCCcCceeecchhHHHH
Confidence            99999987653            77889999999999999999987 8999999999999999765 8999999999976


Q ss_pred             cCCCC-----CCCcccccC--CCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          536 VNDDT-----ESPQFYSTN--PASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       536 ~~~~~-----~~pe~~~~~--~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                      .....     ..||++.++  ...|+..+||||||+.|+||+|+..||....
T Consensus       196 ~r~s~aksvIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~  247 (632)
T KOG0584|consen  196 LRKSHAKSVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECT  247 (632)
T ss_pred             hhccccceeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhC
Confidence            54332     234544442  2568899999999999999999999997654

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=99.93  E-value=8.3e-25  Score=220.04  Aligned_cols=173  Identities=24%  Similarity=0.496  Sum_probs=143.3

Q ss_pred             eEEEEEEEE-CCeEEEEEEcchhH--HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcC
Q 041830          391 EGAVYHGRL-NGKNLAIKRTEHEV--ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLA  467 (600)
Q Consensus       391 ~G~Vy~g~~-~g~~vAvK~~~~~~--~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~  467 (600)
                      .|.||++.. +++.+|||.++...  ...+..|+..+..++|+||+++++++..+ ...+++|||+++++|.++++....
T Consensus        19 ~~~v~~~~~~~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~i~~~~~   97 (261)
T cd05034          19 FGEVWMGTWNGTTKVAVKTLKPGTMSPEAFLQEAQIMKKLRHDKLVQLYAVCSEE-EPIYIVTEYMSKGSLLDFLKSGEG   97 (261)
T ss_pred             ceEEEEEEEcCCceEEEEEecCCccCHHHHHHHHHHHhhCCCCCEeeeeeeeecC-CceEEEEeccCCCCHHHHHhcccc
Confidence            389999988 55789999886532  34678899999999999999999997554 478999999999999999976432


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC---------
Q 041830          468 MKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND---------  538 (600)
Q Consensus       468 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~---------  538 (600)
                                ..+++.++..++.+++.||.|||   +.+++|+||||+||++++++.+||+|||+++....         
T Consensus        98 ----------~~~~~~~~~~~~~~i~~al~~lh---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~  164 (261)
T cd05034          98 ----------KKLRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGA  164 (261)
T ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcchheEEEcCCCCEEECccccceeccchhhhhhhcc
Confidence                      34899999999999999999999   66899999999999999999999999999875532         


Q ss_pred             ----CCCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          539 ----DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       539 ----~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                          ...+||....  ...+.++|+||||+++|||++ |+.||...
T Consensus       165 ~~~~~y~~PE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~  208 (261)
T cd05034         165 KFPIKWTAPEAANY--GRFTIKSDVWSFGILLTEIVTYGRVPYPGM  208 (261)
T ss_pred             CCCccccCHHHhcc--CCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence                1234554433  345778999999999999999 99999653

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>PHA03209 serine/threonine kinase US3; Provisional

Probab=99.93  E-value=3.9e-25  Score=233.82  Aligned_cols=166  Identities=23%  Similarity=0.385  Sum_probs=136.0

Q ss_pred             eeEEEEEEEE--CCeEEEEEEcchhHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcC
Q 041830          390 IEGAVYHGRL--NGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLA  467 (600)
Q Consensus       390 ~~G~Vy~g~~--~g~~vAvK~~~~~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~  467 (600)
                      ..|.||+++.  +++.||+|......   ...|+..+..++||||+++++++... ...++|+||+. |+|.+++.... 
T Consensus        78 ~~g~Vy~~~~~~~~~~valK~~~~~~---~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~-~~l~~~l~~~~-  151 (357)
T PHA03209         78 SEGRVFVATKPGQPDPVVLKIGQKGT---TLIEAMLLQNVNHPSVIRMKDTLVSG-AITCMVLPHYS-SDLYTYLTKRS-  151 (357)
T ss_pred             CCeEEEEEEECCCCceEEEEeCCccc---cHHHHHHHHhCCCCCCcChhheEEeC-CeeEEEEEccC-CcHHHHHHhcc-
Confidence            3499999998  56789999865432   24577788899999999999998665 47899999995 68999886532 


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC---------
Q 041830          468 MKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND---------  538 (600)
Q Consensus       468 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~---------  538 (600)
                                ..++|.+++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++....         
T Consensus       152 ----------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~g  218 (357)
T PHA03209        152 ----------RPLPIDQALIIEKQILEGLRYLH---AQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAG  218 (357)
T ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEecCccccccccCcccccccc
Confidence                      34899999999999999999999   67999999999999999999999999999874321         


Q ss_pred             --CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCC
Q 041830          539 --DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPI  576 (600)
Q Consensus       539 --~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf  576 (600)
                        .+.+||....  ..++.++|||||||++|||+++..|+
T Consensus       219 t~~y~aPE~~~~--~~~~~~~DiwSlGvvl~ell~~~~~~  256 (357)
T PHA03209        219 TVETNAPEVLAR--DKYNSKADIWSAGIVLFEMLAYPSTI  256 (357)
T ss_pred             cccccCCeecCC--CCCCchhhHHHHHHHHHHHHHcCCcc
Confidence              2235666544  45788899999999999999965554

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=99.93  E-value=7.6e-25  Score=219.42  Aligned_cols=181  Identities=27%  Similarity=0.529  Sum_probs=146.3

Q ss_pred             eeEEEEEEEEC-----CeEEEEEEcchhH----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          390 IEGAVYHGRLN-----GKNLAIKRTEHEV----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       390 ~~G~Vy~g~~~-----g~~vAvK~~~~~~----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      ..|.||++...     +..|++|.++...    ...+..|+..+..++|+||+++++++... ...+++|||+++|+|.+
T Consensus         7 ~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~   85 (262)
T cd00192           7 AFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEE-EPLYLVLEYMEGGDLLD   85 (262)
T ss_pred             CceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCC-CceEEEEEeccCCcHHH
Confidence            34899999984     7789999876532    35677889999999999999999998664 58899999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-  539 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-  539 (600)
                      ++.......   .......+++.++..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||.++..... 
T Consensus        86 ~l~~~~~~~---~~~~~~~~~~~~~~~~~~~l~~al~~lH---~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  159 (262)
T cd00192          86 YLRKSRPVF---PSPEKSTLSLKDLLSFAIQIAKGMEYLA---SKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD  159 (262)
T ss_pred             HHhhccccc---cccccccCCHHHHHHHHHHHHHHHHHHH---cCCcccCccCcceEEECCCCcEEEccccccccccccc
Confidence            997652100   0000134899999999999999999999   779999999999999999999999999999765432 


Q ss_pred             -------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          540 -------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       540 -------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                                   ..+||....  ..++.++||||||+++|||++ |+.||...
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~  211 (262)
T cd00192         160 YYRKKTGGKLPIRWMAPESLKD--GIFTSKSDVWSFGVLLWEIFTLGATPYPGL  211 (262)
T ss_pred             ccccccCCCcCccccCHHHhcc--CCcchhhccHHHHHHHHHHHhcCCCCCCCC
Confidence                         124554443  256788999999999999999 69999754

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=6.3e-25  Score=227.77  Aligned_cols=173  Identities=26%  Similarity=0.375  Sum_probs=142.2

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh------HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE------VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~------~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||++..  +++.||+|.+..+      ....+..|+..+..+.|+||+++++.+... ...++||||+++++|.+++
T Consensus        14 ~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~   92 (316)
T cd05574          14 VGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTE-TYLCLVMDYCPGGELFRLL   92 (316)
T ss_pred             cEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecC-CEEEEEEEecCCCCHHHHH
Confidence            389999988  5799999987542      224567888899999999999999997554 5889999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC---
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---  539 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~---  539 (600)
                      .....          ..+++..+..++.|++.||+|||   +.+++||||||+||+++.++.++|+|||++......   
T Consensus        93 ~~~~~----------~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~  159 (316)
T cd05574          93 QRQPG----------KCLSEEVARFYAAEVLLALEYLH---LLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP  159 (316)
T ss_pred             HhCCC----------CccCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccc
Confidence            75431          24899999999999999999999   679999999999999999999999999997644211   


Q ss_pred             --------------------------------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 --------------------------------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 --------------------------------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                                            +.+||....  ..++.++||||||+++|||++|+.||...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~--~~~~~~~Di~slG~ll~~l~~g~~pf~~~  235 (316)
T cd05574         160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG--DGHGSAVDWWTLGILLYEMLYGTTPFKGS  235 (316)
T ss_pred             cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcC--CCCCchHHHHHHHHHHHHHhhCCCCCCCC
Confidence                                                  123444332  34577899999999999999999999654

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=99.93  E-value=6.5e-25  Score=219.97  Aligned_cols=172  Identities=27%  Similarity=0.464  Sum_probs=142.6

Q ss_pred             eEEEEEEEE--CCeEEEEEEcch--------hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEH--------EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~--------~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      .|.||+|..  +++.|++|.+..        +..+.+..|+..+..++|+||+++++++..+ ...++++||+++++|.+
T Consensus        13 ~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~   91 (258)
T cd06632          13 FGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREE-DNLYIFLELVPGGSLAK   91 (258)
T ss_pred             CceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecC-CeEEEEEEecCCCcHHH
Confidence            389999988  688999998643        1335678899999999999999999997655 48899999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCCC
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDT  540 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~~  540 (600)
                      +++...            .+++.++..++.|++.||+|||   +.+++|+||+|+||+++.++.+||+|||++.......
T Consensus        92 ~~~~~~------------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~  156 (258)
T cd06632          92 LLKKYG------------SFPEPVIRLYTRQILLGLEYLH---DRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS  156 (258)
T ss_pred             HHHhcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEccCccceeccccc
Confidence            997542            3889999999999999999999   6699999999999999999999999999987543221


Q ss_pred             -----------CCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          541 -----------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       541 -----------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                 .+||...... .++.++|+||||+++|||++|+.||...
T Consensus       157 ~~~~~~~~~~y~~pe~~~~~~-~~~~~~D~~slG~~l~~l~~g~~pf~~~  205 (258)
T cd06632         157 FAKSFKGSPYWMAPEVIAQQG-GYGLAADIWSLGCTVLEMATGKPPWSQL  205 (258)
T ss_pred             cccccCCCcceeCHHHhcCCC-CCCchhhhHHHHHHHHHHHhCCCCcccC
Confidence                       2344443321 3677899999999999999999999654

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=99.93  E-value=5e-25  Score=221.43  Aligned_cols=172  Identities=23%  Similarity=0.362  Sum_probs=144.5

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh------HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE------VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~------~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||+++.  +|+.||+|.+...      ..+.+..|+..+..++||||+++++.+... ...++|+||+++++|.+++
T Consensus        13 ~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l   91 (258)
T cd05578          13 FGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDE-ENMYLVVDLLLGGDLRYHL   91 (258)
T ss_pred             CceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCC-CeEEEEEeCCCCCCHHHHH
Confidence            389999998  5899999987642      234677889999999999999999987544 5899999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC---
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---  539 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~---  539 (600)
                      ....            .+++.++..++.|++.||.|||   +.+++|+||+|+||++++++.++|+|||++......   
T Consensus        92 ~~~~------------~l~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  156 (258)
T cd05578          92 SQKV------------KFSEEQVKFWICEIVLALEYLH---SKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLT  156 (258)
T ss_pred             HhcC------------CcCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCccc
Confidence            7542            3889999999999999999999   668999999999999999999999999998754332   


Q ss_pred             --------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 --------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 --------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                              ..+||....  ..++.++|+||||+++|||++|+.||...+
T Consensus       157 ~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  203 (258)
T cd05578         157 TSTSGTPGYMAPEVLCR--QGYSVAVDWWSLGVTAYECLRGKRPYRGHS  203 (258)
T ss_pred             cccCCChhhcCHHHHcc--cCCCCcccchhhHHHHHHHHhCCCCCCCCC
Confidence                    124555443  336788999999999999999999998654

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=99.93  E-value=6.4e-25  Score=222.88  Aligned_cols=180  Identities=22%  Similarity=0.426  Sum_probs=141.7

Q ss_pred             eEEEEEEEEC-------CeEEEEEEcchhH----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHH
Q 041830          391 EGAVYHGRLN-------GKNLAIKRTEHEV----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       391 ~G~Vy~g~~~-------g~~vAvK~~~~~~----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~  459 (600)
                      .|.||+|...       +..||+|.+....    ...+.+|+..+..+.||||++++|++... ...++||||+++|+|.
T Consensus        19 ~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~   97 (277)
T cd05032          19 FGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTG-QPTLVVMELMAKGDLK   97 (277)
T ss_pred             CceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCC-CCcEEEEecCCCCCHH
Confidence            3899999873       2679999975332    23566788888899999999999997655 4789999999999999


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD  539 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~  539 (600)
                      +++.........  ......++|.+++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++.....
T Consensus        98 ~~l~~~~~~~~~--~~~~~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~  172 (277)
T cd05032          98 SYLRSRRPEAEN--NPGLGPPTLQKFIQMAAEIADGMAYLA---AKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYET  172 (277)
T ss_pred             HHHHhcccchhh--ccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCccccccChheEEEcCCCCEEECCcccchhhccC
Confidence            999754321100  001134889999999999999999999   679999999999999999999999999998754221


Q ss_pred             --------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCC
Q 041830          540 --------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINR  578 (600)
Q Consensus       540 --------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~  578 (600)
                                    ..+||....  ..++.++|||||||++|||++ |+.||..
T Consensus       173 ~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~  224 (277)
T cd05032         173 DYYRKGGKGLLPVRWMAPESLKD--GVFTTKSDVWSFGVVLWEMATLAEQPYQG  224 (277)
T ss_pred             cccccCCCCCccccccCHHHHhc--CCCCcccchHHHHHHHHHhhccCCCCCcc
Confidence                          224554432  346788999999999999998 9999864

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=99.93  E-value=6.3e-25  Score=225.09  Aligned_cols=184  Identities=22%  Similarity=0.428  Sum_probs=142.4

Q ss_pred             eeEEEEEEEEC-------CeEEEEEEcchhH----HHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCC
Q 041830          390 IEGAVYHGRLN-------GKNLAIKRTEHEV----ITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGS  457 (600)
Q Consensus       390 ~~G~Vy~g~~~-------g~~vAvK~~~~~~----~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~Gs  457 (600)
                      ..|.||++...       ...+|+|.+..+.    ...+..|+..+..+ +|+||+++++++..++ ..+++|||+++|+
T Consensus        24 ~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~-~~~li~e~~~~~~  102 (293)
T cd05053          24 AFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG-PLYVVVEYAAHGN  102 (293)
T ss_pred             ccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC-CeEEEEEeCCCCc
Confidence            34899999873       2579999876422    23466788888888 7999999999986654 7899999999999


Q ss_pred             HHHHHhcCcCccccc----ccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCc
Q 041830          458 LKDWLHGGLAMKNQF----IASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA  533 (600)
Q Consensus       458 L~~~L~~~~~~~~~~----~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla  533 (600)
                      |.++++.........    .......+++.+++.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||++
T Consensus       103 L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~  179 (293)
T cd05053         103 LRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLA---SKKCIHRDLAARNVLVTEDHVMKIADFGLA  179 (293)
T ss_pred             HHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHH---HCCccccccceeeEEEcCCCeEEeCccccc
Confidence            999997543110000    0011245899999999999999999999   679999999999999999999999999998


Q ss_pred             cccCCC--------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          534 RCVNDD--------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       534 ~~~~~~--------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                      +.....              +.+||....  ..++.++|||||||++|||++ |..||...
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~  238 (293)
T cd05053         180 RDIHHIDYYRKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLLWEIFTLGGSPYPGI  238 (293)
T ss_pred             cccccccceeccCCCCCCccccCHHHhcc--CCcCcccceeehhhHHHHHhcCCCCCCCCC
Confidence            754321              224554433  356788999999999999998 99998653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.93  E-value=1.5e-25  Score=236.42  Aligned_cols=175  Identities=27%  Similarity=0.454  Sum_probs=147.1

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH-----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV-----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~-----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      ++.|..++.  +|..||||.+++..     ..++-+|+.+|+.+.|||||+++.+...+ ..+|+||||+.+|.+++||.
T Consensus        69 f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~-~~lylV~eya~~ge~~~yl~  147 (596)
T KOG0586|consen   69 FAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETE-ATLYLVMEYASGGELFDYLV  147 (596)
T ss_pred             eEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeec-ceeEEEEEeccCchhHHHHH
Confidence            388999987  89999999876532     34578999999999999999999997655 48999999999999999998


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD----  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~----  539 (600)
                      .+..            ..+.....+..|+.++++|+|   ++.|+|||||.+||||+.+..+||+|||++..+...    
T Consensus       148 ~~gr------------~~e~~ar~~F~q~vsaveYcH---~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~lq  212 (596)
T KOG0586|consen  148 KHGR------------MKEKEARAKFRQIVSAVEYCH---SKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLMLQ  212 (596)
T ss_pred             hccc------------chhhhhhhhhHHHHHHHHHHh---hcceeccccchhhcccccccceeeeccccceeeccccccc
Confidence            7654            445777788999999999999   789999999999999999999999999998765422    


Q ss_pred             -------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCCCC
Q 041830          540 -------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRKK  582 (600)
Q Consensus       540 -------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~~  582 (600)
                             ..+||++.+.. .-.+.+|+||+||+||-|+.|..||+..+-.
T Consensus       213 t~cgsppyAaPEl~~g~~-y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk  261 (596)
T KOG0586|consen  213 TFCGSPPYAAPELFNGKK-YDGPEVDIWSLGVVLYALVEGSLPFDGQNLK  261 (596)
T ss_pred             ccCCCCCccChHhhcCcc-cCCcceehhhhhhhheeeeecccccCCcccc
Confidence                   23566666543 3467899999999999999999999875533

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=99.93  E-value=5.3e-25  Score=225.39  Aligned_cols=173  Identities=23%  Similarity=0.340  Sum_probs=140.6

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      .|.||+|..  +|+.||+|.+....    ...+..|+..+..++|+||+++++++..+ ...++||||++ ++|.+++..
T Consensus        18 ~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~-~~L~~~~~~   95 (291)
T cd07844          18 YATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTK-KTLTLVFEYLD-TDLKQYMDD   95 (291)
T ss_pred             CeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecC-CeEEEEEecCC-CCHHHHHHh
Confidence            389999987  68899999875432    12346788999999999999999997654 58999999998 499999875


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC------
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND------  538 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~------  538 (600)
                      ..           ..+++.+...++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++....      
T Consensus        96 ~~-----------~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  161 (291)
T cd07844          96 CG-----------GGLSMHNVRLFLFQLLRGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYS  161 (291)
T ss_pred             CC-----------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcccc
Confidence            43           23889999999999999999999   67999999999999999999999999999864321      


Q ss_pred             ------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          539 ------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       539 ------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                            ...+||.... ...++.++||||||+++|||++|+.||....
T Consensus       162 ~~~~~~~~~aPE~~~~-~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~  208 (291)
T cd07844         162 NEVVTLWYRPPDVLLG-STEYSTSLDMWGVGCIFYEMATGRPLFPGST  208 (291)
T ss_pred             ccccccccCCcHHhhc-CcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence                  1224554432 1345778999999999999999999996543

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=99.93  E-value=9.3e-25  Score=218.37  Aligned_cols=172  Identities=28%  Similarity=0.511  Sum_probs=142.8

Q ss_pred             eEEEEEEEE-CCeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcC
Q 041830          391 EGAVYHGRL-NGKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGG  465 (600)
Q Consensus       391 ~G~Vy~g~~-~g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~  465 (600)
                      .|.||++.. +++.||+|..+..    ....+..|+..+..+.|+||+++++++... ...++||||+++++|.++++..
T Consensus         8 ~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e~~~~~~l~~~l~~~   86 (251)
T cd05041           8 FGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQK-QPIYIVMELVPGGSLLTFLRKK   86 (251)
T ss_pred             CceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecC-CCeEEEEEcCCCCcHHHHHHhc
Confidence            489999998 4899999986542    234677888999999999999999998665 4789999999999999999754


Q ss_pred             cCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC-------
Q 041830          466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND-------  538 (600)
Q Consensus       466 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~-------  538 (600)
                      .           ..+++..++.++.+++.||.|||   +.+++||||||+||+++.++.+||+|||+++....       
T Consensus        87 ~-----------~~~~~~~~~~~~~~~~~~l~~lH---~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~  152 (251)
T cd05041          87 K-----------NRLTVKKLLQMSLDAAAGMEYLE---SKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSD  152 (251)
T ss_pred             C-----------CCCCHHHHHHHHHHHHHHHHHHH---hCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecc
Confidence            3           23789999999999999999999   67999999999999999999999999999875431       


Q ss_pred             -------CCCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          539 -------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       539 -------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                             ...+||....  ..++.++|+|||||++|||+| |..||...
T Consensus       153 ~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~i~~~l~t~~~~p~~~~  199 (251)
T cd05041         153 GLKQIPIKWTAPEALNY--GRYTSESDVWSYGILLWETFSLGDTPYPGM  199 (251)
T ss_pred             ccCcceeccCChHhhcc--CCCCcchhHHHHHHHHHHHHhccCCCCccC
Confidence                   1234554433  346788999999999999999 88888653

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=1.1e-24  Score=219.10  Aligned_cols=171  Identities=21%  Similarity=0.324  Sum_probs=136.8

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhHH------HHHHHHH-HHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEVI------TKLEMQL-VQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~~------~~~e~ei-~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      .|.||++..  +|+.||+|.++....      ..+..|. .......|+|++++++++..+ +..|+|+||+++|+|.++
T Consensus         9 ~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~   87 (260)
T cd05611           9 FGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSK-DYLYLVMEYLNGGDCASL   87 (260)
T ss_pred             CeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcC-CeEEEEEeccCCCCHHHH
Confidence            489999988  688999998764221      1122232 233455799999999997654 589999999999999999


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC---
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND---  538 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~---  538 (600)
                      ++...            .+++.++..++.|++.||.|||   +.+++||||+|+||+++.++.+||+|||+++....   
T Consensus        88 l~~~~------------~~~~~~~~~i~~qi~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  152 (260)
T cd05611          88 IKTLG------------GLPEDWAKQYIAEVVLGVEDLH---QRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKK  152 (260)
T ss_pred             HHHcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCcEEEeecccceecccccc
Confidence            97542            3889999999999999999999   67999999999999999999999999999875422   


Q ss_pred             -----CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 -----DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 -----~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                           ...+||....  ..++.++||||||+++|||++|+.||...
T Consensus       153 ~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~  196 (260)
T cd05611         153 FVGTPDYLAPETILG--VGDDKMSDWWSLGCVIFEFLFGYPPFHAE  196 (260)
T ss_pred             CCCCcCccChhhhcC--CCCcchhhhHHHHHHHHHHHHCCCCCCCC
Confidence                 2235665543  23678899999999999999999999653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.93  E-value=8.1e-25  Score=223.81  Aligned_cols=182  Identities=27%  Similarity=0.466  Sum_probs=142.6

Q ss_pred             eEEEEEEEE-------CCeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHH
Q 041830          391 EGAVYHGRL-------NGKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       391 ~G~Vy~g~~-------~g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~  459 (600)
                      .|.||+++.       ++..||+|.++..    ....+..|+..+..++||||+++++++..+ ...+++|||+++|+|.
T Consensus        18 ~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~   96 (288)
T cd05050          18 FGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVG-KPMCLLFEYMAYGDLN   96 (288)
T ss_pred             cccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-CccEEEEecCCCCCHH
Confidence            489999986       3578999987643    234577899999999999999999997654 4789999999999999


Q ss_pred             HHHhcCcCccccc----------ccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEe
Q 041830          460 DWLHGGLAMKNQF----------IASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGN  529 (600)
Q Consensus       460 ~~L~~~~~~~~~~----------~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~D  529 (600)
                      ++++.........          .......+++.+++.++.|++.||.|||   +.+++||||||+||++++++.+||+|
T Consensus        97 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~d  173 (288)
T cd05050          97 EFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIAD  173 (288)
T ss_pred             HHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCeecccccHhheEecCCCceEECc
Confidence            9997543211100          0011234899999999999999999999   67999999999999999999999999


Q ss_pred             ccCccccCCC--------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCC
Q 041830          530 FGMARCVNDD--------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINR  578 (600)
Q Consensus       530 FGla~~~~~~--------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~  578 (600)
                      ||+++.....              ..+||....  ..++.++|||||||++|||++ |..||..
T Consensus       174 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~~~~~p~~~  235 (288)
T cd05050         174 FGLSRNIYSADYYKASENDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGMQPYYG  235 (288)
T ss_pred             cccceecccCccccccCCCccChhhcCHHHHhc--CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            9998753211              223444332  456788999999999999998 8889854

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=99.93  E-value=9.4e-25  Score=221.77  Aligned_cols=171  Identities=26%  Similarity=0.520  Sum_probs=141.1

Q ss_pred             eEEEEEEEE--CCeEEEEEEcch----hHHHHHHHHHHHHHhCC---CCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEH----EVITKLEMQLVQHATHH---HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~----~~~~~~e~ei~~~~~l~---HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      .|.||+|..  +|+.||+|.++.    .....+++|+..+..++   |||++++++++... ...++||||+++++|.++
T Consensus        14 ~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~-~~~~lv~e~~~~~~L~~~   92 (277)
T cd06917          14 YGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKG-PRLWIIMEYAEGGSVRTL   92 (277)
T ss_pred             CceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeC-CEEEEEEecCCCCcHHHH
Confidence            389999998  688999998753    22345677888777776   99999999997654 488999999999999999


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCCC-
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDT-  540 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~~-  540 (600)
                      ++..             .+++...+.++.+++.||.|||   +.+++||||+|+||++++++.++|+|||++....... 
T Consensus        93 ~~~~-------------~l~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  156 (277)
T cd06917          93 MKAG-------------PIAEKYISVIIREVLVALKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS  156 (277)
T ss_pred             HHcc-------------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc
Confidence            8643             2899999999999999999999   6799999999999999999999999999987553321 


Q ss_pred             -----------CCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          541 -----------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       541 -----------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                 .+||.... ...++.++|||||||++|||++|+.||...
T Consensus       157 ~~~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~  205 (277)
T cd06917         157 KRSTFVGTPYWMAPEVITE-GKYYDTKADIWSLGITIYEMATGNPPYSDV  205 (277)
T ss_pred             ccccccCCcceeCHHHhcc-CCccccchhHHHHHHHHHHHHhCCCCCCCC
Confidence                       23554322 234577899999999999999999999654

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=99.93  E-value=7.9e-25  Score=226.26  Aligned_cols=182  Identities=22%  Similarity=0.435  Sum_probs=140.5

Q ss_pred             eEEEEEEEEC---------CeEEEEEEcchh----HHHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCC
Q 041830          391 EGAVYHGRLN---------GKNLAIKRTEHE----VITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNG  456 (600)
Q Consensus       391 ~G~Vy~g~~~---------g~~vAvK~~~~~----~~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~G  456 (600)
                      .|.||+++..         +..+|+|.++.+    ....+..|+..+..+ +||||++++++|...+ ..|+||||+++|
T Consensus        31 ~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~-~~~lv~e~~~~~  109 (307)
T cd05098          31 FGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG-PLYVIVEYASKG  109 (307)
T ss_pred             CeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC-ceEEEEecCCCC
Confidence            3899999762         246999998643    223466788888888 7999999999986654 889999999999


Q ss_pred             CHHHHHhcCcCcccc----cccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccC
Q 041830          457 SLKDWLHGGLAMKNQ----FIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGM  532 (600)
Q Consensus       457 sL~~~L~~~~~~~~~----~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGl  532 (600)
                      +|.++++........    ........++|.++++++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+
T Consensus       110 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~  186 (307)
T cd05098         110 NLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGL  186 (307)
T ss_pred             cHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCcccccccHHheEEcCCCcEEECCCcc
Confidence            999999764321000    00001134899999999999999999999   67999999999999999999999999999


Q ss_pred             ccccCC--------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCC
Q 041830          533 ARCVND--------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINR  578 (600)
Q Consensus       533 a~~~~~--------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~  578 (600)
                      ++....              .+.+||....  ..++.++|||||||++|||++ |+.||..
T Consensus       187 a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~~~g~~p~~~  245 (307)
T cd05098         187 ARDIHHIDYYKKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPG  245 (307)
T ss_pred             cccccccchhhccccCCCccceeChHHhcc--CCCCcHHHHHHHHHHHHHHHcCCCCCCCc
Confidence            874421              1234444432  346778999999999999998 8888864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=99.93  E-value=8.9e-25  Score=223.71  Aligned_cols=180  Identities=22%  Similarity=0.417  Sum_probs=138.8

Q ss_pred             eEEEEEEEEC-------CeEEEEEEcchhH----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHH
Q 041830          391 EGAVYHGRLN-------GKNLAIKRTEHEV----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       391 ~G~Vy~g~~~-------g~~vAvK~~~~~~----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~  459 (600)
                      .|.||+|...       +..||+|.++...    ...+..|+..+..++||||+++++++... ...++||||+++|+|.
T Consensus        19 ~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~g~L~   97 (288)
T cd05061          19 FGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKG-QPTLVVMELMAHGDLK   97 (288)
T ss_pred             CcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC-CCcEEEEeCCCCCCHH
Confidence            3899999752       4579999865322    22456788888899999999999997554 4789999999999999


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC-
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND-  538 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~-  538 (600)
                      ++++.........  .....+++..+..++.|++.||.|||   +++++||||||+||++++++.+||+|||+++.... 
T Consensus        98 ~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~  172 (288)
T cd05061          98 SYLRSLRPEAENN--PGRPPPTLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYET  172 (288)
T ss_pred             HHHHHhccccccC--CCCCCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCCChheEEEcCCCcEEECcCCcccccccc
Confidence            9997533210000  01134678889999999999999999   77999999999999999999999999999874321 


Q ss_pred             -------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCC
Q 041830          539 -------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINR  578 (600)
Q Consensus       539 -------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~  578 (600)
                                   ...+||....  ..++.++|||||||++|||++ |+.||..
T Consensus       173 ~~~~~~~~~~~~~~y~~pE~~~~--~~~~~~~DvwslG~~l~el~~~~~~p~~~  224 (288)
T cd05061         173 DYYRKGGKGLLPVRWMAPESLKD--GVFTTSSDMWSFGVVLWEITSLAEQPYQG  224 (288)
T ss_pred             ccccccCCCcccccccCHHHhcc--CCCChHhHHHHHHHHHHHHHhCCCCCCCC
Confidence                         1223444332  345778999999999999998 7889865

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.93  E-value=4.2e-25  Score=222.29  Aligned_cols=173  Identities=21%  Similarity=0.372  Sum_probs=136.8

Q ss_pred             eeEEEEEEEEC---------CeEEEEEEcchhH---HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCC
Q 041830          390 IEGAVYHGRLN---------GKNLAIKRTEHEV---ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGS  457 (600)
Q Consensus       390 ~~G~Vy~g~~~---------g~~vAvK~~~~~~---~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~Gs  457 (600)
                      .+|.||+|...         ...+++|.+....   .+.+..|...+..++||||+++++++..+ ...++||||+++|+
T Consensus         7 ~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~-~~~~lv~e~~~~g~   85 (258)
T cd05078           7 TFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCG-DESIMVQEYVKFGS   85 (258)
T ss_pred             cchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeC-CCcEEEEecCCCCc
Confidence            34899999762         2348888875433   23566788888889999999999998765 47899999999999


Q ss_pred             HHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCc--------EEEEe
Q 041830          458 LKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFN--------ARVGN  529 (600)
Q Consensus       458 L~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~--------~kI~D  529 (600)
                      |.++++...           ..++|..++.++.||+.||+|||   +.+|+||||||+||+++.++.        +|++|
T Consensus        86 L~~~l~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH---~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d  151 (258)
T cd05078          86 LDTYLKKNK-----------NLINISWKLEVAKQLAWALHFLE---DKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSD  151 (258)
T ss_pred             HHHHHhcCC-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEecccccccCCCceEEecc
Confidence            999997643           23899999999999999999999   679999999999999987665        69999


Q ss_pred             ccCccccCC--------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCC-CCCCC
Q 041830          530 FGMARCVND--------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQ-TPINR  578 (600)
Q Consensus       530 FGla~~~~~--------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~-~Pf~~  578 (600)
                      ||++.....        ...+||.... ...++.++|||||||++|||++|. .||..
T Consensus       152 ~g~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~~l~~l~~g~~~~~~~  208 (258)
T cd05078         152 PGISITVLPKEILLERIPWVPPECIEN-PQNLSLAADKWSFGTTLWEIFSGGDKPLSA  208 (258)
T ss_pred             cccccccCCchhccccCCccCchhccC-CCCCCchhhHHHHHHHHHHHHcCCCCChhh
Confidence            999864432        1235665543 234577899999999999999985 56543

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=99.93  E-value=7.9e-25  Score=224.21  Aligned_cols=172  Identities=23%  Similarity=0.318  Sum_probs=138.1

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhH----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcC
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEV----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGG  465 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~  465 (600)
                      |.||+|..  +|+.||+|.++...    ...+.+|+..+..++|+||+++++++..+ ...++|+||+. ++|.+++...
T Consensus        19 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~-~~~~lv~e~~~-~~l~~~~~~~   96 (291)
T cd07870          19 ATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTK-ETLTFVFEYMH-TDLAQYMIQH   96 (291)
T ss_pred             EEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecC-CeEEEEEeccc-CCHHHHHHhC
Confidence            89999987  68899999875432    12456788889999999999999997655 47899999996 7888877543


Q ss_pred             cCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC------
Q 041830          466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD------  539 (600)
Q Consensus       466 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~------  539 (600)
                      .           ..+++.++..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++.....      
T Consensus        97 ~-----------~~~~~~~~~~~~~qi~~~L~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  162 (291)
T cd07870          97 P-----------GGLHPYNVRLFMFQLLRGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSS  162 (291)
T ss_pred             C-----------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCC
Confidence            2           23788889999999999999999   669999999999999999999999999998753221      


Q ss_pred             ------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 ------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 ------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                            ..+||.... ...++.++|||||||++|||++|+.||...+
T Consensus       163 ~~~~~~y~aPE~~~~-~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~  208 (291)
T cd07870         163 EVVTLWYRPPDVLLG-ATDYSSALDIWGAGCIFIEMLQGQPAFPGVS  208 (291)
T ss_pred             ccccccccCCceeec-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence                  224554432 1235677899999999999999999997543

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=99.93  E-value=9.7e-25  Score=222.48  Aligned_cols=183  Identities=23%  Similarity=0.411  Sum_probs=143.2

Q ss_pred             eEEEEEEEE-------CCeEEEEEEcchh---HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          391 EGAVYHGRL-------NGKNLAIKRTEHE---VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       391 ~G~Vy~g~~-------~g~~vAvK~~~~~---~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      .|.||++..       ++..+|+|.++..   ....+..|+..+..++|+||+++++++... ...+++|||+++|+|.+
T Consensus        18 ~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~   96 (280)
T cd05092          18 FGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEG-RPLLMVFEYMRHGDLNR   96 (280)
T ss_pred             CCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecC-CceEEEEecCCCCCHHH
Confidence            389999864       3567999987542   234678889999999999999999997655 47899999999999999


Q ss_pred             HHhcCcCcccc---cccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC
Q 041830          461 WLHGGLAMKNQ---FIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN  537 (600)
Q Consensus       461 ~L~~~~~~~~~---~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~  537 (600)
                      +++........   ........+++.+++.++.|++.||+|||   +.+++||||||+|||+++++.+||+|||+++...
T Consensus        97 ~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~  173 (280)
T cd05092          97 FLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLA---SLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIY  173 (280)
T ss_pred             HHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHH---HCCeecccccHhhEEEcCCCCEEECCCCceeEcC
Confidence            99764321000   00111134899999999999999999999   6799999999999999999999999999986442


Q ss_pred             C--------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          538 D--------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       538 ~--------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                      .              ...+||....  ..++.++|||||||++|||++ |+.||...
T Consensus       174 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~  228 (280)
T cd05092         174 STDYYRVGGRTMLPIRWMPPESILY--RKFTTESDIWSFGVVLWEIFTYGKQPWYQL  228 (280)
T ss_pred             CCceeecCCCccccccccCHHHhcc--CCcCchhhHHHHHHHHHHHHcCCCCCCccC
Confidence            1              1234554433  346788999999999999998 99998543

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.93  E-value=5.7e-25  Score=223.79  Aligned_cols=173  Identities=27%  Similarity=0.502  Sum_probs=143.2

Q ss_pred             eEEEEEEEEC------CeEEEEEEcchhH----HHHHHHHHHHHHhCCCCceeeeeeEEecc-CCceEEEEeecCCCCHH
Q 041830          391 EGAVYHGRLN------GKNLAIKRTEHEV----ITKLEMQLVQHATHHHPNIVRLLGTCLTD-GPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       391 ~G~Vy~g~~~------g~~vAvK~~~~~~----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~-~~~~~LV~Ey~~~GsL~  459 (600)
                      .|.||+++++      ++.+|+|.++...    ...++.|+..+..+.|+||+++++++... +...+++|||+++|+|.
T Consensus        17 ~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~   96 (284)
T cd05038          17 FGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLR   96 (284)
T ss_pred             CeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHH
Confidence            3999999873      6789999876432    35678899999999999999999997652 33689999999999999


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD  539 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~  539 (600)
                      +++....           ..++|.+++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++......
T Consensus        97 ~~l~~~~-----------~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  162 (284)
T cd05038          97 DYLQRHR-----------DQINLKRLLLFSSQICKGMDYLG---SQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED  162 (284)
T ss_pred             HHHHhCc-----------cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence            9997643           23899999999999999999999   679999999999999999999999999999765421


Q ss_pred             ---------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 ---------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 ---------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                     ..+||....  ..++.++||||||+++|||++|+.||...
T Consensus       163 ~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Di~slG~~l~el~tg~~p~~~~  215 (284)
T cd05038         163 KDYYYVKEPGESPIFWYAPECLRT--SKFSSASDVWSFGVTLYELFTYGDPSQSP  215 (284)
T ss_pred             CcceeccCCCCCcccccCcHHHcc--CCCCcccchHHHhhhhheeeccCCCcccc
Confidence                           123444433  34567899999999999999999998654

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=99.93  E-value=6.5e-25  Score=223.79  Aligned_cols=174  Identities=22%  Similarity=0.404  Sum_probs=142.3

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH-----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV-----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~-----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      .|.||+++.  +|+.||||+++.+.     ...+..|+..+.+++||||+++++++..+ ...++||||+. ++|.+++.
T Consensus        13 ~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e~~~-~~l~~~~~   90 (284)
T cd07860          13 YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-NKLYLVFEFLH-QDLKKFMD   90 (284)
T ss_pred             ceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccC-CcEEEEeeccc-cCHHHHHH
Confidence            389999988  68899999876432     23567899999999999999999997654 58899999996 68999987


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD----  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~----  539 (600)
                      ....          ..+++.++..++.|++.||+|||   +.+++||||+|+||++++++.+||+|||+++.....    
T Consensus        91 ~~~~----------~~l~~~~~~~~~~~i~~~l~~lh---~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~  157 (284)
T cd07860          91 ASPL----------SGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY  157 (284)
T ss_pred             hCCC----------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcccc
Confidence            5432          34899999999999999999999   679999999999999999999999999998754321    


Q ss_pred             --------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 --------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 --------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                              ..+||..... ..++.++|||||||++|||+||+.||...+
T Consensus       158 ~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~il~~l~tg~~p~~~~~  205 (284)
T cd07860         158 THEVVTLWYRAPEILLGC-KYYSTAVDIWSLGCIFAEMVTRRALFPGDS  205 (284)
T ss_pred             ccccccccccCCeEEecC-CCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence                    2345654332 234677999999999999999999997543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=99.93  E-value=1.3e-24  Score=221.98  Aligned_cols=172  Identities=27%  Similarity=0.499  Sum_probs=145.2

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH--HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCc
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV--ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGL  466 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~--~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~  466 (600)
                      .|.||++..  +++.+++|.++...  ...+..|+..+..++|+||+++++.+..+ ...|+++||+++++|.+++....
T Consensus        32 ~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~  110 (286)
T cd06614          32 SGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVG-DELWVVMEYMDGGSLTDIITQNF  110 (286)
T ss_pred             CeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCCCCCeeEEEEEEEEC-CEEEEEEeccCCCcHHHHHHHhc
Confidence            389999998  48899999986543  45677889999999999999999998766 48999999999999999997643


Q ss_pred             CcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-------
Q 041830          467 AMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-------  539 (600)
Q Consensus       467 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-------  539 (600)
                                 ..+++.++..++.+++.||.|||   +.+++|+||+|+||+++.++.+||+|||++......       
T Consensus       111 -----------~~l~~~~~~~i~~~i~~~L~~lH---~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~  176 (286)
T cd06614         111 -----------VRMNEPQIAYVCREVLQGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSV  176 (286)
T ss_pred             -----------cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhhccc
Confidence                       14899999999999999999999   679999999999999999999999999987644321       


Q ss_pred             -----CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 -----TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 -----~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                           +.+||....  ..++.++|||||||++|||++|+.||...
T Consensus       177 ~~~~~y~~PE~~~~--~~~~~~~Dv~slGvil~~l~~g~~p~~~~  219 (286)
T cd06614         177 VGTPYWMAPEVIKR--KDYGPKVDIWSLGIMCIEMAEGEPPYLRE  219 (286)
T ss_pred             cCCcccCCHhHhcC--CCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence                 234555433  34678899999999999999999998753

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=99.93  E-value=8.3e-25  Score=220.78  Aligned_cols=172  Identities=23%  Similarity=0.405  Sum_probs=142.1

Q ss_pred             eeEEEEEEEE--CCeEEEEEEcchh---------HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCH
Q 041830          390 IEGAVYHGRL--NGKNLAIKRTEHE---------VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSL  458 (600)
Q Consensus       390 ~~G~Vy~g~~--~g~~vAvK~~~~~---------~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL  458 (600)
                      ..|.||++..  +|+.+|+|.++..         ....+..|+..+..++|+||+++++++... +..++|+||+++++|
T Consensus        12 ~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~~v~e~~~~~~L   90 (268)
T cd06630          12 AFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCED-SHFNLFVEWMAGGSV   90 (268)
T ss_pred             CceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccC-CeEEEEEeccCCCcH
Confidence            3499999987  7899999987532         234678899999999999999999997554 588999999999999


Q ss_pred             HHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC-cEEEEeccCccccC
Q 041830          459 KDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEF-NARVGNFGMARCVN  537 (600)
Q Consensus       459 ~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~-~~kI~DFGla~~~~  537 (600)
                      .+++....            ++++..+..++.|++.||.|||   +.+++||||||+||+++.++ .+||+|||++....
T Consensus        91 ~~~l~~~~------------~~~~~~~~~~~~ql~~al~~LH---~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~  155 (268)
T cd06630          91 SHLLSKYG------------AFKEAVIINYTEQLLRGLSYLH---ENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA  155 (268)
T ss_pred             HHHHHHhC------------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence            99997532            3889999999999999999999   67999999999999998775 69999999986543


Q ss_pred             CC----------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          538 DD----------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       538 ~~----------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                      ..                ..+||....  ..++.++||||+|+++|||++|+.||...
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~  211 (268)
T cd06630         156 AKGTGAGEFQGQLLGTIAFMAPEVLRG--EQYGRSCDVWSVGCVIIEMATAKPPWNAE  211 (268)
T ss_pred             cccccCCccccccccccceeCHhHhcc--CCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence            21                224554432  34677899999999999999999999643

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=99.93  E-value=3.9e-25  Score=225.44  Aligned_cols=171  Identities=21%  Similarity=0.351  Sum_probs=139.6

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH-----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV-----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~-----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      .|.||+++.  +|+.||+|+++...     ...+..|+..+..++||||+++++++.+. ...++++||++ ++|.+++.
T Consensus        13 ~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~-~~l~~~~~   90 (284)
T cd07839          13 YGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSD-KKLTLVFEYCD-QDLKKYFD   90 (284)
T ss_pred             CeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccC-CceEEEEecCC-CCHHHHHH
Confidence            389999998  68999999875421     23456788899999999999999997555 48899999997 58888886


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD----  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~----  539 (600)
                      ...           ..+++.++..++.||++||.|||   +.+++||||||+||+++.++.+||+|||+++.....    
T Consensus        91 ~~~-----------~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~  156 (284)
T cd07839          91 SCN-----------GDIDPEIVKSFMFQLLKGLAFCH---SHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCY  156 (284)
T ss_pred             hcC-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCc
Confidence            532           23899999999999999999999   669999999999999999999999999998754321    


Q ss_pred             --------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          540 --------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       540 --------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                              ..+||..... ..++.++|||||||++|||++|+.||..
T Consensus       157 ~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~tg~~p~~~  202 (284)
T cd07839         157 SAEVVTLWYRPPDVLFGA-KLYSTSIDMWSAGCIFAELANAGRPLFP  202 (284)
T ss_pred             CCCccccCCcChHHHhCC-cccCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence                    2346654332 3457789999999999999999998643

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.92  E-value=1.2e-24  Score=228.95  Aligned_cols=177  Identities=23%  Similarity=0.400  Sum_probs=147.4

Q ss_pred             CceeEEEEEEEE--CCeEEEEEEcchhHH------HHHHHHHHHHHhCC-CCceeeeeeEEeccCCceEEEEeecCCCCH
Q 041830          388 NRIEGAVYHGRL--NGKNLAIKRTEHEVI------TKLEMQLVQHATHH-HPNIVRLLGTCLTDGPHSFLVFEYAKNGSL  458 (600)
Q Consensus       388 ~~~~G~Vy~g~~--~g~~vAvK~~~~~~~------~~~e~ei~~~~~l~-HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL  458 (600)
                      .|-+|.||+++.  +|+.+|+|.+++...      ...++|+.+|.++. |||||.+.+++... ...++|||++.+|.|
T Consensus        45 ~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~-~~~~lvmEL~~GGeL  123 (382)
T KOG0032|consen   45 RGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDP-DSVYLVMELCEGGEL  123 (382)
T ss_pred             CCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcC-CeEEEEEEecCCchH
Confidence            334499999988  699999999866443      46789999999998 99999999997655 489999999999999


Q ss_pred             HHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC----CcEEEEeccCcc
Q 041830          459 KDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEE----FNARVGNFGMAR  534 (600)
Q Consensus       459 ~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~----~~~kI~DFGla~  534 (600)
                      .+.+...             .+++.....++.|++.++.|||   +.+++||||||+|+|+...    +.+|++|||++.
T Consensus       124 fd~i~~~-------------~~sE~da~~~~~~il~av~~lH---~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~  187 (382)
T KOG0032|consen  124 FDRIVKK-------------HYSERDAAGIIRQILEAVKYLH---SLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAK  187 (382)
T ss_pred             HHHHHHc-------------cCCHHHHHHHHHHHHHHHHHHH---hCCceeccCCHHHeeeccccCCCCcEEEeeCCCce
Confidence            9999653             1889999999999999999999   6799999999999999533    579999999998


Q ss_pred             ccCCCC------CCCcccccC---CCCCCccCchHHHHHHHHHHHhCCCCCCCCCC
Q 041830          535 CVNDDT------ESPQFYSTN---PASWSMGIDIFAYGIVLLEVLSGQTPINRPRK  581 (600)
Q Consensus       535 ~~~~~~------~~pe~~~~~---~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~  581 (600)
                      ......      .+|++..++   ...|+..+||||.||++|.|++|.+||....+
T Consensus       188 ~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~  243 (382)
T KOG0032|consen  188 FIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETE  243 (382)
T ss_pred             EccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCCh
Confidence            776522      234444332   25678899999999999999999999987553

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=99.92  E-value=8.4e-25  Score=224.70  Aligned_cols=183  Identities=21%  Similarity=0.381  Sum_probs=139.7

Q ss_pred             eEEEEEEEEC----------------CeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEE
Q 041830          391 EGAVYHGRLN----------------GKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVF  450 (600)
Q Consensus       391 ~G~Vy~g~~~----------------g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~  450 (600)
                      .|.||+++..                ...||+|.++.+    ....+.+|+..+..++|+||+++++++..+ ...++||
T Consensus        18 ~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~-~~~~lv~   96 (295)
T cd05097          18 FGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLGVCVSD-DPLCMIT   96 (295)
T ss_pred             CceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CccEEEE
Confidence            3899988652                235899987543    234577899999999999999999998665 4889999


Q ss_pred             eecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEec
Q 041830          451 EYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNF  530 (600)
Q Consensus       451 Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DF  530 (600)
                      ||+++++|.+++.................++|.+++.++.|++.||+|||   +.+++||||||+||++++++.+||+||
T Consensus        97 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH---~~~i~H~dlkp~Nill~~~~~~kl~df  173 (295)
T cd05097          97 EYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLA---SLNFVHRDLATRNCLVGNHYTIKIADF  173 (295)
T ss_pred             ecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHH---hcCeeccccChhhEEEcCCCcEEeccc
Confidence            99999999999965321000000000123789999999999999999999   679999999999999999999999999


Q ss_pred             cCccccCCC--------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh--CCCCCCCC
Q 041830          531 GMARCVNDD--------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS--GQTPINRP  579 (600)
Q Consensus       531 Gla~~~~~~--------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt--G~~Pf~~~  579 (600)
                      |+++.....              +.+||....  ..++.++|||||||++|||++  |..||...
T Consensus       174 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~  236 (295)
T cd05097         174 GMSRNLYSGDYYRIQGRAVLPIRWMAWESILL--GKFTTASDVWAFGVTLWEMFTLCKEQPYSLL  236 (295)
T ss_pred             ccccccccCcceeccCcCcCceeecChhhhcc--CCcCchhhHHHHHHHHHHHHHcCCCCCCccc
Confidence            998754211              223444332  346788999999999999998  66788653

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=99.92  E-value=2.3e-24  Score=220.53  Aligned_cols=176  Identities=23%  Similarity=0.358  Sum_probs=143.1

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEecc-CCceEEEEeecCCCCHHHHHh
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTD-GPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~-~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      .|.||++..  +++.+|+|.+...    ...++.+|+..+..++||||+++++++... ....++||||+++++|.+++.
T Consensus        14 ~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   93 (287)
T cd06621          14 GGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYK   93 (287)
T ss_pred             ceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHH
Confidence            489999998  6889999987642    234577889999999999999999998643 236799999999999999876


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD----  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~----  539 (600)
                      .....        ...+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||++......    
T Consensus        94 ~~~~~--------~~~l~~~~~~~i~~~i~~~L~~lH---~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~  162 (287)
T cd06621          94 KVKKR--------GGRIGEKVLGKIAESVLKGLSYLH---SRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGT  162 (287)
T ss_pred             HHHhc--------CCCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecCCeEEEeecccccccccccccc
Confidence            42211        134889999999999999999999   679999999999999999999999999998643321    


Q ss_pred             ------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 ------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 ------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                            ..+||....  ..++.++||||||+++|||++|+.||...
T Consensus       163 ~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~  206 (287)
T cd06621         163 FTGTSFYMAPERIQG--KPYSITSDVWSLGLTLLEVAQNRFPFPPE  206 (287)
T ss_pred             ccCCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence                  124554433  35677899999999999999999999765

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=99.92  E-value=4.8e-25  Score=224.88  Aligned_cols=172  Identities=22%  Similarity=0.353  Sum_probs=140.9

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      .|.||++..  +|+.||+|++...     ..+.+..|+..+..++||||+++++++..+ ...++|+||+++++|.++.+
T Consensus        14 ~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~l~~~~~   92 (286)
T cd07846          14 YGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRK-KRLYLVFEFVDHTVLDDLEK   92 (286)
T ss_pred             CeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccC-CeEEEEEecCCccHHHHHHh
Confidence            389999998  5889999986542     123466788899999999999999998654 48999999999999988775


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD----  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~----  539 (600)
                      ...            .++|.+++.++.|++.||+|||   +.+++||||+|+||++++++.+||+|||++......    
T Consensus        93 ~~~------------~~~~~~~~~~~~~i~~~l~~LH---~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~  157 (286)
T cd07846          93 YPN------------GLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY  157 (286)
T ss_pred             ccC------------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcccc
Confidence            432            3899999999999999999999   669999999999999999999999999998754321    


Q ss_pred             --------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 --------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 --------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                              ..+||..... ..++.++||||||+++|||++|+.||...
T Consensus       158 ~~~~~~~~y~aPE~~~~~-~~~~~~~Dv~slG~~l~el~~g~~~~~~~  204 (286)
T cd07846         158 TDYVATRWYRAPELLVGD-TKYGRAVDIWAVGCLVTEMLTGEPLFPGD  204 (286)
T ss_pred             CcccceeeccCcHHhccc-cccCchHhHHHHHHHHHHHHcCCCCCCCC
Confidence                    1245554322 23567799999999999999999999643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=99.92  E-value=4.1e-24  Score=214.37  Aligned_cols=172  Identities=25%  Similarity=0.421  Sum_probs=142.5

Q ss_pred             EEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      |.+|.++.  +|+.||+|++...     ....++.|+..++.++||||+++++++... +..++|+||+++++|.+++..
T Consensus        14 g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~l~~~~~~   92 (256)
T cd08218          14 GKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEEN-GNLYIVMDYCEGGDLYKKINA   92 (256)
T ss_pred             eEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCC-CeEEEEEecCCCCcHHHHHHh
Confidence            88998887  7889999987532     234677889999999999999999997554 589999999999999999875


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-----
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-----  539 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-----  539 (600)
                      ...          ..+++.+++.++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++......     
T Consensus        93 ~~~----------~~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~  159 (256)
T cd08218          93 QRG----------VLFPEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR  159 (256)
T ss_pred             ccC----------CCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh
Confidence            331          23789999999999999999999   679999999999999999999999999998754321     


Q ss_pred             -------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 -------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 -------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                             ..+||....  ..++.++|+|||||++|||++|+.||...
T Consensus       160 ~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~i~~~l~~g~~~~~~~  204 (256)
T cd08218         160 TCIGTPYYLSPEICEN--RPYNNKSDIWALGCVLYEMCTLKHAFEAG  204 (256)
T ss_pred             hccCCccccCHHHhCC--CCCCCccchhHHHHHHHHHHcCCCCccCC
Confidence                   234555433  34677899999999999999999999643

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=99.92  E-value=3.5e-25  Score=211.94  Aligned_cols=179  Identities=23%  Similarity=0.383  Sum_probs=139.0

Q ss_pred             CCceeEEEEEEEE--CCeEEEEEEcchhH----HHHHHHHHHHH-HhCCCCceeeeeeEEeccCCceEEEEeecCCCCHH
Q 041830          387 SNRIEGAVYHGRL--NGKNLAIKRTEHEV----ITKLEMQLVQH-ATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       387 ~~~~~G~Vy~g~~--~g~~vAvK~~~~~~----~~~~e~ei~~~-~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~  459 (600)
                      ++|.-|.|++.++  +|...|||.|.+..    .+++.+.+..+ ..+..|.||+.+|+++.+. ..++.||.|.- .+.
T Consensus       101 GsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~-dV~IcMelMs~-C~e  178 (391)
T KOG0983|consen  101 GSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT-DVFICMELMST-CAE  178 (391)
T ss_pred             cCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc-hHHHHHHHHHH-HHH
Confidence            4444599999998  67999999987633    22333444333 3345799999999998875 78999999953 677


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD  539 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~  539 (600)
                      .+|++-.           .++++...=++...+..||.||-+  +++|+|||+||+|||+|+.|.+|++|||.+..+...
T Consensus       179 kLlkrik-----------~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS  245 (391)
T KOG0983|consen  179 KLLKRIK-----------GPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS  245 (391)
T ss_pred             HHHHHhc-----------CCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeecc
Confidence            7766533           347787788889999999999986  669999999999999999999999999998654322


Q ss_pred             -----------CCCCcccccC-CCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 -----------TESPQFYSTN-PASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 -----------~~~pe~~~~~-~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                                 +++||..... ...|+.++|||||||.|+||.||+.||...+
T Consensus       246 kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~  298 (391)
T KOG0983|consen  246 KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK  298 (391)
T ss_pred             cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC
Confidence                       2356655443 4568888999999999999999999997643

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.92  E-value=1.7e-24  Score=218.05  Aligned_cols=172  Identities=20%  Similarity=0.452  Sum_probs=141.6

Q ss_pred             eEEEEEEEE-CCeEEEEEEcchhH--HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcC
Q 041830          391 EGAVYHGRL-NGKNLAIKRTEHEV--ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLA  467 (600)
Q Consensus       391 ~G~Vy~g~~-~g~~vAvK~~~~~~--~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~  467 (600)
                      .|.||++.. .+..+|+|.+....  ...+.+|+..++.++|+||+++++++..  ...+++|||+++|+|.+++.....
T Consensus        19 ~~~vy~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~--~~~~~v~e~~~~~~L~~~~~~~~~   96 (260)
T cd05073          19 FGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK--EPIYIITEFMAKGSLLDFLKSDEG   96 (260)
T ss_pred             ceEEEEEEecCCccEEEEecCCChhHHHHHHHHHHHHHhcCCCCcceEEEEEcC--CCeEEEEEeCCCCcHHHHHHhCCc
Confidence            389999987 56779999876533  3467789999999999999999999754  478999999999999999976432


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--------
Q 041830          468 MKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--------  539 (600)
Q Consensus       468 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--------  539 (600)
                                ..+++.+++.++.+++.||.|||   +.+++||||||+||+++.++.+||+|||++......        
T Consensus        97 ----------~~~~~~~~~~~~~~l~~aL~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~  163 (260)
T cd05073          97 ----------SKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGA  163 (260)
T ss_pred             ----------cccCHHHHHHHHHHHHHHHHHHH---hCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcccccCC
Confidence                      23789999999999999999999   679999999999999999999999999988754321        


Q ss_pred             -----CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          540 -----TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       540 -----~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                           ..+||+...  ..++.++|+|||||++||+++ |+.||...
T Consensus       164 ~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~t~g~~p~~~~  207 (260)
T cd05073         164 KFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGM  207 (260)
T ss_pred             cccccccCHhHhcc--CCcCccccchHHHHHHHHHHhcCCCCCCCC
Confidence                 123454432  346778999999999999999 99999753

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=99.92  E-value=1.5e-24  Score=222.35  Aligned_cols=173  Identities=21%  Similarity=0.339  Sum_probs=140.6

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH-----HHHHHHHHHHHHhCCCCceeeeeeEEeccC-CceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV-----ITKLEMQLVQHATHHHPNIVRLLGTCLTDG-PHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~-----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~-~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||+|..  +++.+++|.++...     ...+.+|+..+..++||||+++++++..+. ...|+||||++ ++|.+++
T Consensus        18 ~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~   96 (293)
T cd07843          18 YGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLM   96 (293)
T ss_pred             CeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-cCHHHHH
Confidence            489999998  58899999876422     123467888899999999999999976542 47899999997 5999988


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC---
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---  539 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~---  539 (600)
                      ....           ..+++.+++.++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++.....   
T Consensus        97 ~~~~-----------~~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~  162 (293)
T cd07843          97 ETMK-----------QPFLQSEVKCLMLQLLSGVAHLH---DNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP  162 (293)
T ss_pred             Hhcc-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCccc
Confidence            7543           23899999999999999999999   668999999999999999999999999998755332   


Q ss_pred             ---------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 ---------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 ---------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                               ..+||..... ..++.++|+||||+++|||++|+.||...
T Consensus       163 ~~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~~f~~~  210 (293)
T cd07843         163 YTQLVVTLWYRAPELLLGA-KEYSTAIDMWSVGCIFAELLTKKPLFPGK  210 (293)
T ss_pred             cccccccccccCchhhcCC-ccccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence                     2345544321 23567899999999999999999999754

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=99.92  E-value=1.3e-24  Score=218.05  Aligned_cols=172  Identities=30%  Similarity=0.551  Sum_probs=142.7

Q ss_pred             eEEEEEEEE-CCeEEEEEEcchhH--HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcC
Q 041830          391 EGAVYHGRL-NGKNLAIKRTEHEV--ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLA  467 (600)
Q Consensus       391 ~G~Vy~g~~-~g~~vAvK~~~~~~--~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~  467 (600)
                      .|.||++.+ ++..+|+|.++...  ...+..|+..+..+.|||++++++++... ...+++|||+++|+|.++++... 
T Consensus        17 ~g~v~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~-   94 (256)
T cd05112          17 FGLVWLGYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTER-SPICLVFEFMEHGCLSDYLRAQR-   94 (256)
T ss_pred             cceEEEEEEeCCCeEEEEECCCCCCCHHHHHHHHHHHHhCCCCCeeeEEEEEccC-CceEEEEEcCCCCcHHHHHHhCc-
Confidence            389999988 58889999876532  24677899999999999999999997554 47899999999999999997543 


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--------
Q 041830          468 MKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--------  539 (600)
Q Consensus       468 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--------  539 (600)
                                ..+++..++.++.+++.||+|||   +.+++||||||+||+++.++.+||+|||+++.....        
T Consensus        95 ----------~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~  161 (256)
T cd05112          95 ----------GKFSQETLLGMCLDVCEGMAYLE---SSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGT  161 (256)
T ss_pred             ----------cCCCHHHHHHHHHHHHHHHHHHH---HCCccccccccceEEEcCCCeEEECCCcceeecccCcccccCCC
Confidence                      23889999999999999999999   668999999999999999999999999998743211        


Q ss_pred             -----CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          540 -----TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       540 -----~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                           ..+||....  ..++.++||||||+++|||++ |+.||...
T Consensus       162 ~~~~~~~aPe~~~~--~~~~~~~Dv~slG~~l~el~~~g~~p~~~~  205 (256)
T cd05112         162 KFPVKWSSPEVFSF--SKYSSKSDVWSFGVLMWEVFSEGKTPYENR  205 (256)
T ss_pred             ccchhhcCHhHhcc--CCcChHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence                 234555443  346778999999999999998 99999643

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=99.92  E-value=2.8e-25  Score=210.31  Aligned_cols=179  Identities=25%  Similarity=0.379  Sum_probs=144.1

Q ss_pred             EEEEEEEE--CCeEEEEEEcch---hHHHHHHHHHHHHHhCCCCceeeeeeEEeccC----CceEEEEeecCCCCHHHHH
Q 041830          392 GAVYHGRL--NGKNLAIKRTEH---EVITKLEMQLVQHATHHHPNIVRLLGTCLTDG----PHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~---~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~----~~~~LV~Ey~~~GsL~~~L  462 (600)
                      ..||.++.  +++.+|+|++.-   +..+...+|+...+.++||||+++++++..+.    ...||+++|...|+|.+.+
T Consensus        35 sfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i  114 (302)
T KOG2345|consen   35 SFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEI  114 (302)
T ss_pred             eeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHH
Confidence            56777764  889999998643   33456678999999999999999999876321    2579999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC----
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND----  538 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~----  538 (600)
                      .......        ..+++.+.++|+.+|++||++||+. .+++.||||||.|||+.+.+.++|.|||.+....-    
T Consensus       115 ~~~k~kg--------~~~sE~~iL~if~gic~gL~~lH~~-~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~  185 (302)
T KOG2345|consen  115 ERLKIKG--------NFVSEAQILWIFLGICRGLEALHEK-EPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEG  185 (302)
T ss_pred             HHHhhcC--------CccCHHHHHHHHHHHHHHHHHHhcc-CCcccccCCCcceeEecCCCceEEEeccCccccceEeec
Confidence            7643221        3489999999999999999999965 45799999999999999999999999998764321    


Q ss_pred             -----------------CCCCCccccc-CCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 -----------------DTESPQFYST-NPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 -----------------~~~~pe~~~~-~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                       ...+||.+.- .....+.++|||||||+||+|+-|..||+..
T Consensus       186 ~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~  244 (302)
T KOG2345|consen  186 SRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERI  244 (302)
T ss_pred             hHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHH
Confidence                             2235666543 2344578899999999999999999999754

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=99.92  E-value=1.7e-24  Score=224.62  Aligned_cols=183  Identities=22%  Similarity=0.433  Sum_probs=141.3

Q ss_pred             eEEEEEEEE---------CCeEEEEEEcchh----HHHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCC
Q 041830          391 EGAVYHGRL---------NGKNLAIKRTEHE----VITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNG  456 (600)
Q Consensus       391 ~G~Vy~g~~---------~g~~vAvK~~~~~----~~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~G  456 (600)
                      .|.||+++.         .+..+|+|.++..    ....+..|+..+..+ .||||++++++|..+ ...+++|||+++|
T Consensus        25 ~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~~~lv~e~~~~g  103 (314)
T cd05099          25 FGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE-GPLYVIVEYAAKG  103 (314)
T ss_pred             cccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC-CceEEEEecCCCC
Confidence            489999975         2456999987642    223566788888888 599999999998655 4789999999999


Q ss_pred             CHHHHHhcCcCcccc----cccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccC
Q 041830          457 SLKDWLHGGLAMKNQ----FIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGM  532 (600)
Q Consensus       457 sL~~~L~~~~~~~~~----~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGl  532 (600)
                      +|.+++.........    ........++|.++++++.|++.||.|||   +.+++||||||+|||++.++.+||+|||+
T Consensus       104 ~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH---~~gi~H~dlkp~Nill~~~~~~kL~Dfg~  180 (314)
T cd05099         104 NLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLE---SRRCIHRDLAARNVLVTEDNVMKIADFGL  180 (314)
T ss_pred             cHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHH---HCCeeeccccceeEEEcCCCcEEEccccc
Confidence            999999764321000    00001134899999999999999999999   67999999999999999999999999999


Q ss_pred             ccccCC--------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          533 ARCVND--------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       533 a~~~~~--------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                      ++....              ...+||....  ..++.++|||||||++|||++ |+.||...
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DiwslG~~l~el~~~g~~p~~~~  240 (314)
T cd05099         181 ARGVHDIDYYKKTSNGRLPVKWMAPEALFD--RVYTHQSDVWSFGILMWEIFTLGGSPYPGI  240 (314)
T ss_pred             cccccccccccccccCCCCccccCHHHHcc--CCcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence            975432              1234554433  346788999999999999999 88998653

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.92  E-value=2.6e-24  Score=218.36  Aligned_cols=180  Identities=21%  Similarity=0.435  Sum_probs=141.6

Q ss_pred             eeEEEEEEEE-------CCeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCH
Q 041830          390 IEGAVYHGRL-------NGKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSL  458 (600)
Q Consensus       390 ~~G~Vy~g~~-------~g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL  458 (600)
                      ..|.||+++.       ..+.+++|.+...    ....+..|+..+..++|+||+++++++... ...++||||+++|+|
T Consensus        17 ~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L   95 (275)
T cd05046          17 EFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREA-EPHYMILEYTDLGDL   95 (275)
T ss_pred             ceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCC-CcceEEEEecCCCcH
Confidence            3499999986       2457999987542    234678899999999999999999997554 478999999999999


Q ss_pred             HHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC
Q 041830          459 KDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND  538 (600)
Q Consensus       459 ~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~  538 (600)
                      .++++........   .....+++.++..++.|++.||+|||   +.+++||||||+||+++.++.+|++|||+++....
T Consensus        96 ~~~i~~~~~~~~~---~~~~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~  169 (275)
T cd05046          96 KQFLRATKSKDEK---LKPPPLSTKQKVALCTQIALGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYN  169 (275)
T ss_pred             HHHHHhccccccc---ccccCCCHHHHHHHHHHHHHHHHHhh---hcCcccCcCccceEEEeCCCcEEEcccccccccCc
Confidence            9999764421100   00124899999999999999999999   67899999999999999999999999999864321


Q ss_pred             C-------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCC
Q 041830          539 D-------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINR  578 (600)
Q Consensus       539 ~-------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~  578 (600)
                      .             ..+||....  ..++.++||||||+++|||++ |..||..
T Consensus       170 ~~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~Di~slG~~l~~l~~~~~~p~~~  221 (275)
T cd05046         170 SEYYKLRNALIPLRWLAPEAVQE--DDFSTKSDVWSFGVLMWEVFTQGELPFYG  221 (275)
T ss_pred             ccccccCCceeEEeecChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence            1             233454332  235677999999999999999 8889864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.92  E-value=1.3e-24  Score=223.37  Aligned_cols=182  Identities=21%  Similarity=0.400  Sum_probs=141.0

Q ss_pred             eEEEEEEEE------------------CCeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEE
Q 041830          391 EGAVYHGRL------------------NGKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFL  448 (600)
Q Consensus       391 ~G~Vy~g~~------------------~g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~L  448 (600)
                      .|.||++..                  ++..+|+|.++..    ....+..|+..+..++|+||+++++++..++ ..++
T Consensus        18 ~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~-~~~l   96 (296)
T cd05095          18 FGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSD-PLCM   96 (296)
T ss_pred             CCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC-ccEE
Confidence            389998753                  2346899988643    2346778999999999999999999986654 7899


Q ss_pred             EEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEE
Q 041830          449 VFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVG  528 (600)
Q Consensus       449 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~  528 (600)
                      +|||+++|+|.+++......... .......+++.+...++.|++.||+|||   +.+++||||||+|||+++++.+||+
T Consensus        97 v~e~~~~~~L~~~l~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~~al~~lH---~~~i~H~dlkp~Nili~~~~~~~l~  172 (296)
T cd05095          97 ITEYMENGDLNQFLSRHEPQEAA-EKADVVTISYSTLIFMATQIASGMKYLS---SLNFVHRDLATRNCLVGKNYTIKIA  172 (296)
T ss_pred             EEEeCCCCcHHHHHHhcCccccc-ccccccccCHHHHHHHHHHHHHHHHHHH---HCCeecccCChheEEEcCCCCEEec
Confidence            99999999999999764321110 0111234889999999999999999999   6699999999999999999999999


Q ss_pred             eccCccccCCC--------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh--CCCCCCCC
Q 041830          529 NFGMARCVNDD--------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS--GQTPINRP  579 (600)
Q Consensus       529 DFGla~~~~~~--------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt--G~~Pf~~~  579 (600)
                      |||+++.....              ..+||....  ..++.++|||||||++|||++  |..||...
T Consensus       173 dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~--~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~  237 (296)
T cd05095         173 DFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILL--GKFTTASDVWAFGVTLWEILTLCKEQPYSQL  237 (296)
T ss_pred             cCcccccccCCcceeccCcCcCccccCCHHHHhc--CCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence            99998754221              122333222  346788999999999999998  77888654

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=99.92  E-value=1.9e-24  Score=217.56  Aligned_cols=173  Identities=27%  Similarity=0.459  Sum_probs=143.4

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      .|.||+|..  +++.|++|.++..     ....+..|+..+..++|+||+++++++... +..++|+||+++++|.++++
T Consensus        13 ~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~   91 (264)
T cd06626          13 FGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHR-EKVYIFMEYCSGGTLEELLE   91 (264)
T ss_pred             CcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecC-CEEEEEEecCCCCcHHHHHh
Confidence            389999987  6889999987542     335678899999999999999999997554 58899999999999999997


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD----  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~----  539 (600)
                      ...            .+++..+..++.+++.||.|||   +.+++|+||+|+||++++++.+||+|||++......    
T Consensus        92 ~~~------------~~~~~~~~~i~~~i~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          92 HGR------------ILDEHVIRVYTLQLLEGLAYLH---SHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             hcC------------CCChHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence            542            2788999999999999999999   679999999999999999999999999998754321    


Q ss_pred             ------------CCCCcccccCC-CCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 ------------TESPQFYSTNP-ASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 ------------~~~pe~~~~~~-~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                  ..+||...... ...+.++||||||+++|||++|+.||...
T Consensus       157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~  209 (264)
T cd06626         157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL  209 (264)
T ss_pred             cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence                        22355544322 23677899999999999999999999654

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=99.92  E-value=1.5e-24  Score=222.88  Aligned_cols=171  Identities=26%  Similarity=0.479  Sum_probs=141.9

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh---HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcC
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE---VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGG  465 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~---~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~  465 (600)
                      .|.||++..  +++.|++|.+...   ....+..|+..+..++||||+++++++... +..|+|+||+++|+|.+++...
T Consensus        32 ~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~  110 (293)
T cd06647          32 SGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVG-DELWVVMEYLAGGSLTDVVTET  110 (293)
T ss_pred             CeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeC-CcEEEEEecCCCCcHHHHHhhc
Confidence            489999986  6889999987532   224567788888999999999999998655 4889999999999999999653


Q ss_pred             cCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC------
Q 041830          466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD------  539 (600)
Q Consensus       466 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~------  539 (600)
                                   .+++.++..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++......      
T Consensus       111 -------------~l~~~~~~~i~~~l~~al~~LH---~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~  174 (293)
T cd06647         111 -------------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  174 (293)
T ss_pred             -------------CCCHHHHHHHHHHHHHHHHHHH---hCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccccccc
Confidence                         2789999999999999999999   679999999999999999999999999987644221      


Q ss_pred             ------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 ------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 ------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                            ..+||....  ..++.++|||||||++|||++|+.||...+
T Consensus       175 ~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~  219 (293)
T cd06647         175 MVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMVEGEPPYLNEN  219 (293)
T ss_pred             ccCChhhcCchhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence                  234555433  346778999999999999999999997543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=99.92  E-value=1.5e-24  Score=223.81  Aligned_cols=182  Identities=22%  Similarity=0.436  Sum_probs=141.1

Q ss_pred             eEEEEEEEE---------CCeEEEEEEcchh----HHHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCC
Q 041830          391 EGAVYHGRL---------NGKNLAIKRTEHE----VITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNG  456 (600)
Q Consensus       391 ~G~Vy~g~~---------~g~~vAvK~~~~~----~~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~G  456 (600)
                      .|.||+++.         ++..||+|.++.+    ....+..|+..+..+ +||||+++++++..+ ...|++|||+++|
T Consensus        28 ~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-~~~~lv~e~~~~~  106 (304)
T cd05101          28 FGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD-GPLYVIVEYASKG  106 (304)
T ss_pred             CceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEecC-CceEEEEecCCCC
Confidence            399999975         2347999987642    234577888888888 799999999997655 4789999999999


Q ss_pred             CHHHHHhcCcCcccc----cccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccC
Q 041830          457 SLKDWLHGGLAMKNQ----FIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGM  532 (600)
Q Consensus       457 sL~~~L~~~~~~~~~----~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGl  532 (600)
                      +|.+++.........    ........++|.+++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+
T Consensus       107 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nili~~~~~~kl~D~g~  183 (304)
T cd05101         107 NLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGL  183 (304)
T ss_pred             cHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHH---HCCeeecccccceEEEcCCCcEEECCCcc
Confidence            999999764321000    00001134899999999999999999999   67999999999999999999999999999


Q ss_pred             ccccCCC--------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCC
Q 041830          533 ARCVNDD--------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINR  578 (600)
Q Consensus       533 a~~~~~~--------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~  578 (600)
                      ++.....              ..+||....  ..++.++||||||+++|||++ |..||..
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~  242 (304)
T cd05101         184 ARDVNNIDYYKKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPG  242 (304)
T ss_pred             ceecccccccccccCCCCCceeeCchhhcc--CCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence            8754321              123444332  346788999999999999998 7888864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=99.92  E-value=1.9e-24  Score=217.87  Aligned_cols=172  Identities=23%  Similarity=0.357  Sum_probs=144.4

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      .|.||++..  +++.+|+|++...    ...++.+|+..+..++||||+++++.+..+ ...++++||+++++|.+++..
T Consensus        14 ~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~   92 (265)
T cd06605          14 SGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNN-GDISICMEYMDGGSLDKILKE   92 (265)
T ss_pred             CeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecC-CEEEEEEEecCCCcHHHHHHH
Confidence            489999998  5889999987543    234567788888899999999999998766 489999999999999999975


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCC-CCceecCCCCCCEEeCCCCcEEEEeccCccccCC-----
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMN-PSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND-----  538 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~-----  538 (600)
                      ..           ..+++..+.+++.|++.||+|||   + .+++||||||+||++++++.+||+|||.+.....     
T Consensus        93 ~~-----------~~~~~~~~~~~~~~l~~~l~~lH---~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~  158 (265)
T cd06605          93 VQ-----------GRIPERILGKIAVAVLKGLTYLH---EKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT  158 (265)
T ss_pred             cc-----------CCCCHHHHHHHHHHHHHHHHHHc---CCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhc
Confidence            42           23889999999999999999999   5 7999999999999999999999999999864421     


Q ss_pred             -----CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 -----DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 -----~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                           ...+||....  ..++.++||||||+++|||++|+.||...
T Consensus       159 ~~~~~~y~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~  202 (265)
T cd06605         159 FVGTSSYMAPERIQG--NDYSVKSDIWSLGLSLIELATGRFPYPPE  202 (265)
T ss_pred             ccCChhccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence                 2335666544  35678899999999999999999999764

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=99.92  E-value=1.8e-24  Score=221.97  Aligned_cols=182  Identities=24%  Similarity=0.435  Sum_probs=142.4

Q ss_pred             eEEEEEEEEC------------------CeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEE
Q 041830          391 EGAVYHGRLN------------------GKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFL  448 (600)
Q Consensus       391 ~G~Vy~g~~~------------------g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~L  448 (600)
                      .|.||+++..                  +..||+|.+..+    ..+.+.+|+..+..++||||+++++++..+ ...++
T Consensus        18 ~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~l   96 (296)
T cd05051          18 FGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVD-PPLCM   96 (296)
T ss_pred             CccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeEEEEEEecC-CCcEE
Confidence            3899988762                  245899987643    235677899999999999999999998665 48899


Q ss_pred             EEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEE
Q 041830          449 VFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVG  528 (600)
Q Consensus       449 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~  528 (600)
                      +|||+++++|.+++.......... ......+++..++.++.|++.||+|||   +.+++||||||+||+++.++.+||+
T Consensus        97 v~e~~~~~~L~~~l~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~al~~LH---~~~i~H~dlkp~Nili~~~~~~~l~  172 (296)
T cd05051          97 IMEYMENGDLNQFLQKHVAETSGL-ACNSKSLSFSTLLYMATQIASGMRYLE---SLNFVHRDLATRNCLVGKNYTIKIA  172 (296)
T ss_pred             EEecCCCCCHHHHHHhcccccccc-cccCCCCCHHHHHHHHHHHHHHHHHHH---HcCccccccchhceeecCCCceEEc
Confidence            999999999999997644211100 001135899999999999999999999   6799999999999999999999999


Q ss_pred             eccCccccCCC--------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh--CCCCCCCC
Q 041830          529 NFGMARCVNDD--------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS--GQTPINRP  579 (600)
Q Consensus       529 DFGla~~~~~~--------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt--G~~Pf~~~  579 (600)
                      |||+++.....              ..+||....  ..++.++|||||||++|||++  |..||...
T Consensus       173 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~  237 (296)
T cd05051         173 DFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLL--GKFTTKSDVWAFGVTLWEILTLCREQPYEHL  237 (296)
T ss_pred             cccceeecccCcceeecCcCCCCceecCHHHhhc--CCCCccchhhhhHHHHHHHHhcCCCCCCCCc
Confidence            99998754211              224554433  356788999999999999998  77888653

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=99.92  E-value=4.2e-24  Score=214.85  Aligned_cols=171  Identities=26%  Similarity=0.445  Sum_probs=145.1

Q ss_pred             EEEEEEEE--CCeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcC
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGG  465 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~  465 (600)
                      |.||++..  +|+.|++|++...    ....++.|+..+..++|+||+++++++..+ ...++|+||+++++|.+++...
T Consensus        15 ~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~   93 (264)
T cd06623          15 GVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKE-GEISIVLEYMDGGSLADLLKKV   93 (264)
T ss_pred             eEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccC-CeEEEEEEecCCCcHHHHHHHc
Confidence            89999988  5899999987653    245678899999999999999999998665 5899999999999999999754


Q ss_pred             cCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCC-CCceecCCCCCCEEeCCCCcEEEEeccCccccCCCC----
Q 041830          466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMN-PSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDT----  540 (600)
Q Consensus       466 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~~----  540 (600)
                      .            .+++..++.++.|+++||+|||   + .+++||||+|+||+++.++.++|+|||++.......    
T Consensus        94 ~------------~l~~~~~~~~~~~l~~~l~~lh---~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~  158 (264)
T cd06623          94 G------------KIPEPVLAYIARQILKGLDYLH---TKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCN  158 (264)
T ss_pred             C------------CCCHHHHHHHHHHHHHHHHHHh---ccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCccc
Confidence            2            3899999999999999999999   6 799999999999999999999999999987653221    


Q ss_pred             --------CCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          541 --------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       541 --------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                              .+||....  ..++.++|+||||+++|||++|+.||....
T Consensus       159 ~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~tg~~p~~~~~  204 (264)
T cd06623         159 TFVGTVTYMSPERIQG--ESYSYAADIWSLGLTLLECALGKFPFLPPG  204 (264)
T ss_pred             ceeecccccCHhhhCC--CCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence                    24554433  356778999999999999999999997654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.92  E-value=1.2e-24  Score=224.48  Aligned_cols=171  Identities=26%  Similarity=0.488  Sum_probs=137.8

Q ss_pred             eEEEEEEEE--CCe----EEEEEEcchhH----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          391 EGAVYHGRL--NGK----NLAIKRTEHEV----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       391 ~G~Vy~g~~--~g~----~vAvK~~~~~~----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      .|.||+|.+  +|.    .+|+|.+....    ...+..|+..+..++||||++++|+|...  ..++++||+++|+|.+
T Consensus        20 ~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~--~~~~v~e~~~~g~l~~   97 (303)
T cd05110          20 FGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP--TIQLVTQLMPHGCLLD   97 (303)
T ss_pred             CccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC--CceeeehhcCCCCHHH
Confidence            489999987  454    47889876432    22466788888999999999999998643  5689999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-  539 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-  539 (600)
                      ++....           ..+++..++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++..... 
T Consensus        98 ~~~~~~-----------~~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~  163 (303)
T cd05110          98 YVHEHK-----------DNIGSQLLLNWCVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE  163 (303)
T ss_pred             HHHhcc-----------cCCCHHHHHHHHHHHHHHHHHHh---hcCeeccccccceeeecCCCceEEccccccccccCcc
Confidence            987543           23889999999999999999999   679999999999999999999999999999754321 


Q ss_pred             -------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          540 -------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       540 -------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                                   ..+||....  ..++.++|||||||++|||++ |+.||...
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~--~~~~~~~DiwslG~~l~el~t~g~~p~~~~  215 (303)
T cd05110         164 KEYNADGGKMPIKWMALECIHY--RKFTHQSDVWSYGVTIWELMTFGGKPYDGI  215 (303)
T ss_pred             cccccCCCccccccCCHHHhcc--CCCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                         123333322  346778999999999999998 89999653

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=99.92  E-value=1.9e-24  Score=220.39  Aligned_cols=172  Identities=22%  Similarity=0.383  Sum_probs=142.3

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH-----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV-----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~-----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      .|.||+++.  +|+.||+|++....     ...+..|+..+..++||||+++++++... ...++|+||+ +++|.+++.
T Consensus        13 ~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~~v~e~~-~~~L~~~~~   90 (286)
T cd07832          13 HGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHG-SGFVLVMEYM-PSDLSEVLR   90 (286)
T ss_pred             CcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecC-CeeEEEeccc-CCCHHHHHH
Confidence            389999997  68899999876432     34677889999999999999999997654 5889999999 999999987


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD----  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~----  539 (600)
                      ...           ..+++.++..++.|++.||.|||   +.+++|+||||+||+++.++.++|+|||++......    
T Consensus        91 ~~~-----------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~  156 (286)
T cd07832          91 DEE-----------RPLPEAQVKSYMRMLLKGVAYMH---ANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRL  156 (286)
T ss_pred             hcC-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCc
Confidence            533           34899999999999999999999   679999999999999999999999999998765432    


Q ss_pred             ---------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 ---------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 ---------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                               ..+||..... ..++.++||||+|+++|||++|++||...
T Consensus       157 ~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~  204 (286)
T cd07832         157 YSHQVATRWYRAPELLYGA-RKYDPGVDLWAVGCIFAELLNGSPLFPGE  204 (286)
T ss_pred             cccccCcccccCceeeecc-ccCCchhHHHHHHHHHHHHHcCCcCcCCC
Confidence                     1245544321 23577899999999999999998888543

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=99.92  E-value=2.1e-25  Score=216.08  Aligned_cols=175  Identities=20%  Similarity=0.364  Sum_probs=136.7

Q ss_pred             CceeEEEEEEEE--CCeEEEEEEcchhHHHHHHHHHHHHHhCCCCceeeeeeEEecc---CCceEEEEeecCCCCHHHHH
Q 041830          388 NRIEGAVYHGRL--NGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTD---GPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       388 ~~~~G~Vy~g~~--~g~~vAvK~~~~~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~---~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      -|+.|.|.....  +|+.+|+|.+......+.|.|+..+. -.|||||.+++++...   ...+++|||+|++|.|.+.+
T Consensus        72 ~GinGkV~~C~~k~T~ekfALKvL~Ds~KARrEVeLHw~~-s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsri  150 (400)
T KOG0604|consen   72 AGINGKVVQCVHKRTQEKFALKVLLDSPKARREVELHWMA-SGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRI  150 (400)
T ss_pred             cccCCceEEEEeccchhhhHHHHHhcCHHHHhHhhhhhhh-cCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHH
Confidence            344577766655  78999999987654333344443333 3599999999997532   23468999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC---CCCcEEEEeccCccccCCC
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLD---EEFNARVGNFGMARCVNDD  539 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld---~~~~~kI~DFGla~~~~~~  539 (600)
                      ...+.          ..+++.+.-+|+.||+.|+.|||   +.+|.||||||+|+|..   .|-..||+|||+|+.-...
T Consensus       151 q~~g~----------~afTErea~eI~~qI~~Av~~lH---~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~  217 (400)
T KOG0604|consen  151 QDRGD----------QAFTEREASEIMKQIGLAVRYLH---SMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP  217 (400)
T ss_pred             HHccc----------ccchHHHHHHHHHHHHHHHHHHH---hcchhhccCChhheeeecCCCCcceEecccccccccCCC
Confidence            77553          45999999999999999999999   67999999999999995   4567999999999865422


Q ss_pred             C-----------CCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          540 T-----------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       540 ~-----------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                      .           -+||...  +..|+..+|+||+||+||-|++|.+||-.
T Consensus       218 ~~L~TPc~TPyYvaPevlg--~eKydkscdmwSlgVimYIlLCGyPPFYS  265 (400)
T KOG0604|consen  218 GDLMTPCFTPYYVAPEVLG--PEKYDKSCDMWSLGVIMYILLCGYPPFYS  265 (400)
T ss_pred             ccccCCcccccccCHHHhC--chhcCCCCCccchhHHHHHhhcCCCcccc
Confidence            1           1344443  35688889999999999999999999954

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=7.6e-26  Score=229.76  Aligned_cols=173  Identities=27%  Similarity=0.433  Sum_probs=147.8

Q ss_pred             CceeEEEEEEEE--CCeEEEEEEcchhH----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          388 NRIEGAVYHGRL--NGKNLAIKRTEHEV----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       388 ~~~~G~Vy~g~~--~g~~vAvK~~~~~~----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      .+-+|.||+|..  +++.||+|.++-+.    .+.+++|+..+.+++++||.+++|.+... ..+|++||||.+|++.+.
T Consensus        23 rGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g-~~LwiiMey~~gGsv~~l  101 (467)
T KOG0201|consen   23 RGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKG-TKLWIIMEYCGGGSVLDL  101 (467)
T ss_pred             ccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeec-ccHHHHHHHhcCcchhhh
Confidence            344599999998  78999999986543    35678899999999999999999998765 489999999999999999


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC----
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN----  537 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~----  537 (600)
                      |+.+..            +++.+..-|.+++..||.|||   ..+.+|||||+.|||+..++.+|++|||.+..+.    
T Consensus       102 L~~~~~------------~~E~~i~~ilre~l~~l~ylH---~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~  166 (467)
T KOG0201|consen  102 LKSGNI------------LDEFEIAVILREVLKGLDYLH---SEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK  166 (467)
T ss_pred             hccCCC------------CccceeeeehHHHHHHhhhhh---hcceecccccccceeEeccCcEEEEecceeeeeechhh
Confidence            976542            467777778999999999999   6689999999999999999999999999986543    


Q ss_pred             --------CCCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          538 --------DDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       538 --------~~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                              +-+++||+...  ..|+.++||||+|+..+||.+|.+|+..
T Consensus       167 rr~tfvGTPfwMAPEVI~~--~~Y~~KADIWSLGITaiEla~GePP~s~  213 (467)
T KOG0201|consen  167 RRKTFVGTPFWMAPEVIKQ--SGYDTKADIWSLGITAIELAKGEPPHSK  213 (467)
T ss_pred             ccccccccccccchhhhcc--ccccchhhhhhhhHHHHHHhcCCCCCcc
Confidence                    23457777763  6789999999999999999999999964

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=99.92  E-value=2.5e-24  Score=219.23  Aligned_cols=175  Identities=22%  Similarity=0.406  Sum_probs=136.7

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH----HHHHHHHHH-HHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV----ITKLEMQLV-QHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~----~~~~e~ei~-~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      .|.||+++.  +|+.||+|+++...    ..++..|+. .++..+||||+++++++..++ ..|++|||++ |+|.++++
T Consensus        14 ~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~-~~~lv~e~~~-~~l~~~l~   91 (283)
T cd06617          14 YGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREG-DVWICMEVMD-TSLDKFYK   91 (283)
T ss_pred             CeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCC-cEEEEhhhhc-ccHHHHHH
Confidence            489999998  68999999875432    123333443 355678999999999986654 7999999997 68988886


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCC-CceecCCCCCCEEeCCCCcEEEEeccCccccCCC---
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNP-SYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~---  539 (600)
                      ......        ..+++.+++.++.|++.||+|||   +. +++||||||+||+++.++.+||+|||+++.....   
T Consensus        92 ~~~~~~--------~~~~~~~~~~~~~qi~~~l~~lH---~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~  160 (283)
T cd06617          92 KVYDKG--------LTIPEDILGKIAVSIVKALEYLH---SKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAK  160 (283)
T ss_pred             HhccCC--------CCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeeccccccccccccc
Confidence            532111        34899999999999999999999   44 8999999999999999999999999998754221   


Q ss_pred             --------CCCCcccccC--CCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          540 --------TESPQFYSTN--PASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       540 --------~~~pe~~~~~--~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                              ..+||.....  ...++.++|+||||+++|||++|+.||..
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~  209 (283)
T cd06617         161 TIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS  209 (283)
T ss_pred             ccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence                    2345554321  13457789999999999999999999964

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=99.92  E-value=3.1e-24  Score=219.53  Aligned_cols=170  Identities=26%  Similarity=0.471  Sum_probs=140.9

Q ss_pred             eeEEEEEEEE--CCeEEEEEEcchh---HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          390 IEGAVYHGRL--NGKNLAIKRTEHE---VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       390 ~~G~Vy~g~~--~g~~vAvK~~~~~---~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      ..|.||++..  +++.+++|+++..   ..+.+.+|+..+..++||||+++++++... +..++++||+++++|.+++..
T Consensus        31 ~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~  109 (285)
T cd06648          31 STGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVG-DELWVVMEFLEGGALTDIVTH  109 (285)
T ss_pred             CCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcC-CeEEEEEeccCCCCHHHHHHh
Confidence            3499999987  6788999987532   223467788889999999999999987654 488999999999999999875


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-----
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-----  539 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-----  539 (600)
                      .             .+++.++..++.|++.||+|||   +.+++||||+|+||+++.++.+||+|||++......     
T Consensus       110 ~-------------~~~~~~~~~~~~ql~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~  173 (285)
T cd06648         110 T-------------RMNEEQIATVCLAVLKALSFLH---AQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRK  173 (285)
T ss_pred             C-------------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCcccc
Confidence            2             2889999999999999999999   679999999999999999999999999987643221     


Q ss_pred             -------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          540 -------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       540 -------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                             ..+||....  ..++.++|||||||++|||++|+.||..
T Consensus       174 ~~~~~~~y~aPE~~~~--~~~~~~~Dv~slGv~l~ell~g~~p~~~  217 (285)
T cd06648         174 SLVGTPYWMAPEVISR--LPYGTEVDIWSLGIMVIEMVDGEPPYFN  217 (285)
T ss_pred             cccCCccccCHHHhcC--CCCCCcccHHHHHHHHHHHHhCCCCCcC
Confidence                   224554433  3467789999999999999999999864

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=99.92  E-value=9.3e-24  Score=219.42  Aligned_cols=173  Identities=25%  Similarity=0.375  Sum_probs=141.3

Q ss_pred             eEEEEEEEE--CCeEEEEEEcch------hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEH------EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~------~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||+++.  +|..+|+|.+..      +....+..|+..+..++|||++++++++..+ ...++||||++ |+|.+++
T Consensus        38 ~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~-g~l~~~~  115 (317)
T cd06635          38 FGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLRE-HTAWLVMEYCL-GSASDLL  115 (317)
T ss_pred             CeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC-CeEEEEEeCCC-CCHHHHH
Confidence            489999987  688999998753      1223567788899999999999999998765 47899999997 5888877


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC---
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---  539 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~---  539 (600)
                      ....           ..++|.++..++.+++.||.|||   +.+++||||+|+||+++.++.+||+|||++......   
T Consensus       116 ~~~~-----------~~l~~~~~~~i~~~i~~~l~~lH---~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  181 (317)
T cd06635         116 EVHK-----------KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPANSF  181 (317)
T ss_pred             HHhc-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcccEEECCCCCEEEecCCCccccCCcccc
Confidence            5432           34899999999999999999999   679999999999999999999999999998754322   


Q ss_pred             -----CCCCccccc-CCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 -----TESPQFYST-NPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 -----~~~pe~~~~-~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                           +.+||.... ....++.++|||||||++|||++|+.||...
T Consensus       182 ~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~  227 (317)
T cd06635         182 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM  227 (317)
T ss_pred             cCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence                 235665432 2234678899999999999999999998653

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.92  E-value=2.2e-25  Score=232.01  Aligned_cols=189  Identities=25%  Similarity=0.341  Sum_probs=153.4

Q ss_pred             cCHHHHHHHHhccCCCCceeEEEEEEEE--CCeEEEEEEcch------hHHHHHHHHHHHHHhCCCCceeeeeeEEeccC
Q 041830          372 YSIEDLRRATEKFNSSNRIEGAVYHGRL--NGKNLAIKRTEH------EVITKLEMQLVQHATHHHPNIVRLLGTCLTDG  443 (600)
Q Consensus       372 ~~~~el~~~t~~f~~~~~~~G~Vy~g~~--~g~~vAvK~~~~------~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~  443 (600)
                      -+.+.+.....+.  +.|.+|.||.++.  +.+.||||+|..      +....+.+|+.-+..++|||+|.+-|+|..+.
T Consensus        22 ~DPEklf~dLrEI--GHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~   99 (948)
T KOG0577|consen   22 DDPEKLFSDLREI--GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREH   99 (948)
T ss_pred             CCHHHHHHHHHHh--cCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccc
Confidence            3444444444443  4555699999988  788999999854      22346778999999999999999999988764


Q ss_pred             CceEEEEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC
Q 041830          444 PHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEF  523 (600)
Q Consensus       444 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~  523 (600)
                       ..|||||||- ||-.|.|.-.+           .+|.+.++.-|+.+.+.||+|||   +.+.||||||..||||.+.+
T Consensus       100 -TaWLVMEYCl-GSAsDlleVhk-----------KplqEvEIAAi~~gaL~gLaYLH---S~~~IHRDiKAGNILLse~g  163 (948)
T KOG0577|consen  100 -TAWLVMEYCL-GSASDLLEVHK-----------KPLQEVEIAAITHGALQGLAYLH---SHNRIHRDIKAGNILLSEPG  163 (948)
T ss_pred             -hHHHHHHHHh-ccHHHHHHHHh-----------ccchHHHHHHHHHHHHHHHHHHH---HhhHHhhhccccceEecCCC
Confidence             7899999995 58888875443           56899999999999999999999   67899999999999999999


Q ss_pred             cEEEEeccCccccC--------CCCCCCccccc-CCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          524 NARVGNFGMARCVN--------DDTESPQFYST-NPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       524 ~~kI~DFGla~~~~--------~~~~~pe~~~~-~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                      .+|++|||.|....        +.+++||+... ....|+-++||||+||...||.-+++|+..
T Consensus       164 ~VKLaDFGSAsi~~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFn  227 (948)
T KOG0577|consen  164 LVKLADFGSASIMAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN  227 (948)
T ss_pred             eeeeccccchhhcCchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccC
Confidence            99999999987553        33456776544 346789999999999999999999999743

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=99.92  E-value=5.7e-24  Score=213.64  Aligned_cols=179  Identities=26%  Similarity=0.400  Sum_probs=143.7

Q ss_pred             eEEEEEEEE--CCeEEEEEEcch-----hHHHHHHHHHHHHHhCCCCceeeeeeEEecc-CCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEH-----EVITKLEMQLVQHATHHHPNIVRLLGTCLTD-GPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~-----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~-~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||++..  +|+.+|+|.+..     ...+.+..|+..+..++|+||+++++++... +...+++|||+++++|.+++
T Consensus        13 ~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l   92 (265)
T cd08217          13 FGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLI   92 (265)
T ss_pred             CeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHH
Confidence            389999987  678999998753     2234567788889999999999999987643 34579999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcC--CCCceecCCCCCCEEeCCCCcEEEEeccCccccCCCC
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM--NPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDT  540 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~~  540 (600)
                      ......        ...+++.+++.++.+++.||.|||...  +.+++|+||||+||+++.++.+||+|||++.......
T Consensus        93 ~~~~~~--------~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~  164 (265)
T cd08217          93 QKCKKE--------RKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDS  164 (265)
T ss_pred             HHHhhc--------ccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCCc
Confidence            754211        134899999999999999999999432  4689999999999999999999999999987653322


Q ss_pred             ------------CCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          541 ------------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       541 ------------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                  .+||....  ..++.++||||||+++|||++|+.||...
T Consensus       165 ~~~~~~~~~~~~~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~  213 (265)
T cd08217         165 SFAKTYVGTPYYMSPEQLNH--MSYDEKSDIWSLGCLIYELCALSPPFTAR  213 (265)
T ss_pred             ccccccccCCCccChhhhcC--CCCCchhHHHHHHHHHHHHHHCCCcccCc
Confidence                        23444433  34677899999999999999999999754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=99.92  E-value=2.5e-24  Score=219.36  Aligned_cols=175  Identities=22%  Similarity=0.389  Sum_probs=141.9

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      .|.||+|+.  +|+.||||.++...    ...+..|+..+..++|+||+++++++... +..++||||+++ +|.+++..
T Consensus        13 ~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~-~l~~~~~~   90 (284)
T cd07836          13 YATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTE-NKLMLVFEYMDK-DLKKYMDT   90 (284)
T ss_pred             ceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeC-CcEEEEEecCCc-cHHHHHHh
Confidence            389999998  68999999876432    24556788889999999999999998665 488999999985 89998865


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-----
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-----  539 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-----  539 (600)
                      ....         ..+++.++..++.|++.||.|||   +.+++||||||+||++++++.+||+|||+++.....     
T Consensus        91 ~~~~---------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~  158 (284)
T cd07836          91 HGVR---------GALDPNTVKSFTYQLLKGIAFCH---ENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS  158 (284)
T ss_pred             cCCC---------CCcCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccc
Confidence            4310         34899999999999999999999   668999999999999999999999999998754221     


Q ss_pred             -------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 -------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 -------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                             ..+||..... ..++.++|||||||++|||++|+.||...+
T Consensus       159 ~~~~~~~y~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~  205 (284)
T cd07836         159 NEVVTLWYRAPDVLLGS-RTYSTSIDIWSVGCIMAEMITGRPLFPGTN  205 (284)
T ss_pred             cccccccccChHHhcCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                   2345543321 235678999999999999999999997654

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=99.92  E-value=8.6e-25  Score=219.34  Aligned_cols=172  Identities=30%  Similarity=0.525  Sum_probs=141.7

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhHHH-----HHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEVIT-----KLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~~~-----~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      +|.||+++.  +++.+|+|.+......     ...+|+..+..++||||+++++++..+ ...++||||+++++|.+++.
T Consensus        12 ~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~~v~~~~~~~~L~~~l~   90 (260)
T PF00069_consen   12 FGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDD-NYLYIVMEYCPGGSLQDYLQ   90 (260)
T ss_dssp             SEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEES-SEEEEEEEEETTEBHHHHHH
T ss_pred             CEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccc-cccccccccccccccccccc
Confidence            499999999  6778999997654322     223478888888999999999997665 58899999999999999997


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC-----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND-----  538 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~-----  538 (600)
                      ..            ..+++.+++.++.|+++||.|||   +.+++|+||||+||++++++.++|+|||.+.....     
T Consensus        91 ~~------------~~~~~~~~~~~~~qi~~~L~~Lh---~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~  155 (260)
T PF00069_consen   91 KN------------KPLSEEEILKIAYQILEALAYLH---SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENF  155 (260)
T ss_dssp             HH------------SSBBHHHHHHHHHHHHHHHHHHH---HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEB
T ss_pred             cc------------ccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccccccccc
Confidence            32            33899999999999999999999   56999999999999999999999999999864211     


Q ss_pred             -------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 -------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 -------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                             ...+||... ....++.++||||+|+++|||++|+.||...
T Consensus       156 ~~~~~~~~y~aPE~~~-~~~~~~~~~Di~slG~il~~l~~~~~p~~~~  202 (260)
T PF00069_consen  156 NPFVGTPEYMAPEVLQ-QGKKYTRKSDIWSLGIILYELLTGKLPFEES  202 (260)
T ss_dssp             SSSSSSGGGSCHHHHT-TTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred             cccccccccccccccc-ccccccccccccccccccccccccccccccc
Confidence                   112455543 1355678899999999999999999999865

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=99.92  E-value=2.5e-24  Score=219.34  Aligned_cols=173  Identities=24%  Similarity=0.402  Sum_probs=141.8

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH-----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV-----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~-----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      .|.||+|..  +|+.||+|++..+.     ...+..|+..+..++|||++++++++... ...+++|||++ ++|.+++.
T Consensus        12 ~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~-~~~~iv~e~~~-~~l~~~~~   89 (283)
T cd07835          12 YGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSE-NKLYLVFEFLD-LDLKKYMD   89 (283)
T ss_pred             CeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccC-CeEEEEEeccC-cCHHHHHh
Confidence            389999987  78999999875432     23466788899999999999999998655 58899999995 69999987


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD----  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~----  539 (600)
                      ....          ..+++.+++.++.|+++||+|||   +.+++||||+|+||+++.++.+||+|||+++.....    
T Consensus        90 ~~~~----------~~~~~~~~~~~~~~i~~~L~~lH---~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~  156 (283)
T cd07835          90 SSPL----------TGLDPPLIKSYLYQLLQGIAYCH---SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY  156 (283)
T ss_pred             hCCC----------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcccc
Confidence            5431          23899999999999999999999   679999999999999999999999999998754311    


Q ss_pred             --------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 --------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 --------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                              ..+||..... ..++.++||||||+++|||++|+.||...
T Consensus       157 ~~~~~~~~~~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~pf~~~  203 (283)
T cd07835         157 THEVVTLWYRAPEILLGS-RQYSTPVDIWSIGCIFAEMVNRRPLFPGD  203 (283)
T ss_pred             CccccccCCCCCceeecC-cccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                    2345644331 23577899999999999999999999754

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=99.92  E-value=4.6e-24  Score=214.93  Aligned_cols=175  Identities=25%  Similarity=0.463  Sum_probs=143.8

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      .|.||+|..  ++..+++|++...    ....+.+|+..+..++|+||+++++.+..+ +..++++||+++++|.++++.
T Consensus        14 ~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~iv~e~~~~~~l~~~~~~   92 (267)
T cd06610          14 TAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVG-DELWLVMPYLSGGSLLDIMKS   92 (267)
T ss_pred             CeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeC-CEEEEEEeccCCCcHHHHHHH
Confidence            389999987  6789999987532    235677888889999999999999987655 588999999999999999975


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-----
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-----  539 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-----  539 (600)
                      ....         ..+++.....++.|++.||+|||   +.+++||||||+||++++++.+||+|||++......     
T Consensus        93 ~~~~---------~~~~~~~~~~~~~ql~~al~~lh---~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~  160 (267)
T cd06610          93 SYPR---------GGLDEAIIATVLKEVLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTR  160 (267)
T ss_pred             hccc---------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccc
Confidence            4310         23899999999999999999999   679999999999999999999999999998654322     


Q ss_pred             -----------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 -----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 -----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                 ..+||..... ..++.++|+|||||++|||++|+.||...
T Consensus       161 ~~~~~~~~~~~y~~Pe~~~~~-~~~~~~~Dv~slG~i~~~l~~g~~p~~~~  210 (267)
T cd06610         161 KVRKTFVGTPCWMAPEVMEQV-HGYDFKADIWSFGITAIELATGAAPYSKY  210 (267)
T ss_pred             cccccccCChhhcChHHHccc-cCcCcccchHhHhHHHHHHHhCCCCcccc
Confidence                       1234444332 25677899999999999999999999754

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=99.92  E-value=4e-24  Score=219.64  Aligned_cols=172  Identities=25%  Similarity=0.438  Sum_probs=141.7

Q ss_pred             ceeEEEEEEEE--CCeEEEEEEcchh---HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          389 RIEGAVYHGRL--NGKNLAIKRTEHE---VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       389 ~~~G~Vy~g~~--~g~~vAvK~~~~~---~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      +..|.||++..  +|+.||||++...   ....+..|+..+..++|+||+++++++... +..+++|||+++++|.+++.
T Consensus        31 g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~  109 (292)
T cd06657          31 GSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-DELWVVMEFLEGGALTDIVT  109 (292)
T ss_pred             CCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeC-CEEEEEEecCCCCcHHHHHh
Confidence            34489999988  7899999987532   224567788889999999999999997654 58999999999999999885


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD----  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~----  539 (600)
                      ..             .+++.....++.|++.||+|||   +.+++||||+|+||++++++.++|+|||++......    
T Consensus       110 ~~-------------~~~~~~~~~~~~ql~~~l~~lH---~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~  173 (292)
T cd06657         110 HT-------------RMNEEQIAAVCLAVLKALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR  173 (292)
T ss_pred             cC-------------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEECCCCCEEEcccccceecccccccc
Confidence            42             2789999999999999999999   669999999999999999999999999987644221    


Q ss_pred             --------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 --------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 --------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                              ..+||....  ..++.++|+||||+++|||++|+.||...
T Consensus       174 ~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slGvil~el~tg~~p~~~~  219 (292)
T cd06657         174 KSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNE  219 (292)
T ss_pred             cccccCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence                    224554432  34577899999999999999999998643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=99.92  E-value=5.5e-24  Score=213.15  Aligned_cols=173  Identities=25%  Similarity=0.409  Sum_probs=141.7

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      .|.||++..  +++.+|+|.+...     ....+..|+..++.++||||+++++.+..+ +..++||||+++++|.++++
T Consensus        13 ~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~   91 (256)
T cd08220          13 FGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLED-KALMIVMEYAPGGTLAEYIQ   91 (256)
T ss_pred             ceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecC-CEEEEEEecCCCCCHHHHHH
Confidence            389999887  6888999986532     234677889999999999999999986544 58899999999999999997


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC-CcEEEEeccCccccCCC---
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEE-FNARVGNFGMARCVNDD---  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~-~~~kI~DFGla~~~~~~---  539 (600)
                      ....          ..+++.++..++.+++.||.|||   +.+++|+||||+||+++.+ +.+||+|||++......   
T Consensus        92 ~~~~----------~~~~~~~~~~~~~~i~~~l~~lh---~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~  158 (256)
T cd08220          92 KRCN----------SLLDEDTILHFFVQILLALHHVH---TKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA  158 (256)
T ss_pred             Hhcc----------cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCccc
Confidence            6431          34899999999999999999999   6799999999999999855 56899999998755322   


Q ss_pred             --------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 --------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 --------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                              +.+||....  ..++.++||||||+++|||++|+.||...
T Consensus       159 ~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~~l~~~~~~~~~~  204 (256)
T cd08220         159 YTVVGTPCYISPELCEG--KPYNQKSDIWALGCVLYELASLKRAFEAA  204 (256)
T ss_pred             cccccCCcccCchhccC--CCCCcccchHHHHHHHHHHHhCCCCcccC
Confidence                    234555433  34677899999999999999999999754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=99.92  E-value=3.2e-24  Score=215.02  Aligned_cols=173  Identities=27%  Similarity=0.471  Sum_probs=141.7

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      .|.||++..  +|..+|+|.+...     ....++.|+..++.++|+||+++++.+..+ ...++|+||+++++|.+++.
T Consensus        13 ~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~   91 (257)
T cd08225          13 FGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQEN-GRLFIVMEYCDGGDLMKRIN   91 (257)
T ss_pred             cceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccC-CeEEEEEecCCCCcHHHHHH
Confidence            389999998  6889999987543     224567889999999999999999997655 48899999999999999997


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC-cEEEEeccCccccCCC---
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEF-NARVGNFGMARCVNDD---  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~-~~kI~DFGla~~~~~~---  539 (600)
                      ....          ..++|..+..++.+++.||.|||   +.+++|+||||+||++++++ .+||+|||.+......   
T Consensus        92 ~~~~----------~~~~~~~~~~~~~~l~~~l~~lh---~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~  158 (257)
T cd08225          92 RQRG----------VLFSEDQILSWFVQISLGLKHIH---DRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL  158 (257)
T ss_pred             hccC----------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEcCCCCeEEecccccchhccCCccc
Confidence            5432          23799999999999999999999   66899999999999998885 5799999998755332   


Q ss_pred             ---------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 ---------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 ---------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                               ..+||....  ..++.++||||||+++|||++|+.||...
T Consensus       159 ~~~~~~~~~~~ape~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~  205 (257)
T cd08225         159 AYTCVGTPYYLSPEICQN--RPYNNKTDIWSLGCVLYELCTLKHPFEGN  205 (257)
T ss_pred             ccccCCCccccCHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence                     123444332  34677899999999999999999999753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=99.92  E-value=2.6e-24  Score=222.57  Aligned_cols=173  Identities=25%  Similarity=0.392  Sum_probs=140.3

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhHH-----HHHHHHHHHHHhCCCCceeeeeeEEeccC-CceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEVI-----TKLEMQLVQHATHHHPNIVRLLGTCLTDG-PHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~~-----~~~e~ei~~~~~l~HpNIv~l~g~~~~~~-~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||++..  +|+.||+|.++.+..     .....|+..+..++|+||+++++++.... +..++||||+++ +|.+++
T Consensus        20 ~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l   98 (309)
T cd07845          20 YGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLL   98 (309)
T ss_pred             CEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCCC-CHHHHH
Confidence            399999998  689999998764321     23457888999999999999999976542 357999999974 899988


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC---
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---  539 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~---  539 (600)
                      ....           ..+++.++..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++.....   
T Consensus        99 ~~~~-----------~~l~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~  164 (309)
T cd07845          99 DNMP-----------TPFSESQVKCLMLQLLRGLQYLH---ENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP  164 (309)
T ss_pred             Hhcc-----------cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECccceeeecCCccCC
Confidence            6532           34899999999999999999999   678999999999999999999999999998765322   


Q ss_pred             ---------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 ---------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 ---------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                               +.+||.... ...++.++|||||||++|||++|+.||...
T Consensus       165 ~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwslG~il~el~~g~~~f~~~  212 (309)
T cd07845         165 MTPKVVTLWYRAPELLLG-CTTYTTAIDMWAVGCILAELLAHKPLLPGK  212 (309)
T ss_pred             CCcccccccccChhhhcC-CCCcCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence                     234554432 134677899999999999999999999643

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=99.92  E-value=5.1e-24  Score=220.49  Aligned_cols=179  Identities=22%  Similarity=0.363  Sum_probs=141.6

Q ss_pred             eEEEEEEEE----CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEecc-CCceEEEEeecCCCCHH
Q 041830          391 EGAVYHGRL----NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTD-GPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       391 ~G~Vy~g~~----~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~-~~~~~LV~Ey~~~GsL~  459 (600)
                      .|.||+|..    +++.||+|.+....      .....+|+..+..++||||+++++++... +...++||||+++ +|.
T Consensus        13 ~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~   91 (316)
T cd07842          13 YGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLW   91 (316)
T ss_pred             cEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCCc-CHH
Confidence            499999998    46899999886522      24556788889999999999999998755 1478999999975 787


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC----CCcEEEEeccCccc
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE----EFNARVGNFGMARC  535 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~----~~~~kI~DFGla~~  535 (600)
                      +++........       ..+++..++.++.|++.||.|||   +.+++||||||+||+++.    ++.+||+|||+++.
T Consensus        92 ~~~~~~~~~~~-------~~~~~~~~~~i~~qi~~~l~~lH---~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~  161 (316)
T cd07842          92 QIIKFHRQAKR-------VSIPPSMVKSLLWQILNGVHYLH---SNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARL  161 (316)
T ss_pred             HHHHhhccCCC-------cCcCHHHHHHHHHHHHHHHHHHH---hCCEeeCCCCHHHEEEcCCCCccceEEECCCccccc
Confidence            77754332110       24889999999999999999999   679999999999999999    99999999999875


Q ss_pred             cCCC---------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCCC
Q 041830          536 VNDD---------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRK  581 (600)
Q Consensus       536 ~~~~---------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~  581 (600)
                      ....               ..+||.... ...++.++|||||||++|||++|+.||.....
T Consensus       162 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~  221 (316)
T cd07842         162 FNAPLKPLADLDPVVVTIWYRAPELLLG-ARHYTKAIDIWAIGCIFAELLTLEPIFKGREA  221 (316)
T ss_pred             cCCCcccccccCCccccccccCHHHHhC-CCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence            4321               234554332 13457789999999999999999999976543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=99.92  E-value=3.8e-24  Score=218.33  Aligned_cols=172  Identities=24%  Similarity=0.346  Sum_probs=141.4

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      .|.||++..  +++.||+|.++..     ..+.+..|+..+..+.|+||+++++++..+ +..+++|||++++.+..++.
T Consensus        14 ~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~iv~e~~~~~~l~~~~~   92 (288)
T cd07833          14 YGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRK-GRLYLVFEYVERTLLELLEA   92 (288)
T ss_pred             CeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEEC-CEEEEEEecCCCCHHHHHHh
Confidence            389999988  5789999987542     234677899999999999999999998665 48999999999877766654


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCCC---
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDT---  540 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~~---  540 (600)
                      ..            ..+++.++..++.+|+.||.|||   ..+++||||+|+||++++++.+||+|||++.......   
T Consensus        93 ~~------------~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~  157 (288)
T cd07833          93 SP------------GGLPPDAVRSYIWQLLQAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASP  157 (288)
T ss_pred             cC------------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence            32            23899999999999999999999   6699999999999999999999999999987654322   


Q ss_pred             ----------CCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          541 ----------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       541 ----------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                .+||..... ..++.++||||||+++|||++|+.||...
T Consensus       158 ~~~~~~~~~~~~PE~~~~~-~~~~~~~Dv~slG~~l~~l~~g~~~~~~~  205 (288)
T cd07833         158 LTDYVATRWYRAPELLVGD-TNYGKPVDVWAIGCIMAELLDGEPLFPGD  205 (288)
T ss_pred             ccCcccccCCcCCchhcCC-CCcCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence                      345554432 25678899999999999999999999743

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.92  E-value=4.5e-24  Score=216.15  Aligned_cols=178  Identities=21%  Similarity=0.447  Sum_probs=137.9

Q ss_pred             eEEEEEEEE-----CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCC-----ceEEEEeecCC
Q 041830          391 EGAVYHGRL-----NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGP-----HSFLVFEYAKN  455 (600)
Q Consensus       391 ~G~Vy~g~~-----~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~-----~~~LV~Ey~~~  455 (600)
                      .|.||+|.+     +|+.||||.++.+     ..+.+..|+..+..++||||+++++++.....     ..++++||+++
T Consensus        12 ~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~   91 (273)
T cd05074          12 FGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKH   91 (273)
T ss_pred             CCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCC
Confidence            489999986     3688999987542     23456778889999999999999998764321     24789999999


Q ss_pred             CCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccc
Q 041830          456 GSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARC  535 (600)
Q Consensus       456 GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~  535 (600)
                      |+|.+++........      ...+++...+.++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus        92 ~~l~~~~~~~~~~~~------~~~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~nili~~~~~~kl~dfg~~~~  162 (273)
T cd05074          92 GDLHTFLLMSRIGEE------PFTLPLQTLVRFMIDIASGMEYLS---SKNFIHRDLAARNCMLNENMTVCVADFGLSKK  162 (273)
T ss_pred             CcHHHHHHHhcccCC------CCCCCHHHHHHHHHHHHHHHHHHH---hCCEeecccchhhEEEcCCCCEEECccccccc
Confidence            999998854321111      124889999999999999999999   67999999999999999999999999999885


Q ss_pred             cCCCC--------------CCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          536 VNDDT--------------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       536 ~~~~~--------------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                      .....              .+||...  ...++.++||||||+++|||++ |+.||...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~pe~~~--~~~~~~~sDi~slG~il~el~~~g~~p~~~~  219 (273)
T cd05074         163 IYSGDYYRQGCASKLPVKWLALESLA--DNVYTTHSDVWAFGVTMWEIMTRGQTPYAGV  219 (273)
T ss_pred             ccCCcceecCCCccCchhhcCHhHHh--cCccchhhhhHHHHHHHHHHhhCCCCCCCCC
Confidence            53211              1122221  1335678999999999999999 88998654

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=99.92  E-value=2e-23  Score=207.62  Aligned_cols=171  Identities=30%  Similarity=0.524  Sum_probs=145.1

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhH---HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCc
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEV---ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGL  466 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~---~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~  466 (600)
                      |.||++..  +|+.+++|+.+...   ...+..|+..+..++|+|++++++++..+ ...++++||+++++|.+++....
T Consensus        14 ~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~l~~e~~~~~~L~~~~~~~~   92 (253)
T cd05122          14 GEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKK-DELWIVMEFCSGGSLKDLLKSTN   92 (253)
T ss_pred             eEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEEEecCCCCcHHHHHhhcC
Confidence            89999998  58899999976543   35678899999999999999999997665 48899999999999999987642


Q ss_pred             CcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCCC------
Q 041830          467 AMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDT------  540 (600)
Q Consensus       467 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~~------  540 (600)
                                 ..+++.++..++.+++.||.|||   +.+++||||+|+||++++++.+||+|||.+.......      
T Consensus        93 -----------~~~~~~~~~~i~~~i~~~l~~lh---~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~  158 (253)
T cd05122          93 -----------QTLTESQIAYVCKELLKGLEYLH---SNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMV  158 (253)
T ss_pred             -----------CCCCHHHHHHHHHHHHHHHHHhh---cCCEecCCCCHHHEEEccCCeEEEeecccccccccccccccee
Confidence                       23899999999999999999999   6799999999999999999999999999987664432      


Q ss_pred             -----CCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          541 -----ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       541 -----~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                           .+||....  ...+.++||||||+++|||++|+.||...
T Consensus       159 ~~~~~~~PE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~  200 (253)
T cd05122         159 GTPYWMAPEVING--KPYDYKADIWSLGITAIELAEGKPPYSEL  200 (253)
T ss_pred             cCCcccCHHHHcC--CCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence                 24554433  23677899999999999999999999754

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=99.92  E-value=5e-24  Score=216.99  Aligned_cols=174  Identities=25%  Similarity=0.400  Sum_probs=142.4

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEecc-CCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTD-GPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~-~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||+++.  +|+.+|+|++...     ....+..|+..+..++|+|++++++++..+ ....++|+||+++ +|.+++
T Consensus        12 ~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~   90 (287)
T cd07840          12 YGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLL   90 (287)
T ss_pred             CeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc-cHHHHH
Confidence            389999998  5799999998654     223567788889999999999999998755 2478999999985 899888


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC---
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---  539 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~---  539 (600)
                      ....           ..+++.+++.++.|++.||+|||   +.+++|+||||+||++++++.+||+|||++......   
T Consensus        91 ~~~~-----------~~~~~~~~~~i~~~i~~al~~LH---~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~  156 (287)
T cd07840          91 DSPE-----------VKFTESQIKCYMKQLLEGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA  156 (287)
T ss_pred             hccC-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc
Confidence            6542           23899999999999999999999   668999999999999999999999999998755432   


Q ss_pred             ----------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 ----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 ----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                                ..+||.... ...++.++||||||+++|||++|+.||...+
T Consensus       157 ~~~~~~~~~~y~~PE~~~~-~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~  206 (287)
T cd07840         157 DYTNRVITLWYRPPELLLG-ATRYGPEVDMWSVGCILAELFLGKPIFQGST  206 (287)
T ss_pred             cccccccccccCCceeeEc-cccCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                      124554332 1346778999999999999999999996543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=99.92  E-value=1.8e-23  Score=216.88  Aligned_cols=192  Identities=22%  Similarity=0.313  Sum_probs=149.0

Q ss_pred             cccCHHHHHHHHhccCCCCceeEEEEEEEE--CCeEEEEEEcchh------HHHHHHHHHHHHHhCCCCceeeeeeEEec
Q 041830          370 ESYSIEDLRRATEKFNSSNRIEGAVYHGRL--NGKNLAIKRTEHE------VITKLEMQLVQHATHHHPNIVRLLGTCLT  441 (600)
Q Consensus       370 ~~~~~~el~~~t~~f~~~~~~~G~Vy~g~~--~g~~vAvK~~~~~------~~~~~e~ei~~~~~l~HpNIv~l~g~~~~  441 (600)
                      ...+.+|+.......  +.+..|.||+|+.  +|+.|++|.+...      ....+..|+..+..++|||++++++++.+
T Consensus        15 ~~~~~~~~~~~~~~l--g~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   92 (313)
T cd06633          15 YKDDPEEIFVGLHEI--GHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLK   92 (313)
T ss_pred             ccCCHHHHhhcceee--ccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEe
Confidence            334555554333332  2333499999987  7889999987531      22356778889999999999999999866


Q ss_pred             cCCceEEEEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC
Q 041830          442 DGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE  521 (600)
Q Consensus       442 ~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~  521 (600)
                      . ...|+||||+. |+|.+++....           ..++|.++..++.|++.||.|||   +.+++||||+|+||+++.
T Consensus        93 ~-~~~~lv~e~~~-~~l~~~l~~~~-----------~~l~~~~~~~~~~qi~~al~~LH---~~gi~H~dl~p~nili~~  156 (313)
T cd06633          93 E-HTAWLVMEYCL-GSASDLLEVHK-----------KPLQEVEIAAITHGALQGLAYLH---SHNMIHRDIKAGNILLTE  156 (313)
T ss_pred             C-CEEEEEEecCC-CCHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChhhEEECC
Confidence            5 48899999996 68888876432           34899999999999999999999   669999999999999999


Q ss_pred             CCcEEEEeccCccccCC--------CCCCCccccc-CCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          522 EFNARVGNFGMARCVND--------DTESPQFYST-NPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       522 ~~~~kI~DFGla~~~~~--------~~~~pe~~~~-~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                      ++.+||+|||++.....        ...+||.... ....++.++|||||||++|||++|+.||...
T Consensus       157 ~~~~kL~dfg~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~  223 (313)
T cd06633         157 PGQVKLADFGSASKSSPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM  223 (313)
T ss_pred             CCCEEEeecCCCcccCCCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999864322        1235666532 1244677899999999999999999998653

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=99.92  E-value=5.2e-24  Score=218.39  Aligned_cols=177  Identities=21%  Similarity=0.296  Sum_probs=139.5

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH-----HHHHHHHHHHHHhCC-CCceeeeeeEEeccCC----ceEEEEeecCCCCH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV-----ITKLEMQLVQHATHH-HPNIVRLLGTCLTDGP----HSFLVFEYAKNGSL  458 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~-----~~~~e~ei~~~~~l~-HpNIv~l~g~~~~~~~----~~~LV~Ey~~~GsL  458 (600)
                      .|.||++..  +|+.||+|..+...     ...+.+|+..+..+. ||||+++++++.....    ..|+||||+++ +|
T Consensus        14 ~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l   92 (295)
T cd07837          14 YGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DL   92 (295)
T ss_pred             CeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CH
Confidence            389999998  68999999865432     234667888888885 6999999998765432    27999999985 89


Q ss_pred             HHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC-CCcEEEEeccCccccC
Q 041830          459 KDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE-EFNARVGNFGMARCVN  537 (600)
Q Consensus       459 ~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~-~~~~kI~DFGla~~~~  537 (600)
                      .+++......       ....+++.+++.++.||+.||.|||   +.+++||||||+||+++. ++.+||+|||+++...
T Consensus        93 ~~~~~~~~~~-------~~~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~  162 (295)
T cd07837          93 KKFMDSNGRG-------PGRPLPAKTIKSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFS  162 (295)
T ss_pred             HHHHHHhccc-------CCCCCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHHEEEecCCCeEEEeecccceecC
Confidence            9988653321       0134899999999999999999999   679999999999999998 8999999999987542


Q ss_pred             CC------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          538 DD------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       538 ~~------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                      ..            ..+||.... ...++.++||||||+++|||++|+.||...
T Consensus       163 ~~~~~~~~~~~~~~~~aPE~~~~-~~~~~~~~Di~slG~~l~~l~~g~~~~~~~  215 (295)
T cd07837         163 IPVKSYTHEIVTLWYRAPEVLLG-STHYSTPVDIWSVGCIFAEMSRKQPLFPGD  215 (295)
T ss_pred             CCccccCCcccccCCCChHHhhC-CCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Confidence            21            234555432 134577899999999999999999999653

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.92  E-value=4.8e-24  Score=223.27  Aligned_cols=182  Identities=23%  Similarity=0.434  Sum_probs=140.4

Q ss_pred             eEEEEEEEEC---------CeEEEEEEcchh----HHHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCC
Q 041830          391 EGAVYHGRLN---------GKNLAIKRTEHE----VITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNG  456 (600)
Q Consensus       391 ~G~Vy~g~~~---------g~~vAvK~~~~~----~~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~G  456 (600)
                      .|.||+++..         +..||+|..+.+    ....+..|+..+..+ +||||++++++|..+ ...++++||+++|
T Consensus        25 ~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~~~lv~e~~~~g  103 (334)
T cd05100          25 FGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD-GPLYVLVEYASKG  103 (334)
T ss_pred             CCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccC-CceEEEEecCCCC
Confidence            3899999752         236899987642    234567888888888 799999999998665 4789999999999


Q ss_pred             CHHHHHhcCcCccc--cc--ccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccC
Q 041830          457 SLKDWLHGGLAMKN--QF--IASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGM  532 (600)
Q Consensus       457 sL~~~L~~~~~~~~--~~--~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGl  532 (600)
                      +|.+++........  .+  .......++|.+++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+
T Consensus       104 ~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH---~~givH~dlkp~Nill~~~~~~kL~Dfg~  180 (334)
T cd05100         104 NLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLA---SQKCIHRDLAARNVLVTEDNVMKIADFGL  180 (334)
T ss_pred             cHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHH---HCCeeccccccceEEEcCCCcEEECCccc
Confidence            99999975431100  00  0001134899999999999999999999   67999999999999999999999999999


Q ss_pred             ccccCCC--------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCC
Q 041830          533 ARCVNDD--------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINR  578 (600)
Q Consensus       533 a~~~~~~--------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~  578 (600)
                      ++.....              ..+||....  ..++.++||||||+++|||++ |+.||..
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~  239 (334)
T cd05100         181 ARDVHNIDYYKKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLLWEIFTLGGSPYPG  239 (334)
T ss_pred             ceecccccccccccCCCcCceEcCHHHhcc--CCcCchhhhHHHHHHHHHHHhcCCCCCCC
Confidence            8754321              123444332  346778999999999999998 8888864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=99.92  E-value=5.7e-24  Score=218.85  Aligned_cols=173  Identities=24%  Similarity=0.409  Sum_probs=139.6

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH-----HHHHHHHHHHHHhCCCCceeeeeeEEeccC---------CceEEEEeecC
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV-----ITKLEMQLVQHATHHHPNIVRLLGTCLTDG---------PHSFLVFEYAK  454 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~-----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~---------~~~~LV~Ey~~  454 (600)
                      .|.||+|..  +|+.||+|+++...     ...+..|+..+..++||||+++++++....         ...++|+||++
T Consensus        20 ~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~   99 (302)
T cd07864          20 YGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMD   99 (302)
T ss_pred             CEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccC
Confidence            499999998  68899999985432     134567888899999999999999976432         26899999998


Q ss_pred             CCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCcc
Q 041830          455 NGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR  534 (600)
Q Consensus       455 ~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~  534 (600)
                      + +|.+++....           ..+++.++..++.|++.||+|||   +.+|+||||||+||++++++.+||+|||++.
T Consensus       100 ~-~l~~~l~~~~-----------~~~~~~~~~~i~~qi~~aL~~LH---~~~i~H~dl~p~nili~~~~~~kl~dfg~~~  164 (302)
T cd07864         100 H-DLMGLLESGL-----------VHFSEDHIKSFMKQLLEGLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLAR  164 (302)
T ss_pred             c-cHHHHHhcCC-----------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCcEEeCcccccc
Confidence            6 7777776432           24899999999999999999999   6699999999999999999999999999987


Q ss_pred             ccCCC-------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          535 CVNDD-------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       535 ~~~~~-------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                      .....             ..+||..... ..++.++|||||||++|||++|+.||...
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~~~el~~g~~~~~~~  221 (302)
T cd07864         165 LYNSEESRPYTNKVITLWYRPPELLLGE-ERYGPAIDVWSCGCILGELFTKKPIFQAN  221 (302)
T ss_pred             cccCCcccccccceeccCccChHHhcCC-CCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence            65322             2245544321 34577899999999999999999999753

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=99.92  E-value=1.1e-23  Score=210.21  Aligned_cols=173  Identities=26%  Similarity=0.397  Sum_probs=144.8

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH-----HHHHHHHHHHHHhCCCCceeeeeeEEeccC-CceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV-----ITKLEMQLVQHATHHHPNIVRLLGTCLTDG-PHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~-----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~-~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||+|..  +|+.|++|..+...     .+.+..|+..+.+++|+||+++++.+.... ...++++||+++++|.+++
T Consensus        13 ~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~   92 (260)
T cd06606          13 FGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLL   92 (260)
T ss_pred             ceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHH
Confidence            389999998  48999999875533     456788999999999999999999976541 4789999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCCC--
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDT--  540 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~~--  540 (600)
                      ....            .++|.++..++.+++.||+|||   +.+++|+||+|+||+++.++.+||+|||.+.......  
T Consensus        93 ~~~~------------~~~~~~~~~~~~~l~~~l~~lh---~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~  157 (260)
T cd06606          93 KKFG------------KLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG  157 (260)
T ss_pred             HHcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc
Confidence            7542            3899999999999999999999   6799999999999999999999999999987654332  


Q ss_pred             ------------CCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          541 ------------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       541 ------------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                                  .+||....  ...+.++||||||+++|||++|+.||...+
T Consensus       158 ~~~~~~~~~~~y~~pE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~~  207 (260)
T cd06606         158 EGTGSVRGTPYWMAPEVIRG--EEYGRAADIWSLGCTVIEMATGKPPWSELG  207 (260)
T ss_pred             ccccCCCCCccccCHhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence                        13444333  236778999999999999999999997643

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=99.92  E-value=5.1e-24  Score=217.76  Aligned_cols=176  Identities=23%  Similarity=0.376  Sum_probs=138.0

Q ss_pred             ceeEEEEEEEE--CCeEEEEEEcchh----HHHHHHHHHHHHHhCC-CCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          389 RIEGAVYHGRL--NGKNLAIKRTEHE----VITKLEMQLVQHATHH-HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       389 ~~~G~Vy~g~~--~g~~vAvK~~~~~----~~~~~e~ei~~~~~l~-HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      +..|.||++..  +|+.+|+|.+...    ....+..|+..+.++. |+||++++|++..+ ...+++|||+.. +|.++
T Consensus        15 G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~-~~~~~~~e~~~~-~l~~l   92 (288)
T cd06616          15 GAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFRE-GDCWICMELMDI-SLDKF   92 (288)
T ss_pred             CCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecC-CcEEEEEecccC-CHHHH
Confidence            33499999988  6889999987542    2345677888888886 99999999997665 478999999864 65554


Q ss_pred             Hh---cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC
Q 041830          462 LH---GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND  538 (600)
Q Consensus       462 L~---~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~  538 (600)
                      ..   ....          ..+++.....++.+++.||+|||+  ..+++||||||+||+++.++.+||+|||+++....
T Consensus        93 ~~~~~~~~~----------~~l~~~~~~~i~~~i~~~l~~lh~--~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  160 (288)
T cd06616          93 YKYVYEVLK----------SVIPEEILGKIAVATVKALNYLKE--ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD  160 (288)
T ss_pred             HHHHHHhhc----------CCCCHHHHHHHHHHHHHHHHHHhh--cCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence            32   1111          348999999999999999999995  34899999999999999999999999999865422


Q ss_pred             -----------CCCCCcccccCC-CCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          539 -----------DTESPQFYSTNP-ASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       539 -----------~~~~pe~~~~~~-~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                                 ...+||...... ..++.++|||||||++|||++|+.||..
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  212 (288)
T cd06616         161 SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK  212 (288)
T ss_pred             CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchh
Confidence                       123466554321 3577889999999999999999999964

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=99.92  E-value=7.4e-24  Score=215.51  Aligned_cols=172  Identities=24%  Similarity=0.312  Sum_probs=136.8

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH----HHHHHHHHHHHHhCC-CCceeeeeeEEecc-CCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV----ITKLEMQLVQHATHH-HPNIVRLLGTCLTD-GPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~----~~~~e~ei~~~~~l~-HpNIv~l~g~~~~~-~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||++..  +++.||+|+++...    ......|+..+..+. |+||+++++++.+. ....++|+||++ |+|.+++
T Consensus        12 ~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l   90 (282)
T cd07831          12 FSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELI   90 (282)
T ss_pred             cceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHH
Confidence            489999987  68899999876432    112345777777775 99999999998754 147899999997 5888888


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC---
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---  539 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~---  539 (600)
                      ....           ..++|.++..++.|++.||+|||   +.+++||||||+||+++. +.+||+|||+++.....   
T Consensus        91 ~~~~-----------~~~~~~~~~~~~~qi~~~L~~LH---~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~  155 (282)
T cd07831          91 KGRK-----------RPLPEKRVKSYMYQLLKSLDHMH---RNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY  155 (282)
T ss_pred             Hhcc-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEcC-CCeEEEecccccccccCCCc
Confidence            6532           23899999999999999999999   669999999999999999 99999999998765322   


Q ss_pred             --------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 --------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 --------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                              ..+||..... ..++.++|||||||++|||++|+.||...
T Consensus       156 ~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slGv~l~el~~~~~p~~~~  202 (282)
T cd07831         156 TEYISTRWYRAPECLLTD-GYYGPKMDIWAVGCVFFEILSLFPLFPGT  202 (282)
T ss_pred             CCCCCCcccCChhHhhcC-CCCCcchhHHHHHHHHHHHHcCCcCCCCC
Confidence                    1245543321 33577899999999999999999999754

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.91  E-value=1.2e-23  Score=212.69  Aligned_cols=176  Identities=23%  Similarity=0.400  Sum_probs=137.8

Q ss_pred             eEEEEEEEEC---CeEEEEEEcchh-------------HHHHHHHHHHHHH-hCCCCceeeeeeEEeccCCceEEEEeec
Q 041830          391 EGAVYHGRLN---GKNLAIKRTEHE-------------VITKLEMQLVQHA-THHHPNIVRLLGTCLTDGPHSFLVFEYA  453 (600)
Q Consensus       391 ~G~Vy~g~~~---g~~vAvK~~~~~-------------~~~~~e~ei~~~~-~l~HpNIv~l~g~~~~~~~~~~LV~Ey~  453 (600)
                      .|.||++...   ++.+|+|.+...             ...++..|+..+. .++||||+++++++..+ ...+++|||+
T Consensus        13 ~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~-~~~~lv~e~~   91 (269)
T cd08528          13 FGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLEN-DRLYIVMDLI   91 (269)
T ss_pred             CceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccC-CeEEEEEecC
Confidence            4899999983   578999976421             1123445666554 47899999999998665 4899999999


Q ss_pred             CCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCc
Q 041830          454 KNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA  533 (600)
Q Consensus       454 ~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla  533 (600)
                      ++++|.+++......        ...+++.++++++.|++.||.|||+  ..+++|+||+|+||+++.++.+||+|||++
T Consensus        92 ~~~~l~~~l~~~~~~--------~~~~~~~~~~~~~~~l~~~l~~lh~--~~~i~H~dl~~~nil~~~~~~~~l~dfg~~  161 (269)
T cd08528          92 EGAPLGEHFNSLKEK--------KQRFTEERIWNIFVQMVLALRYLHK--EKRIVHRDLTPNNIMLGEDDKVTITDFGLA  161 (269)
T ss_pred             CCCcHHHHHHHHHhc--------cCCCCHHHHHHHHHHHHHHHHHhcc--CCceeecCCCHHHEEECCCCcEEEecccce
Confidence            999999998542211        1348999999999999999999994  257999999999999999999999999998


Q ss_pred             cccCCC-----------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          534 RCVNDD-----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       534 ~~~~~~-----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                      ......           ..+||....  ..++.++||||||+++|||++|+.||...
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Dv~slG~ll~~l~~g~~p~~~~  216 (269)
T cd08528         162 KQKQPESKLTSVVGTILYSCPEIVKN--EPYGEKADVWAFGCILYQMCTLQPPFYST  216 (269)
T ss_pred             eecccccccccccCcccCcChhhhcC--CCCchHHHHHHHHHHHHHHHhCCCccccc
Confidence            754332           124555443  34677899999999999999999999653

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=5.1e-24  Score=215.40  Aligned_cols=177  Identities=24%  Similarity=0.386  Sum_probs=142.7

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH--HHHHHHHHHHHHhC-CCCceeeeeeEEeccC-----CceEEEEeecCCCCHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV--ITKLEMQLVQHATH-HHPNIVRLLGTCLTDG-----PHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~--~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~-----~~~~LV~Ey~~~GsL~~  460 (600)
                      .|.||++..  +++.+++|.++...  ...++.|+..+..+ .|+||+++++++....     ...++||||+++++|.+
T Consensus        19 ~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~   98 (275)
T cd06608          19 YGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTD   98 (275)
T ss_pred             CeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHH
Confidence            389999998  57889999876432  34677888888888 6999999999986532     34799999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC--
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND--  538 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~--  538 (600)
                      +++.....        ...+++..+..++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||++.....  
T Consensus        99 ~~~~~~~~--------~~~~~~~~~~~~~~ql~~al~~lH---~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~  167 (275)
T cd06608          99 LVKGLRKK--------GKRLKEEWIAYILRETLRGLAYLH---ENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTL  167 (275)
T ss_pred             HHHHHhhc--------CCCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEEccCCeEEECCCccceecccch
Confidence            98653210        034899999999999999999999   67999999999999999999999999999865422  


Q ss_pred             ----------CCCCCcccccC---CCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          539 ----------DTESPQFYSTN---PASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       539 ----------~~~~pe~~~~~---~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                                ...+||.....   ...++.++|||||||+||||++|+.||..
T Consensus       168 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~  220 (275)
T cd06608         168 GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD  220 (275)
T ss_pred             hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccc
Confidence                      12356654332   23467789999999999999999999964

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=99.91  E-value=4.7e-24  Score=223.31  Aligned_cols=172  Identities=23%  Similarity=0.332  Sum_probs=139.7

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhHHH-----------------HHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEe
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEVIT-----------------KLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFE  451 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~~~-----------------~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~E  451 (600)
                      .|.||+++.  +|+.||+|.++.....                 .+.+|+..+..++|+||+++++++..+ +..++|||
T Consensus        22 ~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e  100 (335)
T PTZ00024         22 YGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEG-DFINLVMD  100 (335)
T ss_pred             ceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecC-CcEEEEEe
Confidence            489999987  6899999987543211                 256788889999999999999998655 48899999


Q ss_pred             ecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEecc
Q 041830          452 YAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFG  531 (600)
Q Consensus       452 y~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFG  531 (600)
                      |++ |+|.+++....            .+++.....++.|++.||.|||   +.+++||||+++||+++.++.+||+|||
T Consensus       101 ~~~-~~l~~~l~~~~------------~~~~~~~~~~~~ql~~aL~~LH---~~~i~H~dl~~~nill~~~~~~kl~dfg  164 (335)
T PTZ00024        101 IMA-SDLKKVVDRKI------------RLTESQVKCILLQILNGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFG  164 (335)
T ss_pred             ccc-cCHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHeEECCCCCEEECCcc
Confidence            997 69999986432            3889999999999999999999   6799999999999999999999999999


Q ss_pred             CccccCC--------------------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          532 MARCVND--------------------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       532 la~~~~~--------------------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                      +++....                          ...+||.... ...++.++|||||||++|||++|+.||...+
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~  238 (335)
T PTZ00024        165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMG-AEKYHFAVDMWSVGCIFAELLTGKPLFPGEN  238 (335)
T ss_pred             ceeecccccccccccccccccccccccccccccCCCCChhccc-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9875440                          1123444332 1235778999999999999999999997543

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=99.91  E-value=7e-24  Score=222.23  Aligned_cols=171  Identities=24%  Similarity=0.441  Sum_probs=138.6

Q ss_pred             eEEEEEEEE--CCeEEEEEEcch-----hHHHHHHHHHHHHHhC-CCCceeeeeeEEecc-CCceEEEEeecCCCCHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEH-----EVITKLEMQLVQHATH-HHPNIVRLLGTCLTD-GPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~-----~~~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~-~~~~~LV~Ey~~~GsL~~~  461 (600)
                      .|.||+|..  +|+.+|+|++..     .....+.+|+..+..+ +||||++++|++... +...|+||||++ ++|.++
T Consensus        20 ~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~   98 (337)
T cd07852          20 YGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAV   98 (337)
T ss_pred             CeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHH
Confidence            489999987  688999998743     1223456788899999 999999999997643 336799999997 599998


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--  539 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--  539 (600)
                      +...             .++|.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++.....  
T Consensus        99 ~~~~-------------~~~~~~~~~i~~qi~~~L~~LH---~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~  162 (337)
T cd07852          99 IRAN-------------ILEDVHKRYIMYQLLKALKYIH---SGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEE  162 (337)
T ss_pred             HhcC-------------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccc
Confidence            8653             2789999999999999999999   679999999999999999999999999998754322  


Q ss_pred             ---------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 ---------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 ---------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                     ..+||.... ...++.++||||||+++|||++|+.||...
T Consensus       163 ~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~sDi~slG~~l~el~tg~~pf~~~  216 (337)
T cd07852         163 NPENPVLTDYVATRWYRAPEILLG-STRYTKGVDMWSVGCILGEMLLGKPLFPGT  216 (337)
T ss_pred             cccCcchhcccccccccCceeeec-cccccccchHHHHHHHHHHHHhCCCCCCCC
Confidence                           123444322 134567899999999999999999999653

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.91  E-value=7.5e-24  Score=212.07  Aligned_cols=172  Identities=28%  Similarity=0.582  Sum_probs=142.1

Q ss_pred             eEEEEEEEECC------eEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          391 EGAVYHGRLNG------KNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       391 ~G~Vy~g~~~g------~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      .|.||+++...      ..||+|.++..    ..+.+..|+..+..++|+||+++++++..+ ...+++|||+++++|.+
T Consensus        12 ~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~i~e~~~~~~l~~   90 (258)
T smart00219       12 FGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEE-EPLMIVMEYMEGGDLLD   90 (258)
T ss_pred             CcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCC-CeeEEEEeccCCCCHHH
Confidence            38999999843      78999998653    235677888999999999999999998665 48899999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-  539 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-  539 (600)
                      ++.....          ..+++.++..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++..... 
T Consensus        91 ~~~~~~~----------~~~~~~~~~~~~~ql~~~l~~lh---~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  157 (258)
T smart00219       91 YLRKNRP----------KELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD  157 (258)
T ss_pred             HHHhhhh----------ccCCHHHHHHHHHHHHHHHHHHh---cCCeeecccccceEEEccCCeEEEcccCCceeccccc
Confidence            9976431          12899999999999999999999   679999999999999999999999999998755322 


Q ss_pred             ------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCC
Q 041830          540 ------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINR  578 (600)
Q Consensus       540 ------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~  578 (600)
                                  ..+||...  ...++.++||||+|++++||++ |+.||..
T Consensus       158 ~~~~~~~~~~~~y~~Pe~~~--~~~~~~~~Di~slG~i~~~l~~~g~~p~~~  207 (258)
T smart00219      158 YYKKKGGKLPIRWMAPESLK--DGKFTSKSDVWSFGVLLWEIFTLGESPYPG  207 (258)
T ss_pred             ccccccCCCcccccChHHhc--cCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence                        12344332  2446778999999999999998 8888864

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=99.91  E-value=1.6e-23  Score=209.08  Aligned_cols=172  Identities=24%  Similarity=0.392  Sum_probs=142.8

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||++..  +++.+++|.++...      ...+..|+..+..++|+||+++++.+..+ ...+++|||+++++|.+++
T Consensus         6 ~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~l   84 (250)
T cd05123           6 FGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTE-EKLYLVLEYAPGGELFSHL   84 (250)
T ss_pred             ceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecC-CeeEEEEecCCCCcHHHHH
Confidence            489999988  58899999876532      23567788889999999999999987544 5889999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC---
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---  539 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~---  539 (600)
                      ....            .+++.++..++.|++.||.|||   +.+++|+||+|+||+++.++.++|+|||++......   
T Consensus        85 ~~~~------------~l~~~~~~~~~~qi~~~l~~lh---~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~  149 (250)
T cd05123          85 SKEG------------RFSEERARFYAAEIVLALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSR  149 (250)
T ss_pred             HhcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCc
Confidence            7543            3899999999999999999999   679999999999999999999999999998754332   


Q ss_pred             ---------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 ---------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 ---------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                               ..+||....  ..++.++|+||||+++|||++|+.||...+
T Consensus       150 ~~~~~~~~~~~~Pe~~~~--~~~~~~~D~~slG~~~~~l~~g~~p~~~~~  197 (250)
T cd05123         150 TNTFCGTPEYLAPEVLLG--KGYGKAVDWWSLGVLLYEMLTGKPPFYAED  197 (250)
T ss_pred             ccCCcCCccccChHHhCC--CCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence                     124454433  335778999999999999999999996543

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=99.91  E-value=9.9e-24  Score=216.43  Aligned_cols=173  Identities=22%  Similarity=0.362  Sum_probs=137.6

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      .|.||+|+.  +|+.||+|.++..     ....+..|+..+..++||||+++++++... ...|+||||++ ++|.+++.
T Consensus        15 ~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~-~~l~~~~~   92 (294)
T PLN00009         15 YGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSE-KRLYLVFEYLD-LDLKKHMD   92 (294)
T ss_pred             CEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecC-CeEEEEEeccc-ccHHHHHH
Confidence            389999987  6889999987542     123567788999999999999999998655 58999999996 58888875


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC-CCcEEEEeccCccccCCC---
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE-EFNARVGNFGMARCVNDD---  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~-~~~~kI~DFGla~~~~~~---  539 (600)
                      ....          ..+++.....++.||+.||+|||   +.+++||||+|+||+++. ++.+||+|||+++.....   
T Consensus        93 ~~~~----------~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~  159 (294)
T PLN00009         93 SSPD----------FAKNPRLIKTYLYQILRGIAYCH---SHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT  159 (294)
T ss_pred             hCCC----------CCcCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccc
Confidence            4332          22678888899999999999999   679999999999999985 567999999998754211   


Q ss_pred             ---------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 ---------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 ---------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                               ..+||.... ...++.++|||||||++|||+||+.||...
T Consensus       160 ~~~~~~~~~y~~PE~~~~-~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~  207 (294)
T PLN00009        160 FTHEVVTLWYRAPEILLG-SRHYSTPVDIWSVGCIFAEMVNQKPLFPGD  207 (294)
T ss_pred             cccCceeecccCHHHHhC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                     234554432 234677899999999999999999999653

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.91  E-value=9.6e-24  Score=215.86  Aligned_cols=172  Identities=23%  Similarity=0.329  Sum_probs=138.5

Q ss_pred             eEEEEEEEE-----CCeEEEEEEcchhH-------HHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCC
Q 041830          391 EGAVYHGRL-----NGKNLAIKRTEHEV-------ITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGS  457 (600)
Q Consensus       391 ~G~Vy~g~~-----~g~~vAvK~~~~~~-------~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~Gs  457 (600)
                      .|.||+++.     +++.||||.++...       .+.+..|+..+..+ +||||+++++.+..+ ...++||||+++|+
T Consensus        13 ~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~   91 (288)
T cd05583          13 YGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTD-TKLHLILDYVNGGE   91 (288)
T ss_pred             CceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecC-CEEEEEEecCCCCc
Confidence            489999875     46789999876422       23466788888888 599999999886544 57899999999999


Q ss_pred             HHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC
Q 041830          458 LKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN  537 (600)
Q Consensus       458 L~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~  537 (600)
                      |.+++....            .+++.+...++.|+++||.|||   +.+++||||||+||+++.++.++|+|||+++...
T Consensus        92 L~~~~~~~~------------~~~~~~~~~~~~ql~~~l~~lH---~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~  156 (288)
T cd05583          92 LFTHLYQRE------------HFTESEVRVYIAEIVLALDHLH---QLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFL  156 (288)
T ss_pred             HHHHHhhcC------------CcCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHeEECCCCCEEEEECccccccc
Confidence            999986532            3889999999999999999999   6799999999999999999999999999987542


Q ss_pred             CC-------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          538 DD-------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       538 ~~-------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                      ..             ..+||.........+.++||||||+++|||++|+.||..
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~  210 (288)
T cd05583         157 AEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV  210 (288)
T ss_pred             cccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence            21             124554433222356789999999999999999999964

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=99.91  E-value=1.1e-25  Score=252.84  Aligned_cols=175  Identities=26%  Similarity=0.387  Sum_probs=143.0

Q ss_pred             eeEEEEEEEE--CCeEEEEEEcchhH-----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          390 IEGAVYHGRL--NGKNLAIKRTEHEV-----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       390 ~~G~Vy~g~~--~g~~vAvK~~~~~~-----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .+|.||.+..  +|+..|+|.++...     .+...+|+..+..+.|||+|+++|+-.++ +..+|.||||++|+|.+.+
T Consensus      1247 ~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHR-ekv~IFMEyC~~GsLa~ll 1325 (1509)
T KOG4645|consen 1247 TFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHR-EKVYIFMEYCEGGSLASLL 1325 (1509)
T ss_pred             ceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecH-HHHHHHHHHhccCcHHHHH
Confidence            3499999987  89999999764322     23567888899999999999999997665 4789999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC---
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---  539 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~---  539 (600)
                      ..++.            +++.....+..|++.|++|||   +.+||||||||.||+|+.+|.+|.+|||.|+.+...   
T Consensus      1326 ~~gri------------~dE~vt~vyt~qll~gla~LH---~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1326 EHGRI------------EDEMVTRVYTKQLLEGLAYLH---EHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred             Hhcch------------hhhhHHHHHHHHHHHHHHHHH---hcCceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence            87643            666677778899999999999   679999999999999999999999999999865433   


Q ss_pred             -------------CCCCcccccCC-CCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 -------------TESPQFYSTNP-ASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 -------------~~~pe~~~~~~-~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                                   +++||...+.. .....+.||||+|||+.||+||+.||...+
T Consensus      1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d 1445 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD 1445 (1509)
T ss_pred             CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc
Confidence                         23566554432 233456899999999999999999997543

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=99.91  E-value=7.8e-24  Score=222.76  Aligned_cols=189  Identities=20%  Similarity=0.344  Sum_probs=145.3

Q ss_pred             CHHHHHHHHhccCCCCc----eeEEEEEEEE--CCeEEEEEEcchhH-----HHHHHHHHHHHHhCCCCceeeeeeEEec
Q 041830          373 SIEDLRRATEKFNSSNR----IEGAVYHGRL--NGKNLAIKRTEHEV-----ITKLEMQLVQHATHHHPNIVRLLGTCLT  441 (600)
Q Consensus       373 ~~~el~~~t~~f~~~~~----~~G~Vy~g~~--~g~~vAvK~~~~~~-----~~~~e~ei~~~~~l~HpNIv~l~g~~~~  441 (600)
                      ..+++...++.|.....    ..|.||++..  +|+.||+|+++...     ...+.+|+..+..++||||+++++++..
T Consensus         8 ~~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~   87 (345)
T cd07877           8 LNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTP   87 (345)
T ss_pred             HHHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeee
Confidence            34445555555543222    2389999986  78999999875421     2345678889999999999999998753


Q ss_pred             cC-----CceEEEEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCC
Q 041830          442 DG-----PHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRN  516 (600)
Q Consensus       442 ~~-----~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~N  516 (600)
                      ..     ...++++|++ +++|.+++...             .+++..+..++.|+++||+|||   +.+++||||||+|
T Consensus        88 ~~~~~~~~~~~lv~~~~-~~~L~~~~~~~-------------~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~N  150 (345)
T cd07877          88 ARSLEEFNDVYLVTHLM-GADLNNIVKCQ-------------KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSN  150 (345)
T ss_pred             cccccccccEEEEehhc-ccCHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChHH
Confidence            21     2467888887 78999888642             2899999999999999999999   6799999999999


Q ss_pred             EEeCCCCcEEEEeccCccccCCC---------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          517 IFLDEEFNARVGNFGMARCVNDD---------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       517 ILld~~~~~kI~DFGla~~~~~~---------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                      |++++++.+||+|||+++.....         ..+||.... ...++.++|||||||++|||++|+.||...
T Consensus       151 Ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwslG~il~el~~g~~pf~~~  221 (345)
T cd07877         151 LAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLN-WMHYNQTVDIWSVGCIMAELLTGRTLFPGT  221 (345)
T ss_pred             EEEcCCCCEEEecccccccccccccccccCCCccCHHHHhC-ccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            99999999999999998754322         224554432 134677899999999999999999999643

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=99.91  E-value=4.9e-24  Score=239.14  Aligned_cols=184  Identities=26%  Similarity=0.426  Sum_probs=145.0

Q ss_pred             CCceeEEEEEEEEC---------CeEEEEEEcchhH----HHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEee
Q 041830          387 SNRIEGAVYHGRLN---------GKNLAIKRTEHEV----ITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEY  452 (600)
Q Consensus       387 ~~~~~G~Vy~g~~~---------g~~vAvK~~~~~~----~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey  452 (600)
                      +.+..|.|++|...         ...||||.++...    .+.+..|+..|..+ +|+||+.++|+|..+ ...++|+||
T Consensus       305 g~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~-~~~~~v~Ey  383 (609)
T KOG0200|consen  305 GEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD-GPLYVIVEY  383 (609)
T ss_pred             ecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC-CceEEEEEe
Confidence            44445999999862         3469999976532    34567788877776 499999999999774 488999999


Q ss_pred             cCCCCHHHHHhcCcCccccccccc----c--cCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEE
Q 041830          453 AKNGSLKDWLHGGLAMKNQFIASC----Y--CFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNAR  526 (600)
Q Consensus       453 ~~~GsL~~~L~~~~~~~~~~~~~~----~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~k  526 (600)
                      +++|+|.+||+..+..  ......    .  ..|+..+.+.++.|||.||+||+   +.+++||||..+|||+.++..+|
T Consensus       384 ~~~G~L~~~Lr~~r~~--~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~---~~~~vHRDLAaRNVLi~~~~~~k  458 (609)
T KOG0200|consen  384 AEHGDLLEFLRKKRVT--ESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLA---SVPCVHRDLAARNVLITKNKVIK  458 (609)
T ss_pred             ccCCcHHHHHHhcccc--ccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHh---hCCccchhhhhhhEEecCCCEEE
Confidence            9999999999887610  000000    0  24899999999999999999999   67899999999999999999999


Q ss_pred             EEeccCccccCCC---------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCC
Q 041830          527 VGNFGMARCVNDD---------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINR  578 (600)
Q Consensus       527 I~DFGla~~~~~~---------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~  578 (600)
                      |+|||++|.....               +.+||....  ..++.++|||||||+||||+| |..||..
T Consensus       459 IaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~--~~ft~kSDVWSfGI~L~EifsLG~~PYp~  524 (609)
T KOG0200|consen  459 IADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFD--RVFTSKSDVWSFGILLWEIFTLGGTPYPG  524 (609)
T ss_pred             EccccceeccCCCCceEecCCCCccceeecCHHHhcc--CcccccchhhHHHHHHHHHhhCCCCCCCC
Confidence            9999999843221               223443333  567899999999999999999 9999975

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=99.91  E-value=1.5e-25  Score=213.74  Aligned_cols=180  Identities=23%  Similarity=0.370  Sum_probs=139.2

Q ss_pred             CCceeEEEEEEEE--CCeEEEEEEcchhH----HHHHHHHHHH-HHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHH
Q 041830          387 SNRIEGAVYHGRL--NGKNLAIKRTEHEV----ITKLEMQLVQ-HATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       387 ~~~~~G~Vy~g~~--~g~~vAvK~~~~~~----~~~~e~ei~~-~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~  459 (600)
                      ++|.+|+|++-.+  .|+..|||+++...    .+++.+|... ++.-.-||||+++|.++.++ ..|+.||.|.- ||.
T Consensus        73 G~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EG-dcWiCMELMd~-SlD  150 (361)
T KOG1006|consen   73 GNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEG-DCWICMELMDI-SLD  150 (361)
T ss_pred             cCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCC-ceeeeHHHHhh-hHH
Confidence            5666799999877  79999999976432    2344455443 33446899999999999887 78999999964 665


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC--
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN--  537 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~--  537 (600)
                      .+-..-....       ...+++.-.-.|..-..+||.||-+  ...|+|||+||+|||||..|.+|++|||.+..+.  
T Consensus       151 klYk~vy~vq-------~~~ipE~Ilg~ItvatV~AL~yLK~--~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~S  221 (361)
T KOG1006|consen  151 KLYKRVYSVQ-------KSRIPENILGHITVATVDALDYLKE--ELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDS  221 (361)
T ss_pred             HHHHHHHHHH-------hccCcHhhhhheeeeehhHHHHHHH--HhhhhhccCChhheEEecCCCEeeecccchHhHHHH
Confidence            5432210000       0237787777888888999999986  4689999999999999999999999999875432  


Q ss_pred             ---------CCCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCC
Q 041830          538 ---------DDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN  577 (600)
Q Consensus       538 ---------~~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~  577 (600)
                               ..+.+||...+....|+-++||||+|+.|+|+.||+.||.
T Consensus       222 iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr  270 (361)
T KOG1006|consen  222 IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYR  270 (361)
T ss_pred             HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcc
Confidence                     2345788777766678999999999999999999999996

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=99.91  E-value=1.1e-23  Score=214.52  Aligned_cols=173  Identities=23%  Similarity=0.386  Sum_probs=141.2

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhHH----HHHHHHHHHHHhCC-CCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEVI----TKLEMQLVQHATHH-HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~~----~~~e~ei~~~~~l~-HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      .|.||+|+.  +++.|+||++.....    ....+|+..+..++ |+||+++++++..+ ...++||||+ +|+|.+++.
T Consensus        12 ~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~-~~~~lv~e~~-~~~l~~~~~   89 (283)
T cd07830          12 FGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFREN-DELYFVFEYM-EGNLYQLMK   89 (283)
T ss_pred             ceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcC-CcEEEEEecC-CCCHHHHHH
Confidence            389999998  578899998765321    23356788888888 99999999998664 5899999999 889999987


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD----  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~----  539 (600)
                      ....          ..++|.+++.++.|++.+|.|||   +.+++|+||+|+||++++++.++|+|||++......    
T Consensus        90 ~~~~----------~~~~~~~~~~~~~~l~~~l~~Lh---~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  156 (283)
T cd07830          90 DRKG----------KPFSESVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYT  156 (283)
T ss_pred             hccc----------ccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcC
Confidence            6431          24899999999999999999999   669999999999999999999999999998755431    


Q ss_pred             -------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 -------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 -------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                             ..+||..... ..++.++|+||||+++|||++|+.||...
T Consensus       157 ~~~~~~~~~aPE~~~~~-~~~~~~~Di~s~G~~l~el~~g~~~~~~~  202 (283)
T cd07830         157 DYVSTRWYRAPEILLRS-TSYSSPVDIWALGCIMAELYTLRPLFPGS  202 (283)
T ss_pred             CCCCcccccCceeeecC-cCcCCccchhhHHHHHHHHHhCCCccCCC
Confidence                   1245544322 34577899999999999999999999654

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=99.91  E-value=2.7e-23  Score=215.01  Aligned_cols=173  Identities=25%  Similarity=0.388  Sum_probs=140.6

Q ss_pred             eEEEEEEEE--CCeEEEEEEcch------hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEH------EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~------~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||+|+.  +++.+|+|.+..      .....+..|+..+..++|+|++++++++... ...++||||+. |+|.+++
T Consensus        28 ~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~-~~l~~~~  105 (308)
T cd06634          28 FGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-HTAWLVMEYCL-GSASDLL  105 (308)
T ss_pred             CEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcC-CeeEEEEEccC-CCHHHHH
Confidence            489999998  678899998653      1223566788899999999999999998765 47899999996 6888877


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC---
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---  539 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~---  539 (600)
                      ....           ..+++.++..++.+++.||.|||   +.+++||||||+||+++.++.+||+|||++......   
T Consensus       106 ~~~~-----------~~l~~~~~~~~~~~l~~~l~~LH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~  171 (308)
T cd06634         106 EVHK-----------KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANXF  171 (308)
T ss_pred             HHcC-----------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHhEEECCCCcEEECCcccceeecCcccc
Confidence            5432           23889999999999999999999   679999999999999999999999999998754322   


Q ss_pred             -----CCCCccccc-CCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 -----TESPQFYST-NPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 -----~~~pe~~~~-~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                           +.+||.... ....++.++|||||||++|||++|+.||...
T Consensus       172 ~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  217 (308)
T cd06634         172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM  217 (308)
T ss_pred             cCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccc
Confidence                 234665432 1234677899999999999999999998653

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=99.91  E-value=5.9e-24  Score=222.58  Aligned_cols=172  Identities=22%  Similarity=0.397  Sum_probs=139.5

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEecc---CCceEEEEeecCCCCHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTD---GPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~---~~~~~LV~Ey~~~GsL~~  460 (600)
                      .|.||++..  +|+.||+|++...     ....+..|+..+..++||||+++++++...   ....++||||+. |+|.+
T Consensus        18 ~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~   96 (334)
T cd07855          18 YGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHH   96 (334)
T ss_pred             CeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHH
Confidence            389999987  6899999987643     224566788999999999999999986532   236799999996 69999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-  539 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-  539 (600)
                      +++...            .+++..+..++.|++.||.|||   +.+++||||||+||++++++.+||+|||+++..... 
T Consensus        97 ~~~~~~------------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  161 (334)
T cd07855          97 IIHSDQ------------PLTEEHIRYFLYQLLRGLKYIH---SANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSP  161 (334)
T ss_pred             HhccCC------------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCcEEecccccceeecccC
Confidence            986542            3899999999999999999999   679999999999999999999999999998754321 


Q ss_pred             ---------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 ---------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 ---------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                     ..+||..... ..++.++|||||||++|||++|+.||...
T Consensus       162 ~~~~~~~~~~~~~~~y~~PE~~~~~-~~~~~~~Di~slG~~l~el~~g~~pf~~~  215 (334)
T cd07855         162 TEHKYFMTEYVATRWYRAPELLLSL-PEYTTAIDMWSVGCIFAEMLGRRQLFPGK  215 (334)
T ss_pred             cCCCcccccccccccccChHHhcCC-cccccccchHHHHHHHHHHHcCCCccCCC
Confidence                           1235543321 34678899999999999999999999653

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=99.91  E-value=1.4e-23  Score=221.41  Aligned_cols=169  Identities=21%  Similarity=0.355  Sum_probs=138.2

Q ss_pred             eEEEEEEEE--CCeEEEEEEcch-----hHHHHHHHHHHHHHhCCCCceeeeeeEEeccC-----CceEEEEeecCCCCH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEH-----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDG-----PHSFLVFEYAKNGSL  458 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~-----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~-----~~~~LV~Ey~~~GsL  458 (600)
                      .|.||+++.  +|+.||+|.+..     .....+.+|+..+..++||||+++++++..+.     ...|+||||+. ++|
T Consensus        29 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l  107 (353)
T cd07850          29 QGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANL  107 (353)
T ss_pred             CEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC-CCH
Confidence            499999987  789999998753     22245567888999999999999999875332     24699999996 588


Q ss_pred             HHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC
Q 041830          459 KDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND  538 (600)
Q Consensus       459 ~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~  538 (600)
                      .+++..              .+++.++..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++....
T Consensus       108 ~~~~~~--------------~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  170 (353)
T cd07850         108 CQVIQM--------------DLDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  170 (353)
T ss_pred             HHHHhh--------------cCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEccCccceeCCC
Confidence            888753              2788899999999999999999   66999999999999999999999999999976533


Q ss_pred             C-----------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 D-----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 ~-----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                      .           ..+||....  ..++.++|||||||++|||++|+.||...
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~~l~~g~~pf~~~  220 (353)
T cd07850         171 SFMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIRGTVLFPGT  220 (353)
T ss_pred             CCCCCCCcccccccCHHHHhC--CCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence            2           224554433  45678899999999999999999999754

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=99.91  E-value=8.7e-24  Score=220.86  Aligned_cols=171  Identities=23%  Similarity=0.364  Sum_probs=139.8

Q ss_pred             eEEEEEEEE--CCeEEEEEEcch-----hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEH-----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~-----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      .|.||++..  +|+.||+|++..     ...+.+..|+..+..++||||+++++++...+...++++||+ +++|.++++
T Consensus        23 ~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~  101 (328)
T cd07856          23 FGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLT  101 (328)
T ss_pred             CeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHh
Confidence            389999986  788999998643     123456778889999999999999999876555789999999 568998886


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD----  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~----  539 (600)
                      ..             .+++.....++.|++.||.|||   +.+++||||+|+||++++++.+||+|||+++.....    
T Consensus       102 ~~-------------~~~~~~~~~~~~ql~~aL~~LH---~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~  165 (328)
T cd07856         102 SR-------------PLEKQFIQYFLYQILRGLKYVH---SAGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGY  165 (328)
T ss_pred             cC-------------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEeECCCCCEEeCccccccccCCCcCCC
Confidence            42             2788888899999999999999   679999999999999999999999999998754322    


Q ss_pred             -----CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 -----TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 -----~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                           ..+||.... ...++.++||||||+++|||++|+.||...
T Consensus       166 ~~~~~y~aPE~~~~-~~~~~~~~Dv~slG~il~el~tg~~~f~~~  209 (328)
T cd07856         166 VSTRYYRAPEIMLT-WQKYDVEVDIWSAGCIFAEMLEGKPLFPGK  209 (328)
T ss_pred             cccccccCceeeec-cCCcCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                 234554432 134677899999999999999999999653

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=99.91  E-value=7.7e-24  Score=221.88  Aligned_cols=170  Identities=21%  Similarity=0.384  Sum_probs=137.6

Q ss_pred             EEEEEEEE--CCeEEEEEEcch----hHHHHHHHHHHHHHhCCCCceeeeeeEEeccC----CceEEEEeecCCCCHHHH
Q 041830          392 GAVYHGRL--NGKNLAIKRTEH----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDG----PHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~----~~~~LV~Ey~~~GsL~~~  461 (600)
                      |.||+|+.  +|+.||+|.++.    .....+..|+..+..++|+||+++++++....    ...++++||+++ +|.++
T Consensus        19 g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~   97 (336)
T cd07849          19 GMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKL   97 (336)
T ss_pred             eEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhccc-CHHHH
Confidence            89999987  789999998753    12245667888999999999999999865432    247999999974 88887


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--  539 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--  539 (600)
                      +...             .+++..+..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++.....  
T Consensus        98 ~~~~-------------~l~~~~~~~i~~ql~~aL~~LH---~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~  161 (336)
T cd07849          98 IKTQ-------------HLSNDHIQYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHD  161 (336)
T ss_pred             HhcC-------------CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHEEECCCCCEEECcccceeecccccc
Confidence            7542             3899999999999999999999   679999999999999999999999999998754321  


Q ss_pred             -------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 -------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 -------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                   ..+||.... ...++.++|||||||++|||++|+.||...
T Consensus       162 ~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwslGvil~el~~G~~~f~~~  213 (336)
T cd07849         162 HTGFLTEYVATRWYRAPEIMLN-SKGYTKAIDIWSVGCILAEMLSNRPLFPGK  213 (336)
T ss_pred             ccCCcCCcCcCCCccChHHhhC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                         234554322 234677899999999999999999999643

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=99.91  E-value=1.6e-23  Score=213.46  Aligned_cols=174  Identities=22%  Similarity=0.385  Sum_probs=136.5

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHH---hCCCCceeeeeeEEeccCC----ceEEEEeecCCC
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHA---THHHPNIVRLLGTCLTDGP----HSFLVFEYAKNG  456 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~---~l~HpNIv~l~g~~~~~~~----~~~LV~Ey~~~G  456 (600)
                      .|.||+++.  +|+.||+|+++..     ....+..|+..+.   .+.|+||+++++++.....    ..+++|||+. +
T Consensus        12 ~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~-~   90 (287)
T cd07838          12 YGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-Q   90 (287)
T ss_pred             ceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhcc-c
Confidence            389999998  4899999987532     1123344554443   4569999999999875531    2899999997 5


Q ss_pred             CHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCcccc
Q 041830          457 SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV  536 (600)
Q Consensus       457 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~  536 (600)
                      +|.+++.....          ..++|.+++.++.|++.||.|||   +.+++|+||+|+||+++.++.+||+|||++...
T Consensus        91 ~l~~~l~~~~~----------~~l~~~~~~~~~~~i~~al~~LH---~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~  157 (287)
T cd07838          91 DLATYLSKCPK----------PGLPPETIKDLMRQLLRGVDFLH---SHRIVHRDLKPQNILVTSDGQVKIADFGLARIY  157 (287)
T ss_pred             CHHHHHHHccC----------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhEEEccCCCEEEeccCcceec
Confidence            89998875431          23899999999999999999999   668999999999999999999999999998765


Q ss_pred             CCC-----------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          537 NDD-----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       537 ~~~-----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                      ...           ..+||....  ..++.++|+|||||++|||++|+.||....
T Consensus       158 ~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~  210 (287)
T cd07838         158 SFEMALTSVVVTLWYRAPEVLLQ--SSYATPVDMWSVGCIFAELFRRRPLFRGTS  210 (287)
T ss_pred             cCCcccccccccccccChHHhcc--CCCCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence            322           124555433  346778999999999999999999987543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=99.91  E-value=1.3e-23  Score=216.06  Aligned_cols=173  Identities=24%  Similarity=0.405  Sum_probs=135.4

Q ss_pred             eEEEEEEEEC--CeEEEEEEcchh----HHHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          391 EGAVYHGRLN--GKNLAIKRTEHE----VITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       391 ~G~Vy~g~~~--g~~vAvK~~~~~----~~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      .|.||+++..  |+.||||.++..    ....+..|+..+... .||||++++|++..+ ...|++|||++ ++|.+++.
T Consensus        28 ~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-~~~~~v~e~~~-~~l~~l~~  105 (296)
T cd06618          28 CGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITD-SDVFICMELMS-TCLDKLLK  105 (296)
T ss_pred             CeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecC-CeEEEEeeccC-cCHHHHHH
Confidence            3899999994  899999998642    223344555544444 599999999998665 48999999985 47777765


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC-----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND-----  538 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~-----  538 (600)
                      ...           ..+++.++..++.+++.||+|||+  ..+|+||||+|+||++++++.+||+|||++.....     
T Consensus       106 ~~~-----------~~l~~~~~~~i~~~i~~~l~~lH~--~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~~  172 (296)
T cd06618         106 RIQ-----------GPIPEDILGKMTVAIVKALHYLKE--KHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKT  172 (296)
T ss_pred             Hhc-----------CCCCHHHHHHHHHHHHHHHHHHHh--hCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCccc
Confidence            422           248999999999999999999994  25899999999999999999999999999875432     


Q ss_pred             ------CCCCCcccccCC--CCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          539 ------DTESPQFYSTNP--ASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       539 ------~~~~pe~~~~~~--~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                            ...+||......  ..++.++||||||+++|||++|+.||..
T Consensus       173 ~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  220 (296)
T cd06618         173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN  220 (296)
T ss_pred             CCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence                  123466554322  3467789999999999999999999965

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=99.91  E-value=1e-23  Score=221.10  Aligned_cols=172  Identities=17%  Similarity=0.350  Sum_probs=139.5

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEeccC----CceEEEEeecCCCCHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTDG----PHSFLVFEYAKNGSLK  459 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~----~~~~LV~Ey~~~GsL~  459 (600)
                      .|.||+++.  +|+.||||.++..     ....+..|+..+..++|+||+++++++....    ...++++||+. ++|.
T Consensus        18 ~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~   96 (337)
T cd07858          18 YGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLH   96 (337)
T ss_pred             CeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHH
Confidence            489999987  6899999987542     2234567888888999999999999875432    24799999996 6899


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD  539 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~  539 (600)
                      +++....            .+++.++..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++.....
T Consensus        97 ~~~~~~~------------~l~~~~~~~i~~qi~~aL~~LH---~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~  161 (337)
T cd07858          97 QIIRSSQ------------TLSDDHCQYFLYQLLRGLKYIH---SANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEK  161 (337)
T ss_pred             HHHhcCC------------CCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCEEECcCccccccCCC
Confidence            9886542            3899999999999999999999   679999999999999999999999999998765332


Q ss_pred             ------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 ------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 ------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                  ..+||..... ..++.++|||||||++|||++|+.||...
T Consensus       162 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~DiwslG~il~~l~~g~~pf~~~  212 (337)
T cd07858         162 GDFMTEYVVTRWYRAPELLLNC-SEYTTAIDVWSVGCIFAELLGRKPLFPGK  212 (337)
T ss_pred             cccccccccccCccChHHHhcC-CCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence                        2345544321 23678899999999999999999999653

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=99.91  E-value=4.2e-23  Score=206.29  Aligned_cols=175  Identities=25%  Similarity=0.392  Sum_probs=144.4

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      .|.||++..  +++.+++|++...     ....+..|+..+..++|+|++++++.+... ...++|+||+++++|.++++
T Consensus        13 ~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~   91 (258)
T cd08215          13 FGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEK-GKLCIVMEYADGGDLSQKIK   91 (258)
T ss_pred             CeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecC-CEEEEEEEecCCCcHHHHHH
Confidence            389999998  4899999997642     334567888889999999999999997655 58899999999999999997


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD----  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~----  539 (600)
                      ......        ..+++.++..++.+++.||.|||   +.+++|+||+|+||+++.++.+||+|||++......    
T Consensus        92 ~~~~~~--------~~~~~~~~~~i~~~i~~~l~~lh---~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~  160 (258)
T cd08215          92 KQKKEG--------KPFPEEQILDWFVQLCLALKYLH---SRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA  160 (258)
T ss_pred             HhhccC--------CCcCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHHeEEcCCCcEEECCccceeecccCccee
Confidence            643110        34899999999999999999999   669999999999999999999999999998765332    


Q ss_pred             --------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 --------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 --------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                              ..+||....  ..++.++|+||||+++|||++|+.||...
T Consensus       161 ~~~~~~~~y~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~g~~p~~~~  206 (258)
T cd08215         161 KTVVGTPYYLSPELCQN--KPYNYKSDIWSLGCVLYELCTLKHPFEGE  206 (258)
T ss_pred             cceeeeecccChhHhcc--CCCCccccHHHHHHHHHHHHcCCCCCCCC
Confidence                    123444332  34677899999999999999999999654

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=99.91  E-value=1.8e-23  Score=215.71  Aligned_cols=174  Identities=21%  Similarity=0.353  Sum_probs=138.5

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH-----HHHHHHHHHHHHhCCCCceeeeeeEEeccC-------CceEEEEeecCCC
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV-----ITKLEMQLVQHATHHHPNIVRLLGTCLTDG-------PHSFLVFEYAKNG  456 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~-----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~-------~~~~LV~Ey~~~G  456 (600)
                      .|.||+++.  +|+.||||.+....     ...+..|+..+..++||||++++++|....       ...++||||+.+ 
T Consensus        25 ~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-  103 (310)
T cd07865          25 FGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-  103 (310)
T ss_pred             CEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCCc-
Confidence            389999988  68999999875321     123456888899999999999999986542       235999999974 


Q ss_pred             CHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCcccc
Q 041830          457 SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV  536 (600)
Q Consensus       457 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~  536 (600)
                      +|.+++....           ..+++.+++.++.|++.||.|||   +.+++|+||||+||+++.++.+||+|||++...
T Consensus       104 ~l~~~l~~~~-----------~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~  169 (310)
T cd07865         104 DLAGLLSNKN-----------VKFTLSEIKKVMKMLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAF  169 (310)
T ss_pred             CHHHHHHhcc-----------cCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEECCCCcEEECcCCCcccc
Confidence            8888886432           23899999999999999999999   669999999999999999999999999998754


Q ss_pred             CCC----------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          537 NDD----------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       537 ~~~----------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                      ...                ..+||..... ..++.++||||||+++|||++|+.||...+
T Consensus       170 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~el~t~~~~~~~~~  228 (310)
T cd07865         170 SLSKNSKPNRYTNRVVTLWYRPPELLLGE-RDYGPPIDMWGAGCIMAEMWTRSPIMQGNT  228 (310)
T ss_pred             cCCcccCCCCccCcccCccccCcHHhcCC-cccCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence            221                2345544321 235678999999999999999999996543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=99.91  E-value=3.3e-23  Score=206.92  Aligned_cols=171  Identities=28%  Similarity=0.449  Sum_probs=142.9

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      .|.||++..  +++.|++|.+...     ....+..|+..+..++|+|++++++++... ...+++|||+++++|.+++.
T Consensus        13 ~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~   91 (254)
T cd06627          13 FGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETS-DSLYIILEYAENGSLRQIIK   91 (254)
T ss_pred             CeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeC-CEEEEEEecCCCCcHHHHHH
Confidence            389999987  6789999987543     234678889999999999999999997655 58899999999999999986


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCCC---
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDT---  540 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~~---  540 (600)
                      ...            .+++..+..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++.......   
T Consensus        92 ~~~------------~l~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  156 (254)
T cd06627          92 KFG------------PFPESLVAVYVYQVLQGLAYLH---EQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDD  156 (254)
T ss_pred             hcc------------CCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcccc
Confidence            542            3899999999999999999999   6799999999999999999999999999987654322   


Q ss_pred             ---------CCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          541 ---------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       541 ---------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                               .+||....  ...+.++||||||+++|||++|+.||...
T Consensus       157 ~~~~~~~~y~~pe~~~~--~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~  202 (254)
T cd06627         157 ASVVGTPYWMAPEVIEM--SGASTASDIWSLGCTVIELLTGNPPYYDL  202 (254)
T ss_pred             cccccchhhcCHhhhcC--CCCCcchhHHHHHHHHHHHHhCCCCCCCc
Confidence                     23454433  23577899999999999999999999653

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=99.91  E-value=1.7e-23  Score=219.90  Aligned_cols=169  Identities=21%  Similarity=0.400  Sum_probs=136.6

Q ss_pred             EEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEeccC-----CceEEEEeecCCCCHH
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTDG-----PHSFLVFEYAKNGSLK  459 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~-----~~~~LV~Ey~~~GsL~  459 (600)
                      |.||+|+.  +|+.||+|++...     ....+.+|+..+..++||||+++++++....     ...++|+||+.. +|.
T Consensus        29 g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~  107 (342)
T cd07879          29 GSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQ  107 (342)
T ss_pred             eEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEeccccc-CHH
Confidence            89999987  6899999987542     1234677888999999999999999976432     246899999974 777


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD  539 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~  539 (600)
                      +++.              ..+++.++..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||+++.....
T Consensus       108 ~~~~--------------~~~~~~~~~~~~~qi~~aL~~LH---~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~  170 (342)
T cd07879         108 KIMG--------------HPLSEDKVQYLVYQMLCGLKYIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE  170 (342)
T ss_pred             HHHc--------------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC
Confidence            6652              13889999999999999999999   678999999999999999999999999998764322


Q ss_pred             ---------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 ---------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 ---------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                               ..+||.... ...++.++|||||||++|||++|+.||...
T Consensus       171 ~~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slGvil~el~~g~~pf~~~  218 (342)
T cd07879         171 MTGYVVTRWYRAPEVILN-WMHYNQTVDIWSVGCIMAEMLTGKTLFKGK  218 (342)
T ss_pred             CCCceeeecccChhhhcC-ccccCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence                     234555432 134677899999999999999999999754

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.90  E-value=7.1e-24  Score=195.68  Aligned_cols=174  Identities=21%  Similarity=0.346  Sum_probs=133.9

Q ss_pred             EEEEEEECCeEEEEEEcchhH----HHHHHHHHHHH-HhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcC
Q 041830          393 AVYHGRLNGKNLAIKRTEHEV----ITKLEMQLVQH-ATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLA  467 (600)
Q Consensus       393 ~Vy~g~~~g~~vAvK~~~~~~----~~~~e~ei~~~-~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~  467 (600)
                      .+|+-..+|...|+|+++...    .++..+|+... +....|.+|.|+|..+.++ ..|+.||.|.- ||..|-+.-..
T Consensus        63 ekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~reg-dvwIcME~M~t-Sldkfy~~v~~  140 (282)
T KOG0984|consen   63 EKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREG-DVWICMELMDT-SLDKFYRKVLK  140 (282)
T ss_pred             hheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccc-cEEEeHHHhhh-hHHHHHHHHHh
Confidence            345555599999999976432    23344454433 3345899999999987776 89999999964 88776543111


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC----------
Q 041830          468 MKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN----------  537 (600)
Q Consensus       468 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~----------  537 (600)
                      .        ....++...=+|+..|..||.|||+  ...++|||+||+|||++.+|++||+|||.+..+.          
T Consensus       141 ~--------g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiAkt~daG  210 (282)
T KOG0984|consen  141 K--------GGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIAKTMDAG  210 (282)
T ss_pred             c--------CCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhhHHHHhcC
Confidence            0        0337888888999999999999997  5689999999999999999999999999986542          


Q ss_pred             -CCCCCCcccccC--CCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          538 -DDTESPQFYSTN--PASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       538 -~~~~~pe~~~~~--~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                       ..+.+||....+  ...|+-++||||+|+.+.||.+++.||..
T Consensus       211 CkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~  254 (282)
T KOG0984|consen  211 CKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYES  254 (282)
T ss_pred             CCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccc
Confidence             234567766543  34788999999999999999999999974

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=99.90  E-value=1.6e-23  Score=216.13  Aligned_cols=173  Identities=23%  Similarity=0.379  Sum_probs=137.5

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH-----HHHHHHHHHHHHhCCCCceeeeeeEEeccC-------CceEEEEeecCCC
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV-----ITKLEMQLVQHATHHHPNIVRLLGTCLTDG-------PHSFLVFEYAKNG  456 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~-----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~-------~~~~LV~Ey~~~G  456 (600)
                      .|.||++..  +|+.+|+|++....     .....+|+..+..++||||+++++++....       ...++|+||+.+ 
T Consensus        21 ~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-   99 (311)
T cd07866          21 FGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-   99 (311)
T ss_pred             CEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCCc-
Confidence            389999998  68899999874322     123567888899999999999999875432       246999999975 


Q ss_pred             CHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCcccc
Q 041830          457 SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV  536 (600)
Q Consensus       457 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~  536 (600)
                      +|..++....           ..+++.++..++.|+++||+|||   +.+++||||||+||++++++.+||+|||+++..
T Consensus       100 ~l~~~~~~~~-----------~~~~~~~~~~i~~~l~~al~~lH---~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~  165 (311)
T cd07866         100 DLSGLLENPS-----------VKLTESQIKCYMLQLLEGINYLH---ENHILHRDIKAANILIDNQGILKIADFGLARPY  165 (311)
T ss_pred             CHHHHHhccc-----------cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEECcCccchhc
Confidence            7877776432           23899999999999999999999   679999999999999999999999999998754


Q ss_pred             CCC-----------------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          537 NDD-----------------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       537 ~~~-----------------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                      ...                       ..+||.... ...++.++|||||||++|||++|+.||...
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Dv~slG~il~el~~g~~~~~~~  230 (311)
T cd07866         166 DGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLG-ERRYTTAVDIWGIGCVFAEMFTRRPILQGK  230 (311)
T ss_pred             cCCCcccccCCcccccccccceeccCcCChHHhhC-CCccCchhHhHHHHHHHHHHHhCCCCCCCC
Confidence            321                       223454322 134577899999999999999999999643

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=99.90  E-value=2.7e-23  Score=208.01  Aligned_cols=176  Identities=22%  Similarity=0.356  Sum_probs=143.4

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      .|.||+++.  +|+.+++|.+...     ...++..|+..++.++|+||+++++++... ...++|+||+++++|.+++.
T Consensus        13 ~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~   91 (256)
T cd08530          13 YGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDG-NKLCIVMEYAPFGDLSKAIS   91 (256)
T ss_pred             ceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccC-CEEEEEehhcCCCCHHHHHH
Confidence            389999987  6889999987642     223556788889999999999999997665 58999999999999999987


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD----  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~----  539 (600)
                      .....        ...+++.+++.++.+++.||+|||   +.+++|+||+|+||++++++.+|++|||+++.....    
T Consensus        92 ~~~~~--------~~~~~~~~~~~~~~~l~~al~~lh---~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~  160 (256)
T cd08530          92 KRKKK--------RKLIPEQEIWRIFIQLLRGLQALH---EQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAKT  160 (256)
T ss_pred             HHHhh--------cCCCCHHHHHHHHHHHHHHHHHHh---hCCcccCCCCcceEEEecCCcEEEeeccchhhhccCCccc
Confidence            53211        134899999999999999999999   679999999999999999999999999998765432    


Q ss_pred             ------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 ------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 ------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                            ..+||....  ..++.++|+||||+++|||++|+.||...+
T Consensus       161 ~~~~~~~~~Pe~~~~--~~~~~~~D~~slG~~~~~l~~g~~p~~~~~  205 (256)
T cd08530         161 QIGTPHYMAPEVWKG--RPYSYKSDIWSLGCLLYEMATFAPPFEARS  205 (256)
T ss_pred             ccCCccccCHHHHCC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence                  123444433  345678999999999999999999997543

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=99.90  E-value=1.7e-23  Score=218.46  Aligned_cols=173  Identities=21%  Similarity=0.379  Sum_probs=142.6

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEeccC----CceEEEEeecCCCCHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTDG----PHSFLVFEYAKNGSLK  459 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~----~~~~LV~Ey~~~GsL~  459 (600)
                      .|.||+++.  +|+.||+|++...     ..+.+..|+..+..++|+||+++++++....    ...|++|||++ ++|.
T Consensus        13 ~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~   91 (330)
T cd07834          13 YGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLH   91 (330)
T ss_pred             CeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHH
Confidence            389999998  5899999987542     2346778999999999999999999976542    36799999998 5899


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD  539 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~  539 (600)
                      ++++...            .+++.++..++.+++.||+|||   +.+++||||||+|||++.++.++|+|||++......
T Consensus        92 ~~l~~~~------------~l~~~~~~~i~~~l~~~l~~LH---~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~  156 (330)
T cd07834          92 KVIKSPQ------------PLTDDHIQYFLYQILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPD  156 (330)
T ss_pred             HHHhCCC------------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccc
Confidence            9887543            3899999999999999999999   679999999999999999999999999998765432


Q ss_pred             C---------------CCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 T---------------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 ~---------------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                      .               .+||..... ..++.++|+||||+++|||++|+.||...+
T Consensus       157 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~sDi~slG~il~~l~~g~~pf~~~~  211 (330)
T cd07834         157 EDEKGFLTEYVVTRWYRAPELLLSS-SRYTKAIDIWSVGCIFAELLTRKPLFPGRD  211 (330)
T ss_pred             ccccccccccccccCcCCceeeecc-cCCCcchhHHHHHHHHHHHHcCCCCcCCCC
Confidence            1               245554432 156778999999999999999999996543

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=99.90  E-value=2.2e-23  Score=211.52  Aligned_cols=172  Identities=23%  Similarity=0.446  Sum_probs=140.9

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh------HHHHHHHHHHHHHhCC-CCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE------VITKLEMQLVQHATHH-HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~------~~~~~e~ei~~~~~l~-HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      .|.||++..  +|+.||+|.....      ....+..|...+..+. ||||+++++++..+ ...++||||+++++|.++
T Consensus        14 ~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~   92 (280)
T cd05581          14 FSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDE-ENLYFVLEYAPNGELLQY   92 (280)
T ss_pred             ceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCC-ceEEEEEcCCCCCcHHHH
Confidence            389999988  7899999987642      1234567778888888 99999999997554 488999999999999999


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCCC-
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDT-  540 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~~-  540 (600)
                      +....            .+++.+++.++.|++.||.|||   +.+++|+||+|+||+++.++.++++|||++....... 
T Consensus        93 l~~~~------------~l~~~~~~~i~~ql~~~l~~Lh---~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~  157 (280)
T cd05581          93 IRKYG------------SLDEKCTRFYAAEILLALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSS  157 (280)
T ss_pred             HHHcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHeEECCCCCEEecCCccccccCCccc
Confidence            97543            3899999999999999999999   6799999999999999999999999999987543221 


Q ss_pred             -------------------------------CCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          541 -------------------------------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       541 -------------------------------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                                                     .+||....  ...+.++||||||+++||+++|+.||....
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~~  226 (280)
T cd05581         158 PESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE--KPAGKSSDLWALGCIIYQMLTGKPPFRGSN  226 (280)
T ss_pred             cccCCCCCccccccccccccccccccCCccccCHHHhCC--CCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence                                           12332222  235677999999999999999999997643

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=99.90  E-value=2e-23  Score=212.27  Aligned_cols=172  Identities=23%  Similarity=0.389  Sum_probs=141.9

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhH-----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEV-----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~-----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      |.||++..  +|+.+++|+++...     ...++.|+..+..++|+||+++++++... ...++|+||+++ +|.+++..
T Consensus        13 ~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-~~~~~v~e~~~~-~l~~~l~~   90 (283)
T cd05118          13 GVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHK-GDLYLVFEFMDT-DLYKLIKD   90 (283)
T ss_pred             ceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccC-CCEEEEEeccCC-CHHHHHHh
Confidence            89999988  68899999875432     24567888889999999999999997655 589999999975 89888865


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCCC----
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDT----  540 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~~----  540 (600)
                      ..           ..+++.++..++.+++.||.|||   +.+++|+||||+||+++.++.+||+|||.+.......    
T Consensus        91 ~~-----------~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~  156 (283)
T cd05118          91 RQ-----------RGLPESLIKSYLYQLLQGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYT  156 (283)
T ss_pred             hc-----------ccCCHHHHHHHHHHHHHHHHHHH---HCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCccccc
Confidence            32           23899999999999999999999   6799999999999999999999999999986554321    


Q ss_pred             --------CCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          541 --------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       541 --------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                              .+||..... ..++.++|+||||+++|||++|+.||...+
T Consensus       157 ~~~~~~~~~~PE~~~~~-~~~~~~~Di~slG~~l~~l~tg~~~~~~~~  203 (283)
T cd05118         157 HYVVTRWYRAPELLLGD-KGYSTPVDIWSVGCIFAELLSRRPLFPGKS  203 (283)
T ss_pred             CccCcccccCcHHHhcC-CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence                    245554332 256788999999999999999999996543

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=99.90  E-value=5.5e-23  Score=216.15  Aligned_cols=171  Identities=20%  Similarity=0.359  Sum_probs=139.0

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEeccC-----CceEEEEeecCCCCH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTDG-----PHSFLVFEYAKNGSL  458 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~-----~~~~LV~Ey~~~GsL  458 (600)
                      .|.||++..  +|+.||||++...     ....+..|+..+..++||||+++++++..+.     ...++||||+ +++|
T Consensus        28 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l  106 (343)
T cd07880          28 YGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDL  106 (343)
T ss_pred             CeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCH
Confidence            389999987  6899999987432     1234667899999999999999999876442     1358999999 6799


Q ss_pred             HHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC
Q 041830          459 KDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND  538 (600)
Q Consensus       459 ~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~  538 (600)
                      .+++...             .+++.++..++.|++.||+|||   +.+|+||||||+||+++.++.+||+|||+++....
T Consensus       107 ~~~~~~~-------------~l~~~~~~~i~~qi~~al~~LH---~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~  170 (343)
T cd07880         107 GKLMKHE-------------KLSEDRIQFLVYQMLKGLKYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS  170 (343)
T ss_pred             HHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeccccccccc
Confidence            9888642             3899999999999999999999   67999999999999999999999999999875532


Q ss_pred             C---------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 D---------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 ~---------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                      .         ..+||..... ..++.++|+||||+++|||++|+.||...
T Consensus       171 ~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~ll~~l~~g~~pf~~~  219 (343)
T cd07880         171 EMTGYVVTRWYRAPEVILNW-MHYTQTVDIWSVGCIMAEMLTGKPLFKGH  219 (343)
T ss_pred             CccccccCCcccCHHHHhCC-CCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence            2         1245544321 24677899999999999999999999754

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=6.3e-24  Score=214.60  Aligned_cols=174  Identities=22%  Similarity=0.420  Sum_probs=143.4

Q ss_pred             EEEEEEEE--CCeEEEEEEcc--hhH--------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHH
Q 041830          392 GAVYHGRL--NGKNLAIKRTE--HEV--------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~--~~~--------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~  459 (600)
                      ..||++-.  ..+.||||.-.  ++.        .+...+|..+.+.+.||.||++++++.-+.+.++-|+|||++.+|.
T Consensus       477 SEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLD  556 (775)
T KOG1151|consen  477 SEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLD  556 (775)
T ss_pred             HHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchh
Confidence            68999876  56789999732  211        1234578888899999999999999876767899999999999999


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC---CCCcEEEEeccCcccc
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLD---EEFNARVGNFGMARCV  536 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld---~~~~~kI~DFGla~~~  536 (600)
                      -||+.++            .+++++...|+.||..||.||.+. +++|+|-||||.||||.   ..|.+||.|||+++.+
T Consensus       557 FYLKQhk------------lmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIM  623 (775)
T KOG1151|consen  557 FYLKQHK------------LMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIM  623 (775)
T ss_pred             HHHHhhh------------hhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhhhc
Confidence            9998764            388999999999999999999876 88999999999999994   4588999999999988


Q ss_pred             CCCCC-------------------CCccccc--CCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          537 NDDTE-------------------SPQFYST--NPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       537 ~~~~~-------------------~pe~~~~--~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                      +.+..                   .||.+.-  +|...+.++||||.|||+|..+-|+.||..
T Consensus       624 dddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGh  686 (775)
T KOG1151|consen  624 DDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGH  686 (775)
T ss_pred             cCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCC
Confidence            65432                   2343322  356678899999999999999999999975

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=99.90  E-value=4e-23  Score=209.92  Aligned_cols=172  Identities=26%  Similarity=0.429  Sum_probs=141.7

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH-----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV-----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~-----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      .|.||+|+.  +++.+|+|.+....     ...+..|+..+..++|+||+++++++... ...++|+||++ ++|.+++.
T Consensus        12 ~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~~v~e~~~-~~l~~~i~   89 (282)
T cd07829          12 YGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTE-RKLYLVFEYCD-MDLKKYLD   89 (282)
T ss_pred             cceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC-CceEEEecCcC-cCHHHHHH
Confidence            389999998  58999999876532     23456788888899999999999997655 58999999998 59999997


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD----  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~----  539 (600)
                      ...           ..+++.++..++.+++.||+|||   +.+++||||+|+||++++++.+||+|||+++.....    
T Consensus        90 ~~~-----------~~~~~~~~~~~~~~i~~~l~~LH---~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~  155 (282)
T cd07829          90 KRP-----------GPLSPNLIKSIMYQLLRGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTY  155 (282)
T ss_pred             hhc-----------cCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcccc
Confidence            642           23899999999999999999999   668999999999999999999999999998754322    


Q ss_pred             --------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 --------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 --------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                              ..+||..... ..++.++|||||||++|||++|+.||...
T Consensus       156 ~~~~~~~~~~aPE~~~~~-~~~~~~~Dv~slG~~l~~l~~~~~~~~~~  202 (282)
T cd07829         156 THEVVTLWYRAPEILLGS-KHYSTAVDIWSVGCIFAEMITGKPLFPGD  202 (282)
T ss_pred             CccccCcCcCChHHhcCC-cCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence                    1245544332 35677899999999999999999999654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=99.90  E-value=7.9e-24  Score=217.84  Aligned_cols=193  Identities=22%  Similarity=0.397  Sum_probs=148.8

Q ss_pred             cCHHHHHHHHh-ccCCCCceeEEEEEEEE--CCeEEEEEEcch-----hHHHHHHHHHHHHHhCCCCceeeeeeEEeccC
Q 041830          372 YSIEDLRRATE-KFNSSNRIEGAVYHGRL--NGKNLAIKRTEH-----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDG  443 (600)
Q Consensus       372 ~~~~el~~~t~-~f~~~~~~~G~Vy~g~~--~g~~vAvK~~~~-----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~  443 (600)
                      .++..+.+.-. +..+++. +|.||-|+.  +|+.||||.+++     .....+..|+.++.+++||.||.|.-.|.+. 
T Consensus       558 vd~stvYQif~devLGSGQ-FG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~-  635 (888)
T KOG4236|consen  558 VDISTVYQIFADEVLGSGQ-FGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETP-  635 (888)
T ss_pred             hhHHHHHHhhhHhhccCCc-ceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCC-
Confidence            34444444333 3333333 499999988  899999998754     3345678899999999999999999887655 


Q ss_pred             CceEEEEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC-
Q 041830          444 PHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEE-  522 (600)
Q Consensus       444 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~-  522 (600)
                      +..++|||-+ +|++.+.+-....          ..|++.....++.||+.||.|||   .++|+|+||||+||||.+. 
T Consensus       636 ervFVVMEKl-~GDMLEMILSsEk----------gRL~er~TkFlvtQIL~ALr~LH---~knIvHCDLKPENVLLas~~  701 (888)
T KOG4236|consen  636 ERVFVVMEKL-HGDMLEMILSSEK----------GRLPERITKFLVTQILVALRYLH---FKNIVHCDLKPENVLLASAS  701 (888)
T ss_pred             ceEEEEehhh-cchHHHHHHHhhc----------ccchHHHHHHHHHHHHHHHHHhh---hcceeeccCCchheeeccCC
Confidence            4889999999 5677776643321          23888888889999999999999   6799999999999999643 


Q ss_pred             --CcEEEEeccCccccCCCC-----------CCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCCCC
Q 041830          523 --FNARVGNFGMARCVNDDT-----------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRKK  582 (600)
Q Consensus       523 --~~~kI~DFGla~~~~~~~-----------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~~  582 (600)
                        -.+||+|||+||.+....           .+||++..  ..|...-|+||.|||+|--++|..||++.++.
T Consensus       702 ~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrn--kGyNrSLDMWSVGVIiYVsLSGTFPFNEdEdI  772 (888)
T KOG4236|consen  702 PFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRN--KGYNRSLDMWSVGVIIYVSLSGTFPFNEDEDI  772 (888)
T ss_pred             CCCceeeccccceeecchhhhhhhhcCCccccCHHHHhh--ccccccccceeeeEEEEEEecccccCCCccch
Confidence              479999999999775432           24554443  56777789999999999999999999865443

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=5.9e-24  Score=222.51  Aligned_cols=190  Identities=22%  Similarity=0.327  Sum_probs=152.7

Q ss_pred             cCHHHHHHHHhccCCCCceeEEEEEEEE--CCeEEEEEEcch---hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCce
Q 041830          372 YSIEDLRRATEKFNSSNRIEGAVYHGRL--NGKNLAIKRTEH---EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHS  446 (600)
Q Consensus       372 ~~~~el~~~t~~f~~~~~~~G~Vy~g~~--~g~~vAvK~~~~---~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~  446 (600)
                      ...+|......++  +.|.+|.||++..  ++-..|.|.+.-   +....+..||.++....||+||+|++.|+.++ .+
T Consensus        28 lnP~d~WeIiGEL--GDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~en-kL  104 (1187)
T KOG0579|consen   28 LNPRDHWEIIGEL--GDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFEN-KL  104 (1187)
T ss_pred             CCHHHHHHHHhhh--cCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccC-ce
Confidence            4445555554444  3455699999987  344567777643   33456778999999999999999999888775 89


Q ss_pred             EEEEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEE
Q 041830          447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNAR  526 (600)
Q Consensus       447 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~k  526 (600)
                      |++.|||.||-+...+-.-.           .+|++.++.-++++++.||.|||   +.+|||||||..|||+.-+|.++
T Consensus       105 wiliEFC~GGAVDaimlEL~-----------r~LtE~QIqvvc~q~ldALn~LH---s~~iIHRDLKAGNiL~TldGdir  170 (1187)
T KOG0579|consen  105 WILIEFCGGGAVDAIMLELG-----------RVLTEDQIQVVCYQVLDALNWLH---SQNIIHRDLKAGNILLTLDGDIR  170 (1187)
T ss_pred             EEEEeecCCchHhHHHHHhc-----------cccchHHHHHHHHHHHHHHHHHh---hcchhhhhccccceEEEecCcEe
Confidence            99999999999988875533           45999999999999999999999   77999999999999999999999


Q ss_pred             EEeccCccc------------cCCCCCCCcccccC---CCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          527 VGNFGMARC------------VNDDTESPQFYSTN---PASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       527 I~DFGla~~------------~~~~~~~pe~~~~~---~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                      |+|||.+..            .++.+++||+..-+   ...|+.++|||||||.|.||.-+.+|.+.
T Consensus       171 LADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhe  237 (1187)
T KOG0579|consen  171 LADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHE  237 (1187)
T ss_pred             eecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccc
Confidence            999998742            23445677765542   34578889999999999999999999865

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=99.89  E-value=1.1e-23  Score=214.18  Aligned_cols=173  Identities=21%  Similarity=0.295  Sum_probs=141.5

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhHHHH------HHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEVITK------LEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~~~~------~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      |.||-.+.  +|+.+|.|++++...++      ...|-.++..++.+.||.+--.+ +..+.++||+..|.+|+|.-+|.
T Consensus       199 GEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAf-eTkd~LClVLtlMNGGDLkfHiy  277 (591)
T KOG0986|consen  199 GEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAF-ETKDALCLVLTLMNGGDLKFHIY  277 (591)
T ss_pred             cceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeee-cCCCceEEEEEeecCCceeEEee
Confidence            88887765  89999999987655432      23455556667788999885444 44458999999999999998887


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC------
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN------  537 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~------  537 (600)
                      ....          ..+++...+-++.+|+.||++||   +.+||.|||||+|||||++|+++|+|+|||..+.      
T Consensus       278 n~g~----------~gF~e~ra~FYAAEi~cGLehlH---~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~~~  344 (591)
T KOG0986|consen  278 NHGN----------PGFDEQRARFYAAEIICGLEHLH---RRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKPIR  344 (591)
T ss_pred             ccCC----------CCCchHHHHHHHHHHHhhHHHHH---hcceeeccCChhheeeccCCCeEeeccceEEecCCCCccc
Confidence            6542          34899999999999999999999   7799999999999999999999999999996443      


Q ss_pred             -----CCCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          538 -----DDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       538 -----~~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                           .++++||+...+  .|+...|.||+||+||||+.|+.||....
T Consensus       345 ~rvGT~GYMAPEvl~ne--~Y~~s~Dwf~lGCllYemi~G~sPFr~~K  390 (591)
T KOG0986|consen  345 GRVGTVGYMAPEVLQNE--VYDFSPDWFSLGCLLYEMIAGHSPFRQRK  390 (591)
T ss_pred             cccCcccccCHHHHcCC--cccCCccHHHHHhHHHHHHcccCchhhhh
Confidence                 344678887763  48888999999999999999999997543

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.89  E-value=1.2e-22  Score=208.91  Aligned_cols=172  Identities=17%  Similarity=0.138  Sum_probs=122.6

Q ss_pred             eEEEEEEEEC-----CeEEEEEEcchhH--H--H----------HHHHHHHHHHhCCCCceeeeeeEEeccCC---ceEE
Q 041830          391 EGAVYHGRLN-----GKNLAIKRTEHEV--I--T----------KLEMQLVQHATHHHPNIVRLLGTCLTDGP---HSFL  448 (600)
Q Consensus       391 ~G~Vy~g~~~-----g~~vAvK~~~~~~--~--~----------~~e~ei~~~~~l~HpNIv~l~g~~~~~~~---~~~L  448 (600)
                      +|.||+|...     +..+|+|....+.  .  +          ....++..+..+.|+|++++++++.....   ..++
T Consensus        25 fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~  104 (294)
T PHA02882         25 FGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFI  104 (294)
T ss_pred             CceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEEEeeeEecCCceEEEE
Confidence            3999999983     3466777532111  0  0          01122233445689999999997654321   2367


Q ss_pred             EEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEE
Q 041830          449 VFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVG  528 (600)
Q Consensus       449 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~  528 (600)
                      ++|++.. ++.+.+....            ..++..+..++.|++.||+|||   +.+|+||||||+|||++.++.+||+
T Consensus       105 ~~~~~~~-~~~~~~~~~~------------~~~~~~~~~i~~qi~~~l~~lH---~~~iiHrDiKp~Nill~~~~~~~l~  168 (294)
T PHA02882        105 LLEKLVE-NTKEIFKRIK------------CKNKKLIKNIMKDMLTTLEYIH---EHGISHGDIKPENIMVDGNNRGYII  168 (294)
T ss_pred             EEehhcc-CHHHHHHhhc------------cCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCcEEEE
Confidence            7777643 6666664321            2578888999999999999999   6799999999999999999999999


Q ss_pred             eccCccccCCC-------------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          529 NFGMARCVNDD-------------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       529 DFGla~~~~~~-------------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                      |||+++.....                   ..+|+...  ...++.++|||||||+||||++|+.||....
T Consensus       169 DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~--~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~  237 (294)
T PHA02882        169 DYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHN--GACVTRRGDLESLGYCMLKWAGIKLPWKGFG  237 (294)
T ss_pred             EcCCceeeccCCcccccccccccccCCCccccCHHHhC--CCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence            99998754211                   11233322  2346788999999999999999999997653

>PHA03210 serine/threonine kinase US3; Provisional

Probab=99.89  E-value=7.4e-23  Score=225.65  Aligned_cols=148  Identities=22%  Similarity=0.344  Sum_probs=117.6

Q ss_pred             HHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHH
Q 041830          415 TKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAM  494 (600)
Q Consensus       415 ~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~  494 (600)
                      ..+++|+..+..++|||||++++++..+ +..|+|+|++. ++|.+++........       ....+.+...|+.|++.
T Consensus       208 ~~~~~Ei~il~~l~HpnIv~l~~~~~~~-~~~~lv~e~~~-~~l~~~l~~~~~~~~-------~~~~~~~~~~i~~ql~~  278 (501)
T PHA03210        208 IQLENEILALGRLNHENILKIEEILRSE-ANTYMITQKYD-FDLYSFMYDEAFDWK-------DRPLLKQTRAIMKQLLC  278 (501)
T ss_pred             HHHHHHHHHHHhCCCCCcCcEeEEEEEC-CeeEEEEeccc-cCHHHHHhhcccccc-------ccccHHHHHHHHHHHHH
Confidence            3567899999999999999999997655 47899999995 588888764321100       11345667789999999


Q ss_pred             HHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-------------CCCCcccccCCCCCCccCchHH
Q 041830          495 ALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-------------TESPQFYSTNPASWSMGIDIFA  561 (600)
Q Consensus       495 gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-------------~~~pe~~~~~~~~~t~~sDVwS  561 (600)
                      ||.|||   +.+|+||||||+|||++.++.+||+|||+++.....             +.+||....  ..++.++||||
T Consensus       279 aL~yLH---~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwS  353 (501)
T PHA03210        279 AVEYIH---DKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAG--DGYCEITDIWS  353 (501)
T ss_pred             HHHHHH---hCCeecCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcC--CCCCcHHHHHH
Confidence            999999   679999999999999999999999999999754321             124665544  35778899999


Q ss_pred             HHHHHHHHHhCCCCC
Q 041830          562 YGIVLLEVLSGQTPI  576 (600)
Q Consensus       562 fGvvL~ELltG~~Pf  576 (600)
                      |||+||||++|+.++
T Consensus       354 lGvil~ell~~~~~p  368 (501)
T PHA03210        354 CGLILLDMLSHDFCP  368 (501)
T ss_pred             HHHHHHHHHHCCCCC
Confidence            999999999987543

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=1.4e-23  Score=233.08  Aligned_cols=176  Identities=23%  Similarity=0.281  Sum_probs=142.0

Q ss_pred             CCceeEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCH
Q 041830          387 SNRIEGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSL  458 (600)
Q Consensus       387 ~~~~~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL  458 (600)
                      +.|.+|.|...++  +++.||+|++.+-.      ..-|..|-.+|..-..+-|+.+.-.+ .+..++|+|||||+||+|
T Consensus        84 GrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAF-QD~~~LYlVMdY~pGGDl  162 (1317)
T KOG0612|consen   84 GRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAF-QDERYLYLVMDYMPGGDL  162 (1317)
T ss_pred             cccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHh-cCccceEEEEecccCchH
Confidence            5566699999988  78999999976521      23466666777776788999997654 555699999999999999


Q ss_pred             HHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC-
Q 041830          459 KDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN-  537 (600)
Q Consensus       459 ~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~-  537 (600)
                      -.+|....            .+++.....++..|.-||.-||   +.++|||||||+|||||..|++||+|||.+-.+. 
T Consensus       163 ltLlSk~~------------~~pE~~ArFY~aEiVlAldslH---~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~  227 (1317)
T KOG0612|consen  163 LTLLSKFD------------RLPEDWARFYTAEIVLALDSLH---SMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA  227 (1317)
T ss_pred             HHHHhhcC------------CChHHHHHHHHHHHHHHHHHHH---hccceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence            99997543            3888888889999999999999   6699999999999999999999999999875443 


Q ss_pred             ------------CCCCCCccccc---CCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          538 ------------DDTESPQFYST---NPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       538 ------------~~~~~pe~~~~---~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                                  +++-+||++..   ....|...+|.||+||++|||+.|..||..
T Consensus       228 dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa  283 (1317)
T KOG0612|consen  228 DGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA  283 (1317)
T ss_pred             CCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence                        22334554433   235688899999999999999999999964

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=99.89  E-value=5.8e-23  Score=215.97  Aligned_cols=171  Identities=22%  Similarity=0.378  Sum_probs=138.2

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCC-----ceEEEEeecCCCCH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGP-----HSFLVFEYAKNGSL  458 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~-----~~~LV~Ey~~~GsL  458 (600)
                      .|.||+|+.  +++.||+|++...     ....+..|+..++.+.||||+++++++..+..     ..++|+||+ +++|
T Consensus        28 ~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L  106 (343)
T cd07851          28 YGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADL  106 (343)
T ss_pred             ceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCH
Confidence            389999998  5789999987532     22345678888999999999999997654331     379999999 5699


Q ss_pred             HHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC
Q 041830          459 KDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND  538 (600)
Q Consensus       459 ~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~  538 (600)
                      .+++...             .+++.++..++.|++.||+|||   +.+++||||||+||+++.++.+||+|||++.....
T Consensus       107 ~~~~~~~-------------~l~~~~~~~~~~ql~~aL~~LH---~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~  170 (343)
T cd07851         107 NNIVKCQ-------------KLSDDHIQFLVYQILRGLKYIH---SAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDD  170 (343)
T ss_pred             HHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEECCCCCEEEccccccccccc
Confidence            9988642             3899999999999999999999   67999999999999999999999999999876532


Q ss_pred             C---------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 D---------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 ~---------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                      .         ..+||.... ...++.++|||||||++|||++|+.||...
T Consensus       171 ~~~~~~~~~~y~aPE~~~~-~~~~~~~~DvwslGv~l~elltg~~pf~~~  219 (343)
T cd07851         171 EMTGYVATRWYRAPEIMLN-WMHYNQTVDIWSVGCIMAELLTGKTLFPGS  219 (343)
T ss_pred             cccCCcccccccCHHHHhC-CCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence            2         224554332 124577899999999999999999999653

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=99.89  E-value=6.5e-23  Score=215.48  Aligned_cols=171  Identities=25%  Similarity=0.447  Sum_probs=136.5

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh---HHHHHHHHHHHHHhCCCCceeeeeeEEeccC-------------CceEEEEee
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE---VITKLEMQLVQHATHHHPNIVRLLGTCLTDG-------------PHSFLVFEY  452 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~---~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~-------------~~~~LV~Ey  452 (600)
                      .|.||+|..  +|+.||+|.+...   ..+.+.+|+..+..++||||+++++++...+             ...++||||
T Consensus        18 ~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~   97 (342)
T cd07854          18 NGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEY   97 (342)
T ss_pred             CEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeec
Confidence            389999988  6889999987542   2345677888999999999999998754332             246899999


Q ss_pred             cCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC-CCCcEEEEecc
Q 041830          453 AKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLD-EEFNARVGNFG  531 (600)
Q Consensus       453 ~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld-~~~~~kI~DFG  531 (600)
                      ++ ++|.+++...             .+++.+...++.|++.||.|||   +.+++||||||+||+++ +++.+|++|||
T Consensus        98 ~~-~~L~~~~~~~-------------~l~~~~~~~~~~qi~~aL~~LH---~~givH~dikp~Nili~~~~~~~kl~dfg  160 (342)
T cd07854          98 ME-TDLANVLEQG-------------PLSEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANVFINTEDLVLKIGDFG  160 (342)
T ss_pred             cc-ccHHHHHHcC-------------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCceEEECCcc
Confidence            97 5999888542             2889999999999999999999   66999999999999997 45678999999


Q ss_pred             CccccCC---------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          532 MARCVND---------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       532 la~~~~~---------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                      +++....               ...+||.... ...++.++|||||||++|||++|+.||...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwSlGvil~el~~g~~pf~~~  222 (342)
T cd07854         161 LARIVDPHYSHKGYLSEGLVTKWYRSPRLLLS-PNNYTKAIDMWAAGCIFAEMLTGKPLFAGA  222 (342)
T ss_pred             cceecCCccccccccccccccccccCHHHHhC-ccccCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            9875421               1234554432 234677899999999999999999999643

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=99.89  E-value=1.4e-22  Score=211.87  Aligned_cols=172  Identities=21%  Similarity=0.344  Sum_probs=135.8

Q ss_pred             eEEEEEEEE--C--CeEEEEEEcchh-----HHHHHHHHHHHHHhC-CCCceeeeeeEEecc---CCceEEEEeecCCCC
Q 041830          391 EGAVYHGRL--N--GKNLAIKRTEHE-----VITKLEMQLVQHATH-HHPNIVRLLGTCLTD---GPHSFLVFEYAKNGS  457 (600)
Q Consensus       391 ~G~Vy~g~~--~--g~~vAvK~~~~~-----~~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~---~~~~~LV~Ey~~~Gs  457 (600)
                      .|.||+++.  .  +..||+|+++..     ..+.+..|+..+..+ .||||+++++.+...   ....|+++||+. ++
T Consensus        13 ~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~   91 (332)
T cd07857          13 YGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-AD   91 (332)
T ss_pred             CeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CC
Confidence            489999998  3  678999987542     123456677778777 599999999875432   234688999986 68


Q ss_pred             HHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC
Q 041830          458 LKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN  537 (600)
Q Consensus       458 L~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~  537 (600)
                      |.+++....            .+++.++..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++...
T Consensus        92 L~~~l~~~~------------~~~~~~~~~~~~qi~~aL~~LH---~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~  156 (332)
T cd07857          92 LHQIIRSGQ------------PLTDAHFQSFIYQILCGLKYIH---SANVLHRDLKPGNLLVNADCELKICDFGLARGFS  156 (332)
T ss_pred             HHHHHhcCC------------CCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHeEEcCCCCEEeCcCCCceecc
Confidence            999986532            3899999999999999999999   6799999999999999999999999999987543


Q ss_pred             CC----------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          538 DD----------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       538 ~~----------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                      ..                ..+||.... ...++.++|+|||||++|||++|+.||...
T Consensus       157 ~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~~~Di~slGv~l~~l~~g~~pf~~~  213 (332)
T cd07857         157 ENPGENAGFMTEYVATRWYRAPEIMLS-FQSYTKAIDVWSVGCILAELLGRKPVFKGK  213 (332)
T ss_pred             cccccccccccCcccCccccCcHHHhC-CCCCCcHHHHHHHHHHHHHHHhCCcCCCCC
Confidence            11                224554322 134677899999999999999999999754

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=99.89  E-value=2.4e-23  Score=187.97  Aligned_cols=176  Identities=22%  Similarity=0.338  Sum_probs=139.0

Q ss_pred             CCceeEEEEEEEE--CCeEEEEEEcchhH-----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHH
Q 041830          387 SNRIEGAVYHGRL--NGKNLAIKRTEHEV-----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       387 ~~~~~G~Vy~g~~--~g~~vAvK~~~~~~-----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~  459 (600)
                      +.+.+|+||+|+.  +++.||+|+++-+.     -....+||..++.++|.|||+++++...+ ..+-||+|||.. +|.
T Consensus        11 gegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsd-kkltlvfe~cdq-dlk   88 (292)
T KOG0662|consen   11 GEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-KKLTLVFEFCDQ-DLK   88 (292)
T ss_pred             cCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccC-ceeEEeHHHhhH-HHH
Confidence            4455699999987  68899999875432     23567899999999999999999995444 588999999965 888


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD  539 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~  539 (600)
                      .|...-.           ..++......++.|+++||.|+|   ++++.||||||.|.|++.+|..|++|||++|...-.
T Consensus        89 kyfdsln-----------g~~d~~~~rsfmlqllrgl~fch---shnvlhrdlkpqnllin~ngelkladfglarafgip  154 (292)
T KOG0662|consen   89 KYFDSLN-----------GDLDPEIVRSFMLQLLRGLGFCH---SHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP  154 (292)
T ss_pred             HHHHhcC-----------CcCCHHHHHHHHHHHHhhhhhhh---hhhhhhccCCcceEEeccCCcEEecccchhhhcCCc
Confidence            8876533           23788888999999999999999   779999999999999999999999999999866433


Q ss_pred             CC------------CCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          540 TE------------SPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       540 ~~------------~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                      ..            .|...-+ ..-|+...|+||-||++.|+.. |++-|...
T Consensus       155 vrcysaevvtlwyrppdvlfg-akly~tsidmwsagcifaelanagrplfpg~  206 (292)
T KOG0662|consen  155 VRCYSAEVVTLWYRPPDVLFG-AKLYSTSIDMWSAGCIFAELANAGRPLFPGN  206 (292)
T ss_pred             eEeeeceeeeeeccCcceeee-eehhccchHhhhcchHHHHHhhcCCCCCCCC
Confidence            21            1222211 2346778899999999999987 55556543

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.89  E-value=1.4e-23  Score=205.15  Aligned_cols=180  Identities=22%  Similarity=0.341  Sum_probs=141.7

Q ss_pred             CCceeEEEEEEEE--CCeEEEEEEcchhHH------HHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCH
Q 041830          387 SNRIEGAVYHGRL--NGKNLAIKRTEHEVI------TKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSL  458 (600)
Q Consensus       387 ~~~~~G~Vy~g~~--~g~~vAvK~~~~~~~------~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL  458 (600)
                      +.+.+|.|-..+-  +|+.+|+|.++++.+      ..-..|-..+.+.+||.+..|--. ++..+.++.||||..+|.|
T Consensus       177 GkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYs-FQt~drlCFVMeyanGGeL  255 (516)
T KOG0690|consen  177 GKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYS-FQTQDRLCFVMEYANGGEL  255 (516)
T ss_pred             cCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhh-hccCceEEEEEEEccCceE
Confidence            3444588876655  899999999887653      123456677888899998887544 4445689999999999999


Q ss_pred             HHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC
Q 041830          459 KDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND  538 (600)
Q Consensus       459 ~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~  538 (600)
                      .-+|.+.+            .+++.....+...|..||.|||   +.+||.||||-+|+|||++|++||+|||+.+..-.
T Consensus       256 f~HLsrer------------~FsE~RtRFYGaEIvsAL~YLH---s~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~  320 (516)
T KOG0690|consen  256 FFHLSRER------------VFSEDRTRFYGAEIVSALGYLH---SRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK  320 (516)
T ss_pred             eeehhhhh------------cccchhhhhhhHHHHHHhhhhh---hCCeeeeechhhhheeccCCceEeeecccchhccc
Confidence            98887643            3778777788999999999999   67999999999999999999999999999874322


Q ss_pred             CC-------CCCcccccC---CCCCCccCchHHHHHHHHHHHhCCCCCCCCCCC
Q 041830          539 DT-------ESPQFYSTN---PASWSMGIDIFAYGIVLLEVLSGQTPINRPRKK  582 (600)
Q Consensus       539 ~~-------~~pe~~~~~---~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~~  582 (600)
                      ..       ..||++.++   ...|...+|.|.+|||||||++|+.||...+.+
T Consensus       321 ~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~  374 (516)
T KOG0690|consen  321 YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE  374 (516)
T ss_pred             ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh
Confidence            11       245555442   356788999999999999999999999765443

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=99.89  E-value=1.4e-23  Score=198.08  Aligned_cols=170  Identities=28%  Similarity=0.413  Sum_probs=135.0

Q ss_pred             EEEEEEEE--CCeEEEEEEcch-----hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          392 GAVYHGRL--NGKNLAIKRTEH-----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~-----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      ..||+...  +|+.+|+|.+.-     ...+++++|+.+-..++|||||+|.....+++ ..|||+|+|.+|+|..-+-.
T Consensus        25 SvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~-~~ylvFe~m~G~dl~~eIV~  103 (355)
T KOG0033|consen   25 SVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEES-FHYLVFDLVTGGELFEDIVA  103 (355)
T ss_pred             HHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccc-eeEEEEecccchHHHHHHHH
Confidence            55565544  677777776432     33467899999999999999999999865554 88999999999999865532


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC---CcEEEEeccCccccCCC--
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEE---FNARVGNFGMARCVNDD--  539 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~---~~~kI~DFGla~~~~~~--  539 (600)
                      .            ...++...-..++||+.+|.|+|   ..+|||||+||+|+|+...   --+|++|||+|..+..+  
T Consensus       104 R------------~~ySEa~aSH~~rQiLeal~yCH---~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~  168 (355)
T KOG0033|consen  104 R------------EFYSEADASHCIQQILEALAYCH---SNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEA  168 (355)
T ss_pred             H------------HHHHHHHHHHHHHHHHHHHHHHH---hcCceeccCChhheeeeeccCCCceeecccceEEEeCCccc
Confidence            1            22788889999999999999999   7799999999999999543   45899999999876532  


Q ss_pred             ---------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 ---------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 ---------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                               ..+||....  ..|+..+|||+-|||||-|+.|.+||...
T Consensus       169 ~~G~~GtP~fmaPEvvrk--dpy~kpvDiW~cGViLfiLL~G~~PF~~~  215 (355)
T KOG0033|consen  169 WHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDE  215 (355)
T ss_pred             cccccCCCcccCHHHhhc--CCCCCcchhhhhhHHHHHHHhCCCCCCCc
Confidence                     234554443  45778899999999999999999999763

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.89  E-value=9.4e-23  Score=213.88  Aligned_cols=175  Identities=19%  Similarity=0.321  Sum_probs=132.8

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhHH------HHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEVI------TKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~~------~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      +|.|..++-  +...+|+|.+++..+      .....|-.+++.-+++-||+|+-.+ .+.+.+|+||||+++|++-.+|
T Consensus       642 FGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySF-QDkdnLYFVMdYIPGGDmMSLL  720 (1034)
T KOG0608|consen  642 FGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSF-QDKDNLYFVMDYIPGGDMMSLL  720 (1034)
T ss_pred             cceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEe-ccCCceEEEEeccCCccHHHHH
Confidence            488888765  566799998866332      2234455566677788999999654 5556999999999999999988


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCcccc------
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV------  536 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~------  536 (600)
                      -+..            .+.+.....++.++..|+++.|   +-++|||||||+|||||.+|.+||.||||+.-+      
T Consensus       721 Irmg------------IFeE~LARFYIAEltcAiesVH---kmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHds  785 (1034)
T KOG0608|consen  721 IRMG------------IFEEDLARFYIAELTCAIESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDS  785 (1034)
T ss_pred             HHhc------------cCHHHHHHHHHHHHHHHHHHHH---hccceecccCccceEEccCCceeeeeccccccceecccc
Confidence            6432            3777777778889999999999   669999999999999999999999999997421      


Q ss_pred             ---CCC------CC---------------------------------------CCcccccCCCCCCccCchHHHHHHHHH
Q 041830          537 ---NDD------TE---------------------------------------SPQFYSTNPASWSMGIDIFAYGIVLLE  568 (600)
Q Consensus       537 ---~~~------~~---------------------------------------~pe~~~~~~~~~t~~sDVwSfGvvL~E  568 (600)
                         ...      ..                                       +||++..  ..++..+|.||.||||||
T Consensus       786 kYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r--~g~~q~cdwws~gvil~e  863 (1034)
T KOG0608|consen  786 KYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLAR--TGYTQLCDWWSVGVILYE  863 (1034)
T ss_pred             ccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcc--cCccccchhhHhhHHHHH
Confidence               000      00                                       1222211  345677999999999999


Q ss_pred             HHhCCCCCCCCCCCC
Q 041830          569 VLSGQTPINRPRKKD  583 (600)
Q Consensus       569 LltG~~Pf~~~~~~~  583 (600)
                      |+.|+.||......+
T Consensus       864 m~~g~~pf~~~tp~~  878 (1034)
T KOG0608|consen  864 MLVGQPPFLADTPGE  878 (1034)
T ss_pred             HhhCCCCccCCCCCc
Confidence            999999998765443

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=99.89  E-value=2.9e-22  Score=201.55  Aligned_cols=173  Identities=21%  Similarity=0.301  Sum_probs=133.4

Q ss_pred             eEEEEEEEEC--CeEEEEEEcch--------hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          391 EGAVYHGRLN--GKNLAIKRTEH--------EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       391 ~G~Vy~g~~~--g~~vAvK~~~~--------~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      .|.||+++..  +..+++|.++.        .....+..|+..+..++||||+++++++.+. ...++||||+++++|.+
T Consensus        13 ~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~l~~   91 (260)
T cd08222          13 FGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLER-DAFCIITEYCEGRDLDC   91 (260)
T ss_pred             CceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcC-CceEEEEEeCCCCCHHH
Confidence            4899999873  34455554332        1223456678888899999999999997655 47899999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-  539 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-  539 (600)
                      +++.....        ...+++.+++.++.|++.||.|||   +.+++|+||||+||+++. ..+||+|||+++..... 
T Consensus        92 ~~~~~~~~--------~~~~~~~~~~~~~~~l~~~l~~lH---~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~  159 (260)
T cd08222          92 KLEELKHT--------GKTLSENQVCEWFIQLLLGVHYMH---QRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSC  159 (260)
T ss_pred             HHHHHhhc--------ccccCHHHHHHHHHHHHHHHHHHH---HcCccccCCChhheEeec-CCEeecccCceeecCCCc
Confidence            98653211        134899999999999999999999   679999999999999975 56999999998754321 


Q ss_pred             -----------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          540 -----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       540 -----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                                 ..+||....  ..++.++|+||||+++|||++|..||..
T Consensus       160 ~~~~~~~~~~~~~~pe~~~~--~~~~~~~Dv~slG~~~~~l~~~~~~~~~  207 (260)
T cd08222         160 DLATTFTGTPYYMSPEALKH--QGYDSKSDIWSLGCILYEMCCLAHAFEG  207 (260)
T ss_pred             ccccCCCCCcCccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence                       123444322  3456779999999999999999999964

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=1.4e-23  Score=210.58  Aligned_cols=175  Identities=23%  Similarity=0.388  Sum_probs=136.1

Q ss_pred             ceeEEEEEEEEC--CeEEEEEEcchhHHH--------HHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCH
Q 041830          389 RIEGAVYHGRLN--GKNLAIKRTEHEVIT--------KLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSL  458 (600)
Q Consensus       389 ~~~G~Vy~g~~~--g~~vAvK~~~~~~~~--------~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL  458 (600)
                      +..|.|..+.-.  .+.+|||.++++.+-        ..|+.++.+. -+-|.++++..++.+. +.+|.||||+.+|+|
T Consensus       360 GSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~-~kppFL~qlHScFQTm-DRLyFVMEyvnGGDL  437 (683)
T KOG0696|consen  360 GSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALP-GKPPFLVQLHSCFQTM-DRLYFVMEYVNGGDL  437 (683)
T ss_pred             CccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecC-CCCchHHHHHHHhhhh-hheeeEEEEecCchh
Confidence            334899888774  467999998876531        1233332221 2467888888776554 489999999999999


Q ss_pred             HHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCcccc--
Q 041830          459 KDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV--  536 (600)
Q Consensus       459 ~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~--  536 (600)
                      --.++.-..            +.+....-++..||.||-|||   +++|+.||||-.|||||.+|.+||+|||+.+.-  
T Consensus       438 MyhiQQ~Gk------------FKEp~AvFYAaEiaigLFFLh---~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~  502 (683)
T KOG0696|consen  438 MYHIQQVGK------------FKEPVAVFYAAEIAIGLFFLH---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIF  502 (683)
T ss_pred             hhHHHHhcc------------cCCchhhhhhHHHHHHhhhhh---cCCeeeeeccccceEeccCCceEeeeccccccccc
Confidence            988875432            777888899999999999999   889999999999999999999999999998732  


Q ss_pred             ----------CCCCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCCCC
Q 041830          537 ----------NDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRKK  582 (600)
Q Consensus       537 ----------~~~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~~  582 (600)
                                ++++.+||+..-  ..|...+|.|||||+||||+.|++||+..+++
T Consensus       503 ~~~TTkTFCGTPdYiAPEIi~Y--qPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~  556 (683)
T KOG0696|consen  503 DGVTTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED  556 (683)
T ss_pred             CCcceeeecCCCcccccceEEe--cccccchhHHHHHHHHHHHHcCCCCCCCCCHH
Confidence                      233345665544  34677889999999999999999999876544

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.88  E-value=4.3e-22  Score=196.40  Aligned_cols=169  Identities=30%  Similarity=0.511  Sum_probs=143.0

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhH----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcC
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEV----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGG  465 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~  465 (600)
                      |.||++..  +|+.+++|+.....    .+.+..|+..+..++|+||+++++++..+ ...++++||+++++|.+++...
T Consensus         3 g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~l~~e~~~~~~L~~~~~~~   81 (244)
T smart00220        3 GKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDE-DKLYLVMEYCDGGDLFDLLKKR   81 (244)
T ss_pred             eEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeC-CEEEEEEeCCCCCCHHHHHHhc
Confidence            89999999  46999999976532    35778889999999999999999998765 4889999999999999998753


Q ss_pred             cCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC------
Q 041830          466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD------  539 (600)
Q Consensus       466 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~------  539 (600)
                      .            .+++.+++.++.+++.++.|||   +.+++|+||+|+||++++++.++|+|||.+......      
T Consensus        82 ~------------~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~  146 (244)
T smart00220       82 G------------RLSEDEARFYARQILSALEYLH---SNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTF  146 (244)
T ss_pred             c------------CCCHHHHHHHHHHHHHHHHHHH---HcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccc
Confidence            3            2789999999999999999999   669999999999999999999999999998765442      


Q ss_pred             -----CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          540 -----TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       540 -----~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                           ..+||....  ..++.++||||||+++|||++|+.||..
T Consensus       147 ~~~~~~~~pE~~~~--~~~~~~~Di~slG~~l~~l~~~~~p~~~  188 (244)
T smart00220      147 VGTPEYMAPEVLLG--KGYGKAVDVWSLGVILYELLTGKPPFPG  188 (244)
T ss_pred             cCCcCCCCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence                 123444432  3457789999999999999999999976

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.88  E-value=5.3e-24  Score=203.63  Aligned_cols=179  Identities=18%  Similarity=0.325  Sum_probs=145.2

Q ss_pred             CCceeEEEEEEEE--CCeEEEEEEcchhH-----HHHHHHHHHHHHhCCCCceeeeeeEEeccC----CceEEEEeecCC
Q 041830          387 SNRIEGAVYHGRL--NGKNLAIKRTEHEV-----ITKLEMQLVQHATHHHPNIVRLLGTCLTDG----PHSFLVFEYAKN  455 (600)
Q Consensus       387 ~~~~~G~Vy~g~~--~g~~vAvK~~~~~~-----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~----~~~~LV~Ey~~~  455 (600)
                      +.|.+|.||....  +|+.||.|++..-.     .+.+-+|+.++..++|.|++..+++-....    .++|+++|.|..
T Consensus        62 GYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQS  141 (449)
T KOG0664|consen   62 GYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQS  141 (449)
T ss_pred             cccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHHh
Confidence            3445599999887  89999999986532     246778999999999999999998853322    245889999865


Q ss_pred             CCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccc
Q 041830          456 GSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARC  535 (600)
Q Consensus       456 GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~  535 (600)
                       +|...+-..            ..|+-..+.-+.+||++||.|||   +.+|.||||||.|.|++.+...||+|||++|.
T Consensus       142 -DLHKIIVSP------------Q~Ls~DHvKVFlYQILRGLKYLH---sA~ILHRDIKPGNLLVNSNCvLKICDFGLARv  205 (449)
T KOG0664|consen  142 -DLHKIIVSP------------QALTPDHVKVFVYQILRGLKYLH---TANILHRDIKPGNLLVNSNCILKICDFGLART  205 (449)
T ss_pred             -hhhheeccC------------CCCCcchhhhhHHHHHhhhHHHh---hcchhhccCCCccEEeccCceEEecccccccc
Confidence             777766432            45888888889999999999999   67999999999999999999999999999997


Q ss_pred             cCCCC-------------CCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCCCC
Q 041830          536 VNDDT-------------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRKK  582 (600)
Q Consensus       536 ~~~~~-------------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~~  582 (600)
                      .+.+.             .+||.+++. ..|+...||||.|||+.||+-++.-|...+..
T Consensus       206 ee~d~~~hMTqEVVTQYYRAPEiLMGa-RhYs~AvDiWSVGCIFaELLgRrILFQAq~Pi  264 (449)
T KOG0664|consen  206 WDQRDRLNMTHEVVTQYYRAPELLMGA-RRYTGAVDIWSVGCIFAELLQRKILFQAAGPI  264 (449)
T ss_pred             cchhhhhhhHHHHHHHHhccHHHhhcc-hhhcCccceehhhHHHHHHHhhhhhhhccChH
Confidence            65432             357766553 57889999999999999999999999876554

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.88  E-value=1.2e-21  Score=191.65  Aligned_cols=171  Identities=29%  Similarity=0.469  Sum_probs=143.2

Q ss_pred             EEEEEEEE--CCeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcC
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGG  465 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~  465 (600)
                      |.||++..  +++.+++|.....    ..+.+..|+..+..++|+|++++++++..+ ...++++||+++++|.+++...
T Consensus        13 ~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~   91 (225)
T smart00221       13 GKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDP-EPLYLVMEYCEGGDLFDYLRKK   91 (225)
T ss_pred             eEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecC-CceEEEEeccCCCCHHHHHHhc
Confidence            89999998  3689999998654    345678888899999999999999997655 4789999999999999999754


Q ss_pred             cCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC------
Q 041830          466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD------  539 (600)
Q Consensus       466 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~------  539 (600)
                      ..           .+++.++..++.+++.++.|||   +.+++|+||+++||+++.++.++|+|||.+......      
T Consensus        92 ~~-----------~~~~~~~~~~~~~l~~~l~~lh---~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~  157 (225)
T smart00221       92 GG-----------KLSEEEARFYLRQILEALEYLH---SLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLK  157 (225)
T ss_pred             cc-----------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccccc
Confidence            31           1789999999999999999999   569999999999999999999999999998766443      


Q ss_pred             -------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          540 -------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       540 -------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                             ..+||... ....++.++|||+||++++||++|+.||..
T Consensus       158 ~~~~~~~~~~pe~~~-~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~  202 (225)
T smart00221      158 TVKGTPFYLAPEVLL-GGKGYGEAVDIWSLGVILYELLWGPEPFSG  202 (225)
T ss_pred             ceeccCCcCCHhHhc-CCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence                   12455442 234556689999999999999999999965

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=99.88  E-value=3.5e-22  Score=217.50  Aligned_cols=179  Identities=25%  Similarity=0.445  Sum_probs=143.7

Q ss_pred             CCceeEEEEEEEE--CCeEEEEEEcchh--HHHHHHHHHHHHHhC-CCCceeeeeeEEec----cCCceEEEEeecCCCC
Q 041830          387 SNRIEGAVYHGRL--NGKNLAIKRTEHE--VITKLEMQLVQHATH-HHPNIVRLLGTCLT----DGPHSFLVFEYAKNGS  457 (600)
Q Consensus       387 ~~~~~G~Vy~g~~--~g~~vAvK~~~~~--~~~~~e~ei~~~~~l-~HpNIv~l~g~~~~----~~~~~~LV~Ey~~~Gs  457 (600)
                      +.|.+|.||+++.  +|+.+|+|++..+  ..+++|.|..+++.+ +|||++.++|++..    .++++|||||||.+||
T Consensus        28 g~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGS  107 (953)
T KOG0587|consen   28 GNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGS  107 (953)
T ss_pred             eeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCcc
Confidence            3444577777765  7888888886543  334556666666654 59999999999873    2458999999999999


Q ss_pred             HHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC
Q 041830          458 LKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN  537 (600)
Q Consensus       458 L~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~  537 (600)
                      ..|++++...          ..+.|..+..|++.++.||.+||   +..++|||+|-.|||++.++.+|+.|||.+..++
T Consensus       108 VTDLVKn~~g----------~rl~E~~IaYI~re~lrgl~HLH---~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQld  174 (953)
T KOG0587|consen  108 VTDLVKNTKG----------NRLKEEWIAYILREILRGLAHLH---NNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  174 (953)
T ss_pred             HHHHHhhhcc----------cchhhHHHHHHHHHHHHHHHHHh---hcceeeecccCceEEEeccCcEEEeeeeeeeeee
Confidence            9999986542          33899999999999999999999   7789999999999999999999999999987654


Q ss_pred             C------------CCCCCcccccC---CCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          538 D------------DTESPQFYSTN---PASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       538 ~------------~~~~pe~~~~~---~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                      .            .+++||.....   ...|+..+|+||+|++-.||.-|.+|+..
T Consensus       175 sT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~D  230 (953)
T KOG0587|consen  175 STVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCD  230 (953)
T ss_pred             cccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccC
Confidence            3            23467765542   24567789999999999999999999853

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.88  E-value=5.4e-23  Score=222.81  Aligned_cols=174  Identities=22%  Similarity=0.433  Sum_probs=136.6

Q ss_pred             eEEEEEEEECCeEEEEEEcchhHHHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcCcc
Q 041830          391 EGAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMK  469 (600)
Q Consensus       391 ~G~Vy~g~~~g~~vAvK~~~~~~~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~  469 (600)
                      |+.||+|.+.|+.||||++-.+......+|+..+..- .|||||++++.- .+..+.||..|.|.- +|.+++.... .+
T Consensus       523 Gt~Vf~G~ye~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E-~d~qF~YIalELC~~-sL~dlie~~~-~d  599 (903)
T KOG1027|consen  523 GTVVFRGVYEGREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSE-QDRQFLYIALELCAC-SLQDLIESSG-LD  599 (903)
T ss_pred             CcEEEEEeeCCceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeec-cCCceEEEEehHhhh-hHHHHHhccc-cc
Confidence            4789999999999999999888777778898888765 499999999873 444588999999975 9999998741 11


Q ss_pred             cccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC-----CCcEEEEeccCccccCCCC----
Q 041830          470 NQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE-----EFNARVGNFGMARCVNDDT----  540 (600)
Q Consensus       470 ~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~-----~~~~kI~DFGla~~~~~~~----  540 (600)
                      ..       ...-...+.+..|++.||++||   +.+||||||||.||||+.     ..+++|+|||+++.+..+.    
T Consensus       600 ~~-------~~~~i~~~~~l~q~~~GlaHLH---sl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~  669 (903)
T KOG1027|consen  600 VE-------MQSDIDPISVLSQIASGLAHLH---SLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFS  669 (903)
T ss_pred             hh-------hcccccHHHHHHHHHHHHHHHH---hcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhh
Confidence            10       0111345678899999999999   669999999999999965     3689999999998664432    


Q ss_pred             -----------CCCcccccCCCCCCccCchHHHHHHHHHHHhC-CCCCCCC
Q 041830          541 -----------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSG-QTPINRP  579 (600)
Q Consensus       541 -----------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG-~~Pf~~~  579 (600)
                                 .+||.+...  .-+..+|++|+|||+|..++| +.||...
T Consensus       670 r~s~~sGt~GW~APE~L~~~--~~~~avDiFslGCvfyYvltgG~HpFGd~  718 (903)
T KOG1027|consen  670 RLSGGSGTSGWQAPEQLRED--RKTQAVDIFSLGCVFYYVLTGGSHPFGDS  718 (903)
T ss_pred             cccCCCCcccccCHHHHhcc--ccCcccchhhcCceEEEEecCCccCCCch
Confidence                       356665542  224578999999999999985 9999753

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.88  E-value=2.1e-22  Score=213.79  Aligned_cols=170  Identities=22%  Similarity=0.335  Sum_probs=134.3

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhHHHHHHHHHH-HHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcCc
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEVITKLEMQLV-QHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM  468 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~~~~~e~ei~-~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~  468 (600)
                      +.|-++..  +++..++|++.+.. ....+|+. .+..-.||||+++.+++. ++.+.|+|||.+.+|-|.+.+...+  
T Consensus       336 s~~~~~~~~~t~~~~~vkii~~~~-~~~~~e~~~~~~~~~h~niv~~~~v~~-~~~~~~~v~e~l~g~ell~ri~~~~--  411 (612)
T KOG0603|consen  336 SAVKYCESSPTDQEPAVKIISKRA-DDNQDEIPISLLVRDHPNIVKSHDVYE-DGKEIYLVMELLDGGELLRRIRSKP--  411 (612)
T ss_pred             cceeeeeccccccchhheeccccc-cccccccchhhhhcCCCcceeecceec-CCceeeeeehhccccHHHHHHHhcc--
Confidence            56666655  78889999987763 12233332 223346999999999975 4458999999999998888776543  


Q ss_pred             ccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEe-CCCCcEEEEeccCccccCCC--------
Q 041830          469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFL-DEEFNARVGNFGMARCVNDD--------  539 (600)
Q Consensus       469 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl-d~~~~~kI~DFGla~~~~~~--------  539 (600)
                                 ....++..|+.+++.++.|||   ..++|||||||+|||+ +..++++|+|||.++.....        
T Consensus       412 -----------~~~~e~~~w~~~lv~Av~~LH---~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~~~tp~~t~  477 (612)
T KOG0603|consen  412 -----------EFCSEASQWAAELVSAVDYLH---EQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERSCDTPALTL  477 (612)
T ss_pred             -----------hhHHHHHHHHHHHHHHHHHHH---hcCeeecCCChhheeecCCCCcEEEEEechhhhCchhhcccchhh
Confidence                       222677789999999999999   6799999999999999 68999999999999876544        


Q ss_pred             -CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCCC
Q 041830          540 -TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRK  581 (600)
Q Consensus       540 -~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~  581 (600)
                       ..+||+..  ...++.++|+||||++||||++|+.||.....
T Consensus       478 ~y~APEvl~--~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~  518 (612)
T KOG0603|consen  478 QYVAPEVLA--IQEYTEACDWWSLGVLLYEMLTGRTLFAAHPA  518 (612)
T ss_pred             cccChhhhc--cCCCCcchhhHHHHHHHHHHHhCCCccccCCc
Confidence             23577666  36789999999999999999999999976443

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=99.87  E-value=9.1e-23  Score=209.60  Aligned_cols=195  Identities=21%  Similarity=0.296  Sum_probs=149.7

Q ss_pred             ccccCHHHHHHHHhccCCCCceeEEEEEEEECCeE--EEEEEcchhHH------HHHHHHHHHHHhCCCCceeeeeeEEe
Q 041830          369 LESYSIEDLRRATEKFNSSNRIEGAVYHGRLNGKN--LAIKRTEHEVI------TKLEMQLVQHATHHHPNIVRLLGTCL  440 (600)
Q Consensus       369 ~~~~~~~el~~~t~~f~~~~~~~G~Vy~g~~~g~~--vAvK~~~~~~~------~~~e~ei~~~~~l~HpNIv~l~g~~~  440 (600)
                      .....++++++...-   +-+-+|.|=..+.+++.  +|+|.+++...      +..-.|-.+|...+.|.||+||-.+.
T Consensus       414 ~a~v~l~dl~~iaTL---GvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfr  490 (732)
T KOG0614|consen  414 FAQVKLSDLKRIATL---GVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFR  490 (732)
T ss_pred             hcccchhhhhhhhhc---ccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhc
Confidence            344566666654321   22223888877776655  78888765332      22334556667778999999999864


Q ss_pred             ccCCceEEEEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC
Q 041830          441 TDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLD  520 (600)
Q Consensus       441 ~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld  520 (600)
                       +....|++||-|-+|.|...|+....            ++......++..+.+|++|||   .++||.|||||+|++||
T Consensus       491 -d~kyvYmLmEaClGGElWTiLrdRg~------------Fdd~tarF~~acv~EAfeYLH---~k~iIYRDLKPENllLd  554 (732)
T KOG0614|consen  491 -DSKYVYMLMEACLGGELWTILRDRGS------------FDDYTARFYVACVLEAFEYLH---RKGIIYRDLKPENLLLD  554 (732)
T ss_pred             -cchhhhhhHHhhcCchhhhhhhhcCC------------cccchhhhhHHHHHHHHHHHH---hcCceeccCChhheeec
Confidence             44588999999999999999987543            677777778899999999999   88999999999999999


Q ss_pred             CCCcEEEEeccCccccCCCCC------CCcccccC---CCCCCccCchHHHHHHHHHHHhCCCCCCCCCCC
Q 041830          521 EEFNARVGNFGMARCVNDDTE------SPQFYSTN---PASWSMGIDIFAYGIVLLEVLSGQTPINRPRKK  582 (600)
Q Consensus       521 ~~~~~kI~DFGla~~~~~~~~------~pe~~~~~---~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~~  582 (600)
                      .+|.+||.|||+|+.+.....      .|||..++   ...++.++|.||+|+++|||++|++||...+.-
T Consensus       555 ~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm  625 (732)
T KOG0614|consen  555 NRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM  625 (732)
T ss_pred             cCCceEEeehhhHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH
Confidence            999999999999997765432      45555442   245678899999999999999999999876654

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=1.8e-23  Score=198.12  Aligned_cols=179  Identities=21%  Similarity=0.383  Sum_probs=140.3

Q ss_pred             CCceeEEEEEEEE--CCeEEEEEEcchhH-----HHHHHHHHHHHHhCCCCceeeeeeEEecc-------CCceEEEEee
Q 041830          387 SNRIEGAVYHGRL--NGKNLAIKRTEHEV-----ITKLEMQLVQHATHHHPNIVRLLGTCLTD-------GPHSFLVFEY  452 (600)
Q Consensus       387 ~~~~~G~Vy~g~~--~g~~vAvK~~~~~~-----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~-------~~~~~LV~Ey  452 (600)
                      +.|..|.||+++.  .|+.||+|+.-.+.     -....+|+.++..+.|+|++.++.+|...       ...+||||++
T Consensus        26 gqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~  105 (376)
T KOG0669|consen   26 GQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDF  105 (376)
T ss_pred             CCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHH
Confidence            3444588888877  67889998743222     12346889999999999999999998632       1247999999


Q ss_pred             cCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccC
Q 041830          453 AKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGM  532 (600)
Q Consensus       453 ~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGl  532 (600)
                      |++ +|.-.|....           ..++..++.+++.++..||.|+|   ...|+|||+|+.|+||+.++..||+|||+
T Consensus       106 ceh-DLaGlLsn~~-----------vr~sls~Ikk~Mk~Lm~GL~~iH---r~kilHRDmKaaNvLIt~dgilklADFGl  170 (376)
T KOG0669|consen  106 CEH-DLAGLLSNRK-----------VRFSLSEIKKVMKGLMNGLYYIH---RNKILHRDMKAANVLITKDGILKLADFGL  170 (376)
T ss_pred             hhh-hHHHHhcCcc-----------ccccHHHHHHHHHHHHHHHHHHH---HhhHHhhcccHhhEEEcCCceEEeecccc
Confidence            998 8888886543           23889999999999999999999   66899999999999999999999999999


Q ss_pred             ccccCCCC----------------CCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCCC
Q 041830          533 ARCVNDDT----------------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRK  581 (600)
Q Consensus       533 a~~~~~~~----------------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~  581 (600)
                      +|......                ..||...+ ...|+++.|||.-||||.||.||.+-|+...+
T Consensus       171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG-~r~yg~~iDiWgAgCimaeMwtrspimqgnte  234 (376)
T KOG0669|consen  171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLG-DREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE  234 (376)
T ss_pred             ccceecccccCCCCcccceeeeecCCHHHhhc-ccccCCcchhHhHHHHHHHHHccCccccCChH
Confidence            97553221                12343333 25678889999999999999999988876443

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.87  E-value=1.6e-21  Score=212.08  Aligned_cols=184  Identities=17%  Similarity=0.214  Sum_probs=127.7

Q ss_pred             eEEEEEEEE------------------CCeEEEEEEcchhHH---H--------------HHHHHHHHHHhCCCCc----
Q 041830          391 EGAVYHGRL------------------NGKNLAIKRTEHEVI---T--------------KLEMQLVQHATHHHPN----  431 (600)
Q Consensus       391 ~G~Vy~g~~------------------~g~~vAvK~~~~~~~---~--------------~~e~ei~~~~~l~HpN----  431 (600)
                      +|.||+|..                  .++.||||++..+..   .              ....|+..+.+++|.+    
T Consensus       158 FG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE~~~l~~l~~~~l~~~  237 (507)
T PLN03224        158 FGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVEAYMCAKIKRNPIAAA  237 (507)
T ss_pred             CeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHHHHHHHHhhcccchhh
Confidence            399999964                  346799999753211   1              1234555566665554    


Q ss_pred             -eeeeeeEEecc-------CCceEEEEeecCCCCHHHHHhcCcCccc----------c--cccccccCCCHHHHHHHHHH
Q 041830          432 -IVRLLGTCLTD-------GPHSFLVFEYAKNGSLKDWLHGGLAMKN----------Q--FIASCYCFLTWSQRLRICLD  491 (600)
Q Consensus       432 -Iv~l~g~~~~~-------~~~~~LV~Ey~~~GsL~~~L~~~~~~~~----------~--~~~~~~~~l~~~~~~~i~~~  491 (600)
                       +++++|+|...       ....||||||+++|+|.++|+.......          .  ........++|..+..++.|
T Consensus       238 ~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~q  317 (507)
T PLN03224        238 SCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQ  317 (507)
T ss_pred             hhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHH
Confidence             47888887531       2367999999999999999975321000          0  00001134678899999999


Q ss_pred             HHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC-------------CCCCCcccccCCC-------
Q 041830          492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND-------------DTESPQFYSTNPA-------  551 (600)
Q Consensus       492 ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~-------------~~~~pe~~~~~~~-------  551 (600)
                      ++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....             .+.+||.+.....       
T Consensus       318 l~~aL~~lH---~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~l~~~~~~~~~~~~  394 (507)
T PLN03224        318 VLTGLRKLH---RIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAP  394 (507)
T ss_pred             HHHHHHHHH---HCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhhhcCCCCCCccchh
Confidence            999999999   66899999999999999999999999999865421             2234554332110       


Q ss_pred             -------------CCCccCchHHHHHHHHHHHhCCC-CCC
Q 041830          552 -------------SWSMGIDIFAYGIVLLEVLSGQT-PIN  577 (600)
Q Consensus       552 -------------~~t~~sDVwSfGvvL~ELltG~~-Pf~  577 (600)
                                   ......||||+||+++||++|.. ||.
T Consensus       395 ~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~  434 (507)
T PLN03224        395 AMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA  434 (507)
T ss_pred             hhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence                         01124699999999999999875 664

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.87  E-value=1.5e-21  Score=203.08  Aligned_cols=170  Identities=21%  Similarity=0.330  Sum_probs=134.7

Q ss_pred             EEEEEEEE-CCeEEEEEEcch-----hHHHHHHHHHHHHHhCC-CCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          392 GAVYHGRL-NGKNLAIKRTEH-----EVITKLEMQLVQHATHH-HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       392 G~Vy~g~~-~g~~vAvK~~~~-----~~~~~~e~ei~~~~~l~-HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      ..||++.. +.+.+|+|+...     .....+..|+..+.+++ |.+||+|++|-..++ .+||||||=+. +|..+|+.
T Consensus       375 SkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~-~lYmvmE~Gd~-DL~kiL~k  452 (677)
T KOG0596|consen  375 SKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG-YLYMVMECGDI-DLNKILKK  452 (677)
T ss_pred             ceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc-eEEEEeecccc-cHHHHHHh
Confidence            78999988 556788887543     33456788888888875 899999999987775 89999998754 99999987


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCCC----
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDT----  540 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~~----  540 (600)
                      ....          ...| .+..+..|++.++.++|   ..+|||.||||.|+|+- +|.+||+|||.|..+..+.    
T Consensus       453 ~~~~----------~~~~-~lk~ywkqML~aV~~IH---~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~  517 (677)
T KOG0596|consen  453 KKSI----------DPDW-FLKFYWKQMLLAVKTIH---QHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSIV  517 (677)
T ss_pred             ccCC----------CchH-HHHHHHHHHHHHHHHHH---HhceeecCCCcccEEEE-eeeEEeeeechhcccCcccccee
Confidence            6542          2345 67778899999999999   66999999999999884 5889999999998765443    


Q ss_pred             ----------CCCcccccC---------CCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          541 ----------ESPQFYSTN---------PASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       541 ----------~~pe~~~~~---------~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                                ++||.+...         ....+.++||||+|||||+|+-|++||..
T Consensus       518 kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~  574 (677)
T KOG0596|consen  518 KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ  574 (677)
T ss_pred             eccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH
Confidence                      345543221         22346789999999999999999999964

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.86  E-value=6.7e-22  Score=185.13  Aligned_cols=174  Identities=22%  Similarity=0.344  Sum_probs=141.2

Q ss_pred             eeEEEEEEEE--CCeEEEEEEcchhHHHHHHHHHHHHHhCC-CCceeeeeeEEeccC-CceEEEEeecCCCCHHHHHhcC
Q 041830          390 IEGAVYHGRL--NGKNLAIKRTEHEVITKLEMQLVQHATHH-HPNIVRLLGTCLTDG-PHSFLVFEYAKNGSLKDWLHGG  465 (600)
Q Consensus       390 ~~G~Vy~g~~--~g~~vAvK~~~~~~~~~~e~ei~~~~~l~-HpNIv~l~g~~~~~~-~~~~LV~Ey~~~GsL~~~L~~~  465 (600)
                      -...||.|..  +.+.++||.++.-..+++.+|+.++.++. ||||++|+++..+.. ....||+||..+-+....-   
T Consensus        50 KYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly---  126 (338)
T KOG0668|consen   50 KYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLY---  126 (338)
T ss_pred             cHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHh---
Confidence            3478888875  78899999999988889999999999998 999999999965432 2457999999998876654   


Q ss_pred             cCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC-CcEEEEeccCccccCCCCC---
Q 041830          466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEE-FNARVGNFGMARCVNDDTE---  541 (600)
Q Consensus       466 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~-~~~kI~DFGla~~~~~~~~---  541 (600)
                                  ..|+..++..++.+++.||.|+|   +.+|.|||+||.|+++|.. ...+|.|+|+|.+..+...   
T Consensus       127 ------------~tl~d~dIryY~~elLkALdyCH---S~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnV  191 (338)
T KOG0668|consen  127 ------------PTLTDYDIRYYIYELLKALDYCH---SMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNV  191 (338)
T ss_pred             ------------hhhchhhHHHHHHHHHHHHhHHH---hcCcccccCCcceeeechhhceeeeeecchHhhcCCCceeee
Confidence                        23777888899999999999999   6799999999999999865 5799999999987765432   


Q ss_pred             --------CCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCCCC
Q 041830          542 --------SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRKK  582 (600)
Q Consensus       542 --------~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~~  582 (600)
                              .||.+.. -..|+-..|+|||||+|.+|+..+.||....+.
T Consensus       192 RVASRyfKGPELLVd-y~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN  239 (338)
T KOG0668|consen  192 RVASRYFKGPELLVD-YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN  239 (338)
T ss_pred             eeehhhcCCchheee-chhccccHHHHHHHHHHHHHHhccCcccCCCCC
Confidence                    2444322 123556679999999999999999999765443

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=99.86  E-value=6.4e-22  Score=221.75  Aligned_cols=168  Identities=27%  Similarity=0.488  Sum_probs=128.6

Q ss_pred             eeEEEEEEEE--CCeEEEEEEcchhH----HHHHHHHHHHHHhCCCCceeeeeeEEeccC--------------------
Q 041830          390 IEGAVYHGRL--NGKNLAIKRTEHEV----ITKLEMQLVQHATHHHPNIVRLLGTCLTDG--------------------  443 (600)
Q Consensus       390 ~~G~Vy~g~~--~g~~vAvK~~~~~~----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~--------------------  443 (600)
                      .+|.||+++.  +|+.||||++....    ..++.+|+..+++++|||||+++..+++..                    
T Consensus       491 GFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~ei~~~~~~~~sQs~  570 (1351)
T KOG1035|consen  491 GFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLEIVASDSESRSQSA  570 (1351)
T ss_pred             CCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccccccccccchhhhcccC
Confidence            3499999987  99999999976542    246778999999999999999986531100                    


Q ss_pred             --------------------------------------------------------------------------------
Q 041830          444 --------------------------------------------------------------------------------  443 (600)
Q Consensus       444 --------------------------------------------------------------------------------  443 (600)
                                                                                                      
T Consensus       571 s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e~~~~~d~~~ess~  650 (1351)
T KOG1035|consen  571 SKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSEGSVILDDTSESSE  650 (1351)
T ss_pred             CCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccCCccccCcchhhhh
Confidence                                                                                            


Q ss_pred             ------------------CceEEEEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCC
Q 041830          444 ------------------PHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNP  505 (600)
Q Consensus       444 ------------------~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~  505 (600)
                                        ..+||-||||+.-.|+++++++...           -.-...++++++|+.||+|+|   +.
T Consensus       651 s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~-----------~~~d~~wrLFreIlEGLaYIH---~~  716 (1351)
T KOG1035|consen  651 SIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFN-----------SQRDEAWRLFREILEGLAYIH---DQ  716 (1351)
T ss_pred             hccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccc-----------hhhHHHHHHHHHHHHHHHHHH---hC
Confidence                              0136777888777777777654321           024567899999999999999   67


Q ss_pred             CceecCCCCCCEEeCCCCcEEEEeccCccccC----------C---------C-----------CCCCcccccCC-CCCC
Q 041830          506 SYVHRNIKSRNIFLDEEFNARVGNFGMARCVN----------D---------D-----------TESPQFYSTNP-ASWS  554 (600)
Q Consensus       506 ~ivHrDLk~~NILld~~~~~kI~DFGla~~~~----------~---------~-----------~~~pe~~~~~~-~~~t  554 (600)
                      +||||||||.||++|++..+||+|||+|....          .         .           +.+||...... ..|+
T Consensus       717 giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn  796 (1351)
T KOG1035|consen  717 GIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYN  796 (1351)
T ss_pred             ceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccccc
Confidence            89999999999999999999999999997511          0         0           01466665543 3689


Q ss_pred             ccCchHHHHHHHHHHHh
Q 041830          555 MGIDIFAYGIVLLEVLS  571 (600)
Q Consensus       555 ~~sDVwSfGvvL~ELlt  571 (600)
                      .|+|+||+||||+||+-
T Consensus       797 ~KiDmYSLGIVlFEM~y  813 (1351)
T KOG1035|consen  797 SKIDMYSLGIVLFEMLY  813 (1351)
T ss_pred             chhhhHHHHHHHHHHhc
Confidence            99999999999999983

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.86  E-value=5.5e-22  Score=190.02  Aligned_cols=205  Identities=17%  Similarity=0.311  Sum_probs=146.3

Q ss_pred             cccCHHHHHHHHhccCCCCceeEEEEEEEE--CCeEEEEEEcchhHH--HHHHHHHHHHHhC-CCCceeeeeeEEeccCC
Q 041830          370 ESYSIEDLRRATEKFNSSNRIEGAVYHGRL--NGKNLAIKRTEHEVI--TKLEMQLVQHATH-HHPNIVRLLGTCLTDGP  444 (600)
Q Consensus       370 ~~~~~~el~~~t~~f~~~~~~~G~Vy~g~~--~g~~vAvK~~~~~~~--~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~  444 (600)
                      +..+++|.........+  |-+|.+..+++  ..+.+++|.+.....  .+|.+|+.---.+ .|.||+.-+++.++..+
T Consensus        18 ~kv~l~d~y~I~k~lge--G~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d   95 (378)
T KOG1345|consen   18 KKVDLEDVYTINKQLGE--GRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSD   95 (378)
T ss_pred             cccchhhhhhHHHHhcc--cceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCc
Confidence            34455555444333322  23388888888  457899998876543  4566765432222 48899999888776666


Q ss_pred             ceEEEEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEe-CC-C
Q 041830          445 HSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFL-DE-E  522 (600)
Q Consensus       445 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl-d~-~  522 (600)
                      .+..++||++.|+|.+-+...             .+.+....+++.|++.|+.|||   +.++||||||.+|||| +. .
T Consensus        96 ~YvF~qE~aP~gdL~snv~~~-------------GigE~~~K~v~~ql~SAi~fMH---sknlVHRdlK~eNiLif~~df  159 (378)
T KOG1345|consen   96 AYVFVQEFAPRGDLRSNVEAA-------------GIGEANTKKVFAQLLSAIEFMH---SKNLVHRDLKAENILIFDADF  159 (378)
T ss_pred             eEEEeeccCccchhhhhcCcc-------------cccHHHHHHHHHHHHHHHHHhh---ccchhhcccccceEEEecCCc
Confidence            788999999999998766432             2778888999999999999999   8899999999999999 33 3


Q ss_pred             CcEEEEeccCccccCCCC---------CCCcccccC---CCCCCccCchHHHHHHHHHHHhCCCCCCCCCCCCccchhHH
Q 041830          523 FNARVGNFGMARCVNDDT---------ESPQFYSTN---PASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDEGSVWLS  590 (600)
Q Consensus       523 ~~~kI~DFGla~~~~~~~---------~~pe~~~~~---~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~~~~~~~~l~  590 (600)
                      .++|++|||+.+..+...         ..||.....   .....+..|+|.|||+++..+||+.||+...-.+.....+-
T Consensus       160 ~rvKlcDFG~t~k~g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~  239 (378)
T KOG1345|consen  160 YRVKLCDFGLTRKVGTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWE  239 (378)
T ss_pred             cEEEeeecccccccCceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHH
Confidence            589999999987654321         234443331   22335668999999999999999999986554443333333


Q ss_pred             HH
Q 041830          591 EK  592 (600)
Q Consensus       591 ~~  592 (600)
                      .|
T Consensus       240 ~w  241 (378)
T KOG1345|consen  240 QW  241 (378)
T ss_pred             HH
Confidence            33

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.85  E-value=2.7e-21  Score=201.63  Aligned_cols=174  Identities=24%  Similarity=0.285  Sum_probs=141.4

Q ss_pred             CCceeEEEEEEEE--CCeEEEEEEcchhHH-----------HHHHHHHHHHHhCC---CCceeeeeeEEeccCCceEEEE
Q 041830          387 SNRIEGAVYHGRL--NGKNLAIKRTEHEVI-----------TKLEMQLVQHATHH---HPNIVRLLGTCLTDGPHSFLVF  450 (600)
Q Consensus       387 ~~~~~G~Vy~g~~--~g~~vAvK~~~~~~~-----------~~~e~ei~~~~~l~---HpNIv~l~g~~~~~~~~~~LV~  450 (600)
                      +.|.+|.|+.+.+  +...|+||.+.+++.           .....||.+|..++   |+||++++.++.++ +.+||+|
T Consensus       570 G~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd-d~yyl~t  648 (772)
T KOG1152|consen  570 GEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD-DYYYLET  648 (772)
T ss_pred             cccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecC-CeeEEEe
Confidence            4455699999988  567899998766542           12346777777665   99999999997554 5899999


Q ss_pred             eec-CCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEe
Q 041830          451 EYA-KNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGN  529 (600)
Q Consensus       451 Ey~-~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~D  529 (600)
                      |-. ++-+|.+++..+..            +++.+..-|.+||+.|+++||   +.+|||||||-+|+.+|.+|-+||.|
T Consensus       649 e~hg~gIDLFd~IE~kp~------------m~E~eAk~IFkQV~agi~hlh---~~~ivhrdikdenvivd~~g~~klid  713 (772)
T KOG1152|consen  649 EVHGEGIDLFDFIEFKPR------------MDEPEAKLIFKQVVAGIKHLH---DQGIVHRDIKDENVIVDSNGFVKLID  713 (772)
T ss_pred             cCCCCCcchhhhhhccCc------------cchHHHHHHHHHHHhcccccc---ccCceecccccccEEEecCCeEEEee
Confidence            976 45689999976543            899999999999999999999   77999999999999999999999999


Q ss_pred             ccCccccCC----------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCC
Q 041830          530 FGMARCVND----------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN  577 (600)
Q Consensus       530 FGla~~~~~----------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~  577 (600)
                      ||.+.....          +..+||.+.+++.. ...-|||++||+||.++-...||-
T Consensus       714 fgsaa~~ksgpfd~f~gtv~~aapevl~g~~y~-gk~qdiwalgillytivykenpyy  770 (772)
T KOG1152|consen  714 FGSAAYTKSGPFDVFVGTVDYAAPEVLGGEKYL-GKPQDIWALGILLYTIVYKENPYY  770 (772)
T ss_pred             ccchhhhcCCCcceeeeeccccchhhhCCCccC-CCcchhhhhhheeeEEEeccCCCc
Confidence            999875533          33578887775433 345699999999999999999985

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.84  E-value=9.1e-21  Score=210.82  Aligned_cols=183  Identities=17%  Similarity=0.226  Sum_probs=116.3

Q ss_pred             eEEEEEEEE--C----CeEEEEEEcchhHHHHHHHHHHHHHhCCCCceeeeeeEEe-----ccCCceEEEEeecCCCCHH
Q 041830          391 EGAVYHGRL--N----GKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCL-----TDGPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       391 ~G~Vy~g~~--~----g~~vAvK~~~~~~~~~~e~ei~~~~~l~HpNIv~l~g~~~-----~~~~~~~LV~Ey~~~GsL~  459 (600)
                      +|.||+|+.  +    +..||+|++......+...+. .+....+.++..+...+.     ..+...+|||||+++++|.
T Consensus       145 FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e~~~~e-~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~LV~ey~~~gsL~  223 (566)
T PLN03225        145 FGVVYKASLVNKQSKKEGKYVLKKATEYGAVEIWMNE-RVRRACPNSCADFVYGFLEPVSSKKEDEYWLVWRYEGESTLA  223 (566)
T ss_pred             CeEEEEEEEcCCccccCcEEEEEEecccchhHHHHHH-HHHhhchhhHHHHHHhhhcccccccCCceEEEEEecCCCcHH
Confidence            399999998  4    689999987653221111111 111112223332222111     2334789999999999999


Q ss_pred             HHHhcCcCcc--cccc------cccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC-CCcEEEEec
Q 041830          460 DWLHGGLAMK--NQFI------ASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE-EFNARVGNF  530 (600)
Q Consensus       460 ~~L~~~~~~~--~~~~------~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~-~~~~kI~DF  530 (600)
                      ++++......  ....      ........+..+..++.|++.||.|||   +.+|+||||||+|||++. ++.+||+||
T Consensus       224 ~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH---~~gIiHRDLKP~NILl~~~~~~~KL~DF  300 (566)
T PLN03225        224 DLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLH---STGIVHRDVKPQNIIFSEGSGSFKIIDL  300 (566)
T ss_pred             HHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHH---HCCEEeCcCCHHHEEEeCCCCcEEEEeC
Confidence            9997542100  0000      000011223446679999999999999   679999999999999986 589999999


Q ss_pred             cCccccCC-------------CCCCCcccccCC--------------------CCCCccCchHHHHHHHHHHHhCCCCCC
Q 041830          531 GMARCVND-------------DTESPQFYSTNP--------------------ASWSMGIDIFAYGIVLLEVLSGQTPIN  577 (600)
Q Consensus       531 Gla~~~~~-------------~~~~pe~~~~~~--------------------~~~t~~sDVwSfGvvL~ELltG~~Pf~  577 (600)
                      |+++.+..             .+.+||.+....                    ..++.++|||||||+||||+++..|++
T Consensus       301 GlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSlGviL~el~~~~~~~~  380 (566)
T PLN03225        301 GAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLIFLQMAFPNLRSD  380 (566)
T ss_pred             CCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHHHHHHHHHHhCcCCCc
Confidence            99975421             233555322110                    123456799999999999999876654

>PRK06347 autolysin; Reviewed

Probab=99.83  E-value=3.3e-20  Score=202.39  Aligned_cols=168  Identities=18%  Similarity=0.199  Sum_probs=131.4

Q ss_pred             eeeeecCCCCCChhhHHHhhCCChHHHHhhhCCCCCCCCCCCCCcEEEeeccccCCC-----C---------cceeecce
Q 041830           63 FAILRTNSYYSSLFNLSFYLGLNRFVIARANGFSADTEFLPKDQPLLIPIDCKCNNN-----G---------GFFQADLT  128 (600)
Q Consensus        63 ~~~y~~~~~~~~l~~ia~~~~~~~~~i~~~N~~~~~~~~i~~~~~l~vP~~c~c~~~-----~---------~~~~~~~~  128 (600)
                      ...|+|++ ||||+.||.+||+++.+|+.+|++  ..+.|++||.|.||..-.-...     .         ........
T Consensus       405 ~~~ytVk~-GDTL~sIA~kygVSv~~L~~~N~l--~s~~L~~Gq~L~IP~~~~~~~~t~~~s~~~~~~k~~s~~~~~~~~  481 (592)
T PRK06347        405 AKVYTVVK-GDSLWRIANNNKVTIANLKSWNNL--KSDFIYPGQKLKVSAGSTSNTNTSKPSTNTNTSKPSTNTNTNAKV  481 (592)
T ss_pred             ceeEEecC-CCCHHHHHHHhCCCHHHHHHHhCC--CcceeccCcEEEEecCCccccccccccccccccccccccccccee
Confidence            45799999 999999999999999999999999  5578999999999975210000     0         00111246


Q ss_pred             eeeecCCchhhHHHhcCCCchHHHHHhhCCCCCCCCCCCCCeEeeeeeccCCCCCC-----CCCCceEEEEEEccCCCcc
Q 041830          129 KTTIKGESFYSIAQSLEGLTTCGAIKERNPSVSPWDLDDKARLQVPLRCACPSSSE-----NLPETRILVSYPVGEGDTV  203 (600)
Q Consensus       129 y~v~~gdt~~~ia~~~~gl~t~~~l~~~N~~~~~~~l~~G~~l~vp~~c~c~~~~~-----~~~~~~~~~tY~v~~gd~~  203 (600)
                      |+|++|||||.||++|+  ++.++|++||++. .+.|++||+|.||....-.....     .........+|.|+.||++
T Consensus       482 YtVk~GDTL~sIAkkyg--VSv~~L~~~N~l~-s~~L~~GQ~L~Ip~~~~~s~~~t~~~s~~~~~~~~~~~Y~Vk~GDTL  558 (592)
T PRK06347        482 YTVAKGDSLWRIANNNK--VTIANLKSWNNLK-SDFIYPGQKLKVSAGSTTNNTNTAKPSTNKPSNSTVKTYTVKKGDSL  558 (592)
T ss_pred             eeecCCCCHHHHHHHHC--CCHHHHHHhcCCC-cccccCCcEEEEecCcccccccccCCccCCccCccceeeecCCCCcH
Confidence            99999999999999999  9999999999987 47899999999998653111000     0111123578999999999


Q ss_pred             cccccccCCChHHHHHhcCCCCCCCCcccccCcccccc
Q 041830          204 SGLAAKFNTTPAAIIAANNKSLEGFKPEDLLAFTSILI  241 (600)
Q Consensus       204 ~~ia~~f~~~~~~~~~~n~~~~~g~~p~~l~~~~~~~v  241 (600)
                      ++||++||++..+|..||++...     .|++++.+.|
T Consensus       559 ~sIA~KygvSv~~L~~~N~L~~~-----~L~~GQ~L~I  591 (592)
T PRK06347        559 WAISRQYKTTVDNIKAWNKLTSN-----MIHVGQKLTI  591 (592)
T ss_pred             HHHHHHhCCCHHHHHHhcCCCcc-----cCCCCCEEec
Confidence            99999999999999999988533     6888877765

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.83  E-value=4.2e-19  Score=170.38  Aligned_cols=163  Identities=33%  Similarity=0.552  Sum_probs=135.8

Q ss_pred             eEEEEEEEEC--CeEEEEEEcchhHH----HHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          391 EGAVYHGRLN--GKNLAIKRTEHEVI----TKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       391 ~G~Vy~g~~~--g~~vAvK~~~~~~~----~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      .|.||++...  |+.+++|.......    +.+.+|+..+..+.|++|+++++++... ...++++||+++++|.+++..
T Consensus         6 ~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~-~~~~~~~e~~~~~~l~~~~~~   84 (215)
T cd00180           6 FGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDE-NHLYLVMEYCEGGSLKDLLKE   84 (215)
T ss_pred             ceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecC-CeEEEEEecCCCCcHHHHHHh
Confidence            4899999995  89999999876543    5688999999999999999999997655 478999999999999999975


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC-CCcEEEEeccCccccCCCC---
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE-EFNARVGNFGMARCVNDDT---  540 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~-~~~~kI~DFGla~~~~~~~---  540 (600)
                      ..           ..+++.++..++.++++++.|||   +.+++|+||++.||+++. ++.++|+|||.+.......   
T Consensus        85 ~~-----------~~~~~~~~~~~~~~l~~~l~~lh---~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~  150 (215)
T cd00180          85 NE-----------GKLSEDEILRILLQILEGLEYLH---SNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLL  150 (215)
T ss_pred             cc-----------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchh
Confidence            42           13899999999999999999999   669999999999999999 8999999999987554331   


Q ss_pred             ---------CCCcccccCCCCCCccCchHHHHHHHHHH
Q 041830          541 ---------ESPQFYSTNPASWSMGIDIFAYGIVLLEV  569 (600)
Q Consensus       541 ---------~~pe~~~~~~~~~t~~sDVwSfGvvL~EL  569 (600)
                               .+|+..... ...+.+.|+|++|++++||
T Consensus       151 ~~~~~~~~~~~pe~~~~~-~~~~~~~D~~~lg~~~~~l  187 (215)
T cd00180         151 KTIVGTPAYMAPEVLLGK-GYYSEKSDIWSLGVILYEL  187 (215)
T ss_pred             hcccCCCCccChhHhccc-CCCCchhhhHHHHHHHHHH
Confidence                     234433221 2556778999999999998

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.82  E-value=1.1e-20  Score=185.18  Aligned_cols=160  Identities=21%  Similarity=0.347  Sum_probs=130.2

Q ss_pred             CCeEEEEEEcchhH-----HHHHHHHHHHHHhCCCCceeeeeeEEeccC-----CceEEEEeecCCCCHHHHHhcCcCcc
Q 041830          400 NGKNLAIKRTEHEV-----ITKLEMQLVQHATHHHPNIVRLLGTCLTDG-----PHSFLVFEYAKNGSLKDWLHGGLAMK  469 (600)
Q Consensus       400 ~g~~vAvK~~~~~~-----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~-----~~~~LV~Ey~~~GsL~~~L~~~~~~~  469 (600)
                      .++.||+|++....     .++..+|+..+..+.|+||++++.++....     .+.|+|||||. ++|.+.++.     
T Consensus        40 ~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~-~nl~~vi~~-----  113 (369)
T KOG0665|consen   40 LGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMD-ANLCQVILM-----  113 (369)
T ss_pred             ccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhh-hHHHHHHHH-----
Confidence            68889999864321     235578899999999999999999864321     24699999996 489888862     


Q ss_pred             cccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-C--------
Q 041830          470 NQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-T--------  540 (600)
Q Consensus       470 ~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-~--------  540 (600)
                               .++-.....|..|++.|++|||   +.+|+||||||+||++..+...||.|||+|+..... .        
T Consensus       114 ---------elDH~tis~i~yq~~~~ik~lh---s~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~~~mtpyVvtR  181 (369)
T KOG0665|consen  114 ---------ELDHETISYILYQMLCGIKHLH---SAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTDFMMTPYVVTR  181 (369)
T ss_pred             ---------hcchHHHHHHHHHHHHHHHHHH---hcceeecccCcccceecchhheeeccchhhcccCcccccCchhhee
Confidence                     1677788899999999999999   779999999999999999999999999999876554 2        


Q ss_pred             --CCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          541 --ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       541 --~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                        .+||...+.  .+...+||||.||++.||++|+.-|.+.
T Consensus       182 yyrapevil~~--~~ke~vdiwSvGci~gEli~~~Vlf~g~  220 (369)
T KOG0665|consen  182 YYRAPEVILGM--GYKENVDIWSVGCIMGELILGTVLFPGK  220 (369)
T ss_pred             eccCchheecc--CCcccchhhhhhhHHHHHhhceEEecCc
Confidence              245555442  3788899999999999999999998743

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.82  E-value=3.8e-20  Score=181.70  Aligned_cols=168  Identities=21%  Similarity=0.420  Sum_probs=131.0

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhHHH--------HHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEVIT--------KLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~~~--------~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      ..|..+++  +.+.+|+|.++++...        +.|+.+... .-+||.+|.|..++.++. .+++|.||.++|+|--+
T Consensus       264 akvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~-asn~pflvglhscfqtes-rlffvieyv~ggdlmfh  341 (593)
T KOG0695|consen  264 AKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQ-ASNNPFLVGLHSCFQTES-RLFFVIEYVNGGDLMFH  341 (593)
T ss_pred             hhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHh-ccCCCeEEehhhhhcccc-eEEEEEEEecCcceeee
Confidence            44555555  6788999988765432        112222222 246999999998766664 78999999999999877


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC---
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND---  538 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~---  538 (600)
                      +++.+            .|+++....+...|.-||.|||   +.+|+.||||-.|+|+|..+.+|+.|+|+.+..-.   
T Consensus       342 mqrqr------------klpeeharfys~ei~lal~flh---~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd  406 (593)
T KOG0695|consen  342 MQRQR------------KLPEEHARFYSAEICLALNFLH---ERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGD  406 (593)
T ss_pred             hhhhh------------cCcHHHhhhhhHHHHHHHHHHh---hcCeeeeeccccceEEccCCceeecccchhhcCCCCCc
Confidence            66543            3899999899999999999999   78999999999999999999999999999874322   


Q ss_pred             ---------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          539 ---------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       539 ---------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                               .+-+||.+..  ..|...+|.|++||+|+||+.|+.||+-
T Consensus       407 ~tstfcgtpnyiapeilrg--eeygfsvdwwalgvlmfemmagrspfdi  453 (593)
T KOG0695|consen  407 TTSTFCGTPNYIAPEILRG--EEYGFSVDWWALGVLMFEMMAGRSPFDI  453 (593)
T ss_pred             ccccccCCCcccchhhhcc--cccCceehHHHHHHHHHHHHcCCCCcce
Confidence                     2224555544  5677889999999999999999999975

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=99.82  E-value=1.6e-20  Score=188.17  Aligned_cols=178  Identities=17%  Similarity=0.236  Sum_probs=136.8

Q ss_pred             CceeEEEEEEEE--CCeEEEEEEcchhH--HHHHHHHHHHHHhCC--CC----ceeeeeeEEeccCCceEEEEeecCCCC
Q 041830          388 NRIEGAVYHGRL--NGKNLAIKRTEHEV--ITKLEMQLVQHATHH--HP----NIVRLLGTCLTDGPHSFLVFEYAKNGS  457 (600)
Q Consensus       388 ~~~~G~Vy~g~~--~g~~vAvK~~~~~~--~~~~e~ei~~~~~l~--Hp----NIv~l~g~~~~~~~~~~LV~Ey~~~Gs  457 (600)
                      .|.+|.|.+...  .+..||+|.++.-.  .+....|+..+.++.  -|    -+|.+.+++.-. .+.+||+|.+ +-|
T Consensus        99 eGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr-ghiCivfell-G~S  176 (415)
T KOG0671|consen   99 EGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR-GHICIVFELL-GLS  176 (415)
T ss_pred             CCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc-CceEEEEecc-Chh
Confidence            344588877766  57789999987522  233345565555552  22    367777775444 4899999999 449


Q ss_pred             HHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC----------------
Q 041830          458 LKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE----------------  521 (600)
Q Consensus       458 L~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~----------------  521 (600)
                      +.+||..+..          .+++..++..|+.|++++++|||   +.+++|-||||+|||+-+                
T Consensus       177 ~~dFlk~N~y----------~~fpi~~ir~m~~QL~~sv~fLh---~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~  243 (415)
T KOG0671|consen  177 TFDFLKENNY----------IPFPIDHIRHMGYQLLESVAFLH---DLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFI  243 (415)
T ss_pred             HHHHhccCCc----------cccchHHHHHHHHHHHHHHHHHH---hcceeecCCChheEEEeccceEEEeccCCcccee
Confidence            9999987653          55899999999999999999999   679999999999999831                


Q ss_pred             ----CCcEEEEeccCccccCCC---------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCCCC
Q 041830          522 ----EFNARVGNFGMARCVNDD---------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRKK  582 (600)
Q Consensus       522 ----~~~~kI~DFGla~~~~~~---------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~~  582 (600)
                          +..+||.|||-|......         +.+||+...  ..|+..+||||+||||.||.||..-|+..++.
T Consensus       244 r~~ks~~I~vIDFGsAtf~~e~hs~iVsTRHYRAPEViLg--LGwS~pCDvWSiGCIL~ElytG~~LFqtHen~  315 (415)
T KOG0671|consen  244 RPLKSTAIKVIDFGSATFDHEHHSTIVSTRHYRAPEVILG--LGWSQPCDVWSIGCILVELYTGETLFQTHENL  315 (415)
T ss_pred             ccCCCcceEEEecCCcceeccCcceeeeccccCCchheec--cCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence                345799999999865443         346777776  67999999999999999999999999876533

>PRK06347 autolysin; Reviewed

Probab=99.80  E-value=4e-19  Score=193.96  Aligned_cols=173  Identities=17%  Similarity=0.166  Sum_probs=135.0

Q ss_pred             eeeeeecCCCCCChhhHHHhhCCChHHHHhhhCCCCCCCCCCCCCcEEEeeccccCCCCc---------------ceeec
Q 041830           62 TFAILRTNSYYSSLFNLSFYLGLNRFVIARANGFSADTEFLPKDQPLLIPIDCKCNNNGG---------------FFQAD  126 (600)
Q Consensus        62 ~~~~y~~~~~~~~l~~ia~~~~~~~~~i~~~N~~~~~~~~i~~~~~l~vP~~c~c~~~~~---------------~~~~~  126 (600)
                      ....|+|++ ||||+.||++|++++.+|+++|++  ..+.|.+||.|.||..-.-.....               .....
T Consensus       329 ~~~~Y~V~s-GDTL~~IA~rygvSv~eL~~~N~l--~~d~L~~Gq~L~VP~~~~~~~~~t~~~~~~~~~~~~~~~~~~~~  405 (592)
T PRK06347        329 NAKIYTVVK-GDSLWRIANNHKVTVANLKAWNNL--KSDFIYPGQKLKVSAGSTTSDTNTSKPSTGTSTSKPSTGTSTNA  405 (592)
T ss_pred             CceEEEeCC-CCCHHHHHHHhCCCHHHHHHHhCC--CccccccCcEEEEeccccccccccccccccccccccccccccCc
Confidence            456799998 999999999999999999999998  567999999999997421100000               01122


Q ss_pred             ceeeeecCCchhhHHHhcCCCchHHHHHhhCCCCCCCCCCCCCeEeeeeeccC------CCCCC-----CCCCceEEEEE
Q 041830          127 LTKTTIKGESFYSIAQSLEGLTTCGAIKERNPSVSPWDLDDKARLQVPLRCAC------PSSSE-----NLPETRILVSY  195 (600)
Q Consensus       127 ~~y~v~~gdt~~~ia~~~~gl~t~~~l~~~N~~~~~~~l~~G~~l~vp~~c~c------~~~~~-----~~~~~~~~~tY  195 (600)
                      ..|+|++|||+|.||++|+  ++..+|++||++. .+.|.+||+|.||..-.-      +....     ......-..+|
T Consensus       406 ~~ytVk~GDTL~sIA~kyg--VSv~~L~~~N~l~-s~~L~~Gq~L~IP~~~~~~~~t~~~s~~~~~~k~~s~~~~~~~~Y  482 (592)
T PRK06347        406 KVYTVVKGDSLWRIANNNK--VTIANLKSWNNLK-SDFIYPGQKLKVSAGSTSNTNTSKPSTNTNTSKPSTNTNTNAKVY  482 (592)
T ss_pred             eeEEecCCCCHHHHHHHhC--CCHHHHHHHhCCC-cceeccCcEEEEecCCcccccccccccccccccccccccccceee
Confidence            4799999999999999999  9999999999987 467999999999974211      10000     00011124689


Q ss_pred             EccCCCcccccccccCCChHHHHHhcCCCCCCCCcccccCcccccccCCC
Q 041830          196 PVGEGDTVSGLAAKFNTTPAAIIAANNKSLEGFKPEDLLAFTSILIPLNG  245 (600)
Q Consensus       196 ~v~~gd~~~~ia~~f~~~~~~~~~~n~~~~~g~~p~~l~~~~~~~vp~~~  245 (600)
                      .|+.||++++||.+||++..++..||++...     .|.+++.+.||...
T Consensus       483 tVk~GDTL~sIAkkygVSv~~L~~~N~l~s~-----~L~~GQ~L~Ip~~~  527 (592)
T PRK06347        483 TVAKGDSLWRIANNNKVTIANLKSWNNLKSD-----FIYPGQKLKVSAGS  527 (592)
T ss_pred             eecCCCCHHHHHHHHCCCHHHHHHhcCCCcc-----cccCCcEEEEecCc
Confidence            9999999999999999999999999987433     68999999998654

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.78  E-value=1.3e-18  Score=198.06  Aligned_cols=131  Identities=27%  Similarity=0.431  Sum_probs=113.9

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      +|.||++..  +++.||||.++...      ...++.|+..+..++||||+++++++... ...||||||+++|+|.+++
T Consensus        17 fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-~~~~lVmEy~~g~~L~~li   95 (669)
T cd05610          17 FGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSA-NNVYLVMEYLIGGDVKSLL   95 (669)
T ss_pred             CeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEEC-CEEEEEEeCCCCCCHHHHH
Confidence            399999998  48999999986432      24567888888899999999999887555 4899999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN  537 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~  537 (600)
                      +...            .+++..++.|+.||+.||.|||   ..+|+||||||+|||++.++.+||+|||+++...
T Consensus        96 ~~~~------------~l~~~~~~~i~~qil~aL~yLH---~~gIiHrDLKP~NILl~~~g~vkL~DFGls~~~~  155 (669)
T cd05610          96 HIYG------------YFDEEMAVKYISEVALALDYLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTL  155 (669)
T ss_pred             HhcC------------CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCccHHHEEEcCCCCEEEEeCCCCcccc
Confidence            7532            3788999999999999999999   6699999999999999999999999999998653

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.76  E-value=4.9e-19  Score=182.81  Aligned_cols=180  Identities=19%  Similarity=0.242  Sum_probs=141.2

Q ss_pred             CCceeEEEEEEEE--CCeEEEEEEcchhHH--HHHHHHHHHHHhCC------CCceeeeeeEEeccCCceEEEEeecCCC
Q 041830          387 SNRIEGAVYHGRL--NGKNLAIKRTEHEVI--TKLEMQLVQHATHH------HPNIVRLLGTCLTDGPHSFLVFEYAKNG  456 (600)
Q Consensus       387 ~~~~~G~Vy~g~~--~g~~vAvK~~~~~~~--~~~e~ei~~~~~l~------HpNIv~l~g~~~~~~~~~~LV~Ey~~~G  456 (600)
                      +.|.++.|.+++.  .|..||||+++.+..  +.=.+|+.++..+.      --++++|+-.|... ++++||+|-+. .
T Consensus       441 GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk-nHLClVFE~Ls-l  518 (752)
T KOG0670|consen  441 GKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK-NHLCLVFEPLS-L  518 (752)
T ss_pred             ccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc-ceeEEEehhhh-c
Confidence            4445588999987  688999999876442  11234555565553      23788998887666 49999999884 5


Q ss_pred             CHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC-CcEEEEeccCccc
Q 041830          457 SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEE-FNARVGNFGMARC  535 (600)
Q Consensus       457 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~-~~~kI~DFGla~~  535 (600)
                      +|.+.|......         ..|....+..++.|+.-||..|-   ..+|+|.||||.|||+++. ...||||||.|..
T Consensus       519 NLRevLKKyG~n---------vGL~ikaVRsYaqQLflALklLK---~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~  586 (752)
T KOG0670|consen  519 NLREVLKKYGRN---------VGLHIKAVRSYAQQLFLALKLLK---KCGVLHADIKPDNILVNESKNILKLCDFGSASF  586 (752)
T ss_pred             hHHHHHHHhCcc---------cceeehHHHHHHHHHHHHHHHHH---hcCeeecccCccceEeccCcceeeeccCccccc
Confidence            999999875432         34888999999999999999999   5599999999999999865 5789999999976


Q ss_pred             cCCCC----------CCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCCCC
Q 041830          536 VNDDT----------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRKK  582 (600)
Q Consensus       536 ~~~~~----------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~~  582 (600)
                      .....          .+||++.+  ..|+...|+||.||.||||.||+.-|.+..+.
T Consensus       587 ~~eneitPYLVSRFYRaPEIiLG--~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN  641 (752)
T KOG0670|consen  587 ASENEITPYLVSRFYRAPEIILG--LPYDYPIDTWSVGCTLYELYTGKILFPGRTNN  641 (752)
T ss_pred             cccccccHHHHHHhccCcceeec--CcccCCccceeeceeeEEeeccceecCCCCcH
Confidence            65443          35776666  56777889999999999999999999876654

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.76  E-value=4.2e-19  Score=206.59  Aligned_cols=132  Identities=16%  Similarity=0.235  Sum_probs=101.6

Q ss_pred             CceeeeeeEEec------cCCceEEEEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcC
Q 041830          430 PNIVRLLGTCLT------DGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM  503 (600)
Q Consensus       430 pNIv~l~g~~~~------~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~  503 (600)
                      +||+++++++..      +...+++++||+ +++|.+||+...           ..+++.+++.++.||++||.|||   
T Consensus        33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~al~~lH---   97 (793)
T PLN00181         33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD-----------RSVDAFECFHVFRQIVEIVNAAH---   97 (793)
T ss_pred             HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc-----------ccccHHHHHHHHHHHHHHHHHHH---
Confidence            588888887621      113567888988 569999997432           34899999999999999999999   


Q ss_pred             CCCceecCCCCCCEEeCC-------------------CCcEEEEeccCccccCC--------------------------
Q 041830          504 NPSYVHRNIKSRNIFLDE-------------------EFNARVGNFGMARCVND--------------------------  538 (600)
Q Consensus       504 ~~~ivHrDLk~~NILld~-------------------~~~~kI~DFGla~~~~~--------------------------  538 (600)
                      +.+|+||||||+||||+.                   ++.+|++|||+++....                          
T Consensus        98 ~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g  177 (793)
T PLN00181         98 SQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAME  177 (793)
T ss_pred             hCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCC
Confidence            679999999999999953                   45677788887763210                          


Q ss_pred             --CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          539 --DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       539 --~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                        .+.+||+...  ..++.++|||||||+||||++|..|+..
T Consensus       178 t~~Y~APE~~~~--~~~~~~sDVwSlGviL~ELl~~~~~~~~  217 (793)
T PLN00181        178 MSWYTSPEEDNG--SSSNCASDVYRLGVLLFELFCPVSSREE  217 (793)
T ss_pred             CcceEChhhhcc--CCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence              1335665543  3468899999999999999999988753

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.76  E-value=2.9e-19  Score=171.26  Aligned_cols=179  Identities=23%  Similarity=0.454  Sum_probs=142.2

Q ss_pred             EEEEEEEECCeEEEEEEcchhH-----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCc
Q 041830          392 GAVYHGRLNGKNLAIKRTEHEV-----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGL  466 (600)
Q Consensus       392 G~Vy~g~~~g~~vAvK~~~~~~-----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~  466 (600)
                      |..|+|+|.|..+++|.+....     ...|..|+-.++.+.||||+.++|.|... +.+.++..||+.|||+..||+..
T Consensus       204 gelwrgrwqgndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsp-pnlv~isq~mp~gslynvlhe~t  282 (448)
T KOG0195|consen  204 GELWRGRWQGNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSP-PNLVIISQYMPFGSLYNVLHEQT  282 (448)
T ss_pred             cccccccccCcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCC-CCceEeeeeccchHHHHHHhcCc
Confidence            8999999999888888875432     24678888888889999999999999665 58899999999999999999865


Q ss_pred             CcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEE--eccCc-----cccCCC
Q 041830          467 AMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVG--NFGMA-----RCVNDD  539 (600)
Q Consensus       467 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~--DFGla-----~~~~~~  539 (600)
                      .          ...+-.|..+++.++|+|++|||+. ++-|..-.|.++.+++|++.+++|+  |--++     +...+.
T Consensus       283 ~----------vvvd~sqav~faldiargmaflhsl-ep~ipr~~lns~hvmidedltarismad~kfsfqe~gr~y~pa  351 (448)
T KOG0195|consen  283 S----------VVVDHSQAVRFALDIARGMAFLHSL-EPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQEVGRAYSPA  351 (448)
T ss_pred             c----------EEEecchHHHHHHHHHhhHHHHhhc-chhhhhhhcccceEEecchhhhheecccceeeeeccccccCcc
Confidence            3          2367789999999999999999976 6667777899999999999998875  32222     233444


Q ss_pred             CCCCcccccCCCCC-CccCchHHHHHHHHHHHhCCCCCCCCCCC
Q 041830          540 TESPQFYSTNPASW-SMGIDIFAYGIVLLEVLSGQTPINRPRKK  582 (600)
Q Consensus       540 ~~~pe~~~~~~~~~-t~~sDVwSfGvvL~ELltG~~Pf~~~~~~  582 (600)
                      +.+||.+...+... -..+|+|||.|+||||.|+..||..-..-
T Consensus       352 wmspealqrkped~n~raadmwsfaillwel~trevpfadlspm  395 (448)
T KOG0195|consen  352 WMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPM  395 (448)
T ss_pred             cCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCch
Confidence            55666655543332 24579999999999999999999765443

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.73  E-value=6.4e-19  Score=186.90  Aligned_cols=174  Identities=27%  Similarity=0.440  Sum_probs=142.7

Q ss_pred             CCceeEEEEEEEE--CCeEEEEEEcchh---HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          387 SNRIEGAVYHGRL--NGKNLAIKRTEHE---VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       387 ~~~~~G~Vy~g~~--~g~~vAvK~~~~~---~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      +.+.+|.|||++.  .|+..|+|.++-+   ..+-...|+.+++..+|||||.++|-+..+. .+|+.||||.+|+|.+.
T Consensus        24 gsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~d-klwicMEycgggslQdi  102 (829)
T KOG0576|consen   24 GSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRD-KLWICMEYCGGGSLQDI  102 (829)
T ss_pred             cCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhc-CcEEEEEecCCCcccce
Confidence            4445699999998  7899999987653   3345678888899999999999999987664 89999999999999987


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCcccc-----
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV-----  536 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~-----  536 (600)
                      -+..            .+|++.++-.+++...+||+|||   +.+=+|||||-.|||+.+.+.+|++|||.+..+     
T Consensus       103 y~~T------------gplselqiayvcRetl~gl~ylh---s~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~  167 (829)
T KOG0576|consen  103 YHVT------------GPLSELQIAYVCRETLQGLKYLH---SQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIA  167 (829)
T ss_pred             eeec------------ccchhHHHHHHHhhhhccchhhh---cCCcccccccccceeecccCceeecccCchhhhhhhhh
Confidence            6543            34899999999999999999999   667899999999999999999999999987543     


Q ss_pred             -------CCCCCCCccccc-CCCCCCccCchHHHHHHHHHHHhCCCCC
Q 041830          537 -------NDDTESPQFYST-NPASWSMGIDIFAYGIVLLEVLSGQTPI  576 (600)
Q Consensus       537 -------~~~~~~pe~~~~-~~~~~t~~sDVwSfGvvL~ELltG~~Pf  576 (600)
                             ++.+++||+..- +...|.+.+|||+.|+.-.|+---++|.
T Consensus       168 KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqppl  215 (829)
T KOG0576|consen  168 KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPL  215 (829)
T ss_pred             hhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcc
Confidence                   233445665433 3456788899999999999987767664

>PRK10783 mltD membrane-bound lytic murein transglycosylase D; Provisional

Probab=99.73  E-value=2e-17  Score=177.40  Aligned_cols=168  Identities=13%  Similarity=0.149  Sum_probs=127.1

Q ss_pred             eeeecCCCCCChhhHHHhhCCChHHHHhhhCCCCCCCCC-CCC-CcEEEeeccccC-----CCCc------------cee
Q 041830           64 AILRTNSYYSSLFNLSFYLGLNRFVIARANGFSADTEFL-PKD-QPLLIPIDCKCN-----NNGG------------FFQ  124 (600)
Q Consensus        64 ~~y~~~~~~~~l~~ia~~~~~~~~~i~~~N~~~~~~~~i-~~~-~~l~vP~~c~c~-----~~~~------------~~~  124 (600)
                      ...++.. +.+|..||+++|++..+|...|..- ..... +.| +.|+||..-.-.     ..+.            ...
T Consensus       264 ~~V~v~~-~i~L~~iA~~~gvs~~eL~~LNP~~-kr~~t~p~g~~~llvP~~~~~~f~~~l~~~~~~~~~p~~~~~~~~~  341 (456)
T PRK10783        264 ARVDLGQ-QIELAQAAEMAGMSLTKLKTFNAGY-KRSTTAPSGPHYIMVPKKHADQLRESLASGEIAAVQSTLVADNTPL  341 (456)
T ss_pred             EEEecCC-CcCHHHHHHHcCCCHHHHHHhCccc-cCCCcCCCCCeEEEecCchhhHHHHhhhhhhhhhcccccccccCcC
Confidence            3344444 7799999999999999999999532 33333 333 778888853210     0000            001


Q ss_pred             ecceeeeecCCchhhHHHhcCCCchHHHHHhhCCCCCCCCCCCCCeEeeeeeccCCCCCCCCCCceEEEEEEccCCCccc
Q 041830          125 ADLTKTTIKGESFYSIAQSLEGLTTCGAIKERNPSVSPWDLDDKARLQVPLRCACPSSSENLPETRILVSYPVGEGDTVS  204 (600)
Q Consensus       125 ~~~~y~v~~gdt~~~ia~~~~gl~t~~~l~~~N~~~~~~~l~~G~~l~vp~~c~c~~~~~~~~~~~~~~tY~v~~gd~~~  204 (600)
                      ...+|+|++|||+|+||++|+  +|.++|++||+... +.|.+||+|.||..|.|....    .....++|+|+.|||++
T Consensus       342 ~~~~y~Vk~GDTL~sIA~r~g--vs~~~L~~~N~l~~-~~L~~Gq~L~Ip~~~~~~~~~----~~~~~~~Y~Vr~GDTL~  414 (456)
T PRK10783        342 NSRSYKVRSGDTLSGIASRLN--VSTKDLQQWNNLRG-SKLKVGQTLTIGAGSSAQRLA----NNSDSITYRVRKGDSLS  414 (456)
T ss_pred             CceEEEECCCCcHHHHHHHHC--cCHHHHHHHcCCCc-ccCCCCCEEEecCCccccccc----ccccceeEEeCCCCCHH
Confidence            234799999999999999998  89999999999985 789999999999877654211    22345899999999999


Q ss_pred             ccccccCCChHHHHHhcCCCCCCCCcccccCcccccccCCC
Q 041830          205 GLAAKFNTTPAAIIAANNKSLEGFKPEDLLAFTSILIPLNG  245 (600)
Q Consensus       205 ~ia~~f~~~~~~~~~~n~~~~~g~~p~~l~~~~~~~vp~~~  245 (600)
                      +||.+||++..+++.||+....     .|.+|+.+.+++..
T Consensus       415 sIA~kygVtv~~L~~~N~l~~~-----~L~pGq~L~l~v~~  450 (456)
T PRK10783        415 SIAKRHGVNIKDVMRWNSDTAK-----NLQPGDKLTLFVKN  450 (456)
T ss_pred             HHHHHhCCCHHHHHHhcCCCCC-----cCCCCCEEEEecCC
Confidence            9999999999999999986322     68899988887654

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.69  E-value=2.6e-16  Score=164.57  Aligned_cols=120  Identities=18%  Similarity=0.142  Sum_probs=95.0

Q ss_pred             eEEEEEEEE---CCeEEEEEEcchh--------HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHH
Q 041830          391 EGAVYHGRL---NGKNLAIKRTEHE--------VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       391 ~G~Vy~g~~---~g~~vAvK~~~~~--------~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~  459 (600)
                      +|.||++..   +|+.+|||+....        ....+.+|+..+..+.|+|++..+..   . ...||||||+++++|.
T Consensus        31 fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~-~~~~LVmE~~~G~~L~  106 (365)
T PRK09188         31 FSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---T-GKDGLVRGWTEGVPLH  106 (365)
T ss_pred             cEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---c-CCcEEEEEccCCCCHH
Confidence            499999987   4777899985421        23457899999999999999953322   1 2579999999999996


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCC-CCCCEEeCCCCcEEEEeccCcccc
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNI-KSRNIFLDEEFNARVGNFGMARCV  536 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDL-k~~NILld~~~~~kI~DFGla~~~  536 (600)
                      .. ..               ..   ...++.+++++|.|||   +.+|+|||| ||+|||++.++.+||+|||+++..
T Consensus       107 ~~-~~---------------~~---~~~~~~~i~~aL~~lH---~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~  162 (365)
T PRK09188        107 LA-RP---------------HG---DPAWFRSAHRALRDLH---RAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF  162 (365)
T ss_pred             Hh-Cc---------------cc---hHHHHHHHHHHHHHHH---HCCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence            32 10               01   1356789999999999   679999999 999999999999999999999854

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.68  E-value=1.7e-16  Score=152.29  Aligned_cols=129  Identities=18%  Similarity=0.175  Sum_probs=96.2

Q ss_pred             eEEEEEEEE-CCeEEEEEEcchhHH-----------------------------HHHHHHHHHHHhCCCCceeeeeeEEe
Q 041830          391 EGAVYHGRL-NGKNLAIKRTEHEVI-----------------------------TKLEMQLVQHATHHHPNIVRLLGTCL  440 (600)
Q Consensus       391 ~G~Vy~g~~-~g~~vAvK~~~~~~~-----------------------------~~~e~ei~~~~~l~HpNIv~l~g~~~  440 (600)
                      .|.||+|.. +|+.||||.++.+..                             ...+.|+..+..+.|+++.....+..
T Consensus        10 ~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~~p~~~~~   89 (190)
T cd05147          10 EANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIPCPEPILL   89 (190)
T ss_pred             ceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCcEEEe
Confidence            399999988 799999998754311                             11234777777777766644333321


Q ss_pred             ccCCceEEEEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC
Q 041830          441 TDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLD  520 (600)
Q Consensus       441 ~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld  520 (600)
                       .  ..+|||||++++++...+...            ..+++.+...++.|++.+|.|+||  +.+|+||||||+|||++
T Consensus        90 -~--~~~iVmE~i~g~~l~~~~~~~------------~~~~~~~~~~i~~qi~~~L~~l~H--~~giiHrDlkP~NIli~  152 (190)
T cd05147          90 -K--SHVLVMEFIGDDGWAAPRLKD------------APLSESKARELYLQVIQIMRILYQ--DCRLVHADLSEYNLLYH  152 (190)
T ss_pred             -c--CCEEEEEEeCCCCCcchhhhc------------CCCCHHHHHHHHHHHHHHHHHHHH--hCCcccCCCCHHHEEEE
Confidence             2  338999999988776543221            238899999999999999999943  56899999999999998


Q ss_pred             CCCcEEEEeccCccccC
Q 041830          521 EEFNARVGNFGMARCVN  537 (600)
Q Consensus       521 ~~~~~kI~DFGla~~~~  537 (600)
                       ++.++|+|||++....
T Consensus       153 -~~~v~LiDFG~a~~~~  168 (190)
T cd05147         153 -DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             -CCcEEEEEccccccCC
Confidence             4789999999987543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.67  E-value=5.6e-16  Score=148.91  Aligned_cols=128  Identities=16%  Similarity=0.190  Sum_probs=98.5

Q ss_pred             EEEEEEEE-CCeEEEEEEcchhH-----------------------------HHHHHHHHHHHHhCCCCceeeeeeEEec
Q 041830          392 GAVYHGRL-NGKNLAIKRTEHEV-----------------------------ITKLEMQLVQHATHHHPNIVRLLGTCLT  441 (600)
Q Consensus       392 G~Vy~g~~-~g~~vAvK~~~~~~-----------------------------~~~~e~ei~~~~~l~HpNIv~l~g~~~~  441 (600)
                      |.||+|+. +|+.||||.++...                             ....+.|...+..+.|+++.....+...
T Consensus        11 ~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~   90 (190)
T cd05145          11 ANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGVPVPEPILLK   90 (190)
T ss_pred             cEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCCCCceEEEec
Confidence            99999988 69999999876431                             0113567777888888887555444322


Q ss_pred             cCCceEEEEeecCCCCHHHH-HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC
Q 041830          442 DGPHSFLVFEYAKNGSLKDW-LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLD  520 (600)
Q Consensus       442 ~~~~~~LV~Ey~~~GsL~~~-L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld  520 (600)
                         ..+|||||++++++... +..             ..++..+..+++.+++.++.+||+  ..+|+||||||+|||++
T Consensus        91 ---~~~lVmE~~~g~~~~~~~l~~-------------~~~~~~~~~~i~~~l~~~l~~lH~--~~givHrDlkP~NIll~  152 (190)
T cd05145          91 ---KNVLVMEFIGDDGSPAPRLKD-------------VPLEEEEAEELYEQVVEQMRRLYQ--EAGLVHGDLSEYNILYH  152 (190)
T ss_pred             ---CCEEEEEEecCCCchhhhhhh-------------ccCCHHHHHHHHHHHHHHHHHHHH--hCCEecCCCChhhEEEE
Confidence               24899999998855433 332             227788899999999999999994  16999999999999999


Q ss_pred             CCCcEEEEeccCccccCC
Q 041830          521 EEFNARVGNFGMARCVND  538 (600)
Q Consensus       521 ~~~~~kI~DFGla~~~~~  538 (600)
                       ++.++|+|||+++....
T Consensus       153 -~~~~~liDFG~a~~~~~  169 (190)
T cd05145         153 -DGKPYIIDVSQAVELDH  169 (190)
T ss_pred             -CCCEEEEEcccceecCC
Confidence             89999999999986643

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.66  E-value=2.8e-16  Score=153.28  Aligned_cols=153  Identities=14%  Similarity=0.166  Sum_probs=115.6

Q ss_pred             EEEEEEEECCeEEEEEEcchhH------HHH------HHHHHHHHHhCCCCceeeeeeEEecc-------CCceEEEEee
Q 041830          392 GAVYHGRLNGKNLAIKRTEHEV------ITK------LEMQLVQHATHHHPNIVRLLGTCLTD-------GPHSFLVFEY  452 (600)
Q Consensus       392 G~Vy~g~~~g~~vAvK~~~~~~------~~~------~e~ei~~~~~l~HpNIv~l~g~~~~~-------~~~~~LV~Ey  452 (600)
                      |.||....++..+|+|.+..+.      ...      +++|+..+.++.|++|..+..++...       ....+|+|||
T Consensus        45 ~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEy  124 (232)
T PRK10359         45 TKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEY  124 (232)
T ss_pred             eEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEE
Confidence            8999877778899999986432      111      57888888899999999998885532       1257899999


Q ss_pred             cCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccC
Q 041830          453 AKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGM  532 (600)
Q Consensus       453 ~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGl  532 (600)
                      +++.+|.++..                ++.    ....+++.+|..+|   ..+++|||+||+||+++.++ ++|.|||.
T Consensus       125 i~G~tL~~~~~----------------~~~----~~~~~i~~~l~~lH---~~gi~H~Dikp~Nili~~~g-i~liDfg~  180 (232)
T PRK10359        125 IEGVELNDMPE----------------ISE----DVKAKIKASIESLH---QHGMVSGDPHKGNFIVSKNG-LRIIDLSG  180 (232)
T ss_pred             ECCccHHHhhh----------------ccH----HHHHHHHHHHHHHH---HcCCccCCCChHHEEEeCCC-EEEEECCC
Confidence            99999988742                222    24558999999999   77999999999999999888 99999999


Q ss_pred             ccccCCCCCCCcccccCCCCCCccCchHHHHHHHHHHH
Q 041830          533 ARCVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVL  570 (600)
Q Consensus       533 a~~~~~~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELl  570 (600)
                      .+..........+...  ..+..++|+||||+.+.-+.
T Consensus       181 ~~~~~e~~a~d~~vle--r~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        181 KRCTAQRKAKDRIDLE--RHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             cccccchhhHHHHHHH--hHhcccccccceeEeehHHH
Confidence            8766433322223333  23456899999999877543

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.66  E-value=2e-16  Score=160.98  Aligned_cols=173  Identities=21%  Similarity=0.348  Sum_probs=129.4

Q ss_pred             eEEEEEEEE-----CCeEEEEEEcchhH-HHHHHHHHHHHHhCC-CCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          391 EGAVYHGRL-----NGKNLAIKRTEHEV-ITKLEMQLVQHATHH-HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       391 ~G~Vy~g~~-----~g~~vAvK~~~~~~-~~~~e~ei~~~~~l~-HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      +++||++..     .++.||+|.+.... ......|+..+..+. |.||+++.++. ..++...+|+||+++-+..++.+
T Consensus        49 Fssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~-rnnd~v~ivlp~~~H~~f~~l~~  127 (418)
T KOG1167|consen   49 FSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCF-RNNDQVAIVLPYFEHDRFRDLYR  127 (418)
T ss_pred             hhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhh-ccCCeeEEEecccCccCHHHHHh
Confidence            388999876     35679999875532 234566777666654 88999999875 44568999999999999999885


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC-CcEEEEeccCccccCCC---
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEE-FNARVGNFGMARCVNDD---  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~-~~~kI~DFGla~~~~~~---  539 (600)
                      .               ++..++..+++.+..||.++|   ..+||||||||+|+|.+.. .+-.|.|||+|...+..   
T Consensus       128 ~---------------l~~~~i~~Yl~~ll~Al~~~h---~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~  189 (418)
T KOG1167|consen  128 S---------------LSLAEIRWYLRNLLKALAHLH---KNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQT  189 (418)
T ss_pred             c---------------CCHHHHHHHHHHHHHHhhhhh---ccCccccCCCccccccccccCCceEEechhHHHHHhhhhh
Confidence            3               778889999999999999999   7799999999999999865 67899999998621000   


Q ss_pred             ---------CC-----------------CCc-ccc---c------------CC----------CCCCccCchHHHHHHHH
Q 041830          540 ---------TE-----------------SPQ-FYS---T------------NP----------ASWSMGIDIFAYGIVLL  567 (600)
Q Consensus       540 ---------~~-----------------~pe-~~~---~------------~~----------~~~t~~sDVwSfGvvL~  567 (600)
                               ..                 .|. +..   .            +.          ..-+.++||||-|||++
T Consensus       190 ~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~L  269 (418)
T KOG1167|consen  190 EHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILL  269 (418)
T ss_pred             hhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceee
Confidence                     00                 010 000   0            00          01145689999999999


Q ss_pred             HHHhCCCCCCCCCCC
Q 041830          568 EVLSGQTPINRPRKK  582 (600)
Q Consensus       568 ELltG~~Pf~~~~~~  582 (600)
                      -+++++.||....++
T Consensus       270 slls~~~PFf~a~dd  284 (418)
T KOG1167|consen  270 SLLSRRYPFFKAKDD  284 (418)
T ss_pred             hhhccccccccCccc
Confidence            999999999875544

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.66  E-value=2.6e-15  Score=154.79  Aligned_cols=116  Identities=22%  Similarity=0.267  Sum_probs=92.4

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhH--HHHHHHHHHHHHhCC-----C---CceeeeeeEEecc---CCceEEEEeecCCC
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEV--ITKLEMQLVQHATHH-----H---PNIVRLLGTCLTD---GPHSFLVFEYAKNG  456 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~--~~~~e~ei~~~~~l~-----H---pNIv~l~g~~~~~---~~~~~LV~Ey~~~G  456 (600)
                      .+||.+..  ..+.||+|+.+...  .+....||..+.+++     |   ..||+|++.+...   +.+.+||+|++ +-
T Consensus        92 STVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-Gd  170 (590)
T KOG1290|consen   92 STVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GD  170 (590)
T ss_pred             ceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hh
Confidence            78999987  56789999987643  233455676666543     2   3799999998754   34789999999 45


Q ss_pred             CHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC
Q 041830          457 SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLD  520 (600)
Q Consensus       457 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld  520 (600)
                      +|..+|.....          +.++...+.+|++||+.||.|||.  .-+|||-||||+|||+.
T Consensus       171 nLLklI~~s~Y----------rGlpl~~VK~I~~qvL~GLdYLH~--ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  171 NLLKLIKYSNY----------RGLPLSCVKEICRQVLTGLDYLHR--ECGIIHTDLKPENVLLC  222 (590)
T ss_pred             HHHHHHHHhCC----------CCCcHHHHHHHHHHHHHHHHHHHH--hcCccccCCCcceeeee
Confidence            89999976543          559999999999999999999997  45999999999999994

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.65  E-value=4.8e-16  Score=146.93  Aligned_cols=100  Identities=27%  Similarity=0.281  Sum_probs=83.0

Q ss_pred             CCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccc
Q 041830          456 GSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARC  535 (600)
Q Consensus       456 GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~  535 (600)
                      |+|.++++...           ..++|.+++.++.|++.||.|||+.   +      ||+|||++.++.+|+  ||+++.
T Consensus         1 GsL~~~l~~~~-----------~~l~~~~~~~i~~qi~~~L~~lH~~---~------kp~Nil~~~~~~~~~--fG~~~~   58 (176)
T smart00750        1 VSLADILEVRG-----------RPLNEEEIWAVCLQCLRALRELHRQ---A------KSGNILLTWDGLLKL--DGSVAF   58 (176)
T ss_pred             CcHHHHHHHhC-----------CCCCHHHHHHHHHHHHHHHHHHHhc---C------CcccEeEcCccceee--ccceEe
Confidence            78999997532           3499999999999999999999943   3      999999999999999  999875


Q ss_pred             cCC-------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          536 VND-------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       536 ~~~-------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                      ...       .+.+||....  ..++.++|||||||++|||++|+.||...
T Consensus        59 ~~~~~~~g~~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~p~~~~  107 (176)
T smart00750       59 KTPEQSRVDPYFMAPEVIQG--QSYTEKADIYSLGITLYEALDYELPYNEE  107 (176)
T ss_pred             eccccCCCcccccChHHhcC--CCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence            432       2346776654  45678999999999999999999999653

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.63  E-value=1.1e-15  Score=162.93  Aligned_cols=145  Identities=23%  Similarity=0.450  Sum_probs=119.0

Q ss_pred             HhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCC
Q 041830          425 ATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMN  504 (600)
Q Consensus       425 ~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~  504 (600)
                      +.+.|.|+.+|+|.++.. +..++|.+||+.|+|.|.+....           ..++|.....+.++|+.||+|||+.  
T Consensus         2 ~~l~h~n~~~f~g~~~~~-~~~~~i~~~c~rGsl~D~i~~~~-----------~~~d~~F~~s~~rdi~~Gl~ylh~s--   67 (484)
T KOG1023|consen    2 RQLDHDNLNKFIGASVDG-PEMIVIWEYCSRGSLLDILSNED-----------IKLDYFFILSFIRDISKGLAYLHNS--   67 (484)
T ss_pred             cccchhhhhhheeeEecC-CceEEEEeeecCccHHhHHhccc-----------cCccHHHHHHHHHHHHHHHHHHhcC--
Confidence            456799999999999877 58999999999999999997633           3489999999999999999999953  


Q ss_pred             CCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--------------CCCCcccccC--CC---CCCccCchHHHHHH
Q 041830          505 PSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--------------TESPQFYSTN--PA---SWSMGIDIFAYGIV  565 (600)
Q Consensus       505 ~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--------------~~~pe~~~~~--~~---~~t~~sDVwSfGvv  565 (600)
                      +-..|+.|+++|+++|..|.+||+|||+.......              +.+||.....  ..   ..+.+.||||||++
T Consensus        68 ~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii  147 (484)
T KOG1023|consen   68 PIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGII  147 (484)
T ss_pred             cceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHH
Confidence            33399999999999999999999999998776321              1246655442  11   24677899999999


Q ss_pred             HHHHHhCCCCCCCCCCCC
Q 041830          566 LLEVLSGQTPINRPRKKD  583 (600)
Q Consensus       566 L~ELltG~~Pf~~~~~~~  583 (600)
                      ++|+++++.||+.....+
T Consensus       148 ~~ei~~r~~~~~~~~~~~  165 (484)
T KOG1023|consen  148 MYEILFRSGPFDLRNLVE  165 (484)
T ss_pred             HHHHHhccCccccccccC
Confidence            999999999998755443

>PRK10345 hypothetical protein; Provisional

Probab=99.60  E-value=6.7e-15  Score=142.90  Aligned_cols=127  Identities=17%  Similarity=0.119  Sum_probs=93.9

Q ss_pred             ceeEEEEEEEECCeEEEEEEcchh---HHHHHHHHHHHHHhC-----CCCceeeeeeEEeccCC--c-eEEEEee--cCC
Q 041830          389 RIEGAVYHGRLNGKNLAIKRTEHE---VITKLEMQLVQHATH-----HHPNIVRLLGTCLTDGP--H-SFLVFEY--AKN  455 (600)
Q Consensus       389 ~~~G~Vy~g~~~g~~vAvK~~~~~---~~~~~e~ei~~~~~l-----~HpNIv~l~g~~~~~~~--~-~~LV~Ey--~~~  455 (600)
                      |..|.||....++.. +||++..+   ....+.+|+..+..+     .||||++++|++.++..  . +.+|+||  +++
T Consensus        13 G~~~~Vy~hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~   91 (210)
T PRK10345         13 GRHRKCYAHPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPS   91 (210)
T ss_pred             CCceEEEECCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcc
Confidence            334899973334444 68986543   335678888888888     57999999999876531  3 3488999  668


Q ss_pred             CCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHH-HHHHhcCCCCceecCCCCCCEEeCC----CCcEEEEec
Q 041830          456 GSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMAL-QYMHHVMNPSYVHRNIKSRNIFLDE----EFNARVGNF  530 (600)
Q Consensus       456 GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivHrDLk~~NILld~----~~~~kI~DF  530 (600)
                      |+|.+++.+..             +++.  ..++.+++.++ +|||   +.+|+||||||+|||++.    ++.++|+||
T Consensus        92 ~tL~~~l~~~~-------------~~e~--~~~~~~~L~~l~~yLh---~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg  153 (210)
T PRK10345         92 ITLTEFAEQCR-------------YEED--VAQLRQLLKKLKRYLL---DNRIVTMELKPQNILCQRISESEVIPVVCDN  153 (210)
T ss_pred             hhHHHHHHccc-------------ccHh--HHHHHHHHHHHHHHHH---HCCEeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence            99999996532             4444  35677888777 9999   679999999999999973    348999995


Q ss_pred             cCcc
Q 041830          531 GMAR  534 (600)
Q Consensus       531 Gla~  534 (600)
                      +.++
T Consensus       154 ~G~~  157 (210)
T PRK10345        154 IGES  157 (210)
T ss_pred             CCCc
Confidence            4443

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.60  E-value=1.2e-14  Score=139.05  Aligned_cols=164  Identities=15%  Similarity=0.087  Sum_probs=119.1

Q ss_pred             eEEEEEEEECCeEEEEEEcchhHH-------HHHHHHHHHHHhCC-CCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRLNGKNLAIKRTEHEVI-------TKLEMQLVQHATHH-HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~~g~~vAvK~~~~~~~-------~~~e~ei~~~~~l~-HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      +|.||...-.+..++.+.++....       ..+++|+..+.++. |+++.+++++     ...+++|||+++.+|.+.+
T Consensus        15 f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~-----~~~~lvmeyI~G~~L~~~~   89 (218)
T PRK12274         15 FGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW-----DGRHLDRSYLAGAAMYQRP   89 (218)
T ss_pred             cceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE-----cCEEEEEeeecCccHHhhh
Confidence            389997777888888777655332       24688999999995 5789999886     2469999999999986543


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCC-CCCCEEeCCCCcEEEEeccCccccCCCCC
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNI-KSRNIFLDEEFNARVGNFGMARCVNDDTE  541 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDL-k~~NILld~~~~~kI~DFGla~~~~~~~~  541 (600)
                      ..                   ....+..++..+|.++|   ..+|+|||| ||.|||++.++.++|+|||++........
T Consensus        90 ~~-------------------~~~~~~~qi~~~L~~lH---~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~  147 (218)
T PRK12274         90 PR-------------------GDLAYFRAARRLLQQLH---RCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR  147 (218)
T ss_pred             hh-------------------hhHHHHHHHHHHHHHHH---HCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence            21                   11346788999999999   679999999 79999999999999999999985443221


Q ss_pred             --------------------CCcccccCCC----CCC-ccCchHHHHHHHHHHHhCCCCCCCCCC
Q 041830          542 --------------------SPQFYSTNPA----SWS-MGIDIFAYGIVLLEVLSGQTPINRPRK  581 (600)
Q Consensus       542 --------------------~pe~~~~~~~----~~t-~~sDVwSfGvvL~ELltG~~Pf~~~~~  581 (600)
                                          .|+.......    ..+ ...+.++-|.-+|.++||+.++..+.+
T Consensus       148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~~  212 (218)
T PRK12274        148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDNE  212 (218)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccCC
Confidence                                1222211100    011 124677899999999999998765543

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.58  E-value=4.9e-14  Score=143.82  Aligned_cols=175  Identities=31%  Similarity=0.461  Sum_probs=137.1

Q ss_pred             EEEEEEEECCeEEEEEEcchhH------HHHHHHHHHHHHhCCCC-ceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          392 GAVYHGRLNGKNLAIKRTEHEV------ITKLEMQLVQHATHHHP-NIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       392 G~Vy~g~~~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~Hp-NIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      |.||++... ..+++|.+....      ...+.+|+..+..+.|+ +++++.+++... ...++++||+.++++.+++..
T Consensus        14 ~~v~~~~~~-~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~-~~~~~~~~~~~~~~l~~~~~~   91 (384)
T COG0515          14 GEVYLARDR-KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDE-GSLYLVMEYVDGGSLEDLLKK   91 (384)
T ss_pred             eEEEEEEec-cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecC-CEEEEEEecCCCCcHHHHHHh
Confidence            899999888 788999875432      34567788888889888 799999997443 357999999999999977765


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC-cEEEEeccCccccCCCC---
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEF-NARVGNFGMARCVNDDT---  540 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~-~~kI~DFGla~~~~~~~---  540 (600)
                      ....         ..+.......+..+++.++.|+|   ..+++|||+||+||+++... .+++.|||.++......   
T Consensus        92 ~~~~---------~~~~~~~~~~~~~~~~~~l~~~H---~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~  159 (384)
T COG0515          92 IGRK---------GPLSESEALFILAQILSALEYLH---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTS  159 (384)
T ss_pred             cccc---------cCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccc
Confidence            4210         13888999999999999999999   66899999999999999988 79999999987443221   


Q ss_pred             ---------------CCCcccccCC-CCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          541 ---------------ESPQFYSTNP-ASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       541 ---------------~~pe~~~~~~-~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                                     .+|+...... .......|+||+|++++++++|..||....
T Consensus       160 ~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~  215 (384)
T COG0515         160 SIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK  215 (384)
T ss_pred             cccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence                           1233332211 355667899999999999999999976554

>PRK10783 mltD membrane-bound lytic murein transglycosylase D; Provisional

Probab=99.57  E-value=7.4e-15  Score=157.74  Aligned_cols=107  Identities=17%  Similarity=0.137  Sum_probs=93.1

Q ss_pred             eeeeecCCCCCChhhHHHhhCCChHHHHhhhCCCCCCCCCCCCCcEEEeeccccCCCCcceeecceeeeecCCchhhHHH
Q 041830           63 FAILRTNSYYSSLFNLSFYLGLNRFVIARANGFSADTEFLPKDQPLLIPIDCKCNNNGGFFQADLTKTTIKGESFYSIAQ  142 (600)
Q Consensus        63 ~~~y~~~~~~~~l~~ia~~~~~~~~~i~~~N~~~~~~~~i~~~~~l~vP~~c~c~~~~~~~~~~~~y~v~~gdt~~~ia~  142 (600)
                      ...|+|++ |||+++||++||+++.+|+++|++.  .+.|.+||.|.||.+|.|. .........+|+|++|||+|+||+
T Consensus       343 ~~~y~Vk~-GDTL~sIA~r~gvs~~~L~~~N~l~--~~~L~~Gq~L~Ip~~~~~~-~~~~~~~~~~Y~Vr~GDTL~sIA~  418 (456)
T PRK10783        343 SRSYKVRS-GDTLSGIASRLNVSTKDLQQWNNLR--GSKLKVGQTLTIGAGSSAQ-RLANNSDSITYRVRKGDSLSSIAK  418 (456)
T ss_pred             ceEEEECC-CCcHHHHHHHHCcCHHHHHHHcCCC--cccCCCCCEEEecCCcccc-cccccccceeEEeCCCCCHHHHHH
Confidence            45799999 9999999999999999999999995  4889999999999888763 122223346799999999999999


Q ss_pred             hcCCCchHHHHHhhCCCCCCCCCCCCCeEeeeee
Q 041830          143 SLEGLTTCGAIKERNPSVSPWDLDDKARLQVPLR  176 (600)
Q Consensus       143 ~~~gl~t~~~l~~~N~~~~~~~l~~G~~l~vp~~  176 (600)
                      +|+  +|.++|++||+.... .|++||+|.|++.
T Consensus       419 kyg--Vtv~~L~~~N~l~~~-~L~pGq~L~l~v~  449 (456)
T PRK10783        419 RHG--VNIKDVMRWNSDTAK-NLQPGDKLTLFVK  449 (456)
T ss_pred             HhC--CCHHHHHHhcCCCCC-cCCCCCEEEEecC
Confidence            999  999999999998754 8999999999874

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.57  E-value=2.8e-14  Score=139.16  Aligned_cols=127  Identities=16%  Similarity=0.248  Sum_probs=103.2

Q ss_pred             ceeEEEEEEEECCeEEEEEEcchhH-----------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCC
Q 041830          389 RIEGAVYHGRLNGKNLAIKRTEHEV-----------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGS  457 (600)
Q Consensus       389 ~~~G~Vy~g~~~g~~vAvK~~~~~~-----------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~Gs  457 (600)
                      +..|.||+|.+.|..+++|......           ...++.|+..+..+.|+++.....++... ...+++|||+++++
T Consensus         7 G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-~~~~lv~e~~~G~~   85 (211)
T PRK14879          7 GAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDP-ENFIIVMEYIEGEP   85 (211)
T ss_pred             CceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeC-CCCEEEEEEeCCcC
Confidence            3449999999999999999743211           12456788888888888888777776554 36799999999999


Q ss_pred             HHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCcccc
Q 041830          458 LKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV  536 (600)
Q Consensus       458 L~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~  536 (600)
                      |.+++...               .+ ++..++.+++.+|.+||   ..+++|||++|+|||++ ++.++|+|||+++..
T Consensus        86 L~~~~~~~---------------~~-~~~~i~~~i~~~l~~lH---~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~~  144 (211)
T PRK14879         86 LKDLINSN---------------GM-EELELSREIGRLVGKLH---SAGIIHGDLTTSNMILS-GGKIYLIDFGLAEFS  144 (211)
T ss_pred             HHHHHHhc---------------cH-HHHHHHHHHHHHHHHHH---hCCcccCCCCcccEEEE-CCCEEEEECCcccCC
Confidence            99998532               22 78889999999999999   67999999999999999 788999999998753

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.53  E-value=7.7e-14  Score=134.79  Aligned_cols=124  Identities=16%  Similarity=0.243  Sum_probs=97.1

Q ss_pred             ceeEEEEEEEECCeEEEEEEcchh--------H---HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCC
Q 041830          389 RIEGAVYHGRLNGKNLAIKRTEHE--------V---ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGS  457 (600)
Q Consensus       389 ~~~G~Vy~g~~~g~~vAvK~~~~~--------~---~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~Gs  457 (600)
                      +..|.||+|.++|..+++|.....        .   ...++.|+..+..+.|+++.....++..+ +..++||||+++++
T Consensus         5 G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-~~~~lv~e~~~g~~   83 (199)
T TIGR03724         5 GAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDP-DNKTIVMEYIEGKP   83 (199)
T ss_pred             CceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEC-CCCEEEEEEECCcc
Confidence            344999999999999999984321        0   13456788888888777655444444444 36789999999999


Q ss_pred             HHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCcccc
Q 041830          458 LKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV  536 (600)
Q Consensus       458 L~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~  536 (600)
                      |.+++....             .      .++.+++.+|.+||   +.+++|||++|+||+++ ++.+++.|||+++..
T Consensus        84 l~~~~~~~~-------------~------~~~~~i~~~l~~lH---~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724        84 LKDVIEEGN-------------D------ELLREIGRLVGKLH---KAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             HHHHHhhcH-------------H------HHHHHHHHHHHHHH---HCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            999875321             0      68899999999999   77999999999999999 899999999998764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.48  E-value=5.8e-13  Score=138.84  Aligned_cols=177  Identities=23%  Similarity=0.290  Sum_probs=124.0

Q ss_pred             eEEEEEEEECC---eEEEEEEcchhHH---HHHHHHHHHHHhCC----CCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          391 EGAVYHGRLNG---KNLAIKRTEHEVI---TKLEMQLVQHATHH----HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       391 ~G~Vy~g~~~g---~~vAvK~~~~~~~---~~~e~ei~~~~~l~----HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      .|.||.+....   ..+|+|.......   ..+..|...+..+.    -+++.++++.........|+||+.+ +-+|.+
T Consensus        31 fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~d  109 (322)
T KOG1164|consen   31 FGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLED  109 (322)
T ss_pred             CceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHH
Confidence            49999999833   4688887544211   13444554444443    2477788777532334679999988 569999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC-----CcEEEEeccCcc-
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEE-----FNARVGNFGMAR-  534 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~-----~~~kI~DFGla~-  534 (600)
                      +......          ..++....++|+.|++.+|++||   +.+++||||||.|+++...     ..+.|.|||+++ 
T Consensus       110 l~~~~~~----------~~fs~~T~l~ia~q~l~~l~~lH---~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~  176 (322)
T KOG1164|consen  110 LRKRNPP----------GRFSRKTVLRIAIQNLNALEDLH---SKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARR  176 (322)
T ss_pred             HHHhCCC----------CCcCHhHHHHHHHHHHHHHHHHH---hcCcccCCcCHHHeeecCCCCcccceEEEEecCCCcc
Confidence            7754431          33899999999999999999999   7799999999999999754     468999999998 


Q ss_pred             -ccCCCCC---CCc-----cc-cc---------CCCCCCccCchHHHHHHHHHHHhCCCCCCCCCC
Q 041830          535 -CVNDDTE---SPQ-----FY-ST---------NPASWSMGIDIFAYGIVLLEVLSGQTPINRPRK  581 (600)
Q Consensus       535 -~~~~~~~---~pe-----~~-~~---------~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~  581 (600)
                       .......   .+.     .. .+         .....+.+.|+||++.++.|+..|..||.....
T Consensus       177 ~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~  242 (322)
T KOG1164|consen  177 FKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM  242 (322)
T ss_pred             ccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence             3211110   000     01 11         112235567999999999999999999966543

>smart00090 RIO RIO-like kinase

Probab=99.48  E-value=2.5e-13  Score=134.88  Aligned_cols=126  Identities=14%  Similarity=0.140  Sum_probs=93.6

Q ss_pred             eEEEEEEE--E-CCeEEEEEEcchhH---------------------------HHHHHHHHHHHHhCCCCc--eeeeeeE
Q 041830          391 EGAVYHGR--L-NGKNLAIKRTEHEV---------------------------ITKLEMQLVQHATHHHPN--IVRLLGT  438 (600)
Q Consensus       391 ~G~Vy~g~--~-~g~~vAvK~~~~~~---------------------------~~~~e~ei~~~~~l~HpN--Iv~l~g~  438 (600)
                      .|.||+|.  . +|+.||+|.++...                           ...++.|+..+..+.+..  +.+++++
T Consensus        41 ~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~~~i~~p~~~~~  120 (237)
T smart00090       41 EANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYEAGVPVPKPIAW  120 (237)
T ss_pred             ceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCeeeEe
Confidence            39999998  2 79999999875321                           012456777777775422  3344432


Q ss_pred             EeccCCceEEEEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCC-ceecCCCCCCE
Q 041830          439 CLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS-YVHRNIKSRNI  517 (600)
Q Consensus       439 ~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~-ivHrDLk~~NI  517 (600)
                          + ..++||||+++++|..+....            ..+...+...++.|++.++.+||   ..+ ++||||||+||
T Consensus       121 ----~-~~~lV~E~~~g~~L~~~~~~~------------~~~~~~~~~~i~~qi~~~l~~LH---~~g~iiH~Dikp~NI  180 (237)
T smart00090      121 ----R-RNVLVMEFIGGDGLPAPRLKD------------VEPEEEEEFELYDDILEEMRKLY---KEGELVHGDLSEYNI  180 (237)
T ss_pred             ----c-CceEEEEEecCCccccccccc------------CCcchHHHHHHHHHHHHHHHHHH---hcCCEEeCCCChhhE
Confidence                1 348999999998887654221            12455667889999999999999   668 99999999999


Q ss_pred             EeCCCCcEEEEeccCccccC
Q 041830          518 FLDEEFNARVGNFGMARCVN  537 (600)
Q Consensus       518 Lld~~~~~kI~DFGla~~~~  537 (600)
                      +++ ++.++|+|||.+....
T Consensus       181 li~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      181 LVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             EEE-CCCEEEEEChhhhccC
Confidence            999 8899999999987543

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.47  E-value=2.9e-13  Score=150.69  Aligned_cols=123  Identities=15%  Similarity=0.235  Sum_probs=98.9

Q ss_pred             eeEEEEEEEECCeEEEEEEcch-----h------HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCH
Q 041830          390 IEGAVYHGRLNGKNLAIKRTEH-----E------VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSL  458 (600)
Q Consensus       390 ~~G~Vy~g~~~g~~vAvK~~~~-----~------~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL  458 (600)
                      ..|.||+|.+.+..+++|+...     .      ..+.+++|+..+..++|++++....++..+ ...++||||+++++|
T Consensus       345 ~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~-~~~~lv~E~~~g~~L  423 (535)
T PRK09605        345 AEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDP-EEKTIVMEYIGGKDL  423 (535)
T ss_pred             CcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeC-CCCEEEEEecCCCcH
Confidence            3499999999776666654211     1      113467889999999999999887776654 367899999999999


Q ss_pred             HHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC
Q 041830          459 KDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN  537 (600)
Q Consensus       459 ~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~  537 (600)
                      .+++.                    ....++.+++++|.|||   +.+++||||||+|||+ +++.++|+|||+++...
T Consensus       424 ~~~l~--------------------~~~~~~~~i~~~L~~lH---~~giiHrDlkp~NILl-~~~~~~liDFGla~~~~  478 (535)
T PRK09605        424 KDVLE--------------------GNPELVRKVGEIVAKLH---KAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYSD  478 (535)
T ss_pred             HHHHH--------------------HHHHHHHHHHHHHHHHH---hCCCccCCCChHHEEE-ECCcEEEEeCcccccCC
Confidence            98874                    23568899999999999   6799999999999999 67899999999998653

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.46  E-value=8.3e-13  Score=131.38  Aligned_cols=126  Identities=13%  Similarity=0.144  Sum_probs=97.4

Q ss_pred             EEEEEEEECCeEEEEEEcchh----------------HHHHHHHHHHHHHhCCCCce--eeeeeEEeccCCce---EEEE
Q 041830          392 GAVYHGRLNGKNLAIKRTEHE----------------VITKLEMQLVQHATHHHPNI--VRLLGTCLTDGPHS---FLVF  450 (600)
Q Consensus       392 G~Vy~g~~~g~~vAvK~~~~~----------------~~~~~e~ei~~~~~l~HpNI--v~l~g~~~~~~~~~---~LV~  450 (600)
                      |+||.....+..+++|+.+..                ....+.+|+..+..+.|++|  .+.+++...+....   ++||
T Consensus        46 gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~  125 (239)
T PRK01723         46 GTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILI  125 (239)
T ss_pred             ccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEE
Confidence            899999998999999976431                11345678888888888774  77777754433222   5999


Q ss_pred             eecCC-CCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEe
Q 041830          451 EYAKN-GSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGN  529 (600)
Q Consensus       451 Ey~~~-GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~D  529 (600)
                      ||+++ .+|.+++....             ++..    ...+++.+|.+||   ..+|+||||||+|||++.++.++|+|
T Consensus       126 e~l~G~~~L~~~l~~~~-------------l~~~----~~~~i~~~l~~lH---~~GI~HrDlkp~NILv~~~~~v~LID  185 (239)
T PRK01723        126 ERIEGARDLVALLQEAP-------------LSEE----QWQAIGQLIARFH---DAGVYHADLNAHNILLDPDGKFWLID  185 (239)
T ss_pred             EecCCCCCHHHHHhcCC-------------CCHH----HHHHHHHHHHHHH---HCCCCCCCCCchhEEEcCCCCEEEEE
Confidence            99997 69999886421             4433    3568899999999   77999999999999999989999999


Q ss_pred             ccCccccC
Q 041830          530 FGMARCVN  537 (600)
Q Consensus       530 FGla~~~~  537 (600)
                      ||.++...
T Consensus       186 fg~~~~~~  193 (239)
T PRK01723        186 FDRGELRT  193 (239)
T ss_pred             CCCcccCC
Confidence            99987643

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.45  E-value=7e-13  Score=128.21  Aligned_cols=121  Identities=11%  Similarity=0.095  Sum_probs=91.1

Q ss_pred             EEEEEEEE-CCeEEEEEEcchhH-------------------------HHHHHHHHHHHHhCCCCc--eeeeeeEEeccC
Q 041830          392 GAVYHGRL-NGKNLAIKRTEHEV-------------------------ITKLEMQLVQHATHHHPN--IVRLLGTCLTDG  443 (600)
Q Consensus       392 G~Vy~g~~-~g~~vAvK~~~~~~-------------------------~~~~e~ei~~~~~l~HpN--Iv~l~g~~~~~~  443 (600)
                      |.||++.. +|+.||||+++...                         ....+.|+..+..+.|++  +...++.     
T Consensus        29 g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~v~~~~~~-----  103 (198)
T cd05144          29 SDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFPVPKPIDW-----  103 (198)
T ss_pred             eEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCCCCceeec-----
Confidence            89999988 79999999754211                         012456677777776664  4444332     


Q ss_pred             CceEEEEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC
Q 041830          444 PHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEF  523 (600)
Q Consensus       444 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~  523 (600)
                      ...++||||+++++|.+....                  .....++.+++.++.++|   ..+++||||||+||++++++
T Consensus       104 ~~~~lv~e~~~g~~L~~~~~~------------------~~~~~~~~~i~~~l~~lh---~~gi~H~Dl~p~Nill~~~~  162 (198)
T cd05144         104 NRHAVVMEYIDGVELYRVRVL------------------EDPEEVLDEILEEIVKAY---KHGIIHGDLSEFNILVDDDE  162 (198)
T ss_pred             CCceEEEEEeCCcchhhcccc------------------ccHHHHHHHHHHHHHHHH---HCCCCcCCCCcccEEEcCCC
Confidence            245899999999998764320                  224568889999999999   57999999999999999999


Q ss_pred             cEEEEeccCccccCC
Q 041830          524 NARVGNFGMARCVND  538 (600)
Q Consensus       524 ~~kI~DFGla~~~~~  538 (600)
                      .++|+|||++.....
T Consensus       163 ~~~liDfg~~~~~~~  177 (198)
T cd05144         163 KIYIIDWPQMVSTDH  177 (198)
T ss_pred             cEEEEECCccccCCC
Confidence            999999999865543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.44  E-value=4.1e-13  Score=127.50  Aligned_cols=178  Identities=20%  Similarity=0.204  Sum_probs=123.5

Q ss_pred             CceeEEEEEEEE--CCeEEEEEEcchhHH-HHHHHHHHHHHhCCC-CceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          388 NRIEGAVYHGRL--NGKNLAIKRTEHEVI-TKLEMQLVQHATHHH-PNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       388 ~~~~G~Vy~g~~--~g~~vAvK~~~~~~~-~~~e~ei~~~~~l~H-pNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      .+.+|.+|.|..  +|+.||||.-+.... ..+..|-.....++| ..|..+.-+ ..+...-.||||.. +-||.+...
T Consensus        25 sGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y-~~e~~ynvlVMdLL-GPsLEdLfn  102 (341)
T KOG1163|consen   25 SGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHY-GTEKDYNVLVMDLL-GPSLEDLFN  102 (341)
T ss_pred             CCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhh-ccccccceeeeecc-CccHHHHHH
Confidence            334499999987  899999998654432 233444444444443 244444434 34445678999998 568988775


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC---CcEEEEeccCccccCCCC
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEE---FNARVGNFGMARCVNDDT  540 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~---~~~kI~DFGla~~~~~~~  540 (600)
                      -..           ..++.++++-++-|+..-++|+|   .++++||||||+|.|..-+   ..+-++|||+|+..-+..
T Consensus       103 fC~-----------R~ftmkTvLMLaDQml~RiEyvH---~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~  168 (341)
T KOG1163|consen  103 FCS-----------RRFTMKTVLMLADQMLSRIEYVH---LRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIR  168 (341)
T ss_pred             HHh-----------hhhhHHhHHHHHHHHHHHHHHHH---hhccccccCCccceeeccccccceEEEEeccchhhhcccc
Confidence            322           34889999999999999999999   7799999999999999643   467899999998653322


Q ss_pred             CCCccccc------C-----------CCCCCccCchHHHHHHHHHHHhCCCCCCCCCC
Q 041830          541 ESPQFYST------N-----------PASWSMGIDIFAYGIVLLEVLSGQTPINRPRK  581 (600)
Q Consensus       541 ~~pe~~~~------~-----------~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~  581 (600)
                      ........      .           ...-+.+-|+=|+|.+|...--|..||+....
T Consensus       169 t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka  226 (341)
T KOG1163|consen  169 TRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKA  226 (341)
T ss_pred             ccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccch
Confidence            11000000      0           11124456999999999999999999987543

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.41  E-value=7.3e-13  Score=133.79  Aligned_cols=134  Identities=23%  Similarity=0.404  Sum_probs=100.2

Q ss_pred             CCCceeeeeeEEecc--------------------------CCceEEEEeecCCCCHHHHHhcCcCcccccccccccCCC
Q 041830          428 HHPNIVRLLGTCLTD--------------------------GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLT  481 (600)
Q Consensus       428 ~HpNIv~l~g~~~~~--------------------------~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~  481 (600)
                      +|||||++.+++.++                          +..+|+||.-.+. +|.+||....             .+
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~-------------~s  339 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH-------------RS  339 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC-------------Cc
Confidence            499999999886421                          1245889987765 8999986432             56


Q ss_pred             HHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEe--CCCC--cEEEEeccCccccCC------------------C
Q 041830          482 WSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFL--DEEF--NARVGNFGMARCVND------------------D  539 (600)
Q Consensus       482 ~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl--d~~~--~~kI~DFGla~~~~~------------------~  539 (600)
                      ...+.-|+.|+++|+.|||   .+++.|||+|++|||+  |+|.  ...|+|||.+-.-+.                  .
T Consensus       340 ~r~~~~~laQlLEav~hL~---~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~  416 (598)
T KOG4158|consen  340 YRTGRVILAQLLEAVTHLH---KHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAK  416 (598)
T ss_pred             hHHHHHHHHHHHHHHHHHH---HccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcce
Confidence            6667778899999999999   7799999999999999  4443  578899998642111                  1


Q ss_pred             CCCCcccccCCCCC----CccCchHHHHHHHHHHHhCCCCCCC
Q 041830          540 TESPQFYSTNPASW----SMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       540 ~~~pe~~~~~~~~~----t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                      .++||+....+...    -.++|.|+.|.+-||+++...||..
T Consensus       417 lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~  459 (598)
T KOG4158|consen  417 LMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK  459 (598)
T ss_pred             ecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence            13566655433221    3468999999999999999999965

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.38  E-value=1.2e-13  Score=153.95  Aligned_cols=146  Identities=18%  Similarity=0.298  Sum_probs=113.4

Q ss_pred             HHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHH
Q 041830          418 EMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQ  497 (600)
Q Consensus       418 e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~  497 (600)
                      -.|+.+-..++|+|++..+..+.+. ...+-.||||++ +|..++.+..            .+...++-.+..|+..|++
T Consensus       369 ~sE~~i~~~l~h~~~~e~l~~~~~~-~~~~~~mE~~~~-Dlf~~~~~~~------------~~~~~e~~c~fKqL~~Gv~  434 (601)
T KOG0590|consen  369 TSEFCIGSSLSHPNIIETLDIVQEI-DGILQSMEYCPY-DLFSLVMSNG------------KLTPLEADCFFKQLLRGVK  434 (601)
T ss_pred             hhheeecccccCCchhhhHHHHhhc-ccchhhhhcccH-HHHHHHhccc------------ccchhhhhHHHHHHHHHHH
Confidence            3455555668899998888775443 344555999999 9999987642            2777888899999999999


Q ss_pred             HHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC----------------CCCCcccccCCCCCC-ccCchH
Q 041830          498 YMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD----------------TESPQFYSTNPASWS-MGIDIF  560 (600)
Q Consensus       498 yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~----------------~~~pe~~~~~~~~~t-~~sDVw  560 (600)
                      |||   +.+|.|||+|++|+++..++.+||+|||.+....-+                +.+||....  ..|. ...|||
T Consensus       435 y~h---~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~--~~ydpr~vDiw  509 (601)
T KOG0590|consen  435 YLH---SMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTG--KEYDPRAVDVW  509 (601)
T ss_pred             HHH---hcCceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccc--cccCcchhhhh
Confidence            999   669999999999999999999999999998644322                223454433  3343 347999


Q ss_pred             HHHHHHHHHHhCCCCCCCCCCC
Q 041830          561 AYGIVLLEVLSGQTPINRPRKK  582 (600)
Q Consensus       561 SfGvvL~ELltG~~Pf~~~~~~  582 (600)
                      |.||++..|.+|+.||.....+
T Consensus       510 S~~ii~~~m~~~~~~Wk~a~~~  531 (601)
T KOG0590|consen  510 SCGIIYICMILGRFPWKVAKKS  531 (601)
T ss_pred             hccceEEEEecCCCcccccccc
Confidence            9999999999999999765444

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.37  E-value=4.7e-12  Score=115.32  Aligned_cols=125  Identities=15%  Similarity=0.196  Sum_probs=100.0

Q ss_pred             eEEEEEEEECCeEEEEEEcchhH-HHHHHHHHHHHHhCCC--CceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcC
Q 041830          391 EGAVYHGRLNGKNLAIKRTEHEV-ITKLEMQLVQHATHHH--PNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLA  467 (600)
Q Consensus       391 ~G~Vy~g~~~g~~vAvK~~~~~~-~~~~e~ei~~~~~l~H--pNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~  467 (600)
                      .+.||++..++..+++|..+... ...+..|+..+..+.|  .++.+++++.... +..++++||++++.+..       
T Consensus        11 ~~~v~~~~~~~~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~-~~~~~v~e~~~g~~~~~-------   82 (155)
T cd05120          11 TNRVYLLGTKDEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESD-GWSYLLMEWIEGETLDE-------   82 (155)
T ss_pred             ccceEEEEecCCeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCC-CccEEEEEecCCeeccc-------
Confidence            48999999988899999986543 2456777777777765  5888888875443 47899999998876643       


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccc
Q 041830          468 MKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARC  535 (600)
Q Consensus       468 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~  535 (600)
                                  +++.....++.+++++|++||.....+++|+|++++||++++.+.+++.|||.++.
T Consensus        83 ------------~~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          83 ------------VSEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             ------------CCHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence                        24456677899999999999965446799999999999999999999999998764

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.37  E-value=2.5e-13  Score=145.09  Aligned_cols=157  Identities=22%  Similarity=0.350  Sum_probs=116.8

Q ss_pred             CCeEEEEEEcchhH-------HHHHHHHHHHHHhCC-CCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcCcccc
Q 041830          400 NGKNLAIKRTEHEV-------ITKLEMQLVQHATHH-HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQ  471 (600)
Q Consensus       400 ~g~~vAvK~~~~~~-------~~~~e~ei~~~~~l~-HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~  471 (600)
                      .|..+|+|.+++..       ....++.+  +...+ ||.+|++.-.+..+ ...+++++|..+|+|...+....     
T Consensus        21 a~~~yamkvl~k~t~~~~~~~~t~~er~i--l~~~~~~~f~v~lhyafqt~-~kl~l~ld~~rgg~lft~l~~~~-----   92 (612)
T KOG0603|consen   21 AGHLYAMKVLKKATLKVRDRTHTKQERII--LAFVHNTPFLVKLHYAFQTD-GKLYLILDFLRGGDLFTRLSKEV-----   92 (612)
T ss_pred             ccchhhhhcccccccccccccccccHHHH--HhhccCCCceeeeeeeeccc-cchhHhhhhcccchhhhccccCC-----
Confidence            45556666543321       12233333  33344 99999997665455 48899999999999988776543     


Q ss_pred             cccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--------CCCC
Q 041830          472 FIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--------TESP  543 (600)
Q Consensus       472 ~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--------~~~p  543 (600)
                             .+.+.....+...++-+++++|   +.+++|||+|++||+++.+|.+|+.|||+++..-..        +.+|
T Consensus        93 -------~f~~~~~~~~~aelaLald~lh---~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~cgt~eymAp  162 (612)
T KOG0603|consen   93 -------MFDELDVAFYLAELALALDHLH---KLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIACGTYEYRAP  162 (612)
T ss_pred             -------chHHHHHHHHHHHHHHHHhhcc---hhHHHHhcccccceeecccCccccCCchhhhHhHhhhhcccchhhhhh
Confidence                   2556666667778889999999   779999999999999999999999999999854322        2234


Q ss_pred             cccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          544 QFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       544 e~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                      |...    .+...+|.||||++++||+||..||..
T Consensus       163 EI~~----gh~~a~D~ws~gvl~felltg~~pf~~  193 (612)
T KOG0603|consen  163 EIIN----GHLSAADWWSFGVLAFELLTGTLPFGG  193 (612)
T ss_pred             Hhhh----ccCCcccchhhhhhHHHHhhCCCCCch
Confidence            4433    356778999999999999999999986

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.36  E-value=1.7e-12  Score=147.93  Aligned_cols=165  Identities=21%  Similarity=0.284  Sum_probs=118.6

Q ss_pred             EEEEEEEE-CCeEEEEEEcchhHHHHHHHHHHHHHhCC---CCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcC
Q 041830          392 GAVYHGRL-NGKNLAIKRTEHEVITKLEMQLVQHATHH---HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLA  467 (600)
Q Consensus       392 G~Vy~g~~-~g~~vAvK~~~~~~~~~~e~ei~~~~~l~---HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~  467 (600)
                      |+||+|.. +|+.||+|.-+.....+|-.-...+.+++   -+-|..+...+.-. +.-+||+||.+.|+|.+++...  
T Consensus       712 ~~vy~a~~~~~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~-~~S~lv~ey~~~Gtlld~~N~~--  788 (974)
T KOG1166|consen  712 GSVYVATHSNGKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQ-NASVLVSEYSPYGTLLDLINTN--  788 (974)
T ss_pred             eEEEEeecCCCcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccC-CcceeeeeccccccHHHhhccC--
Confidence            99999988 89999999866543332222111222222   12344443333323 2568999999999999999743  


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC-------CCCcEEEEeccCccccC---
Q 041830          468 MKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLD-------EEFNARVGNFGMARCVN---  537 (600)
Q Consensus       468 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld-------~~~~~kI~DFGla~~~~---  537 (600)
                                ...+|.-...++.++++-++.||   ..+|||+||||+|.||.       +...++|+|||.+-.+.   
T Consensus       789 ----------~~m~e~lv~~~~~qml~ive~lH---~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp  855 (974)
T KOG1166|consen  789 ----------KVMDEYLVMFFSCQMLRIVEHLH---AMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFP  855 (974)
T ss_pred             ----------CCCCchhhhHHHHHHHHHHHHHH---hcceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcC
Confidence                      34889999999999999999999   66999999999999993       23568999999885432   


Q ss_pred             CC-----------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCC
Q 041830          538 DD-----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQT  574 (600)
Q Consensus       538 ~~-----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~  574 (600)
                      ..           ...+|...  ...|+..+|.|.|..+++-|+.|+.
T Consensus       856 ~~~~F~~~~~td~f~C~EM~~--grpWtYq~DyfGlAa~~h~mLFG~y  901 (974)
T KOG1166|consen  856 DGTKFKAVWHTDLFDCIEMRE--GRPWTYQIDYFGLAATVHVMLFGKY  901 (974)
T ss_pred             CCcEEeeeeccccchhHHHhc--CCCCchhhhhHHHHHHHHHHHHHHH
Confidence            11           11233333  3678899999999999999999874

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.32  E-value=1.9e-11  Score=121.16  Aligned_cols=174  Identities=21%  Similarity=0.246  Sum_probs=125.5

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH-HHHHHHHHHHHHhCC-CCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCc
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV-ITKLEMQLVQHATHH-HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGL  466 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~-~~~~e~ei~~~~~l~-HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~  466 (600)
                      +|..+.|+.  +++.||||.-.... ..++..|.+..+.+. -++|-..+-+ -.++.+-.||+|.+ +-||.|+..-..
T Consensus        41 FG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYF-GqeG~~NiLVidLL-GPSLEDLFD~Cg  118 (449)
T KOG1165|consen   41 FGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYF-GQEGKYNILVIDLL-GPSLEDLFDLCG  118 (449)
T ss_pred             ceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeee-ccccchhhhhhhhh-CcCHHHHHHHhc
Confidence            499999976  89999999754422 245566666555543 4677766533 23444567999998 558887764322


Q ss_pred             CcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC-----CcEEEEeccCccccCCCCC
Q 041830          467 AMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEE-----FNARVGNFGMARCVNDDTE  541 (600)
Q Consensus       467 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~-----~~~kI~DFGla~~~~~~~~  541 (600)
                                 +.++.+.+..+|.|+..-++|+|   .+.+|.|||||+|+||...     ..+.|.|||+|+...+...
T Consensus       119 -----------R~FSvKTV~miA~Qmi~rie~vH---~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~T  184 (449)
T KOG1165|consen  119 -----------RRFSVKTVAMIAKQMITRIEYVH---EKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKT  184 (449)
T ss_pred             -----------CcccHHhHHHHHHHHHHHHHHHH---hcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccc
Confidence                       34899999999999999999999   7799999999999999643     4588999999987644332


Q ss_pred             CCc--------------ccccC---CCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          542 SPQ--------------FYSTN---PASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       542 ~pe--------------~~~~~---~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                      ...              +++-.   ...-+.+-|.=|+|-|++..+-|..||+...
T Consensus       185 kqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK  240 (449)
T KOG1165|consen  185 KQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK  240 (449)
T ss_pred             cccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence            111              11000   1122455799999999999999999998754

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.29  E-value=1.4e-12  Score=146.10  Aligned_cols=168  Identities=21%  Similarity=0.271  Sum_probs=120.9

Q ss_pred             EEEEEEEECCeEEEEEEcchhH-------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          392 GAVYHGRLNGKNLAIKRTEHEV-------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       392 G~Vy~g~~~g~~vAvK~~~~~~-------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      =+|.+++.+...|+||++-+..       ..+..+|+. ...++|||.+.+.-+-..+ .-.|||=+|..+ +|+|.|..
T Consensus        37 lKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~-kAAylvRqyvkh-nLyDRlST  113 (1431)
T KOG1240|consen   37 LKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTD-KAAYLVRQYVKH-NLYDRLST  113 (1431)
T ss_pred             hhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhh-HHHHHHHHHHhh-hhhhhhcc
Confidence            3567788754458888753211       122223333 5567899999987763333 356888899876 89998864


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCcccc--CCCC--
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV--NDDT--  540 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~--~~~~--  540 (600)
                      .            ..|...+...|+.|++.||.-+|   +.+|+|||||.+||||.....+.|+||.--+..  ..+.  
T Consensus       114 R------------PFL~~iEKkWiaFQLL~al~qcH---~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa  178 (1431)
T KOG1240|consen  114 R------------PFLVLIEKKWIAFQLLKALSQCH---KLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA  178 (1431)
T ss_pred             c------------hHHHHHHHHHHHHHHHHHHHHHH---HcCccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence            3            23788899999999999999999   779999999999999999999999999865421  1110  


Q ss_pred             ---------------CCCcccccC--------C-CCCCccCchHHHHHHHHHHHh-CCCCCC
Q 041830          541 ---------------ESPQFYSTN--------P-ASWSMGIDIFAYGIVLLEVLS-GQTPIN  577 (600)
Q Consensus       541 ---------------~~pe~~~~~--------~-~~~t~~sDVwSfGvvL~ELlt-G~~Pf~  577 (600)
                                     -+||.+...        . ...+++.||||.|||+.||++ |++||.
T Consensus       179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~  240 (1431)
T KOG1240|consen  179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT  240 (1431)
T ss_pred             cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence                           145543221        0 114677899999999999988 788884

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.28  E-value=3.1e-11  Score=121.55  Aligned_cols=123  Identities=24%  Similarity=0.410  Sum_probs=81.3

Q ss_pred             EEEEeecCCCCHHHHHhc---CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC
Q 041830          447 FLVFEYAKNGSLKDWLHG---GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEF  523 (600)
Q Consensus       447 ~LV~Ey~~~GsL~~~L~~---~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~  523 (600)
                      +++|+-+. +||.+++..   ....        ...+....++.+..|+.+-+++||   ..+++|+|||++|++++.+|
T Consensus       115 ~~l~P~~~-~dL~~~~~~l~~~~~~--------~~~l~~~arl~lT~Q~I~lvA~Lh---~~GlVHgdi~~~nfll~~~G  182 (288)
T PF14531_consen  115 FLLMPRAQ-GDLQDLVEALFSRAQT--------HSPLAFAARLSLTVQMIRLVANLH---SYGLVHGDIKPENFLLDQDG  182 (288)
T ss_dssp             EEEEE--S-EEHHHHHHHHHHHTTT--------SHHHHHHHHHHHHHHHHHHHHHHH---HTTEEEST-SGGGEEE-TTS
T ss_pred             hhccchhh-hcHHHHHHHHhhcccc--------cchhHHHHHHHHHHHHHHHHHHHh---hcceEecccceeeEEEcCCC
Confidence            56777774 588887642   1110        012556677888899999999999   66999999999999999999


Q ss_pred             cEEEEeccCccccC---------CCCCCCccccc------CCCCCCccCchHHHHHHHHHHHhCCCCCCCCCC
Q 041830          524 NARVGNFGMARCVN---------DDTESPQFYST------NPASWSMGIDIFAYGIVLLEVLSGQTPINRPRK  581 (600)
Q Consensus       524 ~~kI~DFGla~~~~---------~~~~~pe~~~~------~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~  581 (600)
                      .+.|+||+......         .....||....      ....++.+.|.|++|+++|.|.+|+.||.....
T Consensus       183 ~v~Lg~F~~~~r~g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~  255 (288)
T PF14531_consen  183 GVFLGDFSSLVRAGTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSP  255 (288)
T ss_dssp             -EEE--GGGEEETTEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGG
T ss_pred             CEEEcChHHHeecCceeeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCc
Confidence            99999998754322         11223333222      123457778999999999999999999986543

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.26  E-value=4.2e-11  Score=114.37  Aligned_cols=127  Identities=14%  Similarity=0.168  Sum_probs=85.0

Q ss_pred             eeEEEEEEEE-CCeEEEEEEcchhHHH-----H----------------------HHHHHHHHHhCCCC--ceeeeeeEE
Q 041830          390 IEGAVYHGRL-NGKNLAIKRTEHEVIT-----K----------------------LEMQLVQHATHHHP--NIVRLLGTC  439 (600)
Q Consensus       390 ~~G~Vy~g~~-~g~~vAvK~~~~~~~~-----~----------------------~e~ei~~~~~l~Hp--NIv~l~g~~  439 (600)
                      ..|.||++.. +|+.||||..+.....     .                      .+.|...+..+.+.  .+.+.++. 
T Consensus         9 ~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~-   87 (187)
T cd05119           9 KEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPVPKPIDL-   87 (187)
T ss_pred             cceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCCCceEec-
Confidence            3499999988 5999999986542110     0                      02233333333222  23344332 


Q ss_pred             eccCCceEEEEeecCCCCHHHH-HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEE
Q 041830          440 LTDGPHSFLVFEYAKNGSLKDW-LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIF  518 (600)
Q Consensus       440 ~~~~~~~~LV~Ey~~~GsL~~~-L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NIL  518 (600)
                          ...++||||++++.+... +....             .. .+...++.+++.++.++|.  +.+|+||||||+||+
T Consensus        88 ----~~~~lv~e~~~g~~~~~~~l~~~~-------------~~-~~~~~~~~~~~~~l~~lh~--~~~ivH~Dl~p~Nil  147 (187)
T cd05119          88 ----NRHVLVMEFIGGDGIPAPRLKDVR-------------LL-EDPEELYDQILELMRKLYR--EAGLVHGDLSEYNIL  147 (187)
T ss_pred             ----CCCEEEEEEeCCCCccChhhhhhh-------------hc-ccHHHHHHHHHHHHHHHhh--ccCcCcCCCChhhEE
Confidence                145899999999654211 11100             11 5567889999999999993  179999999999999


Q ss_pred             eCCCCcEEEEeccCccccCC
Q 041830          519 LDEEFNARVGNFGMARCVND  538 (600)
Q Consensus       519 ld~~~~~kI~DFGla~~~~~  538 (600)
                      ++ ++.++++|||.++....
T Consensus       148 i~-~~~~~liDfg~a~~~~~  166 (187)
T cd05119         148 VD-DGKVYIIDVPQAVEIDH  166 (187)
T ss_pred             EE-CCcEEEEECcccccccC
Confidence            99 99999999999975543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.26  E-value=4.4e-11  Score=129.24  Aligned_cols=130  Identities=18%  Similarity=0.220  Sum_probs=88.9

Q ss_pred             EEEEEEEE-CCeEEEEEEcchhHHHHH-------------------------------------------HHHHHHHHh-
Q 041830          392 GAVYHGRL-NGKNLAIKRTEHEVITKL-------------------------------------------EMQLVQHAT-  426 (600)
Q Consensus       392 G~Vy~g~~-~g~~vAvK~~~~~~~~~~-------------------------------------------e~ei~~~~~-  426 (600)
                      |.||+|++ +|+.||||..+....+.+                                           ..|...+.. 
T Consensus       131 gQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~~Ea~n~~~~  210 (437)
T TIGR01982       131 AQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLRREAANASEL  210 (437)
T ss_pred             hheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHHHHHHHHHHH
Confidence            99999999 899999998654322211                                           122222222 


Q ss_pred             ---CCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHH-HHHHHHhc
Q 041830          427 ---HHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAM-ALQYMHHV  502 (600)
Q Consensus       427 ---l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~~  502 (600)
                         +.|.+-+.+-.++.+-....+|||||+++++|.++......           .+   .+.+++..++. .+..+|  
T Consensus       211 ~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~-----------~~---~~~~ia~~~~~~~l~ql~--  274 (437)
T TIGR01982       211 GENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA-----------GL---DRKALAENLARSFLNQVL--  274 (437)
T ss_pred             HHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc-----------CC---CHHHHHHHHHHHHHHHHH--
Confidence               23444455555544333457999999999999887653210           12   23456666665 356777  


Q ss_pred             CCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC
Q 041830          503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND  538 (600)
Q Consensus       503 ~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~  538 (600)
                       ..+++|+|++|.||++++++++++.|||++..+..
T Consensus       275 -~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       275 -RDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             -hCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence             66999999999999999999999999999876653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>PRK13914 invasion associated secreted endopeptidase; Provisional

Probab=99.20  E-value=6e-11  Score=125.30  Aligned_cols=106  Identities=14%  Similarity=0.184  Sum_probs=86.8

Q ss_pred             eeecCCCCCChhhHHHhhCCChHHHHhhhCCCCCCCCCCCCCcEEEeecccc--------CC------------------
Q 041830           65 ILRTNSYYSSLFNLSFYLGLNRFVIARANGFSADTEFLPKDQPLLIPIDCKC--------NN------------------  118 (600)
Q Consensus        65 ~y~~~~~~~~l~~ia~~~~~~~~~i~~~N~~~~~~~~i~~~~~l~vP~~c~c--------~~------------------  118 (600)
                      .|.|++ ||||+.||++|++++.+|+++|++  ..+.|.+||.|+||-.-+-        ..                  
T Consensus        29 tytVq~-GDTLw~IA~~ygvtv~~I~~~N~l--~~~~I~~Gq~L~Ip~~~~~~~~~~~Vta~~LNVRsgps~s~~IIgsl  105 (481)
T PRK13914         29 TVVVEA-GDTLWGIAQSKGTTVDAIKKANNL--TTDKIVPGQKLQVNEVAAAEKTEKSVSATWLNVRSGAGVDNSIITSI  105 (481)
T ss_pred             eEEECC-CCCHHHHHHHHCCCHHHHHHHhCC--CcccccCCCEEEeCCCCcccccceeEecceEEEecCCCCCcceeeee
Confidence            478898 999999999999999999999999  6678999999999965310        00                  


Q ss_pred             ------------CCcceeec------------------------------------------------------------
Q 041830          119 ------------NGGFFQAD------------------------------------------------------------  126 (600)
Q Consensus       119 ------------~~~~~~~~------------------------------------------------------------  126 (600)
                                  .+++++-.                                                            
T Consensus       106 ~~G~~V~Vl~~~~ngW~kI~~~~GktGwV~~~YLs~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  185 (481)
T PRK13914        106 KGGTKVTVETTESNGWHKITYNDGKTGFVNGKYLTDKVTSTPVAPTQEVKKETTTQQAAPAAETKTEVKQTTQATTPAPK  185 (481)
T ss_pred             cCCCEEEEeecccCCeEEEEcCCCCEEEEecccccCCCccCccccchhhhhccccccccchhcccchhccCCcccCCccc
Confidence                        00111110                                                            


Q ss_pred             --------------ceeeeecCCchhhHHHhcCCCchHHHHHhhCCCCCCCCCCCCCeEeeeee
Q 041830          127 --------------LTKTTIKGESFYSIAQSLEGLTTCGAIKERNPSVSPWDLDDKARLQVPLR  176 (600)
Q Consensus       127 --------------~~y~v~~gdt~~~ia~~~~gl~t~~~l~~~N~~~~~~~l~~G~~l~vp~~  176 (600)
                                    ..|+|++|||||.||+.|+  ++.++|++||++.+ ..|.+||+|.||..
T Consensus       186 ~~~~~~~~~~~~~a~tytVq~GDTL~sIAkrYg--Vtv~eI~~~N~l~s-~~L~pGQ~L~Ip~s  246 (481)
T PRK13914        186 VAETKETPVVDQNATTHAVKSGDTIWALSVKYG--VSVQDIMSWNNLSS-SSIYVGQKLAIKQT  246 (481)
T ss_pred             ccccccCccccCCCeEEEECCCCCHHHHHHHHC--CCHHHHHHhcCCCc-cccCCCCEEEecCC
Confidence                          2499999999999999999  99999999999974 67999999999853

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.07  E-value=1.2e-10  Score=130.88  Aligned_cols=87  Identities=23%  Similarity=0.482  Sum_probs=68.9

Q ss_pred             HHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC----------------------CCCCcccccC-
Q 041830          493 AMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD----------------------TESPQFYSTN-  549 (600)
Q Consensus       493 a~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~----------------------~~~pe~~~~~-  549 (600)
                      +.+++|||   +.+|+|||+||+|.+|..-|++|+.|||+.+.....                      ...|++.... 
T Consensus       153 vla~Eylh---~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV  229 (1205)
T KOG0606|consen  153 VLAVEYLH---SYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV  229 (1205)
T ss_pred             hHHhHhhc---cCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence            77899999   779999999999999999999999999998643111                      0124443331 


Q ss_pred             --CCCCCccCchHHHHHHHHHHHhCCCCCCCCCCC
Q 041830          550 --PASWSMGIDIFAYGIVLLEVLSGQTPINRPRKK  582 (600)
Q Consensus       550 --~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~~  582 (600)
                        ...|...+|.|++|+|+||.+-|+.||.....+
T Consensus       230 ilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe  264 (1205)
T KOG0606|consen  230 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE  264 (1205)
T ss_pred             hhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH
Confidence              245677899999999999999999999876444

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.04  E-value=6.1e-11  Score=124.81  Aligned_cols=110  Identities=27%  Similarity=0.514  Sum_probs=90.5

Q ss_pred             ceEEEEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCc
Q 041830          445 HSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFN  524 (600)
Q Consensus       445 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~  524 (600)
                      .+|+.|++|...+|.+||.+.+..         ...+|...+.++.|++.|+.|      ++.+|||+||.||+...+..
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~---------e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q  394 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTG---------EERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQ  394 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcc---------cccchhHHHHHHHhhccchhh------ccchhhhccccccccccchh
Confidence            478999999999999999865543         337888899999999999999      47899999999999999999


Q ss_pred             EEEEeccCccccCCCC------------------CCCcccccCCCCCCccCchHHHHHHHHHHHh
Q 041830          525 ARVGNFGMARCVNDDT------------------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLS  571 (600)
Q Consensus       525 ~kI~DFGla~~~~~~~------------------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt  571 (600)
                      .||.|||+........                  ++||.+..  ..|+.++||||+|++|+||+.
T Consensus       395 ~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g--~~y~~kvdIyaLGlil~EL~~  457 (516)
T KOG1033|consen  395 LKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRG--QQYSEKVDIYALGLILAELLI  457 (516)
T ss_pred             hhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhh--hhhhhhcchhhHHHHHHHHHH
Confidence            9999999976543322                  13333332  567889999999999999998

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.02  E-value=1.3e-09  Score=102.12  Aligned_cols=122  Identities=13%  Similarity=0.117  Sum_probs=85.4

Q ss_pred             eeEEEEEEEECCeEEEEEEcchhH--HHHHHHHHHHHHhCCCCcee-eeeeEEeccCCceEEEEeecCCCCHHHHHhcCc
Q 041830          390 IEGAVYHGRLNGKNLAIKRTEHEV--ITKLEMQLVQHATHHHPNIV-RLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGL  466 (600)
Q Consensus       390 ~~G~Vy~g~~~g~~vAvK~~~~~~--~~~~e~ei~~~~~l~HpNIv-~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~  466 (600)
                      ..+.||+.+..|+.+++|....+.  ...++.|...+..+.+.+++ +++++.  . ...++||||+++.++.+..    
T Consensus        10 ~~~~vy~~~~~~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~-~~~~lv~e~i~G~~l~~~~----   82 (170)
T cd05151          10 MTNKNYRVEVANKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFD--P-ETGVLITEFIEGSELLTED----   82 (170)
T ss_pred             ccCceEEEEECCeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEe--C-CCCeEEEEecCCCcccccc----
Confidence            348899999999999999975543  12346676666665544443 455442  2 2458999999998775320    


Q ss_pred             CcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcC--CCCceecCCCCCCEEeCCCCcEEEEeccCccc
Q 041830          467 AMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM--NPSYVHRNIKSRNIFLDEEFNARVGNFGMARC  535 (600)
Q Consensus       467 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDLk~~NILld~~~~~kI~DFGla~~  535 (600)
                                   .   ....+..+++++|+.||...  ...++|+|+++.||+++ ++.+++.||+.+..
T Consensus        83 -------------~---~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~  136 (170)
T cd05151          83 -------------F---SDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM  136 (170)
T ss_pred             -------------c---cCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence                         0   01235678999999999532  12369999999999999 67899999998763

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.01  E-value=2e-09  Score=116.59  Aligned_cols=149  Identities=21%  Similarity=0.357  Sum_probs=112.0

Q ss_pred             CCeEEEEEEcchh---HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcCccccccccc
Q 041830          400 NGKNLAIKRTEHE---VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASC  476 (600)
Q Consensus       400 ~g~~vAvK~~~~~---~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~  476 (600)
                      ++..|.|...+..   ......+.+..++.++||||++++.....++ .+|||+|-+.  .|..++..            
T Consensus        36 ~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~-~~ylvTErV~--Pl~~~lk~------------  100 (690)
T KOG1243|consen   36 DGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEG-TLYLVTERVR--PLETVLKE------------  100 (690)
T ss_pred             cCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccC-ceEEEeeccc--cHHHHHHH------------
Confidence            6777777665443   2345677888899999999999999865554 8999999885  57777753            


Q ss_pred             ccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCCCC------------CCc
Q 041830          477 YCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------------SPQ  544 (600)
Q Consensus       477 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~~~------------~pe  544 (600)
                         +......-.+.||+.||.|||+  +.+++|+||.-..|+++..|.-||++|-+.........            .|+
T Consensus       101 ---l~~~~v~~Gl~qIl~AL~FL~~--d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~  175 (690)
T KOG1243|consen  101 ---LGKEEVCLGLFQILAALSFLND--DCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPE  175 (690)
T ss_pred             ---hHHHHHHHHHHHHHHHHHHHhc--cCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChh
Confidence               4445556678999999999986  66899999999999999999999999988754433221            111


Q ss_pred             ccccCCCCCCccCchHHHHHHHHHHHhC
Q 041830          545 FYSTNPASWSMGIDIFAYGIVLLEVLSG  572 (600)
Q Consensus       545 ~~~~~~~~~t~~sDVwSfGvvL~ELltG  572 (600)
                      ....  ..|  ..|.|-||+++||++.|
T Consensus       176 ~~~~--s~~--s~D~~~Lg~li~el~ng  199 (690)
T KOG1243|consen  176 EIDP--SEW--SIDSWGLGCLIEELFNG  199 (690)
T ss_pred             hcCc--ccc--chhhhhHHHHHHHHhCc
Confidence            1111  112  24999999999999999

>PF01476 LysM: LysM domain; InterPro: IPR018392 This domain is about 40 residues long and is found in a variety of enzymes involved in bacterial cell wall degradation []

Probab=99.00  E-value=2.2e-10  Score=82.15  Aligned_cols=44  Identities=25%  Similarity=0.447  Sum_probs=35.6

Q ss_pred             eeeecCCchhhHHHhcCCCchHHHHHhhCCCCCCCCCCCCCeEeee
Q 041830          129 KTTIKGESFYSIAQSLEGLTTCGAIKERNPSVSPWDLDDKARLQVP  174 (600)
Q Consensus       129 y~v~~gdt~~~ia~~~~gl~t~~~l~~~N~~~~~~~l~~G~~l~vp  174 (600)
                      |+|++|||+|.||++|+  ++.++|+++|+..+.+.|.+||+|.||
T Consensus         1 y~V~~gDtl~~IA~~~~--~~~~~l~~~N~~~~~~~l~~G~~l~iP   44 (44)
T PF01476_consen    1 YTVQPGDTLWSIAKRYG--ISVDELMELNPNIDSDNLQPGQKLCIP   44 (44)
T ss_dssp             EEE-TT--HHHHHHHTT--S-HHHHHHHCCTTHGGCGGTTEEEEEC
T ss_pred             CEECcCCcHHHHHhhhh--hhHhHHHHhcCCCCcccCCCCCEEEeC
Confidence            89999999999999998  999999999954335569999999998

This domain may have a general peptidoglycan binding function.; GO: 0016998 cell wall macromolecule catabolic process; PDB: 2DJP_A 3ZQD_A 1Y7M_B 4A52_A 2L9Y_A 1E0G_A.

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=98.96  E-value=1.1e-09  Score=108.68  Aligned_cols=148  Identities=21%  Similarity=0.322  Sum_probs=106.6

Q ss_pred             HHHHHHHHHHhCCCCceeeeeeEEecc----CCceEEEEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHH
Q 041830          416 KLEMQLVQHATHHHPNIVRLLGTCLTD----GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLD  491 (600)
Q Consensus       416 ~~e~ei~~~~~l~HpNIv~l~g~~~~~----~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~  491 (600)
                      +.+.-+..+.++.|.|||++..|+.+.    .....+++|||+.|+|..||++.+..        ...+......+++-|
T Consensus       113 k~~~vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~--------~~a~~~~~wkkw~tq  184 (458)
T KOG1266|consen  113 KRRAVFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKN--------QKALFQKAWKKWCTQ  184 (458)
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHh--------hhhhhHHHHHHHHHH
Confidence            344555666677799999999985322    22457899999999999999875431        144777888899999


Q ss_pred             HHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccc---------cC-------CCCCCCcccccCCCCCCc
Q 041830          492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARC---------VN-------DDTESPQFYSTNPASWSM  555 (600)
Q Consensus       492 ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~---------~~-------~~~~~pe~~~~~~~~~t~  555 (600)
                      |..||.|||.+ +++|+|+++..+.|++..++-+||.--.....         ..       ....+|++-..  ..-+.
T Consensus       185 Ilsal~yLhs~-~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~--tn~~~  261 (458)
T KOG1266|consen  185 ILSALSYLHSC-DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT--TNTTG  261 (458)
T ss_pred             HHhhhhhhhcc-CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcc--ccccc
Confidence            99999999988 89999999999999999999999864221110         00       00111222111  22345


Q ss_pred             cCchHHHHHHHHHHHhCCC
Q 041830          556 GIDIFAYGIVLLEVLSGQT  574 (600)
Q Consensus       556 ~sDVwSfGvvL~ELltG~~  574 (600)
                      .+|||+||...+||..+..
T Consensus       262 a~dIy~fgmcAlemailEi  280 (458)
T KOG1266|consen  262 ASDIYKFGMCALEMAILEI  280 (458)
T ss_pred             chhhhhhhHHHHHHHHhee
Confidence            6899999999999988764

>PRK13914 invasion associated secreted endopeptidase; Provisional

Probab=98.94  E-value=1.3e-09  Score=115.20  Aligned_cols=112  Identities=24%  Similarity=0.228  Sum_probs=87.5

Q ss_pred             cceeeeecCCchhhHHHhcCCCchHHHHHhhCCCCCCCCCCCCCeEeeeeecc--------C---------CCC------
Q 041830          126 DLTKTTIKGESFYSIAQSLEGLTTCGAIKERNPSVSPWDLDDKARLQVPLRCA--------C---------PSS------  182 (600)
Q Consensus       126 ~~~y~v~~gdt~~~ia~~~~gl~t~~~l~~~N~~~~~~~l~~G~~l~vp~~c~--------c---------~~~------  182 (600)
                      ...|+|++|||||.||+.|+  ++.++|+++|++. ++.|.+||+|.||..-.        .         |+.      
T Consensus        27 a~tytVq~GDTLw~IA~~yg--vtv~~I~~~N~l~-~~~I~~Gq~L~Ip~~~~~~~~~~~Vta~~LNVRsgps~s~~IIg  103 (481)
T PRK13914         27 ASTVVVEAGDTLWGIAQSKG--TTVDAIKKANNLT-TDKIVPGQKLQVNEVAAAEKTEKSVSATWLNVRSGAGVDNSIIT  103 (481)
T ss_pred             CceEEECCCCCHHHHHHHHC--CCHHHHHHHhCCC-cccccCCCEEEeCCCCcccccceeEecceEEEecCCCCCcceee
Confidence            35799999999999999999  9999999999987 57899999999996431        0         000      


Q ss_pred             -----C------CCC---------CC---c--------------------------------------------------
Q 041830          183 -----S------ENL---------PE---T--------------------------------------------------  189 (600)
Q Consensus       183 -----~------~~~---------~~---~--------------------------------------------------  189 (600)
                           .      +..         .|   +                                                  
T Consensus       104 sl~~G~~V~Vl~~~~ngW~kI~~~~GktGwV~~~YLs~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  183 (481)
T PRK13914        104 SIKGGTKVTVETTESNGWHKITYNDGKTGFVNGKYLTDKVTSTPVAPTQEVKKETTTQQAAPAAETKTEVKQTTQATTPA  183 (481)
T ss_pred             eecCCCEEEEeecccCCeEEEEcCCCCEEEEecccccCCCccCccccchhhhhccccccccchhcccchhccCCcccCCc
Confidence                 0      000         00   0                                                  


Q ss_pred             -------------eEEEEEEccCCCcccccccccCCChHHHHHhcCCCCCCCCcccccCcccccccCCC
Q 041830          190 -------------RILVSYPVGEGDTVSGLAAKFNTTPAAIIAANNKSLEGFKPEDLLAFTSILIPLNG  245 (600)
Q Consensus       190 -------------~~~~tY~v~~gd~~~~ia~~f~~~~~~~~~~n~~~~~g~~p~~l~~~~~~~vp~~~  245 (600)
                                   .-..+|.|++||+|+.||.+|+++..++.+||++...     .|++++.+.||...
T Consensus       184 ~~~~~~~~~~~~~~~a~tytVq~GDTL~sIAkrYgVtv~eI~~~N~l~s~-----~L~pGQ~L~Ip~sa  247 (481)
T PRK13914        184 PKVAETKETPVVDQNATTHAVKSGDTIWALSVKYGVSVQDIMSWNNLSSS-----SIYVGQKLAIKQTA  247 (481)
T ss_pred             ccccccccCccccCCCeEEEECCCCCHHHHHHHHCCCHHHHHHhcCCCcc-----ccCCCCEEEecCCC
Confidence                         0015799999999999999999999999999987433     68899999998654

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=98.86  E-value=3.3e-08  Score=108.55  Aligned_cols=92  Identities=13%  Similarity=0.150  Sum_probs=58.0

Q ss_pred             CCceeeeeeEEeccCCceEEEEeecCCCCHHHHH--hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 041830          429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS  506 (600)
Q Consensus       429 HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L--~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~  506 (600)
                      +.+.+.+-.++++-....+|||||++++.+.++-  ..... +.       ..+.......++.|+       +   ..+
T Consensus       219 ~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~-d~-------~~la~~~v~~~~~Qi-------f---~~G  280 (537)
T PRK04750        219 DSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGT-DM-------KLLAERGVEVFFTQV-------F---RDG  280 (537)
T ss_pred             CCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCC-CH-------HHHHHHHHHHHHHHH-------H---hCC
Confidence            4444554455443234568999999999998752  22110 00       012222222223332       2   458


Q ss_pred             ceecCCCCCCEEeCCCC----cEEEEeccCccccCC
Q 041830          507 YVHRNIKSRNIFLDEEF----NARVGNFGMARCVND  538 (600)
Q Consensus       507 ivHrDLk~~NILld~~~----~~kI~DFGla~~~~~  538 (600)
                      ++|+|+||.||+++.++    ++++.|||+...++.
T Consensus       281 ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~  316 (537)
T PRK04750        281 FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK  316 (537)
T ss_pred             eeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence            99999999999999888    999999999876543

>COG1388 LytE FOG: LysM repeat [Cell envelope biogenesis, outer membrane]

Probab=98.81  E-value=8.3e-09  Score=91.87  Aligned_cols=95  Identities=23%  Similarity=0.303  Sum_probs=76.3

Q ss_pred             HHHhhCCChHHHHhhhCCCCCCCCCCCCCcEEEeeccccCCCCccee-e----------------cceeeeecCCchhhH
Q 041830           78 LSFYLGLNRFVIARANGFSADTEFLPKDQPLLIPIDCKCNNNGGFFQ-A----------------DLTKTTIKGESFYSI  140 (600)
Q Consensus        78 ia~~~~~~~~~i~~~N~~~~~~~~i~~~~~l~vP~~c~c~~~~~~~~-~----------------~~~y~v~~gdt~~~i  140 (600)
                      ||..|++++..|..+|.+...++.+.+||.|.+|..-.-........ .                -.+|+|++|||||.|
T Consensus         1 ia~~~~~~v~~l~~~n~~~~~s~~i~~gq~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~V~~gdtL~~I   80 (124)
T COG1388           1 IASKYGVSVKALKKANALTGKSDAIKPGQVLKIPGDISSTVNAGQTLSSLSNKVSDSSSASKAPPVVTYTVKKGDTLSKI   80 (124)
T ss_pred             CcccccccHHHHHHHhcccCCCCccccCceEEccCCcccccccccccccccceeeccccccccCCCceEEEecCCCHHHH
Confidence            57889999999999999942299999999999996421110101100 0                147999999999999


Q ss_pred             HHhcCCCchHHHHHhhCCCCCCCCCCCCCeEeeee
Q 041830          141 AQSLEGLTTCGAIKERNPSVSPWDLDDKARLQVPL  175 (600)
Q Consensus       141 a~~~~gl~t~~~l~~~N~~~~~~~l~~G~~l~vp~  175 (600)
                      |++|+  ++..+|+++|+... +.+.+||+|.++.
T Consensus        81 a~~~~--~tv~~l~~~n~l~~-~~i~~gq~l~~~~  112 (124)
T COG1388          81 ARKYG--VTVAELKQLNNLSS-DKIKVGQKLKLPV  112 (124)
T ss_pred             HHHhC--CCHHHHHHHhccCC-CceecCcEEEEec
Confidence            99999  99999999999985 5899999999987

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.71  E-value=2.1e-07  Score=93.95  Aligned_cols=131  Identities=15%  Similarity=0.078  Sum_probs=91.4

Q ss_pred             EEEEEEEECCeEEEEEEcchhH----HH----------HHHHHHHHHHhCCCC--ceeeeeeEEecc----CCceEEEEe
Q 041830          392 GAVYHGRLNGKNLAIKRTEHEV----IT----------KLEMQLVQHATHHHP--NIVRLLGTCLTD----GPHSFLVFE  451 (600)
Q Consensus       392 G~Vy~g~~~g~~vAvK~~~~~~----~~----------~~e~ei~~~~~l~Hp--NIv~l~g~~~~~----~~~~~LV~E  451 (600)
                      ..|++..+.|+.+.||+.....    .+          ...+|...+..+..-  .....+++....    ...-+||||
T Consensus        36 rrvvr~~~~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte  115 (268)
T PRK15123         36 RRTLRFELAGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITE  115 (268)
T ss_pred             ceEEEEEECCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEe
Confidence            4567888899999999753321    11          245666655544221  233444443321    124689999


Q ss_pred             ecCCC-CHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC-------CC
Q 041830          452 YAKNG-SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE-------EF  523 (600)
Q Consensus       452 y~~~G-sL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~-------~~  523 (600)
                      ++++- +|.+++.....          ...+...+..++.+++..+.-||   ..+|+|+|++++|||++.       +.
T Consensus       116 ~l~~~~sL~~~~~~~~~----------~~~~~~~~~~ll~~la~~i~~LH---~~Gi~HgDL~~~NiLl~~~~~~~~~~~  182 (268)
T PRK15123        116 DLAPTISLEDYCADWAT----------NPPDPRLKRMLIKRVATMVRDMH---AAGINHRDCYICHFLLHLPFPGREEDL  182 (268)
T ss_pred             eCCCCccHHHHHHhhcc----------cCCCHHHHHHHHHHHHHHHHHHH---HCcCccCCCChhhEEEeccccCCCCCc
Confidence            99975 89999853211          12456677789999999999999   779999999999999975       47


Q ss_pred             cEEEEeccCccc
Q 041830          524 NARVGNFGMARC  535 (600)
Q Consensus       524 ~~kI~DFGla~~  535 (600)
                      .+.++||+.++.
T Consensus       183 ~~~LIDl~r~~~  194 (268)
T PRK15123        183 KLSVIDLHRAQI  194 (268)
T ss_pred             eEEEEECCcccc
Confidence            899999998853

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=98.69  E-value=2.1e-07  Score=98.13  Aligned_cols=174  Identities=18%  Similarity=0.245  Sum_probs=126.4

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhHHH---HHHHHHHHHHhCCCCceeeeeeEEecc---CCceEEEEeecCC-CCHHHHH
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEVIT---KLEMQLVQHATHHHPNIVRLLGTCLTD---GPHSFLVFEYAKN-GSLKDWL  462 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~~~---~~e~ei~~~~~l~HpNIv~l~g~~~~~---~~~~~LV~Ey~~~-GsL~~~L  462 (600)
                      -..|++..  +|..|+.||+..+...   +.-.-..+++++.|+|||+|..++...   +..+.+||+|.++ ++|.++-
T Consensus       290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~  369 (655)
T KOG3741|consen  290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLY  369 (655)
T ss_pred             ceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHH
Confidence            56788876  8999999999443321   223345567788999999999987622   2367999999986 6787754


Q ss_pred             hcCcCcc---cccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC
Q 041830          463 HGGLAMK---NQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD  539 (600)
Q Consensus       463 ~~~~~~~---~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~  539 (600)
                      -......   +.+..+....+++...|.++.|+..||.++|   +.++.-+-|.+++||++.+.+++|+.-|....+..+
T Consensus       370 F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIH---ssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d  446 (655)
T KOG3741|consen  370 FANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIH---SSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQED  446 (655)
T ss_pred             ccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHH---hcCceeecccHhHeEeeCcceEEEecccceeeecCC
Confidence            3322110   1122222345788999999999999999999   558888999999999999999999988887666554


Q ss_pred             CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCC
Q 041830          540 TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTP  575 (600)
Q Consensus       540 ~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~P  575 (600)
                      ...       +...-++-|.-.||.+++-|.||..-
T Consensus       447 ~~~-------~le~~Qq~D~~~lG~ll~aLAt~~~n  475 (655)
T KOG3741|consen  447 PTE-------PLESQQQNDLRDLGLLLLALATGTEN  475 (655)
T ss_pred             CCc-------chhHHhhhhHHHHHHHHHHHhhcccc
Confidence            321       12223345999999999999999653

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.68  E-value=1.4e-07  Score=92.10  Aligned_cols=133  Identities=18%  Similarity=0.228  Sum_probs=91.8

Q ss_pred             eeEEEEEEEEC-CeEEEEEEcchhH----HHHHHHHHHHHHhCCC--CceeeeeeEEeccC--CceEEEEeecCCCCHHH
Q 041830          390 IEGAVYHGRLN-GKNLAIKRTEHEV----ITKLEMQLVQHATHHH--PNIVRLLGTCLTDG--PHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       390 ~~G~Vy~g~~~-g~~vAvK~~~~~~----~~~~e~ei~~~~~l~H--pNIv~l~g~~~~~~--~~~~LV~Ey~~~GsL~~  460 (600)
                      ..+.+|+.... |+.+++|......    ...++.|...+..+.+  .++.+++++.....  +..++||||++++++.+
T Consensus        10 ~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~   89 (223)
T cd05154          10 QSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRD   89 (223)
T ss_pred             ccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCC
Confidence            34789999885 4899999865432    2456677777776654  34567777653321  24589999999987765


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV--------------------------------------  502 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~--------------------------------------  502 (600)
                      .+..             ..++..++..++.++++.|.+||+.                                      
T Consensus        90 ~~~~-------------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  156 (223)
T cd05154          90 RLLR-------------PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPA  156 (223)
T ss_pred             CCCC-------------CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHH
Confidence            4421             1155566666666777777776632                                      


Q ss_pred             ---------------CCCCceecCCCCCCEEeCC--CCcEEEEeccCccc
Q 041830          503 ---------------MNPSYVHRNIKSRNIFLDE--EFNARVGNFGMARC  535 (600)
Q Consensus       503 ---------------~~~~ivHrDLk~~NILld~--~~~~kI~DFGla~~  535 (600)
                                     ....++|+|+.+.||+++.  +..+.|.||+.+..
T Consensus       157 ~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         157 MERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                           0245799999999999998  56789999998764

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=98.68  E-value=2.5e-07  Score=88.57  Aligned_cols=98  Identities=9%  Similarity=0.079  Sum_probs=69.4

Q ss_pred             HHHHHHHHhCCC--CceeeeeeEEeccCCceEEEEeecCCCCHHH-HHhcCcCcccccccccccCCCHHHHHHHHHHHHH
Q 041830          418 EMQLVQHATHHH--PNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD-WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAM  494 (600)
Q Consensus       418 e~ei~~~~~l~H--pNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~-~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~  494 (600)
                      ++|+..+.++..  -++-+.+++  .   .-+|||||+.++.+.. .|+.             ..++..+...+..++..
T Consensus        74 ~kE~r~L~rl~~~Gv~vP~pi~~--~---~~~lvME~Ig~~~~~~~~Lkd-------------~~~~~~~~~~i~~~i~~  135 (197)
T cd05146          74 EKEMHNLKRMQKAGIPCPEVVVL--K---KHVLVMSFIGDDQVPAPKLKD-------------AKLNDEEMKNAYYQVLS  135 (197)
T ss_pred             HHHHHHHHHHHHcCCCCCeEEEe--c---CCEEEEEEcCCCCccchhhhc-------------cccCHHHHHHHHHHHHH
Confidence            467776666542  355555554  2   3489999997654421 2221             12455566778899999


Q ss_pred             HHHHH-HhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC
Q 041830          495 ALQYM-HHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN  537 (600)
Q Consensus       495 gL~yL-H~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~  537 (600)
                      +|..| |   ..+++|+||++.|||++ ++.+.|+|||.+....
T Consensus       136 ~l~~l~H---~~glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         136 MMKQLYK---ECNLVHADLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             HHHHHHH---hCCeecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence            99999 6   66999999999999996 4679999999887554

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=98.62  E-value=4.9e-09  Score=117.14  Aligned_cols=150  Identities=26%  Similarity=0.412  Sum_probs=110.3

Q ss_pred             HHHHHHhCC-CCceeeeeeEEeccCCceEEEEeecCCCCHHHHH-hcCcCcccccccccccCCCHHHHHHHHHHHHHHHH
Q 041830          420 QLVQHATHH-HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL-HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQ  497 (600)
Q Consensus       420 ei~~~~~l~-HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L-~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~  497 (600)
                      |......+. |+|++++++.... .+..++++||..+|++.+.+ +...           ...+......+..|+..++.
T Consensus        70 e~~~~~~~s~h~n~~~~~~~~~~-~~~~~~~~~~s~g~~~f~~i~~~~~-----------~~~~~~~~~~~~~ql~s~l~  137 (601)
T KOG0590|consen   70 ETDIQKKLSKHSNTVHMIEPSSS-PRSYLLSLSYSDGGSLFSKISHPDS-----------TGTSSSSASRYLPQLNSGLS  137 (601)
T ss_pred             cccccccccccccccccCCccCC-CcccccccCcccccccccccccCCc-----------cCCCCcchhhhhhhhccCcc
Confidence            444444444 9999999998544 45789999999999998877 3322           12455566678899999999


Q ss_pred             HHHhcCCCCceecCCCCCCEEeCCCC-cEEEEeccCccccCC-CC---------C-CCcccccCC----CCCCccCchHH
Q 041830          498 YMHHVMNPSYVHRNIKSRNIFLDEEF-NARVGNFGMARCVND-DT---------E-SPQFYSTNP----ASWSMGIDIFA  561 (600)
Q Consensus       498 yLH~~~~~~ivHrDLk~~NILld~~~-~~kI~DFGla~~~~~-~~---------~-~pe~~~~~~----~~~t~~sDVwS  561 (600)
                      |+|.  ..++.|||+||+|.+++..+ ..|++|||+|..... ..         . .+++...+.    .......|+||
T Consensus       138 ~~H~--~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S  215 (601)
T KOG0590|consen  138 YLHP--ENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWS  215 (601)
T ss_pred             ccCc--ccccccCCCCCccchhccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCccccc
Confidence            9994  35899999999999999999 999999999865433 11         1 222222211    12245679999


Q ss_pred             HHHHHHHHHhCCCCCCCCCCCC
Q 041830          562 YGIVLLEVLSGQTPINRPRKKD  583 (600)
Q Consensus       562 fGvvL~ELltG~~Pf~~~~~~~  583 (600)
                      .|+++.-+++|..|+......+
T Consensus       216 ~g~~l~~~~~g~~p~~~~~~~~  237 (601)
T KOG0590|consen  216 LGIVLSAMLTGELPWDFPSRKD  237 (601)
T ss_pred             ccccccccccCCCCcccccccc
Confidence            9999999999999997765443

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.60  E-value=6.3e-07  Score=83.41  Aligned_cols=122  Identities=18%  Similarity=0.233  Sum_probs=82.2

Q ss_pred             ceeEEEEEEEECCeEEEEEE-cch----hH------HHHHHHHHHHHHhCC--CCceeeeeeEEeccCCceEEEEeecCC
Q 041830          389 RIEGAVYHGRLNGKNLAIKR-TEH----EV------ITKLEMQLVQHATHH--HPNIVRLLGTCLTDGPHSFLVFEYAKN  455 (600)
Q Consensus       389 ~~~G~Vy~g~~~g~~vAvK~-~~~----~~------~~~~e~ei~~~~~l~--HpNIv~l~g~~~~~~~~~~LV~Ey~~~  455 (600)
                      |....+|.+.+-|..+.+|. .++    ..      .....+|...+...+  -=+.-.++.+  +. +...|+|||.++
T Consensus         7 GAEa~i~~~~~~g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dv--D~-~~~~I~me~I~G   83 (204)
T COG3642           7 GAEAIIYLTDFLGLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDV--DP-DNGLIVMEYIEG   83 (204)
T ss_pred             CcceeEEeeeccCcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEE--cC-CCCEEEEEEeCC
Confidence            34467888888777777774 211    11      112334555444432  1233344433  33 366899999999


Q ss_pred             CCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccc
Q 041830          456 GSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARC  535 (600)
Q Consensus       456 GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~  535 (600)
                      -.|.+++...                   +..++..|-.-+.-||   ..+|+|+||.++||++..+. +.+.||||+..
T Consensus        84 ~~lkd~l~~~-------------------~~~~~r~vG~~vg~lH---~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          84 ELLKDALEEA-------------------RPDLLREVGRLVGKLH---KAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             hhHHHHHHhc-------------------chHHHHHHHHHHHHHH---hcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999888643                   1345666777777899   77999999999999997765 89999999874


Q ss_pred             c
Q 041830          536 V  536 (600)
Q Consensus       536 ~  536 (600)
                      -
T Consensus       141 s  141 (204)
T COG3642         141 S  141 (204)
T ss_pred             c
Confidence            3

>PRK14125 cell division suppressor protein YneA; Provisional

Probab=98.60  E-value=5.5e-08  Score=82.62  Aligned_cols=50  Identities=16%  Similarity=0.316  Sum_probs=41.0

Q ss_pred             ceeeeecCCchhhHHHhcCC---Cch---HHHHHhhCCCCCCCCCCCCCeEeeeeec
Q 041830          127 LTKTTIKGESFYSIAQSLEG---LTT---CGAIKERNPSVSPWDLDDKARLQVPLRC  177 (600)
Q Consensus       127 ~~y~v~~gdt~~~ia~~~~g---l~t---~~~l~~~N~~~~~~~l~~G~~l~vp~~c  177 (600)
                      .+|+|++|||+|+||++|..   ++.   .++|++.|.+.+ +.|++||+|.||..-
T Consensus        37 ~~~tV~~GDTLW~IA~~y~~~~~l~~~~~v~~I~~~N~l~~-~~I~~Gq~L~IP~~~   92 (103)
T PRK14125         37 VEITVQEGDTLWALADQYAGKHHMAKNEFIEWVEDVNNLPS-GHIKAGDKLVIPVLK   92 (103)
T ss_pred             EEEEECCCCCHHHHHHHhCCCcCCCHHHHHHHHHHhcCCCC-CcCCCCCEEEEecCC
Confidence            57999999999999999962   222   577888899874 579999999999744

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=98.59  E-value=6.4e-07  Score=83.00  Aligned_cols=133  Identities=15%  Similarity=0.227  Sum_probs=86.3

Q ss_pred             CceeEEEEEEEECCeEEEEEE-c----chhH------HHHHHHHHHHHHhCCCCc--eeeeeeEEeccCCceEEEEeecC
Q 041830          388 NRIEGAVYHGRLNGKNLAIKR-T----EHEV------ITKLEMQLVQHATHHHPN--IVRLLGTCLTDGPHSFLVFEYAK  454 (600)
Q Consensus       388 ~~~~G~Vy~g~~~g~~vAvK~-~----~~~~------~~~~e~ei~~~~~l~HpN--Iv~l~g~~~~~~~~~~LV~Ey~~  454 (600)
                      +|..+.|+++.+.|+...||. +    ++..      ..+...|...+.+++--.  ..+++  +.+. ..-.|+|||.+
T Consensus        17 QGAEArv~~~~~~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~--~~D~-~~~~i~ME~~~   93 (229)
T KOG3087|consen   17 QGAEARVPRGSFSGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLI--FIDT-YGGQIYMEFID   93 (229)
T ss_pred             ccceeeEeeeccCCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEE--EEec-CCCeEEEEecc
Confidence            344589999999999988884 2    2111      123345555555433111  12222  2222 24478999997


Q ss_pred             C-CCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC---cEEEEec
Q 041830          455 N-GSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEF---NARVGNF  530 (600)
Q Consensus       455 ~-GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~---~~kI~DF  530 (600)
                      + -++.+|+......          .-.......++..|-+-+.-||   ...|+|+||.++||+|..++   .+.+.||
T Consensus        94 g~~~vk~~i~~~~~~----------~~~d~~~~~~~~~iG~~igklH---~ndiiHGDLTTSNill~~~~~~~~~~lIdf  160 (229)
T KOG3087|consen   94 GASTVKDFILSTMED----------ESEDEGLAELARRIGELIGKLH---DNDIIHGDLTTSNILLRSDGNQITPILIDF  160 (229)
T ss_pred             chhHHHHHHHHHccC----------cccchhHHHHHHHHHHHHHHhh---hCCeecccccccceEEecCCCcCceEEEee
Confidence            6 4788888654321          1122223677888888899999   77999999999999996543   4689999


Q ss_pred             cCcccc
Q 041830          531 GMARCV  536 (600)
Q Consensus       531 Gla~~~  536 (600)
                      |++..-
T Consensus       161 gls~~s  166 (229)
T KOG3087|consen  161 GLSSVS  166 (229)
T ss_pred             cchhcc
Confidence            998643

>TIGR02899 spore_safA spore coat assembly protein SafA

Probab=98.50  E-value=1.1e-07  Score=67.67  Aligned_cols=42  Identities=19%  Similarity=0.424  Sum_probs=37.5

Q ss_pred             eecCCchhhHHHhcCCCchHHHHHhhCCC-CCCCCCCCCCeEeee
Q 041830          131 TIKGESFYSIAQSLEGLTTCGAIKERNPS-VSPWDLDDKARLQVP  174 (600)
Q Consensus       131 v~~gdt~~~ia~~~~gl~t~~~l~~~N~~-~~~~~l~~G~~l~vp  174 (600)
                      |++|||+|+||++|+  ++.++|+++|+. .+++.+.+||+|.||
T Consensus         1 v~~gdtl~~IA~~~~--~~~~~l~~~N~~~~~~~~~~~g~~l~ip   43 (44)
T TIGR02899         1 VQKGDTLWKIAKKYG--VDFDELIQANPQLSNPNLIYPGMKIKIP   43 (44)
T ss_pred             CCCCCCHHHHHHHHC--cCHHHHHHHhhcCCCCCCcCCCCEEecC
Confidence            689999999999998  899999999984 445679999999997

in which one of which is found in most examples of endospore-forming bacteria. Lysin motifs are repeated in many proteins.

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.49  E-value=7.6e-07  Score=84.87  Aligned_cols=123  Identities=17%  Similarity=0.209  Sum_probs=77.1

Q ss_pred             EEEEEEE-CCeEEEEEEcchhH-----------------------------HHHHHHHHHHHHhCCCC--ceeeeeeEEe
Q 041830          393 AVYHGRL-NGKNLAIKRTEHEV-----------------------------ITKLEMQLVQHATHHHP--NIVRLLGTCL  440 (600)
Q Consensus       393 ~Vy~g~~-~g~~vAvK~~~~~~-----------------------------~~~~e~ei~~~~~l~Hp--NIv~l~g~~~  440 (600)
                      .||.|.. +|..+|+|..+...                             ....++|...|..+..-  ++-+.+++  
T Consensus         1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~--   78 (188)
T PF01163_consen    1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY--   78 (188)
T ss_dssp             EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred             CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence            3899988 89999999632100                             01246788888887654  45566654  


Q ss_pred             ccCCceEEEEeecC--CCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEE
Q 041830          441 TDGPHSFLVFEYAK--NGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIF  518 (600)
Q Consensus       441 ~~~~~~~LV~Ey~~--~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NIL  518 (600)
                      .   .-.|||||++  +..+..+....              ++..+...+..++...+..+++  ..+|+|+||.+.|||
T Consensus        79 ~---~~~ivME~I~~~G~~~~~l~~~~--------------~~~~~~~~~~~~il~~~~~~~~--~~givHGDLs~~NIl  139 (188)
T PF01163_consen   79 N---RNVIVMEYIGEDGVPLPRLKDVD--------------LSPEEPKELLEEILEEIIKMLH--KAGIVHGDLSEYNIL  139 (188)
T ss_dssp             E---TTEEEEE--EETTEEGGCHHHCG--------------GGGSTHHHHHHHHHHHHHHHHH--CTTEEESS-STTSEE
T ss_pred             e---CCEEEEEecCCCccchhhHHhcc--------------ccchhHHHHHHHHHHHHHHHHH--hcCceecCCChhhEE
Confidence            2   2379999998  54443322211              1233445677777776666432  679999999999999


Q ss_pred             eCCCCcEEEEeccCccccC
Q 041830          519 LDEEFNARVGNFGMARCVN  537 (600)
Q Consensus       519 ld~~~~~kI~DFGla~~~~  537 (600)
                      ++++ .+.|.|||.+....
T Consensus       140 v~~~-~~~iIDf~qav~~~  157 (188)
T PF01163_consen  140 VDDG-KVYIIDFGQAVDSS  157 (188)
T ss_dssp             EETT-CEEE--GTTEEETT
T ss_pred             eecc-eEEEEecCcceecC
Confidence            9888 99999999887554

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>cd00118 LysM Lysin domain, found in a variety of enzymes involved in bacterial cell wall degradation

Probab=98.46  E-value=2.4e-07  Score=65.84  Aligned_cols=45  Identities=29%  Similarity=0.363  Sum_probs=41.5

Q ss_pred             eeeeecCCchhhHHHhcCCCchHHHHHhhCCCCCCCCCCCCCeEeee
Q 041830          128 TKTTIKGESFYSIAQSLEGLTTCGAIKERNPSVSPWDLDDKARLQVP  174 (600)
Q Consensus       128 ~y~v~~gdt~~~ia~~~~gl~t~~~l~~~N~~~~~~~l~~G~~l~vp  174 (600)
                      .|+|++|||+|+||..|+  ++..+++++|+..+...+.+|++|.||
T Consensus         2 ~~~v~~gdt~~~ia~~~~--~~~~~~~~~N~~~~~~~~~~g~~l~ip   46 (46)
T cd00118           2 TYTVKKGDTLSSIAQRYG--ISVEELLKLNGLSDPDNLQVGQKLKIP   46 (46)
T ss_pred             EEEECCCCCHHHHHHHHC--cCHHHHHHHcCCCCccccCCCCEEecC
Confidence            699999999999999998  999999999999656789999999886

This domain may have a general peptidoglycan binding function.

>PF01476 LysM: LysM domain; InterPro: IPR018392 This domain is about 40 residues long and is found in a variety of enzymes involved in bacterial cell wall degradation []

Probab=98.44  E-value=1.2e-07  Score=67.83  Aligned_cols=43  Identities=21%  Similarity=0.311  Sum_probs=35.7

Q ss_pred             eecCCCCCChhhHHHhhCCChHHHHhhh-CCCCCCCCCCCCCcEEEe
Q 041830           66 LRTNSYYSSLFNLSFYLGLNRFVIARAN-GFSADTEFLPKDQPLLIP  111 (600)
Q Consensus        66 y~~~~~~~~l~~ia~~~~~~~~~i~~~N-~~~~~~~~i~~~~~l~vP  111 (600)
                      |+|++ |||++.||++|+++..+|.++| ++  ..+.|.+||.|.||
T Consensus         1 y~V~~-gDtl~~IA~~~~~~~~~l~~~N~~~--~~~~l~~G~~l~iP   44 (44)
T PF01476_consen    1 YTVQP-GDTLWSIAKRYGISVDELMELNPNI--DSDNLQPGQKLCIP   44 (44)
T ss_dssp             EEE-T-T--HHHHHHHTTS-HHHHHHHCCTT--HGGCGGTTEEEEEC
T ss_pred             CEECc-CCcHHHHHhhhhhhHhHHHHhcCCC--CcccCCCCCEEEeC
Confidence            78998 9999999999999999999999 88  44449999999998

This domain may have a general peptidoglycan binding function.; GO: 0016998 cell wall macromolecule catabolic process; PDB: 2DJP_A 3ZQD_A 1Y7M_B 4A52_A 2L9Y_A 1E0G_A.

>PRK10871 nlpD lipoprotein NlpD; Provisional

Probab=98.43  E-value=1.7e-07  Score=95.21  Aligned_cols=48  Identities=27%  Similarity=0.315  Sum_probs=45.2

Q ss_pred             cceeeeecCCchhhHHHhcCCCchHHHHHhhCCCCCCCCCCCCCeEeeee
Q 041830          126 DLTKTTIKGESFYSIAQSLEGLTTCGAIKERNPSVSPWDLDDKARLQVPL  175 (600)
Q Consensus       126 ~~~y~v~~gdt~~~ia~~~~gl~t~~~l~~~N~~~~~~~l~~G~~l~vp~  175 (600)
                      ..+|+|++|||||.||..|+  +++++|++||++.+|+.|++||+|.||.
T Consensus        60 ~~~y~Vk~GDTL~~IA~~~g--~~~~~La~~N~l~~p~~I~~GQ~L~i~~  107 (319)
T PRK10871         60 GSTYTVKKGDTLFYIAWITG--NDFRDLAQRNNIQAPYSLNVGQTLQVGN  107 (319)
T ss_pred             CCceEECCCCHHHHHHHHHC--cCHHHHHHhcCCCCCccccCCCEEEeCC
Confidence            35799999999999999999  9999999999999899999999999985

>PRK14125 cell division suppressor protein YneA; Provisional

Probab=98.40  E-value=1.4e-06  Score=74.09  Aligned_cols=53  Identities=11%  Similarity=0.133  Sum_probs=46.1

Q ss_pred             cceeeeeecCCCCCChhhHHHhhCCC--------hHHHHhhhCCCCCCCCCCCCCcEEEeeccc
Q 041830           60 CGTFAILRTNSYYSSLFNLSFYLGLN--------RFVIARANGFSADTEFLPKDQPLLIPIDCK  115 (600)
Q Consensus        60 C~~~~~y~~~~~~~~l~~ia~~~~~~--------~~~i~~~N~~~~~~~~i~~~~~l~vP~~c~  115 (600)
                      +..|..|+|++ |||||+||++|+++        +..|.+.|++  +++.|++||.|.||+.-+
T Consensus        33 ~~~~~~~tV~~-GDTLW~IA~~y~~~~~l~~~~~v~~I~~~N~l--~~~~I~~Gq~L~IP~~~~   93 (103)
T PRK14125         33 KNQYVEITVQE-GDTLWALADQYAGKHHMAKNEFIEWVEDVNNL--PSGHIKAGDKLVIPVLKS   93 (103)
T ss_pred             CCCcEEEEECC-CCCHHHHHHHhCCCcCCCHHHHHHHHHHhcCC--CCCcCCCCCEEEEecCCC
Confidence            45788999999 99999999999876        4788899999  566799999999998754

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.20  E-value=1.1e-05  Score=88.23  Aligned_cols=94  Identities=13%  Similarity=0.149  Sum_probs=60.1

Q ss_pred             CCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCce
Q 041830          429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYV  508 (600)
Q Consensus       429 HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv  508 (600)
                      +..=+++-.++++-.....|+|||++|-.+.+...-...           .++   +..++..++++.  +-+....+++
T Consensus       224 ~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~-----------g~d---~k~ia~~~~~~f--~~q~~~dgff  287 (517)
T COG0661         224 DDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA-----------GID---RKELAELLVRAF--LRQLLRDGFF  287 (517)
T ss_pred             CCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc-----------CCC---HHHHHHHHHHHH--HHHHHhcCcc
Confidence            333345555655433467899999999888877422111           133   223333333321  1111134899


Q ss_pred             ecCCCCCCEEeCCCCcEEEEeccCccccCC
Q 041830          509 HRNIKSRNIFLDEEFNARVGNFGMARCVND  538 (600)
Q Consensus       509 HrDLk~~NILld~~~~~kI~DFGla~~~~~  538 (600)
                      |.|..|.||+++.+++..+-|||+...+.+
T Consensus       288 HaDpHpGNi~v~~~g~i~~lDfGi~g~l~~  317 (517)
T COG0661         288 HADPHPGNILVRSDGRIVLLDFGIVGRLDP  317 (517)
T ss_pred             ccCCCccceEEecCCcEEEEcCcceecCCH
Confidence            999999999999999999999999865543

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.17  E-value=2.2e-05  Score=76.36  Aligned_cols=105  Identities=16%  Similarity=0.116  Sum_probs=75.9

Q ss_pred             HHHHHHHHHhCC--CCceeeeeeEEeccC---CceEEEEeecCC-CCHHHHHhcCcCcccccccccccCCCHHHHHHHHH
Q 041830          417 LEMQLVQHATHH--HPNIVRLLGTCLTDG---PHSFLVFEYAKN-GSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICL  490 (600)
Q Consensus       417 ~e~ei~~~~~l~--HpNIv~l~g~~~~~~---~~~~LV~Ey~~~-GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~  490 (600)
                      ..+|...+..+.  .=...+.+++.....   ...+||+|++++ -+|.+++.....            ++...+..++.
T Consensus        58 a~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~------------~~~~~~~~ll~  125 (206)
T PF06293_consen   58 AKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ------------LDPSQRRELLR  125 (206)
T ss_pred             HHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc------------cchhhHHHHHH
Confidence            344544443332  223455566544321   134899999987 489999875321            45566788999


Q ss_pred             HHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC---cEEEEeccCcccc
Q 041830          491 DVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEF---NARVGNFGMARCV  536 (600)
Q Consensus       491 ~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~---~~kI~DFGla~~~  536 (600)
                      +++..++-||   ..+|+|+|++++|||++.+.   .+.+.||+-++..
T Consensus       126 ~l~~~i~~lH---~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~  171 (206)
T PF06293_consen  126 ALARLIAKLH---DAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR  171 (206)
T ss_pred             HHHHHHHHHH---HCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence            9999999999   77999999999999998876   8999999987654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>TIGR02907 spore_VI_D stage VI sporulation protein D

Probab=98.16  E-value=1.8e-06  Score=86.75  Aligned_cols=47  Identities=15%  Similarity=0.249  Sum_probs=43.5

Q ss_pred             ecceeeeecCCchhhHHHhcCCCchHHHHHhhCCCCCCCCCCCCCeEeee
Q 041830          125 ADLTKTTIKGESFYSIAQSLEGLTTCGAIKERNPSVSPWDLDDKARLQVP  174 (600)
Q Consensus       125 ~~~~y~v~~gdt~~~ia~~~~gl~t~~~l~~~N~~~~~~~l~~G~~l~vp  174 (600)
                      ....|+|++|||+|.||++|+  ++.+.|+++|++. ++.|++||.|.||
T Consensus       292 ~~~~YiVq~GDTL~sIAkRYG--VSV~~L~r~N~L~-~~~L~~GQ~L~IP  338 (338)
T TIGR02907       292 KLRMCIVQEGDTIETIAERYE--ISVSQLIRHNQLE-DFEVNEGQILYIP  338 (338)
T ss_pred             ccEEEEECCCCCHHHHHHHHC--cCHHHHHHHhCCC-ccccCCCCEEEeC
Confidence            345799999999999999999  9999999999998 6889999999997

SpoVID, the stage VI sporulation protein D, is restricted to endospore-forming members of the bacteria, all of which are found among the Firmicutes. It is widely distributed but not quite universal in this group. Between well-conserved N-terminal and C-terminal domains is a poorly conserved, low-complexity region of variable length, rich enough in glutamic acid to cause spurious BLAST search results unless a filter is used. The seed alignment for this model was trimmed, in effect, by choosing member sequences in which these regions are relatively short. SpoVID is involved in spore coat assembly by the mother cell compartment late in the process of sporulation.

>COG1388 LytE FOG: LysM repeat [Cell envelope biogenesis, outer membrane]

Probab=98.16  E-value=2.5e-06  Score=75.85  Aligned_cols=97  Identities=23%  Similarity=0.341  Sum_probs=73.2

Q ss_pred             HHHhcCCCchHHHHHhhCCCCC-CCCCCCCCeEeeeeeccCCCC-CCC-CC-CceE-----------EEEEEccCCCccc
Q 041830          140 IAQSLEGLTTCGAIKERNPSVS-PWDLDDKARLQVPLRCACPSS-SEN-LP-ETRI-----------LVSYPVGEGDTVS  204 (600)
Q Consensus       140 ia~~~~gl~t~~~l~~~N~~~~-~~~l~~G~~l~vp~~c~c~~~-~~~-~~-~~~~-----------~~tY~v~~gd~~~  204 (600)
                      ||.+|.  ++..+|+++|.... .+.+.+||+|.++..-.-+.. .+. .. ..++           ..+|+|+.||+|+
T Consensus         1 ia~~~~--~~v~~l~~~n~~~~~s~~i~~gq~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~V~~gdtL~   78 (124)
T COG1388           1 IASKYG--VSVKALKKANALTGKSDAIKPGQVLKIPGDISSTVNAGQTLSSLSNKVSDSSSASKAPPVVTYTVKKGDTLS   78 (124)
T ss_pred             Cccccc--ccHHHHHHHhcccCCCCccccCceEEccCCcccccccccccccccceeeccccccccCCCceEEEecCCCHH
Confidence            567788  99999999998774 578999999999963111111 111 11 1111           3689999999999


Q ss_pred             ccccccCCChHHHHHhcCCCCCCCCcccccCcccccccC
Q 041830          205 GLAAKFNTTPAAIIAANNKSLEGFKPEDLLAFTSILIPL  243 (600)
Q Consensus       205 ~ia~~f~~~~~~~~~~n~~~~~g~~p~~l~~~~~~~vp~  243 (600)
                      .||++|+++...++.+|+....     .++.++.+.++.
T Consensus        79 ~Ia~~~~~tv~~l~~~n~l~~~-----~i~~gq~l~~~~  112 (124)
T COG1388          79 KIARKYGVTVAELKQLNNLSSD-----KIKVGQKLKLPV  112 (124)
T ss_pred             HHHHHhCCCHHHHHHHhccCCC-----ceecCcEEEEec
Confidence            9999999999999999998444     678888888876

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.13  E-value=1.4e-06  Score=93.87  Aligned_cols=166  Identities=20%  Similarity=0.272  Sum_probs=112.5

Q ss_pred             EEEEEEEE---CCeEEEEEEcchhHHH------HHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          392 GAVYHGRL---NGKNLAIKRTEHEVIT------KLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       392 G~Vy~g~~---~g~~vAvK~~~~~~~~------~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      +.|++...   ++..|++|.+......      .+.+.+..-....|.++++....+... +..|+-.|||+++++...+
T Consensus       279 ~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~-r~~~ip~e~~~~~s~~l~~  357 (524)
T KOG0601|consen  279 SSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQL-RQGYIPLEFCEGGSSSLRS  357 (524)
T ss_pred             ccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCcccc-ccccCchhhhcCcchhhhh
Confidence            34444433   5677888876543221      112222222233477888876654333 4778999999999988766


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC-CcEEEEeccCccccCC---
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEE-FNARVGNFGMARCVND---  538 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~-~~~kI~DFGla~~~~~---  538 (600)
                      .-.            ..+++..++++..+++.++.++|   ++.++|+|+||+||++..+ +..+++|||....+.-   
T Consensus       358 ~~~------------~~~d~~~~~~~~~q~~~~l~~i~---s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~  422 (524)
T KOG0601|consen  358 VTS------------QMLDEDPRLRLTAQILTALNVIH---SKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSG  422 (524)
T ss_pred             HHH------------HhcCcchhhhhHHHHHhcccccc---chhhhcccccccceeeccchhhhhccccccccccceecc
Confidence            221            23788889999999999999999   7899999999999999876 8899999998853211   


Q ss_pred             -----CCCC--CcccccCCCCCCccCchHHHHHHHHHHHhCCC
Q 041830          539 -----DTES--PQFYSTNPASWSMGIDIFAYGIVLLEVLSGQT  574 (600)
Q Consensus       539 -----~~~~--pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~  574 (600)
                           ....  .+... +...+..+.|++|||.-+.|.+++..
T Consensus       423 ~~~~~~r~~p~~~~~~-e~~~~~~~~~~~sl~~~~~e~~~~~~  464 (524)
T KOG0601|consen  423 VFHHIDRLYPIAEILL-EDYPHLSKADIFSLGLSVDEAITGSP  464 (524)
T ss_pred             cccccccccccchhhc-cccccccccccccccccccccccCcc
Confidence                 1111  11111 12334567899999999999988764

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=98.12  E-value=2.3e-06  Score=92.28  Aligned_cols=170  Identities=23%  Similarity=0.312  Sum_probs=119.6

Q ss_pred             eEEEEEEEE----CCeEEEEEEcchhH-----HHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          391 EGAVYHGRL----NGKNLAIKRTEHEV-----ITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       391 ~G~Vy~g~~----~g~~vAvK~~~~~~-----~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      .|.+|.++.    ++..+|+|+-+.-.     ...-.+|+.....+ .|+|.++.+..+. .+...++-+|+|. .+|..
T Consensus       129 ~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e-~~~~lfiqtE~~~-~sl~~  206 (524)
T KOG0601|consen  129 KGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWE-GSGILFIQTELCG-ESLQS  206 (524)
T ss_pred             CceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccc-cCCcceeeecccc-chhHH
Confidence            388998876    57789999732211     11113444444443 4999999877754 4458899999996 68888


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHH----HHHHHHhcCCCCceecCCCCCCEEeCCC-CcEEEEeccCccc
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAM----ALQYMHHVMNPSYVHRNIKSRNIFLDEE-FNARVGNFGMARC  535 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivHrDLk~~NILld~~-~~~kI~DFGla~~  535 (600)
                      +.+...           ..++....+.+..+...    ||.++|   ...++|-|+|+.||++.++ ..+++.|||+...
T Consensus       207 ~~~~~~-----------~~~p~~~l~~~~~~~~~~~~~al~~~h---s~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~  272 (524)
T KOG0601|consen  207 YCHTPC-----------NFLPDNLLWNSLRDWLSRDVTALSHLH---SNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSK  272 (524)
T ss_pred             hhhccc-----------ccCCchhhhhHHhhhhhcccccccccC---CCcccccccchhheecccccceeecCCcceeEE
Confidence            876543           22666677777777777    999999   7799999999999999999 8899999999876


Q ss_pred             cCCCCCC------------CcccccC--CCCCCccCchHHHHHHHHHHHhCCCCC
Q 041830          536 VNDDTES------------PQFYSTN--PASWSMGIDIFAYGIVLLEVLSGQTPI  576 (600)
Q Consensus       536 ~~~~~~~------------pe~~~~~--~~~~t~~sDVwSfGvvL~ELltG~~Pf  576 (600)
                      +......            ..|...+  ...++...|+|++|.+..|..++-...
T Consensus       273 i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~  327 (524)
T KOG0601|consen  273 ISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLP  327 (524)
T ss_pred             ccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccc
Confidence            6443311            1111111  123466789999999999998876554

>COG3858 Predicted glycosyl hydrolase [General function prediction only]

Probab=98.11  E-value=2.5e-06  Score=88.10  Aligned_cols=94  Identities=19%  Similarity=0.207  Sum_probs=83.6

Q ss_pred             eeecCCCCCChhhHHHhhCCChHHHHhhhCCCCCCCCCCCCCcEEEeeccccCCCCcceeecceeeeecCCchhhHHHhc
Q 041830           65 ILRTNSYYSSLFNLSFYLGLNRFVIARANGFSADTEFLPKDQPLLIPIDCKCNNNGGFFQADLTKTTIKGESFYSIAQSL  144 (600)
Q Consensus        65 ~y~~~~~~~~l~~ia~~~~~~~~~i~~~N~~~~~~~~i~~~~~l~vP~~c~c~~~~~~~~~~~~y~v~~gdt~~~ia~~~  144 (600)
                      +|-+++ |+++..|+.+|..+...|...|.++ + +.|..||++.||..-            ..|.|++|||+++||+++
T Consensus         3 i~~~~p-g~~~~~i~~~~~~~~~~i~~~~~~~-~-d~~~~~q~~~v~~~~------------~~y~~~~~d~~~Sia~~~   67 (423)
T COG3858           3 IHLVGP-GDSRLIIAVYFPYTNNRIVNGNDYT-N-DDLVDGQTFVVPPSG------------HFYDVGPGDTLTSIARTV   67 (423)
T ss_pred             EEEccC-Cceeeeehhhccccccccccccccc-c-ccccCceeEEECCcc------------eEEEecCCcchhhhhhhh
Confidence            466776 9999999999999999998888884 4 999999999999432            359999999999999999


Q ss_pred             CCCchHHHHHhhCCCCCCCCCCCCCeEeeee
Q 041830          145 EGLTTCGAIKERNPSVSPWDLDDKARLQVPL  175 (600)
Q Consensus       145 ~gl~t~~~l~~~N~~~~~~~l~~G~~l~vp~  175 (600)
                      .  ||.+.++..|....+..+.+|-+|.+|-
T Consensus        68 ~--vt~~~~~~m~~~~~~~~l~~~~~l~~P~   96 (423)
T COG3858          68 G--VTQDSAAIMNFVICPGYLQYGLNLYIPS   96 (423)
T ss_pred             c--CCHHHHHhhcccccccceeeeeEEeccC
Confidence            9  9999999999987788899999999984

>smart00257 LysM Lysin motif

Probab=98.11  E-value=4.2e-06  Score=58.53  Aligned_cols=44  Identities=27%  Similarity=0.358  Sum_probs=38.9

Q ss_pred             eeeeecCCchhhHHHhcCCCchHHHHHhhCCCCCCCCCCCCCeEee
Q 041830          128 TKTTIKGESFYSIAQSLEGLTTCGAIKERNPSVSPWDLDDKARLQV  173 (600)
Q Consensus       128 ~y~v~~gdt~~~ia~~~~gl~t~~~l~~~N~~~~~~~l~~G~~l~v  173 (600)
                      .|+|++|||+|+||..|+  ++..+++++|+..+.+.+.+|+.|.|
T Consensus         1 ~~~v~~gdt~~~ia~~~~--~~~~~~~~~N~~~~~~~~~~g~~l~i   44 (44)
T smart00257        1 TYTVKKGDTLSSIARRYG--ISVSDLLELNNILDPDNLQVGQKLKI   44 (44)
T ss_pred             CeEeCCCCCHHHHHHHhC--CCHHHHHHHcCCCCccccCCCCEEeC
Confidence            489999999999999998  78899999999655678999998864

>PRK09902 hypothetical protein; Provisional

Probab=98.06  E-value=9e-05  Score=71.40  Aligned_cols=131  Identities=20%  Similarity=0.142  Sum_probs=92.5

Q ss_pred             EEEEEEEECCeEEEEEEcch---------hHHHHHHHHHHHHHhCCC--CceeeeeeEEeccC---CceEEEEeecCC-C
Q 041830          392 GAVYHGRLNGKNLAIKRTEH---------EVITKLEMQLVQHATHHH--PNIVRLLGTCLTDG---PHSFLVFEYAKN-G  456 (600)
Q Consensus       392 G~Vy~g~~~g~~vAvK~~~~---------~~~~~~e~ei~~~~~l~H--pNIv~l~g~~~~~~---~~~~LV~Ey~~~-G  456 (600)
                      ..|++-.+.|+.+-+|+-..         --..-+.+|+..+..+..  -.+.+.........   ..-+||+|-+++ -
T Consensus        32 SgV~r~~~~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pvf~~~~k~~~~~rA~LVTe~L~g~~  111 (216)
T PRK09902         32 SGVQCVERNGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIVFGEAVKIEGEWRALLVTEDMAGFI  111 (216)
T ss_pred             ceEEEEEeCCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccceeeeeccCCceEEEEEEEeCCCCc
Confidence            56888888888899998541         112346677776665542  12444442211111   134799997764 5


Q ss_pred             CHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCc--EEEEeccCcc
Q 041830          457 SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFN--ARVGNFGMAR  534 (600)
Q Consensus       457 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~--~kI~DFGla~  534 (600)
                      +|.+++.....          ...+..++..+..+++..++-||   +.++.|+|+.++||+++.++.  +++.||.-++
T Consensus       112 ~L~~~l~~~~~----------~~~~~~~k~~il~~va~~ia~LH---~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r  178 (216)
T PRK09902        112 SIADWYAQHAV----------SPYSDEVRQAMLKAVALAFKKMH---SVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSR  178 (216)
T ss_pred             cHHHHHhcCCc----------CCcchHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHhheeecCCCCeeEEEEEhhccc
Confidence            89999865331          23577788899999999999999   779999999999999986666  9999997665


Q ss_pred             c
Q 041830          535 C  535 (600)
Q Consensus       535 ~  535 (600)
                      .
T Consensus       179 ~  179 (216)
T PRK09902        179 R  179 (216)
T ss_pred             h
Confidence            3

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=98.02  E-value=2e-05  Score=75.34  Aligned_cols=103  Identities=20%  Similarity=0.310  Sum_probs=78.1

Q ss_pred             HHHHHHHhCCC-CceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHH
Q 041830          419 MQLVQHATHHH-PNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQ  497 (600)
Q Consensus       419 ~ei~~~~~l~H-pNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~  497 (600)
                      .|...+..+.+ +++.+++|+|   |  .+++.||.+.+++...-   ... .+     ...-+|.+|.+|+.++++.+.
T Consensus         8 ~E~lll~~l~~~~~~pk~lG~C---G--~~~v~E~~~~~~~~~~~---~~l-~~-----~~~~~w~~R~~iA~~lL~~l~   73 (188)
T PF12260_consen    8 NEPLLLQLLQGSEPFPKLLGSC---G--RFYVVEYVGAGSLYGIY---RPL-SQ-----FLQSPWEQRAKIALQLLELLE   73 (188)
T ss_pred             cHHHHHHHcCCCCCCCCeeeEC---C--CEEEEEeecCccccccc---ccc-cc-----ccccCHHHHHHHHHHHHHHHH
Confidence            46666666665 5999999999   2  36789999987664210   000 00     022689999999999999999


Q ss_pred             HHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccc
Q 041830          498 YMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARC  535 (600)
Q Consensus       498 yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~  535 (600)
                      ++++.....+.-.|++++|+-+++++++|+.|......
T Consensus        74 ~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~  111 (188)
T PF12260_consen   74 ELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV  111 (188)
T ss_pred             HHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence            99976445577899999999999999999999987643

Proteins in this uncharacterised family are described as transmembrane proteins.

>PRK11198 LysM domain/BON superfamily protein; Provisional

Probab=98.02  E-value=5.5e-06  Score=75.74  Aligned_cols=48  Identities=23%  Similarity=0.247  Sum_probs=41.4

Q ss_pred             ceeeeecCCchhhHHHhc-CCCchHHHHHhhCC--CCCCCCCCCCCeEeee
Q 041830          127 LTKTTIKGESFYSIAQSL-EGLTTCGAIKERNP--SVSPWDLDDKARLQVP  174 (600)
Q Consensus       127 ~~y~v~~gdt~~~ia~~~-~gl~t~~~l~~~N~--~~~~~~l~~G~~l~vp  174 (600)
                      ..|+|++|||+|.||.+| ..-..+++|+++|+  +.+++.|.+||+|.||
T Consensus        96 ~~y~Vk~GDTL~~IA~~~~g~~~~~~~I~~~N~~~l~~~~~I~pGq~L~IP  146 (147)
T PRK11198         96 QFYTVKSGDTLSAIAKKVYGNANKYNKIFEANKPMLKSPDKIYPGQVLRIP  146 (147)
T ss_pred             eEEEECCCCCHHHHHHHHcCChhhHHHHHHhhhhcCCCcCCcCcCCEEecC
Confidence            469999999999999665 54467899999998  6667889999999998

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=98.01  E-value=3.8e-06  Score=95.44  Aligned_cols=138  Identities=22%  Similarity=0.301  Sum_probs=95.1

Q ss_pred             CCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCC
Q 041830          427 HHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS  506 (600)
Q Consensus       427 l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~  506 (600)
                      .+||-+++..-- .......+|+++|..+++|...||....            ++..-.......+...++|||   ...
T Consensus       861 p~~P~v~~~~~s-~~~rsP~~L~~~~~~~~~~~Skl~~~~~------------~saepaRs~i~~~vqs~e~L~---s~~  924 (1205)
T KOG0606|consen  861 PRSPAVVRSFPS-FPCRSPLPLVGHYLNGGDLPSKLHNSGC------------LSAEPARSPILERVQSLESLH---SSL  924 (1205)
T ss_pred             CCCCceecccCC-CCCCCCcchhhHHhccCCchhhhhcCCC------------cccccccchhHHHHhhhhccc---cch
Confidence            345777765543 1233468999999999999999987542            222222334556778899999   556


Q ss_pred             ceecCCCCCCEEeCCCCcEEEEeccCccccCCC----------------C---------------------------CCC
Q 041830          507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD----------------T---------------------------ESP  543 (600)
Q Consensus       507 ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~----------------~---------------------------~~p  543 (600)
                      +.|||++|.|+|...++..+++|||........                .                           ..|
T Consensus       925 r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laP 1004 (1205)
T KOG0606|consen  925 RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAP 1004 (1205)
T ss_pred             hhcccccccchhhcccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCC
Confidence            899999999999999999999999844321100                0                           001


Q ss_pred             cccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCCCC
Q 041830          544 QFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRKK  582 (600)
Q Consensus       544 e~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~~  582 (600)
                      |...  .......+|.|++|++++|.++|.+||+....+
T Consensus      1005 e~~l--g~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq 1041 (1205)
T KOG0606|consen 1005 EILL--GRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQ 1041 (1205)
T ss_pred             cccc--cccCCCcchhhhhhhhhhhhhcCCCCCCCcchh
Confidence            1111  122345589999999999999999999865433

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=97.92  E-value=9e-05  Score=80.99  Aligned_cols=94  Identities=11%  Similarity=0.163  Sum_probs=59.1

Q ss_pred             CCCCc---eeeeeeEEeccCCceEEEEeecCCCCHHHH--HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHh
Q 041830          427 HHHPN---IVRLLGTCLTDGPHSFLVFEYAKNGSLKDW--LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHH  501 (600)
Q Consensus       427 l~HpN---Iv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~--L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~  501 (600)
                      +.|-+   =|++-.++++-.....|+||||+|..+.|.  |.+..             ++...+..-+.++..-+-+   
T Consensus       255 f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~~g-------------i~~~~i~~~l~~~~~~qIf---  318 (538)
T KOG1235|consen  255 FKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDKRG-------------ISPHDILNKLVEAYLEQIF---  318 (538)
T ss_pred             HHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHHcC-------------CCHHHHHHHHHHHHHHHHH---
Confidence            44555   233444555444467999999999766554  33222             4444333333332222222   


Q ss_pred             cCCCCceecCCCCCCEEeCC----CCcEEEEeccCccccCC
Q 041830          502 VMNPSYVHRNIKSRNIFLDE----EFNARVGNFGMARCVND  538 (600)
Q Consensus       502 ~~~~~ivHrDLk~~NILld~----~~~~kI~DFGla~~~~~  538 (600)
                        ..+++|.|=.|.||++..    ++++.+-|||+...+..
T Consensus       319 --~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  319 --KTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             --hcCCccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence              448999999999999983    67899999999875543

>TIGR02899 spore_safA spore coat assembly protein SafA

Probab=97.88  E-value=2e-05  Score=55.89  Aligned_cols=43  Identities=14%  Similarity=0.192  Sum_probs=36.6

Q ss_pred             CCCCCChhhHHHhhCCChHHHHhhhCCCCCCCCCCCCCcEEEee
Q 041830           69 NSYYSSLFNLSFYLGLNRFVIARANGFSADTEFLPKDQPLLIPI  112 (600)
Q Consensus        69 ~~~~~~l~~ia~~~~~~~~~i~~~N~~~~~~~~i~~~~~l~vP~  112 (600)
                      ++ ||||++||++|+++..+|+.+|....+...+.+||.|.||.
T Consensus         2 ~~-gdtl~~IA~~~~~~~~~l~~~N~~~~~~~~~~~g~~l~ip~   44 (44)
T TIGR02899         2 QK-GDTLWKIAKKYGVDFDELIQANPQLSNPNLIYPGMKIKIPS   44 (44)
T ss_pred             CC-CCCHHHHHHHHCcCHHHHHHHhhcCCCCCCcCCCCEEecCC
Confidence            44 99999999999999999999996321456799999999983

in which one of which is found in most examples of endospore-forming bacteria. Lysin motifs are repeated in many proteins.

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=97.79  E-value=0.00013  Score=72.23  Aligned_cols=119  Identities=16%  Similarity=0.109  Sum_probs=78.2

Q ss_pred             EEEEEEEE-CCeEEEEEEcchh------------H-------------HHHHHHHHHHHHhCCCC--ceeeeeeEEeccC
Q 041830          392 GAVYHGRL-NGKNLAIKRTEHE------------V-------------ITKLEMQLVQHATHHHP--NIVRLLGTCLTDG  443 (600)
Q Consensus       392 G~Vy~g~~-~g~~vAvK~~~~~------------~-------------~~~~e~ei~~~~~l~Hp--NIv~l~g~~~~~~  443 (600)
                      +.||.|.. .|..+|||.-+..            .             +...++|+..|..+.-.  .+-+.+++     
T Consensus       105 sdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~VP~P~~~-----  179 (304)
T COG0478         105 SDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKVPKPIAW-----  179 (304)
T ss_pred             ceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCCCCcccc-----
Confidence            89999998 6999999953210            0             01346788888777533  45555554     


Q ss_pred             CceEEEEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC
Q 041830          444 PHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEF  523 (600)
Q Consensus       444 ~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~  523 (600)
                      +.-.+||||+++-.|...-                 ++-...-.++..|+.-+.-.-   ..++||+|+..=||++++++
T Consensus       180 nRHaVvMe~ieG~eL~~~r-----------------~~~en~~~il~~il~~~~~~~---~~GiVHGDlSefNIlV~~dg  239 (304)
T COG0478         180 NRHAVVMEYIEGVELYRLR-----------------LDVENPDEILDKILEEVRKAY---RRGIVHGDLSEFNILVTEDG  239 (304)
T ss_pred             ccceeeeehcccceeeccc-----------------CcccCHHHHHHHHHHHHHHHH---HcCccccCCchheEEEecCC
Confidence            2347999999886554311                 112222233444444333333   34899999999999999999


Q ss_pred             cEEEEeccCccc
Q 041830          524 NARVGNFGMARC  535 (600)
Q Consensus       524 ~~kI~DFGla~~  535 (600)
                      .+.+.||--+..
T Consensus       240 ~~~vIDwPQ~v~  251 (304)
T COG0478         240 DIVVIDWPQAVP  251 (304)
T ss_pred             CEEEEeCccccc
Confidence            999999966543

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=97.74  E-value=2.4e-05  Score=89.80  Aligned_cols=70  Identities=19%  Similarity=0.330  Sum_probs=51.2

Q ss_pred             eecCCCCC-CEEeCCCCcEEEEeccCccccC--------------CCCCCCcccccCCCCCCccCchHHHHHHHHHHHhC
Q 041830          508 VHRNIKSR-NIFLDEEFNARVGNFGMARCVN--------------DDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSG  572 (600)
Q Consensus       508 vHrDLk~~-NILld~~~~~kI~DFGla~~~~--------------~~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG  572 (600)
                      .|++.+|. |++++.....++.|||.++...              ..+.+||.+..  ..++.++|||||||+||||++|
T Consensus       499 ~~~~~~p~~~~~~~p~~~~~~~~~~~~~~~~~g~~~~~~~~~vGT~~Y~APE~l~~--~~~~~~~DiwSlG~il~ElltG  576 (669)
T cd05610         499 PTQKPRPHGNLYQTPKQVKIGTPYRTPKSVRRGAAPVEGERILGTPDYLAPELLLG--KPHGPAVDWWALGVCLFEFLTG  576 (669)
T ss_pred             CCCCCCCCCceeECCccccccccCCCchhhhcccccccCCceeeCccccCHHHcCC--CCCCcHHHHHHHHHHHHHHHHC
Confidence            34555555 6667777777888998876542              22346666654  4478889999999999999999


Q ss_pred             CCCCCCC
Q 041830          573 QTPINRP  579 (600)
Q Consensus       573 ~~Pf~~~  579 (600)
                      +.||...
T Consensus       577 ~~pf~~~  583 (669)
T cd05610         577 IPPFNDE  583 (669)
T ss_pred             CCCCCCC
Confidence            9999753

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd00118 LysM Lysin domain, found in a variety of enzymes involved in bacterial cell wall degradation

Probab=97.74  E-value=5.1e-05  Score=53.46  Aligned_cols=45  Identities=24%  Similarity=0.313  Sum_probs=40.9

Q ss_pred             eeecCCCCCChhhHHHhhCCChHHHHhhhCCCCCCCCCCCCCcEEEe
Q 041830           65 ILRTNSYYSSLFNLSFYLGLNRFVIARANGFSADTEFLPKDQPLLIP  111 (600)
Q Consensus        65 ~y~~~~~~~~l~~ia~~~~~~~~~i~~~N~~~~~~~~i~~~~~l~vP  111 (600)
                      .|++++ |||++.||.+|+++..+|+.+|... ....+.+|+.|.||
T Consensus         2 ~~~v~~-gdt~~~ia~~~~~~~~~~~~~N~~~-~~~~~~~g~~l~ip   46 (46)
T cd00118           2 TYTVKK-GDTLSSIAQRYGISVEELLKLNGLS-DPDNLQVGQKLKIP   46 (46)
T ss_pred             EEEECC-CCCHHHHHHHHCcCHHHHHHHcCCC-CccccCCCCEEecC
Confidence            578888 9999999999999999999999984 66789999999987

This domain may have a general peptidoglycan binding function.

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=97.73  E-value=0.00046  Score=66.85  Aligned_cols=120  Identities=13%  Similarity=0.144  Sum_probs=74.1

Q ss_pred             EEEEEEEECCeEEEEEEcchhHHH------------HHHHHHHHHHhCC---CCceeeeeeEEecc----CCceEEEEee
Q 041830          392 GAVYHGRLNGKNLAIKRTEHEVIT------------KLEMQLVQHATHH---HPNIVRLLGTCLTD----GPHSFLVFEY  452 (600)
Q Consensus       392 G~Vy~g~~~g~~vAvK~~~~~~~~------------~~e~ei~~~~~l~---HpNIv~l~g~~~~~----~~~~~LV~Ey  452 (600)
                      ..|.+-..+|+.+.+|..+.+...            ...+.+.....+.   --....++.+....    ....+|+|||
T Consensus        45 ~~ValIei~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~~~~~~~~~ll~EY  124 (229)
T PF06176_consen   45 NYVALIEIDGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAEKKIFRYTSSYVLLMEY  124 (229)
T ss_pred             cEEEEEEECCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeeeeeeccceeEEEEEEEE
Confidence            445555668999999976543311            1122222222221   12333333332221    1234689999


Q ss_pred             cCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccC
Q 041830          453 AKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGM  532 (600)
Q Consensus       453 ~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGl  532 (600)
                      ++|-.|.++..                ++.    .+...+.+.+.-||   ..+++|+|..|+|+++++++ +++.||+.
T Consensus       125 IeG~~l~d~~~----------------i~e----~~~~ki~~~ikqlH---~~G~~HGD~hpgNFlv~~~~-i~iID~~~  180 (229)
T PF06176_consen  125 IEGVELNDIED----------------IDE----DLAEKIVEAIKQLH---KHGFYHGDPHPGNFLVSNNG-IRIIDTQG  180 (229)
T ss_pred             ecCeecccchh----------------cCH----HHHHHHHHHHHHHH---HcCCccCCCCcCcEEEECCc-EEEEECcc
Confidence            99987765432                222    24456777888999   67999999999999998555 89999987


Q ss_pred             ccc
Q 041830          533 ARC  535 (600)
Q Consensus       533 a~~  535 (600)
                      .+.
T Consensus       181 k~~  183 (229)
T PF06176_consen  181 KRM  183 (229)
T ss_pred             ccc
Confidence            653

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>TIGR02907 spore_VI_D stage VI sporulation protein D

Probab=97.67  E-value=5.2e-05  Score=76.44  Aligned_cols=47  Identities=13%  Similarity=0.120  Sum_probs=43.3

Q ss_pred             eeeeeecCCCCCChhhHHHhhCCChHHHHhhhCCCCCCCCCCCCCcEEEe
Q 041830           62 TFAILRTNSYYSSLFNLSFYLGLNRFVIARANGFSADTEFLPKDQPLLIP  111 (600)
Q Consensus        62 ~~~~y~~~~~~~~l~~ia~~~~~~~~~i~~~N~~~~~~~~i~~~~~l~vP  111 (600)
                      .+..|+|++ ||||+.||++|++++..|+++|++  ..+.|++||.|+||
T Consensus       292 ~~~~YiVq~-GDTL~sIAkRYGVSV~~L~r~N~L--~~~~L~~GQ~L~IP  338 (338)
T TIGR02907       292 KLRMCIVQE-GDTIETIAERYEISVSQLIRHNQL--EDFEVNEGQILYIP  338 (338)
T ss_pred             ccEEEEECC-CCCHHHHHHHHCcCHHHHHHHhCC--CccccCCCCEEEeC
Confidence            445699998 999999999999999999999999  46899999999998

SpoVID, the stage VI sporulation protein D, is restricted to endospore-forming members of the bacteria, all of which are found among the Firmicutes. It is widely distributed but not quite universal in this group. Between well-conserved N-terminal and C-terminal domains is a poorly conserved, low-complexity region of variable length, rich enough in glutamic acid to cause spurious BLAST search results unless a filter is used. The seed alignment for this model was trimmed, in effect, by choosing member sequences in which these regions are relatively short. SpoVID is involved in spore coat assembly by the mother cell compartment late in the process of sporulation.

>PRK10871 nlpD lipoprotein NlpD; Provisional

Probab=97.50  E-value=9.5e-05  Score=75.37  Aligned_cols=48  Identities=17%  Similarity=0.153  Sum_probs=44.5

Q ss_pred             eeeecCCCCCChhhHHHhhCCChHHHHhhhCCCCCCCCCCCCCcEEEeec
Q 041830           64 AILRTNSYYSSLFNLSFYLGLNRFVIARANGFSADTEFLPKDQPLLIPID  113 (600)
Q Consensus        64 ~~y~~~~~~~~l~~ia~~~~~~~~~i~~~N~~~~~~~~i~~~~~l~vP~~  113 (600)
                      -+|+|++ ||||+.||.++|++..+|+++|+|. +...|.+||.|.||..
T Consensus        61 ~~y~Vk~-GDTL~~IA~~~g~~~~~La~~N~l~-~p~~I~~GQ~L~i~~~  108 (319)
T PRK10871         61 STYTVKK-GDTLFYIAWITGNDFRDLAQRNNIQ-APYSLNVGQTLQVGNA  108 (319)
T ss_pred             CceEECC-CCHHHHHHHHHCcCHHHHHHhcCCC-CCccccCCCEEEeCCC
Confidence            3699999 9999999999999999999999997 7788999999999853

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=97.47  E-value=0.0015  Score=64.36  Aligned_cols=31  Identities=10%  Similarity=0.051  Sum_probs=26.7

Q ss_pred             CCceecCCCCCCEEeCCCCcEEEEeccCcccc
Q 041830          505 PSYVHRNIKSRNIFLDEEFNARVGNFGMARCV  536 (600)
Q Consensus       505 ~~ivHrDLk~~NILld~~~~~kI~DFGla~~~  536 (600)
                      ..++|+|+.+.||++++++ ..|.||+.+...
T Consensus       153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~~G  183 (226)
T TIGR02172       153 STCLHGDFQIGNLITSGKG-TYWIDLGDFGYG  183 (226)
T ss_pred             CceEecCCCCCcEEEcCCC-cEEEechhcCcC
Confidence            4578999999999999888 999999987643

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.46  E-value=0.0013  Score=65.40  Aligned_cols=69  Identities=12%  Similarity=0.030  Sum_probs=44.1

Q ss_pred             EEEEEEEECCeEEEEEEcchhHHHHHHHHHHHHHhCC-CCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          392 GAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATHH-HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       392 G~Vy~g~~~g~~vAvK~~~~~~~~~~e~ei~~~~~l~-HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      ..||+....+..+.+|+.........++|+..+..+. +--+.+++++.... +..++|||++++.+|.+.
T Consensus        13 ~~v~~~~~~~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~-~~~~lv~e~i~G~~l~~~   82 (244)
T cd05150          13 ATVYRLDGKNPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSDD-GRAWLLTSAVPGVPAAAL   82 (244)
T ss_pred             CeEEEEcCCCCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEecC-CccEEEEEeeCCccHhHh
Confidence            6789988777788999876542223445555444432 22355666665333 357899999998777643

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>COG3858 Predicted glycosyl hydrolase [General function prediction only]

Probab=97.45  E-value=0.00013  Score=75.73  Aligned_cols=96  Identities=27%  Similarity=0.204  Sum_probs=76.3

Q ss_pred             eeeeecCCchhhHHHhcCCCchHHHHHhhCCCCCCCCCCCCCeEeeeeeccCCCCCCCCCCceEEEEEEccCCCcccccc
Q 041830          128 TKTTIKGESFYSIAQSLEGLTTCGAIKERNPSVSPWDLDDKARLQVPLRCACPSSSENLPETRILVSYPVGEGDTVSGLA  207 (600)
Q Consensus       128 ~y~v~~gdt~~~ia~~~~gl~t~~~l~~~N~~~~~~~l~~G~~l~vp~~c~c~~~~~~~~~~~~~~tY~v~~gd~~~~ia  207 (600)
                      .|.|++||+.+.|++.|.  +|.+.|...|.+.. +.|.+||.+.||.     +          .-.|.|++||++.+||
T Consensus         3 i~~~~pg~~~~~i~~~~~--~~~~~i~~~~~~~~-d~~~~~q~~~v~~-----~----------~~~y~~~~~d~~~Sia   64 (423)
T COG3858           3 IHLVGPGDSRLIIAVYFP--YTNNRIVNGNDYTN-DDLVDGQTFVVPP-----S----------GHFYDVGPGDTLTSIA   64 (423)
T ss_pred             EEEccCCceeeeehhhcc--cccccccccccccc-ccccCceeEEECC-----c----------ceEEEecCCcchhhhh
Confidence            478999999999999998  88888877777775 7899999999984     1          1579999999999999


Q ss_pred             cccCCChHHHHHhcCCCCCCCCcccccCcccccccCCC
Q 041830          208 AKFNTTPAAIIAANNKSLEGFKPEDLLAFTSILIPLNG  245 (600)
Q Consensus       208 ~~f~~~~~~~~~~n~~~~~g~~p~~l~~~~~~~vp~~~  245 (600)
                      .+|+++...+..+|....    |.-+..+--+.+|-..
T Consensus        65 ~~~~vt~~~~~~m~~~~~----~~~l~~~~~l~~P~~~   98 (423)
T COG3858          65 RTVGVTQDSAAIMNFVIC----PGYLQYGLNLYIPSAR   98 (423)
T ss_pred             hhhcCCHHHHHhhccccc----ccceeeeeEEeccCCC
Confidence            999999999999986532    2244444445555443

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=97.20  E-value=0.0019  Score=63.18  Aligned_cols=69  Identities=17%  Similarity=0.231  Sum_probs=44.3

Q ss_pred             EEEEEEEECCeEEEEEEcchh-HHHHHHHHHHHHHhCCCC--ceeeeeeEEecc--CCceEEEEeecCCCCHHH
Q 041830          392 GAVYHGRLNGKNLAIKRTEHE-VITKLEMQLVQHATHHHP--NIVRLLGTCLTD--GPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       392 G~Vy~g~~~g~~vAvK~~~~~-~~~~~e~ei~~~~~l~Hp--NIv~l~g~~~~~--~~~~~LV~Ey~~~GsL~~  460 (600)
                      +.||+...++..+++|..... ....++.|...+..+...  .+.++++++...  ....+++||++++..+..
T Consensus        11 n~~~~v~~~~~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~   84 (239)
T PF01636_consen   11 NRVYRVTTDDGRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDD   84 (239)
T ss_dssp             SEEEEEEETTSEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHH
T ss_pred             eeEEEEEECCcEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccc
Confidence            689999997789999997665 334455555555444321  345666644322  224689999999987777

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=97.15  E-value=8.6e-05  Score=81.56  Aligned_cols=84  Identities=21%  Similarity=0.428  Sum_probs=63.3

Q ss_pred             HHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCCC---------------------CCCccccc
Q 041830          490 LDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDT---------------------ESPQFYST  548 (600)
Q Consensus       490 ~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~~---------------------~~pe~~~~  548 (600)
                      .+++.||.|+|.  +.++||++|.|++|.++.++..||+.|+.+.......                     .+||+...
T Consensus       106 ~~v~dgl~flh~--sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~  183 (700)
T KOG2137|consen  106 GNVADGLAFLHR--SAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG  183 (700)
T ss_pred             hcccchhhhhcc--CcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence            345599999996  5689999999999999999999999999875443311                     12333332


Q ss_pred             CCCCCCccCchHHHHHHHHHHHh-CCCCCC
Q 041830          549 NPASWSMGIDIFAYGIVLLEVLS-GQTPIN  577 (600)
Q Consensus       549 ~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~  577 (600)
                        ...+.++|+||+||++|-+.. |+.-+.
T Consensus       184 --~~~~~~sd~fSlG~li~~i~~~gk~i~~  211 (700)
T KOG2137|consen  184 --TTNTPASDVFSLGVLIYTIYNGGKSIIA  211 (700)
T ss_pred             --ccccccccceeeeeEEEEEecCCcchhh
Confidence              344678999999999999984 554443

>smart00257 LysM Lysin motif

Probab=97.06  E-value=0.00098  Score=46.09  Aligned_cols=43  Identities=19%  Similarity=0.163  Sum_probs=37.5

Q ss_pred             eecCCCCCChhhHHHhhCCChHHHHhhhCCCCCCCCCCCCCcEEE
Q 041830           66 LRTNSYYSSLFNLSFYLGLNRFVIARANGFSADTEFLPKDQPLLI  110 (600)
Q Consensus        66 y~~~~~~~~l~~ia~~~~~~~~~i~~~N~~~~~~~~i~~~~~l~v  110 (600)
                      |++++ +||+++||..|+++...|..+|... ....+++|+.|.|
T Consensus         2 ~~v~~-gdt~~~ia~~~~~~~~~~~~~N~~~-~~~~~~~g~~l~i   44 (44)
T smart00257        2 YTVKK-GDTLSSIARRYGISVSDLLELNNIL-DPDNLQVGQKLKI   44 (44)
T ss_pred             eEeCC-CCCHHHHHHHhCCCHHHHHHHcCCC-CccccCCCCEEeC
Confidence            77888 9999999999999999999999853 5678899988764

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=97.04  E-value=0.0031  Score=65.79  Aligned_cols=99  Identities=13%  Similarity=0.259  Sum_probs=73.0

Q ss_pred             cCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEecc---Ccc--------ccCCCCCCCccc
Q 041830          478 CFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFG---MAR--------CVNDDTESPQFY  546 (600)
Q Consensus       478 ~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFG---la~--------~~~~~~~~pe~~  546 (600)
                      ....|...++.++.+|.+.+-||   +.+.+-+|+.++|+|+.++..+.+.|-.   +..        ........||..
T Consensus       112 P~~~w~fllrvaRnlA~aFA~lH---~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng~~~~cpVg~~eftPPElQ  188 (637)
T COG4248         112 PHCAWDFLLRVARNLASAFATLH---EHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINANGTLHLCPVGVSEFTPPELQ  188 (637)
T ss_pred             CccccHHHHHHHHHHHHHHHHHH---hcCCcccccCccceeeecCceEEEEcccceeeccCCceEecccCccccCCHHHh
Confidence            44799999999999999999999   6688999999999999999999888632   210        001112233432


Q ss_pred             cc---CCCCCCccCchHHHHHHHHHHHhC-CCCCCCC
Q 041830          547 ST---NPASWSMGIDIFAYGIVLLEVLSG-QTPINRP  579 (600)
Q Consensus       547 ~~---~~~~~t~~sDVwSfGvvL~ELltG-~~Pf~~~  579 (600)
                      .-   .....+...|-|-+||++++|+.| +.||...
T Consensus       189 ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI  225 (637)
T COG4248         189 TLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI  225 (637)
T ss_pred             ccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence            21   112335568999999999999885 9999764

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.03  E-value=0.0069  Score=59.56  Aligned_cols=125  Identities=15%  Similarity=0.210  Sum_probs=78.2

Q ss_pred             EEEEEEEE-CCeEEEEEEcchhHHH----------------------H-----HHHHHHHHHhCC--CCceeeeeeEEec
Q 041830          392 GAVYHGRL-NGKNLAIKRTEHEVIT----------------------K-----LEMQLVQHATHH--HPNIVRLLGTCLT  441 (600)
Q Consensus       392 G~Vy~g~~-~g~~vAvK~~~~~~~~----------------------~-----~e~ei~~~~~l~--HpNIv~l~g~~~~  441 (600)
                      ..||+|.. ++..+|||+.+.....                      +     .++|+..|.++.  +=.+-+-+++   
T Consensus        62 A~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP~Pi~~---  138 (268)
T COG1718          62 ANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVPEPIAF---  138 (268)
T ss_pred             eEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCCCceee---
Confidence            78999887 6899999985432110                      0     133444444332  2222333332   


Q ss_pred             cCCceEEEEeecCCCCH-HHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC
Q 041830          442 DGPHSFLVFEYAKNGSL-KDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLD  520 (600)
Q Consensus       442 ~~~~~~LV~Ey~~~GsL-~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld  520 (600)
                        ..-.|||||+..... .-.|.       +      .++...+...+..++.+.+.-|-.  ..++||+||+.=|||+.
T Consensus       139 --~~nVLvMEfIg~~g~pAP~Lk-------D------v~~e~~e~~~~~~~~v~~~~~l~~--~a~LVHgDLSEyNiL~~  201 (268)
T COG1718         139 --RNNVLVMEFIGDDGLPAPRLK-------D------VPLELEEAEGLYEDVVEYMRRLYK--EAGLVHGDLSEYNILVH  201 (268)
T ss_pred             --cCCeEEEEeccCCCCCCCCcc-------c------CCcCchhHHHHHHHHHHHHHHHHH--hcCcccccchhhheEEE
Confidence              123799999965310 00011       0      123333566677788888877763  35899999999999999


Q ss_pred             CCCcEEEEeccCccccC
Q 041830          521 EEFNARVGNFGMARCVN  537 (600)
Q Consensus       521 ~~~~~kI~DFGla~~~~  537 (600)
                       ++.+.|+|||-|....
T Consensus       202 -~~~p~iID~~QaV~~~  217 (268)
T COG1718         202 -DGEPYIIDVSQAVTID  217 (268)
T ss_pred             -CCeEEEEECccccccC
Confidence             8999999999887654

>COG1652 XkdP Uncharacterized protein containing LysM domain [Function unknown]

Probab=97.01  E-value=0.00026  Score=71.83  Aligned_cols=49  Identities=20%  Similarity=0.279  Sum_probs=45.3

Q ss_pred             ceeeeecCCchhhHH-HhcCCCchHHHHHhhCC---CCCCCCCCCCCeEeeee
Q 041830          127 LTKTTIKGESFYSIA-QSLEGLTTCGAIKERNP---SVSPWDLDDKARLQVPL  175 (600)
Q Consensus       127 ~~y~v~~gdt~~~ia-~~~~gl~t~~~l~~~N~---~~~~~~l~~G~~l~vp~  175 (600)
                      ++|+|+.|||+|.|| +.|++-+.+..|..+|.   +.+++.|.+||+|.||-
T Consensus       211 ~~~~v~rgDTl~~is~~~Yg~~~~y~~I~~aNk~~~~~~p~~I~pGq~l~iP~  263 (269)
T COG1652         211 TTNTVKRGDTLWQISKKVYGDGVEYRKIAEANKALVLDNPDKIKPGQVLRIPD  263 (269)
T ss_pred             eEEEeccCCcccccchhhcCcceEEEeHhhhhhhhccCCCCcCCCcceeeCCC
Confidence            489999999999999 89988889999999999   78899999999999984

>PLN02876 acyl-CoA dehydrogenase

Probab=96.89  E-value=0.0098  Score=70.02  Aligned_cols=66  Identities=11%  Similarity=0.243  Sum_probs=43.1

Q ss_pred             EEEEEEEECC----eEEEEEEcchh----HHHHHHHHHHHHHhCC-CCce--eeeeeEEeccC--CceEEEEeecCCCC
Q 041830          392 GAVYHGRLNG----KNLAIKRTEHE----VITKLEMQLVQHATHH-HPNI--VRLLGTCLTDG--PHSFLVFEYAKNGS  457 (600)
Q Consensus       392 G~Vy~g~~~g----~~vAvK~~~~~----~~~~~e~ei~~~~~l~-HpNI--v~l~g~~~~~~--~~~~LV~Ey~~~Gs  457 (600)
                      +.+|+-...+    ..+++|+....    ....+++|...+..+. |.++  .+++++|.+..  ...|+||||+++..
T Consensus        52 n~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~  130 (822)
T PLN02876         52 NPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRI  130 (822)
T ss_pred             CceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCcc
Confidence            5677766633    46778876432    1235678888777764 5554  77788775431  24689999998754

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=96.73  E-value=0.011  Score=58.42  Aligned_cols=33  Identities=18%  Similarity=0.352  Sum_probs=27.1

Q ss_pred             CCCceecCCCCCCEEeCCCCcEEEEeccCcccc
Q 041830          504 NPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV  536 (600)
Q Consensus       504 ~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~  536 (600)
                      .+.++|+|+.+.||+++++...-|.||+.+...
T Consensus       163 ~~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~g  195 (235)
T cd05155         163 PPVWFHGDLAPGNLLVQDGRLSAVIDFGCLGVG  195 (235)
T ss_pred             CceEEeCCCCCCcEEEECCCEEEEEeCcccCcC
Confidence            345899999999999987766779999987543

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK11198 LysM domain/BON superfamily protein; Provisional

Probab=96.66  E-value=0.0021  Score=58.72  Aligned_cols=46  Identities=22%  Similarity=0.106  Sum_probs=39.6

Q ss_pred             eeeecCCCCCChhhHHHhhCCC---hHHHHhhhC--CCCCCCCCCCCCcEEEe
Q 041830           64 AILRTNSYYSSLFNLSFYLGLN---RFVIARANG--FSADTEFLPKDQPLLIP  111 (600)
Q Consensus        64 ~~y~~~~~~~~l~~ia~~~~~~---~~~i~~~N~--~~~~~~~i~~~~~l~vP  111 (600)
                      -.|.+++ ||||+.||+.|..+   ...|..+|+  +. +.+.|.+||.|.||
T Consensus        96 ~~y~Vk~-GDTL~~IA~~~~g~~~~~~~I~~~N~~~l~-~~~~I~pGq~L~IP  146 (147)
T PRK11198         96 QFYTVKS-GDTLSAIAKKVYGNANKYNKIFEANKPMLK-SPDKIYPGQVLRIP  146 (147)
T ss_pred             eEEEECC-CCCHHHHHHHHcCChhhHHHHHHhhhhcCC-CcCCcCcCCEEecC
Confidence            4689998 99999999998643   468999997  75 67889999999998

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=96.64  E-value=0.029  Score=53.99  Aligned_cols=98  Identities=20%  Similarity=0.210  Sum_probs=63.5

Q ss_pred             HHHHHHHHHHHhCC------CCceeeeeeEEeccCCceEEEEeecCC------CCHHHHHhcCcCcccccccccccCCCH
Q 041830          415 TKLEMQLVQHATHH------HPNIVRLLGTCLTDGPHSFLVFEYAKN------GSLKDWLHGGLAMKNQFIASCYCFLTW  482 (600)
Q Consensus       415 ~~~e~ei~~~~~l~------HpNIv~l~g~~~~~~~~~~LV~Ey~~~------GsL~~~L~~~~~~~~~~~~~~~~~l~~  482 (600)
                      .+..+|+.....+.      +..|.+++|+..++. ..-+|+|.+.+      -+|.+++..+.             ++.
T Consensus        56 ~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~-G~Glv~e~I~d~dG~~s~TL~~~l~~~~-------------~~~  121 (199)
T PF10707_consen   56 RQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNL-GLGLVVELIRDADGNISPTLEDYLKEGG-------------LTE  121 (199)
T ss_pred             HHHHHHHHHHHHHhhccCCcccccccEeEEEecCC-ceEEEEEEEECCCCCcCccHHHHHHcCC-------------ccH
Confidence            44556655544444      789999999976553 67888888743      35888885432             444


Q ss_pred             HHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC---C-cEEEEe-ccCc
Q 041830          483 SQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEE---F-NARVGN-FGMA  533 (600)
Q Consensus       483 ~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~---~-~~kI~D-FGla  533 (600)
                       +..+.+.+.   ..||-   +..|+.+|++|+||++...   . .+.|.| ||-.
T Consensus       122 -~~~~~L~~f---~~~l~---~~~Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~~  170 (199)
T PF10707_consen  122 -ELRQALDEF---KRYLL---DHHIVIRDLNPHNIVVQRRDSGEFRLVLIDGLGEK  170 (199)
T ss_pred             -HHHHHHHHH---HHHHH---HcCCeecCCCcccEEEEecCCCceEEEEEeCCCCc
Confidence             333333333   34554   4579999999999999432   2 577777 4543

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>TIGR02721 ycfN_thiK thiamine kinase

Probab=96.63  E-value=0.011  Score=59.38  Aligned_cols=31  Identities=10%  Similarity=0.118  Sum_probs=26.4

Q ss_pred             CCceecCCCCCCEEeCCCCcEEEEeccCcccc
Q 041830          505 PSYVHRNIKSRNIFLDEEFNARVGNFGMARCV  536 (600)
Q Consensus       505 ~~ivHrDLk~~NILld~~~~~kI~DFGla~~~  536 (600)
                      ..++|+|+.+.||++++++ +.|.||..+...
T Consensus       146 ~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~g  176 (256)
T TIGR02721       146 LAPLHMDVHAYNLVVTPQG-LKLIDWEYASDG  176 (256)
T ss_pred             CeeecCCCCcCcEEEeCCC-CEEEeccccCcC
Confidence            4589999999999998877 789999987644

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>PRK10593 hypothetical protein; Provisional

Probab=96.38  E-value=0.038  Score=56.90  Aligned_cols=67  Identities=9%  Similarity=-0.027  Sum_probs=44.4

Q ss_pred             EEEEEEEECCeEEEEEEcchh-HHHHHHHHHHHHHhCCC---CceeeeeeEEecc--CCceEEEEeecCCCCH
Q 041830          392 GAVYHGRLNGKNLAIKRTEHE-VITKLEMQLVQHATHHH---PNIVRLLGTCLTD--GPHSFLVFEYAKNGSL  458 (600)
Q Consensus       392 G~Vy~g~~~g~~vAvK~~~~~-~~~~~e~ei~~~~~l~H---pNIv~l~g~~~~~--~~~~~LV~Ey~~~GsL  458 (600)
                      +.||+-...+..+.+|..+.. ....++.|...+..+.-   -.+.+++++|...  ....+||||+++++++
T Consensus        28 ~~vy~~~~~~~~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~  100 (297)
T PRK10593         28 AALWALYDSQGNPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSV  100 (297)
T ss_pred             eeEEEEEcCCCCEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEec
Confidence            788888765556777775542 23466777777766542   2567788776432  2357999999998754

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=96.32  E-value=0.036  Score=54.61  Aligned_cols=30  Identities=20%  Similarity=0.352  Sum_probs=26.4

Q ss_pred             CCceecCCCCCCEEeCC-CCcEEEEeccCcc
Q 041830          505 PSYVHRNIKSRNIFLDE-EFNARVGNFGMAR  534 (600)
Q Consensus       505 ~~ivHrDLk~~NILld~-~~~~kI~DFGla~  534 (600)
                      ..++|+|+.+.|||+++ +..+.+.||..+.
T Consensus       170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~  200 (235)
T cd05157         170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG  200 (235)
T ss_pred             EEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence            46899999999999998 5789999998765

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>TIGR03505 FimV_core FimV N-terminal domain

Probab=96.31  E-value=0.003  Score=50.23  Aligned_cols=41  Identities=22%  Similarity=0.350  Sum_probs=30.6

Q ss_pred             CchhhHHHhc--CC-CchHH---HHHhhCCC----CCCCCCCCCCeEeeee
Q 041830          135 ESFYSIAQSL--EG-LTTCG---AIKERNPS----VSPWDLDDKARLQVPL  175 (600)
Q Consensus       135 dt~~~ia~~~--~g-l~t~~---~l~~~N~~----~~~~~l~~G~~l~vp~  175 (600)
                      ||||.||..|  +| .+..|   +|.+.||-    .+.+.|++|++|.||-
T Consensus         1 DTLw~IA~~~~~~~~~s~~q~m~ai~~aNp~AF~~~nin~L~~G~~L~iP~   51 (74)
T TIGR03505         1 DTLWGIAQRVRPDNSVSLYQMMLALYRANPDAFIGGNINRLKVGQILRIPS   51 (74)
T ss_pred             CcHHHHHHHHccCCCCCHHHHHHHHHHHCHHhHhcCChhhcCCCCEEeCCC
Confidence            8999999666  33 44443   56688984    3567899999999985

This region is found at, or about 200 amino acids from, the N-terminus of FimV from Pseudomonas aeruginosa, TspA of Neisseria meningitidis, and related proteins. Disruption of FimV blocks twitching motility from type IV pili; Semmler, et al. suggest a role for this family in peptidoglycan layer remodelling required by type IV fimbrial systems. Most but not all members of this protein family have a C-terminal region recognized by TIGR03504. In between is a highly variable, often repeat-filled region rich in the negatively charged amino acids Asp and Glu.

>PRK10260 L,D-transpeptidase; Provisional

Probab=96.27  E-value=0.007  Score=61.17  Aligned_cols=56  Identities=18%  Similarity=0.240  Sum_probs=47.7

Q ss_pred             eecceeeeecCC--chhhHHHhcCCCchHHHHHhhCCCCCCCCCCCCCeEeeeeeccCCC
Q 041830          124 QADLTKTTIKGE--SFYSIAQSLEGLTTCGAIKERNPSVSPWDLDDKARLQVPLRCACPS  181 (600)
Q Consensus       124 ~~~~~y~v~~gd--t~~~ia~~~~gl~t~~~l~~~N~~~~~~~l~~G~~l~vp~~c~c~~  181 (600)
                      ..+..|+|++||  ++..||++|+  +...+|+++||..+++..++|++|+||.+=-=|.
T Consensus        38 G~~~~~~v~~~~~~~le~iA~~f~--~g~~~l~~aNPgvdp~lp~~G~~i~iP~~~ilP~   95 (306)
T PRK10260         38 GQNQVITIPEGNTQPLEYFAAEYQ--MGLSNMMEANPGVDTFLPKGGTVLNIPQQLILPD   95 (306)
T ss_pred             cccEEEEeCCCCCchHHHHHHHhC--CCHHHHHHhCcCCCCCcCCCCCEEEeCCccCCCC
Confidence            356789999966  5999999999  9999999999998888889999999997554443

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=96.26  E-value=0.02  Score=58.70  Aligned_cols=141  Identities=14%  Similarity=0.099  Sum_probs=74.9

Q ss_pred             EEEEEEEECCeEEEEEEcchhHHHHHHHHHHHHHhCCCC--ceeeeeeEE-----eccCCceEEEEeecCCCCHHH----
Q 041830          392 GAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATHHHP--NIVRLLGTC-----LTDGPHSFLVFEYAKNGSLKD----  460 (600)
Q Consensus       392 G~Vy~g~~~g~~vAvK~~~~~~~~~~e~ei~~~~~l~Hp--NIv~l~g~~-----~~~~~~~~LV~Ey~~~GsL~~----  460 (600)
                      ..+|+...++..+++|.........++.|+..+..+.+.  .+.+++...     ...++..++++||++|..+..    
T Consensus        28 n~~y~v~~~~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~  107 (296)
T cd05153          28 NTNYFVTTDSGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAGEHLTRPTAA  107 (296)
T ss_pred             cceEEEEeCCCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCCCCCCCCCHH
Confidence            578888777778999987643333444555544444321  244443321     111224689999998865421    


Q ss_pred             -------H---HhcCcC-cccccccccccCCCHHHHHH----------HHHHHHHHHHHHHh----cCCCCceecCCCCC
Q 041830          461 -------W---LHGGLA-MKNQFIASCYCFLTWSQRLR----------ICLDVAMALQYMHH----VMNPSYVHRNIKSR  515 (600)
Q Consensus       461 -------~---L~~~~~-~~~~~~~~~~~~l~~~~~~~----------i~~~ia~gL~yLH~----~~~~~ivHrDLk~~  515 (600)
                             .   ||.... ....  ........|.....          ....+...+.++..    .....++|+|+.+.
T Consensus       108 ~~~~lg~~La~lH~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~  185 (296)
T cd05153         108 HCRQIGEALARLHLAAQSFPGE--RNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVIHADLFRD  185 (296)
T ss_pred             HHHHHHHHHHHHHHHhccCCcc--CCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCCccCcCcc
Confidence                   1   111000 0000  00001123332210          11122334444442    12356999999999


Q ss_pred             CEEeCCCCcEEEEeccCcc
Q 041830          516 NIFLDEEFNARVGNFGMAR  534 (600)
Q Consensus       516 NILld~~~~~kI~DFGla~  534 (600)
                      ||+++++....|.||+.+.
T Consensus       186 Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         186 NVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             cEEEeCCceEEEeehhhhc
Confidence            9999998778999998765

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>PRK10190 L,D-transpeptidase; Provisional

Probab=96.20  E-value=0.008  Score=60.96  Aligned_cols=56  Identities=18%  Similarity=0.228  Sum_probs=47.9

Q ss_pred             eecceeeeecCC--chhhHHHhcCCCchHHHHHhhCCCCCCCCCCCCCeEeeeeeccCCC
Q 041830          124 QADLTKTTIKGE--SFYSIAQSLEGLTTCGAIKERNPSVSPWDLDDKARLQVPLRCACPS  181 (600)
Q Consensus       124 ~~~~~y~v~~gd--t~~~ia~~~~gl~t~~~l~~~N~~~~~~~l~~G~~l~vp~~c~c~~  181 (600)
                      ..+..|+|+++|  ++-+||++|+  +.+.+|+++||..+++..++|++|+||.+=-=|+
T Consensus        35 G~~~~~~v~~~~~~~le~iA~~f~--~g~~~l~~aNPgvd~~~p~~G~~i~iP~~~ilP~   92 (310)
T PRK10190         35 GQSLTVTVPDHNTQPLETFAAQYG--QGLSNMLEANPGADVFLPKSGSQLTIPQQLILPD   92 (310)
T ss_pred             cceEEEEecCCCCccHHHHHHHhC--CCHHHHHHhCCCCCCCCCCCCCEEEecCcccCCC
Confidence            346779999976  5889999999  9999999999999888889999999997654443

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	600
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		1e-26
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		1e-26
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-18
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		8e-18
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-17
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-17
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		1e-16
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		1e-16
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-14
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		5e-14
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		5e-14
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		6e-14
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		6e-14
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		8e-14
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		9e-14
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		9e-14
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-13
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-13
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		1e-13
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-13
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-13
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		2e-13
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		2e-13
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-13
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		6e-13
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		9e-13
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		9e-13
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-12
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-12
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		1e-12
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-12
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		2e-12
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-12
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		2e-12
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		2e-12
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		2e-12
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		2e-12
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		2e-12
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		2e-12
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-12
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		2e-12
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-12
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-12
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		3e-12
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		3e-12
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		3e-12
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		3e-12
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		3e-12
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		3e-12
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		3e-12
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		3e-12
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		3e-12
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		3e-12
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-12
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		4e-12
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		4e-12
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-12
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		4e-12
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		4e-12
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-12
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-12
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-12
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		4e-12
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		4e-12
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		4e-12
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		5e-12
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		5e-12
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		5e-12
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		5e-12
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-12
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		6e-12
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		7e-12
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		1e-11
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-11
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-11
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-11
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-11
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-11
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-11
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-11
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-11
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		2e-11
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-11
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-11
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		3e-11
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		3e-11
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		3e-11
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		3e-11
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-11
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		3e-11
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		3e-11
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-11
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		3e-11
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		3e-11
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		4e-11
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-11
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		4e-11
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-11
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-11
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		4e-11
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		4e-11
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		5e-11
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		5e-11
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		5e-11
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		5e-11
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		6e-11
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		6e-11
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		6e-11
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		6e-11
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		6e-11
4h58_A	275	Braf In Complex With Compound 3 Length = 275		6e-11
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		6e-11
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		6e-11
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		7e-11
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		7e-11
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		7e-11
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		7e-11
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		8e-11
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		8e-11
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		9e-11
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		9e-11
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		9e-11
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-10
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-10
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-10
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-10
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-10
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-10
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-10
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		1e-10
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		1e-10
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-10
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		1e-10
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		1e-10
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		1e-10
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		1e-10
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		2e-10
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-10
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		2e-10
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-10
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-10
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		2e-10
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		2e-10
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		3e-10
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-10
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		4e-10
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-10
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		5e-10
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-10
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		6e-10
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		7e-10
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-10
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		8e-10
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		8e-10
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		8e-10
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		8e-10
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		8e-10
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		8e-10
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		9e-10
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		9e-10
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		9e-10
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		1e-09
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-09
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		1e-09
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-09
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-09
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-09
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		1e-09
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-09
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		2e-09
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		2e-09
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-09
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-09
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-09
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-09
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-09
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-09
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		2e-09
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-09
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		2e-09
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-09
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-09
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-09
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-09
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-09
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-09
3b2t_A	311	Structure Of Phosphotransferase Length = 311		3e-09
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-09
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		3e-09
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-09
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-09
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		3e-09
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		3e-09
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		3e-09
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		3e-09
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-09
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		3e-09
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-09
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		4e-09
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		4e-09
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		4e-09
2pl0_A	289	Lck Bound To Imatinib Length = 289		4e-09
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		4e-09
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-09
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		4e-09
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		4e-09
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-09
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		5e-09
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		6e-09
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		7e-09
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		7e-09
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		8e-09
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		8e-09
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		9e-09
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-08
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		1e-08
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		1e-08
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		1e-08
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-08
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		1e-08
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		1e-08
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-08
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		1e-08
3a4o_X	286	Lyn Kinase Domain Length = 286		1e-08
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		1e-08
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-08
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		1e-08
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-08
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		1e-08
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-08
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-08
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		2e-08
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-08
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		2e-08
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		2e-08
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		2e-08
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-08
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		2e-08
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		2e-08
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-08
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		2e-08
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-08
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-08
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-08
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-08
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-08
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-08
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-08
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-08
4fl3_A	635	Structural And Biophysical Characterization Of The		3e-08
4fl2_A	636	Structural And Biophysical Characterization Of The		3e-08
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		3e-08
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		4e-08
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		4e-08
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		4e-08
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		4e-08
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		5e-08
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		5e-08
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-08
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		5e-08
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		5e-08
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-08
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		5e-08
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		5e-08
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		5e-08
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		6e-08
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		6e-08
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		6e-08
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		6e-08
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		6e-08
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		7e-08
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		7e-08
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		7e-08
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		7e-08
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		7e-08
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		7e-08
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		8e-08
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		8e-08
4fie_A	423	Full-Length Human Pak4 Length = 423		9e-08
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		9e-08
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-07
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		1e-07
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		1e-07
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		1e-07
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		1e-07
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		2e-07
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		2e-07
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-07
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-07
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		2e-07
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-07
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		2e-07
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		2e-07
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-07
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		2e-07
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-07
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		2e-07
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		2e-07
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-07
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		2e-07
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		2e-07
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		2e-07
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		2e-07
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-07
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-07
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		3e-07
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-07
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		3e-07
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-07
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-07
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		3e-07
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-07
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		3e-07
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		3e-07
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		3e-07
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		3e-07
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-07
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-07
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-07
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		3e-07
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-07
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		3e-07
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-07
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		3e-07
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		4e-07
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		4e-07
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		4e-07
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		4e-07
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		4e-07
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		4e-07
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		4e-07
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		5e-07
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		5e-07
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		5e-07
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		5e-07
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		5e-07
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		5e-07
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		6e-07
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		6e-07
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		7e-07
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		9e-07
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-07
3g51_A	325	Structural Diversity Of The Active Conformation Of		9e-07
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-06
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		1e-06
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-06
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		1e-06
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		1e-06
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		1e-06
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-06
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-06
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-06
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-06
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-06
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		1e-06
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-06
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-06
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-06
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-06
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-06
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-06
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-06
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-06
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		2e-06
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		2e-06
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-06
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		2e-06
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-06
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		2e-06
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-06
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		2e-06
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-06
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		2e-06
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		2e-06
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-06
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-06
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		3e-06
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-06
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-06
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		3e-06
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		3e-06
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		4e-06
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		4e-06
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		4e-06
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		4e-06
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		4e-06
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		5e-06
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		5e-06
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		5e-06
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		5e-06
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-06
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		6e-06
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		6e-06
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		6e-06
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		6e-06
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		7e-06
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		7e-06
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-06
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		7e-06
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		8e-06
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		9e-06
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		9e-06
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		1e-05
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		1e-05
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		1e-05
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		1e-05
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		1e-05
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-05
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		1e-05
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		1e-05
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-05
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-05
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-05
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		1e-05
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-05
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-05
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-05
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		1e-05
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-05
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-05
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-05
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-05
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		2e-05
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		2e-05
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		2e-05
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		2e-05
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-05
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		2e-05
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		2e-05
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-05
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		2e-05
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		2e-05
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		2e-05
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		2e-05
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		2e-05
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		2e-05
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		2e-05
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		2e-05
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		2e-05
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-05
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		2e-05
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		2e-05
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-05
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		3e-05
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		3e-05
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		3e-05
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		3e-05
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		3e-05
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		3e-05
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-05
3a7f_A	303	Human Mst3 Kinase Length = 303		3e-05
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		3e-05
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		3e-05
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		3e-05
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-05
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		3e-05
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		3e-05
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		3e-05
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		3e-05
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-05
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		3e-05
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		3e-05
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		3e-05
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		3e-05
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		3e-05
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-05
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-05
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		3e-05
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		3e-05
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		3e-05
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-05
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		3e-05
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		3e-05
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		3e-05
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		4e-05
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		4e-05
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		4e-05
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		4e-05
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		4e-05
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		4e-05
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		4e-05
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		4e-05
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		4e-05
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		5e-05
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-05
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		5e-05
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		5e-05
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		5e-05
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		5e-05
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		5e-05
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-05
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		6e-05
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		6e-05
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		7e-05
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		7e-05
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		7e-05
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		7e-05
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		7e-05
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		7e-05
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		7e-05
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		7e-05
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		7e-05
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		7e-05
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		7e-05
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		7e-05
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		8e-05
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-05
3gni_B	389	Structure Of Strad And Mo25 Length = 389		8e-05
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		8e-05
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		8e-05
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		8e-05
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		8e-05
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		9e-05
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		9e-05
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		9e-05
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		9e-05
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		9e-05
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		9e-05
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		9e-05
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		9e-05
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		9e-05
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		9e-05
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		9e-05
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-04
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-04
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-04
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		1e-04
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		1e-04
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		1e-04
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-04
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		1e-04
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		1e-04
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		1e-04
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-04
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-04
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		2e-04
3kk8_A	284	Camkii Substrate Complex A Length = 284		2e-04
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		2e-04
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-04
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		2e-04
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		2e-04
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-04
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-04
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		2e-04
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-04
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-04
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-04
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-04
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-04
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-04
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-04
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		2e-04
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-04
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		2e-04
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-04
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		2e-04
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		2e-04
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		2e-04
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		3e-04
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		3e-04
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		3e-04
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		3e-04
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-04
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		3e-04
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		3e-04
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-04
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-04
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		3e-04
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-04
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-04
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		3e-04
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		3e-04
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		3e-04
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		3e-04
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		3e-04
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		3e-04
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		3e-04
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-04
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		3e-04
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-04
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-04
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-04
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		4e-04
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		4e-04
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		4e-04
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		4e-04
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		4e-04
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		4e-04
3soa_A	444	Full-Length Human Camkii Length = 444		4e-04
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-04
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-04
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		4e-04
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		4e-04
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		4e-04
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-04
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		4e-04
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		4e-04
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		5e-04
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		5e-04
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		5e-04
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		5e-04
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		5e-04
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-04
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		5e-04
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		5e-04
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		5e-04
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		5e-04
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		5e-04
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		5e-04
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		5e-04
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-04
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		6e-04
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		6e-04
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		6e-04
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		6e-04
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-04
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		6e-04
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-04
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		6e-04
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-04
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		6e-04
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		6e-04
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		6e-04
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		6e-04
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		6e-04
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		6e-04
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		6e-04
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		6e-04
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		7e-04
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		7e-04
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		7e-04
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		7e-04
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		7e-04
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		7e-04
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		7e-04
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		7e-04
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		7e-04
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		7e-04
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		7e-04
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		7e-04
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		7e-04
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		7e-04
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		7e-04
2oza_B	366	Structure Of P38alpha Complex Length = 366		7e-04
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		7e-04
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		7e-04
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		7e-04
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		7e-04
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		7e-04
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		7e-04
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		7e-04
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		7e-04
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		7e-04
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		7e-04
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		7e-04
3hec_A	348	P38 In Complex With Imatinib Length = 348		7e-04
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		7e-04
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		7e-04
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		7e-04
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		7e-04
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		7e-04
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		7e-04
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		7e-04
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		7e-04
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		7e-04
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		7e-04
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		7e-04
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		7e-04
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		8e-04
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		8e-04
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		8e-04
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		8e-04
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		8e-04
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		8e-04
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		8e-04
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		9e-04
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		9e-04

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score =  118 bits (295), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 83/267 (31%), Positives = 133/267 (49%), Gaps = 51/267 (19%)
Query: 363 EQHKRLLESYSIEDLRRATEKFNSSNRIE----GAVYHGRL-NGKNLAIKRTEHEVITKL 417
           E H   L+ +S+ +L+ A++ F + N +     G VY GRL +G  +A+KR + E     
Sbjct: 11  EVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGG 70
Query: 418 EMQ------LVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQ 471
           E+Q      ++  A H   N++RL G C+T      LV+ Y  NGS              
Sbjct: 71  ELQFQTEVEMISMAVHR--NLLRLRGFCMTP-TERLLVYPYMANGS-------------- 113
Query: 472 FIASCYCF-------LTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFN 524
            +ASC          L W +R RI L  A  L Y+H   +P  +HR++K+ NI LDEEF 
Sbjct: 114 -VASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 172
Query: 525 ARVGNFGMARCVNDDTE-------------SPQFYSTNPASWSMGIDIFAYGIVLLEVLS 571
           A VG+FG+A+ ++                 +P++ ST  +S     D+F YG++LLE+++
Sbjct: 173 AVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPEYLSTGKSSEK--TDVFGYGVMLLELIT 230
Query: 572 GQTPINRPRKKDEGSVWLSEKIKSILQ 598
           GQ   +  R  ++  V L + +K +L+
Sbjct: 231 GQRAFDLARLANDDDVMLLDWVKGLLK 257

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score =  117 bits (294), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 82/267 (30%), Positives = 136/267 (50%), Gaps = 51/267 (19%)
Query: 363 EQHKRLLESYSIEDLRRATEKFNSSNRIE----GAVYHGRL-NGKNLAIKRTEHE----- 412
           E H   L+ +S+ +L+ A++ F++ N +     G VY GRL +G  +A+KR + E     
Sbjct: 19  EVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGG 78
Query: 413 -VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQ 471
            +  + E++++  A H   N++RL G C+T      LV+ Y  NGS              
Sbjct: 79  ELQFQTEVEMISMAVHR--NLLRLRGFCMTP-TERLLVYPYMANGS-------------- 121
Query: 472 FIASCYCF-------LTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFN 524
            +ASC          L W +R RI L  A  L Y+H   +P  +HR++K+ NI LDEEF 
Sbjct: 122 -VASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFE 180
Query: 525 ARVGNFGMARCVNDDTE-------------SPQFYSTNPASWSMGIDIFAYGIVLLEVLS 571
           A VG+FG+A+ ++                 +P++ ST  +S     D+F YG++LLE+++
Sbjct: 181 AVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEYLSTGKSSEK--TDVFGYGVMLLELIT 238
Query: 572 GQTPINRPRKKDEGSVWLSEKIKSILQ 598
           GQ   +  R  ++  V L + +K +L+
Sbjct: 239 GQRAFDLARLANDDDVMLLDWVKGLLK 265

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 90.5 bits (223), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 71/250 (28%), Positives = 113/250 (45%), Gaps = 59/250 (23%)
Query: 369 LESYSIEDLRRATEKFN------SSNRIE----GAVYHGRLNGKNLAIKR-------TEH 411
             S+S  +L+  T  F+        N++     G VY G +N   +A+K+       T  
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE 71
Query: 412 EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQ 471
           E+  + + ++   A   H N+V LLG   +DG    LV+ Y  NGSL D L         
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFS-SDGDDLCLVYVYMPNGSLLDRL--------- 121
Query: 472 FIASCYCF---LTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVG 528
              SC      L+W  R +I    A  + ++H      ++HR+IKS NI LDE F A++ 
Sbjct: 122 ---SCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKIS 175
Query: 529 NFGMARCVNDDTESPQFYSTNPASWSMGI-----------------DIFAYGIVLLEVLS 571
           +FG+AR       S +F  T   S  +G                  DI+++G+VLLE+++
Sbjct: 176 DFGLARA------SEKFAQTVMXSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIIT 229
Query: 572 GQTPINRPRK 581
           G   ++  R+
Sbjct: 230 GLPAVDEHRE 239

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 89.0 bits (219), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 112/250 (44%), Gaps = 59/250 (23%)
Query: 369 LESYSIEDLRRATEKFN------SSNRIE----GAVYHGRLNGKNLAIKR-------TEH 411
             S+S  +L+  T  F+        N++     G VY G +N   +A+K+       T  
Sbjct: 12  FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE 71
Query: 412 EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQ 471
           E+  + + ++   A   H N+V LLG   +DG    LV+ Y  NGSL D L         
Sbjct: 72  ELKQQFDQEIKVMAKCQHENLVELLGFS-SDGDDLCLVYVYMPNGSLLDRL--------- 121
Query: 472 FIASCYCF---LTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVG 528
              SC      L+W  R +I    A  + ++H      ++HR+IKS NI LDE F A++ 
Sbjct: 122 ---SCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKIS 175
Query: 529 NFGMARCVNDDTESPQFYSTNPASWSMGI-----------------DIFAYGIVLLEVLS 571
           +FG+AR       S +F  T      +G                  DI+++G+VLLE+++
Sbjct: 176 DFGLARA------SEKFAQTVMXXRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIIT 229
Query: 572 GQTPINRPRK 581
           G   ++  R+
Sbjct: 230 GLPAVDEHRE 239

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 87.8 bits (216), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 70/250 (28%), Positives = 111/250 (44%), Gaps = 59/250 (23%)
Query: 369 LESYSIEDLRRATEKFN------SSNRIE----GAVYHGRLNGKNLAIKR-------TEH 411
             S+S  +L+  T  F+        N+      G VY G +N   +A+K+       T  
Sbjct: 3   FHSFSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE 62
Query: 412 EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQ 471
           E+  + + ++   A   H N+V LLG   +DG    LV+ Y  NGSL D L         
Sbjct: 63  ELKQQFDQEIKVXAKCQHENLVELLGFS-SDGDDLCLVYVYXPNGSLLDRL--------- 112
Query: 472 FIASCYCF---LTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVG 528
              SC      L+W  R +I    A  + ++H      ++HR+IKS NI LDE F A++ 
Sbjct: 113 ---SCLDGTPPLSWHXRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKIS 166
Query: 529 NFGMARCVNDDTESPQFYSTNPASWSMGI-----------------DIFAYGIVLLEVLS 571
           +FG+AR       S +F      S  +G                  DI+++G+VLLE+++
Sbjct: 167 DFGLARA------SEKFAQXVXXSRIVGTTAYXAPEALRGEITPKSDIYSFGVVLLEIIT 220
Query: 572 GQTPINRPRK 581
           G   ++  R+
Sbjct: 221 GLPAVDEHRE 230

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/244 (27%), Positives = 109/244 (44%), Gaps = 47/244 (19%)
Query: 369 LESYSIEDLRRATEKFN------SSNRIE----GAVYHGRLNGKNLAIKR-------TEH 411
             S+S  +L+  T  F+        N++     G VY G +N   +A+K+       T  
Sbjct: 6   FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTE 65
Query: 412 EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQ 471
           E+  + + ++   A   H N+V LLG   +DG    LV+ Y  NGSL D L         
Sbjct: 66  ELKQQFDQEIKVMAKCQHENLVELLGFS-SDGDDLCLVYVYMPNGSLLDRL--------- 115
Query: 472 FIASCYCF---LTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVG 528
              SC      L+W  R +I    A  + ++H      ++HR+IKS NI LDE F A++ 
Sbjct: 116 ---SCLDGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKIS 169
Query: 529 NFGMARCVNDDTESPQFYSTNPASWSMG-----------IDIFAYGIVLLEVLSGQTPIN 577
           +FG+AR      +          +  M             DI+++G+VLLE+++G   ++
Sbjct: 170 DFGLARASEKFAQXVMXXRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVD 229
Query: 578 RPRK 581
             R+
Sbjct: 230 EHRE 233

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/250 (28%), Positives = 120/250 (48%), Gaps = 42/250 (16%)
Query: 369 LESYSIE--DLRRATEKFNS----SNRIEGAVYHGRL-NGKNLAIKRTEHEV---ITKLE 418
            ESY +   DL  AT  F+      + + G VY G L +G  +A+KR   E    I + E
Sbjct: 24  FESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFE 83
Query: 419 MQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYC 478
            ++   +   HP++V L+G C  +     L+++Y +NG+LK  L+G              
Sbjct: 84  TEIETLSFCRHPHLVSLIGFC-DERNEMILIYKYMENGNLKRHLYGSDLPTMS------- 135
Query: 479 FLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND 538
            ++W QRL IC+  A  L Y+H     + +HR++KS NI LDE F  ++ +FG+++    
Sbjct: 136 -MSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISK---K 188
Query: 539 DTESPQFYSTNPASWSMGI---------------DIFAYGIVLLEVLSGQTPI--NRPRK 581
            TE  Q +       ++G                D++++G+VL EVL  ++ I  + PR+
Sbjct: 189 GTELDQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE 248
Query: 582 KDEGSVWLSE 591
               + W  E
Sbjct: 249 MVNLAEWAVE 258

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/250 (28%), Positives = 120/250 (48%), Gaps = 42/250 (16%)
Query: 369 LESYSIE--DLRRATEKFNS----SNRIEGAVYHGRL-NGKNLAIKRTEHEV---ITKLE 418
            ESY +   DL  AT  F+      + + G VY G L +G  +A+KR   E    I + E
Sbjct: 24  FESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFE 83
Query: 419 MQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYC 478
            ++   +   HP++V L+G C  +     L+++Y +NG+LK  L+G              
Sbjct: 84  TEIETLSFCRHPHLVSLIGFC-DERNEMILIYKYMENGNLKRHLYGSDLPTMS------- 135
Query: 479 FLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND 538
            ++W QRL IC+  A  L Y+H     + +HR++KS NI LDE F  ++ +FG+++    
Sbjct: 136 -MSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISK---K 188
Query: 539 DTESPQFYSTNPASWSMGI---------------DIFAYGIVLLEVLSGQTPI--NRPRK 581
            TE  Q +       ++G                D++++G+VL EVL  ++ I  + PR+
Sbjct: 189 GTELGQTHLXXVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPRE 248
Query: 582 KDEGSVWLSE 591
               + W  E
Sbjct: 249 MVNLAEWAVE 258

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 102/204 (50%), Gaps = 34/204 (16%)
Query: 392 GAVYHGRLNGK-NLAIKRTEHEVITKLEMQLVQHA----THHHPNIVRLLGTCLTDGPHS 446
           G V +G+  G+ ++AIK  +   ++  E + ++ A       H  +V+L G C    P  
Sbjct: 38  GVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP-I 94
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           F++ EY  NG L ++L     M+++F           Q L +C DV  A++Y+    +  
Sbjct: 95  FIITEYMANGCLLNYLR---EMRHRFQTQ--------QLLEMCKDVCEAMEYLE---SKQ 140
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SM 555
           ++HR++ +RN  ++++   +V +FG++R V DD E+    S  P  W           S 
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSS 200
Query: 556 GIDIFAYGIVLLEVLS-GQTPINR 578
             DI+A+G+++ E+ S G+ P  R
Sbjct: 201 KSDIWAFGVLMWEIYSLGKMPYER 224

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 96/199 (48%), Gaps = 29/199 (14%)
Query: 392 GAVYHGRLNGKNLAIKRTEHEVITK-LEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVF 450
           G V   +   K++AIK+ E E   K   ++L Q +  +HPNIV+L G CL       LV 
Sbjct: 23  GVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNP---VCLVM 79
Query: 451 EYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHR 510
           EYA+ GSL + LHG   +          + T +  +  CL  +  + Y+H +   + +HR
Sbjct: 80  EYAEGGSLYNVLHGAEPLP---------YYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 130
Query: 511 NIKSRNIFLDEEFNA-RVGNFGMARCVNDDTESPQFYSTNPASW-----------SMGID 558
           ++K  N+ L       ++ +FG A C   D ++    +   A+W           S   D
Sbjct: 131 DLKPPNLLLVAGGTVLKICDFGTA-C---DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCD 186
Query: 559 IFAYGIVLLEVLSGQTPIN 577
           +F++GI+L EV++ + P +
Sbjct: 187 VFSWGIILWEVITRRKPFD 205

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 76.3 bits (186), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/196 (27%), Positives = 95/196 (48%), Gaps = 37/196 (18%)
Query: 398 RLNGKNLAIKRTEHEVITKLEMQLVQHATHH--------HPNIVRLLGTCLTDGPHSFLV 449
           R NG+  A+K  + E++ +L+   V+H            HP I+R+ GT   D    F++
Sbjct: 28  RHNGRYYAMKVLKKEIVVRLKQ--VEHTNDERLMLSIVTHPFIIRMWGT-FQDAQQIFMI 84
Query: 450 FEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVH 509
            +Y + G L   L       N  +A  Y             +V +AL+Y+H   +   ++
Sbjct: 85  MDYIEGGELFSLLRKSQRFPNP-VAKFYA-----------AEVCLALEYLH---SKDIIY 129
Query: 510 RNIKSRNIFLDEEFNARVGNFGMARCVND---------DTESPQFYSTNPASWSMGIDIF 560
           R++K  NI LD+  + ++ +FG A+ V D         D  +P+  ST P  ++  ID +
Sbjct: 130 RDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLCGTPDYIAPEVVSTKP--YNKSIDWW 187
Query: 561 AYGIVLLEVLSGQTPI 576
           ++GI++ E+L+G TP 
Sbjct: 188 SFGILIYEMLAGYTPF 203

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 57/199 (28%), Positives = 96/199 (48%), Gaps = 29/199 (14%)
Query: 392 GAVYHGRLNGKNLAIKRTEHEVITK-LEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVF 450
           G V   +   K++AIK+ E E   K   ++L Q +  +HPNIV+L G CL       LV 
Sbjct: 22  GVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLNP---VCLVM 78
Query: 451 EYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHR 510
           EYA+ GSL + LHG   +          + T +  +  CL  +  + Y+H +   + +HR
Sbjct: 79  EYAEGGSLYNVLHGAEPLP---------YYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 129
Query: 511 NIKSRNIFLDEEFNA-RVGNFGMARCVNDDTESPQFYSTNPASW-----------SMGID 558
           ++K  N+ L       ++ +FG A C   D ++    +   A+W           S   D
Sbjct: 130 DLKPPNLLLVAGGTVLKICDFGTA-C---DIQTHMTNNKGSAAWMAPEVFEGSNYSEKCD 185
Query: 559 IFAYGIVLLEVLSGQTPIN 577
           +F++GI+L EV++ + P +
Sbjct: 186 VFSWGIILWEVITRRKPFD 204

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 75.9 bits (185), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 81/165 (49%), Gaps = 24/165 (14%)
Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQ----FIASCYCFLTWS 483
           HHPNI+ LLG C   G + +L  EYA +G+L D+L     ++         S    L+  
Sbjct: 81  HHPNIINLLGACEHRG-YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 139
Query: 484 QRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESP 543
           Q L    DVA  + Y+       ++HRN+ +RNI + E + A++ +FG++R    +    
Sbjct: 140 QLLHFAADVARGMDYLSQ---KQFIHRNLAARNILVGENYVAKIADFGLSR--GQEVYVK 194
Query: 544 QFYSTNPASWSMGI------------DIFAYGIVLLEVLS-GQTP 575
           +     P  W M I            D+++YG++L E++S G TP
Sbjct: 195 KTMGRLPVRW-MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 238

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 75.5 bits (184), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 101/204 (49%), Gaps = 34/204 (16%)
Query: 392 GAVYHGRLNGK-NLAIKRTEHEVITKLEMQLVQHA----THHHPNIVRLLGTCLTDGPHS 446
           G V +G+  G+ ++AIK  +   ++  E + ++ A       H  +V+L G C    P  
Sbjct: 38  GVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP-I 94
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           F++ EY  NG L ++L     M+++F           Q L +C DV  A++Y+    +  
Sbjct: 95  FIITEYMANGCLLNYLR---EMRHRFQTQ--------QLLEMCKDVCEAMEYLE---SKQ 140
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SM 555
           ++HR++ +RN  ++++   +V +FG++R V DD  +    S  P  W           S 
Sbjct: 141 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 200
Query: 556 GIDIFAYGIVLLEVLS-GQTPINR 578
             DI+A+G+++ E+ S G+ P  R
Sbjct: 201 KSDIWAFGVLMWEIYSLGKMPYER 224

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 75.5 bits (184), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 101/206 (49%), Gaps = 38/206 (18%)
Query: 392 GAVYHGRLNGK-NLAIKR------TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGP 444
           G V +G+  G+ ++AIK       +E E I + ++ +       H  +V+L G C    P
Sbjct: 22  GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMM----NLSHEKLVQLYGVCTKQRP 77
Query: 445 HSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMN 504
             F++ EY  NG L ++L     M+++F           Q L +C DV  A++Y+    +
Sbjct: 78  -IFIITEYMANGCLLNYLR---EMRHRFQTQ--------QLLEMCKDVCEAMEYLE---S 122
Query: 505 PSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW----------- 553
             ++HR++ +RN  ++++   +V +FG++R V DD  +    S  P  W           
Sbjct: 123 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 182
Query: 554 SMGIDIFAYGIVLLEVLS-GQTPINR 578
           S   DI+A+G+++ E+ S G+ P  R
Sbjct: 183 SSKSDIWAFGVLMWEIYSLGKMPYER 208

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 101/206 (49%), Gaps = 38/206 (18%)
Query: 392 GAVYHGRLNGK-NLAIKR------TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGP 444
           G V +G+  G+ ++AIK       +E E I + ++ +       H  +V+L G C    P
Sbjct: 18  GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMM----NLSHEKLVQLYGVCTKQRP 73
Query: 445 HSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMN 504
             F++ EY  NG L ++L     M+++F           Q L +C DV  A++Y+    +
Sbjct: 74  -IFIITEYMANGCLLNYLR---EMRHRFQTQ--------QLLEMCKDVCEAMEYLE---S 118
Query: 505 PSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW----------- 553
             ++HR++ +RN  ++++   +V +FG++R V DD  +    S  P  W           
Sbjct: 119 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 178
Query: 554 SMGIDIFAYGIVLLEVLS-GQTPINR 578
           S   DI+A+G+++ E+ S G+ P  R
Sbjct: 179 SSKSDIWAFGVLMWEIYSLGKMPYER 204

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 101/204 (49%), Gaps = 34/204 (16%)
Query: 392 GAVYHGRLNGK-NLAIKRTEHEVITKLEMQLVQHA----THHHPNIVRLLGTCLTDGPHS 446
           G V +G+  G+ ++AIK  +   ++  E + ++ A       H  +V+L G C    P  
Sbjct: 29  GVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP-I 85
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           F++ EY  NG L ++L     M+++F           Q L +C DV  A++Y+    +  
Sbjct: 86  FIITEYMANGCLLNYLR---EMRHRFQTQ--------QLLEMCKDVCEAMEYLE---SKQ 131
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SM 555
           ++HR++ +RN  ++++   +V +FG++R V DD  +    S  P  W           S 
Sbjct: 132 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSS 191
Query: 556 GIDIFAYGIVLLEVLS-GQTPINR 578
             DI+A+G+++ E+ S G+ P  R
Sbjct: 192 KSDIWAFGVLMWEIYSLGKMPYER 215

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 75.1 bits (183), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/206 (27%), Positives = 101/206 (49%), Gaps = 38/206 (18%)
Query: 392 GAVYHGRLNGK-NLAIKR------TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGP 444
           G V +G+  G+ ++AIK       +E E I + ++ +       H  +V+L G C    P
Sbjct: 23  GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMM----NLSHEKLVQLYGVCTKQRP 78
Query: 445 HSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMN 504
             F++ EY  NG L ++L     M+++F           Q L +C DV  A++Y+    +
Sbjct: 79  -IFIITEYMANGCLLNYLR---EMRHRFQTQ--------QLLEMCKDVCEAMEYLE---S 123
Query: 505 PSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW----------- 553
             ++HR++ +RN  ++++   +V +FG++R V DD  +    S  P  W           
Sbjct: 124 KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKF 183
Query: 554 SMGIDIFAYGIVLLEVLS-GQTPINR 578
           S   DI+A+G+++ E+ S G+ P  R
Sbjct: 184 SSKSDIWAFGVLMWEIYSLGKMPYER 209

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 94/199 (47%), Gaps = 26/199 (13%)
Query: 392 GAVYHGRLNGKNLAIK-----RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHS 446
           G V+    +G ++A+K         E + +   ++       HPNIV  +G  +T  P+ 
Sbjct: 51  GTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG-AVTQPPNL 109
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
            +V EY   GSL   LH   A +          L   +RL +  DVA  + Y+H+  NP 
Sbjct: 110 SIVTEYLSRGSLYRLLHKSGAREQ---------LDERRRLSMAYDVAKGMNYLHN-RNPP 159
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASWSMGI--------- 557
            VHRN+KS N+ +D+++  +V +FG++R       S +  +  P   +  +         
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEK 219
Query: 558 -DIFAYGIVLLEVLSGQTP 575
            D++++G++L E+ + Q P
Sbjct: 220 SDVYSFGVILWELATLQQP 238

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 74.3 bits (181), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/204 (26%), Positives = 101/204 (49%), Gaps = 34/204 (16%)
Query: 392 GAVYHGRLNGK-NLAIKRTEHEVITKLEMQLVQHA----THHHPNIVRLLGTCLTDGPHS 446
           G V +G+  G+ ++AIK  +   ++  E + ++ A       H  +V+L G C    P  
Sbjct: 23  GVVKYGKWRGQYDVAIKMIKEGSMS--EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRP-I 79
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           F++ EY  NG L ++L     M+++F           Q L +C DV  A++Y+    +  
Sbjct: 80  FIITEYMANGCLLNYLR---EMRHRFQTQ--------QLLEMCKDVCEAMEYLE---SKQ 125
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SM 555
           ++HR++ +RN  ++++   +V +FG++R V DD  +    S  P  W           S 
Sbjct: 126 FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSS 185
Query: 556 GIDIFAYGIVLLEVLS-GQTPINR 578
             DI+A+G+++ E+ S G+ P  R
Sbjct: 186 KSDIWAFGVLMWEIYSLGKMPYER 209

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 81/165 (49%), Gaps = 24/165 (14%)
Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQ----FIASCYCFLTWS 483
           HHPNI+ LLG C   G + +L  EYA +G+L D+L     ++         S    L+  
Sbjct: 84  HHPNIINLLGACEHRG-YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 142
Query: 484 QRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESP 543
           Q L    DVA  + Y+       ++HR++ +RNI + E + A++ +FG++R    +    
Sbjct: 143 QLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVK 197
Query: 544 QFYSTNPASWSMGI------------DIFAYGIVLLEVLS-GQTP 575
           +     P  W M I            D+++YG++L E++S G TP
Sbjct: 198 KTMGRLPVRW-MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 241

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 81/165 (49%), Gaps = 24/165 (14%)
Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQ----FIASCYCFLTWS 483
           HHPNI+ LLG C   G + +L  EYA +G+L D+L     ++         S    L+  
Sbjct: 74  HHPNIINLLGACEHRG-YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQ 132
Query: 484 QRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESP 543
           Q L    DVA  + Y+       ++HR++ +RNI + E + A++ +FG++R    +    
Sbjct: 133 QLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVK 187
Query: 544 QFYSTNPASWSMGI------------DIFAYGIVLLEVLS-GQTP 575
           +     P  W M I            D+++YG++L E++S G TP
Sbjct: 188 KTMGRLPVRW-MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTP 231

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 93/203 (45%), Gaps = 38/203 (18%)
Query: 392 GAVYHGR-LNGKNLAIK------RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGP 444
           G V+ G  LN   +AIK       +E + I + E+ +       HP +V+L G CL   P
Sbjct: 21  GLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMM----KLSHPKLVQLYGVCLEQAP 76
Query: 445 HSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMN 504
              LVFE+ ++G L D+L      +  F A           L +CLDV   + Y+     
Sbjct: 77  IC-LVFEFMEHGCLSDYLR---TQRGLFAAETL--------LGMCLDVCEGMAYLE---E 121
Query: 505 PSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW----------- 553
            S +HR++ +RN  + E    +V +FGM R V DD  +    +  P  W           
Sbjct: 122 ASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 181
Query: 554 SMGIDIFAYGIVLLEVLS-GQTP 575
           S   D++++G+++ EV S G+ P
Sbjct: 182 SSKSDVWSFGVLMWEVFSEGKIP 204

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 72.8 bits (177), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 95/201 (47%), Gaps = 30/201 (14%)
Query: 392 GAVYHGRLNGKNLAIK-----RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHS 446
           G V+    +G ++A+K         E + +   ++       HPNIV  +G  +T  P+ 
Sbjct: 51  GTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMG-AVTQPPNL 109
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
            +V EY   GSL   LH   A +          L   +RL +  DVA  + Y+H+  NP 
Sbjct: 110 SIVTEYLSRGSLYRLLHKSGAREQ---------LDERRRLSMAYDVAKGMNYLHN-RNPP 159
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMAR------------CVNDDTESPQFYSTNPASWS 554
            VHR++KS N+ +D+++  +V +FG++R                +  +P+     P+  +
Sbjct: 160 IVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRDEPS--N 217
Query: 555 MGIDIFAYGIVLLEVLSGQTP 575
              D++++G++L E+ + Q P
Sbjct: 218 EKSDVYSFGVILWELATLQQP 238

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 69/271 (25%), Positives = 118/271 (43%), Gaps = 46/271 (16%)
Query: 342 DKKVSFEGSQSTIEGQIIDTAEQHKRLLESYSIEDLRRATEKFNSS----NRIE------ 391
           D++V FE     +E    D      RL++   +E    A ++F  S    N  E      
Sbjct: 141 DEEVYFENLMQLVEHYTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALNMKELKLLQT 200
Query: 392 ------GAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATH-HHPNIVRLLGTCLTDGP 444
                 G V  G   G  +A+K  +++   +  +      T   H N+V+LLG  + +  
Sbjct: 201 IGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG 260
Query: 445 HSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMN 504
             ++V EY   GSL D+L      + + +    C L +S      LDV  A++Y+     
Sbjct: 261 GLYIVTEYMAKGSLVDYLRS----RGRSVLGGDCLLKFS------LDVCEAMEYLE---G 307
Query: 505 PSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW----------- 553
            ++VHR++ +RN+ + E+  A+V +FG+ +    +  S Q     P  W           
Sbjct: 308 NNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKF 363
Query: 554 SMGIDIFAYGIVLLEVLS-GQTPINRPRKKD 583
           S   D++++GI+L E+ S G+ P  R   KD
Sbjct: 364 STKSDVWSFGILLWEIYSFGRVPYPRIPLKD 394

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 38/203 (18%)
Query: 392 GAVYHGR-LNGKNLAIK------RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGP 444
           G V+ G  LN   +AIK       +E + I + E+ +       HP +V+L G CL   P
Sbjct: 19  GLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMM----KLSHPKLVQLYGVCLEQAP 74
Query: 445 HSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMN 504
              LVFE+ ++G L D+L      +  F A           L +CLDV   + Y+     
Sbjct: 75  IC-LVFEFMEHGCLSDYLR---TQRGLFAAETL--------LGMCLDVCEGMAYLE---E 119
Query: 505 PSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW----------- 553
              +HR++ +RN  + E    +V +FGM R V DD  +    +  P  W           
Sbjct: 120 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 179
Query: 554 SMGIDIFAYGIVLLEVLS-GQTP 575
           S   D++++G+++ EV S G+ P
Sbjct: 180 SSKSDVWSFGVLMWEVFSEGKIP 202

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 72.0 bits (175), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 53/163 (32%), Positives = 81/163 (49%), Gaps = 33/163 (20%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HPNI+RL G      P   +V EY +NGSL  +L    A   QF        T  Q + +
Sbjct: 105 HPNIIRLEGVVTKSKP-VMIVTEYMENGSLDSFLRKHDA---QF--------TVIQLVGM 152
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYST 548
              +A  ++Y+  +    YVHR++ +RNI ++     +V +FG+AR + DD E+   Y+T
Sbjct: 153 LRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAA--YTT 207
Query: 549 N----PASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
                P  W           +   D+++YGIVL EV+S G+ P
Sbjct: 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 72.0 bits (175), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 38/203 (18%)
Query: 392 GAVYHGR-LNGKNLAIK------RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGP 444
           G V+ G  LN   +AIK       +E + I + E+ +       HP +V+L G CL   P
Sbjct: 21  GLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMM----KLSHPKLVQLYGVCLEQAP 76
Query: 445 HSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMN 504
              LVFE+ ++G L D+L      +  F A           L +CLDV   + Y+     
Sbjct: 77  IC-LVFEFMEHGCLSDYLR---TQRGLFAAETL--------LGMCLDVCEGMAYLE---E 121
Query: 505 PSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW----------- 553
              +HR++ +RN  + E    +V +FGM R V DD  +    +  P  W           
Sbjct: 122 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 181
Query: 554 SMGIDIFAYGIVLLEVLS-GQTP 575
           S   D++++G+++ EV S G+ P
Sbjct: 182 SSKSDVWSFGVLMWEVFSEGKIP 204

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 38/203 (18%)
Query: 392 GAVYHGR-LNGKNLAIK------RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGP 444
           G V+ G  LN   +AIK       +E + I + E+ +       HP +V+L G CL   P
Sbjct: 24  GLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMM----KLSHPKLVQLYGVCLEQAP 79
Query: 445 HSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMN 504
              LVFE+ ++G L D+L      +  F A           L +CLDV   + Y+     
Sbjct: 80  IC-LVFEFMEHGCLSDYLR---TQRGLFAAETL--------LGMCLDVCEGMAYLE---E 124
Query: 505 PSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW----------- 553
              +HR++ +RN  + E    +V +FGM R V DD  +    +  P  W           
Sbjct: 125 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 184
Query: 554 SMGIDIFAYGIVLLEVLS-GQTP 575
           S   D++++G+++ EV S G+ P
Sbjct: 185 SSKSDVWSFGVLMWEVFSEGKIP 207

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 99/201 (49%), Gaps = 22/201 (10%)
Query: 392 GAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVF 450
           G V  G   G  +A+K  +++   +  +      T   H N+V+LLG  + +    ++V 
Sbjct: 26  GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 85
Query: 451 EYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHR 510
           EY   GSL D+L      + + +    C L +S      LDV  A++Y+      ++VHR
Sbjct: 86  EYMAKGSLVDYLRS----RGRSVLGGDCLLKFS------LDVCEAMEYLE---GNNFVHR 132
Query: 511 NIKSRNIFLDEEFNARVGNFGM---ARCVNDDTESPQFYST----NPASWSMGIDIFAYG 563
           ++ +RN+ + E+  A+V +FG+   A    D  + P  ++       A++S   D++++G
Sbjct: 133 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREAAFSTKSDVWSFG 192
Query: 564 IVLLEVLS-GQTPINRPRKKD 583
           I+L E+ S G+ P  R   KD
Sbjct: 193 ILLWEIYSFGRVPYPRIPLKD 213

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 92/195 (47%), Gaps = 45/195 (23%)
Query: 401 GKNLAIKRTEH---EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSF-LVFEYAKNG 456
           G+ +A+K+ +H   E +   E ++    +  H NIV+  G C + G  +  L+ EY   G
Sbjct: 40  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 99
Query: 457 SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQY-------MHHVMNPSYVH 509
           SL+D+L                     Q+ +  +D    LQY       M ++    Y+H
Sbjct: 100 SLRDYL---------------------QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH 138
Query: 510 RNIKSRNIFLDEEFNARVGNFGMARCVNDDT---------ESPQFY----STNPASWSMG 556
           RN+ +RNI ++ E   ++G+FG+ + +  D          ESP F+    S   + +S+ 
Sbjct: 139 RNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVA 198
Query: 557 IDIFAYGIVLLEVLS 571
            D++++G+VL E+ +
Sbjct: 199 SDVWSFGVVLYELFT 213

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 92/203 (45%), Gaps = 38/203 (18%)
Query: 392 GAVYHGR-LNGKNLAIK------RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGP 444
           G V+ G  LN   +AIK       +E + I + E+ +       HP +V+L G CL   P
Sbjct: 41  GLVHLGYWLNKDKVAIKTIKEGSMSEDDFIEEAEVMM----KLSHPKLVQLYGVCLEQAP 96
Query: 445 HSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMN 504
              LVFE+ ++G L D+L      +  F A           L +CLDV   + Y+     
Sbjct: 97  IC-LVFEFMEHGCLSDYLR---TQRGLFAAETL--------LGMCLDVCEGMAYLE---E 141
Query: 505 PSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW----------- 553
              +HR++ +RN  + E    +V +FGM R V DD  +    +  P  W           
Sbjct: 142 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 201
Query: 554 SMGIDIFAYGIVLLEVLS-GQTP 575
           S   D++++G+++ EV S G+ P
Sbjct: 202 SSKSDVWSFGVLMWEVFSEGKIP 224

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 81/163 (49%), Gaps = 33/163 (20%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HPNI+RL G      P   +V EY +NGSL  +L    A   QF        T  Q + +
Sbjct: 93  HPNIIRLEGVVTKSKP-VMIVTEYMENGSLDSFLRKHDA---QF--------TVIQLVGM 140
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYST 548
              +A  ++Y+  +    YVHR++ +RNI ++     +V +FG++R + DD E+   Y+T
Sbjct: 141 LRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA--YTT 195
Query: 549 N----PASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
                P  W           +   D+++YGIVL EV+S G+ P
Sbjct: 196 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 238

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 81/163 (49%), Gaps = 33/163 (20%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HPNI+RL G      P   +V EY +NGSL  +L    A   QF        T  Q + +
Sbjct: 76  HPNIIRLEGVVTKSKP-VMIVTEYMENGSLDSFLRKHDA---QF--------TVIQLVGM 123
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYST 548
              +A  ++Y+  +    YVHR++ +RNI ++     +V +FG++R + DD E+   Y+T
Sbjct: 124 LRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA--YTT 178
Query: 549 N----PASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
                P  W           +   D+++YGIVL EV+S G+ P
Sbjct: 179 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/164 (29%), Positives = 77/164 (46%), Gaps = 33/164 (20%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL--HG-GLAMKNQFIASCYCFLTWSQR 485
           HP +V+  G C  + P  ++V EY  NG L ++L  HG GL                SQ 
Sbjct: 62  HPKLVKFYGVCSKEYP-IYIVTEYISNGCLLNYLRSHGKGLEP--------------SQL 106
Query: 486 LRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQF 545
           L +C DV   + ++    +  ++HR++ +RN  +D +   +V +FGM R V DD      
Sbjct: 107 LEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV 163
Query: 546 YSTNPASWSM-----------GIDIFAYGIVLLEVLS-GQTPIN 577
            +  P  WS              D++A+GI++ EV S G+ P +
Sbjct: 164 GTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYD 207

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 81/163 (49%), Gaps = 33/163 (20%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HPNI+RL G      P   +V EY +NGSL  +L    A   QF        T  Q + +
Sbjct: 105 HPNIIRLEGVVTKSKP-VMIVTEYMENGSLDSFLRKHDA---QF--------TVIQLVGM 152
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYST 548
              +A  ++Y+  +    YVHR++ +RNI ++     +V +FG++R + DD E+   Y+T
Sbjct: 153 LRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA--YTT 207
Query: 549 N----PASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
                P  W           +   D+++YGIVL EV+S G+ P
Sbjct: 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 81/163 (49%), Gaps = 33/163 (20%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HPNI+RL G      P   +V EY +NGSL  +L    A   QF        T  Q + +
Sbjct: 105 HPNIIRLEGVVTKSKP-VMIVTEYMENGSLDSFLRKHDA---QF--------TVIQLVGM 152
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYST 548
              +A  ++Y+  +    YVHR++ +RNI ++     +V +FG++R + DD E+   Y+T
Sbjct: 153 LRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA--YTT 207
Query: 549 N----PASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
                P  W           +   D+++YGIVL EV+S G+ P
Sbjct: 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 81/163 (49%), Gaps = 33/163 (20%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HPNI+RL G      P   +V EY +NGSL  +L    A   QF        T  Q + +
Sbjct: 105 HPNIIRLEGVVTKSKP-VMIVTEYMENGSLDSFLRKHDA---QF--------TVIQLVGM 152
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYST 548
              +A  ++Y+  +    YVHR++ +RNI ++     +V +FG++R + DD E+   Y+T
Sbjct: 153 LRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA--YTT 207
Query: 549 N----PASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
                P  W           +   D+++YGIVL EV+S G+ P
Sbjct: 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 81/163 (49%), Gaps = 33/163 (20%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HPNI+RL G      P   +V EY +NGSL  +L    A   QF        T  Q + +
Sbjct: 103 HPNIIRLEGVVTKSKP-VMIVTEYMENGSLDSFLRKHDA---QF--------TVIQLVGM 150
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYST 548
              +A  ++Y+  +    YVHR++ +RNI ++     +V +FG++R + DD E+   Y+T
Sbjct: 151 LRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA--YTT 205
Query: 549 N----PASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
                P  W           +   D+++YGIVL EV+S G+ P
Sbjct: 206 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 248

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 81/163 (49%), Gaps = 33/163 (20%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HPNI+RL G      P   +V EY +NGSL  +L    A   QF        T  Q + +
Sbjct: 105 HPNIIRLEGVVTKSKP-VMIVTEYMENGSLDSFLRKHDA---QF--------TVIQLVGM 152
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYST 548
              +A  ++Y+  +    YVHR++ +RNI ++     +V +FG++R + DD E+   Y+T
Sbjct: 153 LRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA--YTT 207
Query: 549 N----PASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
                P  W           +   D+++YGIVL EV+S G+ P
Sbjct: 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 30/205 (14%)
Query: 392 GAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVF 450
           G V  G   G  +A+K  +++   +  +      T   H N+V+LLG  + +    ++V 
Sbjct: 35  GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 94
Query: 451 EYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHR 510
           EY   GSL D+L      + + +    C L +S      LDV  A++Y+      ++VHR
Sbjct: 95  EYMAKGSLVDYLRS----RGRSVLGGDCLLKFS------LDVCEAMEYLE---GNNFVHR 141
Query: 511 NIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SMGIDI 559
           ++ +RN+ + E+  A+V +FG+ +    +  S Q     P  W           S   D+
Sbjct: 142 DLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 197
Query: 560 FAYGIVLLEVLS-GQTPINRPRKKD 583
           +++GI+L E+ S G+ P  R   KD
Sbjct: 198 WSFGILLWEIYSFGRVPYPRIPLKD 222

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/163 (31%), Positives = 80/163 (49%), Gaps = 33/163 (20%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HPNI+RL G      P   +V EY +NGSL  +L    A   QF        T  Q + +
Sbjct: 105 HPNIIRLEGVVTKSKP-VMIVTEYMENGSLDSFLRKHDA---QF--------TVIQLVGM 152
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYST 548
              +A  ++Y+  +    YVHR++ +RNI ++     +V +FG+ R + DD E+   Y+T
Sbjct: 153 LRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAA--YTT 207
Query: 549 N----PASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
                P  W           +   D+++YGIVL EV+S G+ P
Sbjct: 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 55/205 (26%), Positives = 96/205 (46%), Gaps = 30/205 (14%)
Query: 392 GAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVF 450
           G V  G   G  +A+K  +++   +  +      T   H N+V+LLG  + +    ++V 
Sbjct: 20  GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79
Query: 451 EYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHR 510
           EY   GSL D+L      + + +    C L +S      LDV  A++Y+      ++VHR
Sbjct: 80  EYMAKGSLVDYLRS----RGRSVLGGDCLLKFS------LDVCEAMEYLE---GNNFVHR 126
Query: 511 NIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SMGIDI 559
           ++ +RN+ + E+  A+V +FG+ +    +  S Q     P  W           S   D+
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVKWTAPEALREKKFSTKSDV 182
Query: 560 FAYGIVLLEVLS-GQTPINRPRKKD 583
           +++GI+L E+ S G+ P  R   KD
Sbjct: 183 WSFGILLWEIYSFGRVPYPRIPLKD 207

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/242 (28%), Positives = 112/242 (46%), Gaps = 45/242 (18%)
Query: 361 TAEQHKRLLESYS--IEDLRRATEKFNSSNRIEGAVYHGRLN--GKN---LAIKRTEHEV 413
           T E+  R   S++  IE  R   EK   S    G V +GRL   G+    +AIK  +   
Sbjct: 31  TYEEPGRAGRSFTREIEASRIHIEKIIGSGD-SGEVCYGRLRVPGQRDVPVAIKALKAGY 89
Query: 414 ITKLEMQLVQHAT----HHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMK 469
             +     +  A+      HPNI+RL G  +T G  + +V EY +NGSL  +L       
Sbjct: 90  TERQRRDFLSEASIMGQFDHPNIIRLEG-VVTRGRLAMIVTEYMENGSLDTFLR---THD 145
Query: 470 NQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGN 529
            QF        T  Q + +   V   ++Y+  +    YVHR++ +RN+ +D     +V +
Sbjct: 146 GQF--------TIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSD 194
Query: 530 FGMARCVNDDTESPQFYSTN----PASW-----------SMGIDIFAYGIVLLEVLS-GQ 573
           FG++R + DD ++   Y+T     P  W           S   D++++G+V+ EVL+ G+
Sbjct: 195 FGLSRVLEDDPDAA--YTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGE 252
Query: 574 TP 575
            P
Sbjct: 253 RP 254

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 45/211 (21%)
Query: 392 GAVYHGRL---NGKNL--AIKR----TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTD 442
           G VYHG L   +GK +  A+K     T+   +++   + +      HPN++ LLG CL  
Sbjct: 44  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 103
Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
                +V  Y K+G L++++       N  +     F          L VA  ++Y+   
Sbjct: 104 EGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGF---------GLQVAKGMKYL--- 149
Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN-------PASW-- 553
            +  +VHR++ +RN  LDE+F  +V +FG+AR    D    ++YS +       P  W  
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMA 205
Query: 554 ---------SMGIDIFAYGIVLLEVLSGQTP 575
                    +   D++++G++L E+++   P
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 45/211 (21%)
Query: 392 GAVYHGRL---NGKNL--AIKR----TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTD 442
           G VYHG L   +GK +  A+K     T+   +++   + +      HPN++ LLG CL  
Sbjct: 62  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 121
Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
                +V  Y K+G L++++       N  +     F          L VA  ++Y+   
Sbjct: 122 EGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGF---------GLQVAKGMKYL--- 167
Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN-------PASW-- 553
            +  +VHR++ +RN  LDE+F  +V +FG+AR    D    ++YS +       P  W  
Sbjct: 168 ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMA 223
Query: 554 ---------SMGIDIFAYGIVLLEVLSGQTP 575
                    +   D++++G++L E+++   P
Sbjct: 224 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 254

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 92/195 (47%), Gaps = 45/195 (23%)
Query: 401 GKNLAIKRTEH---EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSF-LVFEYAKNG 456
           G+ +A+K+ +H   E +   E ++    +  H NIV+  G C + G  +  L+ EY   G
Sbjct: 46  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 105
Query: 457 SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQY-------MHHVMNPSYVH 509
           SL+D+L                     Q+ +  +D    LQY       M ++    Y+H
Sbjct: 106 SLRDYL---------------------QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH 144
Query: 510 RNIKSRNIFLDEEFNARVGNFGMARCVNDDT---------ESPQFY----STNPASWSMG 556
           R++ +RNI ++ E   ++G+FG+ + +  D          ESP F+    S   + +S+ 
Sbjct: 145 RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVA 204
Query: 557 IDIFAYGIVLLEVLS 571
            D++++G+VL E+ +
Sbjct: 205 SDVWSFGVVLYELFT 219

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 92/195 (47%), Gaps = 45/195 (23%)
Query: 401 GKNLAIKRTEH---EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSF-LVFEYAKNG 456
           G+ +A+K+ +H   E +   E ++    +  H NIV+  G C + G  +  L+ EY   G
Sbjct: 70  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 129
Query: 457 SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQY-------MHHVMNPSYVH 509
           SL+D+L                     Q+ +  +D    LQY       M ++    Y+H
Sbjct: 130 SLRDYL---------------------QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH 168
Query: 510 RNIKSRNIFLDEEFNARVGNFGMARCVNDDT---------ESPQFY----STNPASWSMG 556
           R++ +RNI ++ E   ++G+FG+ + +  D          ESP F+    S   + +S+ 
Sbjct: 169 RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVA 228
Query: 557 IDIFAYGIVLLEVLS 571
            D++++G+VL E+ +
Sbjct: 229 SDVWSFGVVLYELFT 243

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 45/211 (21%)
Query: 392 GAVYHGRL---NGKNL--AIKR----TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTD 442
           G VYHG L   +GK +  A+K     T+   +++   + +      HPN++ LLG CL  
Sbjct: 63  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 122
Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
                +V  Y K+G L++++       N  +     F          L VA  ++Y+   
Sbjct: 123 EGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGF---------GLQVAKGMKYL--- 168
Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN-------PASW-- 553
            +  +VHR++ +RN  LDE+F  +V +FG+AR    D    ++YS +       P  W  
Sbjct: 169 ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMA 224
Query: 554 ---------SMGIDIFAYGIVLLEVLSGQTP 575
                    +   D++++G++L E+++   P
Sbjct: 225 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 255

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 92/195 (47%), Gaps = 45/195 (23%)
Query: 401 GKNLAIKRTEH---EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSF-LVFEYAKNG 456
           G+ +A+K+ +H   E +   E ++    +  H NIV+  G C + G  +  L+ EY   G
Sbjct: 42  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 101
Query: 457 SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQY-------MHHVMNPSYVH 509
           SL+D+L                     Q+ +  +D    LQY       M ++    Y+H
Sbjct: 102 SLRDYL---------------------QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH 140
Query: 510 RNIKSRNIFLDEEFNARVGNFGMARCVNDDT---------ESPQFY----STNPASWSMG 556
           R++ +RNI ++ E   ++G+FG+ + +  D          ESP F+    S   + +S+ 
Sbjct: 141 RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVA 200
Query: 557 IDIFAYGIVLLEVLS 571
            D++++G+VL E+ +
Sbjct: 201 SDVWSFGVVLYELFT 215

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 45/211 (21%)
Query: 392 GAVYHGRL---NGKNL--AIKR----TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTD 442
           G VYHG L   +GK +  A+K     T+   +++   + +      HPN++ LLG CL  
Sbjct: 36  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 95
Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
                +V  Y K+G L++++       N  +     F          L VA  ++Y+   
Sbjct: 96  EGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGF---------GLQVAKGMKYL--- 141
Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN-------PASW-- 553
            +  +VHR++ +RN  LDE+F  +V +FG+AR    D    ++YS +       P  W  
Sbjct: 142 ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMA 197
Query: 554 ---------SMGIDIFAYGIVLLEVLSGQTP 575
                    +   D++++G++L E+++   P
Sbjct: 198 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 228

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 92/195 (47%), Gaps = 45/195 (23%)
Query: 401 GKNLAIKRTEH---EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSF-LVFEYAKNG 456
           G+ +A+K+ +H   E +   E ++    +  H NIV+  G C + G  +  L+ EY   G
Sbjct: 44  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 103
Query: 457 SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQY-------MHHVMNPSYVH 509
           SL+D+L                     Q+ +  +D    LQY       M ++    Y+H
Sbjct: 104 SLRDYL---------------------QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH 142
Query: 510 RNIKSRNIFLDEEFNARVGNFGMARCVNDDT---------ESPQFY----STNPASWSMG 556
           R++ +RNI ++ E   ++G+FG+ + +  D          ESP F+    S   + +S+ 
Sbjct: 143 RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVA 202
Query: 557 IDIFAYGIVLLEVLS 571
            D++++G+VL E+ +
Sbjct: 203 SDVWSFGVVLYELFT 217

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 92/195 (47%), Gaps = 45/195 (23%)
Query: 401 GKNLAIKRTEH---EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSF-LVFEYAKNG 456
           G+ +A+K+ +H   E +   E ++    +  H NIV+  G C + G  +  L+ EY   G
Sbjct: 45  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 104
Query: 457 SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQY-------MHHVMNPSYVH 509
           SL+D+L                     Q+ +  +D    LQY       M ++    Y+H
Sbjct: 105 SLRDYL---------------------QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH 143
Query: 510 RNIKSRNIFLDEEFNARVGNFGMARCVNDDT---------ESPQFY----STNPASWSMG 556
           R++ +RNI ++ E   ++G+FG+ + +  D          ESP F+    S   + +S+ 
Sbjct: 144 RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVA 203
Query: 557 IDIFAYGIVLLEVLS 571
            D++++G+VL E+ +
Sbjct: 204 SDVWSFGVVLYELFT 218

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 45/211 (21%)
Query: 392 GAVYHGRL---NGKNL--AIKR----TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTD 442
           G VYHG L   +GK +  A+K     T+   +++   + +      HPN++ LLG CL  
Sbjct: 41  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 100
Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
                +V  Y K+G L++++       N  +     F          L VA  ++Y+   
Sbjct: 101 EGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGF---------GLQVAKGMKYL--- 146
Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN-------PASW-- 553
            +  +VHR++ +RN  LDE+F  +V +FG+AR    D    ++YS +       P  W  
Sbjct: 147 ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMA 202
Query: 554 ---------SMGIDIFAYGIVLLEVLSGQTP 575
                    +   D++++G++L E+++   P
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 233

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 92/195 (47%), Gaps = 45/195 (23%)
Query: 401 GKNLAIKRTEH---EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSF-LVFEYAKNG 456
           G+ +A+K+ +H   E +   E ++    +  H NIV+  G C + G  +  L+ EY   G
Sbjct: 39  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 98
Query: 457 SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQY-------MHHVMNPSYVH 509
           SL+D+L                     Q+ +  +D    LQY       M ++    Y+H
Sbjct: 99  SLRDYL---------------------QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH 137
Query: 510 RNIKSRNIFLDEEFNARVGNFGMARCVNDDT---------ESPQFY----STNPASWSMG 556
           R++ +RNI ++ E   ++G+FG+ + +  D          ESP F+    S   + +S+ 
Sbjct: 138 RDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVA 197
Query: 557 IDIFAYGIVLLEVLS 571
            D++++G+VL E+ +
Sbjct: 198 SDVWSFGVVLYELFT 212

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 92/195 (47%), Gaps = 45/195 (23%)
Query: 401 GKNLAIKRTEH---EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSF-LVFEYAKNG 456
           G+ +A+K+ +H   E +   E ++    +  H NIV+  G C + G  +  L+ EY   G
Sbjct: 39  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 98
Query: 457 SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQY-------MHHVMNPSYVH 509
           SL+D+L                     Q+ +  +D    LQY       M ++    Y+H
Sbjct: 99  SLRDYL---------------------QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH 137
Query: 510 RNIKSRNIFLDEEFNARVGNFGMARCVNDDT---------ESPQFY----STNPASWSMG 556
           R++ +RNI ++ E   ++G+FG+ + +  D          ESP F+    S   + +S+ 
Sbjct: 138 RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVA 197
Query: 557 IDIFAYGIVLLEVLS 571
            D++++G+VL E+ +
Sbjct: 198 SDVWSFGVVLYELFT 212

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 92/195 (47%), Gaps = 45/195 (23%)
Query: 401 GKNLAIKRTEH---EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSF-LVFEYAKNG 456
           G+ +A+K+ +H   E +   E ++    +  H NIV+  G C + G  +  L+ EY   G
Sbjct: 39  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 98
Query: 457 SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQY-------MHHVMNPSYVH 509
           SL+D+L                     Q+ +  +D    LQY       M ++    Y+H
Sbjct: 99  SLRDYL---------------------QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH 137
Query: 510 RNIKSRNIFLDEEFNARVGNFGMARCVNDDT---------ESPQFY----STNPASWSMG 556
           R++ +RNI ++ E   ++G+FG+ + +  D          ESP F+    S   + +S+ 
Sbjct: 138 RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVA 197
Query: 557 IDIFAYGIVLLEVLS 571
            D++++G+VL E+ +
Sbjct: 198 SDVWSFGVVLYELFT 212

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 92/195 (47%), Gaps = 45/195 (23%)
Query: 401 GKNLAIKRTEH---EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSF-LVFEYAKNG 456
           G+ +A+K+ +H   E +   E ++    +  H NIV+  G C + G  +  L+ EY   G
Sbjct: 37  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 96
Query: 457 SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQY-------MHHVMNPSYVH 509
           SL+D+L                     Q+ +  +D    LQY       M ++    Y+H
Sbjct: 97  SLRDYL---------------------QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH 135
Query: 510 RNIKSRNIFLDEEFNARVGNFGMARCVNDDT---------ESPQFY----STNPASWSMG 556
           R++ +RNI ++ E   ++G+FG+ + +  D          ESP F+    S   + +S+ 
Sbjct: 136 RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVA 195
Query: 557 IDIFAYGIVLLEVLS 571
            D++++G+VL E+ +
Sbjct: 196 SDVWSFGVVLYELFT 210

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 70.1 bits (170), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 92/195 (47%), Gaps = 45/195 (23%)
Query: 401 GKNLAIKRTEH---EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSF-LVFEYAKNG 456
           G+ +A+K+ +H   E +   E ++    +  H NIV+  G C + G  +  L+ EY   G
Sbjct: 38  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 97
Query: 457 SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQY-------MHHVMNPSYVH 509
           SL+D+L                     Q+ +  +D    LQY       M ++    Y+H
Sbjct: 98  SLRDYL---------------------QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH 136
Query: 510 RNIKSRNIFLDEEFNARVGNFGMARCVNDDT---------ESPQFY----STNPASWSMG 556
           R++ +RNI ++ E   ++G+FG+ + +  D          ESP F+    S   + +S+ 
Sbjct: 137 RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVA 196
Query: 557 IDIFAYGIVLLEVLS 571
            D++++G+VL E+ +
Sbjct: 197 SDVWSFGVVLYELFT 211

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 92/195 (47%), Gaps = 45/195 (23%)
Query: 401 GKNLAIKRTEH---EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSF-LVFEYAKNG 456
           G+ +A+K+ +H   E +   E ++    +  H NIV+  G C + G  +  L+ EY   G
Sbjct: 43  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 102
Query: 457 SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQY-------MHHVMNPSYVH 509
           SL+D+L                     Q+ +  +D    LQY       M ++    Y+H
Sbjct: 103 SLRDYL---------------------QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH 141
Query: 510 RNIKSRNIFLDEEFNARVGNFGMARCVNDDT---------ESPQFY----STNPASWSMG 556
           R++ +RNI ++ E   ++G+FG+ + +  D          ESP F+    S   + +S+ 
Sbjct: 142 RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVA 201
Query: 557 IDIFAYGIVLLEVLS 571
            D++++G+VL E+ +
Sbjct: 202 SDVWSFGVVLYELFT 216

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 45/211 (21%)
Query: 392 GAVYHGRL---NGKNL--AIKR----TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTD 442
           G VYHG L   +GK +  A+K     T+   +++   + +      HPN++ LLG CL  
Sbjct: 43  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 102
Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
                +V  Y K+G L++++       N  +     F          L VA  ++Y+   
Sbjct: 103 EGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGF---------GLQVAKGMKYL--- 148
Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN-------PASW-- 553
            +  +VHR++ +RN  LDE+F  +V +FG+AR    D    ++YS +       P  W  
Sbjct: 149 ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMA 204
Query: 554 ---------SMGIDIFAYGIVLLEVLSGQTP 575
                    +   D++++G++L E+++   P
Sbjct: 205 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 45/211 (21%)
Query: 392 GAVYHGRL---NGKNL--AIKR----TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTD 442
           G VYHG L   +GK +  A+K     T+   +++   + +      HPN++ LLG CL  
Sbjct: 42  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 101
Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
                +V  Y K+G L++++       N  +     F          L VA  ++Y+   
Sbjct: 102 EGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGF---------GLQVAKGMKYL--- 147
Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN-------PASW-- 553
            +  +VHR++ +RN  LDE+F  +V +FG+AR    D    ++YS +       P  W  
Sbjct: 148 ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMA 203
Query: 554 ---------SMGIDIFAYGIVLLEVLSGQTP 575
                    +   D++++G++L E+++   P
Sbjct: 204 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/193 (24%), Positives = 95/193 (49%), Gaps = 32/193 (16%)
Query: 397 GRLNGKNLAIKRTEHEV----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSF-LVFE 451
           G   G+ +A+K  + E     I  L+ ++      +H NIV+  G C  DG +   L+ E
Sbjct: 46  GDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIME 105
Query: 452 YAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRN 511
           +  +GSLK++L      KN+        +   Q+L+  + +   + Y+    +  YVHR+
Sbjct: 106 FLPSGSLKEYLPKN---KNK--------INLKQQLKYAVQICKGMDYLG---SRQYVHRD 151
Query: 512 IKSRNIFLDEEFNARVGNFGMARC---------VNDDTESPQFYSTNP----ASWSMGID 558
           + +RN+ ++ E   ++G+FG+ +          V DD +SP F+        + + +  D
Sbjct: 152 LAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASD 211
Query: 559 IFAYGIVLLEVLS 571
           ++++G+ L E+L+
Sbjct: 212 VWSFGVTLHELLT 224

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 48/183 (26%), Positives = 83/183 (45%), Gaps = 41/183 (22%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HPN+++ +G    D   +F+  EY K G+L+  +    +M +Q+         WSQR+  
Sbjct: 66  HPNVLKFIGVLYKDKRLNFIT-EYIKGGTLRGIIK---SMDSQY--------PWSQRVSF 113
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYST 548
             D+A  + Y+H +   + +HR++ S N  + E  N  V +FG+AR + D+   P+   +
Sbjct: 114 AKDIASGMAYLHSM---NIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRS 170
Query: 549 ------------------------NPASWSMGIDIFAYGIVLLEVLS--GQTPINRPRKK 582
                                   N  S+   +D+F++GIVL E++      P   PR  
Sbjct: 171 LKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTM 230
Query: 583 DEG 585
           D G
Sbjct: 231 DFG 233

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 45/211 (21%)
Query: 392 GAVYHGRL---NGKNL--AIKR----TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTD 442
           G VYHG L   +GK +  A+K     T+   +++   + +      HPN++ LLG CL  
Sbjct: 39  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 98
Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
                +V  Y K+G L++++       N  +     F          L VA  ++Y+   
Sbjct: 99  EGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGF---------GLQVAKGMKYL--- 144
Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN-------PASW-- 553
            +  +VHR++ +RN  LDE+F  +V +FG+AR    D    ++YS +       P  W  
Sbjct: 145 ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMA 200
Query: 554 ---------SMGIDIFAYGIVLLEVLSGQTP 575
                    +   D++++G++L E+++   P
Sbjct: 201 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 231

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 97/211 (45%), Gaps = 45/211 (21%)
Query: 392 GAVYHGRL---NGKNL--AIKR----TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTD 442
           G VYHG L   +GK +  A+K     T+   +++   + +      HPN++ LLG CL  
Sbjct: 44  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 103
Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
                +V  Y K+G L++++       N  +     F          L VA  ++Y+   
Sbjct: 104 EGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGF---------GLQVAKGMKYL--- 149
Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN-------PASW-- 553
            +  +VHR++ +RN  LDE+F  +V +FG+AR    D    ++YS +       P  W  
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVKWMA 205
Query: 554 ---------SMGIDIFAYGIVLLEVLSGQTP 575
                    +   D++++G++L E+++   P
Sbjct: 206 LESLQTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 92/195 (47%), Gaps = 45/195 (23%)
Query: 401 GKNLAIKRTEH---EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSF-LVFEYAKNG 456
           G+ +A+K+ +H   E +   E ++    +  H NIV+  G C + G  +  L+ EY   G
Sbjct: 57  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 116
Query: 457 SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQY-------MHHVMNPSYVH 509
           SL+D+L                     Q+ +  +D    LQY       M ++    Y+H
Sbjct: 117 SLRDYL---------------------QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH 155
Query: 510 RNIKSRNIFLDEEFNARVGNFGMARCVNDDT---------ESPQFY----STNPASWSMG 556
           R++ +RNI ++ E   ++G+FG+ + +  D          ESP F+    S   + +S+ 
Sbjct: 156 RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVA 215
Query: 557 IDIFAYGIVLLEVLS 571
            D++++G+VL E+ +
Sbjct: 216 SDVWSFGVVLYELFT 230

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 69.7 bits (169), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 92/195 (47%), Gaps = 45/195 (23%)
Query: 401 GKNLAIKRTEH---EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSF-LVFEYAKNG 456
           G+ +A+K+ +H   E +   E ++    +  H NIV+  G C + G  +  L+ EY   G
Sbjct: 57  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 116
Query: 457 SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQY-------MHHVMNPSYVH 509
           SL+D+L                     Q+ +  +D    LQY       M ++    Y+H
Sbjct: 117 SLRDYL---------------------QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH 155
Query: 510 RNIKSRNIFLDEEFNARVGNFGMARCVNDDT---------ESPQFY----STNPASWSMG 556
           R++ +RNI ++ E   ++G+FG+ + +  D          ESP F+    S   + +S+ 
Sbjct: 156 RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVA 215
Query: 557 IDIFAYGIVLLEVLS 571
            D++++G+VL E+ +
Sbjct: 216 SDVWSFGVVLYELFT 230

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 69.3 bits (168), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 67/240 (27%), Positives = 110/240 (45%), Gaps = 41/240 (17%)
Query: 361 TAEQHKRLLESYS--IEDLRRATEKFNSSNRIEGAVYHGRLN--GKN---LAIKRTEHEV 413
           T E+  R   S++  IE  R   EK   S    G V +GRL   G+    +AIK  +   
Sbjct: 31  TYEEPGRAGRSFTREIEASRIHIEKIIGSGD-SGEVCYGRLRVPGQRDVPVAIKALKAGY 89
Query: 414 ITKLEMQLVQHAT----HHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMK 469
             +     +  A+      HPNI+RL G  +T G  + +V EY +NGSL  +L       
Sbjct: 90  TERQRRDFLSEASIMGQFDHPNIIRLEG-VVTRGRLAMIVTEYMENGSLDTFLR---THD 145
Query: 470 NQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGN 529
            QF        T  Q + +   V   ++Y+  +    YVHR++ +RN+ +D     +V +
Sbjct: 146 GQF--------TIMQLVGMLRGVGAGMRYLSDL---GYVHRDLAARNVLVDSNLVCKVSD 194
Query: 530 FGMARCVNDDTESPQFYSTN--PASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
           FG++R + DD ++    +    P  W           S   D++++G+V+ EVL+ G+ P
Sbjct: 195 FGLSRVLEDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 81/163 (49%), Gaps = 33/163 (20%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HPNI+RL G      P   +V EY +NGSL  +L    A   QF        T  Q + +
Sbjct: 105 HPNIIRLEGVVTKSKP-VMIVTEYMENGSLDSFLRKHDA---QF--------TVIQLVGM 152
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYST 548
              +A  ++Y+  +    +VHR++ +RNI ++     +V +FG++R + DD E+   Y+T
Sbjct: 153 LRGIASGMKYLSDM---GFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA--YTT 207
Query: 549 N----PASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
                P  W           +   D+++YGIVL EV+S G+ P
Sbjct: 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 69.3 bits (168), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 48/193 (24%), Positives = 95/193 (49%), Gaps = 32/193 (16%)
Query: 397 GRLNGKNLAIKRTEHEV----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSF-LVFE 451
           G   G+ +A+K  + E     I  L+ ++      +H NIV+  G C  DG +   L+ E
Sbjct: 34  GDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIME 93
Query: 452 YAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRN 511
           +  +GSLK++L      KN+        +   Q+L+  + +   + Y+    +  YVHR+
Sbjct: 94  FLPSGSLKEYLPKN---KNK--------INLKQQLKYAVQICKGMDYLG---SRQYVHRD 139
Query: 512 IKSRNIFLDEEFNARVGNFGMARC---------VNDDTESPQFYST----NPASWSMGID 558
           + +RN+ ++ E   ++G+FG+ +          V DD +SP F+        + + +  D
Sbjct: 140 LAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAPECLMQSKFYIASD 199
Query: 559 IFAYGIVLLEVLS 571
           ++++G+ L E+L+
Sbjct: 200 VWSFGVTLHELLT 212

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 49/188 (26%), Positives = 91/188 (48%), Gaps = 31/188 (16%)
Query: 401 GKNLAIKRTEH---EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSF-LVFEYAKNG 456
           G+ +A+K+ +H   E +   E ++    +  H NIV+  G C + G  +  L+ EY   G
Sbjct: 42  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 101
Query: 457 SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRN 516
           SL+D+L       +      Y     SQ   IC       + M ++    Y+HR++ +RN
Sbjct: 102 SLRDYLQAHAERIDHIKLLQYT----SQ---IC-------KGMEYLGTKRYIHRDLATRN 147
Query: 517 IFLDEEFNARVGNFGMARCVNDDT---------ESPQFY----STNPASWSMGIDIFAYG 563
           I ++ E   ++G+FG+ + +  D          ESP F+    S   + +S+  D++++G
Sbjct: 148 ILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFG 207
Query: 564 IVLLEVLS 571
           +VL E+ +
Sbjct: 208 VVLYELFT 215

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 94/207 (45%), Gaps = 37/207 (17%)
Query: 392 GAVYHGRL---NGKNL--AIKR----TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTD 442
           G VYHG L   +GK +  A+K     T+   +++   + +      HPN++ LLG CL  
Sbjct: 43  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 102
Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
                +V  Y K+G L++++       N  +     F          L VA  ++Y+   
Sbjct: 103 EGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGF---------GLQVAKGMKYL--- 148
Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN---PASW------ 553
            +  +VHR++ +RN  LDE+F  +V +FG+AR + D         T    P  W      
Sbjct: 149 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESL 208
Query: 554 -----SMGIDIFAYGIVLLEVLSGQTP 575
                +   D++++G++L E+++   P
Sbjct: 209 QTQKFTTKSDVWSFGVLLWELMTRGAP 235

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 68.6 bits (166), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 63/248 (25%), Positives = 108/248 (43%), Gaps = 53/248 (21%)
Query: 366 KRLLESYSIEDLRRATEKFN-----SSNRIEGAVYHG----------RLNGKN---LAIK 407
           K  ++ ++ ED   A  +F      S  +IE  +  G          +L GK    +AIK
Sbjct: 8   KIFIDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIK 67
Query: 408 RTEHEVITKLEMQLVQHAT----HHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH 463
             +     K     +  A+      HPN++ L G      P   ++ E+ +NGSL  +L 
Sbjct: 68  TLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP-VMIITEFMENGSLDSFLR 126
Query: 464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEF 523
                  QF        T  Q + +   +A  ++Y+  +   +YVHR++ +RNI ++   
Sbjct: 127 QN---DGQF--------TVIQLVGMLRGIAAGMKYLADM---NYVHRDLAARNILVNSNL 172
Query: 524 NARVGNFGMARCVNDDTESPQFYST----NPASWSM-----------GIDIFAYGIVLLE 568
             +V +FG++R + DDT  P + S      P  W+              D+++YGIV+ E
Sbjct: 173 VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWE 232
Query: 569 VLS-GQTP 575
           V+S G+ P
Sbjct: 233 VMSYGERP 240

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 83/165 (50%), Gaps = 37/165 (22%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRL 486
           HPN+V L G  +T G    +V E+ +NG+L  +L  H G     QF        T  Q +
Sbjct: 103 HPNVVHLEGV-VTRGKPVMIVIEFMENGALDAFLRKHDG-----QF--------TVIQLV 148
Query: 487 RICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFY 546
            +   +A  ++Y+  +    YVHR++ +RNI ++     +V +FG++R + DD E+   Y
Sbjct: 149 GMLRGIAAGMRYLADM---GYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEA--VY 203
Query: 547 STN----PASWSM-----------GIDIFAYGIVLLEVLS-GQTP 575
           +T     P  W+              D+++YGIV+ EV+S G+ P
Sbjct: 204 TTTGGKIPVRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERP 248

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 38/203 (18%)
Query: 392 GAVYHGR-LNGKNLAIK------RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGP 444
           G V+ G  LN   +AIK       +E + I + E+ +       HP +V+L G CL   P
Sbjct: 22  GLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMM----KLSHPKLVQLYGVCLEQAP 77
Query: 445 HSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMN 504
              LV E+ ++G L D+L      +  F A           L +CLDV   + Y+     
Sbjct: 78  IC-LVTEFMEHGCLSDYLR---TQRGLFAAETL--------LGMCLDVCEGMAYLE---E 122
Query: 505 PSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW----------- 553
              +HR++ +RN  + E    +V +FGM R V DD  +    +  P  W           
Sbjct: 123 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRY 182
Query: 554 SMGIDIFAYGIVLLEVLS-GQTP 575
           S   D++++G+++ EV S G+ P
Sbjct: 183 SSKSDVWSFGVLMWEVFSEGKIP 205

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 96/200 (48%), Gaps = 30/200 (15%)
Query: 392 GAVYHGRLNGKNLAIK-RTEHEVITKLEMQLVQHATHH---HPNIVRLLGTCLTDGPHSF 447
           G VY G     +L +  +T  E   ++E  L + A      HPN+V+LLG C T  P  +
Sbjct: 25  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-TREPPFY 83
Query: 448 LVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSY 507
           ++ E+   G+L D+L        Q +++          L +   ++ A++Y+      ++
Sbjct: 84  IIIEFMTYGNLLDYLR---ECNRQEVSAVVL-------LYMATQISSAMEYLE---KKNF 130
Query: 508 VHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SMG 556
           +HR++ +RN  + E    +V +FG++R +  DT +    +  P  W           S+ 
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIK 190
Query: 557 IDIFAYGIVLLEVLS-GQTP 575
            D++A+G++L E+ + G +P
Sbjct: 191 SDVWAFGVLLWEIATYGMSP 210

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 67.8 bits (164), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 80/163 (49%), Gaps = 33/163 (20%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HPNI+RL G      P   +V E  +NGSL  +L    A   QF        T  Q + +
Sbjct: 76  HPNIIRLEGVVTKSKP-VMIVTEXMENGSLDSFLRKHDA---QF--------TVIQLVGM 123
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYST 548
              +A  ++Y+  +    YVHR++ +RNI ++     +V +FG++R + DD E+   Y+T
Sbjct: 124 LRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA--YTT 178
Query: 549 N----PASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
                P  W           +   D+++YGIVL EV+S G+ P
Sbjct: 179 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 221

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/203 (27%), Positives = 92/203 (45%), Gaps = 38/203 (18%)
Query: 396 HGRLNGKN---LAIKRTEHEVITKLEMQLVQHAT----HHHPNIVRLLGTCLTDGPHSFL 448
           H +L GK    +AIK  +     K     +  A+      HPN++ L G      P   +
Sbjct: 27  HLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTP-VMI 85
Query: 449 VFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYV 508
           + E+ +NGSL  +L        QF        T  Q + +   +A  ++Y+  +   +YV
Sbjct: 86  ITEFMENGSLDSFLRQN---DGQF--------TVIQLVGMLRGIAAGMKYLADM---NYV 131
Query: 509 HRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYST----NPASWSM--------- 555
           HR + +RNI ++     +V +FG++R + DDT  P + S      P  W+          
Sbjct: 132 HRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKF 191
Query: 556 --GIDIFAYGIVLLEVLS-GQTP 575
               D+++YGIV+ EV+S G+ P
Sbjct: 192 TSASDVWSYGIVMWEVMSYGERP 214

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 80/163 (49%), Gaps = 33/163 (20%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HPNI+RL G      P   +V E  +NGSL  +L    A   QF        T  Q + +
Sbjct: 105 HPNIIRLEGVVTKSKP-VMIVTEXMENGSLDSFLRKHDA---QF--------TVIQLVGM 152
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYST 548
              +A  ++Y+  +    YVHR++ +RNI ++     +V +FG++R + DD E+   Y+T
Sbjct: 153 LRGIASGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA--YTT 207
Query: 549 N----PASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
                P  W           +   D+++YGIVL EV+S G+ P
Sbjct: 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 96/200 (48%), Gaps = 30/200 (15%)
Query: 392 GAVYHGRLNGKNLAIK-RTEHEVITKLEMQLVQHATHH---HPNIVRLLGTCLTDGPHSF 447
           G VY G     +L +  +T  E   ++E  L + A      HPN+V+LLG C T  P  +
Sbjct: 27  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-TREPPFY 85
Query: 448 LVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSY 507
           ++ E+   G+L D+L        Q +++          L +   ++ A++Y+      ++
Sbjct: 86  IIIEFMTYGNLLDYLR---ECNRQEVSAVVL-------LYMATQISSAMEYLE---KKNF 132
Query: 508 VHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SMG 556
           +HR++ +RN  + E    +V +FG++R +  DT +    +  P  W           S+ 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 192
Query: 557 IDIFAYGIVLLEVLS-GQTP 575
            D++A+G++L E+ + G +P
Sbjct: 193 SDVWAFGVLLWEIATYGMSP 212

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 96/200 (48%), Gaps = 30/200 (15%)
Query: 392 GAVYHGRLNGKNLAIK-RTEHEVITKLEMQLVQHATHH---HPNIVRLLGTCLTDGPHSF 447
           G VY G     +L +  +T  E   ++E  L + A      HPN+V+LLG C T  P  +
Sbjct: 25  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-TREPPFY 83
Query: 448 LVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSY 507
           ++ E+   G+L D+L        Q +++          L +   ++ A++Y+      ++
Sbjct: 84  IITEFMTYGNLLDYLR---ECNRQEVSAVVL-------LYMATQISSAMEYLE---KKNF 130
Query: 508 VHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SMG 556
           +HR++ +RN  + E    +V +FG++R +  DT +    +  P  W           S+ 
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIK 190
Query: 557 IDIFAYGIVLLEVLS-GQTP 575
            D++A+G++L E+ + G +P
Sbjct: 191 SDVWAFGVLLWEIATYGMSP 210

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 97/207 (46%), Gaps = 37/207 (17%)
Query: 392 GAVYHGRL---NGKNL--AIKR----TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTD 442
           G VYHG L   +GK +  A+K     T+   +++   + +      HPN++ LLG CL  
Sbjct: 103 GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 162
Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
                +V  Y K+G L++++       N  +     F          L VA  ++++   
Sbjct: 163 EGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGF---------GLQVAKGMKFL--- 208
Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND---DTESPQFYSTNPASW------ 553
            +  +VHR++ +RN  LDE+F  +V +FG+AR + D   D+   +  +  P  W      
Sbjct: 209 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 268
Query: 554 -----SMGIDIFAYGIVLLEVLSGQTP 575
                +   D++++G++L E+++   P
Sbjct: 269 QTQKFTTKSDVWSFGVLLWELMTRGAP 295

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 51/200 (25%), Positives = 96/200 (48%), Gaps = 30/200 (15%)
Query: 392 GAVYHGRLNGKNLAIK-RTEHEVITKLEMQLVQHATHH---HPNIVRLLGTCLTDGPHSF 447
           G VY G     +L +  +T  E   ++E  L + A      HPN+V+LLG C T  P  +
Sbjct: 234 GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-TREPPFY 292
Query: 448 LVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSY 507
           ++ E+   G+L D+L        Q +++          L +   ++ A++Y+      ++
Sbjct: 293 IITEFMTYGNLLDYLR---ECNRQEVSAVVL-------LYMATQISSAMEYLE---KKNF 339
Query: 508 VHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SMG 556
           +HRN+ +RN  + E    +V +FG++R +  DT +    +  P  W           S+ 
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 399
Query: 557 IDIFAYGIVLLEVLS-GQTP 575
            D++A+G++L E+ + G +P
Sbjct: 400 SDVWAFGVLLWEIATYGMSP 419

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 42/209 (20%)
Query: 392 GAVYHGRLN--GKN---LAIKRTEHEVITKLEMQLVQHAT----HHHPNIVRLLGTCLTD 442
           G V  GRL   GK    +AIK  +     K     +  A+      HPNI+ L G     
Sbjct: 28  GEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKC 87
Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
            P   ++ EY +NGSL           + F+       T  Q + +   +   ++Y+  +
Sbjct: 88  KP-VMIITEYMENGSL-----------DAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDM 135
Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN----PASWSM--- 555
              SYVHR++ +RNI ++     +V +FGM+R + DD E+   Y+T     P  W+    
Sbjct: 136 ---SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAA--YTTRGGKIPIRWTAPEA 190
Query: 556 --------GIDIFAYGIVLLEVLS-GQTP 575
                     D+++YGIV+ EV+S G+ P
Sbjct: 191 IAYRKFTSASDVWSYGIVMWEVMSYGERP 219

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 96/200 (48%), Gaps = 30/200 (15%)
Query: 392 GAVYHGRLNGKNLAIK-RTEHEVITKLEMQLVQHATHH---HPNIVRLLGTCLTDGPHSF 447
           G VY G     +L +  +T  E   ++E  L + A      HPN+V+LLG C T  P  +
Sbjct: 27  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-TREPPFY 85
Query: 448 LVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSY 507
           ++ E+   G+L D+L        Q +++          L +   ++ A++Y+      ++
Sbjct: 86  IIIEFMTYGNLLDYLR---ECNRQEVSAVVL-------LYMATQISSAMEYLE---KKNF 132
Query: 508 VHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SMG 556
           +HR++ +RN  + E    +V +FG++R +  DT +    +  P  W           S+ 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 192
Query: 557 IDIFAYGIVLLEVLS-GQTP 575
            D++A+G++L E+ + G +P
Sbjct: 193 SDVWAFGVLLWEIATYGMSP 212

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/209 (24%), Positives = 93/209 (44%), Gaps = 41/209 (19%)
Query: 392 GAVYHGRLNGKNLAIKRTEH-------EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGP 444
           G VY     G  +A+K   H       + I  +  +    A   HPNI+ L G CL + P
Sbjct: 21  GKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE-P 79
Query: 445 HSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMN 504
           +  LV E+A+ G L   L G     +         + W+      + +A  + Y+H    
Sbjct: 80  NLCLVMEFARGGPLNRVLSGKRIPPD-------ILVNWA------VQIARGMNYLHDEAI 126
Query: 505 PSYVHRNIKSRNIFLDEEFN--------ARVGNFGMARCVNDDTE----------SPQFY 546
              +HR++KS NI + ++           ++ +FG+AR  +  T+          +P+  
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVI 186
Query: 547 STNPASWSMGIDIFAYGIVLLEVLSGQTP 575
               + +S G D+++YG++L E+L+G+ P
Sbjct: 187 RA--SMFSKGSDVWSYGVLLWELLTGEVP 213

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/209 (28%), Positives = 94/209 (44%), Gaps = 42/209 (20%)
Query: 392 GAVYHGRLN--GKN---LAIKRTEHEVITKLEMQLVQHAT----HHHPNIVRLLGTCLTD 442
           G V  GRL   GK    +AIK  +     K     +  A+      HPNI+ L G     
Sbjct: 22  GEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKC 81
Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
            P   ++ EY +NGSL           + F+       T  Q + +   +   ++Y+  +
Sbjct: 82  KP-VMIITEYMENGSL-----------DAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDM 129
Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN----PASWSM--- 555
              SYVHR++ +RNI ++     +V +FGM+R + DD E+   Y+T     P  W+    
Sbjct: 130 ---SYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAA--YTTRGGKIPIRWTAPEA 184
Query: 556 --------GIDIFAYGIVLLEVLS-GQTP 575
                     D+++YGIV+ EV+S G+ P
Sbjct: 185 IAYRKFTSASDVWSYGIVMWEVMSYGERP 213

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 67.0 bits (162), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 94/200 (47%), Gaps = 30/200 (15%)
Query: 392 GAVYHGRLNGKNLAIK-RTEHEVITKLEMQLVQHATHH---HPNIVRLLGTCLTDGPHSF 447
           G VY G     +L +  +T  E   ++E  L + A      HPN+V+LLG C T  P  +
Sbjct: 28  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-TREPPFY 86
Query: 448 LVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSY 507
           ++ E+   G+L D+L      +   +   Y          +   ++ A++Y+      ++
Sbjct: 87  IIIEFMTYGNLLDYLRECNRQEVNAVVLLY----------MATQISSAMEYLE---KKNF 133
Query: 508 VHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SMG 556
           +HR++ +RN  + E    +V +FG++R +  DT +    +  P  W           S+ 
Sbjct: 134 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIK 193
Query: 557 IDIFAYGIVLLEVLS-GQTP 575
            D++A+G++L E+ + G +P
Sbjct: 194 SDVWAFGVLLWEIATYGMSP 213

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 47/195 (24%), Positives = 92/195 (47%), Gaps = 45/195 (23%)
Query: 401 GKNLAIKRTEH---EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSF-LVFEYAKNG 456
           G+ +A+K+ +H   E +   E ++    +  H NIV+  G C + G  +  L+ E+   G
Sbjct: 42  GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFLPYG 101
Query: 457 SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQY-------MHHVMNPSYVH 509
           SL+++L                     Q+ +  +D    LQY       M ++    Y+H
Sbjct: 102 SLREYL---------------------QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIH 140
Query: 510 RNIKSRNIFLDEEFNARVGNFGMARCVNDDT---------ESPQFY----STNPASWSMG 556
           R++ +RNI ++ E   ++G+FG+ + +  D          ESP F+    S   + +S+ 
Sbjct: 141 RDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVA 200
Query: 557 IDIFAYGIVLLEVLS 571
            D++++G+VL E+ +
Sbjct: 201 SDVWSFGVVLYELFT 215

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 97/207 (46%), Gaps = 37/207 (17%)
Query: 392 GAVYHGRL---NGKNL--AIKR----TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTD 442
           G VYHG L   +GK +  A+K     T+   +++   + +      HPN++ LLG CL  
Sbjct: 45  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 104
Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
                +V  Y K+G L++++       N  +     F          L VA  ++++   
Sbjct: 105 EGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGF---------GLQVAKGMKFL--- 150
Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND---DTESPQFYSTNPASW------ 553
            +  +VHR++ +RN  LDE+F  +V +FG+AR + D   D+   +  +  P  W      
Sbjct: 151 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 210
Query: 554 -----SMGIDIFAYGIVLLEVLSGQTP 575
                +   D++++G++L E+++   P
Sbjct: 211 QTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 97/207 (46%), Gaps = 37/207 (17%)
Query: 392 GAVYHGRL---NGKNL--AIKR----TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTD 442
           G VYHG L   +GK +  A+K     T+   +++   + +      HPN++ LLG CL  
Sbjct: 44  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 103
Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
                +V  Y K+G L++++       N  +     F          L VA  ++++   
Sbjct: 104 EGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGF---------GLQVAKGMKFL--- 149
Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND---DTESPQFYSTNPASW------ 553
            +  +VHR++ +RN  LDE+F  +V +FG+AR + D   D+   +  +  P  W      
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 209
Query: 554 -----SMGIDIFAYGIVLLEVLSGQTP 575
                +   D++++G++L E+++   P
Sbjct: 210 QTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 98/215 (45%), Gaps = 41/215 (19%)
Query: 392 GAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATH-----HHPNIVRLLGTCLTDGPHS 446
           G VY G+ +G ++A+K       T  ++Q  ++         H NI+  +G   +  P  
Sbjct: 22  GTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG--YSTAPQL 78
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
            +V ++ +  SL   LH         I + +  +   + + I    A  + Y+H     S
Sbjct: 79  AIVTQWCEGSSLYHHLH--------IIETKFEMI---KLIDIARQTAQGMDYLH---AKS 124
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQF-----------------YSTN 549
            +HR++KS NIFL E+   ++G+FG+A   +  + S QF                    N
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 550 PASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDE 584
           P  +S   D++A+GIVL E+++GQ P +    +D+
Sbjct: 185 P--YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 217

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 97/207 (46%), Gaps = 37/207 (17%)
Query: 392 GAVYHGRL---NGKNL--AIKR----TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTD 442
           G VYHG L   +GK +  A+K     T+   +++   + +      HPN++ LLG CL  
Sbjct: 44  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 103
Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
                +V  Y K+G L++++       N  +     F          L VA  ++++   
Sbjct: 104 EGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGF---------GLQVAKGMKFL--- 149
Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND---DTESPQFYSTNPASW------ 553
            +  +VHR++ +RN  LDE+F  +V +FG+AR + D   D+   +  +  P  W      
Sbjct: 150 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 209
Query: 554 -----SMGIDIFAYGIVLLEVLSGQTP 575
                +   D++++G++L E+++   P
Sbjct: 210 QTQKFTTKSDVWSFGVLLWELMTRGAP 236

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 97/207 (46%), Gaps = 37/207 (17%)
Query: 392 GAVYHGRL---NGKNL--AIKR----TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTD 442
           G VYHG L   +GK +  A+K     T+   +++   + +      HPN++ LLG CL  
Sbjct: 42  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 101
Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
                +V  Y K+G L++++       N  +     F          L VA  ++++   
Sbjct: 102 EGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGF---------GLQVAKGMKFL--- 147
Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND---DTESPQFYSTNPASW------ 553
            +  +VHR++ +RN  LDE+F  +V +FG+AR + D   D+   +  +  P  W      
Sbjct: 148 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 207
Query: 554 -----SMGIDIFAYGIVLLEVLSGQTP 575
                +   D++++G++L E+++   P
Sbjct: 208 QTQKFTTKSDVWSFGVLLWELMTRGAP 234

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 96/200 (48%), Gaps = 30/200 (15%)
Query: 392 GAVYHGRLNGKNLAIK-RTEHEVITKLEMQLVQHATHH---HPNIVRLLGTCLTDGPHSF 447
           G VY G     +L +  +T  E   ++E  L + A      HPN+V+LLG C T  P  +
Sbjct: 32  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-TREPPFY 90
Query: 448 LVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSY 507
           ++ E+   G+L D+L        Q +++          L +   ++ A++Y+      ++
Sbjct: 91  IITEFMTYGNLLDYLR---ECNRQEVSAVVL-------LYMATQISSAMEYLE---KKNF 137
Query: 508 VHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SMG 556
           +HR++ +RN  + E    +V +FG++R +  DT +    +  P  W           S+ 
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 197
Query: 557 IDIFAYGIVLLEVLS-GQTP 575
            D++A+G++L E+ + G +P
Sbjct: 198 SDVWAFGVLLWEIATYGMSP 217

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 97/207 (46%), Gaps = 37/207 (17%)
Query: 392 GAVYHGRL---NGKNL--AIKR----TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTD 442
           G VYHG L   +GK +  A+K     T+   +++   + +      HPN++ LLG CL  
Sbjct: 49  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 108
Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
                +V  Y K+G L++++       N  +     F          L VA  ++++   
Sbjct: 109 EGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGF---------GLQVAKGMKFL--- 154
Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND---DTESPQFYSTNPASW------ 553
            +  +VHR++ +RN  LDE+F  +V +FG+AR + D   D+   +  +  P  W      
Sbjct: 155 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESL 214
Query: 554 -----SMGIDIFAYGIVLLEVLSGQTP 575
                +   D++++G++L E+++   P
Sbjct: 215 QTQKFTTKSDVWSFGVLLWELMTRGAP 241

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 94/200 (47%), Gaps = 30/200 (15%)
Query: 392 GAVYHGRLNGKNLAIK-RTEHEVITKLEMQLVQHATHH---HPNIVRLLGTCLTDGPHSF 447
           G VY G     +L +  +T  E   ++E  L + A      HPN+V+LLG C T  P  +
Sbjct: 32  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-TREPPFY 90
Query: 448 LVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSY 507
           ++ E+   G+L D+L      +   +   Y          +   ++ A++Y+      ++
Sbjct: 91  IIIEFMTYGNLLDYLRECNRQEVNAVVLLY----------MATQISSAMEYLE---KKNF 137
Query: 508 VHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SMG 556
           +HR++ +RN  + E    +V +FG++R +  DT +    +  P  W           S+ 
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 197
Query: 557 IDIFAYGIVLLEVLS-GQTP 575
            D++A+G++L E+ + G +P
Sbjct: 198 SDVWAFGVLLWEIATYGMSP 217

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 98/215 (45%), Gaps = 41/215 (19%)
Query: 392 GAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATH-----HHPNIVRLLGTCLTDGPHS 446
           G VY G+ +G ++A+K       T  ++Q  ++         H NI+  +G   +  P  
Sbjct: 27  GTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG--YSTKPQL 83
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
            +V ++ +  SL   LH         I + +  +   + + I    A  + Y+H     S
Sbjct: 84  AIVTQWCEGSSLYHHLH--------IIETKFEMI---KLIDIARQTAQGMDYLH---AKS 129
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQF-----------------YSTN 549
            +HR++KS NIFL E+   ++G+FG+A   +  + S QF                    N
Sbjct: 130 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 189
Query: 550 PASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDE 584
           P  +S   D++A+GIVL E+++GQ P +    +D+
Sbjct: 190 P--YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 222

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 96/200 (48%), Gaps = 30/200 (15%)
Query: 392 GAVYHGRLNGKNLAIK-RTEHEVITKLEMQLVQHATHH---HPNIVRLLGTCLTDGPHSF 447
           G VY G     +L +  +T  E   ++E  L + A      HPN+V+LLG C T  P  +
Sbjct: 27  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-TREPPFY 85
Query: 448 LVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSY 507
           ++ E+   G+L D+L        Q +++          L +   ++ A++Y+      ++
Sbjct: 86  IITEFMTYGNLLDYLR---ECNRQEVSAVVL-------LYMATQISSAMEYLE---KKNF 132
Query: 508 VHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SMG 556
           +HR++ +RN  + E    +V +FG++R +  DT +    +  P  W           S+ 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 192
Query: 557 IDIFAYGIVLLEVLS-GQTP 575
            D++A+G++L E+ + G +P
Sbjct: 193 SDVWAFGVLLWEIATYGMSP 212

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/207 (25%), Positives = 97/207 (46%), Gaps = 37/207 (17%)
Query: 392 GAVYHGRL---NGKNL--AIKR----TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTD 442
           G VYHG L   +GK +  A+K     T+   +++   + +      HPN++ LLG CL  
Sbjct: 45  GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 104
Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
                +V  Y K+G L++++       N  +     F          L VA  ++++   
Sbjct: 105 EGSPLVVLPYMKHGDLRNFIRN--ETHNPTVKDLIGF---------GLQVAKGMKFL--- 150
Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND---DTESPQFYSTNPASW------ 553
            +  +VHR++ +RN  LDE+F  +V +FG+AR + D   D+   +  +  P  W      
Sbjct: 151 ASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESL 210
Query: 554 -----SMGIDIFAYGIVLLEVLSGQTP 575
                +   D++++G++L E+++   P
Sbjct: 211 QTQKFTTKSDVWSFGVLLWELMTRGAP 237

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 96/200 (48%), Gaps = 30/200 (15%)
Query: 392 GAVYHGRLNGKNLAIK-RTEHEVITKLEMQLVQHATHH---HPNIVRLLGTCLTDGPHSF 447
           G VY G     +L +  +T  E   ++E  L + A      HPN+V+LLG C T  P  +
Sbjct: 27  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-TREPPFY 85
Query: 448 LVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSY 507
           ++ E+   G+L D+L        Q +++          L +   ++ A++Y+      ++
Sbjct: 86  IITEFMTYGNLLDYLR---ECNRQEVSAVVL-------LYMATQISSAMEYLE---KKNF 132
Query: 508 VHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SMG 556
           +HR++ +RN  + E    +V +FG++R +  DT +    +  P  W           S+ 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 192
Query: 557 IDIFAYGIVLLEVLS-GQTP 575
            D++A+G++L E+ + G +P
Sbjct: 193 SDVWAFGVLLWEIATYGMSP 212

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 98/215 (45%), Gaps = 41/215 (19%)
Query: 392 GAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATH-----HHPNIVRLLGTCLTDGPHS 446
           G VY G+ +G ++A+K       T  ++Q  ++         H NI+  +G   +  P  
Sbjct: 27  GTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG--YSTKPQL 83
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
            +V ++ +  SL   LH         I + +  +   + + I    A  + Y+H     S
Sbjct: 84  AIVTQWCEGSSLYHHLH--------IIETKFEMI---KLIDIARQTAQGMDYLH---AKS 129
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQF-----------------YSTN 549
            +HR++KS NIFL E+   ++G+FG+A   +  + S QF                    N
Sbjct: 130 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 189
Query: 550 PASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDE 584
           P  +S   D++A+GIVL E+++GQ P +    +D+
Sbjct: 190 P--YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 222

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 96/200 (48%), Gaps = 30/200 (15%)
Query: 392 GAVYHGRLNGKNLAIK-RTEHEVITKLEMQLVQHATHH---HPNIVRLLGTCLTDGPHSF 447
           G VY G     +L +  +T  E   ++E  L + A      HPN+V+LLG C T  P  +
Sbjct: 25  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-TREPPFY 83
Query: 448 LVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSY 507
           ++ E+   G+L D+L        Q +++          L +   ++ A++Y+      ++
Sbjct: 84  IITEFMTYGNLLDYLR---ECNRQEVSAVVL-------LYMATQISSAMEYLE---KKNF 130
Query: 508 VHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SMG 556
           +HR++ +RN  + E    +V +FG++R +  DT +    +  P  W           S+ 
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSIK 190
Query: 557 IDIFAYGIVLLEVLS-GQTP 575
            D++A+G++L E+ + G +P
Sbjct: 191 SDVWAFGVLLWEIATYGMSP 210

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 66.2 bits (160), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 48/163 (29%), Positives = 79/163 (48%), Gaps = 33/163 (20%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HPNI+ L G      P   +V EY +NGSL  +L        QF        T  Q + +
Sbjct: 82  HPNIIHLEGVVTKSKP-VMIVTEYMENGSLDTFLKKN---DGQF--------TVIQLVGM 129
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYST 548
              ++  ++Y+  +    YVHR++ +RNI ++     +V +FG++R + DD E+   Y+T
Sbjct: 130 LRGISAGMKYLSDM---GYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA--YTT 184
Query: 549 N----PASWSM-----------GIDIFAYGIVLLEVLS-GQTP 575
                P  W+              D+++YGIV+ EV+S G+ P
Sbjct: 185 RGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERP 227

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 66.2 bits (160), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 98/215 (45%), Gaps = 41/215 (19%)
Query: 392 GAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATH-----HHPNIVRLLGTCLTDGPHS 446
           G VY G+ +G ++A+K       T  ++Q  ++         H NI+  +G   +  P  
Sbjct: 24  GTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG--YSTKPQL 80
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
            +V ++ +  SL   LH         I + +  +   + + I    A  + Y+H     S
Sbjct: 81  AIVTQWCEGSSLYHHLH--------IIETKFEMI---KLIDIARQTAQGMDYLH---AKS 126
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQF-----------------YSTN 549
            +HR++KS NIFL E+   ++G+FG+A   +  + S QF                    N
Sbjct: 127 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 186
Query: 550 PASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDE 584
           P  +S   D++A+GIVL E+++GQ P +    +D+
Sbjct: 187 P--YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 219

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 104/212 (49%), Gaps = 41/212 (19%)
Query: 392 GAVYHGRL--NGKNLAIK-------RTEHEVITKLE---MQLVQHATHHHPNIVRLLGTC 439
           G V+ GRL  +   +AIK         E E+I K +    ++   +  +HPNIV+L G  
Sbjct: 33  GLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYG-L 91
Query: 440 LTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYM 499
           + + P   +V E+   G L           ++ +   +  + WS +LR+ LD+A+ ++YM
Sbjct: 92  MHNPPR--MVMEFVPCGDLY----------HRLLDKAHP-IKWSVKLRLMLDIALGIEYM 138
Query: 500 HHVMNPSYVHRNIKSRNIF---LDEE--FNARVGNFGMAR---------CVNDDTESPQF 545
            +  NP  VHR+++S NIF   LDE     A+V +FG+++           N    +P+ 
Sbjct: 139 QN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPET 197
Query: 546 YSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
                 S++   D +++ ++L  +L+G+ P +
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 94/200 (47%), Gaps = 30/200 (15%)
Query: 392 GAVYHGRLNGKNLAIK-RTEHEVITKLEMQLVQHATHH---HPNIVRLLGTCLTDGPHSF 447
           G VY G     +L +  +T  E   ++E  L + A      HPN+V+LLG C T  P  +
Sbjct: 32  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-TREPPFY 90
Query: 448 LVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSY 507
           ++ E+   G+L D+L      +   +   Y          +   ++ A++Y+      ++
Sbjct: 91  IITEFMTYGNLLDYLRECNRQEVNAVVLLY----------MATQISSAMEYLE---KKNF 137
Query: 508 VHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SMG 556
           +HR++ +RN  + E    +V +FG++R +  DT +    +  P  W           S+ 
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSIK 197
Query: 557 IDIFAYGIVLLEVLS-GQTP 575
            D++A+G++L E+ + G +P
Sbjct: 198 SDVWAFGVLLWEIATYGMSP 217

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 96/209 (45%), Gaps = 40/209 (19%)
Query: 392 GAVYHGRLN--GKN---LAIKRTEHEVITKLEMQLVQHAT----HHHPNIVRLLGTCLTD 442
           G V  GRL   GK    +AIK  +     +   + +  A+      HPNI+RL G     
Sbjct: 28  GEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNS 87
Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
            P   L  E+ +NG+L  +L        QF        T  Q + +   +A  ++Y+  +
Sbjct: 88  MPVMILT-EFMENGALDSFLR---LNDGQF--------TVIQLVGMLRGIASGMRYLAEM 135
Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYST----NPASWSM--- 555
              SYVHR++ +RNI ++     +V +FG++R + +++  P + S+     P  W+    
Sbjct: 136 ---SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRWTAPEA 192
Query: 556 --------GIDIFAYGIVLLEVLS-GQTP 575
                     D ++YGIV+ EV+S G+ P
Sbjct: 193 IAFRKFTSASDAWSYGIVMWEVMSFGERP 221

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 98/215 (45%), Gaps = 41/215 (19%)
Query: 392 GAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATH-----HHPNIVRLLGTCLTDGPHS 446
           G VY G+ +G ++A+K       T  ++Q  ++         H NI+  +G   +  P  
Sbjct: 50  GTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG--YSTKPQL 106
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
            +V ++ +  SL   LH         I + +  +   + + I    A  + Y+H     S
Sbjct: 107 AIVTQWCEGSSLYHHLH--------IIETKFEMI---KLIDIARQTAQGMDYLH---AKS 152
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQF-----------------YSTN 549
            +HR++KS NIFL E+   ++G+FG+A   +  + S QF                    N
Sbjct: 153 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 212
Query: 550 PASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDE 584
           P  +S   D++A+GIVL E+++GQ P +    +D+
Sbjct: 213 P--YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 245

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 98/215 (45%), Gaps = 41/215 (19%)
Query: 392 GAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATH-----HHPNIVRLLGTCLTDGPHS 446
           G VY G+ +G ++A+K       T  ++Q  ++         H NI+  +G   +  P  
Sbjct: 22  GTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG--YSTKPQL 78
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
            +V ++ +  SL   LH         I + +  +   + + I    A  + Y+H     S
Sbjct: 79  AIVTQWCEGSSLYHHLH--------IIETKFEMI---KLIDIARQTAQGMDYLH---AKS 124
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQF-----------------YSTN 549
            +HR++KS NIFL E+   ++G+FG+A   +  + S QF                    N
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 550 PASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDE 584
           P  +S   D++A+GIVL E+++GQ P +    +D+
Sbjct: 185 P--YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 217

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 65.9 bits (159), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 98/215 (45%), Gaps = 41/215 (19%)
Query: 392 GAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATH-----HHPNIVRLLGTCLTDGPHS 446
           G VY G+ +G ++A+K       T  ++Q  ++         H NI+  +G   +  P  
Sbjct: 49  GTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG--YSTKPQL 105
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
            +V ++ +  SL   LH         I + +  +   + + I    A  + Y+H     S
Sbjct: 106 AIVTQWCEGSSLYHHLH--------IIETKFEMI---KLIDIARQTAQGMDYLH---AKS 151
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQF-----------------YSTN 549
            +HR++KS NIFL E+   ++G+FG+A   +  + S QF                    N
Sbjct: 152 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 211
Query: 550 PASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDE 584
           P  +S   D++A+GIVL E+++GQ P +    +D+
Sbjct: 212 P--YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 244

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 65.9 bits (159), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 99/215 (46%), Gaps = 41/215 (19%)
Query: 392 GAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATH-----HHPNIVRLLGTCLTDGPHS 446
           G VY G+ +G ++A+K       T  ++Q  ++         H NI+  +G   +  P  
Sbjct: 26  GTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG--YSTKPQL 82
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
            +V ++ +  SL   LH   A + +F           + + I    A  + Y+H     S
Sbjct: 83  AIVTQWCEGSSLYHHLH---ASETKF--------EMKKLIDIARQTARGMDYLH---AKS 128
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQF-----------------YSTN 549
            +HR++KS NIFL E+   ++G+FG+A   +  + S QF                   +N
Sbjct: 129 IIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 188
Query: 550 PASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDE 584
           P  +S   D++A+GIVL E+++GQ P +    +D+
Sbjct: 189 P--YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 221

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 94/200 (47%), Gaps = 30/200 (15%)
Query: 392 GAVYHGRLNGKNLAIK-RTEHEVITKLEMQLVQHATHH---HPNIVRLLGTCLTDGPHSF 447
           G VY G     +L +  +T  E   ++E  L + A      HPN+V+LLG C T  P  +
Sbjct: 32  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-TREPPFY 90
Query: 448 LVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSY 507
           ++ E+   G+L D+L      +   +   Y          +   ++ A++Y+      ++
Sbjct: 91  IITEFMTYGNLLDYLRECNRQEVNAVVLLY----------MATQISSAMEYLE---KKNF 137
Query: 508 VHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SMG 556
           +HR++ +RN  + E    +V +FG++R +  DT +    +  P  W           S+ 
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 197
Query: 557 IDIFAYGIVLLEVLS-GQTP 575
            D++A+G++L E+ + G +P
Sbjct: 198 SDVWAFGVLLWEIATYGMSP 217

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 57/225 (25%), Positives = 97/225 (43%), Gaps = 60/225 (26%)
Query: 384 FNSSNRIEG---AVYHGRLNGKNLAIKRTEHEV--ITKLEMQLVQHATHHHPNIVRLLGT 438
           F + N+++    A+   RL  + LA ++   EV  + KLE          HP IVR    
Sbjct: 22  FEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE----------HPGIVRYFNA 71
Query: 439 CLTDG------PHSFLVFEY-----AKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLR 487
            L         P S  V+ Y      +  +LKDW++G   ++ +  + C         L 
Sbjct: 72  WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVC---------LH 122
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYS 547
           I L +A A++++H   +   +HR++K  NIF   +   +VG+FG+   ++ D E     +
Sbjct: 123 IFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLT 179
Query: 548 TNPA----------------------SWSMGIDIFAYGIVLLEVL 570
             PA                      S+S  +DIF+ G++L E+L
Sbjct: 180 PMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 94/200 (47%), Gaps = 30/200 (15%)
Query: 392 GAVYHGRLNGKNLAIK-RTEHEVITKLEMQLVQHATHH---HPNIVRLLGTCLTDGPHSF 447
           G VY G     +L +  +T  E   ++E  L + A      HPN+V+LLG C T  P  +
Sbjct: 273 GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-TREPPFY 331
Query: 448 LVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSY 507
           ++ E+   G+L D+L      +   +   Y          +   ++ A++Y+      ++
Sbjct: 332 IITEFMTYGNLLDYLRECNRQEVNAVVLLY----------MATQISSAMEYLE---KKNF 378
Query: 508 VHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SMG 556
           +HRN+ +RN  + E    +V +FG++R +  DT +    +  P  W           S+ 
Sbjct: 379 IHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 438
Query: 557 IDIFAYGIVLLEVLS-GQTP 575
            D++A+G++L E+ + G +P
Sbjct: 439 SDVWAFGVLLWEIATYGMSP 458

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 94/200 (47%), Gaps = 30/200 (15%)
Query: 392 GAVYHGRLNGKNLAIK-RTEHEVITKLEMQLVQHATHH---HPNIVRLLGTCLTDGPHSF 447
           G VY G     +L +  +T  E   ++E  L + A      HPN+V+LLG C T  P  +
Sbjct: 32  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-TREPPFY 90
Query: 448 LVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSY 507
           ++ E+   G+L D+L      +   +   Y          +   ++ A++Y+      ++
Sbjct: 91  IITEFMTYGNLLDYLRECNRQEVNAVVLLY----------MATQISSAMEYLE---KKNF 137
Query: 508 VHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SMG 556
           +HR++ +RN  + E    +V +FG++R +  DT +    +  P  W           S+ 
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 197
Query: 557 IDIFAYGIVLLEVLS-GQTP 575
            D++A+G++L E+ + G +P
Sbjct: 198 SDVWAFGVLLWEIATYGMSP 217

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 65.5 bits (158), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 94/200 (47%), Gaps = 30/200 (15%)
Query: 392 GAVYHGRLNGKNLAIK-RTEHEVITKLEMQLVQHATHH---HPNIVRLLGTCLTDGPHSF 447
           G VY G     +L +  +T  E   ++E  L + A      HPN+V+LLG C T  P  +
Sbjct: 29  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-TREPPFY 87
Query: 448 LVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSY 507
           ++ E+   G+L D+L      +   +   Y          +   ++ A++Y+      ++
Sbjct: 88  IITEFMTYGNLLDYLRECNRQEVNAVVLLY----------MATQISSAMEYLE---KKNF 134
Query: 508 VHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SMG 556
           +HR++ +RN  + E    +V +FG++R +  DT +    +  P  W           S+ 
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 194
Query: 557 IDIFAYGIVLLEVLS-GQTP 575
            D++A+G++L E+ + G +P
Sbjct: 195 SDVWAFGVLLWEIATYGMSP 214

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 94/200 (47%), Gaps = 30/200 (15%)
Query: 392 GAVYHGRLNGKNLAIK-RTEHEVITKLEMQLVQHATHH---HPNIVRLLGTCLTDGPHSF 447
           G VY G     +L +  +T  E   ++E  L + A      HPN+V+LLG C T  P  +
Sbjct: 31  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-TREPPFY 89
Query: 448 LVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSY 507
           ++ E+   G+L D+L      +   +   Y          +   ++ A++Y+      ++
Sbjct: 90  IITEFMTYGNLLDYLRECNRQEVNAVVLLY----------MATQISSAMEYLE---KKNF 136
Query: 508 VHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SMG 556
           +HR++ +RN  + E    +V +FG++R +  DT +    +  P  W           S+ 
Sbjct: 137 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 196
Query: 557 IDIFAYGIVLLEVLS-GQTP 575
            D++A+G++L E+ + G +P
Sbjct: 197 SDVWAFGVLLWEIATYGMSP 216

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 94/200 (47%), Gaps = 30/200 (15%)
Query: 392 GAVYHGRLNGKNLAIK-RTEHEVITKLEMQLVQHATHH---HPNIVRLLGTCLTDGPHSF 447
           G VY G     +L +  +T  E   ++E  L + A      HPN+V+LLG C T  P  +
Sbjct: 40  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-TREPPFY 98
Query: 448 LVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSY 507
           ++ E+   G+L D+L      +   +   Y          +   ++ A++Y+      ++
Sbjct: 99  IITEFMTYGNLLDYLRECNRQEVNAVVLLY----------MATQISSAMEYLE---KKNF 145
Query: 508 VHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SMG 556
           +HR++ +RN  + E    +V +FG++R +  DT +    +  P  W           S+ 
Sbjct: 146 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 205
Query: 557 IDIFAYGIVLLEVLS-GQTP 575
            D++A+G++L E+ + G +P
Sbjct: 206 SDVWAFGVLLWEIATYGMSP 225

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 65.5 bits (158), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 50/200 (25%), Positives = 95/200 (47%), Gaps = 30/200 (15%)
Query: 392 GAVYHGRLNGKNLAIK-RTEHEVITKLEMQLVQHATHH---HPNIVRLLGTCLTDGPHSF 447
           G VY G     +L +  +T  E   ++E  L + A      HPN+V+LLG C  + P  +
Sbjct: 46  GEVYVGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTLEPPF-Y 104
Query: 448 LVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSY 507
           +V EY   G+L D+L      + +  A    ++           ++ A++Y+      ++
Sbjct: 105 IVTEYMPYGNLLDYLRE--CNREEVTAVVLLYM--------ATQISSAMEYLE---KKNF 151
Query: 508 VHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SMG 556
           +HR++ +RN  + E    +V +FG++R +  DT +    +  P  W           S+ 
Sbjct: 152 IHRDLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIK 211
Query: 557 IDIFAYGIVLLEVLS-GQTP 575
            D++A+G++L E+ + G +P
Sbjct: 212 SDVWAFGVLLWEIATYGMSP 231

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 99/215 (46%), Gaps = 41/215 (19%)
Query: 392 GAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATH-----HHPNIVRLLGTCLTDGPHS 446
           G VY G+ +G ++A+K       T  ++Q  ++         H NI+  +G   +  P  
Sbjct: 38  GTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG--YSTAPQL 94
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
            +V ++ +  SL   LH   A + +F           + + I    A  + Y+H     S
Sbjct: 95  AIVTQWCEGSSLYHHLH---ASETKF--------EMKKLIDIARQTARGMDYLH---AKS 140
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQF-----------------YSTN 549
            +HR++KS NIFL E+   ++G+FG+A   +  + S QF                   +N
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 550 PASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDE 584
           P  +S   D++A+GIVL E+++GQ P +    +D+
Sbjct: 201 P--YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 233

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 94/200 (47%), Gaps = 30/200 (15%)
Query: 392 GAVYHGRLNGKNLAIK-RTEHEVITKLEMQLVQHATHH---HPNIVRLLGTCLTDGPHSF 447
           G VY G     +L +  +T  E   ++E  L + A      HPN+V+LLG C T  P  +
Sbjct: 27  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-TREPPFY 85
Query: 448 LVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSY 507
           ++ E+   G+L D+L      +   +   Y          +   ++ A++Y+      ++
Sbjct: 86  IITEFMTYGNLLDYLRECNRQEVNAVVLLY----------MATQISSAMEYLE---KKNF 132
Query: 508 VHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SMG 556
           +HR++ +RN  + E    +V +FG++R +  DT +    +  P  W           S+ 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 192
Query: 557 IDIFAYGIVLLEVLS-GQTP 575
            D++A+G++L E+ + G +P
Sbjct: 193 SDVWAFGVLLWEIATYGMSP 212

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 94/200 (47%), Gaps = 30/200 (15%)
Query: 392 GAVYHGRLNGKNLAIK-RTEHEVITKLEMQLVQHATHH---HPNIVRLLGTCLTDGPHSF 447
           G VY G     +L +  +T  E   ++E  L + A      HPN+V+LLG C T  P  +
Sbjct: 27  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-TREPPFY 85
Query: 448 LVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSY 507
           ++ E+   G+L D+L      +   +   Y          +   ++ A++Y+      ++
Sbjct: 86  IITEFMTYGNLLDYLRECNRQEVNAVVLLY----------MATQISSAMEYLE---KKNF 132
Query: 508 VHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SMG 556
           +HR++ +RN  + E    +V +FG++R +  DT +    +  P  W           S+ 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 192
Query: 557 IDIFAYGIVLLEVLS-GQTP 575
            D++A+G++L E+ + G +P
Sbjct: 193 SDVWAFGVLLWEIATYGMSP 212

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 91/186 (48%), Gaps = 30/186 (16%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
           +EH  +   E++++ H  HH  N+V LLG C   G    ++ E+ K G+L  +L    + 
Sbjct: 72  SEHRALMS-ELKILIHIGHHL-NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR---SK 126
Query: 469 KNQFI--ASCYC-FLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNA 525
           +N+F+     Y  FLT    +     VA  ++++    +   +HR++ +RNI L E+   
Sbjct: 127 RNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVV 183
Query: 526 RVGNFGMARCVNDDTESPQFYSTN----PASW-----------SMGIDIFAYGIVLLEVL 570
           ++ +FG+AR +  D   P +        P  W           ++  D++++G++L E+ 
Sbjct: 184 KIXDFGLARDIYKD---PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 240
Query: 571 S-GQTP 575
           S G +P
Sbjct: 241 SLGASP 246

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 94/200 (47%), Gaps = 30/200 (15%)
Query: 392 GAVYHGRLNGKNLAIK-RTEHEVITKLEMQLVQHATHH---HPNIVRLLGTCLTDGPHSF 447
           G VY G     +L +  +T  E   ++E  L + A      HPN+V+LLG C T  P  +
Sbjct: 29  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-TREPPFY 87
Query: 448 LVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSY 507
           ++ E+   G+L D+L      +   +   Y          +   ++ A++Y+      ++
Sbjct: 88  IITEFMTYGNLLDYLRECNRQEVNAVVLLY----------MATQISSAMEYLE---KKNF 134
Query: 508 VHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SMG 556
           +HR++ +RN  + E    +V +FG++R +  DT +    +  P  W           S+ 
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIK 194
Query: 557 IDIFAYGIVLLEVLS-GQTP 575
            D++A+G++L E+ + G +P
Sbjct: 195 SDVWAFGVLLWEIATYGMSP 214

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 65.1 bits (157), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 94/200 (47%), Gaps = 30/200 (15%)
Query: 392 GAVYHGRLNGKNLAIK-RTEHEVITKLEMQLVQHATHH---HPNIVRLLGTCLTDGPHSF 447
           G VY G     +L +  +T  E   ++E  L + A      HPN+V+LLG C T  P  +
Sbjct: 28  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-TREPPFY 86
Query: 448 LVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSY 507
           ++ E+   G+L D+L      +   +   Y          +   ++ A++Y+      ++
Sbjct: 87  IITEFMTYGNLLDYLRECNRQEVNAVVLLY----------MATQISSAMEYLE---KKNF 133
Query: 508 VHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SMG 556
           +HR++ +RN  + E    +V +FG++R +  DT +    +  P  W           S+ 
Sbjct: 134 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIK 193
Query: 557 IDIFAYGIVLLEVLS-GQTP 575
            D++A+G++L E+ + G +P
Sbjct: 194 SDVWAFGVLLWEIATYGMSP 213

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 88/187 (47%), Gaps = 42/187 (22%)
Query: 410 EHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSF-LVFEYAKNGSLKDWL--HG-G 465
           +H    K E+ +++  T +H +I++  G C   G  S  LV EY   GSL+D+L  H  G
Sbjct: 58  QHRSGWKQEIDILR--TLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIG 115
Query: 466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNA 525
           LA                Q L     +   + Y+H   +  Y+HRN+ +RN+ LD +   
Sbjct: 116 LA----------------QLLLFAQQICEGMAYLH---SQHYIHRNLAARNVLLDNDRLV 156
Query: 526 RVGNFGMARC---------VNDDTESPQFYST----NPASWSMGIDIFAYGIVLLEVL-- 570
           ++G+FG+A+          V +D +SP F+          +    D++++G+ L E+L  
Sbjct: 157 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTH 216
Query: 571 --SGQTP 575
             S Q+P
Sbjct: 217 CDSSQSP 223

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 57/212 (26%), Positives = 103/212 (48%), Gaps = 41/212 (19%)
Query: 392 GAVYHGRL--NGKNLAIK-------RTEHEVITKLE---MQLVQHATHHHPNIVRLLGTC 439
           G V+ GRL  +   +AIK         E E+I K +    ++   +  +HPNIV+L G  
Sbjct: 33  GLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYG-L 91
Query: 440 LTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYM 499
           + + P   +V E+   G L           ++ +   +  + WS +LR+ LD+A+ ++YM
Sbjct: 92  MHNPPR--MVMEFVPCGDLY----------HRLLDKAHP-IKWSVKLRLMLDIALGIEYM 138
Query: 500 HHVMNPSYVHRNIKSRNIF---LDEE--FNARVGNFGMAR---------CVNDDTESPQF 545
            +  NP  VHR+++S NIF   LDE     A+V +FG ++           N    +P+ 
Sbjct: 139 QN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQSVHSVSGLLGNFQWMAPET 197
Query: 546 YSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
                 S++   D +++ ++L  +L+G+ P +
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 98/215 (45%), Gaps = 41/215 (19%)
Query: 392 GAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATH-----HHPNIVRLLGTCLTDGPHS 446
           G VY G+ +G ++A+K       T  ++Q  ++         H NI+  +G   +  P  
Sbjct: 22  GTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG--YSTKPQL 78
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
            +V ++ +  SL   LH         I + +  +   + + I    A  + Y+H     S
Sbjct: 79  AIVTQWCEGSSLYHHLH--------IIETKFEMI---KLIDIARQTAQGMDYLH---AKS 124
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQF-----------------YSTN 549
            +HR++KS NIFL E+   ++G+FG+A   +  + S QF                    N
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184
Query: 550 PASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDE 584
           P  +S   D++A+GIVL E+++GQ P +    +D+
Sbjct: 185 P--YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 217

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 94/195 (48%), Gaps = 26/195 (13%)
Query: 400 NGKNLAIKRTEHEVITKLEMQLVQHATH-----HHPNIVRLLGTCLTDGPHS-FLVFEYA 453
           +GK L  K  ++  +T+ E Q++    +      HPNIVR     +     + ++V EY 
Sbjct: 30  DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC 89
Query: 454 KNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSY--VHRN 511
           + G L   +  G   + Q++   +        LR+   + +AL+  H   +  +  +HR+
Sbjct: 90  EGGDLASVITKG-TKERQYLDEEFV-------LRVMTQLTLALKECHRRSDGGHTVLHRD 141
Query: 512 IKSRNIFLDEEFNARVGNFGMARCVNDDTE-------SPQFYS---TNPASWSMGIDIFA 561
           +K  N+FLD + N ++G+FG+AR +N DT        +P + S    N  S++   DI++
Sbjct: 142 LKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWS 201
Query: 562 YGIVLLEVLSGQTPI 576
            G +L E+ +   P 
Sbjct: 202 LGCLLYELCALMPPF 216

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 51/195 (26%), Positives = 94/195 (48%), Gaps = 26/195 (13%)
Query: 400 NGKNLAIKRTEHEVITKLEMQLVQHATH-----HHPNIVRLLGTCLTDGPHS-FLVFEYA 453
           +GK L  K  ++  +T+ E Q++    +      HPNIVR     +     + ++V EY 
Sbjct: 30  DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC 89
Query: 454 KNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSY--VHRN 511
           + G L   +  G   + Q++   +        LR+   + +AL+  H   +  +  +HR+
Sbjct: 90  EGGDLASVITKG-TKERQYLDEEFV-------LRVMTQLTLALKECHRRSDGGHTVLHRD 141
Query: 512 IKSRNIFLDEEFNARVGNFGMARCVNDDTE-------SPQFYS---TNPASWSMGIDIFA 561
           +K  N+FLD + N ++G+FG+AR +N DT        +P + S    N  S++   DI++
Sbjct: 142 LKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWS 201
Query: 562 YGIVLLEVLSGQTPI 576
            G +L E+ +   P 
Sbjct: 202 LGCLLYELCALMPPF 216

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 98/215 (45%), Gaps = 41/215 (19%)
Query: 392 GAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATH-----HHPNIVRLLGTCLTDGPHS 446
           G VY G+ +G ++A+K       T  ++Q  ++         H NI+  +G   +  P  
Sbjct: 42  GTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG--YSTKPQL 98
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
            +V ++ +  SL   LH         I + +  +   + + I    A  + Y+H     S
Sbjct: 99  AIVTQWCEGSSLYHHLH--------IIETKFEMI---KLIDIARQTAQGMDYLH---AKS 144
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQF-----------------YSTN 549
            +HR++KS NIFL E+   ++G+FG+A   +  + S QF                    N
Sbjct: 145 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 204
Query: 550 PASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDE 584
           P  +S   D++A+GIVL E+++GQ P +    +D+
Sbjct: 205 P--YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 237

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 55/215 (25%), Positives = 98/215 (45%), Gaps = 41/215 (19%)
Query: 392 GAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATH-----HHPNIVRLLGTCLTDGPHS 446
           G VY G+ +G ++A+K       T  ++Q  ++         H NI+  +G   +  P  
Sbjct: 50  GTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG--YSTKPQL 106
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
            +V ++ +  SL   LH         I + +  +   + + I    A  + Y+H     S
Sbjct: 107 AIVTQWCEGSSLYHHLH--------IIETKFEMI---KLIDIARQTAQGMDYLH---AKS 152
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQF-----------------YSTN 549
            +HR++KS NIFL E+   ++G+FG+A   +  + S QF                    N
Sbjct: 153 IIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 212
Query: 550 PASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDE 584
           P  +S   D++A+GIVL E+++GQ P +    +D+
Sbjct: 213 P--YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 245

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 99/215 (46%), Gaps = 41/215 (19%)
Query: 392 GAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATH-----HHPNIVRLLGTCLTDGPHS 446
           G VY G+ +G ++A+K       T  ++Q  ++         H NI+  +G   +  P  
Sbjct: 38  GTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG--YSTKPQL 94
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
            +V ++ +  SL   LH   A + +F           + + I    A  + Y+H     S
Sbjct: 95  AIVTQWCEGSSLYHHLH---ASETKF--------EMKKLIDIARQTARGMDYLH---AKS 140
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQF-----------------YSTN 549
            +HR++KS NIFL E+   ++G+FG+A   +  + S QF                   +N
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200
Query: 550 PASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDE 584
           P  +S   D++A+GIVL E+++GQ P +    +D+
Sbjct: 201 P--YSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 233

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/200 (24%), Positives = 94/200 (47%), Gaps = 30/200 (15%)
Query: 392 GAVYHGRLNGKNLAIK-RTEHEVITKLEMQLVQHATHH---HPNIVRLLGTCLTDGPHSF 447
           G VY G     +L +  +T  E   ++E  L + A      HPN+V+LLG C T  P  +
Sbjct: 29  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVC-TREPPFY 87
Query: 448 LVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSY 507
           ++ E+   G+L D+L      +   +   Y          +   ++ A++Y+      ++
Sbjct: 88  IITEFMTYGNLLDYLRECNRQEVNAVVLLY----------MATQISSAMEYLE---KKNF 134
Query: 508 VHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SMG 556
           +HR++ +RN  + E    +V +FG++R +  DT +    +  P  W           S+ 
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSIK 194
Query: 557 IDIFAYGIVLLEVLS-GQTP 575
            D++A+G++L E+ + G +P
Sbjct: 195 SDVWAFGVLLWEIATYGMSP 214

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 64.7 bits (156), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 47/185 (25%), Positives = 91/185 (49%), Gaps = 26/185 (14%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
           +EH  +   E++++ H  HH  N+V LLG C   G    ++ E+ K G+L  +L    + 
Sbjct: 74  SEHRALMS-ELKILIHIGHHL-NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR---SK 128
Query: 469 KNQFI----ASCYC-FLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEF 523
           +N+F+       Y  FLT    +     VA  ++++    +   +HR++ +RNI L E+ 
Sbjct: 129 RNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKN 185
Query: 524 NARVGNFGMARCVNDDTESPQFYSTN-PASW-----------SMGIDIFAYGIVLLEVLS 571
             ++ +FG+AR +  D +  +      P  W           ++  D++++G++L E+ S
Sbjct: 186 VVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
Query: 572 -GQTP 575
            G +P
Sbjct: 246 LGASP 250

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 65/248 (26%), Positives = 108/248 (43%), Gaps = 55/248 (22%)
Query: 366 KRLLESYSIEDLRRATEKFN-----SSNRIE--------GAVYHGRLN--GKN---LAIK 407
           +  ++ ++ ED  +A  +F      S  +IE        G V  GRL   GK    +AIK
Sbjct: 4   RTFVDPFTFEDPNQAVREFAKEIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIK 63
Query: 408 RTEHEVITKLEMQLVQHAT----HHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH 463
             +     K     +  A+      HPNI+ L G      P   ++ EY +NGSL     
Sbjct: 64  TLKAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTKCKP-VMIITEYMENGSL----- 117
Query: 464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEF 523
                 + F+       T  Q + +   +   ++Y+  +   S VHR++ +RNI ++   
Sbjct: 118 ------DAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSDM---SAVHRDLAARNILVNSNL 168
Query: 524 NARVGNFGMARCVNDDTESPQFYSTN----PASWSM-----------GIDIFAYGIVLLE 568
             +V +FGM+R + DD E+   Y+T     P  W+              D+++YGIV+ E
Sbjct: 169 VCKVSDFGMSRVLEDDPEAA--YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWE 226
Query: 569 VLS-GQTP 575
           V+S G+ P
Sbjct: 227 VMSYGERP 234

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/169 (25%), Positives = 81/169 (47%), Gaps = 30/169 (17%)
Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCF-------- 479
           +HP++++L G C  DGP   L+ EYAK GSL+ +L     +   ++ S            
Sbjct: 84  NHPHVIKLYGACSQDGP-LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 480 ----LTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARC 535
               LT    +     ++  +QY+  +   S VHR++ +RNI + E    ++ +FG++R 
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEM---SLVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 536 V-NDDTESPQFYSTNPASWSMGI------------DIFAYGIVLLEVLS 571
           V  +D+   +     P  W M I            D++++G++L E+++
Sbjct: 200 VYEEDSXVKRSQGRIPVKW-MAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 94/209 (44%), Gaps = 40/209 (19%)
Query: 392 GAVYHGRLN--GKN---LAIKRTEHEVITKLEMQLVQHAT----HHHPNIVRLLGTCLTD 442
           G V  GRL   GK    +AIK  +     +   + +  A+      HPNI+RL G     
Sbjct: 30  GEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNIIRLEGVVTNS 89
Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
            P   L  E+ +NG+L  +L        QF        T  Q + +   +A  ++Y+  +
Sbjct: 90  MPVMILT-EFMENGALDSFLR---LNDGQF--------TVIQLVGMLRGIASGMRYLAEM 137
Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV----NDDTESPQFYSTNPASWSM--- 555
              SYVHR++ +RNI ++     +V +FG++R +    +D TE+       P  W+    
Sbjct: 138 ---SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRWTAPEA 194
Query: 556 --------GIDIFAYGIVLLEVLS-GQTP 575
                     D ++YGIV+ EV+S G+ P
Sbjct: 195 IAFRKFTSASDAWSYGIVMWEVMSFGERP 223

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/163 (30%), Positives = 79/163 (48%), Gaps = 33/163 (20%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HPNI+RL G      P   +V E  +NGSL  +L    A   QF        T  Q + +
Sbjct: 105 HPNIIRLEGVVTKSKP-VMIVTEXMENGSLDSFLRKHDA---QF--------TVIQLVGM 152
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYST 548
              +A  ++Y+  +     VHR++ +RNI ++     +V +FG++R + DD E+   Y+T
Sbjct: 153 LRGIASGMKYLSDM---GAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAA--YTT 207
Query: 549 N----PASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
                P  W           +   D+++YGIVL EV+S G+ P
Sbjct: 208 RGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 52/187 (27%), Positives = 87/187 (46%), Gaps = 42/187 (22%)
Query: 410 EHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSF-LVFEYAKNGSLKDWL--HG-G 465
           +H    K E+ +++  T +H +I++  G C   G  S  LV EY   GSL+D+L  H  G
Sbjct: 58  QHRSGWKQEIDILR--TLYHEHIIKYKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRHSIG 115
Query: 466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNA 525
           LA                Q L     +   + Y+H      Y+HRN+ +RN+ LD +   
Sbjct: 116 LA----------------QLLLFAQQICEGMAYLH---AQHYIHRNLAARNVLLDNDRLV 156
Query: 526 RVGNFGMARC---------VNDDTESPQFYST----NPASWSMGIDIFAYGIVLLEVL-- 570
           ++G+FG+A+          V +D +SP F+          +    D++++G+ L E+L  
Sbjct: 157 KIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTH 216
Query: 571 --SGQTP 575
             S Q+P
Sbjct: 217 CDSSQSP 223

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 102/212 (48%), Gaps = 41/212 (19%)
Query: 392 GAVYHGRL--NGKNLAIK-------RTEHEVITKLE---MQLVQHATHHHPNIVRLLGTC 439
           G V+ GRL  +   +AIK         E E+I K +    ++   +  +HPNIV+L G  
Sbjct: 33  GLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYG-L 91
Query: 440 LTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYM 499
           + + P   +V E+   G   D  H  L   +         + WS +LR+ LD+A+ ++YM
Sbjct: 92  MHNPPR--MVMEFVPCG---DLYHRLLDKAHP--------IKWSVKLRLMLDIALGIEYM 138
Query: 500 HHVMNPSYVHRNIKSRNIF---LDEE--FNARVGNFGMAR---------CVNDDTESPQF 545
            +  NP  VHR+++S NIF   LDE     A+V +F +++           N    +P+ 
Sbjct: 139 QN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQSVHSVSGLLGNFQWMAPET 197
Query: 546 YSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
                 S++   D +++ ++L  +L+G+ P +
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGEGPFD 229

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 50/195 (25%), Positives = 94/195 (48%), Gaps = 26/195 (13%)
Query: 400 NGKNLAIKRTEHEVITKLEMQLVQHATH-----HHPNIVRLLGTCLTDGPHS-FLVFEYA 453
           +GK L  K  ++  +T+ E Q++    +      HPNIVR     +     + ++V EY 
Sbjct: 30  DGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC 89
Query: 454 KNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSY--VHRN 511
           + G L   +  G   + Q++   +        LR+   + +AL+  H   +  +  +HR+
Sbjct: 90  EGGDLASVITKG-TKERQYLDEEFV-------LRVMTQLTLALKECHRRSDGGHTVLHRD 141
Query: 512 IKSRNIFLDEEFNARVGNFGMARCVNDDTE-------SPQFYS---TNPASWSMGIDIFA 561
           +K  N+FLD + N ++G+FG+AR +N D +       +P + S    N  S++   DI++
Sbjct: 142 LKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMSPEQMNRMSYNEKSDIWS 201
Query: 562 YGIVLLEVLSGQTPI 576
            G +L E+ +   P 
Sbjct: 202 LGCLLYELCALMPPF 216

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 58/212 (27%), Positives = 103/212 (48%), Gaps = 47/212 (22%)
Query: 392 GAVYHGRL---NGKN---LAIKR-----TEHEVITKL-EMQLVQHATHHHPNIVRLLGTC 439
           G VY G L   +GK    +AIK      TE + +  L E  ++   +HH  NI+RL G  
Sbjct: 58  GEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH--NIIRLEGVI 115
Query: 440 LTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYM 499
               P   ++ EY +NG+L           ++F+       +  Q + +   +A  ++Y+
Sbjct: 116 SKYKPM-MIITEYMENGAL-----------DKFLREKDGEFSVLQLVGMLRGIAAGMKYL 163
Query: 500 HHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN----PASWSM 555
               N +YVHR++ +RNI ++     +V +FG++R + DD E+   Y+T+    P  W+ 
Sbjct: 164 A---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT--YTTSGGKIPIRWTA 218
Query: 556 -----------GIDIFAYGIVLLEVLS-GQTP 575
                        D++++GIV+ EV++ G+ P
Sbjct: 219 PEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 63.2 bits (152), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 91/183 (49%), Gaps = 24/183 (13%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
           +EH  +   E++++ H  HH  N+V LLG C   G    ++ E+ K G+L  +L    + 
Sbjct: 72  SEHRALMS-ELKILIHIGHHL-NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR---SK 126
Query: 469 KNQFI--ASCYC-FLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNA 525
           +N+F+     Y  FLT    +     VA  ++++    +   +HR++ +RNI L E+   
Sbjct: 127 RNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKXIHRDLAARNILLSEKNVV 183
Query: 526 RVGNFGMARCVNDDTESPQFYSTN-PASW-----------SMGIDIFAYGIVLLEVLS-G 572
           ++ +FG+AR +  D +  +      P  W           ++  D++++G++L E+ S G
Sbjct: 184 KICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLG 243
Query: 573 QTP 575
            +P
Sbjct: 244 ASP 246

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 90/187 (48%), Gaps = 28/187 (14%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
           +EH  +   E++++ H  HH  N+V LLG C   G    ++ E+ K G+L  +L    + 
Sbjct: 72  SEHRALMS-ELKILIHIGHHL-NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR---SK 126
Query: 469 KNQFIASCYC-------FLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE 521
           +N+F+            FLT    +     VA  ++++    +   +HR++ +RNI L E
Sbjct: 127 RNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSE 183
Query: 522 EFNARVGNFGMARCVNDDTESPQFYSTN-PASW-----------SMGIDIFAYGIVLLEV 569
           +   ++ +FG+AR +  D +  +      P  W           ++  D++++G++L E+
Sbjct: 184 KNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243
Query: 570 LS-GQTP 575
            S G +P
Sbjct: 244 FSLGASP 250

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 42/169 (24%), Positives = 80/169 (47%), Gaps = 30/169 (17%)
Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCF-------- 479
           +HP++++L G C  DGP   L+ EYAK GSL+ +L     +   ++ S            
Sbjct: 84  NHPHVIKLYGACSQDGP-LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 480 ----LTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARC 535
               LT    +     ++  +QY+  +     VHR++ +RNI + E    ++ +FG++R 
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 536 V-NDDTESPQFYSTNPASWSMGI------------DIFAYGIVLLEVLS 571
           V  +D+   +     P  W M I            D++++G++L E+++
Sbjct: 200 VYEEDSXVKRSQGRIPVKW-MAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 62.8 bits (151), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 90/187 (48%), Gaps = 28/187 (14%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
           +EH  +   E++++ H  HH  N+V LLG C   G    ++ E+ K G+L  +L    + 
Sbjct: 63  SEHRALMS-ELKILIHIGHHL-NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR---SK 117
Query: 469 KNQFIASCYC-------FLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE 521
           +N+F+            FLT    +     VA  ++++    +   +HR++ +RNI L E
Sbjct: 118 RNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSE 174
Query: 522 EFNARVGNFGMARCVNDDTESPQFYSTN-PASW-----------SMGIDIFAYGIVLLEV 569
           +   ++ +FG+AR +  D +  +      P  W           ++  D++++G++L E+
Sbjct: 175 KNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 234
Query: 570 LS-GQTP 575
            S G +P
Sbjct: 235 FSLGASP 241

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 90/187 (48%), Gaps = 28/187 (14%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
           +EH  +   E++++ H  HH  N+V LLG C   G    ++ E+ K G+L  +L    + 
Sbjct: 72  SEHRALMS-ELKILIHIGHHL-NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR---SK 126
Query: 469 KNQFIASCYC-------FLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE 521
           +N+F+            FLT    +     VA  ++++    +   +HR++ +RNI L E
Sbjct: 127 RNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSE 183
Query: 522 EFNARVGNFGMARCVNDDTESPQFYSTN-PASW-----------SMGIDIFAYGIVLLEV 569
           +   ++ +FG+AR +  D +  +      P  W           ++  D++++G++L E+
Sbjct: 184 KNVVKICDFGLARDIYKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243
Query: 570 LS-GQTP 575
            S G +P
Sbjct: 244 FSLGASP 250

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 62.4 bits (150), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 43/191 (22%), Positives = 91/191 (47%), Gaps = 24/191 (12%)
Query: 402 KNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW 461
           K+ A ++   ++++++EM         H NI+ LLG C  DGP  +++ EYA  G+L+++
Sbjct: 76  KDDATEKDLSDLVSEMEMM---KMIGKHKNIINLLGACTQDGP-LYVIVEYASKGNLREY 131
Query: 462 LHG----GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNI 517
           L      G+             +T+   +     +A  ++Y+    +   +HR++ +RN+
Sbjct: 132 LRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNV 188
Query: 518 FLDEEFNARVGNFGMARCVND-DTESPQFYSTNPASW-----------SMGIDIFAYGIV 565
            + E    R+ +FG+AR +N+ D          P  W           +   D++++G++
Sbjct: 189 LVTENNVMRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 248
Query: 566 LLEVLS-GQTP 575
           + E+ + G +P
Sbjct: 249 MWEIFTLGGSP 259

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 96/198 (48%), Gaps = 38/198 (19%)
Query: 402 KNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW 461
           K+ A ++   ++I+++EM         H NI+ LLG C  DGP  +++ EYA  G+L+++
Sbjct: 54  KSDATEKDLSDLISEMEMM---KMIGKHKNIINLLGACTQDGP-LYVIVEYASKGNLREY 109
Query: 462 LHGGLAMKNQFIASCYC-------FLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKS 514
           L    A +   +  CY         L+    +     VA  ++Y+    +   +HR++ +
Sbjct: 110 LQ---ARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 163
Query: 515 RNIFLDEEFNARVGNFGMARCVNDDTESPQFY--STN---PASW-----------SMGID 558
           RN+ + E+   ++ +FG+AR    D     +Y  +TN   P  W           +   D
Sbjct: 164 RNVLVTEDNVMKIADFGLAR----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 219
Query: 559 IFAYGIVLLEVLS-GQTP 575
           ++++G++L E+ + G +P
Sbjct: 220 VWSFGVLLWEIFTLGGSP 237

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 93/219 (42%), Gaps = 47/219 (21%)
Query: 392 GAVYHGRLNG-------KNLAIKRTEHEVITKLEMQLVQHAT----HHHPNIVRLLGTCL 440
           G V+  R  G         +A+K  + E    ++    + A       +PNIV+LLG C 
Sbjct: 61  GRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCA 120
Query: 441 TDGPHSFLVFEYAKNGSLKDWL------------HGGLAMKNQFIASCYCFLTWSQRLRI 488
              P   L+FEY   G L ++L            H  L+ + +  +     L+ +++L I
Sbjct: 121 VGKPMC-LLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCI 179
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYST 548
              VA  + Y+       +VHR++ +RN  + E    ++ +FG++R    +  S  +Y  
Sbjct: 180 ARQVAAGMAYLSER---KFVHRDLATRNCLVGENMVVKIADFGLSR----NIYSADYYKA 232
Query: 549 N-----PASW-----------SMGIDIFAYGIVLLEVLS 571
           +     P  W           +   D++AYG+VL E+ S
Sbjct: 233 DGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 62.4 bits (150), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/169 (24%), Positives = 80/169 (47%), Gaps = 30/169 (17%)
Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCF-------- 479
           +HP++++L G C  DGP   L+ EYAK GSL+ +L     +   ++ S            
Sbjct: 84  NHPHVIKLYGACSQDGP-LLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 480 ----LTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARC 535
               LT    +     ++  +QY+  +     VHR++ +RNI + E    ++ +FG++R 
Sbjct: 143 DERALTMGDLISFAWQISQGMQYLAEM---KLVHRDLAARNILVAEGRKMKISDFGLSRD 199
Query: 536 V-NDDTESPQFYSTNPASWSMGI------------DIFAYGIVLLEVLS 571
           V  +D+   +     P  W M I            D++++G++L E+++
Sbjct: 200 VYEEDSYVKRSQGRIPVKW-MAIESLFDHIYTTQSDVWSFGVLLWEIVT 247

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/191 (21%), Positives = 91/191 (47%), Gaps = 24/191 (12%)
Query: 402 KNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW 461
           K+ A ++   ++++++EM         H NI+ LLG C  DGP  +++ EYA  G+L+++
Sbjct: 76  KDDATEKDLSDLVSEMEMM---KMIGKHKNIINLLGACTQDGP-LYVIVEYASKGNLREY 131
Query: 462 LHG----GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNI 517
           L      G+             +T+   +     +A  ++Y+    +   +HR++ +RN+
Sbjct: 132 LRARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNV 188
Query: 518 FLDEEFNARVGNFGMARCVND-DTESPQFYSTNPASW-----------SMGIDIFAYGIV 565
            + E    ++ +FG+AR +N+ D          P  W           +   D++++G++
Sbjct: 189 LVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 248
Query: 566 LLEVLS-GQTP 575
           + E+ + G +P
Sbjct: 249 MWEIFTLGGSP 259

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 96/198 (48%), Gaps = 38/198 (19%)
Query: 402 KNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW 461
           K+ A ++   ++I+++EM         H NI+ LLG C  DGP  +++ EYA  G+L+++
Sbjct: 69  KSDATEKDLSDLISEMEMM---KMIGKHKNIINLLGACTQDGP-LYVIVEYASKGNLREY 124
Query: 462 LHGGLAMKNQFIASCYC-------FLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKS 514
           L    A +   +  CY         L+    +     VA  ++Y+    +   +HR++ +
Sbjct: 125 LQ---ARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAA 178
Query: 515 RNIFLDEEFNARVGNFGMARCVNDDTESPQFY--STN---PASW-----------SMGID 558
           RN+ + E+   ++ +FG+AR    D     +Y  +TN   P  W           +   D
Sbjct: 179 RNVLVTEDNVMKIADFGLAR----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSD 234
Query: 559 IFAYGIVLLEVLS-GQTP 575
           ++++G++L E+ + G +P
Sbjct: 235 VWSFGVLLWEIFTLGGSP 252

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 62.0 bits (149), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 90/187 (48%), Gaps = 28/187 (14%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
           +EH  +   E++++ H  HH  N+V LLG C   G    ++ E+ K G+L  +L    + 
Sbjct: 109 SEHRALMS-ELKILIHIGHHL-NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR---SK 163
Query: 469 KNQFIASCYC-------FLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE 521
           +N+F+            FLT    +     VA  ++++    +   +HR++ +RNI L E
Sbjct: 164 RNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSE 220
Query: 522 EFNARVGNFGMARCVNDDTESPQFYSTN-PASW-----------SMGIDIFAYGIVLLEV 569
           +   ++ +FG+AR +  D +  +      P  W           ++  D++++G++L E+
Sbjct: 221 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 280
Query: 570 LS-GQTP 575
            S G +P
Sbjct: 281 FSLGASP 287

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 47/186 (25%), Positives = 91/186 (48%), Gaps = 27/186 (14%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
           +EH  +   E++++ H  HH  N+V LLG C   G    ++ E+ K G+L  +L    + 
Sbjct: 73  SEHRALMS-ELKILIHIGHHL-NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR---SK 127
Query: 469 KNQFI-----ASCYC-FLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEE 522
           +N+F+        Y  FLT    +     VA  ++++    +   +HR++ +RNI L E+
Sbjct: 128 RNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEK 184
Query: 523 FNARVGNFGMARCVNDDTESPQFYSTN-PASW-----------SMGIDIFAYGIVLLEVL 570
              ++ +FG+AR +  D +  +      P  W           ++  D++++G++L E+ 
Sbjct: 185 NVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244
Query: 571 S-GQTP 575
           S G +P
Sbjct: 245 SLGASP 250

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 93/196 (47%), Gaps = 35/196 (17%)
Query: 400 NGKNLAIKRTEHEVITKLEM---QLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNG 456
            GK +A+K+ +     + E+   ++V    +HH N+V +  + L  G   ++V E+ + G
Sbjct: 69  TGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLV-GDELWVVMEFLEGG 127
Query: 457 SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRN 516
           +L D +     M  + IA+            +CL V  AL Y+H   N   +HR+IKS +
Sbjct: 128 ALTDIV-THTRMNEEQIAT------------VCLSVLRALSYLH---NQGVIHRDIKSDS 171
Query: 517 IFLDEEFNARVGNFGMARCVNDDTE------------SPQFYSTNPASWSMGIDIFAYGI 564
           I L  +   ++ +FG    V+ +              +P+  S  P  +   +DI++ GI
Sbjct: 172 ILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLP--YGTEVDIWSLGI 229
Query: 565 VLLEVLSGQTP-INRP 579
           +++E++ G+ P  N P
Sbjct: 230 MVIEMIDGEPPYFNEP 245

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 62.0 bits (149), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 90/187 (48%), Gaps = 28/187 (14%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
           +EH  +   E++++ H  HH  N+V LLG C   G    ++ E+ K G+L  +L    + 
Sbjct: 63  SEHRALMS-ELKILIHIGHHL-NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLR---SK 117
Query: 469 KNQFIASCYC-------FLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE 521
           +N+F+            FLT    +     VA  ++++    +   +HR++ +RNI L E
Sbjct: 118 RNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSE 174
Query: 522 EFNARVGNFGMARCVNDDTESPQFYSTN-PASW-----------SMGIDIFAYGIVLLEV 569
           +   ++ +FG+AR +  D +  +      P  W           ++  D++++G++L E+
Sbjct: 175 KNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 234
Query: 570 LS-GQTP 575
            S G +P
Sbjct: 235 FSLGASP 241

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 99/201 (49%), Gaps = 34/201 (16%)
Query: 392 GAVYHGRLNG-KNLAIKRTEHEVITK----LEMQLVQHATHHHPNIVRLLGTCLTDGPHS 446
           G V+ G  NG   +A+K  +   ++      E  L++   H    +VRL    +T  P  
Sbjct: 23  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQR--LVRLYA-VVTQEP-I 78
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           +++ EY +NGSL D+L     +K          LT ++ L +   +A  + ++      +
Sbjct: 79  YIITEYMENGSLVDFLKTPSGIK----------LTINKLLDMAAQIAEGMAFIEE---RN 125
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SM 555
           Y+HRN+++ NI + +  + ++ +FG+AR + D+  + +  +  P  W           ++
Sbjct: 126 YIHRNLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 185
Query: 556 GIDIFAYGIVLLEVLS-GQTP 575
             D++++GI+L E+++ G+ P
Sbjct: 186 KSDVWSFGILLTEIVTHGRIP 206

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/191 (21%), Positives = 91/191 (47%), Gaps = 24/191 (12%)
Query: 402 KNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW 461
           K+ A ++   ++++++EM         H NI+ LLG C  DGP  +++ EYA  G+L+++
Sbjct: 76  KDDATEKDLSDLVSEMEMM---KMIGKHKNIINLLGACTQDGP-LYVIVEYASKGNLREY 131
Query: 462 LHG----GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNI 517
           L      G+             +T+   +     +A  ++Y+    +   +HR++ +RN+
Sbjct: 132 LRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNV 188
Query: 518 FLDEEFNARVGNFGMARCVND-DTESPQFYSTNPASW-----------SMGIDIFAYGIV 565
            + E    ++ +FG+AR +N+ D          P  W           +   D++++G++
Sbjct: 189 LVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 248
Query: 566 LLEVLS-GQTP 575
           + E+ + G +P
Sbjct: 249 MWEIFTLGGSP 259

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 66/265 (24%), Positives = 109/265 (41%), Gaps = 47/265 (17%)
Query: 339 TTSDKKVSFEGSQSTIEGQIIDTAE-QHKRLL---ESYSIEDLRRATEKFNSSNRIEGAV 394
           T+ DK        S  E    D  E + K+L    ++  I D+      F S   +   V
Sbjct: 300 TSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIADIELGCGNFGS---VRQGV 356
Query: 395 YHGRLNGKNLAIKRTEHEVITKLEMQLVQHATHHH----PNIVRLLGTCLTDGPHSFLVF 450
           Y  R    ++AIK  +         ++++ A   H    P IVRL+G C  +     LV 
Sbjct: 357 YRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA--LMLVM 414
Query: 451 EYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHR 510
           E A  G L  +L G    K + I         S    +   V+M ++Y+      ++VHR
Sbjct: 415 EMAGGGPLHKFLVG----KREEIPV-------SNVAELLHQVSMGMKYLE---EKNFVHR 460
Query: 511 NIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN-----PASW-----------S 554
           N+ +RN+ L     A++ +FG+++ +  D     +Y+       P  W           S
Sbjct: 461 NLAARNVLLVNRHYAKISDFGLSKALGADD---SYYTARSAGKWPLKWYAPECINFRKFS 517
Query: 555 MGIDIFAYGIVLLEVLS-GQTPINR 578
              D+++YG+ + E LS GQ P  +
Sbjct: 518 SRSDVWSYGVTMWEALSYGQKPYKK 542

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 62.0 bits (149), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 90/187 (48%), Gaps = 28/187 (14%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
           +EH  +   E++++ H  HH  N+V LLG C   G    ++ E+ K G+L  +L    + 
Sbjct: 72  SEHRALMS-ELKILIHIGHHL-NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR---SK 126
Query: 469 KNQFIASCYC-------FLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE 521
           +N+F+            FLT    +     VA  ++++    +   +HR++ +RNI L E
Sbjct: 127 RNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSE 183
Query: 522 EFNARVGNFGMARCVNDDTESPQFYSTN-PASW-----------SMGIDIFAYGIVLLEV 569
           +   ++ +FG+AR +  D +  +      P  W           ++  D++++G++L E+
Sbjct: 184 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 243
Query: 570 LS-GQTP 575
            S G +P
Sbjct: 244 FSLGASP 250

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/187 (28%), Positives = 92/187 (49%), Gaps = 42/187 (22%)
Query: 410 EHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSF-LVFEYAKNGSLKDWL--HG-G 465
           +H    K E+ +++  T +H +I++  G C   G  S  LV EY   GSL+D+L  H  G
Sbjct: 75  QHRSGWKQEIDILR--TLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIG 132
Query: 466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNA 525
           LA            L ++Q+  IC  +A    Y+H      Y+HR++ +RN+ LD +   
Sbjct: 133 LAQ----------LLLFAQQ--ICEGMA----YLH---AQHYIHRDLAARNVLLDNDRLV 173
Query: 526 RVGNFGMARC---------VNDDTESPQFYST----NPASWSMGIDIFAYGIVLLEVL-- 570
           ++G+FG+A+          V +D +SP F+          +    D++++G+ L E+L  
Sbjct: 174 KIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTH 233
Query: 571 --SGQTP 575
             S Q+P
Sbjct: 234 CDSSQSP 240

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 90/187 (48%), Gaps = 28/187 (14%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
           +EH  +   E++++ H  HH  N+V LLG C   G    ++ E+ K G+L  +L    + 
Sbjct: 74  SEHRALMS-ELKILIHIGHHL-NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLR---SK 128
Query: 469 KNQFIASCYC-------FLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE 521
           +N+F+            FLT    +     VA  ++++    +   +HR++ +RNI L E
Sbjct: 129 RNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSE 185
Query: 522 EFNARVGNFGMARCVNDDTESPQFYSTN-PASW-----------SMGIDIFAYGIVLLEV 569
           +   ++ +FG+AR +  D +  +      P  W           ++  D++++G++L E+
Sbjct: 186 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 245
Query: 570 LS-GQTP 575
            S G +P
Sbjct: 246 FSLGASP 252

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 84/179 (46%), Gaps = 34/179 (18%)
Query: 418 EMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL--HGGLAMKNQFIAS 475
           E +L+ +  H H  IV+  G C+   P   +VFEY K+G L  +L  HG  A+    +A 
Sbjct: 65  EAELLTNLQHEH--IVKFYGVCVEGDP-LIMVFEYMKHGDLNKFLRAHGPDAV---LMAE 118
Query: 476 CY--CFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA 533
                 LT SQ L I   +A  + Y+    +  +VHR++ +RN  + E    ++G+FGM+
Sbjct: 119 GNPPTELTQSQMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMS 175
Query: 534 RCVNDDTESPQFYSTN-----PASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
           R    D  S  +Y        P  W           +   D+++ G+VL E+ + G+ P
Sbjct: 176 R----DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQP 230

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 78/168 (46%), Gaps = 34/168 (20%)
Query: 426 THHHPNIVRLLGTCLTDGPHSF-LVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQ 484
           T +H +IV+  G C   G  S  LV EY   GSL+D+L              +C +  +Q
Sbjct: 67  TLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL------------PRHC-VGLAQ 113
Query: 485 RLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARC--------- 535
            L     +   + Y+H      Y+HR + +RN+ LD +   ++G+FG+A+          
Sbjct: 114 LLLFAQQICEGMAYLH---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR 170
Query: 536 VNDDTESPQFYST----NPASWSMGIDIFAYGIVLLEVL----SGQTP 575
           V +D +SP F+          +    D++++G+ L E+L    S Q+P
Sbjct: 171 VREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQSP 218

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 100/208 (48%), Gaps = 38/208 (18%)
Query: 392 GAVYHGRLNGKN-LAIKRTEHEVITK----LEMQLVQHATHHHPNIVRLLGTCLTDGPHS 446
           G V+ G  NG   +AIK  +   ++      E Q+++   H    +V+L    +++ P  
Sbjct: 32  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE--KLVQLYAV-VSEEP-I 87
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           ++V EY   GSL D+L G +            +L   Q + +   +A  + Y+  +   +
Sbjct: 88  YIVIEYMSKGSLLDFLKGEMGK----------YLRLPQLVDMAAQIASGMAYVERM---N 134
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SM 555
           YVHR++++ NI + E    +V +FG+AR + D+  + +  +  P  W           ++
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 556 GIDIFAYGIVLLEVLS-GQTP----INR 578
             D++++GI+L E+ + G+ P    +NR
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNR 222

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/168 (27%), Positives = 78/168 (46%), Gaps = 34/168 (20%)
Query: 426 THHHPNIVRLLGTCLTDGPHSF-LVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQ 484
           T +H +IV+  G C   G  S  LV EY   GSL+D+L              +C +  +Q
Sbjct: 66  TLYHEHIVKYKGCCEDQGEKSVQLVMEYVPLGSLRDYL------------PRHC-VGLAQ 112
Query: 485 RLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARC--------- 535
            L     +   + Y+H      Y+HR + +RN+ LD +   ++G+FG+A+          
Sbjct: 113 LLLFAQQICEGMAYLH---AQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR 169
Query: 536 VNDDTESPQFYST----NPASWSMGIDIFAYGIVLLEVL----SGQTP 575
           V +D +SP F+          +    D++++G+ L E+L    S Q+P
Sbjct: 170 VREDGDSPVFWYAPECLKECKFYYASDVWSFGVTLYELLTYCDSNQSP 217

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/191 (21%), Positives = 91/191 (47%), Gaps = 24/191 (12%)
Query: 402 KNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW 461
           K+ A ++   ++++++EM         H NI+ LLG C  DGP  +++ EYA  G+L+++
Sbjct: 122 KDDATEKDLSDLVSEMEMM---KMIGKHKNIINLLGACTQDGP-LYVIVEYASKGNLREY 177
Query: 462 LHG----GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNI 517
           L      G+             +T+   +     +A  ++Y+    +   +HR++ +RN+
Sbjct: 178 LRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNV 234
Query: 518 FLDEEFNARVGNFGMARCVND-DTESPQFYSTNPASW-----------SMGIDIFAYGIV 565
            + E    ++ +FG+AR +N+ D          P  W           +   D++++G++
Sbjct: 235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 294
Query: 566 LLEVLS-GQTP 575
           + E+ + G +P
Sbjct: 295 MWEIFTLGGSP 305

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 90/187 (48%), Gaps = 28/187 (14%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
           +EH  +   E++++ H  HH  N+V LLG C   G    ++ E+ K G+L  +L    + 
Sbjct: 63  SEHRALMS-ELKILIHIGHHL-NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLR---SK 117
Query: 469 KNQFIASCYC-------FLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE 521
           +N+F+            FLT    +     VA  ++++    +   +HR++ +RNI L E
Sbjct: 118 RNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSE 174
Query: 522 EFNARVGNFGMARCVNDDTESPQFYSTN-PASW-----------SMGIDIFAYGIVLLEV 569
           +   ++ +FG+AR +  D +  +      P  W           ++  D++++G++L E+
Sbjct: 175 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 234
Query: 570 LS-GQTP 575
            S G +P
Sbjct: 235 FSLGASP 241

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 61.2 bits (147), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 90/187 (48%), Gaps = 28/187 (14%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
           +EH  +   E++++ H  HH  N+V LLG C   G    ++ E+ K G+L  +L    + 
Sbjct: 63  SEHRALMS-ELKILIHIGHHL-NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLR---SK 117
Query: 469 KNQFIASCYC-------FLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE 521
           +N+F+            FLT    +     VA  ++++    +   +HR++ +RNI L E
Sbjct: 118 RNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSE 174
Query: 522 EFNARVGNFGMARCVNDDTESPQFYSTN-PASW-----------SMGIDIFAYGIVLLEV 569
           +   ++ +FG+AR +  D +  +      P  W           ++  D++++G++L E+
Sbjct: 175 KNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 234
Query: 570 LS-GQTP 575
            S G +P
Sbjct: 235 FSLGASP 241

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 99/201 (49%), Gaps = 34/201 (16%)
Query: 392 GAVYHGRLNG-KNLAIKRTEHEVITK----LEMQLVQHATHHHPNIVRLLGTCLTDGPHS 446
           G V+ G  NG   +A+K  +   ++      E  L++   H    +VRL    +T  P  
Sbjct: 33  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQR--LVRLYA-VVTQEP-I 88
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           +++ EY +NGSL D+L     +K          LT ++ L +   +A  + ++      +
Sbjct: 89  YIITEYMENGSLVDFLKTPSGIK----------LTINKLLDMAAQIAEGMAFIEER---N 135
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SM 555
           Y+HR++++ NI + +  + ++ +FG+AR + D+  + +  +  P  W           ++
Sbjct: 136 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTI 195
Query: 556 GIDIFAYGIVLLEVLS-GQTP 575
             D++++GI+L E+++ G+ P
Sbjct: 196 KSDVWSFGILLTEIVTHGRIP 216

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/191 (21%), Positives = 91/191 (47%), Gaps = 24/191 (12%)
Query: 402 KNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW 461
           K+ A ++   ++++++EM         H NI+ LLG C  DGP  +++ EYA  G+L+++
Sbjct: 76  KDDATEKDLSDLVSEMEMM---KMIGKHKNIIHLLGACTQDGP-LYVIVEYASKGNLREY 131
Query: 462 LHG----GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNI 517
           L      G+             +T+   +     +A  ++Y+    +   +HR++ +RN+
Sbjct: 132 LRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNV 188
Query: 518 FLDEEFNARVGNFGMARCVND-DTESPQFYSTNPASW-----------SMGIDIFAYGIV 565
            + E    ++ +FG+AR +N+ D          P  W           +   D++++G++
Sbjct: 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 248
Query: 566 LLEVLS-GQTP 575
           + E+ + G +P
Sbjct: 249 MWEIFTLGGSP 259

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 99/201 (49%), Gaps = 34/201 (16%)
Query: 392 GAVYHGRLNG-KNLAIKRTEHEVITK----LEMQLVQHATHHHPNIVRLLGTCLTDGPHS 446
           G V+ G  NG   +A+K  +   ++      E  L++   H    +VRL    +T  P  
Sbjct: 35  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQR--LVRLYA-VVTQEP-I 90
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           +++ EY +NGSL D+L     +K          LT ++ L +   +A  + ++      +
Sbjct: 91  YIITEYMENGSLVDFLKTPSGIK----------LTINKLLDMAAQIAEGMAFIEER---N 137
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SM 555
           Y+HR++++ NI + +  + ++ +FG+AR + D+  + +  +  P  W           ++
Sbjct: 138 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTI 197
Query: 556 GIDIFAYGIVLLEVLS-GQTP 575
             D++++GI+L E+++ G+ P
Sbjct: 198 KSDVWSFGILLTEIVTHGRIP 218

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/191 (21%), Positives = 91/191 (47%), Gaps = 24/191 (12%)
Query: 402 KNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW 461
           K+ A ++   ++++++EM         H NI+ LLG C  DGP  +++ EYA  G+L+++
Sbjct: 65  KDDATEKDLSDLVSEMEMM---KMIGKHKNIINLLGACTQDGP-LYVIVEYASKGNLREY 120
Query: 462 LHG----GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNI 517
           L      G+             +T+   +     +A  ++Y+    +   +HR++ +RN+
Sbjct: 121 LRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNV 177
Query: 518 FLDEEFNARVGNFGMARCVND-DTESPQFYSTNPASW-----------SMGIDIFAYGIV 565
            + E    ++ +FG+AR +N+ D          P  W           +   D++++G++
Sbjct: 178 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 237
Query: 566 LLEVLS-GQTP 575
           + E+ + G +P
Sbjct: 238 MWEIFTLGGSP 248

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 94/203 (46%), Gaps = 34/203 (16%)
Query: 392 GAVYHGRLNGKN--LAIKRTEHEVITKLEMQLVQHA----THHHPNIVRLLGTCLTDGPH 445
           G V+ GRL   N  +A+K     +   L+ + +Q A     + HPNIVRL+G C    P 
Sbjct: 128 GEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP- 186
Query: 446 SFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNP 505
            ++V E  + G   D+L         F+ +    L     L++  D A  ++Y+    + 
Sbjct: 187 IYIVMELVQGG---DFL--------TFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SK 232
Query: 506 SYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDT--------ESPQFYST----NPASW 553
             +HR++ +RN  + E+   ++ +FGM+R   D          + P  ++     N   +
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRY 292
Query: 554 SMGIDIFAYGIVLLEVLS-GQTP 575
           S   D++++GI+L E  S G +P
Sbjct: 293 SSESDVWSFGILLWETFSLGASP 315

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 100/208 (48%), Gaps = 38/208 (18%)
Query: 392 GAVYHGRLNGKN-LAIKRTEHEVITK----LEMQLVQHATHHHPNIVRLLGTCLTDGPHS 446
           G V+ G  NG   +AIK  +   ++      E Q+++   H    +V+L    +++ P  
Sbjct: 32  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE--KLVQLYAV-VSEEP-I 87
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           ++V EY   GSL D+L G +            +L   Q + +   +A  + Y+  +   +
Sbjct: 88  YIVIEYMSKGSLLDFLKGEMGK----------YLRLPQLVDMAAQIASGMAYVERM---N 134
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SM 555
           YVHR++++ NI + E    +V +FG+AR + D+  + +  +  P  W           ++
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 556 GIDIFAYGIVLLEVLS-GQTP----INR 578
             D++++GI+L E+ + G+ P    +NR
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNR 222

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/191 (21%), Positives = 91/191 (47%), Gaps = 24/191 (12%)
Query: 402 KNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW 461
           K+ A ++   ++++++EM         H NI+ LLG C  DGP  +++ EYA  G+L+++
Sbjct: 68  KDDATEKDLSDLVSEMEMM---KMIGKHKNIINLLGACTQDGP-LYVIVEYASKGNLREY 123
Query: 462 LHG----GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNI 517
           L      G+             +T+   +     +A  ++Y+    +   +HR++ +RN+
Sbjct: 124 LRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNV 180
Query: 518 FLDEEFNARVGNFGMARCVND-DTESPQFYSTNPASW-----------SMGIDIFAYGIV 565
            + E    ++ +FG+AR +N+ D          P  W           +   D++++G++
Sbjct: 181 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 240
Query: 566 LLEVLS-GQTP 575
           + E+ + G +P
Sbjct: 241 MWEIFTLGGSP 251

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 60.8 bits (146), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 94/195 (48%), Gaps = 32/195 (16%)
Query: 402 KNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW 461
           K+ A ++   ++I+++EM         H NI+ LLG C  DGP  +++ EYA  G+L+++
Sbjct: 58  KSDATEKDLSDLISEMEMM---KMIGKHKNIINLLGACTQDGP-LYVIVEYASKGNLREY 113
Query: 462 LHG----GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNI 517
           L      GL        +    L+    +     VA  ++Y+    +   +HR++ +RN+
Sbjct: 114 LQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNV 170
Query: 518 FLDEEFNARVGNFGMARCVNDDTESPQFY--STN---PASW-----------SMGIDIFA 561
            + E+   ++ +FG+AR    D     +Y  +TN   P  W           +   D+++
Sbjct: 171 LVTEDNVMKIADFGLAR----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 226
Query: 562 YGIVLLEVLS-GQTP 575
           +G++L E+ + G +P
Sbjct: 227 FGVLLWEIFTLGGSP 241

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/203 (26%), Positives = 94/203 (46%), Gaps = 34/203 (16%)
Query: 392 GAVYHGRLNGKN--LAIKRTEHEVITKLEMQLVQHA----THHHPNIVRLLGTCLTDGPH 445
           G V+ GRL   N  +A+K     +   L+ + +Q A     + HPNIVRL+G C    P 
Sbjct: 128 GEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQP- 186
Query: 446 SFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNP 505
            ++V E  + G   D+L         F+ +    L     L++  D A  ++Y+    + 
Sbjct: 187 IYIVMELVQGG---DFL--------TFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SK 232
Query: 506 SYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDT--------ESPQFYST----NPASW 553
             +HR++ +RN  + E+   ++ +FGM+R   D          + P  ++     N   +
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRY 292
Query: 554 SMGIDIFAYGIVLLEVLS-GQTP 575
           S   D++++GI+L E  S G +P
Sbjct: 293 SSESDVWSFGILLWETFSLGASP 315

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 94/195 (48%), Gaps = 32/195 (16%)
Query: 402 KNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW 461
           K+ A ++   ++I+++EM         H NI+ LLG C  DGP  +++ EYA  G+L+++
Sbjct: 61  KSDATEKDLSDLISEMEMM---KMIGKHKNIINLLGACTQDGP-LYVIVEYASKGNLREY 116
Query: 462 LHG----GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNI 517
           L      GL        +    L+    +     VA  ++Y+    +   +HR++ +RN+
Sbjct: 117 LQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNV 173
Query: 518 FLDEEFNARVGNFGMARCVNDDTESPQFY--STN---PASW-----------SMGIDIFA 561
            + E+   ++ +FG+AR    D     +Y  +TN   P  W           +   D+++
Sbjct: 174 LVTEDNVMKIADFGLAR----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 229
Query: 562 YGIVLLEVLS-GQTP 575
           +G++L E+ + G +P
Sbjct: 230 FGVLLWEIFTLGGSP 244

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 99/201 (49%), Gaps = 34/201 (16%)
Query: 392 GAVYHGRLNG-KNLAIKRTEHEVITK----LEMQLVQHATHHHPNIVRLLGTCLTDGPHS 446
           G V+ G  NG   +A+K  +   ++      E  L++   H    +VRL    +T  P  
Sbjct: 36  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQR--LVRLYA-VVTQEP-I 91
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           +++ EY +NGSL D+L     +K          LT ++ L +   +A  + ++      +
Sbjct: 92  YIITEYMENGSLVDFLKTPSGIK----------LTINKLLDMAAQIAEGMAFIEER---N 138
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SM 555
           Y+HR++++ NI + +  + ++ +FG+AR + D+  + +  +  P  W           ++
Sbjct: 139 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTI 198
Query: 556 GIDIFAYGIVLLEVLS-GQTP 575
             D++++GI+L E+++ G+ P
Sbjct: 199 KSDVWSFGILLTEIVTHGRIP 219

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 99/201 (49%), Gaps = 34/201 (16%)
Query: 392 GAVYHGRLNG-KNLAIKRTEHEVITK----LEMQLVQHATHHHPNIVRLLGTCLTDGPHS 446
           G V+ G  NG   +A+K  +   ++      E  L++   H    +VRL    +T  P  
Sbjct: 27  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQR--LVRLYA-VVTQEP-I 82
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           +++ EY +NGSL D+L     +K          LT ++ L +   +A  + ++      +
Sbjct: 83  YIITEYMENGSLVDFLKTPSGIK----------LTINKLLDMAAQIAEGMAFIEER---N 129
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SM 555
           Y+HR++++ NI + +  + ++ +FG+AR + D+  + +  +  P  W           ++
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 556 GIDIFAYGIVLLEVLS-GQTP 575
             D++++GI+L E+++ G+ P
Sbjct: 190 KSDVWSFGILLTEIVTHGRIP 210

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 42/191 (21%), Positives = 91/191 (47%), Gaps = 24/191 (12%)
Query: 402 KNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW 461
           K+ A ++   ++++++EM         H NI+ LLG C  DGP  +++ EYA  G+L+++
Sbjct: 76  KDDATEKDLSDLVSEMEMM---KMIGKHKNIITLLGACTQDGP-LYVIVEYASKGNLREY 131
Query: 462 LHG----GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNI 517
           L      G+             +T+   +     +A  ++Y+    +   +HR++ +RN+
Sbjct: 132 LRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNV 188
Query: 518 FLDEEFNARVGNFGMARCVND-DTESPQFYSTNPASW-----------SMGIDIFAYGIV 565
            + E    ++ +FG+AR +N+ D          P  W           +   D++++G++
Sbjct: 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 248
Query: 566 LLEVLS-GQTP 575
           + E+ + G +P
Sbjct: 249 MWEIFTLGGSP 259

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 94/195 (48%), Gaps = 32/195 (16%)
Query: 402 KNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW 461
           K+ A ++   ++I+++EM         H NI+ LLG C  DGP  +++ EYA  G+L+++
Sbjct: 69  KSDATEKDLSDLISEMEMM---KMIGKHKNIINLLGACTQDGP-LYVIVEYASKGNLREY 124
Query: 462 LHG----GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNI 517
           L      GL        +    L+    +     VA  ++Y+    +   +HR++ +RN+
Sbjct: 125 LQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNV 181
Query: 518 FLDEEFNARVGNFGMARCVNDDTESPQFY--STN---PASW-----------SMGIDIFA 561
            + E+   ++ +FG+AR    D     +Y  +TN   P  W           +   D+++
Sbjct: 182 LVTEDNVMKIADFGLAR----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 237
Query: 562 YGIVLLEVLS-GQTP 575
           +G++L E+ + G +P
Sbjct: 238 FGVLLWEIFTLGGSP 252

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 42/191 (21%), Positives = 91/191 (47%), Gaps = 24/191 (12%)
Query: 402 KNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW 461
           K+ A ++   ++++++EM         H NI+ LLG C  DGP  +++ EYA  G+L+++
Sbjct: 63  KDDATEKDLSDLVSEMEMM---KMIGKHKNIINLLGACTQDGP-LYVIVEYASKGNLREY 118
Query: 462 LHG----GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNI 517
           L      G+             +T+   +     +A  ++Y+    +   +HR++ +RN+
Sbjct: 119 LRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLTARNV 175
Query: 518 FLDEEFNARVGNFGMARCVND-DTESPQFYSTNPASW-----------SMGIDIFAYGIV 565
            + E    ++ +FG+AR +N+ D          P  W           +   D++++G++
Sbjct: 176 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 235
Query: 566 LLEVLS-GQTP 575
           + E+ + G +P
Sbjct: 236 MWEIFTLGGSP 246

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 94/195 (48%), Gaps = 32/195 (16%)
Query: 402 KNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW 461
           K+ A ++   ++I+++EM         H NI+ LLG C  DGP  +++ EYA  G+L+++
Sbjct: 69  KSDATEKDLSDLISEMEMM---KMIGKHKNIINLLGACTQDGP-LYVIVEYASKGNLREY 124
Query: 462 LHG----GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNI 517
           L      GL        +    L+    +     VA  ++Y+    +   +HR++ +RN+
Sbjct: 125 LQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNV 181
Query: 518 FLDEEFNARVGNFGMARCVNDDTESPQFY--STN---PASW-----------SMGIDIFA 561
            + E+   ++ +FG+AR    D     +Y  +TN   P  W           +   D+++
Sbjct: 182 LVTEDNVMKIADFGLAR----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 237
Query: 562 YGIVLLEVLS-GQTP 575
           +G++L E+ + G +P
Sbjct: 238 FGVLLWEIFTLGGSP 252

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 99/201 (49%), Gaps = 34/201 (16%)
Query: 392 GAVYHGRLNG-KNLAIKRTEHEVITK----LEMQLVQHATHHHPNIVRLLGTCLTDGPHS 446
           G V+ G  NG   +A+K  +   ++      E  L++   H    +VRL    +T  P  
Sbjct: 29  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQR--LVRLYA-VVTQEP-I 84
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           +++ EY +NGSL D+L     +K          LT ++ L +   +A  + ++      +
Sbjct: 85  YIITEYMENGSLVDFLKTPSGIK----------LTINKLLDMAAQIAEGMAFIEE---RN 131
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SM 555
           Y+HR++++ NI + +  + ++ +FG+AR + D+  + +  +  P  W           ++
Sbjct: 132 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTI 191
Query: 556 GIDIFAYGIVLLEVLS-GQTP 575
             D++++GI+L E+++ G+ P
Sbjct: 192 KSDVWSFGILLTEIVTHGRIP 212

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 94/195 (48%), Gaps = 32/195 (16%)
Query: 402 KNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW 461
           K+ A ++   ++I+++EM         H NI+ LLG C  DGP  +++ EYA  G+L+++
Sbjct: 62  KSDATEKDLSDLISEMEMM---KMIGKHKNIINLLGACTQDGP-LYVIVEYASKGNLREY 117
Query: 462 LHG----GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNI 517
           L      GL        +    L+    +     VA  ++Y+    +   +HR++ +RN+
Sbjct: 118 LQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNV 174
Query: 518 FLDEEFNARVGNFGMARCVNDDTESPQFY--STN---PASW-----------SMGIDIFA 561
            + E+   ++ +FG+AR    D     +Y  +TN   P  W           +   D+++
Sbjct: 175 LVTEDNVMKIADFGLAR----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 230
Query: 562 YGIVLLEVLS-GQTP 575
           +G++L E+ + G +P
Sbjct: 231 FGVLLWEIFTLGGSP 245

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/195 (22%), Positives = 95/195 (48%), Gaps = 32/195 (16%)
Query: 402 KNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW 461
           K+ A ++   ++++++EM         H NI+ LLG C  DGP  +++ EYA  G+L+++
Sbjct: 76  KDDATEKDLSDLVSEMEMM---KMIGKHKNIINLLGACTQDGP-LYVIVEYASKGNLREY 131
Query: 462 LHG----GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNI 517
           L      G+             +T+   +     +A  ++Y+    +   +HR++ +RN+
Sbjct: 132 LRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNV 188
Query: 518 FLDEEFNARVGNFGMARCVNDDTESPQFY--STN---PASW-----------SMGIDIFA 561
            + E    ++ +FG+AR +N+      +Y  +TN   P  W           +   D+++
Sbjct: 189 LVTENNVMKIADFGLARDINN----IDYYKNTTNGRLPVKWMAPEALFDRVYTHQSDVWS 244
Query: 562 YGIVLLEVLS-GQTP 575
           +G+++ E+ + G +P
Sbjct: 245 FGVLMWEIFTLGGSP 259

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 99/201 (49%), Gaps = 34/201 (16%)
Query: 392 GAVYHGRLNG-KNLAIKRTEHEVITK----LEMQLVQHATHHHPNIVRLLGTCLTDGPHS 446
           G V+ G  NG   +A+K  +   ++      E  L++   H    +VRL    +T  P  
Sbjct: 27  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQR--LVRLYA-VVTQEP-I 82
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           +++ EY +NGSL D+L     +K          LT ++ L +   +A  + ++      +
Sbjct: 83  YIITEYMENGSLVDFLKTPSGIK----------LTINKLLDMAAQIAEGMAFIEE---RN 129
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SM 555
           Y+HR++++ NI + +  + ++ +FG+AR + D+  + +  +  P  W           ++
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 556 GIDIFAYGIVLLEVLS-GQTP 575
             D++++GI+L E+++ G+ P
Sbjct: 190 KSDVWSFGILLTEIVTHGRIP 210

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 60.5 bits (145), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 99/201 (49%), Gaps = 34/201 (16%)
Query: 392 GAVYHGRLNG-KNLAIKRTEHEVITK----LEMQLVQHATHHHPNIVRLLGTCLTDGPHS 446
           G V+ G  NG   +A+K  +   ++      E  L++   H    +VRL    +T  P  
Sbjct: 28  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQR--LVRLYA-VVTQEP-I 83
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           +++ EY +NGSL D+L     +K          LT ++ L +   +A  + ++      +
Sbjct: 84  YIITEYMENGSLVDFLKTPSGIK----------LTINKLLDMAAQIAEGMAFIEE---RN 130
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SM 555
           Y+HR++++ NI + +  + ++ +FG+AR + D+  + +  +  P  W           ++
Sbjct: 131 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTI 190
Query: 556 GIDIFAYGIVLLEVLS-GQTP 575
             D++++GI+L E+++ G+ P
Sbjct: 191 KSDVWSFGILLTEIVTHGRIP 211

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 99/201 (49%), Gaps = 34/201 (16%)
Query: 392 GAVYHGRLNG-KNLAIKRTEHEVITK----LEMQLVQHATHHHPNIVRLLGTCLTDGPHS 446
           G V+ G  NG   +A+K  +   ++      E  L++   H    +VRL    +T  P  
Sbjct: 33  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQR--LVRLYA-VVTQEP-I 88
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           +++ EY +NGSL D+L     +K          LT ++ L +   +A  + ++      +
Sbjct: 89  YIITEYMENGSLVDFLKTPSGIK----------LTINKLLDMAAQIAEGMAFIEE---RN 135
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SM 555
           Y+HR++++ NI + +  + ++ +FG+AR + D+  + +  +  P  W           ++
Sbjct: 136 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 195
Query: 556 GIDIFAYGIVLLEVLS-GQTP 575
             D++++GI+L E+++ G+ P
Sbjct: 196 KSDVWSFGILLTEIVTHGRIP 216

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 99/201 (49%), Gaps = 34/201 (16%)
Query: 392 GAVYHGRLNG-KNLAIKRTEHEVITK----LEMQLVQHATHHHPNIVRLLGTCLTDGPHS 446
           G V+ G  NG   +A+K  +   ++      E  L++   H    +VRL    +T  P  
Sbjct: 32  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQR--LVRLYA-VVTQEP-I 87
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           +++ EY +NGSL D+L     +K          LT ++ L +   +A  + ++      +
Sbjct: 88  YIITEYMENGSLVDFLKTPSGIK----------LTINKLLDMAAQIAEGMAFIEE---RN 134
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SM 555
           Y+HR++++ NI + +  + ++ +FG+AR + D+  + +  +  P  W           ++
Sbjct: 135 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 194
Query: 556 GIDIFAYGIVLLEVLS-GQTP 575
             D++++GI+L E+++ G+ P
Sbjct: 195 KSDVWSFGILLTEIVTHGRIP 215

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 100/208 (48%), Gaps = 38/208 (18%)
Query: 392 GAVYHGRLNGKN-LAIKRTEHEVITK----LEMQLVQHATHHHPNIVRLLGTCLTDGPHS 446
           G V+ G  NG   +AIK  +   ++      E Q+++   H    +V+L    +++ P  
Sbjct: 23  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE--KLVQLYAV-VSEEP-I 78
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           ++V EY   GSL D+L G +            +L   Q + +   +A  + Y+  +   +
Sbjct: 79  YIVTEYMSKGSLLDFLKGEMGK----------YLRLPQLVDMAAQIASGMAYVERM---N 125
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SM 555
           YVHR++++ NI + E    +V +FG+AR + D+  + +  +  P  W           ++
Sbjct: 126 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 185
Query: 556 GIDIFAYGIVLLEVLS-GQTP----INR 578
             D++++GI+L E+ + G+ P    +NR
Sbjct: 186 KSDVWSFGILLTELTTKGRVPYPGMVNR 213

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 99/201 (49%), Gaps = 34/201 (16%)
Query: 392 GAVYHGRLNG-KNLAIKRTEHEVITK----LEMQLVQHATHHHPNIVRLLGTCLTDGPHS 446
           G V+ G  NG   +A+K  +   ++      E  L++   H    +VRL    +T  P  
Sbjct: 22  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQR--LVRLYA-VVTQEP-I 77
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           +++ EY +NGSL D+L     +K          LT ++ L +   +A  + ++      +
Sbjct: 78  YIITEYMENGSLVDFLKTPSGIK----------LTINKLLDMAAQIAEGMAFIEE---RN 124
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SM 555
           Y+HR++++ NI + +  + ++ +FG+AR + D+  + +  +  P  W           ++
Sbjct: 125 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 184
Query: 556 GIDIFAYGIVLLEVLS-GQTP 575
             D++++GI+L E+++ G+ P
Sbjct: 185 KSDVWSFGILLTEIVTHGRIP 205

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 45/191 (23%), Positives = 91/191 (47%), Gaps = 24/191 (12%)
Query: 402 KNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW 461
           K+ A ++   ++I+++EM         H NI+ LLG C  DGP  +++ EYA  G+L+++
Sbjct: 69  KSDATEKDLSDLISEMEMM---KMIGKHKNIINLLGACTQDGP-LYVIVEYASKGNLREY 124
Query: 462 LHG----GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNI 517
           L      GL        +    L+    +     VA  ++Y+    +   +HR++ +RN+
Sbjct: 125 LQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNV 181
Query: 518 FLDEEFNARVGNFGMARCVND-DTESPQFYSTNPASW-----------SMGIDIFAYGIV 565
            + E+   ++ +FG+AR ++  D          P  W           +   D++++G++
Sbjct: 182 LVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 241
Query: 566 LLEVLS-GQTP 575
           L E+ + G +P
Sbjct: 242 LWEIFTLGGSP 252

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 100/208 (48%), Gaps = 38/208 (18%)
Query: 392 GAVYHGRLNGKN-LAIKRTEHEVITK----LEMQLVQHATHHHPNIVRLLGTCLTDGPHS 446
           G V+ G  NG   +AIK  +   ++      E Q+++   H    +V+L    +++ P  
Sbjct: 21  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE--KLVQLYAV-VSEEP-I 76
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           ++V EY   GSL D+L G +            +L   Q + +   +A  + Y+  +   +
Sbjct: 77  YIVTEYMSKGSLLDFLKGEMGK----------YLRLPQLVDMAAQIASGMAYVERM---N 123
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SM 555
           YVHR++++ NI + E    +V +FG+AR + D+  + +  +  P  W           ++
Sbjct: 124 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 183
Query: 556 GIDIFAYGIVLLEVLS-GQTP----INR 578
             D++++GI+L E+ + G+ P    +NR
Sbjct: 184 KSDVWSFGILLTELTTKGRVPYPGMVNR 211

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 100/208 (48%), Gaps = 38/208 (18%)
Query: 392 GAVYHGRLNGKN-LAIKRTEHEVITK----LEMQLVQHATHHHPNIVRLLGTCLTDGPHS 446
           G V+ G  NG   +AIK  +   ++      E Q+++   H    +V+L    +++ P  
Sbjct: 32  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKIRHE--KLVQLYAV-VSEEP-I 87
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           ++V EY   GSL D+L G +            +L   Q + +   +A  + Y+  +   +
Sbjct: 88  YIVTEYMSKGSLLDFLKGEMGK----------YLRLPQLVDMAAQIASGMAYVERM---N 134
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SM 555
           YVHR++++ NI + E    +V +FG+AR + D+  + +  +  P  W           ++
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 556 GIDIFAYGIVLLEVLS-GQTP----INR 578
             D++++GI+L E+ + G+ P    +NR
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNR 222

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 42/191 (21%), Positives = 90/191 (47%), Gaps = 24/191 (12%)
Query: 402 KNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW 461
           K+ A +    ++++++EM         H NI+ LLG C  DGP  +++ EYA  G+L+++
Sbjct: 76  KDDATEEDLSDLVSEMEMM---KMIGKHKNIINLLGACTQDGP-LYVIVEYASKGNLREY 131
Query: 462 LHG----GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNI 517
           L      G+             +T+   +     +A  ++Y+    +   +HR++ +RN+
Sbjct: 132 LRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNV 188
Query: 518 FLDEEFNARVGNFGMARCVND-DTESPQFYSTNPASW-----------SMGIDIFAYGIV 565
            + E    ++ +FG+AR +N+ D          P  W           +   D++++G++
Sbjct: 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 248
Query: 566 LLEVLS-GQTP 575
           + E+ + G +P
Sbjct: 249 MWEIFTLGGSP 259

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 60.1 bits (144), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 99/201 (49%), Gaps = 34/201 (16%)
Query: 392 GAVYHGRLNG-KNLAIKRTEHEVITK----LEMQLVQHATHHHPNIVRLLGTCLTDGPHS 446
           G V+ G  NG   +A+K  +   ++      E  L++   H    +VRL    +T  P  
Sbjct: 37  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQR--LVRLYA-VVTQEP-I 92
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           +++ EY +NGSL D+L     +K          LT ++ L +   +A  + ++      +
Sbjct: 93  YIITEYMENGSLVDFLKTPSGIK----------LTINKLLDMAAQIAEGMAFIEER---N 139
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SM 555
           Y+HR++++ NI + +  + ++ +FG+AR + D+  + +  +  P  W           ++
Sbjct: 140 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 199
Query: 556 GIDIFAYGIVLLEVLS-GQTP 575
             D++++GI+L E+++ G+ P
Sbjct: 200 KSDVWSFGILLTEIVTHGRIP 220

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/179 (26%), Positives = 82/179 (45%), Gaps = 31/179 (17%)
Query: 418 EMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL--HG--GLAMKNQFI 473
           E +L+ +  H H  IV+  G C  DG    +VFEY K+G L  +L  HG   + + +   
Sbjct: 67  EAELLTNLQHEH--IVKFYGVC-GDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQP 123
Query: 474 ASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA 533
                 L  SQ L I   +A  + Y+    +  +VHR++ +RN  +      ++G+FGM+
Sbjct: 124 RQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMS 180
Query: 534 RCVNDDTESPQFYSTN-----PASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
           R    D  S  +Y        P  W           +   D++++G++L E+ + G+ P
Sbjct: 181 R----DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 48/195 (24%), Positives = 94/195 (48%), Gaps = 32/195 (16%)
Query: 402 KNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW 461
           K+ A ++   ++I+++EM         H NI+ LLG C  DGP  +++ EYA  G+L+++
Sbjct: 110 KSDATEKDLSDLISEMEMM---KMIGKHKNIINLLGACTQDGP-LYVIVEYASKGNLREY 165
Query: 462 LHG----GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNI 517
           L      GL        +    L+    +     VA  ++Y+    +   +HR++ +RN+
Sbjct: 166 LQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNV 222
Query: 518 FLDEEFNARVGNFGMARCVNDDTESPQFY--STN---PASW-----------SMGIDIFA 561
            + E+   ++ +FG+AR    D     +Y  +TN   P  W           +   D+++
Sbjct: 223 LVTEDNVMKIADFGLAR----DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWS 278
Query: 562 YGIVLLEVLS-GQTP 575
           +G++L E+ + G +P
Sbjct: 279 FGVLLWEIFTLGGSP 293

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 100/208 (48%), Gaps = 38/208 (18%)
Query: 392 GAVYHGRLNGKN-LAIKRTEHEVITK----LEMQLVQHATHHHPNIVRLLGTCLTDGPHS 446
           G V+ G  NG   +AIK  +   ++      E Q+++   H    +V+L    +++ P  
Sbjct: 32  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE--KLVQLYAV-VSEEP-I 87
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           ++V EY   GSL D+L G +            +L   Q + +   +A  + Y+  +   +
Sbjct: 88  YIVTEYMSKGSLLDFLKGEMGK----------YLRLPQLVDMAAQIASGMAYVERM---N 134
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SM 555
           YVHR++++ NI + E    +V +FG+AR + D+  + +  +  P  W           ++
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 556 GIDIFAYGIVLLEVLS-GQTP----INR 578
             D++++GI+L E+ + G+ P    +NR
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNR 222

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 100/208 (48%), Gaps = 38/208 (18%)
Query: 392 GAVYHGRLNGKN-LAIKRTEHEVITK----LEMQLVQHATHHHPNIVRLLGTCLTDGPHS 446
           G V+ G  NG   +AIK  +   ++      E Q+++   H    +V+L    +++ P  
Sbjct: 32  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE--KLVQLYAV-VSEEP-I 87
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           ++V EY   GSL D+L G +            +L   Q + +   +A  + Y+  +   +
Sbjct: 88  YIVCEYMSKGSLLDFLKGEMGK----------YLRLPQLVDMAAQIASGMAYVERM---N 134
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SM 555
           YVHR++++ NI + E    +V +FG+AR + D+  + +  +  P  W           ++
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 556 GIDIFAYGIVLLEVLS-GQTP----INR 578
             D++++GI+L E+ + G+ P    +NR
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNR 222

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 99/201 (49%), Gaps = 34/201 (16%)
Query: 392 GAVYHGRLNG-KNLAIKRTEHEVITK----LEMQLVQHATHHHPNIVRLLGTCLTDGPHS 446
           G V+ G  NG   +A+K  +   ++      E  L++   H    +VRL    +T  P  
Sbjct: 27  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQR--LVRLYA-VVTQEP-I 82
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           +++ EY +NGSL D+L     +K          LT ++ L +   +A  + ++      +
Sbjct: 83  YIITEYMENGSLVDFLKTPSGIK----------LTINKLLDMAAQIAEGMAFIEE---RN 129
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SM 555
           Y+HR++++ NI + +  + ++ +FG+AR + D+  + +  +  P  W           ++
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 556 GIDIFAYGIVLLEVLS-GQTP 575
             D++++GI+L E+++ G+ P
Sbjct: 190 KSDVWSFGILLTEIVTHGRIP 210

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 59.7 bits (143), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 98/201 (48%), Gaps = 34/201 (16%)
Query: 392 GAVYHGRLNG-KNLAIKRTEHEVITK----LEMQLVQHATHHHPNIVRLLGTCLTDGPHS 446
           G V+ G  NG   +A+K  +   ++      E  L++   H    +VRL    +T  P  
Sbjct: 27  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQR--LVRLYA-VVTQEP-I 82
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           +++ EY +NGSL D+L     +K          LT ++ L +   +A  + ++      +
Sbjct: 83  YIITEYMENGSLVDFLKTPSGIK----------LTINKLLDMAAQIAEGMAFIEER---N 129
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SM 555
           Y+HR++++ NI + +  + ++ +FG+AR + D   + +  +  P  W           ++
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTI 189
Query: 556 GIDIFAYGIVLLEVLS-GQTP 575
             D++++GI+L E+++ G+ P
Sbjct: 190 KSDVWSFGILLTEIVTHGRIP 210

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 59.3 bits (142), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 99/208 (47%), Gaps = 38/208 (18%)
Query: 392 GAVYHGRLNGKN-LAIKRTEHEVITK----LEMQLVQHATHHHPNIVRLLGTCLTDGPHS 446
           G V+ G  NG   +AIK  +   ++      E Q+++   H    +V+L    +++ P  
Sbjct: 281 GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE--KLVQLYA-VVSEEP-I 336
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           ++V EY   GSL D+L G              +L   Q + +   +A  + Y+  +   +
Sbjct: 337 YIVTEYMSKGSLLDFLKGETGK----------YLRLPQLVDMAAQIASGMAYVERM---N 383
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SM 555
           YVHR++++ NI + E    +V +FG+AR + D+  + +  +  P  W           ++
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 443
Query: 556 GIDIFAYGIVLLEVLS-GQTP----INR 578
             D++++GI+L E+ + G+ P    +NR
Sbjct: 444 KSDVWSFGILLTELTTKGRVPYPGMVNR 471

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 55/214 (25%), Positives = 89/214 (41%), Gaps = 45/214 (21%)
Query: 392 GAVYHGRL-----NGKNLAIKR----TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTD 442
           G VYHG       N    AIK     TE + +     + +     +HPN++ L+G  L  
Sbjct: 35  GVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPP 94
Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
                ++  Y  +G L            QFI S     T    +   L VA  ++Y+   
Sbjct: 95  EGLPHVLLPYMCHGDLL-----------QFIRSPQRNPTVKDLISFGLQVARGMEYL--- 140
Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN-------PASW-- 553
               +VHR++ +RN  LDE F  +V +FG+AR + D     ++YS         P  W  
Sbjct: 141 AEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDR----EYYSVQQHRHARLPVKWTA 196
Query: 554 ---------SMGIDIFAYGIVLLEVLSGQTPINR 578
                    +   D++++G++L E+L+   P  R
Sbjct: 197 LESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYR 230

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 58.9 bits (141), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 83/180 (46%), Gaps = 34/180 (18%)
Query: 418 EMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL--HG---GLAMKNQF 472
           E +L+    H H  IVR  G C T+G    +VFEY ++G L  +L  HG    L    + 
Sbjct: 93  EAELLTMLQHQH--IVRFFGVC-TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGED 149
Query: 473 IASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGM 532
           +A     L   Q L +   VA  + Y+  +    +VHR++ +RN  + +    ++G+FGM
Sbjct: 150 VAPGP--LGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGM 204
Query: 533 ARCVNDDTESPQFYSTN-----PASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
           +R    D  S  +Y        P  W           +   D++++G+VL E+ + G+ P
Sbjct: 205 SR----DIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 99/208 (47%), Gaps = 38/208 (18%)
Query: 392 GAVYHGRLNGKN-LAIKRTEHEVITK----LEMQLVQHATHHHPNIVRLLGTCLTDGPHS 446
           G V+ G  NG   +AIK  +   ++      E Q+++   H    +V+L    +++ P  
Sbjct: 25  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE--KLVQLYAV-VSEEP-I 80
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           ++V EY   GSL D+L G              +L   Q + +   +A  + Y+  +   +
Sbjct: 81  YIVTEYMSKGSLLDFLKGETGK----------YLRLPQLVDMAAQIASGMAYVERM---N 127
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SM 555
           YVHR++++ NI + E    +V +FG+AR + D+  + +  +  P  W           ++
Sbjct: 128 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 187
Query: 556 GIDIFAYGIVLLEVLS-GQTP----INR 578
             D++++GI+L E+ + G+ P    +NR
Sbjct: 188 KSDVWSFGILLTELTTKGRVPYPGMVNR 215

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 58.9 bits (141), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 99/208 (47%), Gaps = 38/208 (18%)
Query: 392 GAVYHGRLNGKN-LAIKRTEHEVITK----LEMQLVQHATHHHPNIVRLLGTCLTDGPHS 446
           G V+ G  NG   +AIK  +   ++      E Q+++   H    +V+L    +++ P  
Sbjct: 32  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE--KLVQLYAV-VSEEP-I 87
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           ++V EY   G L D+L G +            +L   Q + +   +A  + Y+  +   +
Sbjct: 88  YIVMEYMSKGCLLDFLKGEMGK----------YLRLPQLVDMAAQIASGMAYVERM---N 134
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SM 555
           YVHR++++ NI + E    +V +FG+AR + D+  + +  +  P  W           ++
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 556 GIDIFAYGIVLLEVLS-GQTP----INR 578
             D++++GI+L E+ + G+ P    +NR
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNR 222

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 58.5 bits (140), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 99/208 (47%), Gaps = 38/208 (18%)
Query: 392 GAVYHGRLNGKN-LAIKRTEHEVITK----LEMQLVQHATHHHPNIVRLLGTCLTDGPHS 446
           G V+ G  NG   +AIK  +   ++      E Q+++   H    +V+L    +++ P  
Sbjct: 32  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE--KLVQLYAV-VSEEP-I 87
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           ++V EY   GSL D+L G +            +L   Q + +   +A  + Y+  +   +
Sbjct: 88  YIVTEYMSKGSLLDFLKGEMGK----------YLRLPQLVDMAAQIASGMAYVERM---N 134
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SM 555
           YVHR++ + NI + E    +V +FG+AR + D+  + +  +  P  W           ++
Sbjct: 135 YVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 556 GIDIFAYGIVLLEVLS-GQTP----INR 578
             D++++GI+L E+ + G+ P    +NR
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNR 222

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 99/208 (47%), Gaps = 38/208 (18%)
Query: 392 GAVYHGRLNGKN-LAIKRTEHEVITK----LEMQLVQHATHHHPNIVRLLGTCLTDGPHS 446
           G V+ G  NG   +AIK  +   ++      E Q+++   H    +V+L    +++ P  
Sbjct: 198 GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE--KLVQLYAV-VSEEP-I 253
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           ++V EY   GSL D+L G              +L   Q + +   +A  + Y+  +   +
Sbjct: 254 YIVTEYMSKGSLLDFLKGETGK----------YLRLPQLVDMAAQIASGMAYVERM---N 300
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SM 555
           YVHR++++ NI + E    +V +FG+AR + D+  + +  +  P  W           ++
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 556 GIDIFAYGIVLLEVLS-GQTP----INR 578
             D++++GI+L E+ + G+ P    +NR
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPGMVNR 388

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 99/208 (47%), Gaps = 38/208 (18%)
Query: 392 GAVYHGRLNGKN-LAIKRTEHEVITK----LEMQLVQHATHHHPNIVRLLGTCLTDGPHS 446
           G V+ G  NG   +AIK  +   ++      E Q+++   H    +V+L    +++ P  
Sbjct: 29  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE--KLVQLYAV-VSEEP-I 84
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           ++V EY   GSL D+L G              +L   Q + +   +A  + Y+  +   +
Sbjct: 85  YIVTEYMNKGSLLDFLKGETGK----------YLRLPQLVDMSAQIASGMAYVERM---N 131
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SM 555
           YVHR++++ NI + E    +V +FG+AR + D+  + +  +  P  W           ++
Sbjct: 132 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 191
Query: 556 GIDIFAYGIVLLEVLS-GQTP----INR 578
             D++++GI+L E+ + G+ P    +NR
Sbjct: 192 KSDVWSFGILLTELTTKGRVPYPGMVNR 219

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 83/180 (46%), Gaps = 34/180 (18%)
Query: 418 EMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL--HG---GLAMKNQF 472
           E +L+    H H  IVR  G C T+G    +VFEY ++G L  +L  HG    L    + 
Sbjct: 70  EAELLTMLQHQH--IVRFFGVC-TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGED 126
Query: 473 IASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGM 532
           +A     L   Q L +   VA  + Y+  +    +VHR++ +RN  + +    ++G+FGM
Sbjct: 127 VAPGP--LGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGM 181
Query: 533 ARCVNDDTESPQFYSTN-----PASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
           +R    D  S  +Y        P  W           +   D++++G+VL E+ + G+ P
Sbjct: 182 SR----DIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 237

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 83/180 (46%), Gaps = 34/180 (18%)
Query: 418 EMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL--HG---GLAMKNQF 472
           E +L+    H H  IVR  G C T+G    +VFEY ++G L  +L  HG    L    + 
Sbjct: 64  EAELLTMLQHQH--IVRFFGVC-TEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGED 120
Query: 473 IASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGM 532
           +A     L   Q L +   VA  + Y+  +    +VHR++ +RN  + +    ++G+FGM
Sbjct: 121 VAPGP--LGLGQLLAVASQVAAGMVYLAGL---HFVHRDLATRNCLVGQGLVVKIGDFGM 175
Query: 533 ARCVNDDTESPQFYSTN-----PASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
           +R    D  S  +Y        P  W           +   D++++G+VL E+ + G+ P
Sbjct: 176 SR----DIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 231

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 99/208 (47%), Gaps = 38/208 (18%)
Query: 392 GAVYHGRLNGKN-LAIKRTEHEVITK----LEMQLVQHATHHHPNIVRLLGTCLTDGPHS 446
           G V+ G  NG   +AIK  +   ++      E Q+++   H    +V+L    +++ P  
Sbjct: 198 GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE--KLVQLYAV-VSEEP-I 253
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           ++V EY   GSL D+L G              +L   Q + +   +A  + Y+  +   +
Sbjct: 254 YIVTEYMSKGSLLDFLKGETGK----------YLRLPQLVDMAAQIASGMAYVERM---N 300
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SM 555
           YVHR++++ NI + E    +V +FG+AR + D+  + +  +  P  W           ++
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 556 GIDIFAYGIVLLEVLS-GQTP----INR 578
             D++++GI+L E+ + G+ P    +NR
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPGMVNR 388

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/191 (21%), Positives = 90/191 (47%), Gaps = 24/191 (12%)
Query: 402 KNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW 461
           K+ A ++   ++++++EM         H NI+ LLG C  DGP  +++  YA  G+L+++
Sbjct: 76  KDDATEKDLSDLVSEMEMM---KMIGKHKNIINLLGACTQDGP-LYVIVAYASKGNLREY 131
Query: 462 LHG----GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNI 517
           L      G+             +T+   +     +A  ++Y+    +   +HR++ +RN+
Sbjct: 132 LRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNV 188
Query: 518 FLDEEFNARVGNFGMARCVND-DTESPQFYSTNPASW-----------SMGIDIFAYGIV 565
            + E    ++ +FG+AR +N+ D          P  W           +   D++++G++
Sbjct: 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 248
Query: 566 LLEVLS-GQTP 575
           + E+ + G +P
Sbjct: 249 MWEIFTLGGSP 259

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 99/208 (47%), Gaps = 38/208 (18%)
Query: 392 GAVYHGRLNGKN-LAIKRTEHEVITK----LEMQLVQHATHHHPNIVRLLGTCLTDGPHS 446
           G V+ G  NG   +AIK  +   ++      E Q+++   H    +V+L    +++ P  
Sbjct: 29  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE--KLVQLYAV-VSEEP-I 84
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           ++V EY   GSL D+L G              +L   Q + +   +A  + Y+  +   +
Sbjct: 85  YIVTEYMNKGSLLDFLKGETGK----------YLRLPQLVDMSAQIASGMAYVERM---N 131
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SM 555
           YVHR++++ NI + E    +V +FG+AR + D+  + +  +  P  W           ++
Sbjct: 132 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTI 191
Query: 556 GIDIFAYGIVLLEVLS-GQTP----INR 578
             D++++GI+L E+ + G+ P    +NR
Sbjct: 192 KSDVWSFGILLTELTTKGRVPYPGMVNR 219

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score = 58.5 bits (140), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 49/216 (22%)
Query: 392 GAVYHGRLNG-------KNLAIK----RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCL 440
           G VY G L G       + +AIK    + E  +  +   + +  A   HPN+V LLG   
Sbjct: 23  GKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT 82
Query: 441 TDGPHSFLVFEYAKNGSLKDWL-----HG--GLAMKNQFIASCYCFLTWSQRLRICLDVA 493
            D P S ++F Y  +G L ++L     H   G    ++ + S    L     + +   +A
Sbjct: 83  KDQPLS-MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA---LEPPDFVHLVAQIA 138
Query: 494 MALQYM--HHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFY----- 546
             ++Y+  HHV     VH+++ +RN+ + ++ N ++ + G+ R    +  +  +Y     
Sbjct: 139 AGMEYLSSHHV-----VHKDLATRNVLVYDKLNVKISDLGLFR----EVYAADYYKLLGN 189
Query: 547 STNPASW-----------SMGIDIFAYGIVLLEVLS 571
           S  P  W           S+  DI++YG+VL EV S
Sbjct: 190 SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 225

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 99/208 (47%), Gaps = 38/208 (18%)
Query: 392 GAVYHGRLNGKN-LAIKRTEHEVITK----LEMQLVQHATHHHPNIVRLLGTCLTDGPHS 446
           G V+ G  NG   +AIK  +   ++      E Q+++   H    +V+L    +++ P  
Sbjct: 198 GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE--KLVQLYAV-VSEEP-I 253
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           ++V EY   GSL D+L G              +L   Q + +   +A  + Y+  +   +
Sbjct: 254 YIVGEYMSKGSLLDFLKGETGK----------YLRLPQLVDMAAQIASGMAYVERM---N 300
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SM 555
           YVHR++++ NI + E    +V +FG+AR + D+  + +  +  P  W           ++
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 360
Query: 556 GIDIFAYGIVLLEVLS-GQTP----INR 578
             D++++GI+L E+ + G+ P    +NR
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPGMVNR 388

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 56/216 (25%), Positives = 97/216 (44%), Gaps = 49/216 (22%)
Query: 392 GAVYHGRLNG-------KNLAIK----RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCL 440
           G VY G L G       + +AIK    + E  +  +   + +  A   HPN+V LLG   
Sbjct: 40  GKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVT 99
Query: 441 TDGPHSFLVFEYAKNGSLKDWL-----HG--GLAMKNQFIASCYCFLTWSQRLRICLDVA 493
            D P S ++F Y  +G L ++L     H   G    ++ + S    L     + +   +A
Sbjct: 100 KDQPLS-MIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSA---LEPPDFVHLVAQIA 155
Query: 494 MALQYM--HHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFY----- 546
             ++Y+  HHV     VH+++ +RN+ + ++ N ++ + G+ R    +  +  +Y     
Sbjct: 156 AGMEYLSSHHV-----VHKDLATRNVLVYDKLNVKISDLGLFR----EVYAADYYKLLGN 206
Query: 547 STNPASW-----------SMGIDIFAYGIVLLEVLS 571
           S  P  W           S+  DI++YG+VL EV S
Sbjct: 207 SLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS 242

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 37/165 (22%), Positives = 76/165 (46%), Gaps = 32/165 (19%)
Query: 426 THHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL---HGGLAMKNQFIASCYCFLTW 482
           T  H  +VRL      + P  +++ EY   GSL D+L    GG  +  + I         
Sbjct: 64  TLQHDKLVRLYAVVTREEP-IYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFS------ 116
Query: 483 SQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTES 542
                     A   + M ++   +Y+HR++++ N+ + E    ++ +FG+AR + D+  +
Sbjct: 117 ----------AQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 166
Query: 543 PQFYSTNPASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
            +  +  P  W           ++  D++++GI+L E+++ G+ P
Sbjct: 167 AREGAKFPIKWTAPEAINFGCFTIKSDVWSFGILLYEIVTYGKIP 211

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 79/166 (47%), Gaps = 15/166 (9%)
Query: 418 EMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCY 477
           E++++ H   H  NIV LLG C   GP   ++ EY   G L ++L     +     A   
Sbjct: 99  ELKIMSHLGQHE-NIVNLLGACTHGGP-VLVITEYCCYGDLLNFLRRKSRVLETDPAFAI 156
Query: 478 CFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR-CV 536
              T S R  +     +A Q M  + + + +HR++ +RN+ L     A++G+FG+AR  +
Sbjct: 157 ANSTLSTRDLLHFSSQVA-QGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM 215
Query: 537 NDDTESPQFYSTNPASW-----------SMGIDIFAYGIVLLEVLS 571
           ND     +  +  P  W           ++  D+++YGI+L E+ S
Sbjct: 216 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/195 (23%), Positives = 84/195 (43%), Gaps = 33/195 (16%)
Query: 399 LNGKNLAIKRTEHEVITKLEMQLVQHATH-----HHPNIVRLLGTCLTDGPHSFLVFEYA 453
           L G+ +AIK  +   +    +Q +          +HPNIV+L     T+    +L+ EYA
Sbjct: 35  LTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETE-KTLYLIMEYA 93
Query: 454 KNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIK 513
             G + D+L     MK +   S +              +  A+QY H       VHR++K
Sbjct: 94  SGGEVFDYLVAHGRMKEKEARSKFR------------QIVSAVQYCHQ---KRIVHRDLK 138
Query: 514 SRNIFLDEEFNARVGNFGMAR-----------CVNDDTESPQFYSTNPASWSMGIDIFAY 562
           + N+ LD + N ++ +FG +            C +    +P+ +          +D+++ 
Sbjct: 139 AENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDGP-EVDVWSL 197
Query: 563 GIVLLEVLSGQTPIN 577
           G++L  ++SG  P +
Sbjct: 198 GVILYTLVSGSLPFD 212

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 89/203 (43%), Gaps = 29/203 (14%)
Query: 384 FNSSNRIEGAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDG 443
           F  S+     V+ G++  K+L +K  + E   K+ M++  H +  H ++V   G    D 
Sbjct: 56  FEISDADTKEVFAGKIVPKSLLLKPHQRE---KMSMEISIHRSLAHQHVVGFHGF-FEDN 111
Query: 444 PHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM 503
              F+V E  +  SL + LH       +  A  Y        LR    + +  QY+H   
Sbjct: 112 DFVFVVLELCRRRSLLE-LHKRRKALTEPEARYY--------LR---QIVLGCQYLH--- 156
Query: 504 NPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNP----------ASW 553
               +HR++K  N+FL+E+   ++G+FG+A  V  D E  +     P             
Sbjct: 157 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 216
Query: 554 SMGIDIFAYGIVLLEVLSGQTPI 576
           S  +D+++ G ++  +L G+ P 
Sbjct: 217 SFEVDVWSIGCIMYTLLVGKPPF 239

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/191 (21%), Positives = 90/191 (47%), Gaps = 24/191 (12%)
Query: 402 KNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW 461
           K+ A ++   ++++++EM         H NI+ LLG C  DGP  +++  YA  G+L+++
Sbjct: 76  KDDATEKDLSDLVSEMEMM---KMIGKHKNIINLLGACTQDGP-LYVIVGYASKGNLREY 131
Query: 462 LHG----GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNI 517
           L      G+             +T+   +     +A  ++Y+    +   +HR++ +RN+
Sbjct: 132 LRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNV 188
Query: 518 FLDEEFNARVGNFGMARCVND-DTESPQFYSTNPASW-----------SMGIDIFAYGIV 565
            + E    ++ +FG+AR +N+ D          P  W           +   D++++G++
Sbjct: 189 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 248
Query: 566 LLEVLS-GQTP 575
           + E+ + G +P
Sbjct: 249 MWEIFTLGGSP 259

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 52/212 (24%), Positives = 87/212 (41%), Gaps = 35/212 (16%)
Query: 392 GAVYHGRLNG----KNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSF 447
           G VY G+ +G    K L +     E       ++       H NI+  +G    D  +  
Sbjct: 50  GTVYKGKWHGDVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKD--NLA 107
Query: 448 LVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSY 507
           +V ++ +  SL   LH        F           Q + I    A  + Y+H     + 
Sbjct: 108 IVTQWCEGSSLYKHLHVQETKFQMF-----------QLIDIARQTAQGMDYLH---AKNI 153
Query: 508 VHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYS-TNPASW------------- 553
           +HR++KS NIFL E    ++G+FG+A   +  + S Q    T    W             
Sbjct: 154 IHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNP 213
Query: 554 -SMGIDIFAYGIVLLEVLSGQTPINRPRKKDE 584
            S   D+++YGIVL E+++G+ P +    +D+
Sbjct: 214 FSFQSDVYSYGIVLYELMTGELPYSHINNRDQ 245

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/195 (23%), Positives = 83/195 (42%), Gaps = 33/195 (16%)
Query: 399 LNGKNLAIKRTEHEVITKLEMQLVQHATH-----HHPNIVRLLGTCLTDGPHSFLVFEYA 453
           L G+ +AIK  +   +    +Q +          +HPNIV+L     T+    +L+ EYA
Sbjct: 38  LTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETE-KTLYLIMEYA 96
Query: 454 KNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIK 513
             G + D+L     MK +   S +              +  A+QY H       VHR++K
Sbjct: 97  SGGEVFDYLVAHGRMKEKEARSKFR------------QIVSAVQYCHQ---KRIVHRDLK 141
Query: 514 SRNIFLDEEFNARVGNFGM-----------ARCVNDDTESPQFYSTNPASWSMGIDIFAY 562
           + N+ LD + N ++ +FG            A C      +P+ +          +D+++ 
Sbjct: 142 AENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGP-EVDVWSL 200
Query: 563 GIVLLEVLSGQTPIN 577
           G++L  ++SG  P +
Sbjct: 201 GVILYTLVSGSLPFD 215

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 89/203 (43%), Gaps = 29/203 (14%)
Query: 384 FNSSNRIEGAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDG 443
           F  S+     V+ G++  K+L +K  + E   K+ M++  H +  H ++V   G    D 
Sbjct: 58  FEISDADTKEVFAGKIVPKSLLLKPHQRE---KMSMEISIHRSLAHQHVVGFHGF-FEDN 113
Query: 444 PHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM 503
              F+V E  +  SL + LH       +  A  Y        LR    + +  QY+H   
Sbjct: 114 DFVFVVLELCRRRSLLE-LHKRRKALTEPEARYY--------LR---QIVLGCQYLH--- 158
Query: 504 NPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNP----------ASW 553
               +HR++K  N+FL+E+   ++G+FG+A  V  D E  +     P             
Sbjct: 159 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 218
Query: 554 SMGIDIFAYGIVLLEVLSGQTPI 576
           S  +D+++ G ++  +L G+ P 
Sbjct: 219 SFEVDVWSIGCIMYTLLVGKPPF 241

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/208 (24%), Positives = 99/208 (47%), Gaps = 38/208 (18%)
Query: 392 GAVYHGRLNGKN-LAIKRTEHEVITK----LEMQLVQHATHHHPNIVRLLGTCLTDGPHS 446
           G V+ G  NG   +AIK  +   ++      E Q+++   H    +V+L    +++ P  
Sbjct: 32  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE--KLVQLYAV-VSEEP-I 87
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           ++V EY   G L D+L G +            +L   Q + +   +A  + Y+  +   +
Sbjct: 88  YIVTEYMSKGCLLDFLKGEMGK----------YLRLPQLVDMAAQIASGMAYVERM---N 134
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SM 555
           YVHR++++ NI + E    +V +FG+AR + D+  + +  +  P  W           ++
Sbjct: 135 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 194
Query: 556 GIDIFAYGIVLLEVLS-GQTP----INR 578
             D++++GI+L E+ + G+ P    +NR
Sbjct: 195 KSDVWSFGILLTELTTKGRVPYPGMVNR 222

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 51/208 (24%), Positives = 98/208 (47%), Gaps = 38/208 (18%)
Query: 392 GAVYHGRLNGKN-LAIKRTEHEVITK----LEMQLVQHATHHHPNIVRLLGTCLTDGPHS 446
           G V+ G  NG   +AIK  +   ++      E Q+++   H    +V+L    +++ P  
Sbjct: 22  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHE--KLVQLYAV-VSEEPIX 78
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
            +V EY   GSL D+L G              +L   Q + +   +A  + Y+  +   +
Sbjct: 79  -IVTEYMSKGSLLDFLKGETGK----------YLRLPQLVDMAAQIASGMAYVERM---N 124
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SM 555
           YVHR++++ NI + E    +V +FG+AR + D+  + +  +  P  W           ++
Sbjct: 125 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTI 184
Query: 556 GIDIFAYGIVLLEVLS-GQTP----INR 578
             D++++GI+L E+ + G+ P    +NR
Sbjct: 185 KSDVWSFGILLTELTTKGRVPYPGMVNR 212

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/204 (24%), Positives = 89/204 (43%), Gaps = 29/204 (14%)
Query: 384 FNSSNRIEGAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDG 443
           F  S+     V+ G++  K+L +K  + E   K+ M++  H +  H ++V   G    D 
Sbjct: 32  FEISDADTKEVFAGKIVPKSLLLKPHQRE---KMSMEISIHRSLAHQHVVGFHGF-FEDN 87
Query: 444 PHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM 503
              F+V E  +  SL + LH       +  A  Y        LR    + +  QY+H   
Sbjct: 88  DFVFVVLELCRRRSLLE-LHKRRKALTEPEARYY--------LR---QIVLGCQYLH--- 132
Query: 504 NPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNP----------ASW 553
               +HR++K  N+FL+E+   ++G+FG+A  V  D E  +     P             
Sbjct: 133 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 192
Query: 554 SMGIDIFAYGIVLLEVLSGQTPIN 577
           S  +D+++ G ++  +L G+ P  
Sbjct: 193 SFEVDVWSIGCIMYTLLVGKPPFE 216

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 57.8 bits (138), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/166 (27%), Positives = 79/166 (47%), Gaps = 15/166 (9%)
Query: 418 EMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCY 477
           E++++ H   H  NIV LLG C   GP   ++ EY   G L ++L     +     A   
Sbjct: 99  ELKIMSHLGQHE-NIVNLLGACTHGGP-VLVITEYCCYGDLLNFLRRKSRVLETDPAFAI 156
Query: 478 CFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR-CV 536
              T S R  +     +A Q M  + + + +HR++ +RN+ L     A++G+FG+AR  +
Sbjct: 157 ANSTASTRDLLHFSSQVA-QGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM 215
Query: 537 NDDTESPQFYSTNPASW-----------SMGIDIFAYGIVLLEVLS 571
           ND     +  +  P  W           ++  D+++YGI+L E+ S
Sbjct: 216 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 261

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/209 (23%), Positives = 94/209 (44%), Gaps = 50/209 (23%)
Query: 392 GAVYHGRLNGKN-LAIKR------------TEHEVITKLEMQLVQHATHHHPNIVRLLGT 438
           G V+ G  NG   +AIK              E +V+ KL           H  +V+L   
Sbjct: 199 GEVWMGTWNGTTRVAIKTLKPGNMSPEAFLQEAQVMKKL----------RHEKLVQLYAV 248
Query: 439 CLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQY 498
            +++ P  ++V EY   GSL D+L G +            +L   Q + +   +A  + Y
Sbjct: 249 -VSEEP-IYIVTEYMSKGSLLDFLKGEMGK----------YLRLPQLVDMAAQIASGMAY 296
Query: 499 MHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW----- 553
           +  +   +YVHR++++ NI + E    +V +FG+ R + D+  + +  +  P  W     
Sbjct: 297 VERM---NYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEA 353
Query: 554 ------SMGIDIFAYGIVLLEVLS-GQTP 575
                 ++  D++++GI+L E+ + G+ P
Sbjct: 354 ALYGRFTIKSDVWSFGILLTELTTKGRVP 382

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 86/197 (43%), Gaps = 37/197 (18%)
Query: 399 LNGKNLAIK-----RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYA 453
           L GK +A+K     +     + KL  ++      +HPNIV+L     T+    +LV EYA
Sbjct: 37  LTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKT-LYLVMEYA 95
Query: 454 KNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRN 511
             G + D+L  HG +  K               + R    +  A+QY H       VHR+
Sbjct: 96  SGGEVFDYLVAHGRMKEKEA-----------RAKFR---QIVSAVQYCHQKF---IVHRD 138
Query: 512 IKSRNIFLDEEFNARVGNFGMAR-----------CVNDDTESPQFYSTNPASWSMGIDIF 560
           +K+ N+ LD + N ++ +FG +            C +    +P+ +          +D++
Sbjct: 139 LKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGP-EVDVW 197
Query: 561 AYGIVLLEVLSGQTPIN 577
           + G++L  ++SG  P +
Sbjct: 198 SLGVILYTLVSGSLPFD 214

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 71/167 (42%), Gaps = 31/167 (18%)
Query: 425 ATHHHPNIVRLLGTCLTD---GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLT 481
           A  +HP IV +  T   +   GP  ++V EY    +L+D +H    M            T
Sbjct: 67  AALNHPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM------------T 114
Query: 482 WSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE 541
             + + +  D   AL + H       +HR++K  NI +      +V +FG+AR + D   
Sbjct: 115 PKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 171
Query: 542 S----------PQFYSTNPA---SWSMGIDIFAYGIVLLEVLSGQTP 575
           S           Q+ S   A   S     D+++ G VL EVL+G+ P
Sbjct: 172 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/160 (29%), Positives = 77/160 (48%), Gaps = 34/160 (21%)
Query: 425 ATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH---GGLAMKNQFIASCYCFLT 481
           A   HPNIV+   +   +G   ++V +Y + G L   ++   G L  ++Q        L 
Sbjct: 78  ANMKHPNIVQYRESFEENG-SLYIVMDYCEGGDLFKRINAQKGVLFQEDQI-------LD 129
Query: 482 WSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE 541
           W   ++ICL        + HV +   +HR+IKS+NIFL ++   ++G+FG+AR +N   E
Sbjct: 130 WF--VQICLA-------LKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE 180
Query: 542 ------------SPQFYSTNPASWSMGIDIFAYGIVLLEV 569
                       SP+     P  ++   DI+A G VL E+
Sbjct: 181 LARACIGTPYYLSPEICENKP--YNNKSDIWALGCVLYEL 218

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 86/197 (43%), Gaps = 37/197 (18%)
Query: 399 LNGKNLAIK-----RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYA 453
           L GK +A+K     +     + KL  ++      +HPNIV+L     T+    +LV EYA
Sbjct: 37  LTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKT-LYLVMEYA 95
Query: 454 KNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRN 511
             G + D+L  HG +  K               + R    +  A+QY H       VHR+
Sbjct: 96  SGGEVFDYLVAHGRMKEKEA-----------RAKFR---QIVSAVQYCHQKF---IVHRD 138
Query: 512 IKSRNIFLDEEFNARVGNFGMAR-----------CVNDDTESPQFYSTNPASWSMGIDIF 560
           +K+ N+ LD + N ++ +FG +            C +    +P+ +          +D++
Sbjct: 139 LKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGP-EVDVW 197
Query: 561 AYGIVLLEVLSGQTPIN 577
           + G++L  ++SG  P +
Sbjct: 198 SLGVILYTLVSGSLPFD 214

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 89/203 (43%), Gaps = 29/203 (14%)
Query: 384 FNSSNRIEGAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDG 443
           F  S+     V+ G++  K+L +K  + E   K+ M++  H +  H ++V   G    D 
Sbjct: 38  FEISDADTKEVFAGKIVPKSLLLKPHQRE---KMSMEISIHRSLAHQHVVGFHGF-FEDN 93
Query: 444 PHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM 503
              F+V E  +  SL + LH       +  A  Y        LR    + +  QY+H   
Sbjct: 94  DFVFVVLELCRRRSLLE-LHKRRKALTEPEARYY--------LR---QIVLGCQYLH--- 138
Query: 504 NPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNP----------ASW 553
               +HR++K  N+FL+E+   ++G+FG+A  V  D E  +     P             
Sbjct: 139 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGH 198
Query: 554 SMGIDIFAYGIVLLEVLSGQTPI 576
           S  +D+++ G ++  +L G+ P 
Sbjct: 199 SFEVDVWSIGCIMYTLLVGKPPF 221

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 85/197 (43%), Gaps = 37/197 (18%)
Query: 399 LNGKNLAIK-----RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYA 453
           L GK +A+K     +     + KL  ++      +HPNIV+L     T+    +LV EYA
Sbjct: 37  LTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKT-LYLVMEYA 95
Query: 454 KNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRN 511
             G + D+L  HG +  K               + R    +  A+QY H       VHR+
Sbjct: 96  SGGEVFDYLVAHGRMKEKEA-----------RAKFR---QIVSAVQYCHQKF---IVHRD 138
Query: 512 IKSRNIFLDEEFNARVGNFGM-----------ARCVNDDTESPQFYSTNPASWSMGIDIF 560
           +K+ N+ LD + N ++ +FG            A C      +P+ +          +D++
Sbjct: 139 LKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGP-EVDVW 197
Query: 561 AYGIVLLEVLSGQTPIN 577
           + G++L  ++SG  P +
Sbjct: 198 SLGVILYTLVSGSLPFD 214

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 89/203 (43%), Gaps = 29/203 (14%)
Query: 384 FNSSNRIEGAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDG 443
           F  S+     V+ G++  K+L +K  + E   K+ M++  H +  H ++V   G    D 
Sbjct: 34  FEISDADTKEVFAGKIVPKSLLLKPHQRE---KMSMEISIHRSLAHQHVVGFHGF-FEDN 89
Query: 444 PHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM 503
              F+V E  +  SL + LH       +  A  Y        LR    + +  QY+H   
Sbjct: 90  DFVFVVLELCRRRSLLE-LHKRRKALTEPEARYY--------LR---QIVLGCQYLH--- 134
Query: 504 NPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNP----------ASW 553
               +HR++K  N+FL+E+   ++G+FG+A  V  D E  +     P             
Sbjct: 135 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGH 194
Query: 554 SMGIDIFAYGIVLLEVLSGQTPI 576
           S  +D+++ G ++  +L G+ P 
Sbjct: 195 SFEVDVWSIGCIMYTLLVGKPPF 217

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 89/203 (43%), Gaps = 29/203 (14%)
Query: 384 FNSSNRIEGAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDG 443
           F  S+     V+ G++  K+L +K  + E   K+ M++  H +  H ++V   G    D 
Sbjct: 34  FEISDADTKEVFAGKIVPKSLLLKPHQRE---KMSMEISIHRSLAHQHVVGFHGF-FEDN 89
Query: 444 PHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM 503
              F+V E  +  SL + LH       +  A  Y        LR    + +  QY+H   
Sbjct: 90  DFVFVVLELCRRRSLLE-LHKRRKALTEPEARYY--------LR---QIVLGCQYLH--- 134
Query: 504 NPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNP----------ASW 553
               +HR++K  N+FL+E+   ++G+FG+A  V  D E  +     P             
Sbjct: 135 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGH 194
Query: 554 SMGIDIFAYGIVLLEVLSGQTPI 576
           S  +D+++ G ++  +L G+ P 
Sbjct: 195 SFEVDVWSIGCIMYTLLVGKPPF 217

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 48/197 (24%), Positives = 86/197 (43%), Gaps = 37/197 (18%)
Query: 399 LNGKNLAIK-----RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYA 453
           L GK +A+K     +     + KL  ++      +HPNIV+L     T+    +LV EYA
Sbjct: 30  LTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKT-LYLVMEYA 88
Query: 454 KNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRN 511
             G + D+L  HG +  K               + R    +  A+QY H       VHR+
Sbjct: 89  SGGEVFDYLVAHGWMKEKEA-----------RAKFR---QIVSAVQYCHQKF---IVHRD 131
Query: 512 IKSRNIFLDEEFNARVGNFGMAR-----------CVNDDTESPQFYSTNPASWSMGIDIF 560
           +K+ N+ LD + N ++ +FG +            C +    +P+ +          +D++
Sbjct: 132 LKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYD-GPEVDVW 190
Query: 561 AYGIVLLEVLSGQTPIN 577
           + G++L  ++SG  P +
Sbjct: 191 SLGVILYTLVSGSLPFD 207

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/226 (24%), Positives = 95/226 (42%), Gaps = 43/226 (19%)
Query: 374 IEDLRRATEKFNSSNRIEGAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATHHH---- 429
           I D+      F S   +   VY  R    ++AIK  +         ++++ A   H    
Sbjct: 13  IADIELGCGNFGS---VRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDN 69
Query: 430 PNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRIC 489
           P IVRL+G C  +     LV E A  G L  +L G    K + I         S    + 
Sbjct: 70  PYIVRLIGVCQAEA--LMLVMEMAGGGPLHKFLVG----KREEIPV-------SNVAELL 116
Query: 490 LDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN 549
             V+M ++Y+      ++VHR++ +RN+ L     A++ +FG+++ +  D     +Y+  
Sbjct: 117 HQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD---SYYTAR 170
Query: 550 -----PASW-----------SMGIDIFAYGIVLLEVLS-GQTPINR 578
                P  W           S   D+++YG+ + E LS GQ P  +
Sbjct: 171 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 216

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 71/167 (42%), Gaps = 31/167 (18%)
Query: 425 ATHHHPNIVRLLGTCLTD---GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLT 481
           A  +HP IV +  T   +   GP  ++V EY    +L+D +H    M            T
Sbjct: 67  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM------------T 114
Query: 482 WSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE 541
             + + +  D   AL + H       +HR++K  NI +      +V +FG+AR + D   
Sbjct: 115 PKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 171
Query: 542 S----------PQFYSTNPA---SWSMGIDIFAYGIVLLEVLSGQTP 575
           S           Q+ S   A   S     D+++ G VL EVL+G+ P
Sbjct: 172 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 71/167 (42%), Gaps = 31/167 (18%)
Query: 425 ATHHHPNIVRLLGTCLTD---GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLT 481
           A  +HP IV +  T   +   GP  ++V EY    +L+D +H    M            T
Sbjct: 67  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM------------T 114
Query: 482 WSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE 541
             + + +  D   AL + H       +HR++K  NI +      +V +FG+AR + D   
Sbjct: 115 PKRAIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 171
Query: 542 S----------PQFYSTNPA---SWSMGIDIFAYGIVLLEVLSGQTP 575
           S           Q+ S   A   S     D+++ G VL EVL+G+ P
Sbjct: 172 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 71/167 (42%), Gaps = 31/167 (18%)
Query: 425 ATHHHPNIVRLLGTCLTD---GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLT 481
           A  +HP IV +  T   +   GP  ++V EY    +L+D +H    M            T
Sbjct: 67  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM------------T 114
Query: 482 WSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE 541
             + + +  D   AL + H       +HR++K  NI +      +V +FG+AR + D   
Sbjct: 115 PKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 171
Query: 542 S----------PQFYSTNPA---SWSMGIDIFAYGIVLLEVLSGQTP 575
           S           Q+ S   A   S     D+++ G VL EVL+G+ P
Sbjct: 172 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/161 (24%), Positives = 76/161 (47%), Gaps = 31/161 (19%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           +P IVR++G C  +     LV E A+ G L  +L     +K++ I            + +
Sbjct: 429 NPYIVRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI------------IEL 474
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE--SPQFY 546
              V+M ++Y+      ++VHR++ +RN+ L  +  A++ +FG+++ +  D      Q +
Sbjct: 475 VHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 531
Query: 547 STNPASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
              P  W           S   D++++G+++ E  S GQ P
Sbjct: 532 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 572

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/161 (24%), Positives = 76/161 (47%), Gaps = 31/161 (19%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           +P IVR++G C  +     LV E A+ G L  +L     +K++ I            + +
Sbjct: 430 NPYIVRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI------------IEL 475
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE--SPQFY 546
              V+M ++Y+      ++VHR++ +RN+ L  +  A++ +FG+++ +  D      Q +
Sbjct: 476 VHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 532
Query: 547 STNPASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
              P  W           S   D++++G+++ E  S GQ P
Sbjct: 533 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 573

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 57.0 bits (136), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 71/167 (42%), Gaps = 31/167 (18%)
Query: 425 ATHHHPNIVRLLGTCLTD---GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLT 481
           A  +HP IV +  T   +   GP  ++V EY    +L+D +H    M            T
Sbjct: 67  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM------------T 114
Query: 482 WSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE 541
             + + +  D   AL + H       +HR++K  NI +      +V +FG+AR + D   
Sbjct: 115 PKRAIEVIADACQALNFSHQ---NGIIHRDVKPANILISATNAVKVVDFGIARAIADSGN 171
Query: 542 S----------PQFYSTNPA---SWSMGIDIFAYGIVLLEVLSGQTP 575
           S           Q+ S   A   S     D+++ G VL EVL+G+ P
Sbjct: 172 SVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 53/219 (24%), Positives = 96/219 (43%), Gaps = 33/219 (15%)
Query: 373 SIEDLRRATEKFNSSNR-IEGAVYHGR--LNGKNLAIKRTEHEVITKLEM---QLVQHAT 426
           S+ D ++   +F    +   G VY       G+ +AI++   +   K E+   +++    
Sbjct: 15  SVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE 74
Query: 427 HHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRL 486
           + +PNIV  L + L  G   ++V EY   GSL D +      + Q  A C          
Sbjct: 75  NKNPNIVNYLDSYLV-GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVC---------- 123
Query: 487 RICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFY 546
           R CL    AL+++H   +   +HRNIKS NI L  + + ++ +FG    +  +       
Sbjct: 124 RECLQ---ALEFLH---SNQVIHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM 177
Query: 547 STNP----------ASWSMGIDIFAYGIVLLEVLSGQTP 575
              P           ++   +DI++ GI+ +E++ G+ P
Sbjct: 178 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 76/160 (47%), Gaps = 30/160 (18%)
Query: 425 ATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQ 484
           A+  HP++VRLLG CL+  P   LV +   +G L +++H     +++        L W  
Sbjct: 95  ASMDHPHLVRLLGVCLS--PTIQLVTQLMPHGCLLEYVH-----EHKDNIGSQLLLNW-- 145
Query: 485 RLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV-NDDTESP 543
               C+ +A  + Y+        VHR++ +RN+ +    + ++ +FG+AR +  D+ E  
Sbjct: 146 ----CVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN 198
Query: 544 QFYSTNPASWSMGI------------DIFAYGIVLLEVLS 571
                 P  W M +            D+++YG+ + E+++
Sbjct: 199 ADGGKMPIKW-MALECIHYRKFTHQSDVWSYGVTIWELMT 237

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/161 (24%), Positives = 76/161 (47%), Gaps = 31/161 (19%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           +P IVR++G C  +     LV E A+ G L  +L     +K++ I            + +
Sbjct: 87  NPYIVRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI------------IEL 132
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE--SPQFY 546
              V+M ++Y+      ++VHR++ +RN+ L  +  A++ +FG+++ +  D      Q +
Sbjct: 133 VHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 189
Query: 547 STNPASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
              P  W           S   D++++G+++ E  S GQ P
Sbjct: 190 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 56.6 bits (135), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/161 (24%), Positives = 76/161 (47%), Gaps = 31/161 (19%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           +P IVR++G C  +     LV E A+ G L  +L     +K++ I            + +
Sbjct: 87  NPYIVRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI------------IEL 132
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE--SPQFY 546
              V+M ++Y+      ++VHR++ +RN+ L  +  A++ +FG+++ +  D      Q +
Sbjct: 133 VHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 189
Query: 547 STNPASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
              P  W           S   D++++G+++ E  S GQ P
Sbjct: 190 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 230

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 86/197 (43%), Gaps = 37/197 (18%)
Query: 399 LNGKNLAIK-----RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYA 453
           L GK +A++     +     + KL  ++      +HPNIV+L     T+    +LV EYA
Sbjct: 37  LTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKT-LYLVMEYA 95
Query: 454 KNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRN 511
             G + D+L  HG +  K               + R    +  A+QY H       VHR+
Sbjct: 96  SGGEVFDYLVAHGRMKEKEA-----------RAKFR---QIVSAVQYCHQKF---IVHRD 138
Query: 512 IKSRNIFLDEEFNARVGNFGMAR-----------CVNDDTESPQFYSTNPASWSMGIDIF 560
           +K+ N+ LD + N ++ +FG +            C +    +P+ +          +D++
Sbjct: 139 LKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYDGP-EVDVW 197
Query: 561 AYGIVLLEVLSGQTPIN 577
           + G++L  ++SG  P +
Sbjct: 198 SLGVILYTLVSGSLPFD 214

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/161 (24%), Positives = 76/161 (47%), Gaps = 31/161 (19%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           +P IVR++G C  +     LV E A+ G L  +L     +K++ I            + +
Sbjct: 77  NPYIVRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI------------IEL 122
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE--SPQFY 546
              V+M ++Y+      ++VHR++ +RN+ L  +  A++ +FG+++ +  D      Q +
Sbjct: 123 VHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 179
Query: 547 STNPASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
              P  W           S   D++++G+++ E  S GQ P
Sbjct: 180 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 86/197 (43%), Gaps = 37/197 (18%)
Query: 399 LNGKNLAIK-----RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYA 453
           L GK +A++     +     + KL  ++      +HPNIV+L     T+    +LV EYA
Sbjct: 37  LTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEVIETEKT-LYLVMEYA 95
Query: 454 KNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRN 511
             G + D+L  HG +  K               + R    +  A+QY H       VHR+
Sbjct: 96  SGGEVFDYLVAHGRMKEKEA-----------RAKFR---QIVSAVQYCHQKF---IVHRD 138
Query: 512 IKSRNIFLDEEFNARVGNFGMAR-----------CVNDDTESPQFYSTNPASWSMGIDIF 560
           +K+ N+ LD + N ++ +FG +            C +    +P+ +          +D++
Sbjct: 139 LKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGP-EVDVW 197
Query: 561 AYGIVLLEVLSGQTPIN 577
           + G++L  ++SG  P +
Sbjct: 198 SLGVILYTLVSGSLPFD 214

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/161 (24%), Positives = 76/161 (47%), Gaps = 31/161 (19%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           +P IVR++G C  +     LV E A+ G L  +L     +K++ I            + +
Sbjct: 85  NPYIVRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI------------IEL 130
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE--SPQFY 546
              V+M ++Y+      ++VHR++ +RN+ L  +  A++ +FG+++ +  D      Q +
Sbjct: 131 VHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 187
Query: 547 STNPASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
              P  W           S   D++++G+++ E  S GQ P
Sbjct: 188 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 228

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 54/226 (23%), Positives = 103/226 (45%), Gaps = 33/226 (14%)
Query: 366 KRLLESYSIEDLRRATEKFNSSNR-IEGAVYHGR--LNGKNLAIKRTEHEVITKLEM--- 419
           ++L    S+ D ++   +F    +   G VY       G+ +AI++   +   K E+   
Sbjct: 7   EKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN 66
Query: 420 QLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCF 479
           +++    + +PNIV  L + L  G   ++V EY   GSL D +      + Q  A C   
Sbjct: 67  EILVMRENKNPNIVNYLDSYLV-GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVC--- 122
Query: 480 LTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGM-ARCVND 538
                  R CL    AL+++H   +   +HR+IKS NI L  + + ++ +FG  A+   +
Sbjct: 123 -------RECLQ---ALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169
Query: 539 DTESPQFYST---------NPASWSMGIDIFAYGIVLLEVLSGQTP 575
            ++  +   T            ++   +DI++ GI+ +E++ G+ P
Sbjct: 170 QSKRSEMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/161 (24%), Positives = 76/161 (47%), Gaps = 31/161 (19%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           +P IVR++G C  +     LV E A+ G L  +L     +K++ I            + +
Sbjct: 71  NPYIVRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI------------IEL 116
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE--SPQFY 546
              V+M ++Y+      ++VHR++ +RN+ L  +  A++ +FG+++ +  D      Q +
Sbjct: 117 VHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTH 173
Query: 547 STNPASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
              P  W           S   D++++G+++ E  S GQ P
Sbjct: 174 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/161 (24%), Positives = 76/161 (47%), Gaps = 31/161 (19%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           +P IVR++G C  +     LV E A+ G L  +L     +K++ I            + +
Sbjct: 71  NPYIVRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI------------IEL 116
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE--SPQFY 546
              V+M ++Y+      ++VHR++ +RN+ L  +  A++ +FG+++ +  D      Q +
Sbjct: 117 VHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 173
Query: 547 STNPASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
              P  W           S   D++++G+++ E  S GQ P
Sbjct: 174 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 214

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/161 (24%), Positives = 76/161 (47%), Gaps = 31/161 (19%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           +P IVR++G C  +     LV E A+ G L  +L     +K++ I            + +
Sbjct: 67  NPYIVRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI------------IEL 112
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE--SPQFY 546
              V+M ++Y+      ++VHR++ +RN+ L  +  A++ +FG+++ +  D      Q +
Sbjct: 113 VHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 169
Query: 547 STNPASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
              P  W           S   D++++G+++ E  S GQ P
Sbjct: 170 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 210

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 56.2 bits (134), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/161 (24%), Positives = 76/161 (47%), Gaps = 31/161 (19%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           +P IVR++G C  +     LV E A+ G L  +L     +K++ I            + +
Sbjct: 65  NPYIVRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRHVKDKNI------------IEL 110
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE--SPQFY 546
              V+M ++Y+      ++VHR++ +RN+ L  +  A++ +FG+++ +  D      Q +
Sbjct: 111 VHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTH 167
Query: 547 STNPASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
              P  W           S   D++++G+++ E  S GQ P
Sbjct: 168 GKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 208

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 45/167 (26%), Positives = 71/167 (42%), Gaps = 31/167 (18%)
Query: 425 ATHHHPNIVRLLGTCLTD---GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLT 481
           A  +HP IV +  T   +   GP  ++V EY    +L+D +H    M            T
Sbjct: 84  AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPM------------T 131
Query: 482 WSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE 541
             + + +  D   AL + H       +HR++K  NI +      +V +FG+AR + D   
Sbjct: 132 PKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN 188
Query: 542 S----------PQFYSTNPA---SWSMGIDIFAYGIVLLEVLSGQTP 575
           S           Q+ S   A   S     D+++ G VL EVL+G+ P
Sbjct: 189 SVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 235

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 46/197 (23%), Positives = 85/197 (43%), Gaps = 37/197 (18%)
Query: 399 LNGKNLAIKRTEHEVITKLEMQLVQHATH-----HHPNIVRLLGTCLTDGPHSFLVFEYA 453
           L G+ +A+K  +   +    +Q +          +HPNIV+L     T+    +LV EYA
Sbjct: 38  LTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKT-LYLVMEYA 96
Query: 454 KNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRN 511
             G + D+L  HG +  K               + R    +  A+QY H       VHR+
Sbjct: 97  SGGEVFDYLVAHGRMKEKEA-----------RAKFR---QIVSAVQYCHQ---KYIVHRD 139
Query: 512 IKSRNIFLDEEFNARVGNFGMAR-----------CVNDDTESPQFYSTNPASWSMGIDIF 560
           +K+ N+ LD + N ++ +FG +            C +    +P+ +          +D++
Sbjct: 140 LKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYDGP-EVDVW 198
Query: 561 AYGIVLLEVLSGQTPIN 577
           + G++L  ++SG  P +
Sbjct: 199 SLGVILYTLVSGSLPFD 215

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 48/194 (24%), Positives = 89/194 (45%), Gaps = 31/194 (15%)
Query: 394 VYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYA 453
           +Y  +   K   ++R E   + K E+Q++Q     HP +V L  +   D    F+V +  
Sbjct: 42  MYAMKYMNKQKCVERNEVRNVFK-ELQIMQGL--EHPFLVNLWYS-FQDEEDMFMVVDLL 97
Query: 454 KNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIK 513
             G L+  L   +  K + +           +L IC ++ MAL Y+    N   +HR++K
Sbjct: 98  LGGDLRYHLQQNVHFKEETV-----------KLFIC-ELVMALDYLQ---NQRIIHRDMK 142
Query: 514 SRNIFLDEEFNARVGNFGMARCVNDDTE-----------SPQFYSTNP-ASWSMGIDIFA 561
             NI LDE  +  + +F +A  +  +T+           +P+ +S+   A +S  +D ++
Sbjct: 143 PDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWS 202
Query: 562 YGIVLLEVLSGQTP 575
            G+   E+L G+ P
Sbjct: 203 LGVTAYELLRGRRP 216

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 44/183 (24%), Positives = 85/183 (46%), Gaps = 31/183 (16%)
Query: 408 RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL--HGG 465
           R + E + + E ++   +   H NIV ++     D  + +LV EY +  +L +++  HG 
Sbjct: 49  REKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCY-YLVMEYIEGPTLSEYIESHGP 107
Query: 466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNA 525
           L        S    + ++ ++         L  + H  +   VHR+IK +NI +D     
Sbjct: 108 L--------SVDTAINFTNQI---------LDGIKHAHDMRIVHRDIKPQNILIDSNKTL 150
Query: 526 RVGNFGMARCVNDDT--------ESPQFYSTNPASWSMG---IDIFAYGIVLLEVLSGQT 574
           ++ +FG+A+ +++ +         + Q++S   A         DI++ GIVL E+L G+ 
Sbjct: 151 KIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEP 210
Query: 575 PIN 577
           P N
Sbjct: 211 PFN 213

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 55.8 bits (133), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 85/197 (43%), Gaps = 36/197 (18%)
Query: 399 LNGKNLAIKRTEHE------VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEY 452
           L G  +A+K    +      V+ K+  ++       HP+I++L     T     F+V EY
Sbjct: 39  LTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPS-DIFMVMEY 97
Query: 453 AKNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHR 510
              G L D++  +G L  K              +  R+   +   + Y H  M    VHR
Sbjct: 98  VSGGELFDYICKNGRLDEK--------------ESRRLFQQILSGVDYCHRHM---VVHR 140
Query: 511 NIKSRNIFLDEEFNARVGNFGMARCVND------DTESPQFYSTNPASWSM----GIDIF 560
           ++K  N+ LD   NA++ +FG++  ++D         SP + +    S  +     +DI+
Sbjct: 141 DLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAGPEVDIW 200
Query: 561 AYGIVLLEVLSGQTPIN 577
           + G++L  +L G  P +
Sbjct: 201 SSGVILYALLCGTLPFD 217

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 100/233 (42%), Gaps = 49/233 (21%)
Query: 372 YSIEDLRRATEKFNSSNRIE----GAVYHGRLNG-------KNLAIKRTEHEVITKLEMQ 420
           Y  ++   A EK   S  +     G VY G   G         +AIK        +  ++
Sbjct: 15  YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 74
Query: 421 LVQHAT-------HHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG-GLAMKNQF 472
            +  A+       HH   +VRLLG  ++ G  + ++ E    G LK +L     AM N  
Sbjct: 75  FLNEASVMKEFNCHH---VVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNP 130
Query: 473 IASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGM 532
           + +       S+ +++  ++A  + Y++      +VHR++ +RN  + E+F  ++G+FGM
Sbjct: 131 VLAPPSL---SKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGM 184
Query: 533 ARCVNDDTESPQFYS-----------TNPASWSMGI-----DIFAYGIVLLEV 569
            R    D     +Y             +P S   G+     D++++G+VL E+
Sbjct: 185 TR----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 99/226 (43%), Gaps = 33/226 (14%)
Query: 366 KRLLESYSIEDLRRATEKFNSSNR-IEGAVYHGR--LNGKNLAIKRTEHEVITKLEM--- 419
           ++L    S+ D ++   +F    +   G VY       G+ +AI++   +   K E+   
Sbjct: 7   EKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN 66
Query: 420 QLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCF 479
           +++    + +PNIV  L + L  G   ++V EY   GSL D +      + Q  A C   
Sbjct: 67  EILVMRENKNPNIVNYLDSYLV-GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVC--- 122
Query: 480 LTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD 539
                  R CL    AL+++H   +   +HR+IKS NI L  + + ++ +FG    +  +
Sbjct: 123 -------RECLQ---ALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169
Query: 540 TESPQFYSTNP----------ASWSMGIDIFAYGIVLLEVLSGQTP 575
                     P           ++   +DI++ GI+ +E++ G+ P
Sbjct: 170 QSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 75/159 (47%), Gaps = 28/159 (17%)
Query: 425 ATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQ 484
           A+  HP++VRLLG CL+  P   LV +   +G L +++H     +++        L W  
Sbjct: 72  ASMDHPHLVRLLGVCLS--PTIQLVTQLMPHGCLLEYVH-----EHKDNIGSQLLLNW-- 122
Query: 485 RLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV-NDDTESP 543
               C+ +A  + Y+        VHR++ +RN+ +    + ++ +FG+AR +  D+ E  
Sbjct: 123 ----CVQIAKGMMYLE---ERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYN 175
Query: 544 QFYSTNPASW-----------SMGIDIFAYGIVLLEVLS 571
                 P  W           +   D+++YG+ + E+++
Sbjct: 176 ADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMT 214

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 99/226 (43%), Gaps = 33/226 (14%)
Query: 366 KRLLESYSIEDLRRATEKFNSSNR-IEGAVYHGR--LNGKNLAIKRTEHEVITKLEM--- 419
           ++L    S+ D ++   +F    +   G VY       G+ +AI++   +   K E+   
Sbjct: 8   EKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN 67
Query: 420 QLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCF 479
           +++    + +PNIV  L + L  G   ++V EY   GSL D +      + Q  A C   
Sbjct: 68  EILVMRENKNPNIVNYLDSYLV-GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVC--- 123
Query: 480 LTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD 539
                  R CL    AL+++H   +   +HR+IKS NI L  + + ++ +FG    +  +
Sbjct: 124 -------RECLQ---ALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 170
Query: 540 TESPQFYSTNP----------ASWSMGIDIFAYGIVLLEVLSGQTP 575
                     P           ++   +DI++ GI+ +E++ G+ P
Sbjct: 171 QSKRSXMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 216

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 53/226 (23%), Positives = 99/226 (43%), Gaps = 33/226 (14%)
Query: 366 KRLLESYSIEDLRRATEKFNSSNR-IEGAVYHGR--LNGKNLAIKRTEHEVITKLEM--- 419
           ++L    S+ D ++   +F    +   G VY       G+ +AI++   +   K E+   
Sbjct: 7   EKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN 66
Query: 420 QLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCF 479
           +++    + +PNIV  L + L  G   ++V EY   GSL D +      + Q  A C   
Sbjct: 67  EILVMRENKNPNIVNYLDSYLV-GDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVC--- 122
Query: 480 LTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD 539
                  R CL    AL+++H   +   +HR+IKS NI L  + + ++ +FG    +  +
Sbjct: 123 -------RECLQ---ALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169
Query: 540 TESPQFYSTNP----------ASWSMGIDIFAYGIVLLEVLSGQTP 575
                     P           ++   +DI++ GI+ +E++ G+ P
Sbjct: 170 QSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 55.8 bits (133), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 100/233 (42%), Gaps = 49/233 (21%)
Query: 372 YSIEDLRRATEKFNSSNRIE----GAVYHGRLNG-------KNLAIKRTEHEVITKLEMQ 420
           Y  ++   A EK   S  +     G VY G   G         +AIK        +  ++
Sbjct: 5   YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 64
Query: 421 LVQHAT-------HHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG-GLAMKNQF 472
            +  A+       HH   +VRLLG  ++ G  + ++ E    G LK +L     AM N  
Sbjct: 65  FLNEASVMKEFNCHH---VVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNP 120
Query: 473 IASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGM 532
           + +       S+ +++  ++A  + Y++      +VHR++ +RN  + E+F  ++G+FGM
Sbjct: 121 VLAPPSL---SKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGM 174
Query: 533 ARCVNDDTESPQFYS-----------TNPASWSMGI-----DIFAYGIVLLEV 569
            R    D     +Y             +P S   G+     D++++G+VL E+
Sbjct: 175 TR----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 223

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 95/216 (43%), Gaps = 41/216 (18%)
Query: 398 RLNGKNLAIKRTEHE------VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFE 451
           +L G  +A+K    +      V+ K++ ++       HP+I++L    ++     F+V E
Sbjct: 33  QLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY-QVISTPTDFFMVME 91
Query: 452 YAKNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVH 509
           Y   G L D++  HG +                 +  R+   +  A+ Y H  M    VH
Sbjct: 92  YVSGGELFDYICKHGRVEE--------------MEARRLFQQILSAVDYCHRHM---VVH 134
Query: 510 RNIKSRNIFLDEEFNARVGNFGMARCVNDDT------ESPQFYSTNPASWSM----GIDI 559
           R++K  N+ LD   NA++ +FG++  ++D         SP + +    S  +     +DI
Sbjct: 135 RDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDI 194
Query: 560 FAYGIVLLEVLSGQTPINRPRKKDEGSVWLSEKIKS 595
           ++ G++L  +L G  P +     DE    L +KI+ 
Sbjct: 195 WSCGVILYALLCGTLPFD-----DEHVPTLFKKIRG 225

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 55.5 bits (132), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 51/216 (23%), Positives = 95/216 (43%), Gaps = 41/216 (18%)
Query: 398 RLNGKNLAIKRTEHE------VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFE 451
           +L G  +A+K    +      V+ K++ ++       HP+I++L    ++     F+V E
Sbjct: 33  QLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLY-QVISTPTDFFMVME 91
Query: 452 YAKNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVH 509
           Y   G L D++  HG +                 +  R+   +  A+ Y H  M    VH
Sbjct: 92  YVSGGELFDYICKHGRVEE--------------MEARRLFQQILSAVDYCHRHM---VVH 134
Query: 510 RNIKSRNIFLDEEFNARVGNFGMARCVN------DDTESPQFYSTNPASWSM----GIDI 559
           R++K  N+ LD   NA++ +FG++  ++      D   SP + +    S  +     +DI
Sbjct: 135 RDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAGPEVDI 194
Query: 560 FAYGIVLLEVLSGQTPINRPRKKDEGSVWLSEKIKS 595
           ++ G++L  +L G  P +     DE    L +KI+ 
Sbjct: 195 WSCGVILYALLCGTLPFD-----DEHVPTLFKKIRG 225

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 45/193 (23%), Positives = 88/193 (45%), Gaps = 34/193 (17%)
Query: 398 RLNGKNLAIKRTEHEVITKLEM---QLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAK 454
           R +GK +A+K+ +     + E+   ++V    + H N+V +  + L  G   ++V E+ +
Sbjct: 173 RSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-GDELWVVMEFLE 231
Query: 455 NGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKS 514
            G+L D +      + Q  A             +CL V  AL  +H       +HR+IKS
Sbjct: 232 GGALTDIVTHTRMNEEQIAA-------------VCLAVLQALSVLHAQ---GVIHRDIKS 275
Query: 515 RNIFLDEEFNARVGNFGMARCVNDDTE------------SPQFYSTNPASWSMGIDIFAY 562
            +I L  +   ++ +FG    V+ +              +P+  S  P  +   +DI++ 
Sbjct: 276 DSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP--YGPEVDIWSL 333
Query: 563 GIVLLEVLSGQTP 575
           GI+++E++ G+ P
Sbjct: 334 GIMVIEMVDGEPP 346

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 55.5 bits (132), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 39/165 (23%), Positives = 78/165 (47%), Gaps = 27/165 (16%)
Query: 429 HPNIVRLLGTCLTDG-----PHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWS 483
           HP++ +L+G  L        P   ++  + K+G L  +L      +N F       L   
Sbjct: 84  HPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPF------NLPLQ 137
Query: 484 QRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV-NDDTES 542
             +R  +D+A  ++Y+    + +++HR++ +RN  L E+    V +FG++R + + D   
Sbjct: 138 TLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR 194
Query: 543 PQFYSTNPASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
               S  P  W           ++  D++A+G+ + E+++ GQTP
Sbjct: 195 QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 49/197 (24%), Positives = 84/197 (42%), Gaps = 37/197 (18%)
Query: 399 LNGKNLAIK-----RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYA 453
           L GK +A+K     +     + KL  ++      +HPNIV+L     T+    +LV EYA
Sbjct: 37  LTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEVIETEKT-LYLVXEYA 95
Query: 454 KNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRN 511
             G + D+L  HG    K               + R    +  A+QY H       VHR+
Sbjct: 96  SGGEVFDYLVAHGRXKEKEA-----------RAKFR---QIVSAVQYCHQKF---IVHRD 138
Query: 512 IKSRNIFLDEEFNARVGNFGM-----------ARCVNDDTESPQFYSTNPASWSMGIDIF 560
           +K+ N+ LD + N ++ +FG            A C      +P+ +          +D++
Sbjct: 139 LKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPE-VDVW 197
Query: 561 AYGIVLLEVLSGQTPIN 577
           + G++L  ++SG  P +
Sbjct: 198 SLGVILYTLVSGSLPFD 214

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/165 (23%), Positives = 79/165 (47%), Gaps = 28/165 (16%)
Query: 429 HPNIVRLLGTCL---TDG-PHSFLVFEYAKNGSLKDWL-HGGLAMKNQFIASCYCFLTWS 483
           HPN++RLLG C+   + G P   ++  + K G L  +L +  L    + I          
Sbjct: 95  HPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIP-------LQ 147
Query: 484 QRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV-NDDTES 542
             L+  +D+A+ ++Y+    N +++HR++ +RN  L ++    V +FG+++ + + D   
Sbjct: 148 TLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR 204
Query: 543 PQFYSTNPASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
               +  P  W           +   D++A+G+ + E+ + G TP
Sbjct: 205 QGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 35/198 (17%)
Query: 398 RLNGKNLAIKRTEHEVITKLEM---QLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAK 454
           R +GK +A+K+ +     + E+   ++V    + H N+V +  + L  G   ++V E+ +
Sbjct: 53  RSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-GDELWVVMEFLE 111
Query: 455 NGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKS 514
            G+L D +      + Q  A             +CL V  AL  +H       +HR+IKS
Sbjct: 112 GGALTDIVTHTRMNEEQIAA-------------VCLAVLQALSVLH---AQGVIHRDIKS 155
Query: 515 RNIFLDEEFNARVGNFGMARCVNDDTE------------SPQFYSTNPASWSMGIDIFAY 562
            +I L  +   ++ +FG    V+ +              +P+  S  P  +   +DI++ 
Sbjct: 156 DSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP--YGPEVDIWSL 213
Query: 563 GIVLLEVLSGQTP-INRP 579
           GI+++E++ G+ P  N P
Sbjct: 214 GIMVIEMVDGEPPYFNEP 231

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 35/198 (17%)
Query: 398 RLNGKNLAIKRTEHEVITKLEM---QLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAK 454
           R +GK +A+K+ +     + E+   ++V    + H N+V +  + L  G   ++V E+ +
Sbjct: 51  RSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-GDELWVVMEFLE 109
Query: 455 NGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKS 514
            G+L D +      + Q  A             +CL V  AL  +H       +HR+IKS
Sbjct: 110 GGALTDIVTHTRMNEEQIAA-------------VCLAVLQALSVLH---AQGVIHRDIKS 153
Query: 515 RNIFLDEEFNARVGNFGMARCVNDDTE------------SPQFYSTNPASWSMGIDIFAY 562
            +I L  +   ++ +FG    V+ +              +P+  S  P  +   +DI++ 
Sbjct: 154 DSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP--YGPEVDIWSL 211
Query: 563 GIVLLEVLSGQTP-INRP 579
           GI+++E++ G+ P  N P
Sbjct: 212 GIMVIEMVDGEPPYFNEP 229

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/233 (23%), Positives = 100/233 (42%), Gaps = 49/233 (21%)
Query: 372 YSIEDLRRATEKFNSSNRIE----GAVYHGRLNG-------KNLAIKRTEHEVITKLEMQ 420
           Y  ++   A EK   S  +     G VY G   G         +AIK        +  ++
Sbjct: 15  YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 74
Query: 421 LVQHAT-------HHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG-GLAMKNQF 472
            +  A+       HH   +VRLLG  ++ G  + ++ E    G LK +L      M+N  
Sbjct: 75  FLNEASVMKEFNCHH---VVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 130
Query: 473 IASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGM 532
           + +       S+ +++  ++A  + Y++      +VHR++ +RN  + E+F  ++G+FGM
Sbjct: 131 VLAPPSL---SKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGM 184
Query: 533 ARCVNDDTESPQFYS-----------TNPASWSMGI-----DIFAYGIVLLEV 569
            R    D     +Y             +P S   G+     D++++G+VL E+
Sbjct: 185 TR----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 233

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/229 (23%), Positives = 99/229 (43%), Gaps = 41/229 (17%)
Query: 372 YSIEDLRRATEKFNSSNRIE----GAVYHGRLNG-------KNLAIKRTEHEVITKLEMQ 420
           Y  ++   A EK   S  +     G VY G   G         +AIK        +  ++
Sbjct: 9   YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 68
Query: 421 LVQHAT-------HHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG-GLAMKNQF 472
            +  A+       HH   +VRLLG  ++ G  + ++ E    G LK +L      M+N  
Sbjct: 69  FLNEASVMKEFNCHH---VVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 124
Query: 473 IASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGM 532
           + +       S+ +++  ++A  + Y++      +VHR++ +RN  + E+F  ++G+FGM
Sbjct: 125 VLAPPSL---SKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGM 178
Query: 533 ARCVND-DTESPQFYSTNPASWSM------GI-----DIFAYGIVLLEV 569
            R + + D          P  W        G+     D++++G+VL E+
Sbjct: 179 TRDIXETDXXRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/165 (21%), Positives = 76/165 (46%), Gaps = 32/165 (19%)
Query: 426 THHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL---HGGLAMKNQFIASCYCFLTW 482
           T  H  +VRL      + P  +++ E+   GSL D+L    GG  +  + I         
Sbjct: 63  TLQHDKLVRLYAVVTKEEP-IYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFS------ 115
Query: 483 SQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTES 542
                     A   + M ++   +Y+HR++++ N+ + E    ++ +FG+AR + D+  +
Sbjct: 116 ----------AQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 165
Query: 543 PQFYSTNPASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
            +  +  P  W           ++  +++++GI+L E+++ G+ P
Sbjct: 166 AREGAKFPIKWTAPEAINFGCFTIKSNVWSFGILLYEIVTYGKIP 210

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/235 (22%), Positives = 100/235 (42%), Gaps = 59/235 (25%)
Query: 392 GAVYHGR--LNGKNLAIKRTEH--EVITKLEMQLVQHATHHHPNIVRLLG---------- 437
           G V   R  L+ +  AIK+  H  E ++ +  +++  A+ +H  +VR             
Sbjct: 20  GQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79
Query: 438 --TCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMA 495
             T +      F+  EY +NG+L D +H     + +            +  R+   +  A
Sbjct: 80  PMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQR-----------DEYWRLFRQILEA 128
Query: 496 LQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN-PAS-- 552
           L Y+H   +   +HR++K  NIF+DE  N ++G+FG+A+ V+   +  +  S N P S  
Sbjct: 129 LSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 553 ----------------------WSMGIDIFAYGIVLLEVL----SGQTPINRPRK 581
                                 ++  ID+++ GI+  E++    +G   +N  +K
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKK 240

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 54.7 bits (130), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 35/198 (17%)
Query: 398 RLNGKNLAIKRTEHEVITKLEM---QLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAK 454
           R +GK +A+K+ +     + E+   ++V    + H N+V +  + L  G   ++V E+ +
Sbjct: 42  RSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-GDELWVVMEFLE 100
Query: 455 NGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKS 514
            G+L D +      + Q  A             +CL V  AL  +H       +HR+IKS
Sbjct: 101 GGALTDIVTHTRMNEEQIAA-------------VCLAVLQALSVLH---AQGVIHRDIKS 144
Query: 515 RNIFLDEEFNARVGNFGMARCVNDDTE------------SPQFYSTNPASWSMGIDIFAY 562
            +I L  +   ++ +FG    V+ +              +P+  S  P  +   +DI++ 
Sbjct: 145 DSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP--YGPEVDIWSL 202
Query: 563 GIVLLEVLSGQTP-INRP 579
           GI+++E++ G+ P  N P
Sbjct: 203 GIMVIEMVDGEPPYFNEP 220

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 48/205 (23%), Positives = 91/205 (44%), Gaps = 37/205 (18%)
Query: 392 GAVYHGRLNG-------KNLAIKRTEHEVITKLEMQLVQHAT-------HHHPNIVRLLG 437
           G VY G   G         +AIK        +  ++ +  A+       HH   +VRLLG
Sbjct: 24  GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH---VVRLLG 80
Query: 438 TCLTDGPHSFLVFEYAKNGSLKDWLHG-GLAMKNQFIASCYCFLTWSQRLRICLDVAMAL 496
             ++ G  + ++ E    G LK +L      M+N  + +       S+ +++  ++A  +
Sbjct: 81  V-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL---SKMIQMAGEIADGM 136
Query: 497 QYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND-DTESPQFYSTNPASWSM 555
            Y++      +VHR++ +RN  + E+F  ++G+FGM R + + D          P  W  
Sbjct: 137 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMS 193
Query: 556 ------GI-----DIFAYGIVLLEV 569
                 G+     D++++G+VL E+
Sbjct: 194 PESLKDGVFTTYSDVWSFGVVLWEI 218

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 79/170 (46%), Gaps = 21/170 (12%)
Query: 418 EMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG----GLAMKNQFI 473
           E++++ H   H  NIV LLG C   GP   ++ EY   G L ++L      GL       
Sbjct: 99  ELKIMSHLGQHE-NIVNLLGACTHGGP-VLVITEYCCYGDLLNFLRRKRPPGLEYSYNPS 156
Query: 474 ASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA 533
            +    L+    L     VA  + ++    + + +HR++ +RN+ L     A++G+FG+A
Sbjct: 157 HNPEEQLSSRDLLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 213
Query: 534 R-CVNDDTESPQFYSTNPASW-----------SMGIDIFAYGIVLLEVLS 571
           R  +ND     +  +  P  W           ++  D+++YGI+L E+ S
Sbjct: 214 RDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 263

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 77/164 (46%), Gaps = 33/164 (20%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HPNI++L  T  T+    FLVF+  K G L D+L   + +  +            + +R 
Sbjct: 83  HPNIIQLKDTYETN-TFFFLVFDLMKKGELFDYLTEKVTLSEK---------ETRKIMRA 132
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------- 541
            L+V  AL    H +N   VHR++K  NI LD++ N ++ +FG + C  D  E       
Sbjct: 133 LLEVICAL----HKLN--IVHRDLKPENILLDDDMNIKLTDFGFS-CQLDPGEKLRSVCG 185
Query: 542 SPQFYSTNPASWSMG---------IDIFAYGIVLLEVLSGQTPI 576
           +P + +      SM          +D+++ G+++  +L+G  P 
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/233 (23%), Positives = 100/233 (42%), Gaps = 49/233 (21%)
Query: 372 YSIEDLRRATEKFNSSNRIE----GAVYHGRLNG-------KNLAIKRTEHEVITKLEMQ 420
           Y  ++   A EK   S  +     G VY G   G         +AIK        +  ++
Sbjct: 8   YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 67
Query: 421 LVQHAT-------HHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG-GLAMKNQF 472
            +  A+       HH   +VRLLG  ++ G  + ++ E    G LK +L      M+N  
Sbjct: 68  FLNEASVMKEFNCHH---VVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 123
Query: 473 IASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGM 532
           + +       S+ +++  ++A  + Y++      +VHR++ +RN  + E+F  ++G+FGM
Sbjct: 124 VLAPPSL---SKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGM 177
Query: 533 ARCVNDDTESPQFYS-----------TNPASWSMGI-----DIFAYGIVLLEV 569
            R    D     +Y             +P S   G+     D++++G+VL E+
Sbjct: 178 TR----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 47/198 (23%), Positives = 90/198 (45%), Gaps = 35/198 (17%)
Query: 398 RLNGKNLAIKRTEHEVITKLEM---QLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAK 454
           R +GK +A+K+ +     + E+   ++V    + H N+V +  + L  G   ++V E+ +
Sbjct: 46  RSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-GDELWVVMEFLE 104
Query: 455 NGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKS 514
            G+L D +      + Q  A             +CL V  AL  +H       +HR+IKS
Sbjct: 105 GGALTDIVTHTRMNEEQIAA-------------VCLAVLQALSVLH---AQGVIHRDIKS 148
Query: 515 RNIFLDEEFNARVGNFGMARCVNDDTE------------SPQFYSTNPASWSMGIDIFAY 562
            +I L  +   ++ +FG    V+ +              +P+  S  P  +   +DI++ 
Sbjct: 149 DSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP--YGPEVDIWSL 206
Query: 563 GIVLLEVLSGQTP-INRP 579
           GI+++E++ G+ P  N P
Sbjct: 207 GIMVIEMVDGEPPYFNEP 224

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 77/164 (46%), Gaps = 33/164 (20%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HPNI++L  T  T+    FLVF+  K G L D+L   + +  +            + +R 
Sbjct: 70  HPNIIQLKDTYETN-TFFFLVFDLMKKGELFDYLTEKVTLSEK---------ETRKIMRA 119
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------- 541
            L+V  AL    H +N   VHR++K  NI LD++ N ++ +FG + C  D  E       
Sbjct: 120 LLEVICAL----HKLN--IVHRDLKPENILLDDDMNIKLTDFGFS-CQLDPGEKLREVCG 172
Query: 542 SPQFYSTNPASWSMG---------IDIFAYGIVLLEVLSGQTPI 576
           +P + +      SM          +D+++ G+++  +L+G  P 
Sbjct: 173 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 216

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 45/164 (27%), Positives = 77/164 (46%), Gaps = 33/164 (20%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HPNI++L  T  T+    FLVF+  K G L D+L   + +  +            + +R 
Sbjct: 83  HPNIIQLKDTYETN-TFFFLVFDLMKKGELFDYLTEKVTLSEK---------ETRKIMRA 132
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------- 541
            L+V  AL    H +N   VHR++K  NI LD++ N ++ +FG + C  D  E       
Sbjct: 133 LLEVICAL----HKLN--IVHRDLKPENILLDDDMNIKLTDFGFS-CQLDPGEKLREVCG 185
Query: 542 SPQFYSTNPASWSMG---------IDIFAYGIVLLEVLSGQTPI 576
           +P + +      SM          +D+++ G+++  +L+G  P 
Sbjct: 186 TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/233 (23%), Positives = 100/233 (42%), Gaps = 49/233 (21%)
Query: 372 YSIEDLRRATEKFNSSNRIE----GAVYHGRLNG-------KNLAIKRTEHEVITKLEMQ 420
           Y  ++   A EK   S  +     G VY G   G         +AIK        +  ++
Sbjct: 8   YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 67
Query: 421 LVQHAT-------HHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG-GLAMKNQF 472
            +  A+       HH   +VRLLG  ++ G  + ++ E    G LK +L      M+N  
Sbjct: 68  FLNEASVMKEFNCHH---VVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 123
Query: 473 IASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGM 532
           + +       S+ +++  ++A  + Y++      +VHR++ +RN  + E+F  ++G+FGM
Sbjct: 124 VLAPPSL---SKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGM 177
Query: 533 ARCVNDDTESPQFYS-----------TNPASWSMGI-----DIFAYGIVLLEV 569
            R    D     +Y             +P S   G+     D++++G+VL E+
Sbjct: 178 TR----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 226

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 71/161 (44%), Gaps = 30/161 (18%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           H N++RL G  LT  P   +V E A  GSL D L      +  F+             R 
Sbjct: 80  HRNLIRLYGVVLT--PPMKMVTELAPLGSLLDRLR---KHQGHFLLGTLS--------RY 126
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV--NDDTESPQFY 546
            + VA  + Y+    +  ++HR++ +RN+ L      ++G+FG+ R +  NDD    Q +
Sbjct: 127 AVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEH 183
Query: 547 STNPASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
              P +W           S   D + +G+ L E+ + GQ P
Sbjct: 184 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 46/198 (23%), Positives = 90/198 (45%), Gaps = 35/198 (17%)
Query: 398 RLNGKNLAIKRTEHEVITKLEM---QLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAK 454
           R +GK +A+K+ +     + E+   ++V    + H N+V +  + L  G   ++V E+ +
Sbjct: 96  RSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLV-GDELWVVMEFLE 154
Query: 455 NGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKS 514
            G+L D +              +  +   Q   +CL V  AL  +H       +HR+IKS
Sbjct: 155 GGALTDIV-------------THTRMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKS 198
Query: 515 RNIFLDEEFNARVGNFGMARCVNDDTE------------SPQFYSTNPASWSMGIDIFAY 562
            +I L  +   ++ +FG    V+ +              +P+  S  P  +   +DI++ 
Sbjct: 199 DSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLP--YGPEVDIWSL 256
Query: 563 GIVLLEVLSGQTP-INRP 579
           GI+++E++ G+ P  N P
Sbjct: 257 GIMVIEMVDGEPPYFNEP 274

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/233 (23%), Positives = 100/233 (42%), Gaps = 49/233 (21%)
Query: 372 YSIEDLRRATEKFNSSNRIE----GAVYHGRLNG-------KNLAIKRTEHEVITKLEMQ 420
           Y  ++   A EK   S  +     G VY G   G         +AIK        +  ++
Sbjct: 9   YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 68
Query: 421 LVQHAT-------HHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG-GLAMKNQF 472
            +  A+       HH   +VRLLG  ++ G  + ++ E    G LK +L      M+N  
Sbjct: 69  FLNEASVMKEFNCHH---VVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 124
Query: 473 IASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGM 532
           + +       S+ +++  ++A  + Y++      +VHR++ +RN  + E+F  ++G+FGM
Sbjct: 125 VLAPPSL---SKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGM 178
Query: 533 ARCVNDDTESPQFYS-----------TNPASWSMGI-----DIFAYGIVLLEV 569
            R    D     +Y             +P S   G+     D++++G+VL E+
Sbjct: 179 TR----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 227

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 92/209 (44%), Gaps = 45/209 (21%)
Query: 392 GAVYHGRLNG-------KNLAIKRTEHEVITKLEMQLVQHAT-------HHHPNIVRLLG 437
           G VY G   G         +AIK        +  ++ +  A+       HH   +VRLLG
Sbjct: 30  GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH---VVRLLG 86
Query: 438 TCLTDGPHSFLVFEYAKNGSLKDWLHG-GLAMKNQFIASCYCFLTWSQRLRICLDVAMAL 496
             ++ G  + ++ E    G LK +L      M+N  + +       S+ +++  ++A  +
Sbjct: 87  V-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL---SKMIQMAGEIADGM 142
Query: 497 QYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYS--------- 547
            Y++      +VHR++ +RN  + E+F  ++G+FGM R    D     +Y          
Sbjct: 143 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPV 195
Query: 548 --TNPASWSMGI-----DIFAYGIVLLEV 569
              +P S   G+     D++++G+VL E+
Sbjct: 196 RWMSPESLKDGVFTTYSDVWSFGVVLWEI 224

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/209 (23%), Positives = 92/209 (44%), Gaps = 45/209 (21%)
Query: 392 GAVYHGRLNG-------KNLAIKRTEHEVITKLEMQLVQHAT-------HHHPNIVRLLG 437
           G VY G   G         +AIK        +  ++ +  A+       HH   +VRLLG
Sbjct: 26  GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH---VVRLLG 82
Query: 438 TCLTDGPHSFLVFEYAKNGSLKDWLHG-GLAMKNQFIASCYCFLTWSQRLRICLDVAMAL 496
             ++ G  + ++ E    G LK +L      M+N  + +       S+ +++  ++A  +
Sbjct: 83  V-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL---SKMIQMAGEIADGM 138
Query: 497 QYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYS--------- 547
            Y++      +VHR++ +RN  + E+F  ++G+FGM R    D     +Y          
Sbjct: 139 AYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPV 191
Query: 548 --TNPASWSMGI-----DIFAYGIVLLEV 569
              +P S   G+     D++++G+VL E+
Sbjct: 192 RWMSPESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 91/202 (45%), Gaps = 51/202 (25%)
Query: 397 GRLNGKNLAIKRTEH-----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDG-PHSFLVF 450
           G   G  +A+K+ +H     +   + E+Q+++    H   IV+  G     G P   LV 
Sbjct: 32  GDNTGALVAVKQLQHSGPDQQRDFQREIQILK--ALHSDFIVKYRGVSYGPGRPELRLVM 89
Query: 451 EYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQY-------MHHVM 503
           EY  +G L+D+L                     QR R  LD +  L Y       M ++ 
Sbjct: 90  EYLPSGCLRDFL---------------------QRHRARLDASRLLLYSSQICKGMEYLG 128
Query: 504 NPSYVHRNIKSRNIFLDEEFNARVGNFGMAR---------CVNDDTESPQFYSTNPASWS 554
           +   VHR++ +RNI ++ E + ++ +FG+A+          V +  +SP F+   P S S
Sbjct: 129 SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYA-PESLS 187
Query: 555 MGI-----DIFAYGIVLLEVLS 571
             I     D++++G+VL E+ +
Sbjct: 188 DNIFSRQSDVWSFGVVLYELFT 209

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 87/210 (41%), Gaps = 43/210 (20%)
Query: 392 GAVYHGRLNGK-------NLAIKRTEHEVITKLEMQLVQHA----THHHPNIVRLLGTCL 440
           G VY G+++G         +A+K        + E+  +  A      +H NIVR +G  L
Sbjct: 61  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 120
Query: 441 TDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH 500
              P  F++ E    G LK +L       +Q  +     L     L +  D+A   QY+ 
Sbjct: 121 QSLPR-FILLELMAGGDLKSFLRETRPRPSQPSS-----LAMLDLLHVARDIACGCQYLE 174
Query: 501 HVMNPSYVHRNIKSRNIFL---DEEFNARVGNFGMARCVNDDTESPQFYSTN-------- 549
                 ++HR+I +RN  L        A++G+FGMAR    D     +Y           
Sbjct: 175 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 227
Query: 550 ---PASWSMGI-----DIFAYGIVLLEVLS 571
              P ++  GI     D +++G++L E+ S
Sbjct: 228 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 257

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 91/202 (45%), Gaps = 51/202 (25%)
Query: 397 GRLNGKNLAIKRTEH-----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSF-LVF 450
           G   G  +A+K+ +H     +   + E+Q+++    H   IV+  G     G  S  LV 
Sbjct: 35  GDNTGALVAVKQLQHSGPDQQRDFQREIQILK--ALHSDFIVKYRGVSYGPGRQSLRLVM 92
Query: 451 EYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQY-------MHHVM 503
           EY  +G L+D+L                     QR R  LD +  L Y       M ++ 
Sbjct: 93  EYLPSGCLRDFL---------------------QRHRARLDASRLLLYSSQICKGMEYLG 131
Query: 504 NPSYVHRNIKSRNIFLDEEFNARVGNFGMAR---------CVNDDTESPQFYSTNPASWS 554
           +   VHR++ +RNI ++ E + ++ +FG+A+          V +  +SP F+   P S S
Sbjct: 132 SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA-PESLS 190
Query: 555 MGI-----DIFAYGIVLLEVLS 571
             I     D++++G+VL E+ +
Sbjct: 191 DNIFSRQSDVWSFGVVLYELFT 212

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 71/161 (44%), Gaps = 30/161 (18%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           H N++RL G  LT  P   +V E A  GSL D L      +  F+             R 
Sbjct: 70  HRNLIRLYGVVLT--PPMKMVTELAPLGSLLDRLR---KHQGHFLLGTLS--------RY 116
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV--NDDTESPQFY 546
            + VA  + Y+    +  ++HR++ +RN+ L      ++G+FG+ R +  NDD    Q +
Sbjct: 117 AVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEH 173
Query: 547 STNPASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
              P +W           S   D + +G+ L E+ + GQ P
Sbjct: 174 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 91/202 (45%), Gaps = 51/202 (25%)
Query: 397 GRLNGKNLAIKRTEH-----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSF-LVF 450
           G   G  +A+K+ +H     +   + E+Q+++    H   IV+  G     G  S  LV 
Sbjct: 36  GDNTGALVAVKQLQHSGPDQQRDFQREIQILK--ALHSDFIVKYRGVSYGPGRQSLRLVM 93
Query: 451 EYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQY-------MHHVM 503
           EY  +G L+D+L                     QR R  LD +  L Y       M ++ 
Sbjct: 94  EYLPSGCLRDFL---------------------QRHRARLDASRLLLYSSQICKGMEYLG 132
Query: 504 NPSYVHRNIKSRNIFLDEEFNARVGNFGMAR---------CVNDDTESPQFYSTNPASWS 554
           +   VHR++ +RNI ++ E + ++ +FG+A+          V +  +SP F+   P S S
Sbjct: 133 SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA-PESLS 191
Query: 555 MGI-----DIFAYGIVLLEVLS 571
             I     D++++G+VL E+ +
Sbjct: 192 DNIFSRQSDVWSFGVVLYELFT 213

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 79/170 (46%), Gaps = 27/170 (15%)
Query: 418 EMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL----HGGLAMKNQFI 473
           E++++ H   H  NIV LLG C   GP   ++ EY   G L ++L       L  ++   
Sbjct: 99  ELKIMSHLGQHE-NIVNLLGACTHGGP-VLVITEYCCYGDLLNFLRRKAEADLDKEDGRP 156
Query: 474 ASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA 533
                 L +S ++          Q M  + + + +HR++ +RN+ L     A++G+FG+A
Sbjct: 157 LELRDLLHFSSQVA---------QGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 207
Query: 534 R-CVNDDTESPQFYSTNPASW-----------SMGIDIFAYGIVLLEVLS 571
           R  +ND     +  +  P  W           ++  D+++YGI+L E+ S
Sbjct: 208 RDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 257

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 91/202 (45%), Gaps = 51/202 (25%)
Query: 397 GRLNGKNLAIKRTEH-----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSF-LVF 450
           G   G  +A+K+ +H     +   + E+Q+++    H   IV+  G     G  S  LV 
Sbjct: 48  GDNTGALVAVKQLQHSGPDQQRDFQREIQILK--ALHSDFIVKYRGVSYGPGRQSLRLVM 105
Query: 451 EYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQY-------MHHVM 503
           EY  +G L+D+L                     QR R  LD +  L Y       M ++ 
Sbjct: 106 EYLPSGCLRDFL---------------------QRHRARLDASRLLLYSSQICKGMEYLG 144
Query: 504 NPSYVHRNIKSRNIFLDEEFNARVGNFGMAR---------CVNDDTESPQFYSTNPASWS 554
           +   VHR++ +RNI ++ E + ++ +FG+A+          V +  +SP F+   P S S
Sbjct: 145 SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYA-PESLS 203
Query: 555 MGI-----DIFAYGIVLLEVLS 571
             I     D++++G+VL E+ +
Sbjct: 204 DNIFSRQSDVWSFGVVLYELFT 225

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 53.9 bits (128), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/170 (25%), Positives = 79/170 (46%), Gaps = 27/170 (15%)
Query: 418 EMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL----HGGLAMKNQFI 473
           E++++ H   H  NIV LLG C   GP   ++ EY   G L ++L       L  ++   
Sbjct: 91  ELKIMSHLGQHE-NIVNLLGACTHGGP-VLVITEYCCYGDLLNFLRRKAEADLDKEDGRP 148
Query: 474 ASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA 533
                 L +S ++          Q M  + + + +HR++ +RN+ L     A++G+FG+A
Sbjct: 149 LELRDLLHFSSQVA---------QGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLA 199
Query: 534 R-CVNDDTESPQFYSTNPASW-----------SMGIDIFAYGIVLLEVLS 571
           R  +ND     +  +  P  W           ++  D+++YGI+L E+ S
Sbjct: 200 RDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 249

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 86/210 (40%), Gaps = 43/210 (20%)
Query: 392 GAVYHGRLNGK-------NLAIKRTEHEVITKLEMQLVQHA----THHHPNIVRLLGTCL 440
           G VY G+++G         +A+K        + E+  +  A      +H NIVR +G  L
Sbjct: 44  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 103
Query: 441 TDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH 500
              P  F++ E    G LK +L       +Q  +     L     L +  D+A   QY+ 
Sbjct: 104 QSLPR-FILLELMAGGDLKSFLRETRPRPSQPSS-----LAMLDLLHVARDIACGCQYLE 157
Query: 501 HVMNPSYVHRNIKSRNIFLDEEFNARV---GNFGMARCVNDDTESPQFYSTN-------- 549
                 ++HR+I +RN  L      RV   G+FGMAR    D     +Y           
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 210
Query: 550 ---PASWSMGI-----DIFAYGIVLLEVLS 571
              P ++  GI     D +++G++L E+ S
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 87/210 (41%), Gaps = 43/210 (20%)
Query: 392 GAVYHGRLNGK-------NLAIKRTEHEVITKLEMQLVQHA----THHHPNIVRLLGTCL 440
           G VY G+++G         +A+K        + E+  +  A      +H NIVR +G  L
Sbjct: 51  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 110
Query: 441 TDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH 500
              P  F++ E    G LK +L       +Q  +     L     L +  D+A   QY+ 
Sbjct: 111 QSLPR-FILLELMAGGDLKSFLRETRPRPSQPSS-----LAMLDLLHVARDIACGCQYLE 164
Query: 501 HVMNPSYVHRNIKSRNIFL---DEEFNARVGNFGMARCVNDDTESPQFYSTN-------- 549
                 ++HR+I +RN  L        A++G+FGMAR    D     +Y           
Sbjct: 165 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 217
Query: 550 ---PASWSMGI-----DIFAYGIVLLEVLS 571
              P ++  GI     D +++G++L E+ S
Sbjct: 218 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 247

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 47/201 (23%), Positives = 94/201 (46%), Gaps = 34/201 (16%)
Query: 392 GAVYHGRLNGK-NLAIKRTEHEVITKL----EMQLVQHATHHHPNIVRLLGTCLTDGPHS 446
           G V+ G  NG   +AIK  +   ++      E Q+++   H    +V+L    +++ P  
Sbjct: 23  GEVWMGTWNGNTKVAIKTLKPGTMSPESFLEEAQIMKKLKHD--KLVQLYAV-VSEEP-I 78
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           ++V EY   GSL D+L  G              L     + +   VA  + Y+  +   +
Sbjct: 79  YIVTEYMNKGSLLDFLKDGEGRA----------LKLPNLVDMAAQVAAGMAYIERM---N 125
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SM 555
           Y+HR+++S NI +      ++ +FG+AR + D+  + +  +  P  W           ++
Sbjct: 126 YIHRDLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTI 185
Query: 556 GIDIFAYGIVLLEVLS-GQTP 575
             D++++GI+L E+++ G+ P
Sbjct: 186 KSDVWSFGILLTELVTKGRVP 206

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 71/161 (44%), Gaps = 30/161 (18%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           H N++RL G  LT  P   +V E A  GSL D L      +  F+             R 
Sbjct: 80  HRNLIRLYGVVLT--PPMKMVTELAPLGSLLDRLR---KHQGHFLLGTLS--------RY 126
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV--NDDTESPQFY 546
            + VA  + Y+    +  ++HR++ +RN+ L      ++G+FG+ R +  NDD    Q +
Sbjct: 127 AVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 183
Query: 547 STNPASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
              P +W           S   D + +G+ L E+ + GQ P
Sbjct: 184 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 86/210 (40%), Gaps = 43/210 (20%)
Query: 392 GAVYHGRLNGK-------NLAIKRTEHEVITKLEMQLVQHA----THHHPNIVRLLGTCL 440
           G VY G+++G         +A+K        + E+  +  A      +H NIVR +G  L
Sbjct: 36  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 95
Query: 441 TDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH 500
              P  F++ E    G LK +L       +Q  +     L     L +  D+A   QY+ 
Sbjct: 96  QSLPR-FILLELMAGGDLKSFLRETRPRPSQPSS-----LAMLDLLHVARDIACGCQYLE 149
Query: 501 HVMNPSYVHRNIKSRNIFLDEEFNARV---GNFGMARCVNDDTESPQFYSTN-------- 549
                 ++HR+I +RN  L      RV   G+FGMAR    D     +Y           
Sbjct: 150 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 202
Query: 550 ---PASWSMGI-----DIFAYGIVLLEVLS 571
              P ++  GI     D +++G++L E+ S
Sbjct: 203 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 232

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/233 (23%), Positives = 100/233 (42%), Gaps = 49/233 (21%)
Query: 372 YSIEDLRRATEKFNSSNRIE----GAVYHGRLNG-------KNLAIKRTEHEVITKLEMQ 420
           Y  ++   A EK   S  +     G VY G   G         +AIK        +  ++
Sbjct: 2   YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 61
Query: 421 LVQHAT-------HHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG-GLAMKNQF 472
            +  A+       HH   +VRLLG  ++ G  + ++ E    G LK +L      M+N  
Sbjct: 62  FLNEASVMKEFNCHH---VVRLLGV-VSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 117
Query: 473 IASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGM 532
           + +       S+ +++  ++A  + Y++      +VHR++ +RN  + E+F  ++G+FGM
Sbjct: 118 VLAPPSL---SKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCXVAEDFTVKIGDFGM 171
Query: 533 ARCVNDDTESPQFYS-----------TNPASWSMGI-----DIFAYGIVLLEV 569
            R    D     +Y             +P S   G+     D++++G+VL E+
Sbjct: 172 TR----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 220

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 86/210 (40%), Gaps = 43/210 (20%)
Query: 392 GAVYHGRLNGK-------NLAIKRTEHEVITKLEMQLVQHA----THHHPNIVRLLGTCL 440
           G VY G+++G         +A+K        + E+  +  A      +H NIVR +G  L
Sbjct: 44  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 103
Query: 441 TDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH 500
              P  F++ E    G LK +L       +Q  +     L     L +  D+A   QY+ 
Sbjct: 104 QSLPR-FILMELMAGGDLKSFLRETRPRPSQPSS-----LAMLDLLHVARDIACGCQYLE 157
Query: 501 HVMNPSYVHRNIKSRNIFLDEEFNARV---GNFGMARCVNDDTESPQFYSTN-------- 549
                 ++HR+I +RN  L      RV   G+FGMAR    D     +Y           
Sbjct: 158 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 210
Query: 550 ---PASWSMGI-----DIFAYGIVLLEVLS 571
              P ++  GI     D +++G++L E+ S
Sbjct: 211 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 86/210 (40%), Gaps = 43/210 (20%)
Query: 392 GAVYHGRLNGK-------NLAIKRTEHEVITKLEMQLVQHA----THHHPNIVRLLGTCL 440
           G VY G+++G         +A+K        + E+  +  A      +H NIVR +G  L
Sbjct: 45  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 104
Query: 441 TDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH 500
              P  F++ E    G LK +L       +Q  +     L     L +  D+A   QY+ 
Sbjct: 105 QSLPR-FILLELMAGGDLKSFLRETRPRPSQPSS-----LAMLDLLHVARDIACGCQYLE 158
Query: 501 HVMNPSYVHRNIKSRNIFLDEEFNARV---GNFGMARCVNDDTESPQFYSTN-------- 549
                 ++HR+I +RN  L      RV   G+FGMAR    D     +Y           
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 211
Query: 550 ---PASWSMGI-----DIFAYGIVLLEVLS 571
              P ++  GI     D +++G++L E+ S
Sbjct: 212 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 87/210 (41%), Gaps = 43/210 (20%)
Query: 392 GAVYHGRLNGK-------NLAIKRTEHEVITKLEMQLVQHA----THHHPNIVRLLGTCL 440
           G VY G+++G         +A+K        + E+  +  A      +H NIVR +G  L
Sbjct: 62  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 121
Query: 441 TDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH 500
              P  F++ E    G LK +L       +Q  +     L     L +  D+A   QY+ 
Sbjct: 122 QSLPR-FILLELMAGGDLKSFLRETRPRPSQPSS-----LAMLDLLHVARDIACGCQYLE 175
Query: 501 HVMNPSYVHRNIKSRNIFL---DEEFNARVGNFGMARCVNDDTESPQFYSTN-------- 549
                 ++HR+I +RN  L        A++G+FGMAR    D     +Y           
Sbjct: 176 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYRKGGCAMLPVK 228
Query: 550 ---PASWSMGI-----DIFAYGIVLLEVLS 571
              P ++  GI     D +++G++L E+ S
Sbjct: 229 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 258

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 73/163 (44%), Gaps = 32/163 (19%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HP  V+L   C  D    +    YAKNG L  ++         F  +C  F T       
Sbjct: 96  HPFFVKLY-FCFQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYT------- 143
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------- 541
             ++  AL+Y+H       +HR++K  NI L+E+ + ++ +FG A+ ++ +++       
Sbjct: 144 -AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 199
Query: 542 -------SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
                  SP+  +   A  S   D++A G ++ ++++G  P  
Sbjct: 200 VGTAQYVSPELLTEKSACKSS--DLWALGCIIYQLVAGLPPFR 240

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 45/199 (22%), Positives = 94/199 (47%), Gaps = 28/199 (14%)
Query: 405 AIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG 464
           A  +    V TK+E  ++  A  +HP +V+L     T+G   +L+ ++ + G L      
Sbjct: 67  ATLKVRDRVRTKMERDIL--ADVNHPFVVKLHYAFQTEGK-LYLILDFLRGGDL----FT 119
Query: 465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFN 524
            L+ +  F      F           ++A+ L ++H +     ++R++K  NI LDEE +
Sbjct: 120 RLSKEVMFTEEDVKF--------YLAELALGLDHLHSL---GIIYRDLKPENILLDEEGH 168
Query: 525 ARVGNFGMAR-CVNDDTESPQFYST---------NPASWSMGIDIFAYGIVLLEVLSGQT 574
            ++ +FG+++  ++ + ++  F  T         N    S   D ++YG+++ E+L+G  
Sbjct: 169 IKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSL 228
Query: 575 PINRPRKKDEGSVWLSEKI 593
           P     +K+  ++ L  K+
Sbjct: 229 PFQGKDRKETMTLILKAKL 247

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 87/210 (41%), Gaps = 43/210 (20%)
Query: 392 GAVYHGRLNGK-------NLAIKRTEHEVITKLEMQLVQHA----THHHPNIVRLLGTCL 440
           G VY G+++G         +A+K        + E+  +  A      +H NIVR +G  L
Sbjct: 85  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 144
Query: 441 TDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH 500
              P  F++ E    G LK +L       +Q  +     L     L +  D+A   QY+ 
Sbjct: 145 QSLPR-FILLELMAGGDLKSFLRETRPRPSQPSS-----LAMLDLLHVARDIACGCQYLE 198
Query: 501 HVMNPSYVHRNIKSRNIFL---DEEFNARVGNFGMARCVNDDTESPQFYSTN-------- 549
                 ++HR+I +RN  L        A++G+FGMAR    D     +Y           
Sbjct: 199 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYRKGGCAMLPVK 251
Query: 550 ---PASWSMGI-----DIFAYGIVLLEVLS 571
              P ++  GI     D +++G++L E+ S
Sbjct: 252 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 87/210 (41%), Gaps = 43/210 (20%)
Query: 392 GAVYHGRLNGK-------NLAIKRTEHEVITKLEMQLVQHA----THHHPNIVRLLGTCL 440
           G VY G+++G         +A+K        + E+  +  A      +H NIVR +G  L
Sbjct: 71  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 130
Query: 441 TDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH 500
              P  F++ E    G LK +L       +Q  +     L     L +  D+A   QY+ 
Sbjct: 131 QSLPR-FILLELMAGGDLKSFLRETRPRPSQPSS-----LAMLDLLHVARDIACGCQYLE 184
Query: 501 HVMNPSYVHRNIKSRNIFL---DEEFNARVGNFGMARCVNDDTESPQFYSTN-------- 549
                 ++HR+I +RN  L        A++G+FGMAR    D     +Y           
Sbjct: 185 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 237
Query: 550 ---PASWSMGI-----DIFAYGIVLLEVLS 571
              P ++  GI     D +++G++L E+ S
Sbjct: 238 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 267

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 86/210 (40%), Gaps = 43/210 (20%)
Query: 392 GAVYHGRLNGK-------NLAIKRTEHEVITKLEMQLVQHA----THHHPNIVRLLGTCL 440
           G VY G+++G         +A+K        + E+  +  A      +H NIVR +G  L
Sbjct: 59  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 118
Query: 441 TDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH 500
              P  F++ E    G LK +L       +Q  +     L     L +  D+A   QY+ 
Sbjct: 119 QSLPR-FILMELMAGGDLKSFLRETRPRPSQPSS-----LAMLDLLHVARDIACGCQYLE 172
Query: 501 HVMNPSYVHRNIKSRNIFLDEEFNARV---GNFGMARCVNDDTESPQFYSTN-------- 549
                 ++HR+I +RN  L      RV   G+FGMAR    D     +Y           
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 225
Query: 550 ---PASWSMGI-----DIFAYGIVLLEVLS 571
              P ++  GI     D +++G++L E+ S
Sbjct: 226 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 53.5 bits (127), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 71/161 (44%), Gaps = 30/161 (18%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           H N++RL G  LT  P   +V E A  GSL D L      +  F+             R 
Sbjct: 74  HRNLIRLYGVVLT--PPMKMVTELAPLGSLLDRLR---KHQGHFLLGTLS--------RY 120
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV--NDDTESPQFY 546
            + VA  + Y+    +  ++HR++ +RN+ L      ++G+FG+ R +  NDD    Q +
Sbjct: 121 AVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 177
Query: 547 STNPASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
              P +W           S   D + +G+ L E+ + GQ P
Sbjct: 178 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 71/161 (44%), Gaps = 30/161 (18%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           H N++RL G  LT  P   +V E A  GSL D L      +  F+             R 
Sbjct: 74  HRNLIRLYGVVLT--PPMKMVTELAPLGSLLDRLR---KHQGHFLLGTLS--------RY 120
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV--NDDTESPQFY 546
            + VA  + Y+    +  ++HR++ +RN+ L      ++G+FG+ R +  NDD    Q +
Sbjct: 121 AVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 177
Query: 547 STNPASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
              P +W           S   D + +G+ L E+ + GQ P
Sbjct: 178 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 218

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 71/161 (44%), Gaps = 30/161 (18%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           H N++RL G  LT  P   +V E A  GSL D L      +  F+             R 
Sbjct: 70  HRNLIRLYGVVLT--PPMKMVTELAPLGSLLDRLR---KHQGHFLLGTLS--------RY 116
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV--NDDTESPQFY 546
            + VA  + Y+    +  ++HR++ +RN+ L      ++G+FG+ R +  NDD    Q +
Sbjct: 117 AVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 173
Query: 547 STNPASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
              P +W           S   D + +G+ L E+ + GQ P
Sbjct: 174 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 79/174 (45%), Gaps = 35/174 (20%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HP  V+L  T   D    +    YAKNG L  ++         F  +C  F T       
Sbjct: 91  HPFFVKLYFT-FQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYT------- 138
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------- 541
             ++  AL+Y+H       +HR++K  NI L+E+ + ++ +FG A+ ++ +++       
Sbjct: 139 -AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 542 -------SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDEGSVW 588
                  SP+  +   A  S   D++A G ++ ++++G  P    R  +EG ++
Sbjct: 195 VGTAQYVSPELLTEKSAXKSS--DLWALGCIIYQLVAGLPPF---RAGNEGLIF 243

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/157 (22%), Positives = 73/157 (46%), Gaps = 35/157 (22%)
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           ++  +  +  +LKDW++   +++++    C         L I + +A A++++H   +  
Sbjct: 137 YIQMQLCRKENLKDWMNRRCSLEDREHGVC---------LHIFIQIAEAVEFLH---SKG 184
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPA--------------- 551
            +HR++K  NIF   +   +VG+FG+   ++ D E     +  PA               
Sbjct: 185 LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMS 244
Query: 552 -------SWSMGIDIFAYGIVLLEVL-SGQTPINRPR 580
                  ++S  +DIF+ G++L E+L S  T + R R
Sbjct: 245 PEQIHGNNYSHKVDIFSLGLILFELLYSFSTQMERVR 281

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 44/161 (27%), Positives = 71/161 (44%), Gaps = 30/161 (18%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           H N++RL G  LT  P   +V E A  GSL D L      +  F+             R 
Sbjct: 70  HRNLIRLYGVVLT--PPMKMVTELAPLGSLLDRLR---KHQGHFLLGTLS--------RY 116
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV--NDDTESPQFY 546
            + VA  + Y+    +  ++HR++ +RN+ L      ++G+FG+ R +  NDD    Q +
Sbjct: 117 AVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 173
Query: 547 STNPASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
              P +W           S   D + +G+ L E+ + GQ P
Sbjct: 174 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 87/210 (41%), Gaps = 43/210 (20%)
Query: 392 GAVYHGRLNGK-------NLAIKRTEHEVITKLEMQLVQHA----THHHPNIVRLLGTCL 440
           G VY G+++G         +A+K        + E+  +  A      +H NIVR +G  L
Sbjct: 59  GEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVRCIGVSL 118
Query: 441 TDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH 500
              P  F++ E    G LK +L       +Q  +     L     L +  D+A   QY+ 
Sbjct: 119 QSLPR-FILLELMAGGDLKSFLRETRPRPSQPSS-----LAMLDLLHVARDIACGCQYLE 172
Query: 501 HVMNPSYVHRNIKSRNIFL---DEEFNARVGNFGMARCVNDDTESPQFYSTN-------- 549
                 ++HR+I +RN  L        A++G+FGMAR    D     +Y           
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 225
Query: 550 ---PASWSMGI-----DIFAYGIVLLEVLS 571
              P ++  GI     D +++G++L E+ S
Sbjct: 226 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/233 (23%), Positives = 100/233 (42%), Gaps = 49/233 (21%)
Query: 372 YSIEDLRRATEKFNSSNRIE----GAVYHGRLNG-------KNLAIKRTEHEVITKLEMQ 420
           Y  ++   A EK   S  +     G VY G   G         +AIK        +  ++
Sbjct: 37  YVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIE 96
Query: 421 LVQHAT-------HHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG-GLAMKNQF 472
            +  A+       HH   +VRLLG  ++ G  + ++ E    G LK +L      M+N  
Sbjct: 97  FLNEASVMKEFNCHH---VVRLLG-VVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNP 152
Query: 473 IASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGM 532
           + +       S+ +++  ++A  + Y++      +VHR++ +RN  + E+F  ++G+FGM
Sbjct: 153 VLAPPSL---SKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGM 206
Query: 533 ARCVNDDTESPQFYS-----------TNPASWSMGI-----DIFAYGIVLLEV 569
            R    D     +Y             +P S   G+     D++++G+VL E+
Sbjct: 207 TR----DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 255

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 44/206 (21%), Positives = 87/206 (42%), Gaps = 39/206 (18%)
Query: 392 GAVYHGRLNGKNLAIK------------RTEHEVITKLEMQLVQHATHHHPNIVRLLGTC 439
           G ++ GR  G ++ +K            R  +E   +L +         HPN++ +LG C
Sbjct: 24  GELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRI-------FSHPNVLPVLGAC 76
Query: 440 LTD-GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQY 498
            +   PH  L+  +   GSL + LH G      F+         SQ ++  LD+A  + +
Sbjct: 77  QSPPAPHPTLITHWMPYGSLYNVLHEG----TNFVVDQ------SQAVKFALDMARGMAF 126
Query: 499 MHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGM-------ARCVNDDTESPQFYSTNPA 551
           +H  + P      + SR++ +DE+  AR+    +        R       +P+     P 
Sbjct: 127 LH-TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPAWVAPEALQKKPE 185
Query: 552 SWS-MGIDIFAYGIVLLEVLSGQTPI 576
             +    D++++ ++L E+++ + P 
Sbjct: 186 DTNRRSADMWSFAVLLWELVTREVPF 211

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 42/174 (24%), Positives = 79/174 (45%), Gaps = 35/174 (20%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HP  V+L  T   D    +    YAKNG L  ++         F  +C  F T       
Sbjct: 91  HPFFVKLYFT-FQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYT------- 138
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------- 541
             ++  AL+Y+H       +HR++K  NI L+E+ + ++ +FG A+ ++ +++       
Sbjct: 139 -AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 542 -------SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDEGSVW 588
                  SP+  +   A  S   D++A G ++ ++++G  P    R  +EG ++
Sbjct: 195 VGTAQYVSPELLTEKSACKSS--DLWALGCIIYQLVAGLPPF---RAGNEGLIF 243

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 53.1 bits (126), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/210 (25%), Positives = 86/210 (40%), Gaps = 43/210 (20%)
Query: 392 GAVYHGRLNGK-------NLAIKRTEHEVITKLEMQLVQHA----THHHPNIVRLLGTCL 440
           G VY G+++G         +A+K        + E+  +  A      +H NIVR +G  L
Sbjct: 59  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSL 118
Query: 441 TDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH 500
              P  F++ E    G LK +L       +Q  +     L     L +  D+A   QY+ 
Sbjct: 119 QSLPR-FILLELMAGGDLKSFLRETRPRPSQPSS-----LAMLDLLHVARDIACGCQYLE 172
Query: 501 HVMNPSYVHRNIKSRNIFLDEEFNARV---GNFGMARCVNDDTESPQFYSTN-------- 549
                 ++HR+I +RN  L      RV   G+FGMAR    D     +Y           
Sbjct: 173 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 225
Query: 550 ---PASWSMGI-----DIFAYGIVLLEVLS 571
              P ++  GI     D +++G++L E+ S
Sbjct: 226 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 255

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 87/210 (41%), Gaps = 43/210 (20%)
Query: 392 GAVYHGRLNGK-------NLAIKRTEHEVITKLEMQLVQHA----THHHPNIVRLLGTCL 440
           G VY G+++G         +A+K        + E+  +  A      +H NIVR +G  L
Sbjct: 45  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVRCIGVSL 104
Query: 441 TDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH 500
              P  F++ E    G LK +L       +Q  +     L     L +  D+A   QY+ 
Sbjct: 105 QSLPR-FILLELMAGGDLKSFLRETRPRPSQPSS-----LAMLDLLHVARDIACGCQYLE 158
Query: 501 HVMNPSYVHRNIKSRNIFL---DEEFNARVGNFGMARCVNDDTESPQFYSTN-------- 549
                 ++HR+I +RN  L        A++G+FGMAR    D     +Y           
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGCAMLPVK 211
Query: 550 ---PASWSMGI-----DIFAYGIVLLEVLS 571
              P ++  GI     D +++G++L E+ S
Sbjct: 212 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 40/163 (24%), Positives = 74/163 (45%), Gaps = 32/163 (19%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HP  V+L  T   D    +    YAKNG L  ++         F  +C  F T       
Sbjct: 91  HPFFVKLYFT-FQDDEKLYFGLSYAKNGCLLKYIR----KIGSFDETCTRFYT------- 138
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------- 541
             ++  AL+Y+H       +HR++K  NI L+E+ + ++ +FG A+ ++ +++       
Sbjct: 139 -AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 194
Query: 542 -------SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
                  SP+  +   AS S   D++A G ++ ++++G  P  
Sbjct: 195 VGTAQYVSPELLTEKSASKSS--DLWALGCIIYQLVAGLPPFR 235

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 52.8 bits (125), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 42/194 (21%), Positives = 87/194 (44%), Gaps = 29/194 (14%)
Query: 394 VYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYA 453
           V+ G++  K++ +K  + E   K+  ++  H +  +P++V   G    D    ++V E  
Sbjct: 69  VFAGKVVPKSMLLKPHQKE---KMSTEIAIHKSLDNPHVVGFHG-FFEDDDFVYVVLEIC 124
Query: 454 KNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIK 513
           +  SL +     L  + + +          Q ++        +QY+H   N   +HR++K
Sbjct: 125 RRRSLLE-----LHKRRKAVTEPEARYFMRQTIQ-------GVQYLH---NNRVIHRDLK 169
Query: 514 SRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNP----------ASWSMGIDIFAYG 563
             N+FL+++ + ++G+FG+A  +  D E  +     P             S  +DI++ G
Sbjct: 170 LGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKGHSFEVDIWSLG 229
Query: 564 IVLLEVLSGQTPIN 577
            +L  +L G+ P  
Sbjct: 230 CILYTLLVGKPPFE 243

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 44/168 (26%), Positives = 76/168 (45%), Gaps = 31/168 (18%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGG--------LAMKNQFI---ASCY 477
           H NIV LLG C   GP  +L+FEY   G L ++L           +  +NQ         
Sbjct: 108 HENIVNLLGACTLSGP-IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDL 166
Query: 478 CFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN 537
             LT+   L     VA  ++++      S VHR++ +RN+ +      ++ +FG+AR + 
Sbjct: 167 NVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 223
Query: 538 DDTE--------------SPQFYSTNPASWSMGIDIFAYGIVLLEVLS 571
            D+               +P+  S     +++  D+++YGI+L E+ S
Sbjct: 224 SDSNYVVRGNARLPVKWMAPE--SLFEGIYTIKSDVWSYGILLWEIFS 269

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 52.4 bits (124), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 42/194 (21%), Positives = 87/194 (44%), Gaps = 29/194 (14%)
Query: 394 VYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYA 453
           V+ G++  K++ +K  + E   K+  ++  H +  +P++V   G    D    ++V E  
Sbjct: 69  VFAGKVVPKSMLLKPHQKE---KMSTEIAIHKSLDNPHVVGFHG-FFEDDDFVYVVLEIC 124
Query: 454 KNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIK 513
           +  SL +     L  + + +          Q ++        +QY+H   N   +HR++K
Sbjct: 125 RRRSLLE-----LHKRRKAVTEPEARYFMRQTIQ-------GVQYLH---NNRVIHRDLK 169
Query: 514 SRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNP----------ASWSMGIDIFAYG 563
             N+FL+++ + ++G+FG+A  +  D E  +     P             S  +DI++ G
Sbjct: 170 LGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKGHSFEVDIWSLG 229
Query: 564 IVLLEVLSGQTPIN 577
            +L  +L G+ P  
Sbjct: 230 CILYTLLVGKPPFE 243

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 94/218 (43%), Gaps = 44/218 (20%)
Query: 387 SNRIEGAVYHGR--LNGKNLAIK----RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCL 440
            N   G VY GR    G+  AIK      + E   K E+ +++  +HH  NI    G  +
Sbjct: 33  GNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHR-NIATYYGAFI 91
Query: 441 TDGP-----HSFLVFEYAKNGSLKDWLHG--GLAMKNQFIASCYCFLTWSQRLRICLDVA 493
              P       +LV E+   GS+ D +    G  +K ++IA             IC ++ 
Sbjct: 92  KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAY------------ICREIL 139
Query: 494 MALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA----RCV---NDDTESPQFY 546
             L ++H       +HR+IK +N+ L E    ++ +FG++    R V   N    +P + 
Sbjct: 140 RGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWM 196
Query: 547 S-------TNP-ASWSMGIDIFAYGIVLLEVLSGQTPI 576
           +        NP A++    D+++ GI  +E+  G  P+
Sbjct: 197 APEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 234

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 42/194 (21%), Positives = 87/194 (44%), Gaps = 29/194 (14%)
Query: 394 VYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYA 453
           V+ G++  K++ +K  + E   K+  ++  H +  +P++V   G    D    ++V E  
Sbjct: 69  VFAGKVVPKSMLLKPHQKE---KMSTEIAIHKSLDNPHVVGFHG-FFEDDDFVYVVLEIC 124
Query: 454 KNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIK 513
           +  SL +     L  + + +          Q ++        +QY+H   N   +HR++K
Sbjct: 125 RRRSLLE-----LHKRRKAVTEPEARYFMRQTIQ-------GVQYLH---NNRVIHRDLK 169
Query: 514 SRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNP----------ASWSMGIDIFAYG 563
             N+FL+++ + ++G+FG+A  +  D E  +     P             S  +DI++ G
Sbjct: 170 LGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLG 229
Query: 564 IVLLEVLSGQTPIN 577
            +L  +L G+ P  
Sbjct: 230 CILYTLLVGKPPFE 243

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 52.0 bits (123), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 44/199 (22%), Positives = 94/199 (47%), Gaps = 28/199 (14%)
Query: 405 AIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG 464
           A  +    V TK+E  ++     +HP IV+L     T+G   +L+ ++ + G L      
Sbjct: 63  ATLKVRDRVRTKMERDILVEV--NHPFIVKLHYAFQTEGK-LYLILDFLRGGDL----FT 115
Query: 465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFN 524
            L+ +  F      F           ++A+AL ++H +     ++R++K  NI LDEE +
Sbjct: 116 RLSKEVMFTEEDVKF--------YLAELALALDHLHSL---GIIYRDLKPENILLDEEGH 164
Query: 525 ARVGNFGMAR-CVNDDTESPQFYST---------NPASWSMGIDIFAYGIVLLEVLSGQT 574
            ++ +FG+++  ++ + ++  F  T         N    +   D +++G+++ E+L+G  
Sbjct: 165 IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL 224
Query: 575 PINRPRKKDEGSVWLSEKI 593
           P     +K+  ++ L  K+
Sbjct: 225 PFQGKDRKETMTMILKAKL 243

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 42/194 (21%), Positives = 87/194 (44%), Gaps = 29/194 (14%)
Query: 394 VYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYA 453
           V+ G++  K++ +K  + E   K+  ++  H +  +P++V   G    D    ++V E  
Sbjct: 53  VFAGKVVPKSMLLKPHQKE---KMSTEIAIHKSLDNPHVVGFHGF-FEDDDFVYVVLEIC 108
Query: 454 KNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIK 513
           +  SL +     L  + + +          Q ++        +QY+H   N   +HR++K
Sbjct: 109 RRRSLLE-----LHKRRKAVTEPEARYFMRQTIQ-------GVQYLH---NNRVIHRDLK 153
Query: 514 SRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNP----------ASWSMGIDIFAYG 563
             N+FL+++ + ++G+FG+A  +  D E  +     P             S  +DI++ G
Sbjct: 154 LGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLG 213
Query: 564 IVLLEVLSGQTPIN 577
            +L  +L G+ P  
Sbjct: 214 CILYTLLVGKPPFE 227

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 86/210 (40%), Gaps = 43/210 (20%)
Query: 392 GAVYHGRLNGK-------NLAIKRTEHEVITKLEMQLVQHA----THHHPNIVRLLGTCL 440
           G VY G+++G         +A+K        + E+  +  A      +H NIVR +G  L
Sbjct: 45  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSL 104
Query: 441 TDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH 500
              P  F++ E    G LK +L       +Q  +     L     L +  D+A   QY+ 
Sbjct: 105 QSLPR-FILLELMAGGDLKSFLRETRPRPSQPSS-----LAMLDLLHVARDIACGCQYLE 158
Query: 501 HVMNPSYVHRNIKSRNIFLDEEFNARV---GNFGMARCVNDDTESPQFYSTN-------- 549
                 ++HR+I +RN  L      RV   G+FGMA+    D     +Y           
Sbjct: 159 EN---HFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQ----DIYRASYYRKGGCAMLPVK 211
Query: 550 ---PASWSMGI-----DIFAYGIVLLEVLS 571
              P ++  GI     D +++G++L E+ S
Sbjct: 212 WMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 241

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 40/189 (21%), Positives = 88/189 (46%), Gaps = 30/189 (15%)
Query: 400 NGKNLAIKRTEHEVITKLEM---QLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNG 456
           +G+ +A+K  +     + E+   ++V    + H N+V +  + L  G   +++ E+ + G
Sbjct: 69  SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLV-GEELWVLMEFLQGG 127
Query: 457 SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRN 516
           +L D +   + +  + IA+            +C  V  AL Y+H       +HR+IKS +
Sbjct: 128 ALTD-IVSQVRLNEEQIAT------------VCEAVLQALAYLH---AQGVIHRDIKSDS 171
Query: 517 IFLDEEFNARVGNFGMARCVNDDTESPQFYSTNP----------ASWSMGIDIFAYGIVL 566
           I L  +   ++ +FG    ++ D    +     P          + ++  +DI++ GI++
Sbjct: 172 ILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYATEVDIWSLGIMV 231
Query: 567 LEVLSGQTP 575
           +E++ G+ P
Sbjct: 232 IEMVDGEPP 240

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/199 (22%), Positives = 91/199 (45%), Gaps = 28/199 (14%)
Query: 405 AIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG 464
           A  +    V TK+E  ++    H  P IV+L     T+G   +L+ ++ + G L   L  
Sbjct: 64  ATLKVRDRVRTKMERDILVEVNH--PFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRL-- 118
Query: 465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFN 524
                     S     T         ++A+AL ++H +     ++R++K  NI LDEE +
Sbjct: 119 ----------SKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGH 165
Query: 525 ARVGNFGMAR-CVNDDTESPQFYST---------NPASWSMGIDIFAYGIVLLEVLSGQT 574
            ++ +FG+++  ++ + ++  F  T         N    +   D +++G+++ E+L+G  
Sbjct: 166 IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL 225
Query: 575 PINRPRKKDEGSVWLSEKI 593
           P     +K+  ++ L  K+
Sbjct: 226 PFQGKDRKETMTMILKAKL 244

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/199 (22%), Positives = 91/199 (45%), Gaps = 28/199 (14%)
Query: 405 AIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG 464
           A  +    V TK+E  ++    H  P IV+L     T+G   +L+ ++ + G L   L  
Sbjct: 63  ATLKVRDRVRTKMERDILVEVNH--PFIVKLHYAFQTEGK-LYLILDFLRGGDLFTRL-- 117
Query: 465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFN 524
                     S     T         ++A+AL ++H +     ++R++K  NI LDEE +
Sbjct: 118 ----------SKEVMFTEEDVKFYLAELALALDHLHSL---GIIYRDLKPENILLDEEGH 164
Query: 525 ARVGNFGMAR-CVNDDTESPQFYST---------NPASWSMGIDIFAYGIVLLEVLSGQT 574
            ++ +FG+++  ++ + ++  F  T         N    +   D +++G+++ E+L+G  
Sbjct: 165 IKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL 224
Query: 575 PINRPRKKDEGSVWLSEKI 593
           P     +K+  ++ L  K+
Sbjct: 225 PFQGKDRKETMTMILKAKL 243

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/174 (27%), Positives = 81/174 (46%), Gaps = 22/174 (12%)
Query: 418 EMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH-GGLAMKNQFIASC 476
           E++++ H   H  NIV LLG C   GP   ++ EY   G L ++L     AM    +A  
Sbjct: 84  ELKIMSHLGQHE-NIVNLLGACTHGGP-VLVITEYCCYGDLLNFLRRKAEAMLGPSLAPG 141
Query: 477 YCFLTWSQR------LRICLDVAMAL-QYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGN 529
                  +       LR  L  +  + Q M  + + + +HR++ +RN+ L     A++G+
Sbjct: 142 QDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGD 201
Query: 530 FGMAR-CVNDDTESPQFYSTNPASW-----------SMGIDIFAYGIVLLEVLS 571
           FG+AR  +ND     +  +  P  W           ++  D+++YGI+L E+ S
Sbjct: 202 FGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 255

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 73/163 (44%), Gaps = 32/163 (19%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HP  V+L  T   D    +    YAKNG L  ++         F  +C  F T       
Sbjct: 89  HPFFVKLYFT-FQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYT------- 136
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------- 541
             ++  AL+Y+H       +HR++K  NI L+E+ + ++ +FG A+ ++ +++       
Sbjct: 137 -AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 192
Query: 542 -------SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
                  SP+  +   A  S   D++A G ++ ++++G  P  
Sbjct: 193 VGTAQYVSPELLTEKSACKSS--DLWALGCIIYQLVAGLPPFR 233

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 73/163 (44%), Gaps = 32/163 (19%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HP  V+L  T   D    +    YAKNG L  ++         F  +C  F T       
Sbjct: 69  HPFFVKLYFT-FQDDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYT------- 116
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------- 541
             ++  AL+Y+H       +HR++K  NI L+E+ + ++ +FG A+ ++ +++       
Sbjct: 117 -AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 172
Query: 542 -------SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
                  SP+  +   A  S   D++A G ++ ++++G  P  
Sbjct: 173 VGTAQYVSPELLTEKSACKSS--DLWALGCIIYQLVAGLPPFR 213

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 73/163 (44%), Gaps = 32/163 (19%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HP  V+L  T   D    +    YAKNG L  ++         F  +C  F T       
Sbjct: 66  HPFFVKLYFT-FQDDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYT------- 113
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------- 541
             ++  AL+Y+H       +HR++K  NI L+E+ + ++ +FG A+ ++ +++       
Sbjct: 114 -AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 169
Query: 542 -------SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
                  SP+  +   A  S   D++A G ++ ++++G  P  
Sbjct: 170 VGTAQYVSPELLTEKSACKSS--DLWALGCIIYQLVAGLPPFR 210

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 73/163 (44%), Gaps = 32/163 (19%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HP  V+L  T   D    +    YAKNG L  ++         F  +C  F T       
Sbjct: 68  HPFFVKLYFT-FQDDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYT------- 115
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------- 541
             ++  AL+Y+H       +HR++K  NI L+E+ + ++ +FG A+ ++ +++       
Sbjct: 116 -AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 171
Query: 542 -------SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
                  SP+  +   A  S   D++A G ++ ++++G  P  
Sbjct: 172 VGTAQYVSPELLTEKSACKSS--DLWALGCIIYQLVAGLPPFR 212

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 73/163 (44%), Gaps = 32/163 (19%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HP  V+L  T   D    +    YAKNG L  ++         F  +C  F T       
Sbjct: 89  HPFFVKLYFT-FQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYT------- 136
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------- 541
             ++  AL+Y+H       +HR++K  NI L+E+ + ++ +FG A+ ++ +++       
Sbjct: 137 -AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAF 192
Query: 542 -------SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
                  SP+  +   A  S   D++A G ++ ++++G  P  
Sbjct: 193 VGTAQYVSPELLTEKSACKSS--DLWALGCIIYQLVAGLPPFR 233

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 73/163 (44%), Gaps = 32/163 (19%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HP  V+L  T   D    +    YAKNG L  ++         F  +C  F T       
Sbjct: 92  HPFFVKLYFT-FQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYT------- 139
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------- 541
             ++  AL+Y+H       +HR++K  NI L+E+ + ++ +FG A+ ++ +++       
Sbjct: 140 -AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 195
Query: 542 -------SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
                  SP+  +   A  S   D++A G ++ ++++G  P  
Sbjct: 196 VGTAQYVSPELLTEKSACKSS--DLWALGCIIYQLVAGLPPFR 236

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 73/163 (44%), Gaps = 32/163 (19%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HP  V+L  T   D    +    YAKNG L  ++         F  +C  F T       
Sbjct: 91  HPFFVKLYFT-FQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYT------- 138
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------- 541
             ++  AL+Y+H       +HR++K  NI L+E+ + ++ +FG A+ ++ +++       
Sbjct: 139 -AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 542 -------SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
                  SP+  +   A  S   D++A G ++ ++++G  P  
Sbjct: 195 VGTAQYVSPELLTEKSACKSS--DLWALGCIIYQLVAGLPPFR 235

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 73/163 (44%), Gaps = 32/163 (19%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HP  V+L  T   D    +    YAKNG L  ++         F  +C  F T       
Sbjct: 89  HPFFVKLYFT-FQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYT------- 136
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------- 541
             ++  AL+Y+H       +HR++K  NI L+E+ + ++ +FG A+ ++ +++       
Sbjct: 137 -AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 192
Query: 542 -------SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
                  SP+  +   A  S   D++A G ++ ++++G  P  
Sbjct: 193 VGTAQYVSPELLTEKSACKSS--DLWALGCIIYQLVAGLPPFR 233

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 73/163 (44%), Gaps = 32/163 (19%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HP  V+L  T   D    +    YAKNG L  ++         F  +C  F T       
Sbjct: 67  HPFFVKLYFT-FQDDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYT------- 114
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------- 541
             ++  AL+Y+H       +HR++K  NI L+E+ + ++ +FG A+ ++ +++       
Sbjct: 115 -AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 170
Query: 542 -------SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
                  SP+  +   A  S   D++A G ++ ++++G  P  
Sbjct: 171 VGTAQYVSPELLTEKSACKSS--DLWALGCIIYQLVAGLPPFR 211

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 73/163 (44%), Gaps = 32/163 (19%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HP  V+L  T   D    +    YAKNG L  ++         F  +C  F T       
Sbjct: 89  HPFFVKLYFT-FQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYT------- 136
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------- 541
             ++  AL+Y+H       +HR++K  NI L+E+ + ++ +FG A+ ++ +++       
Sbjct: 137 -AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 192
Query: 542 -------SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
                  SP+  +   A  S   D++A G ++ ++++G  P  
Sbjct: 193 VGTAQYVSPELLTEKSACKSS--DLWALGCIIYQLVAGLPPFR 233

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 73/163 (44%), Gaps = 32/163 (19%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HP  V+L  T   D    +    YAKNG L  ++         F  +C  F T       
Sbjct: 91  HPFFVKLYFT-FQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYT------- 138
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------- 541
             ++  AL+Y+H       +HR++K  NI L+E+ + ++ +FG A+ ++ +++       
Sbjct: 139 -AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 542 -------SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
                  SP+  +   A  S   D++A G ++ ++++G  P  
Sbjct: 195 VGTAQYVSPELLTEKSACKSS--DLWALGCIIYQLVAGLPPFR 235

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/235 (22%), Positives = 99/235 (42%), Gaps = 59/235 (25%)
Query: 392 GAVYHGR--LNGKNLAIKRTEH--EVITKLEMQLVQHATHHHPNIVRLLG---------- 437
           G V   R  L+ +  AIK+  H  E ++ +  +++  A+ +H  +VR             
Sbjct: 20  GQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVK 79
Query: 438 --TCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMA 495
             T +      F+  EY +N +L D +H     + +            +  R+   +  A
Sbjct: 80  PMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQR-----------DEYWRLFRQILEA 128
Query: 496 LQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN-PAS-- 552
           L Y+H   +   +HR++K  NIF+DE  N ++G+FG+A+ V+   +  +  S N P S  
Sbjct: 129 LSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSD 185
Query: 553 ----------------------WSMGIDIFAYGIVLLEVL----SGQTPINRPRK 581
                                 ++  ID+++ GI+  E++    +G   +N  +K
Sbjct: 186 NLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYPFSTGMERVNILKK 240

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 73/163 (44%), Gaps = 32/163 (19%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HP  V+L  T   D    +    YAKNG L  ++         F  +C  F T       
Sbjct: 91  HPFFVKLYFT-FQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYT------- 138
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------- 541
             ++  AL+Y+H       +HR++K  NI L+E+ + ++ +FG A+ ++ +++       
Sbjct: 139 -AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 194
Query: 542 -------SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
                  SP+  +   A  S   D++A G ++ ++++G  P  
Sbjct: 195 VGTAQYVSPELLTEKSACKSS--DLWALGCIIYQLVAGLPPFR 235

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 73/163 (44%), Gaps = 32/163 (19%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HP  V+L  T   D    +    YAKNG L  ++         F  +C  F T       
Sbjct: 92  HPFFVKLYFT-FQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYT------- 139
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------- 541
             ++  AL+Y+H       +HR++K  NI L+E+ + ++ +FG A+ ++ +++       
Sbjct: 140 -AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 195
Query: 542 -------SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
                  SP+  +   A  S   D++A G ++ ++++G  P  
Sbjct: 196 VGTAQYVSPELLTEKSACKSS--DLWALGCIIYQLVAGLPPFR 236

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 73/163 (44%), Gaps = 32/163 (19%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HP  V+L  T   D    +    YAKNG L  ++         F  +C  F T       
Sbjct: 94  HPFFVKLYFT-FQDDEKLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYT------- 141
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------- 541
             ++  AL+Y+H       +HR++K  NI L+E+ + ++ +FG A+ ++ +++       
Sbjct: 142 -AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 197
Query: 542 -------SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
                  SP+  +   A  S   D++A G ++ ++++G  P  
Sbjct: 198 VGTAQYVSPELLTEKSACKSS--DLWALGCIIYQLVAGLPPFR 238

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/146 (25%), Positives = 75/146 (51%), Gaps = 21/146 (14%)
Query: 445 HSFLVFEYAKN-GSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM 503
           H F  F+  +N   + ++L+GG  M +  I SC+ F   S+      ++ + LQ++H   
Sbjct: 82  HMFCTFQTKENLFFVMEYLNGGDLMYH--IQSCHKF-DLSRATFYAAEIILGLQFLH--- 135
Query: 504 NPSYVHRNIKSRNIFLDEEFNARVGNFGMAR------------CVNDDTESPQFYSTNPA 551
           +   V+R++K  NI LD++ + ++ +FGM +            C   D  +P+       
Sbjct: 136 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILLGQ-- 193
Query: 552 SWSMGIDIFAYGIVLLEVLSGQTPIN 577
            ++  +D +++G++L E+L GQ+P +
Sbjct: 194 KYNHSVDWWSFGVLLYEMLIGQSPFH 219

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/146 (25%), Positives = 75/146 (51%), Gaps = 21/146 (14%)
Query: 445 HSFLVFEYAKN-GSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM 503
           H F  F+  +N   + ++L+GG  M +  I SC+ F   S+      ++ + LQ++H   
Sbjct: 83  HMFCTFQTKENLFFVMEYLNGGDLMYH--IQSCHKF-DLSRATFYAAEIILGLQFLH--- 136
Query: 504 NPSYVHRNIKSRNIFLDEEFNARVGNFGMAR------------CVNDDTESPQFYSTNPA 551
           +   V+R++K  NI LD++ + ++ +FGM +            C   D  +P+       
Sbjct: 137 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILLGQ-- 194
Query: 552 SWSMGIDIFAYGIVLLEVLSGQTPIN 577
            ++  +D +++G++L E+L GQ+P +
Sbjct: 195 KYNHSVDWWSFGVLLYEMLIGQSPFH 220

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 51.2 bits (121), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/156 (23%), Positives = 69/156 (44%), Gaps = 27/156 (17%)
Query: 430 PNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRIC 489
           P I R  G+ L      +++ EY   GS  D L  G  ++  +IA+            I 
Sbjct: 77  PYITRYFGSYLK-STKLWIIMEYLGGGSALDLLKPG-PLEETYIAT------------IL 122
Query: 490 LDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN 549
            ++   L Y+H   +   +HR+IK+ N+ L E+ + ++ +FG+A  + D       +   
Sbjct: 123 REILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGT 179
Query: 550 P----------ASWSMGIDIFAYGIVLLEVLSGQTP 575
           P          +++    DI++ GI  +E+  G+ P
Sbjct: 180 PFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPP 215

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 73/163 (44%), Gaps = 32/163 (19%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HP  V+L  T   D    +    YAKNG L  ++         F  +C  F T       
Sbjct: 73  HPFFVKLYFT-FQDDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYT------- 120
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------- 541
             ++  AL+Y+H       +HR++K  NI L+E+ + ++ +FG A+ ++ +++       
Sbjct: 121 -AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 176
Query: 542 -------SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
                  SP+  +   A  S   D++A G ++ ++++G  P  
Sbjct: 177 VGTAQYVSPELLTEKSACKSS--DLWALGCIIYQLVAGLPPFR 217

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 79/178 (44%), Gaps = 31/178 (17%)
Query: 392 GAVYHGR--LNGKNLAIKRTEH--EVITKLEMQLVQHATHHHPNIVRLLG---------- 437
           G V   R  L+ +  AIK+  H  E ++ +  ++   A+ +H  +VR             
Sbjct: 20  GQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLNHQYVVRYYAAWLERRNFVK 79
Query: 438 --TCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMA 495
             T +      F+  EY +N +L D +H     + +            +  R+   +  A
Sbjct: 80  PXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQR-----------DEYWRLFRQILEA 128
Query: 496 LQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN-PAS 552
           L Y+H   +   +HRN+K  NIF+DE  N ++G+FG+A+ V+   +  +  S N P S
Sbjct: 129 LSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 42/191 (21%), Positives = 81/191 (42%), Gaps = 35/191 (18%)
Query: 405 AIKRTEHEVITK---LEMQLVQH---ATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSL 458
           AIK  + +V+ +   +E  +V+    A    P  +  L +C       + V EY   G L
Sbjct: 48  AIKILKKDVVIQDDDVECTMVEKRVLALLDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDL 107
Query: 459 KDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIF 518
              +      K              Q +    ++++ L ++H       ++R++K  N+ 
Sbjct: 108 MYHIQQVGKFKE------------PQAVFYAAEISIGLFFLH---KRGIIYRDLKLDNVM 152
Query: 519 LDEEFNARVGNFGMAR------------CVNDDTESPQFYSTNPASWSMGIDIFAYGIVL 566
           LD E + ++ +FGM +            C   D  +P+  +  P  +   +D +AYG++L
Sbjct: 153 LDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQP--YGKSVDWWAYGVLL 210
Query: 567 LEVLSGQTPIN 577
            E+L+GQ P +
Sbjct: 211 YEMLAGQPPFD 221

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/170 (24%), Positives = 76/170 (44%), Gaps = 28/170 (16%)
Query: 418 EMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCY 477
           E  +++  T HH  +VRLLG  ++ G  + +V E   +G LK +L               
Sbjct: 71  EASVMKGFTCHH--VVRLLG-VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 127
Query: 478 CFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN 537
              T  + +++  ++A  + Y++      +VHRN+ +RN  +  +F  ++G+FGM R   
Sbjct: 128 P--TLQEMIQMAAEIADGMAYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTR--- 179
Query: 538 DDTESPQFYSTN-----PASW-----------SMGIDIFAYGIVLLEVLS 571
            D     +Y        P  W           +   D++++G+VL E+ S
Sbjct: 180 -DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 228

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/210 (24%), Positives = 90/210 (42%), Gaps = 41/210 (19%)
Query: 392 GAVYHGRL--NGKNL----AIKRTEHEVITKLEMQLVQHATHH----HPNIVRLLGTCLT 441
           G VY G    +G+N+    AIK        K   +++  A        P + RLLG CLT
Sbjct: 31  GTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVSRLLGICLT 90
Query: 442 DGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHH 501
                 LV +    G L D +      +N+        L W      C+ +A  + Y+  
Sbjct: 91  STVQ--LVTQLMPYGCLLDHVR-----ENRGRLGSQDLLNW------CMQIAKGMSYLED 137
Query: 502 VMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN-DDTESPQFYSTNPASWSMGI--- 557
           V     VHR++ +RN+ +    + ++ +FG+AR ++ D+TE        P  W M +   
Sbjct: 138 V---RLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKW-MALESI 193
Query: 558 ---------DIFAYGIVLLEVLS-GQTPIN 577
                    D+++YG+ + E+++ G  P +
Sbjct: 194 LRRRFTHQSDVWSYGVTVWELMTFGAKPYD 223

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/170 (24%), Positives = 76/170 (44%), Gaps = 28/170 (16%)
Query: 418 EMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCY 477
           E  +++  T HH  +VRLLG  ++ G  + +V E   +G LK +L               
Sbjct: 70  EASVMKGFTCHH--VVRLLG-VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 126
Query: 478 CFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN 537
              T  + +++  ++A  + Y++      +VHRN+ +RN  +  +F  ++G+FGM R   
Sbjct: 127 P--TLQEMIQMAAEIADGMAYLNA---KKFVHRNLAARNCMVAHDFTVKIGDFGMTR--- 178
Query: 538 DDTESPQFYSTN-----PASW-----------SMGIDIFAYGIVLLEVLS 571
            D     +Y        P  W           +   D++++G+VL E+ S
Sbjct: 179 -DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 73/163 (44%), Gaps = 32/163 (19%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HP  V+L  T   D    +    YAKNG L  ++         F  +C  F T       
Sbjct: 88  HPFFVKLYFT-FQDDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYT------- 135
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------- 541
             ++  AL+Y+H       +HR++K  NI L+E+ + ++ +FG A+ ++ +++       
Sbjct: 136 -AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF 191
Query: 542 -------SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
                  SP+  +   A  S   D++A G ++ ++++G  P  
Sbjct: 192 VGTAQYVSPELLTEKSACKSS--DLWALGCIIYQLVAGLPPFR 232

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 73/163 (44%), Gaps = 32/163 (19%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HP  V+L  T   D    +    YAKNG L  ++         F  +C  F T       
Sbjct: 88  HPFFVKLYFT-FQDDEKLYFGLSYAKNGELLKYIRK----IGSFDETCTRFYT------- 135
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------- 541
             ++  AL+Y+H       +HR++K  NI L+E+ + ++ +FG A+ ++ +++       
Sbjct: 136 -AEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF 191
Query: 542 -------SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
                  SP+  +   A  S   D++A G ++ ++++G  P  
Sbjct: 192 VGTAQYVSPELLTEKSACKSS--DLWALGCIIYQLVAGLPPFR 232

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 34/165 (20%)
Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLR 487
            HPNI+ L      DG H +LV E  + G L D +     ++ +F +         +   
Sbjct: 79  QHPNIITL-KDVYDDGKHVYLVTELMRGGELLDKI-----LRQKFFSE-------REASF 125
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNI-FLDEEFNA---RVGNFGMAR--------- 534
           +   +   ++Y+H   +   VHR++K  NI ++DE  N    R+ +FG A+         
Sbjct: 126 VLHTIGKTVEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLL 182
Query: 535 ---CVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPI 576
              C   +  +P+        +  G DI++ GI+L  +L+G TP 
Sbjct: 183 MTPCYTANFVAPEVLKRQ--GYDEGCDIWSLGILLYTMLAGYTPF 225

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 38/167 (22%), Positives = 75/167 (44%), Gaps = 28/167 (16%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HP+IV+L+G  +T+ P  +++ E    G L+ +L        +F       + ++ +L  
Sbjct: 70  HPHIVKLIGV-ITENP-VWIIMELCTLGELRSFLQ-----VRKFSLDLASLILYAYQL-- 120
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYST 548
               + AL Y+    +  +VHR+I +RN+ +      ++G+FG++R + D T        
Sbjct: 121 ----STALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGK 173
Query: 549 NPASW-----------SMGIDIFAYGIVLLEVL-SGQTPINRPRKKD 583
            P  W           +   D++ +G+ + E+L  G  P    +  D
Sbjct: 174 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 220

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 50.4 bits (119), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 42/165 (25%), Positives = 73/165 (44%), Gaps = 34/165 (20%)
Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLR 487
            HPNI+ L      DG H +LV E  + G L D +     ++ +F +         +   
Sbjct: 79  QHPNIITL-KDVYDDGKHVYLVTELMRGGELLDKI-----LRQKFFSE-------REASF 125
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNI-FLDEEFNA---RVGNFGMAR--------- 534
           +   +   ++Y+H   +   VHR++K  NI ++DE  N    R+ +FG A+         
Sbjct: 126 VLHTIGKTVEYLH---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLL 182
Query: 535 ---CVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPI 576
              C   +  +P+        +  G DI++ GI+L  +L+G TP 
Sbjct: 183 MTPCYTANFVAPEVLKRQ--GYDEGCDIWSLGILLYTMLAGYTPF 225

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 37/163 (22%), Positives = 76/163 (46%), Gaps = 29/163 (17%)
Query: 426 THHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQR 485
           T  H  +V+L    +T  P  +++ E+   GSL D+L      K              Q 
Sbjct: 66  TLQHDKLVKL-HAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSK--------------QP 109
Query: 486 LRICLDV-AMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQ 544
           L   +D  A   + M  +   +Y+HR++++ NI +      ++ +FG+AR + D+  + +
Sbjct: 110 LPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR 169
Query: 545 FYSTNPASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
             +  P  W           ++  D++++GI+L+E+++ G+ P
Sbjct: 170 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 212

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/207 (25%), Positives = 87/207 (42%), Gaps = 54/207 (26%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HPNIV+L      D  H+FLV E    G L +     +  K  F        + ++   I
Sbjct: 65  HPNIVKL-HEVFHDQLHTFLVMELLNGGELFE----RIKKKKHF--------SETEASYI 111
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNI-FLDEEFN--ARVGNFGMAR----------- 534
              +  A+ +MH V     VHR++K  N+ F DE  N   ++ +FG AR           
Sbjct: 112 MRKLVSAVSHMHDV---GVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT 168
Query: 535 -CVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTP----------------IN 577
            C      +P+  + N   +    D+++ G++L  +LSGQ P                + 
Sbjct: 169 PCFTLHYAAPELLNQN--GYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMK 226
Query: 578 RPRKKD---EGSVW--LSEKIKSILQA 599
           + +K D   EG  W  +S++ K ++Q 
Sbjct: 227 KIKKGDFSFEGEAWKNVSQEAKDLIQG 253

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 47/207 (22%), Positives = 87/207 (42%), Gaps = 37/207 (17%)
Query: 392 GAVYHGRLNGKNLAIKRTEHEVITKL---------------EMQLVQHATHHHPNIVRLL 436
           G VY G  N +++     E  V  K                E  +++  T HH  +VRLL
Sbjct: 28  GMVYEG--NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH--VVRLL 83
Query: 437 GTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMAL 496
           G  ++ G  + +V E   +G LK +L                  T  + +++  ++A  +
Sbjct: 84  G-VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP--TLQEMIQMAAEIADGM 140
Query: 497 QYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND-DTESPQFYSTNPASW-- 553
            Y++      +VHR++ +RN  +  +F  ++G+FGM R + + D          P  W  
Sbjct: 141 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 197
Query: 554 ---------SMGIDIFAYGIVLLEVLS 571
                    +   D++++G+VL E+ S
Sbjct: 198 PESLKDGVFTTSSDMWSFGVVLWEITS 224

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 92/212 (43%), Gaps = 45/212 (21%)
Query: 398 RLNGKNLAIKRTE--HEVITKLEMQLVQHATHH----------HPNIVRLLGTCLTDGPH 445
           R  G   A+K  E   E ++  +++ V+ AT            HP+I+ L+ +  +    
Sbjct: 116 RATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS-F 174
Query: 446 SFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNP 505
            FLVF+  + G L D+L   +A+  +   S          +R  L+   A+ ++H     
Sbjct: 175 MFLVFDLMRKGELFDYLTEKVALSEKETRSI---------MRSLLE---AVSFLH---AN 219
Query: 506 SYVHRNIKSRNIFLDEEFNARVGNFGMA-----------RCVNDDTESPQFY-----STN 549
           + VHR++K  NI LD+    R+ +FG +            C      +P+        T+
Sbjct: 220 NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETH 279
Query: 550 PASWSMGIDIFAYGIVLLEVLSGQTPINRPRK 581
           P  +   +D++A G++L  +L+G  P    R+
Sbjct: 280 PG-YGKEVDLWACGVILFTLLAGSPPFWHRRQ 310

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 44/206 (21%), Positives = 84/206 (40%), Gaps = 39/206 (18%)
Query: 392 GAVYHGRLNGKNLAIK------------RTEHEVITKLEMQLVQHATHHHPNIVRLLGTC 439
           G ++ GR  G ++ +K            R  +E   +L +         HPN++ +LG C
Sbjct: 24  GELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRI-------FSHPNVLPVLGAC 76
Query: 440 LTD-GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQY 498
            +   PH  L+  +   GSL + LH G      F+         SQ ++  LD A    +
Sbjct: 77  QSPPAPHPTLITHWXPYGSLYNVLHEG----TNFVVDQ------SQAVKFALDXARGXAF 126
Query: 499 MHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGM-------ARCVNDDTESPQFYSTNPA 551
           +H  + P      + SR++ +DE+  AR+    +        R       +P+     P 
Sbjct: 127 LH-TLEPLIPRHALNSRSVXIDEDXTARISXADVKFSFQSPGRXYAPAWVAPEALQKKPE 185
Query: 552 SWS-MGIDIFAYGIVLLEVLSGQTPI 576
             +    D +++ ++L E+++ + P 
Sbjct: 186 DTNRRSADXWSFAVLLWELVTREVPF 211

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/207 (22%), Positives = 87/207 (42%), Gaps = 37/207 (17%)
Query: 392 GAVYHGRLNGKNLAIKRTEHEVITKL---------------EMQLVQHATHHHPNIVRLL 436
           G VY G  N +++     E  V  K                E  +++  T HH  +VRLL
Sbjct: 31  GMVYEG--NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH--VVRLL 86
Query: 437 GTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMAL 496
           G  ++ G  + +V E   +G LK +L                  T  + +++  ++A  +
Sbjct: 87  G-VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP--TLQEMIQMAAEIADGM 143
Query: 497 QYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND-DTESPQFYSTNPASW-- 553
            Y++      +VHR++ +RN  +  +F  ++G+FGM R + + D          P  W  
Sbjct: 144 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 200
Query: 554 ---------SMGIDIFAYGIVLLEVLS 571
                    +   D++++G+VL E+ S
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 47/207 (22%), Positives = 87/207 (42%), Gaps = 37/207 (17%)
Query: 392 GAVYHGRLNGKNLAIKRTEHEVITKL---------------EMQLVQHATHHHPNIVRLL 436
           G VY G  N +++     E  V  K                E  +++  T HH  +VRLL
Sbjct: 31  GMVYEG--NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH--VVRLL 86
Query: 437 GTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMAL 496
           G  ++ G  + +V E   +G LK +L                  T  + +++  ++A  +
Sbjct: 87  G-VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP--TLQEMIQMAAEIADGM 143
Query: 497 QYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND-DTESPQFYSTNPASW-- 553
            Y++      +VHR++ +RN  +  +F  ++G+FGM R + + D          P  W  
Sbjct: 144 AYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMA 200
Query: 554 ---------SMGIDIFAYGIVLLEVLS 571
                    +   D++++G+VL E+ S
Sbjct: 201 PESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 50.1 bits (118), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 37/163 (22%), Positives = 76/163 (46%), Gaps = 29/163 (17%)
Query: 426 THHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQR 485
           T  H  +V+L    +T  P  +++ E+   GSL D+L      K              Q 
Sbjct: 239 TLQHDKLVKL-HAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSK--------------QP 282
Query: 486 LRICLDV-AMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQ 544
           L   +D  A   + M  +   +Y+HR++++ NI +      ++ +FG+AR + D+  + +
Sbjct: 283 LPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR 342
Query: 545 FYSTNPASW-----------SMGIDIFAYGIVLLEVLS-GQTP 575
             +  P  W           ++  D++++GI+L+E+++ G+ P
Sbjct: 343 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 385

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 87/213 (40%), Gaps = 53/213 (24%)
Query: 392 GAVYHGRLNGKNLAIK--RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHS--- 446
           G V+ G   G+N+A+K   +  E     E +L       H NI+  + + +T    S   
Sbjct: 51  GEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 110
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM--- 503
           +L+  Y + GSL D+L     +      SC         LRI L +A  L ++H  +   
Sbjct: 111 WLITHYHEMGSLYDYLQ----LTTLDTVSC---------LRIVLSIASGLAHLHIEIFGT 157
Query: 504 --NPSYVHRNIKSRNIF------------------------LDEEFNARVGNFG-MARCV 536
              P+  HR++KS+NI                         LD   N RVG    MA  V
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 217
Query: 537 NDDTESPQFYSTNPASWSMGIDIFAYGIVLLEV 569
            D+T     + +        +DI+A+G+VL EV
Sbjct: 218 LDETIQVDCFDSYKR-----VDIWAFGLVLWEV 245

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 40/170 (23%), Positives = 76/170 (44%), Gaps = 28/170 (16%)
Query: 418 EMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCY 477
           E  +++  T HH  +VRLLG  ++ G  + +V E   +G LK +L               
Sbjct: 69  EASVMKGFTCHH--VVRLLG-VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP 125
Query: 478 CFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN 537
              T  + +++  ++A  + Y++      +VHR++ +RN  +  +F  ++G+FGM R   
Sbjct: 126 P--TLQEMIQMAAEIADGMAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR--- 177
Query: 538 DDTESPQFYSTN-----PASW-----------SMGIDIFAYGIVLLEVLS 571
            D     +Y        P  W           +   D++++G+VL E+ S
Sbjct: 178 -DIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITS 226

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 49.7 bits (117), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 38/167 (22%), Positives = 75/167 (44%), Gaps = 28/167 (16%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HP+IV+L+G  +T+ P  +++ E    G L+ +L        +F       + ++ +L  
Sbjct: 450 HPHIVKLIGV-ITENP-VWIIMELCTLGELRSFLQ-----VRKFSLDLASLILYAYQL-- 500
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYST 548
               + AL Y+    +  +VHR+I +RN+ +      ++G+FG++R + D T        
Sbjct: 501 ----STALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGK 553
Query: 549 NPASW-----------SMGIDIFAYGIVLLEVL-SGQTPINRPRKKD 583
            P  W           +   D++ +G+ + E+L  G  P    +  D
Sbjct: 554 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 600

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 87/213 (40%), Gaps = 53/213 (24%)
Query: 392 GAVYHGRLNGKNLAIK--RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHS--- 446
           G V+ G   G+N+A+K   +  E     E +L       H NI+  + + +T    S   
Sbjct: 22  GEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM--- 503
           +L+  Y + GSL D+L     +      SC         LRI L +A  L ++H  +   
Sbjct: 82  WLITHYHEMGSLYDYLQ----LTTLDTVSC---------LRIVLSIASGLAHLHIEIFGT 128
Query: 504 --NPSYVHRNIKSRNIF------------------------LDEEFNARVGNFG-MARCV 536
              P+  HR++KS+NI                         LD   N RVG    MA  V
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188
Query: 537 NDDTESPQFYSTNPASWSMGIDIFAYGIVLLEV 569
            D+T     + +        +DI+A+G+VL EV
Sbjct: 189 LDETIQVDCFDSYKR-----VDIWAFGLVLWEV 216

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/187 (22%), Positives = 83/187 (44%), Gaps = 42/187 (22%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
           TE E++ KL          +HP I+++      D    ++V E  + G L D + G    
Sbjct: 64  TEIEILKKL----------NHPCIIKIKN--FFDAEDYYIVLELMEGGELFDKVVG---- 107
Query: 469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFL---DEEFNA 525
            N+ +    C L + Q L       +A+QY+H       +HR++K  N+ L   +E+   
Sbjct: 108 -NKRLKEATCKLYFYQML-------LAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLI 156
Query: 526 RVGNFGMARCVNDDT------ESPQFY------STNPASWSMGIDIFAYGIVLLEVLSGQ 573
           ++ +FG ++ + + +       +P +       S   A ++  +D ++ G++L   LSG 
Sbjct: 157 KITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 216
Query: 574 TPINRPR 580
            P +  R
Sbjct: 217 PPFSEHR 223

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/187 (22%), Positives = 83/187 (44%), Gaps = 42/187 (22%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
           TE E++ KL          +HP I+++      D    ++V E  + G L D + G    
Sbjct: 64  TEIEILKKL----------NHPCIIKIKN--FFDAEDYYIVLELMEGGELFDKVVG---- 107
Query: 469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFL---DEEFNA 525
            N+ +    C L + Q L       +A+QY+H       +HR++K  N+ L   +E+   
Sbjct: 108 -NKRLKEATCKLYFYQML-------LAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLI 156
Query: 526 RVGNFGMARCVNDDT------ESPQFY------STNPASWSMGIDIFAYGIVLLEVLSGQ 573
           ++ +FG ++ + + +       +P +       S   A ++  +D ++ G++L   LSG 
Sbjct: 157 KITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 216
Query: 574 TPINRPR 580
            P +  R
Sbjct: 217 PPFSEHR 223

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/187 (22%), Positives = 83/187 (44%), Gaps = 42/187 (22%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
           TE E++ KL          +HP I+++      D    ++V E  + G L D + G    
Sbjct: 64  TEIEILKKL----------NHPCIIKIKN--FFDAEDYYIVLELMEGGELFDKVVG---- 107
Query: 469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFL---DEEFNA 525
            N+ +    C L + Q L       +A+QY+H       +HR++K  N+ L   +E+   
Sbjct: 108 -NKRLKEATCKLYFYQML-------LAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLI 156
Query: 526 RVGNFGMARCVNDDT------ESPQFY------STNPASWSMGIDIFAYGIVLLEVLSGQ 573
           ++ +FG ++ + + +       +P +       S   A ++  +D ++ G++L   LSG 
Sbjct: 157 KITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 216
Query: 574 TPINRPR 580
            P +  R
Sbjct: 217 PPFSEHR 223

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/187 (22%), Positives = 83/187 (44%), Gaps = 42/187 (22%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
           TE E++ KL          +HP I+++      D    ++V E  + G L D + G    
Sbjct: 63  TEIEILKKL----------NHPCIIKIKN--FFDAEDYYIVLELMEGGELFDKVVG---- 106
Query: 469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFL---DEEFNA 525
            N+ +    C L + Q L       +A+QY+H       +HR++K  N+ L   +E+   
Sbjct: 107 -NKRLKEATCKLYFYQML-------LAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLI 155
Query: 526 RVGNFGMARCVNDDT------ESPQFY------STNPASWSMGIDIFAYGIVLLEVLSGQ 573
           ++ +FG ++ + + +       +P +       S   A ++  +D ++ G++L   LSG 
Sbjct: 156 KITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 215
Query: 574 TPINRPR 580
            P +  R
Sbjct: 216 PPFSEHR 222

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 49.3 bits (116), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 38/167 (22%), Positives = 75/167 (44%), Gaps = 28/167 (16%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HP+IV+L+G  +T+ P  +++ E    G L+ +L        +F       + ++ +L  
Sbjct: 450 HPHIVKLIGV-ITENP-VWIIMELCTLGELRSFLQ-----VRKFSLDLASLILYAYQL-- 500
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYST 548
               + AL Y+    +  +VHR+I +RN+ +      ++G+FG++R + D T        
Sbjct: 501 ----STALAYLE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGK 553
Query: 549 NPASW-----------SMGIDIFAYGIVLLEVL-SGQTPINRPRKKD 583
            P  W           +   D++ +G+ + E+L  G  P    +  D
Sbjct: 554 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 600

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 43/187 (22%), Positives = 83/187 (44%), Gaps = 42/187 (22%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
           TE E++ KL          +HP I+++      D    ++V E  + G L D + G    
Sbjct: 70  TEIEILKKL----------NHPCIIKIKN--FFDAEDYYIVLELMEGGELFDKVVG---- 113
Query: 469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFL---DEEFNA 525
            N+ +    C L + Q L       +A+QY+H       +HR++K  N+ L   +E+   
Sbjct: 114 -NKRLKEATCKLYFYQML-------LAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLI 162
Query: 526 RVGNFGMARCVNDDT------ESPQFY------STNPASWSMGIDIFAYGIVLLEVLSGQ 573
           ++ +FG ++ + + +       +P +       S   A ++  +D ++ G++L   LSG 
Sbjct: 163 KITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 222
Query: 574 TPINRPR 580
            P +  R
Sbjct: 223 PPFSEHR 229

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 48/211 (22%), Positives = 87/211 (41%), Gaps = 45/211 (21%)
Query: 392 GAVYHGRLNGKNLAIKRTEHEVITKL---------------EMQLVQHATHHHPNIVRLL 436
           G VY G  N +++     E  V  K                E  +++  T HH  +VRLL
Sbjct: 31  GMVYEG--NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH--VVRLL 86
Query: 437 GTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMAL 496
           G  ++ G  + +V E   +G LK +L                  T  + +++  ++A  +
Sbjct: 87  G-VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP--TLQEMIQMAAEIADGM 143
Query: 497 QYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN-----PA 551
            Y++      +VHR++ +RN  +  +F  ++G+FGM R    D     +Y        P 
Sbjct: 144 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPV 196
Query: 552 SW-----------SMGIDIFAYGIVLLEVLS 571
            W           +   D++++G+VL E+ S
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 49.3 bits (116), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 38/167 (22%), Positives = 75/167 (44%), Gaps = 28/167 (16%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HP+IV+L+G  +T+ P  +++ E    G L+ +L        +F       + ++ +L  
Sbjct: 70  HPHIVKLIGV-ITENP-VWIIMELCTLGELRSFLQ-----VRKFSLDLASLILYAYQL-- 120
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYST 548
               + AL Y+    +  +VHR+I +RN+ +      ++G+FG++R + D T        
Sbjct: 121 ----STALAYLE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGK 173
Query: 549 NPASW-----------SMGIDIFAYGIVLLEVL-SGQTPINRPRKKD 583
            P  W           +   D++ +G+ + E+L  G  P    +  D
Sbjct: 174 LPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 220

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 87/213 (40%), Gaps = 53/213 (24%)
Query: 392 GAVYHGRLNGKNLAIK--RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHS--- 446
           G V+ G   G+N+A+K   +  E     E +L       H NI+  + + +T    S   
Sbjct: 22  GEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM--- 503
           +L+  Y + GSL D+L     +      SC         LRI L +A  L ++H  +   
Sbjct: 82  WLITHYHEMGSLYDYLQ----LTTLDTVSC---------LRIVLSIASGLAHLHIEIFGT 128
Query: 504 --NPSYVHRNIKSRNIF------------------------LDEEFNARVGNFG-MARCV 536
              P+  HR++KS+NI                         LD   N RVG    MA  V
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188
Query: 537 NDDTESPQFYSTNPASWSMGIDIFAYGIVLLEV 569
            D+T     + +        +DI+A+G+VL EV
Sbjct: 189 LDETIQVDCFDSYKR-----VDIWAFGLVLWEV 216

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 48.9 bits (115), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 48/211 (22%), Positives = 87/211 (41%), Gaps = 45/211 (21%)
Query: 392 GAVYHGRLNGKNLAIKRTEHEVITKL---------------EMQLVQHATHHHPNIVRLL 436
           G VY G  N +++     E  V  K                E  +++  T HH  +VRLL
Sbjct: 31  GMVYEG--NARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH--VVRLL 86
Query: 437 GTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMAL 496
           G  ++ G  + +V E   +G LK +L                  T  + +++  ++A  +
Sbjct: 87  G-VVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPP--TLQEMIQMAAEIADGM 143
Query: 497 QYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN-----PA 551
            Y++      +VHR++ +RN  +  +F  ++G+FGM R    D     +Y        P 
Sbjct: 144 AYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETAYYRKGGKGLLPV 196
Query: 552 SW-----------SMGIDIFAYGIVLLEVLS 571
            W           +   D++++G+VL E+ S
Sbjct: 197 RWMAPESLKDGVFTTSSDMWSFGVVLWEITS 227

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 44/193 (22%), Positives = 86/193 (44%), Gaps = 33/193 (17%)
Query: 401 GKNLAIKRTEHEVITKLEMQ--LVQHATH----HHPNIVRLLGTCLTDGPHSFLVFEYAK 454
           G+ +A+K    +V+ K +MQ  + +  ++     HP+I++L    +       +V EYA 
Sbjct: 38  GQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLY-DVIKSKDEIIMVIEYAG 96
Query: 455 NGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKS 514
           N  L D++     M  Q            +  R    +  A++Y H       VHR++K 
Sbjct: 97  N-ELFDYIVQRDKMSEQ------------EARRFFQQIISAVEYCH---RHKIVHRDLKP 140
Query: 515 RNIFLDEEFNARVGNFGMARCVNDDT------ESPQFYSTNPASWSM----GIDIFAYGI 564
            N+ LDE  N ++ +FG++  + D         SP + +    S  +     +D+++ G+
Sbjct: 141 ENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGV 200
Query: 565 VLLEVLSGQTPIN 577
           +L  +L  + P +
Sbjct: 201 ILYVMLCRRLPFD 213

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 48.9 bits (115), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 44/192 (22%), Positives = 86/192 (44%), Gaps = 33/192 (17%)
Query: 402 KNLAIKRTEHEVITKLEMQL-VQHATHH-----HPNIVRLLGTCLTDGPHSFLVFEYAKN 455
           + +A+K    +++ K +M + V+    +     HP+I++L    +T      +V EYA  
Sbjct: 35  QKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDV-ITTPTDIVMVIEYA-G 92
Query: 456 GSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSR 515
           G L D++     M            T  +  R    +  A++Y H       VHR++K  
Sbjct: 93  GELFDYIVEKKRM------------TEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPE 137
Query: 516 NIFLDEEFNARVGNFGMARCVNDDT------ESPQFYSTNPASWSM----GIDIFAYGIV 565
           N+ LD+  N ++ +FG++  + D         SP + +    +  +     +D+++ GIV
Sbjct: 138 NLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIV 197
Query: 566 LLEVLSGQTPIN 577
           L  +L G+ P +
Sbjct: 198 LYVMLVGRLPFD 209

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/193 (22%), Positives = 86/193 (44%), Gaps = 33/193 (17%)
Query: 401 GKNLAIKRTEHEVITKLEMQ--LVQHATH----HHPNIVRLLGTCLTDGPHSFLVFEYAK 454
           G+ +A+K    +V+ K +MQ  + +  ++     HP+I++L    +       +V EYA 
Sbjct: 39  GQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLY-DVIKSKDEIIMVIEYAG 97
Query: 455 NGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKS 514
           N  L D++     M  Q            +  R    +  A++Y H       VHR++K 
Sbjct: 98  N-ELFDYIVQRDKMSEQ------------EARRFFQQIISAVEYCH---RHKIVHRDLKP 141
Query: 515 RNIFLDEEFNARVGNFGMARCVNDDT------ESPQFYSTNPASWSM----GIDIFAYGI 564
            N+ LDE  N ++ +FG++  + D         SP + +    S  +     +D+++ G+
Sbjct: 142 ENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGV 201
Query: 565 VLLEVLSGQTPIN 577
           +L  +L  + P +
Sbjct: 202 ILYVMLCRRLPFD 214

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/193 (22%), Positives = 86/193 (44%), Gaps = 33/193 (17%)
Query: 401 GKNLAIKRTEHEVITKLEMQ--LVQHATH----HHPNIVRLLGTCLTDGPHSFLVFEYAK 454
           G+ +A+K    +V+ K +MQ  + +  ++     HP+I++L    +       +V EYA 
Sbjct: 33  GQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLY-DVIKSKDEIIMVIEYAG 91
Query: 455 NGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKS 514
           N  L D++     M  Q            +  R    +  A++Y H       VHR++K 
Sbjct: 92  N-ELFDYIVQRDKMSEQ------------EARRFFQQIISAVEYCH---RHKIVHRDLKP 135
Query: 515 RNIFLDEEFNARVGNFGMARCVNDDT------ESPQFYSTNPASWSM----GIDIFAYGI 564
            N+ LDE  N ++ +FG++  + D         SP + +    S  +     +D+++ G+
Sbjct: 136 ENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGV 195
Query: 565 VLLEVLSGQTPIN 577
           +L  +L  + P +
Sbjct: 196 ILYVMLCRRLPFD 208

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 44/193 (22%), Positives = 86/193 (44%), Gaps = 33/193 (17%)
Query: 401 GKNLAIKRTEHEVITKLEMQ--LVQHATH----HHPNIVRLLGTCLTDGPHSFLVFEYAK 454
           G+ +A+K    +V+ K +MQ  + +  ++     HP+I++L    +       +V EYA 
Sbjct: 29  GQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDV-IKSKDEIIMVIEYAG 87
Query: 455 NGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKS 514
           N  L D++     M  Q            +  R    +  A++Y H       VHR++K 
Sbjct: 88  N-ELFDYIVQRDKMSEQ------------EARRFFQQIISAVEYCH---RHKIVHRDLKP 131
Query: 515 RNIFLDEEFNARVGNFGMARCVNDDT------ESPQFYSTNPASWSM----GIDIFAYGI 564
            N+ LDE  N ++ +FG++  + D         SP + +    S  +     +D+++ G+
Sbjct: 132 ENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGV 191
Query: 565 VLLEVLSGQTPIN 577
           +L  +L  + P +
Sbjct: 192 ILYVMLCRRLPFD 204

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 41/194 (21%), Positives = 79/194 (40%), Gaps = 42/194 (21%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
           T   V  K   + +      HP+IV+L+G  +T+ P  +++ E    G L+ +L      
Sbjct: 55  TSDSVREKFLQEALTMRQFDHPHIVKLIGV-ITENP-VWIIMELCTLGELRSFL------ 106
Query: 469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMH-------HVMNPSYVHRNIKSRNIFLDE 521
                          Q  +  LD+A  + Y +       ++ +  +VHR+I +RN+ +  
Sbjct: 107 ---------------QVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSS 151
Query: 522 EFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SMGIDIFAYGIVLLEVL 570
               ++G+FG++R + D T         P  W           +   D++ +G+ + E+L
Sbjct: 152 NDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 211
Query: 571 -SGQTPINRPRKKD 583
             G  P    +  D
Sbjct: 212 MHGVKPFQGVKNND 225

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/174 (21%), Positives = 74/174 (42%), Gaps = 42/174 (24%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HP+IV+L+G  +T+ P  +++ E    G L+ +L                     Q  + 
Sbjct: 98  HPHIVKLIGV-ITENP-VWIIMELCTLGELRSFL---------------------QVRKY 134
Query: 489 CLDVAMALQYMH-------HVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE 541
            LD+A  + Y +       ++ +  +VHR+I +RN+ +      ++G+FG++R + D T 
Sbjct: 135 SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 194
Query: 542 SPQFYSTNPASW-----------SMGIDIFAYGIVLLEVL-SGQTPINRPRKKD 583
                   P  W           +   D++ +G+ + E+L  G  P    +  D
Sbjct: 195 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 248

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/174 (21%), Positives = 74/174 (42%), Gaps = 42/174 (24%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HP+IV+L+G  +T+ P  +++ E    G L+ +L                     Q  + 
Sbjct: 73  HPHIVKLIGV-ITENP-VWIIMELCTLGELRSFL---------------------QVRKY 109
Query: 489 CLDVAMALQYMH-------HVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE 541
            LD+A  + Y +       ++ +  +VHR+I +RN+ +      ++G+FG++R + D T 
Sbjct: 110 SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 169
Query: 542 SPQFYSTNPASW-----------SMGIDIFAYGIVLLEVL-SGQTPINRPRKKD 583
                   P  W           +   D++ +G+ + E+L  G  P    +  D
Sbjct: 170 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 223

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/174 (21%), Positives = 74/174 (42%), Gaps = 42/174 (24%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HP+IV+L+G  +T+ P  +++ E    G L+ +L                     Q  + 
Sbjct: 67  HPHIVKLIGV-ITENP-VWIIMELCTLGELRSFL---------------------QVRKY 103
Query: 489 CLDVAMALQYMH-------HVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE 541
            LD+A  + Y +       ++ +  +VHR+I +RN+ +      ++G+FG++R + D T 
Sbjct: 104 SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 163
Query: 542 SPQFYSTNPASW-----------SMGIDIFAYGIVLLEVL-SGQTPINRPRKKD 583
                   P  W           +   D++ +G+ + E+L  G  P    +  D
Sbjct: 164 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 217

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 48.5 bits (114), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/174 (21%), Positives = 74/174 (42%), Gaps = 42/174 (24%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HP+IV+L+G  +T+ P  +++ E    G L+ +L                     Q  + 
Sbjct: 72  HPHIVKLIGV-ITENP-VWIIMELCTLGELRSFL---------------------QVRKY 108
Query: 489 CLDVAMALQYMH-------HVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE 541
            LD+A  + Y +       ++ +  +VHR+I +RN+ +      ++G+FG++R + D T 
Sbjct: 109 SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 168
Query: 542 SPQFYSTNPASW-----------SMGIDIFAYGIVLLEVL-SGQTPINRPRKKD 583
                   P  W           +   D++ +G+ + E+L  G  P    +  D
Sbjct: 169 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 222

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 78/169 (46%), Gaps = 35/169 (20%)
Query: 425 ATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQ 484
           A+  +P++ RLLG CLT      L+ +    G L D++          I S Y  L W  
Sbjct: 73  ASVDNPHVCRLLGICLTSTVQ--LIMQLMPFGXLLDYVRE----HKDNIGSQY-LLNW-- 123
Query: 485 RLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQ 544
               C+ +A  + Y+    +   VHR++ +RN+ +    + ++ +FG+A+ +    E  +
Sbjct: 124 ----CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKE 174
Query: 545 FYSTN---PASWSMGI------------DIFAYGIVLLEVLS-GQTPIN 577
           +++     P  W M +            D+++YG+ + E+++ G  P +
Sbjct: 175 YHAEGGKVPIKW-MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/174 (21%), Positives = 74/174 (42%), Gaps = 42/174 (24%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HP+IV+L+G  +T+ P  +++ E    G L+ +L                     Q  + 
Sbjct: 70  HPHIVKLIGV-ITENP-VWIIMELCTLGELRSFL---------------------QVRKY 106
Query: 489 CLDVAMALQYMH-------HVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE 541
            LD+A  + Y +       ++ +  +VHR+I +RN+ +      ++G+FG++R + D T 
Sbjct: 107 SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 166
Query: 542 SPQFYSTNPASW-----------SMGIDIFAYGIVLLEVL-SGQTPINRPRKKD 583
                   P  W           +   D++ +G+ + E+L  G  P    +  D
Sbjct: 167 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 220

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 45/190 (23%), Positives = 80/190 (42%), Gaps = 30/190 (15%)
Query: 417 LEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASC 476
           ++ ++  +A  +H N+V+  G    +G   +L  EY   G L D +   + M        
Sbjct: 52  IKKEICINAMLNHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPE------ 104
Query: 477 YCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA--- 533
                     R    +   + Y+H +      HR+IK  N+ LDE  N ++ +FG+A   
Sbjct: 105 ------PDAQRFFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVF 155
Query: 534 RCVNDDTESPQFYSTNPAS----------WSMGIDIFAYGIVLLEVLSGQTPINRPRKK- 582
           R  N +    +   T P             +  +D+++ GIVL  +L+G+ P ++P    
Sbjct: 156 RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSC 215
Query: 583 DEGSVWLSEK 592
            E S W  +K
Sbjct: 216 QEYSDWKEKK 225

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 36/159 (22%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRL 486
           H +IVRLLG C   G    LV +Y   GSL D +  H G A+  Q +      L W    
Sbjct: 92  HAHIVRLLGLC--PGSSLQLVTQYLPLGSLLDHVRQHRG-ALGPQLL------LNWG--- 139
Query: 487 RICLDVAMALQYMH-HVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV-NDDTESPQ 544
              + +A  + Y+  H M    VHRN+ +RN+ L      +V +FG+A  +  DD +   
Sbjct: 140 ---VQIAKGMYYLEEHGM----VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY 192
Query: 545 FYSTNPASWSMGI------------DIFAYGIVLLEVLS 571
             +  P  W M +            D+++YG+ + E+++
Sbjct: 193 SEAKTPIKW-MALESIHFGKYTHQSDVWSYGVTVWELMT 230

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 38/174 (21%), Positives = 74/174 (42%), Gaps = 42/174 (24%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HP+IV+L+G  +T+ P  +++ E    G L+ +L                     Q  + 
Sbjct: 70  HPHIVKLIGV-ITENP-VWIIMELCTLGELRSFL---------------------QVRKY 106
Query: 489 CLDVAMALQYMH-------HVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE 541
            LD+A  + Y +       ++ +  +VHR+I +RN+ +      ++G+FG++R + D T 
Sbjct: 107 SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY 166
Query: 542 SPQFYSTNPASW-----------SMGIDIFAYGIVLLEVL-SGQTPINRPRKKD 583
                   P  W           +   D++ +G+ + E+L  G  P    +  D
Sbjct: 167 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 220

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 78/169 (46%), Gaps = 35/169 (20%)
Query: 425 ATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQ 484
           A+  +P++ RLLG CLT      L+ +    G L D++          I S Y  L W  
Sbjct: 79  ASVDNPHVCRLLGICLTSTVQ--LIMQLMPFGCLLDYVRE----HKDNIGSQY-LLNW-- 129
Query: 485 RLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQ 544
               C+ +A  + Y+    +   VHR++ +RN+ +    + ++ +FG+A+ +    E  +
Sbjct: 130 ----CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKE 180
Query: 545 FYSTN---PASWSMGI------------DIFAYGIVLLEVLS-GQTPIN 577
           +++     P  W M +            D+++YG+ + E+++ G  P +
Sbjct: 181 YHAEGGKVPIKW-MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 78/169 (46%), Gaps = 35/169 (20%)
Query: 425 ATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQ 484
           A+  +P++ RLLG CLT      L+ +    G L D++          I S Y  L W  
Sbjct: 73  ASVDNPHVCRLLGICLTSTVQ--LIMQLMPFGCLLDYVRE----HKDNIGSQY-LLNW-- 123
Query: 485 RLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQ 544
               C+ +A  + Y+    +   VHR++ +RN+ +    + ++ +FG+A+ +    E  +
Sbjct: 124 ----CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKE 174
Query: 545 FYSTN---PASWSMGI------------DIFAYGIVLLEVLS-GQTPIN 577
           +++     P  W M +            D+++YG+ + E+++ G  P +
Sbjct: 175 YHAEGGKVPIKW-MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 222

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 78/169 (46%), Gaps = 35/169 (20%)
Query: 425 ATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQ 484
           A+  +P++ RLLG CLT      L+ +    G L D++          I S Y  L W  
Sbjct: 76  ASVDNPHVCRLLGICLTSTVQ--LIMQLMPFGCLLDYVRE----HKDNIGSQY-LLNW-- 126
Query: 485 RLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQ 544
               C+ +A  + Y+    +   VHR++ +RN+ +    + ++ +FG+A+ +    E  +
Sbjct: 127 ----CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKE 177
Query: 545 FYSTN---PASWSMGI------------DIFAYGIVLLEVLS-GQTPIN 577
           +++     P  W M +            D+++YG+ + E+++ G  P +
Sbjct: 178 YHAEGGKVPIKW-MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 78/169 (46%), Gaps = 35/169 (20%)
Query: 425 ATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQ 484
           A+  +P++ RLLG CLT      L+ +    G L D++          I S Y  L W  
Sbjct: 74  ASVDNPHVCRLLGICLTSTVQ--LIMQLMPFGCLLDYVRE----HKDNIGSQY-LLNW-- 124
Query: 485 RLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQ 544
               C+ +A  + Y+    +   VHR++ +RN+ +    + ++ +FG+A+ +    E  +
Sbjct: 125 ----CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKE 175
Query: 545 FYSTN---PASWSMGI------------DIFAYGIVLLEVLS-GQTPIN 577
           +++     P  W M +            D+++YG+ + E+++ G  P +
Sbjct: 176 YHAEGGKVPIKW-MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 78/169 (46%), Gaps = 35/169 (20%)
Query: 425 ATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQ 484
           A+  +P++ RLLG CLT      L+ +    G L D++          I S Y  L W  
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQ--LIMQLMPFGCLLDYVRE----HKDNIGSQY-LLNW-- 122
Query: 485 RLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQ 544
               C+ +A  + Y+    +   VHR++ +RN+ +    + ++ +FG+A+ +    E  +
Sbjct: 123 ----CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKE 173
Query: 545 FYSTN---PASWSMGI------------DIFAYGIVLLEVLS-GQTPIN 577
           +++     P  W M +            D+++YG+ + E+++ G  P +
Sbjct: 174 YHAEGGKVPIKW-MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 78/169 (46%), Gaps = 35/169 (20%)
Query: 425 ATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQ 484
           A+  +P++ RLLG CLT      L+ +    G L D++          I S Y  L W  
Sbjct: 75  ASVDNPHVCRLLGICLTSTVQ--LIMQLMPFGCLLDYVRE----HKDNIGSQY-LLNW-- 125
Query: 485 RLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQ 544
               C+ +A  + Y+    +   VHR++ +RN+ +    + ++ +FG+A+ +    E  +
Sbjct: 126 ----CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKE 176
Query: 545 FYSTN---PASWSMGI------------DIFAYGIVLLEVLS-GQTPIN 577
           +++     P  W M +            D+++YG+ + E+++ G  P +
Sbjct: 177 YHAEGGKVPIKW-MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 46/159 (28%), Positives = 73/159 (45%), Gaps = 36/159 (22%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRL 486
           H +IVRLLG C   G    LV +Y   GSL D +  H G A+  Q +      L W    
Sbjct: 74  HAHIVRLLGLC--PGSSLQLVTQYLPLGSLLDHVRQHRG-ALGPQLL------LNWG--- 121
Query: 487 RICLDVAMALQYMH-HVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV-NDDTESPQ 544
              + +A  + Y+  H M    VHRN+ +RN+ L      +V +FG+A  +  DD +   
Sbjct: 122 ---VQIAKGMYYLEEHGM----VHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLY 174
Query: 545 FYSTNPASWSMGI------------DIFAYGIVLLEVLS 571
             +  P  W M +            D+++YG+ + E+++
Sbjct: 175 SEAKTPIKW-MALESIHFGKYTHQSDVWSYGVTVWELMT 212

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 74/179 (41%), Gaps = 30/179 (16%)
Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLR 487
           +H N+V+  G    +G   +L  EY   G L D +   + M                  R
Sbjct: 62  NHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPE------------PDAQR 108
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA---RCVNDDTESPQ 544
               +   + Y+H +      HR+IK  N+ LDE  N ++ +FG+A   R  N +    +
Sbjct: 109 FFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 545 FYSTNP----------ASWSMGIDIFAYGIVLLEVLSGQTPINRPRKK-DEGSVWLSEK 592
              T P             +  +D+++ GIVL  +L+G+ P ++P     E S W  +K
Sbjct: 166 MXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 224

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 74/179 (41%), Gaps = 30/179 (16%)
Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLR 487
           +H N+V+  G    +G   +L  EY   G L D +   + M                  R
Sbjct: 62  NHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPE------------PDAQR 108
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA---RCVNDDTESPQ 544
               +   + Y+H +      HR+IK  N+ LDE  N ++ +FG+A   R  N +    +
Sbjct: 109 FFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 545 FYSTNP----------ASWSMGIDIFAYGIVLLEVLSGQTPINRPRK-KDEGSVWLSEK 592
              T P             +  +D+++ GIVL  +L+G+ P ++P     E S W  +K
Sbjct: 166 MXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEKK 224

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 74/179 (41%), Gaps = 30/179 (16%)
Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLR 487
           +H N+V+  G    +G   +L  EY   G L D +   + M                  R
Sbjct: 62  NHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPE------------PDAQR 108
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA---RCVNDDTESPQ 544
               +   + Y+H +      HR+IK  N+ LDE  N ++ +FG+A   R  N +    +
Sbjct: 109 FFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 545 FYSTNP----------ASWSMGIDIFAYGIVLLEVLSGQTPINRPRKK-DEGSVWLSEK 592
              T P             +  +D+++ GIVL  +L+G+ P ++P     E S W  +K
Sbjct: 166 MXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 224

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 74/179 (41%), Gaps = 30/179 (16%)
Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLR 487
           +H N+V+  G    +G   +L  EY   G L D +   + M                  R
Sbjct: 62  NHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPE------------PDAQR 108
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA---RCVNDDTESPQ 544
               +   + Y+H +      HR+IK  N+ LDE  N ++ +FG+A   R  N +    +
Sbjct: 109 FFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 545 FYSTNP----------ASWSMGIDIFAYGIVLLEVLSGQTPINRPRKK-DEGSVWLSEK 592
              T P             +  +D+++ GIVL  +L+G+ P ++P     E S W  +K
Sbjct: 166 MXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 224

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 47.8 bits (112), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 78/169 (46%), Gaps = 35/169 (20%)
Query: 425 ATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQ 484
           A+  +P++ RLLG CLT      L+ +    G L D++          I S Y  L W  
Sbjct: 106 ASVDNPHVCRLLGICLTSTVQ--LITQLMPFGCLLDYVRE----HKDNIGSQY-LLNW-- 156
Query: 485 RLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQ 544
               C+ +A  + Y+    +   VHR++ +RN+ +    + ++ +FG+A+ +    E  +
Sbjct: 157 ----CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKE 207
Query: 545 FYSTN---PASWSMGI------------DIFAYGIVLLEVLS-GQTPIN 577
           +++     P  W M +            D+++YG+ + E+++ G  P +
Sbjct: 208 YHAEGGKVPIKW-MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 255

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 74/179 (41%), Gaps = 30/179 (16%)
Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLR 487
           +H N+V+  G    +G   +L  EY   G L D +   + M                  R
Sbjct: 63  NHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPE------------PDAQR 109
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA---RCVNDDTESPQ 544
               +   + Y+H +      HR+IK  N+ LDE  N ++ +FG+A   R  N +    +
Sbjct: 110 FFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 545 FYSTNPAS----------WSMGIDIFAYGIVLLEVLSGQTPINRPRKK-DEGSVWLSEK 592
              T P             +  +D+++ GIVL  +L+G+ P ++P     E S W  +K
Sbjct: 167 MXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 225

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 74/179 (41%), Gaps = 30/179 (16%)
Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLR 487
           +H N+V+  G    +G   +L  EY   G L D +   + M                  R
Sbjct: 61  NHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPE------------PDAQR 107
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA---RCVNDDTESPQ 544
               +   + Y+H +      HR+IK  N+ LDE  N ++ +FG+A   R  N +    +
Sbjct: 108 FFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 164
Query: 545 FYSTNPAS----------WSMGIDIFAYGIVLLEVLSGQTPINRPRKK-DEGSVWLSEK 592
              T P             +  +D+++ GIVL  +L+G+ P ++P     E S W  +K
Sbjct: 165 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 223

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 75/178 (42%), Gaps = 32/178 (17%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
            EH++  ++E+Q    +   HPNI+RL G    D    +L+ EYA  G++   L      
Sbjct: 53  VEHQLRREVEIQ----SHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKF 107
Query: 469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVG 528
             Q  A+   ++T         ++A AL Y H   +   +HR+IK  N+ L      ++ 
Sbjct: 108 DEQRTAT---YIT---------ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIA 152
Query: 529 NFGMA----------RCVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPI 576
           NFG +           C   D   P+            +D+++ G++  E L G+ P 
Sbjct: 153 NFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMH--DEKVDLWSLGVLCYEFLVGKPPF 208

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 74/179 (41%), Gaps = 30/179 (16%)
Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLR 487
           +H N+V+  G    +G   +L  EY   G L D +   + M                  R
Sbjct: 62  NHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPE------------PDAQR 108
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA---RCVNDDTESPQ 544
               +   + Y+H +      HR+IK  N+ LDE  N ++ +FG+A   R  N +    +
Sbjct: 109 FFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 545 FYSTNP----------ASWSMGIDIFAYGIVLLEVLSGQTPINRPRKK-DEGSVWLSEK 592
              T P             +  +D+++ GIVL  +L+G+ P ++P     E S W  +K
Sbjct: 166 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 224

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 74/179 (41%), Gaps = 30/179 (16%)
Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLR 487
           +H N+V+  G    +G   +L  EY   G L D +   + M                  R
Sbjct: 63  NHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPE------------PDAQR 109
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA---RCVNDDTESPQ 544
               +   + Y+H +      HR+IK  N+ LDE  N ++ +FG+A   R  N +    +
Sbjct: 110 FFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 545 FYSTNPAS----------WSMGIDIFAYGIVLLEVLSGQTPINRPRKK-DEGSVWLSEK 592
              T P             +  +D+++ GIVL  +L+G+ P ++P     E S W  +K
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 225

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 74/179 (41%), Gaps = 30/179 (16%)
Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLR 487
           +H N+V+  G    +G   +L  EY   G L D +   + M                  R
Sbjct: 63  NHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPE------------PDAQR 109
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA---RCVNDDTESPQ 544
               +   + Y+H +      HR+IK  N+ LDE  N ++ +FG+A   R  N +    +
Sbjct: 110 FFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 545 FYSTNPAS----------WSMGIDIFAYGIVLLEVLSGQTPINRPRKK-DEGSVWLSEK 592
              T P             +  +D+++ GIVL  +L+G+ P ++P     E S W  +K
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 225

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 74/179 (41%), Gaps = 30/179 (16%)
Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLR 487
           +H N+V+  G    +G   +L  EY   G L D +   + M                  R
Sbjct: 62  NHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPE------------PDAQR 108
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA---RCVNDDTESPQ 544
               +   + Y+H +      HR+IK  N+ LDE  N ++ +FG+A   R  N +    +
Sbjct: 109 FFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 545 FYSTNPAS----------WSMGIDIFAYGIVLLEVLSGQTPINRPRKK-DEGSVWLSEK 592
              T P             +  +D+++ GIVL  +L+G+ P ++P     E S W  +K
Sbjct: 166 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 224

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 74/179 (41%), Gaps = 30/179 (16%)
Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLR 487
           +H N+V+  G    +G   +L  EY   G L D +   + M                  R
Sbjct: 63  NHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPE------------PDAQR 109
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA---RCVNDDTESPQ 544
               +   + Y+H +      HR+IK  N+ LDE  N ++ +FG+A   R  N +    +
Sbjct: 110 FFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 545 FYSTNP----------ASWSMGIDIFAYGIVLLEVLSGQTPINRPRKK-DEGSVWLSEK 592
              T P             +  +D+++ GIVL  +L+G+ P ++P     E S W  +K
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 225

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 74/179 (41%), Gaps = 30/179 (16%)
Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLR 487
           +H N+V+  G    +G   +L  EY   G L D +   + M                  R
Sbjct: 63  NHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPE------------PDAQR 109
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA---RCVNDDTESPQ 544
               +   + Y+H +      HR+IK  N+ LDE  N ++ +FG+A   R  N +    +
Sbjct: 110 FFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 545 FYSTNPAS----------WSMGIDIFAYGIVLLEVLSGQTPINRPRKK-DEGSVWLSEK 592
              T P             +  +D+++ GIVL  +L+G+ P ++P     E S W  +K
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 225

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/187 (22%), Positives = 83/187 (44%), Gaps = 42/187 (22%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
           TE E++ KL          +HP I+++      D    ++V E  + G L D + G    
Sbjct: 203 TEIEILKKL----------NHPCIIKIKN--FFDAEDYYIVLELMEGGELFDKVVG---- 246
Query: 469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFL---DEEFNA 525
            N+ +    C L + Q L       +A+QY+H       +HR++K  N+ L   +E+   
Sbjct: 247 -NKRLKEATCKLYFYQML-------LAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLI 295
Query: 526 RVGNFGMARCVNDDT------ESPQFY------STNPASWSMGIDIFAYGIVLLEVLSGQ 573
           ++ +FG ++ + + +       +P +       S   A ++  +D ++ G++L   LSG 
Sbjct: 296 KITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 355
Query: 574 TPINRPR 580
            P +  R
Sbjct: 356 PPFSEHR 362

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 74/179 (41%), Gaps = 30/179 (16%)
Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLR 487
           +H N+V+  G    +G   +L  EY   G L D +   + M                  R
Sbjct: 62  NHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPE------------PDAQR 108
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA---RCVNDDTESPQ 544
               +   + Y+H +      HR+IK  N+ LDE  N ++ +FG+A   R  N +    +
Sbjct: 109 FFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 545 FYSTNP----------ASWSMGIDIFAYGIVLLEVLSGQTPINRPRKK-DEGSVWLSEK 592
              T P             +  +D+++ GIVL  +L+G+ P ++P     E S W  +K
Sbjct: 166 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 224

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 74/179 (41%), Gaps = 30/179 (16%)
Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLR 487
           +H N+V+  G    +G   +L  EY   G L D +   + M                  R
Sbjct: 62  NHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPE------------PDAQR 108
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA---RCVNDDTESPQ 544
               +   + Y+H +      HR+IK  N+ LDE  N ++ +FG+A   R  N +    +
Sbjct: 109 FFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 545 FYSTNPAS----------WSMGIDIFAYGIVLLEVLSGQTPINRPRKK-DEGSVWLSEK 592
              T P             +  +D+++ GIVL  +L+G+ P ++P     E S W  +K
Sbjct: 166 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 224

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 43/187 (22%), Positives = 83/187 (44%), Gaps = 42/187 (22%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
           TE E++ KL          +HP I+++      D    ++V E  + G L D + G    
Sbjct: 189 TEIEILKKL----------NHPCIIKIKN--FFDAEDYYIVLELMEGGELFDKVVG---- 232
Query: 469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFL---DEEFNA 525
            N+ +    C L + Q L       +A+QY+H       +HR++K  N+ L   +E+   
Sbjct: 233 -NKRLKEATCKLYFYQML-------LAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLI 281
Query: 526 RVGNFGMARCVNDDT------ESPQFY------STNPASWSMGIDIFAYGIVLLEVLSGQ 573
           ++ +FG ++ + + +       +P +       S   A ++  +D ++ G++L   LSG 
Sbjct: 282 KITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 341
Query: 574 TPINRPR 580
            P +  R
Sbjct: 342 PPFSEHR 348

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 74/179 (41%), Gaps = 30/179 (16%)
Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLR 487
           +H N+V+  G    +G   +L  EY   G L D +   + M                  R
Sbjct: 63  NHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPE------------PDAQR 109
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA---RCVNDDTESPQ 544
               +   + Y+H +      HR+IK  N+ LDE  N ++ +FG+A   R  N +    +
Sbjct: 110 FFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 545 FYSTNPAS----------WSMGIDIFAYGIVLLEVLSGQTPINRPRKK-DEGSVWLSEK 592
              T P             +  +D+++ GIVL  +L+G+ P ++P     E S W  +K
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 225

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 78/169 (46%), Gaps = 35/169 (20%)
Query: 425 ATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQ 484
           A+  +P++ RLLG CLT      L+ +    G L D++          I S Y  L W  
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQ--LITQLMPFGXLLDYVRE----HKDNIGSQY-LLNW-- 122
Query: 485 RLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQ 544
               C+ +A  + Y+    +   VHR++ +RN+ +    + ++ +FG+A+ +    E  +
Sbjct: 123 ----CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKE 173
Query: 545 FYSTN---PASWSMGI------------DIFAYGIVLLEVLS-GQTPIN 577
           +++     P  W M +            D+++YG+ + E+++ G  P +
Sbjct: 174 YHAEGGKVPIKW-MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 78/169 (46%), Gaps = 35/169 (20%)
Query: 425 ATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQ 484
           A+  +P++ RLLG CLT      L+ +    G L D++          I S Y  L W  
Sbjct: 82  ASVDNPHVCRLLGICLTSTVQ--LITQLMPFGCLLDYVRE----HKDNIGSQY-LLNW-- 132
Query: 485 RLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQ 544
               C+ +A  + Y+    +   VHR++ +RN+ +    + ++ +FG+A+ +    E  +
Sbjct: 133 ----CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKE 183
Query: 545 FYSTN---PASWSMGI------------DIFAYGIVLLEVLS-GQTPIN 577
           +++     P  W M +            D+++YG+ + E+++ G  P +
Sbjct: 184 YHAEGGKVPIKW-MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 231

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 47.4 bits (111), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/213 (22%), Positives = 90/213 (42%), Gaps = 37/213 (17%)
Query: 392 GAVYHGRLNGK-----NLAIKRTEHEVI----TKLEMQLVQHATHHHPNIVRLLGTCLTD 442
           G VY G          N+A+K  + +       K   + V      HP+IV+L+G  + +
Sbjct: 38  GEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIG--IIE 95
Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
              ++++ E    G L  +L      +N+        + +S  L+IC     A+ Y+  +
Sbjct: 96  EEPTWIIMELYPYGELGHYLE-----RNKNSLKVLTLVLYS--LQIC----KAMAYLESI 144
Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW--------- 553
              + VHR+I  RNI +      ++G+FG++R + D+       +  P  W         
Sbjct: 145 ---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFR 201
Query: 554 --SMGIDIFAYGIVLLEVLS-GQTPINRPRKKD 583
             +   D++ + + + E+LS G+ P      KD
Sbjct: 202 RFTTASDVWMFAVCMWEILSFGKQPFFWLENKD 234

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 74/179 (41%), Gaps = 30/179 (16%)
Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLR 487
           +H N+V+  G    +G   +L  EY   G L D +   + M                  R
Sbjct: 62  NHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPE------------PDAQR 108
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA---RCVNDDTESPQ 544
               +   + Y+H +      HR+IK  N+ LDE  N ++ +FG+A   R  N +    +
Sbjct: 109 FFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 545 FYSTNPAS----------WSMGIDIFAYGIVLLEVLSGQTPINRPRKK-DEGSVWLSEK 592
              T P             +  +D+++ GIVL  +L+G+ P ++P     E S W  +K
Sbjct: 166 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 224

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 74/179 (41%), Gaps = 30/179 (16%)
Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLR 487
           +H N+V+  G    +G   +L  EY   G L D +   + M                  R
Sbjct: 62  NHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPE------------PDAQR 108
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA---RCVNDDTESPQ 544
               +   + Y+H +      HR+IK  N+ LDE  N ++ +FG+A   R  N +    +
Sbjct: 109 FFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 545 FYSTNP----------ASWSMGIDIFAYGIVLLEVLSGQTPINRPRKK-DEGSVWLSEK 592
              T P             +  +D+++ GIVL  +L+G+ P ++P     E S W  +K
Sbjct: 166 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 224

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 74/179 (41%), Gaps = 30/179 (16%)
Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLR 487
           +H N+V+  G    +G   +L  EY   G L D +   + M                  R
Sbjct: 62  NHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPE------------PDAQR 108
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA---RCVNDDTESPQ 544
               +   + Y+H +      HR+IK  N+ LDE  N ++ +FG+A   R  N +    +
Sbjct: 109 FFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 545 FYSTNP----------ASWSMGIDIFAYGIVLLEVLSGQTPINRPRKK-DEGSVWLSEK 592
              T P             +  +D+++ GIVL  +L+G+ P ++P     E S W  +K
Sbjct: 166 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 224

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 74/179 (41%), Gaps = 30/179 (16%)
Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLR 487
           +H N+V+  G    +G   +L  EY   G L D +   + M                  R
Sbjct: 63  NHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPE------------PDAQR 109
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA---RCVNDDTESPQ 544
               +   + Y+H +      HR+IK  N+ LDE  N ++ +FG+A   R  N +    +
Sbjct: 110 FFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 166
Query: 545 FYSTNPAS----------WSMGIDIFAYGIVLLEVLSGQTPINRPRKK-DEGSVWLSEK 592
              T P             +  +D+++ GIVL  +L+G+ P ++P     E S W  +K
Sbjct: 167 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 225

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 85/189 (44%), Gaps = 31/189 (16%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
           TE E +   E++++ +  +H  NIV LLG C   GP + ++ EY   G L ++L      
Sbjct: 68  TEREALMS-ELKVLSYLGNHM-NIVNLLGACTIGGP-TLVITEYCCYGDLLNFLR---RK 121
Query: 469 KNQFIAS---------CYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFL 519
           ++ FI S             L     L     VA  + ++    + + +HR++ +RNI L
Sbjct: 122 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILL 178
Query: 520 DEEFNARVGNFGMARCV-NDDTESPQFYSTNPASW-----------SMGIDIFAYGIVLL 567
                 ++ +FG+AR + ND     +  +  P  W           +   D+++YGI L 
Sbjct: 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 238
Query: 568 EVLS-GQTP 575
           E+ S G +P
Sbjct: 239 ELFSLGSSP 247

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 75/179 (41%), Gaps = 32/179 (17%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
            EH++  ++E+Q    +   HPNI+RL G    D    +L+ EYA  G++   L      
Sbjct: 54  VEHQLRREVEIQ----SHLRHPNILRLYG-YFHDATRVYLILEYAPLGTVYRELQKLSKF 108
Query: 469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVG 528
             Q  A+   ++T         ++A AL Y H   +   +HR+IK  N+ L      ++ 
Sbjct: 109 DEQRTAT---YIT---------ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIA 153
Query: 529 NFGMA----------RCVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
           NFG +           C   D   P+            +D+++ G++  E L G+ P  
Sbjct: 154 NFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMH--DEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 36/156 (23%), Positives = 65/156 (41%), Gaps = 27/156 (17%)
Query: 430 PNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRIC 489
           P + +  G+ L D    +++ EY   GS  D L  G              L  +Q   I 
Sbjct: 80  PYVTKYYGSYLKDT-KLWIIMEYLGGGSALDLLEPGP-------------LDETQIATIL 125
Query: 490 LDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN 549
            ++   L Y+H   +   +HR+IK+ N+ L E    ++ +FG+A  + D       +   
Sbjct: 126 REILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGT 182
Query: 550 P----------ASWSMGIDIFAYGIVLLEVLSGQTP 575
           P          +++    DI++ GI  +E+  G+ P
Sbjct: 183 PFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 218

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/201 (23%), Positives = 90/201 (44%), Gaps = 36/201 (17%)
Query: 392 GAVYHG--RLNGKNLAIKRTE-----HEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGP 444
           G+VY    +  G+ +AIK+        E+I   E+ ++Q      P++V+  G+   +  
Sbjct: 43  GSVYKAIHKETGQIVAIKQVPVESDLQEIIK--EISIMQQC--DSPHVVKYYGSYFKNT- 97
Query: 445 HSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMN 504
             ++V EY   GS+ D +     ++N+        LT  +   I       L+Y+H +  
Sbjct: 98  DLWIVMEYCGAGSVSDIIR----LRNKT-------LTEDEIATILQSTLKGLEYLHFMRK 146
Query: 505 PSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNP----------ASWS 554
              +HR+IK+ NI L+ E +A++ +FG+A  + D           P            ++
Sbjct: 147 ---IHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGYN 203
Query: 555 MGIDIFAYGIVLLEVLSGQTP 575
              DI++ GI  +E+  G+ P
Sbjct: 204 CVADIWSLGITAIEMAEGKPP 224

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 74/179 (41%), Gaps = 30/179 (16%)
Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLR 487
           +H N+V+  G    +G   +L  EY   G L D +   + M                  R
Sbjct: 62  NHENVVKFYGH-RREGNIQYLFLEYCSGGELFDRIEPDIGMPE------------PDAQR 108
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA---RCVNDDTESPQ 544
               +   + Y+H +      HR+IK  N+ LDE  N ++ +FG+A   R  N +    +
Sbjct: 109 FFHQLMAGVVYLHGI---GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNK 165
Query: 545 FYSTNP----------ASWSMGIDIFAYGIVLLEVLSGQTPINRPRKK-DEGSVWLSEK 592
              T P             +  +D+++ GIVL  +L+G+ P ++P     E S W  +K
Sbjct: 166 MCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK 224

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 78/169 (46%), Gaps = 35/169 (20%)
Query: 425 ATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQ 484
           A+  +P++ RLLG CLT      L+ +    G L D++          I S Y  L W  
Sbjct: 79  ASVDNPHVCRLLGICLTSTVQ--LITQLMPFGCLLDYVRE----HKDNIGSQY-LLNW-- 129
Query: 485 RLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQ 544
               C+ +A  + Y+    +   VHR++ +RN+ +    + ++ +FG+A+ +    E  +
Sbjct: 130 ----CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKE 180
Query: 545 FYSTN---PASWSMGI------------DIFAYGIVLLEVLS-GQTPIN 577
           +++     P  W M +            D+++YG+ + E+++ G  P +
Sbjct: 181 YHAEGGKVPIKW-MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 78/169 (46%), Gaps = 35/169 (20%)
Query: 425 ATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQ 484
           A+  +P++ RLLG CLT      L+ +    G L D++          I S Y  L W  
Sbjct: 75  ASVDNPHVCRLLGICLTSTVQ--LITQLMPFGCLLDYVRE----HKDNIGSQY-LLNW-- 125
Query: 485 RLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQ 544
               C+ +A  + Y+    +   VHR++ +RN+ +    + ++ +FG+A+ +    E  +
Sbjct: 126 ----CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKE 176
Query: 545 FYSTN---PASWSMGI------------DIFAYGIVLLEVLS-GQTPIN 577
           +++     P  W M +            D+++YG+ + E+++ G  P +
Sbjct: 177 YHAEGGKVPIKW-MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/205 (21%), Positives = 85/205 (41%), Gaps = 40/205 (19%)
Query: 392 GAVYHG--RLNGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLG----------TC 439
           G V+    R++GK   IKR ++    K E ++   A   H NIV   G          T 
Sbjct: 25  GQVFKAKHRIDGKTYVIKRVKYNN-EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETS 83
Query: 440 LTDGPHS-----FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAM 494
             +   S     F+  E+   G+L+ W+      K   + +          L +   +  
Sbjct: 84  SKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLA----------LELFEQITK 133
Query: 495 ALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYST------ 548
            + Y+H   +   ++R++K  NIFL +    ++G+FG+   + +D +  +   T      
Sbjct: 134 GVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMSP 190
Query: 549 ---NPASWSMGIDIFAYGIVLLEVL 570
              +   +   +D++A G++L E+L
Sbjct: 191 EQISSQDYGKEVDLYALGLILAELL 215

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 78/169 (46%), Gaps = 35/169 (20%)
Query: 425 ATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQ 484
           A+  +P++ RLLG CLT      L+ +    G L D++          I S Y  L W  
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQ--LITQLMPFGCLLDYVRE----HKDNIGSQY-LLNW-- 122
Query: 485 RLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQ 544
               C+ +A  + Y+    +   VHR++ +RN+ +    + ++ +FG+A+ +    E  +
Sbjct: 123 ----CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKE 173
Query: 545 FYSTN---PASWSMGI------------DIFAYGIVLLEVLS-GQTPIN 577
           +++     P  W M +            D+++YG+ + E+++ G  P +
Sbjct: 174 YHAEGGKVPIKW-MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/213 (22%), Positives = 90/213 (42%), Gaps = 37/213 (17%)
Query: 392 GAVYHGRLNGK-----NLAIKRTEHEVI----TKLEMQLVQHATHHHPNIVRLLGTCLTD 442
           G VY G          N+A+K  + +       K   + V      HP+IV+L+G  + +
Sbjct: 22  GEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIG--IIE 79
Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
              ++++ E    G L  +L      +N+        + +S  L+IC     A+ Y+  +
Sbjct: 80  EEPTWIIMELYPYGELGHYLE-----RNKNSLKVLTLVLYS--LQIC----KAMAYLESI 128
Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW--------- 553
              + VHR+I  RNI +      ++G+FG++R + D+       +  P  W         
Sbjct: 129 ---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFR 185
Query: 554 --SMGIDIFAYGIVLLEVLS-GQTPINRPRKKD 583
             +   D++ + + + E+LS G+ P      KD
Sbjct: 186 RFTTASDVWMFAVCMWEILSFGKQPFFWLENKD 218

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 78/169 (46%), Gaps = 35/169 (20%)
Query: 425 ATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQ 484
           A+  +P++ RLLG CLT      L+ +    G L D++          I S Y  L W  
Sbjct: 75  ASVDNPHVCRLLGICLTSTVQ--LITQLMPFGCLLDYVRE----HKDNIGSQY-LLNW-- 125
Query: 485 RLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQ 544
               C+ +A  + Y+    +   VHR++ +RN+ +    + ++ +FG+A+ +    E  +
Sbjct: 126 ----CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKE 176
Query: 545 FYSTN---PASWSMGI------------DIFAYGIVLLEVLS-GQTPIN 577
           +++     P  W M +            D+++YG+ + E+++ G  P +
Sbjct: 177 YHAEGGKVPIKW-MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 78/169 (46%), Gaps = 35/169 (20%)
Query: 425 ATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQ 484
           A+  +P++ RLLG CLT      L+ +    G L D++          I S Y  L W  
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQ--LITQLMPFGCLLDYVRE----HKDNIGSQY-LLNW-- 122
Query: 485 RLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQ 544
               C+ +A  + Y+    +   VHR++ +RN+ +    + ++ +FG+A+ +    E  +
Sbjct: 123 ----CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKE 173
Query: 545 FYSTN---PASWSMGI------------DIFAYGIVLLEVLS-GQTPIN 577
           +++     P  W M +            D+++YG+ + E+++ G  P +
Sbjct: 174 YHAEGGKVPIKW-MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 85/189 (44%), Gaps = 31/189 (16%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
           TE E +   E++++ +  +H  NIV LLG C   GP + ++ EY   G L ++L      
Sbjct: 84  TEREALMS-ELKVLSYLGNHM-NIVNLLGACTIGGP-TLVITEYCCYGDLLNFLR---RK 137
Query: 469 KNQFIAS---------CYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFL 519
           ++ FI S             L     L     VA  + ++    + + +HR++ +RNI L
Sbjct: 138 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILL 194
Query: 520 DEEFNARVGNFGMARCV-NDDTESPQFYSTNPASW-----------SMGIDIFAYGIVLL 567
                 ++ +FG+AR + ND     +  +  P  W           +   D+++YGI L 
Sbjct: 195 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 254
Query: 568 EVLS-GQTP 575
           E+ S G +P
Sbjct: 255 ELFSLGSSP 263

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 78/169 (46%), Gaps = 35/169 (20%)
Query: 425 ATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQ 484
           A+  +P++ RLLG CLT      L+ +    G L D++          I S Y  L W  
Sbjct: 75  ASVDNPHVCRLLGICLTSTVQ--LITQLMPFGCLLDYVRE----HKDNIGSQY-LLNW-- 125
Query: 485 RLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQ 544
               C+ +A  + Y+    +   VHR++ +RN+ +    + ++ +FG+A+ +    E  +
Sbjct: 126 ----CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKE 176
Query: 545 FYSTN---PASWSMGI------------DIFAYGIVLLEVLS-GQTPIN 577
           +++     P  W M +            D+++YG+ + E+++ G  P +
Sbjct: 177 YHAEGGKVPIKW-MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 224

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 37/156 (23%), Positives = 67/156 (42%), Gaps = 27/156 (17%)
Query: 430 PNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRIC 489
           P + +  G+ L D    +++ EY   GS  D L  G   + Q IA+            I 
Sbjct: 65  PYVTKYYGSYLKD-TKLWIIMEYLGGGSALDLLEPGPLDETQ-IAT------------IL 110
Query: 490 LDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN 549
            ++   L Y+H   +   +HR+IK+ N+ L E    ++ +FG+A  + D       +   
Sbjct: 111 REILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGT 167
Query: 550 P----------ASWSMGIDIFAYGIVLLEVLSGQTP 575
           P          +++    DI++ GI  +E+  G+ P
Sbjct: 168 PFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 48/213 (22%), Positives = 90/213 (42%), Gaps = 37/213 (17%)
Query: 392 GAVYHGRLNGK-----NLAIKRTEHEVI----TKLEMQLVQHATHHHPNIVRLLGTCLTD 442
           G VY G          N+A+K  + +       K   + V      HP+IV+L+G  + +
Sbjct: 26  GEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIG--IIE 83
Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
              ++++ E    G L  +L      +N+        + +S  L+IC     A+ Y+  +
Sbjct: 84  EEPTWIIMELYPYGELGHYLE-----RNKNSLKVLTLVLYS--LQIC----KAMAYLESI 132
Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW--------- 553
              + VHR+I  RNI +      ++G+FG++R + D+       +  P  W         
Sbjct: 133 ---NCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFR 189
Query: 554 --SMGIDIFAYGIVLLEVLS-GQTPINRPRKKD 583
             +   D++ + + + E+LS G+ P      KD
Sbjct: 190 RFTTASDVWMFAVCMWEILSFGKQPFFWLENKD 222

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 78/169 (46%), Gaps = 35/169 (20%)
Query: 425 ATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQ 484
           A+  +P++ RLLG CLT      L+ +    G L D++          I S Y  L W  
Sbjct: 74  ASVDNPHVCRLLGICLTSTVQ--LITQLMPFGCLLDYVRE----HKDNIGSQY-LLNW-- 124
Query: 485 RLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQ 544
               C+ +A  + Y+    +   VHR++ +RN+ +    + ++ +FG+A+ +    E  +
Sbjct: 125 ----CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKE 175
Query: 545 FYSTN---PASWSMGI------------DIFAYGIVLLEVLS-GQTPIN 577
           +++     P  W M +            D+++YG+ + E+++ G  P +
Sbjct: 176 YHAEGGKVPIKW-MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 75/179 (41%), Gaps = 32/179 (17%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
            EH++  ++E+Q    +   HPNI+RL G    D    +L+ EYA  G++   L      
Sbjct: 54  VEHQLRREVEIQ----SHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKF 108
Query: 469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVG 528
             Q  A+   ++T         ++A AL Y H   +   +HR+IK  N+ L      ++ 
Sbjct: 109 DEQRTAT---YIT---------ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIA 153
Query: 529 NFGM----------ARCVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
           +FG           A C   D   P+            +D+++ G++  E L G+ P  
Sbjct: 154 DFGWSVHAPSSRRAALCGTLDYLPPEMIEGRMH--DEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 43/179 (24%), Positives = 74/179 (41%), Gaps = 32/179 (17%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
            EH++  ++E+Q    +   HPNI+RL G    D    +L+ EYA  G +   L      
Sbjct: 56  VEHQLRREVEIQ----SHLRHPNILRLYGY-FHDATRVYLILEYAPRGEVYKELQKLSKF 110
Query: 469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVG 528
             Q  A+   ++T         ++A AL Y H   +   +HR+IK  N+ L      ++ 
Sbjct: 111 DEQRTAT---YIT---------ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIA 155
Query: 529 NFGMA----------RCVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
           +FG +           C   D   P+            +D+++ G++  E L G+ P  
Sbjct: 156 DFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMH--DEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 78/169 (46%), Gaps = 35/169 (20%)
Query: 425 ATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQ 484
           A+  +P++ RLLG CLT      L+ +    G L D++          I S Y  L W  
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQ--LITQLMPFGCLLDYVRE----HKDNIGSQY-LLNW-- 122
Query: 485 RLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQ 544
               C+ +A  + Y+    +   VHR++ +RN+ +    + ++ +FG+A+ +    E  +
Sbjct: 123 ----CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKE 173
Query: 545 FYSTN---PASWSMGI------------DIFAYGIVLLEVLS-GQTPIN 577
           +++     P  W M +            D+++YG+ + E+++ G  P +
Sbjct: 174 YHAEGGKVPIKW-MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 78/169 (46%), Gaps = 35/169 (20%)
Query: 425 ATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQ 484
           A+  +P++ RLLG CLT      L+ +    G L D++          I S Y  L W  
Sbjct: 97  ASVDNPHVCRLLGICLTSTVQ--LITQLMPFGCLLDYVRE----HKDNIGSQY-LLNW-- 147
Query: 485 RLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQ 544
               C+ +A  + Y+    +   VHR++ +RN+ +    + ++ +FG+A+ +    E  +
Sbjct: 148 ----CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKE 198
Query: 545 FYSTN---PASWSMGI------------DIFAYGIVLLEVLS-GQTPIN 577
           +++     P  W M +            D+++YG+ + E+++ G  P +
Sbjct: 199 YHAEGGKVPIKW-MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 246

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 78/169 (46%), Gaps = 35/169 (20%)
Query: 425 ATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQ 484
           A+  +P++ RLLG CLT      L+ +    G L D++          I S Y  L W  
Sbjct: 79  ASVDNPHVCRLLGICLTSTVQ--LITQLMPFGCLLDYVRE----HKDNIGSQY-LLNW-- 129
Query: 485 RLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQ 544
               C+ +A  + Y+    +   VHR++ +RN+ +    + ++ +FG+A+ +    E  +
Sbjct: 130 ----CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKE 180
Query: 545 FYSTN---PASWSMGI------------DIFAYGIVLLEVLS-GQTPIN 577
           +++     P  W M +            D+++YG+ + E+++ G  P +
Sbjct: 181 YHAEGGKVPIKW-MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 78/169 (46%), Gaps = 35/169 (20%)
Query: 425 ATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQ 484
           A+  +P++ RLLG CLT      L+ +    G L D++          I S Y  L W  
Sbjct: 66  ASVDNPHVCRLLGICLTSTVQ--LITQLMPFGCLLDYVRE----HKDNIGSQY-LLNW-- 116
Query: 485 RLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQ 544
               C+ +A  + Y+    +   VHR++ +RN+ +    + ++ +FG+A+ +    E  +
Sbjct: 117 ----CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKE 167
Query: 545 FYSTN---PASWSMGI------------DIFAYGIVLLEVLS-GQTPIN 577
           +++     P  W M +            D+++YG+ + E+++ G  P +
Sbjct: 168 YHAEGGKVPIKW-MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 215

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 78/169 (46%), Gaps = 35/169 (20%)
Query: 425 ATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQ 484
           A+  +P++ RLLG CLT      L+ +    G L D++          I S Y  L W  
Sbjct: 78  ASVDNPHVCRLLGICLTSTVQ--LITQLMPFGCLLDYVRE----HKDNIGSQY-LLNW-- 128
Query: 485 RLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQ 544
               C+ +A  + Y+    +   VHR++ +RN+ +    + ++ +FG+A+ +    E  +
Sbjct: 129 ----CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKE 179
Query: 545 FYSTN---PASWSMGI------------DIFAYGIVLLEVLS-GQTPIN 577
           +++     P  W M +            D+++YG+ + E+++ G  P +
Sbjct: 180 YHAEGGKVPIKW-MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 227

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 85/189 (44%), Gaps = 31/189 (16%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
           TE E +   E++++ +  +H  NIV LLG C   GP + ++ EY   G L ++L      
Sbjct: 91  TEREALMS-ELKVLSYLGNHM-NIVNLLGACTIGGP-TLVITEYCCYGDLLNFLR---RK 144
Query: 469 KNQFIAS---------CYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFL 519
           ++ FI S             L     L     VA  + ++    + + +HR++ +RNI L
Sbjct: 145 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILL 201
Query: 520 DEEFNARVGNFGMARCV-NDDTESPQFYSTNPASW-----------SMGIDIFAYGIVLL 567
                 ++ +FG+AR + ND     +  +  P  W           +   D+++YGI L 
Sbjct: 202 THGRITKICDFGLARHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 261
Query: 568 EVLS-GQTP 575
           E+ S G +P
Sbjct: 262 ELFSLGSSP 270

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 85/189 (44%), Gaps = 31/189 (16%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
           TE E +   E++++ +  +H  NIV LLG C   GP + ++ EY   G L ++L      
Sbjct: 91  TEREALMS-ELKVLSYLGNHM-NIVNLLGACTIGGP-TLVITEYCCYGDLLNFLR---RK 144
Query: 469 KNQFIAS---------CYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFL 519
           ++ FI S             L     L     VA  + ++    + + +HR++ +RNI L
Sbjct: 145 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILL 201
Query: 520 DEEFNARVGNFGMARCV-NDDTESPQFYSTNPASW-----------SMGIDIFAYGIVLL 567
                 ++ +FG+AR + ND     +  +  P  W           +   D+++YGI L 
Sbjct: 202 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 261
Query: 568 EVLS-GQTP 575
           E+ S G +P
Sbjct: 262 ELFSLGSSP 270

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 78/169 (46%), Gaps = 35/169 (20%)
Query: 425 ATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQ 484
           A+  +P++ RLLG CLT      L+ +    G L D++          I S Y  L W  
Sbjct: 69  ASVDNPHVCRLLGICLTSTVQ--LITQLMPFGCLLDYVRE----HKDNIGSQY-LLNW-- 119
Query: 485 RLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQ 544
               C+ +A  + Y+    +   VHR++ +RN+ +    + ++ +FG+A+ +    E  +
Sbjct: 120 ----CVQIAEGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKE 170
Query: 545 FYSTN---PASWSMGI------------DIFAYGIVLLEVLS-GQTPIN 577
           +++     P  W M +            D+++YG+ + E+++ G  P +
Sbjct: 171 YHAEGGKVPIKW-MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 218

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 37/156 (23%), Positives = 67/156 (42%), Gaps = 27/156 (17%)
Query: 430 PNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRIC 489
           P + +  G+ L D    +++ EY   GS  D L  G   + Q IA+            I 
Sbjct: 65  PYVTKYYGSYLKD-TKLWIIMEYLGGGSALDLLEPGPLDETQ-IAT------------IL 110
Query: 490 LDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN 549
            ++   L Y+H   +   +HR+IK+ N+ L E    ++ +FG+A  + D       +   
Sbjct: 111 REILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGT 167
Query: 550 P----------ASWSMGIDIFAYGIVLLEVLSGQTP 575
           P          +++    DI++ GI  +E+  G+ P
Sbjct: 168 PFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 203

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 49/189 (25%), Positives = 85/189 (44%), Gaps = 31/189 (16%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
           TE E +   E++++ +  +H  NIV LLG C   GP + ++ EY   G L ++L      
Sbjct: 86  TEREALMS-ELKVLSYLGNHM-NIVNLLGACTIGGP-TLVITEYCCYGDLLNFLR---RK 139
Query: 469 KNQFIAS---------CYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFL 519
           ++ FI S             L     L     VA  + ++    + + +HR++ +RNI L
Sbjct: 140 RDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILL 196
Query: 520 DEEFNARVGNFGMARCV-NDDTESPQFYSTNPASW-----------SMGIDIFAYGIVLL 567
                 ++ +FG+AR + ND     +  +  P  W           +   D+++YGI L 
Sbjct: 197 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLW 256
Query: 568 EVLS-GQTP 575
           E+ S G +P
Sbjct: 257 ELFSLGSSP 265

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 24/98 (24%), Positives = 51/98 (52%), Gaps = 17/98 (17%)
Query: 491 DVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR------------CVND 538
           ++A+ L ++    +   ++R++K  N+ LD E + ++ +FGM +            C   
Sbjct: 450 EIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTP 506
Query: 539 DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPI 576
           D  +P+  +  P  +   +D +A+G++L E+L+GQ P 
Sbjct: 507 DYIAPEIIAYQP--YGKSVDWWAFGVLLYEMLAGQAPF 542

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 77/169 (45%), Gaps = 35/169 (20%)
Query: 425 ATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQ 484
           A+  +P++ RLLG CLT      L+ +    G L D++          I S Y  L W  
Sbjct: 74  ASVDNPHVCRLLGICLTSTVQ--LIMQLMPFGCLLDYVRE----HKDNIGSQY-LLNW-- 124
Query: 485 RLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQ 544
               C+ +A  + Y+    +   VHR++ +RN+ +    + ++ +FG A+ +    E  +
Sbjct: 125 ----CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLG--AEEKE 175
Query: 545 FYSTN---PASWSMGI------------DIFAYGIVLLEVLS-GQTPIN 577
           +++     P  W M +            D+++YG+ + E+++ G  P +
Sbjct: 176 YHAEGGKVPIKW-MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 77/169 (45%), Gaps = 35/169 (20%)
Query: 425 ATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQ 484
           A+  +P++ RLLG CLT      L+ +    G L D++          I S Y  L W  
Sbjct: 74  ASVDNPHVCRLLGICLTSTVQ--LIMQLMPFGCLLDYVRE----HKDNIGSQY-LLNW-- 124
Query: 485 RLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQ 544
               C+ +A  + Y+    +   VHR++ +RN+ +    + ++ +FG A+ +    E  +
Sbjct: 125 ----CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLG--AEEKE 175
Query: 545 FYSTN---PASWSMGI------------DIFAYGIVLLEVLS-GQTPIN 577
           +++     P  W M +            D+++YG+ + E+++ G  P +
Sbjct: 176 YHAEGGKVPIKW-MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 75/179 (41%), Gaps = 32/179 (17%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
            EH++  ++E+Q    +   HPNI+RL G    D    +L+ EYA  G++   L      
Sbjct: 51  VEHQLRREVEIQ----SHLRHPNILRLYG-YFHDATRVYLILEYAPLGTVYRELQKLSKF 105
Query: 469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVG 528
             Q  A+   ++T         ++A AL Y H   +   +HR+IK  N+ L      ++ 
Sbjct: 106 DEQRTAT---YIT---------ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIA 150
Query: 529 NFGM----------ARCVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
           +FG           A C   D   P+            +D+++ G++  E L G+ P  
Sbjct: 151 DFGWSVHAPSSRRAALCGTLDYLPPEMIEGRMH--DEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 36/156 (23%), Positives = 65/156 (41%), Gaps = 27/156 (17%)
Query: 430 PNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRIC 489
           P + +  G+ L D    +++ EY   GS  D L  G              L  +Q   I 
Sbjct: 85  PYVTKYYGSYLKD-TKLWIIMEYLGGGSALDLLEPGP-------------LDETQIATIL 130
Query: 490 LDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN 549
            ++   L Y+H   +   +HR+IK+ N+ L E    ++ +FG+A  + D       +   
Sbjct: 131 REILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGT 187
Query: 550 P----------ASWSMGIDIFAYGIVLLEVLSGQTP 575
           P          +++    DI++ GI  +E+  G+ P
Sbjct: 188 PFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPP 223

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 46.6 bits (109), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 77/169 (45%), Gaps = 35/169 (20%)
Query: 425 ATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQ 484
           A+  +P++ RLLG CLT      L+ +    G L D++          I S Y  L W  
Sbjct: 76  ASVDNPHVCRLLGICLTSTVQ--LIMQLMPFGCLLDYVRE----HKDNIGSQY-LLNW-- 126
Query: 485 RLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQ 544
               C+ +A  + Y+    +   VHR++ +RN+ +    + ++ +FG A+ +    E  +
Sbjct: 127 ----CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLG--AEEKE 177
Query: 545 FYSTN---PASWSMGI------------DIFAYGIVLLEVLS-GQTPIN 577
           +++     P  W M +            D+++YG+ + E+++ G  P +
Sbjct: 178 YHAEGGKVPIKW-MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 225

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 44/179 (24%), Positives = 75/179 (41%), Gaps = 32/179 (17%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
            EH++  ++E+Q    +   HPNI+RL G    D    +L+ EYA  G++   L      
Sbjct: 51  VEHQLRREVEIQ----SHLRHPNILRLYG-YFHDSTRVYLILEYAPLGTVYRELQKLSKF 105
Query: 469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVG 528
             Q  A+   ++T         ++A AL Y H   +   +HR+IK  N+ L      ++ 
Sbjct: 106 DEQRTAT---YIT---------ELANALSYCH---SKKVIHRDIKPENLLLGSAGELKIA 150
Query: 529 NFGM----------ARCVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
           +FG           A C   D   P+            +D+++ G++  E L G+ P  
Sbjct: 151 DFGWSVHAPSSRRAALCGTLDYLPPEMIEGRMH--DEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 105/234 (44%), Gaps = 57/234 (24%)
Query: 380 ATEKFNSSNRI----EGAVYHGR--LNGKNLAIKR----TEHEVITKL---EMQLVQHAT 426
           + E F    +I     G VY  R  L G+ +A+K+    TE E +      E+ L++   
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL- 62
Query: 427 HHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG----GLAMKNQFIASCYCFLTW 482
            +HPNIV+LL    T+    +LVFE+  +  LKD++      G+ +    +   Y F   
Sbjct: 63  -NHPNIVKLLDVIHTEN-KLYLVFEFL-SMDLKDFMDASALTGIPLP---LIKSYLF--- 113
Query: 483 SQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR-------- 534
            Q L+      +A  + H V+     HR++K +N+ ++ E   ++ +FG+AR        
Sbjct: 114 -QLLQ-----GLAFCHSHRVL-----HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 162
Query: 535 ----CVNDDTESPQ------FYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR 578
                V     +P+      +YST    WS+G  IFA  +    +  G + I++
Sbjct: 163 YXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGC-IFAEMVTRRALFPGDSEIDQ 215

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 105/234 (44%), Gaps = 57/234 (24%)
Query: 380 ATEKFNSSNRI----EGAVYHGR--LNGKNLAIKR----TEHEVITKL---EMQLVQHAT 426
           + E F    +I     G VY  R  L G+ +A+K+    TE E +      E+ L++   
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL- 61
Query: 427 HHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG----GLAMKNQFIASCYCFLTW 482
            +HPNIV+LL    T+    +LVFE+  +  LKD++      G+ +    +   Y F   
Sbjct: 62  -NHPNIVKLLDVIHTEN-KLYLVFEFL-SMDLKDFMDASALTGIPLP---LIKSYLF--- 112
Query: 483 SQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR-------- 534
            Q L+      +A  + H V+     HR++K +N+ ++ E   ++ +FG+AR        
Sbjct: 113 -QLLQ-----GLAFCHSHRVL-----HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 161
Query: 535 ----CVNDDTESPQ------FYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR 578
                V     +P+      +YST    WS+G  IFA  +    +  G + I++
Sbjct: 162 YXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGC-IFAEMVTRRALFPGDSEIDQ 214

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/178 (24%), Positives = 75/178 (42%), Gaps = 32/178 (17%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
            EH++  ++E+Q    +   HPNI+RL G    D    +L+ EYA  G++   L      
Sbjct: 77  VEHQLRREVEIQ----SHLRHPNILRLYG-YFHDATRVYLILEYAPLGTVYRELQKLSKF 131
Query: 469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVG 528
             Q  A+   ++T         ++A AL Y H   +   +HR+IK  N+ L      ++ 
Sbjct: 132 DEQRTAT---YIT---------ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIA 176
Query: 529 NFGMA----------RCVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPI 576
           +FG +           C   D   P+            +D+++ G++  E L G+ P 
Sbjct: 177 DFGWSVHAPSSRRTTLCGTLDYLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPF 232

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 43/178 (24%), Positives = 75/178 (42%), Gaps = 32/178 (17%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
            EH++  ++E+Q    +   HPNI+RL G    D    +L+ EYA  G++   L      
Sbjct: 77  VEHQLRREVEIQ----SHLRHPNILRLYG-YFHDATRVYLILEYAPLGTVYRELQKLSKF 131
Query: 469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVG 528
             Q  A+   ++T         ++A AL Y H   +   +HR+IK  N+ L      ++ 
Sbjct: 132 DEQRTAT---YIT---------ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIA 176
Query: 529 NFGMA----------RCVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPI 576
           +FG +           C   D   P+            +D+++ G++  E L G+ P 
Sbjct: 177 DFGWSVHAPSSRRDDLCGTLDYLPPEMIEGR--MHDEKVDLWSLGVLCYEFLVGKPPF 232

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 24/98 (24%), Positives = 51/98 (52%), Gaps = 17/98 (17%)
Query: 491 DVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR------------CVND 538
           ++A+ L ++    +   ++R++K  N+ LD E + ++ +FGM +            C   
Sbjct: 129 EIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTP 185
Query: 539 DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPI 576
           D  +P+  +  P  +   +D +A+G++L E+L+GQ P 
Sbjct: 186 DYIAPEIIAYQP--YGKSVDWWAFGVLLYEMLAGQAPF 221

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 46.2 bits (108), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 39/159 (24%), Positives = 67/159 (42%), Gaps = 24/159 (15%)
Query: 428 HHPNIVRLLGT--CLTDGPHSF-LVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQ 484
            HPNIVR   +      G     LV E   +G+LK +L      K + + S      W  
Sbjct: 83  QHPNIVRFYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRS------W-- 134
Query: 485 RLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFL-DEEFNARVGNFGMARCVNDD---- 539
               C  +   LQ++H    P  +HR++K  NIF+     + ++G+ G+A          
Sbjct: 135 ----CRQILKGLQFLH-TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA 189
Query: 540 -TESPQFYSTN--PASWSMGIDIFAYGIVLLEVLSGQTP 575
              +P+F +       +   +D++A+G   LE  + + P
Sbjct: 190 VIGTPEFXAPEXYEEKYDESVDVYAFGXCXLEXATSEYP 228

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 46.2 bits (108), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 103/234 (44%), Gaps = 57/234 (24%)
Query: 380 ATEKFNSSNRI----EGAVYHGR--LNGKNLAIKR----TEHEVITKL---EMQLVQHAT 426
           + E F    +I     G VY  R  L G+ +A+K+    TE E +      E+ L++   
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL- 59
Query: 427 HHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG----GLAMKNQFIASCYCFLTW 482
            +HPNIV+LL    T+    +LVFE+     LKD++      G+ +    +   Y F   
Sbjct: 60  -NHPNIVKLLDVIHTEN-KLYLVFEFLHQ-DLKDFMDASALTGIPLP---LIKSYLF--- 110
Query: 483 SQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR-------- 534
            Q L+      +A  + H V+     HR++K  N+ ++ E   ++ +FG+AR        
Sbjct: 111 -QLLQ-----GLAFCHSHRVL-----HRDLKPENLLINTEGAIKLADFGLARAFGVPVRT 159
Query: 535 ----CVNDDTESPQ------FYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR 578
                V     +P+      +YST    WS+G  IFA  +    +  G + I++
Sbjct: 160 YXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGC-IFAEMVTRRALFPGDSEIDQ 212

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 55/233 (23%), Positives = 96/233 (41%), Gaps = 40/233 (17%)
Query: 382 EKFNSSNRIEGAVY------HGRLNGKNLAIKR----TEHEVITKLEMQLVQHATH-HHP 430
           EK+    +I    Y        R  G+ +AIK+     +  VI K+ ++ ++      HP
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHP 62
Query: 431 NIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICL 490
           N+V LL           LVFEY  +  L +       +    + S    +TW        
Sbjct: 63  NLVNLL-EVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKS----ITWQ------- 110
Query: 491 DVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN------DDTESPQ 544
                LQ ++     + +HR++K  NI + +    ++ +FG AR +       DD  + +
Sbjct: 111 ----TLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVATR 166
Query: 545 FYST-----NPASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDEGSVWLSEK 592
           +Y +         +   +D++A G V  E+LSG  P+  P K D   ++L  K
Sbjct: 167 WYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG-VPL-WPGKSDVDQLYLIRK 217

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 45.8 bits (107), Expect = 6e-05,   Method: Compositional matrix adjust.
 Identities = 45/178 (25%), Positives = 72/178 (40%), Gaps = 32/178 (17%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
            EH++  ++E+Q    A  HHPNI+RL      D    +L+ EYA  G L   L      
Sbjct: 66  VEHQLRREIEIQ----AHLHHPNILRLYNY-FYDRRRIYLILEYAPRGELYKELQKSCTF 120
Query: 469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVG 528
             Q  A+            I  ++A AL Y H       +HR+IK  N+ L  +   ++ 
Sbjct: 121 DEQRTAT------------IMEELADALMYCH---GKKVIHRDIKPENLLLGLKGELKIA 165
Query: 529 NFGMA----------RCVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPI 576
           +FG +           C   D   P+         +  +D++  G++  E+L G  P 
Sbjct: 166 DFGWSVHAPSLRRKTMCGTLDYLPPEMIEGR--MHNEKVDLWCIGVLCYELLVGNPPF 221

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/178 (24%), Positives = 75/178 (42%), Gaps = 32/178 (17%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
            EH++  ++E+Q    +   HPNI+RL G    D    +L+ EYA  G++   L      
Sbjct: 68  VEHQLRREVEIQ----SHLRHPNILRLYG-YFHDATRVYLILEYAPLGTVYRELQKLSKF 122
Query: 469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVG 528
             Q  A+   ++T         ++A AL Y H   +   +HR+IK  N+ L      ++ 
Sbjct: 123 DEQRTAT---YIT---------ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIA 167
Query: 529 NFGMA----------RCVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPI 576
           +FG +           C   D   P+            +D+++ G++  E L G+ P 
Sbjct: 168 DFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMH--DEKVDLWSLGVLCYEFLVGKPPF 223

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 80/197 (40%), Gaps = 39/197 (19%)
Query: 402 KNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW 461
           + + ++   +E++T L+ +L      +HPNIV    T + D    ++V  +   GS KD 
Sbjct: 42  RRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN-ELWVVTSFMAYGSAKDL 100
Query: 462 LHGGLAMKNQFIASCYCFLTWSQRLRICL---DVAMALQYMHHVMNPSYVHRNIKSRNIF 518
           +             C  F+     L I      V  AL Y+HH+    YVHR++K+ +I 
Sbjct: 101 I-------------CTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHIL 144
Query: 519 LDEE----FNARVGNFGM------ARCVNDDTE---------SPQFYSTNPASWSMGIDI 559
           +  +     +    N  M       R V+D  +         SP+    N   +    DI
Sbjct: 145 ISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDI 204
Query: 560 FAYGIVLLEVLSGQTPI 576
           ++ GI   E+ +G  P 
Sbjct: 205 YSVGITACELANGHVPF 221

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/179 (24%), Positives = 75/179 (41%), Gaps = 32/179 (17%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
            EH++  ++E+Q    +   HPNI+RL G    D    +L+ EYA  G++   L      
Sbjct: 52  VEHQLRREVEIQ----SHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKF 106
Query: 469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVG 528
             Q  A+   ++T         ++A AL Y H   +   +HR+IK  N+ L      ++ 
Sbjct: 107 DEQRTAT---YIT---------ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIA 151
Query: 529 NFGMA----------RCVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
           +FG +           C   D   P+            +D+++ G++  E L G+ P  
Sbjct: 152 DFGWSVHAPSSRRDTLCGTLDYLPPEMIEGRMH--DEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/179 (24%), Positives = 75/179 (41%), Gaps = 32/179 (17%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
            EH++  ++E+Q    +   HPNI+RL G    D    +L+ EYA  G++   L      
Sbjct: 52  VEHQLRREVEIQ----SHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKF 106
Query: 469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVG 528
             Q  A+   ++T         ++A AL Y H   +   +HR+IK  N+ L      ++ 
Sbjct: 107 DEQRTAT---YIT---------ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIA 151
Query: 529 NFGMA----------RCVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
           +FG +           C   D   P+            +D+++ G++  E L G+ P  
Sbjct: 152 DFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMH--DEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/179 (24%), Positives = 75/179 (41%), Gaps = 32/179 (17%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
            EH++  ++E+Q    +   HPNI+RL G    D    +L+ EYA  G++   L      
Sbjct: 51  VEHQLRREVEIQ----SHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKF 105
Query: 469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVG 528
             Q  A+   ++T         ++A AL Y H   +   +HR+IK  N+ L      ++ 
Sbjct: 106 DEQRTAT---YIT---------ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIA 150
Query: 529 NFGMA----------RCVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
           +FG +           C   D   P+            +D+++ G++  E L G+ P  
Sbjct: 151 DFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMH--DEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/179 (24%), Positives = 75/179 (41%), Gaps = 32/179 (17%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
            EH++  ++E+Q    +   HPNI+RL G    D    +L+ EYA  G++   L      
Sbjct: 53  VEHQLRREVEIQ----SHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKF 107
Query: 469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVG 528
             Q  A+   ++T         ++A AL Y H   +   +HR+IK  N+ L      ++ 
Sbjct: 108 DEQRTAT---YIT---------ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIA 152
Query: 529 NFGMA----------RCVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
           +FG +           C   D   P+            +D+++ G++  E L G+ P  
Sbjct: 153 DFGWSVHAPSSRRXXLCGTLDYLPPEMIEGRMH--DEKVDLWSLGVLCYEFLVGKPPFE 209

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/179 (24%), Positives = 75/179 (41%), Gaps = 32/179 (17%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
            EH++  ++E+Q    +   HPNI+RL G    D    +L+ EYA  G++   L      
Sbjct: 54  VEHQLRREVEIQ----SHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKF 108
Query: 469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVG 528
             Q  A+   ++T         ++A AL Y H   +   +HR+IK  N+ L      ++ 
Sbjct: 109 DEQRTAT---YIT---------ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIA 153
Query: 529 NFGMA----------RCVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
           +FG +           C   D   P+            +D+++ G++  E L G+ P  
Sbjct: 154 DFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMH--DEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/179 (24%), Positives = 75/179 (41%), Gaps = 32/179 (17%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
            EH++  ++E+Q    +   HPNI+RL G    D    +L+ EYA  G++   L      
Sbjct: 51  VEHQLRREVEIQ----SHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKF 105
Query: 469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVG 528
             Q  A+   ++T         ++A AL Y H   +   +HR+IK  N+ L      ++ 
Sbjct: 106 DEQRTAT---YIT---------ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIA 150
Query: 529 NFGMA----------RCVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
           +FG +           C   D   P+            +D+++ G++  E L G+ P  
Sbjct: 151 DFGWSVHAPSSRRTELCGTLDYLPPEMIEGRMH--DEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/179 (24%), Positives = 75/179 (41%), Gaps = 32/179 (17%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
            EH++  ++E+Q    +   HPNI+RL G    D    +L+ EYA  G++   L      
Sbjct: 51  VEHQLRREVEIQ----SHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKF 105
Query: 469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVG 528
             Q  A+   ++T         ++A AL Y H   +   +HR+IK  N+ L      ++ 
Sbjct: 106 DEQRTAT---YIT---------ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIA 150
Query: 529 NFGMA----------RCVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
           +FG +           C   D   P+            +D+++ G++  E L G+ P  
Sbjct: 151 DFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMH--DEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 39/164 (23%), Positives = 71/164 (43%), Gaps = 34/164 (20%)
Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLR 487
            HPNI+ L      DG + ++V E  K G L D +     ++ +F +         +   
Sbjct: 74  QHPNIITL-KDVYDDGKYVYVVTELMKGGELLDKI-----LRQKFFSE-------REASA 120
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNI-FLDEEFN---ARVGNFGMAR--------- 534
           +   +   ++Y+H       VHR++K  NI ++DE  N    R+ +FG A+         
Sbjct: 121 VLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL 177
Query: 535 ---CVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTP 575
              C   +  +P+        +    DI++ G++L  +L+G TP
Sbjct: 178 MTPCYTANFVAPEVLERQ--GYDAACDIWSLGVLLYTMLTGYTP 219

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/179 (24%), Positives = 75/179 (41%), Gaps = 32/179 (17%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
            EH++  ++E+Q    +   HPNI+RL G    D    +L+ EYA  G++   L      
Sbjct: 56  VEHQLRREVEIQ----SHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKF 110
Query: 469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVG 528
             Q  A+   ++T         ++A AL Y H   +   +HR+IK  N+ L      ++ 
Sbjct: 111 DEQRTAT---YIT---------ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIA 155
Query: 529 NFGMA----------RCVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
           +FG +           C   D   P+            +D+++ G++  E L G+ P  
Sbjct: 156 DFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMH--DEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 45.8 bits (107), Expect = 7e-05,   Method: Compositional matrix adjust.
 Identities = 43/179 (24%), Positives = 75/179 (41%), Gaps = 32/179 (17%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
            EH++  ++E+Q    +   HPNI+RL G    D    +L+ EYA  G++   L      
Sbjct: 51  VEHQLRREVEIQ----SHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKF 105
Query: 469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVG 528
             Q  A+   ++T         ++A AL Y H   +   +HR+IK  N+ L      ++ 
Sbjct: 106 DEQRTAT---YIT---------ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIA 150
Query: 529 NFGMA----------RCVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
           +FG +           C   D   P+            +D+++ G++  E L G+ P  
Sbjct: 151 DFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMH--DEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 77/169 (45%), Gaps = 35/169 (20%)
Query: 425 ATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQ 484
           A+  +P++ RLLG CLT      L+ +    G L D++          I S Y  L W  
Sbjct: 74  ASVDNPHVCRLLGICLTSTVQ--LITQLMPFGCLLDYVRE----HKDNIGSQY-LLNW-- 124
Query: 485 RLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQ 544
               C+ +A  + Y+    +   VHR++ +RN+ +    + ++ +FG A+ +    E  +
Sbjct: 125 ----CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLG--AEEKE 175
Query: 545 FYSTN---PASWSMGI------------DIFAYGIVLLEVLS-GQTPIN 577
           +++     P  W M +            D+++YG+ + E+++ G  P +
Sbjct: 176 YHAEGGKVPIKW-MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 223

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/179 (24%), Positives = 75/179 (41%), Gaps = 32/179 (17%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
            EH++  ++E+Q    +   HPNI+RL G    D    +L+ EYA  G++   L      
Sbjct: 56  VEHQLRREVEIQ----SHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKF 110
Query: 469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVG 528
             Q  A+   ++T         ++A AL Y H   +   +HR+IK  N+ L      ++ 
Sbjct: 111 DEQRTAT---YIT---------ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIA 155
Query: 529 NFGMA----------RCVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
           +FG +           C   D   P+            +D+++ G++  E L G+ P  
Sbjct: 156 DFGWSVHAPSSRRTDLCGTLDYLPPEMIEGRMH--DEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 47/197 (23%), Positives = 80/197 (40%), Gaps = 39/197 (19%)
Query: 402 KNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW 461
           + + ++   +E++T L+ +L      +HPNIV    T + D    ++V  +   GS KD 
Sbjct: 58  RRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADN-ELWVVTSFMAYGSAKDL 116
Query: 462 LHGGLAMKNQFIASCYCFLTWSQRLRICL---DVAMALQYMHHVMNPSYVHRNIKSRNIF 518
           +             C  F+     L I      V  AL Y+HH+    YVHR++K+ +I 
Sbjct: 117 I-------------CTHFMDGMNELAIAYILQGVLKALDYIHHM---GYVHRSVKASHIL 160
Query: 519 LDEE----FNARVGNFGM------ARCVNDDTE---------SPQFYSTNPASWSMGIDI 559
           +  +     +    N  M       R V+D  +         SP+    N   +    DI
Sbjct: 161 ISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDI 220
Query: 560 FAYGIVLLEVLSGQTPI 576
           ++ GI   E+ +G  P 
Sbjct: 221 YSVGITACELANGHVPF 237

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 45.8 bits (107), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 77/169 (45%), Gaps = 35/169 (20%)
Query: 425 ATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQ 484
           A+  +P++ RLLG CLT      L+ +    G L D++          I S Y  L W  
Sbjct: 72  ASVDNPHVCRLLGICLTSTVQ--LITQLMPFGCLLDYVRE----HKDNIGSQY-LLNW-- 122
Query: 485 RLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQ 544
               C+ +A  + Y+    +   VHR++ +RN+ +    + ++ +FG A+ +    E  +
Sbjct: 123 ----CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLG--AEEKE 173
Query: 545 FYSTN---PASWSMGI------------DIFAYGIVLLEVLS-GQTPIN 577
           +++     P  W M +            D+++YG+ + E+++ G  P +
Sbjct: 174 YHAEGGKVPIKW-MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 221

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 71/162 (43%), Gaps = 30/162 (18%)
Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLR 487
            HPNI+  L     DG + ++V E  K G L D +     ++ +F +         +   
Sbjct: 74  QHPNII-TLKDVYDDGKYVYVVTELXKGGELLDKI-----LRQKFFSE-------REASA 120
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNI-FLDEEFN---ARVGNFGMA---RCVNDDT 540
           +   +   ++Y+H       VHR++K  NI ++DE  N    R+ +FG A   R  N   
Sbjct: 121 VLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL 177
Query: 541 ESPQFYSTNPA-------SWSMGIDIFAYGIVLLEVLSGQTP 575
            +P + +   A        +    DI++ G++L   L+G TP
Sbjct: 178 XTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTP 219

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 39/169 (23%), Positives = 77/169 (45%), Gaps = 35/169 (20%)
Query: 425 ATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQ 484
           A+  +P++ RLLG CLT      L+ +    G L D++          I S Y  L W  
Sbjct: 79  ASVDNPHVCRLLGICLTSTVQ--LITQLMPFGCLLDYVRE----HKDNIGSQY-LLNW-- 129
Query: 485 RLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQ 544
               C+ +A  + Y+    +   VHR++ +RN+ +    + ++ +FG A+ +    E  +
Sbjct: 130 ----CVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLG--AEEKE 180
Query: 545 FYSTN---PASWSMGI------------DIFAYGIVLLEVLS-GQTPIN 577
           +++     P  W M +            D+++YG+ + E+++ G  P +
Sbjct: 181 YHAEGGKVPIKW-MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYD 228

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 45.4 bits (106), Expect = 8e-05,   Method: Compositional matrix adjust.
 Identities = 43/179 (24%), Positives = 75/179 (41%), Gaps = 32/179 (17%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
            EH++  ++E+Q    +   HPNI+RL G    D    +L+ EYA  G++   L      
Sbjct: 56  VEHQLRREVEIQ----SHLRHPNILRLYGY-FHDATRVYLILEYAPLGTVYRELQKLSKF 110
Query: 469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVG 528
             Q  A+   ++T         ++A AL Y H   +   +HR+IK  N+ L      ++ 
Sbjct: 111 DEQRTAT---YIT---------ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIA 155
Query: 529 NFGMA----------RCVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
           +FG +           C   D   P+            +D+++ G++  E L G+ P  
Sbjct: 156 DFGWSVHAPSSRRTTLCGTLDYLPPE--XIEGRXHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 24/111 (21%), Positives = 49/111 (44%), Gaps = 10/111 (9%)
Query: 484 QRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESP 543
           Q  R     A  +  + H+   + ++R++K  N+ LD++ N R+ + G+A  +       
Sbjct: 287 QEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT 346
Query: 544 QFYSTNPA----------SWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDE 584
           + Y+  P            +   +D FA G+ L E+++ + P     +K E
Sbjct: 347 KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE 397

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 27/133 (20%), Positives = 59/133 (44%), Gaps = 22/133 (16%)
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           F+  E+   G+L+ W+      K   + +          L +   +   + Y+H   +  
Sbjct: 110 FIQMEFCDKGTLEQWIEKRRGEKLDKVLA----------LELFEQITKGVDYIH---SKK 156
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYST---------NPASWSMGI 557
            +HR++K  NIFL +    ++G+FG+   + +D +  +   T         +   +   +
Sbjct: 157 LIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEV 216
Query: 558 DIFAYGIVLLEVL 570
           D++A G++L E+L
Sbjct: 217 DLYALGLILAELL 229

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 24/111 (21%), Positives = 49/111 (44%), Gaps = 10/111 (9%)
Query: 484 QRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESP 543
           Q  R     A  +  + H+   + ++R++K  N+ LD++ N R+ + G+A  +       
Sbjct: 287 QEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT 346
Query: 544 QFYSTNPA----------SWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDE 584
           + Y+  P            +   +D FA G+ L E+++ + P     +K E
Sbjct: 347 KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE 397

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 43/183 (23%), Positives = 79/183 (43%), Gaps = 39/183 (21%)
Query: 429 HPNIVRLLGTCLTDGP---HSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQR 485
           HPN+V+L+   + D P   H ++VFE    G + +                   L+  Q 
Sbjct: 95  HPNVVKLVE--VLDDPNEDHLYMVFELVNQGPVME-------------VPTLKPLSEDQA 139
Query: 486 LRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR-------CVND 538
                D+   ++Y+H+      +HR+IK  N+ + E+ + ++ +FG++         +++
Sbjct: 140 RFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSN 196
Query: 539 DTESPQFYSTNPASWSMGI------DIFAYGIVLLEVLSGQTPINRPRKKDEGSVWLSEK 592
              +P F +    S +  I      D++A G+ L   + GQ P       DE  + L  K
Sbjct: 197 TVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF-----MDERIMCLHSK 251
Query: 593 IKS 595
           IKS
Sbjct: 252 IKS 254

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 43/179 (24%), Positives = 75/179 (41%), Gaps = 32/179 (17%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
            EH++  ++E+Q    +   HPNI+RL G    D    +L+ EYA  G++   L      
Sbjct: 51  VEHQLRREVEIQ----SHLRHPNILRLYG-YFHDATRVYLILEYAPLGTVYRELQKLSKF 105
Query: 469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVG 528
             Q  A+   ++T         ++A AL Y H   +   +HR+IK  N+ L      ++ 
Sbjct: 106 DEQRTAT---YIT---------ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIA 150
Query: 529 NFGMA----------RCVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
           +FG +           C   D   P+            +D+++ G++  E L G+ P  
Sbjct: 151 DFGWSVHAPSSRRXXLCGTLDYLPPEMIEGRMH--DEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 44/196 (22%), Positives = 86/196 (43%), Gaps = 35/196 (17%)
Query: 398 RLNGKNLAIKRTEH--EVITKL-----EMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVF 450
           RL G+ +AIK+  +  +V+T       E+++++H  H   NI+ +        P+     
Sbjct: 77  RLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHD--NIIAIKDILRPTVPYG---- 130
Query: 451 EYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHR 510
           E+     + D +   L   +Q I S    LT          +   L+YMH   +   +HR
Sbjct: 131 EFKSVYVVLDLMESDL---HQIIHSSQP-LTLEHVRYFLYQLLRGLKYMH---SAQVIHR 183
Query: 511 NIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPAS---------------WSM 555
           ++K  N+ ++E    ++G+FGMAR +       Q++ T   +               ++ 
Sbjct: 184 DLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQ 243
Query: 556 GIDIFAYGIVLLEVLS 571
            ID+++ G +  E+L+
Sbjct: 244 AIDLWSVGCIFGEMLA 259

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 43/179 (24%), Positives = 75/179 (41%), Gaps = 32/179 (17%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
            EH++  ++E+Q    +   HPNI+RL G    D    +L+ EYA  G++   L      
Sbjct: 50  VEHQLRREVEIQ----SHLRHPNILRLYG-YFHDATRVYLILEYAPLGTVYRELQKLSKF 104
Query: 469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVG 528
             Q  A+   ++T         ++A AL Y H   +   +HR+IK  N+ L      ++ 
Sbjct: 105 DEQRTAT---YIT---------ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIA 149
Query: 529 NFGMA----------RCVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
           +FG +           C   D   P+            +D+++ G++  E L G+ P  
Sbjct: 150 DFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMH--DEKVDLWSLGVLCYEFLVGKPPFE 206

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 24/111 (21%), Positives = 49/111 (44%), Gaps = 10/111 (9%)
Query: 484 QRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESP 543
           Q  R     A  +  + H+   + ++R++K  N+ LD++ N R+ + G+A  +       
Sbjct: 287 QEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT 346
Query: 544 QFYSTNPA----------SWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDE 584
           + Y+  P            +   +D FA G+ L E+++ + P     +K E
Sbjct: 347 KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE 397

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 24/111 (21%), Positives = 49/111 (44%), Gaps = 10/111 (9%)
Query: 484 QRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESP 543
           Q  R     A  +  + H+   + ++R++K  N+ LD++ N R+ + G+A  +       
Sbjct: 287 QEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT 346
Query: 544 QFYSTNPA----------SWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDE 584
           + Y+  P            +   +D FA G+ L E+++ + P     +K E
Sbjct: 347 KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE 397

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 43/179 (24%), Positives = 75/179 (41%), Gaps = 32/179 (17%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
            EH++  ++E+Q    +   HPNI+RL G    D    +L+ EYA  G++   L      
Sbjct: 54  VEHQLRREVEIQ----SHLRHPNILRLYG-YFHDATRVYLILEYAPLGTVYRELQKLSKF 108
Query: 469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVG 528
             Q  A+   ++T         ++A AL Y H   +   +HR+IK  N+ L      ++ 
Sbjct: 109 DEQRTAT---YIT---------ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIA 153
Query: 529 NFGMA----------RCVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
           +FG +           C   D   P+            +D+++ G++  E L G+ P  
Sbjct: 154 DFGWSVHAPSSRRDDLCGTLDYLPPEMIEGRMH--DEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 45.4 bits (106), Expect = 9e-05,   Method: Compositional matrix adjust.
 Identities = 43/179 (24%), Positives = 75/179 (41%), Gaps = 32/179 (17%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
            EH++  ++E+Q    +   HPNI+RL G    D    +L+ EYA  G++   L      
Sbjct: 51  VEHQLRREVEIQ----SHLRHPNILRLYG-YFHDATRVYLILEYAPLGTVYRELQKLSKF 105
Query: 469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVG 528
             Q  A+   ++T         ++A AL Y H   +   +HR+IK  N+ L      ++ 
Sbjct: 106 DEQRTAT---YIT---------ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIA 150
Query: 529 NFGMA----------RCVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
           +FG +           C   D   P+            +D+++ G++  E L G+ P  
Sbjct: 151 DFGWSVHAPSSRRTXLCGTLDYLPPEMIEGRMH--DEKVDLWSLGVLCYEFLVGKPPFE 207

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/179 (24%), Positives = 75/179 (41%), Gaps = 32/179 (17%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
            EH++  ++E+Q    +   HPNI+RL G    D    +L+ EYA  G++   L      
Sbjct: 54  VEHQLRREVEIQ----SHLRHPNILRLYG-YFHDATRVYLILEYAPLGTVYRELQKLSKF 108
Query: 469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVG 528
             Q  A+   ++T         ++A AL Y H   +   +HR+IK  N+ L      ++ 
Sbjct: 109 DEQRTAT---YIT---------ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIA 153
Query: 529 NFGMA----------RCVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
           +FG +           C   D   P+            +D+++ G++  E L G+ P  
Sbjct: 154 DFGWSVHAPSSRRXXLCGTLDYLPPEMIEGRMH--DEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/179 (24%), Positives = 75/179 (41%), Gaps = 32/179 (17%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
            EH++  ++E+Q    +   HPNI+RL G    D    +L+ EYA  G++   L      
Sbjct: 55  VEHQLRREVEIQ----SHLRHPNILRLYG-YFHDATRVYLILEYAPLGTVYRELQKLSKF 109
Query: 469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVG 528
             Q  A+   ++T         ++A AL Y H   +   +HR+IK  N+ L      ++ 
Sbjct: 110 DEQRTAT---YIT---------ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIA 154
Query: 529 NFGMA----------RCVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
           +FG +           C   D   P+            +D+++ G++  E L G+ P  
Sbjct: 155 DFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMH--DEKVDLWSLGVLCYEFLVGKPPFE 211

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 45.4 bits (106), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/179 (24%), Positives = 75/179 (41%), Gaps = 32/179 (17%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
            EH++  ++E+Q    +   HPNI+RL G    D    +L+ EYA  G++   L      
Sbjct: 54  VEHQLRREVEIQ----SHLRHPNILRLYG-YFHDATRVYLILEYAPLGTVYRELQKLSKF 108
Query: 469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVG 528
             Q  A+   ++T         ++A AL Y H   +   +HR+IK  N+ L      ++ 
Sbjct: 109 DEQRTAT---YIT---------ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIA 153
Query: 529 NFGMA----------RCVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
           +FG +           C   D   P+            +D+++ G++  E L G+ P  
Sbjct: 154 DFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMH--DEKVDLWSLGVLCYEFLVGKPPFE 210

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 71/163 (43%), Gaps = 32/163 (19%)
Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLR 487
            HPNIVRL  +   +  H +LVF         D + GG   ++      Y     S  ++
Sbjct: 86  QHPNIVRLHDSIQEESFH-YLVF---------DLVTGGELFEDIVAREFYSEADASHCIQ 135
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNA---RVGNFGMARCVNDDTE--- 541
             L+   ++ Y H   +   VHRN+K  N+ L  +      ++ +FG+A  VND      
Sbjct: 136 QILE---SIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG 189
Query: 542 --------SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPI 576
                   SP+    +P  +S  +DI+A G++L  +L G  P 
Sbjct: 190 FAGTPGYLSPEVLKKDP--YSKPVDIWACGVILYILLVGYPPF 230

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 40/156 (25%), Positives = 66/156 (42%), Gaps = 29/156 (18%)
Query: 392 GAVYHGRLNGKNLAIK----RTEHEVITKLEMQLVQHATHHHPNIVRLL---GTCLTDGP 444
           GAVY G L+ + +A+K          I   E  + +     H NI R +        DG 
Sbjct: 27  GAVYKGSLDERPVAVKVFSFANRQNFIN--EKNIYRVPLMEHDNIARFIVGDERVTADGR 84
Query: 445 HSFL-VFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM 503
             +L V EY  NGSL  +L       + +++SC          R+   V   L Y+H  +
Sbjct: 85  MEYLLVMEYYPNGSLXKYLS---LHTSDWVSSC----------RLAHSVTRGLAYLHTEL 131
Query: 504 ------NPSYVHRNIKSRNIFLDEEFNARVGNFGMA 533
                  P+  HR++ SRN+ +  +    + +FG++
Sbjct: 132 PRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLS 167

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/196 (22%), Positives = 86/196 (43%), Gaps = 35/196 (17%)
Query: 398 RLNGKNLAIKRTEH--EVITKL-----EMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVF 450
           RL G+ +AIK+  +  +V+T       E+++++H  H   NI+ +        P+     
Sbjct: 76  RLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHD--NIIAIKDILRPTVPYG---- 129
Query: 451 EYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHR 510
           E+     + D +   L   +Q I S    LT          +   L+YMH   +   +HR
Sbjct: 130 EFKSVYVVLDLMESDL---HQIIHSSQP-LTLEHVRYFLYQLLRGLKYMH---SAQVIHR 182
Query: 511 NIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPAS---------------WSM 555
           ++K  N+ ++E    ++G+FGMAR +       Q++ T   +               ++ 
Sbjct: 183 DLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQ 242
Query: 556 GIDIFAYGIVLLEVLS 571
            ID+++ G +  E+L+
Sbjct: 243 AIDLWSVGCIFGEMLA 258

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 41/161 (25%), Positives = 74/161 (45%), Gaps = 25/161 (15%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HP+IV LL T  +DG   ++VFE+     L   +     +K       Y     S  +R 
Sbjct: 85  HPHIVELLETYSSDG-MLYMVFEFMDGADLCFEI-----VKRADAGFVYSEAVASHYMRQ 138
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNA---RVGNFGMARCVNDD------ 539
            L+   AL+Y H   + + +HR++K  N+ L  + N+   ++G+FG+A  + +       
Sbjct: 139 ILE---ALRYCH---DNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGG 192
Query: 540 -TESPQFYSTNPAS---WSMGIDIFAYGIVLLEVLSGQTPI 576
              +P F +        +   +D++  G++L  +LSG  P 
Sbjct: 193 RVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 43/179 (24%), Positives = 75/179 (41%), Gaps = 32/179 (17%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
            EH++  ++E+Q    +   HPNI+RL G    D    +L+ EYA  G++   L      
Sbjct: 48  VEHQLRREVEIQ----SHLRHPNILRLYG-YFHDATRVYLILEYAPLGTVYRELQKLSKF 102
Query: 469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVG 528
             Q  A+   ++T         ++A AL Y H   +   +HR+IK  N+ L      ++ 
Sbjct: 103 DEQRTAT---YIT---------ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIA 147
Query: 529 NFGMA----------RCVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
           +FG +           C   D   P+            +D+++ G++  E L G+ P  
Sbjct: 148 DFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMH--DEKVDLWSLGVLCYEFLVGKPPFE 204

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 76/178 (42%), Gaps = 30/178 (16%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
            EH++  ++E+Q    +   HPNI+RL G    D    +L+ EYA  G++   L      
Sbjct: 52  VEHQLRREVEIQ----SHLRHPNILRLYG-YFHDATRVYLILEYAPLGTVYRELQKLSKF 106
Query: 469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVG 528
             Q  A+   ++T         ++A AL Y H   +   +HR+IK  N+ L      ++ 
Sbjct: 107 DEQRTAT---YIT---------ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIA 151
Query: 529 NFGMARCVNDDTESPQFYST---NPASWSMG------IDIFAYGIVLLEVLSGQTPIN 577
           +FG + C    +       T    P     G      +D+++ G++  E L G+ P  
Sbjct: 152 DFGWS-CHAPSSRRTTLSGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 208

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 37/155 (23%), Positives = 75/155 (48%), Gaps = 23/155 (14%)
Query: 426 THHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQR 485
           T  H  +V+L    +T  P  +++ E+   GSL D+L      K              Q 
Sbjct: 233 TLQHDKLVKL-HAVVTKEP-IYIITEFMAKGSLLDFLKSDEGSK--------------QP 276
Query: 486 LRICLDV-AMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND---DTE 541
           L   +D  A   + M  +   +Y+HR++++ NI +      ++ +FG+AR          
Sbjct: 277 LPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVGAKFPIKWT 336
Query: 542 SPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTP 575
           +P+  + N  S+++  D++++GI+L+E+++ G+ P
Sbjct: 337 APE--AINFGSFTIKSDVWSFGILLMEIVTYGRIP 369

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 45.1 bits (105), Expect = 1e-04,   Method: Compositional matrix adjust.
 Identities = 23/95 (24%), Positives = 54/95 (56%), Gaps = 11/95 (11%)
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQ 544
           +   +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + +
Sbjct: 159 LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR 215
Query: 545 FYST-----NPASWSMGIDIFAYGIVLLEVLSGQT 574
           +Y       N   ++M +DI++ G ++ E+L+G+T
Sbjct: 216 WYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRT 250

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/192 (21%), Positives = 83/192 (43%), Gaps = 37/192 (19%)
Query: 405 AIKRTEHEVITKLE-MQLVQHATH------HHPNIVRLLGTCLTDGPHSFLVFEYAKNGS 457
           A+K  + E++   E +  VQ   H      +HP +V L  +C       F V EY   G 
Sbjct: 49  AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL-HSCFQTESRLFFVIEYVNGGD 107
Query: 458 LKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNI 517
           L   +     +  +  A  Y             ++++AL Y+H       ++R++K  N+
Sbjct: 108 LMFHMQRQRKLPEEH-ARFYS-----------AEISLALNYLHE---RGIIYRDLKLDNV 152
Query: 518 FLDEEFNARVGNFGMAR------------CVNDDTESPQFYSTNPASWSMGIDIFAYGIV 565
            LD E + ++ ++GM +            C   +  +P+        +S  +D +A G++
Sbjct: 153 LLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFS--VDWWALGVL 210
Query: 566 LLEVLSGQTPIN 577
           + E+++G++P +
Sbjct: 211 MFEMMAGRSPFD 222

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/179 (24%), Positives = 74/179 (41%), Gaps = 32/179 (17%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
            EH++  ++E+Q    +   HPNI+RL G    D    +L+ EYA  G++   L      
Sbjct: 55  VEHQLRREVEIQ----SHLRHPNILRLYG-YFHDATRVYLILEYAPLGTVYRELQKLSRF 109
Query: 469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVG 528
             Q  A+   ++T         ++A AL Y H   +   +HR+IK  N+ L      ++ 
Sbjct: 110 DEQRTAT---YIT---------ELANALSYCH---SKRVIHRDIKPENLLLGSNGELKIA 154
Query: 529 NFGMA----------RCVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
           +FG +           C   D   P+            +D+++ G++  E L G  P  
Sbjct: 155 DFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMH--DEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 71/163 (43%), Gaps = 32/163 (19%)
Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLR 487
            HPNIVRL  +   +  H +LVF         D + GG   ++      Y     S  ++
Sbjct: 63  QHPNIVRLHDSIQEESFH-YLVF---------DLVTGGELFEDIVAREFYSEADASHCIQ 112
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNA---RVGNFGMARCVNDDTE--- 541
             L+   ++ Y H   +   VHRN+K  N+ L  +      ++ +FG+A  VND      
Sbjct: 113 QILE---SIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG 166
Query: 542 --------SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPI 576
                   SP+    +P  +S  +DI+A G++L  +L G  P 
Sbjct: 167 FAGTPGYLSPEVLKKDP--YSKPVDIWACGVILYILLVGYPPF 207

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 43/179 (24%), Positives = 74/179 (41%), Gaps = 32/179 (17%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
            EH++  ++E+Q    +   HPNI+RL G    D    +L+ EYA  G++   L      
Sbjct: 55  VEHQLRREVEIQ----SHLRHPNILRLYG-YFHDATRVYLILEYAPLGTVYRELQKLSRF 109
Query: 469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVG 528
             Q  A+   ++T         ++A AL Y H   +   +HR+IK  N+ L      ++ 
Sbjct: 110 DEQRTAT---YIT---------ELANALSYCH---SKRVIHRDIKPENLLLGSNGELKIA 154
Query: 529 NFGMA----------RCVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
           +FG +           C   D   P+            +D+++ G++  E L G  P  
Sbjct: 155 DFGWSVHAPSSRRDTLCGTLDYLPPEMIEGRMH--DEKVDLWSLGVLCYEFLVGMPPFE 211

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 71/163 (43%), Gaps = 32/163 (19%)
Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLR 487
            HPNIVRL  +   +  H +LVF         D + GG   ++      Y     S  ++
Sbjct: 62  QHPNIVRLHDSIQEESFH-YLVF---------DLVTGGELFEDIVAREFYSEADASHCIQ 111
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNA---RVGNFGMARCVNDDTE--- 541
             L+   ++ Y H   +   VHRN+K  N+ L  +      ++ +FG+A  VND      
Sbjct: 112 QILE---SIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG 165
Query: 542 --------SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPI 576
                   SP+    +P  +S  +DI+A G++L  +L G  P 
Sbjct: 166 FAGTPGYLSPEVLKKDP--YSKPVDIWACGVILYILLVGYPPF 206

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 44/163 (26%), Positives = 71/163 (43%), Gaps = 32/163 (19%)
Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLR 487
            HPNIVRL  +   +  H +LVF         D + GG   ++      Y     S  ++
Sbjct: 63  QHPNIVRLHDSIQEESFH-YLVF---------DLVTGGELFEDIVAREFYSEADASHCIQ 112
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNA---RVGNFGMARCVNDDTE--- 541
             L+   ++ Y H   +   VHRN+K  N+ L  +      ++ +FG+A  VND      
Sbjct: 113 QILE---SIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHG 166
Query: 542 --------SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPI 576
                   SP+    +P  +S  +DI+A G++L  +L G  P 
Sbjct: 167 FAGTPGYLSPEVLKKDP--YSKPVDIWACGVILYILLVGYPPF 207

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 42/177 (23%), Positives = 74/177 (41%), Gaps = 28/177 (15%)
Query: 409 TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM 468
            EH++  ++E+Q    +   HPNI+RL G    D    +L+ EYA  G +   L      
Sbjct: 56  VEHQLRREVEIQ----SHLRHPNILRLYG-YFHDATRVYLILEYAPRGEVYKELQKLSKF 110
Query: 469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVG 528
             Q  A+   ++T         ++A AL Y H   +   +HR+IK  N+ L      ++ 
Sbjct: 111 DEQRTAT---YIT---------ELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIA 155
Query: 529 NFGMARCVNDDTESPQFYSTN--PASWSMG------IDIFAYGIVLLEVLSGQTPIN 577
           +FG +             + +  P     G      +D+++ G++  E L G+ P  
Sbjct: 156 DFGWSVHAPSSRRXXLXGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFE 212

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 98/230 (42%), Gaps = 49/230 (21%)
Query: 380 ATEKFNSSNRI----EGAVYHGR--LNGKNLAIKR----TEHEVITKL---EMQLVQHAT 426
           + E F    +I     G VY  R  L G+ +A+K+    TE E +      E+ L++   
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL- 59
Query: 427 HHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRL 486
            +HPNIV+LL    T+    +LVFE+      K      L      +   Y F    Q L
Sbjct: 60  -NHPNIVKLLDVIHTEN-KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF----QLL 113
Query: 487 RICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR------------ 534
           +      +A  + H V+     HR++K +N+ ++ E   ++ +FG+AR            
Sbjct: 114 Q-----GLAFCHSHRVL-----HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE 163
Query: 535 CVNDDTESPQ------FYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR 578
            V     +P+      +YST    WS+G  IFA  +    +  G + I++
Sbjct: 164 VVTLWYRAPEILLGCKYYSTAVDIWSLGC-IFAEMVTRRALFPGDSEIDQ 212

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 98/230 (42%), Gaps = 49/230 (21%)
Query: 380 ATEKFNSSNRI----EGAVYHGR--LNGKNLAIKR----TEHEVITKL---EMQLVQHAT 426
           + E F    +I     G VY  R  L G+ +A+K+    TE E +      E+ L++   
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL- 59
Query: 427 HHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRL 486
            +HPNIV+LL    T+    +LVFE+      K      L      +   Y F    Q L
Sbjct: 60  -NHPNIVKLLDVIHTEN-KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF----QLL 113
Query: 487 RICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR------------ 534
           +      +A  + H V+     HR++K +N+ ++ E   ++ +FG+AR            
Sbjct: 114 Q-----GLAFCHSHRVL-----HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE 163
Query: 535 CVNDDTESPQ------FYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR 578
            V     +P+      +YST    WS+G  IFA  +    +  G + I++
Sbjct: 164 VVTLWYRAPEILLGCKYYSTAVDIWSLGC-IFAEMVTRRALFPGDSEIDQ 212

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 45/214 (21%)
Query: 392 GAVYHGR--LNGKNLAIKR----TEHEVITKL---EMQLVQHATHHHPNIVRLLGTCLTD 442
           G VY  R  L G+ +A+K+    TE E +      E+ L++    +HPNIV+LL    T+
Sbjct: 16  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--NHPNIVKLLDVIHTE 73
Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
               +LVFE+      K      L      +   Y F    Q L+      +A  + H V
Sbjct: 74  N-KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF----QLLQ-----GLAFCHSHRV 123
Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR------------CVNDDTESPQ------ 544
           +     HR++K +N+ ++ E   ++ +FG+AR             V     +P+      
Sbjct: 124 L-----HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 545 FYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR 578
           +YST    WS+G  IFA  +    +  G + I++
Sbjct: 179 YYSTAVDIWSLGC-IFAEMVTRRALFPGDSEIDQ 211

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 98/230 (42%), Gaps = 49/230 (21%)
Query: 380 ATEKFNSSNRI----EGAVYHGR--LNGKNLAIKR----TEHEVITKL---EMQLVQHAT 426
           + E F    +I     G VY  R  L G+ +A+K+    TE E +      E+ L++   
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL- 62
Query: 427 HHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRL 486
            +HPNIV+LL    T+    +LVFE+      K      L      +   Y F    Q L
Sbjct: 63  -NHPNIVKLLDVIHTEN-KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF----QLL 116
Query: 487 RICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR------------ 534
           +      +A  + H V+     HR++K +N+ ++ E   ++ +FG+AR            
Sbjct: 117 Q-----GLAFCHSHRVL-----HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE 166
Query: 535 CVNDDTESPQ------FYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR 578
            V     +P+      +YST    WS+G  IFA  +    +  G + I++
Sbjct: 167 VVTLWYRAPEILLGCKYYSTAVDIWSLGC-IFAEMVTRRALFPGDSEIDQ 215

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 98/230 (42%), Gaps = 49/230 (21%)
Query: 380 ATEKFNSSNRI----EGAVYHGR--LNGKNLAIKR----TEHEVITKL---EMQLVQHAT 426
           + E F    +I     G VY  R  L G+ +A+K+    TE E +      E+ L++   
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL- 61
Query: 427 HHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRL 486
            +HPNIV+LL    T+    +LVFE+      K      L      +   Y F    Q L
Sbjct: 62  -NHPNIVKLLDVIHTEN-KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF----QLL 115
Query: 487 RICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR------------ 534
           +      +A  + H V+     HR++K +N+ ++ E   ++ +FG+AR            
Sbjct: 116 Q-----GLAFCHSHRVL-----HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE 165
Query: 535 CVNDDTESPQ------FYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR 578
            V     +P+      +YST    WS+G  IFA  +    +  G + I++
Sbjct: 166 VVTLWYRAPEILLGCKYYSTAVDIWSLGC-IFAEMVTRRALFPGDSEIDQ 214

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 44.3 bits (103), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 98/230 (42%), Gaps = 49/230 (21%)
Query: 380 ATEKFNSSNRI----EGAVYHGR--LNGKNLAIKR----TEHEVITKL---EMQLVQHAT 426
           + E F    +I     G VY  R  L G+ +A+K+    TE E +      E+ L++   
Sbjct: 5   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL- 63
Query: 427 HHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRL 486
            +HPNIV+LL    T+    +LVFE+      K      L      +   Y F    Q L
Sbjct: 64  -NHPNIVKLLDVIHTEN-KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF----QLL 117
Query: 487 RICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR------------ 534
           +      +A  + H V+     HR++K +N+ ++ E   ++ +FG+AR            
Sbjct: 118 Q-----GLAFCHSHRVL-----HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE 167
Query: 535 CVNDDTESPQ------FYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR 578
            V     +P+      +YST    WS+G  IFA  +    +  G + I++
Sbjct: 168 VVTLWYRAPEILLGCKYYSTAVDIWSLGC-IFAEMVTRRALFPGDSEIDQ 216

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 98/230 (42%), Gaps = 49/230 (21%)
Query: 380 ATEKFNSSNRI----EGAVYHGR--LNGKNLAIKR----TEHEVITKL---EMQLVQHAT 426
           + E F    +I     G VY  R  L G+ +A+K+    TE E +      E+ L++   
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL- 61
Query: 427 HHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRL 486
            +HPNIV+LL    T+    +LVFE+      K      L      +   Y F    Q L
Sbjct: 62  -NHPNIVKLLDVIHTEN-KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF----QLL 115
Query: 487 RICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR------------ 534
           +      +A  + H V+     HR++K +N+ ++ E   ++ +FG+AR            
Sbjct: 116 Q-----GLAFCHSHRVL-----HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE 165
Query: 535 CVNDDTESPQ------FYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR 578
            V     +P+      +YST    WS+G  IFA  +    +  G + I++
Sbjct: 166 VVTLWYRAPEILLGCKYYSTAVDIWSLGC-IFAEMVTRRALFPGDSEIDQ 214

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 98/230 (42%), Gaps = 49/230 (21%)
Query: 380 ATEKFNSSNRI----EGAVYHGR--LNGKNLAIKR----TEHEVITKL---EMQLVQHAT 426
           + E F    +I     G VY  R  L G+ +A+K+    TE E +      E+ L++   
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL- 59
Query: 427 HHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRL 486
            +HPNIV+LL    T+    +LVFE+      K      L      +   Y F    Q L
Sbjct: 60  -NHPNIVKLLDVIHTEN-KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF----QLL 113
Query: 487 RICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR------------ 534
           +      +A  + H V+     HR++K +N+ ++ E   ++ +FG+AR            
Sbjct: 114 Q-----GLAFCHSHRVL-----HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE 163
Query: 535 CVNDDTESPQ------FYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR 578
            V     +P+      +YST    WS+G  IFA  +    +  G + I++
Sbjct: 164 VVTLWYRAPEILLGCKYYSTAVDIWSLGC-IFAEMVTRRALFPGDSEIDQ 212

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 45/214 (21%)
Query: 392 GAVYHGR--LNGKNLAIKR----TEHEVITKL---EMQLVQHATHHHPNIVRLLGTCLTD 442
           G VY  R  L G+ +A+K+    TE E +      E+ L++    +HPNIV+LL    T+
Sbjct: 17  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--NHPNIVKLLDVIHTE 74
Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
               +LVFE+      K      L      +   Y F    Q L+      +A  + H V
Sbjct: 75  N-KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF----QLLQ-----GLAFCHSHRV 124
Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTES------------------PQ 544
           +     HR++K +N+ ++ E   ++ +FG+AR       +                   +
Sbjct: 125 L-----HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXK 179
Query: 545 FYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR 578
           +YST    WS+G  IFA  +    +  G + I++
Sbjct: 180 YYSTAVDIWSLGC-IFAEMVTRRALFPGDSEIDQ 212

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 54/214 (25%), Positives = 91/214 (42%), Gaps = 45/214 (21%)
Query: 392 GAVYHGR--LNGKNLAIKR----TEHEVITKL---EMQLVQHATHHHPNIVRLLGTCLTD 442
           G VY  R  L G+ +A+K+    TE E +      E+ L++    +HPNIV+LL    T+
Sbjct: 24  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--NHPNIVKLLDVIHTE 81
Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
               +LVFE+      K      L      +   Y F    Q L+      +A  + H V
Sbjct: 82  N-KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF----QLLQ-----GLAFCHSHRV 131
Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTES------------------PQ 544
           +     HR++K +N+ ++ E   ++ +FG+AR       +                   +
Sbjct: 132 L-----HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXK 186
Query: 545 FYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR 578
           +YST    WS+G  IFA  +    +  G + I++
Sbjct: 187 YYSTAVDIWSLGC-IFAEMVTRRALFPGDSEIDQ 219

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 45/214 (21%)
Query: 392 GAVYHGR--LNGKNLAIKR----TEHEVITKL---EMQLVQHATHHHPNIVRLLGTCLTD 442
           G VY  R  L G+ +A+K+    TE E +      E+ L++    +HPNIV+LL    T+
Sbjct: 24  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--NHPNIVKLLDVIHTE 81
Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
               +LVFE+      K      L      +   Y F    Q L+      +A  + H V
Sbjct: 82  N-KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF----QLLQ-----GLAFCHSHRV 131
Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR------------CVNDDTESPQ------ 544
           +     HR++K +N+ ++ E   ++ +FG+AR             V     +P+      
Sbjct: 132 L-----HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 186
Query: 545 FYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR 578
           +YST    WS+G  IFA  +    +  G + I++
Sbjct: 187 YYSTAVDIWSLGC-IFAEMVTRRALFPGDSEIDQ 219

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 32/147 (21%), Positives = 67/147 (45%), Gaps = 24/147 (16%)
Query: 392 GAVYHGRLNG----KNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSF 447
           G VYHGR +G    + + I+R   + +   + +++ +    H N+V  +G C++  PH  
Sbjct: 47  GQVYHGRWHGEVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP-PHLA 105
Query: 448 LVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSY 507
           ++    K  +L              +      L  ++  +I  ++   + Y+H       
Sbjct: 106 IITSLCKGRTL-----------YSVVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGI 151
Query: 508 VHRNIKSRNIFLDEEFNARV--GNFGM 532
           +H+++KS+N+F D   N +V   +FG+
Sbjct: 152 LHKDLKSKNVFYD---NGKVVITDFGL 175

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 98/230 (42%), Gaps = 49/230 (21%)
Query: 380 ATEKFNSSNRI----EGAVYHGR--LNGKNLAIKR----TEHEVITKL---EMQLVQHAT 426
           + E F    +I     G VY  R  L G+ +A+K+    TE E +      E+ L++   
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL- 62
Query: 427 HHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRL 486
            +HPNIV+LL    T+    +LVFE+      K      L      +   Y F    Q L
Sbjct: 63  -NHPNIVKLLDVIHTEN-KLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLF----QLL 116
Query: 487 RICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARC----------- 535
           +      +A  + H V+     HR++K +N+ ++ E   ++ +FG+AR            
Sbjct: 117 Q-----GLAFCHSHRVL-----HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE 166
Query: 536 -VNDDTESPQ------FYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR 578
            V     +P+      +YST    WS+G  IFA  +    +  G + I++
Sbjct: 167 VVTLWYRAPEILLGCKYYSTAVDIWSLGC-IFAEMVTRRALFPGDSEIDQ 215

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 98/230 (42%), Gaps = 49/230 (21%)
Query: 380 ATEKFNSSNRI----EGAVYHGR--LNGKNLAIKR----TEHEVITKL---EMQLVQHAT 426
           + E F    +I     G VY  R  L G+ +A+K+    TE E +      E+ L++   
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL- 62
Query: 427 HHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRL 486
            +HPNIV+LL    T+    +LVFE+      K      L      +   Y F    Q L
Sbjct: 63  -NHPNIVKLLDVIHTEN-KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF----QLL 116
Query: 487 RICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARC----------- 535
           +      +A  + H V+     HR++K +N+ ++ E   ++ +FG+AR            
Sbjct: 117 Q-----GLAFCHSHRVL-----HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE 166
Query: 536 -VNDDTESPQ------FYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR 578
            V     +P+      +YST    WS+G  IFA  +    +  G + I++
Sbjct: 167 VVTLWYRAPEILLGCKYYSTAVDIWSLGC-IFAEMVTRRALFPGDSEIDQ 215

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 41/192 (21%), Positives = 83/192 (43%), Gaps = 37/192 (19%)
Query: 405 AIKRTEHEVITKLE-MQLVQHATH------HHPNIVRLLGTCLTDGPHSFLVFEYAKNGS 457
           A+K  + E++   E +  VQ   H      +HP +V L  +C       F V EY   G 
Sbjct: 34  AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL-HSCFQTESRLFFVIEYVNGGD 92
Query: 458 LKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNI 517
           L   +     +  +  A  Y             ++++AL Y+H       ++R++K  N+
Sbjct: 93  LMFHMQRQRKLPEEH-ARFYS-----------AEISLALNYLHE---RGIIYRDLKLDNV 137
Query: 518 FLDEEFNARVGNFGMAR------------CVNDDTESPQFYSTNPASWSMGIDIFAYGIV 565
            LD E + ++ ++GM +            C   +  +P+        +S  +D +A G++
Sbjct: 138 LLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFS--VDWWALGVL 195
Query: 566 LLEVLSGQTPIN 577
           + E+++G++P +
Sbjct: 196 MFEMMAGRSPFD 207

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 45/214 (21%)
Query: 392 GAVYHGR--LNGKNLAIKR----TEHEVITKL---EMQLVQHATHHHPNIVRLLGTCLTD 442
           G VY  R  L G+ +A+K+    TE E +      E+ L++    +HPNIV+LL    T+
Sbjct: 21  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--NHPNIVKLLDVIHTE 78
Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
               +LVFE+      K      L      +   Y F    Q L+      +A  + H V
Sbjct: 79  N-KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF----QLLQ-----GLAFCHSHRV 128
Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR------------CVNDDTESPQ------ 544
           +     HR++K +N+ ++ E   ++ +FG+AR             V     +P+      
Sbjct: 129 L-----HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 183
Query: 545 FYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR 578
           +YST    WS+G  IFA  +    +  G + I++
Sbjct: 184 YYSTAVDIWSLGC-IFAEMVTRRALFPGDSEIDQ 216

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 43.9 bits (102), Expect = 2e-04,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 98/230 (42%), Gaps = 49/230 (21%)
Query: 380 ATEKFNSSNRI----EGAVYHGR--LNGKNLAIKR----TEHEVITKL---EMQLVQHAT 426
           + E F    +I     G VY  R  L G+ +A+K+    TE E +      E+ L++   
Sbjct: 1   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL- 59
Query: 427 HHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRL 486
            +HPNIV+LL    T+    +LVFE+      K      L      +   Y F    Q L
Sbjct: 60  -NHPNIVKLLDVIHTEN-KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF----QLL 113
Query: 487 RICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR------------ 534
           +      +A  + H V+     HR++K +N+ ++ E   ++ +FG+AR            
Sbjct: 114 Q-----GLAFCHSHRVL-----HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE 163
Query: 535 CVNDDTESPQ------FYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR 578
            V     +P+      +YST    WS+G  IFA  +    +  G + I++
Sbjct: 164 VVTLWYRAPEILLGCKYYSTAVDIWSLGC-IFAEMVTRRALFPGDSEIDQ 212

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 98/230 (42%), Gaps = 49/230 (21%)
Query: 380 ATEKFNSSNRI----EGAVYHGR--LNGKNLAIKR----TEHEVITKL---EMQLVQHAT 426
           + E F    +I     G VY  R  L G+ +A+K+    TE E +      E+ L++   
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL- 60
Query: 427 HHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRL 486
            +HPNIV+LL    T+    +LVFE+      K      L      +   Y F    Q L
Sbjct: 61  -NHPNIVKLLDVIHTEN-KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF----QLL 114
Query: 487 RICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR------------ 534
           +      +A  + H V+     HR++K +N+ ++ E   ++ +FG+AR            
Sbjct: 115 Q-----GLAFCHSHRVL-----HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHE 164
Query: 535 CVNDDTESPQ------FYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR 578
            V     +P+      +YST    WS+G  IFA  +    +  G + I++
Sbjct: 165 VVTLWYRAPEILLGCKYYSTAVDIWSLGC-IFAEMVTRRALFPGDSEIDQ 213

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 98/230 (42%), Gaps = 49/230 (21%)
Query: 380 ATEKFNSSNRI----EGAVYHGR--LNGKNLAIKR----TEHEVITKL---EMQLVQHAT 426
           + E F    +I     G VY  R  L G+ +A+K+    TE E +      E+ L++   
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL- 60
Query: 427 HHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRL 486
            +HPNIV+LL    T+    +LVFE+      K      L      +   Y F    Q L
Sbjct: 61  -NHPNIVKLLDVIHTEN-KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF----QLL 114
Query: 487 RICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR------------ 534
           +      +A  + H V+     HR++K +N+ ++ E   ++ +FG+AR            
Sbjct: 115 Q-----GLAFCHSHRVL-----HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE 164
Query: 535 CVNDDTESPQ------FYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR 578
            V     +P+      +YST    WS+G  IFA  +    +  G + I++
Sbjct: 165 VVTLWYRAPEILLGCKYYSTAVDIWSLGC-IFAEMVTRRALFPGDSEIDQ 213

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 45/214 (21%)
Query: 392 GAVYHGR--LNGKNLAIKR----TEHEVITKL---EMQLVQHATHHHPNIVRLLGTCLTD 442
           G VY  R  L G+ +A+K+    TE E +      E+ L++    +HPNIV+LL    T+
Sbjct: 16  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--NHPNIVKLLDVIHTE 73
Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
               +LVFE+      K      L      +   Y F    Q L+      +A  + H V
Sbjct: 74  N-KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF----QLLQ-----GLAFCHSHRV 123
Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR------------CVNDDTESPQ------ 544
           +     HR++K +N+ ++ E   ++ +FG+AR             V     +P+      
Sbjct: 124 L-----HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 178
Query: 545 FYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR 578
           +YST    WS+G  IFA  +    +  G + I++
Sbjct: 179 YYSTAVDIWSLGC-IFAEMVTRRALFPGDSEIDQ 211

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 45/214 (21%)
Query: 392 GAVYHGR--LNGKNLAIKR----TEHEVITKL---EMQLVQHATHHHPNIVRLLGTCLTD 442
           G VY  R  L G+ +A+K+    TE E +      E+ L++    +HPNIV+LL    T+
Sbjct: 17  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--NHPNIVKLLDVIHTE 74
Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
               +LVFE+      K      L      +   Y F    Q L+      +A  + H V
Sbjct: 75  N-KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF----QLLQ-----GLAFCHSHRV 124
Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR------------CVNDDTESPQ------ 544
           +     HR++K +N+ ++ E   ++ +FG+AR             V     +P+      
Sbjct: 125 L-----HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 179
Query: 545 FYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR 578
           +YST    WS+G  IFA  +    +  G + I++
Sbjct: 180 YYSTAVDIWSLGC-IFAEMVTRRALFPGDSEIDQ 212

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 41/192 (21%), Positives = 83/192 (43%), Gaps = 37/192 (19%)
Query: 405 AIKRTEHEVITKLE-MQLVQHATH------HHPNIVRLLGTCLTDGPHSFLVFEYAKNGS 457
           A+K  + E++   E +  VQ   H      +HP +V L  +C       F V EY   G 
Sbjct: 38  AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL-HSCFQTESRLFFVIEYVNGGD 96
Query: 458 LKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNI 517
           L   +     +  +  A  Y             ++++AL Y+H       ++R++K  N+
Sbjct: 97  LMFHMQRQRKLPEEH-ARFYS-----------AEISLALNYLHE---RGIIYRDLKLDNV 141
Query: 518 FLDEEFNARVGNFGMAR------------CVNDDTESPQFYSTNPASWSMGIDIFAYGIV 565
            LD E + ++ ++GM +            C   +  +P+        +S  +D +A G++
Sbjct: 142 LLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGFS--VDWWALGVL 199
Query: 566 LLEVLSGQTPIN 577
           + E+++G++P +
Sbjct: 200 MFEMMAGRSPFD 211

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 45/214 (21%)
Query: 392 GAVYHGR--LNGKNLAIKR----TEHEVITKL---EMQLVQHATHHHPNIVRLLGTCLTD 442
           G VY  R  L G+ +A+K+    TE E +      E+ L++    +HPNIV+LL    T+
Sbjct: 16  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--NHPNIVKLLDVIHTE 73
Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
               +LVFE+      K      L      +   Y F    Q L+      +A  + H V
Sbjct: 74  N-KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF----QLLQ-----GLAFCHSHRV 123
Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR------------CVNDDTESPQ------ 544
           +     HR++K +N+ ++ E   ++ +FG+AR             V     +P+      
Sbjct: 124 L-----HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 545 FYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR 578
           +YST    WS+G  IFA  +    +  G + I++
Sbjct: 179 YYSTAVDIWSLGC-IFAEMVTRRALFPGDSEIDQ 211

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 45/214 (21%)
Query: 392 GAVYHGR--LNGKNLAIKR----TEHEVITKL---EMQLVQHATHHHPNIVRLLGTCLTD 442
           G VY  R  L G+ +A+K+    TE E +      E+ L++    +HPNIV+LL    T+
Sbjct: 16  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--NHPNIVKLLDVIHTE 73
Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
               +LVFE+      K      L      +   Y F    Q L+      +A  + H V
Sbjct: 74  N-KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF----QLLQ-----GLAFCHSHRV 123
Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR------------CVNDDTESPQ------ 544
           +     HR++K +N+ ++ E   ++ +FG+AR             V     +P+      
Sbjct: 124 L-----HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCK 178
Query: 545 FYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR 578
           +YST    WS+G  IFA  +    +  G + I++
Sbjct: 179 YYSTAVDIWSLGC-IFAEMVTRRALFPGDSEIDQ 211

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/154 (22%), Positives = 68/154 (44%), Gaps = 27/154 (17%)
Query: 432 IVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLD 491
           + +  G+ L  G   +++ EY   GS  D L  G   + Q IA+            +  +
Sbjct: 83  VTKYYGSYLK-GSKLWIIMEYLGGGSALDLLRAGPFDEFQ-IAT------------MLKE 128
Query: 492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNP- 550
           +   L Y+H   +   +HR+IK+ N+ L E+ + ++ +FG+A  + D       +   P 
Sbjct: 129 ILKGLDYLH---SEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF 185
Query: 551 ---------ASWSMGIDIFAYGIVLLEVLSGQTP 575
                    +++    DI++ GI  +E+  G+ P
Sbjct: 186 WMAPEVIQQSAYDSKADIWSLGITAIELAKGEPP 219

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 44/191 (23%), Positives = 89/191 (46%), Gaps = 35/191 (18%)
Query: 407 KRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGL 466
           K TEH   T+ E Q+++H     P +V L     T+     L+ +Y   G L  + H  L
Sbjct: 100 KTTEH---TRTERQVLEH-IRQSPFLVTLHYAFQTE-TKLHLILDYINGGEL--FTH--L 150
Query: 467 AMKNQFIASCYCFLTWSQRLRICL-DVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNA 525
           + + +F             ++I + ++ +AL+++H +     ++R+IK  NI LD   + 
Sbjct: 151 SQRERFT---------EHEVQIYVGEIVLALEHLHKL---GIIYRDIKLENILLDSNGHV 198
Query: 526 RVGNFGMAR-CVNDDTE------------SPQFYSTNPASWSMGIDIFAYGIVLLEVLSG 572
            + +FG+++  V D+TE            +P       +     +D ++ G+++ E+L+G
Sbjct: 199 VLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTG 258
Query: 573 QTPINRPRKKD 583
            +P     +K+
Sbjct: 259 ASPFTVDGEKN 269

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 93/214 (43%), Gaps = 45/214 (21%)
Query: 392 GAVYHGR--LNGKNLAIKR----TEHEVITKL---EMQLVQHATHHHPNIVRLLGTCLTD 442
           G VY  R  L G+ +A+K+    TE E +      E+ L++    +HPNIV+LL    T+
Sbjct: 17  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--NHPNIVKLLDVIHTE 74
Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
               +LVFE+      K      L      +   Y F    Q L+      +A  + H V
Sbjct: 75  N-KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF----QLLQ-----GLAFCHSHRV 124
Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR------------CVNDDTESPQ------ 544
           +     HR++K +N+ ++ E   ++ +FG+AR             V     +P+      
Sbjct: 125 L-----HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 179
Query: 545 FYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR 578
           +YST    WS+G  IFA  +    +  G + I++
Sbjct: 180 YYSTAVDIWSLGC-IFAEMVTRRALFPGDSEIDQ 212

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 43.9 bits (102), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 97/230 (42%), Gaps = 49/230 (21%)
Query: 380 ATEKFNSSNRI----EGAVYHGR--LNGKNLAIKR----TEHEVITKL---EMQLVQHAT 426
           + E F    +I     G VY  R  L G+ +A+K+    TE E +      E+ L++   
Sbjct: 3   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL- 61
Query: 427 HHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRL 486
            +HPNIV+LL    T+    +LVFE+      K      L      +   Y F    Q L
Sbjct: 62  -NHPNIVKLLDVIHTEN-KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF----QLL 115
Query: 487 RICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR------------ 534
           +      +A  + H V+     HR++K  N+ ++ E   ++ +FG+AR            
Sbjct: 116 Q-----GLAFCHSHRVL-----HRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE 165
Query: 535 CVNDDTESPQ------FYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR 578
            V     +P+      +YST    WS+G  IFA  +    +  G + I++
Sbjct: 166 VVTLWYRAPEILLGCKYYSTAVDIWSLGC-IFAEMVTRRALFPGDSEIDQ 214

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 97/230 (42%), Gaps = 49/230 (21%)
Query: 380 ATEKFNSSNRI----EGAVYHGR--LNGKNLAIKR----TEHEVITKL---EMQLVQHAT 426
           + E F    +I     G VY  R  L G+ +A+K+    TE E +      E+ L++   
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL- 62
Query: 427 HHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRL 486
            +HPNIV+LL    T+    +LVFE+         LH  L       A     L   +  
Sbjct: 63  -NHPNIVKLLDVIHTEN-KLYLVFEF---------LHQDLKTFMDASALTGIPLPLIKSY 111
Query: 487 RICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR------------ 534
              L   +A  + H V+     HR++K +N+ ++ E   ++ +FG+AR            
Sbjct: 112 LFQLLQGLAFCHSHRVL-----HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHE 166
Query: 535 CVNDDTESPQ------FYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR 578
            V     +P+      +YST    WS+G  IFA  +    +  G + I++
Sbjct: 167 VVTLWYRAPEILLGCKYYSTAVDIWSLGC-IFAEMVTRRALFPGDSEIDQ 215

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 86/204 (42%), Gaps = 35/204 (17%)
Query: 392 GAVYHGR--LNGKNLAIKRTEHEVITKLEMQLVQ---HATHHHPNIVRLLGTCLTDGPHS 446
           G VY  +    G   A K  E +   +LE  +V+    AT  HP IV+LLG    DG   
Sbjct: 33  GKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDG-KL 91
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           +++ E+   G++           +  +      LT  Q   +C  +  AL ++H   +  
Sbjct: 92  WIMIEFCPGGAV-----------DAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKR 137
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGM-ARCVNDDTESPQFYST--------------NPA 551
            +HR++K+ N+ +  E + R+ +FG+ A+ +    +   F  T                 
Sbjct: 138 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDT 197
Query: 552 SWSMGIDIFAYGIVLLEVLSGQTP 575
            +    DI++ GI L+E+   + P
Sbjct: 198 PYDYKADIWSLGITLIEMAQIEPP 221

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 59/228 (25%), Positives = 97/228 (42%), Gaps = 49/228 (21%)
Query: 382 EKFNSSNRI----EGAVYHGR--LNGKNLAIKR----TEHEVITKL---EMQLVQHATHH 428
           E F    +I     G VY  R  L G+ +A+K+    TE E +      E+ L++    +
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--N 61
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HPNIV+LL    T+    +LVFE+      K      L      +   Y F    Q L+ 
Sbjct: 62  HPNIVKLLDVIHTEN-KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF----QLLQ- 115
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR------------CV 536
                +A  + H V+     HR++K +N+ ++ E   ++ +FG+AR             V
Sbjct: 116 ----GLAFCHSHRVL-----HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVV 166
Query: 537 NDDTESPQ------FYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR 578
                +P+      +YST    WS+G  IFA  +    +  G + I++
Sbjct: 167 TLWYRAPEILLGCKYYSTAVDIWSLGC-IFAEMVTRRALFPGDSEIDQ 213

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 97/230 (42%), Gaps = 49/230 (21%)
Query: 380 ATEKFNSSNRI----EGAVYHGR--LNGKNLAIKR----TEHEVITKL---EMQLVQHAT 426
           + E F    +I     G VY  R  L G+ +A+K+    TE E +      E+ L++   
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL- 60
Query: 427 HHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRL 486
            +HPNIV+LL    T+    +LVFE+      K      L      +   Y F    Q L
Sbjct: 61  -NHPNIVKLLDVIHTEN-KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF----QLL 114
Query: 487 RICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR------------ 534
           +      +A  + H V+     HR++K  N+ ++ E   ++ +FG+AR            
Sbjct: 115 Q-----GLAFCHSHRVL-----HRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE 164
Query: 535 CVNDDTESPQ------FYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR 578
            V     +P+      +YST    WS+G  IFA  +    +  G + I++
Sbjct: 165 VVTLWYRAPEILLGCKYYSTAVDIWSLGC-IFAEMVTRRALFPGDSEIDQ 213

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 86/204 (42%), Gaps = 35/204 (17%)
Query: 392 GAVYHGR--LNGKNLAIKRTEHEVITKLEMQLVQ---HATHHHPNIVRLLGTCLTDGPHS 446
           G VY  +    G   A K  E +   +LE  +V+    AT  HP IV+LLG    DG   
Sbjct: 25  GKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDG-KL 83
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           +++ E+   G++           +  +      LT  Q   +C  +  AL ++H   +  
Sbjct: 84  WIMIEFCPGGAV-----------DAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKR 129
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGM-ARCVNDDTESPQFYST--------------NPA 551
            +HR++K+ N+ +  E + R+ +FG+ A+ +    +   F  T                 
Sbjct: 130 IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDT 189
Query: 552 SWSMGIDIFAYGIVLLEVLSGQTP 575
            +    DI++ GI L+E+   + P
Sbjct: 190 PYDYKADIWSLGITLIEMAQIEPP 213

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 35/152 (23%), Positives = 68/152 (44%), Gaps = 23/152 (15%)
Query: 392 GAVYHGRLNGKNLAIK--RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDG---PHS 446
           G V+ G+  G+ +A+K   +  E     E ++ Q     H NI+  +     D       
Sbjct: 56  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 115
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM--- 503
           +LV +Y ++GSL D+L       N++  +    +      ++ L  A  L ++H  +   
Sbjct: 116 WLVSDYHEHGSLFDYL-------NRYTVTVEGMI------KLALSTASGLAHLHMEIVGT 162
Query: 504 --NPSYVHRNIKSRNIFLDEEFNARVGNFGMA 533
              P+  HR++KS+NI + +     + + G+A
Sbjct: 163 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 194

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/159 (24%), Positives = 70/159 (44%), Gaps = 27/159 (16%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HPNI++L    L D    ++V E    G L D     +  + +F        +     RI
Sbjct: 80  HPNIMKLF-EILEDSSSFYIVGELYTGGELFD----EIIKRKRF--------SEHDAARI 126
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLD---EEFNARVGNFGMARCVNDDTESPQ- 544
              V   + YMH     + VHR++K  NI L+   ++ + ++ +FG++ C   +T+    
Sbjct: 127 IKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR 183
Query: 545 ---FYSTNP----ASWSMGIDIFAYGIVLLEVLSGQTPI 576
               Y   P     ++    D+++ G++L  +LSG  P 
Sbjct: 184 IGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 76/182 (41%), Gaps = 38/182 (20%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HPNIVRL  +   +G H +LVF+    G L + +           + C            
Sbjct: 89  HPNIVRLHDSISEEGFH-YLVFDLVTGGELFEDIVAREYYSEADASHC------------ 135
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNA---RVGNFGMARCVNDDTE---- 541
              +   L+ ++H+     VHR++K  N+ L  +      ++ +FG+A  V  + +    
Sbjct: 136 ---IHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFG 192
Query: 542 --------SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDEGSVWLSEKI 593
                   SP+    +P  +   +DI+A G++L  +L G  P       DE    L ++I
Sbjct: 193 FAGTPGYLSPEVLRKDP--YGKPVDIWACGVILYILLVGYPPF-----WDEDQHKLYQQI 245
Query: 594 KS 595
           K+
Sbjct: 246 KA 247

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 26/106 (24%), Positives = 52/106 (49%), Gaps = 19/106 (17%)
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYS 547
           IC  +   L+ + ++ + + +HR++K  N+ L+   + ++ +FG+AR  + D +   F +
Sbjct: 126 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLT 185
Query: 548 T--------------NPASWSMGIDIFAYGIVLLEVLSGQTPINRP 579
                          N   ++  IDI++ G +L E+LS     NRP
Sbjct: 186 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-----NRP 226

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 43.5 bits (101), Expect = 3e-04,   Method: Compositional matrix adjust.
 Identities = 39/159 (24%), Positives = 70/159 (44%), Gaps = 27/159 (16%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HPNI++L    L D    ++V E    G L D     +  + +F        +     RI
Sbjct: 80  HPNIMKLF-EILEDSSSFYIVGELYTGGELFD----EIIKRKRF--------SEHDAARI 126
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLD---EEFNARVGNFGMARCVNDDTESPQ- 544
              V   + YMH     + VHR++K  NI L+   ++ + ++ +FG++ C   +T+    
Sbjct: 127 IKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR 183
Query: 545 ---FYSTNP----ASWSMGIDIFAYGIVLLEVLSGQTPI 576
               Y   P     ++    D+++ G++L  +LSG  P 
Sbjct: 184 IGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 97/230 (42%), Gaps = 49/230 (21%)
Query: 380 ATEKFNSSNRI----EGAVYHGR--LNGKNLAIKR----TEHEVITKL---EMQLVQHAT 426
           + E F    +I     G VY  R  L G+ +A+K+    TE E +      E+ L++   
Sbjct: 4   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL- 62
Query: 427 HHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRL 486
            +HPNIV+LL    T+    +LVFE+      K      L      +   Y F    Q L
Sbjct: 63  -NHPNIVKLLDVIHTEN-KLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLF----QLL 116
Query: 487 RICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR------------ 534
           +      +A  + H V+     HR++K  N+ ++ E   ++ +FG+AR            
Sbjct: 117 Q-----GLAFCHSHRVL-----HRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE 166
Query: 535 CVNDDTESPQ------FYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR 578
            V     +P+      +YST    WS+G  IFA  +    +  G + I++
Sbjct: 167 VVTLWYRAPEILLGCKYYSTAVDIWSLGC-IFAEMVTRRALFPGDSEIDQ 215

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 56/214 (26%), Positives = 91/214 (42%), Gaps = 45/214 (21%)
Query: 392 GAVYHGR--LNGKNLAIKR----TEHEVITKL---EMQLVQHATHHHPNIVRLLGTCLTD 442
           G VY  R  L G+ +A+K+    TE E +      E+ L++    +HPNIV+LL    T+
Sbjct: 17  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--NHPNIVKLLDVIHTE 74
Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
               +LVFE+      K      L      +   Y F    Q L  C        + H V
Sbjct: 75  N-KLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLF-QLLQGLSFC--------HSHRV 124
Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR------------CVNDDTESPQ------ 544
           +     HR++K +N+ ++ E   ++ +FG+AR             V     +P+      
Sbjct: 125 L-----HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCK 179
Query: 545 FYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR 578
           +YST    WS+G  IFA  +    +  G + I++
Sbjct: 180 YYSTAVDIWSLGC-IFAEMVTRRALFPGDSEIDQ 212

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 41/196 (20%), Positives = 85/196 (43%), Gaps = 32/196 (16%)
Query: 394 VYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYA 453
           +Y  R+  K L +   E     + E  + + A++H P +V L  +C       F V EY 
Sbjct: 79  IYAMRVVKKEL-VNDDEDIDWVQTEKHVFEQASNH-PFLVGL-HSCFQTESRLFFVIEYV 135
Query: 454 KNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIK 513
             G L   +     +  +  A  Y             ++++AL Y+H       ++R++K
Sbjct: 136 NGGDLMFHMQRQRKLPEEH-ARFYS-----------AEISLALNYLHE---RGIIYRDLK 180
Query: 514 SRNIFLDEEFNARVGNFGMAR------------CVNDDTESPQFYSTNPASWSMGIDIFA 561
             N+ LD E + ++ ++GM +            C   +  +P+        +S  +D +A
Sbjct: 181 LDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFS--VDWWA 238
Query: 562 YGIVLLEVLSGQTPIN 577
            G+++ E+++G++P +
Sbjct: 239 LGVLMFEMMAGRSPFD 254

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 59/275 (21%), Positives = 112/275 (40%), Gaps = 48/275 (17%)
Query: 335 ASVRTTSDKKVSFEGSQSTIEGQIIDTAEQHKRLLESYSIE----------DLRRATEKF 384
           ++V  TS  + + E  Q  +    +D  EQ ++ LE++  +          D  + +E  
Sbjct: 20  SAVNGTSSAETNLEALQKKLLELELD--EQQRKRLEAFLTQKQKVGELKDDDFEKISELG 77
Query: 385 NSSNRIEGAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATHHH----PNIVRLLGTCL 440
             +  +   V H + +G  +A K    E+   +  Q+++     H    P IV   G   
Sbjct: 78  AGNGGVVFKVSH-KPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFY 136
Query: 441 TDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYM- 499
           +DG  S +  E+   GSL   L     +  Q +             ++ + V   L Y+ 
Sbjct: 137 SDGEIS-ICMEHMDGGSLDQVLKKAGRIPEQILG------------KVSIAVIKGLTYLR 183
Query: 500 --HHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNP------- 550
             H +M     HR++K  NI ++     ++ +FG++  + D   +  F  T         
Sbjct: 184 EKHKIM-----HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVGTRSYMSPERL 237
Query: 551 --ASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKD 583
               +S+  DI++ G+ L+E+  G+ PI  P  K+
Sbjct: 238 QGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKE 272

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 53/210 (25%), Positives = 96/210 (45%), Gaps = 60/210 (28%)
Query: 402 KNLAIKRTEHEVITKLEMQLVQHATHH--------HPNIVRLL------GTCLTDGPHS- 446
           K +AIK+     I   + Q V+HA           H NIV++       G+ LTD   S 
Sbjct: 37  KRVAIKK-----IVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSL 91
Query: 447 ------FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH 500
                 ++V EY +   L + L  G  ++    A  + +    Q LR        L+Y+H
Sbjct: 92  TELNSVYIVQEYMET-DLANVLEQGPLLEEH--ARLFMY----QLLR-------GLKYIH 137
Query: 501 HVMNPSYVHRNIKSRNIFLD-EEFNARVGNFGMARCVNDDT---------------ESPQ 544
              + + +HR++K  N+F++ E+   ++G+FG+AR ++                   SP+
Sbjct: 138 ---SANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPR 194
Query: 545 FYSTNPASWSMGIDIFAYGIVLLEVLSGQT 574
               +P +++  ID++A G +  E+L+G+T
Sbjct: 195 LL-LSPNNYTKAIDMWAAGCIFAEMLTGKT 223

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 43.5 bits (101), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/106 (24%), Positives = 52/106 (49%), Gaps = 19/106 (17%)
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYS 547
           IC  +   L+ + ++ + + +HR++K  N+ L+   + ++ +FG+AR  + D +   F +
Sbjct: 130 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT 189
Query: 548 T--------------NPASWSMGIDIFAYGIVLLEVLSGQTPINRP 579
                          N   ++  IDI++ G +L E+LS     NRP
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-----NRP 230

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQFYST 548
           +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + ++Y  
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRA 190
Query: 549 -----NPASWSMGIDIFAYGIVLLEVLSGQT 574
                N   ++  +DI++ G ++ E+L+G+T
Sbjct: 191 PEIMLNAMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 24/95 (25%), Positives = 44/95 (46%), Gaps = 21/95 (22%)
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM--- 503
           +L+  +   GSL D+L G +             +TW++   +   ++  L Y+H  +   
Sbjct: 89  WLITAFHDKGSLTDYLKGNI-------------ITWNELCHVAETMSRGLSYLHEDVPWC 135
Query: 504 -----NPSYVHRNIKSRNIFLDEEFNARVGNFGMA 533
                 PS  HR+ KS+N+ L  +  A + +FG+A
Sbjct: 136 RGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLA 170

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 97/230 (42%), Gaps = 49/230 (21%)
Query: 380 ATEKFNSSNRI----EGAVYHGR--LNGKNLAIKR----TEHEVITKL---EMQLVQHAT 426
           + E F    +I     G VY  R  L G+ +A+K+    TE E +      E+ L++   
Sbjct: 2   SMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL- 60
Query: 427 HHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRL 486
            +HPNIV+LL    T+    +LVFE+      K      L      +   Y F    Q L
Sbjct: 61  -NHPNIVKLLDVIHTEN-KLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLF----QLL 114
Query: 487 RICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR------------ 534
           +      +A  + H V+     HR++K  N+ ++ E   ++ +FG+AR            
Sbjct: 115 Q-----GLAFCHSHRVL-----HRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHE 164
Query: 535 CVNDDTESPQ------FYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR 578
            V     +P+      +YST    WS+G  IFA  +    +  G + I++
Sbjct: 165 VVTLWYRAPEILLGCKYYSTAVDIWSLGC-IFAEMVTRRALFPGDSEIDQ 213

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 42/182 (23%), Positives = 74/182 (40%), Gaps = 38/182 (20%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HPNIVRL  +   +G H +L+F+    G L + +           + C            
Sbjct: 69  HPNIVRLHDSISEEG-HHYLIFDLVTGGELFEDIVAREYYSEADASHC------------ 115
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNA---RVGNFGMARCVNDDTE---- 541
              +   L+ + H      VHRN+K  N+ L  +      ++ +FG+A  V  + +    
Sbjct: 116 ---IQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG 172
Query: 542 --------SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDEGSVWLSEKI 593
                   SP+    +P  +   +D++A G++L  +L G  P       DE    L ++I
Sbjct: 173 FAGTPGYLSPEVLRKDP--YGKPVDLWACGVILYILLVGYPPF-----WDEDQHRLYQQI 225
Query: 594 KS 595
           K+
Sbjct: 226 KA 227

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 39/167 (23%), Positives = 72/167 (43%), Gaps = 24/167 (14%)
Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLR 487
           HHPNIV    T        +LV +    GS+ D +   +A K +  +      T +  LR
Sbjct: 71  HHPNIVSYY-TSFVVKDELWLVMKLLSGGSVLDIIKHIVA-KGEHKSGVLDESTIATILR 128
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARC------VNDDTE 541
             L+    L+Y+H       +HR++K+ NI L E+ + ++ +FG++        +  +  
Sbjct: 129 EVLE---GLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKV 182
Query: 542 SPQFYST----------NPASWSMGIDIFAYGIVLLEVLSGQTPINR 578
              F  T              +    DI+++GI  +E+ +G  P ++
Sbjct: 183 RKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK 229

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/106 (24%), Positives = 52/106 (49%), Gaps = 19/106 (17%)
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYS 547
           IC  +   L+ + ++ + + +HR++K  N+ L+   + ++ +FG+AR  + D +   F +
Sbjct: 146 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT 205
Query: 548 T--------------NPASWSMGIDIFAYGIVLLEVLSGQTPINRP 579
                          N   ++  IDI++ G +L E+LS     NRP
Sbjct: 206 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-----NRP 246

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/106 (24%), Positives = 52/106 (49%), Gaps = 19/106 (17%)
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYS 547
           IC  +   L+ + ++ + + +HR++K  N+ L+   + ++ +FG+AR  + D +   F +
Sbjct: 130 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT 189
Query: 548 T--------------NPASWSMGIDIFAYGIVLLEVLSGQTPINRP 579
                          N   ++  IDI++ G +L E+LS     NRP
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-----NRP 230

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 26/106 (24%), Positives = 52/106 (49%), Gaps = 19/106 (17%)
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYS 547
           IC  +   L+ + ++ + + +HR++K  N+ L+   + ++ +FG+AR  + D +   F +
Sbjct: 126 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT 185
Query: 548 T--------------NPASWSMGIDIFAYGIVLLEVLSGQTPINRP 579
                          N   ++  IDI++ G +L E+LS     NRP
Sbjct: 186 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-----NRP 226

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 39/159 (24%), Positives = 70/159 (44%), Gaps = 27/159 (16%)
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HPNI++L    L D    ++V E    G L D     +  + +F        +     RI
Sbjct: 80  HPNIMKLF-EILEDSSSFYIVGELYTGGELFD----EIIKRKRF--------SEHDAARI 126
Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLD---EEFNARVGNFGMARCVNDDTESPQ- 544
              V   + YMH     + VHR++K  NI L+   ++ + ++ +FG++ C   +T+    
Sbjct: 127 IKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDR 183
Query: 545 ---FYSTNP----ASWSMGIDIFAYGIVLLEVLSGQTPI 576
               Y   P     ++    D+++ G++L  +LSG  P 
Sbjct: 184 IGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPF 222

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 35/152 (23%), Positives = 68/152 (44%), Gaps = 23/152 (15%)
Query: 392 GAVYHGRLNGKNLAIK--RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDG---PHS 446
           G V+ G+  G+ +A+K   +  E     E ++ Q     H NI+  +     D       
Sbjct: 43  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 102
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM--- 503
           +LV +Y ++GSL D+L       N++  +    +      ++ L  A  L ++H  +   
Sbjct: 103 WLVSDYHEHGSLFDYL-------NRYTVTVEGMI------KLALSTASGLAHLHMEIVGT 149
Query: 504 --NPSYVHRNIKSRNIFLDEEFNARVGNFGMA 533
              P+  HR++KS+NI + +     + + G+A
Sbjct: 150 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 181

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 22/95 (23%), Positives = 53/95 (55%), Gaps = 11/95 (11%)
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQ 544
           +   +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + +
Sbjct: 135 LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR 191
Query: 545 FYST-----NPASWSMGIDIFAYGIVLLEVLSGQT 574
           +Y       N   ++  +DI++ G ++ E+L+G+T
Sbjct: 192 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 226

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 43.1 bits (100), Expect = 4e-04,   Method: Compositional matrix adjust.
 Identities = 22/95 (23%), Positives = 53/95 (55%), Gaps = 11/95 (11%)
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQ 544
           +   +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + +
Sbjct: 141 LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR 197
Query: 545 FYST-----NPASWSMGIDIFAYGIVLLEVLSGQT 574
           +Y       N   ++  +DI++ G ++ E+L+G+T
Sbjct: 198 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 232

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 22/95 (23%), Positives = 53/95 (55%), Gaps = 11/95 (11%)
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQ 544
           +   +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + +
Sbjct: 135 LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR 191
Query: 545 FYST-----NPASWSMGIDIFAYGIVLLEVLSGQT 574
           +Y       N   ++  +DI++ G ++ E+L+G+T
Sbjct: 192 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 226

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 102/232 (43%), Gaps = 57/232 (24%)
Query: 382 EKFNSSNRI----EGAVYHGR--LNGKNLAIKR----TEHEVITKL---EMQLVQHATHH 428
           E F    +I     G VY  R  L G+ +A+K+    TE E +      E+ L++    +
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKEL--N 59
Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG----GLAMKNQFIASCYCFLTWSQ 484
           HPNIV+LL    T+    +LVFE+     LK ++      G+ +    +   Y F    Q
Sbjct: 60  HPNIVKLLDVIHTEN-KLYLVFEHVHQ-DLKTFMDASALTGIPLP---LIKSYLF----Q 110
Query: 485 RLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR---------- 534
            L+      +A  + H V+     HR++K +N+ ++ E   ++ +FG+AR          
Sbjct: 111 LLQ-----GLAFCHSHRVL-----HRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT 160
Query: 535 --CVNDDTESPQ------FYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR 578
              V     +P+      +YST    WS+G  IFA  +    +  G + I++
Sbjct: 161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGC-IFAEMVTRRALFPGDSEIDQ 211

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 22/95 (23%), Positives = 53/95 (55%), Gaps = 11/95 (11%)
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQ 544
           +   +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + +
Sbjct: 130 LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMTGYVATR 186
Query: 545 FYST-----NPASWSMGIDIFAYGIVLLEVLSGQT 574
           +Y       N   ++  +DI++ G ++ E+L+G+T
Sbjct: 187 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 39/167 (23%), Positives = 72/167 (43%), Gaps = 24/167 (14%)
Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLR 487
           HHPNIV    T        +LV +    GS+ D +   +A K +  +      T +  LR
Sbjct: 66  HHPNIVSYY-TSFVVKDELWLVMKLLSGGSVLDIIKHIVA-KGEHKSGVLDESTIATILR 123
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARC------VNDDTE 541
             L+    L+Y+H       +HR++K+ NI L E+ + ++ +FG++        +  +  
Sbjct: 124 EVLE---GLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKV 177
Query: 542 SPQFYST----------NPASWSMGIDIFAYGIVLLEVLSGQTPINR 578
              F  T              +    DI+++GI  +E+ +G  P ++
Sbjct: 178 RKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHK 224

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 43.1 bits (100), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 26/106 (24%), Positives = 52/106 (49%), Gaps = 19/106 (17%)
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYS 547
           IC  +   L+ + ++ + + +HR++K  N+ L+   + ++ +FG+AR  + D +   F +
Sbjct: 126 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLT 185
Query: 548 T--------------NPASWSMGIDIFAYGIVLLEVLSGQTPINRP 579
                          N   ++  IDI++ G +L E+LS     NRP
Sbjct: 186 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-----NRP 226

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 50/230 (21%), Positives = 95/230 (41%), Gaps = 36/230 (15%)
Query: 375 EDLRRATEKFNSSNRIEGAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATHHH----P 430
           +D  R +E    +  +   V H R +G  +A K    E+   +  Q+++     H    P
Sbjct: 16  DDFERISELGAGNGGVVTKVQH-RPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSP 74
Query: 431 NIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICL 490
            IV   G   +DG  S +  E+   GSL   L     +  + +             ++ +
Sbjct: 75  YIVGFYGAFYSDGEIS-ICMEHMDGGSLDQVLKEAKRIPEEILG------------KVSI 121
Query: 491 DVAMALQYM---HHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYS 547
            V   L Y+   H +M     HR++K  NI ++     ++ +FG++  + D   +  F  
Sbjct: 122 AVLRGLAYLREKHQIM-----HRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN-SFVG 175
Query: 548 TNP---------ASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDEGSVW 588
           T             +S+  DI++ G+ L+E+  G+ PI  P  K+  +++
Sbjct: 176 TRSYMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPIPPPDAKELEAIF 225

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 26/106 (24%), Positives = 52/106 (49%), Gaps = 19/106 (17%)
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYS 547
           IC  +   L+ + ++ + + +HR++K  N+ L+   + ++ +FG+AR  + D +   F +
Sbjct: 130 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 548 T--------------NPASWSMGIDIFAYGIVLLEVLSGQTPINRP 579
                          N   ++  IDI++ G +L E+LS     NRP
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-----NRP 230

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 84/198 (42%), Gaps = 35/198 (17%)
Query: 394 VYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYA 453
           VY  +L  K   IKR++     + E  ++  A  + P +V+L      D  + ++V EY 
Sbjct: 101 VYAMKLLSKFEMIKRSDSAFFWE-ERDIMAFA--NSPWVVQLF-YAFQDDRYLYMVMEYM 156
Query: 454 KNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIK 513
             G L +       M N  +        W++      +V +AL  +H +    ++HR++K
Sbjct: 157 PGGDLVN------LMSNYDVPE-----KWARFY--TAEVVLALDAIHSM---GFIHRDVK 200
Query: 514 SRNIFLDEEFNARVGNF---------GMARCVND----DTESPQFYSTNPASWSMG--ID 558
             N+ LD+  + ++ +F         GM RC       D  SP+   +       G   D
Sbjct: 201 PDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECD 260
Query: 559 IFAYGIVLLEVLSGQTPI 576
            ++ G+ L E+L G TP 
Sbjct: 261 WWSVGVFLYEMLVGDTPF 278

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 26/106 (24%), Positives = 52/106 (49%), Gaps = 19/106 (17%)
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYS 547
           IC  +   L+ + ++ + + +HR++K  N+ L+   + ++ +FG+AR  + D +   F +
Sbjct: 131 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 190
Query: 548 T--------------NPASWSMGIDIFAYGIVLLEVLSGQTPINRP 579
                          N   ++  IDI++ G +L E+LS     NRP
Sbjct: 191 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-----NRP 231

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 46/202 (22%), Positives = 92/202 (45%), Gaps = 40/202 (19%)
Query: 393 AVYHGRLNGKNLAIKRTE-------HEVITKLEMQLVQHATHHHPNIVRLL-----GTCL 440
           + Y  RL  K +A+K+         H   T  E++L++H  H   N++ LL      T +
Sbjct: 46  SAYDARLRQK-VAVKKLSRPFQSLIHARRTYRELRLLKHLKHE--NVIGLLDVFTPATSI 102
Query: 441 TDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH 500
            D    +LV        L +       +K+Q ++  +      Q LR        L+Y+H
Sbjct: 103 EDFSEVYLVTTLM-GADLNN------IVKSQALSDEHVQFLVYQLLR-------GLKYIH 148
Query: 501 HVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQFYST-----NPAS 552
              +   +HR++K  N+ ++E+   R+ +FG+AR  +++     + ++Y       N   
Sbjct: 149 ---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMTGYVATRWYRAPEIMLNWMH 205
Query: 553 WSMGIDIFAYGIVLLEVLSGQT 574
           ++  +DI++ G ++ E+L G+ 
Sbjct: 206 YNQTVDIWSVGCIMAELLQGKA 227

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 26/106 (24%), Positives = 52/106 (49%), Gaps = 19/106 (17%)
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYS 547
           IC  +   L+ + ++ + + +HR++K  N+ L+   + ++ +FG+AR  + D +   F +
Sbjct: 132 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 191
Query: 548 T--------------NPASWSMGIDIFAYGIVLLEVLSGQTPINRP 579
                          N   ++  IDI++ G +L E+LS     NRP
Sbjct: 192 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-----NRP 232

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 26/106 (24%), Positives = 52/106 (49%), Gaps = 19/106 (17%)
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYS 547
           IC  +   L+ + ++ + + +HR++K  N+ L+   + ++ +FG+AR  + D +   F +
Sbjct: 123 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 182
Query: 548 T--------------NPASWSMGIDIFAYGIVLLEVLSGQTPINRP 579
                          N   ++  IDI++ G +L E+LS     NRP
Sbjct: 183 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-----NRP 223

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 42.7 bits (99), Expect = 5e-04,   Method: Compositional matrix adjust.
 Identities = 26/106 (24%), Positives = 52/106 (49%), Gaps = 19/106 (17%)
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYS 547
           IC  +   L+ + ++ + + +HR++K  N+ L+   + ++ +FG+AR  + D +   F +
Sbjct: 130 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 548 T--------------NPASWSMGIDIFAYGIVLLEVLSGQTPINRP 579
                          N   ++  IDI++ G +L E+LS     NRP
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-----NRP 230

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/106 (24%), Positives = 52/106 (49%), Gaps = 19/106 (17%)
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYS 547
           IC  +   L+ + ++ + + +HR++K  N+ L+   + ++ +FG+AR  + D +   F +
Sbjct: 128 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLT 187
Query: 548 T--------------NPASWSMGIDIFAYGIVLLEVLSGQTPINRP 579
                          N   ++  IDI++ G +L E+LS     NRP
Sbjct: 188 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-----NRP 228

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/106 (24%), Positives = 52/106 (49%), Gaps = 19/106 (17%)
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYS 547
           IC  +   L+ + ++ + + +HR++K  N+ L+   + ++ +FG+AR  + D +   F +
Sbjct: 130 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 548 T--------------NPASWSMGIDIFAYGIVLLEVLSGQTPINRP 579
                          N   ++  IDI++ G +L E+LS     NRP
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-----NRP 230

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/106 (24%), Positives = 52/106 (49%), Gaps = 19/106 (17%)
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYS 547
           IC  +   L+ + ++ + + +HR++K  N+ L+   + ++ +FG+AR  + D +   F +
Sbjct: 134 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 193
Query: 548 T--------------NPASWSMGIDIFAYGIVLLEVLSGQTPINRP 579
                          N   ++  IDI++ G +L E+LS     NRP
Sbjct: 194 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-----NRP 234

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/106 (24%), Positives = 52/106 (49%), Gaps = 19/106 (17%)
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYS 547
           IC  +   L+ + ++ + + +HR++K  N+ L+   + ++ +FG+AR  + D +   F +
Sbjct: 126 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 185
Query: 548 T--------------NPASWSMGIDIFAYGIVLLEVLSGQTPINRP 579
                          N   ++  IDI++ G +L E+LS     NRP
Sbjct: 186 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-----NRP 226

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/106 (24%), Positives = 52/106 (49%), Gaps = 19/106 (17%)
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYS 547
           IC  +   L+ + ++ + + +HR++K  N+ L+   + ++ +FG+AR  + D +   F +
Sbjct: 124 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 183
Query: 548 T--------------NPASWSMGIDIFAYGIVLLEVLSGQTPINRP 579
                          N   ++  IDI++ G +L E+LS     NRP
Sbjct: 184 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-----NRP 224

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/106 (24%), Positives = 52/106 (49%), Gaps = 19/106 (17%)
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYS 547
           IC  +   L+ + ++ + + +HR++K  N+ L+   + ++ +FG+AR  + D +   F +
Sbjct: 128 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 187
Query: 548 T--------------NPASWSMGIDIFAYGIVLLEVLSGQTPINRP 579
                          N   ++  IDI++ G +L E+LS     NRP
Sbjct: 188 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-----NRP 228

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/106 (24%), Positives = 52/106 (49%), Gaps = 19/106 (17%)
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYS 547
           IC  +   L+ + ++ + + +HR++K  N+ L+   + ++ +FG+AR  + D +   F +
Sbjct: 124 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 183
Query: 548 T--------------NPASWSMGIDIFAYGIVLLEVLSGQTPINRP 579
                          N   ++  IDI++ G +L E+LS     NRP
Sbjct: 184 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-----NRP 224

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/106 (24%), Positives = 52/106 (49%), Gaps = 19/106 (17%)
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYS 547
           IC  +   L+ + ++ + + +HR++K  N+ L+   + ++ +FG+AR  + D +   F +
Sbjct: 128 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 187
Query: 548 T--------------NPASWSMGIDIFAYGIVLLEVLSGQTPINRP 579
                          N   ++  IDI++ G +L E+LS     NRP
Sbjct: 188 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-----NRP 228

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 84/198 (42%), Gaps = 35/198 (17%)
Query: 394 VYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYA 453
           VY  +L  K   IKR++     + E  ++  A  + P +V+L      D  + ++V EY 
Sbjct: 96  VYAMKLLSKFEMIKRSDSAFFWE-ERDIMAFA--NSPWVVQLF-YAFQDDRYLYMVMEYM 151
Query: 454 KNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIK 513
             G L +       M N  +        W++      +V +AL  +H +    ++HR++K
Sbjct: 152 PGGDLVN------LMSNYDVPE-----KWARFY--TAEVVLALDAIHSM---GFIHRDVK 195
Query: 514 SRNIFLDEEFNARVGNF---------GMARCVND----DTESPQFYSTNPASWSMG--ID 558
             N+ LD+  + ++ +F         GM RC       D  SP+   +       G   D
Sbjct: 196 PDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECD 255
Query: 559 IFAYGIVLLEVLSGQTPI 576
            ++ G+ L E+L G TP 
Sbjct: 256 WWSVGVFLYEMLVGDTPF 273

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 35/152 (23%), Positives = 68/152 (44%), Gaps = 23/152 (15%)
Query: 392 GAVYHGRLNGKNLAIK--RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDG---PHS 446
           G V+ G+  G+ +A+K   +  E     E ++ Q     H NI+  +     D       
Sbjct: 18  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 77
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM--- 503
           +LV +Y ++GSL D+L       N++  +    +      ++ L  A  L ++H  +   
Sbjct: 78  WLVSDYHEHGSLFDYL-------NRYTVTVEGMI------KLALSTASGLAHLHMEIVGT 124
Query: 504 --NPSYVHRNIKSRNIFLDEEFNARVGNFGMA 533
              P+  HR++KS+NI + +     + + G+A
Sbjct: 125 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 156

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/106 (24%), Positives = 52/106 (49%), Gaps = 19/106 (17%)
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYS 547
           IC  +   L+ + ++ + + +HR++K  N+ L+   + ++ +FG+AR  + D +   F +
Sbjct: 146 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 205
Query: 548 T--------------NPASWSMGIDIFAYGIVLLEVLSGQTPINRP 579
                          N   ++  IDI++ G +L E+LS     NRP
Sbjct: 206 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-----NRP 246

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 48/198 (24%), Positives = 84/198 (42%), Gaps = 35/198 (17%)
Query: 394 VYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYA 453
           VY  +L  K   IKR++     + E  ++  A  + P +V+L      D  + ++V EY 
Sbjct: 101 VYAMKLLSKFEMIKRSDSAFFWE-ERDIMAFA--NSPWVVQLF-YAFQDDRYLYMVMEYM 156
Query: 454 KNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIK 513
             G L +       M N  +        W++      +V +AL  +H +    ++HR++K
Sbjct: 157 PGGDLVN------LMSNYDVPE-----KWARFY--TAEVVLALDAIHSM---GFIHRDVK 200
Query: 514 SRNIFLDEEFNARVGNF---------GMARCVND----DTESPQFYSTNPASWSMG--ID 558
             N+ LD+  + ++ +F         GM RC       D  SP+   +       G   D
Sbjct: 201 PDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECD 260
Query: 559 IFAYGIVLLEVLSGQTPI 576
            ++ G+ L E+L G TP 
Sbjct: 261 WWSVGVFLYEMLVGDTPF 278

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 26/106 (24%), Positives = 52/106 (49%), Gaps = 19/106 (17%)
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYS 547
           IC  +   L+ + ++ + + +HR++K  N+ L+   + ++ +FG+AR  + D +   F +
Sbjct: 126 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 185
Query: 548 T--------------NPASWSMGIDIFAYGIVLLEVLSGQTPINRP 579
                          N   ++  IDI++ G +L E+LS     NRP
Sbjct: 186 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-----NRP 226

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 35/152 (23%), Positives = 68/152 (44%), Gaps = 23/152 (15%)
Query: 392 GAVYHGRLNGKNLAIK--RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDG---PHS 446
           G V+ G+  G+ +A+K   +  E     E ++ Q     H NI+  +     D       
Sbjct: 23  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 82
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM--- 503
           +LV +Y ++GSL D+L       N++  +    +      ++ L  A  L ++H  +   
Sbjct: 83  WLVSDYHEHGSLFDYL-------NRYTVTVEGMI------KLALSTASGLAHLHMEIVGT 129
Query: 504 --NPSYVHRNIKSRNIFLDEEFNARVGNFGMA 533
              P+  HR++KS+NI + +     + + G+A
Sbjct: 130 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 161

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 35/152 (23%), Positives = 68/152 (44%), Gaps = 23/152 (15%)
Query: 392 GAVYHGRLNGKNLAIK--RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDG---PHS 446
           G V+ G+  G+ +A+K   +  E     E ++ Q     H NI+  +     D       
Sbjct: 20  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 79
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM--- 503
           +LV +Y ++GSL D+L       N++  +    +      ++ L  A  L ++H  +   
Sbjct: 80  WLVSDYHEHGSLFDYL-------NRYTVTVEGMI------KLALSTASGLAHLHMEIVGT 126
Query: 504 --NPSYVHRNIKSRNIFLDEEFNARVGNFGMA 533
              P+  HR++KS+NI + +     + + G+A
Sbjct: 127 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 158

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 35/152 (23%), Positives = 68/152 (44%), Gaps = 23/152 (15%)
Query: 392 GAVYHGRLNGKNLAIK--RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDG---PHS 446
           G V+ G+  G+ +A+K   +  E     E ++ Q     H NI+  +     D       
Sbjct: 17  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76
Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM--- 503
           +LV +Y ++GSL D+L       N++  +    +      ++ L  A  L ++H  +   
Sbjct: 77  WLVSDYHEHGSLFDYL-------NRYTVTVEGMI------KLALSTASGLAHLHMEIVGT 123
Query: 504 --NPSYVHRNIKSRNIFLDEEFNARVGNFGMA 533
              P+  HR++KS+NI + +     + + G+A
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLA 155

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 28/107 (26%), Positives = 52/107 (48%), Gaps = 14/107 (13%)
Query: 491 DVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN- 549
           ++ + L++MH   N   V+R++K  NI LDE  + R+ + G+A C     +      T+ 
Sbjct: 300 EIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHG 355
Query: 550 ---PASWSMGI------DIFAYGIVLLEVLSGQTPINRPRKKDEGSV 587
              P     G+      D F+ G +L ++L G +P  + + KD+  +
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 42.7 bits (99), Expect = 6e-04,   Method: Compositional matrix adjust.
 Identities = 28/107 (26%), Positives = 52/107 (48%), Gaps = 14/107 (13%)
Query: 491 DVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN- 549
           ++ + L++MH   N   V+R++K  NI LDE  + R+ + G+A C     +      T+ 
Sbjct: 300 EIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHG 355
Query: 550 ---PASWSMGI------DIFAYGIVLLEVLSGQTPINRPRKKDEGSV 587
              P     G+      D F+ G +L ++L G +P  + + KD+  +
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/95 (23%), Positives = 53/95 (55%), Gaps = 11/95 (11%)
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQ 544
           +   +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + +
Sbjct: 136 LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR 192
Query: 545 FYST-----NPASWSMGIDIFAYGIVLLEVLSGQT 574
           +Y       N   ++  +DI++ G ++ E+L+G+T
Sbjct: 193 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 227

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/95 (23%), Positives = 53/95 (55%), Gaps = 11/95 (11%)
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQ 544
           +   +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + +
Sbjct: 132 LIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMTGYVATR 188
Query: 545 FYST-----NPASWSMGIDIFAYGIVLLEVLSGQT 574
           +Y       N   ++  +DI++ G ++ E+L+G+T
Sbjct: 189 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 223

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQFYST 548
           +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + ++Y  
Sbjct: 154 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGXVATRWYRA 210
Query: 549 -----NPASWSMGIDIFAYGIVLLEVLSGQT 574
                N   ++  +DI++ G ++ E+L+G+T
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 241

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 42.7 bits (99), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQFYST 548
           +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + ++Y  
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRA 190
Query: 549 -----NPASWSMGIDIFAYGIVLLEVLSGQT 574
                N   ++  +DI++ G ++ E+L+G+T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQFYST 548
           +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + ++Y  
Sbjct: 140 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRA 196
Query: 549 -----NPASWSMGIDIFAYGIVLLEVLSGQT 574
                N   ++  +DI++ G ++ E+L+G+T
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 227

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 39/178 (21%), Positives = 70/178 (39%), Gaps = 40/178 (22%)
Query: 429 HPNIVRLLGT---CLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQR 485
           H NI++ +G      +     +L+  + + GSL D+L   +             ++W++ 
Sbjct: 77  HENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-------------VSWNEL 123
Query: 486 LRICLDVAMALQYMHHVM-------NPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND 538
             I   +A  L Y+H  +        P+  HR+IKS+N+ L     A + +FG+A     
Sbjct: 124 CHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEA 183
Query: 539 DTESPQFYSTNPASWSMG-----------------IDIFAYGIVLLEVLSGQTPINRP 579
              +   +        M                  ID++A G+VL E+ S  T  + P
Sbjct: 184 GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGP 241

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQFYST 548
           +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + ++Y  
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRA 190
Query: 549 -----NPASWSMGIDIFAYGIVLLEVLSGQT 574
                N   ++  +DI++ G ++ E+L+G+T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQFYST 548
           +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + ++Y  
Sbjct: 139 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRA 195
Query: 549 -----NPASWSMGIDIFAYGIVLLEVLSGQT 574
                N   ++  +DI++ G ++ E+L+G+T
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 226

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQFYST 548
           +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + ++Y  
Sbjct: 136 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRA 192
Query: 549 -----NPASWSMGIDIFAYGIVLLEVLSGQT 574
                N   ++  +DI++ G ++ E+L+G+T
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 223

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQFYST 548
           +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + ++Y  
Sbjct: 133 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRA 189
Query: 549 -----NPASWSMGIDIFAYGIVLLEVLSGQT 574
                N   ++  +DI++ G ++ E+L+G+T
Sbjct: 190 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 220

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQFYST 548
           +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + ++Y  
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRA 190
Query: 549 -----NPASWSMGIDIFAYGIVLLEVLSGQT 574
                N   ++  +DI++ G ++ E+L+G+T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQFYST 548
           +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + ++Y  
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRA 190
Query: 549 -----NPASWSMGIDIFAYGIVLLEVLSGQT 574
                N   ++  +DI++ G ++ E+L+G+T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQFYST 548
           +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + ++Y  
Sbjct: 146 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRA 202
Query: 549 -----NPASWSMGIDIFAYGIVLLEVLSGQT 574
                N   ++  +DI++ G ++ E+L+G+T
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 233

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQFYST 548
           +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + ++Y  
Sbjct: 145 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRA 201
Query: 549 -----NPASWSMGIDIFAYGIVLLEVLSGQT 574
                N   ++  +DI++ G ++ E+L+G+T
Sbjct: 202 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 232

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQFYST 548
           +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + ++Y  
Sbjct: 146 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRA 202
Query: 549 -----NPASWSMGIDIFAYGIVLLEVLSGQT 574
                N   ++  +DI++ G ++ E+L+G+T
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 233

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQFYST 548
           +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + ++Y  
Sbjct: 140 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRA 196
Query: 549 -----NPASWSMGIDIFAYGIVLLEVLSGQT 574
                N   ++  +DI++ G ++ E+L+G+T
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 227

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQFYST 548
           +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + ++Y  
Sbjct: 146 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRA 202
Query: 549 -----NPASWSMGIDIFAYGIVLLEVLSGQT 574
                N   ++  +DI++ G ++ E+L+G+T
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 233

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 28/107 (26%), Positives = 52/107 (48%), Gaps = 14/107 (13%)
Query: 491 DVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN- 549
           ++ + L++MH   N   V+R++K  NI LDE  + R+ + G+A C     +      T+ 
Sbjct: 300 EIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHG 355
Query: 550 ---PASWSMGI------DIFAYGIVLLEVLSGQTPINRPRKKDEGSV 587
              P     G+      D F+ G +L ++L G +P  + + KD+  +
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 402

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQFYST 548
           +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + ++Y  
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRA 190
Query: 549 -----NPASWSMGIDIFAYGIVLLEVLSGQT 574
                N   ++  +DI++ G ++ E+L+G+T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQFYST 548
           +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + ++Y  
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGXVATRWYRA 190
Query: 549 -----NPASWSMGIDIFAYGIVLLEVLSGQT 574
                N   ++  +DI++ G ++ E+L+G+T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQFYST 548
           +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + ++Y  
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRA 190
Query: 549 -----NPASWSMGIDIFAYGIVLLEVLSGQT 574
                N   ++  +DI++ G ++ E+L+G+T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQFYST 548
           +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + ++Y  
Sbjct: 141 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRA 197
Query: 549 -----NPASWSMGIDIFAYGIVLLEVLSGQT 574
                N   ++  +DI++ G ++ E+L+G+T
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 228

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQFYST 548
           +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + ++Y  
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRA 190
Query: 549 -----NPASWSMGIDIFAYGIVLLEVLSGQT 574
                N   ++  +DI++ G ++ E+L+G+T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQFYST 548
           +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + ++Y  
Sbjct: 153 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRA 209
Query: 549 -----NPASWSMGIDIFAYGIVLLEVLSGQT 574
                N   ++  +DI++ G ++ E+L+G+T
Sbjct: 210 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 240

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQFYST 548
           +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + ++Y  
Sbjct: 153 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRA 209
Query: 549 -----NPASWSMGIDIFAYGIVLLEVLSGQT 574
                N   ++  +DI++ G ++ E+L+G+T
Sbjct: 210 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 240

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQFYST 548
           +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + ++Y  
Sbjct: 140 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRA 196
Query: 549 -----NPASWSMGIDIFAYGIVLLEVLSGQT 574
                N   ++  +DI++ G ++ E+L+G+T
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 227

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQFYST 548
           +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + ++Y  
Sbjct: 139 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRA 195
Query: 549 -----NPASWSMGIDIFAYGIVLLEVLSGQT 574
                N   ++  +DI++ G ++ E+L+G+T
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 226

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQFYST 548
           +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + ++Y  
Sbjct: 130 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRA 186
Query: 549 -----NPASWSMGIDIFAYGIVLLEVLSGQT 574
                N   ++  +DI++ G ++ E+L+G+T
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 217

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQFYST 548
           +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + ++Y  
Sbjct: 157 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRA 213
Query: 549 -----NPASWSMGIDIFAYGIVLLEVLSGQT 574
                N   ++  +DI++ G ++ E+L+G+T
Sbjct: 214 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 244

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQFYST 548
           +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + ++Y  
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATRWYRA 190
Query: 549 -----NPASWSMGIDIFAYGIVLLEVLSGQT 574
                N   ++  +DI++ G ++ E+L+G+T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 28/107 (26%), Positives = 52/107 (48%), Gaps = 14/107 (13%)
Query: 491 DVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN- 549
           ++ + L++MH   N   V+R++K  NI LDE  + R+ + G+A C     +      T+ 
Sbjct: 299 EIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLA-CDFSKKKPHASVGTHG 354
Query: 550 ---PASWSMGI------DIFAYGIVLLEVLSGQTPINRPRKKDEGSV 587
              P     G+      D F+ G +L ++L G +P  + + KD+  +
Sbjct: 355 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI 401

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQFYST 548
           +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + ++Y  
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATRWYRA 190
Query: 549 -----NPASWSMGIDIFAYGIVLLEVLSGQT 574
                N   ++  +DI++ G ++ E+L+G+T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQFYST 548
           +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + ++Y  
Sbjct: 136 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRA 192
Query: 549 -----NPASWSMGIDIFAYGIVLLEVLSGQT 574
                N   ++  +DI++ G ++ E+L+G+T
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 223

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQFYST 548
           +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + ++Y  
Sbjct: 144 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRA 200
Query: 549 -----NPASWSMGIDIFAYGIVLLEVLSGQT 574
                N   ++  +DI++ G ++ E+L+G+T
Sbjct: 201 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 231

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQFYST 548
           +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + ++Y  
Sbjct: 130 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRA 186
Query: 549 -----NPASWSMGIDIFAYGIVLLEVLSGQT 574
                N   ++  +DI++ G ++ E+L+G+T
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 217

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQFYST 548
           +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + ++Y  
Sbjct: 131 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRA 187
Query: 549 -----NPASWSMGIDIFAYGIVLLEVLSGQT 574
                N   ++  +DI++ G ++ E+L+G+T
Sbjct: 188 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 218

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQFYST 548
           +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + ++Y  
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRA 190
Query: 549 -----NPASWSMGIDIFAYGIVLLEVLSGQT 574
                N   ++  +DI++ G ++ E+L+G+T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQFYST 548
           +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + ++Y  
Sbjct: 157 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMXGYVATRWYRA 213
Query: 549 -----NPASWSMGIDIFAYGIVLLEVLSGQT 574
                N   ++  +DI++ G ++ E+L+G+T
Sbjct: 214 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 244

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQFYST 548
           +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + ++Y  
Sbjct: 131 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRA 187
Query: 549 -----NPASWSMGIDIFAYGIVLLEVLSGQT 574
                N   ++  +DI++ G ++ E+L+G+T
Sbjct: 188 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 218

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 42.4 bits (98), Expect = 7e-04,   Method: Compositional matrix adjust.
 Identities = 42/196 (21%), Positives = 90/196 (45%), Gaps = 36/196 (18%)
Query: 397 GRLNGKNLAIKRTEHEVITKL-------EMQLVQHATHHHPNIVRLLGTCLTDGPHSFLV 449
           GR  G  +AIK+      ++L       E++L++H  H   N++ LL             
Sbjct: 47  GR-TGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHE--NVIGLLDV----------- 92
Query: 450 FEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRL---RICLDVAMALQYMHHVMNPS 506
             +  + +L D+    L M   F+ +    L   ++L   RI   V   L+ + ++    
Sbjct: 93  --FTPDETLDDFTDFYLVMP--FMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAG 148
Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTES---PQFYST-----NPASWSMGID 558
            +HR++K  N+ ++E+   ++ +FG+AR  + +       ++Y       N   ++  +D
Sbjct: 149 IIHRDLKPGNLAVNEDCELKILDFGLARQADSEMXGXVVTRWYRAPEVILNWMRYTQTVD 208
Query: 559 IFAYGIVLLEVLSGQT 574
           I++ G ++ E+++G+T
Sbjct: 209 IWSVGCIMAEMITGKT 224

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQFYST 548
           +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + ++Y  
Sbjct: 132 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRA 188
Query: 549 -----NPASWSMGIDIFAYGIVLLEVLSGQT 574
                N   ++  +DI++ G ++ E+L+G+T
Sbjct: 189 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 219

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQFYST 548
           +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + ++Y  
Sbjct: 136 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRA 192
Query: 549 -----NPASWSMGIDIFAYGIVLLEVLSGQT 574
                N   ++  +DI++ G ++ E+L+G+T
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 223

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQFYST 548
           +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + ++Y  
Sbjct: 130 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMAGFVATRWYRA 186
Query: 549 -----NPASWSMGIDIFAYGIVLLEVLSGQT 574
                N   ++  +DI++ G ++ E+L+G+T
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 217

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQFYST 548
           +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + ++Y  
Sbjct: 154 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRA 210
Query: 549 -----NPASWSMGIDIFAYGIVLLEVLSGQT 574
                N   ++  +DI++ G ++ E+L+G+T
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 241

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQFYST 548
           +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + ++Y  
Sbjct: 154 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRA 210
Query: 549 -----NPASWSMGIDIFAYGIVLLEVLSGQT 574
                N   ++  +DI++ G ++ E+L+G+T
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 241

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQFYST 548
           +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + ++Y  
Sbjct: 130 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRA 186
Query: 549 -----NPASWSMGIDIFAYGIVLLEVLSGQT 574
                N   ++  +DI++ G ++ E+L+G+T
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 217

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 42.4 bits (98), Expect = 8e-04,   Method: Compositional matrix adjust.
 Identities = 22/91 (24%), Positives = 52/91 (57%), Gaps = 11/91 (12%)
Query: 492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQFYST 548
           +   L+Y+H   +   +HR++K  N+ ++E+   ++ +FG+AR  +D+     + ++Y  
Sbjct: 134 ILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRA 190
Query: 549 -----NPASWSMGIDIFAYGIVLLEVLSGQT 574
                N   ++  +DI++ G ++ E+L+G+T
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 221

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 26/106 (24%), Positives = 51/106 (48%), Gaps = 19/106 (17%)
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYS 547
           IC  +   L+ + ++ + + +HR++K  N+ L+   + ++ +FG+AR  + D +   F  
Sbjct: 130 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLX 189
Query: 548 T--------------NPASWSMGIDIFAYGIVLLEVLSGQTPINRP 579
                          N   ++  IDI++ G +L E+LS     NRP
Sbjct: 190 EXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-----NRP 230

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 42.0 bits (97), Expect = 9e-04,   Method: Compositional matrix adjust.
 Identities = 26/106 (24%), Positives = 51/106 (48%), Gaps = 19/106 (17%)
Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYS 547
           IC  +   L+ + ++ + + +HR++K  N+ L+   + ++ +FG+AR  + D +   F  
Sbjct: 131 ICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLX 190
Query: 548 T--------------NPASWSMGIDIFAYGIVLLEVLSGQTPINRP 579
                          N   ++  IDI++ G +L E+LS     NRP
Sbjct: 191 EXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLS-----NRP 231

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	600
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-53
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	5e-50
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	9e-45
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-41
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	6e-39
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	6e-37
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-35
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-35
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-34
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	1e-33
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	2e-33
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	2e-33
3q4u_A	301	Activin receptor type-1; structural genomics conso	9e-33
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-32
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-32
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	4e-32
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	6e-32
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	1e-30
4eby_A	212	Chitin elicitor receptor kinase 1; pathogen-associ	1e-30
4eby_A	212	Chitin elicitor receptor kinase 1; pathogen-associ	4e-04
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	3e-27
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	7e-27
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	8e-27
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-26
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	3e-26
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	7e-26
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	9e-26
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	2e-25
3pls_A	298	Macrophage-stimulating protein receptor; protein k	3e-25
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	3e-25
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	6e-25
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	7e-25
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	7e-25
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	8e-25
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	8e-25
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	8e-25
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-24
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	2e-24
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-24
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	4e-24
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	4e-24
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-23
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	1e-23
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-23
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	2e-23
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	2e-23
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-23
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-23
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-23
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	6e-23
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-23
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	8e-23
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	1e-22
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	1e-22
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-22
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	1e-22
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-22
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	2e-22
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	2e-22
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	2e-22
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-22
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	2e-22
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	2e-22
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	2e-22
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	2e-22
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-22
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-22
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	5e-22
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	8e-22
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	1e-21
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-21
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	3e-21
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	1e-20
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	6e-20
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	2e-19
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	2e-19
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	1e-18
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	2e-18
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	2e-18
2a19_B	284	Interferon-induced, double-stranded RNA-activated	2e-18
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	5e-18
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	6e-17
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-16
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	1e-16
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-16
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	6e-16
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	7e-16
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	1e-15
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-15
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-15
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	5e-15
3ork_A	311	Serine/threonine protein kinase; structural genomi	6e-15
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	7e-15
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	9e-15
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	2e-14
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-14
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	4e-14
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	4e-14
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	5e-14
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	7e-14
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	9e-14
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	1e-13
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-13
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	3e-13
3uqc_A	286	Probable conserved transmembrane protein; structur	3e-13
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	6e-13
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	6e-13
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	8e-13
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	9e-13
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	9e-13
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	1e-12
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-12
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	3e-12
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	4e-12
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	4e-12
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	6e-12
2dyl_A	318	Dual specificity mitogen-activated protein kinase	1e-11
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	1e-11
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-11
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-11
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-11
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-11
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-11
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	5e-11
3o0g_A	292	Cell division protein kinase 5; kinase activator c	6e-11
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	6e-11
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	7e-11
3aln_A	327	Dual specificity mitogen-activated protein kinase;	7e-11
3an0_A	340	Dual specificity mitogen-activated protein kinase;	7e-11
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	9e-11
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-10
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	1e-10
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-10
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	2e-10
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-10
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-10
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-10
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	3e-10
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-10
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-10
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	5e-10
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	8e-10
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	9e-10
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	9e-10
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-09
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-09
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	2e-09
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	3e-09
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-09
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	4e-09
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-09
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	5e-09
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	5e-09
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	6e-09
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	7e-09
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	8e-09
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	9e-09
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-08
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-08
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-08
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	2e-08
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	2e-08
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-08
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	3e-08
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-08
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-08
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-08
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	3e-08
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-08
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	4e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	7e-08
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	1e-06
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	5e-08
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	5e-08
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	5e-08
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	6e-08
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	7e-08
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	8e-08
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-07
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-07
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-07
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-07
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-07
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	2e-07
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	2e-07
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	2e-07
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	4e-07
2djp_A	77	Hypothetical protein SB145; LYSM, structural genom	4e-07
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	5e-07
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	5e-07
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	5e-07
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	6e-07
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	7e-07
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	7e-07
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	9e-07
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	1e-06
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-06
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-06
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	2e-06
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-06
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	2e-06
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-06
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	3e-06
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	3e-06
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	4e-06
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-06
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	7e-06
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	7e-06
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	9e-06
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-05
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-05
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	4e-05
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-05
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	7e-05
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-04
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	1e-04
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-04
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	8e-04

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  185 bits (471), Expect = 1e-53
 Identities = 79/277 (28%), Positives = 129/277 (46%), Gaps = 60/277 (21%)

Query: 360 DTAEQHKRLLE-----SYSIEDLRRATEKFNSSNRI-EG---AVYHGRL-NGKNLAIKR- 408
           D   +    +       +S+ +L+ A++ F++ N +  G    VY GRL +G  +A+KR 
Sbjct: 3   DVPAEEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRL 62

Query: 409 -------------TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKN 455
                        TE E+I+             H N++RL G C        LV+ Y  N
Sbjct: 63  KEERTQGGELQFQTEVEMISMA----------VHRNLLRLRGFC-MTPTERLLVYPYMAN 111

Query: 456 GSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSR 515
           GS+   L      +          L W +R RI L  A  L Y+H   +P  +HR++K+ 
Sbjct: 112 GSVASCLRERPESQ--------PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAA 163

Query: 516 NIFLDEEFNARVGNFGMARCVNDDTES--------------PQFYSTNPASWSMGIDIFA 561
           NI LDEEF A VG+FG+A+ + D  ++              P++ ST  +S     D+F 
Sbjct: 164 NILLDEEFEAVVGDFGLAK-LMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKT--DVFG 220

Query: 562 YGIVLLEVLSGQTPINRPRKKDEGSVWLSEKIKSILQ 598
           YG++LLE+++GQ   +  R  ++  V L + +K +L+
Sbjct: 221 YGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLK 257

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  175 bits (445), Expect = 5e-50
 Identities = 64/248 (25%), Positives = 111/248 (44%), Gaps = 62/248 (25%)

Query: 372 YSIEDLRRATEKFNSSNRI-EG---AVYHGRL-NGKNLAIKR-------------TEHEV 413
             + DL  AT  F+    I  G    VY G L +G  +A+KR             TE E 
Sbjct: 29  VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88

Query: 414 ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFI 473
           ++             HP++V L+G C  +     L+++Y +NG+LK  L+G         
Sbjct: 89  LSFC----------RHPHLVSLIGFC-DERNEMILIYKYMENGNLKRHLYGS-------- 129

Query: 474 ASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA 533
                 ++W QRL IC+  A  L Y+H     + +HR++KS NI LDE F  ++ +FG++
Sbjct: 130 DLPTMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGIS 186

Query: 534 RCVNDDTES--------------PQFYSTN---PASWSMGIDIFAYGIVLLEVLSGQTPI 576
           +   +  ++              P+++        S     D++++G+VL EVL  ++ I
Sbjct: 187 KKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKS-----DVYSFGVVLFEVLCARSAI 241

Query: 577 NRPRKKDE 584
            +   ++ 
Sbjct: 242 VQSLPREM 249

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  160 bits (407), Expect = 9e-45
 Identities = 67/270 (24%), Positives = 108/270 (40%), Gaps = 76/270 (28%)

Query: 355 EGQIIDTAEQHKRLLESYSIEDLRRATEKFNSSNRIE----------GAVYHGRLNGKNL 404
           E + ++ ++       S+S  +L+  T  F+                G VY G +N   +
Sbjct: 1   ENKSLEVSDTR---FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTV 57

Query: 405 AIKR-----------------TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSF 447
           A+K+                  E +V+ K            H N+V LLG    DG    
Sbjct: 58  AVKKLAAMVDITTEELKQQFDQEIKVMAKC----------QHENLVELLGFSS-DGDDLC 106

Query: 448 LVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSY 507
           LV+ Y  NGSL D L                 L+W  R +I    A  + ++H      +
Sbjct: 107 LVYVYMPNGSLLDRLSCLDGTPP---------LSWHMRCKIAQGAANGINFLH---ENHH 154

Query: 508 VHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTES--------------PQFYST---NP 550
           +HR+IKS NI LDE F A++ +FG+AR      ++              P+        P
Sbjct: 155 IHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPE-ALRGEITP 213

Query: 551 ASWSMGIDIFAYGIVLLEVLSGQTPINRPR 580
            S     DI+++G+VLLE+++G   ++  R
Sbjct: 214 KS-----DIYSFGVVLLEIITGLPAVDEHR 238

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  151 bits (383), Expect = 2e-41
 Identities = 47/250 (18%), Positives = 88/250 (35%), Gaps = 56/250 (22%)

Query: 373 SIEDLRRATEKFNSSNRIE----GAVYHGRLNGKNLAIKR----TEHEVITKLEMQLVQH 424
             E+L   +              G V+  +L  + +A+K      +     + E+  +  
Sbjct: 15  GTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPG 74

Query: 425 ATHHHPNIVRLLGTCLTDGPHS---FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLT 481
               H NI++ +G            +L+  + + GSL D+L   +             ++
Sbjct: 75  M--KHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV-------------VS 119

Query: 482 WSQRLRICLDVAMALQYMHH-------VMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR 534
           W++   I   +A  L Y+H           P+  HR+IKS+N+ L     A + +FG+A 
Sbjct: 120 WNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLAL 179

Query: 535 CVNDDTESPQFYSTNP--------------------ASWSMGIDIFAYGIVLLEVLSGQT 574
                        T+                         + ID++A G+VL E+ S  T
Sbjct: 180 KFEAGK---SAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCT 236

Query: 575 PINRPRKKDE 584
             + P  +  
Sbjct: 237 AADGPVDEYM 246

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  144 bits (365), Expect = 6e-39
 Identities = 53/201 (26%), Positives = 90/201 (44%), Gaps = 30/201 (14%)

Query: 392 GAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQH-----ATHHHPNIVRLLGTCLTDGPHS 446
           G V+    +G ++A+K    +      +              HPNIV  +G   T  P+ 
Sbjct: 51  GTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV-TQPPNL 109

Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
            +V EY   GSL   LH   A +          L   +RL +  DVA  + Y+H+  NP 
Sbjct: 110 SIVTEYLSRGSLYRLLHKSGAREQ---------LDERRRLSMAYDVAKGMNYLHN-RNPP 159

Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTES------------PQFYSTNPASWS 554
            VHRN+KS N+ +D+++  +V +FG++R       S            P+     P++  
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEK 219

Query: 555 MGIDIFAYGIVLLEVLSGQTP 575
              D++++G++L E+ + Q P
Sbjct: 220 --SDVYSFGVILWELATLQQP 238

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  138 bits (350), Expect = 6e-37
 Identities = 53/195 (27%), Positives = 93/195 (47%), Gaps = 25/195 (12%)

Query: 392 GAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQH-ATHHHPNIVRLLGTCLTDGPHSFLVF 450
           G V   +   K++AIK+ E E   K  +  ++  +  +HPNIV+L G CL       LV 
Sbjct: 22  GVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACLN---PVCLVM 78

Query: 451 EYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHR 510
           EYA+ GSL + LHG         A    + T +  +  CL  +  + Y+H +   + +HR
Sbjct: 79  EYAEGGSLYNVLHG---------AEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHR 129

Query: 511 NIKSRNIFLDEEFN-ARVGNFGMARCVNDDTES---------PQFYSTNPASWSMGIDIF 560
           ++K  N+ L       ++ +FG A  +     +         P+ +  +   +S   D+F
Sbjct: 130 DLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAAWMAPEVFEGSN--YSEKCDVF 187

Query: 561 AYGIVLLEVLSGQTP 575
           ++GI+L EV++ + P
Sbjct: 188 SWGIILWEVITRRKP 202

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  134 bits (339), Expect = 1e-35
 Identities = 39/198 (19%), Positives = 82/198 (41%), Gaps = 25/198 (12%)

Query: 392 GAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQH-----ATHHHPNIVRLLGTCLT-DGPH 445
           G ++ GR  G ++ +K  +    +  + +             HPN++ +LG C +   PH
Sbjct: 24  GELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPH 83

Query: 446 SFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNP 505
             L+  +   GSL + LH G              +  SQ ++  LD+A  + ++H  + P
Sbjct: 84  PTLITHWMPYGSLYNVLHEGTNFV----------VDQSQAVKFALDMARGMAFLHT-LEP 132

Query: 506 SYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE-------SPQFYSTNPAS-WSMGI 557
                 + SR++ +DE+  AR+    +                +P+     P        
Sbjct: 133 LIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMYAPAWVAPEALQKKPEDTNRRSA 192

Query: 558 DIFAYGIVLLEVLSGQTP 575
           D++++ ++L E+++ + P
Sbjct: 193 DMWSFAVLLWELVTREVP 210

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  133 bits (338), Expect = 1e-35
 Identities = 52/209 (24%), Positives = 88/209 (42%), Gaps = 41/209 (19%)

Query: 392 GAVYHGRLNGKNLAIKR---TEHEVITKLEMQLVQHATH----HHPNIVRLLGTCLTDGP 444
           G VY     G  +A+K       E I++    + Q A       HPNI+ L G C    P
Sbjct: 21  GKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVC-LKEP 79

Query: 445 HSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMN 504
           +  LV E+A+ G L   L G    K          +     +   + +A  + Y+H    
Sbjct: 80  NLCLVMEFARGGPLNRVLSG----KR---------IPPDILVNWAVQIARGMNYLHDEAI 126

Query: 505 PSYVHRNIKSRNIFLDEEFNAR--------VGNFGMARCVNDDTES----------PQFY 546
              +HR++KS NI + ++            + +FG+AR  +  T+           P+  
Sbjct: 127 VPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVI 186

Query: 547 STNPASWSMGIDIFAYGIVLLEVLSGQTP 575
             +    S G D+++YG++L E+L+G+ P
Sbjct: 187 RASMF--SKGSDVWSYGVLLWELLTGEVP 213

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  130 bits (328), Expect = 4e-34
 Identities = 51/210 (24%), Positives = 90/210 (42%), Gaps = 41/210 (19%)

Query: 392 GAVYHGRL--NGKNLAIKR------TEHEVITKLEMQLVQHATH----HHPNIVRLLGTC 439
           G V+ GRL  +   +AIK            + +   +  +        +HPNIV+L G  
Sbjct: 33  GLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLM 92

Query: 440 LTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYM 499
             + P   +V E+   G L   L                 + WS +LR+ LD+A+ ++YM
Sbjct: 93  -HNPPR--MVMEFVPCGDLYHRLL-----------DKAHPIKWSVKLRLMLDIALGIEYM 138

Query: 500 HHVMNPSYVHRNIKSRNIFLDE-----EFNARVGNFGMARCVNDDTES---------PQF 545
            +  NP  VHR+++S NIFL          A+V +FG+++                 P+ 
Sbjct: 139 QN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHSVSGLLGNFQWMAPET 197

Query: 546 YSTNPASWSMGIDIFAYGIVLLEVLSGQTP 575
                 S++   D +++ ++L  +L+G+ P
Sbjct: 198 IGAEEESYTEKADTYSFAMILYTILTGEGP 227

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  130 bits (328), Expect = 1e-33
 Identities = 46/247 (18%), Positives = 79/247 (31%), Gaps = 58/247 (23%)

Query: 373 SIEDLRRATEKFNSSNRIE----GAVYHGRLNGKNLAIK----RTEHEVITKLEMQLVQH 424
           +  +     +       I     GAVY G L+ + +A+K          I +  +  V  
Sbjct: 4   AASEPSLDLDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPL 63

Query: 425 ATHHHPNIVRLLGTCL----TDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFL 480
               H NI R +               LV EY  NGSL  +L                  
Sbjct: 64  M--EHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT-------------S 108

Query: 481 TWSQRLRICLDVAMALQYMH------HVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR 534
            W    R+   V   L Y+H          P+  HR++ SRN+ +  +    + +FG++ 
Sbjct: 109 DWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSM 168

Query: 535 CVNDDTESPQFYSTNPASWSMG-------------------------IDIFAYGIVLLEV 569
            +  +         N A   +G                         +D++A G++  E+
Sbjct: 169 RLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEI 228

Query: 570 LSGQTPI 576
               T +
Sbjct: 229 FMRCTDL 235

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  129 bits (327), Expect = 2e-33
 Identities = 42/216 (19%), Positives = 81/216 (37%), Gaps = 47/216 (21%)

Query: 392 GAVYHGRLNGKNLAIK----RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDG---P 444
           G V+ G+  G+ +A+K    R E     + E+         H NI+  +     D     
Sbjct: 56  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVML--RHENILGFIAADNKDNGTWT 113

Query: 445 HSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH---- 500
             +LV +Y ++GSL D+L+                +T    +++ L  A  L ++H    
Sbjct: 114 QLWLVSDYHEHGSLFDYLNRY-------------TVTVEGMIKLALSTASGLAHLHMEIV 160

Query: 501 -HVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPA---SW--- 553
                P+  HR++KS+NI + +     + + G+A   +  T++      +      +   
Sbjct: 161 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 220

Query: 554 --------------SMGIDIFAYGIVLLEVLSGQTP 575
                             DI+A G+V  E+    + 
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 256

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  126 bits (319), Expect = 9e-33
 Identities = 48/214 (22%), Positives = 81/214 (37%), Gaps = 43/214 (20%)

Query: 392 GAVYHGRLNGKNLAIK--RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHS--- 446
           G V+ G   G+N+A+K   +  E     E +L       H NI+  + + +T    S   
Sbjct: 22  GEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQL 81

Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH-----H 501
           +L+  Y + GSL D+L                 L     LRI L +A  L ++H      
Sbjct: 82  WLITHYHEMGSLYDYLQ-----LTT--------LDTVSCLRIVLSIASGLAHLHIEIFGT 128

Query: 502 VMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYST------------- 548
              P+  HR++KS+NI + +     + + G+A   +  T      +              
Sbjct: 129 QGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEV 188

Query: 549 -------NPASWSMGIDIFAYGIVLLEVLSGQTP 575
                  +       +DI+A+G+VL EV      
Sbjct: 189 LDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVS 222

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  127 bits (321), Expect = 1e-32
 Identities = 41/214 (19%), Positives = 77/214 (35%), Gaps = 43/214 (20%)

Query: 392 GAVYHGRLNGKNLAIK--RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDG---PHS 446
           G V+ G+  G+ +A+K   T  E     E ++ Q     H NI+  +   +         
Sbjct: 51  GEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL 110

Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH-----H 501
           +L+ +Y +NGSL D+L                 L     L++       L ++H      
Sbjct: 111 YLITDYHENGSLYDYLK-----STT--------LDAKSMLKLAYSSVSGLCHLHTEIFST 157

Query: 502 VMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPA---SW----- 553
              P+  HR++KS+NI + +     + + G+A     DT               +     
Sbjct: 158 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEV 217

Query: 554 ------------SMGIDIFAYGIVLLEVLSGQTP 575
                        +  D++++G++L EV      
Sbjct: 218 LDESLNRNHFQSYIMADMYSFGLILWEVARRCVS 251

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  126 bits (319), Expect = 1e-32
 Identities = 43/214 (20%), Positives = 77/214 (35%), Gaps = 46/214 (21%)

Query: 392 GAVYHGRLNGKN--LAIKRTEHEVITKLEMQLVQHATH----HHPNIVRLLGTCLTDGPH 445
           G             + +K        + +   ++         HPN+++ +G        
Sbjct: 24  GQAIKVTHRETGEVMVMKELIRF-DEETQRTFLKEVKVMRCLEHPNVLKFIGVL-YKDKR 81

Query: 446 SFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNP 505
              + EY K G+L+  +     M +Q          WSQR+    D+A  + Y+H  MN 
Sbjct: 82  LNFITEYIKGGTLRGIIKS---MDSQ--------YPWSQRVSFAKDIASGMAYLHS-MN- 128

Query: 506 SYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASWSMGI-------- 557
             +HR++ S N  + E  N  V +FG+AR + D+   P+   +                 
Sbjct: 129 -IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY 187

Query: 558 ----------------DIFAYGIVLLEVLSGQTP 575
                           D+F++GIVL E++     
Sbjct: 188 WMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  124 bits (313), Expect = 6e-32
 Identities = 53/204 (25%), Positives = 88/204 (43%), Gaps = 37/204 (18%)

Query: 392 GAVYHGRLNGKNLAIKRTEHEVITKLEMQL----VQH-ATHHHPNIVRLLGTCLTDGPHS 446
           G VY G+ +G  +A+K       T  ++Q     V       H NI+  +G      P  
Sbjct: 38  GTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST--APQL 94

Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
            +V ++ +  SL   LH     + +            + + I    A  + Y+H     S
Sbjct: 95  AIVTQWCEGSSLYHHLHAS---ETK--------FEMKKLIDIARQTARGMDYLH---AKS 140

Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYS-TNPASW------------ 553
            +HR++KS NIFL E+   ++G+FG+A   +  + S QF   +    W            
Sbjct: 141 IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSN 200

Query: 554 --SMGIDIFAYGIVLLEVLSGQTP 575
             S   D++A+GIVL E+++GQ P
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLP 224

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  121 bits (305), Expect = 1e-30
 Identities = 40/213 (18%), Positives = 78/213 (36%), Gaps = 46/213 (21%)

Query: 392 GAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQH-----ATHHHPNIVRLLGTCLTDGPHS 446
           G VYHGR +G+ +AI+  + E   + +++  +          H N+V  +G C    PH 
Sbjct: 47  GQVYHGRWHGE-VAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGAC-MSPPHL 104

Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
            ++    K  +L   +      K          L  ++  +I  ++   + Y+H      
Sbjct: 105 AIITSLCKGRTLYSVVRDA---KIV--------LDVNKTRQIAQEIVKGMGYLH---AKG 150

Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQF-YSTNPASW------------ 553
            +H+++KS+N+F D      + +FG+           +         W            
Sbjct: 151 ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQL 209

Query: 554 -----------SMGIDIFAYGIVLLEVLSGQTP 575
                      S   D+FA G +  E+ + + P
Sbjct: 210 SPDTEEDKLPFSKHSDVFALGTIWYELHAREWP 242

>4eby_A Chitin elicitor receptor kinase 1; pathogen-associated molecular patterns, pattern recognition receptors, LYSM, lysine chitin oligomer; HET: NAG BMA; 1.65A {Arabidopsis thaliana} PDB: 4ebz_A* Length = 212

 Score =  118 bits (296), Expect = 1e-30
 Identities = 40/198 (20%), Positives = 75/198 (37%), Gaps = 13/198 (6%)

Query: 68  TNSYYSSLFNLS--FYLGLNRFVIARANGFSADTEFLPKDQPLLIPIDCKCNNNGGFFQA 125
           T S  +   N S   Y  +N   I R N    D + +     +L+P  C+C   G F   
Sbjct: 19  TLSVINQNLNSSIAPYDQINFDPILRYNSNIKDKDRIQMGSRVLVPFPCECQP-GDFLGH 77

Query: 126 DLTKTTIKGESFYSIAQSLE-GLTTCGAIKERNPSVSPWDLDDKARLQVPLRCACPSSSE 184
           + + +  + +++  +A S    LTT  +++ RNP     ++   A L V + C+C   S 
Sbjct: 78  NFSYSVRQEDTYERVAISNYANLTTMESLQARNPF-PATNIPLSATLNVLVNCSCGDESV 136

Query: 185 NLPETRILVSYPVGEGDTVSGLAAKFNTTPAAIIAANNKSLEGFKPEDLLAFTSILIPLN 244
           +  +  + V+YP+   D++S +A     +   +   N                 + +P  
Sbjct: 137 S-KDFGLFVTYPLRPEDSLSSIARSSGVSADILQRYNPGV------NFNSGNGIVYVPGR 189

Query: 245 GEP-VLAPLAKPHDPNLH 261
                  P        +H
Sbjct: 190 DPNGAFPPFKSSKQDGVH 207

>4eby_A Chitin elicitor receptor kinase 1; pathogen-associated molecular patterns, pattern recognition receptors, LYSM, lysine chitin oligomer; HET: NAG BMA; 1.65A {Arabidopsis thaliana} PDB: 4ebz_A* Length = 212

 Score = 41.3 bits (96), Expect = 4e-04
 Identities = 11/58 (18%), Positives = 23/58 (39%), Gaps = 5/58 (8%)

Query: 192 LVSYPVGEGDTVSGLAAKFNTTPAAIIAANNKSLEGFKP-----EDLLAFTSILIPLN 244
           L SY +  G T+S +    N++ A     N   +  +       + +   + +L+P  
Sbjct: 9   LASYYLENGTTLSVINQNLNSSIAPYDQINFDPILRYNSNIKDKDRIQMGSRVLVPFP 66

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  112 bits (283), Expect = 3e-27
 Identities = 52/209 (24%), Positives = 89/209 (42%), Gaps = 46/209 (22%)

Query: 392 GAVYHGRLNGKNL--AIKRTEHEVITKLEMQLVQHA----THHHPNIVRLLGTCLTDGPH 445
           G V+ GRL   N   A+K     +   L+ + +Q A     + HPNIVRL+G C    P 
Sbjct: 128 GEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPI 187

Query: 446 SFLVFEYAKNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM 503
            ++V E  + G    +L   G               L     L++  D A  ++Y+    
Sbjct: 188 -YIVMELVQGGDFLTFLRTEGAR-------------LRVKTLLQMVGDAAAGMEYLES-K 232

Query: 504 NPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYS-----------TNPAS 552
               +HR++ +RN  + E+   ++ +FGM+R   D      + +           T P +
Sbjct: 233 C--CIHRDLAARNCLVTEKNVLKISDFGMSREEADGV----YAASGGLRQVPVKWTAPEA 286

Query: 553 WSMGI-----DIFAYGIVLLEVLS-GQTP 575
            + G      D++++GI+L E  S G +P
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGASP 315

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  113 bits (284), Expect = 7e-27
 Identities = 48/204 (23%), Positives = 94/204 (46%), Gaps = 38/204 (18%)

Query: 392 GAVYHGRLNGKNL--AIKRTEHEVITK----LEMQLVQHATHHHPNIVRLLGTCLTDGPH 445
           G VY G     +L  A+K  + + +       E  +++     HPN+V+LLG C  + P 
Sbjct: 234 GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMK--EIKHPNLVQLLGVCTREPP- 290

Query: 446 SFLVFEYAKNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM 503
            +++ E+   G+L D+L                   ++    L +   ++ A++Y+    
Sbjct: 291 FYIITEFMTYGNLLDYLRECNRQE------------VSAVVLLYMATQISSAMEYLEK-K 337

Query: 504 NPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW---------- 553
           N  ++HRN+ +RN  + E    +V +FG++R +  DT +    +  P  W          
Sbjct: 338 N--FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNK 395

Query: 554 -SMGIDIFAYGIVLLEVLS-GQTP 575
            S+  D++A+G++L E+ + G +P
Sbjct: 396 FSIKSDVWAFGVLLWEIATYGMSP 419

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  112 bits (283), Expect = 8e-27
 Identities = 53/209 (25%), Positives = 91/209 (43%), Gaps = 54/209 (25%)

Query: 392 GAVYHGRLNGKNLAIKR-----------TEHEVITKLEMQLVQHATHHHPNIVRLLGTCL 440
           G V  G   G  +A+K             E  V+T+L           H N+V+LLG  +
Sbjct: 207 GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQL----------RHSNLVQLLGVIV 256

Query: 441 TDGPHSFLVFEYAKNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQY 498
            +    ++V EY   GSL D+L   G               L     L+  LDV  A++Y
Sbjct: 257 EEKGGLYIVTEYMAKGSLVDYLRSRGRSV------------LGGDCLLKFSLDVCEAMEY 304

Query: 499 MHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASWS---- 554
           +    N  +VHR++ +RN+ + E+  A+V +FG+ +  +   ++ +     P  W+    
Sbjct: 305 LEG-NN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL----PVKWTAPEA 357

Query: 555 --MGI-----DIFAYGIVLLEVLS-GQTP 575
                     D++++GI+L E+ S G+ P
Sbjct: 358 LREKKFSTKSDVWSFGILLWEIYSFGRVP 386

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  108 bits (272), Expect = 1e-26
 Identities = 53/209 (25%), Positives = 91/209 (43%), Gaps = 54/209 (25%)

Query: 392 GAVYHGRLNGKNLAIKR-----------TEHEVITKLEMQLVQHATHHHPNIVRLLGTCL 440
           G V  G   G  +A+K             E  V+T+L           H N+V+LLG  +
Sbjct: 35  GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQL----------RHSNLVQLLGVIV 84

Query: 441 TDGPHSFLVFEYAKNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQY 498
            +    ++V EY   GSL D+L   G               L     L+  LDV  A++Y
Sbjct: 85  EEKGGLYIVTEYMAKGSLVDYLRSRGRSV------------LGGDCLLKFSLDVCEAMEY 132

Query: 499 MHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASWS---- 554
           +    N  +VHR++ +RN+ + E+  A+V +FG+ +  +   ++ +     P  W+    
Sbjct: 133 LEG-NN--FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL----PVKWTAPEA 185

Query: 555 --MGI-----DIFAYGIVLLEVLS-GQTP 575
                     D++++GI+L E+ S G+ P
Sbjct: 186 LREKKFSTKSDVWSFGILLWEIYSFGRVP 214

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  107 bits (269), Expect = 3e-26
 Identities = 57/211 (27%), Positives = 87/211 (41%), Gaps = 54/211 (25%)

Query: 392 GAVYHGRLNGKNL-AIKR------------TEHEVITKLEMQLVQHATHHHPNIVRLLGT 438
           G V+ G    K+  AIK              E EV+ KL           HP +V+L G 
Sbjct: 22  GLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKL----------SHPKLVQLYGV 71

Query: 439 CLTDGPHSFLVFEYAKNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMAL 496
           CL   P   LV E+ ++G L D+L    GL                   L +CLDV   +
Sbjct: 72  CLEQAPI-CLVTEFMEHGCLSDYLRTQRGL-------------FAAETLLGMCLDVCEGM 117

Query: 497 QYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASWS-- 554
            Y+        +HR++ +RN  + E    +V +FGM R V DD  +    +  P  W+  
Sbjct: 118 AYLEE-AC--VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASP 174

Query: 555 ----MGI-----DIFAYGIVLLEVLS-GQTP 575
                       D++++G+++ EV S G+ P
Sbjct: 175 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIP 205

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  106 bits (266), Expect = 7e-26
 Identities = 56/211 (26%), Positives = 90/211 (42%), Gaps = 54/211 (25%)

Query: 392 GAVYHGRLNGK-NLAIKR------------TEHEVITKLEMQLVQHATHHHPNIVRLLGT 438
           G V  G+  G+ ++A+K              E + + KL           HP +V+  G 
Sbjct: 22  GVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKL----------SHPKLVKFYGV 71

Query: 439 CLTDGPHSFLVFEYAKNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMAL 496
           C  + P  ++V EY  NG L ++L  HG               L  SQ L +C DV   +
Sbjct: 72  CSKEYPI-YIVTEYISNGCLLNYLRSHGKG-------------LEPSQLLEMCYDVCEGM 117

Query: 497 QYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASWS-- 554
            ++       ++HR++ +RN  +D +   +V +FGM R V DD       +  P  WS  
Sbjct: 118 AFLES-HQ--FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAP 174

Query: 555 ----MGI-----DIFAYGIVLLEVLS-GQTP 575
                       D++A+GI++ EV S G+ P
Sbjct: 175 EVFHYFKYSSKSDVWAFGILMWEVFSLGKMP 205

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  106 bits (267), Expect = 9e-26
 Identities = 49/203 (24%), Positives = 94/203 (46%), Gaps = 36/203 (17%)

Query: 392 GAVYHGRLNGKNL--AIK-----RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGP 444
           G VY G     +L  A+K       E E   K E  +++     HPN+V+LLG C  + P
Sbjct: 27  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK-EAAVMK--EIKHPNLVQLLGVCTREPP 83

Query: 445 HSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMN 504
             +++ E+   G+L D+L      +          ++    L +   ++ A++Y+    N
Sbjct: 84  -FYIITEFMTYGNLLDYLRECNRQE----------VSAVVLLYMATQISSAMEYLEK-KN 131

Query: 505 PSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASWS------MGI- 557
             ++HR++ +RN  + E    +V +FG++R +  DT +    +  P  W+          
Sbjct: 132 --FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKF 189

Query: 558 ----DIFAYGIVLLEVLS-GQTP 575
               D++A+G++L E+ + G +P
Sbjct: 190 SIKSDVWAFGVLLWEIATYGMSP 212

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  105 bits (264), Expect = 2e-25
 Identities = 52/210 (24%), Positives = 91/210 (43%), Gaps = 42/210 (20%)

Query: 392 GAVYHGRLNGKN-----LAIKRTEHEVITKLEMQ-LVQHAT----HHHPNIVRLLGTCLT 441
           G VYHG L   +      A+K + + +    E+   +          HPN++ LLG CL 
Sbjct: 39  GCVYHGTLLDNDGKKIHCAVK-SLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLR 97

Query: 442 DGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHH 501
                 +V  Y K+G L++++       +          T    +   L VA  ++Y+  
Sbjct: 98  SEGSPLVVLPYMKHGDLRNFIR---NETHN--------PTVKDLIGFGLQVAKGMKYLAS 146

Query: 502 VMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN---PASWSMGI- 557
                +VHR++ +RN  LDE+F  +V +FG+AR + D         T    P  W M + 
Sbjct: 147 -KK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKW-MALE 202

Query: 558 -----------DIFAYGIVLLEVLS-GQTP 575
                      D++++G++L E+++ G  P
Sbjct: 203 SLQTQKFTTKSDVWSFGVLLWELMTRGAPP 232

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  105 bits (263), Expect = 3e-25
 Identities = 53/210 (25%), Positives = 85/210 (40%), Gaps = 42/210 (20%)

Query: 392 GAVYHGRLNGKN-----LAIK-----RTEHEVITKL-EMQLVQHATHHHPNIVRLLGTCL 440
           G VYHG    +       AIK         +V   L E  L++    +HPN++ L+G  L
Sbjct: 35  GVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGL--NHPNVLALIGIML 92

Query: 441 TDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH 500
                  ++  Y  +G L             FI S     T    +   L VA  ++Y+ 
Sbjct: 93  PPEGLPHVLLPYMCHGDLLQ-----------FIRSPQRNPTVKDLISFGLQVARGMEYLA 141

Query: 501 HVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN---PASW---- 553
                 +VHR++ +RN  LDE F  +V +FG+AR + D          +   P  W    
Sbjct: 142 E-QK--FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALE 198

Query: 554 --SMGI-----DIFAYGIVLLEVLS-GQTP 575
                      D++++G++L E+L+ G  P
Sbjct: 199 SLQTYRFTTKSDVWSFGVLLWELLTRGAPP 228

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  104 bits (262), Expect = 3e-25
 Identities = 52/218 (23%), Positives = 92/218 (42%), Gaps = 68/218 (31%)

Query: 392 GAVYHGRLNGK-NLAIKR------------TEHEVITKLEMQLVQHATHHHPNIVRLLGT 438
           G V +G+  G+ ++AIK              E +V+  L           H  +V+L G 
Sbjct: 38  GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNL----------SHEKLVQLYGV 87

Query: 439 CLTDGPHSFLVFEYAKNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMAL 496
           C    P  F++ EY  NG L ++L                       Q L +C DV  A+
Sbjct: 88  CTKQRPI-FIITEYMANGCLLNYLREMRHR-------------FQTQQLLEMCKDVCEAM 133

Query: 497 QYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDT---------------- 540
           +Y+       ++HR++ +RN  ++++   +V +FG++R V DD                 
Sbjct: 134 EYLES-KQ--FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPP 190

Query: 541 ESPQF--YSTNPASWSMGIDIFAYGIVLLEVLS-GQTP 575
           E   +  +S+   S     DI+A+G+++ E+ S G+ P
Sbjct: 191 EVLMYSKFSS--KS-----DIWAFGVLMWEIYSLGKMP 221

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  105 bits (265), Expect = 6e-25
 Identities = 60/277 (21%), Positives = 116/277 (41%), Gaps = 51/277 (18%)

Query: 330 LQQLSASVRTTSDKKVSFEGSQSTIEGQIIDTAEQHKRLLESYSIEDLRRATEKFNSSNR 389
           +++LS S+   +  +  +    +T+   +     +  + ++   I     ++   + +  
Sbjct: 40  IEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIG---PSSLIVHFNEV 96

Query: 390 I-EGA---VYHGRLNGKN-----LAIKR-----TEHEVITKL-EMQLVQHATHHHPNIVR 434
           I  G    VYHG L   +      A+K         EV   L E  +++     HPN++ 
Sbjct: 97  IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDF--SHPNVLS 154

Query: 435 LLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAM 494
           LLG CL       +V  Y K+G L++++       +          T    +   L VA 
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIR---NETHN--------PTVKDLIGFGLQVAK 203

Query: 495 ALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN---PA 551
            ++++       +VHR++ +RN  LDE+F  +V +FG+AR + D         T    P 
Sbjct: 204 GMKFLAS-KK--FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPV 260

Query: 552 SWSMGI------------DIFAYGIVLLEVLS-GQTP 575
            W M +            D++++G++L E+++ G  P
Sbjct: 261 KW-MALESLQTQKFTTKSDVWSFGVLLWELMTRGAPP 296

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  104 bits (262), Expect = 7e-25
 Identities = 53/219 (24%), Positives = 91/219 (41%), Gaps = 44/219 (20%)

Query: 392 GAVYHGRLNG-------KNLAIKR-----TEHEVITKL-EMQLVQHATHHHPNIVRLLGT 438
           G V      G       + +A+K      T  E    + E++++ H   HH N+V LLG 
Sbjct: 41  GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH-IGHHLNVVNLLGA 99

Query: 439 CLTDGPHSFLVFEYAKNGSLKDWL----HGGLAMKNQFIASCYCFLTWSQRLRICLDVAM 494
           C   G    ++ E+ K G+L  +L    +  +  K         FLT    +     VA 
Sbjct: 100 CTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAK 159

Query: 495 ALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN----- 549
               M  + +   +HR++ +RNI L E+   ++ +FG+AR +  D +    Y        
Sbjct: 160 G---MEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD----YVRKGDARL 212

Query: 550 PASWSMGI------------DIFAYGIVLLEVLS-GQTP 575
           P  W M              D++++G++L E+ S G +P
Sbjct: 213 PLKW-MAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASP 250

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  104 bits (262), Expect = 7e-25
 Identities = 43/210 (20%), Positives = 84/210 (40%), Gaps = 45/210 (21%)

Query: 392 GAVYHGRLNGKNL------AIKRTEHEVITKLEMQLVQHA----THHHPNIVRLLGTCLT 441
           G VY G    +        AIK        K   +++  A    +  +P++ RLLG CLT
Sbjct: 29  GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 88

Query: 442 DGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHH 501
                 L+ +    G L D++      K+         +     L  C+ +A  + Y+  
Sbjct: 89  STV--QLITQLMPFGCLLDYVREH---KDN--------IGSQYLLNWCVQIAKGMNYLED 135

Query: 502 VMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN----PASW---- 553
                 VHR++ +RN+ +    + ++ +FG+A+ +  + +    Y       P  W    
Sbjct: 136 -RR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYHAEGGKVPIKWMALE 189

Query: 554 -------SMGIDIFAYGIVLLEVLS-GQTP 575
                  +   D+++YG+ + E+++ G  P
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  104 bits (262), Expect = 8e-25
 Identities = 45/221 (20%), Positives = 91/221 (41%), Gaps = 55/221 (24%)

Query: 392 GAVYHGRLNGKNL-----AIK------RTEHEVITKL-EMQLVQHATHHHPNIVRLLGTC 439
           G+V   +L  ++      A+K          ++   L E   ++     HP++ +L+G  
Sbjct: 37  GSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEF--DHPHVAKLVGVS 94

Query: 440 LTDGPHS-----FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAM 494
           L            ++  + K+G L  +L      +N F       L     +R  +D+A 
Sbjct: 95  LRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFN------LPLQTLVRFMVDIAC 148

Query: 495 ALQYM--HHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN--- 549
            ++Y+   +     ++HR++ +RN  L E+    V +FG++R       S  +Y      
Sbjct: 149 GMEYLSSRN-----FIHRDLAARNCMLAEDMTVCVADFGLSR----KIYSGDYYRQGCAS 199

Query: 550 --PASWSM-------GI-----DIFAYGIVLLEVLS-GQTP 575
             P  W +        +     D++A+G+ + E+++ GQTP
Sbjct: 200 KLPVKW-LALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  104 bits (261), Expect = 8e-25
 Identities = 45/220 (20%), Positives = 92/220 (41%), Gaps = 54/220 (24%)

Query: 392 GAVYHGRLNGKNL-----AIK------RTEHEVITKL-EMQLVQHATHHHPNIVRLLGTC 439
           G+V  G L  ++      A+K       ++ E+   L E   ++     HPN++RLLG C
Sbjct: 48  GSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDF--SHPNVIRLLGVC 105

Query: 440 LTDGPHS----FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMA 495
           +           ++  + K G L  +L          + +    +     L+  +D+A+ 
Sbjct: 106 IEMSSQGIPKPMVILPFMKYGDLHTYL------LYSRLETGPKHIPLQTLLKFMVDIALG 159

Query: 496 LQYM--HHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN---- 549
           ++Y+   +     ++HR++ +RN  L ++    V +FG+++       S  +Y       
Sbjct: 160 MEYLSNRN-----FLHRDLAARNCMLRDDMTVCVADFGLSK----KIYSGDYYRQGRIAK 210

Query: 550 -PASWSMGI------------DIFAYGIVLLEVLS-GQTP 575
            P  W + I            D++A+G+ + E+ + G TP
Sbjct: 211 MPVKW-IAIESLADRVYTSKSDVWAFGVTMWEIATRGMTP 249

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  104 bits (262), Expect = 8e-25
 Identities = 58/217 (26%), Positives = 99/217 (45%), Gaps = 47/217 (21%)

Query: 392 GAVYHGRLNGKNL----AIKR-----TEHEVITKL-EMQLVQHATHHHPNIVRLLGTCLT 441
           G V   R+    L    AIKR     ++ +      E++++     HHPNI+ LLG C  
Sbjct: 39  GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCK-LGHHPNIINLLGACEH 97

Query: 442 DGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCF----LTWSQRLRICLDVAMALQ 497
            G   +L  EYA +G+L D+L     ++     +        L+  Q L    DVA  + 
Sbjct: 98  RGYL-YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMD 156

Query: 498 YMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDT----------------E 541
           Y+       ++HR++ +RNI + E + A++ +FG++R    +                 E
Sbjct: 157 YLSQ-KQ--FIHRDLAARNILVGENYVAKIADFGLSR--GQEVYVKKTMGRLPVRWMAIE 211

Query: 542 SPQF--YSTNPASWSMGIDIFAYGIVLLEVLS-GQTP 575
           S  +  Y+T   S     D+++YG++L E++S G TP
Sbjct: 212 SLNYSVYTT--NS-----DVWSYGVLLWEIVSLGGTP 241

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  104 bits (261), Expect = 1e-24
 Identities = 56/216 (25%), Positives = 96/216 (44%), Gaps = 55/216 (25%)

Query: 392 GAVYHGRLNGKNL------AIK-----RTEHEVITKLE-----MQLVQHATHHHPNIVRL 435
           G VY G L   +       AIK      TE + +  L       Q        H NI+RL
Sbjct: 58  GEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF------SHHNIIRL 111

Query: 436 LGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMA 495
            G      P   ++ EY +NG+L  +L        +         +  Q + +   +A  
Sbjct: 112 EGVISKYKPM-MIITEYMENGALDKFLREK---DGE--------FSVLQLVGMLRGIAAG 159

Query: 496 LQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN----PA 551
           ++Y+ + MN  YVHR++ +RNI ++     +V +FG++R + DD E+   Y+T+    P 
Sbjct: 160 MKYLAN-MN--YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA--TYTTSGGKIPI 214

Query: 552 SWS------MGI-----DIFAYGIVLLEVLS-GQTP 575
            W+              D++++GIV+ EV++ G+ P
Sbjct: 215 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERP 250

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  103 bits (260), Expect = 2e-24
 Identities = 61/209 (29%), Positives = 91/209 (43%), Gaps = 42/209 (20%)

Query: 392 GAVYHGRLNGKNL-----AIKRTEHEVITKLEMQLVQHA----THHHPNIVRLLGTCLTD 442
           G V  GRL   +      AIK  +     K     +  A       HPNI+RL G     
Sbjct: 59  GEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS 118

Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
            P   +V EY +NGSL  +L        Q         T  Q + +   +A  ++Y+   
Sbjct: 119 KPV-MIVTEYMENGSLDSFLRKH---DAQ--------FTVIQLVGMLRGIASGMKYLSD- 165

Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN----PASW----- 553
           M   YVHR++ +RNI ++     +V +FG+ R + DD E+   Y+T     P  W     
Sbjct: 166 MG--YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA--AYTTRGGKIPIRWTSPEA 221

Query: 554 ------SMGIDIFAYGIVLLEVLS-GQTP 575
                 +   D+++YGIVL EV+S G+ P
Sbjct: 222 IAYRKFTSASDVWSYGIVLWEVMSYGERP 250

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  103 bits (258), Expect = 3e-24
 Identities = 47/180 (26%), Positives = 79/180 (43%), Gaps = 34/180 (18%)

Query: 418 EMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL--HGGLAMKNQFIAS 475
           E++++ H    H NIV LLG C   GP   ++ EY   G L ++L     +   +   A 
Sbjct: 99  ELKIMSH-LGQHENIVNLLGACTHGGPV-LVITEYCCYGDLLNFLRRKSRVLETDPAFAI 156

Query: 476 CYCFLTWSQRLRICLDVAMALQYM--HHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA 533
                +    L     VA  + ++   +      +HR++ +RN+ L     A++G+FG+A
Sbjct: 157 ANSTASTRDLLHFSSQVAQGMAFLASKN-----CIHRDVAARNVLLTNGHVAKIGDFGLA 211

Query: 534 RCVNDDTESPQFY--STN---PASWSMGI------------DIFAYGIVLLEVLS-GQTP 575
           R + +D+     Y    N   P  W M              D+++YGI+L E+ S G  P
Sbjct: 212 RDIMNDSN----YIVKGNARLPVKW-MAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  104 bits (262), Expect = 4e-24
 Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 40/204 (19%)

Query: 392 GAVYHGRLNGK-NLAIK-----RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPH 445
           G V+ G  NG   +AIK         E   + E Q+++     H  +V+L     ++ P 
Sbjct: 198 GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMK--KLRHEKLVQLYAVV-SEEPI 253

Query: 446 SFLVFEYAKNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM 503
            ++V EY   GSL D+L    G             +L   Q + +   +A  + Y+   M
Sbjct: 254 -YIVTEYMSKGSLLDFLKGETG------------KYLRLPQLVDMAAQIASGMAYVER-M 299

Query: 504 NPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW---------- 553
           N  YVHR++++ NI + E    +V +FG+AR + D+  + +  +  P  W          
Sbjct: 300 N--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 357

Query: 554 -SMGIDIFAYGIVLLEVLS-GQTP 575
            ++  D++++GI+L E+ + G+ P
Sbjct: 358 FTIKSDVWSFGILLTELTTKGRVP 381

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  102 bits (257), Expect = 4e-24
 Identities = 54/209 (25%), Positives = 90/209 (43%), Gaps = 42/209 (20%)

Query: 392 GAVYHGRLNGKNL-----AIKRTEHEVITKLEMQLVQHA----THHHPNIVRLLGTCLTD 442
           G V +GRL          AIK  +     +     +  A       HPNI+RL G     
Sbjct: 63  GEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG 122

Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
                +V EY +NGSL  +L        Q         T  Q + +   V   ++Y+   
Sbjct: 123 RLA-MIVTEYMENGSLDTFLRTH---DGQ--------FTIMQLVGMLRGVGAGMRYLSD- 169

Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN----PASWS---- 554
           +   YVHR++ +RN+ +D     +V +FG++R + DD ++   Y+T     P  W+    
Sbjct: 170 LG--YVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDA--AYTTTGGKIPIRWTAPEA 225

Query: 555 --MGI-----DIFAYGIVLLEVLS-GQTP 575
                     D++++G+V+ EVL+ G+ P
Sbjct: 226 IAFRTFSSASDVWSFGVVMWEVLAYGERP 254

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  100 bits (251), Expect = 1e-23
 Identities = 49/212 (23%), Positives = 86/212 (40%), Gaps = 51/212 (24%)

Query: 392 GAVYHGRLNGKNL-----AIKRTEHEVITKLEMQLVQHA----THHHPNIVRLLGTCLTD 442
           G VY G            A+K  + +     + + +  A       HP+IV+L+G    +
Sbjct: 26  GEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGII-EE 84

Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
            P  +++ E    G L  +L      KN         L     +   L +  A+ Y+   
Sbjct: 85  EPT-WIIMELYPYGELGHYLERN---KNS--------LKVLTLVLYSLQICKAMAYLES- 131

Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDT----------------ESPQF- 545
           +N   VHR+I  RNI +      ++G+FG++R + D+                 ES  F 
Sbjct: 132 IN--CVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFR 189

Query: 546 -YSTNPASWSMGIDIFAYGIVLLEVLS-GQTP 575
            ++T  AS     D++ + + + E+LS G+ P
Sbjct: 190 RFTT--AS-----DVWMFAVCMWEILSFGKQP 214

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  101 bits (253), Expect = 1e-23
 Identities = 46/221 (20%), Positives = 93/221 (42%), Gaps = 47/221 (21%)

Query: 392 GAVYHGRLNGKNLAIKRTEHEVITKL---------------EMQLVQHATHHHPNIVRLL 436
           G V      G +    +    V  K+               EM++++     H NI+ LL
Sbjct: 49  GQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKM-IGKHKNIINLL 107

Query: 437 GTCLTDGPHSFLVFEYAKNGSLKDWL----HGGLAMKNQFIASCYCFLTWSQRLRICLDV 492
           G C  DGP  +++ EYA  G+L+++L      G+             +T+   +     +
Sbjct: 108 GACTQDGPL-YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQL 166

Query: 493 AMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN--- 549
           A  ++Y+    +   +HR++ +RN+ + E    ++ +FG+AR +N+      +Y      
Sbjct: 167 ARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNI----DYYKKTTNG 219

Query: 550 --PASWSMGI------------DIFAYGIVLLEVLS-GQTP 575
             P  W M              D++++G+++ E+ + G +P
Sbjct: 220 RLPVKW-MAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 259

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  100 bits (252), Expect = 1e-23
 Identities = 51/217 (23%), Positives = 90/217 (41%), Gaps = 48/217 (22%)

Query: 392 GAVYHGRLNGKNL-------AIK-----RTEHEVITKL-EMQLVQHATHHHPNIVRLLGT 438
           G VY G   G          AIK      +  E I  L E  +++    +  ++VRLLG 
Sbjct: 39  GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF--NCHHVVRLLGV 96

Query: 439 CLTDGPHSFLVFEYAKNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMAL 496
                P   ++ E    G LK +L         N  +A      + S+ +++  ++A  +
Sbjct: 97  VSQGQPT-LVIMELMTRGDLKSYLRSLRPAMANNPVLAP----PSLSKMIQMAGEIADGM 151

Query: 497 QYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN-----PA 551
            Y++      +VHR++ +RN  + E+F  ++G+FGM R    D     +Y        P 
Sbjct: 152 AYLNA-NK--FVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPV 204

Query: 552 SWSMGI------------DIFAYGIVLLEVLS-GQTP 575
            W M              D++++G+VL E+ +  + P
Sbjct: 205 RW-MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQP 240

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 99.6 bits (249), Expect = 2e-23
 Identities = 49/209 (23%), Positives = 95/209 (45%), Gaps = 50/209 (23%)

Query: 392 GAVYHGRLNGKNL-AIKR------------TEHEVITKLEMQLVQHATHHHPNIVRLLGT 438
           G V+ G  NG    A+K              E  ++ +L           H  +VRL   
Sbjct: 27  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL----------QHQRLVRLYAV 76

Query: 439 CLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQY 498
             T  P  +++ EY +NGSL D+L     +K          LT ++ L +   +A  + +
Sbjct: 77  V-TQEPI-YIITEYMENGSLVDFLKTPSGIK----------LTINKLLDMAAQIAEGMAF 124

Query: 499 MHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASWS---- 554
           +    N  Y+HR++++ NI + +  + ++ +FG+AR + D+  + +  +  P  W+    
Sbjct: 125 IEE-RN--YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEA 181

Query: 555 --MGI-----DIFAYGIVLLEVLS-GQTP 575
              G      D++++GI+L E+++ G+ P
Sbjct: 182 INYGTFTIKSDVWSFGILLTEIVTHGRIP 210

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  101 bits (253), Expect = 2e-23
 Identities = 48/223 (21%), Positives = 95/223 (42%), Gaps = 51/223 (22%)

Query: 392 GAVYHGRLNGKNLAIKRTEHEVITKL---------------EMQLVQHATHHHPNIVRLL 436
           G V      G +    +    V  K+               EM++++     H NI+ LL
Sbjct: 95  GQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKM-IGKHKNIINLL 153

Query: 437 GTCLTDGPHSFLVFEYAKNGSLKDWL----HGGLAMKNQFIASCYCFLTWSQRLRICLDV 492
           G C  DGP  +++ EYA  G+L+++L      G+             +T+   +     +
Sbjct: 154 GACTQDGPL-YVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQL 212

Query: 493 AMALQYM--HHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFY--ST 548
           A  ++Y+          +HR++ +RN+ + E    ++ +FG+AR +N+      +Y  +T
Sbjct: 213 ARGMEYLASQK-----CIHRDLAARNVLVTENNVMKIADFGLARDINNI----DYYKKTT 263

Query: 549 N---PASWSMGI------------DIFAYGIVLLEVLS-GQTP 575
           N   P  W M              D++++G+++ E+ + G +P
Sbjct: 264 NGRLPVKW-MAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSP 305

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 99.6 bits (249), Expect = 2e-23
 Identities = 54/220 (24%), Positives = 82/220 (37%), Gaps = 48/220 (21%)

Query: 392 GAVYHGRLNGKNL-------AIKR-----TEHEVITKL-EMQLVQHATHHHPNIVRLLGT 438
           G VY G L G          AIK                E  L   A   HPN+V LLG 
Sbjct: 23  GKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLR--ARLQHPNVVCLLGV 80

Query: 439 CLTDGPHSFLVFEYAKNGSLKDWLHG----GLAMKNQFIASCYCFLTWSQRLRICLDVAM 494
              D P   ++F Y  +G L ++L                +    L     + +   +A 
Sbjct: 81  VTKDQPL-SMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAA 139

Query: 495 ALQYM--HHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN--- 549
            ++Y+  HH      VH+++ +RN+ + ++ N ++ + G+ R V         Y      
Sbjct: 140 GMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADY----YKLLGNS 190

Query: 550 --PASW------SMGI-----DIFAYGIVLLEVLS-GQTP 575
             P  W        G      DI++YG+VL EV S G  P
Sbjct: 191 LLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQP 230

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  103 bits (257), Expect = 2e-23
 Identities = 52/204 (25%), Positives = 94/204 (46%), Gaps = 40/204 (19%)

Query: 392 GAVYHGRLNGK-NLAIK-----RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPH 445
           G V+ G  NG   +AIK         E   + E Q+++     H  +V+L     ++ P 
Sbjct: 281 GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQ-EAQVMK--KLRHEKLVQLYAVV-SEEPI 336

Query: 446 SFLVFEYAKNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM 503
            ++V EY   GSL D+L    G             +L   Q + +   +A  + Y+   M
Sbjct: 337 -YIVTEYMSKGSLLDFLKGETGK------------YLRLPQLVDMAAQIASGMAYVER-M 382

Query: 504 NPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW---------- 553
           N  YVHR++++ NI + E    +V +FG+AR + D+  + +  +  P  W          
Sbjct: 383 N--YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR 440

Query: 554 -SMGIDIFAYGIVLLEVLS-GQTP 575
            ++  D++++GI+L E+ + G+ P
Sbjct: 441 FTIKSDVWSFGILLTELTTKGRVP 464

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 99.6 bits (249), Expect = 2e-23
 Identities = 47/218 (21%), Positives = 82/218 (37%), Gaps = 45/218 (20%)

Query: 392 GAVYHGRLNGKNL-------AIKRTEHEVITKLEMQLVQHA----THHHPNIVRLLGTCL 440
           G V+       +        A+K    +          + A       H +IV+  G C 
Sbjct: 29  GKVFLAECYNLSPTKDKMLVAVK-ALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCG 87

Query: 441 TDGPHSFLVFEYAKNGSLKDWLHG----GLAMKNQFIASCYCFLTWSQRLRICLDVAMAL 496
              P   +VFEY K+G L  +L       + + +         L  SQ L I   +A  +
Sbjct: 88  DGDPL-IMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGM 146

Query: 497 QYM--HHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN----- 549
            Y+   H     +VHR++ +RN  +      ++G+FGM+R V        +Y        
Sbjct: 147 VYLASQH-----FVHRDLATRNCLVGANLLVKIGDFGMSRDVYST----DYYRVGGHTML 197

Query: 550 ------PASWSMGI-----DIFAYGIVLLEVLS-GQTP 575
                 P S          D++++G++L E+ + G+ P
Sbjct: 198 PIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQP 235

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  100 bits (250), Expect = 6e-23
 Identities = 50/221 (22%), Positives = 97/221 (43%), Gaps = 47/221 (21%)

Query: 392 GAVYHGRLNGKNL---------AIKR-----TEHEVITKL-EMQLVQHATHHHPNIVRLL 436
           G V      G +          A+K      TE ++   + EM++++     H NI+ LL
Sbjct: 83  GQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKM-IGKHKNIINLL 141

Query: 437 GTCLTDGPHSFLVFEYAKNGSLKDWL----HGGLAMKNQFIASCYCFLTWSQRLRICLDV 492
           G C  DGP  +++ EYA  G+L+++L      GL        +    L+    +     V
Sbjct: 142 GACTQDGPL-YVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQV 200

Query: 493 AMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN--- 549
           A  ++Y+    +   +HR++ +RN+ + E+   ++ +FG+AR ++       +Y      
Sbjct: 201 ARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI----DYYKKTTNG 253

Query: 550 --PASWSMGI------------DIFAYGIVLLEVLS-GQTP 575
             P  W M              D++++G++L E+ + G +P
Sbjct: 254 RLPVKW-MAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP 293

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 98.9 bits (247), Expect = 7e-23
 Identities = 43/210 (20%), Positives = 84/210 (40%), Gaps = 45/210 (21%)

Query: 392 GAVYHGRLNGKNL------AIKRTEHEVITKLEMQLVQHA----THHHPNIVRLLGTCLT 441
           G VY G    +        AIK        K   +++  A    +  +P++ RLLG CLT
Sbjct: 29  GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 88

Query: 442 DGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHH 501
                 L+ +    G L D++      K+         +     L  C+ +A  + Y+  
Sbjct: 89  STV--QLITQLMPFGCLLDYVREH---KDN--------IGSQYLLNWCVQIAKGMNYLED 135

Query: 502 VMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN----PASW---- 553
                 VHR++ +RN+ +    + ++ +FG+A+ +  + +    Y       P  W    
Sbjct: 136 -RR--LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK---EYHAEGGKVPIKWMALE 189

Query: 554 -------SMGIDIFAYGIVLLEVLS-GQTP 575
                  +   D+++YG+ + E+++ G  P
Sbjct: 190 SILHRIYTHQSDVWSYGVTVWELMTFGSKP 219

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 98.5 bits (246), Expect = 8e-23
 Identities = 52/229 (22%), Positives = 92/229 (40%), Gaps = 58/229 (25%)

Query: 392 GAVYHGRLNGKNL-------AIKR-----TEHEVITKL-EMQLVQHATHHHPNIVRLLGT 438
           G V                 A+K      +  E+   L E  +++    +HP++++L G 
Sbjct: 37  GKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV--NHPHVIKLYGA 94

Query: 439 CLTDGPHSFLVFEYAKNGSLKDWL------------HGGLAMKNQFIASCYCFLTWSQRL 486
           C  DGP   L+ EYAK GSL+ +L             GG    +         LT    +
Sbjct: 95  CSQDGPL-LLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLI 153

Query: 487 RICLDVAMALQYM--HHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQ 544
                ++  +QY+          VHR++ +RNI + E    ++ +FG++R V ++     
Sbjct: 154 SFAWQISQGMQYLAEMK-----LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS--- 205

Query: 545 FYSTN-----PASWSMGI------------DIFAYGIVLLEVLS-GQTP 575
            Y        P  W M I            D++++G++L E+++ G  P
Sbjct: 206 -YVKRSQGRIPVKW-MAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 97.4 bits (243), Expect = 1e-22
 Identities = 44/225 (19%), Positives = 77/225 (34%), Gaps = 69/225 (30%)

Query: 392 GAVYHGRLNGKNLAIKRTEHEVITK-------------LE-----MQLVQHATHHHPNIV 433
             ++ G         +  E EV+ K              E      +L       H ++V
Sbjct: 22  TKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKL------SHKHLV 75

Query: 434 RLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVA 493
              G C+    +  LV E+ K GSL  +L      KN         +    +L +   +A
Sbjct: 76  LNYGVCVCGDEN-ILVQEFVKFGSLDTYLKKN---KNC--------INILWKLEVAKQLA 123

Query: 494 MALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGN--------FGMARCVNDDT----- 540
            A+ ++        +H N+ ++NI L  E + + GN         G++  V         
Sbjct: 124 AAMHFLEE-NT--LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDILQER 180

Query: 541 ------ES---PQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTP 575
                 E    P+  +   A+     D +++G  L E+ S G  P
Sbjct: 181 IPWVPPECIENPKNLNL--AT-----DKWSFGTTLWEICSGGDKP 218

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 98.5 bits (246), Expect = 1e-22
 Identities = 56/226 (24%), Positives = 86/226 (38%), Gaps = 52/226 (23%)

Query: 392 GAVYHGRLNGKNL-------AIKR-----TEHEVITKL-EMQLVQHATHHHPNIVRLLGT 438
           G V +    G +        A+K         E    + E++++      H NIV LLG 
Sbjct: 59  GKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ-LGSHENIVNLLGA 117

Query: 439 CLTDGPHSFLVFEYAKNGSLKDWL-----------HGGLAMKNQFIASCYCFLTWSQRLR 487
           C   GP  +L+FEY   G L ++L                 K          LT+   L 
Sbjct: 118 CTLSGPI-YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLC 176

Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFY- 546
               VA     M  +   S VHR++ +RN+ +      ++ +FG+AR +  D+     Y 
Sbjct: 177 FAYQVAKG---MEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN----YV 229

Query: 547 -STN---PASWSMGI------------DIFAYGIVLLEVLS-GQTP 575
              N   P  W M              D+++YGI+L E+ S G  P
Sbjct: 230 VRGNARLPVKW-MAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNP 274

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 98.2 bits (245), Expect = 1e-22
 Identities = 50/221 (22%), Positives = 91/221 (41%), Gaps = 47/221 (21%)

Query: 392 GAVYHGRLNGKNL------AIKRTEHEVITKLEMQLVQHA----THHHPNIVRLLGTCLT 441
           G V     +  N       A+K  + +   +      Q      T +H +I++  G C  
Sbjct: 45  GKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCED 104

Query: 442 DGPHS-FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH 500
            G  S  LV EY   GSL+D+L      ++         +  +Q L     +   + Y+H
Sbjct: 105 AGAASLQLVMEYVPLGSLRDYLP-----RHS--------IGLAQLLLFAQQICEGMAYLH 151

Query: 501 HVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN-----PASW-- 553
              +  Y+HR++ +RN+ LD +   ++G+FG+A+ V +  E   +Y        P  W  
Sbjct: 152 A-QH--YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE---YYRVREDGDSPVFWYA 205

Query: 554 ----SMGI-----DIFAYGIVLLEVLS-GQTPINRPRKKDE 584
                        D++++G+ L E+L+   +  + P K  E
Sbjct: 206 PECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE 246

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 97.4 bits (243), Expect = 1e-22
 Identities = 44/223 (19%), Positives = 89/223 (39%), Gaps = 49/223 (21%)

Query: 392 GAVYHGRLNGKNL------AIKRTEHEVITKLEMQLVQHA----THHHPNIVRLLGTCLT 441
           G V   R + +        A+K  + E        L +        +H NIV+  G C  
Sbjct: 35  GKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTE 94

Query: 442 DGPHS-FLVFEYAKNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQY 498
           DG +   L+ E+  +GSLK++L  +                +   Q+L+  + +   + Y
Sbjct: 95  DGGNGIKLIMEFLPSGSLKEYLPKNKNK-------------INLKQQLKYAVQICKGMDY 141

Query: 499 MHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYS----------- 547
           +       YVHR++ +RN+ ++ E   ++G+FG+ + +  D E   +Y+           
Sbjct: 142 LGS-RQ--YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE---YYTVKDDRDSPVFW 195

Query: 548 TNPASWSMGI-----DIFAYGIVLLEVLS-GQTPINRPRKKDE 584
             P            D++++G+ L E+L+   +  +      +
Sbjct: 196 YAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLK 238

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 97.8 bits (244), Expect = 2e-22
 Identities = 53/218 (24%), Positives = 86/218 (39%), Gaps = 46/218 (21%)

Query: 392 GAVYHGRLNGKNL-------AIK----RTEHEVITKL-EMQLVQHATHHHPNIVRLLGTC 439
           G V+    +           A+K     +E        E +L+      H +IVR  G C
Sbjct: 55  GKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTML--QHQHIVRFFGVC 112

Query: 440 LTDGPHSFLVFEYAKNGSLKDWL--HGGLAMKNQFIASCYCF-LTWSQRLRICLDVAMAL 496
               P   +VFEY ++G L  +L  HG  A             L   Q L +   VA  +
Sbjct: 113 TEGRPL-LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGM 171

Query: 497 QYM--HHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN----- 549
            Y+   H     +VHR++ +RN  + +    ++G+FGM+R    D  S  +Y        
Sbjct: 172 VYLAGLH-----FVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYRVGGRTML 222

Query: 550 ------PASWSMGI-----DIFAYGIVLLEVLS-GQTP 575
                 P S          D++++G+VL E+ + G+ P
Sbjct: 223 PIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQP 260

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 96.9 bits (242), Expect = 2e-22
 Identities = 50/213 (23%), Positives = 89/213 (41%), Gaps = 52/213 (24%)

Query: 392 GAVYHGRLNGKN----LAIKRTEHEVITKLEMQLVQHA----THHHPNIVRLLGTCLTDG 443
           G+V  G    +     +AIK  +         ++++ A       +P IVRL+G C  + 
Sbjct: 24  GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAE- 82

Query: 444 PHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM 503
               LV E A  G L  +L G    + +        +  S    +   V+M ++Y+    
Sbjct: 83  AL-MLVMEMAGGGPLHKFLVGK---REE--------IPVSNVAELLHQVSMGMKYLEE-K 129

Query: 504 NPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDT------------------ESPQF 545
           N  +VHR++ +RN+ L     A++ +FG+++ +  D                   E   F
Sbjct: 130 N--FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 187

Query: 546 --YSTNPASWSMGIDIFAYGIVLLEVLS-GQTP 575
             +S+   S     D+++YG+ + E LS GQ P
Sbjct: 188 RKFSS--RS-----DVWSYGVTMWEALSYGQKP 213

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 99.4 bits (248), Expect = 2e-22
 Identities = 41/210 (19%), Positives = 88/210 (41%), Gaps = 52/210 (24%)

Query: 392 GAVYHGRLNGK-NLAIKRTEHEVITKL----EMQLVQHATHHHPNIVRLLGTCLTDGPHS 446
           G V+    N    +A+K  +   ++      E  +++  T  H  +V+L     T  P  
Sbjct: 202 GEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMK--TLQHDKLVKLHAVV-TKEPI- 257

Query: 447 FLVFEYAKNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMN 504
           +++ E+   GSL D+L    G                  + +     +A  + ++    N
Sbjct: 258 YIITEFMAKGSLLDFLKSDEGS------------KQPLPKLIDFSAQIAEGMAFIEQ-RN 304

Query: 505 PSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDT----------------ESPQF--Y 546
             Y+HR++++ NI +      ++ +FG+AR + D+                 E+  F  +
Sbjct: 305 --YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSF 362

Query: 547 STNPASWSMGIDIFAYGIVLLEVLS-GQTP 575
           +    S     D++++GI+L+E+++ G+ P
Sbjct: 363 TI--KS-----DVWSFGILLMEIVTYGRIP 385

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 97.8 bits (244), Expect = 2e-22
 Identities = 55/228 (24%), Positives = 91/228 (39%), Gaps = 56/228 (24%)

Query: 392 GAVYHGRLNGKNL-------AIKR-----TEHEVITKL-EMQLVQHATHHHPNIVRLLGT 438
           G V+  R  G          A+K      +         E  L+      +PNIV+LLG 
Sbjct: 61  GRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEF--DNPNIVKLLGV 118

Query: 439 CLTDGPHSFLVFEYAKNGSLKDWL------------HGGLAMKNQFIASCYCFLTWSQRL 486
           C    P   L+FEY   G L ++L            H  L+ + +  +     L+ +++L
Sbjct: 119 CAVGKPM-CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQL 177

Query: 487 RICLDVAMALQYM--HHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQ 544
            I   VA  + Y+         +VHR++ +RN  + E    ++ +FG++R    +  S  
Sbjct: 178 CIARQVAAGMAYLSERK-----FVHRDLATRNCLVGENMVVKIADFGLSR----NIYSAD 228

Query: 545 FYSTN-----PASW------SMGI-----DIFAYGIVLLEVLS-GQTP 575
           +Y  +     P  W               D++AYG+VL E+ S G  P
Sbjct: 229 YYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 276

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 96.5 bits (241), Expect = 2e-22
 Identities = 48/212 (22%), Positives = 89/212 (41%), Gaps = 51/212 (24%)

Query: 392 GAVYHGRLNGKN-----LAIKRTEHEVITKLEMQLVQHA----THHHPNIVRLLGTCLTD 442
           G V+ G           +AIK  ++     +  + +Q A       HP+IV+L+G   T+
Sbjct: 29  GDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TE 87

Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
            P  +++ E    G L+ +L      K          L  +  +     ++ AL Y+   
Sbjct: 88  NPV-WIIMELCTLGELRSFLQVR---KYS--------LDLASLILYAYQLSTALAYLES- 134

Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDT----------------ESPQF- 545
               +VHR+I +RN+ +      ++G+FG++R + D T                ES  F 
Sbjct: 135 KR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 192

Query: 546 -YSTNPASWSMGIDIFAYGIVLLEVLS-GQTP 575
            +++  AS     D++ +G+ + E+L  G  P
Sbjct: 193 RFTS--AS-----DVWMFGVCMWEILMHGVKP 217

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 96.6 bits (241), Expect = 2e-22
 Identities = 46/212 (21%), Positives = 90/212 (42%), Gaps = 50/212 (23%)

Query: 392 GAVYHGRLNGKNL----AIK-----RTEHEVITKL--EMQLVQHATHHHPNIVRLLGTCL 440
           G V  G    K +    A+K       +  +  +L  E  ++      +P IVR++G C 
Sbjct: 31  GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVM--QQLDNPYIVRMIGICE 88

Query: 441 TDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH 500
            +     LV E A+ G L  +L      +N+        +     + +   V+M ++Y+ 
Sbjct: 89  AE-SW-MLVMEMAELGPLNKYLQ-----QNRH-------VKDKNIIELVHQVSMGMKYLE 134

Query: 501 HVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN-----PASW-- 553
              N  +VHR++ +RN+ L  +  A++ +FG+++ +  D     +Y        P  W  
Sbjct: 135 E-SN--FVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN---YYKAQTHGKWPVKWYA 188

Query: 554 ----SMGI-----DIFAYGIVLLEVLS-GQTP 575
               +        D++++G+++ E  S GQ P
Sbjct: 189 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKP 220

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 97.4 bits (243), Expect = 2e-22
 Identities = 49/214 (22%), Positives = 79/214 (36%), Gaps = 53/214 (24%)

Query: 392 GAVYHGRLNGKNL------AIKRTEHEVITKLEMQLVQHA----THHHPNIVRLLGTCLT 441
           G V+ G    +         IK  E +   +    +  H     +  H +IVRLLG C  
Sbjct: 27  GTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPG 86

Query: 442 DGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHH 501
                 LV +Y   GSL D +      +          L     L   + +A  + Y+  
Sbjct: 87  SSL--QLVTQYLPLGSLLDHVRQH---RGA--------LGPQLLLNWGVQIAKGMYYLEE 133

Query: 502 VMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDT-----------------ESPQ 544
                 VHRN+ +RN+ L      +V +FG+A  +  D                  ES  
Sbjct: 134 -HG--MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 190

Query: 545 F--YSTNPASWSMGIDIFAYGIVLLEVLS-GQTP 575
           F  Y+    S     D+++YG+ + E+++ G  P
Sbjct: 191 FGKYTH--QS-----DVWSYGVTVWELMTFGAEP 217

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 97.4 bits (243), Expect = 2e-22
 Identities = 47/212 (22%), Positives = 82/212 (38%), Gaps = 46/212 (21%)

Query: 392 GAVYHGRLNGKNL------AIKRTEHEVITKLEMQLVQHA----THHHPNIVRLLGTCLT 441
           G+V   R +          A+K          +    +        H   IV+  G    
Sbjct: 37  GSVELCRYDPLGDNTGALVAVK-QLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYG 95

Query: 442 DGPHS-FLVFEYAKNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQY 498
            G  S  LV EY  +G L+D+L  H                L  S+ L     +   ++Y
Sbjct: 96  PGRQSLRLVMEYLPSGCLRDFLQRHRAR-------------LDASRLLLYSSQICKGMEY 142

Query: 499 MHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---------SPQFYSTN 549
           +        VHR++ +RNI ++ E + ++ +FG+A+ +  D +         SP F+   
Sbjct: 143 LGS-RR--CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFW-YA 198

Query: 550 PASWSMGI-----DIFAYGIVLLEVLS-GQTP 575
           P S S  I     D++++G+VL E+ +     
Sbjct: 199 PESLSDNIFSRQSDVWSFGVVLYELFTYCDKS 230

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 96.9 bits (242), Expect = 2e-22
 Identities = 52/221 (23%), Positives = 84/221 (38%), Gaps = 47/221 (21%)

Query: 392 GAVYHGRLNGKNL-------AIKR-----TEHEVITKL-EMQLVQHATHHHPNIVRLLGT 438
           G V      G          A+K         E    + E++++ +   +H NIV LLG 
Sbjct: 37  GKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY-LGNHMNIVNLLGA 95

Query: 439 CLTDGPHSFLVFEYAKNGSLKDWL------HGGLAMKNQFIASCYCFLTWSQRLRICLDV 492
           C   GP   ++ EY   G L ++L                +      L     L     V
Sbjct: 96  CTIGGPT-LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQV 154

Query: 493 AMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFY--STN- 549
           A     M  + + + +HR++ +RNI L      ++ +FG+AR + +D+     Y    N 
Sbjct: 155 AKG---MAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN----YVVKGNA 207

Query: 550 --PASWSMGI------------DIFAYGIVLLEVLS-GQTP 575
             P  W M              D+++YGI L E+ S G +P
Sbjct: 208 RLPVKW-MAPESIFNCVYTFESDVWSYGIFLWELFSLGSSP 247

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 97.0 bits (242), Expect = 3e-22
 Identities = 56/221 (25%), Positives = 91/221 (41%), Gaps = 56/221 (25%)

Query: 392 GAVYHGRLNGKNL-------AIK-----RTEHEVITKL-EMQLVQHATHHHPNIVRLLGT 438
           G VY G+++G          A+K      +E + +  L E  ++     +H NIVR +G 
Sbjct: 44  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF--NHQNIVRCIGV 101

Query: 439 CLTDGPHSFLVFEYAKNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMAL 496
            L   P  F++ E    G LK +L        +          L     L +  D+A   
Sbjct: 102 SLQSLPR-FILMELMAGGDLKSFLRETRPRPSQPS-------SLAMLDLLHVARDIACGC 153

Query: 497 QYM--HHVMNPSYVHRNIKSRNIFLD---EEFNARVGNFGMARCVNDDTESPQFYSTN-- 549
           QY+  +H     ++HR+I +RN  L        A++G+FGMAR    D     +Y     
Sbjct: 154 QYLEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRASYYRKGGC 204

Query: 550 ---------PASWSMGI-----DIFAYGIVLLEVLS-GQTP 575
                    P ++  GI     D +++G++L E+ S G  P
Sbjct: 205 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 245

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 96.2 bits (240), Expect = 3e-22
 Identities = 49/219 (22%), Positives = 95/219 (43%), Gaps = 47/219 (21%)

Query: 392 GAVYHGRLNGKNL------AIKRTEHEVITKL-----EMQLVQHATHHHPNIVRLLGTCL 440
           G+V   R +          A+K+ +H     L     E+++++  +  H NIV+  G C 
Sbjct: 24  GSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK--SLQHDNIVKYKGVCY 81

Query: 441 TDGPHS-FLVFEYAKNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQ 497
           + G  +  L+ EY   GSL+D+L  H                +   + L+    +   ++
Sbjct: 82  SAGRRNLKLIMEYLPYGSLRDYLQKHKER-------------IDHIKLLQYTSQICKGME 128

Query: 498 YMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---------SPQFYST 548
           Y+       Y+HR++ +RNI ++ E   ++G+FG+ + +  D E         SP F+  
Sbjct: 129 YLGT-KR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFW-Y 184

Query: 549 NPASWSMGI-----DIFAYGIVLLEVLSGQTPINRPRKK 582
            P S +        D++++G+VL E+ +       P  +
Sbjct: 185 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 223

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 96.3 bits (240), Expect = 5e-22
 Identities = 49/219 (22%), Positives = 95/219 (43%), Gaps = 47/219 (21%)

Query: 392 GAVYHGRLNGKNL------AIKRTEHEVITKL-----EMQLVQHATHHHPNIVRLLGTCL 440
           G+V   R +          A+K+ +H     L     E+++++  +  H NIV+  G C 
Sbjct: 55  GSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK--SLQHDNIVKYKGVCY 112

Query: 441 TDGPHS-FLVFEYAKNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQ 497
           + G  +  L+ EY   GSL+D+L  H                +   + L+    +   ++
Sbjct: 113 SAGRRNLKLIMEYLPYGSLRDYLQKHKER-------------IDHIKLLQYTSQICKGME 159

Query: 498 YMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---------SPQFYST 548
           Y+       Y+HR++ +RNI ++ E   ++G+FG+ + +  D E         SP F+  
Sbjct: 160 YLGT-KR--YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFW-Y 215

Query: 549 NPASWSMGI-----DIFAYGIVLLEVLSGQTPINRPRKK 582
            P S +        D++++G+VL E+ +       P  +
Sbjct: 216 APESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAE 254

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 95.0 bits (237), Expect = 8e-22
 Identities = 43/212 (20%), Positives = 76/212 (35%), Gaps = 47/212 (22%)

Query: 392 GAVYHGRLNGKNL-----AIK--RTEHEVITKLEMQLVQHATH----HHPNIVRLLGTCL 440
           G V  G  +  +      A+K  + +     +     ++         H N++RL G  L
Sbjct: 32  GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 91

Query: 441 TDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH 500
              P   +V E A  GSL D L      +                 R  + VA  + Y+ 
Sbjct: 92  --TPPMKMVTELAPLGSLLDRLRKH---QGH--------FLLGTLSRYAVQVAEGMGYLE 138

Query: 501 HVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN-----PASW-- 553
                 ++HR++ +RN+ L      ++G+FG+ R +  +      Y        P +W  
Sbjct: 139 S-KR--FIHRDLAARNLLLATRDLVKIGDFGLMRALPQN---DDHYVMQEHRKVPFAWCA 192

Query: 554 ----SMGI-----DIFAYGIVLLEVLS-GQTP 575
                        D + +G+ L E+ + GQ P
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 98.4 bits (245), Expect = 1e-21
 Identities = 45/205 (21%), Positives = 84/205 (40%), Gaps = 37/205 (18%)

Query: 392 GAVYHGRLNGKN-----LAIKRTEHEVITKLEMQLVQHA----THHHPNIVRLLGTCLTD 442
           G V+ G           +AIK  ++     +  + +Q A       HP+IV+L+G   T+
Sbjct: 404 GDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TE 462

Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
            P  +++ E    G L+ +L      K          L  +  +     ++ AL Y+   
Sbjct: 463 NPV-WIIMELCTLGELRSFLQVR---KFS--------LDLASLILYAYQLSTALAYLES- 509

Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW--------- 553
               +VHR+I +RN+ +      ++G+FG++R + D T         P  W         
Sbjct: 510 KR--FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 567

Query: 554 --SMGIDIFAYGIVLLEVLS-GQTP 575
             +   D++ +G+ + E+L  G  P
Sbjct: 568 RFTSASDVWMFGVCMWEILMHGVKP 592

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score = 94.3 bits (235), Expect = 2e-21
 Identities = 48/220 (21%), Positives = 85/220 (38%), Gaps = 55/220 (25%)

Query: 392 GAVYHGR--LNGKNLAIKRTEHEVITKLEMQLVQ----HATHHHPNIVRLLGTCLTDGPH 445
           G V+  +  ++  N AIKR           ++++     A   HP IVR     L     
Sbjct: 19  GVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTT 78

Query: 446 S-----------FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAM 494
                       ++  +  +  +LKDW++G   ++             S  L I L +A 
Sbjct: 79  EKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIE---------ERERSVCLHIFLQIAE 129

Query: 495 ALQYMH--HVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPAS 552
           A++++H   +M     HR++K  NIF   +   +VG+FG+   ++ D E     +  PA 
Sbjct: 130 AVEFLHSKGLM-----HRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184

Query: 553 WSMG----------------------IDIFAYGIVLLEVL 570
                                     +DIF+ G++L E+L
Sbjct: 185 ARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELL 224

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 94.8 bits (236), Expect = 3e-21
 Identities = 57/219 (26%), Positives = 94/219 (42%), Gaps = 52/219 (23%)

Query: 392 GAVYHGRLNGKN-------LAIK-----RTEHEVITKL-EMQLVQHATHHHPNIVRLLGT 438
           G VY G+++G         +A+K      +E + +  L E  ++     +H NIVR +G 
Sbjct: 85  GEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKF--NHQNIVRCIGV 142

Query: 439 CLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQY 498
            L   P  F++ E    G LK +L      + +   S    L     L +  D+A   QY
Sbjct: 143 SLQSLPR-FILLELMAGGDLKSFLR-----ETRPRPSQPSSLAMLDLLHVARDIACGCQY 196

Query: 499 M--HHVMNPSYVHRNIKSRNIFLD---EEFNARVGNFGMARCVNDDTESPQFYSTN---- 549
           +  +H     ++HR+I +RN  L        A++G+FGMAR    D     +Y       
Sbjct: 197 LEENH-----FIHRDIAARNCLLTCPGPGRVAKIGDFGMAR----DIYRAGYYRKGGCAM 247

Query: 550 -------PASWSMGI-----DIFAYGIVLLEVLS-GQTP 575
                  P ++  GI     D +++G++L E+ S G  P
Sbjct: 248 LPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMP 286

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 95.0 bits (236), Expect = 1e-20
 Identities = 50/211 (23%), Positives = 86/211 (40%), Gaps = 48/211 (22%)

Query: 392 GAVYHGRLNGKN----LAIKRTEHEVITKLEMQLVQHA----THHHPNIVRLLGTCLTDG 443
           G+V  G    +     +AIK  +         ++++ A       +P IVRL+G C  + 
Sbjct: 350 GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA 409

Query: 444 PHSFLVFEYAKNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHH 501
               LV E A  G L  +L                   +  S    +   V+M ++Y+  
Sbjct: 410 L--MLVMEMAGGGPLHKFLVGKREE-------------IPVSNVAELLHQVSMGMKYLEE 454

Query: 502 VMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN-----PASW--- 553
             N  +VHRN+ +RN+ L     A++ +FG+++ +  D     +Y+       P  W   
Sbjct: 455 -KN--FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS---YYTARSAGKWPLKWYAP 508

Query: 554 --------SMGIDIFAYGIVLLEVLS-GQTP 575
                   S   D+++YG+ + E LS GQ P
Sbjct: 509 ECINFRKFSSRSDVWSYGVTMWEALSYGQKP 539

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score = 89.7 bits (223), Expect = 6e-20
 Identities = 44/204 (21%), Positives = 80/204 (39%), Gaps = 35/204 (17%)

Query: 392 GAVYHG--RLNGKNLAIKRTEHEVITKLEMQLVQH-----ATHHHPNIVRLLGTCL-TDG 443
             VY G        +A    +   +TK E Q  +          HPNIVR   +   T  
Sbjct: 40  KTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 99

Query: 444 PHSFLVF--EYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHH 501
               +V   E   +G+LK +L              +  +        C  +   LQ++H 
Sbjct: 100 GKKCIVLVTELMTSGTLKTYLKR------------FKVMKIKVLRSWCRQILKGLQFLHT 147

Query: 502 VMNPSYVHRNIKSRNIFLDEEF-NARVGNFGMARCVNDDTE-----SPQFYSTNP----A 551
              P  +HR++K  NIF+     + ++G+ G+A             +P+F +  P     
Sbjct: 148 -RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMA--PEMYEE 204

Query: 552 SWSMGIDIFAYGIVLLEVLSGQTP 575
            +   +D++A+G+ +LE+ + + P
Sbjct: 205 KYDESVDVYAFGMCMLEMATSEYP 228

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score = 89.0 bits (221), Expect = 2e-19
 Identities = 49/203 (24%), Positives = 88/203 (43%), Gaps = 35/203 (17%)

Query: 392 GAVYHGR--LNGKNLAIKRTEHEVITKLEMQLVQ-----HATHHHPNIVRLLGTCLTDGP 444
           G     +   +G+   IK      ++  E +  +      A   HPNIV+   +   +G 
Sbjct: 38  GKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENG- 96

Query: 445 HSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMN 504
             ++V +Y + G L   ++   A K              Q L   + + +AL+++H   +
Sbjct: 97  SLYIVMDYCEGGDLFKRIN---AQKGVLFQE-------DQILDWFVQICLALKHVH---D 143

Query: 505 PSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------------SPQFYSTNPAS 552
              +HR+IKS+NIFL ++   ++G+FG+AR +N   E            SP+     P +
Sbjct: 144 RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYN 203

Query: 553 WSMGIDIFAYGIVLLEVLSGQTP 575
                DI+A G VL E+ + +  
Sbjct: 204 NK--SDIWALGCVLYELCTLKHA 224

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score = 88.6 bits (220), Expect = 2e-19
 Identities = 39/163 (23%), Positives = 64/163 (39%), Gaps = 23/163 (14%)

Query: 392 GAVY--HGRLNGKNLAIKR-----TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGP 444
             V    G  +G   A+KR      +     + E  +  H   +HPNI+RL+  CL +  
Sbjct: 43  SYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADM--HRLFNHPNILRLVAYCLRERG 100

Query: 445 HS---FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHH 501
                +L+  + K G+L + +       N        FLT  Q L + L +   L+ +H 
Sbjct: 101 AKHEAWLLLPFFKRGTLWNEIERLKDKGN--------FLTEDQILWLLLGICRGLEAIHA 152

Query: 502 VMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQ 544
                Y HR++K  NI L +E    + + G         E  +
Sbjct: 153 ---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSR 192

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score = 85.5 bits (212), Expect = 1e-18
 Identities = 44/223 (19%), Positives = 79/223 (35%), Gaps = 56/223 (25%)

Query: 392 GAVYHG--RLNGKNLAIKRTEHEVITKLEMQLVQH------ATHHHPNIVRLLGTCLTDG 443
           G+V+    RL+G   AIKR++  +   ++ Q              H ++VR       D 
Sbjct: 25  GSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDD 84

Query: 444 PHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM 503
            H  +  EY   GSL D +     + + F          ++   + L V   L+Y+H   
Sbjct: 85  -HMLIQNEYCNGGSLADAISENYRIMSYF--------KEAELKDLLLQVGRGLRYIH--- 132

Query: 504 NPSYVHRNIKSRNIFLDEE-------------------FNARVGNFGMARCVND-DTE-- 541
           + S VH +IK  NIF+                         ++G+ G    ++    E  
Sbjct: 133 SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEG 192

Query: 542 -----SP----QFYSTNPASWSMGIDIFAYGIVLLEVLSGQTP 575
                +     + Y+  P +     DIFA  + ++     +  
Sbjct: 193 DSRFLANEVLQENYTHLPKA-----DIFALALTVVCAAGAEPL 230

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score = 85.4 bits (212), Expect = 2e-18
 Identities = 44/206 (21%), Positives = 71/206 (34%), Gaps = 44/206 (21%)

Query: 392 GAVYHGR--LNGKNLAIKR------TEHEVITKL-EMQLVQHATHHHPNIVRLLGTCLTD 442
           G V+  R   +G+  A+KR         +   KL E+   +     HP  VRL       
Sbjct: 71  GEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHE-KVGQHPCCVRLEQAWEEG 129

Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
           G   +L  E     SL+           Q   +    L  +Q      D  +AL ++H  
Sbjct: 130 G-ILYLQTELC-GPSLQ-----------QHCEAWGASLPEAQVWGYLRDTLLALAHLH-- 174

Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYST-------------N 549
            +   VH ++K  NIFL      ++G+FG+   +                          
Sbjct: 175 -SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYG 233

Query: 550 PASWSMGIDIFAYGIVLLEVLSGQTP 575
            A+     D+F+ G+ +LEV      
Sbjct: 234 TAA-----DVFSLGLTILEVACNMEL 254

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score = 85.4 bits (212), Expect = 2e-18
 Identities = 44/208 (21%), Positives = 80/208 (38%), Gaps = 42/208 (20%)

Query: 392 GAVYHGR--LNGKNLAIKR-------TEHEVI-TKLEMQLVQHATHHHPNIVRLLGTCLT 441
             VY     L+G  +A+K+                 E+ L+     +HPN+++   + + 
Sbjct: 46  SEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLL--KQLNHPNVIKYYASFIE 103

Query: 442 DGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH- 500
           D     +V E A  G L   +      K                 +  + +  AL++MH 
Sbjct: 104 DN-ELNIVLELADAGDLSRMIKHFKKQKRLI--------PERTVWKYFVQLCSALEHMHS 154

Query: 501 -HVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------------SPQFYS 547
             VM     HR+IK  N+F+      ++G+ G+ R  +  T             SP+   
Sbjct: 155 RRVM-----HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIH 209

Query: 548 TNPASWSMGIDIFAYGIVLLEVLSGQTP 575
            N  ++    DI++ G +L E+ + Q+P
Sbjct: 210 ENGYNFK--SDIWSLGCLLYEMAALQSP 235

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score = 84.7 bits (210), Expect = 2e-18
 Identities = 42/213 (19%), Positives = 84/213 (39%), Gaps = 46/213 (21%)

Query: 392 GAVYHGR--LNGKNLAIKRTEHEVITKL-EMQLVQHATHHHPNIVRLLG----------- 437
           G V+  +  ++GK   IKR ++       E++    A   H NIV   G           
Sbjct: 25  GQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKA--LAKLDHVNIVHYNGCWDGFDYDPET 82

Query: 438 ----TCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVA 493
               +  +     F+  E+   G+L+ W+      + +        L     L +   + 
Sbjct: 83  SSKNSSRSKTKCLFIQMEFCDKGTLEQWIE---KRRGEK-------LDKVLALELFEQIT 132

Query: 494 MALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE-----------S 542
             + Y+H   +   ++R++K  NIFL +    ++G+FG+   + +D +           S
Sbjct: 133 KGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMS 189

Query: 543 PQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTP 575
           P+  S+        +D++A G++L E+L     
Sbjct: 190 PEQISSQDYGKE--VDLYALGLILAELLHVCDT 220

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score = 83.5 bits (207), Expect = 5e-18
 Identities = 50/206 (24%), Positives = 87/206 (42%), Gaps = 32/206 (15%)

Query: 392 GAVYHGR--LNGKNLAIKRTEHEVITKLEMQLVQH-----ATHHHPNIVRLLGTCL-TDG 443
           G     R   +GK L  K  ++  +T+ E Q++           HPNIVR     +    
Sbjct: 20  GRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN 79

Query: 444 PHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM 503
              ++V EY + G L   +  G   +                LR+   + +AL+  H   
Sbjct: 80  TTLYIVMEYCEGGDLASVITKGTKERQYL--------DEEFVLRVMTQLTLALKECHRRS 131

Query: 504 NPSY--VHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------------SPQFYSTN 549
           +  +  +HR++K  N+FLD + N ++G+FG+AR +N DT             SP+  +  
Sbjct: 132 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRM 191

Query: 550 PASWSMGIDIFAYGIVLLEVLSGQTP 575
             +     DI++ G +L E+ +   P
Sbjct: 192 SYNEK--SDIWSLGCLLYELCALMPP 215

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score = 81.7 bits (202), Expect = 6e-17
 Identities = 36/219 (16%), Positives = 74/219 (33%), Gaps = 47/219 (21%)

Query: 392 GAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATH------------------------ 427
             +     + K  A+K        K  ++  +  T                         
Sbjct: 45  NKIILCEKDNKFYALK-----KYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITD 99

Query: 428 -HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRL 486
             +   +   G  +T+    ++++EY +N S+  +             +  CF+      
Sbjct: 100 IKNEYCLTCEGI-ITNYDEVYIIYEYMENDSILKFDE----YFFVLDKNYTCFIPIQVIK 154

Query: 487 RICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDT------ 540
            I   V  +  Y+H+  N    HR++K  NI +D+    ++ +FG +  + D        
Sbjct: 155 CIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRG 212

Query: 541 ----ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTP 575
                 P+F+S   +     +DI++ GI L  +     P
Sbjct: 213 TYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVP 251

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score = 80.1 bits (198), Expect = 1e-16
 Identities = 50/225 (22%), Positives = 86/225 (38%), Gaps = 61/225 (27%)

Query: 392 GAVYHGR--LNGKNLAIKRTEHEVITKLEMQLVQH-----ATHHHPNIVRLLGTCLTDGP 444
           G V   R  L+ +  AIK+  H   T+ ++  +       A+ +H  +VR     L    
Sbjct: 20  GQVVKARNALDSRYYAIKKIRH---TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRN 76

Query: 445 HS------------FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDV 492
                         F+  EY +NG+L D            I S        +  R+   +
Sbjct: 77  FVKPMTAVKKKSTLFIQMEYCENGTLYDL-----------IHSENLNQQRDEYWRLFRQI 125

Query: 493 AMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPAS 552
             AL Y+H   +   +HR++K  NIF+DE  N ++G+FG+A+ V+   +  +  S N   
Sbjct: 126 LEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPG 182

Query: 553 WSMG-------------------------IDIFAYGIVLLEVLSG 572
            S                           ID+++ GI+  E++  
Sbjct: 183 SSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIYP 227

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 35/163 (21%), Positives = 72/163 (44%), Gaps = 37/163 (22%)

Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           H NIV ++     +    +LV EY +  +L +++                 L+    +  
Sbjct: 70  HQNIVSMIDVD-EEDDCYYLVMEYIEGPTLSEYIESHGP------------LSVDTAINF 116

Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------- 541
              +   +++ H +     VHR+IK +NI +D     ++ +FG+A+ +++ +        
Sbjct: 117 TNQILDGIKHAHDM---RIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVL 173

Query: 542 -SPQFYS--------TNPASWSMGIDIFAYGIVLLEVLSGQTP 575
            + Q++S        T+  +     DI++ GIVL E+L G+ P
Sbjct: 174 GTVQYFSPEQAKGEATDECT-----DIYSIGIVLYEMLVGEPP 211

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 80.4 bits (198), Expect = 2e-16
 Identities = 51/267 (19%), Positives = 94/267 (35%), Gaps = 90/267 (33%)

Query: 392 GAVYHGRLNGKN-------LAIK-------RTEHEVITKLEMQLVQHATHHHPNIVRLLG 437
           G V      G +       +A+K        +EH  +   E++++ H   HH N+V LLG
Sbjct: 36  GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS-ELKILIHI-GHHLNVVNLLG 93

Query: 438 TCLTDGPHSFLVFEYAKNGSLKDWLH---------------------------------- 463
            C   G    ++ E+ K G+L  +L                                   
Sbjct: 94  ACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRL 153

Query: 464 ------------GGLAMKNQFIASCYCFLTWSQRLRICLD--VAMALQY---MHHVMNPS 506
                       G +  K+              +  + L+  +  + Q    M  + +  
Sbjct: 154 DSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK 213

Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN-----PASWSMGI---- 557
            +HR++ +RNI L E+   ++ +FG+AR +  D +    Y        P  W M      
Sbjct: 214 CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD----YVRKGDARLPLKW-MAPETIF 268

Query: 558 --------DIFAYGIVLLEVLS-GQTP 575
                   D++++G++L E+ S G +P
Sbjct: 269 DRVYTIQSDVWSFGVLLWEIFSLGASP 295

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score = 78.3 bits (193), Expect = 6e-16
 Identities = 46/224 (20%), Positives = 79/224 (35%), Gaps = 53/224 (23%)

Query: 392 GAVYHGR--LNGKNLAIKR-----TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTD-- 442
             VY  +   +G+  A+KR      E       E+  ++  + H PNIV+          
Sbjct: 42  AFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGH-PNIVQFCSAASIGKE 100

Query: 443 ----GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQY 498
               G   FL+      G L ++L    +            L+    L+I      A+Q+
Sbjct: 101 ESDTGQAEFLLLTELCKGQLVEFLKKMESRG---------PLSCDTVLKIFYQTCRAVQH 151

Query: 499 MHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE----------------- 541
           MH    P  +HR++K  N+ L  +   ++ +FG A  ++   +                 
Sbjct: 152 MHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITR 210

Query: 542 --SPQF--------YSTNPASWSMGIDIFAYGIVLLEVLSGQTP 575
             +P +        YS  P       DI+A G +L  +   Q P
Sbjct: 211 NTTPMYRTPEIIDLYSNFPIGEK--QDIWALGCILYLLCFRQHP 252

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 80.3 bits (198), Expect = 7e-16
 Identities = 39/215 (18%), Positives = 72/215 (33%), Gaps = 64/215 (29%)

Query: 392 GAVYHG---RLNGKNLAIK--------------RTEHEVITKLEMQLVQHATHHHPNIVR 434
           G +Y      +NG+ + +K                E + + ++           HP+IV+
Sbjct: 94  GWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEV----------VHPSIVQ 143

Query: 435 LLGTCLTDGPHS----FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICL 490
           +         H     ++V EY    SLK      L                ++ +   L
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKL--------------PVAEAIAYLL 189

Query: 491 DVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---SPQFYS 547
           ++  AL Y+H +     V+ ++K  NI L EE   ++ + G    +N       +P F +
Sbjct: 190 EILPALSYLHSI---GLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFGYLYGTPGFQA 245

Query: 548 -------TNPASWSMGIDIFAYGIVLLEVLSGQTP 575
                     A+     DI+  G  L  +      
Sbjct: 246 PEIVRTGPTVAT-----DIYTVGRTLAALTLDLPT 275

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score = 77.6 bits (191), Expect = 1e-15
 Identities = 42/261 (16%), Positives = 96/261 (36%), Gaps = 39/261 (14%)

Query: 343 KKVSFEGSQSTIEGQIIDTAEQHKRLLESYSIEDLRRATEKFNSSNRIEGAVYHGRLNGK 402
           K++     +   E +++   +   +L     +       E      + E      +    
Sbjct: 37  KRIRLPNRELARE-KVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDEST 95

Query: 403 NLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL 462
           +  +          ++++          N V  L        + ++  +  +  +LKDW+
Sbjct: 96  DWPLSSPSPMDAPSVKIRR--MDPFSTKNTVGQLQPSSPKV-YLYIQMQLCRKENLKDWM 152

Query: 463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEE 522
           +   +++++    C         L I + +A A++++H   +   +HR++K  NIF   +
Sbjct: 153 NRRCSLEDREHGVC---------LHIFIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMD 200

Query: 523 FNARVGNFGMARCVNDDTESPQFYSTNPASWSMG----------------------IDIF 560
              +VG+FG+   ++ D E     +  PA  +                        +DIF
Sbjct: 201 DVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIF 260

Query: 561 AYGIVLLEVLSG-QTPINRPR 580
           + G++L E+L    T + R R
Sbjct: 261 SLGLILFELLYSFSTQMERVR 281

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score = 77.1 bits (190), Expect = 2e-15
 Identities = 40/202 (19%), Positives = 70/202 (34%), Gaps = 36/202 (17%)

Query: 392 GAVYHG--RLNGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLV 449
           G V+    +  G   A+K+   EV    E+     A    P IV L G    +GP   + 
Sbjct: 72  GEVHRMKDKQTGFQCAVKKVRLEVFRVEELVA--CAGLSSPRIVPLYGAVR-EGPWVNIF 128

Query: 450 FEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVH 509
            E  + GSL   +     +                           L+Y+H       +H
Sbjct: 129 MELLEGGSLGQLIKQMGCLPEDRALY------------YLGQALEGLEYLH---TRRILH 173

Query: 510 RNIKSRNIFLDEE-FNARVGNFGMARCVNDDTESPQFYSTN----------P-----ASW 553
            ++K+ N+ L  +   A + +FG A C+  D       + +          P        
Sbjct: 174 GDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPC 233

Query: 554 SMGIDIFAYGIVLLEVLSGQTP 575
              +DI++   ++L +L+G  P
Sbjct: 234 DAKVDIWSSCCMMLHMLNGCHP 255

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score = 76.5 bits (188), Expect = 4e-15
 Identities = 33/156 (21%), Positives = 55/156 (35%), Gaps = 25/156 (16%)

Query: 392 GAVYHGR--LNGKNLAIKRTEHEVITKLEMQLVQH-----ATHHHPNIVRLLGTCLTDGP 444
             V   R    G+ + ++R   E  +   +  +Q         +HPNIV           
Sbjct: 41  MTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRA-TFIADN 99

Query: 445 HSFLVFEYAKNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
             ++V  +   GS KD +  H    M    IA             I   V  AL Y+HH+
Sbjct: 100 ELWVVTSFMAYGSAKDLICTHFMDGMNELAIAY------------ILQGVLKALDYIHHM 147

Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND 538
               YVHR++K+ +I +  +    +        +  
Sbjct: 148 ---GYVHRSVKASHILISVDGKVYLSGLRSNLSMIS 180

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score = 74.9 bits (185), Expect = 5e-15
 Identities = 41/204 (20%), Positives = 79/204 (38%), Gaps = 38/204 (18%)

Query: 392 GAVYHGR--LNGKNLAIKRTEHEVITKLEM--QLVQ----HATHHHPNIVRLLGTCLTDG 443
              +        +  A K     ++ K     ++      H +  H ++V   G    D 
Sbjct: 29  AKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG-FFEDN 87

Query: 444 PHSFLVFEYAKNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHH 501
              F+V E  +  SL +       L    +  A  Y      Q       + +  QY+H 
Sbjct: 88  DFVFVVLELCRRRSLLELHKRRKAL---TEPEARYY----LRQ-------IVLGCQYLHR 133

Query: 502 VMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE-------SPQFYS---TNPA 551
                 +HR++K  N+FL+E+   ++G+FG+A  V  D E       +P + +    +  
Sbjct: 134 NR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKK 190

Query: 552 SWSMGIDIFAYGIVLLEVLSGQTP 575
             S  +D+++ G ++  +L G+ P
Sbjct: 191 GHSFEVDVWSIGCIMYTLLVGKPP 214

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 75.0 bits (185), Expect = 6e-15
 Identities = 40/169 (23%), Positives = 69/169 (40%), Gaps = 41/169 (24%)

Query: 428 HHPNIVRLLGTCLTDG---PHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQ 484
           +HP IV +  T   +    P  ++V EY    +L+D +H                +T  +
Sbjct: 70  NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP------------MTPKR 117

Query: 485 RLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE--- 541
            + +  D   AL + H       +HR++K  NI +      +V +FG+AR + D      
Sbjct: 118 AIEVIADACQALNFSHQN---GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 174

Query: 542 -------SPQFYS--------TNPASWSMGIDIFAYGIVLLEVLSGQTP 575
                  + Q+ S         +  S     D+++ G VL EVL+G+ P
Sbjct: 175 QTAAVIGTAQYLSPEQARGDSVDARS-----DVYSLGCVLYEVLTGEPP 218

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 76.0 bits (187), Expect = 7e-15
 Identities = 41/205 (20%), Positives = 81/205 (39%), Gaps = 40/205 (19%)

Query: 394 VYHGRLNGKNLAIKRTEHEVITKL--EMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFE 451
           VY G  + +++A+KR   E  +    E+QL++ +  H PN++R   T   D    ++  E
Sbjct: 41  VYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEH-PNVIRYFCTE-KDRQFQYIAIE 98

Query: 452 YAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRN 511
                +L++           ++          + + +       L ++H  +N   VHR+
Sbjct: 99  LC-AATLQE-----------YVEQKDFAHLGLEPITLLQQTTSGLAHLHS-LN--IVHRD 143

Query: 512 IKSRNIFLDE-----EFNARVGNFGMARCVNDDTESPQFYSTNPAS--W----------- 553
           +K  NI +       +  A + +FG+ + +     S    S  P +  W           
Sbjct: 144 LKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCK 203

Query: 554 ---SMGIDIFAYGIVLLEVLSGQTP 575
              +  +DIF+ G V   V+S  + 
Sbjct: 204 ENPTYTVDIFSAGCVFYYVISEGSH 228

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score = 74.1 bits (183), Expect = 9e-15
 Identities = 32/152 (21%), Positives = 60/152 (39%), Gaps = 27/152 (17%)

Query: 392 GAVYHGR--LNGKNLAIKRTEHEVITKLEM--QLVQ----HATHHHPNIVRLLGTCLTDG 443
             VY       G  +AIK  + + + K  M  ++      H    HP+I+ L      D 
Sbjct: 25  AGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN-YFEDS 83

Query: 444 PHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH--H 501
            + +LV E   NG +  +L   +   ++  A  +      Q       +   + Y+H   
Sbjct: 84  NYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHF----MHQ-------IITGMLYLHSHG 132

Query: 502 VMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA 533
           +     +HR++   N+ L    N ++ +FG+A
Sbjct: 133 I-----LHRDLTLSNLLLTRNMNIKIADFGLA 159

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score = 73.5 bits (181), Expect = 2e-14
 Identities = 42/208 (20%), Positives = 78/208 (37%), Gaps = 46/208 (22%)

Query: 392 GAVYHGR--LNGKNLAIKRTEHEVITKLEM--QLVQ----HATHHHPNIVRLLGTCLTDG 443
              +        +  A K     ++ K     ++      H +  H ++V   G    D 
Sbjct: 55  AKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG-FFEDN 113

Query: 444 PHSFLVFEYAKNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH- 500
              F+V E  +  SL +       L        + Y      Q       + +  QY+H 
Sbjct: 114 DFVFVVLELCRRRSLLELHKRRKALTEP----EARYYLR---Q-------IVLGCQYLHR 159

Query: 501 -HVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------------SPQFYS 547
             V     +HR++K  N+FL+E+   ++G+FG+A  V  D E            +P+  S
Sbjct: 160 NRV-----IHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLS 214

Query: 548 TNPASWSMGIDIFAYGIVLLEVLSGQTP 575
                 S  +D+++ G ++  +L G+ P
Sbjct: 215 KKG--HSFEVDVWSIGCIMYTLLVGKPP 240

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score = 73.1 bits (180), Expect = 2e-14
 Identities = 39/215 (18%), Positives = 72/215 (33%), Gaps = 49/215 (22%)

Query: 392 GAVYHGR-LNGKNLAIKR-----TEHEVITKL--EMQLVQHATHHHPNIVRLLGTCLTDG 443
             V+       +  AIK       +++ +     E+  +     H   I+RL    +TD 
Sbjct: 42  SKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 101

Query: 444 PHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM 503
            + ++V E   N  L  WL    ++      S      W         +  A+  +H   
Sbjct: 102 -YIYMVMECG-NIDLNSWLKKKKSIDPWERKS-----YWKN-------MLEAVHTIHQHG 147

Query: 504 NPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE--------------SP-----Q 544
               VH ++K  N  + +    ++ +FG+A  +  DT                P      
Sbjct: 148 ---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 203

Query: 545 FYSTNPASWSMGI----DIFAYGIVLLEVLSGQTP 575
             S         I    D+++ G +L  +  G+TP
Sbjct: 204 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score = 73.3 bits (180), Expect = 4e-14
 Identities = 36/215 (16%), Positives = 72/215 (33%), Gaps = 49/215 (22%)

Query: 392 GAVYHGR-LNGKNLAIKR-----TEHEVITKL--EMQLVQHATHHHPNIVRLLGTCLTDG 443
             V+       +  AIK       +++ +     E+  +     H   I+RL    +TD 
Sbjct: 70  SKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 129

Query: 444 PHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM 503
            + ++V E   N  L  WL    ++      S      W         +  A+  +H   
Sbjct: 130 -YIYMVMECG-NIDLNSWLKKKKSIDPWERKS-----YWKN-------MLEAVHTIHQHG 175

Query: 504 NPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDT---------------------ES 542
               VH ++K  N  + +    ++ +FG+A  +  DT                     + 
Sbjct: 176 ---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDM 231

Query: 543 PQFYSTNPASWSMG--IDIFAYGIVLLEVLSGQTP 575
                   +   +    D+++ G +L  +  G+TP
Sbjct: 232 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score = 72.9 bits (179), Expect = 4e-14
 Identities = 45/217 (20%), Positives = 73/217 (33%), Gaps = 50/217 (23%)

Query: 392 GAVYHG--RLNGKNLAIKRTEHEVITKLE---------MQLVQHATHHHPNIVRLLGTCL 440
             V+ G  +  G   AIK   +    +           ++ +     +H NIV+L     
Sbjct: 23  ANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-----NHKNIVKLFAIEE 77

Query: 441 TDGP-HSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYM 499
                H  L+ E+   GSL   L       N         L  S+ L +  DV   + ++
Sbjct: 78  ETTTRHKVLIMEFCPCGSLYTVLE---EPSNA------YGLPESEFLIVLRDVVGGMNHL 128

Query: 500 HHVMNPSYVHRNIKSRNIFL----DEEFNARVGNFGMARCVNDDTE-----------SPQ 544
                   VHRNIK  NI      D +   ++ +FG AR + DD +            P 
Sbjct: 129 RENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD 185

Query: 545 FYSTNPASWSMG------IDIFAYGIVLLEVLSGQTP 575
            Y                +D+++ G+      +G  P
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score = 72.8 bits (179), Expect = 5e-14
 Identities = 39/215 (18%), Positives = 72/215 (33%), Gaps = 49/215 (22%)

Query: 392 GAVYHGR-LNGKNLAIKR-----TEHEVITKL--EMQLVQHATHHHPNIVRLLGTCLTDG 443
             V+       +  AIK       +++ +     E+  +     H   I+RL    +TD 
Sbjct: 23  SKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ 82

Query: 444 PHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM 503
            + ++V E   N  L  WL    ++      S      W         +  A+  +H   
Sbjct: 83  -YIYMVMECG-NIDLNSWLKKKKSIDPWERKS-----YWKN-------MLEAVHTIHQHG 128

Query: 504 NPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE--------------SP-----Q 544
               VH ++K  N  + +    ++ +FG+A  +  DT                P      
Sbjct: 129 ---IVHSDLKPANFLIVDG-MLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDM 184

Query: 545 FYSTNPASWSMGI----DIFAYGIVLLEVLSGQTP 575
             S         I    D+++ G +L  +  G+TP
Sbjct: 185 SSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score = 72.3 bits (177), Expect = 7e-14
 Identities = 33/245 (13%), Positives = 69/245 (28%), Gaps = 53/245 (21%)

Query: 392 GAVYHGR-------LNGKNLAIK------RTEHEVITKLEMQLVQHATHHHPNIVRLLGT 438
             VY           N +   +K        E  + T+L  +L           ++    
Sbjct: 79  AQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPS---MQHMFMKFYSA 135

Query: 439 CLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQY 498
            L     S LV E    G+L + +       N +  +    +     +   + +   ++ 
Sbjct: 136 HLFQN-GSVLVGELYSYGTLLNAI-------NLYKNTPEKVMPQGLVISFAMRMLYMIEQ 187

Query: 499 MHHVMNPSYVHRNIKSRNIFL-----------DEEFNARVGNFGMARCVNDDTESPQFYS 547
           +H   +   +H +IK  N  L           D      + + G +  +    +   F +
Sbjct: 188 VH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTA 244

Query: 548 T------------NPASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDEGSVWLSEKIKS 595
                        +   W+  ID F     +  +L G        K + G        + 
Sbjct: 245 KCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYM---KVKNEGGECKPEGLFRR 301

Query: 596 ILQAE 600
           +   +
Sbjct: 302 LPHLD 306

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score = 72.6 bits (178), Expect = 9e-14
 Identities = 45/217 (20%), Positives = 73/217 (33%), Gaps = 50/217 (23%)

Query: 392 GAVYHG--RLNGKNLAIKRTEHEVITKLE---------MQLVQHATHHHPNIVRLLGTCL 440
             V+ G  +  G   AIK   +    +           ++ +     +H NIV+L     
Sbjct: 23  ANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL-----NHKNIVKLFAIEE 77

Query: 441 TDGP-HSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYM 499
                H  L+ E+   GSL   L       N         L  S+ L +  DV   + ++
Sbjct: 78  ETTTRHKVLIMEFCPCGSLYTVLE---EPSN------AYGLPESEFLIVLRDVVGGMNHL 128

Query: 500 HHVMNPSYVHRNIKSRNIFL----DEEFNARVGNFGMARCVNDDTE-----------SPQ 544
                   VHRNIK  NI      D +   ++ +FG AR + DD +            P 
Sbjct: 129 RENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPD 185

Query: 545 FYSTNPASWSMG------IDIFAYGIVLLEVLSGQTP 575
            Y                +D+++ G+      +G  P
Sbjct: 186 MYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 24/226 (10%), Positives = 56/226 (24%), Gaps = 51/226 (22%)

Query: 392 GAVYHGR--LNGKNLAIK----------------RTEHEVITKLEMQLVQHATHH----- 428
             V+  R     ++ A+K                        +L  +  + A        
Sbjct: 76  SVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLL 135

Query: 429 ---------HPNIVRLL-GTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYC 478
                     P   +L  G       +  L+   A    L+            F+     
Sbjct: 136 PSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFS-----TLDFVYVFRG 189

Query: 479 FLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND 538
                    +   +      +        VH +    N+F+  +    +G+      V  
Sbjct: 190 DEGILALHILTAQLIRLAANLQSK---GLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGT 246

Query: 539 DTE---------SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTP 575
                         +F + + A+++  ++ +  G+ +  V     P
Sbjct: 247 RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP 292

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 71.4 bits (175), Expect = 2e-13
 Identities = 42/219 (19%), Positives = 84/219 (38%), Gaps = 48/219 (21%)

Query: 394 VYHGRLNGKNLAIKR--TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFE 451
           V+ G   G+ +A+KR   +   I  +E++L+   +  HPN++R   +  TD    ++  E
Sbjct: 32  VFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTE-SDDHPNVIRYYCSETTDR-FLYIALE 89

Query: 452 YAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRN 511
              N +L+D +                       + +   +A  + ++H +     +HR+
Sbjct: 90  LC-NLNLQDLV-----ESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRD 140

Query: 512 IKSRNIFLD-------------EEFNARVGNFGMARCVNDDTESPQFYSTNPA------- 551
           +K +NI +              E     + +FG+ + ++    S +    NP+       
Sbjct: 141 LKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRA 200

Query: 552 --------------SWSMGIDIFAYGIVLLEVLS-GQTP 575
                           +  IDIF+ G V   +LS G+ P
Sbjct: 201 PELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP 239

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score = 71.6 bits (175), Expect = 3e-13
 Identities = 43/216 (19%), Positives = 74/216 (34%), Gaps = 49/216 (22%)

Query: 392 GAVYHGR--LNGKNLAIKRTEHEVITKLEMQLVQ----HATHHHPNIVRLL-----GTCL 440
           G V        G+ +AIK+   E+  K   +           +HPN+V           L
Sbjct: 28  GYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKL 87

Query: 441 TDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH 500
                  L  EY + G L+ +L+     +N       C L       +  D++ AL+Y+H
Sbjct: 88  APNDLPLLAMEYCEGGDLRKYLN---QFEN------CCGLKEGPIRTLLSDISSALRYLH 138

Query: 501 HVMNPSYVHRNIKSRNIFLDEEFNAR---VGNFGMARCVNDDTE------SPQF------ 545
                  +HR++K  NI L          + + G A+ ++          + Q+      
Sbjct: 139 ENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELL 195

Query: 546 ----YSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN 577
               Y+     WS        G +  E ++G  P  
Sbjct: 196 EQKKYTVTVDYWSF-------GTLAFECITGFRPFL 224

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 69.4 bits (170), Expect = 3e-13
 Identities = 20/148 (13%), Positives = 38/148 (25%), Gaps = 35/148 (23%)

Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLR 487
             P + R+L   +       +V E+ + GSL++                    +    +R
Sbjct: 89  DKPGVARVLDV-VHTRAGGLVVAEWIRGGSLQEVADTS--------------PSPVGAIR 133

Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYS 547
               +A A    H                + +  + +  +                    
Sbjct: 134 AMQSLAAAADAAHRA---GVALSIDHPSRVRVSIDGDVVLAYPATMP------------D 178

Query: 548 TNPASWSMGIDIFAYGIVLLEVLSGQTP 575
            NP       DI   G  L  +L  + P
Sbjct: 179 ANPQD-----DIRGIGASLYALLVNRWP 201

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score = 68.4 bits (168), Expect = 6e-13
 Identities = 45/215 (20%), Positives = 73/215 (33%), Gaps = 62/215 (28%)

Query: 392 GAVYHGR--LNGKNLAIKRTEHEVITK---LEMQLVQHATH--------HHPNIVRLLGT 438
           G VY  R   +   LA+K     V+ K    +  +               HPNI+RL G 
Sbjct: 23  GNVYLAREKQSKFILALK-----VLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGY 77

Query: 439 CLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRL------RICLDV 492
              D    +L+ EYA  G++                  Y  L    +           ++
Sbjct: 78  -FHDATRVYLILEYAPLGTV------------------YRELQKLSKFDEQRTATYITEL 118

Query: 493 AMALQYMH--HVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE--------- 541
           A AL Y H   V     +HR+IK  N+ L      ++ +FG +                 
Sbjct: 119 ANALSYCHSKRV-----IHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTDLCGTLDY 173

Query: 542 -SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTP 575
             P+            +D+++ G++  E L G+ P
Sbjct: 174 LPPEMIEGRM--HDEKVDLWSLGVLCYEFLVGKPP 206

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score = 69.7 bits (170), Expect = 6e-13
 Identities = 29/263 (11%), Positives = 68/263 (25%), Gaps = 63/263 (23%)

Query: 392 GAVYHGR--LNGKNLAIK--------------RTEHEVITKLEMQLVQHATH-------- 427
            A         G++  +               + + EV+    ++ +++           
Sbjct: 92  YAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 151

Query: 428 ---------HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYC 478
                        ++R+          S          +L+      L   +    S   
Sbjct: 152 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQT-FGEVLLSHSSTHKS--- 207

Query: 479 FLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND 538
            L    RL++ L V   L  +HH      VH  ++  +I LD+     +  F        
Sbjct: 208 -LVHHARLQLTLQVIRLLASLHHY---GLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 263

Query: 539 DT----------------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTP------I 576
                                 F   +P   +   D +  G+ +  +     P      +
Sbjct: 264 SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAAL 323

Query: 577 NRPRKKDEGSVWLSEKIKSILQA 599
                       + + ++++L+ 
Sbjct: 324 GGSEWIFRSCKNIPQPVRALLEG 346

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 68.9 bits (169), Expect = 8e-13
 Identities = 45/189 (23%), Positives = 77/189 (40%), Gaps = 33/189 (17%)

Query: 362 AEQHKRLLESYSIEDLRRATEKFNSSNRI----EGAVYHGR--LNGKNLAIK----RTEH 411
           ++   R L+   +  LR     F     +     G VY GR    G+  AIK      + 
Sbjct: 4   SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE 63

Query: 412 EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSF-----LVFEYAKNGSLKDWLHGGL 466
           E   K E+ +++  +HH  NI    G  +   P        LV E+   GS+ D +    
Sbjct: 64  EEEIKQEINMLKKYSHH-RNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTK 122

Query: 467 A--MKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFN 524
              +K ++IA             IC ++   L ++H       +HR+IK +N+ L E   
Sbjct: 123 GNTLKEEWIAY------------ICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAE 167

Query: 525 ARVGNFGMA 533
            ++ +FG++
Sbjct: 168 VKLVDFGVS 176

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 68.4 bits (168), Expect = 9e-13
 Identities = 32/164 (19%), Positives = 53/164 (32%), Gaps = 37/164 (22%)

Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLR 487
             P++V +      DG   ++         L   L                 L   + + 
Sbjct: 92  QEPHVVPIHDFGEIDGQL-YVDMRLINGVDLAAMLRRQGP------------LAPPRAVA 138

Query: 488 ICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------ 541
           I   +  AL   H        HR++K  NI +  +  A + +FG+A    D+        
Sbjct: 139 IVRQIGSALDAAHAA---GATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNT 195

Query: 542 -------SP-QF--YSTNPASWSMGIDIFAYGIVLLEVLSGQTP 575
                  +P +F        +     DI+A   VL E L+G  P
Sbjct: 196 VGTLYYMAPERFSESHATYRA-----DIYALTCVLYECLTGSPP 234

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score = 68.5 bits (168), Expect = 9e-13
 Identities = 44/196 (22%), Positives = 78/196 (39%), Gaps = 44/196 (22%)

Query: 392 GAVYHGR--LNGKNLAIKRTEHEVITKLEMQLVQHATH-----HHPNIVRLLGTCLTDGP 444
             V   R  L G+ +AIK  +   +    +Q +          +HPNIV+L     T+  
Sbjct: 29  AKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEK- 87

Query: 445 HSFLVFEYAKNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
             +L+ EYA  G + D+L  HG +  K              +       +  A+QY H  
Sbjct: 88  TLYLIMEYASGGEVFDYLVAHGRMKEK--------------EARSKFRQIVSAVQYCHQK 133

Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------SPQFYS--------- 547
                VHR++K+ N+ LD + N ++ +FG +       +      +P + +         
Sbjct: 134 R---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKY 190

Query: 548 TNPAS--WSMGIDIFA 561
             P    WS+G+ ++ 
Sbjct: 191 DGPEVDVWSLGVILYT 206

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score = 67.7 bits (166), Expect = 1e-12
 Identities = 39/150 (26%), Positives = 69/150 (46%), Gaps = 28/150 (18%)

Query: 392 GAVYHGR--LNGKNLAIKR------TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDG 443
           G VY       G+ +AI++       + E+I   E+ +++   + +PNIV  L + L   
Sbjct: 34  GTVYTAMDVATGQEVAIRQMNLQQQPKKELIIN-EILVMR--ENKNPNIVNYLDSYLVGD 90

Query: 444 PHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM 503
              ++V EY   GSL D +     M    IA+            +C +   AL+++H   
Sbjct: 91  -ELWVVMEYLAGGSLTDVVTET-CMDEGQIAA------------VCRECLQALEFLH--- 133

Query: 504 NPSYVHRNIKSRNIFLDEEFNARVGNFGMA 533
           +   +HR+IKS NI L  + + ++ +FG  
Sbjct: 134 SNQVIHRDIKSDNILLGMDGSVKLTDFGFC 163

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 37/154 (24%), Positives = 66/154 (42%), Gaps = 25/154 (16%)

Query: 392 GAVYHGR--LNGKNLAIKRTEHEVITKLEMQLVQH-----ATHHHPNIVRLLGTCLTDGP 444
           G V+ G      K +AIK  + E   + E++ +Q      +    P + +  G+ L    
Sbjct: 36  GEVFKGIDNRTQKVVAIKIIDLEE-AEDEIEDIQQEITVLSQCDSPYVTKYYGSYL-KDT 93

Query: 445 HSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMN 504
             +++ EY   GS  D L  G  +    IA+            I  ++   L Y+H   +
Sbjct: 94  KLWIIMEYLGGGSALDLLEPGP-LDETQIAT------------ILREILKGLDYLH---S 137

Query: 505 PSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND 538
              +HR+IK+ N+ L E    ++ +FG+A  + D
Sbjct: 138 EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score = 66.9 bits (164), Expect = 3e-12
 Identities = 47/207 (22%), Positives = 78/207 (37%), Gaps = 41/207 (19%)

Query: 392 GAVYHG--RLNGKNLAIKR---TEHEVITKL--EMQLVQHATHHHPNIVRLLGTCLTDGP 444
           G VY G    N   +AIK     +      L  E+ L +H    H NIV+ LG+   +G 
Sbjct: 36  GIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHL--KHKNIVQYLGSFSENG- 92

Query: 445 HSFLVFEYAKNGSLKDWL---HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHH 501
              +  E    GSL   L    G L    Q I                  +   L+Y+H 
Sbjct: 93  FIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGF------------YTKQILEGLKYLH- 139

Query: 502 VMNPSYVHRNIKSRNIFLDEEF-NARVGNFGMARCVNDDTESPQ------FY------ST 548
             +   VHR+IK  N+ ++      ++ +FG ++ +       +       Y        
Sbjct: 140 --DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDK 197

Query: 549 NPASWSMGIDIFAYGIVLLEVLSGQTP 575
            P  +    DI++ G  ++E+ +G+ P
Sbjct: 198 GPRGYGKAADIWSLGCTIIEMATGKPP 224

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score = 66.6 bits (163), Expect = 4e-12
 Identities = 33/150 (22%), Positives = 66/150 (44%), Gaps = 28/150 (18%)

Query: 392 GAVYHGR--LNGKNLAIKR------TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDG 443
           G V   R   +G+ +A+K          E++   E+ +++   + H N+V +  + L   
Sbjct: 59  GIVCLAREKHSGRQVAVKMMDLRKQQRRELLFN-EVVIMR--DYQHFNVVEMYKSYLVGE 115

Query: 444 PHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM 503
              +++ E+ + G+L D +     +  + IA+            +C  V  AL Y+H   
Sbjct: 116 -ELWVLMEFLQGGALTDIVSQVR-LNEEQIAT------------VCEAVLQALAYLH--- 158

Query: 504 NPSYVHRNIKSRNIFLDEEFNARVGNFGMA 533
               +HR+IKS +I L  +   ++ +FG  
Sbjct: 159 AQGVIHRDIKSDSILLTLDGRVKLSDFGFC 188

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 67.1 bits (164), Expect = 4e-12
 Identities = 35/161 (21%), Positives = 64/161 (39%), Gaps = 25/161 (15%)

Query: 392 GAVYHGR----LNGKNLAIKRTEHEVI--TKL-EMQLVQHATHHHPNIVRLLGTCLTDGP 444
           G VY  +     + K+ A+K+ E   I  +   E+ L++     HPN++ L    L+   
Sbjct: 35  GHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLREL--KHPNVISLQKVFLSHAD 92

Query: 445 HS-FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH--H 501
              +L+F+YA++  L   +      +          L       +   +   + Y+H   
Sbjct: 93  RKVWLLFDYAEH-DLWHIIK---FHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW 148

Query: 502 VMNPSYVHRNIKSRNIFLDEEFNAR----VGNFGMARCVND 538
           V+     HR++K  NI +  E   R    + + G AR  N 
Sbjct: 149 VL-----HRDLKPANILVMGEGPERGRVKIADMGFARLFNS 184

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 66.4 bits (162), Expect = 6e-12
 Identities = 42/210 (20%), Positives = 81/210 (38%), Gaps = 31/210 (14%)

Query: 392 GAVYHGRLN--GKNLAIKR----TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPH 445
           G V+       G  +A K      +  +  ++  +L      + P IV   G   +DG  
Sbjct: 47  GVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-E 105

Query: 446 SFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNP 505
             +  E+   GSL   L     +  Q +             ++ + V   L Y+      
Sbjct: 106 ISICMEHMDGGSLDQVLKKAGRIPEQILG------------KVSIAVIKGLTYLREKHK- 152

Query: 506 SYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYST---------NPASWSMG 556
             +HR++K  NI ++     ++ +FG++  +  D+ +  F  T             +S+ 
Sbjct: 153 -IMHRDVKPSNILVNSRGEIKLCDFGVSGQL-IDSMANSFVGTRSYMSPERLQGTHYSVQ 210

Query: 557 IDIFAYGIVLLEVLSGQTPINRPRKKDEGS 586
            DI++ G+ L+E+  G+ PI  P  K+   
Sbjct: 211 SDIWSMGLSLVEMAVGRYPIPPPDAKELEL 240

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 65.5 bits (160), Expect = 1e-11
 Identities = 43/205 (20%), Positives = 79/205 (38%), Gaps = 36/205 (17%)

Query: 392 GAVYHGRLN--GKNLAIKR----TEHEVITKLEMQL-VQHATHHHPNIVRLLGTCLTDGP 444
           G V+  R    G  +A+K+       E   ++ M L V   +H  P IV+  GT +T+  
Sbjct: 39  GQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNT- 97

Query: 445 HSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMN 504
             F+  E     + K        +  + +             ++ + +  AL Y+     
Sbjct: 98  DVFIAMELMGTCAEKLKKRMQGPIPERILG------------KMTVAIVKALYYLKEKHG 145

Query: 505 PSYVHRNIKSRNIFLDEEFNARVGNFG--------MARCVNDDT------ESPQFYSTNP 550
              +HR++K  NI LDE    ++ +FG         A+  +         E         
Sbjct: 146 --VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTK 203

Query: 551 ASWSMGIDIFAYGIVLLEVLSGQTP 575
             + +  D+++ GI L+E+ +GQ P
Sbjct: 204 PDYDIRADVWSLGISLVELATGQFP 228

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score = 65.0 bits (159), Expect = 1e-11
 Identities = 42/215 (19%), Positives = 75/215 (34%), Gaps = 48/215 (22%)

Query: 392 GAVYHGR--LNGKNLAIKRTEHEVITKLEMQLVQH-----ATHHHPNIVRLLGTCLTDGP 444
             V         + +AIKR   E      M  +       +  HHPNIV           
Sbjct: 29  AVVQAAYCAPKKEKVAIKRINLEKCQT-SMDELLKEIQAMSQCHHPNIVSYYT-SFVVKD 86

Query: 445 HSFLVFEYAKNGSLKD--------WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMAL 496
             +LV +    GS+ D          H    +    IA+            I  +V   L
Sbjct: 87  ELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIAT------------ILREVLEGL 134

Query: 497 QYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN------- 549
           +Y+H       +HR++K+ NI L E+ + ++ +FG++  +    +  +            
Sbjct: 135 EYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPC 191

Query: 550 ---------PASWSMGIDIFAYGIVLLEVLSGQTP 575
                       +    DI+++GI  +E+ +G  P
Sbjct: 192 WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score = 64.5 bits (158), Expect = 1e-11
 Identities = 31/155 (20%), Positives = 58/155 (37%), Gaps = 36/155 (23%)

Query: 392 GAVYHGR--LNGKNLAIKRTEHEVITKLE---------MQLVQHATHHHPNIVRLLGTCL 440
           G V      +  + +A+K  + +                +++     +H N+V+  G   
Sbjct: 21  GEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-----NHENVVKFYGHRR 75

Query: 441 TDGPHSFLVFEYAKNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQY 498
                 +L  EY   G L D +    G+        +   F     +L +       + Y
Sbjct: 76  EGN-IQYLFLEYCSGGELFDRIEPDIGMPEP----DAQRFF----HQL-MA-----GVVY 120

Query: 499 MHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA 533
           +H +      HR+IK  N+ LDE  N ++ +FG+A
Sbjct: 121 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLA 152

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 64.3 bits (157), Expect = 2e-11
 Identities = 34/150 (22%), Positives = 64/150 (42%), Gaps = 26/150 (17%)

Query: 392 GAVYHGR--LNGKNLAIKRTEHEVITKLEMQLVQH-----ATHHHPNIVRLLGTCLTDGP 444
           G VY  +    G   A K  E    ++ E++         AT  HP IV+LLG    DG 
Sbjct: 33  GKVYKAKNKETGALAAAKVIE--TKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHDG- 89

Query: 445 HSFLVFEYAKNGSLKDWL-HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM 503
             +++ E+   G++   +      +    I              +C  +  AL ++H   
Sbjct: 90  KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV------------VCRQMLEALNFLH--- 134

Query: 504 NPSYVHRNIKSRNIFLDEEFNARVGNFGMA 533
           +   +HR++K+ N+ +  E + R+ +FG++
Sbjct: 135 SKRIIHRDLKAGNVLMTLEGDIRLADFGVS 164

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score = 63.9 bits (156), Expect = 3e-11
 Identities = 31/155 (20%), Positives = 58/155 (37%), Gaps = 36/155 (23%)

Query: 392 GAVYHGR--LNGKNLAIKRTEHEVITKLE---------MQLVQHATHHHPNIVRLLGTCL 440
           G V      +  + +A+K  + +                +++     +H N+V+  G   
Sbjct: 21  GEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKML-----NHENVVKFYGHRR 75

Query: 441 TDGPHSFLVFEYAKNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQY 498
                 +L  EY   G L D +    G+        +   F     +L +       + Y
Sbjct: 76  EGN-IQYLFLEYCSGGELFDRIEPDIGMPEP----DAQRFF----HQL-MA-----GVVY 120

Query: 499 MHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA 533
           +H +      HR+IK  N+ LDE  N ++ +FG+A
Sbjct: 121 LHGIG---ITHRDIKPENLLLDERDNLKISDFGLA 152

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score = 64.3 bits (156), Expect = 3e-11
 Identities = 28/234 (11%), Positives = 63/234 (26%), Gaps = 58/234 (24%)

Query: 392 GAVYHGR--LNGKNLAIK--------------RTEHEVITKLEMQLVQHATH-------- 427
            A         G++  +               + + EV+    ++ +++           
Sbjct: 87  YAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFI 146

Query: 428 ---------HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYC 478
                        ++R+          S          +L+ +    L+  +      + 
Sbjct: 147 FPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSST-----HK 201

Query: 479 FLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND 538
            L    RL++ L V   L  +HH      VH  ++  +I LD+     +  F        
Sbjct: 202 SLVHHARLQLTLQVIRLLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 258

Query: 539 DTES-----------------PQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTP 575
              S                   ++       +   D +A G+V+  +     P
Sbjct: 259 RVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLP 312

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score = 63.5 bits (155), Expect = 3e-11
 Identities = 44/183 (24%), Positives = 82/183 (44%), Gaps = 33/183 (18%)

Query: 362 AEQHKRLLESYSIEDLRRATEKFNSSNRI----EGAVYHG--RLNGKNLAIKR----TEH 411
             Q K+L E    +      E F+   ++     G+VY    +  G+ +AIK+    ++ 
Sbjct: 12  RRQLKKLDEDSLTKQ---PEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDL 68

Query: 412 EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG-GLAMKN 470
           + I K E+ ++Q      P++V+  G+   +    ++V EY   GS+ D +      +  
Sbjct: 69  QEIIK-EISIMQ--QCDSPHVVKYYGSYFKNT-DLWIVMEYCGAGSVSDIIRLRNKTLTE 124

Query: 471 QFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNF 530
             IA+            I       L+Y+H       +HR+IK+ NI L+ E +A++ +F
Sbjct: 125 DEIAT------------ILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADF 169

Query: 531 GMA 533
           G+A
Sbjct: 170 GVA 172

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 63.4 bits (155), Expect = 5e-11
 Identities = 37/178 (20%), Positives = 72/178 (40%), Gaps = 45/178 (25%)

Query: 379 RATEKFNSSNRIE----GAVYHGR--LNGKNLAIK--RTEHEV----ITKL-EMQLVQHA 425
            + +++    ++     G VY     +  + +AIK  R EHE      T + E+ L++  
Sbjct: 31  TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKEL 90

Query: 426 THHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL--HGGLAMKNQFIASCYCFLTWS 483
              H NI+ L      +     L+FEYA+N  LK ++  +  ++M+       + +    
Sbjct: 91  --QHRNIIELKSVIHHNH-RLHLIFEYAEN-DLKKYMDKNPDVSMRV---IKSFLY---- 139

Query: 484 QRLRICLDVAMALQYMHH--VMNPSYVHRNIKSRNIFLDEEFNARVGN-----FGMAR 534
           Q +         + + H    +     HR++K +N+ L     +         FG+AR
Sbjct: 140 QLIN-------GVNFCHSRRCL-----HRDLKPQNLLLSVSDASETPVLKIGDFGLAR 185

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 62.5 bits (153), Expect = 6e-11
 Identities = 47/231 (20%), Positives = 86/231 (37%), Gaps = 66/231 (28%)

Query: 382 EKFNSSNRIE----GAVYHGR--LNGKNLAIK--RTEHEV----ITKL-EMQLVQHATHH 428
           +K+    +I     G V+  +     + +A+K  R + +      + L E+ L++     
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKEL--K 59

Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIAS---CYCFLTWSQR 485
           H NIVRL     +D     LVFE+     LK +     +            + F    Q 
Sbjct: 60  HKNIVRLHDVLHSDK-KLTLVFEFCDQ-DLKKYFD---SCNGDLDPEIVKSFLF----QL 110

Query: 486 LRICLDVAMALQYMHH--VMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE-- 541
           L+        L + H   V+     HR++K +N+ ++     ++ NFG+AR         
Sbjct: 111 LK-------GLGFCHSRNVL-----HRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY 158

Query: 542 ----------SP------QFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPI 576
                      P      + YST        ID+++ G +  E+ +   P+
Sbjct: 159 SAEVVTLWYRPPDVLFGAKLYST-------SIDMWSAGCIFAELANAGRPL 202

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score = 62.6 bits (153), Expect = 6e-11
 Identities = 43/215 (20%), Positives = 70/215 (32%), Gaps = 62/215 (28%)

Query: 392 GAVYHGR--LNGKNLAIKRTEHEVITK---LEMQLVQHATH--------HHPNIVRLLGT 438
           G VY  R   N   +A+K     V+ K    +  +               HPNI+R+   
Sbjct: 28  GNVYLAREKQNKFIMALK-----VLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNY 82

Query: 439 CLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRL------RICLDV 492
              D    +L+ E+A  G L                  Y  L    R           ++
Sbjct: 83  -FHDRKRIYLMLEFAPRGEL------------------YKELQKHGRFDEQRSATFMEEL 123

Query: 493 AMALQYMH--HVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE--------- 541
           A AL Y H   V     +HR+IK  N+ +  +   ++ +FG +                 
Sbjct: 124 ADALHYCHERKV-----IHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRTMCGTLDY 178

Query: 542 -SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTP 575
             P+            +D++  G++  E L G  P
Sbjct: 179 LPPEMIEGKT--HDEKVDLWCAGVLCYEFLVGMPP 211

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 63.0 bits (154), Expect = 7e-11
 Identities = 48/233 (20%), Positives = 94/233 (40%), Gaps = 62/233 (26%)

Query: 379 RATEKFNSSNRI-EGA---VY---HGRLNGKNLAIK--RTEHEV----ITKL-EMQLVQH 424
           RA +++     I EGA   V+     +  G+ +A+K  R +       ++ + E+ +++H
Sbjct: 8   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 67

Query: 425 -ATHHHPNIVRLLGTCLTDGPHS----FLVFEYAKNGSLKDWLHGGLAMKNQFIAS---- 475
             T  HPN+VRL   C            LVFE+     L  +L     +    + +    
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLD---KVPEPGVPTETIK 123

Query: 476 CYCFLTWSQRLRICLDVAMALQYMHH--VMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA 533
              F    Q LR        L ++H   V+     HR++K +NI +      ++ +FG+A
Sbjct: 124 DMMF----QLLR-------GLDFLHSHRVV-----HRDLKPQNILVTSSGQIKLADFGLA 167

Query: 534 RCVNDDTESPQFYSTN--------P-----ASWSMGIDIFAYGIVLLEVLSGQ 573
           R  +         ++         P     +S++  +D+++ G +  E+   +
Sbjct: 168 RIYS----FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 216

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 62.7 bits (153), Expect = 7e-11
 Identities = 43/207 (20%), Positives = 82/207 (39%), Gaps = 37/207 (17%)

Query: 392 GAVYHGRLN--GKNLAIKR----TEHEVITKLEMQL-VQHATHHHPNIVRLLGTCLTDGP 444
           G+V        G+ +A+KR     + +   +L M L V   +   P IV+  G    +G 
Sbjct: 36  GSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREG- 94

Query: 445 HSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMN 504
             ++  E   + S   +     ++ +  I             +I L    AL ++   + 
Sbjct: 95  DCWICMELM-STSFDKFYKYVYSVLDDVIPEEIL-------GKITLATVKALNHLKENLK 146

Query: 505 PSYVHRNIKSRNIFLDEEFNARVGNFG--------MARCVNDDTESPQFY--------ST 548
              +HR+IK  NI LD   N ++ +FG        +A+  +      + Y        S 
Sbjct: 147 --IIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGC---RPYMAPERIDPSA 201

Query: 549 NPASWSMGIDIFAYGIVLLEVLSGQTP 575
           +   + +  D+++ GI L E+ +G+ P
Sbjct: 202 SRQGYDVRSDVWSLGITLYELATGRFP 228

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score = 63.7 bits (155), Expect = 9e-11
 Identities = 46/276 (16%), Positives = 94/276 (34%), Gaps = 51/276 (18%)

Query: 334 SASVRTTSDKKVSFEGSQSTIEGQII--------DTAEQHKRLLESYSIEDLRRATEKFN 385
           +A V    D++    G     +G+I+        +       + + Y  + +    +   
Sbjct: 97  TAPVLIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVL 156

Query: 386 SSNRIE--------GAVYHG--RLNGKNLAIK-----RTEHEVITKLEMQLVQHATHHHP 430
               I         G V+    R  G N A K         +   + E+Q +      HP
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL--RHP 214

Query: 431 NIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICL 490
            +V L      D     +++E+   G L +            +A  +  ++  + +    
Sbjct: 215 TLVNLHDAFEDDN-EMVMIYEFMSGGELFE-----------KVADEHNKMSEDEAVEYMR 262

Query: 491 DVAMALQYMHHVMNPSYVHRNIKSRNIFL--DEEFNARVGNFGMARCVNDDTE------S 542
            V   L +MH   N  YVH ++K  NI          ++ +FG+   ++          +
Sbjct: 263 QVCKGLCHMHE-NN--YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGT 319

Query: 543 PQFYS---TNPASWSMGIDIFAYGIVLLEVLSGQTP 575
            +F +             D+++ G++   +LSG +P
Sbjct: 320 AEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSP 355

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score = 62.6 bits (153), Expect = 1e-10
 Identities = 50/238 (21%), Positives = 91/238 (38%), Gaps = 63/238 (26%)

Query: 379 RATEKFNSSNRIE----GAVYHGR--LNGKNLAIK--RTEHEV----ITKL-EMQLVQHA 425
               K+    +I     G V+  R    G+ +A+K    E+E     IT L E++++Q  
Sbjct: 14  DEVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLL 73

Query: 426 THHHPNIVRLLGTCLTDGPHS-------FLVFEYAKNGSLKDWLHGGLAMKNQFIAS--- 475
              H N+V L+  C T            +LVF++ ++  L   L     +  +F  S   
Sbjct: 74  --KHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLS---NVLVKFTLSEIK 127

Query: 476 CYCFLTWSQRLRICLDVAMALQYMHH--VMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA 533
                     L         L Y+H   ++     HR++K+ N+ +  +   ++ +FG+A
Sbjct: 128 RVMQ----MLLN-------GLYYIHRNKIL-----HRDMKAANVLITRDGVLKLADFGLA 171

Query: 534 RCVNDDTESPQFYSTN---------P------ASWSMGIDIFAYGIVLLEVLSGQTPI 576
           R  +    S     TN         P        +   ID++  G ++ E+ +   PI
Sbjct: 172 RAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS-PI 228

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score = 61.9 bits (151), Expect = 1e-10
 Identities = 48/243 (19%), Positives = 85/243 (34%), Gaps = 63/243 (25%)

Query: 377 LRRATEKFNSSNRIEGAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRL- 435
           L R                 G        I++   E+     ++ +      HPN+V+L 
Sbjct: 51  LIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAI---LKKL-----DHPNVVKLV 102

Query: 436 --LGTCLTDGPHSFLVFEYAKNGSLKDWL-HGGLAMKNQFIASCYCFLTWSQRLRICLDV 492
             L     D  H ++VFE    G + +      L+      A  Y F           D+
Sbjct: 103 EVLDDPNED--HLYMVFELVNQGPVMEVPTLKPLSEDQ---ARFY-FQ----------DL 146

Query: 493 AMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE-------SPQF 545
              ++Y+H+      +HR+IK  N+ + E+ + ++ +FG++               +P F
Sbjct: 147 IKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAF 203

Query: 546 ------------YSTNPAS-WSMGIDIFAYGIVLLEVLSGQTPINRPRKKDEGSVWLSEK 592
                       +S      W+MG+ ++         + GQ P       DE  + L  K
Sbjct: 204 MAPESLSETRKIFSGKALDVWAMGVTLYC-------FVFGQCPFM-----DERIMCLHSK 251

Query: 593 IKS 595
           IKS
Sbjct: 252 IKS 254

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 61.9 bits (151), Expect = 1e-10
 Identities = 38/211 (18%), Positives = 81/211 (38%), Gaps = 46/211 (21%)

Query: 392 GAVYHGRLN--GKNLAIKR----TEHEVITKLEMQL-VQHATHHHPNIVRLLGTCLTDGP 444
           G V   R    G+ +A+KR       +   +L M L +   T   P  V   G    +G 
Sbjct: 21  GVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREG- 79

Query: 445 HSFLVFEYAKNGSLKDWLHGGLAMKNQF----IASCYCFLTWSQRLRICLDVAMALQYMH 500
             ++  E   + SL  +    +          +             +I + +  AL+++H
Sbjct: 80  DVWICMELM-DTSLDKFYKQVIDKGQTIPEDILG------------KIAVSIVKALEHLH 126

Query: 501 HVMNPSYVHRNIKSRNIFLDEEFNARVGNFG--------MARCVNDDTESPQFY------ 546
             ++   +HR++K  N+ ++     ++ +FG        +A+ ++      + Y      
Sbjct: 127 SKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGC---KPYMAPERI 181

Query: 547 --STNPASWSMGIDIFAYGIVLLEVLSGQTP 575
               N   +S+  DI++ GI ++E+   + P
Sbjct: 182 NPELNQKGYSVKSDIWSLGITMIELAILRFP 212

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 41/215 (19%), Positives = 80/215 (37%), Gaps = 31/215 (14%)

Query: 331 QQLSASVRTTSDKKVSFEGSQSTIEGQIIDTAEQHKRLLESYSIEDLRRATEKFNSSNRI 390
                     + + + F+G+   +       + +   + E +  +D     + F+    I
Sbjct: 6   HHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDP---EKLFSDLREI 62

Query: 391 ----EGAVYHGR--LNGKNLAIKRTE-HEVITKLEMQLVQH-----ATHHHPNIVRLLGT 438
                GAVY  R   N + +AIK+       +  + Q +           HPN ++  G 
Sbjct: 63  GHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGC 122

Query: 439 CLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQY 498
            L +   ++LV EY    +          ++   IA+            +       L Y
Sbjct: 123 YLREH-TAWLVMEYCLGSASDLLEVHKKPLQEVEIAA------------VTHGALQGLAY 169

Query: 499 MHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA 533
           +H   + + +HR++K+ NI L E    ++G+FG A
Sbjct: 170 LH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSA 201

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 61.0 bits (149), Expect = 3e-10
 Identities = 46/235 (19%), Positives = 88/235 (37%), Gaps = 64/235 (27%)

Query: 379 RATEKFNSSNRIE----GAVYHGR--LNGKNLAIK--RTEHEV-------ITKL-EMQLV 422
            AT ++     I     G VY  R   +G  +A+K  R  +         I+ + E+ L+
Sbjct: 6   MATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALL 65

Query: 423 QH-ATHHHPNIVRLLGTCLTDGPHS----FLVFEYAKNGSLKDWLHGGLAMKNQFIAS-- 475
           +      HPN+VRL+  C T          LVFE+     L+ +L          + +  
Sbjct: 66  RRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLD---KAPPPGLPAET 121

Query: 476 --CYCFLTWSQRLRICLDVAMALQYMHH--VMNPSYVHRNIKSRNIFLDEEFNARVGNFG 531
                     Q LR        L ++H   ++     HR++K  NI +      ++ +FG
Sbjct: 122 IKDLMR----QFLR-------GLDFLHANCIV-----HRDLKPENILVTSGGTVKLADFG 165

Query: 532 MARCVNDDTESPQFYSTN--------P-----ASWSMGIDIFAYGIVLLEVLSGQ 573
           +AR  +         +          P     ++++  +D+++ G +  E+   +
Sbjct: 166 LARIYS----YQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 216

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score = 60.8 bits (148), Expect = 3e-10
 Identities = 47/248 (18%), Positives = 86/248 (34%), Gaps = 66/248 (26%)

Query: 392 GAVYHGR--LNGKNLAIK-----------RTEHEVITKLEMQLVQHATHHHPNIVRLLGT 438
           G+VY G    +   +AIK              +     +E+ L++  +     ++RLL  
Sbjct: 57  GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 116

Query: 439 CLTDGPHSFLVFEYAKN-GSLKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMA 495
                    L+ E  +    L D++   G L  +     +   F    Q       V  A
Sbjct: 117 FERPD-SFVLILERPEPVQDLFDFITERGALQEE----LARSFF---WQ-------VLEA 161

Query: 496 LQYMHHVMNPSYVHRNIKSRNIFLDEE-FNARVGNFGMARCVND---DTE--SPQF---- 545
           +++ H+      +HR+IK  NI +D      ++ +FG    + D        +  +    
Sbjct: 162 VRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPE 218

Query: 546 ------YSTNPA-SWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDEGSV----WLSEK-- 592
                 Y    A  WS+       GI+L +++ G  P     +   G V     +S +  
Sbjct: 219 WIRYHRYHGRSAAVWSL-------GILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQ 271

Query: 593 --IKSILQ 598
             I+  L 
Sbjct: 272 HLIRWCLA 279

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 61.1 bits (149), Expect = 3e-10
 Identities = 50/237 (21%), Positives = 90/237 (37%), Gaps = 69/237 (29%)

Query: 376 DLRRATEKFNSSNRI-EGA---VYHGR--LNGKNLAIK--RTEHEV-------ITKL-EM 419
           D++   +++   + + EG    VY  R     + +AIK  +  H          T L E+
Sbjct: 4   DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63

Query: 420 QLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIAS---C 476
           +L+Q     HPNI+ LL        +  LVF++ +   L+  +            S    
Sbjct: 64  KLLQEL--SHPNIIGLLDAFGHKS-NISLVFDFMET-DLEVIIK---DNSLVLTPSHIKA 116

Query: 477 YCFLTWSQRLRICLDVAMALQYMHH--VMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR 534
           Y        L+        L+Y+H   ++     HR++K  N+ LDE    ++ +FG+A+
Sbjct: 117 YML----MTLQ-------GLEYLHQHWIL-----HRDLKPNNLLLDENGVLKLADFGLAK 160

Query: 535 CVNDDTE------------SP------QFYSTNPASWSMGIDIFAYGIVLLEVLSGQ 573
                              +P      + Y         G+D++A G +L E+L   
Sbjct: 161 SFGSPNRAYTHQVVTRWYRAPELLFGARMYGV-------GVDMWAVGCILAELLLRV 210

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score = 60.3 bits (147), Expect = 3e-10
 Identities = 49/202 (24%), Positives = 82/202 (40%), Gaps = 55/202 (27%)

Query: 392 GAVYHGR--LNGKNLAIKRTEHEVITKLE-----------MQLVQHATHHHPNIVRLLGT 438
           G V  G   L G  +A+K    + I  L+           ++L       HP+I++L   
Sbjct: 25  GKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLF-----RHPHIIKLYQV 79

Query: 439 CLTDGPHSFLVFEYAKNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMAL 496
             T     F+V EY   G L D++  HG +        +   F    Q++ +      A+
Sbjct: 80  ISTPT-DFFMVMEYVSGGELFDYICKHGRVEEM----EARRLF----QQI-LS-----AV 124

Query: 497 QYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------SP------- 543
            Y H  M    VHR++K  N+ LD   NA++ +FG++  ++D         SP       
Sbjct: 125 DYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEV 181

Query: 544 ---QFYSTNPA-SWSMGIDIFA 561
              + Y+      WS G+ ++A
Sbjct: 182 ISGRLYAGPEVDIWSCGVILYA 203

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 60.6 bits (148), Expect = 3e-10
 Identities = 43/189 (22%), Positives = 79/189 (41%), Gaps = 41/189 (21%)

Query: 363 EQHKRLLESYSIEDLRRATEKFNSSNRIE----GAVYHGR-LNGKNLAIK--RTEHEV-- 413
             H       ++   +   EK+    ++     G VY  +   G+ +A+K  R + E   
Sbjct: 3   HHHHHSSGRENLY-FQGLMEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEG 61

Query: 414 --ITKL-EMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKN 470
              T + E+ L++    HHPNIV L+    ++     LVFE+ +   LK  L      K 
Sbjct: 62  IPSTAIREISLLKEL--HHPNIVSLIDVIHSER-CLTLVFEFMEK-DLKKVLD---ENKT 114

Query: 471 QFIAS---CYCFLTWSQRLRICLDVAMALQYMHH--VMNPSYVHRNIKSRNIFLDEEFNA 525
               S    Y +    Q LR        + + H   ++     HR++K +N+ ++ +   
Sbjct: 115 GLQDSQIKIYLY----QLLR-------GVAHCHQHRIL-----HRDLKPQNLLINSDGAL 158

Query: 526 RVGNFGMAR 534
           ++ +FG+AR
Sbjct: 159 KLADFGLAR 167

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score = 61.3 bits (149), Expect = 4e-10
 Identities = 41/169 (24%), Positives = 71/169 (42%), Gaps = 50/169 (29%)

Query: 392 GAVYHGR--LNGKNLAIK---RT---EHEVITKLE-----MQLVQHATHHHPNIVRLLGT 438
           G V  G+  L G  +A+K   R      +V+ K+      ++L       HP+I++L   
Sbjct: 30  GKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLF-----RHPHIIKLYQV 84

Query: 439 CLTDGPHSFLVFEYAKNGSLKDWL--HGGL----AMK--NQFIASCYCFLTWSQRLRICL 490
             T     F+V EY   G L D++  +G L    + +   Q ++                
Sbjct: 85  ISTPS-DIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILS---------------- 127

Query: 491 DVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD 539
                + Y H  M    VHR++K  N+ LD   NA++ +FG++  ++D 
Sbjct: 128 ----GVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG 169

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 60.3 bits (147), Expect = 5e-10
 Identities = 37/174 (21%), Positives = 73/174 (41%), Gaps = 39/174 (22%)

Query: 380 ATEKFNSSNRIE----GAVYHGR--LNGKNLAIK--RTEHE---VITKL-EMQLVQHATH 427
           ++ +F    ++       VY G     G  +A+K  + + E     T + E+ L++    
Sbjct: 3   SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKEL-- 60

Query: 428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL--HGGLAMKNQFIAS---CYCFLTW 482
            H NIVRL     T+     LVFE+  +  LK ++              +    + +   
Sbjct: 61  KHENIVRLYDVIHTEN-KLTLVFEFM-DNDLKKYMDSRTVGNTPRGLELNLVKYFQW--- 115

Query: 483 SQRLRICLDVAMALQYMHH--VMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR 534
            Q L+        L + H   ++     HR++K +N+ +++    ++G+FG+AR
Sbjct: 116 -QLLQ-------GLAFCHENKIL-----HRDLKPQNLLINKRGQLKLGDFGLAR 156

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score = 59.7 bits (145), Expect = 8e-10
 Identities = 41/247 (16%), Positives = 84/247 (34%), Gaps = 64/247 (25%)

Query: 392 GAVYHGR--LNGKNLAIKRTEHEVITKLEMQLVQHATH-----------HHPNIVRLLGT 438
           G V+        K + +K  + E + +                       H NI+++L  
Sbjct: 38  GFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDI 97

Query: 439 CLTDGPHSFLVFEYAKNGS-LKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMA 495
               G    LV E   +G  L  ++  H  L        + Y F    Q       +  A
Sbjct: 98  FENQG-FFQLVMEKHGSGLDLFAFIDRHPRLDEP----LASYIF---RQ-------LVSA 142

Query: 496 LQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------SPQF---- 545
           + Y+        +HR+IK  NI + E+F  ++ +FG A  +           + ++    
Sbjct: 143 VGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPE 199

Query: 546 ------YSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDEGSV----WLSEK--- 592
                 Y           ++++ G+ L  ++  + P     +  E ++     +S++   
Sbjct: 200 VLMGNPYRGPEL------EMWSLGVTLYTLVFEENPFCELEETVEAAIHPPYLVSKELMS 253

Query: 593 -IKSILQ 598
            +  +LQ
Sbjct: 254 LVSGLLQ 260

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 59.7 bits (145), Expect = 9e-10
 Identities = 35/164 (21%), Positives = 60/164 (36%), Gaps = 42/164 (25%)

Query: 392 GAVYHGR--LNGKNLAIK----------RTEHEVITKLEMQLVQHATHHHPNIVRLLGTC 439
           G     R  L  + +A+K            + E+I     + +      HPNIVR     
Sbjct: 34  GVARLMRDKLTKELVAVKYIERGAAIDENVQREIIN---HRSL-----RHPNIVRFKEVI 85

Query: 440 LTDGPHSFLVFEYAKNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQ 497
           LT   H  ++ EYA  G L + +   G  +       + + F    Q+L +       + 
Sbjct: 86  LTPT-HLAIIMEYASGGELYERICNAGRFSED----EARFFF----QQL-LS-----GVS 130

Query: 498 YMHHVMNPSYVHRNIKSRNIFLDEEF--NARVGNFGMARCVNDD 539
           Y H +      HR++K  N  LD       ++ +FG ++     
Sbjct: 131 YCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH 171

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score = 60.1 bits (146), Expect = 9e-10
 Identities = 44/236 (18%), Positives = 92/236 (38%), Gaps = 57/236 (24%)

Query: 392 GAVYHG--RLNGKNLAIK-----------RTEHEVITKL--EMQLVQHATHHHPNIVRLL 436
           G V     R   K +AI+             E +    +  E+++++    +HP I+++ 
Sbjct: 149 GEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKL--NHPCIIKIK 206

Query: 437 GTCLTDGPHSFLVFEYAKNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAM 494
                D    ++V E  + G L D +  +                L  +        + +
Sbjct: 207 NFF--DAEDYYIVLELMEGGELFDKVVGNK--------------RLKEATCKLYFYQMLL 250

Query: 495 ALQYMHHVMNPSYVHRNIKSRNIFL---DEEFNARVGNFGMARCVNDDTE------SPQ- 544
           A+QY+H       +HR++K  N+ L   +E+   ++ +FG ++ + + +       +P  
Sbjct: 251 AVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTY 307

Query: 545 -----FYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDEGSVWLSEKIKS 595
                  S   A ++  +D ++ G++L   LSG  P +         V L ++I S
Sbjct: 308 LAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSE----HRTQVSLKDQITS 359

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 59.2 bits (144), Expect = 1e-09
 Identities = 47/229 (20%), Positives = 91/229 (39%), Gaps = 62/229 (27%)

Query: 379 RATEKFNSSNRI-EGA---VYHGR--LNGKNLAIKR----TEHEVI--TKL-EMQLVQHA 425
           ++ EK+ +   + EG+   V   R    G+ +AIK+     + +++    + E++L++  
Sbjct: 22  QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL 81

Query: 426 THHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIAS---CYCFLTW 482
              H N+V LL  C       +LVFE+  + ++ D L       N         Y F   
Sbjct: 82  --RHENLVNLLEVCKKKK-RWYLVFEFVDH-TILDDLE---LFPNGLDYQVVQKYLF--- 131

Query: 483 SQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE- 541
            Q +         + + H     + +HR+IK  NI + +    ++ +FG AR +    E 
Sbjct: 132 -QIIN-------GIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 180

Query: 542 -----------SP------QFYSTNPASWSMGIDIFAYGIVLLEVLSGQ 573
                      +P        Y          +D++A G ++ E+  G+
Sbjct: 181 YDDEVATRWYRAPELLVGDVKYGK-------AVDVWAIGCLVTEMFMGE 222

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 58.8 bits (143), Expect = 1e-09
 Identities = 46/170 (27%), Positives = 71/170 (41%), Gaps = 40/170 (23%)

Query: 382 EKFNSSNRIE----GAVYHGR--LNGKNLAIK--RTEHE---VITKL-EMQLVQHATHHH 429
           E +   +++       VY G+  L    +A+K  R EHE     T + E+ L++     H
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDL--KH 59

Query: 430 PNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIAS---CYCFLTWSQRL 486
            NIV L     T+     LVFEY     LK +L       N         + F    Q L
Sbjct: 60  ANIVTLHDIIHTEK-SLTLVFEYLDK-DLKQYLD---DCGNIINMHNVKLFLF----QLL 110

Query: 487 RICLDVAMALQYMHH--VMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR 534
           R        L Y H   V+     HR++K +N+ ++E    ++ +FG+AR
Sbjct: 111 R-------GLAYCHRQKVL-----HRDLKPQNLLINERGELKLADFGLAR 148

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score = 58.1 bits (141), Expect = 3e-09
 Identities = 49/236 (20%), Positives = 90/236 (38%), Gaps = 60/236 (25%)

Query: 378 RRATEKFNSSNRI-EGA---VYHGRL--NGKNLAIKRTEHEVITKL----EMQLVQHATH 427
           R+  ++F       +G    V  G+    G ++AIK+   +   +      MQ +     
Sbjct: 19  RKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL-- 76

Query: 428 HHPNIVRLLGTCLTDGPHSF------LVFEYAKNGSLKDWLH---GGLAMKNQFIASCYC 478
           HHPNIV+L     T G          +V EY     + D LH        +         
Sbjct: 77  HHPNIVQLQSYFYTLGERDRRDIYLNVVMEY-----VPDTLHRCCRNYYRRQVAPPPILI 131

Query: 479 FLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNA-RVGNFGMARCVN 537
            +   Q +R       ++  +H   + +  HR+IK  N+ ++E     ++ +FG A+ ++
Sbjct: 132 KVFLFQLIR-------SIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183

Query: 538 DDTES-----------P------QFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPI 576
               +           P      Q Y+T        +DI++ G +  E++ G+ PI
Sbjct: 184 PSEPNVAYICSRYYRAPELIFGNQHYTT-------AVDIWSVGCIFAEMMLGE-PI 231

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 57.6 bits (140), Expect = 3e-09
 Identities = 47/206 (22%), Positives = 84/206 (40%), Gaps = 40/206 (19%)

Query: 392 GAVYHGRL--NGKNLAIKRTEHEVITKLEMQLVQH--------ATHHHPNIVRLLGTCLT 441
             V   R     +  AIK  E   I K     V +        +   HP  V+L  T   
Sbjct: 44  STVVLARELATSREYAIKILEKRHIIK--ENKVPYVTRERDVMSRLDHPFFVKLYFTFQD 101

Query: 442 DGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHH 501
           D    +    YAKNG L  ++         F  +C  F T ++       +  AL+Y+H 
Sbjct: 102 DE-KLYFGLSYAKNGELLKYIR----KIGSFDETCTRFYT-AE-------IVSALEYLHG 148

Query: 502 VMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYS---T---------N 549
                 +HR++K  NI L+E+ + ++ +FG A+ ++ +++  +  S   T          
Sbjct: 149 -KG--IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 205

Query: 550 PASWSMGIDIFAYGIVLLEVLSGQTP 575
             S     D++A G ++ ++++G  P
Sbjct: 206 EKSACKSSDLWALGCIIYQLVAGLPP 231

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score = 57.7 bits (140), Expect = 4e-09
 Identities = 44/202 (21%), Positives = 80/202 (39%), Gaps = 56/202 (27%)

Query: 392 GAVYHGR--LNGKNLAIK---RT---EHEVITKLE-----MQLVQHATHHHPNIVRLLGT 438
           G V         + +A+K   R    + ++  ++E     ++L+      HP+I++L   
Sbjct: 23  GKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLL-----RHPHIIKLYDV 77

Query: 439 CLTDGPHSFLVFEYAKNGSLKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMAL 496
             T      +V EYA  G L D++     +            F    Q++ IC     A+
Sbjct: 78  ITTPT-DIVMVIEYA-GGELFDYIVEKKRMTED----EGRRFF----QQI-IC-----AI 121

Query: 497 QYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------SP------- 543
           +Y H       VHR++K  N+ LD+  N ++ +FG++  + D         SP       
Sbjct: 122 EYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEV 178

Query: 544 ---QFYSTNPA-SWSMGIDIFA 561
              + Y+      WS GI ++ 
Sbjct: 179 INGKLYAGPEVDVWSCGIVLYV 200

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 57.7 bits (140), Expect = 4e-09
 Identities = 37/209 (17%), Positives = 71/209 (33%), Gaps = 57/209 (27%)

Query: 401 GKNLAIKRTEHEVITKLEMQLVQHATH--------------HHPNIVRLLGTCLTDGPHS 446
           G  +AIKR  + V     + ++  +                HHPNI+ L    +     +
Sbjct: 46  GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPA 105

Query: 447 F----LVFEYAKNGSLKDWLH-----GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQ 497
                LV E  +     D L        + +  Q I     +  +   L         L 
Sbjct: 106 MHKLYLVTELMRT----D-LAQVIHDQRIVISPQHI----QYFMY-HILL-------GLH 148

Query: 498 YMH--HVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYST------- 548
            +H   V     VHR++   NI L +  +  + +F +AR    D     + +        
Sbjct: 149 VLHEAGV-----VHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPE 203

Query: 549 ---NPASWSMGIDIFAYGIVLLEVLSGQT 574
                  ++  +D+++ G V+ E+ + + 
Sbjct: 204 LVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 57.2 bits (139), Expect = 5e-09
 Identities = 51/223 (22%), Positives = 90/223 (40%), Gaps = 56/223 (25%)

Query: 382 EKFNSSNRI-EGA---VYHGR--LNGKNLAIKRT----EHEVI--TKL-EMQLVQHATHH 428
           EK+    +I EG+   V+  R    G+ +AIK+     +  VI    L E+++++     
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQL--K 60

Query: 429 HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI 488
           HPN+V LL           LVFEY  + ++   L        + +     +    Q L+ 
Sbjct: 61  HPNLVNLLEVFRRKR-RLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITW----QTLQ- 113

Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------- 541
                 A+ + H     + +HR++K  NI + +    ++ +FG AR +   ++       
Sbjct: 114 ------AVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVA 164

Query: 542 -----SP------QFYSTNPASWSMGIDIFAYGIVLLEVLSGQ 573
                SP        Y          +D++A G V  E+LSG 
Sbjct: 165 TRWYRSPELLVGDTQYGP-------PVDVWAIGCVFAELLSGV 200

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score = 57.3 bits (139), Expect = 5e-09
 Identities = 45/201 (22%), Positives = 81/201 (40%), Gaps = 48/201 (23%)

Query: 398 RLNGKNLAIKRTEHEVITK------LEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFE 451
           +      A+K     +I K       E++++     H PNI+ L      DG + ++V E
Sbjct: 44  KATNMEFAVK-----IIDKSKRDPTEEIEILLRYGQH-PNIITLKDVY-DDGKYVYVVTE 96

Query: 452 YAKNGSLKDWLHGGLAMKNQF---IASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYV 508
             K G L D +      +  F    AS            +   +   ++Y+H       V
Sbjct: 97  LMKGGELLDKIL----RQKFFSEREAS-----------AVLFTITKTVEYLHA-QG--VV 138

Query: 509 HRNIKSRNI-FLDEEFNA---RVGNFGMARCVNDDTE-------SPQFYS---TNPASWS 554
           HR++K  NI ++DE  N    R+ +FG A+ +  +         +  F +        + 
Sbjct: 139 HRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYD 198

Query: 555 MGIDIFAYGIVLLEVLSGQTP 575
              DI++ G++L  +L+G TP
Sbjct: 199 AACDIWSLGVLLYTMLTGYTP 219

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score = 56.5 bits (137), Expect = 6e-09
 Identities = 46/217 (21%), Positives = 85/217 (39%), Gaps = 52/217 (23%)

Query: 392 GAVYHG--RLNGKNLAIK---RTEHEVITKLEMQLVQHATH----------HHPNIVRLL 436
             V     +   K  A+K    T     +  E+Q ++ AT            HPNI++L 
Sbjct: 31  SVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK 90

Query: 437 GTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQF---IASCYCFLTWSQRLRICLDVA 493
            T        FLVF+  K G L D+L      K                    +I   + 
Sbjct: 91  DTY-ETNTFFFLVFDLMKKGELFDYL----TEKVTLSEKETR-----------KIMRALL 134

Query: 494 MALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------SPQF-- 545
             +  +H  +N   VHR++K  NI LD++ N ++ +FG +  ++   +      +P +  
Sbjct: 135 EVICALHK-LN--IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLA 191

Query: 546 -------YSTNPASWSMGIDIFAYGIVLLEVLSGQTP 575
                   + N   +   +D+++ G+++  +L+G  P
Sbjct: 192 PEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 228

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 57.0 bits (138), Expect = 7e-09
 Identities = 49/211 (23%), Positives = 81/211 (38%), Gaps = 48/211 (22%)

Query: 392 GAVYHGRL--NGKNLAIKRTEHEVITKL-EMQLVQHATHHHPNIVRLLGTCLTDGPHS-- 446
           G VY  +L  +G+ +AIK+   +   K  E+Q+++     H NIVRL     + G     
Sbjct: 68  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL--DHCNIVRLRYFFYSSGEKKDE 125

Query: 447 ---FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM 503
               LV +Y    ++          K            + Q  R       +L Y+H   
Sbjct: 126 VYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMY-QLFR-------SLAYIHSF- 175

Query: 504 NPSYVHRNIKSRNIFLDEEFNA-RVGNFGMARCVNDD---TE--------------SPQF 545
                HR+IK +N+ LD +    ++ +FG A+ +                          
Sbjct: 176 --GICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATD 233

Query: 546 YSTNPASWSMGIDIFAYGIVLLEVLSGQTPI 576
           Y++        ID+++ G VL E+L GQ PI
Sbjct: 234 YTS-------SIDVWSAGCVLAELLLGQ-PI 256

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score = 56.5 bits (137), Expect = 8e-09
 Identities = 28/160 (17%), Positives = 55/160 (34%), Gaps = 40/160 (25%)

Query: 392 GAVYHGR--LNGKNLAIKRTEHEVITKLE------------MQLVQHATHHHPNIVRLLG 437
           G V            A+K  + + + ++             ++ +      H N+++L+ 
Sbjct: 19  GKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRL-----RHKNVIQLVD 73

Query: 438 TCLTDGP-HSFLVFEYAKNGS--LKDWL-HGGLAMKNQFIASCYCFLTWSQRLRICLDVA 493
               +     ++V EY   G   + D +            A  Y F     +L I     
Sbjct: 74  VLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRF---PVCQAHGY-F----CQL-ID---- 120

Query: 494 MALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA 533
             L+Y+H       VH++IK  N+ L      ++   G+A
Sbjct: 121 -GLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVA 156

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 56.4 bits (135), Expect = 9e-09
 Identities = 34/231 (14%), Positives = 64/231 (27%), Gaps = 55/231 (23%)

Query: 380 ATEKFNSSNRI-EGA---VYHGRLNGKNLAIK---------------RTEHEV-----IT 415
            TEK     +I EG    V+    +   +AIK               +T  E+     I+
Sbjct: 18  PTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIIS 77

Query: 416 KLEMQLVQHATHHHPNIVRLLGTCLTDGP-HSFLVFEY----AKNGSLKDWLHGGLAMKN 470
           K    L     +     + L       G     L+  +    +  GS  D        + 
Sbjct: 78  KELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ- 136

Query: 471 QFIASCYC------------FLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIF 518
            FI   +               + +    I   +  +L      +   + HR++   N+ 
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEASLR--FEHRDLHWGNVL 194

Query: 519 LDEEFNA-----------RVGNFGMARCVNDDTESPQFYSTNPASWSMGID 558
           L +                + + G+   + D T S            + +D
Sbjct: 195 LKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMD 245

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 56.0 bits (136), Expect = 1e-08
 Identities = 43/170 (25%), Positives = 71/170 (41%), Gaps = 40/170 (23%)

Query: 382 EKFNSSNRI-EGA---VYHGRLN-GKNLAIK--RTEHEV----ITKL-EMQLVQHATHHH 429
           EK++   +I EG    VY  + N G+  A+K  R E E      T + E+ +++     H
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKEL--KH 59

Query: 430 PNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIAS---CYCFLTWSQRL 486
            NIV+L     T      LVFE+     LK  L      +    +     +      Q L
Sbjct: 60  SNIVKLYDVIHTKK-RLVLVFEHLDQ-DLKKLLD---VCEGGLESVTAKSFLL----QLL 110

Query: 487 RICLDVAMALQYMHH--VMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR 534
                    + Y H   V+     HR++K +N+ ++ E   ++ +FG+AR
Sbjct: 111 N-------GIAYCHDRRVL-----HRDLKPQNLLINREGELKIADFGLAR 148

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score = 55.7 bits (135), Expect = 1e-08
 Identities = 39/201 (19%), Positives = 75/201 (37%), Gaps = 34/201 (16%)

Query: 392 GAVYHG--RLNGKNLAIK----RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPH 445
           G V+      + K    K    +   +V+ K E+ ++  A   H NI+ L  +       
Sbjct: 19  GIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA--RHRNILHLHESF-ESMEE 75

Query: 446 SFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNP 505
             ++FE+     + +            I +    L   + +     V  ALQ++H   N 
Sbjct: 76  LVMIFEFISGLDIFE-----------RINTSAFELNEREIVSYVHQVCEALQFLHS-HN- 122

Query: 506 SYVHRNIKSRNIFLDEEFNARV--GNFGMARCVNDDTE------SPQFYS---TNPASWS 554
              H +I+  NI      ++ +    FG AR +           +P++Y+         S
Sbjct: 123 -IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVS 181

Query: 555 MGIDIFAYGIVLLEVLSGQTP 575
              D+++ G ++  +LSG  P
Sbjct: 182 TATDMWSLGTLVYVLLSGINP 202

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score = 56.6 bits (137), Expect = 1e-08
 Identities = 43/231 (18%), Positives = 85/231 (36%), Gaps = 50/231 (21%)

Query: 392 GAVYHG--RLNGKNLAIK-------RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTD 442
           G V     ++     AIK        T        E+ +++     HPNI++L      D
Sbjct: 51  GEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLL--DHPNIMKLYDFF-ED 107

Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
             + +LV E  K G L D            I     F        I   V   + Y+H  
Sbjct: 108 KRNYYLVMECYKGGELFDE-----------IIHRMKF-NEVDAAVIIKQVLSGVTYLHK- 154

Query: 503 MNPSYVHRNIKSRNIFL---DEEFNARVGNFGMARCVNDDTE------SPQFYSTNP--- 550
            N   VHR++K  N+ L   +++   ++ +FG++    +  +      +  + +  P   
Sbjct: 155 HN--IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIA--PEVL 210

Query: 551 -ASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDEGSVWLSEKIKSILQAE 600
              +    D+++ G++L  +L+G  P      +        E ++ + + +
Sbjct: 211 RKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQ--------EILRKVEKGK 253

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score = 55.9 bits (135), Expect = 2e-08
 Identities = 41/203 (20%), Positives = 79/203 (38%), Gaps = 37/203 (18%)

Query: 392 GAVYHG--RLNGKNLAIK------RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDG 443
           G V+    +  G+    K        +   + K E+ ++     HHP ++ L      D 
Sbjct: 65  GVVHRCVEKATGRVFVAKFINTPYPLDKYTV-KNEISIMNQL--HHPKLINLHDAF-EDK 120

Query: 444 PHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM 503
               L+ E+   G L D            IA+    ++ ++ +         L++MH   
Sbjct: 121 YEMVLILEFLSGGELFD-----------RIAAEDYKMSEAEVINYMRQACEGLKHMHE-H 168

Query: 504 NPSYVHRNIKSRNIFLDEEFNARV--GNFGMARCVNDDTE------SPQFYS---TNPAS 552
           +   VH +IK  NI  + +  + V   +FG+A  +N D        + +F +    +   
Sbjct: 169 S--IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREP 226

Query: 553 WSMGIDIFAYGIVLLEVLSGQTP 575
                D++A G++   +LSG +P
Sbjct: 227 VGFYTDMWAIGVLGYVLLSGLSP 249

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 55.8 bits (135), Expect = 2e-08
 Identities = 45/211 (21%), Positives = 83/211 (39%), Gaps = 63/211 (29%)

Query: 398 RLNGKNLAIKRT---EHEVITKL---EMQLVQHATHHHPNIVRLLGTCLTDGPHSF---- 447
            LN   +AIK+    EH+   +    E++++      H NI+ +                
Sbjct: 49  NLNKVRVAIKKISPFEHQTYCQRTLREIKILLRF--RHENIIGINDIIRAPTIEQMKDVY 106

Query: 448 LVFEYA--------KNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYM 499
           +V +          K   L +  H              C+  + Q LR        L+Y+
Sbjct: 107 IVQDLMETDLYKLLKTQHLSN-DH-------------ICYFLY-QILR-------GLKYI 144

Query: 500 H--HVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQF---Y-ST----- 548
           H  +V     +HR++K  N+ L+   + ++ +FG+AR  + D +   F   Y +T     
Sbjct: 145 HSANV-----LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199

Query: 549 -----NPASWSMGIDIFAYGIVLLEVLSGQT 574
                N   ++  IDI++ G +L E+LS + 
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRP 230

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score = 55.0 bits (133), Expect = 2e-08
 Identities = 57/251 (22%), Positives = 86/251 (34%), Gaps = 70/251 (27%)

Query: 392 GAVYHGR--LNGKNLAIK-----------RTEHEVITKLE---MQLVQHATHHHPNIVRL 435
           G V+ G    +   +AIK                V   LE   +  V  A   HP ++RL
Sbjct: 45  GTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKV-GAGGGHPGVIRL 103

Query: 436 LGTCLTDGPHSFLVFEYAKNGS-LKDWL--HGGLAMKNQFIASCYCFLTWSQRLRICLDV 492
           L    T      LV E       L D++   G L        S   F    Q       V
Sbjct: 104 LDWFETQE-GFMLVLERPLPAQDLFDYITEKGPLGEG----PSRCFF---GQ-------V 148

Query: 493 AMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNA-RVGNFGMARCVND---DTE--SPQF- 545
             A+Q+ H       VHR+IK  NI +D      ++ +FG    ++D        +  + 
Sbjct: 149 VAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYTDFDGTRVYS 205

Query: 546 ---------YSTNPA-SWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDEGSV----WLSE 591
                    Y   PA  WS+       GI+L +++ G  P  R ++  E  +     +S 
Sbjct: 206 PPEWISRHQYHALPATVWSL-------GILLYDMVCGDIPFERDQEILEAELHFPAHVSP 258

Query: 592 K----IKSILQ 598
                I+  L 
Sbjct: 259 DCCALIRRCLA 269

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 55.0 bits (133), Expect = 3e-08
 Identities = 42/212 (19%), Positives = 80/212 (37%), Gaps = 57/212 (26%)

Query: 392 GAVYHG--RLNGKNLAIK--RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSF 447
             V+      N + + +K  +   +   K E++++++     PNI+ L    + D P S 
Sbjct: 50  SEVFEAINITNNEKVVVKILKPVKKKKIKREIKILEN-LRGGPNIITLADI-VKD-PVSR 106

Query: 448 ---LVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH--HV 502
              LVFE+  N   K        + +  I   Y +    + L+       AL Y H   +
Sbjct: 107 TPALVFEHVNNTDFKQLYQ---TLTDYDIRF-YMY----EILK-------ALDYCHSMGI 151

Query: 503 MNPSYVHRNIKSRNIFLDEEFNA-RVGNFGMARCVNDDTE-----------------SPQ 544
           M     HR++K  N+ +D E    R+ ++G+A   +   E                   Q
Sbjct: 152 M-----HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQ 206

Query: 545 FYSTNPASWSMGIDIFAYGIVLLEVLSGQTPI 576
            Y          +D+++ G +L  ++  + P 
Sbjct: 207 MYDY-------SLDMWSLGCMLASMIFRKEPF 231

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 55.2 bits (133), Expect = 3e-08
 Identities = 36/188 (19%), Positives = 75/188 (39%), Gaps = 33/188 (17%)

Query: 398 RLNGKNLAIKR----TEHEVITKL---EMQLVQHATHHHPNIVRLLGTCLTDGPHSF--- 447
           +L  + +AIK+     E  +  K    E+ ++     +H ++V++L   +      F   
Sbjct: 75  KLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL--NHDHVVKVLDIVIPKDVEKFDEL 132

Query: 448 -LVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH--HVMN 504
            +V E A +   K      + +    I      L +   L         ++Y+H   +  
Sbjct: 133 YVVLEIA-DSDFKKLFRTPVYLTELHI----KTLLY-NLLV-------GVKYVHSAGI-- 177

Query: 505 PSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASWSMGIDIFAYGI 564
              +HR++K  N  ++++ + +V +FG+AR V+           +P    M +  F +  
Sbjct: 178 ---LHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTK 234

Query: 565 VLLEVLSG 572
            L   L+G
Sbjct: 235 NLKRQLTG 242

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 55.7 bits (134), Expect = 3e-08
 Identities = 45/221 (20%), Positives = 84/221 (38%), Gaps = 47/221 (21%)

Query: 406 IKRTEHEVITKLEMQ-LVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL-- 462
           IK  + E +   E   L   +T   P IV +     T       + +    G L   L  
Sbjct: 227 IKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPD-KLSFILDLMNGGDLHYHLSQ 285

Query: 463 HGGLAMKN-QFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE 521
           HG  +  + +F A+                + + L++MH   N   V+R++K  NI LDE
Sbjct: 286 HGVFSEADMRFYAAE---------------IILGLEHMH---NRFVVYRDLKPANILLDE 327

Query: 522 EFNARVGNFGMARCVNDDTES----------PQFYSTNPASWSMGIDIFAYGIVLLEVLS 571
             + R+ + G+A   +               P+       ++    D F+ G +L ++L 
Sbjct: 328 HGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKG-VAYDSSADWFSLGCMLFKLLR 386

Query: 572 GQTPINRPRKKDEGSV-------------WLSEKIKSILQA 599
           G +P  + + KD+  +               S +++S+L+ 
Sbjct: 387 GHSPFRQHKTKDKHEIDRMTLTMAVELPDSFSPELRSLLEG 427

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score = 54.6 bits (132), Expect = 3e-08
 Identities = 50/196 (25%), Positives = 83/196 (42%), Gaps = 38/196 (19%)

Query: 398 RLNGKNLAIK--RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKN 455
           + + +  A+K      E  T+ E+  ++    H PNIV+L      D  H+FLV E    
Sbjct: 33  KKSNQAFAVKIISKRMEANTQKEITALKLCEGH-PNIVKLHEVF-HDQLHTFLVMELLNG 90

Query: 456 GSLKDWLHGGLAMKNQF---IASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNI 512
           G L + +      K  F    AS            I   +  A+ +MH  +    VHR++
Sbjct: 91  GELFERIK----KKKHFSETEAS-----------YIMRKLVSAVSHMHD-VG--VVHRDL 132

Query: 513 KSRNI-FLDEEFNA--RVGNFGMARCVNDDTE-------SPQFYS---TNPASWSMGIDI 559
           K  N+ F DE  N   ++ +FG AR    D +       +  + +    N   +    D+
Sbjct: 133 KPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDL 192

Query: 560 FAYGIVLLEVLSGQTP 575
           ++ G++L  +LSGQ P
Sbjct: 193 WSLGVILYTMLSGQVP 208

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score = 54.6 bits (132), Expect = 4e-08
 Identities = 54/259 (20%), Positives = 103/259 (39%), Gaps = 52/259 (20%)

Query: 346 SFEGSQSTIEGQIIDTAEQHKRLLESYSI--EDLRRATEKFNSSNRI-EGA---VYHGRL 399
           SF  S + + G  ++  +   ++++  +   +   +    + +   I  G+   V+  +L
Sbjct: 2   SFTMSNAPLNGVKLNPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQAKL 61

Query: 400 NGKN-LAIKRTEHEVITKL-EMQLVQHATHHHPNIVRLLGTCLTDGPHS-----FLVFEY 452
              + +AIK+   +   K  E+Q+++     HPN+V L     ++G         LV EY
Sbjct: 62  VESDEVAIKKVLQDKRFKNRELQIMRIV--KHPNVVDLKAFFYSNGDKKDEVFLNLVLEY 119

Query: 453 AKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNI 512
               ++        A   Q +      L   Q LR       +L Y+H +      HR+I
Sbjct: 120 VPE-TVYRASR-HYAKLKQTMPMLLIKLYMYQLLR-------SLAYIHSI---GICHRDI 167

Query: 513 KSRNIFLDEEFNA-RVGNFGMARCVNDDTES-----------P------QFYSTNPASWS 554
           K +N+ LD      ++ +FG A+ +     +           P        Y+T      
Sbjct: 168 KPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTT------ 221

Query: 555 MGIDIFAYGIVLLEVLSGQ 573
             IDI++ G V+ E++ GQ
Sbjct: 222 -NIDIWSTGCVMAELMQGQ 239

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 55.2 bits (133), Expect = 4e-08
 Identities = 42/217 (19%), Positives = 81/217 (37%), Gaps = 39/217 (17%)

Query: 406 IKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGG 465
           IK+ + E +   E Q+++    +   +V L     T      LV      G LK  ++  
Sbjct: 222 IKKRKGEAMALNEKQILEKV--NSRFVVSLAYAYETKD-ALCLVLTLMNGGDLKFHIYH- 277

Query: 466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNA 525
              +  F  +   F           ++   L+ +H       V+R++K  NI LD+  + 
Sbjct: 278 -MGQAGFPEARAVFYA--------AEICCGLEDLH---RERIVYRDLKPENILLDDHGHI 325

Query: 526 RVGNFGMARCVNDDTESPQFYST---------NPASWSMGIDIFAYGIVLLEVLSGQTPI 576
           R+ + G+A  V +         T             ++   D +A G +L E+++GQ+P 
Sbjct: 326 RISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPF 385

Query: 577 ---NRPRKKDE-----------GSVWLSEKIKSILQA 599
               +  K++E            S   S + +S+   
Sbjct: 386 QQRKKKIKREEVERLVKEVPEEYSERFSPQARSLCSQ 422

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 55.2 bits (132), Expect = 5e-08
 Identities = 46/333 (13%), Positives = 97/333 (29%), Gaps = 92/333 (27%)

Query: 316 QSPMISHKDCRDVELQQLSASVRTTSD-KKV---------------SFEGSQSTIEGQII 359
           +   + + DC+DV+   +  S+ +  +   +               +    Q  +  + +
Sbjct: 26  EDAFVDNFDCKDVQ--DMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFV 83

Query: 360 DTAEQ--HKRLLESYSIEDLRRA--TEKFNSSNRIEGAVYHGRLNGKNLAIKRTEHEVIT 415
           +   +  +K L+     E  + +  T  +             RL   N        +V  
Sbjct: 84  EEVLRINYKFLMSPIKTEQRQPSMMTRMYIE--------QRDRLYNDN--------QVFA 127

Query: 416 KLEMQLVQHATHHHPNIVRLLGTCLT-DGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIA 474
           K       + +   P     L   L    P   ++      GS K W+       +  + 
Sbjct: 128 KY------NVSRLQP--YLKLRQALLELRPAKNVLI-DGVLGSGKTWV-ALDVCLSYKVQ 177

Query: 475 SCYCF----LTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLD-EEFNARVGN 529
               F    L           + M LQ + + ++P++  R+  S NI L      A +  
Sbjct: 178 CKMDFKIFWLNLKNCNSPETVLEM-LQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRR 236

Query: 530 FGM----ARC--VNDDTESPQFYSTNPASWSMGIDIFAYG--IVLL-------EVLSGQT 574
                    C  V  + ++ +             + F     I+L        + LS  T
Sbjct: 237 LLKSKPYENCLLVLLNVQNAKA-----------WNAFNLSCKILLTTRFKQVTDFLSAAT 285

Query: 575 ----PINRPRK---KDEG----SVWLSEKIKSI 596
                ++        DE       +L  + + +
Sbjct: 286 TTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDL 318

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 54.9 bits (131), Expect = 7e-08
 Identities = 59/483 (12%), Positives = 134/483 (27%), Gaps = 133/483 (27%)

Query: 60  CG----TFAILRTNSYYSSLFNLSFYLGLNRFVIARANGFSADTEFLPKDQPLLIPIDCK 115
            G       +  +      +    F+L L           ++    L   Q LL  ID  
Sbjct: 161 SGKTWVALDVCLSYKVQCKMDFKIFWLNLKNC--------NSPETVLEMLQKLLYQIDPN 212

Query: 116 CNNNGGFFQADLTKTTIKGESFYSIAQSLEGLTTCGAIKERNPSVSPWDLDDKARLQV-- 173
             +     ++D +         +SI   L  L     +K +        L +    +   
Sbjct: 213 WTS-----RSDHSSNIK--LRIHSIQAELRRL-----LKSKPYENCLLVLLNVQNAKAWN 260

Query: 174 --PLRCACPSSSENLPETRILV-SYPVGEGDTVSGLAAKFNTTPAAIIAANNKSLEGFKP 230
              L C            +IL+ +      D +S       TT  ++    +       P
Sbjct: 261 AFNLSC------------KILLTTRFKQVTDFLSAA----TTTHISL----DHHSMTLTP 300

Query: 231 EDLLA-FTSIL-IPLNGEPVLAPLAKPHDPNLHV----------PET--NYSIPDITPPK 276
           +++ +     L       P         +P   +            T  N+   +     
Sbjct: 301 DEVKSLLLKYLDCRPQDLP---REVLTTNP-RRLSIIAESIRDGLATWDNWKHVNC---D 353

Query: 277 KKSKMLKV-----------GAYIALSGAVVGGCIAIAAVVIVILLKKKKQQSPMISHKDC 325
           K + +++              +  L  +V      I  +++ ++     +   M+     
Sbjct: 354 KLTTIIESSLNVLEPAEYRKMFDRL--SVFPPSAHIPTILLSLIWFDVIKSDVMVV---- 407

Query: 326 RDVELQQLSASVRTTSDKKVSFEGSQSTIEGQIIDTAEQHKRLLESYSI----------- 374
              +L + S   +   +  +S       ++ ++ +    H+ +++ Y+I           
Sbjct: 408 -VNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEYALHRSIVDHYNIPKTFDSDDLIP 466

Query: 375 --ED----------LRRA--TEKFNSSNR-------IEGAVYHGRLNGKNLAIKRTEHEV 413
              D          L+     E+             +E  +   R +        +    
Sbjct: 467 PYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRFLEQKI---RHDSTAWNASGSILNT 523

Query: 414 ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKN---GSLKDWLHGGLAMKN 470
           + +L+     +   + P   RL+   L      FL  +  +N       D L   L  ++
Sbjct: 524 LQQLKFYK-PYICDNDPKYERLVNAILD-----FL-PKIEENLICSKYTDLLRIALMAED 576

Query: 471 QFI 473
           + I
Sbjct: 577 EAI 579

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 50.6 bits (120), Expect = 1e-06
 Identities = 75/471 (15%), Positives = 138/471 (29%), Gaps = 144/471 (30%)

Query: 157 NPSVSPWD---LDDKARLQVPLRCACPSSSENL-PETRILVSYPVGEGDTVSGLAAKFNT 212
           N   + ++   L    +L+  L          L P   +L+   +G G T   +A     
Sbjct: 123 NQVFAKYNVSRLQPYLKLRQALL--------ELRPAKNVLIDGVLGSGKTW--VALD--- 169

Query: 213 TPAAIIAANNKSLEGFKPEDL--LAFTSILIPLNGEPVLAPLAKPH---DPNLHV-PETN 266
                    +  ++      +  L   +   P   E VL  L K     DPN     + +
Sbjct: 170 ------VCLSYKVQCKMDFKIFWLNLKNCNSP---ETVLEMLQKLLYQIDPNWTSRSDHS 220

Query: 267 YSIP-DITPPKKKSKML-----KVGAYIAL----SGAVV----GGC-IAIA---AVVIVI 308
            +I   I   + + + L          + L    +          C I +      V   
Sbjct: 221 SNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWNAFNLSCKILLTTRFKQVTDF 280

Query: 309 LLKKKKQQSPMISHKD-------------CRDVELQQL---------------SASVR-- 338
           L         +  H                 D   Q L               + S+R  
Sbjct: 281 LSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDG 340

Query: 339 -TTSD--KKVSFEGSQSTIEGQI--IDTAEQHKRLLESYSIEDLRRATEKFNSSNRIEGA 393
             T D  K V+ +   + IE  +  ++ AE ++++ +  S+         F  S  I   
Sbjct: 341 LATWDNWKHVNCDKLTTIIESSLNVLEPAE-YRKMFDRLSV---------FPPSAHIPTI 390

Query: 394 VYHGRLNGKNLAI------KRTEHEVITKLEMQ-LVQHATHHHPNIVRLLGTCLTDGPHS 446
           +         L++      K     V+ KL    LV+       + + +          S
Sbjct: 391 L---------LSLIWFDVIKSDVMVVVNKLHKYSLVEK--QPKESTISI---------PS 430

Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQF-IASCYCFLTWSQRLRICLDVAMALQY-----MH 500
            +  E       +  LH  +   + + I   +        +   LD     QY      H
Sbjct: 431 -IYLELKVKLENEYALHRSIV--DHYNIPKTFD---SDDLIPPYLD-----QYFYSHIGH 479

Query: 501 HVMNPSYVHRNIKSRNIFLDEEF-NARVGNFGMARC----VNDDTESPQFY 546
           H+ N  +  R    R +FLD  F   ++ +   A      + +  +  +FY
Sbjct: 480 HLKNIEHPERMTLFRMVFLDFRFLEQKIRHDSTAWNASGSILNTLQQLKFY 530

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score = 54.3 bits (131), Expect = 5e-08
 Identities = 44/217 (20%), Positives = 78/217 (35%), Gaps = 53/217 (24%)

Query: 392 GAVYHG--RLNGKNLAIK-------------RTEHEVITKLEMQLVQHATHHHPNIVRLL 436
             V     R  G   A+K               E    T+ E  +++    H P+I+ L+
Sbjct: 108 SVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH-PHIITLI 166

Query: 437 GTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQF---IASCYCFLTWSQRLRICLDVA 493
            +        FLVF+  + G L D+L      K                     I   + 
Sbjct: 167 DSY-ESSSFMFLVFDLMRKGELFDYL----TEKVALSEKETR-----------SIMRSLL 210

Query: 494 MALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------SPQF-- 545
            A+ ++H   N   VHR++K  NI LD+    R+ +FG +  +    +      +P +  
Sbjct: 211 EAVSFLHA-NN--IVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLA 267

Query: 546 -------YSTNPASWSMGIDIFAYGIVLLEVLSGQTP 575
                         +   +D++A G++L  +L+G  P
Sbjct: 268 PEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPP 304

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 54.2 bits (131), Expect = 5e-08
 Identities = 35/217 (16%), Positives = 79/217 (36%), Gaps = 70/217 (32%)

Query: 398 RLNGKNLAIKRT---EHEVITKL---EMQLVQHATHHHPNIVRLLGTCLTDGPHSF---- 447
           +  G+ +AIK+    +  +       E+++++H    H NI+ +      D   +F    
Sbjct: 33  KPTGEIVAIKKIEPFDKPLFALRTLREIKILKHF--KHENIITIFNIQRPDSFENFNEVY 90

Query: 448 LVFEYA--------KNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYM 499
           ++ E              L D  H               +  + Q LR       A++ +
Sbjct: 91  IIQELMQTDLHRVISTQMLSD-DH-------------IQYFIY-QTLR-------AVKVL 128

Query: 500 H--HVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW---- 553
           H  +V     +HR++K  N+ ++   + +V +FG+AR +++        +   +      
Sbjct: 129 HGSNV-----IHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183

Query: 554 -----------------SMGIDIFAYGIVLLEVLSGQ 573
                            S  +D+++ G +L E+   +
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score = 54.1 bits (130), Expect = 5e-08
 Identities = 46/242 (19%), Positives = 76/242 (31%), Gaps = 64/242 (26%)

Query: 392 GAVYHG--RLNGKNLAIK--------RTEHEVITKL--EMQLVQHATHHHPNIVRLLGTC 439
           G V            AIK        +   + + ++  E++L++    HHPNI RL    
Sbjct: 40  GVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKL--HHPNIARLYE-V 96

Query: 440 LTDGPHSFLVFEYAKNGSLKDWL----------------------------HGGLAMKNQ 471
             D  +  LV E    G L D L                                   + 
Sbjct: 97  YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHG 156

Query: 472 FIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFL--DEEFNARVGN 529
           F  S            I   +  AL Y+H+       HR+IK  N     ++ F  ++ +
Sbjct: 157 FRESLDFVQREKLISNIMRQIFSALHYLHN-QG--ICHRDIKPENFLFSTNKSFEIKLVD 213

Query: 530 FGMARCVNDDTESPQFYSTNPA----------------SWSMGIDIFAYGIVLLEVLSGQ 573
           FG+++          +  T  A                S+    D ++ G++L  +L G 
Sbjct: 214 FGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273

Query: 574 TP 575
            P
Sbjct: 274 VP 275

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score = 54.3 bits (131), Expect = 6e-08
 Identities = 48/209 (22%), Positives = 84/209 (40%), Gaps = 47/209 (22%)

Query: 392 GAVYHG--RLNGKNLAIK--------RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLT 441
           G V     ++ G+  A+K        +   +     E+QL++     HPNI++L      
Sbjct: 40  GEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQL--DHPNIMKLYEFF-E 96

Query: 442 DGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRL--RICLDVAMALQYM 499
           D  + +LV E    G L D            I S   F   S+    RI   V   + YM
Sbjct: 97  DKGYFYLVGEVYTGGELFDE-----------IISRKRF---SEVDAARIIRQVLSGITYM 142

Query: 500 HHVMNPSYVHRNIKSRNIFL---DEEFNARVGNFGMARCVNDDTE------SPQFYSTNP 550
           H       VHR++K  N+ L    ++ N R+ +FG++       +      +  + +  P
Sbjct: 143 HK-NK--IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIA--P 197

Query: 551 ----ASWSMGIDIFAYGIVLLEVLSGQTP 575
                ++    D+++ G++L  +LSG  P
Sbjct: 198 EVLHGTYDEKCDVWSTGVILYILLSGCPP 226

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 53.8 bits (130), Expect = 7e-08
 Identities = 45/199 (22%), Positives = 91/199 (45%), Gaps = 44/199 (22%)

Query: 398 RLNGKNLAIKRT----EHEVITKL---EMQLVQHATHHHPNIVRLLGTCLTDGPHS---- 446
           + +G+ +AIK+     + E+  K    E+ L++H    H N++ LL              
Sbjct: 46  KRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHM--QHENVIGLLDVFTPASSLRNFYD 103

Query: 447 -FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH--HVM 503
            +LV  + +     D L     M  +F      +L + Q L+        L+Y+H   V 
Sbjct: 104 FYLVMPFMQ----TD-LQK--IMGLKFSEEKIQYLVY-QMLK-------GLKYIHSAGV- 147

Query: 504 NPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-TE--SPQFYS-----TNPASWSM 555
               VHR++K  N+ ++E+   ++ +FG+AR  + + T     ++Y       +   ++ 
Sbjct: 148 ----VHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYRAPEVILSWMHYNQ 203

Query: 556 GIDIFAYGIVLLEVLSGQT 574
            +DI++ G ++ E+L+G+T
Sbjct: 204 TVDIWSVGCIMAEMLTGKT 222

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 53.1 bits (128), Expect = 8e-08
 Identities = 37/210 (17%), Positives = 76/210 (36%), Gaps = 38/210 (18%)

Query: 398 RLNGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLG---TCLTDGPHSFLVFEYAK 454
           +   +  A+K  +     + E++L   A+   P+IVR++              +V E   
Sbjct: 40  KRTQEKFALKMLQDCPKARREVELHWRASQC-PHIVRIVDVYENLYAGRKCLLIVMECLD 98

Query: 455 NGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKS 514
            G L            +         T  +   I   +  A+QY+H  +N    HR++K 
Sbjct: 99  GGELFS----------RIQDRGDQAFTEREASEIMKSIGEAIQYLHS-IN--IAHRDVKP 145

Query: 515 RNI-FLDEEFNA--RVGNFGMARCVNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLS 571
            N+ +  +  NA  ++ +FG A+         + Y           D+++ G+++  +L 
Sbjct: 146 ENLLYTSKRPNAILKLTDFGFAKETTG-----EKYDK-------SCDMWSLGVIMYILLC 193

Query: 572 GQTPINRPRKKDEGSVWLSEKI-KSILQAE 600
           G  P           + +S  +   I   +
Sbjct: 194 GYPPFY-----SNHGLAISPGMKTRIRMGQ 218

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score = 53.0 bits (128), Expect = 1e-07
 Identities = 39/212 (18%), Positives = 78/212 (36%), Gaps = 50/212 (23%)

Query: 392 GAVYHG--RLNGKNLAIK-------RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTD 442
             V     +  G+  A K         +       E+ +++ A    P ++ L      +
Sbjct: 43  AVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSC-PRVINLHEVY-EN 100

Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
                L+ EYA  G +              +      ++ +  +R+   +   + Y+H  
Sbjct: 101 TSEIILILEYAAGGEIFSLC----------LPELAEMVSENDVIRLIKQILEGVYYLHQ- 149

Query: 503 MNPSYVHRNIKSRNIFL---DEEFNARVGNFGMARCVNDDTE------SPQF-------- 545
            N   VH ++K +NI L       + ++ +FGM+R +    E      +P++        
Sbjct: 150 NN--IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNY 207

Query: 546 --YSTNPASWSMGIDIFAYGIVLLEVLSGQTP 575
              +T    W++GI I AY  +L   L+  +P
Sbjct: 208 DPITTATDMWNIGI-I-AY--ML---LTHTSP 232

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 53.1 bits (128), Expect = 1e-07
 Identities = 44/237 (18%), Positives = 91/237 (38%), Gaps = 59/237 (24%)

Query: 392 GAVYHG--RLNGKNLAIK-----------RTEHEVITKL--EMQLVQHATHHHPNIVRLL 436
           G V     R   K +AIK             E +    +  E+++++    +HP I+++ 
Sbjct: 24  GEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKL--NHPCIIKIK 81

Query: 437 GTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQF---IASCYCFLTWSQRLRICLDVA 493
                D    ++V E  + G L D     +    +                       + 
Sbjct: 82  NFF--DAEDYYIVLELMEGGELFDK----VVGNKRLKEATCK-----------LYFYQML 124

Query: 494 MALQYMHHVMNPSYVHRNIKSRNIFL---DEEFNARVGNFGMARCVNDDTE------SPQ 544
           +A+QY+H       +HR++K  N+ L   +E+   ++ +FG ++ + + +       +P 
Sbjct: 125 LAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPT 181

Query: 545 ------FYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDEGSVWLSEKIKS 595
                   S   A ++  +D ++ G++L   LSG  P +  R +      L ++I S
Sbjct: 182 YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVS----LKDQITS 234

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 42/202 (20%), Positives = 74/202 (36%), Gaps = 35/202 (17%)

Query: 392 GAVYHG--RLNGKNLAIK-----RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGP 444
           G V+       G  LA K       + +   K E+ ++      H N+++L         
Sbjct: 103 GQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQL--DHANLIQLYDA-FESKN 159

Query: 445 HSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMN 504
              LV EY   G L D            I      LT    +     +   +++MH  M 
Sbjct: 160 DIVLVMEYVDGGELFDR-----------IIDESYNLTELDTILFMKQICEGIRHMHQ-MY 207

Query: 505 PSYVHRNIKSRNIFLDEEFNARV--GNFGMARCVNDDTE------SPQFYS---TNPASW 553
              +H ++K  NI        ++   +FG+AR      +      +P+F +    N    
Sbjct: 208 --ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFV 265

Query: 554 SMGIDIFAYGIVLLEVLSGQTP 575
           S   D+++ G++   +LSG +P
Sbjct: 266 SFPTDMWSVGVIAYMLLSGLSP 287

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score = 52.8 bits (127), Expect = 1e-07
 Identities = 37/200 (18%), Positives = 80/200 (40%), Gaps = 45/200 (22%)

Query: 398 RLNGKNLAIKRT----EHEVITKL---EMQLVQHATHHHPNIVRLL-----GTCLTDGPH 445
            +  +N+AIK+     +++   K    E+ L++    +H NI+ LL        L +   
Sbjct: 47  AILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV--NHKNIIGLLNVFTPQKSLEEFQD 104

Query: 446 SFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH--HVM 503
            ++V E   + +L   +   L  +         +L + Q L         ++++H   + 
Sbjct: 105 VYIVMELM-DANLCQVIQMELDHER------MSYLLY-QMLC-------GIKHLHSAGI- 148

Query: 504 NPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN----P---ASW--S 554
               +HR++K  NI +  +   ++ +FG+AR          +  T     P         
Sbjct: 149 ----IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 204

Query: 555 MGIDIFAYGIVLLEVLSGQT 574
             +DI++ G ++ E++ G  
Sbjct: 205 ENVDIWSVGCIMGEMIKGGV 224

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score = 52.3 bits (126), Expect = 2e-07
 Identities = 41/211 (19%), Positives = 76/211 (36%), Gaps = 46/211 (21%)

Query: 392 GAVYHG--RLNGKNLAIK------------RTEHEVITKLEMQLVQHATHHHPNIVRLLG 437
             V     +  G   A K                E I + E+ +++     H N++ L  
Sbjct: 26  AIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEI-EREVSILRQV--LHHNVITLHD 82

Query: 438 TCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQ 497
               +     L+ E    G L D+    LA K          L+  +       +   + 
Sbjct: 83  VY-ENRTDVVLILELVSGGELFDF----LAQKE--------SLSEEEATSFIKQILDGVN 129

Query: 498 YMHHVMNPSYVHRNIKSRNI-FLDEEFNA---RVGNFGMARCVNDDTE------SPQFYS 547
           Y+H        H ++K  NI  LD+       ++ +FG+A  + D  E      +P+F +
Sbjct: 130 YLHT-KK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186

Query: 548 ---TNPASWSMGIDIFAYGIVLLEVLSGQTP 575
               N     +  D+++ G++   +LSG +P
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 32/168 (19%), Positives = 65/168 (38%), Gaps = 33/168 (19%)

Query: 398 RLNGKNLAIKRT----EHEVITKL---EMQLVQHATHHHPNIVRLLGTCLTDGPHSF--- 447
           +   KN+AIK+     E  +  K    E+ ++         I+RL    + D    F   
Sbjct: 48  KNTEKNVAIKKVNRMFEDLIDCKRILREITILNRL--KSDYIIRLYDLIIPDDLLKFDEL 105

Query: 448 -LVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH--HVMN 504
            +V E A +  LK      + +  + I      + +   L           ++H   +  
Sbjct: 106 YIVLEIA-DSDLKKLFKTPIFLTEEHI----KTILY-NLLL-------GENFIHESGI-- 150

Query: 505 PSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPAS 552
              +HR++K  N  L+++ + +V +FG+AR +N + ++          
Sbjct: 151 ---IHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENE 195

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score = 52.8 bits (127), Expect = 2e-07
 Identities = 46/206 (22%), Positives = 85/206 (41%), Gaps = 42/206 (20%)

Query: 392 GAVYHG--RLNGKNLAIK-------RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTD 442
           G V     R+  +  A+K       + +       E++L++     HPNI++L      D
Sbjct: 36  GEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKL--DHPNIMKLFEIL-ED 92

Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
               ++V E    G L D            I     F +     RI   V   + YMH  
Sbjct: 93  SSSFYIVGELYTGGELFDE-----------IIKRKRF-SEHDAARIIKQVFSGITYMHK- 139

Query: 503 MNPSYVHRNIKSRNIFL---DEEFNARVGNFGMARCVNDDTE------SPQFYSTNP--- 550
            N   VHR++K  NI L   +++ + ++ +FG++ C   +T+      +  + +  P   
Sbjct: 140 HN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIA--PEVL 195

Query: 551 -ASWSMGIDIFAYGIVLLEVLSGQTP 575
             ++    D+++ G++L  +LSG  P
Sbjct: 196 RGTYDEKCDVWSAGVILYILLSGTPP 221

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score = 52.4 bits (126), Expect = 2e-07
 Identities = 36/193 (18%), Positives = 74/193 (38%), Gaps = 29/193 (15%)

Query: 398 RLNGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTC---LTDGPHSFLVFEYAK 454
           +   +  A+K  +     + E++L   A+   P+IVR++              +V E   
Sbjct: 84  KRTQEKFALKMLQDCPKARREVELHWRASQC-PHIVRIVDVYENLYAGRKCLLIVMECLD 142

Query: 455 NGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKS 514
            G L            +         T  +   I   +  A+QY+H  +N    HR++K 
Sbjct: 143 GGELFS----------RIQDRGDQAFTEREASEIMKSIGEAIQYLHS-IN--IAHRDVKP 189

Query: 515 RNI-FLDEEFNA--RVGNFGMARCVNDDTE------SPQFYS---TNPASWSMGIDIFAY 562
            N+ +  +  NA  ++ +FG A+             +P + +     P  +    D+++ 
Sbjct: 190 ENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSL 249

Query: 563 GIVLLEVLSGQTP 575
           G+++  +L G  P
Sbjct: 250 GVIMYILLCGYPP 262

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 51.6 bits (124), Expect = 4e-07
 Identities = 44/205 (21%), Positives = 87/205 (42%), Gaps = 55/205 (26%)

Query: 398 RLNGKNLAIKRT----EHEVITKL---EMQLVQHATHHHPNIVRLLGTCLTDGPHS---- 446
              G  +AIK+     + E+  K    E++L++H    H N++ LL     D        
Sbjct: 47  GRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM--RHENVIGLLDVFTPDETLDDFTD 104

Query: 447 -FLVFEYAKNGSLKDWLHGGLAMKNQFIAS-CYCFLTWSQRLRICLDVAMALQYMHHVMN 504
            +LV  +       D L     MK++ +      FL + Q L+        L+Y+H    
Sbjct: 105 FYLVMPFMG----TD-LGK--LMKHEKLGEDRIQFLVY-QMLK-------GLRYIH---A 146

Query: 505 PSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-TE--------------SPQFYSTN 549
              +HR++K  N+ ++E+   ++ +FG+AR  + + T               +   Y+  
Sbjct: 147 AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWMRYTQ- 205

Query: 550 PASWSMGIDIFAYGIVLLEVLSGQT 574
                  +DI++ G ++ E+++G+T
Sbjct: 206 ------TVDIWSVGCIMAEMITGKT 224

>2djp_A Hypothetical protein SB145; LYSM, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens} Length = 77

 Score = 46.7 bits (111), Expect = 4e-07
 Identities = 18/67 (26%), Positives = 29/67 (43%), Gaps = 4/67 (5%)

Query: 181 SSSENLPETRILVSYPVGEGDTVSGLAAKFNTTPAAIIAANNKSLEGFKPEDLLAFTSIL 240
            SS   P     + + +  GDT++GLA K+  T   I  AN         + +    ++ 
Sbjct: 4   GSSGCSPVRERRLEHQLEPGDTLAGLALKYGVTMEQIKRANRLY----TNDSIFLKKTLY 59

Query: 241 IPLNGEP 247
           IP+  EP
Sbjct: 60  IPILTEP 66

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 51.1 bits (123), Expect = 5e-07
 Identities = 44/212 (20%), Positives = 84/212 (39%), Gaps = 56/212 (26%)

Query: 398 RLNGKNLAIKRT--EHEVITKL---EMQLVQHATHHHPNIVRLL---------GTCLTDG 443
               K +AIK+         K    E+++++     H NIV++           T     
Sbjct: 33  NDCDKRVAIKKIVLTDPQSVKHALREIKIIRRL--DHDNIVKVFEILGPSGSQLTDDVGS 90

Query: 444 PHSF----LVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYM 499
                   +V EY +     D L   +  +   +        + Q LR        L+Y+
Sbjct: 91  LTELNSVYIVQEYME----TD-LAN-VLEQGPLLEEHARLFMY-QLLR-------GLKYI 136

Query: 500 H--HVMNPSYVHRNIKSRNIFLDEEF-NARVGNFGMARCVNDDTESPQF---Y-ST---- 548
           H  +V     +HR++K  N+F++ E    ++G+FG+AR ++              T    
Sbjct: 137 HSANV-----LHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYR 191

Query: 549 ------NPASWSMGIDIFAYGIVLLEVLSGQT 574
                 +P +++  ID++A G +  E+L+G+T
Sbjct: 192 SPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKT 223

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score = 51.2 bits (123), Expect = 5e-07
 Identities = 36/192 (18%), Positives = 74/192 (38%), Gaps = 28/192 (14%)

Query: 398 RLNGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHS---FLVFEYAK 454
           R  G+  A+K        + E+     A+   P+IV +L              ++ E  +
Sbjct: 51  RRTGQKCALKLLYDSPKARQEVDHHWQASGG-PHIVCILDVYENMHHGKRCLLIIMECME 109

Query: 455 NGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKS 514
            G L            +         T  +   I  D+  A+Q++H   N    HR++K 
Sbjct: 110 GGELFS----------RIQERGDQAFTEREAAEIMRDIGTAIQFLHS-HN--IAHRDVKP 156

Query: 515 RNI-FLDEEFNA--RVGNFGMARCVNDDTE-----SPQFYS---TNPASWSMGIDIFAYG 563
            N+ +  +E +A  ++ +FG A+    +       +P + +     P  +    D+++ G
Sbjct: 157 ENLLYTSKEKDAVLKLTDFGFAKETTQNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLG 216

Query: 564 IVLLEVLSGQTP 575
           +++  +L G  P
Sbjct: 217 VIMYILLCGFPP 228

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 51.3 bits (123), Expect = 5e-07
 Identities = 36/217 (16%), Positives = 74/217 (34%), Gaps = 38/217 (17%)

Query: 406 IKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGG 465
           +K+ +      +E +++     H   IV L     T      LV      G ++  ++  
Sbjct: 223 LKKRKGYQGAMVEKKILAKV--HSRFIVSLAYAFETKT-DLCLVMTIMNGGDIRYHIYNV 279

Query: 466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNA 525
                 F      F T          +   L+++H     + ++R++K  N+ LD++ N 
Sbjct: 280 DEDNPGFQEPRAIFYT--------AQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNV 328

Query: 526 RVGNFGMA-RCVNDDTESPQFYST---------NPASWSMGIDIFAYGIVLLEVLSGQTP 575
           R+ + G+A       T++  +  T             +   +D FA G+ L E+++ + P
Sbjct: 329 RISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGP 388

Query: 576 ---INRPRKKDEG-----------SVWLSEKIKSILQ 598
                   +  E                S   K   +
Sbjct: 389 FRARGEKVENKELKQRVLEQAVTYPDKFSPASKDFCE 425

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 51.0 bits (122), Expect = 6e-07
 Identities = 37/200 (18%), Positives = 81/200 (40%), Gaps = 45/200 (22%)

Query: 398 RLNGKNLAIKRT----EHEVITKL---EMQLVQHATHHHPNIVRLL-----GTCLTDGPH 445
            +  +N+AIK+     +++   K    E+ L++    +H NI+ LL        L +   
Sbjct: 84  AVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV--NHKNIISLLNVFTPQKTLEEFQD 141

Query: 446 SFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH--HVM 503
            +LV E   + +L   +   L  +         +L + Q L         ++++H   + 
Sbjct: 142 VYLVMELM-DANLCQVIQMELDHER------MSYLLY-QMLC-------GIKHLHSAGI- 185

Query: 504 NPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTN----P-----ASWS 554
               +HR++K  NI +  +   ++ +FG+AR          +  T     P       + 
Sbjct: 186 ----IHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYK 241

Query: 555 MGIDIFAYGIVLLEVLSGQT 574
             +DI++ G ++ E++  + 
Sbjct: 242 ENVDIWSVGCIMGEMVRHKI 261

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score = 50.3 bits (121), Expect = 7e-07
 Identities = 33/160 (20%), Positives = 61/160 (38%), Gaps = 34/160 (21%)

Query: 392 GAVYHG--RLNGKNLAIK-----RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGP 444
             V+    RL GK  A+K         +   + E+ +++     H NIV L     +   
Sbjct: 23  SEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKI--KHENIVTLEDIYESTT- 79

Query: 445 HSFLVFEYAKNGSLKDWLHGGLAMKNQF---IASCYCFLTWSQRLRICLDVAMALQYMHH 501
           H +LV +    G L D     +  +  +    AS            +   V  A++Y+H 
Sbjct: 80  HYYLVMQLVSGGELFDR----ILERGVYTEKDAS-----------LVIQQVLSAVKYLHE 124

Query: 502 VMNPSYVHRNIKSRNIFL---DEEFNARVGNFGMARCVND 538
                 VHR++K  N+     +E     + +FG+++   +
Sbjct: 125 -NG--IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN 161

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score = 50.3 bits (121), Expect = 7e-07
 Identities = 37/161 (22%), Positives = 67/161 (41%), Gaps = 30/161 (18%)

Query: 392 GAVYHG--RLNGKNLAIK-------RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTD 442
           G V     R+  +  A+K       + +       E++L++   H  PNI++L      D
Sbjct: 36  GEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH--PNIMKLFEIL-ED 92

Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
               ++V E    G L D     +  + +F        +     RI   V   + YMH  
Sbjct: 93  SSSFYIVGELYTGGELFDE----IIKRKRF--------SEHDAARIIKQVFSGITYMHK- 139

Query: 503 MNPSYVHRNIKSRNIFL---DEEFNARVGNFGMARCVNDDT 540
            N   VHR++K  NI L   +++ + ++ +FG++ C   +T
Sbjct: 140 HN--IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT 178

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score = 50.4 bits (121), Expect = 9e-07
 Identities = 43/211 (20%), Positives = 77/211 (36%), Gaps = 46/211 (21%)

Query: 392 GAVYHG--RLNGKNLAIK------------RTEHEVITKLEMQLVQHATHHHPNIVRLLG 437
             V     +  G   A K                E I + E+ +++     HPNI+ L  
Sbjct: 26  AIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEI-EREVSILRQV--LHPNIITLHD 82

Query: 438 TCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQ 497
               +     L+ E    G L D+    LA K          L+  +       +   + 
Sbjct: 83  VY-ENRTDVVLILELVSGGELFDF----LAQKE--------SLSEEEATSFIKQILDGVN 129

Query: 498 YMHHVMNPSYVHRNIKSRNI-FLDEEFNA---RVGNFGMARCVNDDTE------SPQFYS 547
           Y+H        H ++K  NI  LD+       ++ +FG+A  + D  E      +P+F +
Sbjct: 130 YLHT-KK--IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVA 186

Query: 548 ---TNPASWSMGIDIFAYGIVLLEVLSGQTP 575
               N     +  D+++ G++   +LSG +P
Sbjct: 187 PEIVNYEPLGLEADMWSIGVITYILLSGASP 217

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 50.0 bits (120), Expect = 1e-06
 Identities = 35/193 (18%), Positives = 87/193 (45%), Gaps = 37/193 (19%)

Query: 400 NGKNLAIKRTEHEVITKLEMQLVQH--------ATHHHPNIVRLLGTCLTDGPHSFLVFE 451
           +G + A+K  + + +  ++++ ++H           + P +V+L  +   +  + ++V E
Sbjct: 65  SGNHYAMKILDKQKV--VKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNS-NLYMVME 121

Query: 452 YAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRN 511
           Y   G +  + H  L    +F      F   +Q       + +  +Y+H +     ++R+
Sbjct: 122 YVAGGEM--FSH--LRRIGRFSEPHARFYA-AQ-------IVLTFEYLHSL---DLIYRD 166

Query: 512 IKSRNIFLDEEFNARVGNFGMARCVNDDTES---------PQFYSTNPASWSMGIDIFAY 562
           +K  N+ +D++   +V +FG A+ V   T +         P+   +    ++  +D +A 
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKG--YNKAVDWWAL 224

Query: 563 GIVLLEVLSGQTP 575
           G+++ E+ +G  P
Sbjct: 225 GVLIYEMAAGYPP 237

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score = 50.0 bits (120), Expect = 1e-06
 Identities = 36/166 (21%), Positives = 63/166 (37%), Gaps = 38/166 (22%)

Query: 392 GAVYHG--RLNGKNLAIK--------RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLT 441
             V      L G+  A            +H+ + + E ++ +     HPNIVRL  +   
Sbjct: 25  SVVRRCVKVLAGQEYAAMIINTKKLSARDHQKL-EREARICRLL--KHPNIVRLHDSISE 81

Query: 442 DGPHSFLVFEYAKNGSLKDWLHGGLAMKNQF---IASCYCFLTWSQRLRICLDVAMALQY 498
           +G H +L+F+    G L +     +  +  +    AS                +  A+ +
Sbjct: 82  EG-HHYLIFDLVTGGELFED----IVAREYYSEADAS-----------HCIQQILEAVLH 125

Query: 499 MHHVMNPSYVHRNIKSRNI-FLDEEFNARV--GNFGMARCVNDDTE 541
            H  M    VHRN+K  N+    +   A V   +FG+A  V  + +
Sbjct: 126 CHQ-MG--VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ 168

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 49.6 bits (119), Expect = 1e-06
 Identities = 42/181 (23%), Positives = 79/181 (43%), Gaps = 33/181 (18%)

Query: 407 KRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGL 466
               +      E+Q++Q     HP +V L  +   +    F+V +    G L+  L    
Sbjct: 57  NEVRN---VFKELQIMQGL--EHPFLVNLWYSFQDEE-DMFMVVDLLLGGDLRYHLQ--- 107

Query: 467 AMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNAR 526
             +N        F   + +L IC ++ MAL Y+    N   +HR++K  NI LDE  +  
Sbjct: 108 --QNV------HFKEETVKLFIC-ELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVH 155

Query: 527 VGNFGMARCVNDDTES-----------PQFYSTNPAS-WSMGIDIFAYGIVLLEVLSGQT 574
           + +F +A  +  +T+            P+ +S+   + +S  +D ++ G+   E+L G+ 
Sbjct: 156 ITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

Query: 575 P 575
           P
Sbjct: 216 P 216

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 49.7 bits (119), Expect = 2e-06
 Identities = 32/182 (17%), Positives = 68/182 (37%), Gaps = 52/182 (28%)

Query: 398 RLNGKNLAIKRT----EHEVITKL---EMQLVQHATHHHPNIVRLLGTCLTDGPHSF--- 447
           R  G+ +A+K+     ++    +    E+ ++      H NIV LL         +    
Sbjct: 31  RRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTE-LSGHENIVNLLNVLR---ADNDRDV 86

Query: 448 -LVFEYA--------KNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQY 498
            LVF+Y         +   L+  +H               ++ + Q ++        ++Y
Sbjct: 87  YLVFDYMETDLHAVIRANILEP-VH-------------KQYVVY-QLIK-------VIKY 124

Query: 499 MH--HVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASWSMG 556
           +H   +     +HR++K  NI L+ E + +V +FG++R   +          +    +  
Sbjct: 125 LHSGGL-----LHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179

Query: 557 ID 558
            D
Sbjct: 180 FD 181

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score = 49.2 bits (118), Expect = 2e-06
 Identities = 32/160 (20%), Positives = 61/160 (38%), Gaps = 27/160 (16%)

Query: 392 GAVYHG--RLNGKNLAIK-------RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTD 442
           G V+    R +G    IK       +   E I + E+++++     HPNI+++      D
Sbjct: 36  GDVHLVEERSSGLERVIKTINKDRSQVPMEQI-EAEIEVLKSL--DHPNIIKIFEVF-ED 91

Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
             + ++V E  + G L + +    A             +      +   +  AL Y H  
Sbjct: 92  YHNMYIVMETCEGGELLERIVSAQARGKAL--------SEGYVAELMKQMMNALAYFHS- 142

Query: 503 MNPSYVHRNIKSRNIFL---DEEFNARVGNFGMARCVNDD 539
            +   VH+++K  NI           ++ +FG+A     D
Sbjct: 143 QH--VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD 180

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score = 49.2 bits (118), Expect = 2e-06
 Identities = 38/211 (18%), Positives = 78/211 (36%), Gaps = 53/211 (25%)

Query: 398 RLNGKNLAIK-----RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEY 452
            +  +  A+K               E++++     H  N++ L+     +    +LVFE 
Sbjct: 35  LITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGH-RNVLELIEFF-EEEDRFYLVFEK 92

Query: 453 AKNGSLKDWLHGGLAMKNQF---IASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVH 509
            + GS+   +H     +  F    AS            +  DVA AL ++H   N    H
Sbjct: 93  MRGGSILSHIH----KRRHFNELEAS-----------VVVQDVASALDFLH---NKGIAH 134

Query: 510 RNIKSRNI-FLDEEFNA--RVGNFGMARCVNDDTE--------------SPQF------- 545
           R++K  NI        +  ++ +F +   +  + +              S ++       
Sbjct: 135 RDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVE 194

Query: 546 -YSTNPASWSMGIDIFAYGIVLLEVLSGQTP 575
            +S   + +    D+++ G++L  +LSG  P
Sbjct: 195 AFSEEASIYDKRCDLWSLGVILYILLSGYPP 225

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score = 48.9 bits (117), Expect = 2e-06
 Identities = 37/189 (19%), Positives = 70/189 (37%), Gaps = 44/189 (23%)

Query: 406 IKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGG 465
           +K+T  + I + E+ ++      HPNI++L     T      LV E    G L D     
Sbjct: 86  LKKTVDKKIVRTEIGVLLRL--SHPNIIKLKEIFETPT-EISLVLELVTGGELFDR---- 138

Query: 466 LAMKNQF---IASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNI-FLDE 521
           +  K  +    A+                +  A+ Y+H       VHR++K  N+ +   
Sbjct: 139 IVEKGYYSERDAA-----------DAVKQILEAVAYLHE-NG--IVHRDLKPENLLYATP 184

Query: 522 EFNARV--GNFGMARCVNDDTESPQFYST-------------NPASWSMGIDIFAYGIVL 566
             +A +   +FG+++ V           T                ++   +D+++ GI+ 
Sbjct: 185 APDAPLKIADFGLSKIVEHQ----VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIIT 240

Query: 567 LEVLSGQTP 575
             +L G  P
Sbjct: 241 YILLCGFEP 249

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score = 48.4 bits (116), Expect = 3e-06
 Identities = 39/211 (18%), Positives = 75/211 (35%), Gaps = 46/211 (21%)

Query: 392 GAVYHG--RLNGKNLAIK------------RTEHEVITKLEMQLVQHATHHHPNIVRLLG 437
             V     +  G   A K                E I + E+ +++     HPN++ L  
Sbjct: 25  AVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDI-EREVSILKEI--QHPNVITLHE 81

Query: 438 TCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQ 497
               +     L+ E    G L D           F+A      T  +       +   + 
Sbjct: 82  VY-ENKTDVILILELVAGGELFD-----------FLAEKESL-TEEEATEFLKQILNGVY 128

Query: 498 YMHHVMNPSYVHRNIKSRNIFL----DEEFNARVGNFGMARCVNDDTE------SPQFYS 547
           Y+H  +     H ++K  NI L      +   ++ +FG+A  ++   E      +P+F +
Sbjct: 129 YLHS-LQ--IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVA 185

Query: 548 ---TNPASWSMGIDIFAYGIVLLEVLSGQTP 575
               N     +  D+++ G++   +LSG +P
Sbjct: 186 PEIVNYEPLGLEADMWSIGVITYILLSGASP 216

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 48.5 bits (116), Expect = 3e-06
 Identities = 44/205 (21%), Positives = 88/205 (42%), Gaps = 55/205 (26%)

Query: 398 RLNGKNLAIKRT----EHEVITKL---EMQLVQHATHHHPNIVRLL-----GTCLTDGPH 445
              G  +A+K+     +  +  K    E++L++H    H N++ LL        L +   
Sbjct: 51  TKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM--KHENVIGLLDVFTPARSLEEFND 108

Query: 446 SFLVFEYAKNGSLKDWLHGGLAMKNQFIAS------CYCFLTWSQRLRICLDVAMALQYM 499
            +LV          D L+         +           FL + Q LR        L+Y+
Sbjct: 109 VYLVTHLMG----AD-LN-------NIVKCQKLTDDHVQFLIY-QILR-------GLKYI 148

Query: 500 H--HVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-TE--SPQFYS-----TN 549
           H   +     +HR++K  N+ ++E+   ++ +FG+AR   D+ T   + ++Y       N
Sbjct: 149 HSADI-----IHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYRAPEIMLN 203

Query: 550 PASWSMGIDIFAYGIVLLEVLSGQT 574
              ++  +DI++ G ++ E+L+G+T
Sbjct: 204 WMHYNQTVDIWSVGCIMAELLTGRT 228

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score = 48.0 bits (115), Expect = 4e-06
 Identities = 36/158 (22%), Positives = 57/158 (36%), Gaps = 28/158 (17%)

Query: 392 GAVYHG--RLNGKNLAIK-----RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGP 444
           G V     +      A K       E     K E+++++   H  PNI+RL  T   D  
Sbjct: 23  GEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDH--PNIIRLYETF-EDNT 79

Query: 445 HSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMN 504
             +LV E    G L + +   +  +             S   RI  DV  A+ Y H  +N
Sbjct: 80  DIYLVMELCTGGELFERV---VHKRV---------FRESDAARIMKDVLSAVAYCHK-LN 126

Query: 505 PSYVHRNIKSRNIFL---DEEFNARVGNFGMARCVNDD 539
               HR++K  N        +   ++ +FG+A      
Sbjct: 127 --VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score = 47.9 bits (115), Expect = 4e-06
 Identities = 40/213 (18%), Positives = 74/213 (34%), Gaps = 50/213 (23%)

Query: 392 GAVYHG--RLNGKNLAIK------------RTEHEVITKLEMQLVQHATHHHPNIVRLLG 437
             V     +  GK  A K                E I + E+ +++     HPNI+ L  
Sbjct: 19  AIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEI-EREVNILREI--RHPNIITLHD 75

Query: 438 TCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQR--LRICLDVAMA 495
               +     L+ E    G L D           F+A        ++    +    +   
Sbjct: 76  IF-ENKTDVVLILELVSGGELFD-----------FLAEKESL---TEDEATQFLKQILDG 120

Query: 496 LQYMHHVMNPSYVHRNIKSRNIFL----DEEFNARVGNFGMARCVNDDTE------SPQF 545
           + Y+H        H ++K  NI L          ++ +FG+A  +    E      +P+F
Sbjct: 121 VHYLHS-KR--IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEF 177

Query: 546 YS---TNPASWSMGIDIFAYGIVLLEVLSGQTP 575
            +    N     +  D+++ G++   +LSG +P
Sbjct: 178 VAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score = 47.8 bits (114), Expect = 7e-06
 Identities = 42/219 (19%), Positives = 81/219 (36%), Gaps = 57/219 (26%)

Query: 392 GAVYHG--RLNGKNLAIK------------------RTEHEVITKLEMQLVQHATHHHPN 431
           G V     +      AIK                    +       E+ L++     HPN
Sbjct: 50  GEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL--DHPN 107

Query: 432 IVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQR--LRIC 489
           I++L      D  + +LV E+ + G L +            I + + F    +     I 
Sbjct: 108 IIKLFDVF-EDKKYFYLVTEFYEGGELFEQ-----------IINRHKF---DECDAANIM 152

Query: 490 LDVAMALQYMHHVMNPSYVHRNIKSRNIFL---DEEFNARVGNFGMARCVNDDTE----- 541
             +   + Y+H   N   VHR+IK  NI L   +   N ++ +FG++   + D +     
Sbjct: 153 KQILSGICYLHK-HN--IVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRL 209

Query: 542 -SPQFYSTNP----ASWSMGIDIFAYGIVLLEVLSGQTP 575
            +  + +  P      ++   D+++ G+++  +L G  P
Sbjct: 210 GTAYYIA--PEVLKKKYNEKCDVWSCGVIMYILLCGYPP 246

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score = 47.3 bits (113), Expect = 7e-06
 Identities = 41/206 (19%), Positives = 73/206 (35%), Gaps = 35/206 (16%)

Query: 350 SQSTIEGQIIDTAEQHKRLLESYSIEDL---------RRATEKFNSSNRIEGAVYHGRLN 400
             S   G I+D A+      + Y + ++         RR   +       + AV    ++
Sbjct: 4   GISGGGGGILDMADDDVLFEDVYELCEVIGKGPFSVVRRCINR---ETGQQFAV--KIVD 58

Query: 401 GKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD 460
                          K E  +       HP+IV LL T  +DG   ++VFE+     L  
Sbjct: 59  VAKFTSSPGLSTEDLKREASICHML--KHPHIVELLETYSSDG-MLYMVFEFMDGADLCF 115

Query: 461 WLHGGLAMKNQFIASCYCFLTWSQRL--RICLDVAMALQYMHHVMNPSYVHRNIKSRNIF 518
            +     +K       Y     S+ +       +  AL+Y H   N   +HR++K   + 
Sbjct: 116 EI-----VKRADAGFVY-----SEAVASHYMRQILEALRYCHD-NN--IIHRDVKPHCVL 162

Query: 519 L---DEEFNARVGNFGMARCVNDDTE 541
           L   +     ++G FG+A  + +   
Sbjct: 163 LASKENSAPVKLGGFGVAIQLGESGL 188

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 47.4 bits (113), Expect = 9e-06
 Identities = 38/209 (18%), Positives = 71/209 (33%), Gaps = 58/209 (27%)

Query: 398 RLNGKNLAIKRTEHEVITKLEMQLVQH--------ATHHHPNIVRLLGTCLTDGPHSFLV 449
           +   K  A+K      +  ++              A  + P +V+L      D  + ++V
Sbjct: 91  KSTRKVYAMKLLSKFEM--IKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDR-YLYMV 147

Query: 450 FEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVA--------MALQYMHH 501
            EY   G L                     +       +    A        +AL  +H 
Sbjct: 148 MEYMPGGDL---------------------VNLMSNYDVPEKWARFYTAEVVLALDAIHS 186

Query: 502 VMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE-------------SPQFYST 548
            M   ++HR++K  N+ LD+  + ++ +FG    +N +               SP+   +
Sbjct: 187 -MG--FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKS 243

Query: 549 NPASWSMG--IDIFAYGIVLLEVLSGQTP 575
                  G   D ++ G+ L E+L G TP
Sbjct: 244 QGGDGYYGRECDWWSVGVFLYEMLVGDTP 272

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score = 46.9 bits (112), Expect = 1e-05
 Identities = 36/164 (21%), Positives = 60/164 (36%), Gaps = 38/164 (23%)

Query: 392 GAVYHG--RLNGKNLAIK--------RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLT 441
             V     +  G   A K          + + + + E ++ +   H  PNIVRL  +   
Sbjct: 43  SVVRRCVHKTTGLEFAAKIINTKKLSARDFQKL-EREARICRKLQH--PNIVRLHDSIQE 99

Query: 442 DGPHSFLVFEYAKNGSLKDWLHGGLAMKNQF---IASCYCFLTWSQRLRICLDVAMALQY 498
           +  H +LVF+    G L +     +  +  +    AS                +  ++ Y
Sbjct: 100 ESFH-YLVFDLVTGGELFED----IVAREFYSEADAS-----------HCIQQILESIAY 143

Query: 499 MHHVMNPSYVHRNIKSRNI-FLDEEFNARV--GNFGMARCVNDD 539
            H       VHRN+K  N+    +   A V   +FG+A  VND 
Sbjct: 144 CHS-NG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score = 45.6 bits (109), Expect = 2e-05
 Identities = 35/163 (21%), Positives = 56/163 (34%), Gaps = 36/163 (22%)

Query: 392 GAVYHG--RLNGKNLAIK-------RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTD 442
             V     +  G   A K               + E ++ +     HPNIVRL  +   +
Sbjct: 20  SVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL--QHPNIVRLHDSIQEE 77

Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQF---IASCYCFLTWSQRLRICLDVAMALQYM 499
               +LVF+    G L +     +  +  +    AS                +  ++ Y 
Sbjct: 78  S-FHYLVFDLVTGGELFED----IVAREFYSEADAS-----------HCIQQILESIAYC 121

Query: 500 HHVMNPSYVHRNIKSRNI-FLDEEFNARV--GNFGMARCVNDD 539
           H       VHRN+K  N+    +   A V   +FG+A  VND 
Sbjct: 122 HS-NG--IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 45.5 bits (108), Expect = 4e-05
 Identities = 39/179 (21%), Positives = 73/179 (40%), Gaps = 30/179 (16%)

Query: 407 KRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGL 466
               H   T  E +++Q++   HP +  L  +  T       V EYA  G L  + H   
Sbjct: 190 DEVAH---TLTENRVLQNS--RHPFLTALKYSFQTHD-RLCFVMEYANGGEL--FFH--- 238

Query: 467 AMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNAR 526
                 ++    F     R     ++  AL Y+H   N   V+R++K  N+ LD++ + +
Sbjct: 239 ------LSRERVFSEDRARFYGA-EIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIK 289

Query: 527 VGNFGMAR-CVNDDTESPQFYST---------NPASWSMGIDIFAYGIVLLEVLSGQTP 575
           + +FG+ +  + D      F  T             +   +D +  G+V+ E++ G+ P
Sbjct: 290 ITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLP 348

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 45.5 bits (108), Expect = 4e-05
 Identities = 41/202 (20%), Positives = 70/202 (34%), Gaps = 58/202 (28%)

Query: 402 KNLAIKR--TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK 459
           K   +KR  T      + E  ++ +       I  L      D  + +LV +Y   G L 
Sbjct: 109 KWEMLKRAETAC---FREERDVLVNG--DSKWITTLHY-AFQDDNNLYLVMDYYVGGDL- 161

Query: 460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLD----------VAMALQYMHHVMNPSYVH 509
                               LT   +    L           + +A+  +H  ++  YVH
Sbjct: 162 --------------------LTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ-LH--YVH 198

Query: 510 RNIKSRNIFLDEEFNARVGNFGMARCVNDDTE-------------SP---QFYSTNPASW 553
           R+IK  NI +D   + R+ +FG    + +D               SP   Q        +
Sbjct: 199 RDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRY 258

Query: 554 SMGIDIFAYGIVLLEVLSGQTP 575
               D ++ G+ + E+L G+TP
Sbjct: 259 GPECDWWSLGVCMYEMLYGETP 280

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 44.3 bits (105), Expect = 7e-05
 Identities = 37/224 (16%), Positives = 79/224 (35%), Gaps = 47/224 (20%)

Query: 392 GAVYHGRLN--GKNLAIKRTEHEVITKL-EMQLVQHATHHHPNIVRLL---GTCLTDGPH 445
           G V        GK  A+K+   +   K  E+ +++     H NI++L+    T   + P 
Sbjct: 21  GIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVL--DHVNIIKLVDYFYTTGDEEPK 78

Query: 446 SFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFL---------TWSQRLRICLDVAM-- 494
                +       K+              S   +L         T  + L+  +      
Sbjct: 79  PPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSI 138

Query: 495 --------------ALQYMHHVMNPSYVHRNIKSRNIFLDEEFNA-RVGNFGMARCVNDD 539
                         A+ ++H +      HR+IK +N+ ++ + N  ++ +FG A+ +   
Sbjct: 139 PMNLISIYIYQLFRAVGFIHSL---GICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS 195

Query: 540 TESPQFYST----------NPASWSMGIDIFAYGIVLLEVLSGQ 573
             S  +  +              ++  ID+++ G V  E++ G+
Sbjct: 196 EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGK 239

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 43.5 bits (103), Expect = 1e-04
 Identities = 28/102 (27%), Positives = 41/102 (40%), Gaps = 21/102 (20%)

Query: 492 VAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---------- 541
           + MA+  +H  +   YVHR+IK  NI LD   + R+ +FG    +  D            
Sbjct: 171 IVMAIDSVHR-LG--YVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTP 227

Query: 542 ---SP-----QFYSTNPASWSMGIDIFAYGIVLLEVLSGQTP 575
              SP             S+    D +A G+   E+  GQTP
Sbjct: 228 DYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 43.3 bits (103), Expect = 1e-04
 Identities = 50/193 (25%), Positives = 94/193 (48%), Gaps = 37/193 (19%)

Query: 400 NGKNLAIKRTEHEVITKLEMQLVQH--------ATHHHPNIVRLLGTCLTDGPHSFLVFE 451
           NG+  A+K  + E++  + ++ V+H        +   HP I+R+ GT        F++ +
Sbjct: 30  NGRYYAMKVLKKEIV--VRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQ-QIFMIMD 86

Query: 452 YAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRN 511
           Y + G L  +    L    +F      F   ++       V +AL+Y+H       ++R+
Sbjct: 87  YIEGGEL--FSL--LRKSQRFPNPVAKFYA-AE-------VCLALEYLHSK---DIIYRD 131

Query: 512 IKSRNIFLDEEFNARVGNFGMARCVNDDTES---------PQFYSTNPASWSMGIDIFAY 562
           +K  NI LD+  + ++ +FG A+ V D T +         P+  ST P  ++  ID +++
Sbjct: 132 LKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKP--YNKSIDWWSF 189

Query: 563 GIVLLEVLSGQTP 575
           GI++ E+L+G TP
Sbjct: 190 GILIYEMLAGYTP 202

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 42.4 bits (100), Expect = 3e-04
 Identities = 38/209 (18%), Positives = 81/209 (38%), Gaps = 52/209 (24%)

Query: 400 NGKNLAIK------------RTEHEVITKL-EMQLVQHATHHHPNIVRLLGT---CLTDG 443
           N  ++A+K              E +++ ++ +    +  +    +I++LL        +G
Sbjct: 43  NNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNG 102

Query: 444 PHSFLVFE-YAKN--GSLKDWLHGGLAMKN-QFIASCYCFLTWSQRLRICLDVAMALQYM 499
            H  +VFE   +N    +K + H G+ +   + I+         Q L         L YM
Sbjct: 103 VHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISK--------QLLL-------GLDYM 147

Query: 500 HHVMNPSYVHRNIKSRNIFLDEE------FNARVGNFGMARCVNDDTES---PQFYSTNP 550
           H       +H +IK  N+ ++           ++ + G A   ++   +    + Y + P
Sbjct: 148 HR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRS-P 204

Query: 551 -----ASWSMGIDIFAYGIVLLEVLSGQT 574
                A W  G DI++   ++ E+++G  
Sbjct: 205 EVLLGAPWGCGADIWSTACLIFELITGDF 233

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 41.5 bits (97), Expect = 8e-04
 Identities = 38/184 (20%), Positives = 77/184 (41%), Gaps = 28/184 (15%)

Query: 402 KNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW 461
           K++ I+  + E  T +E +++       P + +L     T     + V EY   G L   
Sbjct: 376 KDVVIQDDDVE-CTMVEKRVLALPGKP-PFLTQLHSCFQTMD-RLYFVMEYVNGGDLMYH 432

Query: 462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE 521
           +        +F      F           ++A+ L ++    +   ++R++K  N+ LD 
Sbjct: 433 IQQ----VGRFKEPHAVFYA--------AEIAIGLFFLQ---SKGIIYRDLKLDNVMLDS 477

Query: 522 EFNARVGNFGMAR-CVNDDTESPQFYST---------NPASWSMGIDIFAYGIVLLEVLS 571
           E + ++ +FGM +  + D   +  F  T             +   +D +A+G++L E+L+
Sbjct: 478 EGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 537

Query: 572 GQTP 575
           GQ P
Sbjct: 538 GQAP 541

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	600
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4eby_A	212	Chitin elicitor receptor kinase 1; pathogen-associ	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	99.98
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	99.98
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	99.97
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	99.97
3soc_A	322	Activin receptor type-2A; structural genomics cons	99.97
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	99.97
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	99.97
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	99.97
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	99.97
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	99.97
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	99.96
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	99.96
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	99.96
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	99.96
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	99.96
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	99.96
3q4u_A	301	Activin receptor type-1; structural genomics conso	99.96
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	99.96
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	99.96
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	99.96
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	99.96
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	99.96
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	99.96
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	99.96
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	99.96
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	99.96
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	99.96
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	99.96
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	99.96
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	99.96
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	99.96
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	99.96
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	99.96
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	99.96
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	99.96
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	99.96
3niz_A	311	Rhodanese family protein; structural genomics, str	99.96
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	99.96
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	99.96
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	99.96
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	99.96
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	99.96
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	99.96
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	99.96
3ork_A	311	Serine/threonine protein kinase; structural genomi	99.96
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	99.96
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	99.96
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	99.96
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	99.96
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	99.96
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	99.96
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	99.96
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	99.96
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	99.96
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	99.96
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	99.96
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	99.96
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	99.96
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	99.96
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	99.96
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	99.96
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	99.96
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	99.96
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	99.96
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	99.96
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	99.96
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	99.96
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	99.96
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	99.96
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	99.96
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	99.96
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	99.96
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	99.96
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	99.95
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	99.95
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	99.95
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	99.95
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	99.95
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	99.95
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	99.95
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	99.95
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	99.95
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	99.95
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	99.95
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	99.95
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	99.95
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	99.95
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	99.95
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	99.95
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	99.95
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	99.95
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	99.95
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	99.95
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	99.95
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	99.95
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	99.95
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	99.95
3rp9_A	458	Mitogen-activated protein kinase; structural genom	99.95
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	99.95
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	99.95
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	99.95
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	99.95
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	99.95
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	99.95
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	99.95
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	99.95
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	99.95
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	99.95
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	99.95
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	99.95
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	99.95
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	99.95
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	99.95
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	99.95
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	99.95
3o0g_A	292	Cell division protein kinase 5; kinase activator c	99.95
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	99.95
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	99.95
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	99.95
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	99.95
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	99.95
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	99.95
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	99.95
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	99.95
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	99.95
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	99.95
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	99.95
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	99.95
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	99.95
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	99.95
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	99.95
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	99.95
3bhy_A	283	Death-associated protein kinase 3; death associate	99.95
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	99.95
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	99.95
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	99.95
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	99.95
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	99.95
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	99.95
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	99.95
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	99.95
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	99.95
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	99.95
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	99.95
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	99.95
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	99.95
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	99.95
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	99.95
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	99.95
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	99.95
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	99.95
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	99.95
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	99.95
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	99.95
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	99.95
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	99.95
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	99.95
3uqc_A	286	Probable conserved transmembrane protein; structur	99.95
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	99.95
3pls_A	298	Macrophage-stimulating protein receptor; protein k	99.95
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	99.95
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	99.95
2a19_B	284	Interferon-induced, double-stranded RNA-activated	99.95
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	99.95
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	99.95
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	99.95
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	99.95
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	99.95
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	99.95
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	99.95
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	99.95
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	99.95
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	99.95
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	99.95
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	99.95
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	99.95
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	99.95
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	99.95
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	99.95
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	99.95
3an0_A	340	Dual specificity mitogen-activated protein kinase;	99.95
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	99.95
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	99.95
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	99.95
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	99.95
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	99.95
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	99.95
3fme_A	290	Dual specificity mitogen-activated protein kinase;	99.95
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	99.95
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	99.94
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	99.94
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	99.94
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	99.94
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	99.94
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	99.94
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	99.94
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	99.94
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	99.94
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	99.94
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	99.94
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	99.94
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	99.94
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	99.94
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	99.94
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	99.94
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	99.94
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	99.94
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	99.94
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	99.94
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	99.94
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	99.94
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	99.94
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	99.94
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	99.94
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	99.94
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	99.94
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	99.94
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	99.94
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	99.93
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	99.93
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	99.93
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	99.93
3aln_A	327	Dual specificity mitogen-activated protein kinase;	99.93
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	99.93
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	99.93
2dyl_A	318	Dual specificity mitogen-activated protein kinase	99.93
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	99.93
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	99.93
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	99.93
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	99.93
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.93
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	99.92
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	99.92
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	99.9
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.89
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.8
4eby_A	212	Chitin elicitor receptor kinase 1; pathogen-associ	99.7
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.68
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.58
2l9y_A	167	CVNH-LYSM lectin; carbohydrate, sugar binding prot	99.45
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.21
2djp_A	77	Hypothetical protein SB145; LYSM, structural genom	99.06
1e0g_A	48	Membrane-bound lytic murein transglycosylase D; ce	98.98
2l9y_A	167	CVNH-LYSM lectin; carbohydrate, sugar binding prot	98.97
2gu1_A	361	Zinc peptidase; alpha/beta, beta barrel, structura	98.97
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	98.95
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.8
2gu1_A	361	Zinc peptidase; alpha/beta, beta barrel, structura	98.79
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.62
2djp_A	77	Hypothetical protein SB145; LYSM, structural genom	98.46
1e0g_A	48	Membrane-bound lytic murein transglycosylase D; ce	98.34
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.29
4a1k_A	165	Putative L, D-transpeptidase YKUD; transferase, pe	98.0
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	97.99
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	97.98
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	97.87
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.68
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.44
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.26
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.21
4a1k_A	165	Putative L, D-transpeptidase YKUD; transferase, pe	96.85
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	96.7
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	96.32
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	96.29
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	95.84
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	95.34
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	95.32
3slu_A	371	M23 peptidase domain protein; outer membrane, hydr	94.45
2k1k_A	38	Ephrin type-A receptor 1; EPHA1, receptor tyrosine	94.42
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	93.89
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	93.39
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	93.34
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	93.33
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	92.8
3slu_A	371	M23 peptidase domain protein; outer membrane, hydr	92.76
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	92.45
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	92.21
2jwa_A	44	Receptor tyrosine-protein kinase ERBB-2; transmemb	91.8
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	89.35
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	88.61
2ks1_B	44	Epidermal growth factor receptor; ERBB1, ERBB2, tr	87.09
2l2t_A	44	Receptor tyrosine-protein kinase ERBB-4; transmemb	85.31

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.2e-38  Score=326.64  Aligned_cols=176  Identities=26%  Similarity=0.460  Sum_probs=147.1

Q ss_pred             CCceeEEEEEEEECCeEEEEEEcch-----hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          387 SNRIEGAVYHGRLNGKNLAIKRTEH-----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       387 ~~~~~G~Vy~g~~~g~~vAvK~~~~-----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      +.|.+|.||+|++.+ .||||.++.     +..+.+.+|+..+.+++|||||+++|+|. + +.++||||||++|+|.++
T Consensus        45 G~G~fG~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~-~-~~~~iVmEy~~gGsL~~~  121 (307)
T 3omv_A           45 GSGSFGTVYKGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRKTRHVNILLFMGYMT-K-DNLAIVTQWCEGSSLYKH  121 (307)
T ss_dssp             CCCSSSEEEEEESSS-EEEEEECCCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEC-S-SSCEEEEECCSSCBHHHH
T ss_pred             eeCCCcEEEEEEECC-cEEEEEEEecCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEE-C-CeEEEEEEcCCCCCHHHH
Confidence            333449999999866 489998753     33457889999999999999999999974 3 368999999999999999


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC----
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN----  537 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~----  537 (600)
                      |+...           ..++|.++++|+.|||.||+|||   +.+|+||||||+||||++++.+||+|||+|+...    
T Consensus       122 l~~~~-----------~~l~~~~~~~i~~qia~gL~yLH---~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~  187 (307)
T 3omv_A          122 LHVQE-----------TKFQMFQLIDIARQTAQGMDYLH---AKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG  187 (307)
T ss_dssp             HHTSC-----------CCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCSSSEEEETTEEEEECCCSSCBC------
T ss_pred             HhhcC-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCccCHHHEEECCCCcEEEeeccCceecccCCc
Confidence            97643           34999999999999999999999   5699999999999999999999999999997542    


Q ss_pred             ----------CCCCCCcccccC-CCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          538 ----------DDTESPQFYSTN-PASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       538 ----------~~~~~pe~~~~~-~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                ..+.+||.+... ...++.++|||||||+||||+||+.||...
T Consensus       188 ~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~  240 (307)
T 3omv_A          188 SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHI  240 (307)
T ss_dssp             ------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCC
Confidence                      223467766432 345788999999999999999999999754

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=9e-39  Score=327.15  Aligned_cols=185  Identities=24%  Similarity=0.409  Sum_probs=149.3

Q ss_pred             ceeEEEEEEEE-------CCeEEEEEEcch---hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCH
Q 041830          389 RIEGAVYHGRL-------NGKNLAIKRTEH---EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSL  458 (600)
Q Consensus       389 ~~~G~Vy~g~~-------~g~~vAvK~~~~---~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL  458 (600)
                      |.+|.||+|++       +|..||||+++.   +..+++.+|+..+.+++|||||+++|+|.++ +..|||||||++|+|
T Consensus        24 G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~-~~~~lV~Ey~~~G~L  102 (299)
T 4asz_A           24 GAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEG-DPLIMVFEYMKHGDL  102 (299)
T ss_dssp             --CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-SSEEEEEECCTTCBH
T ss_pred             CCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeC-CEEEEEEEcCCCCcH
Confidence            33499999987       367899999864   2345788999999999999999999998765 489999999999999


Q ss_pred             HHHHhcCcCcccc-cccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC
Q 041830          459 KDWLHGGLAMKNQ-FIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN  537 (600)
Q Consensus       459 ~~~L~~~~~~~~~-~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~  537 (600)
                      .++|+........ ........|+|.++++|+.||++||+|||   +++|+||||||+||||++++.+||+|||+|+...
T Consensus       103 ~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~  179 (299)
T 4asz_A          103 NKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVY  179 (299)
T ss_dssp             HHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHT
T ss_pred             HHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccCHhhEEECCCCcEEECCcccceecC
Confidence            9999864310000 00011245999999999999999999999   5699999999999999999999999999997542


Q ss_pred             C--------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          538 D--------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       538 ~--------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                      .              .+.+||....  ..++.++|||||||+||||+| |+.||...
T Consensus       180 ~~~~~~~~~~~~gt~~ymAPE~~~~--~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~  234 (299)
T 4asz_A          180 STDYYRVGGHTMLPIRWMPPESIMY--RKFTTESDVWSLGVVLWEIFTYGKQPWYQL  234 (299)
T ss_dssp             GGGCEEETTTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             CCCceeecCceecChhhcCHHHHcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCC
Confidence            1              2346676655  458899999999999999999 89999764

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.5e-38  Score=326.80  Aligned_cols=183  Identities=25%  Similarity=0.444  Sum_probs=148.6

Q ss_pred             eEEEEEEEE-------CCeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHH
Q 041830          391 EGAVYHGRL-------NGKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       391 ~G~Vy~g~~-------~g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~  459 (600)
                      +|.||+|++       +++.||||+++..    ..++|.+|+..+.+++|||||+++|+|.++ +.++||||||++|+|.
T Consensus        39 fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~-~~~~lV~Ey~~~G~L~  117 (308)
T 4gt4_A           39 FGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKD-QPLSMIFSYCSHGDLH  117 (308)
T ss_dssp             SCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSCEEEEECCSSCBHH
T ss_pred             CcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCCCCCCCCcceEEEEC-CEEEEEEEcCCCCcHH
Confidence            499999997       3578999998643    235788999999999999999999998765 4789999999999999


Q ss_pred             HHHhcCcCcccc----cccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccc
Q 041830          460 DWLHGGLAMKNQ----FIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARC  535 (600)
Q Consensus       460 ~~L~~~~~~~~~----~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~  535 (600)
                      ++|+........    ........|+|.++++|+.|||+||+|||   +.+|+||||||+||||++++.+||+|||+++.
T Consensus       118 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~  194 (308)
T 4gt4_A          118 EFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLS---SHHVVHKDLATRNVLVYDKLNVKISDLGLFRE  194 (308)
T ss_dssp             HHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCSCCBCG
T ss_pred             HHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCccccceEECCCCCEEECCccccee
Confidence            999764321100    00111245999999999999999999999   56899999999999999999999999999985


Q ss_pred             cCC--------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          536 VND--------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       536 ~~~--------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                      ...              .+.+||....  ..++.++|||||||+||||+| |+.||...
T Consensus       195 ~~~~~~~~~~~~~~gt~~ymAPE~l~~--~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~  251 (308)
T 4gt4_A          195 VYAADYYKLLGNSLLPIRWMAPEAIMY--GKFSIDSDIWSYGVVLWEVFSYGLQPYCGY  251 (308)
T ss_dssp             GGGGGCBCSSSSSCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTC
T ss_pred             ccCCCceeEecccccCCcccCHHHHhC--CCCCccchhhhHHHHHHHHHhCCCCCCCCC
Confidence            421              1345666554  457899999999999999999 89999754

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=5.2e-38  Score=325.83  Aligned_cols=184  Identities=22%  Similarity=0.400  Sum_probs=145.0

Q ss_pred             eeEEEEEEEE-------CCeEEEEEEcch---hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHH
Q 041830          390 IEGAVYHGRL-------NGKNLAIKRTEH---EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       390 ~~G~Vy~g~~-------~g~~vAvK~~~~---~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~  459 (600)
                      .+|.||+|++       +++.||||+++.   ...+.|.+|+..+.+++|||||+++|+|.++ +.+|||||||++|+|.
T Consensus        53 ~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~-~~~~lV~Ey~~~G~L~  131 (329)
T 4aoj_A           53 AFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEG-RPLLMVFEYMRHGDLN  131 (329)
T ss_dssp             SSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-SSEEEEEECCTTCBHH
T ss_pred             CCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEEEcCCCCcHH
Confidence            3499999987       367899999864   2345788999999999999999999998765 4899999999999999


Q ss_pred             HHHhcCcCcccc---cccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCcccc
Q 041830          460 DWLHGGLAMKNQ---FIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV  536 (600)
Q Consensus       460 ~~L~~~~~~~~~---~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~  536 (600)
                      ++|+........   .......+|+|.++++|+.|||+||+|||   +.+|+||||||+||||++++.+||+|||+++..
T Consensus       132 ~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH---~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~  208 (329)
T 4aoj_A          132 RFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDI  208 (329)
T ss_dssp             HHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC-----
T ss_pred             HHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHh---cCCeecccccHhhEEECCCCcEEEcccccceec
Confidence            999865421110   00011245999999999999999999999   568999999999999999999999999999854


Q ss_pred             CCC--------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          537 NDD--------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       537 ~~~--------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                      ...              +.+||....  ..++.++|||||||+||||+| |+.||...
T Consensus       209 ~~~~~~~~~~~~~gt~~ymAPE~~~~--~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~  264 (329)
T 4aoj_A          209 YSTDYYRVGGRTMLPIRWMPPESILY--RKFTTESDVWSFGVVLWEIFTYGKQPWYQL  264 (329)
T ss_dssp             -----------CCCCGGGCCHHHHTT--CCCCHHHHHHHHHHHHHHHHTTSCCTTCSS
T ss_pred             cCCCcceecCcccccccccChhhhcC--CCCCccccccchHHHHHHHHcCCCCCCCCC
Confidence            221              245666554  467899999999999999999 89999754

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=4.9e-38  Score=323.01  Aligned_cols=175  Identities=23%  Similarity=0.338  Sum_probs=144.0

Q ss_pred             eEEEEEEEECCeEEEEEEcchhHHH--HHHHHHHHHHhCCCCceeeeeeEEeccCC---ceEEEEeecCCCCHHHHHhcC
Q 041830          391 EGAVYHGRLNGKNLAIKRTEHEVIT--KLEMQLVQHATHHHPNIVRLLGTCLTDGP---HSFLVFEYAKNGSLKDWLHGG  465 (600)
Q Consensus       391 ~G~Vy~g~~~g~~vAvK~~~~~~~~--~~e~ei~~~~~l~HpNIv~l~g~~~~~~~---~~~LV~Ey~~~GsL~~~L~~~  465 (600)
                      +|.||+|+++|+.||||+++.+...  .+|.|+..+..++|||||+++|+|.+++.   .+|||||||++|+|.++|+..
T Consensus        16 fG~Vy~~~~~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~~   95 (303)
T 3hmm_A           16 FGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY   95 (303)
T ss_dssp             SSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC
T ss_pred             CeEEEEEEECCEEEEEEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHhC
Confidence            3999999999999999998765443  34567777778899999999999986542   579999999999999999753


Q ss_pred             cCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC--
Q 041830          466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV-----MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND--  538 (600)
Q Consensus       466 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~--  538 (600)
                                   .++|.++++++.|+++||+|||+.     .+++|+||||||+|||||.++.+||+|||+++....  
T Consensus        96 -------------~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~  162 (303)
T 3hmm_A           96 -------------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSAT  162 (303)
T ss_dssp             -------------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTT
T ss_pred             -------------CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCC
Confidence                         389999999999999999999953     235899999999999999999999999999975432  


Q ss_pred             --------------CCCCCcccccCC----CCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          539 --------------DTESPQFYSTNP----ASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       539 --------------~~~~pe~~~~~~----~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                                    .+.+||++....    ..++.++|||||||+||||+||+.||..
T Consensus       163 ~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~  220 (303)
T 3hmm_A          163 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI  220 (303)
T ss_dssp             TEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred             CceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCc
Confidence                          123566654321    1356789999999999999999887643

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=2.7e-37  Score=321.39  Aligned_cols=176  Identities=24%  Similarity=0.387  Sum_probs=148.9

Q ss_pred             CceeEEEEEEEE--CCeEEEEEEcch-----hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          388 NRIEGAVYHGRL--NGKNLAIKRTEH-----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       388 ~~~~G~Vy~g~~--~g~~vAvK~~~~-----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      .|.+|.||+++.  +|+.||||+++.     ...+.+.+|+..++.++|||||++++++.++ +.+|||||||++|+|.+
T Consensus        34 ~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~-~~~yiVmEy~~gg~L~~  112 (350)
T 4b9d_A           34 EGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHPNIVQYRESFEEN-GSLYIVMDYCEGGDLFK  112 (350)
T ss_dssp             -----CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEECCTTCBHHH
T ss_pred             cCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEEC-CEEEEEEeCCCCCcHHH
Confidence            334499999998  699999999753     2345688999999999999999999998665 48999999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCcccc----
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV----  536 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~----  536 (600)
                      +|+..+.          ..+++.+.+.|+.||+.||+|||   +.+|+||||||+||||++++.+||+|||+|+..    
T Consensus       113 ~i~~~~~----------~~~~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  179 (350)
T 4b9d_A          113 RINAQKG----------VLFQEDQILDWFVQICLALKHVH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV  179 (350)
T ss_dssp             HHHHTTT----------CCCCHHHHHHHHHHHHHHHHHHH---HTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH
T ss_pred             HHHHcCC----------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc
Confidence            9975432          34789999999999999999999   679999999999999999999999999999754    


Q ss_pred             --------CCCCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          537 --------NDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       537 --------~~~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                              +..+.+||.+..  ..|+.++|||||||+||||++|+.||...
T Consensus       180 ~~~~~~~GT~~YmAPE~l~~--~~y~~~~DiwSlGvilyemltG~~PF~~~  228 (350)
T 4b9d_A          180 ELARACIGTPYYLSPEICEN--KPYNNKSDIWALGCVLYELCTLKHAFEAG  228 (350)
T ss_dssp             HHHHHHHSCCTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccCCCccccCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence                    334567887765  45788999999999999999999999754

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=7.5e-37  Score=311.03  Aligned_cols=175  Identities=22%  Similarity=0.401  Sum_probs=146.4

Q ss_pred             ceeEEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEecc---CCceEEEEeecCCCCH
Q 041830          389 RIEGAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTD---GPHSFLVFEYAKNGSL  458 (600)
Q Consensus       389 ~~~G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~---~~~~~LV~Ey~~~GsL  458 (600)
                      |.+|.||+|+.  +|..||+|++...     ..+.+.+|+..+..++|||||++++++...   ...+|||||||++|+|
T Consensus        37 G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L  116 (290)
T 3fpq_A           37 GSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTL  116 (290)
T ss_dssp             CSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBH
T ss_pred             CcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCH
Confidence            33499999998  6889999987542     235688999999999999999999997642   2357999999999999


Q ss_pred             HHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC-CCcEEEEeccCccccC
Q 041830          459 KDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE-EFNARVGNFGMARCVN  537 (600)
Q Consensus       459 ~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~-~~~~kI~DFGla~~~~  537 (600)
                      .++|+...            .+++.++..++.||+.||+|||+. .++|+||||||+||||+. ++.+||+|||+|+...
T Consensus       117 ~~~l~~~~------------~l~~~~~~~~~~qi~~aL~ylH~~-~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~  183 (290)
T 3fpq_A          117 KTYLKRFK------------VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  183 (290)
T ss_dssp             HHHHHHHS------------SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             HHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHHC-CCCEEecccChhheeEECCCCCEEEEeCcCCEeCC
Confidence            99997543            389999999999999999999943 234999999999999984 7999999999997532


Q ss_pred             ----------CCCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          538 ----------DDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       538 ----------~~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                ..+.+||....   .++.++|||||||+||||+||+.||...
T Consensus       184 ~~~~~~~~GTp~YmAPE~~~~---~y~~~~DiwSlGvilyelltg~~Pf~~~  232 (290)
T 3fpq_A          184 ASFAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSEC  232 (290)
T ss_dssp             TTSBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             CCccCCcccCccccCHHHcCC---CCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence                      33457887643   4889999999999999999999999653

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.1e-37  Score=320.43  Aligned_cols=172  Identities=25%  Similarity=0.440  Sum_probs=148.0

Q ss_pred             ceeEEEEEEEE--CCeEEEEEEcchhH---HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          389 RIEGAVYHGRL--NGKNLAIKRTEHEV---ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       389 ~~~G~Vy~g~~--~g~~vAvK~~~~~~---~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      |.+|.||+++.  +|+.||||+++...   .+.+.+|+.++..++|||||++++++.++ +.+|||||||++|+|.+++.
T Consensus        85 G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-~~~~ivmEy~~gg~L~~~l~  163 (346)
T 4fih_A           85 GSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-DELWVVMEFLEGGALTDIVT  163 (346)
T ss_dssp             CSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEECCCTTEEHHHHHH
T ss_pred             CcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEEeCCCCCcHHHHHH
Confidence            33499999998  69999999986432   24578899999999999999999998766 48999999999999999997


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD----  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~----  539 (600)
                      ..             .+++.++..++.||+.||+|||   +.+|+||||||+||||+.++.+||+|||+|+.+...    
T Consensus       164 ~~-------------~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~  227 (346)
T 4fih_A          164 HT-------------RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR  227 (346)
T ss_dssp             HS-------------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCB
T ss_pred             cC-------------CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCcc
Confidence            53             2899999999999999999999   669999999999999999999999999999865322    


Q ss_pred             --------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 --------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 --------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                              +.+||.+..  ..|+.++|||||||+||||++|+.||...
T Consensus       228 ~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~  273 (346)
T 4fih_A          228 KSLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNE  273 (346)
T ss_dssp             CCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             cccccCcCcCCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence                    235665543  45789999999999999999999999753

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.7e-37  Score=319.90  Aligned_cols=171  Identities=24%  Similarity=0.336  Sum_probs=145.8

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcCc
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM  468 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~  468 (600)
                      +|.||+++.  +|+.||||+++.+..  ..+|+..+..++|||||++++++.++ +.+|||||||++|+|.++|+...  
T Consensus        71 fG~Vy~a~~~~~g~~vAiK~i~~~~~--~~~E~~il~~l~HpnIV~l~~~~~~~-~~~~ivmEy~~gg~L~~~l~~~~--  145 (336)
T 4g3f_A           71 FGEVHRMKDKQTGFQCAVKKVRLEVF--RVEELVACAGLSSPRIVPLYGAVREG-PWVNIFMELLEGGSLGQLIKQMG--  145 (336)
T ss_dssp             TEEEEEEEETTTCCEEEEEEEETTTC--CTHHHHTTTTCCCTTBCCEEEEEEET-TEEEEEECCCTTCBHHHHHHHHS--
T ss_pred             CeEEEEEEECCCCCEEEEEEECHHHh--HHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEEeccCCCcHHHHHHHcC--
Confidence            399999998  699999999976542  25688889999999999999998665 48999999999999999997543  


Q ss_pred             ccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC-cEEEEeccCccccCC---------
Q 041830          469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEF-NARVGNFGMARCVND---------  538 (600)
Q Consensus       469 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~-~~kI~DFGla~~~~~---------  538 (600)
                                .|++.++..++.||+.||+|||   +.+|+||||||+||||+.++ ++||+|||+|+....         
T Consensus       146 ----------~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~  212 (336)
T 4g3f_A          146 ----------CLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLT  212 (336)
T ss_dssp             ----------SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC-----------
T ss_pred             ----------CCCHHHHHHHHHHHHHHHHHHH---HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceec
Confidence                      3999999999999999999999   77999999999999999987 699999999986532         


Q ss_pred             --------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCCC
Q 041830          539 --------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRK  581 (600)
Q Consensus       539 --------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~  581 (600)
                              .+.+||....  ..++.++|||||||+||||+||+.||...+.
T Consensus       213 ~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyemltG~~Pf~~~~~  261 (336)
T 4g3f_A          213 GDYIPGTETHMAPEVVMG--KPCDAKVDIWSSCCMMLHMLNGCHPWTQYFR  261 (336)
T ss_dssp             -CCCCCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSTTTCC
T ss_pred             CCccccCccccCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH
Confidence                    1235666544  4578899999999999999999999976443

>4eby_A Chitin elicitor receptor kinase 1; pathogen-associated molecular patterns, pattern recognition receptors, LYSM, lysine chitin oligomer; HET: NAG BMA; 1.65A {Arabidopsis thaliana} PDB: 4ebz_A*

Probab=100.00  E-value=2.9e-36  Score=290.13  Aligned_cols=178  Identities=20%  Similarity=0.320  Sum_probs=158.5

Q ss_pred             CCcc-eeeeeecCCCCCChhhHHHhhCCCh--------HHHHhhh-CCCCCCCCCCCCCcEEEeeccccCCCCcceeecc
Q 041830           58 YQCG-TFAILRTNSYYSSLFNLSFYLGLNR--------FVIARAN-GFSADTEFLPKDQPLLIPIDCKCNNNGGFFQADL  127 (600)
Q Consensus        58 ~~C~-~~~~y~~~~~~~~l~~ia~~~~~~~--------~~i~~~N-~~~~~~~~i~~~~~l~vP~~c~c~~~~~~~~~~~  127 (600)
                      ++|+ +|+.|+|++ ||||+.||++|++++        .+|+++| ++. +.+.|++||.|+||++|+|. .+.++++..
T Consensus         3 ~~C~~a~~~Y~V~~-GDTL~~IA~~~~vsv~~~~~~~~~~I~~~Np~l~-~~~~l~~Gq~L~IP~~~~~~-~~~~~~~~~   79 (212)
T 4eby_A            3 TSCPLALASYYLEN-GTTLSVINQNLNSSIAPYDQINFDPILRYNSNIK-DKDRIQMGSRVLVPFPCECQ-PGDFLGHNF   79 (212)
T ss_dssp             CCCSCEEEEEECCT-TCCHHHHHHHTCCSSSCCCSSCCHHHHTTCTTCS-CTTSCCTTCEEEEEECCEEE-TTTEEEEEE
T ss_pred             CCCccceEEEEeCC-CCCHHHHHHHHCCCchhccccCHHHHHHhccCCC-CcCccCCCCEEEEecccccc-CCccccCce
Confidence            6899 999999999 999999999999999        9999999 995 57899999999999999996 456777889


Q ss_pred             eeeeecCCchhhHH-HhcCCCchHHHHHhhCCCCCCCCCCCCCeEeeeeeccCCCCCCCCCCceEEEEEEccCCCccccc
Q 041830          128 TKTTIKGESFYSIA-QSLEGLTTCGAIKERNPSVSPWDLDDKARLQVPLRCACPSSSENLPETRILVSYPVGEGDTVSGL  206 (600)
Q Consensus       128 ~y~v~~gdt~~~ia-~~~~gl~t~~~l~~~N~~~~~~~l~~G~~l~vp~~c~c~~~~~~~~~~~~~~tY~v~~gd~~~~i  206 (600)
                      +|+|++|||||.|| +.|+||+++++|+++|++. ++.|.+||+|.||.+|+|++.. ...+....++|+|++||+|++|
T Consensus        80 ~Y~V~~GDTL~~IA~~~y~~lvt~~~L~~~N~~~-~~~l~~Gq~L~IP~~~~~~~~~-~~~~~~~~~~Y~V~~GDTL~~I  157 (212)
T 4eby_A           80 SYSVRQEDTYERVAISNYANLTTMESLQARNPFP-ATNIPLSATLNVLVNCSCGDES-VSKDFGLFVTYPLRPEDSLSSI  157 (212)
T ss_dssp             EEECCTTCCHHHHHHTTTTTSSCHHHHHHHCCSC-TTCCCTTCEEEEEEECCCCCTT-TCSSCCCEEEEECCTTCCHHHH
T ss_pred             EEEecCCCcHHHHHHHhcCCCCCHHHHHHhcCCC-cccCCCCCEEEEcCCCcCCCcc-cccCCCCeEEEEECCCCcHHHH
Confidence            99999999999999 8999999999999999965 6889999999999999998764 4456677899999999999999


Q ss_pred             ccccCCChHHHHHhcCCCCCCCCcccccCcccccccCCCC
Q 041830          207 AAKFNTTPAAIIAANNKSLEGFKPEDLLAFTSILIPLNGE  246 (600)
Q Consensus       207 a~~f~~~~~~~~~~n~~~~~g~~p~~l~~~~~~~vp~~~~  246 (600)
                      |.+||++..++..||+....     .+..+. ++||++..
T Consensus       158 A~~fgvsv~~L~~~N~~~~~-----~~~~g~-l~IP~~~~  191 (212)
T 4eby_A          158 ARSSGVSADILQRYNPGVNF-----NSGNGI-VYVPGRDP  191 (212)
T ss_dssp             HHHHTSCHHHHHHHSTTCCT-----TSCSSE-EEEECCCT
T ss_pred             HHHHCcCHHHHHHhcCCCcc-----CCCCCE-EEecCCCC
Confidence            99999999999999997322     333444 89998874

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=9.4e-37  Score=312.22  Aligned_cols=171  Identities=23%  Similarity=0.384  Sum_probs=147.3

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      +|.||+++.  +|+.||||.++...      .+.+.+|+.++..++|||||++++++.++ +.+|||||||++|+|.++|
T Consensus        45 fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-~~~yivmEy~~gG~L~~~i  123 (311)
T 4aw0_A           45 FSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD-EKLYFGLSYAKNGELLKYI  123 (311)
T ss_dssp             TEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEEECCCTTEEHHHHH
T ss_pred             CeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-CEEEEEEecCCCCCHHHHH
Confidence            399999998  79999999986533      34578899999999999999999997655 5899999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC---
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---  539 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~---  539 (600)
                      +...            .+++.+...++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.+...   
T Consensus       124 ~~~~------------~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~  188 (311)
T 4aw0_A          124 RKIG------------SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  188 (311)
T ss_dssp             HHHS------------SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTC
T ss_pred             HHcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCc
Confidence            7543            3999999999999999999999   679999999999999999999999999999865321   


Q ss_pred             -----------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 -----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 -----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                 +.+||....  ..|+.++||||+||+||||++|+.||...
T Consensus       189 ~~~~~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~  237 (311)
T 4aw0_A          189 ARANSFVGTAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAG  237 (311)
T ss_dssp             CCBCCCCSCGGGCCHHHHHH--SCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccccCcccCcccCCHHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                       124555443  45788999999999999999999999754

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=1.9e-36  Score=322.19  Aligned_cols=171  Identities=25%  Similarity=0.435  Sum_probs=148.1

Q ss_pred             eeEEEEEEEE--CCeEEEEEEcchh---HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          390 IEGAVYHGRL--NGKNLAIKRTEHE---VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       390 ~~G~Vy~g~~--~g~~vAvK~~~~~---~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      .+|.||+|+.  +|+.||||+++..   ..+.+.+|+.+++.++|||||++++++.++ +.+|||||||++|+|.++++.
T Consensus       163 ~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~-~~~~iVmEy~~gG~L~~~i~~  241 (423)
T 4fie_A          163 STGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVG-DELWVVMEFLEGGALTDIVTH  241 (423)
T ss_dssp             SSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEECCTTEEHHHHHHH
T ss_pred             cCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCCCCCCCceEEEEEEC-CEEEEEEeCCCCCcHHHHHhc
Confidence            3499999998  6999999998542   234578999999999999999999998765 489999999999999999975


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC------
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND------  538 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~------  538 (600)
                      ..             +++.++..|+.||+.||+|||   +.+|+||||||+||||+.++.+||+|||+|+.+..      
T Consensus       242 ~~-------------l~e~~~~~~~~qil~aL~ylH---~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~  305 (423)
T 4fie_A          242 TR-------------MNEEQIAAVCLAVLQALSVLH---AQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK  305 (423)
T ss_dssp             SC-------------CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCBC
T ss_pred             cC-------------CCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCcccc
Confidence            32             899999999999999999999   67999999999999999999999999999986532      


Q ss_pred             ------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 ------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 ------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                            .+.+||.+..  ..|+.++|||||||+||||++|+.||...
T Consensus       306 ~~~GTp~YmAPEvl~~--~~y~~~~DiWSlGvilyeml~G~~PF~~~  350 (423)
T 4fie_A          306 SLVGTPYWMAPELISR--LPYGPEVDIWSLGIMVIEMVDGEPPYFNE  350 (423)
T ss_dssp             CCEECTTTCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             ccccCcCcCCHHHHCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence                  2346666544  46789999999999999999999999753

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=1.8e-36  Score=316.99  Aligned_cols=185  Identities=24%  Similarity=0.406  Sum_probs=148.6

Q ss_pred             eEEEEEEEECC-------eEEEEEEcchh----HHHHHHHHHHHHHhCCC-CceeeeeeEEeccCCceEEEEeecCCCCH
Q 041830          391 EGAVYHGRLNG-------KNLAIKRTEHE----VITKLEMQLVQHATHHH-PNIVRLLGTCLTDGPHSFLVFEYAKNGSL  458 (600)
Q Consensus       391 ~G~Vy~g~~~g-------~~vAvK~~~~~----~~~~~e~ei~~~~~l~H-pNIv~l~g~~~~~~~~~~LV~Ey~~~GsL  458 (600)
                      +|.||+|++.+       +.||||+++..    ..+.+.+|+..+.++.| ||||+++|+|.+++..++||||||++|+|
T Consensus        77 fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L  156 (353)
T 4ase_A           77 FGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL  156 (353)
T ss_dssp             SEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEH
T ss_pred             CeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCH
Confidence            49999999833       57999998652    23467889999988865 89999999997766678999999999999


Q ss_pred             HHHHhcCcCcccc----cccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCcc
Q 041830          459 KDWLHGGLAMKNQ----FIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR  534 (600)
Q Consensus       459 ~~~L~~~~~~~~~----~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~  534 (600)
                      .++|+........    ........|+|.+++.|+.|||+||+|||   +.+||||||||+|||+++++.+||+|||+|+
T Consensus       157 ~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH---~~~iiHRDLK~~NILl~~~~~vKi~DFGlar  233 (353)
T 4ase_A          157 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLAR  233 (353)
T ss_dssp             HHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGS
T ss_pred             HHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHh---hCCeecCccCccceeeCCCCCEEECcchhhh
Confidence            9999864321000    00011245899999999999999999999   6699999999999999999999999999998


Q ss_pred             ccCCC--------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCCC
Q 041830          535 CVNDD--------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRPR  580 (600)
Q Consensus       535 ~~~~~--------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~~  580 (600)
                      .+...              +.+||....  ..++.++|||||||+||||+| |+.||...+
T Consensus       234 ~~~~~~~~~~~~~~~gt~~ymAPE~l~~--~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~  292 (353)
T 4ase_A          234 DIYKDPDYVRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  292 (353)
T ss_dssp             CTTTCTTSEEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             hcccCCCceeeccccccccccCHHHHhc--CCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence            65322              235666554  457899999999999999998 999997644

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.4e-35  Score=299.21  Aligned_cols=173  Identities=23%  Similarity=0.425  Sum_probs=141.9

Q ss_pred             ceeEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          389 RIEGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       389 ~~~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      |.+|.||+++.  +|+.||||.++...      ...+++|+..++.++|||||++++++.++ +..|+||||| +|+|.+
T Consensus        24 G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-~~~~ivmEy~-~g~L~~  101 (275)
T 3hyh_A           24 GSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSK-DEIIMVIEYA-GNELFD  101 (275)
T ss_dssp             ---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEEECC-CEEHHH
T ss_pred             CcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-CEEEEEEeCC-CCCHHH
Confidence            33499999987  79999999975422      34678999999999999999999997655 5899999999 689999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC--
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND--  538 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~--  538 (600)
                      ++....            .+++.+...++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+|+....  
T Consensus       102 ~l~~~~------------~l~e~~~~~~~~qi~~al~ylH---~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~  166 (275)
T 3hyh_A          102 YIVQRD------------KMSEQEARRFFQQIISAVEYCH---RHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGN  166 (275)
T ss_dssp             HHHHSC------------SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTCCEEECCSSCC-------
T ss_pred             HHHHcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCChHHeEECCCCCEEEeecCCCeecCCCC
Confidence            997643            3999999999999999999999   67999999999999999999999999999975432  


Q ss_pred             ---------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 ---------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 ---------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                               .+.+||..... ..++.++||||+||+||||+||+.||...
T Consensus       167 ~~~~~~GT~~Y~APE~~~~~-~y~~~~~DiwSlGvily~lltg~~PF~~~  215 (275)
T 3hyh_A          167 FLKTSCGSPNYAAPEVISGK-LYAGPEVDVWSCGVILYVMLCRRLPFDDE  215 (275)
T ss_dssp             --------CTTSCHHHHSSS-SCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccCCeeECcccCChhhhcCC-CCCCChhhhHHHHHHHHHHHHCCCCCCCC
Confidence                     23466766542 22357899999999999999999999753

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=2e-36  Score=309.46  Aligned_cols=174  Identities=22%  Similarity=0.366  Sum_probs=140.6

Q ss_pred             ceeEEEEEEEE-----CCeEEEEEEcchhH-----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCH
Q 041830          389 RIEGAVYHGRL-----NGKNLAIKRTEHEV-----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSL  458 (600)
Q Consensus       389 ~~~G~Vy~g~~-----~g~~vAvK~~~~~~-----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL  458 (600)
                      |.+|.||+++.     +++.||||.++...     ...+.+|+..+..++|||||++++++.++ +.+|||||||++|+|
T Consensus        35 G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-~~~~ivmEy~~gg~L  113 (304)
T 3ubd_A           35 GSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKLHYAFQTE-GKLYLILDFLRGGDL  113 (304)
T ss_dssp             GGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCCCTTEECEEEEEEET-TEEEEEECCCTTCEE
T ss_pred             CCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCCCCCCCeEEEEEEEC-CEEEEEEEcCCCCCH
Confidence            33499999986     46789999875422     23567888889999999999999998665 489999999999999


Q ss_pred             HHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC
Q 041830          459 KDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND  538 (600)
Q Consensus       459 ~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~  538 (600)
                      .++|+...            .+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+....
T Consensus       114 ~~~l~~~~------------~l~e~~~~~~~~qi~~aL~ylH---~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~  178 (304)
T 3ubd_A          114 FTRLSKEV------------MFTEEDVKFYLAELALALDHLH---SLGIIYRDLKPENILLDEEGHIKLTDFGLSKESID  178 (304)
T ss_dssp             HHHHHHHC------------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTSCEEEESSEEEEC---
T ss_pred             HHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHeEEcCCCCEEecccccceeccC
Confidence            99997543            3999999999999999999999   67999999999999999999999999999985421


Q ss_pred             ------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          539 ------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       539 ------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                                  .+.+||....  ..++.++|||||||+||||+||+.||...+
T Consensus       179 ~~~~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyemltG~~PF~~~~  230 (304)
T 3ubd_A          179 HEKKAYSFCGTVEYMAPEVVNR--RGHTQSADWWSFGVLMFEMLTGTLPFQGKD  230 (304)
T ss_dssp             --CCCCSCCCCGGGCCHHHHHT--SCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CCccccccccCcccCCHHHhcc--CCCCCCCcccchHHHHHHHHhCCCCCCCcC
Confidence                        1235565544  457889999999999999999999997543

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.4e-34  Score=294.64  Aligned_cols=171  Identities=29%  Similarity=0.500  Sum_probs=138.5

Q ss_pred             eEEEEEEEE--CCeEEEEEEcch----hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCC-----------ceEEEEeec
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEH----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGP-----------HSFLVFEYA  453 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~-----------~~~LV~Ey~  453 (600)
                      +|.||+++.  +|+.||||+++.    ...+.+.+|+..+..++|||||++++++...+.           .+|+|||||
T Consensus        18 fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~   97 (299)
T 4g31_A           18 FGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLC   97 (299)
T ss_dssp             --EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECC
T ss_pred             CeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecC
Confidence            499999998  699999998753    223567899999999999999999999865432           369999999


Q ss_pred             CCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCc
Q 041830          454 KNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA  533 (600)
Q Consensus       454 ~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla  533 (600)
                      ++|+|.++++.....         ...++...+.|+.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|
T Consensus        98 ~gg~L~~~l~~~~~~---------~~~~~~~~~~i~~qi~~al~ylH---~~~IiHRDlKp~NILl~~~~~vKl~DFGla  165 (299)
T 4g31_A           98 RKENLKDWMNGRCTI---------EERERSVCLHIFLQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLV  165 (299)
T ss_dssp             CSCCHHHHHHTCCSG---------GGSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCCCC
T ss_pred             CCCcHHHHHHhcCCC---------ChhHHHHHHHHHHHHHHHHHHHH---HCcCccccCcHHHeEECCCCcEEEccCccc
Confidence            999999999865431         22677888999999999999999   669999999999999999999999999999


Q ss_pred             cccC------------------------CCCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          534 RCVN------------------------DDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       534 ~~~~------------------------~~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                      +...                        ..+.+||....  ..++.++|||||||+||||++   ||..
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~--~~y~~~~DiwSlGvilyell~---Pf~~  229 (299)
T 4g31_A          166 TAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG--NSYSHKVDIFSLGLILFELLY---PFST  229 (299)
T ss_dssp             --------------------------CCCTTSCHHHHTT--CCCCTHHHHHHHHHHHHHHHS---CCSS
T ss_pred             eecCCCccccccccccccccccCCcccCccccCHHHHcC--CCCCCHHHHHHHHHHHHHHcc---CCCC
Confidence            7543                        22346666654  457899999999999999996   7753

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=2.4e-33  Score=298.14  Aligned_cols=174  Identities=21%  Similarity=0.371  Sum_probs=144.2

Q ss_pred             eeEEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEec-----cCCceEEEEeecCCCC
Q 041830          390 IEGAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLT-----DGPHSFLVFEYAKNGS  457 (600)
Q Consensus       390 ~~G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~-----~~~~~~LV~Ey~~~Gs  457 (600)
                      .+|.||+++.  +|+.||||+++..     ..+.+.+|+.++..++|||||++++++..     +...+|||||||+ |+
T Consensus        66 ~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~  144 (398)
T 4b99_A           66 AYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SD  144 (398)
T ss_dssp             SSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EE
T ss_pred             cCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CC
Confidence            3499999998  7999999998542     23456789999999999999999998653     2246899999996 78


Q ss_pred             HHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC
Q 041830          458 LKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN  537 (600)
Q Consensus       458 L~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~  537 (600)
                      |.+++....            .+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|+.+.
T Consensus       145 L~~~i~~~~------------~l~~~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~  209 (398)
T 4b99_A          145 LHQIIHSSQ------------PLTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLC  209 (398)
T ss_dssp             HHHHHTSSS------------CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-
T ss_pred             HHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHH---HCcCcCCCcCccccccCCCCCEEEeecceeeecc
Confidence            999997643            3999999999999999999999   6799999999999999999999999999997542


Q ss_pred             C----------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          538 D----------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       538 ~----------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                      .                .+.+||..... ..++.++||||+||++|||++|+.||...+
T Consensus       210 ~~~~~~~~~~~~~~GT~~Y~APEv~~~~-~~~~~~~DiWSlG~il~ell~G~~pF~g~~  267 (398)
T 4b99_A          210 TSPAEHQYFMTEYVATRWYRAPELMLSL-HEYTQAIDLWSVGCIFGEMLARRQLFPGKN  267 (398)
T ss_dssp             ------CCCCCSSCCCCTTCCHHHHTTC-SCCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred             cCccccccccccceeChHhcCHHHhcCC-CCCCChhheehhHHHHHHHHHCCCCCCCCC
Confidence            1                22356654432 346888999999999999999999997643

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=99.98  E-value=1.4e-32  Score=305.39  Aligned_cols=172  Identities=24%  Similarity=0.352  Sum_probs=142.0

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhHHH------HH---HHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEVIT------KL---EMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~~~------~~---e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      |.||+++.  +|+.||||.++.....      ..   ..++..+..++|||||++++++.++ +.+|||||||++|+|.+
T Consensus       203 G~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~-~~lylVmEy~~GGdL~~  281 (689)
T 3v5w_A          203 GEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-DKLSFILDLMNGGDLHY  281 (689)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS-SEEEEEECCCCSCBHHH
T ss_pred             eEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC-CEEEEEEecCCCCcHHH
Confidence            99999998  7999999998654321      11   2234455567899999999997655 58999999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-  539 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-  539 (600)
                      +|....            .+++.+...++.||+.||+|||   +.+|+||||||+||||+.++.+||+|||+|+..... 
T Consensus       282 ~l~~~~------------~l~E~~a~~y~~qIl~aL~yLH---~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~  346 (689)
T 3v5w_A          282 HLSQHG------------VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK  346 (689)
T ss_dssp             HHHHHC------------CCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC
T ss_pred             HHHhcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCchHHeEEeCCCCEEecccceeeecCCCC
Confidence            997543            3899999999999999999999   779999999999999999999999999999865432 


Q ss_pred             ---------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 ---------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 ---------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                               +.+||.+.. ...|+.++|+||+||+||||++|+.||...+
T Consensus       347 ~~t~~GTp~YmAPEvl~~-~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~  395 (689)
T 3v5w_A          347 PHASVGTHGYMAPEVLQK-GVAYDSSADWFSLGCMLFKLLRGHSPFRQHK  395 (689)
T ss_dssp             CCSCCSCGGGCCHHHHST-TCCCCTHHHHHHHHHHHHHHHHSSCTTCGGG
T ss_pred             CCCccCCcCccCHHHHhC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                     235555432 2457889999999999999999999997543

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=99.98  E-value=1.1e-32  Score=289.75  Aligned_cols=170  Identities=20%  Similarity=0.344  Sum_probs=140.4

Q ss_pred             eEEEEEEEE-----CCeEEEEEEcchh-HHHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          391 EGAVYHGRL-----NGKNLAIKRTEHE-VITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       391 ~G~Vy~g~~-----~g~~vAvK~~~~~-~~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      +|.||+++.     +++.||||++... ...++.+|+..+..+ +|||||++++++.++ +..|||||||++|+|.++++
T Consensus        34 fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~-~~~~lvmE~~~g~~L~~~~~  112 (361)
T 4f9c_A           34 FSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKN-DHVVIAMPYLEHESFLDILN  112 (361)
T ss_dssp             SEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEET-TEEEEEEECCCCCCHHHHHT
T ss_pred             CcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEEC-CEEEEEEeCCCcccHHHHHc
Confidence            399999976     3678999987543 234567888888877 699999999997655 58999999999999999984


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC-CcEEEEeccCccccCC----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEE-FNARVGNFGMARCVND----  538 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~-~~~kI~DFGla~~~~~----  538 (600)
                                     .+++.++..++.|++.||+|||   +.+|+||||||+|||++.+ +.+||+|||+|+....    
T Consensus       113 ---------------~l~~~~~~~~~~qll~al~ylH---~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~  174 (361)
T 4f9c_A          113 ---------------SLSFQEVREYMLNLFKALKRIH---QFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIE  174 (361)
T ss_dssp             ---------------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCG
T ss_pred             ---------------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccc
Confidence                           2889999999999999999999   6799999999999999877 7999999999974321    


Q ss_pred             ------------------------------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          539 ------------------------------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       539 ------------------------------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                                                          .+.+||.... ...++.++||||+||++|||++|+.||...+
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~-~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~  251 (361)
T 4f9c_A          175 LLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTK-CPNQTTAIDMWSAGVIFLSLLSGRYPFYKAS  251 (361)
T ss_dssp             GGGGC--------------------------CCCCGGGCCHHHHTT-CSCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred             ccccccccccccccccccccccccccccccccccCccccCHHHHcC-CCCCCCccchhhhHHHHHHHHHCCCCCCCCC
Confidence                                                1234555433 2347888999999999999999999997544

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=99.97  E-value=1.7e-31  Score=297.12  Aligned_cols=173  Identities=19%  Similarity=0.304  Sum_probs=146.8

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh---HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcC
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE---VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGG  465 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~---~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~  465 (600)
                      +|.||+++.  +|+.||+|.+...   ..+.+.+|+..|..++|||||++++++.++ ..+|||||||++|+|.++|...
T Consensus       170 fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~-~~~~iv~E~~~gg~L~~~i~~~  248 (573)
T 3uto_A          170 FGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD-NEMVMIYEFMSGGELFEKVADE  248 (573)
T ss_dssp             TEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECS-SEEEEEEECCCCCBHHHHHTCT
T ss_pred             CeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-CEEEEEEeecCCCcHHHHHHHh
Confidence            399999998  7999999987542   234578899999999999999999997655 5899999999999999999653


Q ss_pred             cCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC--CcEEEEeccCccccCCC----
Q 041830          466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEE--FNARVGNFGMARCVNDD----  539 (600)
Q Consensus       466 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~--~~~kI~DFGla~~~~~~----  539 (600)
                      .           ..|++.++..++.||+.||.|||   +.+|+||||||+|||++.+  +.+||+|||+++.+...    
T Consensus       249 ~-----------~~l~e~~~~~~~~qi~~al~ylH---~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~~  314 (573)
T 3uto_A          249 H-----------NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK  314 (573)
T ss_dssp             T-----------SCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEEE
T ss_pred             C-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCcee
Confidence            3           23899999999999999999999   6699999999999999854  89999999999876433    


Q ss_pred             -------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 -------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 -------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                             +.+||.+..  ..|+.++||||+||+||||++|+.||...+
T Consensus       315 ~~~GT~~y~APEv~~~--~~y~~~~DiWSlGvilyeml~G~~Pf~~~~  360 (573)
T 3uto_A          315 VTTGTAEFAAPEVAEG--KPVGYYTDMWSVGVLSYILLSGLSPFGGEN  360 (573)
T ss_dssp             EECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred             eeEECccccCHHHhCC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence                   235666554  457889999999999999999999997543

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=99.97  E-value=2.7e-31  Score=274.93  Aligned_cols=198  Identities=36%  Similarity=0.671  Sum_probs=162.7

Q ss_pred             ccccCHHHHHHHHhccCCCCcee----EEEEEEEE-CCeEEEEEEcchhHHH----HHHHHHHHHHhCCCCceeeeeeEE
Q 041830          369 LESYSIEDLRRATEKFNSSNRIE----GAVYHGRL-NGKNLAIKRTEHEVIT----KLEMQLVQHATHHHPNIVRLLGTC  439 (600)
Q Consensus       369 ~~~~~~~el~~~t~~f~~~~~~~----G~Vy~g~~-~g~~vAvK~~~~~~~~----~~e~ei~~~~~l~HpNIv~l~g~~  439 (600)
                      ...|++.++....++|.....+|    |.||+++. +|+.||||++......    .+.+|+..+..++||||+++++++
T Consensus        17 ~~~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           17 LKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             CEECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-----CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             cceecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCchHHHHHHHHHHHHHhccCCCccceEEEE
Confidence            45688899999999987766665    89999988 6899999998754322    578889999999999999999998


Q ss_pred             eccCCceEEEEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEe
Q 041830          440 LTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFL  519 (600)
Q Consensus       440 ~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl  519 (600)
                      ..+ ...++||||+++|+|.++++......        ..++|.+++.++.|++.||.|||+...++|+||||||+|||+
T Consensus        97 ~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~--------~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~  167 (326)
T 3uim_A           97 MTP-TERLLVYPYMANGSVASCLRERPESQ--------PPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILL  167 (326)
T ss_dssp             CCS-SCCEEEEECCTTCBHHHHHHCCSTTC--------CCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEE
T ss_pred             ecC-CceEEEEEeccCCCHHHHHHhccccC--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEE
Confidence            655 47899999999999999998654211        349999999999999999999995434499999999999999


Q ss_pred             CCCCcEEEEeccCccccCCC-------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCC
Q 041830          520 DEEFNARVGNFGMARCVNDD-------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN  577 (600)
Q Consensus       520 d~~~~~kI~DFGla~~~~~~-------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~  577 (600)
                      +.++.+||+|||+++.....             +.+||....  ..++.++||||||+++|||++|+.||.
T Consensus       168 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~  236 (326)
T 3uim_A          168 DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLST--GKSSEKTDVFGYGVMLLELITGQRAFD  236 (326)
T ss_dssp             CTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHH--SEECHHHHHHHHHHHHHHHHHCCCSBC
T ss_pred             CCCCCEEeccCccccccCcccccccccccCCcCccCHHHhcc--CCCCccccchhHHHHHHHHHhCCCccc
Confidence            99999999999999765322             124444433  346788999999999999999999996

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=99.97  E-value=1.1e-30  Score=270.38  Aligned_cols=174  Identities=25%  Similarity=0.439  Sum_probs=143.3

Q ss_pred             EEEEEEEECCeEEEEEEcchhHH--HHHHHHHHHHHhCCCCceeeeeeEEeccC---CceEEEEeecCCCCHHHHHhcCc
Q 041830          392 GAVYHGRLNGKNLAIKRTEHEVI--TKLEMQLVQHATHHHPNIVRLLGTCLTDG---PHSFLVFEYAKNGSLKDWLHGGL  466 (600)
Q Consensus       392 G~Vy~g~~~g~~vAvK~~~~~~~--~~~e~ei~~~~~l~HpNIv~l~g~~~~~~---~~~~LV~Ey~~~GsL~~~L~~~~  466 (600)
                      |.||+|++.|+.||||+++....  ...+.|+..+..++||||+++++++....   ..+++||||+++|+|.++++.. 
T Consensus        38 g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-  116 (322)
T 3soc_A           38 GCVWKAQLLNEYVAVKIFPIQDKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-  116 (322)
T ss_dssp             CEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC-
T ss_pred             eEEEEEEECCCEEEEEEeecCchHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHhc-
Confidence            99999999999999999865432  34567888888899999999999987643   2379999999999999999753 


Q ss_pred             CcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCC----------CceecCCCCCCEEeCCCCcEEEEeccCcccc
Q 041830          467 AMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNP----------SYVHRNIKSRNIFLDEEFNARVGNFGMARCV  536 (600)
Q Consensus       467 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~----------~ivHrDLk~~NILld~~~~~kI~DFGla~~~  536 (600)
                                  .++|.+++.++.|++.||.|||   +.          +|+||||||+|||++.++.+||+|||+++..
T Consensus       117 ------------~~~~~~~~~i~~qi~~al~~LH---~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~  181 (322)
T 3soc_A          117 ------------VVSWNELCHIAETMARGLAYLH---EDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKF  181 (322)
T ss_dssp             ------------CBCHHHHHHHHHHHHHHHHHHT---CCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEE
T ss_pred             ------------CCCHHHHHHHHHHHHHHHHHHH---hhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCccccc
Confidence                        2899999999999999999999   66          9999999999999999999999999999754


Q ss_pred             CCC--------------CCCCcccccC---CCCCCccCchHHHHHHHHHHHhCCCCCCCCCC
Q 041830          537 NDD--------------TESPQFYSTN---PASWSMGIDIFAYGIVLLEVLSGQTPINRPRK  581 (600)
Q Consensus       537 ~~~--------------~~~pe~~~~~---~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~  581 (600)
                      ...              +.+||.....   ...++.++|||||||++|||++|+.||....+
T Consensus       182 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~  243 (322)
T 3soc_A          182 EAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVD  243 (322)
T ss_dssp             CTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCC
T ss_pred             ccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcc
Confidence            321              1245544321   12345678999999999999999999976443

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=99.97  E-value=3.3e-30  Score=277.79  Aligned_cols=174  Identities=23%  Similarity=0.285  Sum_probs=145.7

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhHH------HHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEVI------TKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~~------~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      |.||+++.  +|+.||+|+++....      ..+..|...+..++||||+++++++.++ ...|||||||++|+|.++++
T Consensus        88 G~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~-~~~~lV~Ey~~gg~L~~~l~  166 (437)
T 4aw2_A           88 GEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDD-NNLYLVMDYYVGGDLLTLLS  166 (437)
T ss_dssp             EEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECS-SEEEEEECCCTTCBHHHHHH
T ss_pred             EEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeC-CEEEEEEecCCCCcHHHHHH
Confidence            99999999  579999999876332      1267788888999999999999998665 58999999999999999997


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD----  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~----  539 (600)
                      ...           ..+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....    
T Consensus       167 ~~~-----------~~l~e~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~  232 (437)
T 4aw2_A          167 KFE-----------DRLPEEMARFYLAEMVIAIDSVH---QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ  232 (437)
T ss_dssp             TTT-----------TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCEE
T ss_pred             Hcc-----------CCCCHHHHHHHHHHHHHHHHHHH---hCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCcc
Confidence            632           23899999999999999999999   669999999999999999999999999999754321    


Q ss_pred             ---------CCCCccccc---CCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 ---------TESPQFYST---NPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 ---------~~~pe~~~~---~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                               +.+||....   ....++.++|||||||+||||++|+.||...+
T Consensus       233 ~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~  285 (437)
T 4aw2_A          233 SSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAES  285 (437)
T ss_dssp             CCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             cccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCC
Confidence                     234555431   13457889999999999999999999997543

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=99.97  E-value=1.4e-29  Score=259.25  Aligned_cols=169  Identities=25%  Similarity=0.477  Sum_probs=144.3

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhH---HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCc
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEV---ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGL  466 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~---~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~  466 (600)
                      |.||+++.  +|+.||||++....   .+.+.+|+..+..++||||+++++++... +..++||||+++|+|.+++... 
T Consensus        34 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~-  111 (297)
T 3fxz_A           34 GTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-DELWVVMEYLAGGSLTDVVTET-  111 (297)
T ss_dssp             EEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEECCTTCBHHHHHHHS-
T ss_pred             eEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCCCCCCCeEeEEEEEC-CEEEEEEECCCCCCHHHHHhhc-
Confidence            99999986  78999999875432   34577899999999999999999998665 4899999999999999999753 


Q ss_pred             CcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-------
Q 041830          467 AMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-------  539 (600)
Q Consensus       467 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-------  539 (600)
                                  .+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....       
T Consensus       112 ------------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  176 (297)
T 3fxz_A          112 ------------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM  176 (297)
T ss_dssp             ------------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCCC
T ss_pred             ------------CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccCCc
Confidence                        2899999999999999999999   569999999999999999999999999998765432       


Q ss_pred             -----CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 -----TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 -----~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                           +.+||....  ..++.++|||||||++|||++|+.||...
T Consensus       177 ~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~  219 (297)
T 3fxz_A          177 VGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNE  219 (297)
T ss_dssp             CSCGGGCCHHHHHC--SCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             cCCcCccChhhhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                 124555443  45688999999999999999999999754

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=99.97  E-value=8.3e-30  Score=261.28  Aligned_cols=197  Identities=31%  Similarity=0.559  Sum_probs=164.1

Q ss_pred             ccccCHHHHHHHHhccCCC------Ccee----EEEEEEEECCeEEEEEEcch-------hHHHHHHHHHHHHHhCCCCc
Q 041830          369 LESYSIEDLRRATEKFNSS------NRIE----GAVYHGRLNGKNLAIKRTEH-------EVITKLEMQLVQHATHHHPN  431 (600)
Q Consensus       369 ~~~~~~~el~~~t~~f~~~------~~~~----G~Vy~g~~~g~~vAvK~~~~-------~~~~~~e~ei~~~~~l~HpN  431 (600)
                      ...|+++++.+++++|...      ..+|    |.||+|+.+++.||||++..       +....+.+|+..+..++|||
T Consensus        12 ~~~~~~~~l~~~~~~f~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~   91 (307)
T 2nru_A           12 FHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHEN   91 (307)
T ss_dssp             CEECCHHHHHHHTTTTCCSBTTTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTT
T ss_pred             CCcccHHHHHHHHcccccccccccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCC
Confidence            3668999999999999876      4444    99999999999999998743       23456788999999999999


Q ss_pred             eeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecC
Q 041830          432 IVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRN  511 (600)
Q Consensus       432 Iv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrD  511 (600)
                      |+++++++... ...++||||+++|+|.+++.....         ...++|.+++.++.|++.||.|||   +.+++|||
T Consensus        92 i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~---------~~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~d  158 (307)
T 2nru_A           92 LVELLGFSSDG-DDLCLVYVYMPNGSLLDRLSCLDG---------TPPLSWHMRCKIAQGAANGINFLH---ENHHIHRD  158 (307)
T ss_dssp             BCCEEEEECSS-SSCEEEEECCTTCBHHHHHHTGGG---------CCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSC
T ss_pred             eEEEEEEEecC-CceEEEEEecCCCcHHHHHHhccC---------CCCCCHHHHHHHHHHHHHHHHHHh---cCCeecCC
Confidence            99999997655 488999999999999999975321         134899999999999999999999   56999999


Q ss_pred             CCCCCEEeCCCCcEEEEeccCccccCCC--------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCC
Q 041830          512 IKSRNIFLDEEFNARVGNFGMARCVNDD--------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN  577 (600)
Q Consensus       512 Lk~~NILld~~~~~kI~DFGla~~~~~~--------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~  577 (600)
                      |||+||+++.++.+||+|||+++.....              +.+||....   .++.++||||||+++|||++|+.||.
T Consensus       159 lkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~---~~~~~~Dv~slG~il~~l~~g~~p~~  235 (307)
T 2nru_A          159 IKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG---EITPKSDIYSFGVVLLEIITGLPAVD  235 (307)
T ss_dssp             CCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT---EECTHHHHHHHHHHHHHHHHCCCSBC
T ss_pred             CCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC---CCCccchhHHHHHHHHHHHHCCCCcc
Confidence            9999999999999999999998754321              124444322   35778999999999999999999998


Q ss_pred             CCCC
Q 041830          578 RPRK  581 (600)
Q Consensus       578 ~~~~  581 (600)
                      ....
T Consensus       236 ~~~~  239 (307)
T 2nru_A          236 EHRE  239 (307)
T ss_dssp             TTBS
T ss_pred             cCcc
Confidence            6543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=99.97  E-value=6.9e-30  Score=264.45  Aligned_cols=191  Identities=24%  Similarity=0.408  Sum_probs=156.5

Q ss_pred             cccCHHHHHHHHhccCCCC----------ce----eEEEEEEEE--CCeEEEEEEcchh---HHHHHHHHHHHHHhCCCC
Q 041830          370 ESYSIEDLRRATEKFNSSN----------RI----EGAVYHGRL--NGKNLAIKRTEHE---VITKLEMQLVQHATHHHP  430 (600)
Q Consensus       370 ~~~~~~el~~~t~~f~~~~----------~~----~G~Vy~g~~--~g~~vAvK~~~~~---~~~~~e~ei~~~~~l~Hp  430 (600)
                      ..+++++++.+++......          .+    .|.||+|+.  +|+.||||+++..   ..+.+.+|+..+..++||
T Consensus        23 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~  102 (321)
T 2c30_A           23 GVVTHEQFKAALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHF  102 (321)
T ss_dssp             --CCHHHHHHHHHTTSCSSCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCCCT
T ss_pred             CcCcHHHHHHHHhhccCCCCchhhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCCCC
Confidence            4578888888887643321          12    299999998  6999999997643   234577899999999999


Q ss_pred             ceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceec
Q 041830          431 NIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHR  510 (600)
Q Consensus       431 NIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHr  510 (600)
                      ||+++++++... ...++||||+++|+|.+++...             .++|.++..++.|++.||.|||   +.+|+||
T Consensus       103 niv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~-------------~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~  165 (321)
T 2c30_A          103 NVVEMYKSYLVG-EELWVLMEFLQGGALTDIVSQV-------------RLNEEQIATVCEAVLQALAYLH---AQGVIHR  165 (321)
T ss_dssp             TBCCEEEEEEET-TEEEEEECCCCSCBHHHHHTTC-------------CCCHHHHHHHHHHHHHHHHHHH---HTTEECC
T ss_pred             CcceEEEEEEEC-CEEEEEEecCCCCCHHHHHHhc-------------CCCHHHHHHHHHHHHHHHHHHH---HCCeecC
Confidence            999999998765 4899999999999999998643             3899999999999999999999   5699999


Q ss_pred             CCCCCCEEeCCCCcEEEEeccCccccCCC------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          511 NIKSRNIFLDEEFNARVGNFGMARCVNDD------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       511 DLk~~NILld~~~~~kI~DFGla~~~~~~------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                      ||||+|||++.++.+||+|||+++.....            +.+||....  ..++.++||||||+++|||++|+.||..
T Consensus       166 Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Dv~slG~il~el~~g~~pf~~  243 (321)
T 2c30_A          166 DIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISR--SLYATEVDIWSLGIMVIEMVDGEPPYFS  243 (321)
T ss_dssp             CCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             CCCHHHEEECCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence            99999999999999999999998765332            124555433  4567889999999999999999999965


Q ss_pred             C
Q 041830          579 P  579 (600)
Q Consensus       579 ~  579 (600)
                      .
T Consensus       244 ~  244 (321)
T 2c30_A          244 D  244 (321)
T ss_dssp             S
T ss_pred             C
Confidence            3

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=99.97  E-value=1.9e-29  Score=259.21  Aligned_cols=172  Identities=25%  Similarity=0.449  Sum_probs=146.1

Q ss_pred             eEEEEEEEE--CCeEEEEEEcch---hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcC
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEH---EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGG  465 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~---~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~  465 (600)
                      .|.||+++.  +|+.||+|.+..   +....+.+|+..+..++||||+++++++..+ ...++||||+++|+|.++++..
T Consensus        23 ~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~  101 (310)
T 3s95_A           23 FGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKD-KRLNFITEYIKGGTLRGIIKSM  101 (310)
T ss_dssp             SEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEEEEECCTTCBHHHHHHHC
T ss_pred             CEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecC-CeeEEEEEecCCCcHHHHHHhc
Confidence            399999998  589999998743   3445678999999999999999999998765 4899999999999999999764


Q ss_pred             cCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC------
Q 041830          466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD------  539 (600)
Q Consensus       466 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~------  539 (600)
                      .           ..++|.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....      
T Consensus       102 ~-----------~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  167 (310)
T 3s95_A          102 D-----------SQYPWSQRVSFAKDIASGMAYLH---SMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEG  167 (310)
T ss_dssp             C-----------TTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--------
T ss_pred             c-----------CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCcCeEEECCCCCEEEeecccceecccccccccc
Confidence            3           34899999999999999999999   668999999999999999999999999999754221      


Q ss_pred             --------------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 --------------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 --------------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                          +.+||....  ..++.++||||||+++|||++|..||...
T Consensus       168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~~~~~~  225 (310)
T 3s95_A          168 LRSLKKPDRKKRYTVVGNPYWMAPEMING--RSYDEKVDVFSFGIVLCEIIGRVNADPDY  225 (310)
T ss_dssp             ------------CCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHTCCSSTTT
T ss_pred             cccccccccccccccCCCcceeCHHHhcC--CCCCcHHHHHHHHHHHHHHhcCCCCCcch
Confidence                                234555443  45678899999999999999999998754

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=99.96  E-value=7.5e-30  Score=262.77  Aligned_cols=173  Identities=29%  Similarity=0.484  Sum_probs=142.4

Q ss_pred             EEEEEEEECCeEEEEEEcch-----hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCc
Q 041830          392 GAVYHGRLNGKNLAIKRTEH-----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGL  466 (600)
Q Consensus       392 G~Vy~g~~~g~~vAvK~~~~-----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~  466 (600)
                      |.||+++.+|+.||||.+..     +....+.+|+..+..++||||+++++++... ...++||||+++|+|.+++....
T Consensus        51 g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~  129 (309)
T 3p86_A           51 GTVHRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQP-PNLSIVTEYLSRGSLYRLLHKSG  129 (309)
T ss_dssp             EEEEEEEETTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST-TCCEEEEECCTTCBHHHHHHSTT
T ss_pred             eEEEEEEECCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-CceEEEEecCCCCcHHHHHhhcC
Confidence            99999999999999999743     2335678899999999999999999997655 47899999999999999997643


Q ss_pred             CcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCC--ceecCCCCCCEEeCCCCcEEEEeccCccccCC------
Q 041830          467 AMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS--YVHRNIKSRNIFLDEEFNARVGNFGMARCVND------  538 (600)
Q Consensus       467 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDLk~~NILld~~~~~kI~DFGla~~~~~------  538 (600)
                      ..         ..+++.+++.++.|++.||+|||   +.+  |+||||||+|||++.++.+||+|||+++....      
T Consensus       130 ~~---------~~~~~~~~~~i~~qi~~aL~~LH---~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~  197 (309)
T 3p86_A          130 AR---------EQLDERRRLSMAYDVAKGMNYLH---NRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSK  197 (309)
T ss_dssp             HH---------HHSCHHHHHHHHHHHHHHHHHHH---TSSSCCCCTTCCGGGEEECTTCCEEECCCC-------------
T ss_pred             CC---------CCCCHHHHHHHHHHHHHHHHHHH---cCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccccccc
Confidence            11         23899999999999999999999   556  99999999999999999999999999864322      


Q ss_pred             ------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 ------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 ------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                            .+.+||....  ..++.++|||||||++|||++|+.||...
T Consensus       198 ~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~Pf~~~  242 (309)
T 3p86_A          198 SAAGTPEWMAPEVLRD--EPSNEKSDVYSFGVILWELATLQQPWGNL  242 (309)
T ss_dssp             ----CCTTSCHHHHTT--CCCCTTHHHHHHHHHHHHHHHCCCTTTTS
T ss_pred             cCCCCccccChhhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence                  2335665544  44678899999999999999999999754

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=99.96  E-value=4.1e-30  Score=270.79  Aligned_cols=175  Identities=14%  Similarity=0.165  Sum_probs=145.8

Q ss_pred             eEEEEEEE-------ECCeEEEEEEcchhHHHHHHHHHHHHHhCC---CCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          391 EGAVYHGR-------LNGKNLAIKRTEHEVITKLEMQLVQHATHH---HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       391 ~G~Vy~g~-------~~g~~vAvK~~~~~~~~~~e~ei~~~~~l~---HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      +|.||+|.       .+++.||||+++.....++.+|+..+..++   |+||+++++++..+ +..++|||||++|+|.+
T Consensus        78 ~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~-~~~~lv~e~~~~g~L~~  156 (365)
T 3e7e_A           78 FAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ-NGSVLVGELYSYGTLLN  156 (365)
T ss_dssp             SEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS-SCEEEEECCCCSCBHHH
T ss_pred             CEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC-CCcEEEEeccCCCcHHH
Confidence            39999993       278899999998776667778888777777   89999999998766 48899999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC-----------CCcEEEEe
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE-----------EFNARVGN  529 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~-----------~~~~kI~D  529 (600)
                      +++......       ...++|.+++.|+.||+.||+|||   +.+|+||||||+|||++.           ++.+||+|
T Consensus       157 ~l~~~~~~~-------~~~l~~~~~~~i~~qi~~~L~~lH---~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~D  226 (365)
T 3e7e_A          157 AINLYKNTP-------EKVMPQGLVISFAMRMLYMIEQVH---DCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALID  226 (365)
T ss_dssp             HHHHHHTST-------TCSCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECGGGTCC------CTTEEECC
T ss_pred             HHHHhhccc-------ccCCCHHHHHHHHHHHHHHHHHHh---hCCeecCCCCHHHEEecccccCccccccccCCEEEee
Confidence            997532110       134999999999999999999999   679999999999999998           89999999


Q ss_pred             ccCccccC--------------CCCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          530 FGMARCVN--------------DDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       530 FGla~~~~--------------~~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                      ||+++...              ..+.+||....  ..++.++|||||||++|||++|+.||..
T Consensus       227 FG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~  287 (365)
T 3e7e_A          227 LGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN--KPWNYQIDYFGVAATVYCMLFGTYMKVK  287 (365)
T ss_dssp             CTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT--CCBSTHHHHHHHHHHHHHHHHSSCCCEE
T ss_pred             CchhhhhhccCCCceeeeecCCCCCCChHHhcC--CCCCccccHHHHHHHHHHHHhCCCcccc
Confidence            99996432              22346676654  3478899999999999999999999854

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=99.96  E-value=1.3e-29  Score=259.04  Aligned_cols=171  Identities=25%  Similarity=0.403  Sum_probs=144.7

Q ss_pred             EEEEEEEE--CCeEEEEEEcc------hhHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          392 GAVYHGRL--NGKNLAIKRTE------HEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~------~~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      |.||+++.  +|+.||+|.+.      .+..+.+++|+..+..++||||+++++++..+ ...|+||||+++|+|.+++.
T Consensus        25 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~g~~L~~~l~  103 (294)
T 4eqm_A           25 STVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEED-DCYYLVMEYIEGPTLSEYIE  103 (294)
T ss_dssp             EEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECS-SEEEEEEECCCSCBHHHHHH
T ss_pred             EEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeC-CeEEEEEeCCCCCCHHHHHH
Confidence            99999997  68899999863      23345678999999999999999999997655 48999999999999999997


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC-----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND-----  538 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~-----  538 (600)
                      ...            .+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....     
T Consensus       104 ~~~------------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  168 (294)
T 4eqm_A          104 SHG------------PLSVDTAINFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ  168 (294)
T ss_dssp             HHC------------SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-------
T ss_pred             hcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccccc
Confidence            542            3899999999999999999999   56999999999999999999999999999975432     


Q ss_pred             --------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          539 --------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       539 --------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                              .+.+||....  ..++.++||||||+++|||++|+.||....
T Consensus       169 ~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  216 (294)
T 4eqm_A          169 TNHVLGTVQYFSPEQAKG--EATDECTDIYSIGIVLYEMLVGEPPFNGET  216 (294)
T ss_dssp             ------CCSSCCHHHHHT--CCCCTTHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred             cCccccCccccCHhHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence                    2235565544  346788999999999999999999997643

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=99.96  E-value=6.9e-30  Score=268.11  Aligned_cols=171  Identities=22%  Similarity=0.371  Sum_probs=142.0

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      |.||+++.  +|+.||||.++...      ...+..|...+..+ .||||+++++++..+ ...|+||||+++|+|.+++
T Consensus        37 g~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~-~~~~lv~E~~~gg~L~~~l  115 (353)
T 3txo_A           37 GKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTP-DRLFFVMEFVNGGDLMFHI  115 (353)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEEEEEECCCSCBHHHHH
T ss_pred             EEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeC-CEEEEEEeCCCCCcHHHHH
Confidence            99999998  68999999987543      23455677777776 699999999997655 4899999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC---
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---  539 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~---  539 (600)
                      ....            .+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....   
T Consensus       116 ~~~~------------~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~  180 (353)
T 3txo_A          116 QKSR------------RFDEARARFYAAEIISALMFLH---DKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVT  180 (353)
T ss_dssp             HHHS------------SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC----
T ss_pred             HHcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCCHHHEEECCCCCEEEccccceeecccCCcc
Confidence            7543            3899999999999999999999   569999999999999999999999999999853211   


Q ss_pred             ---------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 ---------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 ---------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                               +.+||....  ..++.++|||||||++|||++|+.||...+
T Consensus       181 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~  228 (353)
T 3txo_A          181 TATFCGTPDYIAPEILQE--MLYGPAVDWWAMGVLLYEMLCGHAPFEAEN  228 (353)
T ss_dssp             -----CCGGGCCHHHHHH--HHCTTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccccCCCcCeEChhhcCC--CCcCCccCCCcchHHHHHHHhCCCCCCCCC
Confidence                     224554433  346788999999999999999999997643

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=99.96  E-value=8.8e-30  Score=264.60  Aligned_cols=173  Identities=25%  Similarity=0.442  Sum_probs=145.3

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      .|.||+++.  +|+.||||++...     ...++.+|+..+..++||||+++++++..+ ...|+||||+++|+|.+++.
T Consensus        28 ~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-~~~~lv~e~~~~~~L~~~l~  106 (328)
T 3fe3_A           28 FAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETE-KTLYLIMEYASGGEVFDYLV  106 (328)
T ss_dssp             SEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEECCCTTCBHHHHHH
T ss_pred             CEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-CEEEEEEECCCCCcHHHHHH
Confidence            399999998  7999999997542     234577899999999999999999998655 48999999999999999997


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD----  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~----  539 (600)
                      ...            .+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....    
T Consensus       107 ~~~------------~l~~~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~  171 (328)
T 3fe3_A          107 AHG------------RMKEKEARSKFRQIVSAVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLD  171 (328)
T ss_dssp             HHC------------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGGG
T ss_pred             HcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCccc
Confidence            543            3899999999999999999999   569999999999999999999999999999754322    


Q ss_pred             -------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 -------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 -------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                             +.+||..... ...+.++|||||||++|||++|+.||...+
T Consensus       172 ~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~~  218 (328)
T 3fe3_A          172 AFCGAPPYAAPELFQGK-KYDGPEVDVWSLGVILYTLVSGSLPFDGQN  218 (328)
T ss_dssp             TTSSSGGGCCHHHHHTC-CCCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cccCCcceeCcccccCC-CcCCchhhhhhhHHHHHHHHhCCCCCCCCC
Confidence                   2345555432 223468999999999999999999997543

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=99.96  E-value=5e-30  Score=274.24  Aligned_cols=172  Identities=23%  Similarity=0.313  Sum_probs=144.4

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhHH------HHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEVI------TKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~~------~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      |.||+++.  +|+.||+|+++....      ..+.+|+..+..++|||||++++++.++ ...|+||||+++|+|.++++
T Consensus        83 G~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-~~~~lV~E~~~gg~L~~~l~  161 (410)
T 3v8s_A           83 GEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDD-RYLYMVMEYMPGGDLVNLMS  161 (410)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEECCCTTEEHHHHHH
T ss_pred             EEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-CEEEEEEeCCCCCcHHHHHH
Confidence            99999998  688999999876332      2366788889999999999999998655 58999999999999999997


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD----  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~----  539 (600)
                      ..             .+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....    
T Consensus       162 ~~-------------~~~e~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~~  225 (410)
T 3v8s_A          162 NY-------------DVPEKWARFYTAEVVLALDAIH---SMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVR  225 (410)
T ss_dssp             HC-------------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEEE
T ss_pred             cC-------------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCccc
Confidence            53             2899999999999999999999   569999999999999999999999999999755332    


Q ss_pred             ---------CCCCcccccCC--CCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 ---------TESPQFYSTNP--ASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 ---------~~~pe~~~~~~--~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                               +.+||......  ..++.++|||||||+||||++|+.||...+
T Consensus       226 ~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~  277 (410)
T 3v8s_A          226 CDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS  277 (410)
T ss_dssp             CCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             ccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCC
Confidence                     23455554322  126788999999999999999999997543

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=99.96  E-value=8e-30  Score=260.31  Aligned_cols=175  Identities=26%  Similarity=0.419  Sum_probs=139.3

Q ss_pred             EEEEEEEECCeEEEEEEcchhHHHHHHH--HHHHHHhCCCCceeeeeeEEecc---CCceEEEEeecCCCCHHHHHhcCc
Q 041830          392 GAVYHGRLNGKNLAIKRTEHEVITKLEM--QLVQHATHHHPNIVRLLGTCLTD---GPHSFLVFEYAKNGSLKDWLHGGL  466 (600)
Q Consensus       392 G~Vy~g~~~g~~vAvK~~~~~~~~~~e~--ei~~~~~l~HpNIv~l~g~~~~~---~~~~~LV~Ey~~~GsL~~~L~~~~  466 (600)
                      |.||+|+++|+.||||++.......+..  |+.....++||||+++++++...   ....++||||+++|+|.++++.. 
T Consensus        22 g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-  100 (301)
T 3q4u_A           22 GEVWRGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-  100 (301)
T ss_dssp             EEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHTTC-
T ss_pred             cEEEEEEECCEEEEEEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHhhc-
Confidence            9999999999999999987665444444  44444448999999999997643   23579999999999999999643 


Q ss_pred             CcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--
Q 041830          467 AMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM-----NPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--  539 (600)
Q Consensus       467 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--  539 (600)
                                  .+++.++++++.|++.||+|||...     +.+|+||||||+|||++.++.+||+|||+++.....  
T Consensus       101 ------------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~  168 (301)
T 3q4u_A          101 ------------TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTN  168 (301)
T ss_dssp             ------------CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTT
T ss_pred             ------------ccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeecccccc
Confidence                        3899999999999999999999321     458999999999999999999999999998643221  


Q ss_pred             --------------CCCCcccccCCC----CCCccCchHHHHHHHHHHHhC----------CCCCCCC
Q 041830          540 --------------TESPQFYSTNPA----SWSMGIDIFAYGIVLLEVLSG----------QTPINRP  579 (600)
Q Consensus       540 --------------~~~pe~~~~~~~----~~t~~sDVwSfGvvL~ELltG----------~~Pf~~~  579 (600)
                                    +.+||.......    .++.++|||||||++|||++|          +.||...
T Consensus       169 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~  236 (301)
T 3q4u_A          169 QLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV  236 (301)
T ss_dssp             EEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             cccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence                          234555443211    344689999999999999999          8888654

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=99.96  E-value=1.2e-29  Score=263.05  Aligned_cols=172  Identities=23%  Similarity=0.389  Sum_probs=140.2

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhHHHHHHHHHHHHHhCC-CCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcC
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEVITKLEMQLVQHATHH-HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLA  467 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~~~~~e~ei~~~~~l~-HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~  467 (600)
                      .|.||+++.  +|+.||||.++.......++|+..+..+. ||||+++++++.++ ...|+||||+++|+|.+++.... 
T Consensus        24 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~-  101 (325)
T 3kn6_A           24 FSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQ-LHTFLVMELLNGGELFERIKKKK-  101 (325)
T ss_dssp             TEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHHHHCS-
T ss_pred             CeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcC-CEEEEEEEccCCCcHHHHHHhcC-
Confidence            399999998  68999999998877677788999999887 99999999998655 48899999999999999997643 


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC---cEEEEeccCccccCCC-----
Q 041830          468 MKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEF---NARVGNFGMARCVNDD-----  539 (600)
Q Consensus       468 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~---~~kI~DFGla~~~~~~-----  539 (600)
                                 .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++   .+||+|||+++.....     
T Consensus       102 -----------~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~  167 (325)
T 3kn6_A          102 -----------HFSETEASYIMRKLVSAVSHMH---DVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLK  167 (325)
T ss_dssp             -----------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred             -----------CCCHHHHHHHHHHHHHHHHHHH---HCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCccc
Confidence                       3899999999999999999999   66999999999999997655   8999999999754322     


Q ss_pred             -------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 -------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 -------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                             +.+||....  ..++.++|||||||++|||++|+.||...+
T Consensus       168 ~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~  213 (325)
T 3kn6_A          168 TPCFTLHYAAPELLNQ--NGYDESCDLWSLGVILYTMLSGQVPFQSHD  213 (325)
T ss_dssp             ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred             ccCCCcCccCHHHhcC--CCCCCccchHHHHHHHHHHHhCCCCCCCCc
Confidence                   235665543  457888999999999999999999997643

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=99.96  E-value=8e-30  Score=276.40  Aligned_cols=175  Identities=27%  Similarity=0.497  Sum_probs=149.7

Q ss_pred             eEEEEEEEECCeEEEEEEcchhH-HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcCcc
Q 041830          391 EGAVYHGRLNGKNLAIKRTEHEV-ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMK  469 (600)
Q Consensus       391 ~G~Vy~g~~~g~~vAvK~~~~~~-~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~  469 (600)
                      .|.||+|.++|+.||||.++.+. .+.+.+|+..+..++||||++++|++..+....++|||||++|+|.++++....  
T Consensus       206 fg~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~--  283 (450)
T 1k9a_A          206 FGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR--  283 (450)
T ss_dssp             SEEEEEEEETTEEEEEEEESSCTTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCT--
T ss_pred             CeeEEEEEecCCeEEEEEeCCchHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCC--
Confidence            39999999999999999987643 356789999999999999999999987765578999999999999999976432  


Q ss_pred             cccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC---------CC
Q 041830          470 NQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND---------DT  540 (600)
Q Consensus       470 ~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~---------~~  540 (600)
                              ..+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....         .+
T Consensus       284 --------~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~y  352 (450)
T 1k9a_A          284 --------SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKW  352 (450)
T ss_dssp             --------TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTSCEEECCCTTCEECC------CCCTTT
T ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccccCCCCCcce
Confidence                    23799999999999999999999   66999999999999999999999999999975432         23


Q ss_pred             CCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCCC
Q 041830          541 ESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRPR  580 (600)
Q Consensus       541 ~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~~  580 (600)
                      .+||....  ..++.++|||||||+||||++ |+.||....
T Consensus       353 ~aPE~~~~--~~~~~~sDvwslG~~l~el~t~g~~P~~~~~  391 (450)
T 1k9a_A          353 TAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRIP  391 (450)
T ss_dssp             SCHHHHHS--SCCCHHHHHHHHHHHHHHHHTTTCCSSTTSC
T ss_pred             eCHHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence            45666544  457889999999999999999 999997644

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=99.96  E-value=1.9e-29  Score=263.08  Aligned_cols=171  Identities=23%  Similarity=0.350  Sum_probs=145.6

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||+++.  +|+.||+|.++.+.      ...+..|+..+..++||||+++++++... ...|+||||+++|+|.+++
T Consensus        18 fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~-~~~~lv~E~~~gg~L~~~l   96 (337)
T 1o6l_A           18 FGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-DRLCFVMEYANGGELFFHL   96 (337)
T ss_dssp             SEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS-SEEEEEEECCTTCBHHHHH
T ss_pred             CeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeC-CEEEEEEeCCCCCcHHHHH
Confidence            399999998  68999999986543      23567888899999999999999998655 4899999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC----
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND----  538 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~----  538 (600)
                      ....            .+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....    
T Consensus        97 ~~~~------------~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~  161 (337)
T 1o6l_A           97 SRER------------VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             HHHS------------CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred             HhcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCc
Confidence            7532            3899999999999999999999   66999999999999999999999999999975322    


Q ss_pred             --------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 --------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 --------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                              .+.+||....  ..++.++|||||||++|||++|+.||...
T Consensus       162 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~  208 (337)
T 1o6l_A          162 MKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQ  208 (337)
T ss_dssp             BCCCEECGGGCCGGGGSS--SCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccccccChhhCChhhhcC--CCCCchhhcccchhHHHHHhcCCCCCCCC
Confidence                    1235666544  45788999999999999999999999754

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=99.96  E-value=1.8e-29  Score=261.02  Aligned_cols=171  Identities=28%  Similarity=0.483  Sum_probs=146.2

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||+++.  +|+.||+|.++...      ...+.+|...+..++||||+++++++.+. ...|+||||+++|+|.+++
T Consensus        19 ~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~-~~~~lv~e~~~gg~L~~~l   97 (318)
T 1fot_A           19 FGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA-QQIFMIMDYIEGGELFSLL   97 (318)
T ss_dssp             SCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHH
T ss_pred             CEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeC-CEEEEEEeCCCCCCHHHHH
Confidence            399999998  68999999987643      23466788889999999999999997655 4899999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC----
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND----  538 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~----  538 (600)
                      +...            .+++..+..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++....    
T Consensus        98 ~~~~------------~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~~~~  162 (318)
T 1fot_A           98 RKSQ------------RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT  162 (318)
T ss_dssp             HHTS------------SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCC
T ss_pred             HHcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChheEEEcCCCCEEEeecCcceecCCcccc
Confidence            7643            3899999999999999999999   77999999999999999999999999999976532    


Q ss_pred             -----CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 -----DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 -----~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                           .+.+||....  ..++.++|||||||++|||++|+.||...
T Consensus       163 ~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~  206 (318)
T 1fot_A          163 LCGTPDYIAPEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDS  206 (318)
T ss_dssp             CCSCTTTCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             ccCCccccCHhHhcC--CCCCcccchhhhHHHHHHHHhCCCCCCCC
Confidence                 2335665544  45788899999999999999999999754

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=99.96  E-value=1.1e-29  Score=270.38  Aligned_cols=171  Identities=21%  Similarity=0.393  Sum_probs=141.5

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhHH------HHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEVI------TKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~~------~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      .|.||+++.  +|+.||+|+++....      ..+..|...+..+ +||||+++++++..+ ...|+||||+++|+|.++
T Consensus        65 fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~-~~~~lV~E~~~gg~L~~~  143 (396)
T 4dc2_A           65 YAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-SRLFFVIEYVNGGDLMFH  143 (396)
T ss_dssp             SEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECS-SEEEEEEECCTTCBHHHH
T ss_pred             CeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEEC-CEEEEEEEcCCCCcHHHH
Confidence            399999998  688999999865421      2355666666554 799999999997655 489999999999999999


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC---
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND---  538 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~---  538 (600)
                      +....            .+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....   
T Consensus       144 l~~~~------------~l~~~~~~~~~~qi~~aL~~LH---~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~  208 (396)
T 4dc2_A          144 MQRQR------------KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD  208 (396)
T ss_dssp             HHHHS------------SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred             HHHcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEECCCCCEEEeecceeeecccCCC
Confidence            97543            3899999999999999999999   66999999999999999999999999999975321   


Q ss_pred             ---------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 ---------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 ---------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                               .+.+||....  ..++.++|||||||++|||++|+.||...
T Consensus       209 ~~~~~~gt~~Y~aPE~l~~--~~~~~~~DiwslGvllyell~G~~Pf~~~  256 (396)
T 4dc2_A          209 TTSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDIV  256 (396)
T ss_dssp             CBCCCCBCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred             ccccccCCcccCCchhhcC--CCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence                     1234555543  45788999999999999999999999643

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=99.96  E-value=2.3e-29  Score=263.35  Aligned_cols=170  Identities=22%  Similarity=0.392  Sum_probs=142.5

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh------HHHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE------VITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~------~~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      .|.||+++.  +|+.||+|.++..      ....+.+|...+..+ +||||+++++++..+ ...|+||||+++|+|.++
T Consensus        22 fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~-~~~~lv~e~~~gg~L~~~  100 (345)
T 3a8x_A           22 YAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTE-SRLFFVIEYVNGGDLMFH  100 (345)
T ss_dssp             SEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEEEEECCCCSCBHHHH
T ss_pred             CeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeC-CEEEEEEeCCCCCcHHHH
Confidence            399999998  6899999998643      223466777777776 899999999997655 489999999999999999


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC---
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND---  538 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~---  538 (600)
                      +....            .+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....   
T Consensus       101 l~~~~------------~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~  165 (345)
T 3a8x_A          101 MQRQR------------KLPEEHARFYSAEISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD  165 (345)
T ss_dssp             HHHHS------------SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTC
T ss_pred             HHHcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEEeccccccccCCCC
Confidence            97532            3899999999999999999999   66999999999999999999999999999975321   


Q ss_pred             ---------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          539 ---------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       539 ---------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                               .+.+||....  ..++.++|||||||++|||++|+.||..
T Consensus       166 ~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~  212 (345)
T 3a8x_A          166 TTSTFCGTPNYIAPEILRG--EDYGFSVDWWALGVLMFEMMAGRSPFDI  212 (345)
T ss_dssp             CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             cccccCCCccccCccccCC--CCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence                     1224555443  4578889999999999999999999965

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=99.96  E-value=2.5e-29  Score=267.08  Aligned_cols=177  Identities=24%  Similarity=0.331  Sum_probs=148.9

Q ss_pred             EEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      |.||+++.  +|+.||||+++..     ....+.+|+..+..++|||||++++++..+ ...++|||||++|+|.+++..
T Consensus        41 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~  119 (389)
T 3gni_B           41 MTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIAD-NELWVVTSFMAYGSAKDLICT  119 (389)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEECCTTCBHHHHHHH
T ss_pred             eEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEEC-CEEEEEEEccCCCCHHHHHhh
Confidence            89999999  6899999998643     235677899999999999999999998765 489999999999999999976


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC------
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND------  538 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~------  538 (600)
                      ...          ..+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||.+.....      
T Consensus       120 ~~~----------~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~  186 (389)
T 3gni_B          120 HFM----------DGMNELAIAYILQGVLKALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQR  186 (389)
T ss_dssp             TCT----------TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECS
T ss_pred             hcc----------cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEcccccceeecccccccc
Confidence            432          33899999999999999999999   56999999999999999999999999998753211      


Q ss_pred             -------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCCCC
Q 041830          539 -------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRKK  582 (600)
Q Consensus       539 -------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~~  582 (600)
                                   .+.+||........++.++|||||||++|||++|+.||...+..
T Consensus       187 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~  243 (389)
T 3gni_B          187 VVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPAT  243 (389)
T ss_dssp             CBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCST
T ss_pred             ccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHH
Confidence                         12456666554356788999999999999999999999765443

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=99.96  E-value=2.7e-30  Score=267.09  Aligned_cols=176  Identities=32%  Similarity=0.641  Sum_probs=146.6

Q ss_pred             eEEEEEEEE-CCeEEEEEEcchh---HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCc
Q 041830          391 EGAVYHGRL-NGKNLAIKRTEHE---VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGL  466 (600)
Q Consensus       391 ~G~Vy~g~~-~g~~vAvK~~~~~---~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~  466 (600)
                      .|.||+|+. +|+.||||++...   ....+++|+..+..++||||+++++++... ...++||||+++|+|.+++....
T Consensus        52 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~  130 (321)
T 2qkw_B           52 FGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDER-NEMILIYKYMENGNLKRHLYGSD  130 (321)
T ss_dssp             SSEEEEEECTTCCEEEEEECCSCCSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCT-TCCEEEEECCTTCBTGGGSSSSC
T ss_pred             CeeEEEEEECCCCEEEEEEecccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCC-CeEEEEEEcCCCCcHHHHHhccC
Confidence            399999998 6899999987542   345678899999999999999999997654 48899999999999999987543


Q ss_pred             CcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC--------
Q 041830          467 AMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND--------  538 (600)
Q Consensus       467 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~--------  538 (600)
                      ..        ...++|.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....        
T Consensus       131 ~~--------~~~~~~~~~~~i~~~i~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  199 (321)
T 2qkw_B          131 LP--------TMSMSWEQRLEICIGAARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST  199 (321)
T ss_dssp             CC--------SCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBC
T ss_pred             CC--------ccccCHHHHHHHHHHHHHHHHHhc---CCCeecCCCCHHHEEECCCCCEEEeeccccccccccccccccc
Confidence            21        134899999999999999999999   56999999999999999999999999999875422        


Q ss_pred             ------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          539 ------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       539 ------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                            .+.+||....  ..++.++||||||+++|||++|+.||....
T Consensus       200 ~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~p~~~~~  245 (321)
T 2qkw_B          200 VVKGTLGYIDPEYFIK--GRLTEKSDVYSFGVVLFEVLCARSAIVQSL  245 (321)
T ss_dssp             CCEEETTTCCHHHHHH--CBCCTHHHHHHHHHHHHHHHHCCTTCSCSS
T ss_pred             ccCCCccccCHHHhcC--CCCCcccchHhHHHHHHHHHhCCCcccccC
Confidence                  1234555443  356788999999999999999999997543

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=99.96  E-value=3.8e-29  Score=265.09  Aligned_cols=174  Identities=23%  Similarity=0.383  Sum_probs=147.6

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      +|.||+++.  +|+.||+|.+....      ...+.+|+..+..++|||||++++++... ...|+||||+++|+|.+++
T Consensus        28 fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-~~~~lv~e~~~gg~L~~~l  106 (384)
T 4fr4_A           28 FGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDE-EDMFMVVDLLLGGDLRYHL  106 (384)
T ss_dssp             TCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEEEECCCTTEEHHHHH
T ss_pred             CeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-CEEEEEEecCCCCcHHHHH
Confidence            399999998  68899999986543      23567899999999999999999998655 4899999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC---
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---  539 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~---  539 (600)
                      ....            .+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....   
T Consensus       107 ~~~~------------~l~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~  171 (384)
T 4fr4_A          107 QQNV------------HFKEETVKLFICELVMALDYLQ---NQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI  171 (384)
T ss_dssp             HTTC------------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCCB
T ss_pred             HhcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCce
Confidence            7643            3899999999999999999999   669999999999999999999999999999865322   


Q ss_pred             --------CCCCcccccC-CCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 --------TESPQFYSTN-PASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 --------~~~pe~~~~~-~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                              +.+||..... ...++.++|||||||++|||++|+.||....
T Consensus       172 ~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~  221 (384)
T 4fr4_A          172 TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS  221 (384)
T ss_dssp             CCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCT
T ss_pred             eccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCC
Confidence                    2356665432 2457889999999999999999999997543

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=99.96  E-value=8.6e-30  Score=272.59  Aligned_cols=192  Identities=23%  Similarity=0.276  Sum_probs=152.3

Q ss_pred             HHHHHHHHhccCCCCce----eEEEEEEEE--CCeEEEEEEcchhHH------HHHHHHHHHHHhCCCCceeeeeeEEec
Q 041830          374 IEDLRRATEKFNSSNRI----EGAVYHGRL--NGKNLAIKRTEHEVI------TKLEMQLVQHATHHHPNIVRLLGTCLT  441 (600)
Q Consensus       374 ~~el~~~t~~f~~~~~~----~G~Vy~g~~--~g~~vAvK~~~~~~~------~~~e~ei~~~~~l~HpNIv~l~g~~~~  441 (600)
                      ++++....++|.....+    +|.||+++.  +|+.||||+++....      ..+..|...+..++||||+++++++.+
T Consensus        53 ~~~~~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~  132 (412)
T 2vd5_A           53 LKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQD  132 (412)
T ss_dssp             HHHHSCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEEC
T ss_pred             hhhccCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEee
Confidence            33444444555433333    399999998  689999999865321      236778888889999999999999765


Q ss_pred             cCCceEEEEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC
Q 041830          442 DGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE  521 (600)
Q Consensus       442 ~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~  521 (600)
                      + ...||||||+++|+|.++++...           ..+++..+..++.||+.||.|||   +.+|+||||||+|||++.
T Consensus       133 ~-~~~~lVmE~~~gg~L~~~l~~~~-----------~~l~~~~~~~~~~qi~~aL~~LH---~~giiHrDLKp~NILld~  197 (412)
T 2vd5_A          133 E-NYLYLVMEYYVGGDLLTLLSKFG-----------ERIPAEMARFYLAEIVMAIDSVH---RLGYVHRDIKPDNILLDR  197 (412)
T ss_dssp             S-SEEEEEECCCCSCBHHHHHHHHS-----------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECT
T ss_pred             C-CEEEEEEcCCCCCcHHHHHHhcC-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccCHHHeeecC
Confidence            5 48999999999999999997532           23899999999999999999999   669999999999999999


Q ss_pred             CCcEEEEeccCccccCCC-------------CCCCccccc-----CCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          522 EFNARVGNFGMARCVNDD-------------TESPQFYST-----NPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       522 ~~~~kI~DFGla~~~~~~-------------~~~pe~~~~-----~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                      ++.+||+|||+++.....             +.+||....     ....++.++|||||||++|||++|+.||...+
T Consensus       198 ~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~  274 (412)
T 2vd5_A          198 CGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS  274 (412)
T ss_dssp             TSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             CCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC
Confidence            999999999999765322             224554431     12357888999999999999999999997643

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=3.4e-29  Score=259.33  Aligned_cols=173  Identities=18%  Similarity=0.230  Sum_probs=145.6

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh--HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCc
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE--VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGL  466 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~--~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~  466 (600)
                      .|.||+++.  +|+.||+|.++..  ....+.+|+..+..++||||+++++++... ...++||||+++|+|.+++....
T Consensus        18 ~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~lv~e~~~g~~L~~~l~~~~   96 (321)
T 1tki_A           18 FGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESM-EELVMIFEFISGLDIFERINTSA   96 (321)
T ss_dssp             SEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEET-TEEEEEECCCCCCBHHHHHTSSS
T ss_pred             CeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCCCCCCCeEeEEEecC-CEEEEEEEeCCCCCHHHHHHhcC
Confidence            399999998  6899999987543  334577899999999999999999998655 48999999999999999997543


Q ss_pred             CcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC--CCcEEEEeccCccccCCC-----
Q 041830          467 AMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE--EFNARVGNFGMARCVNDD-----  539 (600)
Q Consensus       467 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~--~~~~kI~DFGla~~~~~~-----  539 (600)
                                 ..+++.++..++.|++.||.|||   +.+|+||||||+|||++.  ++.+||+|||+++.....     
T Consensus        97 -----------~~~~~~~~~~i~~qi~~al~~lH---~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~  162 (321)
T 1tki_A           97 -----------FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL  162 (321)
T ss_dssp             -----------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEE
T ss_pred             -----------CCCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcccc
Confidence                       24899999999999999999999   669999999999999987  789999999999866432     


Q ss_pred             ------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 ------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 ------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                            +.+||....  ..++.++|||||||++|||++|+.||....
T Consensus       163 ~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~~  207 (321)
T 1tki_A          163 LFTAPEYYAPEVHQH--DVVSTATDMWSLGTLVYVLLSGINPFLAET  207 (321)
T ss_dssp             EESCGGGSCHHHHTT--CEECHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             ccCChhhcCcHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCCcCCC
Confidence                  234554433  346788999999999999999999997643

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=99.96  E-value=2.1e-29  Score=263.51  Aligned_cols=171  Identities=23%  Similarity=0.415  Sum_probs=141.3

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      |.||+++.  +|+.||||.++...      ......|...+..+ +||||+++++++.++ ...|+||||+++|+|.+++
T Consensus        31 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~-~~~~lv~E~~~gg~L~~~l  109 (345)
T 1xjd_A           31 GKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK-ENLFFVMEYLNGGDLMYHI  109 (345)
T ss_dssp             SEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS-SEEEEEEECCTTCBHHHHH
T ss_pred             eEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeC-CEEEEEEeCCCCCcHHHHH
Confidence            99999998  68999999987643      23345566666544 899999999997655 4899999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC---
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---  539 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~---  539 (600)
                      ....            .+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....   
T Consensus       110 ~~~~------------~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~  174 (345)
T 1xjd_A          110 QSCH------------KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK  174 (345)
T ss_dssp             HHHS------------SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred             HHcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCc
Confidence            7532            3899999999999999999999   569999999999999999999999999999753211   


Q ss_pred             ---------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 ---------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 ---------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                               +.+||....  ..++.++|||||||++|||++|+.||...+
T Consensus       175 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~  222 (345)
T 1xjd_A          175 TNTFCGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD  222 (345)
T ss_dssp             BCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccCCCCCcccCChhhhcC--CCCCChhhhHHHHHHHHHHhcCCCCCCCCC
Confidence                     124555443  457888999999999999999999997543

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=99.96  E-value=4e-29  Score=257.99  Aligned_cols=178  Identities=25%  Similarity=0.365  Sum_probs=146.4

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH----HHHHHHHHHHHHhCCCCceeeeeeEEeccC-CceEEEEeecCCCCHHHHHh
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV----ITKLEMQLVQHATHHHPNIVRLLGTCLTDG-PHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~-~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      .|.||+++.  +|+.||||+++...    ...+.+|+..+..++||||+++++++.... ...++||||+++|+|.+++.
T Consensus        22 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~  101 (319)
T 4euu_A           22 TANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLE  101 (319)
T ss_dssp             SEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHH
T ss_pred             CeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHH
Confidence            399999999  58999999986532    345678999999999999999999986543 36799999999999999997


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEe----CCCCcEEEEeccCccccCCC
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFL----DEEFNARVGNFGMARCVNDD  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl----d~~~~~kI~DFGla~~~~~~  539 (600)
                      .....         ..+++.+++.++.|++.||+|||   +.+|+||||||+|||+    +.++.+||+|||+++.....
T Consensus       102 ~~~~~---------~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~  169 (319)
T 4euu_A          102 EPSNA---------YGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD  169 (319)
T ss_dssp             SGGGT---------TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTT
T ss_pred             Hhccc---------cCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCC
Confidence            64321         23899999999999999999999   6699999999999999    88889999999999865432


Q ss_pred             C-----------CCCccccc------CCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 T-----------ESPQFYST------NPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 ~-----------~~pe~~~~------~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                      .           .+||....      ....++.++|||||||++|||++|+.||....
T Consensus       170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~  227 (319)
T 4euu_A          170 EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE  227 (319)
T ss_dssp             CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred             CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            2           24554431      13567889999999999999999999997544

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=99.96  E-value=3e-29  Score=265.26  Aligned_cols=175  Identities=21%  Similarity=0.278  Sum_probs=144.7

Q ss_pred             ceeEEEEEEEE--CCeEEEEEEcch---hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          389 RIEGAVYHGRL--NGKNLAIKRTEH---EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       389 ~~~G~Vy~g~~--~g~~vAvK~~~~---~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      |..|.||+++.  +|+.||+|.++.   .....+.+|+..+..++||||+++++++... ...+|||||+++|+|.+++.
T Consensus       100 G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~lv~E~~~~~~L~~~l~  178 (373)
T 2x4f_A          100 GRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESK-NDIVLVMEYVDGGELFDRII  178 (373)
T ss_dssp             ----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEEEECCTTCEEHHHHH
T ss_pred             CcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-CEEEEEEeCCCCCcHHHHHH
Confidence            33499999998  689999999765   2345678999999999999999999998665 48999999999999999987


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEe--CCCCcEEEEeccCccccCCC--
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFL--DEEFNARVGNFGMARCVNDD--  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl--d~~~~~kI~DFGla~~~~~~--  539 (600)
                      ...           ..+++.+++.++.||+.||.|||   +.+|+||||||+|||+  +.++.+||+|||+++.....  
T Consensus       179 ~~~-----------~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~  244 (373)
T 2x4f_A          179 DES-----------YNLTELDTILFMKQICEGIRHMH---QMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK  244 (373)
T ss_dssp             HTG-----------GGCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB
T ss_pred             hcC-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc
Confidence            543           23899999999999999999999   5689999999999999  67789999999999865322  


Q ss_pred             ---------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 ---------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 ---------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                               +.+||....  ..++.++|||||||++|||++|+.||...+
T Consensus       245 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~elltg~~pf~~~~  292 (373)
T 2x4f_A          245 LKVNFGTPEFLAPEVVNY--DFVSFPTDMWSVGVIAYMLLSGLSPFLGDN  292 (373)
T ss_dssp             CCCCCSSCTTCCHHHHTT--CBCCHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             cccccCCCcEeChhhccC--CCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence                     235555433  456788999999999999999999997543

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=99.96  E-value=4.3e-29  Score=261.75  Aligned_cols=170  Identities=19%  Similarity=0.340  Sum_probs=145.6

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      |.||+++.  +|+.||+|.++...      ...+.+|+..+..++||||+++++++.++ ...|+||||+++|+|.+++.
T Consensus        55 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~gg~L~~~l~  133 (350)
T 1rdq_E           55 GRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN-SNLYMVMEYVAGGEMFSHLR  133 (350)
T ss_dssp             CEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEEEECCTTCBHHHHHH
T ss_pred             cEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC-CEEEEEEcCCCCCcHHHHHH
Confidence            99999998  68999999986543      23567788889999999999999997655 58999999999999999997


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD----  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~----  539 (600)
                      ...            .+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....    
T Consensus       134 ~~~------------~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~~~~~  198 (350)
T 1rdq_E          134 RIG------------RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWTL  198 (350)
T ss_dssp             HHC------------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBCCC
T ss_pred             HcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCcccccCccceEEECCCCCEEEcccccceeccCCcccc
Confidence            532            3899999999999999999999   669999999999999999999999999999865432    


Q ss_pred             -----CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 -----TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 -----~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                           +.+||....  ..++.++|||||||++|||++|+.||...
T Consensus       199 ~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~  241 (350)
T 1rdq_E          199 CGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFAD  241 (350)
T ss_dssp             EECGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cCCccccCHHHhcC--CCCCCcCCEecccHhHhHHhhCCCCCCCC
Confidence                 235565543  45788899999999999999999999754

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=99.96  E-value=2.9e-29  Score=265.36  Aligned_cols=171  Identities=31%  Similarity=0.517  Sum_probs=137.2

Q ss_pred             EEEEEEEEC-----CeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          392 GAVYHGRLN-----GKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       392 G~Vy~g~~~-----g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      |.||+|+..     +..||||+++..    ....+.+|+..+..++||||++++|++... ...++||||+++|+|.+++
T Consensus        59 g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~~sL~~~l  137 (373)
T 2qol_A           59 GEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKS-KPVMIVTEYMENGSLDSFL  137 (373)
T ss_dssp             SEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-SSCEEEEECCTTCBHHHHH
T ss_pred             eEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-CceEEEEeCCCCCcHHHHH
Confidence            899999873     667999997642    335678899999999999999999998655 4889999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC---
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---  539 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~---  539 (600)
                      +...           ..+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....   
T Consensus       138 ~~~~-----------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  203 (373)
T 2qol_A          138 RKHD-----------AQFTVIQLVGMLRGIASGMKYLS---DMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA  203 (373)
T ss_dssp             HTTT-----------TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC------------
T ss_pred             HhCC-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCcc
Confidence            7643           24899999999999999999999   569999999999999999999999999999765321   


Q ss_pred             ------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          540 ------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       540 ------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                                  +.+||....  ..++.++|||||||++|||++ |+.||...
T Consensus       204 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~SlG~il~ellt~g~~P~~~~  254 (373)
T 2qol_A          204 AYTTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEVMSYGERPYWEM  254 (373)
T ss_dssp             ----------CTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTC-CTTTTC
T ss_pred             ceeccCCCcCCCccChhhhcc--CCcCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence                        335555543  346788999999999999998 99999653

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=99.96  E-value=3.8e-29  Score=264.19  Aligned_cols=184  Identities=21%  Similarity=0.418  Sum_probs=145.8

Q ss_pred             eEEEEEEEE---------CCeEEEEEEcchh----HHHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCC
Q 041830          391 EGAVYHGRL---------NGKNLAIKRTEHE----VITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNG  456 (600)
Q Consensus       391 ~G~Vy~g~~---------~g~~vAvK~~~~~----~~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~G  456 (600)
                      +|.||+++.         ++..||||.++..    ....+.+|+..+..+ +||||++++++|..+ ...|+||||+++|
T Consensus        94 fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~-~~~~lv~e~~~~g  172 (370)
T 2psq_A           94 FGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD-GPLYVIVEYASKG  172 (370)
T ss_dssp             SSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSS-SSCEEEEECCTTC
T ss_pred             CeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccC-CCEEEEEEcCCCC
Confidence            499999986         2357999998643    234678899999999 899999999998655 4899999999999


Q ss_pred             CHHHHHhcCcCcccc----cccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccC
Q 041830          457 SLKDWLHGGLAMKNQ----FIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGM  532 (600)
Q Consensus       457 sL~~~L~~~~~~~~~----~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGl  532 (600)
                      +|.++++........    ........+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus       173 ~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~  249 (370)
T 2psq_A          173 NLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGL  249 (370)
T ss_dssp             BHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCSS
T ss_pred             CHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeccccchhhEEECCCCCEEEccccC
Confidence            999999865421100    00011134899999999999999999999   66999999999999999999999999999


Q ss_pred             ccccCCC--------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCCC
Q 041830          533 ARCVNDD--------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRPR  580 (600)
Q Consensus       533 a~~~~~~--------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~~  580 (600)
                      ++.....              +.+||....  ..++.++|||||||++|||++ |+.||....
T Consensus       250 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~ellt~g~~p~~~~~  310 (370)
T 2psq_A          250 ARDINNIDYYKKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGIP  310 (370)
T ss_dssp             CEETTCCCTTCTTTTTTSCGGGCCHHHHHT--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             CcccCcccceecccCCCcccceECHhHhcC--CCCCcHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence            9854321              234554433  457888999999999999999 999997543

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=99.96  E-value=7.2e-30  Score=270.32  Aligned_cols=171  Identities=27%  Similarity=0.496  Sum_probs=144.5

Q ss_pred             EEEEEEEE--CCeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcC
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGG  465 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~  465 (600)
                      |.||+|++  +|+.||||.++..    ....+.+|+..+..++||||++++|+|..+ ...++||||+++|+|.++++..
T Consensus       128 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv~e~~~~g~L~~~l~~~  206 (377)
T 3cbl_A          128 GEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQK-QPIYIVMELVQGGDFLTFLRTE  206 (377)
T ss_dssp             EEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSS-SSCEEEEECCTTCBHHHHHHHH
T ss_pred             CeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecC-CCcEEEEEcCCCCCHHHHHHhc
Confidence            99999999  6899999997643    234567899999999999999999998655 4789999999999999999753


Q ss_pred             cCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC------
Q 041830          466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD------  539 (600)
Q Consensus       466 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~------  539 (600)
                      .           ..+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....      
T Consensus       207 ~-----------~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~  272 (377)
T 3cbl_A          207 G-----------ARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASG  272 (377)
T ss_dssp             G-----------GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCS
T ss_pred             C-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecC
Confidence            2           23899999999999999999999   669999999999999999999999999999754321      


Q ss_pred             --------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          540 --------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       540 --------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                              +.+||....  ..++.++|||||||++|||++ |+.||...
T Consensus       273 ~~~~~~~~y~aPE~~~~--~~~~~~~DvwslG~il~el~t~g~~p~~~~  319 (377)
T 3cbl_A          273 GLRQVPVKWTAPEALNY--GRYSSESDVWSFGILLWETFSLGASPYPNL  319 (377)
T ss_dssp             SCCEEEGGGSCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCSSTTS
T ss_pred             CCCCCCcCcCCHhHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence                    234554433  346778999999999999998 99999754

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=99.96  E-value=6.4e-29  Score=255.93  Aligned_cols=175  Identities=23%  Similarity=0.370  Sum_probs=144.3

Q ss_pred             eEEEEEEEE-CCeEEEEEEcchhH-----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          391 EGAVYHGRL-NGKNLAIKRTEHEV-----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       391 ~G~Vy~g~~-~g~~vAvK~~~~~~-----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      .|.||+++. +|+.||+|+++.+.     ...+.+|+..+..++||||+++++++..+ ...++||||++ |+|.+++..
T Consensus        34 ~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~-~~l~~~~~~  111 (311)
T 3niz_A           34 YGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVIHSE-RCLTLVFEFME-KDLKKVLDE  111 (311)
T ss_dssp             SCEEEEEEETTSCEEEEEEEC------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCS-SCEEEEEECCS-EEHHHHHHT
T ss_pred             CeEEEEEEECCCCEEEEEEEecccccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccC-CEEEEEEcCCC-CCHHHHHHh
Confidence            399999999 78999999976432     24567899999999999999999997654 58999999998 489888875


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-----
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-----  539 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-----  539 (600)
                      ..           ..+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....     
T Consensus       112 ~~-----------~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~  177 (311)
T 3niz_A          112 NK-----------TGLQDSQIKIYLYQLLRGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYT  177 (311)
T ss_dssp             CT-----------TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC---
T ss_pred             cc-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCchHhEEECCCCCEEEccCcCceecCCCccccc
Confidence            43           34899999999999999999999   669999999999999999999999999999764321     


Q ss_pred             -------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCCCC
Q 041830          540 -------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRKK  582 (600)
Q Consensus       540 -------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~~  582 (600)
                             +.+||.... ...++.++|||||||++|||++|+.||....+.
T Consensus       178 ~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~  226 (311)
T 3niz_A          178 HEVVTLWYRAPDVLMG-SKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD  226 (311)
T ss_dssp             CCCCCCTTCCHHHHTT-CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT
T ss_pred             CCcccCCcCCHHHhcC-CCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH
Confidence                   235565433 245688899999999999999999999765433

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=99.96  E-value=6.2e-29  Score=265.29  Aligned_cols=173  Identities=19%  Similarity=0.322  Sum_probs=141.1

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhHHHHHHHHHHHH-HhCCCCceeeeeeEEec---cCCceEEEEeecCCCCHHHHHhc
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEVITKLEMQLVQH-ATHHHPNIVRLLGTCLT---DGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~~~~~e~ei~~~-~~l~HpNIv~l~g~~~~---~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      +|.||+++.  +|+.||||+++...  .+.+|+..+ ...+||||+++++++..   +....|||||||++|+|.+++..
T Consensus        75 ~g~V~~~~~~~~~~~vAiK~~~~~~--~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~  152 (400)
T 1nxk_A           75 NGKVLQIFNKRTQEKFALKMLQDCP--KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQD  152 (400)
T ss_dssp             TEEEEEEEETTTCCEEEEEEEECSH--HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHC
T ss_pred             CeEEEEEEECCCCCEEEEEEeCcch--hHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHH
Confidence            399999998  68999999987543  345555554 44689999999998753   23468999999999999999976


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC---CCcEEEEeccCccccCC---
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE---EFNARVGNFGMARCVND---  538 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~---~~~~kI~DFGla~~~~~---  538 (600)
                      ...          ..+++.++..++.||+.||.|||   +.+|+||||||+|||++.   ++.+||+|||+++....   
T Consensus       153 ~~~----------~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~  219 (400)
T 1nxk_A          153 RGD----------QAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS  219 (400)
T ss_dssp             C-------------CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC----
T ss_pred             hCC----------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCcceEEEecCCCCccEEEEecccccccCCCCc
Confidence            432          34899999999999999999999   569999999999999987   78999999999975432   


Q ss_pred             --------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          539 --------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       539 --------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                              .+.+||....  ..++.++|||||||+||||++|+.||....
T Consensus       220 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~  267 (400)
T 1nxk_A          220 LTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSNH  267 (400)
T ss_dssp             -------CTTCCGGGSCC--CCSSSHHHHHHHHHHHHHHHHSSCSCCCCT
T ss_pred             cccCCCCCCccCHhhcCC--CCCCCcccHHHHHHHHHHHHhCCCCCCCCc
Confidence                    2346776644  467889999999999999999999997654

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=99.96  E-value=3.3e-29  Score=263.64  Aligned_cols=170  Identities=21%  Similarity=0.331  Sum_probs=144.4

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhH---------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEV---------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~---------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      |.||+++.  +|+.||+|.++...         ...+++|+..+..++||||+++++++... ...++||||+++|+|.+
T Consensus        26 g~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~~~lv~e~~~gg~L~~  104 (361)
T 2yab_A           26 AIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENR-TDVVLILELVSGGELFD  104 (361)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEEEECCCSCBHHH
T ss_pred             EEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeC-CEEEEEEEcCCCCcHHH
Confidence            99999998  68999999875421         35678899999999999999999997655 58999999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC----cEEEEeccCcccc
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEF----NARVGNFGMARCV  536 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~----~~kI~DFGla~~~  536 (600)
                      ++....            .+++.++..++.||+.||.|||   +.+|+||||||+|||++.++    .+||+|||+++..
T Consensus       105 ~l~~~~------------~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~  169 (361)
T 2yab_A          105 FLAQKE------------SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI  169 (361)
T ss_dssp             HHTTCS------------CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEEC
T ss_pred             HHHhcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEc
Confidence            996542            3899999999999999999999   56999999999999998776    7999999999865


Q ss_pred             CCC-----------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          537 NDD-----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       537 ~~~-----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                      ...           +.+||....  ..++.++|||||||++|||++|+.||...
T Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslGvil~~ll~g~~Pf~~~  221 (361)
T 2yab_A          170 EDGVEFKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGD  221 (361)
T ss_dssp             CTTCCCCCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred             CCCCccccCCCCccEECchHHcC--CCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence            432           124554433  45688899999999999999999999754

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.96  E-value=6.3e-29  Score=249.94  Aligned_cols=171  Identities=30%  Similarity=0.547  Sum_probs=146.1

Q ss_pred             EEEEEEEE-CCeEEEEEEcchhH--HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcCc
Q 041830          392 GAVYHGRL-NGKNLAIKRTEHEV--ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM  468 (600)
Q Consensus       392 G~Vy~g~~-~g~~vAvK~~~~~~--~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~  468 (600)
                      |.||+++. +++.||+|++....  .+.+.+|+..+..++||||+++++++.++ ...++||||+++|+|.++++...  
T Consensus        24 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--  100 (269)
T 4hcu_A           24 GLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-APICLVFEFMEHGCLSDYLRTQR--  100 (269)
T ss_dssp             CEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSS-SSEEEEEECCTTCBHHHHHHTTT--
T ss_pred             cEEEEEEecCCCeEEEEEecccccCHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CceEEEEEeCCCCcHHHHHHhcC--
Confidence            99999999 78899999986532  35678999999999999999999998655 47899999999999999997543  


Q ss_pred             ccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC----------
Q 041830          469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND----------  538 (600)
Q Consensus       469 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~----------  538 (600)
                               ..+++.+++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++....          
T Consensus       101 ---------~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  168 (269)
T 4hcu_A          101 ---------GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK  168 (269)
T ss_dssp             ---------TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTT
T ss_pred             ---------cccCHHHHHHHHHHHHHHHHHHH---hCCeecCCcchheEEEcCCCCEEeccccccccccccccccccCcc
Confidence                     34899999999999999999999   66899999999999999999999999999975422          


Q ss_pred             ---CCCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          539 ---DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       539 ---~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                         ...+||....  ..++.++||||||+++|||++ |+.||...
T Consensus       169 ~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~~g~~p~~~~  211 (269)
T 4hcu_A          169 FPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENR  211 (269)
T ss_dssp             CCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             cccccCCHHHhcC--CCCCchhhhHHHHHHHHHHhcCCCCCCCCC
Confidence               1335565543  346788999999999999999 99999753

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=99.96  E-value=4.9e-29  Score=261.60  Aligned_cols=171  Identities=21%  Similarity=0.342  Sum_probs=141.7

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhHH------HHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEVI------TKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~~------~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      |.||+++.  +|+.||||.++....      ..+..|...+..+ +||||+++++++... ...|+||||+++|+|.+++
T Consensus        34 g~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~-~~~~lv~E~~~gg~L~~~l  112 (353)
T 2i0e_A           34 GKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM-DRLYFVMEYVNGGDLMYHI  112 (353)
T ss_dssp             EEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECS-SEEEEEEECCCSCBHHHHH
T ss_pred             EEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcC-CEEEEEEeCCCCCcHHHHH
Confidence            99999999  478899999876432      3455677777665 799999999997655 4899999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC---
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---  539 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~---  539 (600)
                      ....            .+++.+++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....   
T Consensus       113 ~~~~------------~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~  177 (353)
T 2i0e_A          113 QQVG------------RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT  177 (353)
T ss_dssp             HHHS------------SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred             HhcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCcc
Confidence            7532            3899999999999999999999   669999999999999999999999999999753211   


Q ss_pred             ---------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 ---------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 ---------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                               +.+||....  ..++.++|||||||++|||++|+.||...+
T Consensus       178 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~~  225 (353)
T 2i0e_A          178 TKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGED  225 (353)
T ss_dssp             BCCCCSCGGGCCHHHHTT--CCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cccccCCccccChhhhcC--CCcCCcccccchHHHHHHHHcCCCCCCCCC
Confidence                     224554433  457888999999999999999999997543

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=99.96  E-value=5.8e-29  Score=254.15  Aligned_cols=173  Identities=21%  Similarity=0.329  Sum_probs=141.6

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH-----------------------------HHHHHHHHHHHHhCCCCceeeeeeEE
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV-----------------------------ITKLEMQLVQHATHHHPNIVRLLGTC  439 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~-----------------------------~~~~e~ei~~~~~l~HpNIv~l~g~~  439 (600)
                      .|.||+++.  +|+.||||.+....                             .+.+.+|+..+..++||||+++++++
T Consensus        26 ~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~  105 (298)
T 2zv2_A           26 YGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVL  105 (298)
T ss_dssp             CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             CEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCCCCeEEEEE
Confidence            399999988  68999999875422                             23567899999999999999999998


Q ss_pred             ecc-CCceEEEEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEE
Q 041830          440 LTD-GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIF  518 (600)
Q Consensus       440 ~~~-~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NIL  518 (600)
                      ... ....++||||+++|+|.+++..             ..+++.+++.++.|++.||.|||   +.+|+||||||+|||
T Consensus       106 ~~~~~~~~~lv~e~~~~~~l~~~~~~-------------~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil  169 (298)
T 2zv2_A          106 DDPNEDHLYMVFELVNQGPVMEVPTL-------------KPLSEDQARFYFQDLIKGIEYLH---YQKIIHRDIKPSNLL  169 (298)
T ss_dssp             ECSSSSEEEEEEECCTTCBSCCSSCS-------------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEE
T ss_pred             EcCCCCEEEEEEecCCCCcHHHHhhc-------------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEE
Confidence            653 3478999999999999775432             24899999999999999999999   569999999999999


Q ss_pred             eCCCCcEEEEeccCccccCCC------------CCCCcccccCCC-CCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          519 LDEEFNARVGNFGMARCVNDD------------TESPQFYSTNPA-SWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       519 ld~~~~~kI~DFGla~~~~~~------------~~~pe~~~~~~~-~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                      ++.++.+||+|||+++.....            +.+||....... ..+.++|||||||++|||++|+.||...
T Consensus       170 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~  243 (298)
T 2zv2_A          170 VGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDE  243 (298)
T ss_dssp             ECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCc
Confidence            999999999999999765322            235665544322 1366789999999999999999999653

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=99.96  E-value=4.3e-29  Score=254.59  Aligned_cols=172  Identities=25%  Similarity=0.511  Sum_probs=142.6

Q ss_pred             eEEEEEEEE------CCeEEEEEEcchh---HHHHHHHHHHHHHhCCCCceeeeeeEEeccC-CceEEEEeecCCCCHHH
Q 041830          391 EGAVYHGRL------NGKNLAIKRTEHE---VITKLEMQLVQHATHHHPNIVRLLGTCLTDG-PHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       391 ~G~Vy~g~~------~g~~vAvK~~~~~---~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~-~~~~LV~Ey~~~GsL~~  460 (600)
                      .|.||++++      +|+.||||++...   ..+.+++|+..+..++||||+++++++...+ ...++||||+++|+|.+
T Consensus        23 ~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~  102 (295)
T 3ugc_A           23 FGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD  102 (295)
T ss_dssp             SEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHH
T ss_pred             CEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHH
Confidence            399999985      6889999997643   2356789999999999999999999986432 35899999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-  539 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-  539 (600)
                      ++....           ..+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++..... 
T Consensus       103 ~l~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  168 (295)
T 3ugc_A          103 YLQKHK-----------ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK  168 (295)
T ss_dssp             HHHHCG-----------GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCSCC------
T ss_pred             HHHhcc-----------cccCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCc
Confidence            997643           23899999999999999999999   669999999999999999999999999999765322 


Q ss_pred             --------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          540 --------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       540 --------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                                    +.+||....  ..++.++||||||+++|||++|..||..
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~~~~~  219 (295)
T 3ugc_A          169 EFFKVKEPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYIEKSKS  219 (295)
T ss_dssp             -------CTTCGGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTTCTTCS
T ss_pred             ceeeeccCCCCccceeCcHHhcC--CCCChHHHHHHHHHHHHHHHhcccccCC
Confidence                          234555443  3468889999999999999999999864

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=99.96  E-value=1.8e-29  Score=261.67  Aligned_cols=173  Identities=23%  Similarity=0.413  Sum_probs=142.8

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhH----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcC
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEV----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGG  465 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~  465 (600)
                      |.||+++.  +|+.||||.++...    .+.+.+|+..+..++||||+++++++..+ ...|+||||+++|+|.+++...
T Consensus        21 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~   99 (323)
T 3tki_A           21 GEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG-NIQYLFLEYCSGGELFDRIEPD   99 (323)
T ss_dssp             EEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEEECCTTEEGGGGSBTT
T ss_pred             EEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CeEEEEEEcCCCCcHHHHHhhc
Confidence            99999988  68999999875432    24577899999999999999999998655 4889999999999999988654


Q ss_pred             cCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC-------
Q 041830          466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND-------  538 (600)
Q Consensus       466 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~-------  538 (600)
                      .            .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....       
T Consensus       100 ~------------~~~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~  164 (323)
T 3tki_A          100 I------------GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  164 (323)
T ss_dssp             T------------BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             C------------CCCHHHHHHHHHHHHHHHHHHH---HCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccccc
Confidence            2            3899999999999999999999   66999999999999999999999999999975421       


Q ss_pred             -------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCCC
Q 041830          539 -------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRK  581 (600)
Q Consensus       539 -------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~  581 (600)
                             .+.+||..... ..++.++|||||||++|||++|+.||.....
T Consensus       165 ~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~pf~~~~~  213 (323)
T 3tki_A          165 NKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSD  213 (323)
T ss_dssp             CSCCSCGGGSCHHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT
T ss_pred             CCCccCcCccCcHHhccC-CCCCCcccHHHHHHHHHHHHhCCCCCCCCch
Confidence                   12245554332 2236679999999999999999999976544

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=99.96  E-value=1.3e-29  Score=260.90  Aligned_cols=172  Identities=26%  Similarity=0.435  Sum_probs=141.6

Q ss_pred             EEEEEEEE--CCeEEEEEEcchh------HHHHHHHHHHHHHhCCCCceeeeeeEEeccCC---ceEEEEeecCCCCHHH
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHE------VITKLEMQLVQHATHHHPNIVRLLGTCLTDGP---HSFLVFEYAKNGSLKD  460 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~------~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~---~~~LV~Ey~~~GsL~~  460 (600)
                      |.||+++.  +|+.||||.++.+      ....+.+|+..+..++||||+++++++.....   ..|+||||+++|+|.+
T Consensus        26 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~  105 (311)
T 3ork_A           26 SEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRD  105 (311)
T ss_dssp             EEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHH
T ss_pred             EEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHH
Confidence            99999997  7899999998543      22456788888888999999999999765432   2499999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC--
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND--  538 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~--  538 (600)
                      +++...            .+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....  
T Consensus       106 ~l~~~~------------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~  170 (311)
T 3ork_A          106 IVHTEG------------PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG  170 (311)
T ss_dssp             HHHHHC------------SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEETTSCEEECCCSCC-------
T ss_pred             HHHhcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccc
Confidence            997532            3899999999999999999999   56999999999999999999999999999875422  


Q ss_pred             -------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          539 -------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       539 -------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                                   .+.+||....  ..++.++||||||+++|||++|+.||....
T Consensus       171 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~~ll~g~~pf~~~~  223 (311)
T 3ork_A          171 NSVTQTAAVIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGDS  223 (311)
T ss_dssp             -----------CCTTCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccccCcCcccCCHHHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence                         2335665544  356788999999999999999999997643

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=99.96  E-value=3.4e-29  Score=259.74  Aligned_cols=171  Identities=29%  Similarity=0.507  Sum_probs=142.9

Q ss_pred             EEEEEEEE-----CCeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          392 GAVYHGRL-----NGKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       392 G~Vy~g~~-----~g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      |.||+|++     .+..||||.++..    ....+.+|+..+..++||||+++++++... ...++||||+++|+|.+++
T Consensus        63 g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l  141 (325)
T 3kul_A           63 GEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRG-RLAMIVTEYMENGSLDTFL  141 (325)
T ss_dssp             EEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGG-GCCEEEEECCTTCBHHHHH
T ss_pred             cEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-CccEEEeeCCCCCcHHHHH
Confidence            99999998     2446999998642    335678899999999999999999997554 4789999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC---
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---  539 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~---  539 (600)
                      +...           ..+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....   
T Consensus       142 ~~~~-----------~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  207 (325)
T 3kul_A          142 RTHD-----------GQFTIMQLVGMLRGVGAGMRYLS---DLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDA  207 (325)
T ss_dssp             HTTT-----------TCSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----C
T ss_pred             Hhcc-----------cCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccc
Confidence            7543           23899999999999999999999   669999999999999999999999999999865332   


Q ss_pred             ------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          540 ------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       540 ------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                                  +.+||....  ..++.++||||||+++|||++ |+.||...
T Consensus       208 ~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~  258 (325)
T 3kul_A          208 AYTTTGGKIPIRWTAPEAIAF--RTFSSASDVWSFGVVMWEVLAYGERPYWNM  258 (325)
T ss_dssp             CEECC---CCGGGSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTS
T ss_pred             eeeccCCCCcccccCHhHhcC--CCCCcHHHHHHHHHHHHHHHcCCCCCcccC
Confidence                        234454433  346778999999999999999 99999653

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=99.96  E-value=9.2e-29  Score=256.54  Aligned_cols=171  Identities=20%  Similarity=0.309  Sum_probs=145.1

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh---------HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE---------VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~---------~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~  459 (600)
                      .|.||+++.  +|+.||+|.++..         ....+++|+..+..++||||+++++++... ...++||||+++|+|.
T Consensus        24 ~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~  102 (326)
T 2y0a_A           24 FAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK-TDVILILELVAGGELF  102 (326)
T ss_dssp             SEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEEECCCSCBHH
T ss_pred             CeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-CEEEEEEEcCCCCCHH
Confidence            399999998  6899999987542         235678999999999999999999998655 4899999999999999


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC----cEEEEeccCccc
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEF----NARVGNFGMARC  535 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~----~~kI~DFGla~~  535 (600)
                      +++....            .+++.++..++.|++.||.|||   +.+|+||||||+|||++.++    .+||+|||+++.
T Consensus       103 ~~l~~~~------------~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~  167 (326)
T 2y0a_A          103 DFLAEKE------------SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK  167 (326)
T ss_dssp             HHHTTSS------------CCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             HHHHhcC------------CcCHHHHHHHHHHHHHHHHHHH---HCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence            9997542            3899999999999999999999   66999999999999998887    899999999976


Q ss_pred             cCCC-----------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          536 VNDD-----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       536 ~~~~-----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                      ....           +.+||....  ..++.++|||||||++|||++|+.||...
T Consensus       168 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~  220 (326)
T 2y0a_A          168 IDFGNEFKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGD  220 (326)
T ss_dssp             CCTTSCCCCCCSCTTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred             CCCCCccccccCCcCcCCceeecC--CCCCcHHHHHHHHHHHHHHHHCcCCCCCC
Confidence            5321           234555543  45678899999999999999999999754

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=99.96  E-value=1.2e-28  Score=249.53  Aligned_cols=173  Identities=27%  Similarity=0.474  Sum_probs=145.7

Q ss_pred             eeEEEEEEEE-CCeEEEEEEcchh--HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCc
Q 041830          390 IEGAVYHGRL-NGKNLAIKRTEHE--VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGL  466 (600)
Q Consensus       390 ~~G~Vy~g~~-~g~~vAvK~~~~~--~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~  466 (600)
                      ..|.||++++ ++..||+|.++..  ..+.+.+|+..+..++||||+++++++..+ ...++||||+++|+|.+++....
T Consensus        36 ~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~  114 (283)
T 3gen_A           36 QFGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-RPIFIITEYMANGCLLNYLREMR  114 (283)
T ss_dssp             -CEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHHTCCCTTBCCEEEEECSS-SSEEEEECCCTTCBHHHHHHCGG
T ss_pred             CCceEEEEEEcCCCeEEEEEecCCCCCHHHHHHHHHHHhcCCCCCEeeEEEEEecC-CCeEEEEeccCCCcHHHHHHHhc
Confidence            3499999999 5678999998754  235678899999999999999999997554 48899999999999999997632


Q ss_pred             CcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC--------
Q 041830          467 AMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND--------  538 (600)
Q Consensus       467 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~--------  538 (600)
                                 ..+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....        
T Consensus       115 -----------~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~  180 (283)
T 3gen_A          115 -----------HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVG  180 (283)
T ss_dssp             -----------GCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTTS
T ss_pred             -----------cCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCccceEEEcCCCCEEEccccccccccccccccccC
Confidence                       23899999999999999999999   66999999999999999999999999999975422        


Q ss_pred             -----CCCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          539 -----DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       539 -----~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                           ...+||....  ..++.++||||||+++|||++ |+.||...
T Consensus       181 ~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~  225 (283)
T 3gen_A          181 SKFPVRWSPPEVLMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERF  225 (283)
T ss_dssp             TTSCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             CccCcccCCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence                 1335555543  346788999999999999998 99999753

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=99.96  E-value=1e-28  Score=260.08  Aligned_cols=170  Identities=27%  Similarity=0.414  Sum_probs=143.7

Q ss_pred             EEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      |.||++..  +|+.||+|.++..     ....+++|+..+..++||||+++++++.++ ...|+||||+++|+|.+++..
T Consensus        43 g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-~~~~lv~e~~~gg~L~~~l~~  121 (362)
T 2bdw_A           43 SVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-SFHYLVFDLVTGGELFEDIVA  121 (362)
T ss_dssp             EEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHHTT
T ss_pred             eEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-CEEEEEEecCCCCCHHHHHHH
Confidence            99999998  6899999997542     235678899999999999999999998655 488999999999999999975


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC---CcEEEEeccCccccCCC--
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEE---FNARVGNFGMARCVNDD--  539 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~---~~~kI~DFGla~~~~~~--  539 (600)
                      ..            .+++.++..++.||+.||.|||   +.+|+||||||+|||++.+   +.+||+|||+++.....  
T Consensus       122 ~~------------~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~  186 (362)
T 2bdw_A          122 RE------------FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA  186 (362)
T ss_dssp             CS------------CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS
T ss_pred             cC------------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc
Confidence            42            3899999999999999999999   5699999999999999865   45999999999765422  


Q ss_pred             ---------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 ---------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 ---------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                               +.+||....  ..++.++|||||||++|||++|+.||...
T Consensus       187 ~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~Pf~~~  233 (362)
T 2bdw_A          187 WHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDE  233 (362)
T ss_dssp             CCCSCSCTTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cccCCCCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence                     235665543  35788899999999999999999999753

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=99.96  E-value=4.7e-29  Score=261.34  Aligned_cols=171  Identities=22%  Similarity=0.370  Sum_probs=135.3

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhH-HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcCc
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEV-ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM  468 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~-~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~  468 (600)
                      |.||+++.  +++.||||.++... .+.+++|+..+..++||||+++++++... ...++||||+++|+|.+++....  
T Consensus        67 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--  143 (349)
T 2w4o_A           67 SIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLSHPNIIKLKEIFETP-TEISLVLELVTGGELFDRIVEKG--  143 (349)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEC----------CHHHHHCCCTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHHTTCS--
T ss_pred             EEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCCCCCCcceeeeEecC-CeEEEEEEeCCCCCHHHHHHhcC--
Confidence            99999999  57889999987643 24567899999999999999999998655 48999999999999999997543  


Q ss_pred             ccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC---CCcEEEEeccCccccCCC------
Q 041830          469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE---EFNARVGNFGMARCVNDD------  539 (600)
Q Consensus       469 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~---~~~~kI~DFGla~~~~~~------  539 (600)
                                .+++.+++.++.|++.||.|||   +.+|+||||||+|||++.   ++.+||+|||+++.....      
T Consensus       144 ----------~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~  210 (349)
T 2w4o_A          144 ----------YYSERDAADAVKQILEAVAYLH---ENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTV  210 (349)
T ss_dssp             ----------SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESSSSTTCCEEECCCC--------------
T ss_pred             ----------CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccccccc
Confidence                      3899999999999999999999   569999999999999975   899999999998755322      


Q ss_pred             -----CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 -----TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 -----~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                           +.+||....  ..++.++|||||||++|||++|+.||....
T Consensus       211 ~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~  254 (349)
T 2w4o_A          211 CGTPGYCAPEILRG--CAYGPEVDMWSVGIITYILLCGFEPFYDER  254 (349)
T ss_dssp             --CGGGSCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCTT
T ss_pred             cCCCCccCHHHhcC--CCCCcccchHHHHHHHHHHHhCCCCCCCCc
Confidence                 235665543  357889999999999999999999996543

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=99.96  E-value=8e-29  Score=256.15  Aligned_cols=173  Identities=27%  Similarity=0.473  Sum_probs=143.6

Q ss_pred             eEEEEEEEE--CCeEEEEEEcch----hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCC--------------------
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEH----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGP--------------------  444 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~--------------------  444 (600)
                      .|.||+++.  +|+.||||+++.    ...+.+.+|+..+..++||||+++++++.+...                    
T Consensus        19 ~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   98 (332)
T 3qd2_B           19 FGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWP   98 (332)
T ss_dssp             CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC-----------
T ss_pred             CeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhcccccccc
Confidence            399999998  689999999752    234567899999999999999999999865421                    


Q ss_pred             ------------------------------------ceEEEEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHH
Q 041830          445 ------------------------------------HSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRI  488 (600)
Q Consensus       445 ------------------------------------~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i  488 (600)
                                                          ..++||||+++|+|.+++......         ...++..++.+
T Consensus        99 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~---------~~~~~~~~~~i  169 (332)
T 3qd2_B           99 LSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL---------EDREHGVCLHI  169 (332)
T ss_dssp             ---------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSG---------GGSCHHHHHHH
T ss_pred             ccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCc---------cchhhHHHHHH
Confidence                                                279999999999999999875431         23678889999


Q ss_pred             HHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC------------------------CCCCc
Q 041830          489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD------------------------TESPQ  544 (600)
Q Consensus       489 ~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~------------------------~~~pe  544 (600)
                      +.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....                        +.+||
T Consensus       170 ~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE  246 (332)
T 3qd2_B          170 FIQIAEAVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPE  246 (332)
T ss_dssp             HHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHH
T ss_pred             HHHHHHHHHHHH---hCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChH
Confidence            999999999999   669999999999999999999999999999865432                        12455


Q ss_pred             ccccCCCCCCccCchHHHHHHHHHHHhCCCCCC
Q 041830          545 FYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN  577 (600)
Q Consensus       545 ~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~  577 (600)
                      ....  ..++.++|||||||++|||++|..|+.
T Consensus       247 ~~~~--~~~~~~~Di~slG~il~el~~~~~~~~  277 (332)
T 3qd2_B          247 QIHG--NNYSHKVDIFSLGLILFELLYSFSTQM  277 (332)
T ss_dssp             HHHC--CCCCTHHHHHHHHHHHHHHHSCCCCHH
T ss_pred             HhcC--CCCcchhhHHHHHHHHHHHHHcCCChh
Confidence            4433  356888999999999999999988763

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=99.96  E-value=6.6e-29  Score=257.75  Aligned_cols=171  Identities=21%  Similarity=0.348  Sum_probs=138.7

Q ss_pred             EEEEEEEE-----CCeEEEEEEcchhH-------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHH
Q 041830          392 GAVYHGRL-----NGKNLAIKRTEHEV-------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       392 G~Vy~g~~-----~g~~vAvK~~~~~~-------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~  459 (600)
                      |.||+++.     +|+.||+|.++...       ...+.+|+..+..++||||+++++++..+ ...|+||||+++|+|.
T Consensus        31 g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~  109 (327)
T 3a62_A           31 GKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTG-GKLYLILEYLSGGELF  109 (327)
T ss_dssp             EEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECS-SCEEEEEECCTTEEHH
T ss_pred             EEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcC-CEEEEEEeCCCCCcHH
Confidence            99999987     68899999986432       23456788899999999999999998655 4899999999999999


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC--
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN--  537 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~--  537 (600)
                      +++....            .+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++...  
T Consensus       110 ~~l~~~~------------~~~~~~~~~~~~qi~~al~~lH---~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~  174 (327)
T 3a62_A          110 MQLEREG------------IFMEDTACFYLAEISMALGHLH---QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHD  174 (327)
T ss_dssp             HHHHHHS------------SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCTTTEEECTTSCEEECCCSCC------
T ss_pred             HHHHhCC------------CCCHHHHHHHHHHHHHHHHHHH---hCCEEcccCCHHHeEECCCCcEEEEeCCcccccccC
Confidence            9997532            3889999999999999999999   5699999999999999999999999999987432  


Q ss_pred             ----------CCCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          538 ----------DDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       538 ----------~~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                                ..+.+||....  ..++.++|||||||++|||++|+.||...+
T Consensus       175 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~  225 (327)
T 3a62_A          175 GTVTHTFCGTIEYMAPEILMR--SGHNRAVDWWSLGALMYDMLTGAPPFTGEN  225 (327)
T ss_dssp             ----CTTSSCCTTSCHHHHTT--SCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             CccccccCCCcCccCHhhCcC--CCCCCcccchhHHHHHHHHHHCCCCCCCCC
Confidence                      12335665543  346788999999999999999999997543

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=99.96  E-value=1.9e-28  Score=251.92  Aligned_cols=175  Identities=30%  Similarity=0.555  Sum_probs=143.1

Q ss_pred             eEEEEEEEECCeEEEEEEcchh-HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcCcc
Q 041830          391 EGAVYHGRLNGKNLAIKRTEHE-VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMK  469 (600)
Q Consensus       391 ~G~Vy~g~~~g~~vAvK~~~~~-~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~  469 (600)
                      .|.||++++.++.||||.++.+ ..+.+.+|+..+..++||||++++|++.   +..++||||+++|+|.++++..... 
T Consensus        21 ~g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~-   96 (307)
T 2eva_A           21 FGVVCKAKWRAKDVAIKQIESESERKAFIVELRQLSRVNHPNIVKLYGACL---NPVCLVMEYAEGGSLYNVLHGAEPL-   96 (307)
T ss_dssp             SSEEEEEEETTEEEEEEECSSTTHHHHHHHHHHHHHHCCCTTBCCEEEBCT---TTTEEEEECCTTCBHHHHHHCSSSE-
T ss_pred             CceEEEEEECCeeEEEEEecChhHHHHHHHHHHHHhcCCCCCcCeEEEEEc---CCcEEEEEcCCCCCHHHHHhccCCC-
Confidence            3899999999999999998654 3456788999999999999999999864   2579999999999999999865421 


Q ss_pred             cccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCc-EEEEeccCccccCC---------C
Q 041830          470 NQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFN-ARVGNFGMARCVND---------D  539 (600)
Q Consensus       470 ~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~-~kI~DFGla~~~~~---------~  539 (600)
                              ..+++.+++.++.|+++||+|||+....+|+||||||+|||++.++. +||+|||+++....         .
T Consensus        97 --------~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~~~~~~gt~~  168 (307)
T 2eva_A           97 --------PYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNNKGSAA  168 (307)
T ss_dssp             --------ECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC------------CCTT
T ss_pred             --------CccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccccccCCCCCc
Confidence                    23789999999999999999999543378999999999999988876 79999999865432         2


Q ss_pred             CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 ~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                      +.+||....  ..++.++||||||+++|||++|+.||...
T Consensus       169 y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~p~~~~  206 (307)
T 2eva_A          169 WMAPEVFEG--SNYSEKCDVFSWGIILWEVITRRKPFDEI  206 (307)
T ss_dssp             SSCHHHHTC--CCCCTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred             eEChhhhCC--CCCCcHHHHHHHHHHHHHHHHCCCCchhh
Confidence            345666544  45788899999999999999999999754

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=99.96  E-value=2.3e-29  Score=276.08  Aligned_cols=173  Identities=25%  Similarity=0.513  Sum_probs=146.7

Q ss_pred             EEEEEEEE--CCeEEEEEEcchh--HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcC
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHE--VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLA  467 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~--~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~  467 (600)
                      |.||+|++  ++..||||.++.+  ..+.+.+|+..+..++|||||+++|+|..+ ...++|||||++|+|.++++....
T Consensus       234 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~  312 (495)
T 1opk_A          234 GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-PPFYIITEFMTYGNLLDYLRECNR  312 (495)
T ss_dssp             SSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSCEEEEECCTTCBHHHHHHHSCT
T ss_pred             eEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcCCCCEeeEEEEEecC-CcEEEEEEccCCCCHHHHHHhcCc
Confidence            89999999  4889999998653  245788999999999999999999998655 478999999999999999976432


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--------
Q 041830          468 MKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--------  539 (600)
Q Consensus       468 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--------  539 (600)
                                ..+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....        
T Consensus       313 ----------~~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~  379 (495)
T 1opk_A          313 ----------QEVSAVVLLYMATQISSAMEYLE---KKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA  379 (495)
T ss_dssp             ----------TTSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECCTTC
T ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEECCCCcEEEeecccceeccCCceeecCCC
Confidence                      34899999999999999999999   669999999999999999999999999999865432        


Q ss_pred             -----CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCCC
Q 041830          540 -----TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRPR  580 (600)
Q Consensus       540 -----~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~~  580 (600)
                           +.+||....  ..++.++|||||||+||||++ |+.||...+
T Consensus       380 ~~~~~y~aPE~~~~--~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~  424 (495)
T 1opk_A          380 KFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGID  424 (495)
T ss_dssp             CCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             cCCcceeCHhHHhc--CCCCcHHhHHhHHHHHHHHHhCCCCCCCCCC
Confidence                 224444433  346788999999999999999 999997643

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=99.96  E-value=9.6e-29  Score=259.12  Aligned_cols=173  Identities=22%  Similarity=0.352  Sum_probs=143.4

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhH--------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEV--------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~--------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      |.||+++.  +|+.||||.++...        .+.+.+|+..+..++||||+++++++..+ ...|+|||||++|+|.++
T Consensus        38 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~lv~e~~~g~~L~~~  116 (351)
T 3c0i_A           38 SVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSD-GMLYMVFEFMDGADLCFE  116 (351)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEECCSSCBHHHH
T ss_pred             EEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-CEEEEEEeCCCCCCHHHH
Confidence            99999998  68999999976432        34678899999999999999999998665 489999999999999988


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCc---EEEEeccCccccCC
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFN---ARVGNFGMARCVND  538 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~---~kI~DFGla~~~~~  538 (600)
                      +......        ...+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.   +||+|||+++....
T Consensus       117 l~~~~~~--------~~~~~~~~~~~i~~qi~~al~~lH---~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~  185 (351)
T 3c0i_A          117 IVKRADA--------GFVYSEAVASHYMRQILEALRYCH---DNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGE  185 (351)
T ss_dssp             HHHHHHT--------TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCT
T ss_pred             HHHhccc--------CCCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChHHeEEecCCCCCcEEEecCcceeEecC
Confidence            8643210        134899999999999999999999   669999999999999986654   99999999976543


Q ss_pred             C------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          539 D------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       539 ~------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                      .            +.+||....  ..++.++|||||||++|||++|+.||..
T Consensus       186 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~  235 (351)
T 3c0i_A          186 SGLVAGGRVGTPHFMAPEVVKR--EPYGKPVDVWGCGVILFILLSGCLPFYG  235 (351)
T ss_dssp             TSCBCCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCS
T ss_pred             CCeeecCCcCCcCccCHHHHcC--CCCCchHhhHHHHHHHHHHHHCCCCCCC
Confidence            2            124555443  3568889999999999999999999975

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=99.96  E-value=1.4e-28  Score=257.69  Aligned_cols=173  Identities=25%  Similarity=0.388  Sum_probs=144.5

Q ss_pred             eEEEEEEEE--CCeEEEEEEcch------hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEH------EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~------~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||+++.  +|+.||||++..      +....+.+|+..+..++||||+++++++..+ ...++||||++ |+|.+++
T Consensus        67 ~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv~e~~~-g~l~~~l  144 (348)
T 1u5q_A           67 FGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-HTAWLVMEYCL-GSASDLL  144 (348)
T ss_dssp             SEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEECCS-EEHHHHH
T ss_pred             CEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEEC-CeEEEEEecCC-CCHHHHH
Confidence            399999997  789999998753      2234577899999999999999999998765 48999999997 6898888


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC---
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---  539 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~---  539 (600)
                      ....           ..+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....   
T Consensus       145 ~~~~-----------~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~  210 (348)
T 1u5q_A          145 EVHK-----------KPLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF  210 (348)
T ss_dssp             HHHT-----------SCCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCCC
T ss_pred             HHhc-----------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEECCCCCEEEeeccCceecCCCCcc
Confidence            6432           34899999999999999999999   568999999999999999999999999999765422   


Q ss_pred             -----CCCCccccc-CCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 -----TESPQFYST-NPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 -----~~~pe~~~~-~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                           +.+||.... ....++.++|||||||++|||++|+.||...
T Consensus       211 ~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~  256 (348)
T 1u5q_A          211 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM  256 (348)
T ss_dssp             CSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             cCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                 235665532 2345788899999999999999999999653

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=99.96  E-value=8.3e-29  Score=255.71  Aligned_cols=179  Identities=22%  Similarity=0.358  Sum_probs=144.3

Q ss_pred             eeEEEEEEEE--CCeEEEEEEcchhH----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          390 IEGAVYHGRL--NGKNLAIKRTEHEV----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       390 ~~G~Vy~g~~--~g~~vAvK~~~~~~----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      ..|.||+++.  +|+.||+|.++...    ...+.+|+..+..++||||+++++++..+ +..++||||++ |+|.+++.
T Consensus        17 ~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~-~~L~~~l~   94 (317)
T 2pmi_A           17 TYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKHENIVRLYDVIHTE-NKLTLVFEFMD-NDLKKYMD   94 (317)
T ss_dssp             --CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCT-TEEEEEEECCC-CBHHHHHH
T ss_pred             CCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcCCCCcceEEEEEEEC-CeEEEEEEecC-CCHHHHHH
Confidence            3499999987  68999999875422    24567899999999999999999997655 48999999998 69999986


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC-----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND-----  538 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~-----  538 (600)
                      ......      ....+++..+..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....     
T Consensus        95 ~~~~~~------~~~~~~~~~~~~~~~qi~~aL~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  165 (317)
T 2pmi_A           95 SRTVGN------TPRGLELNLVKYFQWQLLQGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTF  165 (317)
T ss_dssp             HHHSSS------CCCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCCCC
T ss_pred             hccccc------cccCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCcccC
Confidence            532110      0134899999999999999999999   56999999999999999999999999999976432     


Q ss_pred             -------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          539 -------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       539 -------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                             .+.+||.... ...++.++|||||||++|||++|+.||...+
T Consensus       166 ~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~  213 (317)
T 2pmi_A          166 SSEVVTLWYRAPDVLMG-SRTYSTSIDIWSCGCILAEMITGKPLFPGTN  213 (317)
T ss_dssp             CCCCSCCTTCCHHHHTT-CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             CCCcccccccCchHhhC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                   1235665433 2346888999999999999999999997543

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=99.96  E-value=8.3e-29  Score=258.08  Aligned_cols=170  Identities=25%  Similarity=0.471  Sum_probs=143.0

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhHH------HHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEVI------TKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~~------~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      |.||+++.  +|+.||+|.+.....      ..+++|+..+..++||||+++++++..+ ...++||||+ +|+|.+++.
T Consensus        23 g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~-~~~~lv~E~~-~g~l~~~l~  100 (336)
T 3h4j_B           23 GKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTP-TDIVMVIEYA-GGELFDYIV  100 (336)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEEECCC-CEEHHHHHH
T ss_pred             eEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-CEEEEEEECC-CCcHHHHHH
Confidence            99999998  789999999865432      3578899999999999999999998665 4899999999 689999986


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC-----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND-----  538 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~-----  538 (600)
                      ...            .+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....     
T Consensus       101 ~~~------------~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~~~  165 (336)
T 3h4j_B          101 EKK------------RMTEDEGRRFFQQIICAIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLK  165 (336)
T ss_dssp             HHC------------SCCHHHHHHHHHHHHHHHHHHH---HHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBTTC
T ss_pred             HcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcccc
Confidence            532            3899999999999999999999   55899999999999999999999999999975432     


Q ss_pred             ------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 ------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 ------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                            .+.+||..... ...+.++|||||||++|||++|+.||...
T Consensus       166 ~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~~ll~g~~Pf~~~  211 (336)
T 3h4j_B          166 TSCGSPNYAAPEVINGK-LYAGPEVDVWSCGIVLYVMLVGRLPFDDE  211 (336)
T ss_dssp             CCTTSTTTSCGGGSCCS-GGGCHHHHHHHHHHHHHHHHHSSCSSBCS
T ss_pred             cccCCcCcCCHHHHcCC-CCCCCccchhHHHHHHHHHHhCCCCCCCc
Confidence                  22356655431 12267899999999999999999999754

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=99.96  E-value=2.1e-28  Score=248.38  Aligned_cols=173  Identities=28%  Similarity=0.505  Sum_probs=143.1

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH----------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV----------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSL  458 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~----------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL  458 (600)
                      .|.||+++.  +++.||+|++....          .+.+.+|+..+..++||||+++++++.+.   .++||||+++|+|
T Consensus        32 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---~~lv~e~~~~~~L  108 (287)
T 4f0f_A           32 FGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNP---PRMVMEFVPCGDL  108 (287)
T ss_dssp             SSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTT---TEEEEECCTTCBH
T ss_pred             ceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCC---CeEEEEecCCCCH
Confidence            499999998  78999999874311          14678899999999999999999997432   3799999999999


Q ss_pred             HHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCC--ceecCCCCCCEEeCCCCc-----EEEEecc
Q 041830          459 KDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS--YVHRNIKSRNIFLDEEFN-----ARVGNFG  531 (600)
Q Consensus       459 ~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDLk~~NILld~~~~-----~kI~DFG  531 (600)
                      .+++....           ..+++.+++.++.|++.||+|||   +.+  |+||||||+|||++.++.     +||+|||
T Consensus       109 ~~~l~~~~-----------~~~~~~~~~~~~~~l~~~l~~lH---~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg  174 (287)
T 4f0f_A          109 YHRLLDKA-----------HPIKWSVKLRLMLDIALGIEYMQ---NQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFG  174 (287)
T ss_dssp             HHHHHCTT-----------SCCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCT
T ss_pred             HHHHhccc-----------CCccHHHHHHHHHHHHHHHHHHH---hCCCCeecCCCCcceEEEeccCCCCceeEEeCCCC
Confidence            99987543           34899999999999999999999   556  999999999999987776     9999999


Q ss_pred             CccccCC---------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          532 MARCVND---------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       532 la~~~~~---------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                      +++....         .+.+||........++.++||||||+++|||++|+.||....
T Consensus       175 ~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~  232 (287)
T 4f0f_A          175 LSQQSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS  232 (287)
T ss_dssp             TCBCCSSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             ccccccccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence            9874432         234677664444556788999999999999999999997543

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=99.96  E-value=4e-29  Score=271.20  Aligned_cols=172  Identities=20%  Similarity=0.449  Sum_probs=145.8

Q ss_pred             eEEEEEEEE-CCeEEEEEEcchh--HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcC
Q 041830          391 EGAVYHGRL-NGKNLAIKRTEHE--VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLA  467 (600)
Q Consensus       391 ~G~Vy~g~~-~g~~vAvK~~~~~--~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~  467 (600)
                      .|.||+|.+ ++..||||+++..  ..+.+.+|+..+..++|||||++++++. + ...++||||+++|+|.++++....
T Consensus       201 fg~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~-~~~~lv~e~~~~g~L~~~l~~~~~  278 (454)
T 1qcf_A          201 FGEVWMATYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQHDKLVKLHAVVT-K-EPIYIITEFMAKGSLLDFLKSDEG  278 (454)
T ss_dssp             SEEEEEEEETTTEEEEEEEECTTSBCHHHHHHHHHHHTTCCCTTBCCEEEEEC-S-SSCEEEECCCTTCBHHHHHHSHHH
T ss_pred             ceEEEEEEECCccEEEEEEecCCCccHHHHHHHHHHHhhCCCCCEeeEEEEEe-C-CccEEEEeecCCCcHHHHHHhccC
Confidence            399999999 5788999998753  2457889999999999999999999974 3 478999999999999999975321


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC---------
Q 041830          468 MKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND---------  538 (600)
Q Consensus       468 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~---------  538 (600)
                                ..+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....         
T Consensus       279 ----------~~~~~~~~~~~~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~~~~~  345 (454)
T 1qcf_A          279 ----------SKQPLPKLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGA  345 (454)
T ss_dssp             ----------HTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHTTCSS
T ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceeccCCC
Confidence                      23899999999999999999999   56999999999999999999999999999986532         


Q ss_pred             ----CCCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          539 ----DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       539 ----~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                          .+.+||....  ..++.++|||||||+||||++ |+.||...
T Consensus       346 ~~~~~y~aPE~~~~--~~~~~~~DvwslG~~l~el~t~g~~P~~~~  389 (454)
T 1qcf_A          346 KFPIKWTAPEAINF--GSFTIKSDVWSFGILLMEIVTYGRIPYPGM  389 (454)
T ss_dssp             SSCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             cccccccCHHHhcc--CCCCcHHHHHhHHHHHHHHHhCCCCCCCCC
Confidence                1235565543  347888999999999999999 99999753

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=99.96  E-value=3e-28  Score=246.07  Aligned_cols=172  Identities=20%  Similarity=0.434  Sum_probs=138.4

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      |.||+++.  +|+.||+|.+....      ...+.+|+..+..++||||+++++++... ...++||||+++|+|.+++.
T Consensus        25 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~  103 (278)
T 3cok_A           25 AGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDS-NYVYLVLEMCHNGEMNRYLK  103 (278)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECS-SEEEEEEECCTTEEHHHHHH
T ss_pred             eEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccC-CeEEEEEecCCCCcHHHHHh
Confidence            99999997  78999999986543      24577899999999999999999997655 48899999999999999997


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD----  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~----  539 (600)
                      ...           ..+++.+++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++.....    
T Consensus       104 ~~~-----------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~  169 (278)
T 3cok_A          104 NRV-----------KPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKH  169 (278)
T ss_dssp             TCS-----------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSSCCGGGEEECTTCCEEECCCTTCEECC------
T ss_pred             hcc-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCCcc
Confidence            543           34899999999999999999999   569999999999999999999999999998765321    


Q ss_pred             --------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 --------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 --------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                              ..+||....  ..++.++||||||+++|||++|+.||....
T Consensus       170 ~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~  216 (278)
T 3cok_A          170 YTLCGTPNYISPEIATR--SAHGLESDVWSLGCMFYTLLIGRPPFDTDT  216 (278)
T ss_dssp             ------------------------CTHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred             eeccCCCCcCCcchhcC--CCCCchhhHHHHHHHHHHHHhCCCCCCChh
Confidence                    234555443  345778999999999999999999997543

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=99.96  E-value=8.3e-29  Score=248.75  Aligned_cols=171  Identities=28%  Similarity=0.526  Sum_probs=144.2

Q ss_pred             EEEEEEEE-CCeEEEEEEcchhH--HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcCc
Q 041830          392 GAVYHGRL-NGKNLAIKRTEHEV--ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM  468 (600)
Q Consensus       392 G~Vy~g~~-~g~~vAvK~~~~~~--~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~  468 (600)
                      |.||+++. ++..||+|.++...  ...+.+|+..+..++||||+++++++..+ ...++||||+++|+|.+++....  
T Consensus        22 g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~--   98 (268)
T 3sxs_A           22 GVVKLGKWKGQYDVAVKMIKEGSMSEDEFFQEAQTMMKLSHPKLVKFYGVCSKE-YPIYIVTEYISNGCLLNYLRSHG--   98 (268)
T ss_dssp             EEEEEEEETTTEEEEEEEECBTTBCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSEEEEEECCTTCBHHHHHHHHG--
T ss_pred             ceEEEEEecCceeEEEEEeccCCCcHHHHHHHHHHHHhCCCCCEeeEEEEEccC-CceEEEEEccCCCcHHHHHHHcC--
Confidence            99999998 56789999986532  35678899999999999999999997554 47899999999999999997532  


Q ss_pred             ccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC---------
Q 041830          469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---------  539 (600)
Q Consensus       469 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~---------  539 (600)
                               ..+++.+++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++.....         
T Consensus        99 ---------~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~  166 (268)
T 3sxs_A           99 ---------KGLEPSQLLEMCYDVCEGMAFLE---SHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTK  166 (268)
T ss_dssp             ---------GGCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECCSCC
T ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhcccCCC
Confidence                     23899999999999999999999   569999999999999999999999999999755332         


Q ss_pred             ----CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          540 ----TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       540 ----~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                          ..+||....  ..++.++||||||+++|||++ |+.||...
T Consensus       167 ~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~  209 (268)
T 3sxs_A          167 FPVKWSAPEVFHY--FKYSSKSDVWAFGILMWEVFSLGKMPYDLY  209 (268)
T ss_dssp             CCGGGCCHHHHHH--SEEETTHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             cCcccCCHHHHhc--cCCchhhhhHHHHHHHHHHHcCCCCCcccc
Confidence                234444433  346778999999999999999 99999653

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=2.5e-28  Score=253.29  Aligned_cols=170  Identities=24%  Similarity=0.402  Sum_probs=136.0

Q ss_pred             EEEEEEEECCeEEEEEEcchhHHHHH--HHHHHHHHhCCCCceeeeeeEEeccC---CceEEEEeecCCCCHHHHHhcCc
Q 041830          392 GAVYHGRLNGKNLAIKRTEHEVITKL--EMQLVQHATHHHPNIVRLLGTCLTDG---PHSFLVFEYAKNGSLKDWLHGGL  466 (600)
Q Consensus       392 G~Vy~g~~~g~~vAvK~~~~~~~~~~--e~ei~~~~~l~HpNIv~l~g~~~~~~---~~~~LV~Ey~~~GsL~~~L~~~~  466 (600)
                      |.||+|+.+|+.||||++........  +.|+.....++||||+++++++....   ...++||||+++|+|.++++.. 
T Consensus        51 g~V~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-  129 (337)
T 3mdy_A           51 GEVWMGKWRGEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-  129 (337)
T ss_dssp             EEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHHC-
T ss_pred             eEEEEEEECCceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhcc-
Confidence            99999999999999999866544433  44444444568999999999987552   3689999999999999999653 


Q ss_pred             CcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCC--------CceecCCCCCCEEeCCCCcEEEEeccCccccCC
Q 041830          467 AMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNP--------SYVHRNIKSRNIFLDEEFNARVGNFGMARCVND  538 (600)
Q Consensus       467 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~--------~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~  538 (600)
                                  .+++.+++.++.|++.||.|||   +.        +|+||||||+|||++.++.+||+|||+++....
T Consensus       130 ------------~~~~~~~~~i~~~i~~~l~~lH---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~  194 (337)
T 3mdy_A          130 ------------TLDAKSMLKLAYSSVSGLCHLH---TEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFIS  194 (337)
T ss_dssp             ------------CBCHHHHHHHHHHHHHHHHHHH---SCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC-
T ss_pred             ------------CCCHHHHHHHHHHHHHHHHHHH---HhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeecc
Confidence                        2899999999999999999999   55        999999999999999999999999999965422


Q ss_pred             C----------------CCCCcccccCCCCCCc------cCchHHHHHHHHHHHhC----------CCCCCCC
Q 041830          539 D----------------TESPQFYSTNPASWSM------GIDIFAYGIVLLEVLSG----------QTPINRP  579 (600)
Q Consensus       539 ~----------------~~~pe~~~~~~~~~t~------~sDVwSfGvvL~ELltG----------~~Pf~~~  579 (600)
                      .                +.+||.....  .++.      ++|||||||++|||++|          +.||...
T Consensus       195 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~  265 (337)
T 3mdy_A          195 DTNEVDIPPNTRVGTKRYMPPEVLDES--LNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDL  265 (337)
T ss_dssp             --------CCSSCSCGGGCCHHHHTTC--CCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             ccccccCCCCCCccCcceeChhhcccc--cCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhh
Confidence            1                2345544332  2222      38999999999999999          7777543

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=99.96  E-value=6e-29  Score=258.23  Aligned_cols=171  Identities=25%  Similarity=0.414  Sum_probs=135.9

Q ss_pred             EEEEEEEECCeEEEEEEcchhHHHHH--HHHHHHHHhCCCCceeeeeeEEec----cCCceEEEEeecCCCCHHHHHhcC
Q 041830          392 GAVYHGRLNGKNLAIKRTEHEVITKL--EMQLVQHATHHHPNIVRLLGTCLT----DGPHSFLVFEYAKNGSLKDWLHGG  465 (600)
Q Consensus       392 G~Vy~g~~~g~~vAvK~~~~~~~~~~--e~ei~~~~~l~HpNIv~l~g~~~~----~~~~~~LV~Ey~~~GsL~~~L~~~  465 (600)
                      |.||+|+.+|+.||||+++......+  +.++..+..++||||+++++.+..    .....++||||+++|+|.+++...
T Consensus        27 g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~  106 (336)
T 3g2f_A           27 GAVYKGSLDERPVAVKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH  106 (336)
T ss_dssp             EEEEEEEETTEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHC
T ss_pred             eEEEEEEECCeEEEEEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhc
Confidence            99999999999999999876554433  445555556899999999986532    222568999999999999999754


Q ss_pred             cCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCC---------CceecCCCCCCEEeCCCCcEEEEeccCcccc
Q 041830          466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNP---------SYVHRNIKSRNIFLDEEFNARVGNFGMARCV  536 (600)
Q Consensus       466 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~---------~ivHrDLk~~NILld~~~~~kI~DFGla~~~  536 (600)
                      .             ++|.++++++.|++.||.|||   +.         +|+||||||+|||++.++.+||+|||+++..
T Consensus       107 ~-------------~~~~~~~~i~~qi~~~L~~LH---~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~  170 (336)
T 3g2f_A          107 T-------------SDWVSSCRLAHSVTRGLAYLH---TELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRL  170 (336)
T ss_dssp             C-------------BCHHHHHHHHHHHHHHHHHHH---CCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             c-------------cchhHHHHHHHHHHHHHHHHH---hhhccccccccceeecccccceEEEcCCCcEEEeeccceeec
Confidence            3             689999999999999999999   56         9999999999999999999999999999765


Q ss_pred             CCC--------------------CCCCcccccCC-----CCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          537 NDD--------------------TESPQFYSTNP-----ASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       537 ~~~--------------------~~~pe~~~~~~-----~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                      ...                    +.+||......     ..++.++|||||||++|||++|+.||..
T Consensus       171 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~  237 (336)
T 3g2f_A          171 TGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFP  237 (336)
T ss_dssp             SSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGST
T ss_pred             ccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCC
Confidence            321                    22455443211     2345678999999999999999777643

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=99.96  E-value=9.1e-29  Score=260.94  Aligned_cols=180  Identities=26%  Similarity=0.436  Sum_probs=144.0

Q ss_pred             ceeEEEEEEEE-------CCeEEEEEEcch----hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCC
Q 041830          389 RIEGAVYHGRL-------NGKNLAIKRTEH----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGS  457 (600)
Q Consensus       389 ~~~G~Vy~g~~-------~g~~vAvK~~~~----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~Gs  457 (600)
                      |.+|.||+|++       +++.||||+++.    .....+.+|+..+..++||||+++++++... ...++||||+++|+
T Consensus        82 G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-~~~~lv~e~~~~g~  160 (367)
T 3l9p_A           82 GAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS-LPRFILLELMAGGD  160 (367)
T ss_dssp             CSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSCEEEEECCTTEE
T ss_pred             CCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CCCEEEEEeCCCCC
Confidence            33499999995       356899999853    2334677899999999999999999998655 47899999999999


Q ss_pred             HHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC---cEEEEeccCcc
Q 041830          458 LKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEF---NARVGNFGMAR  534 (600)
Q Consensus       458 L~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~---~~kI~DFGla~  534 (600)
                      |.++++.......     ....+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++   .+||+|||+++
T Consensus       161 L~~~l~~~~~~~~-----~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~  232 (367)
T 3l9p_A          161 LKSFLRETRPRPS-----QPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR  232 (367)
T ss_dssp             HHHHHHHHSCCSS-----SCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHH
T ss_pred             HHHHHHhhccccC-----ccccccHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEEecCCCCceEEECCCcccc
Confidence            9999976432111     1134899999999999999999999   66999999999999999544   59999999987


Q ss_pred             ccC--------------CCCCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          535 CVN--------------DDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       535 ~~~--------------~~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                      ...              ..+.+||....  ..++.++|||||||++|||++ |+.||...
T Consensus       233 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DvwslG~il~ellt~g~~pf~~~  290 (367)
T 3l9p_A          233 DIYRAGYYRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSLGYMPYPSK  290 (367)
T ss_dssp             HHHHHSSCTTCCGGGSCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ccccccccccCCCcCCcccEECHHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            431              11335665544  357889999999999999998 99999754

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=99.96  E-value=1.7e-28  Score=252.65  Aligned_cols=176  Identities=20%  Similarity=0.332  Sum_probs=141.5

Q ss_pred             eeEEEEEEEE--CCeEEEEEEcchh---HHHHHHHHHHHHHh-CCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          390 IEGAVYHGRL--NGKNLAIKRTEHE---VITKLEMQLVQHAT-HHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       390 ~~G~Vy~g~~--~g~~vAvK~~~~~---~~~~~e~ei~~~~~-l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      ..|.||+++.  +|+.||||.++..   ....+.+|+..+.. .+||||+++++++..+ +..++||||+++|+|.+++.
T Consensus        25 ~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~  103 (316)
T 2ac3_A           25 AHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEE-DRFYLVFEKMRGGSILSHIH  103 (316)
T ss_dssp             SSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEEEECCTTCBHHHHHH
T ss_pred             ceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeC-CEEEEEEEcCCCCcHHHHHh
Confidence            3499999987  7899999998543   23567788888877 4799999999998665 48999999999999999997


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCc---EEEEeccCccccCC--
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFN---ARVGNFGMARCVND--  538 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~---~kI~DFGla~~~~~--  538 (600)
                      ...            .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.   +||+|||+++....  
T Consensus       104 ~~~------------~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~  168 (316)
T 2ac3_A          104 KRR------------HFNELEASVVVQDVASALDFLH---NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNG  168 (316)
T ss_dssp             HHS------------SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC------
T ss_pred             ccC------------CCCHHHHHHHHHHHHHHHHHHH---hCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCC
Confidence            532            3899999999999999999999   569999999999999988765   99999999875421  


Q ss_pred             -----------------CCCCCcccccC---CCCCCccCchHHHHHHHHHHHhCCCCCCCCCC
Q 041830          539 -----------------DTESPQFYSTN---PASWSMGIDIFAYGIVLLEVLSGQTPINRPRK  581 (600)
Q Consensus       539 -----------------~~~~pe~~~~~---~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~  581 (600)
                                       .+.+||.....   ...++.++|||||||++|||++|+.||.....
T Consensus       169 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~  231 (316)
T 2ac3_A          169 DCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCG  231 (316)
T ss_dssp             -------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCC
T ss_pred             ccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccc
Confidence                             12244443321   12357789999999999999999999976543

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=99.96  E-value=4.6e-29  Score=261.55  Aligned_cols=184  Identities=24%  Similarity=0.420  Sum_probs=146.1

Q ss_pred             EEEEEEEE-------CCeEEEEEEcchh----HHHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCCHH
Q 041830          392 GAVYHGRL-------NGKNLAIKRTEHE----VITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       392 G~Vy~g~~-------~g~~vAvK~~~~~----~~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~  459 (600)
                      |.||++++       +++.||||+++..    ....+.+|+..+..+ +||||+++++++..++...++||||+++|+|.
T Consensus        36 g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~  115 (359)
T 3vhe_A           36 GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLS  115 (359)
T ss_dssp             EEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHH
T ss_pred             ceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHH
Confidence            99999985       3478999998652    234578899988888 79999999999877665689999999999999


Q ss_pred             HHHhcCcCcccc------------------------------------------------------cccccccCCCHHHH
Q 041830          460 DWLHGGLAMKNQ------------------------------------------------------FIASCYCFLTWSQR  485 (600)
Q Consensus       460 ~~L~~~~~~~~~------------------------------------------------------~~~~~~~~l~~~~~  485 (600)
                      ++++........                                                      ........+++.++
T Consensus       116 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  195 (359)
T 3vhe_A          116 TYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHL  195 (359)
T ss_dssp             HHHHTTTTSBCSCC------------------------------------------------------CTTTTCBCHHHH
T ss_pred             HHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHH
Confidence            999765321000                                                      00000123899999


Q ss_pred             HHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--------------CCCCcccccCCC
Q 041830          486 LRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--------------TESPQFYSTNPA  551 (600)
Q Consensus       486 ~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--------------~~~pe~~~~~~~  551 (600)
                      +.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....              +.+||....  .
T Consensus       196 ~~~~~ql~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~  270 (359)
T 3vhe_A          196 ICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFD--R  270 (359)
T ss_dssp             HHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHH--C
T ss_pred             HHHHHHHHHHHHHHH---HCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcC--C
Confidence            999999999999999   569999999999999999999999999999754321              234555443  4


Q ss_pred             CCCccCchHHHHHHHHHHHh-CCCCCCCCC
Q 041830          552 SWSMGIDIFAYGIVLLEVLS-GQTPINRPR  580 (600)
Q Consensus       552 ~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~~  580 (600)
                      .++.++|||||||++|||++ |+.||....
T Consensus       271 ~~~~~~Di~slG~il~ellt~g~~p~~~~~  300 (359)
T 3vhe_A          271 VYTIQSDVWSFGVLLWEIFSLGASPYPGVK  300 (359)
T ss_dssp             CCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             CCCchhhhhhHHHHHHHHHhcCCCCCCccc
Confidence            56788999999999999998 999997644

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=99.96  E-value=1.6e-28  Score=260.87  Aligned_cols=174  Identities=23%  Similarity=0.426  Sum_probs=140.9

Q ss_pred             ceeEEEEEEEE--CCeEEEEEEcch-----hHHHHHHHHHHHHHhCC-CCceeeeeeEEeccC-CceEEEEeecCCCCHH
Q 041830          389 RIEGAVYHGRL--NGKNLAIKRTEH-----EVITKLEMQLVQHATHH-HPNIVRLLGTCLTDG-PHSFLVFEYAKNGSLK  459 (600)
Q Consensus       389 ~~~G~Vy~g~~--~g~~vAvK~~~~-----~~~~~~e~ei~~~~~l~-HpNIv~l~g~~~~~~-~~~~LV~Ey~~~GsL~  459 (600)
                      |.+|.||++..  +|+.||||++..     .....+.+|+..+..+. ||||+++++++..++ ...|+|||||+ |+|.
T Consensus        20 G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~   98 (388)
T 3oz6_A           20 GAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLH   98 (388)
T ss_dssp             ----CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHH
T ss_pred             CCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHH
Confidence            33499999988  689999998743     22345678888888887 999999999986433 36899999998 6999


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC-
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND-  538 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~-  538 (600)
                      ++++..             .+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.... 
T Consensus        99 ~~~~~~-------------~~~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  162 (388)
T 3oz6_A           99 AVIRAN-------------ILEPVHKQYVVYQLIKVIKYLH---SGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNI  162 (388)
T ss_dssp             HHHHHT-------------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSC
T ss_pred             HHHHcC-------------CCCHHHHHHHHHHHHHHHHHHH---hCCEEeCCCCHHHeEEcCCCCEEecCCccccccccc
Confidence            999753             2899999999999999999999   66999999999999999999999999999975422 


Q ss_pred             --------------------------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          539 --------------------------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       539 --------------------------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                                                      .+.+||.... ...++.++|||||||++|||++|+.||...+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  235 (388)
T 3oz6_A          163 RRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG-STKYTKGIDMWSLGCILGEILCGKPIFPGSS  235 (388)
T ss_dssp             CCCCCCGGGCCC---------------CCCGGGGCCHHHHTT-CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             ccccccccccccccccccccccccccCCcccCCcCCHHHhcC-CCCCCChhhHHHHHHHHHHHHhCCCCCCCCC
Confidence                                            1234554432 2457888999999999999999999997644

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=99.96  E-value=2.6e-28  Score=269.96  Aligned_cols=173  Identities=22%  Similarity=0.300  Sum_probs=146.6

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhHH------HHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEVI------TKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~~------~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      |.||+++.  +|+.||+|.++....      ..+..|+..+..++|||||++++++.+. ...|+||||+++|+|.+++.
T Consensus       198 G~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-~~l~lVmEy~~gg~L~~~l~  276 (576)
T 2acx_A          198 GEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETK-DALCLVLTLMNGGDLKFHIY  276 (576)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHHH
T ss_pred             EEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeC-CEEEEEEEcCCCCcHHHHHH
Confidence            99999998  699999999865432      3456788899999999999999997655 48999999999999999997


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD----  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~----  539 (600)
                      ....          ..+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....    
T Consensus       277 ~~~~----------~~l~e~~~~~i~~qIl~aL~yLH---~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~~~  343 (576)
T 2acx_A          277 HMGQ----------AGFPEARAVFYAAEICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK  343 (576)
T ss_dssp             SSSS----------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCEE
T ss_pred             hcCC----------CCCCHHHHHHHHHHHHHHHHHHH---HCCEeccCCchheEEEeCCCCeEEEecccceecccCcccc
Confidence            6432          33899999999999999999999   569999999999999999999999999999865432    


Q ss_pred             -------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 -------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 -------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                             +.+||....  ..++.++|||||||++|||++|+.||....
T Consensus       344 ~~~GT~~Y~APEvl~~--~~~~~~~DiwSLGvilyeLltG~~PF~~~~  389 (576)
T 2acx_A          344 GRVGTVGYMAPEVVKN--ERYTFSPDWWALGCLLYEMIAGQSPFQQRK  389 (576)
T ss_dssp             CCCSCGGGCCHHHHTT--CEESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred             ccCCCccccCHHHHcC--CCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence                   224555443  457888999999999999999999998654

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=99.96  E-value=3.4e-28  Score=268.17  Aligned_cols=175  Identities=19%  Similarity=0.305  Sum_probs=146.9

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhHH------HHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEVI------TKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~~------~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      |.||+++.  +|+.||+|+++....      ..+..|+..+..++||||+++++++... ...|+||||+++|+|.+++.
T Consensus       199 G~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~-~~l~lVmE~~~gg~L~~~l~  277 (543)
T 3c4z_A          199 GEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETK-TDLCLVMTIMNGGDIRYHIY  277 (543)
T ss_dssp             SEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEECCCTTCBHHHHHH
T ss_pred             eEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeC-CEEEEEEEeccCCCHHHHHH
Confidence            99999998  689999999865432      3467788899999999999999997655 58999999999999999997


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD----  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~----  539 (600)
                      ......        ..+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....    
T Consensus       278 ~~~~~~--------~~l~e~~~~~~~~qi~~aL~~LH---~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~~  346 (543)
T 3c4z_A          278 NVDEDN--------PGFQEPRAIFYTAQIVSGLEHLH---QRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKT  346 (543)
T ss_dssp             TSSTTS--------CSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCCB
T ss_pred             Hhhccc--------ccccHHHHHHHHHHHHHHHHHHH---HcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCccc
Confidence            643211        34899999999999999999999   569999999999999999999999999999754321    


Q ss_pred             --------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 --------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 --------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                              +.+||....  ..++.++|||||||++|||++|+.||....
T Consensus       347 ~~~~GT~~Y~APE~l~~--~~~~~~~DiwSlGvilyelltG~~PF~~~~  393 (543)
T 3c4z_A          347 KGYAGTPGFMAPELLLG--EEYDFSVDYFALGVTLYEMIAARGPFRARG  393 (543)
T ss_dssp             CCCCSCTTTSCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred             ccccCCccccChhhhcC--CCCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence                    234555543  457889999999999999999999997654

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=99.96  E-value=7.7e-29  Score=261.97  Aligned_cols=171  Identities=23%  Similarity=0.314  Sum_probs=136.7

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhHH------HHHHHHHHH-HHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEVI------TKLEMQLVQ-HATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~~------~~~e~ei~~-~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      .|.||+++.  +++.||||.++....      ..+..|... +..++||||+++++++..+ ...|+||||+++|+|.++
T Consensus        51 fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~-~~~~lv~E~~~gg~L~~~  129 (373)
T 2r5t_A           51 FGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTA-DKLYFVLDYINGGELFYH  129 (373)
T ss_dssp             TCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECS-SEEEEEEECCCSCBHHHH
T ss_pred             CeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeC-CEEEEEEeCCCCCcHHHH
Confidence            399999998  688999999865431      122333333 3457899999999997655 489999999999999999


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC----
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN----  537 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~----  537 (600)
                      +....            .+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++...    
T Consensus       130 l~~~~------------~~~~~~~~~~~~qi~~aL~~LH---~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~  194 (373)
T 2r5t_A          130 LQRER------------CFLEPRARFYAAEIASALGYLH---SLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS  194 (373)
T ss_dssp             HHHHS------------SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCC
T ss_pred             HHhcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEECCCCCEEEeeCccccccccCCC
Confidence            97532            3889999999999999999999   6699999999999999999999999999997532    


Q ss_pred             --------CCCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          538 --------DDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       538 --------~~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                              ..+.+||....  ..++.++|||||||++|||++|+.||...
T Consensus       195 ~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~G~~Pf~~~  242 (373)
T 2r5t_A          195 TTSTFCGTPEYLAPEVLHK--QPYDRTVDWWCLGAVLYEMLYGLPPFYSR  242 (373)
T ss_dssp             CCCSBSCCCCCCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             ccccccCCccccCHHHhCC--CCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence                    12235555543  45788899999999999999999999754

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=99.96  E-value=6.9e-29  Score=260.62  Aligned_cols=173  Identities=21%  Similarity=0.310  Sum_probs=141.7

Q ss_pred             EEEEEEEE-----CCeEEEEEEcchh-------HHHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCCH
Q 041830          392 GAVYHGRL-----NGKNLAIKRTEHE-------VITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSL  458 (600)
Q Consensus       392 G~Vy~g~~-----~g~~vAvK~~~~~-------~~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL  458 (600)
                      |.||+++.     +|+.||||+++..       ....+.+|+..+..+ +||||+++++++..+ ...++||||+++|+|
T Consensus        68 g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L  146 (355)
T 1vzo_A           68 GKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-TKLHLILDYINGGEL  146 (355)
T ss_dssp             EEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-TEEEEEECCCCSCBH
T ss_pred             EEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeC-ceEEEEeecCCCCCH
Confidence            99999988     6899999987542       123445677777777 699999999997655 488999999999999


Q ss_pred             HHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC-
Q 041830          459 KDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN-  537 (600)
Q Consensus       459 ~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~-  537 (600)
                      .+++....            .+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++... 
T Consensus       147 ~~~l~~~~------------~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~  211 (355)
T 1vzo_A          147 FTHLSQRE------------RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVA  211 (355)
T ss_dssp             HHHHHHHS------------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred             HHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEECCCCcEEEeeCCCCeeccc
Confidence            99997532            3899999999999999999999   5699999999999999999999999999987432 


Q ss_pred             ------------CCCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          538 ------------DDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       538 ------------~~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                                  ..+.+||........++.++|||||||+||||++|+.||....
T Consensus       212 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~  266 (355)
T 1vzo_A          212 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG  266 (355)
T ss_dssp             GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred             CCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCC
Confidence                        2234677665444556788999999999999999999997543

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=99.95  E-value=3.1e-28  Score=244.29  Aligned_cols=175  Identities=22%  Similarity=0.459  Sum_probs=143.9

Q ss_pred             EEEEEEEECCeEEEEEEcch-----hHHHHHHHHHHHHHhCCCCceeeeeeEEecc-CCceEEEEeecCCCCHHHHHhcC
Q 041830          392 GAVYHGRLNGKNLAIKRTEH-----EVITKLEMQLVQHATHHHPNIVRLLGTCLTD-GPHSFLVFEYAKNGSLKDWLHGG  465 (600)
Q Consensus       392 G~Vy~g~~~g~~vAvK~~~~-----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~-~~~~~LV~Ey~~~GsL~~~L~~~  465 (600)
                      |.||+|+++|+.||||.++.     ...+.+.+|+..+..++||||+++++++... +...++||||+++|+|.++++..
T Consensus        24 g~V~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~  103 (271)
T 3kmu_A           24 GELWKGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEG  103 (271)
T ss_dssp             EEEEEEEETTEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSC
T ss_pred             ceEEEEEECCeeEEEEEecccccCHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhc
Confidence            99999999999999999753     2235678899999999999999999998654 24779999999999999999864


Q ss_pred             cCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCC--ceecCCCCCCEEeCCCCcEEEEeccCccccCCC----
Q 041830          466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS--YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD----  539 (600)
Q Consensus       466 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~----  539 (600)
                      ..          ..+++.+++.++.|++.||.|||   +.+  ++||||||+|||++.++.+||+|||++......    
T Consensus       104 ~~----------~~~~~~~~~~i~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~  170 (271)
T 3kmu_A          104 TN----------FVVDQSQAVKFALDMARGMAFLH---TLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRMY  170 (271)
T ss_dssp             SS----------CCCCHHHHHHHHHHHHHHHHHHT---TSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTSCTTCBS
T ss_pred             cc----------CCCCHHHHHHHHHHHHHHHHHHh---cCCCceecCCCccceEEEcCCcceeEEeccceeeecccCccC
Confidence            42          24899999999999999999999   556  999999999999999999999999887543322    


Q ss_pred             ---CCCCcccccCC-CCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 ---TESPQFYSTNP-ASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 ---~~~pe~~~~~~-~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                         +.+||...... ..++.++||||||+++|||++|+.||...
T Consensus       171 t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  214 (271)
T 3kmu_A          171 APAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADL  214 (271)
T ss_dssp             CGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTS
T ss_pred             CccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence               23566554321 12234689999999999999999999753

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=99.95  E-value=9.8e-29  Score=256.46  Aligned_cols=174  Identities=18%  Similarity=0.177  Sum_probs=144.5

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH-HHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCc
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV-ITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGL  466 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~-~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~  466 (600)
                      .|.||+++.  +|+.||||.+.... ...+..|+..+..+ +||||+++++++... ...++||||+ +|+|.+++....
T Consensus        22 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-~~~~lv~e~~-~~~L~~~~~~~~   99 (330)
T 2izr_A           22 FGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCG-KYNAMVLELL-GPSLEDLFDLCD   99 (330)
T ss_dssp             TTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEET-TEEEEEEECC-CCBHHHHHHHTT
T ss_pred             CceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecC-CccEEEEEeC-CCCHHHHHHHcC
Confidence            389999996  79999999976432 23577888888888 899999999997665 4889999999 999999997542


Q ss_pred             CcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCc-----EEEEeccCccccCCC--
Q 041830          467 AMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFN-----ARVGNFGMARCVNDD--  539 (600)
Q Consensus       467 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~-----~kI~DFGla~~~~~~--  539 (600)
                                 ..+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.     +||+|||+++.....  
T Consensus       100 -----------~~~~~~~~~~i~~qi~~~l~~LH---~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~  165 (330)
T 2izr_A          100 -----------RTFSLKTVLMIAIQLISRMEYVH---SKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPET  165 (330)
T ss_dssp             -----------TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTT
T ss_pred             -----------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCC
Confidence                       24999999999999999999999   569999999999999998887     999999999854221  


Q ss_pred             -----------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCCCC
Q 041830          540 -----------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRKK  582 (600)
Q Consensus       540 -----------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~~  582 (600)
                                       +.+||....  ..++.++|||||||++|||++|+.||...+..
T Consensus       166 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~  223 (330)
T 2izr_A          166 KKHIPYREHKSLTGTARYMSINTHLG--KEQSRRDDLEALGHMFMYFLRGSLPWQGLKAD  223 (330)
T ss_dssp             CCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCS
T ss_pred             CccccccccCCcCCCccccChHHHcC--CCCCchhHHHHHHHHHHHHhcCCCCccccccc
Confidence                             224444433  44678899999999999999999999875433

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=99.95  E-value=9.8e-29  Score=251.33  Aligned_cols=171  Identities=24%  Similarity=0.358  Sum_probs=143.2

Q ss_pred             EEEEEEEE-CCeEEEEEEcchhH-----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcC
Q 041830          392 GAVYHGRL-NGKNLAIKRTEHEV-----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGG  465 (600)
Q Consensus       392 G~Vy~g~~-~g~~vAvK~~~~~~-----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~  465 (600)
                      |.||+++. +|+.||+|+++...     ...+.+|+..+..++||||+++++++..+ ...++||||+++ +|.+++...
T Consensus        16 g~V~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~-~l~~~~~~~   93 (288)
T 1ob3_A           16 GVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-KRLVLVFEHLDQ-DLKKLLDVC   93 (288)
T ss_dssp             EEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-SCEEEEEECCSE-EHHHHHHTS
T ss_pred             EEEEEEEcCCCCEEEEEEEeccccccccchhHHHHHHHHHhcCCCCEeeeeeEEccC-CeEEEEEEecCC-CHHHHHHhc
Confidence            99999998 68999999875322     24567899999999999999999998655 489999999985 999998754


Q ss_pred             cCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC--------
Q 041830          466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN--------  537 (600)
Q Consensus       466 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~--------  537 (600)
                      .           ..+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...        
T Consensus        94 ~-----------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  159 (288)
T 1ob3_A           94 E-----------GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH  159 (288)
T ss_dssp             T-----------TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred             c-----------cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHEEEcCCCCEEEeECccccccCcccccccc
Confidence            3           23899999999999999999999   6699999999999999999999999999986542        


Q ss_pred             ----CCCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          538 ----DDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       538 ----~~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                          ....+||.... ...++.++|||||||++|||++|+.||...
T Consensus       160 ~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~~l~~g~~pf~~~  204 (288)
T 1ob3_A          160 EIVTLWYRAPDVLMG-SKKYSTTIDIWSVGCIFAEMVNGTPLFPGV  204 (288)
T ss_dssp             --CCCTTCCHHHHTT-CCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccccCchheeC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence                12345665543 235788899999999999999999999753

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=99.95  E-value=3.5e-28  Score=262.73  Aligned_cols=171  Identities=23%  Similarity=0.344  Sum_probs=144.0

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      .|.||++..  +|+.+|+|.+...     ....+++|+..+..++||||+++++++.++ ...|+||||+++|+|.+++.
T Consensus        24 fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~-~~~~lv~E~~~gg~L~~~i~  102 (444)
T 3soa_A           24 FSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDSISEE-GHHYLIFDLVTGGELFEDIV  102 (444)
T ss_dssp             -CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECS-SEEEEEECCCBCCBHHHHHH
T ss_pred             CeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEEC-CEEEEEEEeCCCCCHHHHHH
Confidence            399999988  7999999987532     234678999999999999999999998655 48999999999999999997


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC---CCCcEEEEeccCccccCCC-
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLD---EEFNARVGNFGMARCVNDD-  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld---~~~~~kI~DFGla~~~~~~-  539 (600)
                      ...            .+++.++..++.||+.||.|||   +.+|+||||||+|||++   .++.+||+|||+++..... 
T Consensus       103 ~~~------------~~~e~~~~~i~~qil~aL~~lH---~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~  167 (444)
T 3soa_A          103 ARE------------YYSEADASHCIQQILEAVLHCH---QMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ  167 (444)
T ss_dssp             HCS------------CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC
T ss_pred             HcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC
Confidence            643            3899999999999999999999   66999999999999998   4678999999999765432 


Q ss_pred             -----------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 -----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 -----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                 +.+||....  ..++.++|||||||++|||++|+.||...
T Consensus       168 ~~~~~~~gt~~Y~APE~l~~--~~~~~~~DIwSlGvilyell~G~~Pf~~~  216 (444)
T 3soa_A          168 QAWFGFAGTPGYLSPEVLRK--DPYGKPVDLWACGVILYILLVGYPPFWDE  216 (444)
T ss_dssp             CBCCCSCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ceeecccCCcccCCHHHhcC--CCCCCccccHHHHHHHHHHHhCCCCCCCc
Confidence                       124555433  45788999999999999999999999653

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=99.95  E-value=2.5e-28  Score=245.46  Aligned_cols=172  Identities=29%  Similarity=0.539  Sum_probs=136.4

Q ss_pred             EEEEEEEECCeEEEEEEcchhH-------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          392 GAVYHGRLNGKNLAIKRTEHEV-------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       392 G~Vy~g~~~g~~vAvK~~~~~~-------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      |.||+++..|+.||||.++...       .+.+.+|+..+..++||||+++++++..+ +..++||||+++|+|.++++.
T Consensus        21 g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~   99 (271)
T 3dtc_A           21 GKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKE-PNLCLVMEFARGGPLNRVLSG   99 (271)
T ss_dssp             EEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC---CEEEEECCTTEEHHHHHTS
T ss_pred             eEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecC-CceEEEEEcCCCCCHHHHhhc
Confidence            9999999999999999975432       24577899999999999999999998655 478999999999999999964


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC--------CCcEEEEeccCcccc
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE--------EFNARVGNFGMARCV  536 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~--------~~~~kI~DFGla~~~  536 (600)
                      .             .+++.+++.++.|++.||.|||+....+++||||||+|||++.        ++.+||+|||+++..
T Consensus       100 ~-------------~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~  166 (271)
T 3dtc_A          100 K-------------RIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREW  166 (271)
T ss_dssp             S-------------CCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC----
T ss_pred             C-------------CCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccccc
Confidence            2             3899999999999999999999541123999999999999986        778999999999754


Q ss_pred             CCC----------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          537 NDD----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       537 ~~~----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                      ...          ..+||....  ..++.++||||||+++|||++|+.||...
T Consensus       167 ~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~  217 (271)
T 3dtc_A          167 HRTTKMSAAGAYAWMAPEVIRA--SMFSKGSDVWSYGVLLWELLTGEVPFRGI  217 (271)
T ss_dssp             ---------CCGGGSCHHHHHH--CCCSHHHHHHHHHHHHHHHHHCCCTTTTS
T ss_pred             ccccccCCCCccceeCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence            322          224555443  34678899999999999999999999753

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=7e-29  Score=262.41  Aligned_cols=174  Identities=28%  Similarity=0.554  Sum_probs=137.8

Q ss_pred             eEEEEEEEE---CC--eEEEEEEcch----hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          391 EGAVYHGRL---NG--KNLAIKRTEH----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       391 ~G~Vy~g~~---~g--~~vAvK~~~~----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      +|.||+|++   ++  ..||+|.++.    .....+.+|+..+..++||||++++++|.......++||||+++|+|.++
T Consensus       102 fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~  181 (373)
T 3c1x_A          102 FGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF  181 (373)
T ss_dssp             SSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHH
T ss_pred             CeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHH
Confidence            399999987   22  3689998753    33456788999999999999999999987665578999999999999999


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--  539 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--  539 (600)
                      ++...           ..+++.+++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....  
T Consensus       182 l~~~~-----------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~  247 (373)
T 3c1x_A          182 IRNET-----------HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  247 (373)
T ss_dssp             HHCTT-----------CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred             Hhhcc-----------cCCCHHHHHHHHHHHHHHHHHHH---HCCEecCccchheEEECCCCCEEEeecccccccccccc
Confidence            97643           23889999999999999999999   669999999999999999999999999999754221  


Q ss_pred             --------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCCC
Q 041830          540 --------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRPR  580 (600)
Q Consensus       540 --------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~~  580 (600)
                                    +.+||....  ..++.++|||||||++|||++ |.+||...+
T Consensus       248 ~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~DvwSlG~il~ellt~~~~p~~~~~  301 (373)
T 3c1x_A          248 DSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDVN  301 (373)
T ss_dssp             ----------CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTSC
T ss_pred             ccccccCCCCCcccccChHHhcC--CCCCcHHHHHHHHHHHHHHHhCcCCCCCCCC
Confidence                          234554433  356788999999999999999 677886543

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=99.95  E-value=5.9e-29  Score=269.26  Aligned_cols=172  Identities=23%  Similarity=0.353  Sum_probs=138.7

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhHH------HHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEVI------TKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~~------~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      |.||+++.  +|+.||||.++.+..      ..+.+|+..+..++||||+++++++... +..++||||+++|+|.+++.
T Consensus       162 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~-~~~~lv~e~~~~~~L~~~l~  240 (446)
T 4ejn_A          162 GKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTH-DRLCFVMEYANGGELFFHLS  240 (446)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEET-TEEEEEECCCSSCBHHHHHH
T ss_pred             EEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeC-CEEEEEEeeCCCCcHHHHHH
Confidence            99999998  789999999875432      2445677777888999999999998665 48999999999999999997


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD----  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~----  539 (600)
                      ...            .+++.++..++.|++.||+|||+  ..+|+||||||+|||++.++.+||+|||+++.....    
T Consensus       241 ~~~------------~~~~~~~~~~~~qi~~aL~~LH~--~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~  306 (446)
T 4ejn_A          241 RER------------VFSEDRARFYGAEIVSALDYLHS--EKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATM  306 (446)
T ss_dssp             HHS------------CCCHHHHHHHHHHHHHHHHHHHH--HTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-----
T ss_pred             hcC------------CCCHHHHHHHHHHHHHHHHHHhh--cCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCccc
Confidence            532            38999999999999999999994  168999999999999999999999999999753221    


Q ss_pred             --------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 --------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 --------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                              +.+||....  ..++.++|||||||+||||++|+.||...+
T Consensus       307 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~~  353 (446)
T 4ejn_A          307 KTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD  353 (446)
T ss_dssp             CCSSSCGGGCCHHHHHT--SCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccccCCccccCHhhcCC--CCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence                    234555543  457889999999999999999999997543

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=99.95  E-value=1.1e-28  Score=267.60  Aligned_cols=172  Identities=26%  Similarity=0.477  Sum_probs=142.7

Q ss_pred             eEEEEEEEEC-CeEEEEEEcchhH--HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcC
Q 041830          391 EGAVYHGRLN-GKNLAIKRTEHEV--ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLA  467 (600)
Q Consensus       391 ~G~Vy~g~~~-g~~vAvK~~~~~~--~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~  467 (600)
                      .|.||+|.+. +..||||.++...  .+.+.+|+..+..++||||++++|++..  ...++||||+++|+|.++++....
T Consensus       197 fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~~iv~e~~~~gsL~~~l~~~~~  274 (452)
T 1fmk_A          197 FGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTEYMSKGSLLDFLKGETG  274 (452)
T ss_dssp             SCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEECCCTTCBHHHHHSHHHH
T ss_pred             CeEEEEEEECCCceEEEEEeccCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEcC--CceEEEehhhcCCCHHHHHHhcCC
Confidence            3999999994 5789999987532  3567899999999999999999999744  478999999999999999974321


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--------
Q 041830          468 MKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--------  539 (600)
Q Consensus       468 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--------  539 (600)
                                ..+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....        
T Consensus       275 ----------~~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~  341 (452)
T 1fmk_A          275 ----------KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA  341 (452)
T ss_dssp             ----------TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------------
T ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceecccCC
Confidence                      34899999999999999999999   669999999999999999999999999999865321        


Q ss_pred             -----CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          540 -----TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       540 -----~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                           +.+||....  ..++.++|||||||+||||++ |+.||...
T Consensus       342 ~~~~~y~aPE~~~~--~~~~~~sDvwslG~~l~el~t~g~~P~~~~  385 (452)
T 1fmk_A          342 KFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGM  385 (452)
T ss_dssp             -CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             cccccccCHhHHhc--CCCCccccHHhHHHHHHHHHhCCCCCCCCC
Confidence                 234554443  356888999999999999999 99999754

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=99.95  E-value=1.9e-28  Score=260.33  Aligned_cols=171  Identities=21%  Similarity=0.311  Sum_probs=144.6

Q ss_pred             EEEEEEEE--CCeEEEEEEcchh---HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCc
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHE---VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGL  466 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~---~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~  466 (600)
                      |.||++..  +|+.||+|.+...   ....+.+|+..+..++||||+++++++... ...++||||+++|+|.+++....
T Consensus        65 g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-~~~~lv~E~~~gg~L~~~l~~~~  143 (387)
T 1kob_A           65 GVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK-YEMVLILEFLSGGELFDRIAAED  143 (387)
T ss_dssp             EEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS-SEEEEEEECCCCCBHHHHTTCTT
T ss_pred             EEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeC-CEEEEEEEcCCCCcHHHHHHhhc
Confidence            99999998  6899999987642   234678899999999999999999998655 58999999999999999997543


Q ss_pred             CcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC--CCcEEEEeccCccccCCC-----
Q 041830          467 AMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE--EFNARVGNFGMARCVNDD-----  539 (600)
Q Consensus       467 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~--~~~~kI~DFGla~~~~~~-----  539 (600)
                                 ..+++.+++.++.||+.||.|||   +.+|+||||||+|||++.  ++.+||+|||+++.....     
T Consensus       144 -----------~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~~  209 (387)
T 1kob_A          144 -----------YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV  209 (387)
T ss_dssp             -----------CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEEE
T ss_pred             -----------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccchHHeEEecCCCCceEEEecccceecCCCcceee
Confidence                       23899999999999999999999   569999999999999974  578999999999865432     


Q ss_pred             ------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 ------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 ------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                            +.+||....  ..++.++|||||||++|||++|+.||...
T Consensus       210 ~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~Pf~~~  253 (387)
T 1kob_A          210 TTATAEFAAPEIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGE  253 (387)
T ss_dssp             ECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred             eccCCCccCchhccC--CCCCCcccEeeHhHHHHHHHhCCCCCCCC
Confidence                  235665543  45678899999999999999999999754

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=99.95  E-value=1.8e-28  Score=258.15  Aligned_cols=172  Identities=22%  Similarity=0.356  Sum_probs=139.3

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH--HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCc
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV--ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGL  466 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~--~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~  466 (600)
                      +|.||+++.  +|+.||||.++...  ...+.+|+..+..++||||+++++++... ...++||||+++|+|.+++....
T Consensus        33 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~  111 (361)
T 3uc3_A           33 FGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLRHPNIVRFKEVILTP-THLAIIMEYASGGELYERICNAG  111 (361)
T ss_dssp             TSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEEECCCSCBHHHHHHHHS
T ss_pred             CEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCCCCCCCcEEEEEeeC-CEEEEEEEeCCCCCHHHHHHhcC
Confidence            389999998  78999999986532  24577899999999999999999998665 48999999999999999996532


Q ss_pred             CcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCc--EEEEeccCccccC-------
Q 041830          467 AMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFN--ARVGNFGMARCVN-------  537 (600)
Q Consensus       467 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~--~kI~DFGla~~~~-------  537 (600)
                                  .+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.  +||+|||+++...       
T Consensus       112 ------------~~~~~~~~~i~~ql~~~L~~LH---~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~  176 (361)
T 3uc3_A          112 ------------RFSEDEARFFFQQLLSGVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS  176 (361)
T ss_dssp             ------------SCCHHHHHHHHHHHHHHHHHHH---HTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----------
T ss_pred             ------------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCC
Confidence                        3899999999999999999999   669999999999999987765  9999999987432       


Q ss_pred             ----CCCCCCcccccCCCCCC-ccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          538 ----DDTESPQFYSTNPASWS-MGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       538 ----~~~~~pe~~~~~~~~~t-~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                          ..+.+||....  ..++ .++|||||||++|||++|+.||....
T Consensus       177 ~~gt~~y~aPE~~~~--~~~~~~~~DiwslG~il~ell~g~~Pf~~~~  222 (361)
T 3uc3_A          177 TVGTPAYIAPEVLLR--QEYDGKIADVWSCGVTLYVMLVGAYPFEDPE  222 (361)
T ss_dssp             ----CTTSCHHHHHC--SSCCHHHHHHHHHHHHHHHHHHSSCSCC---
T ss_pred             CcCCCCcCChhhhcC--CCCCCCeeeeehhHHHHHHHHhCCCCCCCCc
Confidence                12235665543  2333 34899999999999999999997644

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=99.95  E-value=1.4e-28  Score=256.21  Aligned_cols=172  Identities=20%  Similarity=0.326  Sum_probs=143.5

Q ss_pred             eeEEEEEEEE--CCeEEEEEEcchhH-----------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCC
Q 041830          390 IEGAVYHGRL--NGKNLAIKRTEHEV-----------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNG  456 (600)
Q Consensus       390 ~~G~Vy~g~~--~g~~vAvK~~~~~~-----------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~G  456 (600)
                      ..|.||+++.  +|+.||||.++...           ...+.+|+..+..++||||+++++++..+ ...++||||+..|
T Consensus        36 ~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~-~~~~lv~e~~~~g  114 (335)
T 3dls_A           36 AFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQ-GFFQLVMEKHGSG  114 (335)
T ss_dssp             SSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECS-SEEEEEEECCTTS
T ss_pred             CCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeC-CEEEEEEEeCCCC
Confidence            3499999987  78999999876532           23456789999999999999999998655 4889999999877


Q ss_pred             -CHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccc
Q 041830          457 -SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARC  535 (600)
Q Consensus       457 -sL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~  535 (600)
                       +|.+++....            .+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       115 ~~l~~~~~~~~------------~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~  179 (335)
T 3dls_A          115 LDLFAFIDRHP------------RLDEPLASYIFRQLVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAY  179 (335)
T ss_dssp             CBHHHHHHTCC------------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             ccHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHH---hCCeEEeccCHHHEEEcCCCcEEEeecccceE
Confidence             9999997643            3899999999999999999999   56999999999999999999999999999986


Q ss_pred             cCCCC-----------CCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          536 VNDDT-----------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       536 ~~~~~-----------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                      .....           .+||..... ...+.++|||||||++|||++|+.||..
T Consensus       180 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwslG~il~el~~g~~pf~~  232 (335)
T 3dls_A          180 LERGKLFYTFCGTIEYCAPEVLMGN-PYRGPELEMWSLGVTLYTLVFEENPFCE  232 (335)
T ss_dssp             CCTTCCBCEECSCGGGCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSCSS
T ss_pred             CCCCCceeccCCCccccChhhhcCC-CCCCCcccchhHHHHHHHHHhCCCchhh
Confidence            54322           345554432 2236788999999999999999999965

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=99.95  E-value=3e-28  Score=251.79  Aligned_cols=170  Identities=20%  Similarity=0.313  Sum_probs=144.4

Q ss_pred             EEEEEEEE--CCeEEEEEEcchh---------HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHE---------VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~---------~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      |.||+++.  +|+.||+|.++..         ....+++|+..+..++||||+++++++... ...++||||+++|+|.+
T Consensus        26 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~  104 (321)
T 2a2a_A           26 AIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENR-TDVVLILELVSGGELFD  104 (321)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEECCCCSCBHHH
T ss_pred             EEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecC-CEEEEEEEcCCCCcHHH
Confidence            99999998  6899999987542         235678999999999999999999998655 48999999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC----cEEEEeccCcccc
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEF----NARVGNFGMARCV  536 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~----~~kI~DFGla~~~  536 (600)
                      ++....            .+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++    .+||+|||+++..
T Consensus       105 ~l~~~~------------~~~~~~~~~i~~qi~~aL~~lH---~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~  169 (321)
T 2a2a_A          105 FLAQKE------------SLSEEEATSFIKQILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEI  169 (321)
T ss_dssp             HHHTCS------------CEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEEC
T ss_pred             HHHhcC------------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCChHHEEEecCCCCcCCEEEccCccceec
Confidence            997543            3889999999999999999999   56999999999999999887    7999999999765


Q ss_pred             CCC-----------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          537 NDD-----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       537 ~~~-----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                      ...           +.+||....  ..++.++||||||+++|||++|+.||...
T Consensus       170 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~  221 (321)
T 2a2a_A          170 EDGVEFKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGD  221 (321)
T ss_dssp             CTTCCCCCCCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred             CccccccccCCCCCccCcccccC--CCCCCccccHHHHHHHHHHHHCCCCCCCC
Confidence            432           124554433  45678899999999999999999999754

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=99.95  E-value=2.5e-28  Score=265.79  Aligned_cols=172  Identities=26%  Similarity=0.479  Sum_probs=145.7

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||+|+.  +|+.||||.++...      ...+.+|+..+..++||||+++++++... ...|+||||+++|+|.+++
T Consensus        29 fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~-~~~~lv~E~~~gg~L~~~l  107 (476)
T 2y94_A           29 FGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTP-SDIFMVMEYVSGGELFDYI  107 (476)
T ss_dssp             SSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEEEECCSSEEHHHHT
T ss_pred             CeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEEeCCCCCcHHHHH
Confidence            389999998  69999999986543      24578899999999999999999998665 4899999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC---
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---  539 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~---  539 (600)
                      ....            .+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....   
T Consensus       108 ~~~~------------~l~~~~~~~i~~qi~~aL~~LH---~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~~  172 (476)
T 2y94_A          108 CKNG------------RLDEKESRRLFQQILSGVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL  172 (476)
T ss_dssp             TSSS------------SCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCCB
T ss_pred             HhcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCCCcccccHHHEEEecCCCeEEEeccchhhccccccc
Confidence            7543            3899999999999999999999   779999999999999999999999999999865332   


Q ss_pred             --------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 --------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 --------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                              +.+||..... ...+.++|||||||++|||++|+.||...
T Consensus       173 ~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~elltG~~Pf~~~  219 (476)
T 2y94_A          173 RTSCGSPNYAAPEVISGR-LYAGPEVDIWSSGVILYALLCGTLPFDDD  219 (476)
T ss_dssp             CCCCSCSTTCCHHHHTTC-CBCSHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cccCCCcCeEChhhccCC-CCCCCcceehhhHHHHHHHhhCCCCCCCC
Confidence                    2345554432 22367899999999999999999999754

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=99.95  E-value=1.1e-28  Score=256.71  Aligned_cols=182  Identities=27%  Similarity=0.488  Sum_probs=145.1

Q ss_pred             EEEEEEEECC-------eEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          392 GAVYHGRLNG-------KNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       392 G~Vy~g~~~g-------~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      |.||+++..+       +.||||.++.+    ....+++|+..+..++||||+++++++..+ ...++||||+++|+|.+
T Consensus        61 g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~  139 (343)
T 1luf_A           61 GRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG-KPMCLLFEYMAYGDLNE  139 (343)
T ss_dssp             CEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-SSCEEEEECCTTCBHHH
T ss_pred             eeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccC-CceEEEEecCCCCcHHH
Confidence            9999999853       78999998653    235678899999999999999999998654 48899999999999999


Q ss_pred             HHhcCcCccc------------ccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEE
Q 041830          461 WLHGGLAMKN------------QFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVG  528 (600)
Q Consensus       461 ~L~~~~~~~~------------~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~  528 (600)
                      +++.......            .........+++.+++.++.||+.||.|||   +.+|+||||||+|||++.++.+||+
T Consensus       140 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~  216 (343)
T 1luf_A          140 FLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKIA  216 (343)
T ss_dssp             HHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred             HHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEECCCCeEEEe
Confidence            9976431100            000001145999999999999999999999   6699999999999999999999999


Q ss_pred             eccCccccCCC--------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          529 NFGMARCVNDD--------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       529 DFGla~~~~~~--------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                      |||+++.....              +.+||....  ..++.++||||||+++|||++ |+.||...
T Consensus       217 Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~  280 (343)
T 1luf_A          217 DFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGLQPYYGM  280 (343)
T ss_dssp             CCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             ecCCCcccccCccccccCCCcccceecChhhhcc--CCcCcccccHHHHHHHHHHHhcCCCcCCCC
Confidence            99998643211              234555443  347788999999999999999 99999754

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=99.95  E-value=4.3e-28  Score=244.73  Aligned_cols=170  Identities=24%  Similarity=0.357  Sum_probs=144.1

Q ss_pred             EEEEEEEE--CCeEEEEEEcchh---HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCc
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHE---VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGL  466 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~---~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~  466 (600)
                      |.||+++.  ++..+|+|++...   ..+.+.+|+..+..++||||+++++++... ...++||||+++++|.+++....
T Consensus        23 g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~  101 (277)
T 3f3z_A           23 GEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYETFEDN-TDIYLVMELCTGGELFERVVHKR  101 (277)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEEEEECCCSCBHHHHHHHHC
T ss_pred             EEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeEEEEEeccCCCcHHHHHHHcC
Confidence            99999998  5678999987653   235678899999999999999999998655 48899999999999999987532


Q ss_pred             CcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEe---CCCCcEEEEeccCccccCCC----
Q 041830          467 AMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFL---DEEFNARVGNFGMARCVNDD----  539 (600)
Q Consensus       467 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl---d~~~~~kI~DFGla~~~~~~----  539 (600)
                                  .+++.+++.++.|++.||.|||   +.+++||||||+|||+   +.++.+||+|||++......    
T Consensus       102 ------------~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~  166 (277)
T 3f3z_A          102 ------------VFRESDAARIMKDVLSAVAYCH---KLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMR  166 (277)
T ss_dssp             ------------SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBC
T ss_pred             ------------CCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchh
Confidence                        3899999999999999999999   6699999999999999   78899999999998754322    


Q ss_pred             -------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 -------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 -------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                             ..+||....   .++.++||||||+++|||++|+.||....
T Consensus       167 ~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~~  211 (277)
T 3f3z_A          167 TKVGTPYYVSPQVLEG---LYGPECDEWSAGVMMYVLLCGYPPFSAPT  211 (277)
T ss_dssp             CCCSCTTTCCHHHHTT---CBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccCCCCCccChHHhcc---cCCchhhehhHHHHHHHHHHCCCCCCCCC
Confidence                   234555432   37888999999999999999999997643

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=99.95  E-value=1.5e-28  Score=256.27  Aligned_cols=184  Identities=23%  Similarity=0.302  Sum_probs=144.0

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhH--------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEV--------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~--------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      |.||+++.  +++.||+|.++...        ...+.+|+..+..++||||+++++++.++ ...++||||+++|+|.++
T Consensus        40 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv~e~~~gg~L~~~  118 (345)
T 3hko_A           40 GVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDE-QYICLVMELCHGGHLLDK  118 (345)
T ss_dssp             CEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEEECCCSCBHHHH
T ss_pred             eEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccC-CeEEEEEeCCCCCcHHHH
Confidence            89999998  68899999876532        24678899999999999999999998655 489999999999999999


Q ss_pred             HhcCcCcccc----------------------------cccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCC
Q 041830          462 LHGGLAMKNQ----------------------------FIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIK  513 (600)
Q Consensus       462 L~~~~~~~~~----------------------------~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk  513 (600)
                      +.........                            ........+++..+..++.|++.||+|||   +.+|+|||||
T Consensus       119 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlk  195 (345)
T 3hko_A          119 LNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLH---NQGICHRDIK  195 (345)
T ss_dssp             EEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHH---HTTEECCCCC
T ss_pred             HHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHH---HCCccccCCC
Confidence            9631110000                            00000122467788899999999999999   5699999999


Q ss_pred             CCCEEeCCCC--cEEEEeccCccccCC----------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCC
Q 041830          514 SRNIFLDEEF--NARVGNFGMARCVND----------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTP  575 (600)
Q Consensus       514 ~~NILld~~~--~~kI~DFGla~~~~~----------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~P  575 (600)
                      |+|||++.++  .+||+|||+++....                .+.+||........++.++|||||||++|||++|+.|
T Consensus       196 p~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~p  275 (345)
T 3hko_A          196 PENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVP  275 (345)
T ss_dssp             GGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred             hhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence            9999998766  899999999975421                1235666544345678899999999999999999999


Q ss_pred             CCCC
Q 041830          576 INRP  579 (600)
Q Consensus       576 f~~~  579 (600)
                      |...
T Consensus       276 f~~~  279 (345)
T 3hko_A          276 FPGV  279 (345)
T ss_dssp             SCCS
T ss_pred             CCCC
Confidence            9754

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=99.95  E-value=3.7e-28  Score=243.57  Aligned_cols=171  Identities=29%  Similarity=0.529  Sum_probs=145.5

Q ss_pred             EEEEEEEE-CCeEEEEEEcchhH--HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcCc
Q 041830          392 GAVYHGRL-NGKNLAIKRTEHEV--ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM  468 (600)
Q Consensus       392 G~Vy~g~~-~g~~vAvK~~~~~~--~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~  468 (600)
                      |.||+++. +++.||+|.++...  .+.+.+|+..+..++||||+++++++..+ ...++||||+++|+|.+++....  
T Consensus        22 g~V~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~--   98 (267)
T 3t9t_A           22 GLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-APICLVTEFMEHGCLSDYLRTQR--   98 (267)
T ss_dssp             EEEEEEEETTTEEEEEEEECTTTBCHHHHHHHHHHHHTCCCTTBCCEEEEECSS-SSCEEEECCCTTCBHHHHHHHTT--
T ss_pred             eeEEEEEecCCCeEEEEEccccCCCHHHHHHHHHHHHhCCCCCEeeEEEEEccC-CCeEEEEeCCCCCcHHHHHhhCc--
Confidence            89999999 78899999987542  35678899999999999999999998655 47899999999999999997643  


Q ss_pred             ccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC----------
Q 041830          469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND----------  538 (600)
Q Consensus       469 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~----------  538 (600)
                               ..+++.+++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++....          
T Consensus        99 ---------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~  166 (267)
T 3t9t_A           99 ---------GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTK  166 (267)
T ss_dssp             ---------TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTSTT
T ss_pred             ---------ccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEECCCCCEEEccccccccccccccccccccc
Confidence                     23899999999999999999999   66999999999999999999999999999875422          


Q ss_pred             ---CCCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          539 ---DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       539 ---~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                         ...+||....  ..++.++||||||+++|||++ |+.||...
T Consensus       167 ~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~  209 (267)
T 3t9t_A          167 FPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYENR  209 (267)
T ss_dssp             CCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             ccccccChhhhcC--CCccchhchhhhHHHHHHHhccCCCCCCCC
Confidence               1234555443  346788999999999999999 89999753

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=99.95  E-value=3.1e-28  Score=264.84  Aligned_cols=170  Identities=19%  Similarity=0.320  Sum_probs=139.4

Q ss_pred             eEEEEEEEE--CCeEEEEEEcch-----hHHHHHHHHHHHHHhCCCCceeeeeeEEeccC-----CceEEEEeecCCCCH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEH-----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDG-----PHSFLVFEYAKNGSL  458 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~-----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~-----~~~~LV~Ey~~~GsL  458 (600)
                      +|.||+++.  +|+.||||++..     ....++.+|+..+..++||||+++++++....     ...|+||||+++ +|
T Consensus        75 ~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l  153 (464)
T 3ttj_A           75 QGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NL  153 (464)
T ss_dssp             SCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EH
T ss_pred             CeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CH
Confidence            399999988  689999999853     23356778999999999999999999975432     357999999986 57


Q ss_pred             HHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC
Q 041830          459 KDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND  538 (600)
Q Consensus       459 ~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~  538 (600)
                      .+.+..              .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       154 ~~~~~~--------------~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~  216 (464)
T 3ttj_A          154 CQVIQM--------------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  216 (464)
T ss_dssp             HHHHTS--------------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCCC-----
T ss_pred             HHHHhh--------------cCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCC
Confidence            776642              2889999999999999999999   56999999999999999999999999999976543


Q ss_pred             C-----------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          539 D-----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       539 ~-----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                      .           +.+||....  ..++.++|||||||+||||++|+.||...+
T Consensus       217 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~ell~g~~pF~g~~  267 (464)
T 3ttj_A          217 SFMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRD  267 (464)
T ss_dssp             CCCC----CCCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CcccCCCcccccccCHHHHcC--CCCCHHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            2           345666654  457889999999999999999999997643

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=4.1e-28  Score=252.31  Aligned_cols=171  Identities=27%  Similarity=0.472  Sum_probs=139.0

Q ss_pred             EEEEEEEEC------CeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          392 GAVYHGRLN------GKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       392 G~Vy~g~~~------g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      |.||+|+..      +..||||.++..    ....+.+|+..+..++||||+++++++... ...++||||+++|+|.++
T Consensus        58 g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~  136 (333)
T 1mqb_A           58 GEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY-KPMMIITEYMENGALDKF  136 (333)
T ss_dssp             SEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-SSEEEEEECCTTEEHHHH
T ss_pred             eEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecC-CCcEEEEeCCCCCcHHHH
Confidence            899999873      235999997642    234577899999999999999999997554 588999999999999999


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--  539 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--  539 (600)
                      +....           ..+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....  
T Consensus       137 l~~~~-----------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  202 (333)
T 1mqb_A          137 LREKD-----------GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  202 (333)
T ss_dssp             HHHTT-----------TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred             HHhCC-----------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCChheEEECCCCcEEECCCCcchhhccccc
Confidence            97543           23899999999999999999999   569999999999999999999999999999765321  


Q ss_pred             -------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          540 -------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       540 -------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                                   +.+||....  ..++.++||||||+++|||++ |+.||...
T Consensus       203 ~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~pf~~~  254 (333)
T 1mqb_A          203 ATYTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPYWEL  254 (333)
T ss_dssp             --------CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             cccccCCCCccccccCchhccc--CCCCchhhhHHHHHHHHHHHcCCCCCcccC
Confidence                         234555433  456788999999999999999 99999643

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=99.95  E-value=1.5e-28  Score=276.24  Aligned_cols=173  Identities=27%  Similarity=0.471  Sum_probs=145.8

Q ss_pred             eeEEEEEEEE----CCeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          390 IEGAVYHGRL----NGKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       390 ~~G~Vy~g~~----~g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      .+|.||+|.+    ++..||||.++..    ..+.+.+|+..+..++|||||+++|+|..  +..++|||||++|+|.++
T Consensus       348 ~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~--~~~~lv~E~~~~g~L~~~  425 (613)
T 2ozo_A          348 NFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--EALMLVMEMAGGGPLHKF  425 (613)
T ss_dssp             SSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES--SSEEEEEECCTTCBHHHH
T ss_pred             CCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc--CCeEEEEEeCCCCcHHHH
Confidence            3499999987    3567999998652    34578899999999999999999999854  368999999999999999


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC---
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND---  538 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~---  538 (600)
                      +....           ..+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....   
T Consensus       426 l~~~~-----------~~l~~~~~~~i~~qi~~~L~~LH---~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~  491 (613)
T 2ozo_A          426 LVGKR-----------EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS  491 (613)
T ss_dssp             HTTCT-----------TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred             Hhhcc-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence            97543           34899999999999999999999   66999999999999999999999999999986532   


Q ss_pred             ------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCCC
Q 041830          539 ------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRPR  580 (600)
Q Consensus       539 ------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~~  580 (600)
                                  .+.+||....  ..++.++|||||||+||||++ |+.||...+
T Consensus       492 ~~~~~~~~~~~~~y~APE~~~~--~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~  544 (613)
T 2ozo_A          492 YYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMK  544 (613)
T ss_dssp             ----------CCTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             eeeeccCCCCccceeCHhhhcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence                        1335565543  457888999999999999998 999997643

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=99.95  E-value=1.8e-28  Score=257.44  Aligned_cols=172  Identities=23%  Similarity=0.349  Sum_probs=143.3

Q ss_pred             EEEEEEEE--CCeEEEEEEcch--hHHHHHHHHHHHHHhCC-----CCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          392 GAVYHGRL--NGKNLAIKRTEH--EVITKLEMQLVQHATHH-----HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~--~~~~~~e~ei~~~~~l~-----HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      |.||+++.  +|+.||||.++.  ........|+..+..+.     ||||+++++++... +..++||||+ +++|.+++
T Consensus        49 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~-~~~~lv~e~~-~~~L~~~~  126 (360)
T 3llt_A           49 GRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY-DHMCLIFEPL-GPSLYEII  126 (360)
T ss_dssp             EEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET-TEEEEEECCC-CCBHHHHH
T ss_pred             eEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC-CeeEEEEcCC-CCCHHHHH
Confidence            99999999  789999999864  22345567777777775     99999999998665 4899999999 89999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC---------------------
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE---------------------  521 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~---------------------  521 (600)
                      .....          ..+++.++..++.||+.||+|||   +.+|+||||||+|||++.                     
T Consensus       127 ~~~~~----------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~  193 (360)
T 3llt_A          127 TRNNY----------NGFHIEDIKLYCIEILKALNYLR---KMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQI  193 (360)
T ss_dssp             HHTTT----------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEE
T ss_pred             HhcCC----------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCcccEEEccccccccccchhcccccccccc
Confidence            76442          34899999999999999999999   669999999999999975                     


Q ss_pred             ----CCcEEEEeccCccccCCC---------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          522 ----EFNARVGNFGMARCVNDD---------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       522 ----~~~~kI~DFGla~~~~~~---------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                          ++.+||+|||+++.....         +.+||....  ..++.++|||||||++|||++|+.||...+
T Consensus       194 ~~~~~~~~kl~DFG~a~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~pf~~~~  263 (360)
T 3llt_A          194 YRTKSTGIKLIDFGCATFKSDYHGSIINTRQYRAPEVILN--LGWDVSSDMWSFGCVLAELYTGSLLFRTHE  263 (360)
T ss_dssp             EEESCCCEEECCCTTCEETTSCCCSCCSCGGGCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccCCCCEEEEeccCceecCCCCcCccCcccccCcHHHcC--CCCCCccchHHHHHHHHHHHHCCCCCCCCc
Confidence                789999999999765332         235665544  457889999999999999999999997543

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=99.95  E-value=9.6e-29  Score=256.38  Aligned_cols=171  Identities=23%  Similarity=0.452  Sum_probs=139.7

Q ss_pred             EEEEEEEE--CCe----EEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          392 GAVYHGRL--NGK----NLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       392 G~Vy~g~~--~g~----~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      |.||+|++  +|+    .||+|.++..    ....+.+|+..+..++||||++++++|...  ..++|+||+++|+|.++
T Consensus        29 g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--~~~~v~e~~~~g~L~~~  106 (327)
T 3poz_A           29 GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--TVQLITQLMPFGCLLDY  106 (327)
T ss_dssp             EEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS--SEEEEEECCTTCBHHHH
T ss_pred             eEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC--CeEEEEEecCCCcHHHH
Confidence            99999997  444    3688887542    234678899999999999999999998653  57899999999999999


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--  539 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--  539 (600)
                      ++...           ..+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....  
T Consensus       107 l~~~~-----------~~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~  172 (327)
T 3poz_A          107 VREHK-----------DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK  172 (327)
T ss_dssp             HHHST-----------TSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC
T ss_pred             HHhcC-----------CCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCChheEEECCCCCEEEccCcceeEccCCcc
Confidence            97643           34899999999999999999999   569999999999999999999999999999754322  


Q ss_pred             ------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCCC
Q 041830          540 ------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRPR  580 (600)
Q Consensus       540 ------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~~  580 (600)
                                  +.+||....  ..++.++|||||||++|||++ |+.||....
T Consensus       173 ~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~  224 (327)
T 3poz_A          173 EYHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIP  224 (327)
T ss_dssp             -------CCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             cccccCCCccccccChHHhcc--CCCCchhhhhhhHHHHHHHHhcCCCCccCCC
Confidence                        234554443  456888999999999999999 999997643

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=99.95  E-value=8e-28  Score=243.80  Aligned_cols=170  Identities=23%  Similarity=0.366  Sum_probs=144.6

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      |.||+++.  +++.||+|.+....      ...+.+|+..+..++||||+++++++... ...++||||+++|+|.+++.
T Consensus        28 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~  106 (284)
T 2vgo_A           28 GNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDR-KRIYLMLEFAPRGELYKELQ  106 (284)
T ss_dssp             EEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEEEECCCTTEEHHHHHH
T ss_pred             eEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcC-CEEEEEEEeCCCCcHHHHHH
Confidence            99999998  57899999986532      24577899999999999999999998655 48899999999999999997


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD----  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~----  539 (600)
                      ...            .+++.+++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++......    
T Consensus       107 ~~~------------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  171 (284)
T 2vgo_A          107 KHG------------RFDEQRSATFMEELADALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRRT  171 (284)
T ss_dssp             HHS------------SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSCBCC
T ss_pred             hcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCHHHEEEcCCCCEEEecccccccCccccccc
Confidence            542            3899999999999999999999   779999999999999999999999999998654321    


Q ss_pred             ------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 ------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 ------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                            ..+||....  ..++.++||||||+++|||++|+.||...
T Consensus       172 ~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~  215 (284)
T 2vgo_A          172 MCGTLDYLPPEMIEG--KTHDEKVDLWCAGVLCYEFLVGMPPFDSP  215 (284)
T ss_dssp             CCSCGGGCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             ccCCCCcCCHHHhcc--CCCCcccchhhHHHHHHHHHHCCCCCCCC
Confidence                  234555443  45678899999999999999999999754

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=99.95  E-value=7.9e-29  Score=250.42  Aligned_cols=173  Identities=28%  Similarity=0.512  Sum_probs=142.2

Q ss_pred             EEEEEEEECCeEEEEEEcchh-HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcCccc
Q 041830          392 GAVYHGRLNGKNLAIKRTEHE-VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKN  470 (600)
Q Consensus       392 G~Vy~g~~~g~~vAvK~~~~~-~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~  470 (600)
                      |.||+++.+|+.||||.++.+ ..+.+.+|+..+..++||||+++++++..+....++||||+++|+|.+++.....   
T Consensus        35 g~V~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---  111 (278)
T 1byg_A           35 GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR---  111 (278)
T ss_dssp             CEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHH---
T ss_pred             ceEEEEEEcCCEEEEEEecchhHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhccc---
Confidence            899999999999999998754 3356788999999999999999999977665578999999999999999975321   


Q ss_pred             ccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC---------CCC
Q 041830          471 QFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND---------DTE  541 (600)
Q Consensus       471 ~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~---------~~~  541 (600)
                             ..+++.+++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++....         ...
T Consensus       112 -------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~y~  181 (278)
T 1byg_A          112 -------SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWT  181 (278)
T ss_dssp             -------HHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC------------CCTTTS
T ss_pred             -------ccCCHHHHHHHHHHHHHHHHHHH---hCCccccCCCcceEEEeCCCcEEEeeccccccccccccCCCcccccc
Confidence                   23899999999999999999999   56999999999999999999999999999875432         233


Q ss_pred             CCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          542 SPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       542 ~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                      +||....  ..++.++||||||+++|||++ |+.||...
T Consensus       182 aPE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~  218 (278)
T 1byg_A          182 APEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRI  218 (278)
T ss_dssp             CHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred             CHHHhCC--CCCCchhcHHHHHHHHHHHHhCCCCCCCCC
Confidence            5665543  346788999999999999998 99999754

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=99.95  E-value=3.7e-28  Score=263.84  Aligned_cols=166  Identities=19%  Similarity=0.377  Sum_probs=133.9

Q ss_pred             ceeEEEEEEEE--CCeEEEEEEcch-----hHHHHHHHHHHHHHhCCCCceeeeeeEEeccC----CceEEEEeecCCCC
Q 041830          389 RIEGAVYHGRL--NGKNLAIKRTEH-----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDG----PHSFLVFEYAKNGS  457 (600)
Q Consensus       389 ~~~G~Vy~g~~--~g~~vAvK~~~~-----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~----~~~~LV~Ey~~~Gs  457 (600)
                      |.+|.||+++.  +|+.||||++..     ...+.+.+|+..+..++|||||++++++....    ...|+||||+. |+
T Consensus        64 G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~~-~~  142 (458)
T 3rp9_A           64 GSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIAD-SD  142 (458)
T ss_dssp             ----CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCCS-EE
T ss_pred             cCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEeccc-cc
Confidence            33499999987  689999998754     22356778999999999999999999975432    36899999985 79


Q ss_pred             HHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC
Q 041830          458 LKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN  537 (600)
Q Consensus       458 L~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~  537 (600)
                      |.++++...            .+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       143 L~~~~~~~~------------~l~~~~~~~~~~qi~~aL~~LH---~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  207 (458)
T 3rp9_A          143 FKKLFRTPV------------YLTELHIKTLLYNLLVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD  207 (458)
T ss_dssp             HHHHHHSSC------------CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred             hhhhcccCC------------CCCHHHHHHHHHHHHHHHHHHH---hCCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence            999997543            3899999999999999999999   5699999999999999999999999999998653


Q ss_pred             C---------------------------------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHh
Q 041830          538 D---------------------------------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLS  571 (600)
Q Consensus       538 ~---------------------------------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt  571 (600)
                      .                                       .+.+||.+.. ...++.++|||||||+||||++
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~-~~~~~~~~DiwSlG~il~ellt  279 (458)
T 3rp9_A          208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILL-QENYTEAIDVWSIGCIFAELLN  279 (458)
T ss_dssp             SCTTCCCCCC---------------------------CCCTTCCHHHHTT-CCCCCTHHHHHHHHHHHHHHHT
T ss_pred             CccccccccccCccccccccccccccccccccccCCcccccccChHHhhC-CCCCCcHhHHHHHHHHHHHHHH
Confidence            1                                       1345665432 2457889999999999999999

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=99.95  E-value=1.5e-28  Score=256.79  Aligned_cols=170  Identities=21%  Similarity=0.358  Sum_probs=137.0

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhHHHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcC
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEVITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLA  467 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~  467 (600)
                      +|.||+++.  +|+.||||.++.... ...+|+..+..+ +||||+++++++.+. ...|+||||+++|+|.+++.... 
T Consensus        35 ~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~E~~~l~~~~~hp~iv~~~~~~~~~-~~~~lv~E~~~gg~L~~~i~~~~-  111 (342)
T 2qr7_A           35 YSVCKRCIHKATNMEFAVKIIDKSKR-DPTEEIEILLRYGQHPNIITLKDVYDDG-KYVYVVTELMKGGELLDKILRQK-  111 (342)
T ss_dssp             SEEEEEEEETTTTEEEEEEEEETTTC-CCHHHHHHHHHHTTSTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHHHTCT-
T ss_pred             CEEEEEEEECCCCCEEEEEEEEcccC-ChHHHHHHHHHhcCCCCcCeEEEEEEcC-CEEEEEEeCCCCCcHHHHHHHcC-
Confidence            399999998  689999999876542 234566666555 799999999997654 58999999999999999997543 


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC----CcEEEEeccCccccCCC----
Q 041830          468 MKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEE----FNARVGNFGMARCVNDD----  539 (600)
Q Consensus       468 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~----~~~kI~DFGla~~~~~~----  539 (600)
                                 .+++.++..++.||+.||.|||   +.+|+||||||+|||+.++    +.+||+|||+++.....    
T Consensus       112 -----------~~~~~~~~~~~~qi~~al~~lH---~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~  177 (342)
T 2qr7_A          112 -----------FFSEREASAVLFTITKTVEYLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL  177 (342)
T ss_dssp             -----------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCB
T ss_pred             -----------CCCHHHHHHHHHHHHHHHHHHH---HCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCce
Confidence                       3899999999999999999999   5699999999999998433    35999999999865322    


Q ss_pred             --------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 --------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 --------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                              +.+||....  ..++.++|||||||++|||++|+.||...
T Consensus       178 ~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~ell~g~~Pf~~~  223 (342)
T 2qr7_A          178 MTPCYTANFVAPEVLER--QGYDAACDIWSLGVLLYTMLTGYTPFANG  223 (342)
T ss_dssp             CCSSCCSSCCCHHHHHH--HHHHHHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred             eccCCCccccCHHHhcC--CCCCCccCeeeHhHHHHHHhcCCCCCCCC
Confidence                    123444332  23567899999999999999999999753

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=99.95  E-value=8.5e-28  Score=250.09  Aligned_cols=170  Identities=23%  Similarity=0.400  Sum_probs=144.4

Q ss_pred             EEEEEEEE--CCeEEEEEEcchh------HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHE------VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~------~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      |.||+++.  +++.||+|.+...      ....+.+|+..+..++||||+++++++... ...++||||+++++|.+++.
T Consensus        55 g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~  133 (335)
T 2owb_A           55 AKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN-DFVFVVLELCRRRSLLELHK  133 (335)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEEEECCCTTCBHHHHHH
T ss_pred             eEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecC-CeEEEEEecCCCCCHHHHHh
Confidence            99999998  5789999987543      345678899999999999999999998655 48899999999999999986


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD----  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~----  539 (600)
                      ...            .+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....    
T Consensus       134 ~~~------------~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  198 (335)
T 2owb_A          134 RRK------------ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK  198 (335)
T ss_dssp             HHC------------SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred             ccC------------CCCHHHHHHHHHHHHHHHHHHH---HCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcccc
Confidence            532            3899999999999999999999   569999999999999999999999999999765321    


Q ss_pred             --------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 --------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 --------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                              +.+||....  ..++.++||||||+++|||++|+.||...
T Consensus       199 ~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~  244 (335)
T 2owb_A          199 KVLCGTPNYIAPEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETS  244 (335)
T ss_dssp             CCCCSCCSSCCHHHHHT--SCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             cccCCCccccCHHHhcc--CCCCchhhHHHHHHHHHHHHHCcCCCCCC
Confidence                    234555443  34677899999999999999999999754

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=99.95  E-value=5.6e-28  Score=249.55  Aligned_cols=170  Identities=24%  Similarity=0.437  Sum_probs=143.0

Q ss_pred             eEEEEEEEE------CCeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEecc-CCceEEEEeecCCCCHH
Q 041830          391 EGAVYHGRL------NGKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTD-GPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       391 ~G~Vy~g~~------~g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~-~~~~~LV~Ey~~~GsL~  459 (600)
                      .|.||++.+      +|+.||||+++.+    ....+.+|+..+..++||||+++++++... ....++||||+++|+|.
T Consensus        44 ~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~  123 (318)
T 3lxp_A           44 FGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLR  123 (318)
T ss_dssp             SEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHH
T ss_pred             CeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHH
Confidence            399998876      6788999998653    235678899999999999999999998764 34689999999999999


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD  539 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~  539 (600)
                      +++...             .+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       124 ~~l~~~-------------~~~~~~~~~i~~~l~~~l~~LH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  187 (318)
T 3lxp_A          124 DYLPRH-------------SIGLAQLLLFAQQICEGMAYLH---AQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  187 (318)
T ss_dssp             HHGGGS-------------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTT
T ss_pred             HHHhhC-------------CCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEEcCCCCEEECCcccccccccc
Confidence            999653             2899999999999999999999   568999999999999999999999999999865432


Q ss_pred             ---------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          540 ---------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       540 ---------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                                     +.+||....  ..++.++||||||+++|||++|+.||..
T Consensus       188 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~g~~p~~~  239 (318)
T 3lxp_A          188 HEYYRVREDGDSPVFWYAPECLKE--YKFYYASDVWSFGVTLYELLTHCDSSQS  239 (318)
T ss_dssp             CSEEEC---CCCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred             ccccccccCCCCCceeeChHHhcC--CCCCcHHHHHHHHHHHHHHHhCCCcccc
Confidence                           123444332  3456789999999999999999999864

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=99.95  E-value=1.4e-28  Score=272.33  Aligned_cols=172  Identities=26%  Similarity=0.474  Sum_probs=144.9

Q ss_pred             eEEEEEEEEC-CeEEEEEEcchhH--HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcC
Q 041830          391 EGAVYHGRLN-GKNLAIKRTEHEV--ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLA  467 (600)
Q Consensus       391 ~G~Vy~g~~~-g~~vAvK~~~~~~--~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~  467 (600)
                      +|.||+|++. +..||||+++...  .+.+.+|+..+..++||||+++++++..  ...+||||||++|+|.++|+....
T Consensus       280 fg~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~--~~~~lv~e~~~~gsL~~~l~~~~~  357 (535)
T 2h8h_A          280 FGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE--EPIYIVTEYMSKGSLLDFLKGETG  357 (535)
T ss_dssp             SEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEECCCTTEEHHHHHSHHHH
T ss_pred             CeEEEEEEECCCceEEEEEeCCCCCCHHHHHHHHHHHHhCCCCCEeeEEEEEee--ccceEeeehhcCCcHHHHHhhcCC
Confidence            3999999994 5789999987532  3567899999999999999999999744  478999999999999999975321


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC---------
Q 041830          468 MKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND---------  538 (600)
Q Consensus       468 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~---------  538 (600)
                                ..+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++....         
T Consensus       358 ----------~~l~~~~~~~i~~qi~~~L~~LH---~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~  424 (535)
T 2h8h_A          358 ----------KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA  424 (535)
T ss_dssp             ----------TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTTCST
T ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecccCC
Confidence                      34899999999999999999999   66999999999999999999999999999986532         


Q ss_pred             ----CCCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          539 ----DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       539 ----~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                          .+.+||....  ..++.++|||||||+||||++ |+.||...
T Consensus       425 ~~~~~y~aPE~~~~--~~~~~~sDvwSlGv~l~el~t~g~~P~~~~  468 (535)
T 2h8h_A          425 KFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPYPGM  468 (535)
T ss_dssp             TSCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTTCCSSTTC
T ss_pred             cCcccccCHHHhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence                1235555443  357888999999999999999 99999754

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=99.95  E-value=1.2e-27  Score=243.76  Aligned_cols=170  Identities=23%  Similarity=0.400  Sum_probs=144.0

Q ss_pred             EEEEEEEE--CCeEEEEEEcchh------HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHE------VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~------~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      |.||+++.  +|+.||+|.+...      ....+.+|+..+..++||||+++++++..+ +..++||||+++++|.+++.
T Consensus        29 g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~  107 (294)
T 2rku_A           29 AKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDN-DFVFVVLELCRRRSLLELHK  107 (294)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEEEEECCTTCBHHHHHH
T ss_pred             EEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccC-CEEEEEEecCCCCCHHHHHH
Confidence            99999999  5889999987542      335677899999999999999999998655 48899999999999999986


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD----  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~----  539 (600)
                      ...            .+++.+++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++.....    
T Consensus       108 ~~~------------~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  172 (294)
T 2rku_A          108 RRK------------ALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERK  172 (294)
T ss_dssp             HHC------------SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCCB
T ss_pred             hcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEcCCCCEEEEeccCceecccCcccc
Confidence            532            3899999999999999999999   569999999999999999999999999999765321    


Q ss_pred             --------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 --------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 --------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                              ..+||....  ..++.++||||||+++|||++|+.||...
T Consensus       173 ~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~p~~~~  218 (294)
T 2rku_A          173 KVLCGTPNYIAPEVLSK--KGHSFEVDVWSIGCIMYTLLVGKPPFETS  218 (294)
T ss_dssp             CCCCSCCSSCCHHHHTT--SCBCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             ccccCCCCcCCcchhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence                    234555433  34677899999999999999999999754

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=99.95  E-value=8.9e-28  Score=244.75  Aligned_cols=172  Identities=22%  Similarity=0.194  Sum_probs=142.9

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhH-HHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcC
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEV-ITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLA  467 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~-~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~  467 (600)
                      |.||+++.  +|+.||||.+.... ...+.+|+..+..+ +|+|++++++++... ...++||||+ +|+|.+++.... 
T Consensus        24 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-~~~~lv~e~~-~~~L~~~l~~~~-  100 (298)
T 1csn_A           24 GVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEG-LHNVLVIDLL-GPSLEDLLDLCG-  100 (298)
T ss_dssp             CEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEET-TEEEEEEECC-CCBHHHHHHHTT-
T ss_pred             EEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCC-ceeEEEEEec-CCCHHHHHHHhc-
Confidence            89999996  79999999876432 24567888888888 799999999997554 5889999999 999999997543 


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCc-----EEEEeccCccccCCC---
Q 041830          468 MKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFN-----ARVGNFGMARCVNDD---  539 (600)
Q Consensus       468 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~-----~kI~DFGla~~~~~~---  539 (600)
                                ..+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.     +||+|||+++.....   
T Consensus       101 ----------~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~  167 (298)
T 1csn_A          101 ----------RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTK  167 (298)
T ss_dssp             ----------TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTC
T ss_pred             ----------cCCCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEeccCCCCCCCeEEEEECcccccccccccc
Confidence                      24899999999999999999999   779999999999999987766     999999999755322   


Q ss_pred             ----------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCCC
Q 041830          540 ----------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRK  581 (600)
Q Consensus       540 ----------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~  581 (600)
                                      +.+||....  ..++.++||||||+++|||++|+.||.....
T Consensus       168 ~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~~  223 (298)
T 1csn_A          168 QHIPYREKKNLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKA  223 (298)
T ss_dssp             CBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred             ccccccCccCCCCCcccCCchhhcC--CCCChHHHHHHHHHHHHHHHcCCCCcchhhc
Confidence                            224554433  3467889999999999999999999987543

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=5.3e-28  Score=255.11  Aligned_cols=173  Identities=21%  Similarity=0.359  Sum_probs=142.4

Q ss_pred             eeEEEEEEEE--CCeEEEEEEcch-----hHHHHHHHHHHHHHhCCCCceeeeeeEEeccC-----CceEEEEeecCCCC
Q 041830          390 IEGAVYHGRL--NGKNLAIKRTEH-----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDG-----PHSFLVFEYAKNGS  457 (600)
Q Consensus       390 ~~G~Vy~g~~--~g~~vAvK~~~~-----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~-----~~~~LV~Ey~~~Gs  457 (600)
                      ..|.||++..  +|+.||||++..     ...+.+.+|+..+..++||||+++++++..+.     ...|+||||+ +++
T Consensus        37 ~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~  115 (367)
T 1cm8_A           37 AYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTD  115 (367)
T ss_dssp             ---CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEE
T ss_pred             CCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCC
Confidence            3499999998  689999999743     22346778999999999999999999976542     2469999999 789


Q ss_pred             HHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC
Q 041830          458 LKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN  537 (600)
Q Consensus       458 L~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~  537 (600)
                      |.++++..             .+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       116 L~~~~~~~-------------~l~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~  179 (367)
T 1cm8_A          116 LGKLMKHE-------------KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLARQAD  179 (367)
T ss_dssp             HHHHHHHC-------------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECC
T ss_pred             HHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCcCHHHEEEcCCCCEEEEeeecccccc
Confidence            99999753             2899999999999999999999   5699999999999999999999999999998654


Q ss_pred             CC---------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          538 DD---------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       538 ~~---------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                      ..         +.+||.... ...++.++|||||||++|||++|+.||...+
T Consensus       180 ~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~  230 (367)
T 1cm8_A          180 SEMTGYVVTRWYRAPEVILN-WMRYTQTVDIWSVGCIMAEMITGKTLFKGSD  230 (367)
T ss_dssp             SSCCSSCSCGGGCCTHHHHT-TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cccCcCcCCCCcCCHHHHhC-CCCCChhhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            32         234555443 2457889999999999999999999997643

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=99.95  E-value=2.4e-28  Score=247.45  Aligned_cols=171  Identities=24%  Similarity=0.480  Sum_probs=135.6

Q ss_pred             EEEEEEEEC-----CeEEEEEEcch----hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          392 GAVYHGRLN-----GKNLAIKRTEH----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       392 G~Vy~g~~~-----g~~vAvK~~~~----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      |.||+|+..     +..||+|..+.    .....+.+|+..+..++||||+++++++ .+ +..++||||+++|+|.+++
T Consensus        29 g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~-~~-~~~~lv~e~~~~~~L~~~l  106 (281)
T 1mp8_A           29 GDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TE-NPVWIIMELCTLGELRSFL  106 (281)
T ss_dssp             SEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEE-CS-SSCEEEEECCTTEEHHHHH
T ss_pred             eeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCccceEEEEE-cc-CccEEEEecCCCCCHHHHH
Confidence            899999872     45799999754    2335678899999999999999999996 34 3789999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC---
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---  539 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~---  539 (600)
                      ....           ..+++.+++.++.|++.||.|||   +.+++||||||+|||++.++.+||+|||+++.....   
T Consensus       107 ~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  172 (281)
T 1mp8_A          107 QVRK-----------YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY  172 (281)
T ss_dssp             HHTT-----------TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC-------------
T ss_pred             HhcC-----------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecccccHHHEEECCCCCEEECccccccccCccccc
Confidence            7543           24899999999999999999999   569999999999999999999999999999765322   


Q ss_pred             ----------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCCC
Q 041830          540 ----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRPR  580 (600)
Q Consensus       540 ----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~~  580 (600)
                                +.+||....  ..++.++||||||+++|||++ |+.||....
T Consensus       173 ~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~ell~~g~~pf~~~~  222 (281)
T 1mp8_A          173 KASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVK  222 (281)
T ss_dssp             ------CCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             ccccCCCcccccChhhccc--CCCCCccCchHHHHHHHHHHhcCCCCCCcCC
Confidence                      234554433  346788999999999999997 999997643

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=99.95  E-value=7.3e-28  Score=243.47  Aligned_cols=170  Identities=25%  Similarity=0.380  Sum_probs=143.5

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      |.||+++.  +++.||+|.+....      ...+.+|+..+..++||||+++++++... ...++||||+++|+|.+++.
T Consensus        23 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~l~~~l~  101 (279)
T 3fdn_A           23 GNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-TRVYLILEYAPLGTVYRELQ  101 (279)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEEECCCTTEEHHHHHH
T ss_pred             eEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecC-CEEEEEEecCCCCcHHHHHH
Confidence            99999998  57789999985533      23567889999999999999999998655 48899999999999999997


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC-----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND-----  538 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~-----  538 (600)
                      ...            .+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||++.....     
T Consensus       102 ~~~------------~~~~~~~~~~~~qi~~~l~~LH---~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  166 (279)
T 3fdn_A          102 KLS------------KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTD  166 (279)
T ss_dssp             HHS------------SCCHHHHHHHHHHHHHHHHHHH---TTTCEECCCCGGGEEECTTSCEEECSCCEESCC-------
T ss_pred             hcC------------CCCHHHHHHHHHHHHHHHHHHH---hCCEecccCChHhEEEcCCCCEEEEeccccccCCcccccc
Confidence            532            3899999999999999999999   77999999999999999999999999998864322     


Q ss_pred             -----CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 -----DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 -----~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                           ...+||....  ..++.++||||||+++|||++|+.||...
T Consensus       167 ~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~  210 (279)
T 3fdn_A          167 LCGTLDYLPPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEAN  210 (279)
T ss_dssp             -CCCCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             cCCCCCccCHhHhcc--CCCCccchhHhHHHHHHHHHHCCCCCCCC
Confidence                 2345665543  45677899999999999999999999754

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=99.95  E-value=7.8e-28  Score=245.51  Aligned_cols=172  Identities=28%  Similarity=0.547  Sum_probs=140.9

Q ss_pred             EEEEEEEEC-----CeEEEEEEcch----hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          392 GAVYHGRLN-----GKNLAIKRTEH----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       392 G~Vy~g~~~-----g~~vAvK~~~~----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      |.||+|+..     +..+|+|.++.    .....+.+|+..+..++||||++++++|..+....++||||+++|+|.+++
T Consensus        39 g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l  118 (298)
T 3f66_A           39 GCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI  118 (298)
T ss_dssp             EEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHH
T ss_pred             ceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHH
Confidence            999999872     23589998754    233567889999999999999999999876666789999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC---
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---  539 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~---  539 (600)
                      +...           ..+++.+++.++.|++.||.|||   +.+++||||||+|||++.++.+||+|||+++.....   
T Consensus       119 ~~~~-----------~~~~~~~~~~i~~ql~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~  184 (298)
T 3f66_A          119 RNET-----------HNPTVKDLIGFGLQVAKGMKYLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYY  184 (298)
T ss_dssp             HCTT-----------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGC
T ss_pred             Hhcc-----------cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCchheEEECCCCCEEECcccccccccccchh
Confidence            7543           34899999999999999999999   669999999999999999999999999999754321   


Q ss_pred             -------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          540 -------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       540 -------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                                   ..+||....  ..++.++||||||+++|||++ |.+||...
T Consensus       185 ~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~~~~~~~~~  236 (298)
T 3f66_A          185 SVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYPDV  236 (298)
T ss_dssp             BC-----CCBCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTS
T ss_pred             ccccccCCCCCccccChHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCCccC
Confidence                         223444433  346788999999999999999 55666543

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=99.95  E-value=4.9e-28  Score=248.43  Aligned_cols=183  Identities=24%  Similarity=0.388  Sum_probs=145.3

Q ss_pred             EEEEEEEE-------CCeEEEEEEcchh----HHHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCCHH
Q 041830          392 GAVYHGRL-------NGKNLAIKRTEHE----VITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       392 G~Vy~g~~-------~g~~vAvK~~~~~----~~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~  459 (600)
                      |.||+++.       +++.||+|.++..    ....+.+|+..+..+ +||||+++++++..+ ...++||||+++|+|.
T Consensus        37 g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~  115 (313)
T 1t46_A           37 GKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG-GPTLVITEYCCYGDLL  115 (313)
T ss_dssp             EEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSCEEEEECCTTEEHH
T ss_pred             cceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecC-CCcEEEEecCCCCCHH
Confidence            99999985       4578999998642    235678899999988 899999999998655 4789999999999999


Q ss_pred             HHHhcCcCccc------ccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCc
Q 041830          460 DWLHGGLAMKN------QFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA  533 (600)
Q Consensus       460 ~~L~~~~~~~~------~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla  533 (600)
                      +++........      .........+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus       116 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  192 (313)
T 1t46_A          116 NFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGLA  192 (313)
T ss_dssp             HHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEETTTEEEECCCGGG
T ss_pred             HHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCccceEEEcCCCCEEEcccccc
Confidence            99976542100      000001134899999999999999999999   569999999999999999999999999999


Q ss_pred             cccCCC--------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCCC
Q 041830          534 RCVNDD--------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRPR  580 (600)
Q Consensus       534 ~~~~~~--------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~~  580 (600)
                      +.....              ..+||....  ..++.++||||||+++|||++ |+.||....
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~  252 (313)
T 1t46_A          193 RDIKNDSNYVVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSPYPGMP  252 (313)
T ss_dssp             SCTTSCTTSEECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             ccccccccceeccCCCCcceeeChHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCCCccc
Confidence            765432              234554433  346788999999999999999 999997644

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=99.95  E-value=1.4e-28  Score=259.62  Aligned_cols=172  Identities=12%  Similarity=0.149  Sum_probs=126.6

Q ss_pred             EEEEEEEE--CCeEEEEEEcchh------HHHHHHHH---HHHHHhCCCCceeeee-------eEEeccC----------
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHE------VITKLEMQ---LVQHATHHHPNIVRLL-------GTCLTDG----------  443 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~------~~~~~e~e---i~~~~~l~HpNIv~l~-------g~~~~~~----------  443 (600)
                      |.||+++.  +|+.||||+++..      ....+.+|   +..+.. +||||++++       +++..++          
T Consensus        76 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~  154 (371)
T 3q60_A           76 SVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPG  154 (371)
T ss_dssp             EEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEEETTSCSSSBCSCC
T ss_pred             EEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehheecCCCCCeeeccCC
Confidence            99999998  7899999997652      22344555   445555 799988754       3433222          


Q ss_pred             ------CceEEEEeecCCCCHHHHHhcCcCcccccccccccCCCHHHH------HHHHHHHHHHHHHHHhcCCCCceecC
Q 041830          444 ------PHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQR------LRICLDVAMALQYMHHVMNPSYVHRN  511 (600)
Q Consensus       444 ------~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~------~~i~~~ia~gL~yLH~~~~~~ivHrD  511 (600)
                            ...|||||||+ |+|.+++....           ..+.+..+      +.++.||+.||+|||   +.+|+|||
T Consensus       155 ~~~~~~~~~~lv~e~~~-~~L~~~l~~~~-----------~~~~~~~~~~~~vk~~i~~qi~~aL~~LH---~~~ivHrD  219 (371)
T 3q60_A          155 QDDYAVANYLLLMPAAS-VDLELLFSTLD-----------FVYVFRGDEGILALHILTAQLIRLAANLQ---SKGLVHGH  219 (371)
T ss_dssp             ---CCEEEEEEEECCCS-EEHHHHHHHHH-----------HSCCCCHHHHHHHHHHHHHHHHHHHHHHH---HTTEEETT
T ss_pred             cccceeeeEEEEecCCC-CCHHHHHHHhc-----------cccchhhhhhhhhHHHHHHHHHHHHHHHH---HCCCccCc
Confidence                  23799999999 89999997642           22556666      788899999999999   66999999


Q ss_pred             CCCCCEEeCCCCcEEEEeccCccccCCC---------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          512 IKSRNIFLDEEFNARVGNFGMARCVNDD---------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       512 Lk~~NILld~~~~~kI~DFGla~~~~~~---------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                      |||+|||++.++.+||+|||+++.....         +.+||........++.++|||||||+||||++|+.||...
T Consensus       220 ikp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~  296 (371)
T 3q60_A          220 FTPDNLFIMPDGRLMLGDVSALWKVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLV  296 (371)
T ss_dssp             CSGGGEEECTTSCEEECCGGGEEETTCEEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBC
T ss_pred             CCHHHEEECCCCCEEEEecceeeecCCCccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCc
Confidence            9999999999999999999999755332         2456666443346788999999999999999999999765

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=99.95  E-value=2.3e-28  Score=275.51  Aligned_cols=171  Identities=25%  Similarity=0.477  Sum_probs=144.2

Q ss_pred             eEEEEEEEE----CCeEEEEEEcchhH-----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          391 EGAVYHGRL----NGKNLAIKRTEHEV-----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       391 ~G~Vy~g~~----~g~~vAvK~~~~~~-----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      +|.||+|.+    .++.||||+++...     .+.+.+|+..+..++|||||+++|+|. + +..++|||||++|+|.++
T Consensus       382 fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~-~-~~~~lv~E~~~~g~L~~~  459 (635)
T 4fl3_A          382 FGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICE-A-ESWMLVMEMAELGPLNKY  459 (635)
T ss_dssp             SEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCCCTTBCCEEEEEE-S-SSEEEEEECCTTEEHHHH
T ss_pred             CEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-c-CCEEEEEEccCCCCHHHH
Confidence            399999976    45789999986532     356788999999999999999999984 3 368999999999999999


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--  539 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--  539 (600)
                      ++...            .+++.+++.|+.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  
T Consensus       460 l~~~~------------~l~~~~~~~i~~qi~~~L~yLH---~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~  524 (635)
T 4fl3_A          460 LQQNR------------HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN  524 (635)
T ss_dssp             HHHCT------------TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC---
T ss_pred             HhhCC------------CCCHHHHHHHHHHHHHHHHHHH---HCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc
Confidence            97543            3899999999999999999999   569999999999999999999999999999865322  


Q ss_pred             -------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCCC
Q 041830          540 -------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRPR  580 (600)
Q Consensus       540 -------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~~  580 (600)
                                   +.+||....  ..++.++|||||||+||||++ |+.||....
T Consensus       525 ~~~~~~~~~~t~~y~APE~~~~--~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~  577 (635)
T 4fl3_A          525 YYKAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGMK  577 (635)
T ss_dssp             ----------CGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred             ccccccCCCCceeeeChhhhcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCCC
Confidence                         234555433  357888999999999999999 999997643

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=4.5e-28  Score=246.17  Aligned_cols=171  Identities=27%  Similarity=0.498  Sum_probs=143.1

Q ss_pred             EEEEEEEE----CCeEEEEEEcch----hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          392 GAVYHGRL----NGKNLAIKRTEH----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       392 G~Vy~g~~----~g~~vAvK~~~~----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      |.||+|.+    ++..||||.++.    .....+.+|+..+..++||||+++++++ .. +..++||||+++|+|.+++.
T Consensus        24 g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~-~~~~lv~e~~~~~~L~~~l~  101 (287)
T 1u59_A           24 GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QA-EALMLVMEMAGGGPLHKFLV  101 (287)
T ss_dssp             EEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ES-SSEEEEEECCTTEEHHHHHT
T ss_pred             eeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cC-CCcEEEEEeCCCCCHHHHHH
Confidence            99999986    578899999865    2345678899999999999999999997 33 36899999999999999997


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD----  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~----  539 (600)
                      ...           ..+++.+++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++.....    
T Consensus       102 ~~~-----------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~  167 (287)
T 1u59_A          102 GKR-----------EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYY  167 (287)
T ss_dssp             TCT-----------TTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEE
T ss_pred             hCC-----------ccCCHHHHHHHHHHHHHHHHHHH---HCCEeeCCCchheEEEcCCCCEEECcccceeeeccCccee
Confidence            533           34899999999999999999999   569999999999999999999999999999765322    


Q ss_pred             -----------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCCC
Q 041830          540 -----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRPR  580 (600)
Q Consensus       540 -----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~~  580 (600)
                                 ..+||....  ..++.++||||||+++|||++ |+.||....
T Consensus       168 ~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~~  218 (287)
T 1u59_A          168 TARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMK  218 (287)
T ss_dssp             CCCCSSCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             eccccccccccccCHHHhcc--CCCCchhhHHHHHHHHHHHHcCCCCCcccCC
Confidence                       223444332  346778999999999999999 999997543

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=99.95  E-value=8.4e-28  Score=254.86  Aligned_cols=183  Identities=21%  Similarity=0.409  Sum_probs=144.9

Q ss_pred             eEEEEEEEEC---------CeEEEEEEcchh----HHHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCC
Q 041830          391 EGAVYHGRLN---------GKNLAIKRTEHE----VITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNG  456 (600)
Q Consensus       391 ~G~Vy~g~~~---------g~~vAvK~~~~~----~~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~G  456 (600)
                      .|.||+++..         +..||||+++..    ....+.+|+..+..+ +||||+++++++..+ ...++||||+++|
T Consensus        82 ~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~-~~~~lv~e~~~~g  160 (382)
T 3tt0_A           82 FGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD-GPLYVIVEYASKG  160 (382)
T ss_dssp             SEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSCEEEEECCTTC
T ss_pred             CeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeeccC-CceEEEEEecCCC
Confidence            3999999862         257999997643    234577888888888 899999999998655 4789999999999


Q ss_pred             CHHHHHhcCcCccccc----ccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccC
Q 041830          457 SLKDWLHGGLAMKNQF----IASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGM  532 (600)
Q Consensus       457 sL~~~L~~~~~~~~~~----~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGl  532 (600)
                      +|.+++..........    .......+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+
T Consensus       161 ~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~DFG~  237 (382)
T 3tt0_A          161 NLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGL  237 (382)
T ss_dssp             BHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSCSC
T ss_pred             cHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHH---hCCEecCCCCcceEEEcCCCcEEEcccCc
Confidence            9999997654210000    0001134999999999999999999999   56999999999999999999999999999


Q ss_pred             ccccCCC--------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          533 ARCVNDD--------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       533 a~~~~~~--------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                      ++.....              ..+||....  ..++.++|||||||++|||++ |+.||...
T Consensus       238 a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwslG~il~ellt~g~~p~~~~  297 (382)
T 3tt0_A          238 ARDIHHIDYYKKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPGV  297 (382)
T ss_dssp             CCCSSCCCTTCCCTTCCCGGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ccccccccccccccCCCCCcceeCHHHhcC--CCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9755321              224554433  457888999999999999999 99999753

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=99.95  E-value=7e-28  Score=248.10  Aligned_cols=177  Identities=24%  Similarity=0.356  Sum_probs=145.3

Q ss_pred             eEEEEEEEE--CCeEEEEEEcch---hHHHHHHHHHHHHHhCCCCceeeeeeEEecc---CCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEH---EVITKLEMQLVQHATHHHPNIVRLLGTCLTD---GPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~---~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~---~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||+++.  +|+.||||++..   .....+.+|+..+..++||||+++++++..+   ....++||||+++|+|.+++
T Consensus        42 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l  121 (317)
T 2buj_A           42 FSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI  121 (317)
T ss_dssp             CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHH
T ss_pred             CeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHH
Confidence            399999997  789999998743   3345678899999999999999999998632   23679999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC-----
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN-----  537 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~-----  537 (600)
                      ......        ...+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...     
T Consensus       122 ~~~~~~--------~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~  190 (317)
T 2buj_A          122 ERLKDK--------GNFLTEDQILWLLLGICRGLEAIH---AKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEG  190 (317)
T ss_dssp             HHHHTT--------TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEES
T ss_pred             HHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEcCCCCEEEEecCcchhccccccc
Confidence            753211        134899999999999999999999   5699999999999999999999999999876542     


Q ss_pred             ----------------CCCCCCcccccCC-CCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          538 ----------------DDTESPQFYSTNP-ASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       538 ----------------~~~~~pe~~~~~~-~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                                      ..+.+||...... ..++.++||||||+++|||++|+.||..
T Consensus       191 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~  248 (317)
T 2buj_A          191 SRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM  248 (317)
T ss_dssp             HHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHH
T ss_pred             ccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhh
Confidence                            2245677654321 2357789999999999999999999953

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=99.95  E-value=4.4e-29  Score=264.21  Aligned_cols=180  Identities=15%  Similarity=0.207  Sum_probs=137.2

Q ss_pred             EEEEEEEE--CCeEEEEEEcch------hHHHHHHHHH---HHHHhCCCCceeeee-------eEEeccCC---------
Q 041830          392 GAVYHGRL--NGKNLAIKRTEH------EVITKLEMQL---VQHATHHHPNIVRLL-------GTCLTDGP---------  444 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~------~~~~~~e~ei---~~~~~l~HpNIv~l~-------g~~~~~~~---------  444 (600)
                      |.||+|+.  +|+.||||+++.      ...+.+.+|+   ..+..++|||||+++       +++..++.         
T Consensus        87 g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (377)
T 3byv_A           87 YAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLD  166 (377)
T ss_dssp             EEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC---
T ss_pred             EEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccC
Confidence            99999996  699999999752      2335677888   455566899999998       55433321         


Q ss_pred             -------ceEEEEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCE
Q 041830          445 -------HSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNI  517 (600)
Q Consensus       445 -------~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NI  517 (600)
                             ..|+||||+ +|+|.+++........     ....++|..++.|+.||+.||+|||   +.+|+||||||+||
T Consensus       167 ~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~-----~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivHrDikp~NI  237 (377)
T 3byv_A          167 ERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSS-----THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDI  237 (377)
T ss_dssp             ---CEEESEEEEEECC-SEEHHHHHHHHHHTTT-----TTHHHHHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGE
T ss_pred             CCceEEEEEEEEEecc-CCCHHHHHHhcccccc-----ccccccHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHE
Confidence                   278999999 6899999975432110     0023567899999999999999999   56999999999999


Q ss_pred             EeCCCCcEEEEeccCccccC--------CCCCCCcccccC---------CCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          518 FLDEEFNARVGNFGMARCVN--------DDTESPQFYSTN---------PASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       518 Lld~~~~~kI~DFGla~~~~--------~~~~~pe~~~~~---------~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                      |++.++.+||+|||+++...        ..+.+||.....         ...++.++|||||||+||||++|+.||....
T Consensus       238 ll~~~~~~kL~DFG~a~~~~~~~~~~~g~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~  317 (377)
T 3byv_A          238 VLDQRGGVFLTGFEHLVRDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDA  317 (377)
T ss_dssp             EECTTCCEEECCGGGCEETTCEEECCCCTTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             EEcCCCCEEEEechhheecCCcccCCCCcCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccc
Confidence            99999999999999997543        234566665542         1157889999999999999999999997644

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=99.95  E-value=3.9e-28  Score=247.27  Aligned_cols=170  Identities=22%  Similarity=0.367  Sum_probs=139.6

Q ss_pred             EEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      |.||+++.  +|+.||+|+++..     ....+.+|+..+..++||||+++++++..+ ...++||||+++ +|.+++..
T Consensus        16 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~-~l~~~~~~   93 (292)
T 3o0g_A           16 GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-KKLTLVFEFCDQ-DLKKYFDS   93 (292)
T ss_dssp             SEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEEEEECCSE-EHHHHHHH
T ss_pred             eEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeC-CEEEEEEecCCC-CHHHHHHh
Confidence            89999998  6899999987532     235667899999999999999999998665 489999999985 66666654


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-----
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-----  539 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-----  539 (600)
                      ..           ..+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....     
T Consensus        94 ~~-----------~~l~~~~~~~~~~ql~~~l~~lH---~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  159 (292)
T 3o0g_A           94 CN-----------GDLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS  159 (292)
T ss_dssp             TT-----------TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCC
T ss_pred             CC-----------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccccc
Confidence            32           23899999999999999999999   569999999999999999999999999999765322     


Q ss_pred             -------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          540 -------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       540 -------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                             ..+||.... ...++.++|||||||++|||++|+.||..
T Consensus       160 ~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~~l~~~~~p~~~  204 (292)
T 3o0g_A          160 AEVVTLWYRPPDVLFG-AKLYSTSIDMWSAGCIFAELANAGRPLFP  204 (292)
T ss_dssp             SCCSCGGGCCHHHHTT-CSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred             CCccccCCcChHHHcC-CCCcCchHHHHHHHHHHHHHHHcCCCCcC
Confidence                   224554433 23468889999999999999999888654

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=99.95  E-value=5.2e-28  Score=274.52  Aligned_cols=172  Identities=21%  Similarity=0.341  Sum_probs=142.4

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhHH------HHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEVI------TKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~~------~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      +|.||+++.  +|+.||||+++.+..      ..+..|...+..+ +||||+++++++.+. +.+||||||+++|+|.++
T Consensus       354 fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~-~~~~lV~E~~~gg~L~~~  432 (674)
T 3pfq_A          354 FGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTM-DRLYFVMEYVNGGDLMYH  432 (674)
T ss_dssp             TBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCS-SEEEEEEECCCSCBHHHH
T ss_pred             CEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeC-CEEEEEEeCcCCCcHHHH
Confidence            499999998  678899999876432      2345566666655 699999999986544 589999999999999999


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC----
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN----  537 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~----  537 (600)
                      ++...            .+++.++..++.||+.||+|||   +.+|+||||||+||||+.++.+||+|||+++...    
T Consensus       433 l~~~~------------~~~~~~~~~~~~qi~~aL~~LH---~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~  497 (674)
T 3pfq_A          433 IQQVG------------RFKEPHAVFYAAEIAIGLFFLQ---SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV  497 (674)
T ss_dssp             HHHHS------------SCCHHHHHHHHHHHHHHHHHHH---HTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC
T ss_pred             HHhcC------------CCCHHHHHHHHHHHHHHHHHHH---hCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCc
Confidence            97543            3899999999999999999999   6699999999999999999999999999998532    


Q ss_pred             --------CCCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          538 --------DDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       538 --------~~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                              ..+.+||....  ..++.++|||||||+||||++|+.||...+
T Consensus       498 ~~~~~~GT~~Y~APE~l~~--~~~~~~~DvwSlGvilyelltG~~Pf~~~~  546 (674)
T 3pfq_A          498 TTKTFCGTPDYIAPEIIAY--QPYGKSVDWWAFGVLLYEMLAGQAPFEGED  546 (674)
T ss_dssp             CBCCCCSCSSSCCHHHHTC--CCBSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccccccCCCcccCHhhhcC--CCCCccceEechHHHHHHHHcCCCCCCCCC
Confidence                    12335665543  457889999999999999999999997643

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=99.95  E-value=1.2e-27  Score=245.75  Aligned_cols=175  Identities=21%  Similarity=0.346  Sum_probs=139.3

Q ss_pred             eEEEEEEEE--CCeEEEEEEcch------hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEH------EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~------~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||++..  +|+.||+|+++.      .....+.+|+..+..++||||+++++++..+ ...++||||+++|+|.+++
T Consensus        45 ~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l  123 (310)
T 2wqm_A           45 FSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIED-NELNIVLELADAGDLSRMI  123 (310)
T ss_dssp             -CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEEEECCCSCBHHHHH
T ss_pred             CceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-CcEEEEEecCCCCCHHHHH
Confidence            389999997  789999998753      2335678899999999999999999998765 4899999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC---
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---  539 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~---  539 (600)
                      ......        ...+++.+++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++.....   
T Consensus       124 ~~~~~~--------~~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  192 (310)
T 2wqm_A          124 KHFKKQ--------KRLIPERTVWKYFVQLCSALEHMH---SRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA  192 (310)
T ss_dssp             HHHHHT--------TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCC------------
T ss_pred             HHhccc--------ccCCCHHHHHHHHHHHHHHHHHHh---hCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCcc
Confidence            652210        134899999999999999999999   669999999999999999999999999998754321   


Q ss_pred             ---------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 ---------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 ---------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                               ..+||....  ..++.++||||||+++|||++|+.||...
T Consensus       193 ~~~~~~~~~y~aPE~~~~--~~~~~~~Dv~slG~il~~l~~g~~p~~~~  239 (310)
T 2wqm_A          193 AHSLVGTPYYMSPERIHE--NGYNFKSDIWSLGCLLYEMAALQSPFYGD  239 (310)
T ss_dssp             ------CCSSCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTC--
T ss_pred             ccccCCCeeEeChHHhCC--CCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence                     234555443  45678899999999999999999999653

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=99.95  E-value=1.2e-27  Score=248.74  Aligned_cols=175  Identities=24%  Similarity=0.368  Sum_probs=141.5

Q ss_pred             EEEEEEEECCeEEEEEEcchhHHHHHHHHHHHHHh--CCCCceeeeeeEEeccC---CceEEEEeecCCCCHHHHHhcCc
Q 041830          392 GAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHAT--HHHPNIVRLLGTCLTDG---PHSFLVFEYAKNGSLKDWLHGGL  466 (600)
Q Consensus       392 G~Vy~g~~~g~~vAvK~~~~~~~~~~e~ei~~~~~--l~HpNIv~l~g~~~~~~---~~~~LV~Ey~~~GsL~~~L~~~~  466 (600)
                      |.||+++.+|+.||||.++......+.+|...+..  ++||||+++++++..+.   ...++||||+++|+|.+++... 
T Consensus        56 g~Vy~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-  134 (342)
T 1b6c_B           56 GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-  134 (342)
T ss_dssp             EEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHHC-
T ss_pred             cEEEEEEEcCccEEEEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhcc-
Confidence            89999999999999999977665555666666655  78999999999987653   2689999999999999999753 


Q ss_pred             CcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcC-----CCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--
Q 041830          467 AMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM-----NPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--  539 (600)
Q Consensus       467 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~-----~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--  539 (600)
                                  .+++.+++.++.|++.||.|||...     +.+|+||||||+|||++.++.+||+|||+++.....  
T Consensus       135 ------------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  202 (342)
T 1b6c_B          135 ------------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATD  202 (342)
T ss_dssp             ------------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTT
T ss_pred             ------------CccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceecccccc
Confidence                        2899999999999999999999311     358999999999999999999999999998654322  


Q ss_pred             --------------CCCCcccccCCC----CCCccCchHHHHHHHHHHHhC----------CCCCCCC
Q 041830          540 --------------TESPQFYSTNPA----SWSMGIDIFAYGIVLLEVLSG----------QTPINRP  579 (600)
Q Consensus       540 --------------~~~pe~~~~~~~----~~t~~sDVwSfGvvL~ELltG----------~~Pf~~~  579 (600)
                                    +.+||.......    .++.++|||||||++|||++|          +.||...
T Consensus       203 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~  270 (342)
T 1b6c_B          203 TIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL  270 (342)
T ss_dssp             EEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             ccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCcccc
Confidence                          224555433211    223678999999999999999          7888654

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=99.95  E-value=4.8e-28  Score=250.13  Aligned_cols=178  Identities=22%  Similarity=0.455  Sum_probs=136.2

Q ss_pred             EEEEEEEEC--Ce---EEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCC-----ceEEEEeecCCC
Q 041830          392 GAVYHGRLN--GK---NLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGP-----HSFLVFEYAKNG  456 (600)
Q Consensus       392 G~Vy~g~~~--g~---~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~-----~~~LV~Ey~~~G  456 (600)
                      |.||+++..  +.   .||||.++.+     ....+.+|+..+..++||||+++++++.....     ..++||||+++|
T Consensus        37 g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~  116 (323)
T 3qup_A           37 GSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHG  116 (323)
T ss_dssp             EEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTC
T ss_pred             eEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCC
Confidence            999999873  32   7999997643     23567889999999999999999999865431     138999999999


Q ss_pred             CHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCcccc
Q 041830          457 SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV  536 (600)
Q Consensus       457 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~  536 (600)
                      +|.+++........      ...+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       117 ~L~~~l~~~~~~~~------~~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~  187 (323)
T 3qup_A          117 DLHAFLLASRIGEN------PFNLPLQTLVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKI  187 (323)
T ss_dssp             BHHHHHHHHHC---------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC----
T ss_pred             cHHHHHHhhhcccc------ccccCHHHHHHHHHHHHHHHHHHH---cCCcccCCCCcceEEEcCCCCEEEeeccccccc
Confidence            99999965331111      124899999999999999999999   569999999999999999999999999999754


Q ss_pred             CCC--------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCCC
Q 041830          537 NDD--------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRPR  580 (600)
Q Consensus       537 ~~~--------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~~  580 (600)
                      ...              +.+||....  ..++.++|||||||++|||++ |+.||....
T Consensus       188 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~  244 (323)
T 3qup_A          188 YSGDYYRQGCASKLPVKWLALESLAD--NLYTVHSDVWAFGVTMWEIMTRGQTPYAGIE  244 (323)
T ss_dssp             -------------CCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             cccccccccccccCcccccCchhhcC--CCCCCccchhhHHHHHHHHHhCCCCCccccC
Confidence            321              224444433  346788999999999999999 999997643

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=99.95  E-value=2.9e-28  Score=256.57  Aligned_cols=174  Identities=17%  Similarity=0.250  Sum_probs=138.0

Q ss_pred             ceeEEEEEEEEC-------CeEEEEEEcchhHHH--------------HHHHHHHHHHhCCCCceeeeeeEEeccC---C
Q 041830          389 RIEGAVYHGRLN-------GKNLAIKRTEHEVIT--------------KLEMQLVQHATHHHPNIVRLLGTCLTDG---P  444 (600)
Q Consensus       389 ~~~G~Vy~g~~~-------g~~vAvK~~~~~~~~--------------~~e~ei~~~~~l~HpNIv~l~g~~~~~~---~  444 (600)
                      |.+|.||+|.+.       ++.||||.+......              ....|+..+..++||||+++++++..+.   .
T Consensus        46 G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~  125 (364)
T 3op5_A           46 GGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKS  125 (364)
T ss_dssp             C-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEEEETTEE
T ss_pred             CCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeeeccCCcc
Confidence            334999999882       478999997643211              1223445566778999999999987542   2


Q ss_pred             ceEEEEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC--CC
Q 041830          445 HSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLD--EE  522 (600)
Q Consensus       445 ~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld--~~  522 (600)
                      ..+|||||+ +|+|.+++....           ..+++.+++.++.||+.||+|||   +.+|+||||||+|||++  .+
T Consensus       126 ~~~lv~e~~-g~~L~~~~~~~~-----------~~l~~~~~~~i~~qi~~~l~~lH---~~~iiHrDlkp~Nill~~~~~  190 (364)
T 3op5_A          126 YRFMIMDRF-GSDLQKIYEANA-----------KRFSRKTVLQLSLRILDILEYIH---EHEYVHGDIKASNLLLNYKNP  190 (364)
T ss_dssp             EEEEEEECE-EEEHHHHHHHTT-----------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEESSCT
T ss_pred             eEEEEEeCC-CCCHHHHHHhcc-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCeEEecCCHHHEEEecCCC
Confidence            479999999 999999997642           34999999999999999999999   56999999999999998  88


Q ss_pred             CcEEEEeccCccccCC-------------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          523 FNARVGNFGMARCVND-------------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       523 ~~~kI~DFGla~~~~~-------------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                      +.+||+|||+++....                   .+.+||....  ..++.++|||||||+||||++|+.||...
T Consensus       191 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~g~~Pf~~~  264 (364)
T 3op5_A          191 DQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNG--VAPSRRGDLEILGYCMIQWLTGHLPWEDN  264 (364)
T ss_dssp             TCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSCCTTGGG
T ss_pred             CeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCC--CCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence            9999999999965321                   2234555543  34688899999999999999999999853

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=99.95  E-value=4.4e-28  Score=248.85  Aligned_cols=174  Identities=22%  Similarity=0.368  Sum_probs=138.8

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH--------HHHHHHHHHHHHh---CCCCceeeeeeEEeccCC----ceEEEEeec
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV--------ITKLEMQLVQHAT---HHHPNIVRLLGTCLTDGP----HSFLVFEYA  453 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~--------~~~~e~ei~~~~~---l~HpNIv~l~g~~~~~~~----~~~LV~Ey~  453 (600)
                      .|.||+++.  +|+.||||.++...        ...+.+|+..+..   +.||||+++++++.....    ..++||||+
T Consensus        22 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~  101 (308)
T 3g33_A           22 YGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV  101 (308)
T ss_dssp             SCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECC
T ss_pred             CeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhh
Confidence            499999996  78999999875311        1233445544444   459999999999875432    478999999


Q ss_pred             CCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCc
Q 041830          454 KNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA  533 (600)
Q Consensus       454 ~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla  533 (600)
                      . |+|.+++.....          ..+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus       102 ~-~~L~~~~~~~~~----------~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a  167 (308)
T 3g33_A          102 D-QDLRTYLDKAPP----------PGLPAETIKDLMRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLA  167 (308)
T ss_dssp             C-CBHHHHHHTCCT----------TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCTTTEEECTTSCEEECSCSCT
T ss_pred             h-cCHHHHHhhccC----------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEcCCCCEEEeeCccc
Confidence            7 699999976542          33899999999999999999999   568999999999999999999999999999


Q ss_pred             cccCCC-----------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          534 RCVNDD-----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       534 ~~~~~~-----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                      +.....           +.+||....  ..++.++|||||||++|||++|+.||...+
T Consensus       168 ~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~l~~g~~pf~~~~  223 (308)
T 3g33_A          168 RIYSYQMALTPVVVTLWYRAPEVLLQ--STYATPVDMWSVGCIFAEMFRRKPLFCGNS  223 (308)
T ss_dssp             TTSTTCCCSGGGGCCCSSCCHHHHHT--SCCCSTHHHHHHHHHHHHTTTSSCSCCCSS
T ss_pred             cccCCCcccCCccccccccCchHHcC--CCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            755322           235665543  447888999999999999999999997543

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=99.95  E-value=5.1e-28  Score=259.81  Aligned_cols=172  Identities=22%  Similarity=0.387  Sum_probs=140.8

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhH-----------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCH
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEV-----------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSL  458 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~-----------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL  458 (600)
                      |.||++..  +|+.||||.+....           ...+++|+..+..++||||+++++++. . ...++||||+++|+|
T Consensus       149 g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~-~-~~~~lv~e~~~~g~L  226 (419)
T 3i6u_A          149 GEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFD-A-EDYYIVLELMEGGEL  226 (419)
T ss_dssp             SEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEE-S-SEEEEEEECCTTCBG
T ss_pred             eEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEe-c-CceEEEEEcCCCCcH
Confidence            99999998  68899999976432           124678999999999999999999963 3 368999999999999


Q ss_pred             HHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC---CcEEEEeccCccc
Q 041830          459 KDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEE---FNARVGNFGMARC  535 (600)
Q Consensus       459 ~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~---~~~kI~DFGla~~  535 (600)
                      .+++....            .+++.++..++.|++.||+|||   +.+|+||||||+|||++.+   +.+||+|||+++.
T Consensus       227 ~~~l~~~~------------~~~~~~~~~i~~qi~~~l~~LH---~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~  291 (419)
T 3i6u_A          227 FDKVVGNK------------RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI  291 (419)
T ss_dssp             GGGTSSSC------------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTS
T ss_pred             HHHHhccC------------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCCCcceEEEeeccccee
Confidence            98886543            3899999999999999999999   5689999999999999654   4599999999986


Q ss_pred             cCC-----------CCCCCccccc-CCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          536 VND-----------DTESPQFYST-NPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       536 ~~~-----------~~~~pe~~~~-~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                      ...           .+.+||.... ....++.++|||||||++|||++|+.||....
T Consensus       292 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~  348 (419)
T 3i6u_A          292 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHR  348 (419)
T ss_dssp             CC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCS
T ss_pred             cCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCc
Confidence            532           2345666532 22456778999999999999999999997643

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=99.95  E-value=9.1e-28  Score=253.10  Aligned_cols=172  Identities=23%  Similarity=0.429  Sum_probs=143.3

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhH-----------HHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCC
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEV-----------ITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGS  457 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~-----------~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~Gs  457 (600)
                      |.||+++.  +|+.||||.++...           ...+.+|+..+..+ .||||+++++++... ...++||||+++|+
T Consensus       108 g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-~~~~lv~e~~~g~~  186 (365)
T 2y7j_A          108 SVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESS-SFMFLVFDLMRKGE  186 (365)
T ss_dssp             EEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBS-SEEEEEECCCTTCB
T ss_pred             EEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeC-CEEEEEEEeCCCCc
Confidence            99999998  58999999875321           23567788888887 799999999997655 48999999999999


Q ss_pred             HHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC
Q 041830          458 LKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN  537 (600)
Q Consensus       458 L~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~  537 (600)
                      |.+++...            ..+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||++....
T Consensus       187 L~~~l~~~------------~~l~~~~~~~i~~qi~~~L~~LH---~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~  251 (365)
T 2y7j_A          187 LFDYLTEK------------VALSEKETRSIMRSLLEAVSFLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLE  251 (365)
T ss_dssp             HHHHHHHH------------SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             HHHHHHhc------------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence            99999753            23899999999999999999999   5699999999999999999999999999987654


Q ss_pred             CC-----------CCCCcccccC----CCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          538 DD-----------TESPQFYSTN----PASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       538 ~~-----------~~~pe~~~~~----~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                      ..           +.+||.....    ...++.++|||||||++|||++|+.||...
T Consensus       252 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~  308 (365)
T 2y7j_A          252 PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHR  308 (365)
T ss_dssp             TTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCC
Confidence            32           2345654321    235788899999999999999999999753

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=99.95  E-value=1.2e-27  Score=247.14  Aligned_cols=173  Identities=22%  Similarity=0.396  Sum_probs=142.8

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhH-----------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCH
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEV-----------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSL  458 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~-----------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL  458 (600)
                      |.||+++.  +|+.||||.+....           ...+++|+..+..++||||+++++++..+  ..++||||+++|+|
T Consensus        24 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--~~~lv~e~~~~~~L  101 (322)
T 2ycf_A           24 GEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAE--DYYIVLELMEGGEL  101 (322)
T ss_dssp             EEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESS--SEEEEEECCTTEET
T ss_pred             EEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCC--ceEEEEecCCCCcH
Confidence            99999998  68999999875432           12467899999999999999999997443  58999999999999


Q ss_pred             HHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCc---EEEEeccCccc
Q 041830          459 KDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFN---ARVGNFGMARC  535 (600)
Q Consensus       459 ~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~---~kI~DFGla~~  535 (600)
                      .+++....            .+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.   +||+|||+++.
T Consensus       102 ~~~~~~~~------------~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  166 (322)
T 2ycf_A          102 FDKVVGNK------------RLKEATCKLYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI  166 (322)
T ss_dssp             HHHHSTTC------------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred             HHHHhccC------------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence            99997543            3899999999999999999999   569999999999999987654   99999999976


Q ss_pred             cCC-----------CCCCCccccc-CCCCCCccCchHHHHHHHHHHHhCCCCCCCCCC
Q 041830          536 VND-----------DTESPQFYST-NPASWSMGIDIFAYGIVLLEVLSGQTPINRPRK  581 (600)
Q Consensus       536 ~~~-----------~~~~pe~~~~-~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~  581 (600)
                      ...           .+.+||.... ....++.++|||||||++|||++|+.||.....
T Consensus       167 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  224 (322)
T 2ycf_A          167 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT  224 (322)
T ss_dssp             CCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC
T ss_pred             cccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch
Confidence            532           3456776532 234578889999999999999999999976543

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=99.95  E-value=2.3e-28  Score=260.51  Aligned_cols=178  Identities=25%  Similarity=0.359  Sum_probs=144.4

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH----HHHHHHHHHHHHhCCCCceeeeeeEEeccC-CceEEEEeecCCCCHHHHHh
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV----ITKLEMQLVQHATHHHPNIVRLLGTCLTDG-PHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~-~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      .|.||+++.  +|+.||||+++...    ...+.+|+..+..++||||+++++++...+ ...++||||+++|+|.+++.
T Consensus        22 ~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~  101 (396)
T 4eut_A           22 TANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLE  101 (396)
T ss_dssp             SEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTT
T ss_pred             CeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHH
Confidence            399999999  58999999986532    345678999999999999999999986543 36799999999999999997


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEe----CCCCcEEEEeccCccccCCC
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFL----DEEFNARVGNFGMARCVNDD  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl----d~~~~~kI~DFGla~~~~~~  539 (600)
                      .....         ..+++.+++.++.|++.||+|||   +.+|+||||||+|||+    +.++.+||+|||+++.....
T Consensus       102 ~~~~~---------~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~  169 (396)
T 4eut_A          102 EPSNA---------YGLPESEFLIVLRDVVGGMNHLR---ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDD  169 (396)
T ss_dssp             SGGGT---------TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCG
T ss_pred             hhhcc---------cCCCHHHHHHHHHHHHHHHHHHH---HCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCC
Confidence            64321         23899999999999999999999   5699999999999999    78888999999999765322


Q ss_pred             -----------CCCCcccccC------CCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 -----------TESPQFYSTN------PASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 -----------~~~pe~~~~~------~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                                 +.+||.....      ...++.++|||||||++|||++|+.||....
T Consensus       170 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~  227 (396)
T 4eut_A          170 EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE  227 (396)
T ss_dssp             GGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred             CccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence                       2345543221      0235667999999999999999999997543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=99.95  E-value=8.2e-28  Score=247.58  Aligned_cols=168  Identities=24%  Similarity=0.334  Sum_probs=135.4

Q ss_pred             EEEEEEEE--CCeEEEEEEcch-----hHHHHHHHHHHHHH-hCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          392 GAVYHGRL--NGKNLAIKRTEH-----EVITKLEMQLVQHA-THHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~-----~~~~~~e~ei~~~~-~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      |.||+|+.  +|+.||||++..     ........|+..+. ...||||++++++|... ...++||||+ +|+|.+++.
T Consensus        71 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~-~~~~lv~e~~-~~~L~~~~~  148 (311)
T 3p1a_A           71 GEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEG-GILYLQTELC-GPSLQQHCE  148 (311)
T ss_dssp             EEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEECC-CCBHHHHHH
T ss_pred             eEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeC-CEEEEEEecc-CCCHHHHHH
Confidence            99999999  689999998643     11123334444443 34899999999998655 4899999999 679999986


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC-----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND-----  538 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~-----  538 (600)
                      ...           ..++|.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....     
T Consensus       149 ~~~-----------~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~~~  214 (311)
T 3p1a_A          149 AWG-----------ASLPEAQVWGYLRDTLLALAHLH---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE  214 (311)
T ss_dssp             HHC-----------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECGGGCEEECCCTTCEECC------
T ss_pred             hcC-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCCCc
Confidence            543           34999999999999999999999   56899999999999999999999999999875532     


Q ss_pred             ------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          539 ------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       539 ------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                            .+.+||....   .++.++|||||||++|||++|..|+..
T Consensus       215 ~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~el~~g~~~~~~  257 (311)
T 3p1a_A          215 VQEGDPRYMAPELLQG---SYGTAADVFSLGLTILEVACNMELPHG  257 (311)
T ss_dssp             CCCCCGGGCCGGGGGT---CCSTHHHHHHHHHHHHHHHHTCCCCSS
T ss_pred             ccCCCccccCHhHhcC---CCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence                  2236776543   478899999999999999999776643

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=99.95  E-value=2.4e-27  Score=241.06  Aligned_cols=170  Identities=22%  Similarity=0.418  Sum_probs=142.7

Q ss_pred             EEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEecc---CCceEEEEeecCCCCHHHH
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTD---GPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~---~~~~~LV~Ey~~~GsL~~~  461 (600)
                      |.||+|..  ++..||+|.+...     ....+.+|+..+..++||||+++++++...   ....++||||+++|+|.++
T Consensus        40 g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~  119 (290)
T 1t4h_A           40 KTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTY  119 (290)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHH
T ss_pred             eEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHH
Confidence            99999998  6788999987542     335678899999999999999999997642   3457999999999999999


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCC--ceecCCCCCCEEeC-CCCcEEEEeccCccccCC
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS--YVHRNIKSRNIFLD-EEFNARVGNFGMARCVND  538 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDLk~~NILld-~~~~~kI~DFGla~~~~~  538 (600)
                      +....            .+++.+++.++.|++.||.|||   +.+  ++||||||+|||++ .++.+||+|||++.....
T Consensus       120 l~~~~------------~~~~~~~~~~~~qi~~~l~~lH---~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~  184 (290)
T 1t4h_A          120 LKRFK------------VMKIKVLRSWCRQILKGLQFLH---TRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             HHHHS------------SCCHHHHHHHHHHHHHHHHHHH---TSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             HHHcc------------CCCHHHHHHHHHHHHHHHHHHH---cCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence            97532            3899999999999999999999   556  99999999999997 789999999999864432


Q ss_pred             ----------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 ----------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 ----------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                ...+||....   .++.++||||||+++|||++|+.||...
T Consensus       185 ~~~~~~~~t~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~pf~~~  232 (290)
T 1t4h_A          185 SFAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSEC  232 (290)
T ss_dssp             TSBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             cccccccCCcCcCCHHHHhc---cCCCcchHHHHHHHHHHHHhCCCCCCCc
Confidence                      2346776542   3788899999999999999999999753

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=99.95  E-value=9.8e-28  Score=245.76  Aligned_cols=170  Identities=22%  Similarity=0.378  Sum_probs=143.9

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhH---HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCc
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEV---ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGL  466 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~---~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~  466 (600)
                      |.||+++.  +|+.||+|.++...   ...+++|+..+..++||||+++++++... ...++||||+++|+|.+++....
T Consensus        23 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~  101 (304)
T 2jam_A           23 SEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYEST-THYYLVMQLVSGGELFDRILERG  101 (304)
T ss_dssp             EEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHHHHHS
T ss_pred             ceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCCCCCeeehhhhcccC-CEEEEEEEcCCCccHHHHHHHcC
Confidence            99999998  68999999986432   24578899999999999999999997655 48899999999999999986532


Q ss_pred             CcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEe---CCCCcEEEEeccCccccCC-----
Q 041830          467 AMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFL---DEEFNARVGNFGMARCVND-----  538 (600)
Q Consensus       467 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl---d~~~~~kI~DFGla~~~~~-----  538 (600)
                                  .+++.++..++.|++.||.|||   +.+++||||||+||++   +.++.+||+|||+++....     
T Consensus       102 ------------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~  166 (304)
T 2jam_A          102 ------------VYTEKDASLVIQQVLSAVKYLH---ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMST  166 (304)
T ss_dssp             ------------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTTHH
T ss_pred             ------------CCCHHHHHHHHHHHHHHHHHHH---HCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCcccc
Confidence                        3899999999999999999999   5699999999999999   7889999999999875432     


Q ss_pred             -----CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 -----DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 -----~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                           .+.+||....  ..++.++||||||+++|||++|+.||...
T Consensus       167 ~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~  210 (304)
T 2jam_A          167 ACGTPGYVAPEVLAQ--KPYSKAVDCWSIGVITYILLCGYPPFYEE  210 (304)
T ss_dssp             HHSCCCBCCTTTBSS--CSCCHHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             ccCCCCccChHHhcc--CCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence                 2346666544  45678899999999999999999999653

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=99.95  E-value=6.2e-28  Score=244.84  Aligned_cols=173  Identities=24%  Similarity=0.509  Sum_probs=146.5

Q ss_pred             EEEEEEEE--CCeEEEEEEcchh--HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcC
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHE--VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLA  467 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~--~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~  467 (600)
                      |.||++..  ++..||+|.++.+  ..+.+.+|+..+..++||||+++++++..+ ...++||||+++|+|.+++.....
T Consensus        27 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~  105 (288)
T 3kfa_A           27 GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-PPFYIITEFMTYGNLLDYLRECNR  105 (288)
T ss_dssp             CSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSEEEEEECCTTEEHHHHHHHCCT
T ss_pred             eeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccC-CCEEEEEEcCCCCcHHHHHHhccc
Confidence            89999999  4899999998653  335678899999999999999999997555 478999999999999999976432


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--------
Q 041830          468 MKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--------  539 (600)
Q Consensus       468 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--------  539 (600)
                                ..+++.+++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++.....        
T Consensus       106 ----------~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  172 (288)
T 3kfa_A          106 ----------QEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGA  172 (288)
T ss_dssp             ----------TTSCHHHHHHHHHHHHHHHHHHH---HHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEEETTE
T ss_pred             ----------CCccHhHHHHHHHHHHHHHHHHH---HCCccCCCCCcceEEEcCCCCEEEccCccceeccCCccccccCC
Confidence                      34899999999999999999999   558999999999999999999999999999865432        


Q ss_pred             -----CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCCC
Q 041830          540 -----TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRPR  580 (600)
Q Consensus       540 -----~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~~  580 (600)
                           ..+||....  ..++.++||||||+++|||++ |+.||...+
T Consensus       173 ~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~~g~~p~~~~~  217 (288)
T 3kfa_A          173 KFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYPGID  217 (288)
T ss_dssp             EECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ccccCcCChhhhcc--CCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence                 234554443  346788999999999999999 999997543

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=99.95  E-value=7.7e-28  Score=247.47  Aligned_cols=170  Identities=22%  Similarity=0.313  Sum_probs=139.2

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      |.||+++.  +|+.||+|.++...      ...+.+|+..+..++||||+++++++..+ ...++||||+++++|.+++.
T Consensus        48 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~  126 (309)
T 2h34_A           48 GDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEID-GQLYVDMRLINGVDLAAMLR  126 (309)
T ss_dssp             SEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEEEEECCCCEEHHHHHH
T ss_pred             eeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeC-CeEEEEEEecCCCCHHHHHH
Confidence            89999998  68999999976432      24678899999999999999999998665 48899999999999999997


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD----  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~----  539 (600)
                      ...            .+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....    
T Consensus       127 ~~~------------~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  191 (309)
T 2h34_A          127 RQG------------PLAPPRAVAIVRQIGSALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ  191 (309)
T ss_dssp             HHC------------SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSCCC-----------
T ss_pred             hcC------------CCCHHHHHHHHHHHHHHHHHHH---HCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccccc
Confidence            532            3899999999999999999999   569999999999999999999999999998754322    


Q ss_pred             ---------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 ---------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 ---------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                               +.+||....  ..++.++||||||+++|||++|+.||...
T Consensus       192 ~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~  238 (309)
T 2h34_A          192 LGNTVGTLYYMAPERFSE--SHATYRADIYALTCVLYECLTGSPPYQGD  238 (309)
T ss_dssp             -----CCGGGCCGGGTCC------CCCHHHHHHHHHHHHHHSSCSSCSC
T ss_pred             ccccCCCcCccCHHHHcC--CCCCchHhHHHHHHHHHHHHHCCCCCCCc
Confidence                     235665543  45678899999999999999999999753

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=99.95  E-value=2.1e-27  Score=239.34  Aligned_cols=171  Identities=26%  Similarity=0.479  Sum_probs=143.9

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      |.||+++.  +|+.||||.+....      ...+.+|+..+..++||||+++++++... ...++||||+++++|.+++.
T Consensus        25 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~  103 (276)
T 2h6d_A           25 GKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTP-TDFFMVMEYVSGGELFDYIC  103 (276)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEEEEECCCSCBHHHHHH
T ss_pred             eEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-CeEEEEEeccCCCcHHHHHh
Confidence            89999998  68999999986543      23577899999999999999999998655 48999999999999999997


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD----  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~----  539 (600)
                      ...            .+++.+++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++......    
T Consensus       104 ~~~------------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~  168 (276)
T 2h6d_A          104 KHG------------RVEEMEARRLFQQILSAVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR  168 (276)
T ss_dssp             HHC------------SCCHHHHHHHHHHHHHHHHHHH---HHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC-----
T ss_pred             ccC------------CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChhhEEECCCCCEEEeecccccccCCCccee
Confidence            532            3899999999999999999999   568999999999999999999999999998765332    


Q ss_pred             -------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 -------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 -------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                             ..+||..... ...+.++||||||+++|||++|+.||...
T Consensus       169 ~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~~l~~l~~g~~p~~~~  214 (276)
T 2h6d_A          169 TSCGSPNYAAPEVISGR-LYAGPEVDIWSCGVILYALLCGTLPFDDE  214 (276)
T ss_dssp             --------CCTGGGTTS-CCCHHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cccCCccccCHHHHcCC-CCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence                   2356655432 12356799999999999999999999753

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=99.95  E-value=9.8e-28  Score=242.73  Aligned_cols=170  Identities=22%  Similarity=0.342  Sum_probs=143.7

Q ss_pred             EEEEEEEE--CCeEEEEEEcchh---------HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHE---------VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~---------~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      |.||+++.  +|+.||+|.++..         ..+.+++|+..+..++||||+++++++... ...++||||+++++|.+
T Consensus        19 g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~   97 (283)
T 3bhy_A           19 AIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENK-TDVVLILELVSGGELFD   97 (283)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEEECCCSCBHHH
T ss_pred             eEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCC-CeEEEEEeecCCCcHHH
Confidence            99999999  5899999987542         235678899999999999999999998655 48899999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC----cEEEEeccCcccc
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEF----NARVGNFGMARCV  536 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~----~~kI~DFGla~~~  536 (600)
                      ++...            ..+++.+++.++.|++.||.|||   +.+++||||||+||+++.++    .+||+|||+++..
T Consensus        98 ~l~~~------------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~  162 (283)
T 3bhy_A           98 FLAEK------------ESLTEDEATQFLKQILDGVHYLH---SKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI  162 (283)
T ss_dssp             HHHHH------------SSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             HHHhc------------CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence            99653            23899999999999999999999   56999999999999998877    8999999999765


Q ss_pred             CCC-----------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          537 NDD-----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       537 ~~~-----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                      ...           ..+||....  ..++.++||||||+++|||++|+.||...
T Consensus       163 ~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~  214 (283)
T 3bhy_A          163 EAGNEFKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGE  214 (283)
T ss_dssp             C--------CCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             cCCCcccccCCCcCccCcceecC--CCCCcchhhhhHHHHHHHHHHCCCCCCCc
Confidence            322           234555433  45678899999999999999999999754

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=99.95  E-value=2.2e-28  Score=253.39  Aligned_cols=172  Identities=26%  Similarity=0.417  Sum_probs=140.8

Q ss_pred             eEEEEEEEE--CCeE----EEEEEcchhH----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          391 EGAVYHGRL--NGKN----LAIKRTEHEV----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~----vAvK~~~~~~----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      .|.||+|++  +|+.    ||+|.+....    ...+.+|+..+..++||||+++++++. + ...++||||+++|+|.+
T Consensus        26 ~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~-~~~~~v~e~~~~~~L~~  103 (325)
T 3kex_A           26 FGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-G-SSLQLVTQYLPLGSLLD  103 (325)
T ss_dssp             SCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-B-SSEEEEEECCTTCBSHH
T ss_pred             CceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-C-CccEEEEEeCCCCCHHH
Confidence            399999998  4544    7888764322    134567888899999999999999974 3 47899999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-  539 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-  539 (600)
                      ++....           ..+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++..... 
T Consensus       104 ~l~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~  169 (325)
T 3kex_A          104 HVRQHR-----------GALGPQLLLNWGVQIAKGMYYLE---EHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDD  169 (325)
T ss_dssp             HHHSSG-----------GGSCTTHHHHHHHHHHHHHHHHH---HTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCT
T ss_pred             HHHHcc-----------ccCCHHHHHHHHHHHHHHHHHHH---hCCCCCCccchheEEECCCCeEEECCCCcccccCccc
Confidence            997643           23899999999999999999999   568999999999999999999999999999865322 


Q ss_pred             -------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCCC
Q 041830          540 -------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRPR  580 (600)
Q Consensus       540 -------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~~  580 (600)
                                   +.+||....  ..++.++||||||+++|||++ |+.||....
T Consensus       170 ~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~el~~~g~~p~~~~~  222 (325)
T 3kex_A          170 KQLLYSEAKTPIKWMALESIHF--GKYTHQSDVWSYGVTVWELMTFGAEPYAGLR  222 (325)
T ss_dssp             TCCC-----CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred             ccccccCCCCcccccChHHhcc--CCCChhhHhHHhHHHHHHHHhCCCCCccccC
Confidence                         224444433  346788999999999999999 999997643

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=99.95  E-value=9.5e-28  Score=246.40  Aligned_cols=172  Identities=24%  Similarity=0.347  Sum_probs=144.4

Q ss_pred             EEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      |.||+++.  +|+.||+|++...     ....+.+|+..+..++||||+++++++... ...++||||+++++|.++++.
T Consensus        17 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~l~~~~~~   95 (311)
T 4agu_A           17 GVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRK-RRLHLVFEYCDHTVLHELDRY   95 (311)
T ss_dssp             EEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEECCSEEHHHHHHHT
T ss_pred             eEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCCCCCccchhheeecC-CeEEEEEEeCCCchHHHHHhh
Confidence            99999998  5899999986432     234567899999999999999999998655 488999999999999998875


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-----
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-----  539 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-----  539 (600)
                      ..            .+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....     
T Consensus        96 ~~------------~~~~~~~~~i~~~l~~~l~~lH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (311)
T 4agu_A           96 QR------------GVPEHLVKSITWQTLQAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD  160 (311)
T ss_dssp             SS------------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred             hc------------CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccC
Confidence            43            3899999999999999999999   669999999999999999999999999999765421     


Q ss_pred             -------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 -------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 -------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                             ..+||.... ...++.++||||||+++|||++|+.||....
T Consensus       161 ~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~il~~l~~g~~p~~~~~  207 (311)
T 4agu_A          161 DEVATRWYRSPELLVG-DTQYGPPVDVWAIGCVFAELLSGVPLWPGKS  207 (311)
T ss_dssp             -----GGGCCHHHHHT-CSCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             CCcCCccccChHHHhc-CCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence                   134555433 2456888999999999999999999997644

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=99.95  E-value=8e-28  Score=244.13  Aligned_cols=169  Identities=20%  Similarity=0.345  Sum_probs=140.6

Q ss_pred             EEEEEEEE--CC-------eEEEEEEcchh---HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHH
Q 041830          392 GAVYHGRL--NG-------KNLAIKRTEHE---VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       392 G~Vy~g~~--~g-------~~vAvK~~~~~---~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~  459 (600)
                      |.||+++.  ++       ..||+|.++..   ..+.+.+|+..+..++||||+++++++..+ +..++||||+++|+|.
T Consensus        22 g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~  100 (289)
T 4fvq_A           22 TKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCG-DENILVQEFVKFGSLD  100 (289)
T ss_dssp             EEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCT-TCCEEEEECCTTCBHH
T ss_pred             ceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeC-CCCEEEEECCCCCCHH
Confidence            99999987  33       57999997543   335678899999999999999999998655 4789999999999999


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCc--------EEEEecc
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFN--------ARVGNFG  531 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~--------~kI~DFG  531 (600)
                      +++....           ..+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.        +||+|||
T Consensus       101 ~~l~~~~-----------~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg  166 (289)
T 4fvq_A          101 TYLKKNK-----------NCINILWKLEVAKQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG  166 (289)
T ss_dssp             HHHHHTG-----------GGCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCC
T ss_pred             HHHHhCC-----------CCCCHHHHHHHHHHHHHHHHHHh---hCCeECCCcCcceEEEecCCcccccccceeeeccCc
Confidence            9997643           23899999999999999999999   668999999999999988877        9999999


Q ss_pred             CccccC--------CCCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCC
Q 041830          532 MARCVN--------DDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPI  576 (600)
Q Consensus       532 la~~~~--------~~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf  576 (600)
                      +++...        ..+.+||.... ...++.++||||||+++|||++|..|+
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~el~~g~~~~  218 (289)
T 4fvq_A          167 ISITVLPKDILQERIPWVPPECIEN-PKNLNLATDKWSFGTTLWEICSGGDKP  218 (289)
T ss_dssp             SCTTTSCHHHHHHTTTTSCHHHHHC-GGGCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred             ccccccCccccCCcCcccCHHHhCC-CCCCCchhHHHHHHHHHHHHHcCCCCC
Confidence            986542        23456776643 234688899999999999999955444

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=99.95  E-value=6.8e-28  Score=245.38  Aligned_cols=169  Identities=25%  Similarity=0.490  Sum_probs=140.8

Q ss_pred             EEEEEEEE----CCeEEEEEEcchhH-----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          392 GAVYHGRL----NGKNLAIKRTEHEV-----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       392 G~Vy~g~~----~g~~vAvK~~~~~~-----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      |.||++.+    .++.||||.++...     ...+.+|+..+..++||||+++++++ .. +..++||||+++|+|.+++
T Consensus        31 g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~-~~~~lv~e~~~~~~L~~~l  108 (291)
T 1xbb_A           31 GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGIC-EA-ESWMLVMEMAELGPLNKYL  108 (291)
T ss_dssp             EEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-ES-SSEEEEEECCTTEEHHHHH
T ss_pred             eeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-CC-CCcEEEEEeCCCCCHHHHH
Confidence            99999965    46889999986532     35678899999999999999999997 33 4789999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC---
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---  539 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~---  539 (600)
                      ....            .+++.+++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++.....   
T Consensus       109 ~~~~------------~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  173 (291)
T 1xbb_A          109 QQNR------------HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY  173 (291)
T ss_dssp             HHCT------------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE
T ss_pred             HhCc------------CCCHHHHHHHHHHHHHHHHHHH---hCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCc
Confidence            7643            3899999999999999999999   569999999999999999999999999999765332   


Q ss_pred             ------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          540 ------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       540 ------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                                  +.+||....  ..++.++||||||+++|||++ |+.||...
T Consensus       174 ~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~  224 (291)
T 1xbb_A          174 YKAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGM  224 (291)
T ss_dssp             EEC----CCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             ccccccCCCCceeeChHHhcc--CCCChhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence                        223444332  345678999999999999999 99999754

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=99.95  E-value=7.4e-28  Score=259.59  Aligned_cols=168  Identities=24%  Similarity=0.426  Sum_probs=138.9

Q ss_pred             EEEEEEEE--CCeEEEEEEcch-----hHHHHHHHHHHHHHhCCCCceeeeeeEEeccC----CceEEEEeecCCCCHHH
Q 041830          392 GAVYHGRL--NGKNLAIKRTEH-----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDG----PHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~-----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~----~~~~LV~Ey~~~GsL~~  460 (600)
                      |.||+++.  +|+.||||+++.     ...+.+.+|+..+..++||||+++++++....    ...|+||||++ |+|.+
T Consensus        40 g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~  118 (432)
T 3n9x_A           40 GYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKK  118 (432)
T ss_dssp             EEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHH
T ss_pred             EEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHH
Confidence            99999998  689999999854     22356788999999999999999999976543    46899999997 59999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-  539 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-  539 (600)
                      +++...            .+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..... 
T Consensus       119 ~~~~~~------------~l~~~~~~~i~~qil~aL~~LH---~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~  183 (432)
T 3n9x_A          119 LFKTPI------------FLTEEHIKTILYNLLLGENFIH---ESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEK  183 (432)
T ss_dssp             HHHSSC------------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEEC----
T ss_pred             HHhccC------------CCCHHHHHHHHHHHHHHHHHHH---HCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccc
Confidence            997543            3899999999999999999999   569999999999999999999999999999865321 


Q ss_pred             ---------------------------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCC
Q 041830          540 ---------------------------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPI  576 (600)
Q Consensus       540 ---------------------------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf  576 (600)
                                                       +.+||.... ...++.++|||||||++|||++|..||
T Consensus       184 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~-~~~~~~~~DiwSlG~il~ell~g~~p~  252 (432)
T 3n9x_A          184 DTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL-QENYTKSIDIWSTGCIFAELLNMLQSH  252 (432)
T ss_dssp             ---------------------------CCCCCTTCCHHHHTT-CSCCCTHHHHHHHHHHHHHHHTTCTTT
T ss_pred             cccccccccccccccccccchhccccCCCCCccccCHHHHhc-CCCCCcccccchHHHHHHHHHhccccc
Confidence                                             235665432 245788999999999999999855544

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=99.95  E-value=1.3e-27  Score=245.75  Aligned_cols=172  Identities=26%  Similarity=0.422  Sum_probs=144.9

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH-HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcC
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV-ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLA  467 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~-~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~  467 (600)
                      .|.||++..  +|+.||+|.+..+. ...+.+|+..+..++||||+++++++..+ ...++||||+++|+|.+++.... 
T Consensus        42 ~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~-  119 (314)
T 3com_A           42 YGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSYFKN-TDLWIVMEYCGAGSVSDIIRLRN-  119 (314)
T ss_dssp             -CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEEEECCTTEEHHHHHHHHT-
T ss_pred             CeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeC-CEEEEEeecCCCCCHHHHHHhcC-
Confidence            489999998  58999999986532 35678899999999999999999998765 48899999999999999996322 


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--------
Q 041830          468 MKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--------  539 (600)
Q Consensus       468 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--------  539 (600)
                                ..+++.+++.++.+++.||.|||   +.+++||||||+||+++.++.+||+|||+++.....        
T Consensus       120 ----------~~~~~~~~~~i~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  186 (314)
T 3com_A          120 ----------KTLTEDEIATILQSTLKGLEYLH---FMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVI  186 (314)
T ss_dssp             ----------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCCCC
T ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHH---hCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCccC
Confidence                      34899999999999999999999   569999999999999999999999999999754322        


Q ss_pred             ----CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 ----TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 ----~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                          +.+||....  ..++.++||||||+++|||++|+.||...
T Consensus       187 ~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~  228 (314)
T 3com_A          187 GTPFWMAPEVIQE--IGYNCVADIWSLGITAIEMAEGKPPYADI  228 (314)
T ss_dssp             SCGGGCCHHHHSS--SCBCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             CCCCccChhhcCC--CCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence                124554433  34678899999999999999999999753

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=4.1e-28  Score=252.88  Aligned_cols=183  Identities=26%  Similarity=0.420  Sum_probs=143.5

Q ss_pred             EEEEEEEE-------CCeEEEEEEcchhH----HHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCCHH
Q 041830          392 GAVYHGRL-------NGKNLAIKRTEHEV----ITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       392 G~Vy~g~~-------~g~~vAvK~~~~~~----~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~  459 (600)
                      |.||+++.       ++..||+|.++...    ...+.+|+..+..+ .||||+++++++... ...++||||+++|+|.
T Consensus        59 g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-~~~~lv~e~~~~g~L~  137 (344)
T 1rjb_A           59 GKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS-GPIYLIFEYCCYGDLL  137 (344)
T ss_dssp             EEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSCEEEEECCTTCBHH
T ss_pred             ceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeC-CccEEEEecCCCCcHH
Confidence            99999997       35679999986432    24577899999998 899999999998655 4889999999999999


Q ss_pred             HHHhcCcCcccc-----------cccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEE
Q 041830          460 DWLHGGLAMKNQ-----------FIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVG  528 (600)
Q Consensus       460 ~~L~~~~~~~~~-----------~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~  528 (600)
                      +++.........           ........+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+
T Consensus       138 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~  214 (344)
T 1rjb_A          138 NYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKIC  214 (344)
T ss_dssp             HHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGGGEEEETTTEEEEC
T ss_pred             HHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCChhhEEEcCCCcEEeC
Confidence            999764321000           00000134899999999999999999999   6699999999999999999999999


Q ss_pred             eccCccccCCC--------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCCC
Q 041830          529 NFGMARCVNDD--------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRPR  580 (600)
Q Consensus       529 DFGla~~~~~~--------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~~  580 (600)
                      |||+++.....              +.+||....  ..++.++||||||+++|||+| |+.||....
T Consensus       215 Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~  279 (344)
T 1rjb_A          215 DFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  279 (344)
T ss_dssp             CCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             CCccCcccccCccceeccCccCccCccCHHHhcc--CCCChhHhHHHHHHHHHHHHcCCCCCcccCC
Confidence            99999754321              334555443  346788999999999999998 999997644

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=99.95  E-value=8.1e-28  Score=249.64  Aligned_cols=172  Identities=22%  Similarity=0.350  Sum_probs=141.7

Q ss_pred             EEEEEEEE--CCeEEEEEEcch-----hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          392 GAVYHGRL--NGKNLAIKRTEH-----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~-----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      |.||+++.  +|+.||+|++..     .....+.+|+..+..++||||+++++++... ...++||||+++++|.+++..
T Consensus        39 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~l~~~~~~  117 (331)
T 4aaa_A           39 GMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKK-KRWYLVFEFVDHTILDDLELF  117 (331)
T ss_dssp             SSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEECCSEEHHHHHHHS
T ss_pred             EEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecC-CEEEEEEecCCcchHHHHHhh
Confidence            89999998  589999998643     2234567899999999999999999998655 488999999999999988764


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC------
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND------  538 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~------  538 (600)
                      ..            .+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....      
T Consensus       118 ~~------------~~~~~~~~~~~~qi~~~l~~LH---~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  182 (331)
T 4aaa_A          118 PN------------GLDYQVVQKYLFQIINGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYD  182 (331)
T ss_dssp             TT------------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCTTC-----------
T ss_pred             cc------------CCCHHHHHHHHHHHHHHHHHHH---HCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCccccC
Confidence            32            3899999999999999999999   56999999999999999999999999999975432      


Q ss_pred             ------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          539 ------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       539 ------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                            .+.+||.... ...++.++|||||||++|||++|+.||....
T Consensus       183 ~~~~t~~y~aPE~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  229 (331)
T 4aaa_A          183 DEVATRWYRAPELLVG-DVKYGKAVDVWAIGCLVTEMFMGEPLFPGDS  229 (331)
T ss_dssp             -CCCCCTTCCHHHHTT-CTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             CCcCCccccCcccccC-CCCcchHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                  1235665543 2356788999999999999999999997644

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=99.95  E-value=8.3e-28  Score=242.89  Aligned_cols=171  Identities=23%  Similarity=0.494  Sum_probs=142.7

Q ss_pred             EEEEEEEE-CCeEEEEEEcchh--HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcCc
Q 041830          392 GAVYHGRL-NGKNLAIKRTEHE--VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM  468 (600)
Q Consensus       392 G~Vy~g~~-~g~~vAvK~~~~~--~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~  468 (600)
                      |.||+++. ++..||+|.++..  ..+.+.+|+..+..++||||+++++++. + +..++||||+++|+|.+++..... 
T Consensus        27 g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~-~~~~~v~e~~~~~~L~~~l~~~~~-  103 (279)
T 1qpc_A           27 GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-Q-EPIYIITEYMENGSLVDFLKTPSG-  103 (279)
T ss_dssp             EEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-S-SSCEEEEECCTTCBHHHHTTSHHH-
T ss_pred             eEEEEEEEcCCcEEEEEEecCCcccHHHHHHHHHHHHhCCCcCcceEEEEEc-C-CCcEEEEecCCCCCHHHHHhcCCC-
Confidence            99999999 5678999998653  2356788999999999999999999964 3 368999999999999999965321 


Q ss_pred             ccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC---------
Q 041830          469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---------  539 (600)
Q Consensus       469 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~---------  539 (600)
                               ..+++.+++.++.|++.||.|||   +.+++||||||+||++++++.+||+|||+++.....         
T Consensus       104 ---------~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~  171 (279)
T 1qpc_A          104 ---------IKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAK  171 (279)
T ss_dssp             ---------HTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTCC
T ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccccCCC
Confidence                     24899999999999999999999   569999999999999999999999999999765322         


Q ss_pred             ----CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          540 ----TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       540 ----~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                          ..+||....  ..++.++||||||+++|||++ |+.||...
T Consensus       172 ~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~  214 (279)
T 1qpc_A          172 FPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTHGRIPYPGM  214 (279)
T ss_dssp             CCTTTSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             CccCccChhhhcc--CCCCchhhhHHHHHHHHHHHhCCCCCCccc
Confidence                234444432  345778999999999999999 99999753

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=99.95  E-value=7.4e-28  Score=243.66  Aligned_cols=170  Identities=25%  Similarity=0.460  Sum_probs=140.2

Q ss_pred             EEEEEEEEC-----CeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          392 GAVYHGRLN-----GKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       392 G~Vy~g~~~-----g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      |.||+|++.     +..||+|.++..    ....+.+|+..+..++||||+++++++. + +..++||||+++|+|.+++
T Consensus        26 g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~-~~~~~v~e~~~~~~L~~~l  103 (281)
T 3cc6_A           26 GEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIVKLIGIIE-E-EPTWIIMELYPYGELGHYL  103 (281)
T ss_dssp             SEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHCCTTBCCEEEEEC-S-SSCEEEEECCTTCBHHHHH
T ss_pred             eeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCCCCCcceEEEEEc-C-CCCEEEEecCCCCCHHHHH
Confidence            899999872     235999998653    3456788999999999999999999964 3 3679999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC---
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---  539 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~---  539 (600)
                      ....           ..+++.+++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++.....   
T Consensus       104 ~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  169 (281)
T 3cc6_A          104 ERNK-----------NSLKVLTLVLYSLQICKAMAYLE---SINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY  169 (281)
T ss_dssp             HHHT-----------TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC------
T ss_pred             Hhcc-----------ccCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCccceEEECCCCcEEeCccCCCccccccccc
Confidence            7532           34899999999999999999999   669999999999999999999999999998754321   


Q ss_pred             ----------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          540 ----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       540 ----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                                +.+||....  ..++.++||||||+++|||++ |+.||...
T Consensus       170 ~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~llt~g~~p~~~~  218 (281)
T 3cc6_A          170 KASVTRLPIKWMSPESINF--RRFTTASDVWMFAVCMWEILSFGKQPFFWL  218 (281)
T ss_dssp             ---CCCCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             ccccCCCCcceeCchhhcc--CCCCchhccHHHHHHHHHHHhCCCCCcccC
Confidence                      234554433  346788999999999999998 99999653

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=99.95  E-value=1.6e-27  Score=241.26  Aligned_cols=170  Identities=27%  Similarity=0.416  Sum_probs=142.3

Q ss_pred             EEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      |.||++..  +|+.||+|.+...     ....+++|+..+..++||||+++++++..+ ...++||||+++|+|.+++..
T Consensus        20 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~~v~e~~~~~~l~~~~~~   98 (284)
T 3kk8_A           20 SVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEE-SFHYLVFDLVTGGELFEDIVA   98 (284)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHHHH
T ss_pred             eEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcC-CEEEEEEecCCCCCHHHHHHh
Confidence            99999998  6899999987543     234677899999999999999999998655 478999999999999998865


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCc---EEEEeccCccccCCC--
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFN---ARVGNFGMARCVNDD--  539 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~---~kI~DFGla~~~~~~--  539 (600)
                      ..            .+++.++..++.|++.||.|||   +.+|+||||||+||+++.++.   +||+|||++......  
T Consensus        99 ~~------------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~  163 (284)
T 3kk8_A           99 RE------------FYSEADASHCIQQILESIAYCH---SNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA  163 (284)
T ss_dssp             HS------------SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB
T ss_pred             cC------------CCCHHHHHHHHHHHHHHHHHHH---HCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc
Confidence            32            3899999999999999999999   569999999999999976655   999999999755432  


Q ss_pred             ---------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 ---------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 ---------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                               ..+||....  ..++.++||||||+++|||++|+.||...
T Consensus       164 ~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~~l~~l~~g~~pf~~~  210 (284)
T 3kk8_A          164 WHGFAGTPGYLSPEVLKK--DPYSKPVDIWACGVILYILLVGYPPFWDE  210 (284)
T ss_dssp             CCCSCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccCCCCCcCCcCchhhcC--CCCCcccchHHHHHHHHHHHHCCCCCCCC
Confidence                     124555443  45678899999999999999999999653

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=99.95  E-value=9.6e-28  Score=241.74  Aligned_cols=173  Identities=23%  Similarity=0.417  Sum_probs=143.9

Q ss_pred             EEEEEEEE--CCeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcC
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGG  465 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~  465 (600)
                      |.||+++.  +|+.||+|.++..    ..+.+.+|+..+..++||||+++++++... ...++||||+++|+|.+++...
T Consensus        21 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~   99 (276)
T 2yex_A           21 GEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG-NIQYLFLEYCSGGELFDRIEPD   99 (276)
T ss_dssp             SEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEEEECCTTEEGGGGSBTT
T ss_pred             cEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcCCCCceeeeeEEEcC-CEEEEEEEecCCCcHHHHHhhc
Confidence            89999998  6899999997542    235678899999999999999999998655 4889999999999999988643


Q ss_pred             cCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC-------
Q 041830          466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND-------  538 (600)
Q Consensus       466 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~-------  538 (600)
                      .            .+++.+++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++.....       
T Consensus       100 ~------------~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  164 (276)
T 2yex_A          100 I------------GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLL  164 (276)
T ss_dssp             T------------BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCB
T ss_pred             c------------CCCHHHHHHHHHHHHHHHHHHH---hCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcc
Confidence            2            3899999999999999999999   56999999999999999999999999999875321       


Q ss_pred             -------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCCC
Q 041830          539 -------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRK  581 (600)
Q Consensus       539 -------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~  581 (600)
                             ...+||..... ...+.++||||||+++|||++|+.||.....
T Consensus       165 ~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~p~~~~~~  213 (276)
T 2yex_A          165 NKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSD  213 (276)
T ss_dssp             CCCCSCGGGCCGGGGTCS-SBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT
T ss_pred             cCCccccCccChHHHhcC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Confidence                   12355554432 2236679999999999999999999976543

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=99.95  E-value=1e-27  Score=248.22  Aligned_cols=170  Identities=20%  Similarity=0.332  Sum_probs=143.9

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhHHHHHHHHHHHHHhCC-CCceeeeeeEEecc-CCceEEEEeecCCCCHHHHHhcCcC
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEVITKLEMQLVQHATHH-HPNIVRLLGTCLTD-GPHSFLVFEYAKNGSLKDWLHGGLA  467 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~~~~~e~ei~~~~~l~-HpNIv~l~g~~~~~-~~~~~LV~Ey~~~GsL~~~L~~~~~  467 (600)
                      |.||+++.  +|+.||||.++....+.+.+|+..+..+. ||||+++++++... ....++||||+++++|.++++.   
T Consensus        50 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~---  126 (330)
T 3nsz_A           50 SEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---  126 (330)
T ss_dssp             EEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGGG---
T ss_pred             eEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHHh---
Confidence            99999987  78999999998766677889999999987 99999999998653 3468999999999999998842   


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC-cEEEEeccCccccCCCC------
Q 041830          468 MKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEF-NARVGNFGMARCVNDDT------  540 (600)
Q Consensus       468 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~-~~kI~DFGla~~~~~~~------  540 (600)
                                  +++.++..++.|++.||+|||   +.+|+||||||+|||++.++ .+||+|||+++......      
T Consensus       127 ------------~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~  191 (330)
T 3nsz_A          127 ------------LTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV  191 (330)
T ss_dssp             ------------CCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSCC
T ss_pred             ------------CCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCcccccc
Confidence                        889999999999999999999   66999999999999999776 89999999998654321      


Q ss_pred             -----CCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          541 -----ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       541 -----~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                           .+||.... ...++.++|||||||++|||++|+.||....
T Consensus       192 ~~~~y~aPE~~~~-~~~~~~~~DiwslG~il~~ll~g~~p~~~~~  235 (330)
T 3nsz_A          192 ASRYFKGPELLVD-YQMYDYSLDMWSLGCMLASMIFRKEPFFHGH  235 (330)
T ss_dssp             SCGGGCCHHHHTT-CCCCCTHHHHHHHHHHHHHHHHTCSSSSCCS
T ss_pred             ccccccChhhhcC-CCcCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence                 24444432 2457888999999999999999999996543

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=99.95  E-value=7.4e-28  Score=244.95  Aligned_cols=171  Identities=28%  Similarity=0.519  Sum_probs=136.2

Q ss_pred             EEEEEEEECCeEEEEEEcch-----hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCc
Q 041830          392 GAVYHGRLNGKNLAIKRTEH-----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGL  466 (600)
Q Consensus       392 G~Vy~g~~~g~~vAvK~~~~-----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~  466 (600)
                      |.||+|+..+ .||+|.++.     ...+.+.+|+..+..++||||+++++++ .. ...++||||+++++|.+++....
T Consensus        38 g~Vy~~~~~~-~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~-~~~~lv~e~~~~~~L~~~l~~~~  114 (289)
T 3og7_A           38 GTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TA-PQLAIVTQWCEGSSLYHHLHASE  114 (289)
T ss_dssp             EEEEEEESSS-EEEEEEESCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CS-SSCEEEEECCCEEEHHHHHTTC-
T ss_pred             eEEEEEEEcC-ceEEEEEeccCCCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cC-CccEEEEEecCCCcHHHHHhhcc
Confidence            9999998765 499998753     3345678899999999999999999975 33 46899999999999999996543


Q ss_pred             CcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC--------
Q 041830          467 AMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND--------  538 (600)
Q Consensus       467 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~--------  538 (600)
                                 ..+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....        
T Consensus       115 -----------~~~~~~~~~~i~~qi~~~L~~lH---~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  180 (289)
T 3og7_A          115 -----------TKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFE  180 (289)
T ss_dssp             -------------CCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTTEEEECCCC---------------
T ss_pred             -----------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEEccceecccccccccccccc
Confidence                       34899999999999999999999   56999999999999999999999999999864321        


Q ss_pred             ------CCCCCccccc-CCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 ------DTESPQFYST-NPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 ------~~~~pe~~~~-~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                            .+.+||.... ....++.++||||||+++|||++|+.||...
T Consensus       181 ~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  228 (289)
T 3og7_A          181 QLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNI  228 (289)
T ss_dssp             ---CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred             ccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCcccc
Confidence                  2235665432 1345677899999999999999999999754

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=99.95  E-value=4.6e-28  Score=248.77  Aligned_cols=183  Identities=22%  Similarity=0.410  Sum_probs=144.2

Q ss_pred             EEEEEEEE-------CCeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          392 GAVYHGRL-------NGKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       392 G~Vy~g~~-------~g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      |.||++..       +++.||||.++..    ....+.+|+..+..++||||+++++++..+ ...++||||+++|+|.+
T Consensus        37 g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~  115 (314)
T 2ivs_A           37 GKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQD-GPLLLIVEYAKYGSLRG  115 (314)
T ss_dssp             SEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSS-SSCEEEEECCTTCBHHH
T ss_pred             eeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCceeeEEEEEecC-CceEEEEeecCCCCHHH
Confidence            89999986       3478999998642    235678899999999999999999997655 47899999999999999


Q ss_pred             HHhcCcCcccc------------cccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEE
Q 041830          461 WLHGGLAMKNQ------------FIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVG  528 (600)
Q Consensus       461 ~L~~~~~~~~~------------~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~  528 (600)
                      ++.........            ........+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+
T Consensus       116 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dikp~NIli~~~~~~kl~  192 (314)
T 2ivs_A          116 FLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLA---EMKLVHRDLAARNILVAEGRKMKIS  192 (314)
T ss_dssp             HHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTEEEEC
T ss_pred             HHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHH---HCCCcccccchheEEEcCCCCEEEc
Confidence            99764321000            00001134899999999999999999999   5699999999999999999999999


Q ss_pred             eccCccccCCC--------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCCC
Q 041830          529 NFGMARCVNDD--------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRPR  580 (600)
Q Consensus       529 DFGla~~~~~~--------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~~  580 (600)
                      |||+++.....              +.+||....  ..++.++||||||+++|||++ |+.||....
T Consensus       193 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~  257 (314)
T 2ivs_A          193 DFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFD--HIYTTQSDVWSFGVLLWEIVTLGGNPYPGIP  257 (314)
T ss_dssp             CCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             cccccccccccccceeccCCCCcccccChhhhcC--CCcCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence            99999755322              223444332  346778999999999999999 999997543

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=99.95  E-value=1.6e-27  Score=243.89  Aligned_cols=161  Identities=20%  Similarity=0.333  Sum_probs=135.6

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhHHHHHHHHHHHH-HhCCCCceeeeeeEEec---cCCceEEEEeecCCCCHHHHHhcC
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEVITKLEMQLVQH-ATHHHPNIVRLLGTCLT---DGPHSFLVFEYAKNGSLKDWLHGG  465 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~~~~~e~ei~~~-~~l~HpNIv~l~g~~~~---~~~~~~LV~Ey~~~GsL~~~L~~~  465 (600)
                      |.||++..  +|+.||+|.++...  ...+|+..+ ....||||+++++++..   +....++||||+++|+|.+++...
T Consensus        32 g~V~~~~~~~~~~~vaiK~~~~~~--~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~  109 (299)
T 3m2w_A           32 GKVLQIFNKRTQEKFALKMLQDCP--KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR  109 (299)
T ss_dssp             EEEEEEEETTTCCEEEEEEEECSH--HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHC
T ss_pred             eEEEEEEEcCCCcEEEEEEecccH--HHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhc
Confidence            99999998  78999999987643  345566555 55689999999999764   134689999999999999999764


Q ss_pred             cCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC---CCcEEEEeccCccccCCCCCC
Q 041830          466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE---EFNARVGNFGMARCVNDDTES  542 (600)
Q Consensus       466 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~---~~~~kI~DFGla~~~~~~~~~  542 (600)
                      ..          ..+++.+++.++.|++.||.|||   +.+|+||||||+|||++.   ++.+||+|||+++....    
T Consensus       110 ~~----------~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~----  172 (299)
T 3m2w_A          110 GD----------QAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG----  172 (299)
T ss_dssp             TT----------CCCBHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT----
T ss_pred             cC----------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCHHHEEEecCCCCCcEEEecccccccccc----
Confidence            32          34899999999999999999999   669999999999999998   78999999999875532    


Q ss_pred             CcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          543 PQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       543 pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                              ..++.++|||||||++|||++|+.||...
T Consensus       173 --------~~~~~~~DiwslG~il~el~tg~~pf~~~  201 (299)
T 3m2w_A          173 --------EKYDKSCDMWSLGVIMYILLCGYPPFYSN  201 (299)
T ss_dssp             --------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-
T ss_pred             --------ccCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence                    34677899999999999999999999653

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=99.95  E-value=3.7e-28  Score=257.66  Aligned_cols=176  Identities=19%  Similarity=0.288  Sum_probs=141.4

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhHHHHHHHHHHHHHhCCCCceeeeeeEEeccC-------------------------
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDG-------------------------  443 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~-------------------------  443 (600)
                      .|.||+++.  +|+.||||++..+. ....+|+..+..++||||+++++++...+                         
T Consensus        20 fg~V~~a~~~~~~~~vAiK~~~~~~-~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   98 (383)
T 3eb0_A           20 FGIVCEVFDIESGKRFALKKVLQDP-RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNN   98 (383)
T ss_dssp             CEEEEEEEETTTCCEEEEEEEECCT-TSCCHHHHHHTTCCCTTBCCEEEEEEEC--------------------------
T ss_pred             CEEEEEEEECCCCCEEEEEEEecCc-chHHHHHHHHHHcCCCCccchhheeeecCccccccccccccccccccccccccc
Confidence            499999988  78999999986654 33357888899999999999999985432                         


Q ss_pred             ------------CceEEEEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecC
Q 041830          444 ------------PHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRN  511 (600)
Q Consensus       444 ------------~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrD  511 (600)
                                  ...++||||++ |+|.+.+......        ...+++..+..++.|+++||.|||   +.+|+|||
T Consensus        99 ~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~--------~~~l~~~~~~~i~~qi~~aL~~LH---~~gi~H~D  166 (383)
T 3eb0_A           99 HHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRS--------GRSIPMNLISIYIYQLFRAVGFIH---SLGICHRD  166 (383)
T ss_dssp             -----------CCEEEEEECCCS-EEHHHHHHHHHHT--------TCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSC
T ss_pred             ccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhc--------CCCCCHHHHHHHHHHHHHHHHHHH---HCcCccCc
Confidence                        23789999998 5888877642110        134999999999999999999999   77999999


Q ss_pred             CCCCCEEeC-CCCcEEEEeccCccccCCC-----------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          512 IKSRNIFLD-EEFNARVGNFGMARCVNDD-----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       512 Lk~~NILld-~~~~~kI~DFGla~~~~~~-----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                      |||+|||++ .++.+||+|||+++.....           +.+||.... ...++.++|||||||++|||++|+.||...
T Consensus       167 ikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~  245 (383)
T 3eb0_A          167 IKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLG-ATEYTPSIDLWSIGCVFGELILGKPLFSGE  245 (383)
T ss_dssp             CCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTT-CSSCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcC-CCCCCcchhhhhHHHHHHHHHhCCCCCCCC
Confidence            999999997 6899999999999865322           234554432 234788999999999999999999999764


Q ss_pred             C
Q 041830          580 R  580 (600)
Q Consensus       580 ~  580 (600)
                      +
T Consensus       246 ~  246 (383)
T 3eb0_A          246 T  246 (383)
T ss_dssp             S
T ss_pred             C
Confidence            3

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=99.95  E-value=7e-28  Score=251.41  Aligned_cols=175  Identities=21%  Similarity=0.392  Sum_probs=145.9

Q ss_pred             EEEEEEEECCeEEEEEEcchhHH--------------------HHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEe
Q 041830          392 GAVYHGRLNGKNLAIKRTEHEVI--------------------TKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFE  451 (600)
Q Consensus       392 G~Vy~g~~~g~~vAvK~~~~~~~--------------------~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~E  451 (600)
                      |.||+++.+|+.||+|.+.....                    ..+.+|+..+..++||||+++++++..+ +..++|||
T Consensus        45 g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e  123 (348)
T 2pml_X           45 NKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNY-DEVYIIYE  123 (348)
T ss_dssp             CCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEESS-SEEEEEEE
T ss_pred             eEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEeeC-CeEEEEEe
Confidence            89999999999999999865432                    5678899999999999999999998665 48999999


Q ss_pred             ecCCCCHHHH------HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcE
Q 041830          452 YAKNGSLKDW------LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNA  525 (600)
Q Consensus       452 y~~~GsL~~~------L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~  525 (600)
                      |+++|+|.++      +....          ...+++.+++.++.|++.||.|||+  ..+++||||||+||+++.++.+
T Consensus       124 ~~~~~~L~~~~~~~~~l~~~~----------~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~~~~~~  191 (348)
T 2pml_X          124 YMENDSILKFDEYFFVLDKNY----------TCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRV  191 (348)
T ss_dssp             CCTTCBSSEESSSEESSCSSS----------CCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEECTTSCE
T ss_pred             ccCCCcHHHHHHHhhhhhhcc----------ccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEcCCCcE
Confidence            9999999998      43321          1459999999999999999999994  2799999999999999999999


Q ss_pred             EEEeccCccccCCC----------CCCCcccccCCCCCCc-cCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          526 RVGNFGMARCVNDD----------TESPQFYSTNPASWSM-GIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       526 kI~DFGla~~~~~~----------~~~pe~~~~~~~~~t~-~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                      ||+|||+++.....          ..+||...... .++. ++||||||+++|||++|+.||....
T Consensus       192 kl~dfg~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~~  256 (348)
T 2pml_X          192 KLSDFGESEYMVDKKIKGSRGTYEFMPPEFFSNES-SYNGAKVDIWSLGICLYVMFYNVVPFSLKI  256 (348)
T ss_dssp             EECCCTTCEECBTTEECSSCSCGGGCCGGGGSSCC-CEEHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             EEeccccccccccccccCCCCCcCccCchhhcCCC-CCCcchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            99999999764321          23566654421 3444 8999999999999999999997643

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=99.95  E-value=2.1e-27  Score=244.22  Aligned_cols=179  Identities=22%  Similarity=0.468  Sum_probs=138.7

Q ss_pred             eEEEEEEEE-----CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCC----ceEEEEeecCCC
Q 041830          391 EGAVYHGRL-----NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGP----HSFLVFEYAKNG  456 (600)
Q Consensus       391 ~G~Vy~g~~-----~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~----~~~LV~Ey~~~G  456 (600)
                      .|.||+++.     ++..||+|.++..     ....+.+|+..+..++||||+++++++...+.    ..++||||+++|
T Consensus        47 ~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~  126 (313)
T 3brb_A           47 FGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYG  126 (313)
T ss_dssp             CCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTC
T ss_pred             CeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCC
Confidence            389999987     2357999997532     23567889999999999999999999875432    359999999999


Q ss_pred             CHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCcccc
Q 041830          457 SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV  536 (600)
Q Consensus       457 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~  536 (600)
                      +|.+++........      ...+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       127 ~L~~~l~~~~~~~~------~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~  197 (313)
T 3brb_A          127 DLHTYLLYSRLETG------PKHIPLQTLLKFMVDIALGMEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKI  197 (313)
T ss_dssp             BHHHHHHHTTBTTS------CCCCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCSGGGEEECTTSCEEECSCSCC---
T ss_pred             CHHHHHHHhhhhcC------CccCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEEeecCcceec
Confidence            99999964321111      145999999999999999999999   779999999999999999999999999999754


Q ss_pred             CCC--------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCCC
Q 041830          537 NDD--------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRPR  580 (600)
Q Consensus       537 ~~~--------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~~  580 (600)
                      ...              +.+||....  ..++.++||||||+++|||++ |+.||....
T Consensus       198 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~~  254 (313)
T 3brb_A          198 YSGDYYRQGRIAKMPVKWIAIESLAD--RVYTSKSDVWAFGVTMWEIATRGMTPYPGVQ  254 (313)
T ss_dssp             -------------CCGGGSCHHHHHS--SCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             ccccccCcccccCCCccccCchhhcC--CCccchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence            321              123444433  456788999999999999999 899997543

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=99.95  E-value=1e-27  Score=243.88  Aligned_cols=173  Identities=20%  Similarity=0.252  Sum_probs=142.0

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhH-HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcCc
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEV-ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM  468 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~-~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~  468 (600)
                      |.||+++.  +|+.||||...... ...+.+|+..+..+.|+|++..++.+..++...++||||+ +|+|.+++....  
T Consensus        23 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--   99 (296)
T 4hgt_A           23 GDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCS--   99 (296)
T ss_dssp             SEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT--
T ss_pred             eEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhc--
Confidence            89999996  78999999865433 2356788888888889998888888776666889999999 999999997533  


Q ss_pred             ccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEe---CCCCcEEEEeccCccccCCCC-----
Q 041830          469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFL---DEEFNARVGNFGMARCVNDDT-----  540 (600)
Q Consensus       469 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl---d~~~~~kI~DFGla~~~~~~~-----  540 (600)
                               ..+++.+++.++.|++.||.|||   +.+|+||||||+|||+   +.++.+||+|||+++......     
T Consensus       100 ---------~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~  167 (296)
T 4hgt_A          100 ---------RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI  167 (296)
T ss_dssp             ---------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBC
T ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccC
Confidence                     23899999999999999999999   5699999999999999   788999999999997653321     


Q ss_pred             --------------CCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCCC
Q 041830          541 --------------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRK  581 (600)
Q Consensus       541 --------------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~  581 (600)
                                    .+||....  ..++.++|||||||++|||++|+.||...+.
T Consensus       168 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~~  220 (296)
T 4hgt_A          168 PYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKA  220 (296)
T ss_dssp             CCCCSCCCCSCGGGCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred             CCCcccccCCCccccchHHhcC--CCCCchhHHHHHHHHHHHHhcCCCCCcccch
Confidence                          23444333  3467889999999999999999999986543

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=99.95  E-value=5e-28  Score=244.35  Aligned_cols=179  Identities=27%  Similarity=0.403  Sum_probs=143.9

Q ss_pred             EEEEEEEE--CCeEEEEEEcch-----hHHHHHHHHHHHHHhCCCCceeeeeeEEec-cCCceEEEEeecCCCCHHHHHh
Q 041830          392 GAVYHGRL--NGKNLAIKRTEH-----EVITKLEMQLVQHATHHHPNIVRLLGTCLT-DGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~-----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~-~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      |.||+++.  +|+.||+|.+..     ...+.+.+|+..+..++||||+++++++.. .+...++||||+++|+|.+++.
T Consensus        20 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~   99 (279)
T 2w5a_A           20 GRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVIT   99 (279)
T ss_dssp             SEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHH
T ss_pred             cEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHH
Confidence            89999998  689999998753     233567889999999999999999998764 3347899999999999999997


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcC--CCCceecCCCCCCEEeCCCCcEEEEeccCccccCC---
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM--NPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND---  538 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~---  538 (600)
                      .....        ...+++.+++.++.|++.||.|||+..  ..+++||||||+||+++.++.+||+|||+++....   
T Consensus       100 ~~~~~--------~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~  171 (279)
T 2w5a_A          100 KGTKE--------RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS  171 (279)
T ss_dssp             HHHHT--------TCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CH
T ss_pred             hhccc--------CCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeeccccc
Confidence            53211        134899999999999999999999541  02299999999999999999999999999875432   


Q ss_pred             ---------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          539 ---------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       539 ---------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                               ...+||....  ..++.++||||||+++|||++|+.||...+
T Consensus       172 ~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~~  220 (279)
T 2w5a_A          172 FAKTFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAFS  220 (279)
T ss_dssp             HHHHHHSCCTTCCHHHHHC--C-CCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cccccCCCccccChHHhcc--CCCCchhhHHHHHHHHHHHHHCCCCCcccC
Confidence                     2446666554  356788999999999999999999997643

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=99.95  E-value=1.4e-27  Score=244.42  Aligned_cols=169  Identities=27%  Similarity=0.472  Sum_probs=144.2

Q ss_pred             EEEEEEEE--CCeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcC
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGG  465 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~  465 (600)
                      |.||+|+.  +|+.||+|.++..    ....+.+|+..+..++||||+++++++..+ ...++||||+++++|.+++...
T Consensus        36 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~  114 (303)
T 3a7i_A           36 GEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKD-TKLWIIMEYLGGGSALDLLEPG  114 (303)
T ss_dssp             SEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEECCTTEEHHHHHTTS
T ss_pred             eEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-CeEEEEEEeCCCCcHHHHHhcC
Confidence            89999988  6899999997542    345678899999999999999999998765 4889999999999999999642


Q ss_pred             cCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC------
Q 041830          466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD------  539 (600)
Q Consensus       466 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~------  539 (600)
                                   .+++.+++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++.....      
T Consensus       115 -------------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  178 (303)
T 3a7i_A          115 -------------PLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT  178 (303)
T ss_dssp             -------------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBCC
T ss_pred             -------------CCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCChheEEECCCCCEEEeecccceecCccccccCc
Confidence                         3899999999999999999999   569999999999999999999999999999755322      


Q ss_pred             ------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 ------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 ------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                            +.+||....  ..++.++||||||+++|||++|+.||...
T Consensus       179 ~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~~~  222 (303)
T 3a7i_A          179 FVGTPFWMAPEVIKQ--SAYDSKADIWSLGITAIELARGEPPHSEL  222 (303)
T ss_dssp             CCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             cCCCcCccCHHHHhc--CCCCchhhhHHHHHHHHHHccCCCCCCCc
Confidence                  124555433  45677899999999999999999999753

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=99.95  E-value=7.5e-28  Score=252.77  Aligned_cols=172  Identities=22%  Similarity=0.345  Sum_probs=145.7

Q ss_pred             EEEEEEEE--CCeEEEEEEcch----hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcC
Q 041830          392 GAVYHGRL--NGKNLAIKRTEH----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGG  465 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~  465 (600)
                      |.||+++.  +|+.||+|.++.    .....+.+|+..+..++||||+++++++..+ ...++||||+++|+|.++++..
T Consensus        47 g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~  125 (360)
T 3eqc_A           47 GVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-GEISICMEHMDGGSLDQVLKKA  125 (360)
T ss_dssp             CEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEET-TEEEEEECCCTTCBHHHHHHHH
T ss_pred             eEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEEC-CEEEEEEECCCCCCHHHHHHHc
Confidence            99999999  589999998753    2335678899999999999999999998765 4899999999999999999754


Q ss_pred             cCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCcccc---------
Q 041830          466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV---------  536 (600)
Q Consensus       466 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~---------  536 (600)
                      .            .+++..+..++.+++.||.|||+.  .+|+||||||+|||++.++.+||+|||+++..         
T Consensus       126 ~------------~~~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  191 (360)
T 3eqc_A          126 G------------RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV  191 (360)
T ss_dssp             S------------SCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC----C
T ss_pred             C------------CCCHHHHHHHHHHHHHHHHHHHHh--CCEEcCCccHHHEEECCCCCEEEEECCCCcccccccccCCC
Confidence            2            389999999999999999999941  38999999999999999999999999998632         


Q ss_pred             -CCCCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          537 -NDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       537 -~~~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                       ...+.+||....  ..++.++|||||||++|||++|+.||...+
T Consensus       192 gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~  234 (360)
T 3eqc_A          192 GTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAVGRYPIPPPD  234 (360)
T ss_dssp             CCCTTCCHHHHTT--CCCSHHHHHHHHHHHHHHHHHTSCCSSCCC
T ss_pred             CCCCeECHHHHcC--CCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence             223446666554  457888999999999999999999997643

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.95  E-value=1.2e-27  Score=243.66  Aligned_cols=155  Identities=14%  Similarity=0.135  Sum_probs=132.9

Q ss_pred             EEEEEEEE--CCeEEEEEEcchh------HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHE------VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~------~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      |.||+++.  +|+.||||.++..      ....+.+|+..+..++||||+++++++..+ +..|+||||+++++|.++++
T Consensus        45 g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~g~~L~~~l~  123 (286)
T 3uqc_A           45 LQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTR-AGGLVVAEWIRGGSLQEVAD  123 (286)
T ss_dssp             CEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEEEECCCEEEHHHHHT
T ss_pred             eEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEEC-CcEEEEEEecCCCCHHHHHh
Confidence            89999999  4899999998643      235678889999999999999999998665 48999999999999999995


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCCCCCC
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESP  543 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~~~~p  543 (600)
                      .+              ....+..+++.|++.||+|||   +.+|+||||||+|||++.++.+||+++|..          
T Consensus       124 ~~--------------~~~~~~~~i~~ql~~aL~~lH---~~givH~Dikp~NIll~~~g~~kl~~~~~~----------  176 (286)
T 3uqc_A          124 TS--------------PSPVGAIRAMQSLAAAADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPATM----------  176 (286)
T ss_dssp             TC--------------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEEETTSCEEECSCCCC----------
T ss_pred             cC--------------CChHHHHHHHHHHHHHHHHHH---HCCCccCCCCcccEEEcCCCCEEEEecccc----------
Confidence            32              345578899999999999999   669999999999999999999999866542          


Q ss_pred             cccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCCC
Q 041830          544 QFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRK  581 (600)
Q Consensus       544 e~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~  581 (600)
                             ..++.++|||||||++|||++|+.||...+.
T Consensus       177 -------~~~~~~~Di~slG~il~elltg~~Pf~~~~~  207 (286)
T 3uqc_A          177 -------PDANPQDDIRGIGASLYALLVNRWPLPEAGV  207 (286)
T ss_dssp             -------TTCCHHHHHHHHHHHHHHHHHSEECSCCCSB
T ss_pred             -------CCCCchhHHHHHHHHHHHHHHCCCCCCcCCc
Confidence                   1357789999999999999999999986543

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=99.95  E-value=5.4e-28  Score=246.99  Aligned_cols=171  Identities=26%  Similarity=0.513  Sum_probs=140.4

Q ss_pred             eEEEEEEEE------CCeEEEEEEcchhH----HHHHHHHHHHHHhCCCCceeeeeeEEeccC-CceEEEEeecCCCCHH
Q 041830          391 EGAVYHGRL------NGKNLAIKRTEHEV----ITKLEMQLVQHATHHHPNIVRLLGTCLTDG-PHSFLVFEYAKNGSLK  459 (600)
Q Consensus       391 ~G~Vy~g~~------~g~~vAvK~~~~~~----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~-~~~~LV~Ey~~~GsL~  459 (600)
                      .|.||++++      +|+.||+|+++...    ...+.+|+..+..++||||+++++++..++ ...++||||+++|+|.
T Consensus        34 ~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~  113 (302)
T 4e5w_A           34 FGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLK  113 (302)
T ss_dssp             SEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHH
T ss_pred             ceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHH
Confidence            399999985      68899999986532    346788999999999999999999987553 3679999999999999


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD  539 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~  539 (600)
                      +++....           ..+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....
T Consensus       114 ~~l~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~  179 (302)
T 4e5w_A          114 EYLPKNK-----------NKINLKQQLKYAVQICKGMDYLG---SRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETD  179 (302)
T ss_dssp             HHHHHHT-----------TTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTT
T ss_pred             HHHHhcc-----------ccCCHHHHHHHHHHHHHHHHHhh---cCCcccCCCchheEEEcCCCCEEECcccccccccCC
Confidence            9996533           33899999999999999999999   669999999999999999999999999999765432


Q ss_pred             ---------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCC
Q 041830          540 ---------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN  577 (600)
Q Consensus       540 ---------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~  577 (600)
                                     +.+||....  ..++.++||||||+++|||++|+.|+.
T Consensus       180 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~p~~  230 (302)
T 4e5w_A          180 KEYYTVKDDRDSPVFWYAPECLMQ--SKFYIASDVWSFGVTLHELLTYCDSDS  230 (302)
T ss_dssp             CCEEECCCCTTCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGG
T ss_pred             CcceeccCCCCCCccccCCeeecC--CCCCcchhHHHHHHHHHHHHHccCCCc
Confidence                           123443332  345677999999999999999998864

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=1.3e-27  Score=243.43  Aligned_cols=170  Identities=26%  Similarity=0.464  Sum_probs=138.9

Q ss_pred             EEEEEEEE--CC---eEEEEEEcch----hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          392 GAVYHGRL--NG---KNLAIKRTEH----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       392 G~Vy~g~~--~g---~~vAvK~~~~----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      |.||+|++  ++   ..||+|.++.    ...+.+.+|+..+..++||||+++++++...+...++||||+.+|+|.+++
T Consensus        35 g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~  114 (298)
T 3pls_A           35 GVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI  114 (298)
T ss_dssp             EEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHH
T ss_pred             ceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHH
Confidence            99999987  33   3799998754    233567889999999999999999999876654559999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC---
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---  539 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~---  539 (600)
                      +...           ..+++.+++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++.....   
T Consensus       115 ~~~~-----------~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  180 (298)
T 3pls_A          115 RSPQ-----------RNPTVKDLISFGLQVARGMEYLA---EQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY  180 (298)
T ss_dssp             HCTT-----------CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG
T ss_pred             hccc-----------cCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccc
Confidence            7633           34899999999999999999999   569999999999999999999999999999754221   


Q ss_pred             -------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCC
Q 041830          540 -------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN  577 (600)
Q Consensus       540 -------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~  577 (600)
                                   ..+||....  ..++.++||||||+++|||++|..|+.
T Consensus       181 ~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~~~~  229 (298)
T 3pls_A          181 SVQQHRHARLPVKWTALESLQT--YRFTTKSDVWSFGVLLWELLTRGAPPY  229 (298)
T ss_dssp             CSCCSSCTTCGGGGSCHHHHTT--CCCCHHHHHHHHHHHHHHHHHTSCCTT
T ss_pred             ccccCcCCCCCccccChhhhcc--CCCChhhchhhHHHHHHHHhhCCCCCC
Confidence                         123443332  456788999999999999999655543

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=99.95  E-value=3.1e-28  Score=252.20  Aligned_cols=173  Identities=23%  Similarity=0.361  Sum_probs=140.9

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhHHH----HHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEVIT----KLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~~~----~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      .|.||+++.  +|+.||+|+++.....    .+.+|+..+..++||||+++++++..+ ...++||||++ |+|.+++..
T Consensus        15 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~-~~l~~~~~~   92 (324)
T 3mtl_A           15 YATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTE-KSLTLVFEYLD-KDLKQYLDD   92 (324)
T ss_dssp             SEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCCCTTBCCEEEEEECS-SCEEEEEECCS-EEHHHHHHH
T ss_pred             CEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcCCCCCCeeeeEEeeC-CEEEEEecccc-cCHHHHHHh
Confidence            399999998  6899999998654322    234688889999999999999998655 48999999998 599999876


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-----
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-----  539 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-----  539 (600)
                      ..           ..+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....     
T Consensus        93 ~~-----------~~~~~~~~~~~~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~  158 (324)
T 3mtl_A           93 CG-----------NIINMHNVKLFLFQLLRGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYD  158 (324)
T ss_dssp             TT-----------TCCCHHHHHHHHHHHHHHHHHHH---HTTEEESSCCGGGEEECTTCCEEECSSSEEECC--------
T ss_pred             cC-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCcCHHHEEECCCCCEEEccCcccccccCCccccc
Confidence            43           34899999999999999999999   669999999999999999999999999998754321     


Q ss_pred             -------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 -------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 -------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                             +.+||.... ...++.++|||||||++|||++|+.||...+
T Consensus       159 ~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~~l~~g~~pf~~~~  205 (324)
T 3mtl_A          159 NEVVTLWYRPPDILLG-STDYSTQIDMWGVGCIFYEMATGRPLFPGST  205 (324)
T ss_dssp             ----CGGGCCHHHHTT-CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccCcccccChhhhcC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                   234555433 2456888999999999999999999997643

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=99.95  E-value=5e-28  Score=251.22  Aligned_cols=170  Identities=22%  Similarity=0.340  Sum_probs=139.4

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhH-----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEV-----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~-----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      |.||+++.  +|+.||||+++...     ...+.+|+..+..++||||+++++++..+ ...++||||++ |+|.+++..
T Consensus        48 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~-~~L~~~~~~  125 (329)
T 3gbz_A           48 GEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKSVIHHN-HRLHLIFEYAE-NDLKKYMDK  125 (329)
T ss_dssp             SEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCCCTTBCCEEEEEEET-TEEEEEEECCS-EEHHHHHHH
T ss_pred             eEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcCCCCcceEEEEEecC-CEEEEEEecCC-CCHHHHHhh
Confidence            89999987  78999999985432     23456889999999999999999998665 48999999998 599999976


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEe-----CCCCcEEEEeccCccccC--
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFL-----DEEFNARVGNFGMARCVN--  537 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl-----d~~~~~kI~DFGla~~~~--  537 (600)
                      ..            .+++.++..++.|++.||.|||   +.+|+||||||+|||+     +.++.+||+|||+++...  
T Consensus       126 ~~------------~~~~~~~~~i~~ql~~~l~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~  190 (329)
T 3gbz_A          126 NP------------DVSMRVIKSFLYQLINGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIP  190 (329)
T ss_dssp             CT------------TCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC--
T ss_pred             cC------------CCCHHHHHHHHHHHHHHHHHHH---hCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCc
Confidence            43            3899999999999999999999   5699999999999999     455669999999987543  


Q ss_pred             ----------CCCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          538 ----------DDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       538 ----------~~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                ..+.+||..... ..++.++|||||||++|||++|+.||...
T Consensus       191 ~~~~~~~~~t~~y~aPE~~~~~-~~~~~~~DiwslG~il~ell~g~~pf~~~  241 (329)
T 3gbz_A          191 IRQFTHEIITLWYRPPEILLGS-RHYSTSVDIWSIACIWAEMLMKTPLFPGD  241 (329)
T ss_dssp             ---------CCTTCCHHHHTTC-CCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccccCCCcCCccccCHHHhcCC-CCCCcHHHHHHHHHHHHHHHHCCCCcCCC
Confidence                      223456665432 34788999999999999999999999754

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=99.95  E-value=5.5e-28  Score=244.39  Aligned_cols=171  Identities=25%  Similarity=0.452  Sum_probs=143.2

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhHHHHHHHHHHHHHhCCCCceeeeeeEEec---------------cCCceEEEEeec
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLT---------------DGPHSFLVFEYA  453 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~---------------~~~~~~LV~Ey~  453 (600)
                      .|.||+++.  +|+.||+|.++... ..+++|+..+..++||||+++++++..               .....++||||+
T Consensus        24 ~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~  102 (284)
T 2a19_B           24 FGQVFKAKHRIDGKTYVIKRVKYNN-EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFC  102 (284)
T ss_dssp             SCCEEEEEETTTCCEEEEEEEECCS-GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCC
T ss_pred             ceEEEEEEEcCCCeEEEEEEecccc-HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEecc
Confidence            389999999  58999999987654 456789999999999999999998743               123479999999


Q ss_pred             CCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCc
Q 041830          454 KNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA  533 (600)
Q Consensus       454 ~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla  533 (600)
                      ++|+|.+++.....          ..+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus       103 ~~~~L~~~l~~~~~----------~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~  169 (284)
T 2a19_B          103 DKGTLEQWIEKRRG----------EKLDKVLALELFEQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLV  169 (284)
T ss_dssp             CSCBHHHHHHHGGG----------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             CCCCHHHHHhhccC----------CCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCCHHHEEEcCCCCEEECcchhh
Confidence            99999999975431          34899999999999999999999   569999999999999999999999999998


Q ss_pred             cccCCC-----------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCC
Q 041830          534 RCVNDD-----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN  577 (600)
Q Consensus       534 ~~~~~~-----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~  577 (600)
                      +.....           +.+||....  ..++.++||||||+++|||++|..||.
T Consensus       170 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~~~~~~  222 (284)
T 2a19_B          170 TSLKNDGKRTRSKGTLRYMSPEQISS--QDYGKEVDLYALGLILAELLHVCDTAF  222 (284)
T ss_dssp             EESSCCSCCCCCCSCCTTSCHHHHHC--SCCCTHHHHHHHHHHHHHHHSCCSSHH
T ss_pred             eeccccccccccCCcccccChhhhcc--CCCcchhhhHHHHHHHHHHHhcCCcch
Confidence            765432           234555443  346788999999999999999998874

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=99.95  E-value=1.7e-27  Score=248.62  Aligned_cols=170  Identities=19%  Similarity=0.294  Sum_probs=137.4

Q ss_pred             eEEEEEEEE-CCeEEEEEEcch-----hHHHHHHHHHHHHHhCCC--CceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL-NGKNLAIKRTEH-----EVITKLEMQLVQHATHHH--PNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~-~g~~vAvK~~~~-----~~~~~~e~ei~~~~~l~H--pNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||++.. +++.||||++..     .....+.+|+..+..+.|  |||+++++++..+ ...++||| +.+|+|.+++
T Consensus        22 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~-~~~~lv~e-~~~~~L~~~l   99 (343)
T 3dbq_A           22 SSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-QYIYMVME-CGNIDLNSWL   99 (343)
T ss_dssp             SEEEEEEECTTSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEEEEEC-CCSEEHHHHH
T ss_pred             CeEEEEEEeCCCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeC-CEEEEEEe-CCCCCHHHHH
Confidence            499999988 788999998753     223456788888887765  9999999998665 48999999 5678999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC----
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND----  538 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~----  538 (600)
                      ....            .+++.++..++.|++.||.|||   +.+|+||||||+|||++ ++.+||+|||+++....    
T Consensus       100 ~~~~------------~~~~~~~~~i~~qi~~al~~lH---~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~  163 (343)
T 3dbq_A          100 KKKK------------SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS  163 (343)
T ss_dssp             HHSC------------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred             HhcC------------CCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence            7643            3899999999999999999999   56999999999999997 67899999999975422    


Q ss_pred             ----------CCCCCccccc---------CCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          539 ----------DTESPQFYST---------NPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       539 ----------~~~~pe~~~~---------~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                                .+.+||....         ....++.++|||||||++|||++|+.||..
T Consensus       164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  222 (343)
T 3dbq_A          164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ  222 (343)
T ss_dssp             ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchh
Confidence                      2235665432         124567889999999999999999999975

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=99.95  E-value=1.2e-27  Score=242.99  Aligned_cols=173  Identities=21%  Similarity=0.364  Sum_probs=142.4

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhH----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcC
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEV----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGG  465 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~  465 (600)
                      |.||+++.  +|+.+|+|.+..+.    .+.+++|+..+..++||||+++++++... ...++||||+++|+|.+++...
T Consensus        36 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~  114 (285)
T 3is5_A           36 GDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDY-HNMYIVMETCEGGELLERIVSA  114 (285)
T ss_dssp             CEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEEEECCCSCCBHHHHHHHH
T ss_pred             eEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCCCchHHhHHHheecC-CeEEEEEEeCCCCcHHHHHHhh
Confidence            99999998  68899999976533    35678899999999999999999998655 4889999999999999998643


Q ss_pred             cCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEe---CCCCcEEEEeccCccccCCC---
Q 041830          466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFL---DEEFNARVGNFGMARCVNDD---  539 (600)
Q Consensus       466 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl---d~~~~~kI~DFGla~~~~~~---  539 (600)
                      ...        ...+++.+++.++.|++.||.|||   +.+|+||||||+|||+   +.++.+||+|||+++.....   
T Consensus       115 ~~~--------~~~~~~~~~~~i~~qi~~~L~~LH---~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~  183 (285)
T 3is5_A          115 QAR--------GKALSEGYVAELMKQMMNALAYFH---SQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHS  183 (285)
T ss_dssp             HHH--------TCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-------
T ss_pred             hhc--------ccCCCHHHHHHHHHHHHHHHHHHH---hCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcccC
Confidence            210        134899999999999999999999   6699999999999999   45688999999999754322   


Q ss_pred             --------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 --------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 --------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                              ..+||...   ..++.++||||||+++|||++|+.||...
T Consensus       184 ~~~~~t~~y~aPE~~~---~~~~~~~Di~slG~il~~ll~g~~pf~~~  228 (285)
T 3is5_A          184 TNAAGTALYMAPEVFK---RDVTFKCDIWSAGVVMYFLLTGCLPFTGT  228 (285)
T ss_dssp             ---CTTGGGCCHHHHT---TCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cCcccccCcCChHHhc---cCCCcccCeehHHHHHHHHHhCCCCCCCC
Confidence                    23455543   34678899999999999999999999753

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=99.95  E-value=2.7e-27  Score=245.18  Aligned_cols=175  Identities=24%  Similarity=0.335  Sum_probs=135.9

Q ss_pred             eEEEEEEEE--CCeEEEEEEcch---hHHHHHHHHHHHHHhCC-CCceeeeeeEEe-------ccCCceEEEEeecCCCC
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEH---EVITKLEMQLVQHATHH-HPNIVRLLGTCL-------TDGPHSFLVFEYAKNGS  457 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~---~~~~~~e~ei~~~~~l~-HpNIv~l~g~~~-------~~~~~~~LV~Ey~~~Gs  457 (600)
                      .|.||+++.  +|+.||||++..   .....+.+|+..+..+. ||||+++++++.       ......++||||+. |+
T Consensus        41 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~  119 (337)
T 3ll6_A           41 FAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQ  119 (337)
T ss_dssp             SEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EE
T ss_pred             ceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecC-CC
Confidence            399999998  789999998743   22345678888888886 999999999984       22235799999996 79


Q ss_pred             HHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCC--ceecCCCCCCEEeCCCCcEEEEeccCccc
Q 041830          458 LKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS--YVHRNIKSRNIFLDEEFNARVGNFGMARC  535 (600)
Q Consensus       458 L~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~--ivHrDLk~~NILld~~~~~kI~DFGla~~  535 (600)
                      |.+++.....         ...+++.+++.++.|++.||.|||   +.+  |+||||||+|||++.++.+||+|||+++.
T Consensus       120 L~~~l~~~~~---------~~~~~~~~~~~i~~qi~~~l~~LH---~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  187 (337)
T 3ll6_A          120 LVEFLKKMES---------RGPLSCDTVLKIFYQTCRAVQHMH---RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATT  187 (337)
T ss_dssp             HHHHHHHHHT---------TCSCCHHHHHHHHHHHHHHHHHHH---TSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBC
T ss_pred             HHHHHHHhhc---------cCCCCHHHHHHHHHHHHHHHHHHH---hCCCCEEEccCCcccEEECCCCCEEEecCcccee
Confidence            9999865221         034999999999999999999999   556  99999999999999999999999999976


Q ss_pred             cCC------------------------CCCCCccccc-CCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          536 VND------------------------DTESPQFYST-NPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       536 ~~~------------------------~~~~pe~~~~-~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                      ...                        .+.+||.... ....++.++|||||||++|||++|+.||..
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~  255 (337)
T 3ll6_A          188 ISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFED  255 (337)
T ss_dssp             CSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred             ccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence            532                        1235665421 234567889999999999999999999965

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=99.95  E-value=5.2e-28  Score=259.85  Aligned_cols=176  Identities=24%  Similarity=0.308  Sum_probs=139.4

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhHHHHHHHHHHHHHhCCCCceeeeeeEEeccC-----CceEEEEeecCCCCHHHHHh
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDG-----PHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~-----~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      +|.||+++.  +|+.||||++..+. ....+|+..+..++|||||++++++...+     ..+++||||+++ +|.+++.
T Consensus        67 fg~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~  144 (420)
T 1j1b_A           67 FGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVAR  144 (420)
T ss_dssp             SEEEEEEEETTTCCEEEEEEEECCT-TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHH
T ss_pred             CEEEEEEEECCCCcEEEEEEecccc-hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHH
Confidence            399999999  68999999986543 23357888999999999999999986422     135799999986 6776664


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC-CcEEEEeccCccccCCC---
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEE-FNARVGNFGMARCVNDD---  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~-~~~kI~DFGla~~~~~~---  539 (600)
                      .....        ...+++..+..++.||++||.|||   +.+|+||||||+|||++.+ +.+||+|||+++.....   
T Consensus       145 ~~~~~--------~~~l~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~~  213 (420)
T 1j1b_A          145 HYSRA--------KQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPN  213 (420)
T ss_dssp             HHHHT--------TCCCCHHHHHHHHHHHHHHHHHHH---TTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCC
T ss_pred             HHhhc--------cCCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCCCc
Confidence            32110        134999999999999999999999   7799999999999999965 67899999999865322   


Q ss_pred             --------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 --------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 --------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                              +.+||.... ...++.++|||||||+||||++|+.||...+
T Consensus       214 ~~~~~t~~y~aPE~~~~-~~~~~~~~DiwSlG~il~ell~G~~pf~~~~  261 (420)
T 1j1b_A          214 VSYICSRYYRAPELIFG-ATDYTSSIDVWSAGCVLAELLLGQPIFPGDS  261 (420)
T ss_dssp             CSCCSCTTSCCHHHHTT-CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             eeeeeCCCcCCHHHHcC-CCCCCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence                    235665433 2357888999999999999999999997643

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=99.95  E-value=1.6e-27  Score=242.54  Aligned_cols=172  Identities=20%  Similarity=0.251  Sum_probs=142.3

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhH-HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcCc
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEV-ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM  468 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~-~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~  468 (600)
                      |.||+++.  +|+.||||.+.... ...+.+|+..+..++|++++..++++..++...++||||+ +|+|.+++....  
T Consensus        23 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~--   99 (296)
T 3uzp_A           23 GDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCS--   99 (296)
T ss_dssp             EEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT--
T ss_pred             eEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhc--
Confidence            89999996  79999999875432 2457788888888999988888888766666889999999 899999997433  


Q ss_pred             ccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEe---CCCCcEEEEeccCccccCCC------
Q 041830          469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFL---DEEFNARVGNFGMARCVNDD------  539 (600)
Q Consensus       469 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl---d~~~~~kI~DFGla~~~~~~------  539 (600)
                               ..+++.+++.++.|++.||.|||   +.+|+||||||+|||+   +.++.+||+|||+++.....      
T Consensus       100 ---------~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~  167 (296)
T 3uzp_A          100 ---------RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHI  167 (296)
T ss_dssp             ---------TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBC
T ss_pred             ---------cCCCHHHHHHHHHHHHHHHHHHH---hCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccccc
Confidence                     24899999999999999999999   6699999999999999   48899999999999754332      


Q ss_pred             -------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 -------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 -------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                                   +.+||....  ..++.++|||||||++|||++|+.||....
T Consensus       168 ~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~  219 (296)
T 3uzp_A          168 PYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLK  219 (296)
T ss_dssp             CCCCSCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred             ccccccccccccccCChhhhcC--CCCCcchhhHHHHHHHHHHHhCCCCCCCcC
Confidence                         223444433  346788999999999999999999998654

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=99.95  E-value=4.6e-28  Score=253.16  Aligned_cols=170  Identities=19%  Similarity=0.234  Sum_probs=137.6

Q ss_pred             eEEEEEEEE-----CCeEEEEEEcchhHH--------------HHHHHHHHHHHhCCCCceeeeeeEEecc---CCceEE
Q 041830          391 EGAVYHGRL-----NGKNLAIKRTEHEVI--------------TKLEMQLVQHATHHHPNIVRLLGTCLTD---GPHSFL  448 (600)
Q Consensus       391 ~G~Vy~g~~-----~g~~vAvK~~~~~~~--------------~~~e~ei~~~~~l~HpNIv~l~g~~~~~---~~~~~L  448 (600)
                      .|.||+++.     ++..+|+|.......              ..+.+|+..+..+.||||+++++++...   ....++
T Consensus        50 ~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~l  129 (345)
T 2v62_A           50 FGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFM  129 (345)
T ss_dssp             --CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEE
T ss_pred             CeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccccCCCcEEEE
Confidence            499999998     457899998754210              1245677778889999999999998762   347899


Q ss_pred             EEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC--cEE
Q 041830          449 VFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEF--NAR  526 (600)
Q Consensus       449 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~--~~k  526 (600)
                      ||||+ +|+|.+++....            .+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++  .+|
T Consensus       130 v~e~~-~~~L~~~l~~~~------------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~~~k  193 (345)
T 2v62_A          130 VMERL-GIDLQKISGQNG------------TFKKSTVLQLGIRMLDVLEYIH---ENEYVHGDIKAANLLLGYKNPDQVY  193 (345)
T ss_dssp             EEECE-EEEHHHHCBGGG------------BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEESSSTTSEE
T ss_pred             EEecc-CCCHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCcCHHHEEEccCCCCcEE
Confidence            99999 999999987532            3899999999999999999999   56999999999999998877  999


Q ss_pred             EEeccCccccCC-------------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          527 VGNFGMARCVND-------------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       527 I~DFGla~~~~~-------------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                      |+|||+++....                   .+.+||....  ..++.++|||||||++|||++|+.||..
T Consensus       194 L~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~g~~pf~~  262 (345)
T 2v62_A          194 LADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKG--VALSRRSDVEILGYCMLRWLCGKLPWEQ  262 (345)
T ss_dssp             ECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCTTGG
T ss_pred             EEeCCCceecccccccccchhccccccCCCccccCHHHhcC--CCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence            999999975421                   2234555443  3568889999999999999999999964

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=99.95  E-value=3.2e-27  Score=238.79  Aligned_cols=173  Identities=23%  Similarity=0.359  Sum_probs=140.4

Q ss_pred             EEEEEEEE--CCeEEEEEEcch-----hHHHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          392 GAVYHGRL--NGKNLAIKRTEH-----EVITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~-----~~~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      |.||+++.  +|+.||+|.++.     .....+.+|+..+..+ +||||+++++++..+ +..++||||+++|+|.+++.
T Consensus        25 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~  103 (289)
T 1x8b_A           25 GSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAED-DHMLIQNEYCNGGSLADAIS  103 (289)
T ss_dssp             EEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEET-TEEEEEEECCTTCBHHHHHH
T ss_pred             eEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecC-CeEEEEEEecCCCcHHHHHH
Confidence            99999999  699999998763     2234567788888888 899999999998665 48999999999999999997


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC-------------------CCc
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE-------------------EFN  524 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~-------------------~~~  524 (600)
                      .....        ...+++.+++.++.|++.||.|||   +.+|+||||||+|||++.                   ...
T Consensus       104 ~~~~~--------~~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~  172 (289)
T 1x8b_A          104 ENYRI--------MSYFKEAELKDLLLQVGRGLRYIH---SMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVM  172 (289)
T ss_dssp             HHHHH--------TCCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEC--------------------CCC
T ss_pred             hhccc--------ccCCCHHHHHHHHHHHHHHHHHHH---hCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceE
Confidence            54211        134899999999999999999999   569999999999999984                   447


Q ss_pred             EEEEeccCccccCCCC--------CCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCC
Q 041830          525 ARVGNFGMARCVNDDT--------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN  577 (600)
Q Consensus       525 ~kI~DFGla~~~~~~~--------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~  577 (600)
                      +||+|||++.......        .+||.... ...++.++||||||+++|||++|++|+.
T Consensus       173 ~kl~Dfg~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~Di~slG~il~~l~~~~~~~~  232 (289)
T 1x8b_A          173 FKIGDLGHVTRISSPQVEEGDSRFLANEVLQE-NYTHLPKADIFALALTVVCAAGAEPLPR  232 (289)
T ss_dssp             EEECCCTTCEETTCSCCCCCCGGGCCHHHHTT-CCTTHHHHHHHHHHHHHHHHTTCCCCCS
T ss_pred             EEEcccccccccCCccccCCCccccChhHhcC-CCCCCchhhHHHHHHHHHHHhcCCCCCc
Confidence            9999999987654322        34555443 2345678999999999999999998764

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=99.95  E-value=2.6e-27  Score=260.39  Aligned_cols=171  Identities=21%  Similarity=0.368  Sum_probs=143.7

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH----------------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEee
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV----------------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEY  452 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~----------------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey  452 (600)
                      .|.||+++.  +++.||+|.++...                ...+.+|+..+..++||||+++++++... ...++||||
T Consensus        49 ~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv~e~  127 (504)
T 3q5i_A           49 YGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDK-KYFYLVTEF  127 (504)
T ss_dssp             CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEEEEEC
T ss_pred             CeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcC-CEEEEEEec
Confidence            499999998  67899999875421                24577899999999999999999998655 589999999


Q ss_pred             cCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC---cEEEEe
Q 041830          453 AKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEF---NARVGN  529 (600)
Q Consensus       453 ~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~---~~kI~D  529 (600)
                      |++|+|.+++....            .+++.++..++.|++.||.|||   +.+|+||||||+|||++.++   .+||+|
T Consensus       128 ~~gg~L~~~l~~~~------------~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~D  192 (504)
T 3q5i_A          128 YEGGELFEQIINRH------------KFDECDAANIMKQILSGICYLH---KHNIVHRDIKPENILLENKNSLLNIKIVD  192 (504)
T ss_dssp             CTTCBHHHHHHHHS------------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESSTTCCSSEEECC
T ss_pred             CCCCcHHHHHHHcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeCCCcHHHEEEecCCCCccEEEEE
Confidence            99999999986532            3899999999999999999999   56999999999999998765   699999


Q ss_pred             ccCccccCCC-----------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          530 FGMARCVNDD-----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       530 FGla~~~~~~-----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                      ||+++.....           +.+||...   ..++.++|||||||++|||++|+.||...+
T Consensus       193 fg~a~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~  251 (504)
T 3q5i_A          193 FGLSSFFSKDYKLRDRLGTAYYIAPEVLK---KKYNEKCDVWSCGVIMYILLCGYPPFGGQN  251 (504)
T ss_dssp             CTTCEECCTTSCBCCCCSCTTTCCHHHHT---TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CCCCEEcCCCCccccccCCcCCCCHHHhc---cCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence            9999765332           23566543   347889999999999999999999997643

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=99.95  E-value=2.8e-27  Score=241.28  Aligned_cols=172  Identities=24%  Similarity=0.401  Sum_probs=142.7

Q ss_pred             EEEEEEEE--CCeEEEEEEcchh------------HHHHHHHHHHHHHhCC-CCceeeeeeEEeccCCceEEEEeecCCC
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHE------------VITKLEMQLVQHATHH-HPNIVRLLGTCLTDGPHSFLVFEYAKNG  456 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~------------~~~~~e~ei~~~~~l~-HpNIv~l~g~~~~~~~~~~LV~Ey~~~G  456 (600)
                      |.||++..  +|+.||||.++..            ....+.+|+..+..+. ||||+++++++..+ ...++||||+++|
T Consensus        31 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~-~~~~lv~e~~~~~  109 (298)
T 1phk_A           31 SVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN-TFFFLVFDLMKKG  109 (298)
T ss_dssp             EEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS-SEEEEEEECCTTC
T ss_pred             eEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccC-CeEEEEEeccCCC
Confidence            89999998  6899999987532            1235667888888885 99999999998655 4899999999999


Q ss_pred             CHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCcccc
Q 041830          457 SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV  536 (600)
Q Consensus       457 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~  536 (600)
                      +|.+++....            .+++.+++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++..
T Consensus       110 ~L~~~l~~~~------------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  174 (298)
T 1phk_A          110 ELFDYLTEKV------------TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL  174 (298)
T ss_dssp             BHHHHHHHHS------------SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             cHHHHHhccC------------CCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCcceEEEcCCCcEEEecccchhhc
Confidence            9999997532            3899999999999999999999   669999999999999999999999999999765


Q ss_pred             CCC-----------CCCCccccc----CCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          537 NDD-----------TESPQFYST----NPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       537 ~~~-----------~~~pe~~~~----~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                      ...           ..+||....    ....++.++||||||+++|||++|+.||...
T Consensus       175 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~  232 (298)
T 1phk_A          175 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR  232 (298)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             CCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc
Confidence            332           124554421    1245678899999999999999999999653

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=99.95  E-value=2.1e-27  Score=246.82  Aligned_cols=182  Identities=21%  Similarity=0.431  Sum_probs=142.4

Q ss_pred             EEEEEEEE---------CCeEEEEEEcchh----HHHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCC
Q 041830          392 GAVYHGRL---------NGKNLAIKRTEHE----VITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGS  457 (600)
Q Consensus       392 G~Vy~g~~---------~g~~vAvK~~~~~----~~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~Gs  457 (600)
                      |.||+++.         ++..||||+++.+    ....+.+|+..+..+ +||||+++++++..+ ...++||||+++|+
T Consensus        49 g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~  127 (334)
T 2pvf_A           49 GQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQD-GPLYVIVEYASKGN  127 (334)
T ss_dssp             CEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SCCEEEEECCTTCB
T ss_pred             eeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccC-CceEEEEECCCCCc
Confidence            99999986         3567999998643    234577888888888 899999999998655 48899999999999


Q ss_pred             HHHHHhcCcCcccc----cccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCc
Q 041830          458 LKDWLHGGLAMKNQ----FIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMA  533 (600)
Q Consensus       458 L~~~L~~~~~~~~~----~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla  533 (600)
                      |.+++.........    ........+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||++
T Consensus       128 L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~  204 (334)
T 2pvf_A          128 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLA  204 (334)
T ss_dssp             HHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             HHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCeeCCCCccceEEEcCCCCEEEcccccc
Confidence            99999865421000    00001134899999999999999999999   569999999999999999999999999999


Q ss_pred             cccCCC--------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          534 RCVNDD--------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       534 ~~~~~~--------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                      +.....              +.+||....  ..++.++||||||+++|||++ |+.||...
T Consensus       205 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~  263 (334)
T 2pvf_A          205 RDINNIDYYKKTTNGRLPVKWMAPEALFD--RVYTHQSDVWSFGVLMWEIFTLGGSPYPGI  263 (334)
T ss_dssp             EECTTTSSEECCSCCCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ccccccccccccCCCCcccceeChHHhcC--CCcChHHHHHHHHHHHHHHHhCCCCCcCcC
Confidence            755322              224444433  346778999999999999999 99999753

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=99.95  E-value=2.3e-27  Score=260.07  Aligned_cols=172  Identities=23%  Similarity=0.345  Sum_probs=141.7

Q ss_pred             eeEEEEEEEE--CCeEEEEEEcchhH-----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          390 IEGAVYHGRL--NGKNLAIKRTEHEV-----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       390 ~~G~Vy~g~~--~g~~vAvK~~~~~~-----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      ..|.||+++.  +|..||+|.++...     ...+.+|+..+..++||||+++++++... ...|+|||||++|+|.+++
T Consensus        49 ~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv~e~~~~g~L~~~~  127 (494)
T 3lij_A           49 AYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDK-RNYYLVMECYKGGELFDEI  127 (494)
T ss_dssp             ---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEEEECCCSCBHHHHH
T ss_pred             CCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCCCCCCCeEEEEEEeC-CEEEEEEecCCCCcHHHHH
Confidence            3499999998  68899999976432     24578899999999999999999998655 4899999999999999988


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC---CCcEEEEeccCccccCC-
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE---EFNARVGNFGMARCVND-  538 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~---~~~~kI~DFGla~~~~~-  538 (600)
                      ....            .+++.++..++.||+.||.|||   +.+|+||||||+|||++.   ++.+||+|||+++.... 
T Consensus       128 ~~~~------------~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~  192 (494)
T 3lij_A          128 IHRM------------KFNEVDAAVIIKQVLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ  192 (494)
T ss_dssp             HHHS------------SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT
T ss_pred             HHcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC
Confidence            6532            3899999999999999999999   569999999999999976   45599999999875432 


Q ss_pred             ----------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          539 ----------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       539 ----------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                                .+.+||...   ..++.++|||||||++|||++|+.||....
T Consensus       193 ~~~~~~~gt~~y~aPE~l~---~~~~~~~DiwslG~il~~ll~g~~pf~~~~  241 (494)
T 3lij_A          193 KKMKERLGTAYYIAPEVLR---KKYDEKCDVWSIGVILFILLAGYPPFGGQT  241 (494)
T ss_dssp             BCBCCCCSCTTTCCHHHHT---TCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccccccCCCcCeeCHHHHc---ccCCCchhHHHHHHHHHHHHhCCCCCCCCC
Confidence                      234566553   347889999999999999999999997543

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=99.95  E-value=1.6e-27  Score=249.07  Aligned_cols=171  Identities=24%  Similarity=0.364  Sum_probs=140.2

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhHH--------HHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEVI--------TKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~~--------~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      |.||+++.  +|+.||||.++....        ..+.+|+..+..++||||+++++++... ...++||||+++ +|.++
T Consensus        24 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~-~l~~~  101 (346)
T 1ua2_A           24 ATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK-SNISLVFDFMET-DLEVI  101 (346)
T ss_dssp             EEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT-TCCEEEEECCSE-EHHHH
T ss_pred             EEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeC-CceEEEEEcCCC-CHHHH
Confidence            89999998  589999999864221        2467899999999999999999997654 488999999986 89999


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--  539 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--  539 (600)
                      +....           ..+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....  
T Consensus       102 ~~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  167 (346)
T 1ua2_A          102 IKDNS-----------LVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR  167 (346)
T ss_dssp             HTTCC-----------SSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred             HHhcC-----------cCCCHHHHHHHHHHHHHHHHHHH---HCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcc
Confidence            87543           34889999999999999999999   568999999999999999999999999999765321  


Q ss_pred             ----------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 ----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 ----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                +.+||.... ...++.++|||||||++|||++|+.||...
T Consensus       168 ~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~~~~~~  216 (346)
T 1ua2_A          168 AYTHQVVTRWYRAPELLFG-ARMYGVGVDMWAVGCILAELLLRVPFLPGD  216 (346)
T ss_dssp             CCCCSCCCCTTCCHHHHTT-CSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cCCcccccccccCchHhhC-CCCCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence                      234555432 234678899999999999999999998754

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=99.95  E-value=1.1e-27  Score=243.77  Aligned_cols=174  Identities=24%  Similarity=0.380  Sum_probs=143.6

Q ss_pred             EEEEEEEE--CCeEEEEEEcchh---HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCc
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHE---VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGL  466 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~---~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~  466 (600)
                      |.||+|+.  +++.||||.++..   ..+.+.+|+..+..++||||+++++++... ...++||||+++|+|.+++....
T Consensus        36 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~  114 (295)
T 2clq_A           36 GIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSEN-GFIKIFMEQVPGGSLSALLRSKW  114 (295)
T ss_dssp             SEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEEEECCSEEEHHHHHHHTT
T ss_pred             EEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeC-CcEEEEEEeCCCCCHHHHHHhhc
Confidence            89999998  6889999987542   235678899999999999999999998665 48899999999999999997643


Q ss_pred             CcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC-CCcEEEEeccCccccCCC------
Q 041830          467 AMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE-EFNARVGNFGMARCVNDD------  539 (600)
Q Consensus       467 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~-~~~~kI~DFGla~~~~~~------  539 (600)
                      ..         ..+++..+..++.|++.||.|||   +.+++||||||+||+++. ++.+||+|||+++.....      
T Consensus       115 ~~---------~~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~  182 (295)
T 2clq_A          115 GP---------LKDNEQTIGFYTKQILEGLKYLH---DNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTET  182 (295)
T ss_dssp             CC---------CTTCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----CC
T ss_pred             cC---------CCccHHHHHHHHHHHHHHHHHHH---hCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCcccc
Confidence            21         23678999999999999999999   569999999999999987 899999999999765321      


Q ss_pred             ------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          540 ------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       540 ------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                            ..+||........++.++||||||+++|||++|+.||..
T Consensus       183 ~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  227 (295)
T 2clq_A          183 FTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYE  227 (295)
T ss_dssp             CCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGG
T ss_pred             cCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccC
Confidence                  224555443333467889999999999999999999964

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=99.95  E-value=2.9e-27  Score=249.73  Aligned_cols=170  Identities=19%  Similarity=0.332  Sum_probs=138.7

Q ss_pred             eEEEEEEEE--CCeEEEEEEcch-----hHHHHHHHHHHHHHhCCCCceeeeeeEEeccC-----CceEEEEeecCCCCH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEH-----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDG-----PHSFLVFEYAKNGSL  458 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~-----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~-----~~~~LV~Ey~~~GsL  458 (600)
                      .|.||+++.  +|+.||||++..     .....+.+|+..+..++||||+++++++...+     ...++||||++ |+|
T Consensus        38 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l  116 (371)
T 2xrw_A           38 QGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANL  116 (371)
T ss_dssp             SEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCS-EEH
T ss_pred             CEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCC-CCH
Confidence            399999988  689999999754     22345678999999999999999999976443     26799999997 478


Q ss_pred             HHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC
Q 041830          459 KDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND  538 (600)
Q Consensus       459 ~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~  538 (600)
                      .+++..              .+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       117 ~~~~~~--------------~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~  179 (371)
T 2xrw_A          117 CQVIQM--------------ELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGT  179 (371)
T ss_dssp             HHHHHS--------------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCC------
T ss_pred             HHHHhh--------------ccCHHHHHHHHHHHHHHHHHHH---HCCeecccCCHHHEEEcCCCCEEEEEeeccccccc
Confidence            888852              2889999999999999999999   56999999999999999999999999999975432


Q ss_pred             C-----------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          539 D-----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       539 ~-----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                      .           +.+||....  ..++.++|||||||++|||++|+.||...+
T Consensus       180 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~el~~g~~pf~~~~  230 (371)
T 2xrw_A          180 SFMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMIKGGVLFPGTD  230 (371)
T ss_dssp             ----------CTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccccCCceecCCccCHHHhcC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence            2           345666554  457889999999999999999999997643

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=99.95  E-value=2.3e-27  Score=244.81  Aligned_cols=180  Identities=22%  Similarity=0.423  Sum_probs=143.7

Q ss_pred             EEEEEEEEC-------CeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          392 GAVYHGRLN-------GKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       392 G~Vy~g~~~-------g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      |.||+|+..       ++.||+|.+...    ....+.+|+..+..++||||+++++++... ...++||||+++|+|.+
T Consensus        39 g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~  117 (322)
T 1p4o_A           39 GMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-QPTLVIMELMTRGDLKS  117 (322)
T ss_dssp             SEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS-SSCEEEEECCTTCBHHH
T ss_pred             eEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccC-CccEEEEEeCCCCcHHH
Confidence            899999863       578999998642    234577899999999999999999997554 47899999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC--
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND--  538 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~--  538 (600)
                      +++.......  .......+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....  
T Consensus       118 ~l~~~~~~~~--~~~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~  192 (322)
T 1p4o_A          118 YLRSLRPAMA--NNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD  192 (322)
T ss_dssp             HHHHHHHHHH--HCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGG
T ss_pred             HHHHhchhhc--cCCCCCCcCHHHHHHHHHHHHHHHHHHH---HCCCccCCCccceEEEcCCCeEEECcCcccccccccc
Confidence            9975321000  0000134799999999999999999999   56999999999999999999999999999875422  


Q ss_pred             ------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          539 ------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       539 ------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                                  ...+||....  ..++.++||||||+++|||++ |+.||...
T Consensus       193 ~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~~g~~p~~~~  244 (322)
T 1p4o_A          193 YYRKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQGL  244 (322)
T ss_dssp             CEEGGGSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTSCCTTTTS
T ss_pred             ccccccCCCCCCCccChhhhcc--CCCCchhhHHHHHHHHHHHHhcCCCccccC
Confidence                        1335555443  346788999999999999999 89999653

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=99.95  E-value=4.6e-28  Score=250.48  Aligned_cols=175  Identities=24%  Similarity=0.438  Sum_probs=141.4

Q ss_pred             EEEEEEEE--CCeEEEEEEcchh--HHHHHHHHHHHHHhC-CCCceeeeeeEEecc-----CCceEEEEeecCCCCHHHH
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHE--VITKLEMQLVQHATH-HHPNIVRLLGTCLTD-----GPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~--~~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~-----~~~~~LV~Ey~~~GsL~~~  461 (600)
                      |.||+++.  +|+.||||.++..  ....+.+|+..+..+ +||||+++++++...     ....++||||+++|+|.++
T Consensus        38 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~  117 (326)
T 2x7f_A           38 GQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDL  117 (326)
T ss_dssp             EEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHH
T ss_pred             EEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHH
Confidence            89999999  7899999987542  235677888888887 799999999998753     3478999999999999999


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--  539 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--  539 (600)
                      +.....          ..+++..+..++.|++.||.|||   +.+++||||||+|||++.++.+||+|||++......  
T Consensus       118 l~~~~~----------~~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  184 (326)
T 2x7f_A          118 IKNTKG----------NTLKEEWIAYICREILRGLSHLH---QHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG  184 (326)
T ss_dssp             HHHSGG----------GCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCTTTC-------
T ss_pred             HHhccc----------CCCCHHHHHHHHHHHHHHHHHHH---HCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCcc
Confidence            976431          34899999999999999999999   569999999999999999999999999998754321  


Q ss_pred             ----------CCCCcccccC---CCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 ----------TESPQFYSTN---PASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 ----------~~~pe~~~~~---~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                +.+||.....   ...++.++|||||||++|||++|+.||...
T Consensus       185 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  237 (326)
T 2x7f_A          185 RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM  237 (326)
T ss_dssp             ------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             ccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence                      2356655421   345678899999999999999999999653

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=99.95  E-value=3.9e-27  Score=250.51  Aligned_cols=171  Identities=20%  Similarity=0.282  Sum_probs=137.7

Q ss_pred             eEEEEEEEE-CCeEEEEEEcch-----hHHHHHHHHHHHHHhCC--CCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL-NGKNLAIKRTEH-----EVITKLEMQLVQHATHH--HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~-~g~~vAvK~~~~-----~~~~~~e~ei~~~~~l~--HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      +|.||++.. +|+.||||.+..     .....+.+|+..+..+.  ||||+++++++..++ ..|+||| +.+|+|.+++
T Consensus        69 fg~Vy~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~-~~~lv~E-~~~~~L~~~l  146 (390)
T 2zmd_A           69 SSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ-YIYMVME-CGNIDLNSWL  146 (390)
T ss_dssp             SEEEEEEECTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS-EEEEEEE-CCSEEHHHHH
T ss_pred             CeEEEEEEcCCCCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCC-EEEEEEe-cCCCCHHHHH
Confidence            399999988 688999998743     22356778888887775  699999999987664 7999999 5688999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC---
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---  539 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~---  539 (600)
                      ....            .+++.++..++.||+.||.|||   +.+|+||||||+|||++ ++.+||+|||+++.....   
T Consensus       147 ~~~~------------~~~~~~~~~i~~qi~~aL~~lH---~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~  210 (390)
T 2zmd_A          147 KKKK------------SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS  210 (390)
T ss_dssp             HHCS------------SCCHHHHHHHHHHHHHHHHHHH---TTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC------
T ss_pred             HhcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcc
Confidence            7643            3889999999999999999999   67999999999999995 589999999999755321   


Q ss_pred             -----------CCCCcccccC---------CCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 -----------TESPQFYSTN---------PASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 -----------~~~pe~~~~~---------~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                 +.+||.....         ...++.++|||||||+||||++|+.||...
T Consensus       211 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~  270 (390)
T 2zmd_A          211 VVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI  270 (390)
T ss_dssp             ---CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             ccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhh
Confidence                       2345554321         135788899999999999999999999753

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=99.95  E-value=1.4e-27  Score=247.72  Aligned_cols=171  Identities=23%  Similarity=0.458  Sum_probs=138.2

Q ss_pred             EEEEEEEE--CCeE----EEEEEcch----hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          392 GAVYHGRL--NGKN----LAIKRTEH----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       392 G~Vy~g~~--~g~~----vAvK~~~~----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      |.||+++.  +|+.    ||+|.+..    .....+.+|+..+..++||||+++++++..+  ..++|+||+++|+|.++
T Consensus        29 g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--~~~~v~~~~~~g~L~~~  106 (327)
T 3lzb_A           29 GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--TVQLITQLMPFGCLLDY  106 (327)
T ss_dssp             EEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESS--SEEEEECCCSSCBHHHH
T ss_pred             eEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecC--CceEEEEecCCCcHHHH
Confidence            99999998  5554    57777643    2345678899999999999999999998654  58899999999999999


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--  539 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--  539 (600)
                      +....           ..+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....  
T Consensus       107 l~~~~-----------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~  172 (327)
T 3lzb_A          107 VREHK-----------DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK  172 (327)
T ss_dssp             HHHTT-----------TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCTTC---------
T ss_pred             HHhcC-----------CCCCHHHHHHHHHHHHHHHHHHh---hCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccc
Confidence            97643           34899999999999999999999   569999999999999999999999999999765321  


Q ss_pred             ------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCCC
Q 041830          540 ------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRPR  580 (600)
Q Consensus       540 ------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~~  580 (600)
                                  +.+||....  ..++.++|||||||++|||++ |+.||....
T Consensus       173 ~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~ell~~g~~p~~~~~  224 (327)
T 3lzb_A          173 EYHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIP  224 (327)
T ss_dssp             -------CCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             cccccCCCccccccCHHHHcC--CCCChHHHHHHHHHHHHHHHHCCCCCCCCCC
Confidence                        234554443  356788999999999999999 999997643

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=99.95  E-value=4.6e-28  Score=253.82  Aligned_cols=171  Identities=22%  Similarity=0.270  Sum_probs=140.4

Q ss_pred             EEEEEEEEC----------CeEEEEEEcchhHHHHHHHHHHHHHhCCCCceee---------------eeeEEeccCCce
Q 041830          392 GAVYHGRLN----------GKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVR---------------LLGTCLTDGPHS  446 (600)
Q Consensus       392 G~Vy~g~~~----------g~~vAvK~~~~~~~~~~e~ei~~~~~l~HpNIv~---------------l~g~~~~~~~~~  446 (600)
                      |.||+++..          ++.||+|.++..  ..+.+|+..+..++||||++               +++++..++...
T Consensus        56 g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~  133 (352)
T 2jii_A           56 GILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYR  133 (352)
T ss_dssp             EEEEEEEECC-----------CEEEEEEETT--STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEE
T ss_pred             eEEEEEeecCCccccccccCceEEEEEeccc--chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEE
Confidence            999999883          688999998765  45678888888889999988               677776645688


Q ss_pred             EEEEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC--c
Q 041830          447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEF--N  524 (600)
Q Consensus       447 ~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~--~  524 (600)
                      ++||||+ +|+|.+++.....          ..+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++  .
T Consensus       134 ~lv~e~~-~~~L~~~l~~~~~----------~~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dikp~NIl~~~~~~~~  199 (352)
T 2jii_A          134 FLVLPSL-GRSLQSALDVSPK----------HVLSERSVLQVACRLLDALEFLH---ENEYVHGNVTAENIFVDPEDQSQ  199 (352)
T ss_dssp             EEEEECC-CEEHHHHHHHSGG----------GCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCCGGGEEEETTEEEE
T ss_pred             EEEecCC-CcCHHHHHHhCCc----------CCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCCHHHEEEcCCCCce
Confidence            9999999 9999999986421          34999999999999999999999   56999999999999999998  9


Q ss_pred             EEEEeccCccccCC-------------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          525 ARVGNFGMARCVND-------------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       525 ~kI~DFGla~~~~~-------------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                      +||+|||+++....                   .+.+||....  ..++.++|||||||+||||++|+.||....
T Consensus       200 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~  272 (352)
T 2jii_A          200 VTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG--CGPSRRSDLQSLGYCMLKWLYGFLPWTNCL  272 (352)
T ss_dssp             EEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred             EEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc--CCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence            99999999965421                   1224554433  356788999999999999999999997643

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=99.95  E-value=8.9e-28  Score=246.86  Aligned_cols=184  Identities=24%  Similarity=0.436  Sum_probs=145.3

Q ss_pred             EEEEEEEE-------CCeEEEEEEcchh----HHHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCCHH
Q 041830          392 GAVYHGRL-------NGKNLAIKRTEHE----VITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       392 G~Vy~g~~-------~g~~vAvK~~~~~----~~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~  459 (600)
                      |.||++++       +++.||||.++..    ....+.+|+..+..+ +||||+++++++..++...++||||+++|+|.
T Consensus        41 g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~  120 (316)
T 2xir_A           41 GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLS  120 (316)
T ss_dssp             EEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHH
T ss_pred             eeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHH
Confidence            99999985       3578999997652    234567888888888 69999999999876655689999999999999


Q ss_pred             HHHhcCcCccccc----ccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccc
Q 041830          460 DWLHGGLAMKNQF----IASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARC  535 (600)
Q Consensus       460 ~~L~~~~~~~~~~----~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~  535 (600)
                      +++..........    .......+++.+++.++.|++.||.|||   +.+|+||||||+||+++.++.+||+|||+++.
T Consensus       121 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH---~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  197 (316)
T 2xir_A          121 TYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARD  197 (316)
T ss_dssp             HHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCGGGSC
T ss_pred             HHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHH---hCCcccccCccceEEECCCCCEEECCCccccc
Confidence            9998654210000    0000123789999999999999999999   56999999999999999999999999999975


Q ss_pred             cCCC--------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCCC
Q 041830          536 VNDD--------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRPR  580 (600)
Q Consensus       536 ~~~~--------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~~  580 (600)
                      ....              +.+||....  ..++.++||||||+++|||++ |+.||....
T Consensus       198 ~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~t~g~~p~~~~~  255 (316)
T 2xir_A          198 IYKDPDYVRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  255 (316)
T ss_dssp             TTTCTTSEEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             cccCccceeccCCCcceeecCchhhcc--ccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence            5322              234554433  346788999999999999998 999997644

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=99.95  E-value=6.4e-27  Score=239.36  Aligned_cols=174  Identities=18%  Similarity=0.285  Sum_probs=141.5

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhH-------HHHHHHHHHHHHhCCCCceeeeeeEEec-cCCceEEEEeecCCCCHHHH
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEV-------ITKLEMQLVQHATHHHPNIVRLLGTCLT-DGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~-------~~~~e~ei~~~~~l~HpNIv~l~g~~~~-~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      |.||++..  +|+.||+|.++...       ...+.+|+..+..++||||+++++++.. +....++||||+++| |.++
T Consensus        19 g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~   97 (305)
T 2wtk_C           19 GKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEM   97 (305)
T ss_dssp             CEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHH
T ss_pred             eEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHH
Confidence            89999998  68899999986532       2457889999999999999999999753 334789999999876 8787


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--  539 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--  539 (600)
                      +.....          ..+++.+++.++.|++.||.|||   +.+++||||||+|||++.++.+||+|||+++.....  
T Consensus        98 ~~~~~~----------~~~~~~~~~~~~~qi~~al~~LH---~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~  164 (305)
T 2wtk_C           98 LDSVPE----------KRFPVCQAHGYFCQLIDGLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA  164 (305)
T ss_dssp             HHHSTT----------CSCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCS
T ss_pred             HHhCcc----------cccCHHHHHHHHHHHHHHHHHHH---HCCeeecCCCcccEEEcCCCcEEeeccccccccCcccc
Confidence            765332          34899999999999999999999   569999999999999999999999999999765321  


Q ss_pred             ------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 ------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 ------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                  +.+||........++.++||||||+++|||++|+.||...
T Consensus       165 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  216 (305)
T 2wtk_C          165 DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGD  216 (305)
T ss_dssp             SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCc
Confidence                        1245554433333467899999999999999999999753

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=99.95  E-value=3.9e-27  Score=242.13  Aligned_cols=172  Identities=24%  Similarity=0.443  Sum_probs=139.2

Q ss_pred             eEEEEEEEE--CCeEEEEEEcch---hHHHHHHHHHHHHHhCCCCceeeeeeEEec-------------cCCceEEEEee
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEH---EVITKLEMQLVQHATHHHPNIVRLLGTCLT-------------DGPHSFLVFEY  452 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~---~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~-------------~~~~~~LV~Ey  452 (600)
                      .|.||+++.  +|+.||+|++..   ...+.+.+|+..+..++||||+++++++..             +....++||||
T Consensus        24 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~  103 (320)
T 2i6l_A           24 NGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY  103 (320)
T ss_dssp             --CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEEC
T ss_pred             CeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeec
Confidence            389999999  589999998753   233567889999999999999999998642             22467999999


Q ss_pred             cCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC-CCCcEEEEecc
Q 041830          453 AKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLD-EEFNARVGNFG  531 (600)
Q Consensus       453 ~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld-~~~~~kI~DFG  531 (600)
                      ++ |+|.+++...             .+++.++..++.|++.||+|||   +.+|+||||||+|||++ +++.+||+|||
T Consensus       104 ~~-~~L~~~~~~~-------------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg  166 (320)
T 2i6l_A          104 ME-TDLANVLEQG-------------PLLEEHARLFMYQLLRGLKYIH---SANVLHRDLKPANLFINTEDLVLKIGDFG  166 (320)
T ss_dssp             CS-EEHHHHHTTC-------------CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTTEEEECCCT
T ss_pred             cC-CCHHHHhhcC-------------CccHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHEEEcCCCCeEEEccCc
Confidence            98 6999999642             3899999999999999999999   56999999999999997 56799999999


Q ss_pred             CccccCCC---------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          532 MARCVNDD---------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       532 la~~~~~~---------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                      +++.....               ..+||.... ...++.++||||||+++|||++|+.||....
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~~~  229 (320)
T 2i6l_A          167 LARIMDPHYSHKGHLSEGLVTKWYRSPRLLLS-PNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH  229 (320)
T ss_dssp             TCBCC--------CCCGGGSCCTTCCHHHHHC-TTCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cccccCCCcccccccccccccccccCcHHhcC-cccCCchhhhHhHHHHHHHHHhCCCCCCCCC
Confidence            99865321               234554432 2456788999999999999999999997654

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=99.95  E-value=3.1e-27  Score=239.72  Aligned_cols=174  Identities=21%  Similarity=0.324  Sum_probs=131.3

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhH----HH-HHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEV----IT-KLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~----~~-~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      |.||+++.  +|+.||+|+++...    .. .+.++...+..++||||+++++++..+ ...++||||++ |+|.+++..
T Consensus        21 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~-~~~~lv~e~~~-~~l~~~l~~   98 (290)
T 3fme_A           21 GVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGALFRE-GDVWICMELMD-TSLDKFYKQ   98 (290)
T ss_dssp             EEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SSEEEEEECCS-EEHHHHHHH
T ss_pred             eEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeecc-CCEEEEEehhc-cchHHHHHH
Confidence            99999998  79999999986432    11 223334446678999999999998765 48999999997 599888764


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCC-CceecCCCCCCEEeCCCCcEEEEeccCccccCC-----
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNP-SYVHRNIKSRNIFLDEEFNARVGNFGMARCVND-----  538 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~-----  538 (600)
                      ....        ...+++.+++.++.|++.||.|||   +. +++||||||+|||++.++.+||+|||+++....     
T Consensus        99 ~~~~--------~~~~~~~~~~~i~~qi~~~l~~lH---~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  167 (290)
T 3fme_A           99 VIDK--------GQTIPEDILGKIAVSIVKALEHLH---SKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKD  167 (290)
T ss_dssp             HHHT--------TCCCCHHHHHHHHHHHHHHHHHHH---HHSCCCCCCCSGGGCEECTTCCEEBCCC-------------
T ss_pred             HHhc--------CCCCCHHHHHHHHHHHHHHHHHHh---hcCCeecCCCCHHHEEECCCCCEEEeecCCccccccccccc
Confidence            2110        134999999999999999999999   54 899999999999999999999999999865422     


Q ss_pred             ------CCCCCccccc--CCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          539 ------DTESPQFYST--NPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       539 ------~~~~pe~~~~--~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                            ...+||....  ....++.++||||||+++|||++|+.||..
T Consensus       168 ~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~  215 (290)
T 3fme_A          168 IDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS  215 (290)
T ss_dssp             --CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred             ccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence                  2345666432  234567889999999999999999999974

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=99.95  E-value=3.4e-27  Score=258.18  Aligned_cols=170  Identities=22%  Similarity=0.389  Sum_probs=143.9

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH-----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV-----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~-----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      .|.||+++.  +|+.||||.+....     ...+.+|+..+..++||||+++++++... ...|+||||+++|+|.+++.
T Consensus        35 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~  113 (486)
T 3mwu_A           35 FGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS-SSFYIVGELYTGGELFDEII  113 (486)
T ss_dssp             SSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHHH
T ss_pred             CEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcC-CEEEEEEEcCCCCcHHHHHH
Confidence            399999998  68999999985432     34678899999999999999999998655 48999999999999999986


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC---CCCcEEEEeccCccccCCC-
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLD---EEFNARVGNFGMARCVNDD-  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld---~~~~~kI~DFGla~~~~~~-  539 (600)
                      ...            .+++.++..++.|++.||.|||   +.+|+||||||+|||++   .++.+||+|||+++..... 
T Consensus       114 ~~~------------~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~  178 (486)
T 3mwu_A          114 KRK------------RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT  178 (486)
T ss_dssp             HHS------------SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-
T ss_pred             hcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC
Confidence            532            3899999999999999999999   66999999999999995   4568999999999754322 


Q ss_pred             ----------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 ----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 ----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                +.+||....   .++.++|||||||++|||++|+.||...
T Consensus       179 ~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~  225 (486)
T 3mwu_A          179 KMKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGK  225 (486)
T ss_dssp             ---CCTTGGGGCCGGGGGS---CCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccCCCcCCCCCCCHHHhCC---CCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence                      235666543   4788899999999999999999999754

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=99.94  E-value=2.6e-27  Score=249.32  Aligned_cols=171  Identities=20%  Similarity=0.349  Sum_probs=142.3

Q ss_pred             EEEEEEEE--CCeEEEEEEcch----hHHHHHHHHHHHHHhCCCCceeeeeeEEeccC----CceEEEEeecCCCCHHHH
Q 041830          392 GAVYHGRL--NGKNLAIKRTEH----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDG----PHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~----~~~~LV~Ey~~~GsL~~~  461 (600)
                      |.||+++.  +|+.||||++..    .....+.+|+..+..++||||+++++++....    ...++||||++ |+|.++
T Consensus        41 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~  119 (364)
T 3qyz_A           41 GMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKL  119 (364)
T ss_dssp             EEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHH
T ss_pred             eEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHH
Confidence            99999988  689999999753    22356788999999999999999999975432    35799999997 599999


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--  539 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--  539 (600)
                      +...             .+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....  
T Consensus       120 l~~~-------------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~  183 (364)
T 3qyz_A          120 LKTQ-------------HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD  183 (364)
T ss_dssp             HHHC-------------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC
T ss_pred             HHhC-------------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCC
Confidence            9653             2899999999999999999999   669999999999999999999999999999754321  


Q ss_pred             -------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 -------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 -------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                                   +.+||.... ...++.++|||||||++|||++|+.||...+
T Consensus       184 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~  236 (364)
T 3qyz_A          184 HTGFLTEYVATRWYRAPEIMLN-SKGYTKSIDIWSVGCILAEMLSNRPIFPGKH  236 (364)
T ss_dssp             BCCTTCCCCSCGGGCCHHHHHT-BCSCSTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccccccccccccCCCCCHHhcC-CCCCCcchhHHHHHHHHHHHHHCCCCCCCCC
Confidence                         124554332 2346888999999999999999999997654

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=99.94  E-value=1.1e-27  Score=248.07  Aligned_cols=171  Identities=25%  Similarity=0.391  Sum_probs=142.9

Q ss_pred             EEEEEEEE------CCeEEEEEEcchh---HHHHHHHHHHHHHhCCCCceeeeeeEEecc-CCceEEEEeecCCCCHHHH
Q 041830          392 GAVYHGRL------NGKNLAIKRTEHE---VITKLEMQLVQHATHHHPNIVRLLGTCLTD-GPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       392 G~Vy~g~~------~g~~vAvK~~~~~---~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~-~~~~~LV~Ey~~~GsL~~~  461 (600)
                      |.||++++      +|+.||||++...   ....+.+|+..+..++||||+++++++..+ ....++||||+++|+|.++
T Consensus        37 g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~  116 (327)
T 3lxl_A           37 GSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDF  116 (327)
T ss_dssp             EEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHH
T ss_pred             eEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHH
Confidence            99999985      5789999998543   234578999999999999999999998743 3468999999999999999


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--  539 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--  539 (600)
                      +....           ..+++.+++.++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....  
T Consensus       117 l~~~~-----------~~~~~~~~~~i~~qi~~al~~lH---~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  182 (327)
T 3lxl_A          117 LQRHR-----------ARLDASRLLLYSSQICKGMEYLG---SRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD  182 (327)
T ss_dssp             HHHHG-----------GGCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCS
T ss_pred             HHhcc-----------cCCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCChhhEEECCCCCEEEcccccceecccCCc
Confidence            97532           23899999999999999999999   569999999999999999999999999999865322  


Q ss_pred             -------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          540 -------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       540 -------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                                   +.+||....  ..++.++||||||+++|||++|+.||..
T Consensus       183 ~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~ll~g~~p~~~  232 (327)
T 3lxl_A          183 YYVVREPGQSPIFWYAPESLSD--NIFSRQSDVWSFGVVLYELFTYCDKSCS  232 (327)
T ss_dssp             EEECSSCCCSCGGGSCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCGGGS
T ss_pred             cceeeccCCccccccCHHHhcc--CCCChHHhHHHHHHHHHHHHhCCCCCcc
Confidence                         223444333  3457789999999999999999999854

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=99.94  E-value=1.9e-27  Score=250.80  Aligned_cols=174  Identities=21%  Similarity=0.322  Sum_probs=132.9

Q ss_pred             ceeEEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEecc-----CCceEEEEeecCCC
Q 041830          389 RIEGAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTD-----GPHSFLVFEYAKNG  456 (600)
Q Consensus       389 ~~~G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~-----~~~~~LV~Ey~~~G  456 (600)
                      |..|.||++..  +|+.||||++...     ....+.+|+..+..++||||+++++++...     ....|+|+||+ ++
T Consensus        40 G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~  118 (367)
T 2fst_X           40 GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GA  118 (367)
T ss_dssp             ---CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CE
T ss_pred             cCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CC
Confidence            33499999987  7899999997542     234667899999999999999999997543     23579999999 68


Q ss_pred             CHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCcccc
Q 041830          457 SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV  536 (600)
Q Consensus       457 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~  536 (600)
                      +|.++++..             .+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       119 ~L~~~~~~~-------------~l~~~~~~~i~~qi~~aL~~LH---~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~  182 (367)
T 2fst_X          119 DLNNIVKCQ-------------KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHT  182 (367)
T ss_dssp             ECC-----C-------------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred             CHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence            998888642             3899999999999999999999   669999999999999999999999999999754


Q ss_pred             CC---------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          537 ND---------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       537 ~~---------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                      ..         .+.+||.... ...++.++|||||||++|||++|+.||...+
T Consensus       183 ~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~  234 (367)
T 2fst_X          183 ADEMTGYVATRWYRAPEIMLN-WMHYNQTVDIWSVGCIMAELLTGRTLFPGTD  234 (367)
T ss_dssp             --------CCCTTCCHHHHTT-CCSCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccCCCcCcCcCccChHHHcC-CcCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence            32         2345665543 2457888999999999999999999997644

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=99.94  E-value=1.3e-27  Score=255.28  Aligned_cols=186  Identities=22%  Similarity=0.336  Sum_probs=140.1

Q ss_pred             CCceeEEEEEEEE----CCeEEEEEEcchhH-HHHHHHHHHHHHhCCCCceeeeeeEEec-cCCceEEEEeecCCCCHHH
Q 041830          387 SNRIEGAVYHGRL----NGKNLAIKRTEHEV-ITKLEMQLVQHATHHHPNIVRLLGTCLT-DGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       387 ~~~~~G~Vy~g~~----~g~~vAvK~~~~~~-~~~~e~ei~~~~~l~HpNIv~l~g~~~~-~~~~~~LV~Ey~~~GsL~~  460 (600)
                      +.|.+|.||+++.    +++.||||+++... ...+.+|+..+..++||||+++++++.. .+...++||||++ |+|.+
T Consensus        30 G~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~l~~  108 (405)
T 3rgf_A           30 GRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWH  108 (405)
T ss_dssp             C-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-EEHHH
T ss_pred             eecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CCHHH
Confidence            3344499999997    36789999987543 2456789999999999999999999864 3457899999997 58888


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEe----CCCCcEEEEeccCcccc
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFL----DEEFNARVGNFGMARCV  536 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl----d~~~~~kI~DFGla~~~  536 (600)
                      ++.........   .....+++.+++.++.||+.||.|||   +.+|+||||||+|||+    +.++.+||+|||+++..
T Consensus       109 ~~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~al~~LH---~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~  182 (405)
T 3rgf_A          109 IIKFHRASKAN---KKPVQLPRGMVKSLLYQILDGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLF  182 (405)
T ss_dssp             HHHHHHHHC----------CCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC--
T ss_pred             HHHHhcccccc---ccccCCCHHHHHHHHHHHHHHHHHHH---hCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceec
Confidence            88643210000   00134899999999999999999999   5689999999999999    77899999999999754


Q ss_pred             CC---------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          537 ND---------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       537 ~~---------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                      ..               .+.+||..... ..++.++|||||||+||||++|+.||....
T Consensus       183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG~il~ell~g~~pf~~~~  240 (405)
T 3rgf_A          183 NSPLKPLADLDPVVVTFWYRAPELLLGA-RHYTKAIDIWAIGCIFAELLTSEPIFHCRQ  240 (405)
T ss_dssp             --------------CCCTTCCHHHHTTC-CSCCHHHHHHHHHHHHHHHHHSSCTTCCCC
T ss_pred             CCCCcccccCCCceecCcccCchhhcCC-CcccchhhhHHHHHHHHHHHhCCCCCCCcc
Confidence            32               13456655432 347888999999999999999999997644

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=99.94  E-value=1.2e-27  Score=248.22  Aligned_cols=183  Identities=25%  Similarity=0.417  Sum_probs=143.7

Q ss_pred             EEEEEEEEC--C-----eEEEEEEcchh----HHHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCCHH
Q 041830          392 GAVYHGRLN--G-----KNLAIKRTEHE----VITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       392 G~Vy~g~~~--g-----~~vAvK~~~~~----~~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~  459 (600)
                      |.||++...  |     +.||+|.++..    ....+.+|+..+..+ +||||+++++++... ...++||||+++|+|.
T Consensus        60 g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~-~~~~lv~e~~~~g~L~  138 (333)
T 2i1m_A           60 GKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHG-GPVLVITEYCCYGDLL  138 (333)
T ss_dssp             EEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSCEEEEECCTTEEHH
T ss_pred             cceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecC-CceEEEEecCCCCcHH
Confidence            999999983  3     37999997643    335678899999998 899999999998655 4889999999999999


Q ss_pred             HHHhcCcCccc--ccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC
Q 041830          460 DWLHGGLAMKN--QFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN  537 (600)
Q Consensus       460 ~~L~~~~~~~~--~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~  537 (600)
                      +++........  .........+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       139 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~  215 (333)
T 2i1m_A          139 NFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIM  215 (333)
T ss_dssp             HHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGG
T ss_pred             HHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHh---cCCcccCCcccceEEECCCCeEEECccccccccc
Confidence            99975321000  000000134899999999999999999999   5699999999999999999999999999997542


Q ss_pred             CC--------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCCC
Q 041830          538 DD--------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRPR  580 (600)
Q Consensus       538 ~~--------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~~  580 (600)
                      ..              +.+||....  ..++.++||||||+++|||++ |+.||....
T Consensus       216 ~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~t~g~~p~~~~~  271 (333)
T 2i1m_A          216 NDSNYIVKGNARLPVKWMAPESIFD--CVYTVQSDVWSYGILLWEIFSLGLNPYPGIL  271 (333)
T ss_dssp             GCTTSEECSSCEECGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             cccceeecCCCCCCccccCHHHhcc--CCCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence            21              234554443  346788999999999999999 999997643

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=99.94  E-value=2.2e-27  Score=249.24  Aligned_cols=191  Identities=21%  Similarity=0.335  Sum_probs=147.4

Q ss_pred             HHHHHHHHhccCCCCcee----EEEEEEEE-CCeEEEEEEcchh--------------HHHHHHHHHHHHHhCCCCceee
Q 041830          374 IEDLRRATEKFNSSNRIE----GAVYHGRL-NGKNLAIKRTEHE--------------VITKLEMQLVQHATHHHPNIVR  434 (600)
Q Consensus       374 ~~el~~~t~~f~~~~~~~----G~Vy~g~~-~g~~vAvK~~~~~--------------~~~~~e~ei~~~~~l~HpNIv~  434 (600)
                      +.++....+.|.....+|    |.||++.. +|+.||||++...              ..+.+.+|+..+..++||||++
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~   93 (362)
T 3pg1_A           14 IAELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILG   93 (362)
T ss_dssp             HHHHHHTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCC
T ss_pred             HHHHHHhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccc
Confidence            344444455554433333    99999987 7899999987431              1256788999999999999999


Q ss_pred             eeeEEeccC----CceEEEEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceec
Q 041830          435 LLGTCLTDG----PHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHR  510 (600)
Q Consensus       435 l~g~~~~~~----~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHr  510 (600)
                      +++++....    ...++||||++ |+|.+++....           ..+++.++..++.|++.||.|||   +.+|+||
T Consensus        94 ~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~-----------~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~  158 (362)
T 3pg1_A           94 LRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQR-----------IVISPQHIQYFMYHILLGLHVLH---EAGVVHR  158 (362)
T ss_dssp             CSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTT-----------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCC
T ss_pred             eeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcc-----------cCCCHHHHHHHHHHHHHHHHHHH---HCcCEec
Confidence            999986422    25799999998 68999887543           34899999999999999999999   5699999


Q ss_pred             CCCCCCEEeCCCCcEEEEeccCccccCCC-----------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          511 NIKSRNIFLDEEFNARVGNFGMARCVNDD-----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       511 DLk~~NILld~~~~~kI~DFGla~~~~~~-----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                      ||||+|||++.++.+||+|||+++.....           +.+||.... ...++.++|||||||++|||++|+.||...
T Consensus       159 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~~l~~g~~pf~~~  237 (362)
T 3pg1_A          159 DLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQ-FKGFTKLVDMWSAGCVMAEMFNRKALFRGS  237 (362)
T ss_dssp             CCCGGGEEECTTCCEEECCTTC---------------CGGGCCHHHHTT-CTTCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CCChHHEEEcCCCCEEEEecCcccccccccccceecccceecCcHHhcC-CCCCCcHhHHHhHHHHHHHHHhCCCCCCCC
Confidence            99999999999999999999999744322           235555433 235788899999999999999999999764


Q ss_pred             C
Q 041830          580 R  580 (600)
Q Consensus       580 ~  580 (600)
                      .
T Consensus       238 ~  238 (362)
T 3pg1_A          238 T  238 (362)
T ss_dssp             S
T ss_pred             C
Confidence            3

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=99.94  E-value=2.1e-27  Score=259.66  Aligned_cols=170  Identities=25%  Similarity=0.359  Sum_probs=145.0

Q ss_pred             EEEEEEEE--CCeEEEEEEcchh------HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHE------VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~------~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      |.||+++.  +|+.||||.+...      ....+.+|+..+..++||||+++++++... ...++||||+++|+|.+++.
T Consensus        40 g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~  118 (484)
T 3nyv_A           40 GEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDK-GYFYLVGEVYTGGELFDEII  118 (484)
T ss_dssp             EEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHHH
T ss_pred             EEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeC-CEEEEEEecCCCCCHHHHHH
Confidence            99999998  7899999997432      235678899999999999999999998655 48999999999999999997


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEe---CCCCcEEEEeccCccccCCC-
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFL---DEEFNARVGNFGMARCVNDD-  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl---d~~~~~kI~DFGla~~~~~~-  539 (600)
                      ...            .+++.++..++.|++.||.|||   +.+|+||||||+|||+   +.++.+||+|||+++..... 
T Consensus       119 ~~~------------~~~~~~~~~i~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~  183 (484)
T 3nyv_A          119 SRK------------RFSEVDAARIIRQVLSGITYMH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK  183 (484)
T ss_dssp             TCS------------CCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC
T ss_pred             hcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc
Confidence            543            3899999999999999999999   5699999999999999   56789999999998765432 


Q ss_pred             ----------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 ----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 ----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                                +.+||....   .++.++|||||||++|||++|+.||...+
T Consensus       184 ~~~~~~gt~~y~aPE~~~~---~~~~~~DiwslG~il~~ll~g~~pf~~~~  231 (484)
T 3nyv_A          184 KMKDKIGTAYYIAPEVLHG---TYDEKCDVWSTGVILYILLSGCPPFNGAN  231 (484)
T ss_dssp             SHHHHTTGGGTCCHHHHHT---CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccccCCCCccccCceeecC---CCCCcceeHHHHHHHHHHHHCCCCCCCCC
Confidence                      345666543   47889999999999999999999997643

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=99.94  E-value=1.8e-27  Score=246.46  Aligned_cols=172  Identities=26%  Similarity=0.518  Sum_probs=142.4

Q ss_pred             eEEEEEEEE------CCeEEEEEEcch---hHHHHHHHHHHHHHhCCCCceeeeeeEEeccC-CceEEEEeecCCCCHHH
Q 041830          391 EGAVYHGRL------NGKNLAIKRTEH---EVITKLEMQLVQHATHHHPNIVRLLGTCLTDG-PHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       391 ~G~Vy~g~~------~g~~vAvK~~~~---~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~-~~~~LV~Ey~~~GsL~~  460 (600)
                      .|.||++++      +|+.||||++..   +....+++|+..+..++||||+++++++...+ ...++||||+++|+|.+
T Consensus        54 ~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~  133 (326)
T 2w1i_A           54 FGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD  133 (326)
T ss_dssp             SEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHH
T ss_pred             CeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHH
Confidence            399999985      588999999754   23456789999999999999999999976543 36799999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-  539 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-  539 (600)
                      ++....           ..+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++..... 
T Consensus       134 ~l~~~~-----------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~  199 (326)
T 2w1i_A          134 YLQKHK-----------ERIDHIKLLQYTSQICKGMEYLG---TKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDK  199 (326)
T ss_dssp             HHHHST-----------TSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSC
T ss_pred             HHHhcc-----------cCCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEEcCCCcEEEecCcchhhccccc
Confidence            997643           23899999999999999999999   569999999999999999999999999999865432 


Q ss_pred             --------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          540 --------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       540 --------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                                    ..+||....  ..++.++||||||+++|||++|+.||..
T Consensus       200 ~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~el~tg~~~~~~  250 (326)
T 2w1i_A          200 EYYKVKEPGESPIFWYAPESLTE--SKFSVASDVWSFGVVLYELFTYIEKSKS  250 (326)
T ss_dssp             SEEECSSCCSCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHHTTCGGGS
T ss_pred             cccccccCCCCceeEECchhhcC--CCCCchhhHHHHHHHHHHHHhcCCCCCC
Confidence                          123444332  2457789999999999999999998863

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=99.94  E-value=2.2e-27  Score=245.84  Aligned_cols=183  Identities=29%  Similarity=0.515  Sum_probs=143.4

Q ss_pred             eEEEEEEEE--CCeEE--EEEEcchh----HHHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          391 EGAVYHGRL--NGKNL--AIKRTEHE----VITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~v--AvK~~~~~----~~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      .|.||+++.  +|..+  |+|.++..    ....+.+|+..+..+ +||||+++++++... ...++||||+++|+|.++
T Consensus        38 ~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~  116 (327)
T 1fvr_A           38 FGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-GYLYLAIEYAPHGNLLDF  116 (327)
T ss_dssp             GCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-TEEEEEECCCTTCBHHHH
T ss_pred             CceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeC-CceEEEEecCCCCCHHHH
Confidence            399999987  66654  99987642    234578899999999 899999999998665 489999999999999999


Q ss_pred             HhcCcCcccc----cccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC
Q 041830          462 LHGGLAMKNQ----FIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN  537 (600)
Q Consensus       462 L~~~~~~~~~----~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~  537 (600)
                      +.........    ........+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       117 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~  193 (327)
T 1fvr_A          117 LRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQE  193 (327)
T ss_dssp             HHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEESSC
T ss_pred             HHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHH---hCCccCCCCccceEEEcCCCeEEEcccCcCcccc
Confidence            9765310000    00001135899999999999999999999   6699999999999999999999999999986332


Q ss_pred             -----------CCCCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          538 -----------DDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       538 -----------~~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                                 ....+||....  ..++.++||||||+++|||++ |+.||...
T Consensus       194 ~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~pf~~~  245 (327)
T 1fvr_A          194 VYVKKTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCGM  245 (327)
T ss_dssp             EECCC----CCTTTCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             ccccccCCCCCccccChhhhcc--ccCCchhcchHHHHHHHHHHcCCCCCCCCC
Confidence                       12335555433  346778999999999999998 99999653

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=99.94  E-value=3e-27  Score=247.34  Aligned_cols=174  Identities=22%  Similarity=0.380  Sum_probs=141.8

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH-----HHHHHHHHHHHHhCCCCceeeeeeEEecc-------CCceEEEEeecCCC
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV-----ITKLEMQLVQHATHHHPNIVRLLGTCLTD-------GPHSFLVFEYAKNG  456 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~-----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~-------~~~~~LV~Ey~~~G  456 (600)
                      .|.||+++.  +|+.||||++....     ...+.+|+..+..++||||+++++++...       +...++||||+++ 
T Consensus        30 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-  108 (351)
T 3mi9_A           30 FGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-  108 (351)
T ss_dssp             TTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-
T ss_pred             CcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-
Confidence            389999998  68999999874322     23567899999999999999999998653       2357999999985 


Q ss_pred             CHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCcccc
Q 041830          457 SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV  536 (600)
Q Consensus       457 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~  536 (600)
                      +|.+++....           ..+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       109 ~l~~~l~~~~-----------~~~~~~~~~~i~~qi~~~l~~LH---~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~  174 (351)
T 3mi9_A          109 DLAGLLSNVL-----------VKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAF  174 (351)
T ss_dssp             EHHHHHHCTT-----------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             CHHHHHhhcc-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeCCCCCHHHEEEcCCCCEEEccchhcccc
Confidence            8888876543           23899999999999999999999   569999999999999999999999999999754


Q ss_pred             CCC----------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          537 NDD----------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       537 ~~~----------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                      ...                +.+||.... ...++.++|||||||++|||++|+.||....
T Consensus       175 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwslG~il~ell~g~~pf~~~~  233 (351)
T 3mi9_A          175 SLAKNSQPNRYTNRVVTLWYRPPELLLG-ERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT  233 (351)
T ss_dssp             CCCSSSSCCCCCSSCSCGGGCCHHHHTT-CCSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccccccccccCCcccccCccCchhhcC-CCCCCcHhHHHHHHHHHHHHHhCCCCCCCCC
Confidence            311                224554432 2346888999999999999999999997643

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=99.94  E-value=2.1e-27  Score=242.56  Aligned_cols=173  Identities=24%  Similarity=0.389  Sum_probs=143.2

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhH---HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCc
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEV---ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGL  466 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~---~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~  466 (600)
                      |.||+++.  +|+.||+|.+....   ...+.+|+..+..++||||+++++++..+ ...++||||+++|+|.+++....
T Consensus        33 g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~l~~~~~~~~  111 (302)
T 2j7t_A           33 GKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYYHD-GKLWIMIEFCPGGAVDAIMLELD  111 (302)
T ss_dssp             CCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC--CEEEEEECCTTEEHHHHHHHHT
T ss_pred             eEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeC-CeEEEEEEeCCCCcHHHHHHhhc
Confidence            89999999  58899999876432   34677899999999999999999998765 48899999999999999986532


Q ss_pred             CcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCcccc----------
Q 041830          467 AMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV----------  536 (600)
Q Consensus       467 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~----------  536 (600)
                                 ..+++.+++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||++...          
T Consensus       112 -----------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  177 (302)
T 2j7t_A          112 -----------RGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSF  177 (302)
T ss_dssp             -----------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHHC----
T ss_pred             -----------cCCCHHHHHHHHHHHHHHHHHHh---cCCcccCCCCHHHEEECCCCCEEEEECCCCccccccccccccc
Confidence                       33899999999999999999999   569999999999999999999999999987421          


Q ss_pred             --CCCCCCCccccc---CCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          537 --NDDTESPQFYST---NPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       537 --~~~~~~pe~~~~---~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                        .....+||....   ....++.++||||||+++|||++|+.||...
T Consensus       178 ~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~  225 (302)
T 2j7t_A          178 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL  225 (302)
T ss_dssp             -CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             cCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccC
Confidence              112346666531   2345678899999999999999999999754

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=99.94  E-value=7.7e-28  Score=245.64  Aligned_cols=180  Identities=24%  Similarity=0.388  Sum_probs=134.5

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      .|.||+++.  +|+.||||.+..+.    ...+.+|+..+..++||||+++++++..+ +..++||||+++|+|.+++..
T Consensus        28 ~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~  106 (303)
T 2vwi_A           28 TAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTSFVVK-DELWLVMKLLSGGSVLDIIKH  106 (303)
T ss_dssp             CCCEEEEEC----CEEEEECCC----------------CCCCCCCTTBCCEEEEEESS-SCEEEEEECCTTCBHHHHHHH
T ss_pred             ceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcCCCCEeeEEEEEeec-CCcEEEehhccCCchHHHHHH
Confidence            389999987  78999999876432    23566788888888999999999998665 488999999999999999964


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC------
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND------  538 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~------  538 (600)
                      ......    .....+++.+++.++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++....      
T Consensus       107 ~~~~~~----~~~~~~~~~~~~~i~~qi~~~l~~lH---~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  179 (303)
T 2vwi_A          107 IVAKGE----HKSGVLDESTIATILREVLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITR  179 (303)
T ss_dssp             HHHTTT----TTTCSSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC-------
T ss_pred             Hhhccc----cccCCCCHHHHHHHHHHHHHHHHHHH---hCCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccc
Confidence            211000    00134899999999999999999999   56999999999999999999999999999865432      


Q ss_pred             -----------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 -----------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 -----------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                 .+.+||..... ..++.++||||||+++|||++|+.||...
T Consensus       180 ~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~~  230 (303)
T 2vwi_A          180 NKVRKTFVGTPCWMAPEVMEQV-RGYDFKADIWSFGITAIELATGAAPYHKY  230 (303)
T ss_dssp             --------CCCTTCCHHHHHHH-HCCCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             hhhhcccCCCccccCHHHhccc-cCCCchhhHHHHHHHHHHHHhCCCCCccC
Confidence                       12345544321 23577899999999999999999999753

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=99.94  E-value=4.8e-27  Score=245.52  Aligned_cols=171  Identities=19%  Similarity=0.347  Sum_probs=141.4

Q ss_pred             EEEEEEEE--CCeEEEEEEcch----hHHHHHHHHHHHHHhCCCCceeeeeeEEecc----CCceEEEEeecCCCCHHHH
Q 041830          392 GAVYHGRL--NGKNLAIKRTEH----EVITKLEMQLVQHATHHHPNIVRLLGTCLTD----GPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~----~~~~~LV~Ey~~~GsL~~~  461 (600)
                      |.||+++.  +|+.||||.++.    .....+.+|+..+..++||||+++++++..+    ....++||||++ |+|.++
T Consensus        25 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~  103 (353)
T 2b9h_A           25 GVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRV  103 (353)
T ss_dssp             EEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHH
T ss_pred             eEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHH
Confidence            99999998  599999999753    2234567899999999999999999987543    246899999997 699999


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--  539 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--  539 (600)
                      +...             .+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....  
T Consensus       104 ~~~~-------------~~~~~~~~~~~~qi~~~L~~LH---~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~  167 (353)
T 2b9h_A          104 ISTQ-------------MLSDDHIQYFIYQTLRAVKVLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAA  167 (353)
T ss_dssp             HHHC-------------CCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred             Hhhc-------------CCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEcCCCcEEEEecccccccccccc
Confidence            8753             3899999999999999999999   569999999999999999999999999999765321  


Q ss_pred             --------------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 --------------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 --------------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                                          +.+||.... ...++.++|||||||++|||++|+.||...+
T Consensus       168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~Di~slG~il~~l~~g~~pf~~~~  227 (353)
T 2b9h_A          168 DNSEPTGQQSGMVEFVATRWYRAPEVMLT-SAKYSRAMDVWSCGCILAELFLRRPIFPGRD  227 (353)
T ss_dssp             ------------CCCCCCGGGCCHHHHHS-CCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cccCccccccchhhccccccccCCeeecc-CCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence                                234554332 2456788999999999999999999997643

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=99.94  E-value=4.6e-27  Score=244.78  Aligned_cols=172  Identities=18%  Similarity=0.310  Sum_probs=130.4

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhHHHHHHHHHHHHHhCCCCceeeeeeEEecc---CCceEEEEeecCCCCHHHHHhcCc
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTD---GPHSFLVFEYAKNGSLKDWLHGGL  466 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~---~~~~~LV~Ey~~~GsL~~~L~~~~  466 (600)
                      |.||+++.  +|+.||||++....... ++....+..+.||||+++++++...   +...++||||+++|+|.+++....
T Consensus        43 g~V~~~~~~~~~~~vavK~~~~~~~~~-~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~  121 (336)
T 3fhr_A           43 GKVLECFHRRTGQKCALKLLYDSPKAR-QEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERG  121 (336)
T ss_dssp             EEEEEEEETTTCCEEEEEEEESSHHHH-HHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-
T ss_pred             eEEEEEEECCCCCEEEEEEecCcHHHH-HHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcC
Confidence            99999998  58999999987654222 2222335567899999999997642   235799999999999999997643


Q ss_pred             CcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC---CCcEEEEeccCccccCCC----
Q 041830          467 AMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE---EFNARVGNFGMARCVNDD----  539 (600)
Q Consensus       467 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~---~~~~kI~DFGla~~~~~~----  539 (600)
                      .          ..+++.+++.++.|++.||.|||   +.+|+||||||+|||++.   ++.+||+|||+++.....    
T Consensus       122 ~----------~~l~~~~~~~i~~ql~~~l~~LH---~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~~~~  188 (336)
T 3fhr_A          122 D----------QAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQT  188 (336)
T ss_dssp             C----------CCCBHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-------
T ss_pred             C----------CCCCHHHHHHHHHHHHHHHHHHH---hCCeecCCCCHHHEEEEecCCCceEEEeccccceecccccccc
Confidence            2          34899999999999999999999   569999999999999976   456999999999755322    


Q ss_pred             ------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 ------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 ------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                            +.+||....  ..++.++||||||+++|||++|+.||...
T Consensus       189 ~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~  232 (336)
T 3fhr_A          189 PCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGFPPFYSN  232 (336)
T ss_dssp             -----------------CHHHHHHHHHHHHHHHHHHHHSSCCC---
T ss_pred             CCCCcCccChhhhCC--CCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence                  234555432  34577899999999999999999999654

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=99.94  E-value=5.8e-27  Score=252.35  Aligned_cols=173  Identities=18%  Similarity=0.254  Sum_probs=140.5

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH--HHHHHHHHHHHHhC------CCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV--ITKLEMQLVQHATH------HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~--~~~~e~ei~~~~~l------~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      +|.||+++.  +|+.||||+++.+.  ...+..|+..+..+      .|+||+++++++... ...++||||+. |+|.+
T Consensus       110 fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~-~~~~lv~e~~~-~~L~~  187 (429)
T 3kvw_A          110 FGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR-NHICMTFELLS-MNLYE  187 (429)
T ss_dssp             SEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET-TEEEEEECCCC-CBHHH
T ss_pred             cEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC-CeEEEEEeccC-CCHHH
Confidence            399999988  68999999986543  23445566555544      578999999998655 48999999996 69999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCc--EEEEeccCccccCC
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFN--ARVGNFGMARCVND  538 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~--~kI~DFGla~~~~~  538 (600)
                      ++.....          ..+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.  +||+|||+++....
T Consensus       188 ~l~~~~~----------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~  254 (429)
T 3kvw_A          188 LIKKNKF----------QGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ  254 (429)
T ss_dssp             HHHHTTT----------CCCCHHHHHHHHHHHHHHHHHHH---HHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTC
T ss_pred             HHHhccC----------CCCCHHHHHHHHHHHHHHHHHHH---HCCeecCCCCHHHeEEccCCCcceEEeecccceecCC
Confidence            9976542          34899999999999999999999   558999999999999999887  99999999975433


Q ss_pred             C---------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          539 D---------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       539 ~---------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                      .         +.+||....  ..++.++|||||||+||||++|+.||...+
T Consensus       255 ~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltG~~pf~~~~  303 (429)
T 3kvw_A          255 RVYTYIQSRFYRAPEVILG--ARYGMPIDMWSLGCILAELLTGYPLLPGED  303 (429)
T ss_dssp             CCCSSCSCGGGCCHHHHHT--BCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cccccCCCCCccChHHHhC--CCCCchHHHHhHHHHHHHHHhCCCCCCCCC
Confidence            2         235665544  347889999999999999999999997654

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=99.94  E-value=3.7e-27  Score=244.14  Aligned_cols=178  Identities=26%  Similarity=0.452  Sum_probs=142.4

Q ss_pred             eEEEEEEEE-------CCeEEEEEEcch----hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHH
Q 041830          391 EGAVYHGRL-------NGKNLAIKRTEH----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       391 ~G~Vy~g~~-------~g~~vAvK~~~~----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~  459 (600)
                      .|.||+|++       +++.||||.+..    .....+.+|+..+..++||||+++++++..+ ...++||||+++|+|.
T Consensus        43 ~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~  121 (327)
T 2yfx_A           43 FGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVRCIGVSLQS-LPRFILMELMAGGDLK  121 (327)
T ss_dssp             SSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSCEEEEECCTTEEHH
T ss_pred             CeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCC-CCcEEEEecCCCCcHH
Confidence            389999984       466899999753    2334677899999999999999999998655 4789999999999999


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC---CCcEEEEeccCcccc
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE---EFNARVGNFGMARCV  536 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~---~~~~kI~DFGla~~~  536 (600)
                      +++........     ....+++.+++.++.|++.||.|||   +.+|+||||||+|||++.   +..+||+|||+++..
T Consensus       122 ~~l~~~~~~~~-----~~~~~~~~~~~~i~~qi~~al~~LH---~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~  193 (327)
T 2yfx_A          122 SFLRETRPRPS-----QPSSLAMLDLLHVARDIACGCQYLE---ENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI  193 (327)
T ss_dssp             HHHHHTSCCSS-----STTSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHH
T ss_pred             HHHHhhccccc-----ccccccHHHHHHHHHHHHHHHHHHh---hCCeecCcCCHhHEEEecCCCcceEEECcccccccc
Confidence            99986542111     1134899999999999999999999   569999999999999984   456999999998643


Q ss_pred             CC--------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          537 ND--------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       537 ~~--------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                      ..              .+.+||....  ..++.++||||||+++|||++ |+.||...
T Consensus       194 ~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~ellt~g~~p~~~~  249 (327)
T 2yfx_A          194 YRASYYRKGGCAMLPVKWMPPEAFME--GIFTSKTDTWSFGVLLWEIFSLGYMPYPSK  249 (327)
T ss_dssp             HC------CCGGGSCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred             ccccccccCCCcCCCcceeCHhHhcC--CCCCchhhHHHHHHHHHHHHcCCCCCCCCc
Confidence            11              1335555543  346788999999999999998 99999754

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=99.94  E-value=4.1e-27  Score=244.11  Aligned_cols=172  Identities=19%  Similarity=0.314  Sum_probs=141.6

Q ss_pred             EEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      |.||+++.  +|+.||+|.++..     ....+.+|+..+..+ +||||+++++++... ...++||||+++|+|.+++.
T Consensus        43 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~  121 (327)
T 3lm5_A           43 AVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENT-SEIILILEYAAGGEIFSLCL  121 (327)
T ss_dssp             EEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEEEEEECCTTEEGGGGGS
T ss_pred             eEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeC-CeEEEEEEecCCCcHHHHHH
Confidence            99999998  6899999987542     234667888888877 469999999997655 48999999999999999986


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC---CCcEEEEeccCccccCCC-
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE---EFNARVGNFGMARCVNDD-  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~---~~~~kI~DFGla~~~~~~-  539 (600)
                      ....          ..+++.+++.++.|++.||+|||   +.+|+||||||+|||++.   ++.+||+|||+++..... 
T Consensus       122 ~~~~----------~~~~~~~~~~i~~ql~~~L~~LH---~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~  188 (327)
T 3lm5_A          122 PELA----------EMVSENDVIRLIKQILEGVYYLH---QNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC  188 (327)
T ss_dssp             SCC-----------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC----
T ss_pred             Hhcc----------cCCCHHHHHHHHHHHHHHHHHHH---HCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCcc
Confidence            4321          34899999999999999999999   569999999999999987   789999999999765432 


Q ss_pred             ----------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 ----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 ----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                +.+||....  ..++.++||||||+++|||++|+.||...
T Consensus       189 ~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~il~~ll~g~~pf~~~  236 (327)
T 3lm5_A          189 ELREIMGTPEYLAPEILNY--DPITTATDMWNIGIIAYMLLTHTSPFVGE  236 (327)
T ss_dssp             -----CCCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccccccCCcCccCCeeecC--CCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence                      234555443  45678899999999999999999999654

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=99.94  E-value=1.9e-26  Score=234.89  Aligned_cols=165  Identities=27%  Similarity=0.501  Sum_probs=137.5

Q ss_pred             EEEEEEEE--CCeEEEEEEcchh--HHHHHHHHHHHHHhCCCCceeeeeeEEecc------------CCceEEEEeecCC
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHE--VITKLEMQLVQHATHHHPNIVRLLGTCLTD------------GPHSFLVFEYAKN  455 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~--~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~------------~~~~~LV~Ey~~~  455 (600)
                      |.||+++.  +|+.||||.++..  ....+.+|+..+..++||||+++++++...            ....++||||+++
T Consensus        20 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~   99 (303)
T 1zy4_A           20 GQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCEN   99 (303)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCS
T ss_pred             EEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCC
Confidence            99999998  7899999998643  335678899999999999999999987642            2367999999999


Q ss_pred             CCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccc
Q 041830          456 GSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARC  535 (600)
Q Consensus       456 GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~  535 (600)
                      |+|.+++....           ..+++.+++.++.|++.||+|||   +.+++||||||+|||++.++.+||+|||+++.
T Consensus       100 ~~L~~~l~~~~-----------~~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~  165 (303)
T 1zy4_A          100 GTLYDLIHSEN-----------LNQQRDEYWRLFRQILEALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKN  165 (303)
T ss_dssp             CBHHHHHHHSC-----------GGGCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCCCCCSC
T ss_pred             CCHHHhhhccc-----------cccchHHHHHHHHHHHHHHHHHH---hCCeecccCCHHhEEEcCCCCEEEeeCcchhh
Confidence            99999997543           23788999999999999999999   56999999999999999999999999999875


Q ss_pred             cCC--------------------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHh
Q 041830          536 VND--------------------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLS  571 (600)
Q Consensus       536 ~~~--------------------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt  571 (600)
                      ...                          .+.+||.... ...++.++||||||+++|||++
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~~~Di~slG~il~~l~~  226 (303)
T 1zy4_A          166 VHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDG-TGHYNEKIDMYSLGIIFFEMIY  226 (303)
T ss_dssp             TTC-------------------------CTTSCHHHHTS-CSCCCTHHHHHHHHHHHHHHHS
T ss_pred             cccccchhccccccccccccccccCCCcccccCcccccC-CCCCcchhhHHHHHHHHHHHHh
Confidence            431                          1234555432 1356788999999999999998

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=99.94  E-value=3.5e-27  Score=251.21  Aligned_cols=175  Identities=22%  Similarity=0.330  Sum_probs=136.8

Q ss_pred             EEEEEEEE-CCeEEEEEEcchhHHHHHHHHHHHHHhCCCCceeeeeeEEeccCC-----ceEEEEeecCCCCHHHHHhcC
Q 041830          392 GAVYHGRL-NGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGP-----HSFLVFEYAKNGSLKDWLHGG  465 (600)
Q Consensus       392 G~Vy~g~~-~g~~vAvK~~~~~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~-----~~~LV~Ey~~~GsL~~~L~~~  465 (600)
                      |.||+++. .+..+|+|++..+. ....+|+..+..++||||+++++++...+.     ..++||||++++ +.+.+...
T Consensus        54 g~V~~a~~~~~~~~aikk~~~~~-~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~  131 (394)
T 4e7w_A           54 GVVFQAKLVESDEVAIKKVLQDK-RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPET-VYRASRHY  131 (394)
T ss_dssp             EEEEEEEETTTEEEEEEEEECCT-TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEE-HHHHHHHH
T ss_pred             eEEEEEEECCCCeEEEEEEecCc-chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCcc-HHHHHHHH
Confidence            99999999 56679999875543 223568888999999999999999865432     278999999875 44433221


Q ss_pred             cCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC-CCCcEEEEeccCccccCCC-----
Q 041830          466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLD-EEFNARVGNFGMARCVNDD-----  539 (600)
Q Consensus       466 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld-~~~~~kI~DFGla~~~~~~-----  539 (600)
                      ...        ...+++..+..++.|+++||+|||   +.+|+||||||+|||++ .++.+||+|||+++.....     
T Consensus       132 ~~~--------~~~~~~~~~~~~~~qi~~aL~~LH---~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~~~~  200 (394)
T 4e7w_A          132 AKL--------KQTMPMLLIKLYMYQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVS  200 (394)
T ss_dssp             HHT--------TSCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCS
T ss_pred             Hhh--------cCCCCHHHHHHHHHHHHHHHHHHH---HCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCCCcc
Confidence            100        134899999999999999999999   56999999999999998 7999999999999865322     


Q ss_pred             ------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 ------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 ------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                            +.+||.... ...++.++|||||||++|||++|+.||...+
T Consensus       201 ~~~t~~y~aPE~~~~-~~~~~~~~DiwSlG~il~ell~g~~pf~~~~  246 (394)
T 4e7w_A          201 YICSRYYRAPELIFG-ATNYTTNIDIWSTGCVMAELMQGQPLFPGES  246 (394)
T ss_dssp             SCSCGGGCCHHHHTT-CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cccCcCccCHHHHcC-CCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                  224554432 2357889999999999999999999997644

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=99.94  E-value=1.6e-26  Score=251.98  Aligned_cols=173  Identities=20%  Similarity=0.232  Sum_probs=137.7

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhH-HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcCc
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEV-ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM  468 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~-~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~  468 (600)
                      |.||+++.  +|+.||||.++... ...+..|+..+..+.|++.+..+.++...+...+|||||+ +++|.+++....  
T Consensus        21 G~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~--   97 (483)
T 3sv0_A           21 GEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCS--   97 (483)
T ss_dssp             CEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTT--
T ss_pred             EEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhc--
Confidence            99999997  68999999875432 2356778888888887555444444444555889999999 999999997532  


Q ss_pred             ccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEe---CCCCcEEEEeccCccccCCC------
Q 041830          469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFL---DEEFNARVGNFGMARCVNDD------  539 (600)
Q Consensus       469 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl---d~~~~~kI~DFGla~~~~~~------  539 (600)
                               ..+++.+++.|+.||+.||.|||   +.+|+||||||+|||+   +.++.+||+|||+++.....      
T Consensus        98 ---------~~l~~~~~~~i~~qi~~aL~yLH---~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~  165 (483)
T 3sv0_A           98 ---------RKLSLKTVLMLADQMINRVEFVH---SKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHI  165 (483)
T ss_dssp             ---------TCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBC
T ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHHH---HCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcccccc
Confidence                     24999999999999999999999   6699999999999999   68899999999999765332      


Q ss_pred             -------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCCC
Q 041830          540 -------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRK  581 (600)
Q Consensus       540 -------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~  581 (600)
                                   +.+||....  ..++.++|||||||+||||++|+.||.....
T Consensus       166 ~~~~~~~~~gt~~Y~aPE~~~~--~~~s~~sDvwSlGvil~elltG~~Pf~~~~~  218 (483)
T 3sv0_A          166 PYRENKNLTGTARYASVNTHLG--IEQSRRDDLESLGYVLMYFLRGSLPWQGLKA  218 (483)
T ss_dssp             CCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred             ccccccccCCCccccCHHHhcC--CCCChHHHHHHHHHHHHHHHhCCCCCccccc
Confidence                         123444333  3467889999999999999999999987544

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=99.94  E-value=5.5e-27  Score=238.07  Aligned_cols=171  Identities=26%  Similarity=0.442  Sum_probs=138.4

Q ss_pred             eEEEEEEEE---CCe--EEEEEEcchh------HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHH
Q 041830          391 EGAVYHGRL---NGK--NLAIKRTEHE------VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       391 ~G~Vy~g~~---~g~--~vAvK~~~~~------~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~  459 (600)
                      .|.||++++   +++  .||+|.++..      ..+.+.+|+..+..++||||+++++++..+  ..++||||+++|+|.
T Consensus        31 ~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--~~~~v~e~~~~~~L~  108 (291)
T 1u46_A           31 FGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTP--PMKMVTELAPLGSLL  108 (291)
T ss_dssp             -CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS--SCEEEEECCTTCBHH
T ss_pred             ceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccC--CceeeEecccCCCHH
Confidence            389999986   233  6899987542      235678899999999999999999997543  589999999999999


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD  539 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~  539 (600)
                      +++....           ..+++.++..++.|++.||.|||   +.+++||||||+||+++.++.+||+|||+++.....
T Consensus       109 ~~l~~~~-----------~~~~~~~~~~~~~~i~~~l~~lH---~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~  174 (291)
T 1u46_A          109 DRLRKHQ-----------GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN  174 (291)
T ss_dssp             HHHHHHG-----------GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred             HHHHhcc-----------CCcCHHHHHHHHHHHHHHHHHHH---hCCcccCCCchheEEEcCCCCEEEcccccccccccc
Confidence            9997532           23899999999999999999999   569999999999999999999999999998765332


Q ss_pred             ---------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          540 ---------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       540 ---------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                                     +.+||....  ..++.++||||||+++|||++ |+.||...
T Consensus       175 ~~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~~g~~p~~~~  228 (291)
T 1u46_A          175 DDHYVMQEHRKVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGL  228 (291)
T ss_dssp             CCEEEC-----CCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             ccchhhhccCCCCceeeCchhhcC--CCCCchhhHHHHHHHHHHHHhCCCCCcccC
Confidence                           224444433  345778999999999999999 99999653

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=99.94  E-value=1.8e-26  Score=243.59  Aligned_cols=171  Identities=20%  Similarity=0.372  Sum_probs=139.2

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCC-----ceEEEEeecCCCCH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGP-----HSFLVFEYAKNGSL  458 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~-----~~~LV~Ey~~~GsL  458 (600)
                      .|.||++..  +|+.||||++...     ....+.+|+..+..++||||+++++++...+.     ..++||||++ |+|
T Consensus        55 ~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l  133 (371)
T 4exu_A           55 YGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDL  133 (371)
T ss_dssp             SEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEH
T ss_pred             CeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccH
Confidence            399999988  6999999997542     23567789999999999999999999865432     2399999998 689


Q ss_pred             HHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC
Q 041830          459 KDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND  538 (600)
Q Consensus       459 ~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~  538 (600)
                      .+++.              ..+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus       134 ~~~~~--------------~~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  196 (371)
T 4exu_A          134 QKIMG--------------MEFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA  196 (371)
T ss_dssp             HHHTT--------------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECSTTCC-----
T ss_pred             HHHhh--------------cCCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCcCHHHeEECCCCCEEEEecCccccccc
Confidence            88874              23899999999999999999999   56999999999999999999999999999975432


Q ss_pred             ---------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          539 ---------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       539 ---------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                               .+.+||.... ...++.++|||||||++|||++|+.||...+
T Consensus       197 ~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~il~el~~g~~pf~~~~  246 (371)
T 4exu_A          197 EMTGYVVTRWYRAPEVILS-WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD  246 (371)
T ss_dssp             ---CTTCCCTTSCHHHHSC-CSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             CcCCcccCccccCHHHhcC-CCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence                     2235665443 2457888999999999999999999997643

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=99.94  E-value=1.1e-26  Score=246.41  Aligned_cols=175  Identities=19%  Similarity=0.259  Sum_probs=139.7

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhH--HHHHHHHHHHHHhCC--------CCceeeeeeEEec---cCCceEEEEeecCCC
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEV--ITKLEMQLVQHATHH--------HPNIVRLLGTCLT---DGPHSFLVFEYAKNG  456 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~--~~~~e~ei~~~~~l~--------HpNIv~l~g~~~~---~~~~~~LV~Ey~~~G  456 (600)
                      |.||+++.  +|+.||||+++...  ...+.+|+..+..++        |+||+++++++..   ++...++||||+ +|
T Consensus        51 g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~  129 (397)
T 1wak_A           51 STVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GH  129 (397)
T ss_dssp             EEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CC
T ss_pred             eeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEecc-Cc
Confidence            99999987  68999999986532  345667777777664        7889999999762   334789999999 56


Q ss_pred             CHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCC-CceecCCCCCCEEeCCCC------------
Q 041830          457 SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNP-SYVHRNIKSRNIFLDEEF------------  523 (600)
Q Consensus       457 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDLk~~NILld~~~------------  523 (600)
                      +|.+++.....          ..+++.+++.++.||+.||.|||   +. +|+||||||+|||++.++            
T Consensus       130 ~l~~~~~~~~~----------~~~~~~~~~~i~~qi~~aL~~lH---~~~givHrDikp~NIll~~~~~~~~~~~~~~~~  196 (397)
T 1wak_A          130 HLLKWIIKSNY----------QGLPLPCVKKIIQQVLQGLDYLH---TKCRIIHTDIKPENILLSVNEQYIRRLAAEATE  196 (397)
T ss_dssp             BHHHHHHHTTT----------SCCCHHHHHHHHHHHHHHHHHHH---HTTCEECCCCSGGGEEECCCHHHHHHHHHHHC-
T ss_pred             cHHHHHHhccc----------CCCCHHHHHHHHHHHHHHHHHHH---HhCCEecCCCCHHHeeEeccchhhhhhhhhhHH
Confidence            77777654321          34899999999999999999999   55 899999999999998775            


Q ss_pred             -------------------------------------cEEEEeccCccccCCC---------CCCCcccccCCCCCCccC
Q 041830          524 -------------------------------------NARVGNFGMARCVNDD---------TESPQFYSTNPASWSMGI  557 (600)
Q Consensus       524 -------------------------------------~~kI~DFGla~~~~~~---------~~~pe~~~~~~~~~t~~s  557 (600)
                                                           .+||+|||+++.....         +.+||....  ..++.++
T Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~  274 (397)
T 1wak_A          197 WQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYRSLEVLIG--SGYNTPA  274 (397)
T ss_dssp             --------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBCSCSCCSCGGGCCHHHHHT--SCCCTHH
T ss_pred             HhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccccccCccCCCCCcccCChhhcC--CCCCcHH
Confidence                                                 8999999999755322         235665544  3478899


Q ss_pred             chHHHHHHHHHHHhCCCCCCCCCCC
Q 041830          558 DIFAYGIVLLEVLSGQTPINRPRKK  582 (600)
Q Consensus       558 DVwSfGvvL~ELltG~~Pf~~~~~~  582 (600)
                      |||||||+||||++|+.||...+..
T Consensus       275 DiwslG~il~elltg~~pf~~~~~~  299 (397)
T 1wak_A          275 DIWSTACMAFELATGDYLFEPHSGE  299 (397)
T ss_dssp             HHHHHHHHHHHHHHSSCSCCCCCCS
T ss_pred             HHHHHHHHHHHHhhCCCCCCCCccc
Confidence            9999999999999999999865543

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=99.94  E-value=2.7e-26  Score=233.08  Aligned_cols=169  Identities=22%  Similarity=0.390  Sum_probs=142.7

Q ss_pred             EEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      |.||+++.  +|+.||+|.+...     ....+.+|+..+..++||||+++++++... ...++||||+++++|.+++..
T Consensus        36 g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~  114 (287)
T 2wei_A           36 GEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDS-SSFYIVGELYTGGELFDEIIK  114 (287)
T ss_dssp             EEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHHHH
T ss_pred             EEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhccCCCccEEEEEEeCC-CeEEEEEEccCCCCHHHHHHh
Confidence            99999998  6899999997543     235678899999999999999999998655 488999999999999999865


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC---CcEEEEeccCccccCCC--
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEE---FNARVGNFGMARCVNDD--  539 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~---~~~kI~DFGla~~~~~~--  539 (600)
                      ..            .+++.+++.++.|++.||.|||   +.+++||||||+||+++.+   +.+||+|||+++.....  
T Consensus       115 ~~------------~~~~~~~~~i~~qi~~~l~~LH---~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~  179 (287)
T 2wei_A          115 RK------------RFSEHDAARIIKQVFSGITYMH---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK  179 (287)
T ss_dssp             HS------------SCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS
T ss_pred             cC------------CCCHHHHHHHHHHHHHHHHHHH---HCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc
Confidence            32            3899999999999999999999   5699999999999999754   47999999998765432  


Q ss_pred             ---------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 ---------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 ---------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                               ..+||....   .++.++||||||+++|||++|+.||...
T Consensus       180 ~~~~~~~~~y~aPE~~~~---~~~~~~Di~slG~~l~~l~~g~~p~~~~  225 (287)
T 2wei_A          180 MKDRIGTAYYIAPEVLRG---TYDEKCDVWSAGVILYILLSGTPPFYGK  225 (287)
T ss_dssp             CSCHHHHHTTCCHHHHTT---CCCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cccccCcccccChHHhcC---CCCCchhhHhHHHHHHHHHhCCCCCCCC
Confidence                     235665543   3678899999999999999999999754

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=99.94  E-value=2.2e-26  Score=241.22  Aligned_cols=179  Identities=21%  Similarity=0.300  Sum_probs=135.6

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH--HHHHHHHHHHHHhCCCCceeeeeeEEeccCC------ceEEEEeecCCCCHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV--ITKLEMQLVQHATHHHPNIVRLLGTCLTDGP------HSFLVFEYAKNGSLKD  460 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~--~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~------~~~LV~Ey~~~GsL~~  460 (600)
                      .|.||+++.  +|+.||||++..+.  ......++..+..++||||+++++++...+.      ..++||||+++ +|.+
T Consensus        36 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~  114 (360)
T 3e3p_A           36 FGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHR  114 (360)
T ss_dssp             ---CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHH
T ss_pred             CeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHH
Confidence            499999998  58999999875432  2244566667777899999999999865331      27899999986 5655


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC-CCcEEEEeccCccccCCC
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE-EFNARVGNFGMARCVNDD  539 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~-~~~~kI~DFGla~~~~~~  539 (600)
                      .+......        ...+++..+..++.|++.||.|||.. +.+|+||||||+|||++. ++.+||+|||+++.....
T Consensus       115 ~~~~~~~~--------~~~~~~~~~~~~~~qi~~al~~lH~~-~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~  185 (360)
T 3e3p_A          115 CCRNYYRR--------QVAPPPILIKVFLFQLIRSIGCLHLP-SVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS  185 (360)
T ss_dssp             HHHHHHTT--------TCCCCHHHHHHHHHHHHHHHHHHTST-TTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTT
T ss_pred             HHHHHhhc--------ccCCCHHHHHHHHHHHHHHHHHHhCC-CCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCC
Confidence            55421110        13489999999999999999999943 568999999999999996 899999999999865432


Q ss_pred             -----------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 -----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 -----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                                 +.+||.... ...++.++|||||||++|||++|+.||...+
T Consensus       186 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~~Di~slG~il~ell~g~~pf~~~~  236 (360)
T 3e3p_A          186 EPNVAYICSRYYRAPELIFG-NQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN  236 (360)
T ss_dssp             SCCCSTTSCGGGCCHHHHTT-CSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             CCcccccCCcceeCHHHHcC-CCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC
Confidence                       124554432 2347888999999999999999999997644

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=99.94  E-value=1.2e-26  Score=239.58  Aligned_cols=173  Identities=22%  Similarity=0.373  Sum_probs=137.7

Q ss_pred             EEEEEEEE---CCeEEEEEEcchhH-----HHHHHHHHHHHH---hCCCCceeeeeeEEec----cCCceEEEEeecCCC
Q 041830          392 GAVYHGRL---NGKNLAIKRTEHEV-----ITKLEMQLVQHA---THHHPNIVRLLGTCLT----DGPHSFLVFEYAKNG  456 (600)
Q Consensus       392 G~Vy~g~~---~g~~vAvK~~~~~~-----~~~~e~ei~~~~---~l~HpNIv~l~g~~~~----~~~~~~LV~Ey~~~G  456 (600)
                      |.||+++.   +|+.||+|+++...     ...+.+|+..+.   .+.||||+++++++..    .....++||||++ |
T Consensus        25 g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~  103 (326)
T 1blx_A           25 GKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-Q  103 (326)
T ss_dssp             EEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-C
T ss_pred             EEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-C
Confidence            99999987   47899999875321     113344554444   4589999999999862    2346899999998 6


Q ss_pred             CHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCcccc
Q 041830          457 SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV  536 (600)
Q Consensus       457 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~  536 (600)
                      +|.+++.....          ..+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       104 ~L~~~l~~~~~----------~~~~~~~~~~~~~qi~~~l~~lH---~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~  170 (326)
T 1blx_A          104 DLTTYLDKVPE----------PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIY  170 (326)
T ss_dssp             BHHHHHHHSCT----------TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCSCCCC
T ss_pred             CHHHHHHhccc----------CCCCHHHHHHHHHHHHHHHHHHH---HCCceeccCCHHHeEEcCCCCEEEecCcccccc
Confidence            99999976432          23899999999999999999999   569999999999999999999999999998754


Q ss_pred             CC-----------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          537 ND-----------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       537 ~~-----------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                      ..           ...+||....  ..++.++||||||+++|||++|+.||....
T Consensus       171 ~~~~~~~~~~~~~~y~aPE~~~~--~~~~~~~Di~slG~il~~l~~g~~pf~~~~  223 (326)
T 1blx_A          171 SFQMALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGSS  223 (326)
T ss_dssp             CGGGGGCCCCCCCTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             cCCCCccccccccceeCHHHHhc--CCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence            31           2235665544  346888999999999999999999997543

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=99.94  E-value=7.8e-27  Score=251.72  Aligned_cols=178  Identities=21%  Similarity=0.403  Sum_probs=135.5

Q ss_pred             EEEE-EEEECCeEEEEEEcchhHHHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcCcc
Q 041830          392 GAVY-HGRLNGKNLAIKRTEHEVITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMK  469 (600)
Q Consensus       392 G~Vy-~g~~~g~~vAvK~~~~~~~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~  469 (600)
                      |.|| .+..+|+.||||++..+..+.+.+|+..+..+ +|||||++++++..+ ...|+|||||+ |+|.+++.......
T Consensus        29 g~V~~~~~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~-~~~~lv~E~~~-gsL~~~l~~~~~~~  106 (434)
T 2rio_A           29 GTVVFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTD-RFLYIALELCN-LNLQDLVESKNVSD  106 (434)
T ss_dssp             TCEEEEEESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECS-SEEEEEECCCS-EEHHHHHHTC----
T ss_pred             eEEEEEEEECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecC-CeEEEEEecCC-CCHHHHHhccCCCc
Confidence            7775 55558999999998876666677888888764 899999999997555 58999999996 69999997654211


Q ss_pred             cccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCC-------------CcEEEEeccCcccc
Q 041830          470 NQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEE-------------FNARVGNFGMARCV  536 (600)
Q Consensus       470 ~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~-------------~~~kI~DFGla~~~  536 (600)
                      ..     ....++.+++.++.||+.||+|||   +.+|+||||||+|||++.+             +.+||+|||+++..
T Consensus       107 ~~-----~~~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~  178 (434)
T 2rio_A          107 EN-----LKLQKEYNPISLLRQIASGVAHLH---SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKL  178 (434)
T ss_dssp             -------------CCHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEEC
T ss_pred             hh-----hhhccchhHHHHHHHHHHHHHHHH---HCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceec
Confidence            10     011245567889999999999999   5699999999999999654             58999999999754


Q ss_pred             CC----------------CCCCCccccc-----CCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          537 ND----------------DTESPQFYST-----NPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       537 ~~----------------~~~~pe~~~~-----~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                      ..                .+.+||....     ....++.++|||||||++|||++ |+.||...
T Consensus       179 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~  243 (434)
T 2rio_A          179 DSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDK  243 (434)
T ss_dssp             CC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCST
T ss_pred             CCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCc
Confidence            32                2335666543     12457888999999999999999 99999653

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=99.94  E-value=1.7e-26  Score=261.24  Aligned_cols=171  Identities=24%  Similarity=0.468  Sum_probs=142.6

Q ss_pred             eEEEEEEEEC-----CeEEEEEEcch----hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          391 EGAVYHGRLN-----GKNLAIKRTEH----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       391 ~G~Vy~g~~~-----g~~vAvK~~~~----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      .|.||+|++.     +..||||.++.    ...+.+.+|+..+..++||||++++|++ .+ +..|+||||+++|+|.++
T Consensus       403 fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~-~~-~~~~lv~E~~~~g~L~~~  480 (656)
T 2j0j_A          403 FGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVI-TE-NPVWIIMELCTLGELRSF  480 (656)
T ss_dssp             SCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-CS-SSCEEEEECCTTCBHHHH
T ss_pred             CEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEE-ec-CceEEEEEcCCCCcHHHH
Confidence            3999999982     45799998754    2235678899999999999999999997 34 368999999999999999


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--  539 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--  539 (600)
                      ++...           ..+++.+++.++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....  
T Consensus       481 l~~~~-----------~~l~~~~~~~i~~qi~~aL~~LH---~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~  546 (656)
T 2j0j_A          481 LQVRK-----------FSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY  546 (656)
T ss_dssp             HHHTT-----------TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC---
T ss_pred             HHhcc-----------CCCCHHHHHHHHHHHHHHHHHHH---hCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcc
Confidence            97543           24899999999999999999999   569999999999999999999999999999865322  


Q ss_pred             -----------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          540 -----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       540 -----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                                 +.+||....  ..++.++|||||||++|||++ |+.||...
T Consensus       547 ~~~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~ellt~g~~Pf~~~  596 (656)
T 2j0j_A          547 YKASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGV  596 (656)
T ss_dssp             -------CCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             eeccCCCCCcceeCHHHhcC--CCCCchhhHHHHHHHHHHHHHcCCCCCCCC
Confidence                       234555443  356788999999999999997 99999754

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=99.93  E-value=2e-26  Score=241.35  Aligned_cols=170  Identities=21%  Similarity=0.379  Sum_probs=139.1

Q ss_pred             EEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCC-----ceEEEEeecCCCCHH
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGP-----HSFLVFEYAKNGSLK  459 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~-----~~~LV~Ey~~~GsL~  459 (600)
                      |.||+++.  +|+.||||.+...     ....+.+|+..+..++||||+++++++...+.     ..++||||++ |+|.
T Consensus        38 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~  116 (353)
T 3coi_A           38 GSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQ  116 (353)
T ss_dssp             EEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGG
T ss_pred             eEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHH
Confidence            99999998  6999999997542     23467789999999999999999999765432     2499999997 5887


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC-
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND-  538 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~-  538 (600)
                      +++.              ..+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++.... 
T Consensus       117 ~~~~--------------~~~~~~~~~~i~~qi~~al~~LH---~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  179 (353)
T 3coi_A          117 KIMG--------------LKFSEEKIQYLVYQMLKGLKYIH---SAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE  179 (353)
T ss_dssp             GTTT--------------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSSCCGGGEEECTTCCEEECSTTCTTC----
T ss_pred             HHhc--------------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC
Confidence            7663              23899999999999999999999   56999999999999999999999999999975432 


Q ss_pred             --------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          539 --------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       539 --------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                              ...+||.... ...++.++|||||||++|||++|+.||...+
T Consensus       180 ~~~~~~t~~y~aPE~~~~-~~~~~~~~Di~slG~il~el~~g~~pf~~~~  228 (353)
T 3coi_A          180 MTGYVVTRWYRAPEVILS-WMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD  228 (353)
T ss_dssp             ----CCSBCCSCHHHHSC-CSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC
T ss_pred             ccccccCcCcCCHHHHhC-cCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence                    2235665433 2456788999999999999999999997643

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=99.93  E-value=2.9e-26  Score=237.44  Aligned_cols=172  Identities=18%  Similarity=0.276  Sum_probs=139.6

Q ss_pred             EEEEEEEE---CCeEEEEEEcchhH--HHHHHHHHHHHHhCCC------CceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          392 GAVYHGRL---NGKNLAIKRTEHEV--ITKLEMQLVQHATHHH------PNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       392 G~Vy~g~~---~g~~vAvK~~~~~~--~~~~e~ei~~~~~l~H------pNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      |.||++..   +|+.||||.++...  ...+.+|+..+..++|      ++++++++++..+ ...++||||+ +++|.+
T Consensus        28 g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~-~~~~lv~e~~-~~~l~~  105 (339)
T 1z57_A           28 GKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH-GHICIVFELL-GLSTYD  105 (339)
T ss_dssp             EEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET-TEEEEEEECC-CCBHHH
T ss_pred             eEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccC-CcEEEEEcCC-CCCHHH
Confidence            99999987   68899999986532  3455667776666554      4599999997655 4899999999 889999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC-------------------
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE-------------------  521 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~-------------------  521 (600)
                      ++.....          ..+++.++..++.|++.||+|||   +.+|+||||||+|||++.                   
T Consensus       106 ~l~~~~~----------~~~~~~~~~~~~~qi~~~l~~lH---~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~  172 (339)
T 1z57_A          106 FIKENGF----------LPFRLDHIRKMAYQICKSVNFLH---SNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLI  172 (339)
T ss_dssp             HHHHTTT----------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESCCCEEEEEC----CEEEEES
T ss_pred             HHHhcCC----------CCCcHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeccccccccCCcccccccccc
Confidence            9976432          34899999999999999999999   569999999999999987                   


Q ss_pred             CCcEEEEeccCccccCCC---------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          522 EFNARVGNFGMARCVNDD---------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       522 ~~~~kI~DFGla~~~~~~---------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                      ++.+||+|||+++.....         +.+||....  ..++.++|||||||++|||++|+.||...+
T Consensus       173 ~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~  238 (339)
T 1z57_A          173 NPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILA--LGWSQPCDVWSIGCILIEYYLGFTVFPTHD  238 (339)
T ss_dssp             CCCEEECCCSSCEETTSCCCSSCSCGGGCCHHHHTT--SCCCTHHHHHHHHHHHHHHHHSSCSCCCSC
T ss_pred             CCCceEeeCcccccCccccccccCCccccChHHhhC--CCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence            678999999999865432         234555543  457888999999999999999999997644

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=99.93  E-value=8.6e-27  Score=251.14  Aligned_cols=171  Identities=22%  Similarity=0.412  Sum_probs=135.3

Q ss_pred             EE-EEEEEECCeEEEEEEcchhHHHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcCcc
Q 041830          392 GA-VYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMK  469 (600)
Q Consensus       392 G~-Vy~g~~~g~~vAvK~~~~~~~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~  469 (600)
                      |. ||++..+|+.||||++..+......+|+..+..+ +|||||++++++... ...|+|||||+ |+|.+++.....  
T Consensus        38 G~V~~~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~-~~~~lv~E~~~-g~L~~~l~~~~~--  113 (432)
T 3p23_A           38 GTIVYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDR-QFQYIAIELCA-ATLQEYVEQKDF--  113 (432)
T ss_dssp             GCEEEEEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEET-TEEEEEEECCS-EEHHHHHHSSSC--
T ss_pred             EEEEEEEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecC-CEEEEEEECCC-CCHHHHHHhcCC--
Confidence            55 6777779999999998765545567888888888 799999999997655 48899999996 699999976542  


Q ss_pred             cccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC-----CCCcEEEEeccCccccCC------
Q 041830          470 NQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLD-----EEFNARVGNFGMARCVND------  538 (600)
Q Consensus       470 ~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld-----~~~~~kI~DFGla~~~~~------  538 (600)
                               .+.+.+++.++.||+.||.|||   +.+|+||||||+|||++     ....+||+|||+++....      
T Consensus       114 ---------~~~~~~~~~i~~qi~~aL~~LH---~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~  181 (432)
T 3p23_A          114 ---------AHLGLEPITLLQQTTSGLAHLH---SLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFS  181 (432)
T ss_dssp             ---------CCCSSCHHHHHHHHHHHHHHHH---HTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--------
T ss_pred             ---------CccchhHHHHHHHHHHHHHHHH---HCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCccee
Confidence                     2455567789999999999999   56899999999999994     334689999999875432      


Q ss_pred             ---------CCCCCcccccC-CCCCCccCchHHHHHHHHHHHh-CCCCCCC
Q 041830          539 ---------DTESPQFYSTN-PASWSMGIDIFAYGIVLLEVLS-GQTPINR  578 (600)
Q Consensus       539 ---------~~~~pe~~~~~-~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~  578 (600)
                               .+.+||..... ...++.++|||||||++|||++ |+.||..
T Consensus       182 ~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~  232 (432)
T 3p23_A          182 RRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK  232 (432)
T ss_dssp             ----CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBS
T ss_pred             eccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcch
Confidence                     23367766432 2345678999999999999999 9999954

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=99.93  E-value=2.9e-27  Score=243.53  Aligned_cols=172  Identities=23%  Similarity=0.456  Sum_probs=137.5

Q ss_pred             eEEEEEEEECCeEEEEEEcchhH-----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcC
Q 041830          391 EGAVYHGRLNGKNLAIKRTEHEV-----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGG  465 (600)
Q Consensus       391 ~G~Vy~g~~~g~~vAvK~~~~~~-----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~  465 (600)
                      .|.||+|+..+ .+|+|.++...     .+.+++|+..+..++||||+++++++..+ ...++||||+++++|.+++...
T Consensus        46 ~g~V~~~~~~~-~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~-~~~~iv~e~~~~~~L~~~l~~~  123 (319)
T 2y4i_B           46 FGQVYHGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSP-PHLAIITSLCKGRTLYSVVRDA  123 (319)
T ss_dssp             SSEEEEEEESS-SEEEEECCCCSCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECS-SCEEEECBCCCSEEHHHHTTSS
T ss_pred             ceEEEEEEEcC-eEEEEEeecCCCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecC-CceEEEeecccCCcHHHHHHhc
Confidence            39999999866 48999875421     23456788888899999999999998765 4799999999999999999764


Q ss_pred             cCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC-------
Q 041830          466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND-------  538 (600)
Q Consensus       466 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~-------  538 (600)
                      .           ..+++.+++.++.|++.||+|||   +.+++||||||+|||++ ++.+||+|||+++....       
T Consensus       124 ~-----------~~~~~~~~~~i~~qi~~al~~lH---~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~  188 (319)
T 2y4i_B          124 K-----------IVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRRE  188 (319)
T ss_dssp             C-----------CCCCSHHHHHHHHHHHHHHHHHH---HTTCCCCCCCSTTEEEC---CCEECCCSCCC----------C
T ss_pred             C-----------CCCCHHHHHHHHHHHHHHHHHHH---hCCccccCCChhhEEEe-CCCEEEeecCCccccccccccccc
Confidence            3           24899999999999999999999   56999999999999998 67999999999764321       


Q ss_pred             ----------CCCCCccccc-------CCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 ----------DTESPQFYST-------NPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 ----------~~~~pe~~~~-------~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                .+.+||....       ....++.++||||||+++|||++|+.||...
T Consensus       189 ~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~  246 (319)
T 2y4i_B          189 DKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQ  246 (319)
T ss_dssp             CSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSC
T ss_pred             cccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence                      1235555432       1234678899999999999999999999753

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=99.93  E-value=7.3e-26  Score=234.25  Aligned_cols=175  Identities=22%  Similarity=0.357  Sum_probs=131.2

Q ss_pred             EEEEEEEE--CCeEEEEEEcchh----HHHHHHHHHH-HHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHE----VITKLEMQLV-QHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~----~~~~~e~ei~-~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      |.||++..  +|+.||||+++..    ....+..|+. .+..++||||+++++++..+ +..++||||+++ +|.+++..
T Consensus        36 g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~-~~~~lv~e~~~~-~l~~~~~~  113 (327)
T 3aln_A           36 GSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFRE-GDCWICMELMST-SFDKFYKY  113 (327)
T ss_dssp             EEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECS-SEEEEEECCCSE-EHHHHHHH
T ss_pred             EEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeC-CceEEEEeecCC-ChHHHHHH
Confidence            99999999  5999999987542    2233444544 55667899999999998765 488999999985 88888753


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCC-CceecCCCCCCEEeCCCCcEEEEeccCccccCCC----
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNP-SYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD----  539 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~----  539 (600)
                      ....       ....+++..+..++.|++.||.|||   +. +++||||||+|||++.++.+||+|||+++.....    
T Consensus       114 ~~~~-------~~~~~~~~~~~~i~~~i~~~l~~lH---~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~  183 (327)
T 3aln_A          114 VYSV-------LDDVIPEEILGKITLATVKALNHLK---ENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKT  183 (327)
T ss_dssp             HHHT-------TCCCCCHHHHHHHHHHHHHHHHHHH---HHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC--------
T ss_pred             HHhh-------hcccCcHHHHHHHHHHHHHHHHHHh---ccCCEeECCCCHHHEEEcCCCCEEEccCCCceecccccccc
Confidence            1100       0134899999999999999999999   55 8999999999999999999999999999754321    


Q ss_pred             -------CCCCccccc--CCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          540 -------TESPQFYST--NPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       540 -------~~~pe~~~~--~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                             +.+||....  ....++.++||||||+++|||++|+.||..
T Consensus       184 ~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  231 (327)
T 3aln_A          184 RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPK  231 (327)
T ss_dssp             ----------------------CCSHHHHHHHHHHHHHHHHSCCCSSC
T ss_pred             cCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence                   235666532  123467889999999999999999999965

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=99.93  E-value=2.2e-26  Score=237.87  Aligned_cols=171  Identities=23%  Similarity=0.359  Sum_probs=137.7

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhHH---------HHHHHHHHHHHhCC--CCceeeeeeEEeccCCceEEEEeecCC-C
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEVI---------TKLEMQLVQHATHH--HPNIVRLLGTCLTDGPHSFLVFEYAKN-G  456 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~~---------~~~e~ei~~~~~l~--HpNIv~l~g~~~~~~~~~~LV~Ey~~~-G  456 (600)
                      .|.||+++.  +|+.||||.++....         ..+.+|+..+..+.  |+||+++++++..+ ...++|+||+.+ +
T Consensus        56 ~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~  134 (320)
T 3a99_A           56 FGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP-DSFVLILERPEPVQ  134 (320)
T ss_dssp             SCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS-SEEEEEEECCSSEE
T ss_pred             CeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecC-CcEEEEEEcCCCCc
Confidence            399999988  789999999865421         23345666666654  69999999998655 488999999986 8


Q ss_pred             CHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC-CCCcEEEEeccCccc
Q 041830          457 SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLD-EEFNARVGNFGMARC  535 (600)
Q Consensus       457 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld-~~~~~kI~DFGla~~  535 (600)
                      +|.+++....            .+++.+++.++.|++.||+|||   +.+|+||||||+|||++ +++.+||+|||+++.
T Consensus       135 ~L~~~l~~~~------------~l~~~~~~~i~~qi~~~L~~LH---~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~  199 (320)
T 3a99_A          135 DLFDFITERG------------ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL  199 (320)
T ss_dssp             EHHHHHHHHC------------SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             cHHHHHhccC------------CCCHHHHHHHHHHHHHHHHHHH---HCCcEeCCCCHHHEEEeCCCCCEEEeeCccccc
Confidence            9999997532            3899999999999999999999   66999999999999999 789999999999976


Q ss_pred             cCCC----------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          536 VNDD----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       536 ~~~~----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                      ....          +.+||..... ...+.++||||||+++|||++|+.||..
T Consensus       200 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~Di~slG~il~el~~g~~pf~~  251 (320)
T 3a99_A          200 LKDTVYTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEH  251 (320)
T ss_dssp             CCSSCBCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred             cccccccCCCCCccCCChHHhccC-CCCCccchHHhHHHHHHHHHHCCCCCCC
Confidence            5432          2245544332 2235678999999999999999999964

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=99.93  E-value=5.1e-26  Score=241.07  Aligned_cols=174  Identities=20%  Similarity=0.295  Sum_probs=138.8

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhH--HHHHHHHHHHHHhCC-CC-----ceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEV--ITKLEMQLVQHATHH-HP-----NIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~--~~~~e~ei~~~~~l~-Hp-----NIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      |.||+++.  +|+.||||+++...  ...++.|+..+..+. |+     +|+++++++... ...++||||++ |+|.++
T Consensus        68 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~-~~~~lv~e~~~-~~L~~~  145 (382)
T 2vx3_A           68 GQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR-NHLCLVFEMLS-YNLYDL  145 (382)
T ss_dssp             EEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET-TEEEEEEECCC-CBHHHH
T ss_pred             EEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC-CceEEEEecCC-CCHHHH
Confidence            99999988  68999999986533  234455665555443 43     599999998665 48999999996 599999


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC--CCCcEEEEeccCccccCCC
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLD--EEFNARVGNFGMARCVNDD  539 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld--~~~~~kI~DFGla~~~~~~  539 (600)
                      +.....          ..+++.++..++.|++.||.|||.. +.+|+||||||+|||++  .++.+||+|||+++.....
T Consensus       146 l~~~~~----------~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~  214 (382)
T 2vx3_A          146 LRNTNF----------RGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR  214 (382)
T ss_dssp             HHHTTT----------SCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC
T ss_pred             HhhcCc----------CCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceecccc
Confidence            976432          3489999999999999999999953 46899999999999994  5788999999999765432


Q ss_pred             ---------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 ---------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 ---------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                               +.+||....  ..++.++|||||||++|||++|+.||...+
T Consensus       215 ~~~~~~t~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~pf~~~~  262 (382)
T 2vx3_A          215 IYQYIQSRFYRSPEVLLG--MPYDLAIDMWSLGCILVEMHTGEPLFSGAN  262 (382)
T ss_dssp             CCSSCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cccccCCccccChHHHcC--CCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence                     235665544  357889999999999999999999998643

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=99.93  E-value=1.1e-25  Score=231.49  Aligned_cols=173  Identities=23%  Similarity=0.362  Sum_probs=130.4

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH----H-HHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV----I-TKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~----~-~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      .|.||+++.  +|+.||||.+....    . ..+.++...+..++||||+++++++..+ ...++||||+ ++.+..+..
T Consensus        38 ~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~-~~~~lv~e~~-~~~~~~l~~  115 (318)
T 2dyl_A           38 CGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITN-TDVFIAMELM-GTCAEKLKK  115 (318)
T ss_dssp             --CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECS-SEEEEEECCC-SEEHHHHHH
T ss_pred             CeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcCCCceeeEEEEEecC-CcEEEEEecc-CCcHHHHHH
Confidence            489999999  68999999985421    1 2223334456778999999999998665 4899999999 455655554


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC-----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND-----  538 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~-----  538 (600)
                      ...           ..+++.++..++.|++.||.|||+.  .+++||||||+|||++.++.+||+|||+++....     
T Consensus       116 ~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  182 (318)
T 2dyl_A          116 RMQ-----------GPIPERILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKD  182 (318)
T ss_dssp             HHT-----------SCCCHHHHHHHHHHHHHHHHHHHHH--HCCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred             Hhc-----------cCCCHHHHHHHHHHHHHHHHHHHhh--CCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcccc
Confidence            321           3489999999999999999999941  3899999999999999999999999999865422     


Q ss_pred             ------CCCCCccccc---CCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          539 ------DTESPQFYST---NPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       539 ------~~~~pe~~~~---~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                            .+.+||....   ....++.++||||||+++|||++|+.||..
T Consensus       183 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~  231 (318)
T 2dyl_A          183 RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN  231 (318)
T ss_dssp             ----CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred             ccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCC
Confidence                  2345666542   124567889999999999999999999975

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=99.93  E-value=5.4e-26  Score=233.76  Aligned_cols=171  Identities=20%  Similarity=0.283  Sum_probs=137.1

Q ss_pred             eEEEEEEEE-CCeEEEEEEcch-----hHHHHHHHHHHHHHhCC--CCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL-NGKNLAIKRTEH-----EVITKLEMQLVQHATHH--HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~-~g~~vAvK~~~~-----~~~~~~e~ei~~~~~l~--HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||+++. +|+.||||.+..     .....+.+|+..+..+.  ||||+++++++..+ ...++||| +.+|+|.+++
T Consensus        41 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~-~~~~lv~e-~~~~~L~~~l  118 (313)
T 3cek_A           41 SSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD-QYIYMVME-CGNIDLNSWL  118 (313)
T ss_dssp             SEEEEEEECTTCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS-SEEEEEEC-CCSEEHHHHH
T ss_pred             CEEEEEEEcCCCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecC-CEEEEEEe-cCCCcHHHHH
Confidence            399999988 688999998743     23356677888887776  59999999998665 48899999 5688999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC---
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---  539 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~---  539 (600)
                      ....            .+++.+++.++.|++.||.|||   +.+|+||||||+|||+++ +.+||+|||+++.....   
T Consensus       119 ~~~~------------~~~~~~~~~i~~qi~~aL~~LH---~~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~  182 (313)
T 3cek_A          119 KKKK------------SIDPWERKSYWKNMLEAVHTIH---QHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTS  182 (313)
T ss_dssp             HHCS------------SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEEET-TEEEECCCSSSCC-------
T ss_pred             HhcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCceecCCCcccEEEEC-CeEEEeeccccccccCcccc
Confidence            7643            3899999999999999999999   569999999999999964 89999999999754321   


Q ss_pred             -----------CCCCcccccC---------CCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 -----------TESPQFYSTN---------PASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 -----------~~~pe~~~~~---------~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                 +.+||.....         ...++.++||||||+++|||++|+.||...
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~  242 (313)
T 3cek_A          183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI  242 (313)
T ss_dssp             -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence                       2345554321         135677899999999999999999999753

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=99.93  E-value=1.5e-26  Score=237.80  Aligned_cols=170  Identities=25%  Similarity=0.365  Sum_probs=134.9

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhH---------HHHHHHHHHHHHhC----CCCceeeeeeEEeccCCceEEEEee-cCC
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEV---------ITKLEMQLVQHATH----HHPNIVRLLGTCLTDGPHSFLVFEY-AKN  455 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~---------~~~~e~ei~~~~~l----~HpNIv~l~g~~~~~~~~~~LV~Ey-~~~  455 (600)
                      |.||+++.  +|+.||||.++...         ...+++|+..+..+    +||||+++++++..+ +..++|+|| +++
T Consensus        45 g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~-~~~~~v~e~~~~~  123 (312)
T 2iwi_A           45 GTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ-EGFMLVLERPLPA  123 (312)
T ss_dssp             EEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC------CEEEEECCSSE
T ss_pred             EEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC-CeEEEEEEecCCC
Confidence            89999988  78899999985432         12344677777776    899999999997655 478999999 789


Q ss_pred             CCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC-CCCcEEEEeccCcc
Q 041830          456 GSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLD-EEFNARVGNFGMAR  534 (600)
Q Consensus       456 GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld-~~~~~kI~DFGla~  534 (600)
                      ++|.+++....            .+++.+++.++.|++.||.|||   +.+|+||||||+||+++ .++.+||+|||+++
T Consensus       124 ~~L~~~l~~~~------------~~~~~~~~~~~~qi~~~l~~lH---~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~  188 (312)
T 2iwi_A          124 QDLFDYITEKG------------PLGEGPSRCFFGQVVAAIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGA  188 (312)
T ss_dssp             EEHHHHHHHHC------------SCCHHHHHHHHHHHHHHHHHHH---HHTEECCCCSGGGEEEETTTTEEEECCCSSCE
T ss_pred             CCHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCeeecCCChhhEEEeCCCCeEEEEEcchhh
Confidence            99999997532            3899999999999999999999   55899999999999999 88999999999987


Q ss_pred             ccCCC----------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          535 CVNDD----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       535 ~~~~~----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                      .....          +.+||..... ...+.++||||||+++|||++|+.||..
T Consensus       189 ~~~~~~~~~~~~~~~y~aPE~~~~~-~~~~~~~Di~slG~il~~l~~g~~pf~~  241 (312)
T 2iwi_A          189 LLHDEPYTDFDGTRVYSPPEWISRH-QYHALPATVWSLGILLYDMVCGDIPFER  241 (312)
T ss_dssp             ECCSSCBCCCCSCTTTSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred             hcccCcccccCCcccccCceeeecC-CCCCccchHHHHHHHHHHHHHCCCCCCC
Confidence            65432          2345544331 2224578999999999999999999964

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=99.93  E-value=9.5e-26  Score=235.24  Aligned_cols=172  Identities=17%  Similarity=0.267  Sum_probs=137.8

Q ss_pred             EEEEEEEE--CC-eEEEEEEcchh--HHHHHHHHHHHHHhCCCCc------eeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          392 GAVYHGRL--NG-KNLAIKRTEHE--VITKLEMQLVQHATHHHPN------IVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       392 G~Vy~g~~--~g-~~vAvK~~~~~--~~~~~e~ei~~~~~l~HpN------Iv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      |.||+++.  ++ +.||+|.++..  ....+.+|+..+..++|+|      ++.+++++... ...++||||+ +|+|.+
T Consensus        33 g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~-~~~~lv~e~~-~~~l~~  110 (355)
T 2eu9_A           33 GKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH-GHMCIAFELL-GKNTFE  110 (355)
T ss_dssp             EEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET-TEEEEEEECC-CCBHHH
T ss_pred             eEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC-CeEEEEEecc-CCChHH
Confidence            99999998  34 78999998653  2345667777777665554      89999987655 4899999999 667888


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEe-------------------CC
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFL-------------------DE  521 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILl-------------------d~  521 (600)
                      ++.....          ..+++.+++.++.||+.||.|||   +.+|+||||||+|||+                   +.
T Consensus       111 ~l~~~~~----------~~~~~~~~~~i~~qi~~~L~~lH---~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~  177 (355)
T 2eu9_A          111 FLKENNF----------QPYPLPHVRHMAYQLCHALRFLH---ENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVK  177 (355)
T ss_dssp             HHHHTTT----------CCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEES
T ss_pred             HHHhccC----------CCCCHHHHHHHHHHHHHHHHHHH---HCCcccCCCCHHHEEEecccccccccccccccccccC
Confidence            7765431          34899999999999999999999   7799999999999999                   56


Q ss_pred             CCcEEEEeccCccccCCC---------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          522 EFNARVGNFGMARCVNDD---------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       522 ~~~~kI~DFGla~~~~~~---------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                      ++.+||+|||+++.....         +.+||....  ..++.++|||||||++|||++|+.||....
T Consensus       178 ~~~~kl~Dfg~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~  243 (355)
T 2eu9_A          178 NTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILE--LGWAQPCDVWSIGCILFEYYRGFTLFQTHE  243 (355)
T ss_dssp             CCCEEECCCTTCEETTSCCCSSCSCGGGCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             CCcEEEeecCccccccccccCCcCCCcccCCeeeec--CCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence            789999999999754332         235665543  457888999999999999999999997644

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=99.93  E-value=4.1e-26  Score=240.18  Aligned_cols=173  Identities=20%  Similarity=0.341  Sum_probs=137.2

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhH--HHHHHHHHHHHHhCC-----------CCceeeeeeEEeccC---CceEEEEeec
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEV--ITKLEMQLVQHATHH-----------HPNIVRLLGTCLTDG---PHSFLVFEYA  453 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~--~~~~e~ei~~~~~l~-----------HpNIv~l~g~~~~~~---~~~~LV~Ey~  453 (600)
                      |.||+++.  +|+.||||.+..+.  ...+.+|+..+..+.           ||||+++++++...+   ...++||||+
T Consensus        33 g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~  112 (373)
T 1q8y_A           33 STVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL  112 (373)
T ss_dssp             EEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC
T ss_pred             eEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC
Confidence            99999997  78999999987533  244566776666554           899999999986532   2679999999


Q ss_pred             CCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCC-CceecCCCCCCEEeC------CCCcEE
Q 041830          454 KNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNP-SYVHRNIKSRNIFLD------EEFNAR  526 (600)
Q Consensus       454 ~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~-~ivHrDLk~~NILld------~~~~~k  526 (600)
                       +++|.+++.....          ..+++.++..++.||+.||+|||   +. +|+||||||+|||++      ..+.+|
T Consensus       113 -~~~L~~~~~~~~~----------~~~~~~~~~~i~~qi~~aL~~lH---~~~~ivH~Dikp~NIll~~~~~~~~~~~~k  178 (373)
T 1q8y_A          113 -GENLLALIKKYEH----------RGIPLIYVKQISKQLLLGLDYMH---RRCGIIHTDIKPENVLMEIVDSPENLIQIK  178 (373)
T ss_dssp             -CEEHHHHHHHTTT----------SCCCHHHHHHHHHHHHHHHHHHH---HTTCEECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred             -CCCHHHHHHHhhc----------cCCcHHHHHHHHHHHHHHHHHHH---hcCCEEecCCChHHeEEeccCCCcCcceEE
Confidence             8899999976432          33899999999999999999999   55 899999999999994      455899


Q ss_pred             EEeccCccccCCC---------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          527 VGNFGMARCVNDD---------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       527 I~DFGla~~~~~~---------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                      |+|||+++.....         +.+||....  ..++.++|||||||++|||++|+.||....
T Consensus       179 l~Dfg~a~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~~Di~slG~il~el~~g~~pf~~~~  239 (373)
T 1q8y_A          179 IADLGNACWYDEHYTNSIQTREYRSPEVLLG--APWGCGADIWSTACLIFELITGDFLFEPDE  239 (373)
T ss_dssp             ECCCTTCEETTBCCCSCCSCGGGCCHHHHHT--CCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             EcccccccccCCCCCCCCCCccccCcHHHhC--CCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence            9999999765432         235665544  346888999999999999999999998654

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.93  E-value=6.4e-26  Score=258.23  Aligned_cols=166  Identities=25%  Similarity=0.348  Sum_probs=136.5

Q ss_pred             EEEEEEEE---CCeEEEEEEcch----hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCc----eEEEEeecCCCCHHH
Q 041830          392 GAVYHGRL---NGKNLAIKRTEH----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPH----SFLVFEYAKNGSLKD  460 (600)
Q Consensus       392 G~Vy~g~~---~g~~vAvK~~~~----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~----~~LV~Ey~~~GsL~~  460 (600)
                      |.||++..   +|+.||||.+..    +....+.+|+..+..++||||+++++++...+..    .||||||+++++|.+
T Consensus        94 g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~  173 (681)
T 2pzi_A           94 GWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKR  173 (681)
T ss_dssp             EEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC-
T ss_pred             eEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHH
Confidence            99999998   489999998753    2334567888899999999999999998765422    699999999999988


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC--
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND--  538 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~--  538 (600)
                      ++..              .++|.+++.++.||+.||.|||   +.+|+||||||+|||++.+ .+||+|||+++....  
T Consensus       174 ~~~~--------------~l~~~~~~~~~~qi~~aL~~lH---~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~~  235 (681)
T 2pzi_A          174 SKGQ--------------KLPVAEAIAYLLEILPALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSFG  235 (681)
T ss_dssp             ---C--------------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCCS
T ss_pred             HHhC--------------CCCHHHHHHHHHHHHHHHHHHH---HCCCeecccChHHeEEeCC-cEEEEecccchhcccCC
Confidence            7753              2899999999999999999999   5689999999999999886 899999999986543  


Q ss_pred             ------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          539 ------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       539 ------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                            .+.+||.....   .+.++|||||||+||||++|..||..
T Consensus       236 ~~~gt~~y~aPE~~~~~---~~~~sDi~slG~~l~~l~~g~~~~~~  278 (681)
T 2pzi_A          236 YLYGTPGFQAPEIVRTG---PTVATDIYTVGRTLAALTLDLPTRNG  278 (681)
T ss_dssp             CCCCCTTTSCTTHHHHC---SCHHHHHHHHHHHHHHHHSCCCEETT
T ss_pred             ccCCCccccCHHHHcCC---CCCceehhhhHHHHHHHHhCCCCCcc
Confidence                  23456665442   37789999999999999999999865

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=99.92  E-value=6.2e-26  Score=235.95  Aligned_cols=167  Identities=13%  Similarity=0.200  Sum_probs=133.2

Q ss_pred             EEEEEEEECCeEEEEEEcchhH-----------HHHHHHHHHHHHhCC---------CCceeeeeeEEec----------
Q 041830          392 GAVYHGRLNGKNLAIKRTEHEV-----------ITKLEMQLVQHATHH---------HPNIVRLLGTCLT----------  441 (600)
Q Consensus       392 G~Vy~g~~~g~~vAvK~~~~~~-----------~~~~e~ei~~~~~l~---------HpNIv~l~g~~~~----------  441 (600)
                      |.||+++.+|+.||||+++...           .+.+.+|+..+..++         |||||++.+++..          
T Consensus        34 g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~  113 (336)
T 2vuw_A           34 GEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLK  113 (336)
T ss_dssp             EEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHH
T ss_pred             eEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHH
Confidence            9999999999999999986432           245667777766664         7777777776431          


Q ss_pred             -------------------cCCceEEEEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHH-h
Q 041830          442 -------------------DGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH-H  501 (600)
Q Consensus       442 -------------------~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~  501 (600)
                                         +....|||||||++|++.+.+.+             ..+++.++..++.||+.||.||| .
T Consensus       114 ~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-------------~~~~~~~~~~i~~qi~~aL~~lH~~  180 (336)
T 2vuw_A          114 AWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-------------KLSSLATAKSILHQLTASLAVAEAS  180 (336)
T ss_dssp             HHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-------------TCCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-------------cCCCHHHHHHHHHHHHHHHHHHHHh
Confidence                               14578999999999977666643             23899999999999999999999 4


Q ss_pred             cCCCCceecCCCCCCEEeCCCC--------------------cEEEEeccCccccC-------CCCCCCcccccCCCCCC
Q 041830          502 VMNPSYVHRNIKSRNIFLDEEF--------------------NARVGNFGMARCVN-------DDTESPQFYSTNPASWS  554 (600)
Q Consensus       502 ~~~~~ivHrDLk~~NILld~~~--------------------~~kI~DFGla~~~~-------~~~~~pe~~~~~~~~~t  554 (600)
                      .   +|+||||||+|||++.++                    .+||+|||+++...       ..+.+||.+....   +
T Consensus       181 ~---~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~~~~gt~~y~aPE~~~g~~---~  254 (336)
T 2vuw_A          181 L---RFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDG---D  254 (336)
T ss_dssp             H---CCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETTEEECCCCTTCSGGGCCCS---S
T ss_pred             C---CEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCCcEEEeecccChhhhcCCC---c
Confidence            4   899999999999999886                    99999999998643       3346788776532   6


Q ss_pred             ccCchHHHHHH-HHHHHhCCCCCC
Q 041830          555 MGIDIFAYGIV-LLEVLSGQTPIN  577 (600)
Q Consensus       555 ~~sDVwSfGvv-L~ELltG~~Pf~  577 (600)
                      .++||||+|++ .+++++|..||.
T Consensus       255 ~~~Diwsl~~~~~~~~~~g~~p~~  278 (336)
T 2vuw_A          255 YQFDIYRLMKKENNNRWGEYHPYS  278 (336)
T ss_dssp             HHHHHHHHHHHHHTTCTTSCCTHH
T ss_pred             cceehhhhhCCCCcccccccCCCc
Confidence            78999998776 778889999985

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=99.92  E-value=2.8e-25  Score=248.48  Aligned_cols=174  Identities=21%  Similarity=0.378  Sum_probs=143.3

Q ss_pred             eEEEEEEEE--CCeEEEEEEcch----hHHHHHHHHHHHHHhCCCCceeeeeeEEec-----cCCceEEEEeecCCCCHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEH----EVITKLEMQLVQHATHHHPNIVRLLGTCLT-----DGPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~-----~~~~~~LV~Ey~~~GsL~  459 (600)
                      .|.||++..  +|+.||||+++.    .....+.+|+..+..++||||+++++++..     ++...++||||+++|+|.
T Consensus        27 fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~  106 (676)
T 3qa8_A           27 FGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLR  106 (676)
T ss_dssp             SSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHH
T ss_pred             CeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHH
Confidence            389999987  689999998754    233567889999999999999999998643     134679999999999999


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCc---EEEEeccCcccc
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFN---ARVGNFGMARCV  536 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~---~kI~DFGla~~~  536 (600)
                      +++......         ..+++.+++.++.+++.||.|||   +.+|+||||||+|||++.++.   +||+|||+++..
T Consensus       107 ~~L~~~~~~---------~~lse~~i~~I~~QLl~aL~yLH---s~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~  174 (676)
T 3qa8_A          107 KYLNQFENC---------CGLKEGPIRTLLSDISSALRYLH---ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKEL  174 (676)
T ss_dssp             HHHHSSSCT---------TCCCSSHHHHHHHHHHHHHHHHH---HTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBT
T ss_pred             HHHHhcccC---------CCCCHHHHHHHHHHHHHHHHHHH---HCCCccCCCCHHHeEeecCCCceeEEEccccccccc
Confidence            999764321         24899999999999999999999   569999999999999986654   999999999765


Q ss_pred             CCC-----------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          537 NDD-----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       537 ~~~-----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                      ...           +.+||....  ..++.++||||||+++|||++|+.||..
T Consensus       175 ~~~~~~~~~~gt~~Y~APE~l~~--~~~s~ksDIwSLGviLyeLltG~~Pf~~  225 (676)
T 3qa8_A          175 DQGELCTEFVGTLQYLAPELLEQ--KKYTVTVDYWSFGTLAFECITGFRPFLP  225 (676)
T ss_dssp             TSCCCCCCCCSCCTTCSSCSSCC--SCCSTTHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccccccccccCCcccCChHHhcc--CCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence            332           235665543  4568889999999999999999999953

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=99.90  E-value=2.4e-24  Score=230.68  Aligned_cols=181  Identities=15%  Similarity=0.195  Sum_probs=129.3

Q ss_pred             EEEEEEEE--CCeEEEEEEcchh------HHHHHHHHHHHHHhCCC-Cce---------------eeeee------EEec
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHE------VITKLEMQLVQHATHHH-PNI---------------VRLLG------TCLT  441 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~------~~~~~e~ei~~~~~l~H-pNI---------------v~l~g------~~~~  441 (600)
                      |.||+++.  +|+.||||+++..      ..+.+++|+..+..+.| +|.               +.+.+      +...
T Consensus        92 G~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  171 (413)
T 3dzo_A           92 YAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLD  171 (413)
T ss_dssp             EEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC----------
T ss_pred             EEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCC
Confidence            99999998  5999999987621      12457788888888776 221               11111      1111


Q ss_pred             c----CCceEEEEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCE
Q 041830          442 D----GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNI  517 (600)
Q Consensus       442 ~----~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NI  517 (600)
                      .    ....+++|+++ +|+|.+++........     ....++|..++.++.|++.||+|||   +.+|+||||||+||
T Consensus       172 ~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~-----~~~~l~~~~~~~i~~qi~~aL~~LH---~~~iiHrDiKp~NI  242 (413)
T 3dzo_A          172 ERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSS-----THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDI  242 (413)
T ss_dssp             -----CCSEEEEEECC-SEEHHHHHHHHHHHTT-----TSHHHHHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGE
T ss_pred             CccccccceEEEeehh-cCCHHHHHHHhhcccc-----cCCCCCHHHHHHHHHHHHHHHHHHH---hCCcccCCcccceE
Confidence            0    11346677765 6799998852110000     0134889999999999999999999   66999999999999


Q ss_pred             EeCCCCcEEEEeccCccccC--------CCCCCCccccc--------CCCCCCccCchHHHHHHHHHHHhCCCCCCCCCC
Q 041830          518 FLDEEFNARVGNFGMARCVN--------DDTESPQFYST--------NPASWSMGIDIFAYGIVLLEVLSGQTPINRPRK  581 (600)
Q Consensus       518 Lld~~~~~kI~DFGla~~~~--------~~~~~pe~~~~--------~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~  581 (600)
                      |++.++.+||+|||+++...        ..+.+||....        ....++.++|||||||++|||++|+.||.....
T Consensus       243 Ll~~~~~~kL~DFG~a~~~~~~~~~~~g~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~  322 (413)
T 3dzo_A          243 VLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAA  322 (413)
T ss_dssp             EECTTCCEEECCGGGCEETTEEECCCCCTTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGG
T ss_pred             EEecCCeEEEEeccceeecCCccccCCCCceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcch
Confidence            99999999999999986432        33456776531        223467789999999999999999999976543

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.89  E-value=2.7e-24  Score=239.15  Aligned_cols=152  Identities=14%  Similarity=0.135  Sum_probs=108.4

Q ss_pred             CCeEEEEEEcchh-------------HHHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcC
Q 041830          400 NGKNLAIKRTEHE-------------VITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGG  465 (600)
Q Consensus       400 ~g~~vAvK~~~~~-------------~~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~  465 (600)
                      .|+.+|+|.+..+             ..+++.+|+..+.++ .|+||+++++++.++ ...||||||++||+|.++|...
T Consensus       258 fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~-~~~yLVMEyv~G~~L~d~i~~~  336 (569)
T 4azs_A          258 FGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENA-QSGWLVMEKLPGRLLSDMLAAG  336 (569)
T ss_dssp             ECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECS-SEEEEEEECCCSEEHHHHHHTT
T ss_pred             ccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEEC-CEEEEEEecCCCCcHHHHHHhC
Confidence            7899999987432             124578899999998 699999999997655 5899999999999999999865


Q ss_pred             cCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCCCC----
Q 041830          466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE----  541 (600)
Q Consensus       466 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~~~----  541 (600)
                      ..            ++..   +|+.||+.||+|+|   +.+||||||||+|||+++++++||+|||+|+.......    
T Consensus       337 ~~------------l~~~---~I~~QIl~AL~ylH---~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~~t  398 (569)
T 4azs_A          337 EE------------IDRE---KILGSLLRSLAALE---KQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWPTN  398 (569)
T ss_dssp             CC------------CCHH---HHHHHHHHHHHHHH---HTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCSHH
T ss_pred             CC------------CCHH---HHHHHHHHHHHHHH---HCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccccC
Confidence            42            5554   48899999999999   67999999999999999999999999999987654321    


Q ss_pred             --------CCcccccCCCCCCccCchHHHHHHHHHHHhCC
Q 041830          542 --------SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQ  573 (600)
Q Consensus       542 --------~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~  573 (600)
                              +||....   ....++|+||+|+++++|.++.
T Consensus       399 ~vGTp~YmAPE~l~g---~~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          399 LVQSFFVFVNELFAE---NKSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             HHHHHHHHHHHHC--------------------CCCCTTH
T ss_pred             ceechhhccHHHhCC---CCCCcccccccccchhhhcccc
Confidence                    3444332   2345678888888877665543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.80  E-value=1.9e-20  Score=206.97  Aligned_cols=162  Identities=12%  Similarity=0.152  Sum_probs=128.7

Q ss_pred             eeEEEEEEEECCeEEEEEEcchh-----------HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCH
Q 041830          390 IEGAVYHGRLNGKNLAIKRTEHE-----------VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSL  458 (600)
Q Consensus       390 ~~G~Vy~g~~~g~~vAvK~~~~~-----------~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL  458 (600)
                      .+|.||++...++.+++|+....           ..+.+.+|+..+.+++||||+++..++..+ ...||||||+++|+|
T Consensus       348 ~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~-~~~~lVmE~~~ggsL  426 (540)
T 3en9_A          348 AEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDL-DNKRIMMSYINGKLA  426 (540)
T ss_dssp             CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEET-TTTEEEEECCCSEEH
T ss_pred             CCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeC-CccEEEEECCCCCCH
Confidence            34999999889999999974211           123478999999999999999666666554 367999999999999


Q ss_pred             HHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC
Q 041830          459 KDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND  538 (600)
Q Consensus       459 ~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~  538 (600)
                      .++++.                    ++.++.|++.||.|||   +.+|+||||||+|||++.  .+||+|||+++....
T Consensus       427 ~~~l~~--------------------~~~i~~qi~~aL~~LH---~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~  481 (540)
T 3en9_A          427 KDVIED--------------------NLDIAYKIGEIVGKLH---KNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNL  481 (540)
T ss_dssp             HHHSTT--------------------CTHHHHHHHHHHHHHH---HTTEECTTCCTTSEEESS--SEEECCCTTCEECCC
T ss_pred             HHHHHH--------------------HHHHHHHHHHHHHHHH---HCcCccCCCCHHHEEECC--eEEEEECccCEECCC
Confidence            999863                    3468999999999999   669999999999999999  999999999987654


Q ss_pred             C-------------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCC
Q 041830          539 D-------------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN  577 (600)
Q Consensus       539 ~-------------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~  577 (600)
                      .                   +.+||++......|+..+|+||..+-..|.+.++.+|.
T Consensus       482 ~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          482 DEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence            2                   12345443322345667899999999999888887774

>4eby_A Chitin elicitor receptor kinase 1; pathogen-associated molecular patterns, pattern recognition receptors, LYSM, lysine chitin oligomer; HET: NAG BMA; 1.65A {Arabidopsis thaliana} PDB: 4ebz_A*

Probab=99.70  E-value=4.5e-17  Score=156.41  Aligned_cols=108  Identities=18%  Similarity=0.210  Sum_probs=90.7

Q ss_pred             eeeeecCCCCCChhhHH-HhhC--CChHHHHhhhCCCCCCCCCCCCCcEEEeeccccCCCCc--ceeecceeeeecCCch
Q 041830           63 FAILRTNSYYSSLFNLS-FYLG--LNRFVIARANGFSADTEFLPKDQPLLIPIDCKCNNNGG--FFQADLTKTTIKGESF  137 (600)
Q Consensus        63 ~~~y~~~~~~~~l~~ia-~~~~--~~~~~i~~~N~~~~~~~~i~~~~~l~vP~~c~c~~~~~--~~~~~~~y~v~~gdt~  137 (600)
                      ...|+|++ ||||+.|| ++|+  +++.+|..+|++  ..+.|++||.|.||.+|+|.....  .+....+|+|++||||
T Consensus        78 ~~~Y~V~~-GDTL~~IA~~~y~~lvt~~~L~~~N~~--~~~~l~~Gq~L~IP~~~~~~~~~~~~~~~~~~~Y~V~~GDTL  154 (212)
T 4eby_A           78 NFSYSVRQ-EDTYERVAISNYANLTTMESLQARNPF--PATNIPLSATLNVLVNCSCGDESVSKDFGLFVTYPLRPEDSL  154 (212)
T ss_dssp             EEEEECCT-TCCHHHHHHTTTTTSSCHHHHHHHCCS--CTTCCCTTCEEEEEEECCCCCTTTCSSCCCEEEEECCTTCCH
T ss_pred             ceEEEecC-CCcHHHHHHHhcCCCCCHHHHHHhcCC--CcccCCCCCEEEEcCCCcCCCcccccCCCCeEEEEECCCCcH
Confidence            46799999 99999999 7999  999999999997  668899999999999999952210  1112257999999999


Q ss_pred             hhHHHhcCCCchHHHHHhhCCCCCCCCCCCCCeEeeeeec
Q 041830          138 YSIAQSLEGLTTCGAIKERNPSVSPWDLDDKARLQVPLRC  177 (600)
Q Consensus       138 ~~ia~~~~gl~t~~~l~~~N~~~~~~~l~~G~~l~vp~~c  177 (600)
                      |.||++|+  ++.++|++||+..+ ..+..|+ |.||.+-
T Consensus       155 ~~IA~~fg--vsv~~L~~~N~~~~-~~~~~g~-l~IP~~~  190 (212)
T 4eby_A          155 SSIARSSG--VSADILQRYNPGVN-FNSGNGI-VYVPGRD  190 (212)
T ss_dssp             HHHHHHHT--SCHHHHHHHSTTCC-TTSCSSE-EEEECCC
T ss_pred             HHHHHHHC--cCHHHHHHhcCCCc-cCCCCCE-EEecCCC
Confidence            99999999  99999999999874 4566665 9999754

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.68  E-value=5e-17  Score=164.72  Aligned_cols=126  Identities=10%  Similarity=0.055  Sum_probs=99.9

Q ss_pred             EEEEEEEE-CCeEEEEEEcchh---------------------HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEE
Q 041830          392 GAVYHGRL-NGKNLAIKRTEHE---------------------VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLV  449 (600)
Q Consensus       392 G~Vy~g~~-~g~~vAvK~~~~~---------------------~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV  449 (600)
                      |.||++.. +|+.||+|.++..                     ....+.+|+..+..++  | +++.+++ +. +..|+|
T Consensus       104 g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~~~~-~~-~~~~lv  178 (282)
T 1zar_A          104 SAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVPKVY-AW-EGNAVL  178 (282)
T ss_dssp             EEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSCCEE-EE-ETTEEE
T ss_pred             ceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcCeEE-ec-cceEEE
Confidence            99999999 6899999998532                     2345778999999888  5 7777764 33 356999


Q ss_pred             EeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEe
Q 041830          450 FEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGN  529 (600)
Q Consensus       450 ~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~D  529 (600)
                      |||+++|+|.+ +..                  .+...++.|++.||.|||   +.+|+||||||+|||++ ++.+||+|
T Consensus       179 mE~~~g~~L~~-l~~------------------~~~~~i~~qi~~~l~~lH---~~giiHrDlkp~NILl~-~~~vkl~D  235 (282)
T 1zar_A          179 MELIDAKELYR-VRV------------------ENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVS-EEGIWIID  235 (282)
T ss_dssp             EECCCCEEGGG-CCC------------------SCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEE-TTEEEECC
T ss_pred             EEecCCCcHHH-cch------------------hhHHHHHHHHHHHHHHHH---HCCCEeCCCCHHHEEEE-CCcEEEEE
Confidence            99999999987 421                  123469999999999999   66999999999999999 99999999


Q ss_pred             ccCccccCCCCCCCccc
Q 041830          530 FGMARCVNDDTESPQFY  546 (600)
Q Consensus       530 FGla~~~~~~~~~pe~~  546 (600)
                      ||+++..... .+|++.
T Consensus       236 FG~a~~~~~~-~a~e~l  251 (282)
T 1zar_A          236 FPQSVEVGEE-GWREIL  251 (282)
T ss_dssp             CTTCEETTST-THHHHH
T ss_pred             CCCCeECCCC-CHHHHH
Confidence            9999865432 344544

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.58  E-value=3.5e-15  Score=149.03  Aligned_cols=122  Identities=16%  Similarity=0.177  Sum_probs=92.0

Q ss_pred             EEEEEEEE--CCeE--EEEEEcchhH---------------------------HHHHHHHHHHHHhCCCCce--eeeeeE
Q 041830          392 GAVYHGRL--NGKN--LAIKRTEHEV---------------------------ITKLEMQLVQHATHHHPNI--VRLLGT  438 (600)
Q Consensus       392 G~Vy~g~~--~g~~--vAvK~~~~~~---------------------------~~~~e~ei~~~~~l~HpNI--v~l~g~  438 (600)
                      |.||+|..  +|+.  ||||.++...                           ...+++|+..+..+.|+++  ..++++
T Consensus        61 g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~  140 (258)
T 1zth_A           61 ANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEAGVSVPQPYTY  140 (258)
T ss_dssp             EEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHHHTTCCCCCEEEE
T ss_pred             EEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHHhCCCCCCeEEEc
Confidence            99999998  8999  9999753211                           1246778888888777754  333332


Q ss_pred             EeccCCceEEEEeecCC-C----CHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCC
Q 041830          439 CLTDGPHSFLVFEYAKN-G----SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIK  513 (600)
Q Consensus       439 ~~~~~~~~~LV~Ey~~~-G----sL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk  513 (600)
                           ...+|||||+.+ |    +|.++...               .++.+...++.|++.||.|||.  +.+|+|||||
T Consensus       141 -----~~~~lVmE~~g~~g~~~~~L~~~~~~---------------~~~~~~~~i~~qi~~~l~~lH~--~~givHrDlk  198 (258)
T 1zth_A          141 -----MKNVLLMEFIGEDELPAPTLVELGRE---------------LKELDVEGIFNDVVENVKRLYQ--EAELVHADLS  198 (258)
T ss_dssp             -----ETTEEEEECCEETTEECCBHHHHGGG---------------GGGSCHHHHHHHHHHHHHHHHH--TSCEECSSCS
T ss_pred             -----CCCEEEEEecCCCCCccccHHHHhhc---------------cChHHHHHHHHHHHHHHHHHHH--HCCEEeCCCC
Confidence                 256899999952 4    67766432               2244567899999999999993  3489999999


Q ss_pred             CCCEEeCCCCcEEEEeccCccccC
Q 041830          514 SRNIFLDEEFNARVGNFGMARCVN  537 (600)
Q Consensus       514 ~~NILld~~~~~kI~DFGla~~~~  537 (600)
                      |+|||++.  .++|+|||++....
T Consensus       199 p~NILl~~--~~~liDFG~a~~~~  220 (258)
T 1zth_A          199 EYNIMYID--KVYFIDMGQAVTLR  220 (258)
T ss_dssp             TTSEEESS--SEEECCCTTCEETT
T ss_pred             HHHEEEcC--cEEEEECcccccCC
Confidence            99999998  99999999998653

>2l9y_A CVNH-LYSM lectin; carbohydrate, sugar binding protein; NMR {Magnaporthe oryzae 70-15}

Probab=99.45  E-value=1.9e-14  Score=132.72  Aligned_cols=96  Identities=15%  Similarity=0.048  Sum_probs=77.9

Q ss_pred             ecceeeeecCCchhhHHHhcCCCchHHHHHhhCCCCCCCCCCCCCeEeeeeeccCCCCCCCCCCceEEEEEEccCCCccc
Q 041830          125 ADLTKTTIKGESFYSIAQSLEGLTTCGAIKERNPSVSPWDLDDKARLQVPLRCACPSSSENLPETRILVSYPVGEGDTVS  204 (600)
Q Consensus       125 ~~~~y~v~~gdt~~~ia~~~~gl~t~~~l~~~N~~~~~~~l~~G~~l~vp~~c~c~~~~~~~~~~~~~~tY~v~~gd~~~  204 (600)
                      +..+|+||+|||||.||++|+  +++++|++||++.+|+.|++||+|.||..-.-+... ..........|+|+.||+|+
T Consensus        61 ~~~~y~V~~GDTL~~IA~~~~--~~~~~l~~~N~~~~~~~i~~Gq~L~ip~~~~~~~~~-~~~~~~~~~~~~v~~GdtL~  137 (167)
T 2l9y_A           61 GTATVTVQQGDTLRDIGRRFD--CDFHEIARRNNIQNEDLIYPGQVLQVPTKGGSGGGA-GNFWDSARDVRLVDGGKVLE  137 (167)
T ss_dssp             SCEEEEECTTCCHHHHHHHTT--CCHHHHHHHHTCCGGGCCCTTEEEEESCCCCCSSSS-CCGGGGEEEEEEETTTTEEE
T ss_pred             CCceEEECCCCcHHHHHHHcC--CCHHHHHHHcCCCCcccccCCCEEEEcCCCCccccc-cccccccceEEEeCCcCChH
Confidence            456899999999999999998  999999999999989999999999999754211101 11111234689999999999


Q ss_pred             ccccccCCChHHHHHhcCC
Q 041830          205 GLAAKFNTTPAAIIAANNK  223 (600)
Q Consensus       205 ~ia~~f~~~~~~~~~~n~~  223 (600)
                      +||+++|.+....+++|+.
T Consensus       138 aIA~r~G~~v~s~i~Ln~~  156 (167)
T 2l9y_A          138 AELRYSGGWNRSRIYLDEH  156 (167)
T ss_dssp             EEEEETTEEEEEEECGGGT
T ss_pred             HHHHHcCCceEEEEEcccc
Confidence            9999999888888888865

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.21  E-value=6.9e-12  Score=131.23  Aligned_cols=121  Identities=9%  Similarity=0.038  Sum_probs=80.1

Q ss_pred             EEEEEEEE-CCeEEEEEEcchhH-----------------HHH--------HHHHHHHHHhCCCCceeeeeeEEeccCCc
Q 041830          392 GAVYHGRL-NGKNLAIKRTEHEV-----------------ITK--------LEMQLVQHATHHHPNIVRLLGTCLTDGPH  445 (600)
Q Consensus       392 G~Vy~g~~-~g~~vAvK~~~~~~-----------------~~~--------~e~ei~~~~~l~HpNIv~l~g~~~~~~~~  445 (600)
                      |.||+|.. +|+.||||.++...                 ...        .++|...+.++.+.++.-..-+...   .
T Consensus       109 a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~vp~p~~~~---~  185 (397)
T 4gyi_A          109 SDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFPVPEPIAQS---R  185 (397)
T ss_dssp             EEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCSCCCEEEEE---T
T ss_pred             eEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCCCCeeeecc---C
Confidence            89999998 89999999753210                 000        1234444444433222111111111   2


Q ss_pred             eEEEEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC--
Q 041830          446 SFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEF--  523 (600)
Q Consensus       446 ~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~--  523 (600)
                      .+|||||+++++|.++..                  ..+...+..|++.+|.|||   ..+||||||||.|||+++++  
T Consensus       186 ~~LVME~i~G~~L~~l~~------------------~~~~~~l~~qll~~l~~lH---~~gIVHrDLKp~NILl~~dgd~  244 (397)
T 4gyi_A          186 HTIVMSLVDALPMRQVSS------------------VPDPASLYADLIALILRLA---KHGLIHGDFNEFNILIREEKDA  244 (397)
T ss_dssp             TEEEEECCSCEEGGGCCC------------------CSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEEEEECS
T ss_pred             ceEEEEecCCccHhhhcc------------------cHHHHHHHHHHHHHHHHHH---HCCCcCCCCCHHHEEEeCCCCc
Confidence            379999999888754321                  1223467899999999999   56899999999999998766  


Q ss_pred             --------cEEEEeccCcccc
Q 041830          524 --------NARVGNFGMARCV  536 (600)
Q Consensus       524 --------~~kI~DFGla~~~  536 (600)
                              .+.|+||+-+...
T Consensus       245 ~d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          245 EDPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             SCTTSEEEEEEECCCTTCEET
T ss_pred             ccccccccceEEEEeCCcccC
Confidence                    4899999987643

>2djp_A Hypothetical protein SB145; LYSM, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens}

Probab=99.06  E-value=5.8e-11  Score=95.15  Aligned_cols=62  Identities=18%  Similarity=0.145  Sum_probs=54.2

Q ss_pred             CCCcEEEeeccccCCCCcceeecceeeeecCCchhhHHHhcCCCchHHHHHhhCCCCCCCCCCCCCeEeeeeec
Q 041830          104 KDQPLLIPIDCKCNNNGGFFQADLTKTTIKGESFYSIAQSLEGLTTCGAIKERNPSVSPWDLDDKARLQVPLRC  177 (600)
Q Consensus       104 ~~~~l~vP~~c~c~~~~~~~~~~~~y~v~~gdt~~~ia~~~~gl~t~~~l~~~N~~~~~~~l~~G~~l~vp~~c  177 (600)
                      .||.+.||..-          ....|+|++|||||.||++|+  ++.++|+++|++.+++.|.+||+|.||..-
T Consensus         3 ~Gq~l~ip~~~----------~~~~y~V~~GDTL~~IA~~~~--~~~~~l~~~N~l~~~~~l~~Gq~l~iP~~~   64 (77)
T 2djp_A            3 SGSSGCSPVRE----------RRLEHQLEPGDTLAGLALKYG--VTMEQIKRANRLYTNDSIFLKKTLYIPILT   64 (77)
T ss_dssp             CCCCCCCCCCE----------EEEEECCCTTCCHHHHHHHHT--CCHHHHHHHHTCCCSSCGGGSSCEEEEEEC
T ss_pred             CCcEeeccCCC----------CcEEEEECCCCcHHHHHHHHC--cCHHHHHHHcCCCCccccCCCCEEEECCCC
Confidence            68899988431          236799999999999999999  999999999999877899999999999854

>1e0g_A Membrane-bound lytic murein transglycosylase D; cell WALL, hydrolase, glycosidase, lipoprotein, outer membrane, multigene family; NMR {Escherichia coli} SCOP: d.7.1.1

Probab=98.98  E-value=2.5e-10  Score=82.42  Aligned_cols=45  Identities=22%  Similarity=0.252  Sum_probs=42.0

Q ss_pred             ceeeeecCCchhhHHHhcCCCchHHHHHhhCCCCCCCCCCCCCeEeeee
Q 041830          127 LTKTTIKGESFYSIAQSLEGLTTCGAIKERNPSVSPWDLDDKARLQVPL  175 (600)
Q Consensus       127 ~~y~v~~gdt~~~ia~~~~gl~t~~~l~~~N~~~~~~~l~~G~~l~vp~  175 (600)
                      .+|+|++|||+|.||++|+  ++.++|+++|+  +++.|.+||+|.||+
T Consensus         3 ~~y~V~~GDtl~~Ia~~~~--~~~~~l~~~N~--~~~~l~~G~~l~ip~   47 (48)
T 1e0g_A            3 ITYRVRKGDSLSSIAKRHG--VNIKDVMRWNS--DTANLQPGDKLTLFV   47 (48)
T ss_dssp             CEEEECTTCCHHHHHHHHT--CCHHHHHHHCS--CGGGCCTTEEEECCC
T ss_pred             EEEEEcCCCcHHHHHHHHC--cCHHHHHHhCC--CCCcCCcCCEEEEec
Confidence            5799999999999999998  99999999999  478899999999996

>2l9y_A CVNH-LYSM lectin; carbohydrate, sugar binding protein; NMR {Magnaporthe oryzae 70-15}

Probab=98.97  E-value=8.3e-11  Score=108.38  Aligned_cols=94  Identities=15%  Similarity=0.133  Sum_probs=71.0

Q ss_pred             ceeeeeecCCCCCChhhHHHhhCCChHHHHhhhCCCCCCCCCCCCCcEEEeeccccCCC-Ccce-eecceeeeecCCchh
Q 041830           61 GTFAILRTNSYYSSLFNLSFYLGLNRFVIARANGFSADTEFLPKDQPLLIPIDCKCNNN-GGFF-QADLTKTTIKGESFY  138 (600)
Q Consensus        61 ~~~~~y~~~~~~~~l~~ia~~~~~~~~~i~~~N~~~~~~~~i~~~~~l~vP~~c~c~~~-~~~~-~~~~~y~v~~gdt~~  138 (600)
                      .+...|+|++ ||||+.||.+|+++..+|+++|++. +.+.|.+||.|.||..-.-... ..+. .....|+|++||||+
T Consensus        60 ~~~~~y~V~~-GDTL~~IA~~~~~~~~~l~~~N~~~-~~~~i~~Gq~L~ip~~~~~~~~~~~~~~~~~~~~~v~~GdtL~  137 (167)
T 2l9y_A           60 GGTATVTVQQ-GDTLRDIGRRFDCDFHEIARRNNIQ-NEDLIYPGQVLQVPTKGGSGGGAGNFWDSARDVRLVDGGKVLE  137 (167)
T ss_dssp             CSCEEEEECT-TCCHHHHHHHTTCCHHHHHHHHTCC-GGGCCCTTEEEEESCCCCCSSSSCCGGGGEEEEEEETTTTEEE
T ss_pred             CCCceEEECC-CCcHHHHHHHcCCCHHHHHHHcCCC-CcccccCCCEEEEcCCCCccccccccccccceEEEeCCcCChH
Confidence            3557899999 9999999999999999999999996 6699999999999976431000 1111 123568999999999


Q ss_pred             hHHHhcCCCchHHHHHhhCC
Q 041830          139 SIAQSLEGLTTCGAIKERNP  158 (600)
Q Consensus       139 ~ia~~~~gl~t~~~l~~~N~  158 (600)
                      .||++|+  ++.++....|.
T Consensus       138 aIA~r~G--~~v~s~i~Ln~  155 (167)
T 2l9y_A          138 AELRYSG--GWNRSRIYLDE  155 (167)
T ss_dssp             EEEEETT--EEEEEEECGGG
T ss_pred             HHHHHcC--CceEEEEEccc
Confidence            9995576  55554444443

>2gu1_A Zinc peptidase; alpha/beta, beta barrel, structural genomics, PSI, protein structure initiative; 1.90A {Vibrio cholerae}

Probab=98.97  E-value=5.9e-10  Score=116.16  Aligned_cols=112  Identities=12%  Similarity=0.130  Sum_probs=86.7

Q ss_pred             eeeeeecCCCCCChhhHHHhhCCChHHHHhhhCCCC---CCCCCCCCCcEEEeeccccC------------------C-C
Q 041830           62 TFAILRTNSYYSSLFNLSFYLGLNRFVIARANGFSA---DTEFLPKDQPLLIPIDCKCN------------------N-N  119 (600)
Q Consensus        62 ~~~~y~~~~~~~~l~~ia~~~~~~~~~i~~~N~~~~---~~~~i~~~~~l~vP~~c~c~------------------~-~  119 (600)
                      ....|+|++ ||||+.|+++||+++.+|.++|++..   +.+.|++||.|.||..-.-.                  . .
T Consensus         6 ~~~~~~Vk~-GDTL~~Ia~r~gvs~~~l~~~n~~~~~~~~~~~L~~Gq~L~i~~~~~~~l~~l~~~~~~~~~~~~~~~~~   84 (361)
T 2gu1_A            6 KRIHYMVKV-GDTLSGIFAQLGVPYSILQKILSVDLDHLQLDMIQPGEELELMMDDMGQLSRLIYHMSIVEKAIYTREND   84 (361)
T ss_dssp             -CEEEECCT-TCCHHHHHHHTTCCHHHHHHHHHHGGGTCCGGGCCTTCEEEEEECTTSCEEEEEEEEETTEEEEEEECTT
T ss_pred             CceEEEECC-CCcHHHHHHHcCCCHHHHHHHHhhcccccchhcCCCCCEEEEEECCCCcceEEEEEcCccceEEEEecCC
Confidence            356799999 99999999999999999999998842   25789999999999753200                  0 0


Q ss_pred             Cccee---------ecceeeeecCCchhhHHHhcCCCchHHHHHhhCCCCCC-----CCCCCCCeEeeeee
Q 041830          120 GGFFQ---------ADLTKTTIKGESFYSIAQSLEGLTTCGAIKERNPSVSP-----WDLDDKARLQVPLR  176 (600)
Q Consensus       120 ~~~~~---------~~~~y~v~~gdt~~~ia~~~~gl~t~~~l~~~N~~~~~-----~~l~~G~~l~vp~~  176 (600)
                      +.+..         ....|+++.|||||.||++|+  ++...|++||++...     ..|++||+|.|+..
T Consensus        85 g~f~~~~~~~~~~~~~~~~~v~igdSL~~iA~~~G--vs~~~i~~ln~i~~~~idf~~~Lr~GD~l~V~~~  153 (361)
T 2gu1_A           85 GSFSYDFQEISGEWREILFSGEINGSFSVSARRVG--LTSSQVANITQVMKDKIDFSRSLRAGDRFDILVK  153 (361)
T ss_dssp             SCEEEEEEECCCEEEEEEEEEESSSCHHHHHHHTT--CCHHHHHHHHHHHTTTCCTTTCCCC-CEEEEEEE
T ss_pred             CcceeeecccCceEEEEEEEEEECCcHHHHHHHcC--CCHHHHHHHHHhhcccccccccCCCCCEEEEEEE
Confidence            00100         113588999999999999999  999999999987532     46999999999874

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=98.95  E-value=1.2e-09  Score=108.58  Aligned_cols=126  Identities=16%  Similarity=0.104  Sum_probs=94.5

Q ss_pred             EEEEEEEECCeEEEEEEcchh---HHHHHHHHHHHHHhCC-CCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcC
Q 041830          392 GAVYHGRLNGKNLAIKRTEHE---VITKLEMQLVQHATHH-HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLA  467 (600)
Q Consensus       392 G~Vy~g~~~g~~vAvK~~~~~---~~~~~e~ei~~~~~l~-HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~  467 (600)
                      +.||+....|+.+++|.....   ....+++|...+..+. |..+.++++++... ...|+||||+++.+|.+.+.    
T Consensus        28 ~~v~~~~~~~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~-~~~~lv~e~i~G~~l~~~~~----  102 (263)
T 3tm0_A           28 AKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD-GWSNLLMSEADGVLCSEEYE----  102 (263)
T ss_dssp             SEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET-TEEEEEEECCSSEEHHHHCC----
T ss_pred             CeEEEEECCCCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecC-CceEEEEEecCCeehhhccC----
Confidence            779999888899999997642   2234677777776653 66788899887554 47899999999999987631    


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------------
Q 041830          468 MKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM--------------------------------------------  503 (600)
Q Consensus       468 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------------------  503 (600)
                                   +..+...++.+++++|+.||...                                            
T Consensus       103 -------------~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (263)
T 3tm0_A          103 -------------DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRE  169 (263)
T ss_dssp             -------------TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHH
T ss_pred             -------------CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHH
Confidence                         11123467888999999999710                                            


Q ss_pred             ------------CCCceecCCCCCCEEeCCCCcEEEEeccCccc
Q 041830          504 ------------NPSYVHRNIKSRNIFLDEEFNARVGNFGMARC  535 (600)
Q Consensus       504 ------------~~~ivHrDLk~~NILld~~~~~kI~DFGla~~  535 (600)
                                  ...++|+|+++.|||++++..+.|.||+.+..
T Consensus       170 l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          170 LYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             HHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                        14489999999999998766677999998753

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.80  E-value=4.5e-09  Score=103.70  Aligned_cols=127  Identities=13%  Similarity=0.081  Sum_probs=85.1

Q ss_pred             ceeEEEEEEEE-CCeEEEEEEcchhHHHHHHHHHHHHHhCCCCc--eeeeeeEEeccCCceEEEEeecCCCCHHHHHhcC
Q 041830          389 RIEGAVYHGRL-NGKNLAIKRTEHEVITKLEMQLVQHATHHHPN--IVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGG  465 (600)
Q Consensus       389 ~~~G~Vy~g~~-~g~~vAvK~~~~~~~~~~e~ei~~~~~l~HpN--Iv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~  465 (600)
                      +..+.||+... +|+.+++|.........++.|...+..+.+.+  +.+++++.... ...++||||+++.+|.  ... 
T Consensus        31 g~~~~v~~~~~~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~-~~~~~v~e~i~G~~l~--~~~-  106 (264)
T 1nd4_A           31 CSDAAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEA-GRDWLLLGEVPGQDLL--SSH-  106 (264)
T ss_dssp             TSSCEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS-SCEEEEEECCSSEETT--TSC-
T ss_pred             CCCceEEEEecCCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCC-CCCEEEEEecCCcccC--cCc-
Confidence            33478999876 57789999876543334566666665554333  55688876444 4689999999998774  110 


Q ss_pred             cCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcC------------------------------------------
Q 041830          466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM------------------------------------------  503 (600)
Q Consensus       466 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------------------------------------------  503 (600)
                                    .+   ...++.++++.|..||...                                          
T Consensus       107 --------------~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  169 (264)
T 1nd4_A          107 --------------LA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAE  169 (264)
T ss_dssp             --------------CC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHH
T ss_pred             --------------CC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHH
Confidence                          11   1234556666666666421                                          


Q ss_pred             -------------CCCceecCCCCCCEEeCCCCcEEEEeccCcccc
Q 041830          504 -------------NPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV  536 (600)
Q Consensus       504 -------------~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~  536 (600)
                                   ...++|+|+++.|||++++..++|.||+.+...
T Consensus       170 ~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~g  215 (264)
T 1nd4_A          170 LFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGVA  215 (264)
T ss_dssp             HHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEEE
T ss_pred             HHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhcccC
Confidence                         123999999999999988777789999987643

>2gu1_A Zinc peptidase; alpha/beta, beta barrel, structural genomics, PSI, protein structure initiative; 1.90A {Vibrio cholerae}

Probab=98.79  E-value=2.5e-09  Score=111.46  Aligned_cols=114  Identities=9%  Similarity=-0.028  Sum_probs=83.6

Q ss_pred             ceeeeecCCchhhHHHhcCCCchHHHHHhhCCCCC----CCCCCCCCeEeeeeeccCCCC---------C------CCCC
Q 041830          127 LTKTTIKGESFYSIAQSLEGLTTCGAIKERNPSVS----PWDLDDKARLQVPLRCACPSS---------S------ENLP  187 (600)
Q Consensus       127 ~~y~v~~gdt~~~ia~~~~gl~t~~~l~~~N~~~~----~~~l~~G~~l~vp~~c~c~~~---------~------~~~~  187 (600)
                      .+|+|++|||||.||++|+  ++.++|+++|+...    .+.|++||+|.||..-. ...         .      ....
T Consensus         8 ~~~~Vk~GDTL~~Ia~r~g--vs~~~l~~~n~~~~~~~~~~~L~~Gq~L~i~~~~~-~~l~~l~~~~~~~~~~~~~~~~~   84 (361)
T 2gu1_A            8 IHYMVKVGDTLSGIFAQLG--VPYSILQKILSVDLDHLQLDMIQPGEELELMMDDM-GQLSRLIYHMSIVEKAIYTREND   84 (361)
T ss_dssp             EEEECCTTCCHHHHHHHTT--CCHHHHHHHHHHGGGTCCGGGCCTTCEEEEEECTT-SCEEEEEEEEETTEEEEEEECTT
T ss_pred             eEEEECCCCcHHHHHHHcC--CCHHHHHHHHhhcccccchhcCCCCCEEEEEECCC-CcceEEEEEcCccceEEEEecCC
Confidence            5799999999999999999  99999999998752    36799999999997421 000         0      0001


Q ss_pred             -----------CceEEEEEEccCCCcccccccccCCChHHHHHhcCCCCCCCCc-ccccCcccccccC
Q 041830          188 -----------ETRILVSYPVGEGDTVSGLAAKFNTTPAAIIAANNKSLEGFKP-EDLLAFTSILIPL  243 (600)
Q Consensus       188 -----------~~~~~~tY~v~~gd~~~~ia~~f~~~~~~~~~~n~~~~~g~~p-~~l~~~~~~~vp~  243 (600)
                                 ......+|.|+.||+|+.||.++|++...+.+||+......+. ..|++++.+.|+.
T Consensus        85 g~f~~~~~~~~~~~~~~~~~v~igdSL~~iA~~~Gvs~~~i~~ln~i~~~~idf~~~Lr~GD~l~V~~  152 (361)
T 2gu1_A           85 GSFSYDFQEISGEWREILFSGEINGSFSVSARRVGLTSSQVANITQVMKDKIDFSRSLRAGDRFDILV  152 (361)
T ss_dssp             SCEEEEEEECCCEEEEEEEEEESSSCHHHHHHHTTCCHHHHHHHHHHHTTTCCTTTCCCC-CEEEEEE
T ss_pred             CcceeeecccCceEEEEEEEEEECCcHHHHHHHcCCCHHHHHHHHHhhcccccccccCCCCCEEEEEE
Confidence                       1123457999999999999999999999999999872111111 2577887776654

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.62  E-value=4.7e-08  Score=101.83  Aligned_cols=130  Identities=13%  Similarity=0.187  Sum_probs=95.2

Q ss_pred             EEEEEEEECCeEEEEEEcc--hhH----HHHHHHHHHHHHhCC--CCceeeeeeEEeccC--CceEEEEeecCCCCHHHH
Q 041830          392 GAVYHGRLNGKNLAIKRTE--HEV----ITKLEMQLVQHATHH--HPNIVRLLGTCLTDG--PHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       392 G~Vy~g~~~g~~vAvK~~~--~~~----~~~~e~ei~~~~~l~--HpNIv~l~g~~~~~~--~~~~LV~Ey~~~GsL~~~  461 (600)
                      +.+|+....+..+++|+..  ...    ...+++|...+..+.  +..+.++++++.+..  ...|+||||+++..+.+.
T Consensus        52 n~~y~v~~~~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~  131 (359)
T 3dxp_A           52 NPTFKLVTPGQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQ  131 (359)
T ss_dssp             SCEEEEECSSCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCT
T ss_pred             ceEEEEEECCceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCC
Confidence            6789988877889999876  322    235667777776665  456788888875431  247899999998766321


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcC--------------------------------------
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM--------------------------------------  503 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------------  503 (600)
                      .              ...++..++..++.++++.|+.||...                                      
T Consensus       132 ~--------------~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (359)
T 3dxp_A          132 S--------------LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM  197 (359)
T ss_dssp             T--------------CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred             c--------------cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence            0              023778888999999999999999631                                      


Q ss_pred             -----------------CCCceecCCCCCCEEeCCCCc--EEEEeccCccc
Q 041830          504 -----------------NPSYVHRNIKSRNIFLDEEFN--ARVGNFGMARC  535 (600)
Q Consensus       504 -----------------~~~ivHrDLk~~NILld~~~~--~kI~DFGla~~  535 (600)
                                       ...++|+|+++.|||++.++.  +.|.||+.+..
T Consensus       198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                             246899999999999987653  68999998864

>2djp_A Hypothetical protein SB145; LYSM, structural genomics, NPPSFA, national project on protein structural and functional analyses; NMR {Homo sapiens}

Probab=98.46  E-value=2e-07  Score=74.26  Aligned_cols=51  Identities=22%  Similarity=0.180  Sum_probs=47.0

Q ss_pred             eeeeeecCCCCCChhhHHHhhCCChHHHHhhhCCCCCCCCCCCCCcEEEeecc
Q 041830           62 TFAILRTNSYYSSLFNLSFYLGLNRFVIARANGFSADTEFLPKDQPLLIPIDC  114 (600)
Q Consensus        62 ~~~~y~~~~~~~~l~~ia~~~~~~~~~i~~~N~~~~~~~~i~~~~~l~vP~~c  114 (600)
                      .+..|+|++ ||||+.||++|++++.+|+++|++. +.+.|.+||.|.||..-
T Consensus        14 ~~~~y~V~~-GDTL~~IA~~~~~~~~~l~~~N~l~-~~~~l~~Gq~l~iP~~~   64 (77)
T 2djp_A           14 RRLEHQLEP-GDTLAGLALKYGVTMEQIKRANRLY-TNDSIFLKKTLYIPILT   64 (77)
T ss_dssp             EEEEECCCT-TCCHHHHHHHHTCCHHHHHHHHTCC-CSSCGGGSSCEEEEEEC
T ss_pred             CcEEEEECC-CCcHHHHHHHHCcCHHHHHHHcCCC-CccccCCCCEEEECCCC
Confidence            678899999 9999999999999999999999995 56899999999999863

>1e0g_A Membrane-bound lytic murein transglycosylase D; cell WALL, hydrolase, glycosidase, lipoprotein, outer membrane, multigene family; NMR {Escherichia coli} SCOP: d.7.1.1

Probab=98.34  E-value=2.8e-07  Score=66.10  Aligned_cols=46  Identities=24%  Similarity=0.188  Sum_probs=41.8

Q ss_pred             eeeecCCCCCChhhHHHhhCCChHHHHhhhCCCCCCCCCCCCCcEEEeec
Q 041830           64 AILRTNSYYSSLFNLSFYLGLNRFVIARANGFSADTEFLPKDQPLLIPID  113 (600)
Q Consensus        64 ~~y~~~~~~~~l~~ia~~~~~~~~~i~~~N~~~~~~~~i~~~~~l~vP~~  113 (600)
                      ..|+|++ ||||++||++|+++..+|.++|+   +.+.|.+||.|.||++
T Consensus         3 ~~y~V~~-GDtl~~Ia~~~~~~~~~l~~~N~---~~~~l~~G~~l~ip~~   48 (48)
T 1e0g_A            3 ITYRVRK-GDSLSSIAKRHGVNIKDVMRWNS---DTANLQPGDKLTLFVK   48 (48)
T ss_dssp             CEEEECT-TCCHHHHHHHHTCCHHHHHHHCS---CGGGCCTTEEEECCCC
T ss_pred             EEEEEcC-CCcHHHHHHHHCcCHHHHHHhCC---CCCcCCcCCEEEEecC
Confidence            3689998 99999999999999999999998   5678999999999964

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.29  E-value=5.4e-07  Score=91.47  Aligned_cols=168  Identities=19%  Similarity=0.188  Sum_probs=103.0

Q ss_pred             EEEEEEEECCeEEEEEEcchh-HHHHHHHHHHHHHhCC-CCc--eeeeeeEEeccC--CceEEEEeecCCCCHHHHHhcC
Q 041830          392 GAVYHGRLNGKNLAIKRTEHE-VITKLEMQLVQHATHH-HPN--IVRLLGTCLTDG--PHSFLVFEYAKNGSLKDWLHGG  465 (600)
Q Consensus       392 G~Vy~g~~~g~~vAvK~~~~~-~~~~~e~ei~~~~~l~-HpN--Iv~l~g~~~~~~--~~~~LV~Ey~~~GsL~~~L~~~  465 (600)
                      ..||+.   +..+++|..... ....+++|...+..+. +..  +.++++.....+  ...|+|||++++.+|.+...  
T Consensus        34 n~v~~v---~~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~--  108 (304)
T 3sg8_A           34 CIAYEI---NRDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL--  108 (304)
T ss_dssp             EEEEES---TTSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH--
T ss_pred             ceEEEE---CCEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcccc--
Confidence            455553   356888986544 2356677877776652 222  334444432221  12489999999977754321  


Q ss_pred             cCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhc-------------------------------------------
Q 041830          466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV-------------------------------------------  502 (600)
Q Consensus       466 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-------------------------------------------  502 (600)
                                  ..++..++..++.++++.|+.||..                                           
T Consensus       109 ------------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  176 (304)
T 3sg8_A          109 ------------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDF  176 (304)
T ss_dssp             ------------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHH
T ss_pred             ------------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHH
Confidence                        1256666667777777777777741                                           


Q ss_pred             ------------CCCCceecCCCCCCEEeCC--CCcEEEEeccCccccCCCC-----------CCCccccc----CCCC-
Q 041830          503 ------------MNPSYVHRNIKSRNIFLDE--EFNARVGNFGMARCVNDDT-----------ESPQFYST----NPAS-  552 (600)
Q Consensus       503 ------------~~~~ivHrDLk~~NILld~--~~~~kI~DFGla~~~~~~~-----------~~pe~~~~----~~~~-  552 (600)
                                  ....++|+|+++.||++++  ...+.|.||+.+.......           ..++....    -+.. 
T Consensus       177 ~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~  256 (304)
T 3sg8_A          177 YRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKD  256 (304)
T ss_dssp             HHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSC
T ss_pred             HHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCC
Confidence                        0135799999999999988  5668899999886543211           11111000    0000 


Q ss_pred             ---C----CccCchHHHHHHHHHHHhCCCCC
Q 041830          553 ---W----SMGIDIFAYGIVLLEVLSGQTPI  576 (600)
Q Consensus       553 ---~----t~~sDVwSfGvvL~ELltG~~Pf  576 (600)
                         .    ....+.|+++.++|++.+|+.+|
T Consensus       257 ~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          257 IPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             cHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence               0    01148999999999999998876

>4a1k_A Putative L, D-transpeptidase YKUD; transferase, peptidoglycan synthesis; HET: CME; 1.75A {Bacillus subtilis} PDB: 4a1j_A 4a1i_A* 1y7m_A 3zqd_A 4a52_A*

Probab=98.00  E-value=2.5e-06  Score=78.32  Aligned_cols=46  Identities=26%  Similarity=0.387  Sum_probs=42.1

Q ss_pred             ceeeeecCCchhhHHHhcCCCchHHHHHhhCCCCCCCCCCCCCeEeeee
Q 041830          127 LTKTTIKGESFYSIAQSLEGLTTCGAIKERNPSVSPWDLDDKARLQVPL  175 (600)
Q Consensus       127 ~~y~v~~gdt~~~ia~~~~gl~t~~~l~~~N~~~~~~~l~~G~~l~vp~  175 (600)
                      .+|+||+||||.+||++|+  +..++|+++||..+++ |.+||+|.||.
T Consensus         3 ~~y~V~~GdtL~~IA~~f~--~g~~~l~~aNp~vd~~-l~~g~~i~ip~   48 (165)
T 4a1k_A            3 LTYQVKQGDTLNSIAADFR--ISTAALLQANPSLQAG-LTAGQSIVIPG   48 (165)
T ss_dssp             EEEECCTTCCHHHHHHHTT--CCHHHHHHHCGGGGGC-CCTTCEEEETT
T ss_pred             EEEEECCCCCHHHHHHHhC--CCHHHHHHhCccCCCc-cCCCccccCcc
Confidence            5799999999999999999  9999999999987654 89999999983

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=97.99  E-value=2.9e-05  Score=76.84  Aligned_cols=128  Identities=14%  Similarity=0.107  Sum_probs=83.3

Q ss_pred             EEEEEEEE--CCeEEEEEEcchhHHHHHHHHHHHHHhCC-CCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcCc
Q 041830          392 GAVYHGRL--NGKNLAIKRTEHEVITKLEMQLVQHATHH-HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAM  468 (600)
Q Consensus       392 G~Vy~g~~--~g~~vAvK~~~~~~~~~~e~ei~~~~~l~-HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~  468 (600)
                      ..||+-..  .+..+.+|+-.......+..|...+..+. +--+-++++++..+ +..++|||++++.++.+......  
T Consensus        39 ~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~-~~~~lvme~l~G~~~~~~~~~~~--  115 (272)
T 4gkh_A           39 ATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTP-DDAWLLTTAIPGKTAFQVLEEYP--  115 (272)
T ss_dssp             CEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEET-TEEEEEEECCCSEEHHHHHHHCG--
T ss_pred             CeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEEC-CeEEEEEEeeCCccccccccCCH--
Confidence            46888665  46689999987766666777777766553 22356777777555 47899999999988766543211  


Q ss_pred             ccccccccccCCCHHHHHHHHHHHHHHHHHHHh-----------------------------------------------
Q 041830          469 KNQFIASCYCFLTWSQRLRICLDVAMALQYMHH-----------------------------------------------  501 (600)
Q Consensus       469 ~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-----------------------------------------------  501 (600)
                                    .+...+..+++..|+-||.                                               
T Consensus       116 --------------~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  181 (272)
T 4gkh_A          116 --------------DSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWK  181 (272)
T ss_dssp             --------------GGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHH
T ss_pred             --------------HHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHH
Confidence                          0111222333333333332                                               


Q ss_pred             ----cC----CCCceecCCCCCCEEeCCCCcEEEEeccCcccc
Q 041830          502 ----VM----NPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV  536 (600)
Q Consensus       502 ----~~----~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~  536 (600)
                          ..    ...++|+|+.+.|||++++..+-|.||+.+...
T Consensus       182 ~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~g  224 (272)
T 4gkh_A          182 EMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGIA  224 (272)
T ss_dssp             HHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEEE
T ss_pred             HHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECcccccC
Confidence                10    123799999999999998777789999987643

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=97.87  E-value=6.8e-05  Score=76.04  Aligned_cols=66  Identities=8%  Similarity=0.013  Sum_probs=43.8

Q ss_pred             EEEEEEEECCeEEEEEEcchh-HHHHHHHHHHHHHhCCCC---ceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          392 GAVYHGRLNGKNLAIKRTEHE-VITKLEMQLVQHATHHHP---NIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       392 G~Vy~g~~~g~~vAvK~~~~~-~~~~~e~ei~~~~~l~Hp---NIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      ..||+.   |..+++|.-+.. ....++.|...+..+.+.   .+.+.++++.......++||||+++..|.+
T Consensus        33 n~v~~v---g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~  102 (306)
T 3tdw_A           33 NYAILV---NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGE  102 (306)
T ss_dssp             EEEEEE---TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHH
T ss_pred             eeEEEE---CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECch
Confidence            466765   677888886543 335677788777776542   355666665433335789999999987765

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.44  E-value=0.00013  Score=75.32  Aligned_cols=32  Identities=13%  Similarity=0.203  Sum_probs=26.5

Q ss_pred             CCCceecCCCCCCEEeCCCCcEEEEeccCccc
Q 041830          504 NPSYVHRNIKSRNIFLDEEFNARVGNFGMARC  535 (600)
Q Consensus       504 ~~~ivHrDLk~~NILld~~~~~kI~DFGla~~  535 (600)
                      ...++|+|+.+.|||++++..+.|.||+.+..
T Consensus       221 ~~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~  252 (357)
T 3ats_A          221 EPVLLWGDARVGNVLYRDFQPVAVLDWEMVAL  252 (357)
T ss_dssp             CCEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred             CceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence            35689999999999999655578999998753

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.26  E-value=0.0014  Score=66.63  Aligned_cols=32  Identities=19%  Similarity=0.290  Sum_probs=28.6

Q ss_pred             CCCceecCCCCCCEEeCCCCcEEEEeccCccc
Q 041830          504 NPSYVHRNIKSRNIFLDEEFNARVGNFGMARC  535 (600)
Q Consensus       504 ~~~ivHrDLk~~NILld~~~~~kI~DFGla~~  535 (600)
                      ...++|+|+++.|||++.++.+.|.||+.+..
T Consensus       221 ~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          221 SPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             SCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             cCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            56899999999999998888999999998753

>4a1k_A Putative L, D-transpeptidase YKUD; transferase, peptidoglycan synthesis; HET: CME; 1.75A {Bacillus subtilis} PDB: 4a1j_A 4a1i_A* 1y7m_A 3zqd_A 4a52_A*

Probab=96.85  E-value=0.00071  Score=61.87  Aligned_cols=46  Identities=15%  Similarity=0.161  Sum_probs=40.7

Q ss_pred             eeeeecCCCCCChhhHHHhhCCChHHHHhhhCCCCCCCCCCCCCcEEEe
Q 041830           63 FAILRTNSYYSSLFNLSFYLGLNRFVIARANGFSADTEFLPKDQPLLIP  111 (600)
Q Consensus        63 ~~~y~~~~~~~~l~~ia~~~~~~~~~i~~~N~~~~~~~~i~~~~~l~vP  111 (600)
                      ..+|+|++ ||||..||++|+++..+|+++|..  ....+++||.|.||
T Consensus         2 ~~~y~V~~-GdtL~~IA~~f~~g~~~l~~aNp~--vd~~l~~g~~i~ip   47 (165)
T 4a1k_A            2 MLTYQVKQ-GDTLNSIAADFRISTAALLQANPS--LQAGLTAGQSIVIP   47 (165)
T ss_dssp             CEEEECCT-TCCHHHHHHHTTCCHHHHHHHCGG--GGGCCCTTCEEEET
T ss_pred             CEEEEECC-CCCHHHHHHHhCCCHHHHHHhCcc--CCCccCCCccccCc
Confidence            46899998 999999999999999999999954  34457899999998

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=96.70  E-value=0.0047  Score=65.24  Aligned_cols=32  Identities=6%  Similarity=0.190  Sum_probs=28.0

Q ss_pred             CCCceecCCCCCCEEeCCCCcEEEEeccCcccc
Q 041830          504 NPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV  536 (600)
Q Consensus       504 ~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~  536 (600)
                      ...++|+|+++.|||++.++ ++|.||+.+...
T Consensus       231 ~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          231 AQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             CCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             CCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            56799999999999998776 999999988654

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=96.32  E-value=0.01  Score=61.94  Aligned_cols=32  Identities=19%  Similarity=0.291  Sum_probs=26.6

Q ss_pred             CCCceecCCCCCCEEeCCCCcEEEEeccCcccc
Q 041830          504 NPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV  536 (600)
Q Consensus       504 ~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~  536 (600)
                      ...++|+|+.+.||+++.+ .+++.||..+...
T Consensus       226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~G  257 (397)
T 2olc_A          226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAFYG  257 (397)
T ss_dssp             CCEEECSCCSGGGEEECSS-CEEECCCTTCEEE
T ss_pred             CCceeeCCCCcCcEEEeCC-CeEEEeCcccccC
Confidence            4679999999999999875 4899999877643

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=96.29  E-value=0.016  Score=58.71  Aligned_cols=137  Identities=18%  Similarity=0.191  Sum_probs=80.6

Q ss_pred             EEEEEEEECCeEEEEEEcchhHHHHHHHHHHHHHhCC---CCceeeeeeEEeccCCceEEEEeecCCCCHH--------H
Q 041830          392 GAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQHATHH---HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK--------D  460 (600)
Q Consensus       392 G~Vy~g~~~g~~vAvK~~~~~~~~~~e~ei~~~~~l~---HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~--------~  460 (600)
                      ..+|+...++..+++|+........++.|...+..+.   ...+.++++++..+ ...++||||+++..+.        +
T Consensus        50 n~~y~v~~~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~-g~~~lvme~l~G~~~~~~~~~~lG~  128 (312)
T 3jr1_A           50 NEIWLINDEVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQ-GHSFLLLEALNKSKNKQSSFTIFAE  128 (312)
T ss_dssp             SEEEEEESSSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECS-SEEEEEEECCCCCCCCTTHHHHHHH
T ss_pred             eeeeEEEECCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecC-CceEEEEEeccCCCCCchhHHHHHH
Confidence            6788887778889999877655556677766555442   34677888876544 4789999999987531        1


Q ss_pred             ---HHhcCcCccccc-------cc----ccccCCCHHHHH---HHH--HH--------------HHHH-HHHHHh-cCCC
Q 041830          461 ---WLHGGLAMKNQF-------IA----SCYCFLTWSQRL---RIC--LD--------------VAMA-LQYMHH-VMNP  505 (600)
Q Consensus       461 ---~L~~~~~~~~~~-------~~----~~~~~l~~~~~~---~i~--~~--------------ia~g-L~yLH~-~~~~  505 (600)
                         .||..... ..+       .+    .....-+|.+..   ++.  .+              +..- ...|.. ...+
T Consensus       129 ~LA~LH~~~~~-~~fG~~~~~~~G~~~q~n~w~~~W~~f~~~~Rl~~~l~~a~~~g~~~~~~~~l~~~l~~~L~~~~~~~  207 (312)
T 3jr1_A          129 KIAQLHQIQGP-DKYGLDFDTWLGPIYQPNDWQTSWAKFFSENRIGWQLQICKEKGLIFGNIDLIVQIVADTLSKHNPKP  207 (312)
T ss_dssp             HHHHHHHCCCC-SSBBCSSCEEETTEEECCCCBSCHHHHHHHHTHHHHHHHHHHHTCCCSCHHHHHHHHHHHHTTCCCCC
T ss_pred             HHHHHHcCCCC-CCCCCCCCCCCCCcCCCCCCcCCHHHHHHHHHHHHHHHHHHHcCCChHHHHHHHHHHHHHhccCCCCc
Confidence               23332110 000       00    000112565432   111  11              1111 123321 1246


Q ss_pred             CceecCCCCCCEEeCCCCcEEEEecc
Q 041830          506 SYVHRNIKSRNIFLDEEFNARVGNFG  531 (600)
Q Consensus       506 ~ivHrDLk~~NILld~~~~~kI~DFG  531 (600)
                      .++|+|+.+.|++++.++ +.|.||.
T Consensus       208 ~l~HgD~~~~N~l~~~~~-~~~iD~~  232 (312)
T 3jr1_A          208 SILHGNLWIENCIQVDDK-IFVCNPA  232 (312)
T ss_dssp             EEECSSCSGGGEEEETTE-EEECSCC
T ss_pred             eeEeCCCCcCcEeecCCC-eEEEcCc
Confidence            799999999999998887 8888974

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=95.84  E-value=0.015  Score=58.98  Aligned_cols=33  Identities=24%  Similarity=0.334  Sum_probs=28.1

Q ss_pred             CCCceecCCCCCCEEeCCC----CcEEEEeccCcccc
Q 041830          504 NPSYVHRNIKSRNIFLDEE----FNARVGNFGMARCV  536 (600)
Q Consensus       504 ~~~ivHrDLk~~NILld~~----~~~kI~DFGla~~~  536 (600)
                      ...++|+|+.+.|||++.+    ..+.|.||+.+...
T Consensus       182 ~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          182 DMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             CCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            4579999999999999875    68999999988654

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=95.34  E-value=0.033  Score=55.63  Aligned_cols=31  Identities=10%  Similarity=0.067  Sum_probs=25.6

Q ss_pred             CCCceecCCCCCCEEeCCCCcEEEEeccCccc
Q 041830          504 NPSYVHRNIKSRNIFLDEEFNARVGNFGMARC  535 (600)
Q Consensus       504 ~~~ivHrDLk~~NILld~~~~~kI~DFGla~~  535 (600)
                      ...++|+|+.+.||+ ..++.+.+.||..+..
T Consensus       172 ~~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          172 PLAACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             CCEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             CceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            345899999999999 5667789999988764

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=95.32  E-value=0.032  Score=56.12  Aligned_cols=43  Identities=14%  Similarity=0.263  Sum_probs=31.7

Q ss_pred             HHHHHHHHHhc----CCCCceecCCCCCCEEeCCCCcEEEEeccCcc
Q 041830          492 VAMALQYMHHV----MNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR  534 (600)
Q Consensus       492 ia~gL~yLH~~----~~~~ivHrDLk~~NILld~~~~~kI~DFGla~  534 (600)
                      +...+++++..    ....++|+|+.+.|||++++....|.||+.+.
T Consensus       170 l~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          170 IRPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             HHHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            34455555532    13468999999999999887666899998764

>3slu_A M23 peptidase domain protein; outer membrane, hydrolase; 2.41A {Neisseria meningitidis}

Probab=94.45  E-value=0.058  Score=55.62  Aligned_cols=112  Identities=11%  Similarity=0.051  Sum_probs=68.0

Q ss_pred             ceeeeecCCchhhHHHhcCCCchHHHHHhhCCCC----CCCCCCCCCeEeeeeeccCCCCC-----CCCCCceEEE----
Q 041830          127 LTKTTIKGESFYSIAQSLEGLTTCGAIKERNPSV----SPWDLDDKARLQVPLRCACPSSS-----ENLPETRILV----  193 (600)
Q Consensus       127 ~~y~v~~gdt~~~ia~~~~gl~t~~~l~~~N~~~----~~~~l~~G~~l~vp~~c~c~~~~-----~~~~~~~~~~----  193 (600)
                      ..|+|++||||..|-..++  .+.+++.+.+...    +...|++||+|.+.+.-. ..-.     ....+....+    
T Consensus        15 ~~~~V~~GDTL~~IL~r~G--ls~~di~~i~~~~~~~~~l~~LrpGq~l~i~~~~~-~~l~~l~~~~~~~~~~~~v~i~~   91 (371)
T 3slu_A           15 VQEAVQPGDSLADVLARSG--MARDEIARITEKYGGEADLRHLRADQSVHVLVGGD-GGAREVQFFTDEDGERNLVALEK   91 (371)
T ss_dssp             EEEECCTTCCHHHHHHHTT--CCHHHHHHHHTTC------CCBCSSSEEEEEECTT-SCEEEEEEEECCTTEEEEEEEEE
T ss_pred             EEEEECCCCcHHHHHHHcC--CCHHHHHHHHHhccccCchhhCCCCCEEEEEECCC-CCeEEEEEEecCCCceeEEEEEe
Confidence            4699999999999998887  7767776664432    356899999999987421 0000     0000110011    


Q ss_pred             ---EEEc----------------cCCCcccccccccCCChHHHHHhcCC-CCCCCCcccccCccccccc
Q 041830          194 ---SYPV----------------GEGDTVSGLAAKFNTTPAAIIAANNK-SLEGFKPEDLLAFTSILIP  242 (600)
Q Consensus       194 ---tY~v----------------~~gd~~~~ia~~f~~~~~~~~~~n~~-~~~g~~p~~l~~~~~~~vp  242 (600)
                         .|.+                .-+++|+..+.+.|++...+..++.. ... .+-..|.+++...|.
T Consensus        92 ~dg~f~~~~~~~~~~~~~~~~~g~I~~Sl~~a~~~agl~~~~~~~l~~i~~~~-idf~~l~~GD~f~v~  159 (371)
T 3slu_A           92 KGGIWRRSASEADMKVLPTLRSVVVKTSARGSLARAEVPVEIRESLSGIFAGR-FSLDGLKEGDAVRLI  159 (371)
T ss_dssp             ETTEEEECCCGGGEEEEEEEEEEECSSCHHHHHHHTTCCHHHHHHHHHHHTTT-CCTTCCCTTCEEEEE
T ss_pred             cCCeeEEEeeecccceeeeEEEEEEeccHHHHHHHcCCCHHHHHHHHHHHccC-cCHHHcCCCCEEEEE
Confidence               1222                23778888899999999888888765 211 111256666555443

>2k1k_A Ephrin type-A receptor 1; EPHA1, receptor tyrosine kinase, dimeric transmembrane domain, ATP-binding, glycoprotein, nucleotide-binding; NMR {Homo sapiens} PDB: 2k1l_A

Probab=94.42  E-value=0.014  Score=38.87  Aligned_cols=31  Identities=16%  Similarity=0.205  Sum_probs=18.7

Q ss_pred             CCccccceeeeehHHHHHHHHHHHHHHHHHH
Q 041830          279 SKMLKVGAYIALSGAVVGGCIAIAAVVIVIL  309 (600)
Q Consensus       279 ~~~~~~~~~i~i~~~~v~~~lll~~v~~~~~  309 (600)
                      ++.++.+.+.+|+++++++++++++++++++
T Consensus         5 ~~~ls~GaIAGiVvG~v~gv~li~~l~~~~~   35 (38)
T 2k1k_A            5 SRGLTGGEIVAVIFGLLLGAALLLGILVFRS   35 (38)
T ss_dssp             STTCCHHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCCCCceeeeehHHHHHHHHHHHHHHHHe
Confidence            3445667777887777665555555544443

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=93.89  E-value=0.22  Score=49.21  Aligned_cols=61  Identities=13%  Similarity=0.162  Sum_probs=40.0

Q ss_pred             EEEEEEEE-CCeEEEEEEcchhH---HHHHHHHHHHHHhCCC---CceeeeeeEEeccCCceEEEEeecCCCC
Q 041830          392 GAVYHGRL-NGKNLAIKRTEHEV---ITKLEMQLVQHATHHH---PNIVRLLGTCLTDGPHSFLVFEYAKNGS  457 (600)
Q Consensus       392 G~Vy~g~~-~g~~vAvK~~~~~~---~~~~e~ei~~~~~l~H---pNIv~l~g~~~~~~~~~~LV~Ey~~~Gs  457 (600)
                      +.||+.+. +|+.|.+|+.....   ...++.|...+..+.-   --+.+++++  .   .-++||||++.+.
T Consensus        29 ~~vyrv~l~DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~---~~~lv~e~l~~~~   96 (288)
T 3f7w_A           29 WHLYRVELADGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--D---DRTLAMEWVDERP   96 (288)
T ss_dssp             EEEEEEEETTSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--E---TTEEEEECCCCCC
T ss_pred             eEEEEEEECCCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--c---CceEEEEeecccC
Confidence            78999998 78999999865432   1346777776665531   123444444  2   2378999998754

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=93.39  E-value=0.07  Score=36.68  Aligned_cols=11  Identities=9%  Similarity=0.359  Sum_probs=4.7

Q ss_pred             HHHHHHHhhcc
Q 041830          305 VIVILLKKKKQ  315 (600)
Q Consensus       305 ~~~~~~rrkr~  315 (600)
                      ++++|+|||++
T Consensus        30 ~~~~~~RRr~~   40 (44)
T 2ks1_B           30 GIGLFMRRRHI   40 (44)
T ss_dssp             HHHHHHHTTTC
T ss_pred             HHHHHhhhhHh
Confidence            33444444443

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=93.34  E-value=0.056  Score=57.16  Aligned_cols=60  Identities=15%  Similarity=0.135  Sum_probs=34.6

Q ss_pred             eEEEEEEEEC---------CeEEEEEEcch-hHHHHHHHHHHHHHhCCCCc-eeeeeeEEeccCCceEEEEeecCC
Q 041830          391 EGAVYHGRLN---------GKNLAIKRTEH-EVITKLEMQLVQHATHHHPN-IVRLLGTCLTDGPHSFLVFEYAKN  455 (600)
Q Consensus       391 ~G~Vy~g~~~---------g~~vAvK~~~~-~~~~~~e~ei~~~~~l~HpN-Iv~l~g~~~~~~~~~~LV~Ey~~~  455 (600)
                      ...+|+....         ++.+.+|+... .....+..|...+..+...+ ..++++.+ .+    .+|+||+++
T Consensus        86 tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~-~~----g~v~e~l~G  156 (429)
T 1nw1_A           86 SNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF-SG----GRLEEYIPS  156 (429)
T ss_dssp             TEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE-TT----EEEECCCCE
T ss_pred             ccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEe-CC----CEEEEEeCC
Confidence            3788988873         46888998743 21123334554444432122 35666653 22    389999986

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=93.33  E-value=0.047  Score=37.46  Aligned_cols=11  Identities=9%  Similarity=0.389  Sum_probs=4.8

Q ss_pred             HHHHHHHhhcc
Q 041830          305 VIVILLKKKKQ  315 (600)
Q Consensus       305 ~~~~~~rrkr~  315 (600)
                      ++++|+|||++
T Consensus        29 ~~~~~~RRRr~   39 (44)
T 2l2t_A           29 TFAVYVRRKSI   39 (44)
T ss_dssp             HHHHHHHTTCS
T ss_pred             HHHHHhhhhhh
Confidence            33444444443

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=92.80  E-value=0.25  Score=52.60  Aligned_cols=64  Identities=11%  Similarity=-0.033  Sum_probs=37.2

Q ss_pred             ceeEEEEEEEECC--eEEEEEEcchhHH--HHHHHHHHHHHhCCCCce-eeeeeEEeccCCceEEEEeecCCCC
Q 041830          389 RIEGAVYHGRLNG--KNLAIKRTEHEVI--TKLEMQLVQHATHHHPNI-VRLLGTCLTDGPHSFLVFEYAKNGS  457 (600)
Q Consensus       389 ~~~G~Vy~g~~~g--~~vAvK~~~~~~~--~~~e~ei~~~~~l~HpNI-v~l~g~~~~~~~~~~LV~Ey~~~Gs  457 (600)
                      |....+|+....+  ..+.+|.......  -..+.|...+..+...++ .++++.+ . +   .+||||+++.+
T Consensus       119 G~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~-~-~---G~v~e~I~G~~  187 (458)
T 2qg7_A          119 GITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFF-T-N---GRIEEFMDGYA  187 (458)
T ss_dssp             --CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEE-T-T---EEEEECCCSEE
T ss_pred             CeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEe-C-C---eEEEEeeCCcc
Confidence            3347899988865  8888987643211  112456655555543334 4677764 2 2   25999998643

>3slu_A M23 peptidase domain protein; outer membrane, hydrolase; 2.41A {Neisseria meningitidis}

Probab=92.76  E-value=0.36  Score=49.73  Aligned_cols=112  Identities=14%  Similarity=0.020  Sum_probs=72.8

Q ss_pred             eeeeeecCCCCCChhhHHHhhCCChHHHHhhhCCCC---CCCCCCCCCcEEEeeccccC---------CCCcc--ee---
Q 041830           62 TFAILRTNSYYSSLFNLSFYLGLNRFVIARANGFSA---DTEFLPKDQPLLIPIDCKCN---------NNGGF--FQ---  124 (600)
Q Consensus        62 ~~~~y~~~~~~~~l~~ia~~~~~~~~~i~~~N~~~~---~~~~i~~~~~l~vP~~c~c~---------~~~~~--~~---  124 (600)
                      ..-.|++++ ||||+.|-+++|++..++.++++...   ....|++||.|.+.++-.-.         .....  ..   
T Consensus        13 ~W~~~~V~~-GDTL~~IL~r~Gls~~di~~i~~~~~~~~~l~~LrpGq~l~i~~~~~~~l~~l~~~~~~~~~~~~v~i~~   91 (371)
T 3slu_A           13 YWVQEAVQP-GDSLADVLARSGMARDEIARITEKYGGEADLRHLRADQSVHVLVGGDGGAREVQFFTDEDGERNLVALEK   91 (371)
T ss_dssp             EEEEEECCT-TCCHHHHHHHTTCCHHHHHHHHTTC------CCBCSSSEEEEEECTTSCEEEEEEEECCTTEEEEEEEEE
T ss_pred             ceEEEEECC-CCcHHHHHHHcCCCHHHHHHHHHhccccCchhhCCCCCEEEEEECCCCCeEEEEEEecCCCceeEEEEEe
Confidence            456799999 99999999999999999998876532   45899999999998763210         00000  00   


Q ss_pred             ecceeeee----------------cCCchhhHHHhcCCCchHHHHHhhCCCC----CCCCCCCCCeEeeeee
Q 041830          125 ADLTKTTI----------------KGESFYSIAQSLEGLTTCGAIKERNPSV----SPWDLDDKARLQVPLR  176 (600)
Q Consensus       125 ~~~~y~v~----------------~gdt~~~ia~~~~gl~t~~~l~~~N~~~----~~~~l~~G~~l~vp~~  176 (600)
                      ....|+++                -+++||..|...+  .+...+++.+.+-    +-..|++|+++.|...
T Consensus        92 ~dg~f~~~~~~~~~~~~~~~~~g~I~~Sl~~a~~~ag--l~~~~~~~l~~i~~~~idf~~l~~GD~f~v~~~  161 (371)
T 3slu_A           92 KGGIWRRSASEADMKVLPTLRSVVVKTSARGSLARAE--VPVEIRESLSGIFAGRFSLDGLKEGDAVRLIYD  161 (371)
T ss_dssp             ETTEEEECCCGGGEEEEEEEEEEECSSCHHHHHHHTT--CCHHHHHHHHHHHTTTCCTTCCCTTCEEEEEEE
T ss_pred             cCCeeEEEeeecccceeeeEEEEEEeccHHHHHHHcC--CCHHHHHHHHHHHccCcCHHHcCCCCEEEEEEE
Confidence            00123222                2788999887775  4555544444321    1235899999999864

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=92.45  E-value=0.15  Score=52.36  Aligned_cols=29  Identities=17%  Similarity=0.358  Sum_probs=24.1

Q ss_pred             CCceecCCCCCCEEeCCCCcEEEEeccCcc
Q 041830          505 PSYVHRNIKSRNIFLDEEFNARVGNFGMAR  534 (600)
Q Consensus       505 ~~ivHrDLk~~NILld~~~~~kI~DFGla~  534 (600)
                      ..++|+|+.+.|||++++. +.|.||..+.
T Consensus       212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~  240 (369)
T 3c5i_A          212 IVFCHNDLQENNIINTNKC-LRLIDFEYSG  240 (369)
T ss_dssp             EEEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred             eEEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence            4689999999999998655 8999998764

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=92.21  E-value=0.36  Score=49.02  Aligned_cols=32  Identities=13%  Similarity=0.189  Sum_probs=27.9

Q ss_pred             CCceecCCCCCCEEeCCCCcEEEEeccCcccc
Q 041830          505 PSYVHRNIKSRNIFLDEEFNARVGNFGMARCV  536 (600)
Q Consensus       505 ~~ivHrDLk~~NILld~~~~~kI~DFGla~~~  536 (600)
                      ..++|+|+.+.||++++++.+.|.||+.+...
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~~  237 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPMLA  237 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCeeC
Confidence            46899999999999998888999999877543

>2jwa_A Receptor tyrosine-protein kinase ERBB-2; transmembrane helix dimer, protein kinase receptor membrane domain, ATP-binding, glycoprotein; NMR {Homo sapiens} PDB: 2ks1_A

Probab=91.80  E-value=0.095  Score=35.86  Aligned_cols=12  Identities=50%  Similarity=0.780  Sum_probs=5.3

Q ss_pred             HHHHHHHHhhcc
Q 041830          304 VVIVILLKKKKQ  315 (600)
Q Consensus       304 v~~~~~~rrkr~  315 (600)
                      +++++|+|||++
T Consensus        29 l~~~~~~RRR~~   40 (44)
T 2jwa_A           29 VVFGILIKRRQQ   40 (44)
T ss_dssp             HHHHHHHHHHCS
T ss_pred             HHHHhheehhhh
Confidence            334444444443

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=89.35  E-value=0.41  Score=49.58  Aligned_cols=30  Identities=23%  Similarity=0.337  Sum_probs=26.3

Q ss_pred             CCceecCCCCCCEEeCCC----CcEEEEeccCcc
Q 041830          505 PSYVHRNIKSRNIFLDEE----FNARVGNFGMAR  534 (600)
Q Consensus       505 ~~ivHrDLk~~NILld~~----~~~kI~DFGla~  534 (600)
                      ..++|+|+.+.|||++.+    +.+.+.||..+.
T Consensus       220 ~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          220 VVFCHNDIQEGNILLLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             EEEECSCCCGGGEEEESCC---CCEEECCCTTCE
T ss_pred             cEEEcCCCCCCeEEEcCCCCccCcEEEEecccCC
Confidence            458999999999999876    789999998875

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=88.61  E-value=1  Score=42.64  Aligned_cols=99  Identities=13%  Similarity=0.043  Sum_probs=61.0

Q ss_pred             CCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccc
Q 041830          456 GSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARC  535 (600)
Q Consensus       456 GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~  535 (600)
                      -||.+.|....           .+|++.+.+-++.|.+..|.-+-.. ..+ ..+=+.+..|++..+|.+.+.+ ..+..
T Consensus        33 vSL~eIL~~~~-----------~PlsEEqaWALc~Qc~~~L~~~~~~-~~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~~   98 (229)
T 2yle_A           33 LSLEEILRLYN-----------QPINEEQAWAVCYQCCGSLRAAARR-RQP-RHRVRSAAQIRVWRDGAVTLAP-AADDA   98 (229)
T ss_dssp             EEHHHHHHHHT-----------SCCCHHHHHHHHHHHHHHHHHHHHT-TCC-CCCCCSGGGEEEETTSCEEECC-C----
T ss_pred             ccHHHHHHHcC-----------CCcCHHHHHHHHHHHHHHHHhhhhc-ccC-CceecCCcceEEecCCceeccc-ccccc
Confidence            47999887543           5699999999999999988766211 011 1222346899999999987774 22211


Q ss_pred             cCCCCCCCcccccCCCCCCccCchHHHHHHHHHHHh
Q 041830          536 VNDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLS  571 (600)
Q Consensus       536 ~~~~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt  571 (600)
                      -.....+|+...   ..-+.+.=|||+|+++|.-+-
T Consensus        99 ~~~~~~~pe~~~---~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A           99 GEPPPVAGKLGY---SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             --------CCSS---SSSCHHHHHHHHHHHHHHHHT
T ss_pred             cccCCCChhhcc---ccchHHHHHHHHHHHHHHHhh
Confidence            111122343321   123456689999999999875

>2ks1_B Epidermal growth factor receptor; ERBB1, ERBB2, transmembrane, heterodimer, complex, tyrosine receptor, bicelles, transferase; NMR {Homo sapiens}

Probab=87.09  E-value=0.76  Score=31.51  Aligned_cols=12  Identities=8%  Similarity=-0.075  Sum_probs=5.2

Q ss_pred             HHHHHHHhhccC
Q 041830          305 VIVILLKKKKQQ  316 (600)
Q Consensus       305 ~~~~~~rrkr~~  316 (600)
                      +...++.-.|++
T Consensus        27 i~~~~~~~~RRr   38 (44)
T 2ks1_B           27 VALGIGLFMRRR   38 (44)
T ss_dssp             HHHHHHHHHHTT
T ss_pred             HHHHHHHHhhhh
Confidence            344444444443

>2l2t_A Receptor tyrosine-protein kinase ERBB-4; transmembrane dimer, membrane domain, membrane protei; NMR {Homo sapiens}

Probab=85.31  E-value=0.89  Score=31.12  Aligned_cols=13  Identities=23%  Similarity=0.048  Sum_probs=5.3

Q ss_pred             HHHHHHHHHHHhh
Q 041830          301 IAAVVIVILLKKK  313 (600)
Q Consensus       301 l~~v~~~~~~rrk  313 (600)
                      ++..+++..++++
T Consensus        28 ~~~~~~~RRRr~~   40 (44)
T 2l2t_A           28 LTFAVYVRRKSIK   40 (44)
T ss_dssp             HHHHHHHHTTCSS
T ss_pred             HHHHHHhhhhhhh
Confidence            3444444444433

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	600
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-36
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-34
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-33
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	3e-33
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	8e-32
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-31
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-30
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	9e-30
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-29
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	2e-29
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-29
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	3e-29
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-28
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-28
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	4e-28
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-27
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	1e-27
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-27
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-27
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-27
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	7e-27
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	1e-26
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	3e-26
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-26
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	5e-26
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	7e-26
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-25
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-25
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	5e-25
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	8e-25
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-24
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-24
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	2e-24
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	3e-24
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	3e-24
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	3e-24
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-24
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	2e-23
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	6e-23
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	8e-23
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-22
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-22
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	3e-22
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	6e-22
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	1e-21
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	7e-20
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	8e-20
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	3e-19
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	7e-19
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-18
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-18
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-18
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	6e-18
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	1e-17
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-17
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	7e-17
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	8e-17
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	3e-16
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	7e-16
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	6e-15
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	1e-14
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	9e-12
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-08
d1e0ga_	48	d.7.1.1 (A:) Membrane-bound lytic murein transclyc	7e-05
d1y7ma2	48	d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-term	2e-04

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  135 bits (340), Expect = 2e-36
 Identities = 52/213 (24%), Positives = 91/213 (42%), Gaps = 37/213 (17%)

Query: 392 GAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQH-----ATHHHPNIVRLLGTCLTDGPHS 446
           G VY G+ +G  +A+K       T  ++Q  ++         H NI+  +G      P  
Sbjct: 22  GTVYKGKWHGD-VAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS--TAPQL 78

Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
            +V ++ +  SL   LH                    + + I    A  + Y+H     S
Sbjct: 79  AIVTQWCEGSSLYHHLH-----------IIETKFEMIKLIDIARQTAQGMDYLHA---KS 124

Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYST---------------NPA 551
            +HR++KS NIFL E+   ++G+FG+A   +  + S QF                  +  
Sbjct: 125 IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKN 184

Query: 552 SWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDE 584
            +S   D++A+GIVL E+++GQ P +    +D+
Sbjct: 185 PYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 217

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  129 bits (326), Expect = 1e-34
 Identities = 45/194 (23%), Positives = 85/194 (43%), Gaps = 25/194 (12%)

Query: 392 GAVYHGRLNGKNLAIKRTEHEVITKLEMQLVQ-HATHHHPNIVRLLGTCLTDGPHSFLVF 450
           G V  G   G  +A+K  +++   +  +          H N+V+LLG  + +    ++V 
Sbjct: 21  GDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 80

Query: 451 EYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHR 510
           EY   GSL D+L                 L     L+  LDV  A++Y+      ++VHR
Sbjct: 81  EYMAKGSLVDYLRS----------RGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHR 127

Query: 511 NIKSRNIFLDEEFNARVGNFGMARCVNDDTE---------SPQFYSTNPASWSMGIDIFA 561
           ++ +RN+ + E+  A+V +FG+ +  +   +         +P+       S     D+++
Sbjct: 128 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKWTAPEALREKKFSTK--SDVWS 185

Query: 562 YGIVLLEVLSGQTP 575
           +GI+L E+ S    
Sbjct: 186 FGILLWEIYSFGRV 199

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (321), Expect = 2e-33
 Identities = 40/201 (19%), Positives = 75/201 (37%), Gaps = 33/201 (16%)

Query: 392 GAVYHGRL--NGKNLAIKRTEHEVITKLEMQLVQ----HATHHHPNIVRLLGTCLTDGPH 445
           G V+      +G  +A K    E+   +  Q+++        + P IV   G   +DG  
Sbjct: 20  GVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDG-E 78

Query: 446 SFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNP 505
             +  E+   GSL   L                 +      ++ + V   L Y+      
Sbjct: 79  ISICMEHMDGGSLDQVLKK------------AGRIPEQILGKVSIAVIKGLTYLREKHK- 125

Query: 506 SYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE----------SPQFYSTNPASWSM 555
             +HR++K  NI ++     ++ +FG++  + D             SP+       S   
Sbjct: 126 -IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQ- 183

Query: 556 GIDIFAYGIVLLEVLSGQTPI 576
             DI++ G+ L+E+  G+ PI
Sbjct: 184 -SDIWSMGLSLVEMAVGRYPI 203

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  125 bits (316), Expect = 3e-33
 Identities = 51/206 (24%), Positives = 89/206 (43%), Gaps = 32/206 (15%)

Query: 392 GAVYHGRL--NGKNLAIKRTEHEVITKLEMQLVQ-----HATHHHPNIVRLLGTCLTDGP 444
           G     R   +GK L  K  ++  +T+ E Q++           HPNIVR     +    
Sbjct: 18  GRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTN 77

Query: 445 HS-FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH--H 501
            + ++V EY + G L   +  G   +         +L     LR+   + +AL+  H   
Sbjct: 78  TTLYIVMEYCEGGDLASVITKGTKER--------QYLDEEFVLRVMTQLTLALKECHRRS 129

Query: 502 VMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------------SPQFYSTN 549
               + +HR++K  N+FLD + N ++G+FG+AR +N DT             SP+  +  
Sbjct: 130 DGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRM 189

Query: 550 PASWSMGIDIFAYGIVLLEVLSGQTP 575
             +     DI++ G +L E+ +   P
Sbjct: 190 SYNEK--SDIWSLGCLLYELCALMPP 213

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (308), Expect = 8e-32
 Identities = 42/214 (19%), Positives = 82/214 (38%), Gaps = 43/214 (20%)

Query: 392 GAVYHGRLNGKNLAIKR--TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHS--- 446
           G V+ G+  G+ +A+K   +  E     E ++ Q     H NI+  +     D       
Sbjct: 17  GEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL 76

Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHH----- 501
           +LV +Y ++GSL D+L+                +T    +++ L  A  L ++H      
Sbjct: 77  WLVSDYHEHGSLFDYLNRYT-------------VTVEGMIKLALSTASGLAHLHMEIVGT 123

Query: 502 VMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTES----------------PQF 545
              P+  HR++KS+NI + +     + + G+A   +  T++                P+ 
Sbjct: 124 QGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEV 183

Query: 546 YSTNPASWSMGID----IFAYGIVLLEVLSGQTP 575
              +             I+A G+V  E+    + 
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 217

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  121 bits (305), Expect = 2e-31
 Identities = 58/248 (23%), Positives = 99/248 (39%), Gaps = 53/248 (21%)

Query: 366 KRLLESYSIEDLRRATEKFNSSNRIE-------------GAVYHGRLNGKN-----LAIK 407
           K  ++ ++ ED   A  +F     I              G V  G L         +AIK
Sbjct: 1   KIFIDPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIK 60

Query: 408 RTEHEVITKLEMQLVQHATH----HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH 463
             +     K     +  A+      HPN++ L G      P   ++ E+ +NGSL  +L 
Sbjct: 61  TLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV-MIITEFMENGSLDSFLR 119

Query: 464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEF 523
                            T  Q + +   +A  ++Y+      +YVHR++ +RNI ++   
Sbjct: 120 -----------QNDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNL 165

Query: 524 NARVGNFGMARCVNDDTESPQFYSTN----------PASWSMG-----IDIFAYGIVLLE 568
             +V +FG++R + DDT  P + S            P +          D+++YGIV+ E
Sbjct: 166 VCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWE 225

Query: 569 VLS-GQTP 575
           V+S G+ P
Sbjct: 226 VMSYGERP 233

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (298), Expect = 1e-30
 Identities = 41/202 (20%), Positives = 93/202 (46%), Gaps = 37/202 (18%)

Query: 392 GAVYHGRLN-GKNLAIKRTEHEVITK----LEMQLVQHATHHHPNIVRLLGTCLTDGPHS 446
           G V+ G  N    +A+K  +   ++      E  L++     H  +VRL      +    
Sbjct: 27  GEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQL--QHQRLVRLYAVVTQEPI-- 82

Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           +++ EY +NGSL D+L     +K          LT ++ L +   +A  + ++      +
Sbjct: 83  YIITEYMENGSLVDFLKTPSGIK----------LTINKLLDMAAQIAEGMAFIEE---RN 129

Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE-------------SPQFYSTNPASW 553
           Y+HR++++ NI + +  + ++ +FG+AR + D+               +P+  +     +
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGT--F 187

Query: 554 SMGIDIFAYGIVLLEVLSGQTP 575
           ++  D++++GI+L E+++    
Sbjct: 188 TIKSDVWSFGILLTEIVTHGRI 209

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  117 bits (293), Expect = 9e-30
 Identities = 54/226 (23%), Positives = 91/226 (40%), Gaps = 30/226 (13%)

Query: 392 GAVYHGRLNGKNL----AIKRTEHEVITKLEMQLVQHAT-----HHHPNIVRLLGTCLTD 442
           G V   R+    L    AIKR +                      HHPNI+ LLG C   
Sbjct: 24  GQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 83

Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQ----FIASCYCFLTWSQRLRICLDVAMALQY 498
           G + +L  EYA +G+L D+L     ++         S    L+  Q L    DVA  + Y
Sbjct: 84  G-YLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDY 142

Query: 499 MHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYST---------N 549
           +       ++HR++ +RNI + E + A++ +FG++R      +                N
Sbjct: 143 LS---QKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLN 199

Query: 550 PASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDEGSVWLSEKIKS 595
            + ++   D+++YG++L E++S                 L EK+  
Sbjct: 200 YSVYTTNSDVWSYGVLLWEIVSLG----GTPYCGMTCAELYEKLPQ 241

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (289), Expect = 1e-29
 Identities = 52/209 (24%), Positives = 87/209 (41%), Gaps = 33/209 (15%)

Query: 392 GAVYHGRL-NGKNLAIKRTEHEVITKL----EMQLVQHATHHHPNIVRLLGTCLTDGPHS 446
           G V+ G   N   +AIK      +++     E +++      HP +V+L G CL   P  
Sbjct: 19  GLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKL--SHPKLVQLYGVCLEQAPI- 75

Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
            LVFE+ ++G L D+L            +          L +CLDV   +    ++    
Sbjct: 76  CLVFEFMEHGCLSDYLR-----------TQRGLFAAETLLGMCLDVCEGM---AYLEEAC 121

Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------SM 555
            +HR++ +RN  + E    +V +FGM R V DD  +    +  P  W           S 
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181

Query: 556 GIDIFAYGIVLLEVLSGQTPINRPRKKDE 584
             D++++G+++ EV S        R   E
Sbjct: 182 KSDVWSFGVLMWEVFSEGKIPYENRSNSE 210

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  116 bits (292), Expect = 2e-29
 Identities = 55/257 (21%), Positives = 98/257 (38%), Gaps = 56/257 (21%)

Query: 392 GAVYHGRLNGKN-------LAIKRTEHEVITKLEMQLVQHAT-----HHHPNIVRLLGTC 439
           G V +    G +       +A+K  + +  +     L+           H NIV LLG C
Sbjct: 51  GKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGAC 110

Query: 440 LTDGPHSFLVFEYAKNGSLKDWLHG-----------GLAMKNQFIASCYCFLTWSQRLRI 488
              GP  +L+FEY   G L ++L                 K          LT+   L  
Sbjct: 111 TLSGPI-YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCF 169

Query: 489 CLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------- 541
              VA  ++++      S VHR++ +RN+ +      ++ +FG+AR +  D+        
Sbjct: 170 AYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNA 226

Query: 542 -------SPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTP------------INRPRK 581
                  +P+       +     D+++YGI+L E+ S G  P            + +   
Sbjct: 227 RLPVKWMAPESLFEGIYTIKS--DVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGF 284

Query: 582 KDEGSVWLSEKIKSILQ 598
           K +   + +E+I  I+Q
Sbjct: 285 KMDQPFYATEEIYIIMQ 301

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  116 bits (291), Expect = 2e-29
 Identities = 44/229 (19%), Positives = 86/229 (37%), Gaps = 44/229 (19%)

Query: 370 ESYSIEDLRRATEKFNSSNRI-EGA---VYHGRL--NGKNLAIKRTEHEVITKL------ 417
           E +  +D     + F+    I  G+   VY  R   N + +AIK+  +            
Sbjct: 6   ELFFKDDPE---KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDI 62

Query: 418 --EMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIAS 475
             E++ +Q     HPN ++  G  L +   ++LV EY    +                  
Sbjct: 63  IKEVRFLQKL--RHPNTIQYRGCYLREH-TAWLVMEYCLGSASDLLEVHK---------- 109

Query: 476 CYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARC 535
               L   +   +       L Y+H     + +HR++K+ NI L E    ++G+FG A  
Sbjct: 110 --KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASI 164

Query: 536 VNDDTE---SPQFYS------TNPASWSMGIDIFAYGIVLLEVLSGQTP 575
           +        +P + +       +   +   +D+++ GI  +E+   + P
Sbjct: 165 MAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPP 213

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  115 bits (288), Expect = 3e-29
 Identities = 41/204 (20%), Positives = 82/204 (40%), Gaps = 35/204 (17%)

Query: 392 GAVYHGRL--NGKNLAIKRTEHEVITKLEMQLVQ---HATHHHPNIVRLLGTCLTDGPHS 446
           G VY  +        A K  + +   +LE  +V+    A+  HPNIV+LL     +  + 
Sbjct: 26  GKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN-NL 84

Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
           +++ E+   G++   +                 LT SQ   +C     AL Y+H   +  
Sbjct: 85  WILIEFCAGGAVDAVML-----------ELERPLTESQIQVVCKQTLDALNYLH---DNK 130

Query: 507 YVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASWSMGI--------- 557
            +HR++K+ NI    + + ++ +FG++       +    +   P   +  +         
Sbjct: 131 IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 190

Query: 558 ------DIFAYGIVLLEVLSGQTP 575
                 D+++ GI L+E+   + P
Sbjct: 191 PYDYKADVWSLGITLIEMAEIEPP 214

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (285), Expect = 1e-28
 Identities = 44/225 (19%), Positives = 78/225 (34%), Gaps = 38/225 (16%)

Query: 392 GAVYHGRL-------NGKNLAIKRTEHEVITKLEMQLVQHAT-----HHHPNIVRLLGTC 439
           G V                +A+K  +          L+          +H NIV LLG C
Sbjct: 37  GKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGAC 96

Query: 440 LTDGPHSFLVFEYAKNGSLKDWLHG------GLAMKNQFIASCYCFLTWSQRLRICLDVA 493
              GP   ++ EY   G L ++L                +      L     L     VA
Sbjct: 97  TIGGPT-LVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVA 155

Query: 494 MALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------------ 541
             + ++      + +HR++ +RNI L      ++ +FG+AR + +D+             
Sbjct: 156 KGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVK 212

Query: 542 --SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDE 584
             +P+        ++   D+++YGI L E+ S  +        D 
Sbjct: 213 WMAPESIFNCV--YTFESDVWSYGIFLWELFSLGSSPYPGMPVDS 255

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (281), Expect = 2e-28
 Identities = 46/241 (19%), Positives = 86/241 (35%), Gaps = 50/241 (20%)

Query: 392 GAVYHGRL--NGKNLAIKRTEHEVITKLEMQLVQH-----ATHHHPNIVRLLGTCLTDGP 444
             VY G        +A    +   +TK E Q  +          HPNIVR   +  +   
Sbjct: 23  KTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVK 82

Query: 445 HS---FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHH 501
                 LV E   +G+LK +L              +  +        C  +   LQ++H 
Sbjct: 83  GKKCIVLVTELMTSGTLKTYLKR------------FKVMKIKVLRSWCRQILKGLQFLHT 130

Query: 502 VMNPSYVHRNIKSRNIFL-DEEFNARVGNFGMARCVNDDTE----------SPQFYSTNP 550
              P  +HR++K  NIF+     + ++G+ G+A                  +P+ Y    
Sbjct: 131 -RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEMYEEK- 188

Query: 551 ASWSMGIDIFAYGIVLLEVLSGQTP-------------INRPRKKDEGSVWLSEKIKSIL 597
             +   +D++A+G+ +LE+ + + P             +    K          ++K I+
Sbjct: 189 --YDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEII 246

Query: 598 Q 598
           +
Sbjct: 247 E 247

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 4e-28
 Identities = 46/208 (22%), Positives = 85/208 (40%), Gaps = 42/208 (20%)

Query: 392 GAVYHGRLNGKN----LAIKRTEHEVITKLEMQLVQ----HATHHHPNIVRLLGTCLTDG 443
           G+V  G    +     +AIK  +         ++++         +P IVRL+G C    
Sbjct: 23  GSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVC--QA 80

Query: 444 PHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM 503
               LV E A  G L  +L G               +  S    +   V+M ++Y+    
Sbjct: 81  EALMLVMEMAGGGPLHKFLVG-----------KREEIPVSNVAELLHQVSMGMKYLEE-- 127

Query: 504 NPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---------------SPQFYST 548
             ++VHR++ +RN+ L     A++ +FG+++ +  D                 +P+  + 
Sbjct: 128 -KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINF 186

Query: 549 NPASWSMGIDIFAYGIVLLEVLS-GQTP 575
               +S   D+++YG+ + E LS GQ P
Sbjct: 187 RK--FSSRSDVWSYGVTMWEALSYGQKP 212

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (277), Expect = 1e-27
 Identities = 41/200 (20%), Positives = 81/200 (40%), Gaps = 33/200 (16%)

Query: 392 GAVYHGRL-NGKNLAIKRTEHEVITKLEMQ--LVQHATHHHPNIVRLLGTCLTDGPHSFL 448
           G V+ G       +AIK  +   ++               H  +V+L      +    ++
Sbjct: 31  GEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPI--YI 88

Query: 449 VFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYV 508
           V EY   GSL D+L G              +L   Q + +   +A  + Y+      +YV
Sbjct: 89  VTEYMSKGSLLDFLKG----------ETGKYLRLPQLVDMAAQIASGMAYVER---MNYV 135

Query: 509 HRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE-------------SPQFYSTNPASWSM 555
           HR++++ NI + E    +V +FG+AR + D+               +P+        +++
Sbjct: 136 HRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGR--FTI 193

Query: 556 GIDIFAYGIVLLEVLSGQTP 575
             D++++GI+L E+ +    
Sbjct: 194 KSDVWSFGILLTELTTKGRV 213

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (277), Expect = 1e-27
 Identities = 50/265 (18%), Positives = 98/265 (36%), Gaps = 59/265 (22%)

Query: 374 IEDLRRATEKFNSSNRIE----------GAVYHGR--LNGKNLAIKRTEHEVITKLEM-- 419
           +E LR      +   +            G VY       G+ +AI++   +   K E+  
Sbjct: 6   LEKLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELII 65

Query: 420 -QLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYC 478
            +++    + +PNIV  L + L      ++V EY   GSL D +                
Sbjct: 66  NEILVMRENKNPNIVNYLDSYLVGD-ELWVVMEYLAGGSLTDVVTET------------- 111

Query: 479 FLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND 538
            +   Q   +C +   AL+++H   +   +HR+IKS NI L  + + ++ +FG    +  
Sbjct: 112 CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITP 168

Query: 539 DTE------------SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTP----------- 575
           +              +P+  +         +DI++ GI+ +E++ G+ P           
Sbjct: 169 EQSKRSTMVGTPYWMAPEVVTRKAYGPK--VDIWSLGIMAIEMIEGEPPYLNENPLRALY 226

Query: 576 --INRPRKKDEGSVWLSEKIKSILQ 598
                   + +    LS   +  L 
Sbjct: 227 LIATNGTPELQNPEKLSAIFRDFLN 251

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (274), Expect = 2e-27
 Identities = 39/213 (18%), Positives = 77/213 (36%), Gaps = 37/213 (17%)

Query: 392 GAVYHGRL--NGKNLAIKRTEHEVITKLEMQLVQ----HATHHHPNIVRLLGTCLTDGPH 445
           G V         + +A+K  + +        + +    +   +H N+V+  G        
Sbjct: 19  GEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGN-I 77

Query: 446 SFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNP 505
            +L  EY   G L D +   +             +      R    +   + Y+H     
Sbjct: 78  QYLFLEYCSGGELFDRIEPDIG------------MPEPDAQRFFHQLMAGVVYLHG---I 122

Query: 506 SYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE--------------SPQFYSTNPA 551
              HR+IK  N+ LDE  N ++ +FG+A     +                +P+       
Sbjct: 123 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 182

Query: 552 SWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDE 584
             +  +D+++ GIVL  +L+G+ P ++P    +
Sbjct: 183 H-AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 214

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  110 bits (275), Expect = 2e-27
 Identities = 53/244 (21%), Positives = 93/244 (38%), Gaps = 47/244 (19%)

Query: 373 SIEDLRRATEKFNSSNRI-EGA---VYHGRL-------NGKNLAIKRTEHEVITKLEMQL 421
            +  L            I EGA   V+  R            +A+K  + E    ++   
Sbjct: 4   KLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADF 63

Query: 422 VQ----HATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG------------G 465
            +     A   +PNIV+LLG C    P   L+FEY   G L ++L               
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVGKPM-CLLFEYMAYGDLNEFLRSMSPHTVCSLSHSD 122

Query: 466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNA 525
           L+ + +  +     L+ +++L I   VA  + Y+       +VHR++ +RN  + E    
Sbjct: 123 LSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVV 179

Query: 526 RVGNFGMARCVNDDTES--------------PQFYSTNPASWSMGIDIFAYGIVLLEVLS 571
           ++ +FG++R +                    P+    N  +     D++AYG+VL E+ S
Sbjct: 180 KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTE--SDVWAYGVVLWEIFS 237

Query: 572 GQTP 575
               
Sbjct: 238 YGLQ 241

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (272), Expect = 2e-27
 Identities = 48/201 (23%), Positives = 88/201 (43%), Gaps = 34/201 (16%)

Query: 392 GAVYHGRL-NGKNLAIKRTEHEVITKLEMQ--LVQHATHHHPNIVRLLGTCLTDGPHSFL 448
           G V +G+     ++AIK  +   +++ E            H  +V+L G C    P  F+
Sbjct: 18  GVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPI-FI 76

Query: 449 VFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYV 508
           + EY  NG L ++L                     Q L +C DV  A++Y+       ++
Sbjct: 77  ITEYMANGCLLNYLR-----------EMRHRFQTQQLLEMCKDVCEAMEYLES---KQFL 122

Query: 509 HRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE-------------SPQFYSTNPASWSM 555
           HR++ +RN  ++++   +V +FG++R V DD                P+    +  S   
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK- 181

Query: 556 GIDIFAYGIVLLEVLS-GQTP 575
             DI+A+G+++ E+ S G+ P
Sbjct: 182 -SDIWAFGVLMWEIYSLGKMP 201

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  109 bits (272), Expect = 7e-27
 Identities = 51/244 (20%), Positives = 103/244 (42%), Gaps = 41/244 (16%)

Query: 359 IDTAEQHKRLLESYSIEDLRRATEKFNSSNRI-EGA---VYHGRLNGKN-----LAIKR- 408
           ID +  +  L+++     +  ++   + +  I  G    VYHG L   +      A+K  
Sbjct: 4   IDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL 63

Query: 409 ---TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGG 465
              T+   +++   + +      HPN++ LLG CL       +V  Y K+G L++++   
Sbjct: 64  NRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIR-- 121

Query: 466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNA 525
                    +     T    +   L VA  ++++       +VHR++ +RN  LDE+F  
Sbjct: 122 ---------NETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTV 169

Query: 526 RVGNFGMARCVNDDTESPQFYSTNPA--------------SWSMGIDIFAYGIVLLEVLS 571
           +V +FG+AR + D         T                  ++   D++++G++L E+++
Sbjct: 170 KVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 229

Query: 572 GQTP 575
              P
Sbjct: 230 RGAP 233

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (270), Expect = 1e-26
 Identities = 44/232 (18%), Positives = 88/232 (37%), Gaps = 34/232 (14%)

Query: 392 GAVYHGRL-------NGKNLAIKRTEHEVITKLEMQLVQ-----HATHHHPNIVRLLGTC 439
           G V              + +A+K  +          L+          HH N+V LLG C
Sbjct: 27  GQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGAC 86

Query: 440 LTDGPHSFLVFEYAKNGSLKDWLHG----GLAMKNQFIASCYCFLTWSQRLRICLDVAMA 495
              G    ++ E+ K G+L  +L       +  K         FLT    +     VA  
Sbjct: 87  TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKG 146

Query: 496 LQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---------SPQFY 546
           ++++        +HR++ +RNI L E+   ++ +FG+AR +  D +           ++ 
Sbjct: 147 MEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 203

Query: 547 STNPAS---WSMGIDIFAYGIVLLEVLSGQTPINRPRKKDEGSVWLSEKIKS 595
           +        +++  D++++G++L E+ S       P    +       ++K 
Sbjct: 204 APETIFDRVYTIQSDVWSFGVLLWEIFSLGAS---PYPGVKIDEEFCRRLKE 252

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (265), Expect = 3e-26
 Identities = 43/202 (21%), Positives = 74/202 (36%), Gaps = 36/202 (17%)

Query: 392 GAVYHGRL--NGKNLAIKR------TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDG 443
           G VY  R   +   LA+K        +  V  +L  ++   +   HPNI+RL G    D 
Sbjct: 20  GNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYF-HDA 78

Query: 444 PHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM 503
              +L+ EYA  G++   L                     +      ++A AL Y H   
Sbjct: 79  TRVYLILEYAPLGTVYRELQ------------KLSKFDEQRTATYITELANALSYCH--- 123

Query: 504 NPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE----------SPQFYSTNPASW 553
           +   +HR+IK  N+ L      ++ +FG +                   P+         
Sbjct: 124 SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTTLCGTLDYLPPEMIEGRMHDE 183

Query: 554 SMGIDIFAYGIVLLEVLSGQTP 575
              +D+++ G++  E L G+ P
Sbjct: 184 K--VDLWSLGVLCYEFLVGKPP 203

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  106 bits (265), Expect = 3e-26
 Identities = 42/209 (20%), Positives = 85/209 (40%), Gaps = 44/209 (21%)

Query: 392 GAVYHGRLNGKNL----AIKRTEHEVITKLEMQLVQ-----HATHHHPNIVRLLGTCLTD 442
           G V  G    K +    A+K  ++E         +           +P IVR++G C  +
Sbjct: 21  GTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEAE 80

Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
                LV E A+ G L  +L                 +     + +   V+M ++Y+   
Sbjct: 81  SW--MLVMEMAELGPLNKYLQQN------------RHVKDKNIIELVHQVSMGMKYLEE- 125

Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---------------SPQFYS 547
              ++VHR++ +RN+ L  +  A++ +FG+++ +  D                 +P+  +
Sbjct: 126 --SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183

Query: 548 TNPASWSMGIDIFAYGIVLLEVLS-GQTP 575
                +S   D++++G+++ E  S GQ P
Sbjct: 184 YYK--FSSKSDVWSFGVLMWEAFSYGQKP 210

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  105 bits (264), Expect = 5e-26
 Identities = 44/203 (21%), Positives = 91/203 (44%), Gaps = 37/203 (18%)

Query: 392 GAVYHGRL--NGKNLAIKRTEHEVI----TKLEMQLVQHATHHHPNIVRLLGTCLTDGPH 445
           G VY G        +A+K  + + +       E  +++     HPN+V+LLG C T  P 
Sbjct: 31  GEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI--KHPNLVQLLGVC-TREPP 87

Query: 446 SFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNP 505
            +++ E+   G+L D+L      +          ++    L +   ++ A++Y+      
Sbjct: 88  FYIITEFMTYGNLLDYLRECNRQE----------VSAVVLLYMATQISSAMEYLEK---K 134

Query: 506 SYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDT-------------ESPQFYSTNPAS 552
           +++HR++ +RN  + E    +V +FG++R +  DT              +P+  + N  S
Sbjct: 135 NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 194

Query: 553 WSMGIDIFAYGIVLLEVLSGQTP 575
                D++A+G++L E+ +    
Sbjct: 195 IK--SDVWAFGVLLWEIATYGMS 215

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (263), Expect = 7e-26
 Identities = 44/208 (21%), Positives = 81/208 (38%), Gaps = 44/208 (21%)

Query: 392 GAVYHGR--LNGKNLAIKRTEHEVITK--------LEMQLVQHATHHHPNIVRLLGTCLT 441
             V   R     +  AIK  E   I K         E  ++      HP  V+L  T   
Sbjct: 22  STVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRL--DHPFFVKLYFTFQD 79

Query: 442 DGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHH 501
           D    +    YAKNG L  ++                    +       ++  AL+Y+H 
Sbjct: 80  DE-KLYFGLSYAKNGELLKYIR------------KIGSFDETCTRFYTAEIVSALEYLHG 126

Query: 502 VMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE--------------SPQFYS 547
                 +HR++K  NI L+E+ + ++ +FG A+ ++ +++              SP+  +
Sbjct: 127 ---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLT 183

Query: 548 TNPASWSMGIDIFAYGIVLLEVLSGQTP 575
              A  S   D++A G ++ ++++G  P
Sbjct: 184 EKSACKSS--DLWALGCIIYQLVAGLPP 209

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  106 bits (265), Expect = 2e-25
 Identities = 40/212 (18%), Positives = 75/212 (35%), Gaps = 36/212 (16%)

Query: 392 GAVYHGRL--NGKNLAIKR--------TEHEVITKLEMQLVQHATH-HHPNIVRLLGTCL 440
           G VY  R    GK  A+K          + E +   E  ++   +    P IV +     
Sbjct: 18  GEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFH 77

Query: 441 TDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH 500
           T       + +    G L   L              +   + +       ++ + L++MH
Sbjct: 78  TPD-KLSFILDLMNGGDLHYHLS------------QHGVFSEADMRFYAAEIILGLEHMH 124

Query: 501 HVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW------- 553
           +      V+R++K  NI LDE  + R+ + G+A   +         +    +        
Sbjct: 125 N---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASVGTHGYMAPEVLQKGV 181

Query: 554 --SMGIDIFAYGIVLLEVLSGQTPINRPRKKD 583
                 D F+ G +L ++L G +P  + + KD
Sbjct: 182 AYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 213

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  104 bits (261), Expect = 3e-25
 Identities = 36/204 (17%), Positives = 73/204 (35%), Gaps = 39/204 (19%)

Query: 392 GAVYHGR--LNGKNLAIKRTEHEVITKL-----EMQLVQHATHHHPNIVRLLGTCLTDGP 444
           G V+       G N A K       +       E+Q +      HP +V L      D  
Sbjct: 40  GVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVL--RHPTLVNLHDAFEDDN- 96

Query: 445 HSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMN 504
              +++E+   G L + +              +  ++  + +     V   L +MH    
Sbjct: 97  EMVMIYEFMSGGELFEKVA-----------DEHNKMSEDEAVEYMRQVCKGLCHMHE--- 142

Query: 505 PSYVHRNIKSRNIFLDEEFNARV--GNFGMARCVNDDTE-----------SPQFYSTNPA 551
            +YVH ++K  NI    + +  +   +FG+   ++               +P+     P 
Sbjct: 143 NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPV 202

Query: 552 SWSMGIDIFAYGIVLLEVLSGQTP 575
            +    D+++ G++   +LSG +P
Sbjct: 203 GYY--TDMWSVGVLSYILLSGLSP 224

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (257), Expect = 5e-25
 Identities = 40/214 (18%), Positives = 82/214 (38%), Gaps = 34/214 (15%)

Query: 392 GAVYHGRL---------NGKNLAIKRTEHEVITKLEMQLVQHAT-----HHHPNIVRLLG 437
           G V                  +A+K  + +   K    L+           H NI+ LLG
Sbjct: 27  GQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLG 86

Query: 438 TCLTDGPHSFLVFEYAKNGSLKDWLH----GGLAMKNQFIASCYCFLTWSQRLRICLDVA 493
            C T     +++ EYA  G+L+++L      GL        +    L+    +     VA
Sbjct: 87  AC-TQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVA 145

Query: 494 MALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW 553
             ++Y+        +HR++ +RN+ + E+   ++ +FG+AR ++      +  +      
Sbjct: 146 RGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVK 202

Query: 554 SMG------------IDIFAYGIVLLEVLSGQTP 575
            M              D++++G++L E+ +    
Sbjct: 203 WMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS 236

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  103 bits (258), Expect = 8e-25
 Identities = 35/201 (17%), Positives = 69/201 (34%), Gaps = 31/201 (15%)

Query: 392 GAVYHGR--LNGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTC---LTDGPHS 446
           G V         +  A+K  +     + E++L   A+   P+IVR++             
Sbjct: 26  GKVLQIFNKRTQEKFALKMLQDCPKARREVELHWRASQC-PHIVRIVDVYENLYAGRKCL 84

Query: 447 FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPS 506
            +V E    G L   +                  T  +   I   +  A+QY+H   + +
Sbjct: 85  LIVMECLDGGELFSRIQDRGDQA----------FTEREASEIMKSIGEAIQYLH---SIN 131

Query: 507 YVHRNIKSRNIFLDEEFN---ARVGNFGMARCVNDDTESPQFYST---------NPASWS 554
             HR++K  N+    +      ++ +FG A+             T          P  + 
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD 191

Query: 555 MGIDIFAYGIVLLEVLSGQTP 575
              D+++ G+++  +L G  P
Sbjct: 192 KSCDMWSLGVIMYILLCGYPP 212

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  101 bits (253), Expect = 1e-24
 Identities = 42/214 (19%), Positives = 79/214 (36%), Gaps = 46/214 (21%)

Query: 392 GAVYHGR--LNGKNLAIKRTEHEVITKLEMQLVQ-------------HATHHHPNIVRLL 436
             V         K  A+K  +         + VQ                  HPNI++L 
Sbjct: 17  SVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLK 76

Query: 437 GTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMAL 496
            T        FLVF+  K G L D+L   +             L+  +  +I   +   +
Sbjct: 77  DTY-ETNTFFFLVFDLMKKGELFDYLTEKVT------------LSEKETRKIMRALLEVI 123

Query: 497 QYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYST-------- 548
             +H     + VHR++K  NI LD++ N ++ +FG +  ++   +  +   T        
Sbjct: 124 CALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEI 180

Query: 549 -------NPASWSMGIDIFAYGIVLLEVLSGQTP 575
                  N   +   +D+++ G+++  +L+G  P
Sbjct: 181 IECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPP 214

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  102 bits (256), Expect = 2e-24
 Identities = 38/202 (18%), Positives = 71/202 (35%), Gaps = 35/202 (17%)

Query: 392 GAVYHGR--LNGKNLAIKRTEHEVITKL-----EMQLVQHATHHHPNIVRLLGTCLTDGP 444
           G V+       G+    K               E+ ++     HHP ++ L         
Sbjct: 43  GVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQL--HHPKLINLHDAFEDKY- 99

Query: 445 HSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMN 504
              L+ E+   G L D +            +    ++ ++ +         L++MH    
Sbjct: 100 EMVLILEFLSGGELFDRIA-----------AEDYKMSEAEVINYMRQACEGLKHMH---E 145

Query: 505 PSYVHRNIKSRNIFLDEEFNARV--GNFGMARCVNDDTESPQFYST---------NPASW 553
            S VH +IK  NI  + +  + V   +FG+A  +N D       +T         +    
Sbjct: 146 HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPV 205

Query: 554 SMGIDIFAYGIVLLEVLSGQTP 575
               D++A G++   +LSG +P
Sbjct: 206 GFYTDMWAIGVLGYVLLSGLSP 227

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (250), Expect = 2e-24
 Identities = 41/204 (20%), Positives = 77/204 (37%), Gaps = 36/204 (17%)

Query: 392 GAVYHGRLNGKN-----LAIKR----TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTD 442
           G V+ G           +AIK     T   V  K   + +      HP+IV+L+G    +
Sbjct: 21  GDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITEN 80

Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
               +++ E    G L+ +L                 L  +  +     ++ AL Y+   
Sbjct: 81  --PVWIIMELCTLGELRSFLQ-----------VRKYSLDLASLILYAYQLSTALAYLES- 126

Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW--------- 553
               +VHR+I +RN+ +      ++G+FG++R + D T         P  W         
Sbjct: 127 --KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 184

Query: 554 --SMGIDIFAYGIVLLEVLSGQTP 575
             +   D++ +G+ + E+L     
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVK 208

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  101 bits (252), Expect = 3e-24
 Identities = 41/202 (20%), Positives = 73/202 (36%), Gaps = 34/202 (16%)

Query: 392 GAVYHGR--LNGKNLAIKRTEHEVITKLEMQLVQ----HATHHHPNIVRLLGTCLTDGPH 445
             V         K +AIK    + +   E  +           HPNIV L     + G H
Sbjct: 23  SEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGG-H 81

Query: 446 SFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNP 505
            +L+ +    G L D +                F T     R+   V  A++Y+H +   
Sbjct: 82  LYLIMQLVSGGELFDRIVE------------KGFYTERDASRLIFQVLDAVKYLHDLG-- 127

Query: 506 SYVHRNIKSRNIFL---DEEFNARVGNFGMARCVNDDTESPQFYST---------NPASW 553
             VHR++K  N+     DE+    + +FG+++  +  +       T             +
Sbjct: 128 -IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPY 186

Query: 554 SMGIDIFAYGIVLLEVLSGQTP 575
           S  +D ++ G++   +L G  P
Sbjct: 187 SKAVDCWSIGVIAYILLCGYPP 208

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (250), Expect = 3e-24
 Identities = 49/218 (22%), Positives = 90/218 (41%), Gaps = 42/218 (19%)

Query: 392 GAVYHGRLNGKN------LAIKRTEHEVITKLEMQLVQHA----THHHPNIVRLLGTCLT 441
           G VY G L   +      +AIK  +     K  +  +  A       H NI+RL G   +
Sbjct: 21  GEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVI-S 79

Query: 442 DGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHH 501
                 ++ EY +NG+L  +L                  +  Q + +   +A  ++Y+  
Sbjct: 80  KYKPMMIITEYMENGALDKFLR-----------EKDGEFSVLQLVGMLRGIAAGMKYLA- 127

Query: 502 VMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---------------SPQFY 546
             N +YVHR++ +RNI ++     +V +FG++R + DD E               +P+  
Sbjct: 128 --NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAI 185

Query: 547 STNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDE 584
           S     ++   D++++GIV+ EV++            E
Sbjct: 186 SYRK--FTSASDVWSFGIVMWEVMTYGERPYWELSNHE 221

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (253), Expect = 3e-24
 Identities = 35/201 (17%), Positives = 74/201 (36%), Gaps = 34/201 (16%)

Query: 392 GAVYHGRL--NGKNLAIK----RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPH 445
           G V+      + K    K    +   +V+ K E+ ++  A   H NI+ L  +  +    
Sbjct: 19  GIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA--RHRNILHLHESFESME-E 75

Query: 446 SFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNP 505
             ++FE+     + + ++           +    L   + +     V  ALQ++H   + 
Sbjct: 76  LVMIFEFISGLDIFERIN-----------TSAFELNEREIVSYVHQVCEALQFLH---SH 121

Query: 506 SYVHRNIKSRNIFLDEEFNARV--GNFGMARCVNDDTESPQFYSTNPASW---------S 554
           +  H +I+  NI      ++ +    FG AR +         ++               S
Sbjct: 122 NIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVS 181

Query: 555 MGIDIFAYGIVLLEVLSGQTP 575
              D+++ G ++  +LSG  P
Sbjct: 182 TATDMWSLGTLVYVLLSGINP 202

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  100 bits (249), Expect = 3e-24
 Identities = 45/210 (21%), Positives = 81/210 (38%), Gaps = 43/210 (20%)

Query: 392 GAVYHGR--LNGKNLAIKR------TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTD- 442
             V+  R     +++A+K        +     +   +    A  +HP IV +  T   + 
Sbjct: 21  SEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAET 80

Query: 443 --GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH 500
             GP  ++V EY    +L+D +H                +T  + + +  D   AL + H
Sbjct: 81  PAGPLPYIVMEYVDGVTLRDIVH------------TEGPMTPKRAIEVIADACQALNFSH 128

Query: 501 HVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE---------------SPQF 545
                  +HR++K  NI +      +V +FG+AR + D                  SP+ 
Sbjct: 129 Q---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQ 185

Query: 546 YSTNPASWSMGIDIFAYGIVLLEVLSGQTP 575
              +        D+++ G VL EVL+G+ P
Sbjct: 186 ARGDSVDAR--SDVYSLGCVLYEVLTGEPP 213

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 98.3 bits (244), Expect = 2e-23
 Identities = 44/209 (21%), Positives = 80/209 (38%), Gaps = 41/209 (19%)

Query: 392 GAVYHGRLNGKN-----LAIKRTEHEVITKLEMQ------LVQHATHHHPNIVRLLGTCL 440
           G V  G  +  +     +A+K  + +V+++ E        +    +  H N++RL G  L
Sbjct: 22  GVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL 81

Query: 441 TDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH 500
           T  P   +V E A  GSL D L                        R  + VA  + Y+ 
Sbjct: 82  T--PPMKMVTELAPLGSLLDRLR-----------KHQGHFLLGTLSRYAVQVAEGMGYLE 128

Query: 501 HVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW------- 553
                 ++HR++ +RN+ L      ++G+FG+ R +  + +           +       
Sbjct: 129 S---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPES 185

Query: 554 ------SMGIDIFAYGIVLLEVLS-GQTP 575
                 S   D + +G+ L E+ + GQ P
Sbjct: 186 LKTRTFSHASDTWMFGVTLWEMFTYGQEP 214

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 97.9 bits (243), Expect = 6e-23
 Identities = 41/205 (20%), Positives = 78/205 (38%), Gaps = 39/205 (19%)

Query: 392 GAVYHGRL--NGKNLAIKR-------TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTD 442
           G V+        +  AIK         + +V   +  + V      HP +  +  T  T 
Sbjct: 16  GKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK 75

Query: 443 GPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
             + F V EY   G L   +                    S+      ++ + LQ++H  
Sbjct: 76  E-NLFFVMEYLNGGDLMYHIQSC------------HKFDLSRATFYAAEIILGLQFLHS- 121

Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE------------SPQFYSTNP 550
                V+R++K  NI LD++ + ++ +FGM +                   +P+      
Sbjct: 122 --KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQK 179

Query: 551 ASWSMGIDIFAYGIVLLEVLSGQTP 575
            + S  +D +++G++L E+L GQ+P
Sbjct: 180 YNHS--VDWWSFGVLLYEMLIGQSP 202

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 97.1 bits (241), Expect = 8e-23
 Identities = 52/201 (25%), Positives = 92/201 (45%), Gaps = 35/201 (17%)

Query: 392 GAVYHGRL--NGKNLAIKRTEHEVITKLEMQ------LVQHATHHHPNIVRLLGTCLTDG 443
           G V+  R   NG+  A+K  + E++ +L+         +  +   HP I+R+ GT   D 
Sbjct: 18  GRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTF-QDA 76

Query: 444 PHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM 503
              F++ +Y + G L   L                            +V +AL+Y+H   
Sbjct: 77  QQIFMIMDYIEGGELFSLLR------------KSQRFPNPVAKFYAAEVCLALEYLHS-- 122

Query: 504 NPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTES---------PQFYSTNPASWS 554
               ++R++K  NI LD+  + ++ +FG A+ V D T +         P+  ST P + S
Sbjct: 123 -KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLCGTPDYIAPEVVSTKPYNKS 181

Query: 555 MGIDIFAYGIVLLEVLSGQTP 575
             ID +++GI++ E+L+G TP
Sbjct: 182 --IDWWSFGILIYEMLAGYTP 200

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.5 bits (239), Expect = 2e-22
 Identities = 46/235 (19%), Positives = 93/235 (39%), Gaps = 37/235 (15%)

Query: 370 ESYSIEDLRRATEKFNSSNRI-EGA---VYHGRL-------NGKNLAIKRTEHEVITKLE 418
           + Y  ++   A EK   S  + +G+   VY G             +AIK        +  
Sbjct: 8   DVYVPDEWEVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRER 67

Query: 419 MQLVQHA----THHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIA 474
           ++ +  A      +  ++VRLLG      P   ++ E    G LK +L            
Sbjct: 68  IEFLNEASVMKEFNCHHVVRLLGVVSQGQPT-LVIMELMTRGDLKSYLRSL--RPAMANN 124

Query: 475 SCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR 534
                 + S+ +++  ++A  + Y++      +VHR++ +RN  + E+F  ++G+FGM R
Sbjct: 125 PVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR 181

Query: 535 CVNDDTE--------------SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTP 575
            + +                 SP+       +     D++++G+VL E+ +    
Sbjct: 182 DIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS--DVWSFGVVLWEIATLAEQ 234

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 96.8 bits (240), Expect = 2e-22
 Identities = 46/203 (22%), Positives = 82/203 (40%), Gaps = 33/203 (16%)

Query: 392 GAVYHGRL--NGKNLAIKRTEHEVITKL-EMQLVQHATHHHPNIVRLLGTCLTDG----- 443
           G VY  +L  +G+ +AIK+   +   K  E+Q+++     H NIVRL     + G     
Sbjct: 34  GVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKL--DHCNIVRLRYFFYSSGEKKDE 91

Query: 444 PHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM 503
            +  LV +Y      +   H   A +          L           +  +L Y+H   
Sbjct: 92  VYLNLVLDYVPETVYRVARHYSRAKQT---------LPVIYVKLYMYQLFRSLAYIHS-- 140

Query: 504 NPSYVHRNIKSRNIFLDEE-FNARVGNFGMARCVNDDTESPQFYSTNP----------AS 552
                HR+IK +N+ LD +    ++ +FG A+ +     +  +  +              
Sbjct: 141 -FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATD 199

Query: 553 WSMGIDIFAYGIVLLEVLSGQTP 575
           ++  ID+++ G VL E+L GQ  
Sbjct: 200 YTSSIDVWSAGCVLAELLLGQPI 222

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.9 bits (235), Expect = 3e-22
 Identities = 40/205 (19%), Positives = 72/205 (35%), Gaps = 37/205 (18%)

Query: 392 GAVYHGRL--NGKNLAIKRTEHEVITKLEMQLVQHATH--------HHPNIVRLLGTCLT 441
             VY  R     + +AIK+ +    ++ +  + + A           HPNI+ LL     
Sbjct: 12  ATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGH 71

Query: 442 DGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHH 501
              +  LVF++ +                         LT S      L     L+Y+H 
Sbjct: 72  KS-NISLVFDFMETDLEVIIKDNS------------LVLTPSHIKAYMLMTLQGLEYLHQ 118

Query: 502 VMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASWSM------ 555
                 +HR++K  N+ LDE    ++ +FG+A+       +           +       
Sbjct: 119 HW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGA 175

Query: 556 -----GIDIFAYGIVLLEVLSGQTP 575
                G+D++A G +L E+L     
Sbjct: 176 RMYGVGVDMWAVGCILAELLLRVPF 200

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.0 bits (233), Expect = 6e-22
 Identities = 38/235 (16%), Positives = 79/235 (33%), Gaps = 44/235 (18%)

Query: 392 GAVYHGR--LNGKNLAIKR-----------TEHEVITKLEMQLVQHATHHHPNIVRLLGT 438
           G+VY G    +   +AIK              +     +E+ L++  +     ++RLL  
Sbjct: 18  GSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDW 77

Query: 439 CLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQY 498
                    L+ E  +                    +    L           V  A+++
Sbjct: 78  FERPD-SFVLILERPEPVQDLFDFI-----------TERGALQEELARSFFWQVLEAVRH 125

Query: 499 MHHVMNPSYVHRNIKSRNIFLDEE-FNARVGNFGMARCVNDDTE----------SPQFYS 547
            H   N   +HR+IK  NI +D      ++ +FG    + D              P++  
Sbjct: 126 CH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSPPEWIR 182

Query: 548 TNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDEGSV----WLSEKIKSILQ 598
            +         +++ GI+L +++ G  P     +   G V     +S + + +++
Sbjct: 183 YHRY-HGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIR 236

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 94.1 bits (233), Expect = 1e-21
 Identities = 37/208 (17%), Positives = 80/208 (38%), Gaps = 42/208 (20%)

Query: 392 GAVYHGRLNGKN------LAIKRTEHEVITKLEMQLVQ----HATHHHPNIVRLLGTCLT 441
           G VY G    +       +AIK        K   +++      A+  +P++ RLLG CLT
Sbjct: 23  GTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLT 82

Query: 442 DGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHH 501
                 L+ +    G L D++                 +     L  C+ +A  + Y+  
Sbjct: 83  STVQ--LITQLMPFGCLLDYVR-----------EHKDNIGSQYLLNWCVQIAKGMNYLED 129

Query: 502 VMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDT--------------ESPQFYS 547
                 VHR++ +RN+ +    + ++ +FG+A+ +  +                + +   
Sbjct: 130 ---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186

Query: 548 TNPASWSMGIDIFAYGIVLLEVLSGQTP 575
               +     D+++YG+ + E+++  + 
Sbjct: 187 HRIYTHQ--SDVWSYGVTVWELMTFGSK 212

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.4 bits (218), Expect = 7e-20
 Identities = 44/225 (19%), Positives = 82/225 (36%), Gaps = 42/225 (18%)

Query: 379 RATEKFNSSNRI-EGA---VYHGR---LNGKNLAIKR-------TEHEVITKLEMQLVQH 424
           RA +++     I EGA   V+  R     G+ +A+KR           + T  E+ +++H
Sbjct: 4   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63

Query: 425 -ATHHHPNIVRLLGTCLT----DGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCF 479
             T  HPN+VRL   C            LVFE+                           
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDK-----------VPEPG 112

Query: 480 LTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD 539
           +       +   +   L ++H       VHR++K +NI +      ++ +FG+AR  +  
Sbjct: 113 VPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ 169

Query: 540 TESPQFYST---------NPASWSMGIDIFAYGIVLLEVLSGQTP 575
                   T           +S++  +D+++ G +  E+   +  
Sbjct: 170 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPL 214

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 88.0 bits (217), Expect = 8e-20
 Identities = 39/202 (19%), Positives = 74/202 (36%), Gaps = 33/202 (16%)

Query: 392 GAVYHGR--LNGKNLAIKRTEHEVITKLEMQLVQ-----HATHHHPNIVRLLGTCLTDGP 444
           G VY  R  L G+ +A+K+   +  T+                +HPNIV+LL    T+  
Sbjct: 16  GVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTEN- 74

Query: 445 HSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMN 504
             +LVFE+      K               S    +           +   L + H    
Sbjct: 75  KLYLVFEFLHQDLKKFMDA-----------SALTGIPLPLIKSYLFQLLQGLAFCHSHR- 122

Query: 505 PSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPA-----------SW 553
              +HR++K +N+ ++ E   ++ +FG+AR       +                     +
Sbjct: 123 --VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180

Query: 554 SMGIDIFAYGIVLLEVLSGQTP 575
           S  +DI++ G +  E+++ +  
Sbjct: 181 STAVDIWSLGCIFAEMVTRRAL 202

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 86.1 bits (212), Expect = 3e-19
 Identities = 38/201 (18%), Positives = 69/201 (34%), Gaps = 33/201 (16%)

Query: 392 GAVYHGRLN-GKNLAIK-----RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPH 445
           G VY  + N G+  A+K     + +  + +    ++       H NIV+L          
Sbjct: 16  GVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI-HTKKR 74

Query: 446 SFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNP 505
             LVFE+      K                C   L         L +   + Y H   + 
Sbjct: 75  LVLVFEHLDQDLKKLLDV------------CEGGLESVTAKSFLLQLLNGIAYCH---DR 119

Query: 506 SYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASW-----------S 554
             +HR++K +N+ ++ E   ++ +FG+AR                              S
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179

Query: 555 MGIDIFAYGIVLLEVLSGQTP 575
             IDI++ G +  E+++G   
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPL 200

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 86.0 bits (212), Expect = 7e-19
 Identities = 35/207 (16%), Positives = 71/207 (34%), Gaps = 39/207 (18%)

Query: 392 GAVYHGR--LNGKNLAIKRTEHEVITKLEMQLVQ----HATHHHPNIVRLLGTCLTDGPH 445
           G V      +N   +AIK+           + ++         H NI+ +          
Sbjct: 22  GMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIE 81

Query: 446 S---FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
                 +  +     L   L                 L+          +   L+Y+H  
Sbjct: 82  QMKDVYLVTHLMGADLYKLLKTQ-------------HLSNDHICYFLYQILRGLKYIH-- 126

Query: 503 MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYST-------------- 548
            + + +HR++K  N+ L+   + ++ +FG+AR  + D +   F +               
Sbjct: 127 -SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIML 185

Query: 549 NPASWSMGIDIFAYGIVLLEVLSGQTP 575
           N   ++  IDI++ G +L E+LS +  
Sbjct: 186 NSKGYTKSIDIWSVGCILAEMLSNRPI 212

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 85.3 bits (210), Expect = 1e-18
 Identities = 35/226 (15%), Positives = 78/226 (34%), Gaps = 43/226 (19%)

Query: 376 DLRRATEKFNSSNRIE----------GAVYHGR--LNGKNLAIKRTEHEVITKLEMQL-V 422
           D      ++ + +  +            V+      N + + +K  +     K++ ++ +
Sbjct: 23  DYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKI 82

Query: 423 QHATHHHPNIVRLLGTCLTDGPHS-FLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLT 481
                  PNI+ L          +  LVFE+  N   K                    LT
Sbjct: 83  LENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQT---------------LT 127

Query: 482 WSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFN-ARVGNFGMARCVNDDT 540
                    ++  AL Y H +     +HR++K  N+ +D E    R+ ++G+A   +   
Sbjct: 128 DYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 184

Query: 541 ESPQFYST----------NPASWSMGIDIFAYGIVLLEVLSGQTPI 576
           E     ++          +   +   +D+++ G +L  ++  + P 
Sbjct: 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPF 230

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.9 bits (209), Expect = 1e-18
 Identities = 36/213 (16%), Positives = 75/213 (35%), Gaps = 44/213 (20%)

Query: 392 GAVYHGRL--NGKNLAIKRTEHEVITKLEMQLVQ-----HATHHHPNIVRLLGTCLTDGP 444
           G V+  R    G+ +A+K+   E   +                 H N+V L+  C T   
Sbjct: 24  GEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKAS 83

Query: 445 -------HSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQ 497
                    +LVF++ ++       +                 T S+  R+     M L 
Sbjct: 84  PYNRCKGSIYLVFDFCEHDLAGLLSN------------VLVKFTLSEIKRVM---QMLLN 128

Query: 498 YMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPA------ 551
            ++++     +HR++K+ N+ +  +   ++ +FG+AR  +    S     TN        
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188

Query: 552 ---------SWSMGIDIFAYGIVLLEVLSGQTP 575
                     +   ID++  G ++ E+ +    
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 221

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 84.8 bits (209), Expect = 2e-18
 Identities = 44/204 (21%), Positives = 78/204 (38%), Gaps = 38/204 (18%)

Query: 392 GAVYHGR--LNGKNLAIKRTEHEVITK--------LEMQLVQHATHHHPNIVRLLGTCLT 441
           G V   R    G+  A+K    EVI           E +++Q+    HP +  L     T
Sbjct: 19  GKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNT--RHPFLTALKYAFQT 76

Query: 442 DGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHH 501
                  V EYA  G L   L                  T  +      ++  AL+Y+H 
Sbjct: 77  HD-RLCFVMEYANGGELFFHLSRE------------RVFTEERARFYGAEIVSALEYLHS 123

Query: 502 VMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASWSMGI---- 557
                 V+R+IK  N+ LD++ + ++ +FG+ +    D  + + +   P   +  +    
Sbjct: 124 ---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDN 180

Query: 558 ------DIFAYGIVLLEVLSGQTP 575
                 D +  G+V+ E++ G+ P
Sbjct: 181 DYGRAVDWWGLGVVMYEMMCGRLP 204

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.5 bits (203), Expect = 6e-18
 Identities = 36/216 (16%), Positives = 68/216 (31%), Gaps = 40/216 (18%)

Query: 392 GAVYHGRL--NGKNLAIKRTEHEVITKLEMQLVQHATH---------HHPNIVRLLGTCL 440
             V   R    G   A K  +          + +              HPN++ L     
Sbjct: 24  AVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYE 83

Query: 441 TDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH 500
                  L+ E    G L D+L                 LT  +       +   + Y+H
Sbjct: 84  NKT-DVILILELVAGGELFDFLAEK------------ESLTEEEATEFLKQILNGVYYLH 130

Query: 501 HVMNPSYVHRNIKSRNIFLDEE----FNARVGNFGMARCVNDDTESPQFYSTNP------ 550
              +    H ++K  NI L +        ++ +FG+A  ++   E    + T        
Sbjct: 131 ---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEI 187

Query: 551 ---ASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKD 583
                  +  D+++ G++   +LSG +P     K++
Sbjct: 188 VNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE 223

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 82.2 bits (202), Expect = 1e-17
 Identities = 37/204 (18%), Positives = 77/204 (37%), Gaps = 37/204 (18%)

Query: 392 GAVYHGR--LNGKNLAIKRTEHEVITKLEMQLVQ-----HATHHHPNIVRLLGTCLTDGP 444
           GAV        G  +AIK+      ++L  +             H N++ LL     D  
Sbjct: 32  GAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDET 91

Query: 445 -----HSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYM 499
                  +LV  +      K   H  L                 +   +   +   L+Y+
Sbjct: 92  LDDFTDFYLVMPFMGTDLGKLMKHEKL--------------GEDRIQFLVYQMLKGLRYI 137

Query: 500 HHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTES----PQFYS----TNPA 551
           H       +HR++K  N+ ++E+   ++ +FG+AR  + +         + +     N  
Sbjct: 138 HA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYRAPEVILNWM 194

Query: 552 SWSMGIDIFAYGIVLLEVLSGQTP 575
            ++  +DI++ G ++ E+++G+T 
Sbjct: 195 RYTQTVDIWSVGCIMAEMITGKTL 218

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 80.3 bits (197), Expect = 4e-17
 Identities = 41/211 (19%), Positives = 79/211 (37%), Gaps = 44/211 (20%)

Query: 392 GAVYHGRL-----NGKNLAIKRTEHEVI---------TKLEMQLVQHATHHHPNIVRLLG 437
           G V+  R       GK  A+K  +   I         T+ E Q+++H     P +V L  
Sbjct: 38  GKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHI-RQSPFLVTLHY 96

Query: 438 TCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQ 497
              T+     L+ +Y   G L   L                  T  +      ++ +AL+
Sbjct: 97  AFQTET-KLHLILDYINGGELFTHLS------------QRERFTEHEVQIYVGEIVLALE 143

Query: 498 YMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPASWSMG- 556
           ++H       ++R+IK  NI LD   +  + +FG+++    D     +       +    
Sbjct: 144 HLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPD 200

Query: 557 ------------IDIFAYGIVLLEVLSGQTP 575
                       +D ++ G+++ E+L+G +P
Sbjct: 201 IVRGGDSGHDKAVDWWSLGVLMYELLTGASP 231

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 79.2 bits (194), Expect = 7e-17
 Identities = 37/211 (17%), Positives = 70/211 (33%), Gaps = 34/211 (16%)

Query: 392 GAVYHGRL--NGKNLAIKR-----TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGP 444
           G V+  +     + +A+KR      +  V +    ++       H NIVRL         
Sbjct: 16  GTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVL-HSDK 74

Query: 445 HSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMN 504
              LVFE+      K +              C   L           +   L + H    
Sbjct: 75  KLTLVFEFCDQDLKKYFDS------------CNGDLDPEIVKSFLFQLLKGLGFCHS--- 119

Query: 505 PSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYSTNPA-----------SW 553
            + +HR++K +N+ ++     ++ NFG+AR                             +
Sbjct: 120 RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLY 179

Query: 554 SMGIDIFAYGIVLLEVLSGQTPINRPRKKDE 584
           S  ID+++ G +  E+ +   P+      D+
Sbjct: 180 STSIDMWSAGCIFAELANAGRPLFPGNDVDD 210

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 79.1 bits (194), Expect = 8e-17
 Identities = 33/210 (15%), Positives = 71/210 (33%), Gaps = 48/210 (22%)

Query: 392 GAVYHGR--LNGKNLAIK----RTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPH 445
           G +Y G     G+ +AIK    +T+H  +  +E ++ +         +  +  C  +G +
Sbjct: 21  GDIYLGTDIAAGEEVAIKLECVKTKHPQL-HIESKIYKMM--QGGVGIPTIRWCGAEGDY 77

Query: 446 SFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNP 505
           + +V E         +              C    +    L +   +   ++Y+H   + 
Sbjct: 78  NVMVMELLGPSLEDLFNF------------CSRKFSLKTVLLLADQMISRIEYIH---SK 122

Query: 506 SYVHRNIKSRNIF---LDEEFNARVGNFGMARCVNDDTE-------------------SP 543
           +++HR++K  N       +     + +FG+A+   D                      S 
Sbjct: 123 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASI 182

Query: 544 QFYSTNPASWSMGIDIFAYGIVLLEVLSGQ 573
             +     S     D+ + G VL+    G 
Sbjct: 183 NTHLGIEQSRR--DDLESLGYVLMYFNLGS 210

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 78.3 bits (192), Expect = 3e-16
 Identities = 41/245 (16%), Positives = 96/245 (39%), Gaps = 52/245 (21%)

Query: 363 EQHKRLLESYSIEDLRRATEKFNSSNRIE-------------GAVYHGR--LNGKNLAIK 407
           E  K  L     + L++      ++ +++             G V   +   +G + A+K
Sbjct: 13  ESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMK 72

Query: 408 RTEHEVITKL--------EMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK 459
             + + + KL        E +++Q    + P +V+L  +   D  + ++V EY   G + 
Sbjct: 73  ILDKQKVVKLKQIEHTLNEKRILQAV--NFPFLVKLEFSF-KDNSNLYMVMEYVAGGEMF 129

Query: 460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFL 519
             L                  +          + +  +Y+H +     ++R++K  N+ +
Sbjct: 130 SHLRR------------IGRFSEPHARFYAAQIVLTFEYLHSL---DLIYRDLKPENLLI 174

Query: 520 DEEFNARVGNFGMARCVNDDTES---------PQFYSTNPASWSMGIDIFAYGIVLLEVL 570
           D++   +V +FG A+ V   T +         P+   +   + +  +D +A G+++ E+ 
Sbjct: 175 DQQGYIQVTDFGFAKRVKGRTWTLCGTPEALAPEIILSKGYNKA--VDWWALGVLIYEMA 232

Query: 571 SGQTP 575
           +G  P
Sbjct: 233 AGYPP 237

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score = 76.4 bits (187), Expect = 7e-16
 Identities = 36/236 (15%), Positives = 67/236 (28%), Gaps = 49/236 (20%)

Query: 392 GAVYHGR--LNGKNLAIKR-TEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFL 448
           G ++ G   LN + +AIK         +L  +   +        +  +     +G H+ L
Sbjct: 19  GVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 78

Query: 449 VFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYV 508
           V +                     +  C    +          +   +Q +H     S V
Sbjct: 79  VIDLLGPSLE------------DLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLV 123

Query: 509 HRNIKSRNIFLDEEF-----NARVGNFGMARCVNDDTE-------------------SPQ 544
           +R+IK  N  +            V +FGM +   D                      S  
Sbjct: 124 YRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSIN 183

Query: 545 FYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRKKDEGSVWLSEKIKSILQAE 600
            +     S     D+ A G V +  L G         +   +    +K + I + +
Sbjct: 184 THLGREQSRR--DDLEALGHVFMYFLRG-----SLPWQGLKAATNKQKYERIGEKK 232

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 74.2 bits (181), Expect = 6e-15
 Identities = 30/205 (14%), Positives = 67/205 (32%), Gaps = 39/205 (19%)

Query: 392 GAVYHGR--LNGKNLAIKRTEHEVITKLEMQLVQ-----HATHHHPNIVRLLGTC----- 439
           G V      +  +N+AIK+       +   +            +H NI+ LL        
Sbjct: 31  GIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKT 90

Query: 440 LTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYM 499
           L +    +LV E       +                        +   +   +   ++++
Sbjct: 91  LEEFQDVYLVMELMDANLCQVIQMEL---------------DHERMSYLLYQMLCGIKHL 135

Query: 500 HHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQFYST---------NP 550
           H       +HR++K  NI +  +   ++ +FG+AR          +  T           
Sbjct: 136 HSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILG 192

Query: 551 ASWSMGIDIFAYGIVLLEVLSGQTP 575
             +   +DI++ G ++ E++  +  
Sbjct: 193 MGYKENVDIWSVGCIMGEMVRHKIL 217

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 73.4 bits (179), Expect = 1e-14
 Identities = 33/203 (16%), Positives = 74/203 (36%), Gaps = 35/203 (17%)

Query: 392 GAVYHGR--LNGKNLAIKRTEHEVITKLEMQLVQH-----ATHHHPNIVRLLGTCLTDGP 444
           G+V        G  +A+K+      + +  +             H N++ LL        
Sbjct: 32  GSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARS 91

Query: 445 ----HSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMH 500
               +   +  +     L + +                 LT      +   +   L+Y+H
Sbjct: 92  LEEFNDVYLVTHLMGADLNNIVKCQ-------------KLTDDHVQFLIYQILRGLKYIH 138

Query: 501 HVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTESPQF--------YSTNPAS 552
                  +HR++K  N+ ++E+   ++ +FG+AR  +D+                 N   
Sbjct: 139 SAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATRWYRAPEIMLNWMH 195

Query: 553 WSMGIDIFAYGIVLLEVLSGQTP 575
           ++  +DI++ G ++ E+L+G+T 
Sbjct: 196 YNQTVDIWSVGCIMAELLTGRTL 218

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 64.7 bits (156), Expect = 9e-12
 Identities = 29/208 (13%), Positives = 71/208 (34%), Gaps = 30/208 (14%)

Query: 392 GAVYHGR--LNGKNLAIKRTEHEVI----TKLEMQLVQHATHHHPNIVRLLGTCLTDGPH 445
             V+  +  +N  ++A+K    + +     + E++L+Q    +  +  +           
Sbjct: 27  STVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRV--NDADNTKEDSMGANHILK 84

Query: 446 SFLVFEYAKNGSLKDWL---HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV 502
               F +     +   +     G  +        +  +      +I   + + L YMH  
Sbjct: 85  LLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR- 143

Query: 503 MNPSYVHRNIKSRNIFLDEE------FNARVGNFGMARCVNDDTE---------SPQFYS 547
                +H +IK  N+ ++           ++ + G A   ++            SP+   
Sbjct: 144 -RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPEVLL 202

Query: 548 TNPASWSMGIDIFAYGIVLLEVLSGQTP 575
             P  W  G DI++   ++ E+++G   
Sbjct: 203 GAP--WGCGADIWSTACLIFELITGDFL 228

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 51.3 bits (122), Expect = 4e-08
 Identities = 19/158 (12%), Positives = 43/158 (27%), Gaps = 34/158 (21%)

Query: 391 EGAVYHGRL-NGKNLAIK--RTEHEVITKLEMQLVQHATH-----------HHPNIVRLL 436
           E AV++          +K  +  H    K++ +      H               + +L 
Sbjct: 13  ESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ 72

Query: 437 GTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMAL 496
           G  +           Y        W    + M+       Y     +    +   +   +
Sbjct: 73  GLAV--------PKVY-------AWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEV 116

Query: 497 QYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR 534
              +H      VH ++   N+ +  E    + +F  + 
Sbjct: 117 AKFYHRG---IVHGDLSQYNVLVS-EEGIWIIDFPQSV 150

>d1e0ga_ d.7.1.1 (A:) Membrane-bound lytic murein transclycosylase D, MltD {Escherichia coli [TaxId: 562]} Length = 48

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Membrane-bound lytic murein transclycosylase D, MltD
species: Escherichia coli [TaxId: 562]

 Score = 38.5 bits (90), Expect = 7e-05
 Identities = 7/32 (21%), Positives = 18/32 (56%)

Query: 193 VSYPVGEGDTVSGLAAKFNTTPAAIIAANNKS 224
           ++Y V +GD++S +A +       ++  N+ +
Sbjct: 3   ITYRVRKGDSLSSIAKRHGVNIKDVMRWNSDT 34

>d1y7ma2 d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-terminal domain {Bacillus subtilis [TaxId: 1423]} Length = 48

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Hypothetical protein YkuD, N-terminal domain
species: Bacillus subtilis [TaxId: 1423]

 Score = 37.1 bits (86), Expect = 2e-04
 Identities = 17/51 (33%), Positives = 28/51 (54%), Gaps = 5/51 (9%)

Query: 192 LVSYPVGEGDTVSGLAAKFNTTPAAIIAANNKSLEGFKPEDLLAFTSILIP 242
           +++Y V +GDT++ +AA F  + AA++ AN     G          SI+IP
Sbjct: 1   MLTYQVKQGDTLNSIAADFRISTAALLQANPSLQAGLTAGQ-----SIVIP 46

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	600
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	99.98
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	99.98
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	99.98
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	99.98
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	99.98
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	99.98
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	99.97
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	99.97
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	99.97
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	99.97
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	99.97
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	99.97
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	99.97
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	99.97
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	99.97
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	99.97
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	99.97
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	99.96
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	99.96
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	99.96
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	99.96
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	99.96
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	99.96
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	99.96
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	99.96
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	99.95
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	99.9
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.72
d1e0ga_	48	Membrane-bound lytic murein transclycosylase D, Ml	99.28
d1y7ma2	48	Hypothetical protein YkuD, N-terminal domain {Baci	99.21
d1y7ma2	48	Hypothetical protein YkuD, N-terminal domain {Baci	98.83
d1e0ga_	48	Membrane-bound lytic murein transclycosylase D, Ml	98.82
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.68
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.12
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	95.11
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	92.86
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	92.15
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	86.47

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6.8e-37  Score=311.45  Aligned_cols=193  Identities=27%  Similarity=0.484  Sum_probs=150.0

Q ss_pred             cccCHHHHHHHHhccCCCC---------ce----eEEEEEEEE--CC---eEEEEEEcch----hHHHHHHHHHHHHHhC
Q 041830          370 ESYSIEDLRRATEKFNSSN---------RI----EGAVYHGRL--NG---KNLAIKRTEH----EVITKLEMQLVQHATH  427 (600)
Q Consensus       370 ~~~~~~el~~~t~~f~~~~---------~~----~G~Vy~g~~--~g---~~vAvK~~~~----~~~~~~e~ei~~~~~l  427 (600)
                      ..++++|+.+++.+|..+.         .+    +|.||+|++  +|   ..||||++..    ...+.+.+|+..+..+
T Consensus         5 d~~t~~d~~~a~~~f~~~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l   84 (299)
T d1jpaa_           5 DPFTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQF   84 (299)
T ss_dssp             CGGGSSSHHHHHHHHSCBCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTC
T ss_pred             CCCCHHHHHHHHhhhchhhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhC
Confidence            4466777777777775321         12    289999998  33   2589998753    2335688999999999


Q ss_pred             CCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCc
Q 041830          428 HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSY  507 (600)
Q Consensus       428 ~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i  507 (600)
                      +|||||+++|+|..+ +..++|||||++|+|.+++....           ..++|.+++.++.||++||.|||   +.+|
T Consensus        85 ~HpnIv~l~g~~~~~-~~~~iv~Ey~~~g~L~~~~~~~~-----------~~l~~~~~~~i~~qia~gl~yLH---~~~i  149 (299)
T d1jpaa_          85 DHPNVIHLEGVVTKS-TPVMIITEFMENGSLDSFLRQND-----------GQFTVIQLVGMLRGIAAGMKYLA---DMNY  149 (299)
T ss_dssp             CCTTBCCEEEEECSS-SSCEEEEECCTTEEHHHHHHTTT-----------TCSCHHHHHHHHHHHHHHHHHHH---HTTC
T ss_pred             CCCCCccEEEEEeeC-CEEEEEEEecCCCcceeeecccc-----------CCCCHHHHHHHHHHHHHHHHHHh---hCCC
Confidence            999999999998665 48999999999999999987643           24899999999999999999999   5699


Q ss_pred             eecCCCCCCEEeCCCCcEEEEeccCccccCCC-----------------CCCCcccccCCCCCCccCchHHHHHHHHHHH
Q 041830          508 VHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-----------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVL  570 (600)
Q Consensus       508 vHrDLk~~NILld~~~~~kI~DFGla~~~~~~-----------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELl  570 (600)
                      +||||||+||||+.++.+||+|||+++.....                 +.+||....  ..++.++|||||||+||||+
T Consensus       150 iHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~--~~~~~~sDvwS~Gvvl~el~  227 (299)
T d1jpaa_         150 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQY--RKFTSASDVWSYGIVMWEVM  227 (299)
T ss_dssp             CCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHH
T ss_pred             ccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhc--CCCCcccccccchHHHHHHH
Confidence            99999999999999999999999999865322                 224454443  45788899999999999999


Q ss_pred             h-CCCCCCCC
Q 041830          571 S-GQTPINRP  579 (600)
Q Consensus       571 t-G~~Pf~~~  579 (600)
                      | |+.||...
T Consensus       228 t~g~~Pf~~~  237 (299)
T d1jpaa_         228 SYGERPYWDM  237 (299)
T ss_dssp             TTSCCTTTTC
T ss_pred             hCCCCCCCCC
Confidence            8 89999754

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-36  Score=303.33  Aligned_cols=173  Identities=27%  Similarity=0.488  Sum_probs=144.5

Q ss_pred             eEEEEEEEECCeEEEEEEcch-----hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcC
Q 041830          391 EGAVYHGRLNGKNLAIKRTEH-----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGG  465 (600)
Q Consensus       391 ~G~Vy~g~~~g~~vAvK~~~~-----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~  465 (600)
                      +|.||+|++++ .||||+++.     +..+.+.+|+..+.+++|||||+++|++. + +..+||||||++|+|.++|+..
T Consensus        21 fg~Vy~~~~~~-~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~-~-~~~~lv~Ey~~~g~L~~~l~~~   97 (276)
T d1uwha_          21 FGTVYKGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYST-A-PQLAIVTQWCEGSSLYHHLHII   97 (276)
T ss_dssp             SCEEEEEESSS-EEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEEC-S-SSCEEEEECCCEEEHHHHHHTS
T ss_pred             CcEEEEEEECC-EEEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEe-c-cEEEEEEecCCCCCHHHHHhhc
Confidence            39999999866 599999753     33467889999999999999999999974 3 3689999999999999999754


Q ss_pred             cCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC-------
Q 041830          466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND-------  538 (600)
Q Consensus       466 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~-------  538 (600)
                      .           ..++|.+++.|+.||++||+|||   +.+|+||||||+|||++.++.+||+|||+|+....       
T Consensus        98 ~-----------~~~~~~~~~~i~~qi~~gl~yLH---~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~  163 (276)
T d1uwha_          98 E-----------TKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQF  163 (276)
T ss_dssp             C-----------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEETTSSEEECCCCCSCC----------
T ss_pred             c-----------CCCCHHHHHHHHHHHHHHHHHHh---cCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccc
Confidence            3           34999999999999999999999   56999999999999999999999999999975432       


Q ss_pred             -------CCCCCcccccC-CCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          539 -------DTESPQFYSTN-PASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       539 -------~~~~pe~~~~~-~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                             .+.+||.+... ...++.++|||||||+||||+||+.||...+
T Consensus       164 ~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~  213 (276)
T d1uwha_         164 EQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN  213 (276)
T ss_dssp             --CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred             cccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCC
Confidence                   12356665432 2357889999999999999999999997543

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.4e-36  Score=297.22  Aligned_cols=171  Identities=24%  Similarity=0.365  Sum_probs=147.8

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||+++.  +|+.||+|.+....      ...+.+|+..+..++|||||++++++.++ +..|+|||||++|+|.+++
T Consensus        19 fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-~~~~ivmEy~~~g~L~~~l   97 (263)
T d2j4za1          19 FGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDA-TRVYLILEYAPLGTVYREL   97 (263)
T ss_dssp             SEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECS-SEEEEEEECCTTCBHHHHH
T ss_pred             CcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC-CEEEEEEeecCCCcHHHHH
Confidence            399999998  68899999986432      24577899999999999999999998665 4899999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCCC--
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDT--  540 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~~--  540 (600)
                      ....            .+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++......  
T Consensus        98 ~~~~------------~l~e~~~~~i~~qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~~~  162 (263)
T d2j4za1          98 QKLS------------KFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRT  162 (263)
T ss_dssp             HHHS------------SCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCCCE
T ss_pred             hhcC------------CCCHHHHHHHHHHHHHHHHHHH---HCCeeeeeeccccceecCCCCEeecccceeeecCCCccc
Confidence            7543            3899999999999999999999   6699999999999999999999999999998664332  


Q ss_pred             --------CCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          541 --------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       541 --------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                              .+||....  ..++.++|||||||+||||++|+.||...
T Consensus       163 ~~~Gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyell~G~~Pf~~~  207 (263)
T d2j4za1         163 TLCGTLDYLPPEMIEG--RMHDEKVDLWSLGVLCYEFLVGKPPFEAN  207 (263)
T ss_dssp             ETTEEGGGCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             ccCCCCcccCHHHHcC--CCCCchhhhhhHhHHHHHHhcCCCCCCCC
Confidence                    35666654  45788999999999999999999999754

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=6e-36  Score=302.67  Aligned_cols=174  Identities=24%  Similarity=0.474  Sum_probs=147.8

Q ss_pred             ceeEEEEEEEE--CCeEEEEEEcchhH--HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          389 RIEGAVYHGRL--NGKNLAIKRTEHEV--ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       389 ~~~G~Vy~g~~--~g~~vAvK~~~~~~--~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      |.+|.||+|++  +|+.||||+++.+.  .+++.+|+..+..++|||||+++|+|.++ +..++|||||++|+|.+++..
T Consensus        28 G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~iv~E~~~~g~l~~~l~~  106 (287)
T d1opja_          28 GQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTRE-PPFYIITEFMTYGNLLDYLRE  106 (287)
T ss_dssp             TTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSCEEEEECCTTCBHHHHHHH
T ss_pred             CCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCCCCCEecCCccEeeC-CeeEEEeecccCcchHHHhhh
Confidence            33499999999  68899999986543  35688999999999999999999998655 588999999999999999976


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCCC----
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDT----  540 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~~----  540 (600)
                      ...          ..++|.+++.|+.||+.||.|||   +.+|+||||||+||||++++.+||+|||+++......    
T Consensus       107 ~~~----------~~~~~~~~~~i~~qi~~gL~yLH---~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~  173 (287)
T d1opja_         107 CNR----------QEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH  173 (287)
T ss_dssp             SCT----------TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEE
T ss_pred             ccc----------cchHHHHHHHHHHHHHHHHHHHH---HCCcccCccccCeEEECCCCcEEEccccceeecCCCCceee
Confidence            432          34999999999999999999999   5699999999999999999999999999998764332    


Q ss_pred             ---------CCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          541 ---------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       541 ---------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                               .+||....  ..++.++|||||||++|||++|+.||..
T Consensus       174 ~~~~g~~~y~aPE~~~~--~~~~~k~DiwS~Gv~l~ell~~~~p~~~  218 (287)
T d1opja_         174 AGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIATYGMSPYP  218 (287)
T ss_dssp             TTEEECGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred             ccccccccccChHHHcC--CCCCchhhhhhHHHHHHHHHhCCCCCCC
Confidence                     25665554  4578899999999999999997777643

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-35  Score=299.92  Aligned_cols=175  Identities=24%  Similarity=0.460  Sum_probs=148.4

Q ss_pred             CCceeEEEEEEEE--CCeEEEEEEcchh---HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          387 SNRIEGAVYHGRL--NGKNLAIKRTEHE---VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       387 ~~~~~G~Vy~g~~--~g~~vAvK~~~~~---~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      +.|.+|.||+++.  +|+.||||+++..   ..+.+.+|+..++.++|||||++++++..+ +..|||||||++|+|.++
T Consensus        29 G~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~ivmEy~~gg~L~~~  107 (293)
T d1yhwa1          29 GQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVG-DELWVVMEYLAGGSLTDV  107 (293)
T ss_dssp             CCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEECCTTCBHHHH
T ss_pred             ecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCCCCCEeeEeEEEEEC-CEEEEEEEecCCCcHHHH
Confidence            3344499999997  6999999997643   235678999999999999999999998665 489999999999999998


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--  539 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--  539 (600)
                      +..+             .+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....  
T Consensus       108 ~~~~-------------~l~~~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~  171 (293)
T d1yhwa1         108 VTET-------------CMDEGQIAAVCRECLQALEFLH---SNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS  171 (293)
T ss_dssp             HHHS-------------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             hhcc-------------CCCHHHHHHHHHHHHHHHHHHH---HCCCcccCCcHHHeEECCCCcEeeccchhheeeccccc
Confidence            8653             2899999999999999999999   669999999999999999999999999999865322  


Q ss_pred             ----------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 ----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 ----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                                +.+||....  ..++.++|||||||++|||++|+.||...+
T Consensus       172 ~~~~~~gt~~Y~aPE~~~~--~~~~~~~DiwSlGvilyemltG~~Pf~~~~  220 (293)
T d1yhwa1         172 KRSTMVGTPYWMAPEVVTR--KAYGPKVDIWSLGIMAIEMIEGEPPYLNEN  220 (293)
T ss_dssp             CBCCCCSCGGGCCHHHHSS--SCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             cccccccCCCccChhhhcC--CCCCchhceehHhHHHHHHhhCCCCCCCCC
Confidence                      135665544  457889999999999999999999997543

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-36  Score=298.47  Aligned_cols=170  Identities=29%  Similarity=0.530  Sum_probs=140.9

Q ss_pred             eEEEEEEEE-CCeEEEEEEcchhH--HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcC
Q 041830          391 EGAVYHGRL-NGKNLAIKRTEHEV--ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLA  467 (600)
Q Consensus       391 ~G~Vy~g~~-~g~~vAvK~~~~~~--~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~  467 (600)
                      +|.||+|++ +++.||||+++.+.  .+++.+|+..+..++|||||+++|+|..+ +..++|||||++|+|.++++... 
T Consensus        18 fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-~~~~lv~E~~~~g~L~~~l~~~~-   95 (263)
T d1sm2a_          18 FGLVHLGYWLNKDKVAIKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ-APICLVFEFMEHGCLSDYLRTQR-   95 (263)
T ss_dssp             SCCEEEEEETTTEEEEEEECCSSSSCHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSCEEEEECCTTCBHHHHHHTTT-
T ss_pred             CeEEEEEEECCCCEEEEEEECCCcCcHHHHHHHHHHHHhcCCCCcccccceeccC-CceEEEEEecCCCcHHHHhhccc-
Confidence            499999999 68889999986532  35688999999999999999999998766 48899999999999999987643 


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC---------
Q 041830          468 MKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND---------  538 (600)
Q Consensus       468 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~---------  538 (600)
                                ..++|.+++.++.||+.||.|||   +.+|+||||||+|||+|+++.+||+|||+++....         
T Consensus        96 ----------~~~~~~~~~~i~~qia~gl~~lH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~  162 (263)
T d1sm2a_          96 ----------GLFAAETLLGMCLDVCEGMAYLE---EACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT  162 (263)
T ss_dssp             ----------TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCTTCSGGGEEECGGGCEEECSCC----------------
T ss_pred             ----------cCCCHHHHHHHHHHHHHHHHhhh---ccceeecccchhheeecCCCCeEecccchheeccCCCceeecce
Confidence                      34899999999999999999999   66899999999999999999999999999975432         


Q ss_pred             ----CCCCCcccccCCCCCCccCchHHHHHHHHHHHhC-CCCCC
Q 041830          539 ----DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSG-QTPIN  577 (600)
Q Consensus       539 ----~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG-~~Pf~  577 (600)
                          .+.+||....  ..++.++|||||||+||||+|+ ++||.
T Consensus       163 ~gt~~y~aPE~l~~--~~~~~k~DVwS~Gvil~el~t~~~~~~~  204 (263)
T d1sm2a_         163 KFPVKWASPEVFSF--SRYSSKSDVWSFGVLMWEVFSEGKIPYE  204 (263)
T ss_dssp             --CTTSCCHHHHTT--CCCCHHHHHHHHHHHHHHHHTTSCCTTC
T ss_pred             ecCcccCChHHhcC--CCCCchhhhcchHHHHHHHHHCCCCCCC
Confidence                1345666554  4578899999999999999995 55554

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-36  Score=301.38  Aligned_cols=175  Identities=22%  Similarity=0.354  Sum_probs=148.9

Q ss_pred             eEEEEEEEE--CCeEEEEEEcch---hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcC
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEH---EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGG  465 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~---~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~  465 (600)
                      +|.||+|+.  +|+.||||+++.   +..+.+.+|+..+..++|||||++++++.++ +..|+|||||++|+|.+++...
T Consensus        25 fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-~~~~lvmEy~~~g~L~~~~~~~  103 (288)
T d2jfla1          25 FGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYE-NNLWILIEFCAGGAVDAVMLEL  103 (288)
T ss_dssp             TEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEET-TEEEEEEECCTTEEHHHHHHHH
T ss_pred             CcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeC-CeEEEEEecCCCCcHHHHHHhc
Confidence            399999998  689999999754   2335678899999999999999999998765 4899999999999999998643


Q ss_pred             cCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCcccc---------
Q 041830          466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV---------  536 (600)
Q Consensus       466 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~---------  536 (600)
                      .           ..+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++..         
T Consensus       104 ~-----------~~l~e~~~~~i~~qi~~gL~ylH---~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~~  169 (288)
T d2jfla1         104 E-----------RPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS  169 (288)
T ss_dssp             T-----------SCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHTC
T ss_pred             C-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCEEEeecChhheeECCCCCEEEEechhhhccCCCcccccc
Confidence            2           34999999999999999999999   569999999999999999999999999998643         


Q ss_pred             ---CCCCCCCccccc---CCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          537 ---NDDTESPQFYST---NPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       537 ---~~~~~~pe~~~~---~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                         +..+.+||....   ....++.++|||||||+||||++|+.||...+
T Consensus       170 ~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~  219 (288)
T d2jfla1         170 FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELN  219 (288)
T ss_dssp             CCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred             cccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCC
Confidence               223457887643   23457889999999999999999999997643

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-36  Score=300.59  Aligned_cols=174  Identities=22%  Similarity=0.405  Sum_probs=145.2

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      +|.||+++.  +|+.||||+++...    .+.+++|+..+..++|||||++++++.++ +..|||||||++|+|.++|..
T Consensus        18 fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~-~~~~ivmEy~~gg~L~~~l~~   96 (271)
T d1nvra_          18 YGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREG-NIQYLFLEYCSGGELFDRIEP   96 (271)
T ss_dssp             TEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEET-TEEEEEEECCTTEEGGGGSBT
T ss_pred             CeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCCCCCEeeEeeeeccC-ceeEEEEeccCCCcHHHHHhc
Confidence            399999998  68999999975432    24578899999999999999999998665 489999999999999999865


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC------
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND------  538 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~------  538 (600)
                      ..            .+++.++..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+|+....      
T Consensus        97 ~~------------~l~e~~~~~i~~qi~~al~ylH---~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~  161 (271)
T d1nvra_          97 DI------------GMPEPDAQRFFHQLMAGVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  161 (271)
T ss_dssp             TT------------BCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             CC------------CCCHHHHHHHHHHHHHHHHHHH---HcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence            32            3999999999999999999999   66999999999999999999999999999985421      


Q ss_pred             --------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCCC
Q 041830          539 --------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRK  581 (600)
Q Consensus       539 --------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~  581 (600)
                              .+.+||..... ..++.++|||||||+||||++|+.||....+
T Consensus       162 ~~~~~GT~~Y~APE~~~~~-~~~~~~~DiwSlGvilyeml~G~~pf~~~~~  211 (271)
T d1nvra_         162 LNKMCGTLPYVAPELLKRR-EFHAEPVDVWSCGIVLTAMLAGELPWDQPSD  211 (271)
T ss_dssp             BCCCCSCGGGSCTHHHHCS-SBCHHHHHHHHHHHHHHHHHHSSCSCSSSST
T ss_pred             ccceeeCcCccCHhHhcCC-CCCCCceeeeHhHHHHHHHHhCCCCCCCCCh
Confidence                    12356655432 2246779999999999999999999976543

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-35  Score=299.72  Aligned_cols=174  Identities=26%  Similarity=0.473  Sum_probs=144.9

Q ss_pred             ceeEEEEEEEE----CCeEEEEEEcch----hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          389 RIEGAVYHGRL----NGKNLAIKRTEH----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       389 ~~~G~Vy~g~~----~g~~vAvK~~~~----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      |.+|.||+|.+    ++..||||+++.    ...+.+.+|+..+.+++|||||+++|+|..  +..|||||||++|+|.+
T Consensus        20 G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~--~~~~lvmE~~~~g~L~~   97 (285)
T d1u59a_          20 GNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA--EALMLVMEMAGGGPLHK   97 (285)
T ss_dssp             CTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES--SSEEEEEECCTTEEHHH
T ss_pred             ccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc--CeEEEEEEeCCCCcHHH
Confidence            33499999977    345799999754    234568899999999999999999999854  36899999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-  539 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-  539 (600)
                      ++...+           ..++|.++++++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++..... 
T Consensus        98 ~l~~~~-----------~~l~~~~~~~i~~qi~~gL~ylH---~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~  163 (285)
T d1u59a_          98 FLVGKR-----------EEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD  163 (285)
T ss_dssp             HHTTCT-----------TTSCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCS
T ss_pred             Hhhccc-----------cCCCHHHHHHHHHHHHHHHHHHH---hCCeecCcCchhheeeccCCceeeccchhhhcccccc
Confidence            986543           34999999999999999999999   669999999999999999999999999999865332 


Q ss_pred             --------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCCC
Q 041830          540 --------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRPR  580 (600)
Q Consensus       540 --------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~~  580 (600)
                                    +.+||....  ..++.++|||||||++|||+| |+.||...+
T Consensus       164 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~  217 (285)
T d1u59a_         164 SYYTARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGVTMWEALSYGQKPYKKMK  217 (285)
T ss_dssp             CEECCCCSSCCCGGGCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred             cccccccccccCccccChHHHhC--CCCCccchhhcchHHHHHHHhCCCCCCCCCC
Confidence                          124554433  356888999999999999998 999997543

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-35  Score=298.70  Aligned_cols=170  Identities=22%  Similarity=0.451  Sum_probs=142.5

Q ss_pred             eEEEEEEEE-CCeEEEEEEcchhH--HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcC
Q 041830          391 EGAVYHGRL-NGKNLAIKRTEHEV--ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLA  467 (600)
Q Consensus       391 ~G~Vy~g~~-~g~~vAvK~~~~~~--~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~  467 (600)
                      +|.||+|++ +++.||||+++.+.  .+.+.+|+..+.+++|||||+++|+|. + +..++|||||++|+|.+++.....
T Consensus        26 fg~Vy~~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~-~-~~~~iv~Ey~~~g~L~~~~~~~~~  103 (272)
T d1qpca_          26 FGEVWMGYYNGHTKVAVKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-Q-EPIYIITEYMENGSLVDFLKTPSG  103 (272)
T ss_dssp             TEEEEEEEETTTEEEEEEEECTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-S-SSCEEEEECCTTCBHHHHTTSHHH
T ss_pred             CcEEEEEEECCCCEEEEEEEccCcCCHHHHHHHHHHHHhCCCCCEeEEEeeec-c-CCeEEEEEeCCCCcHHHHHhhcCC
Confidence            399999999 56889999986533  356889999999999999999999874 3 367999999999999998865331


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--------
Q 041830          468 MKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--------  539 (600)
Q Consensus       468 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--------  539 (600)
                                ..++|.++++|+.||++||.|||   +.+|+||||||+||||++++.+||+|||+|+.....        
T Consensus       104 ----------~~l~~~~~~~i~~qi~~gl~~lH---~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~~~  170 (272)
T d1qpca_         104 ----------IKLTINKLLDMAAQIAEGMAFIE---ERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGA  170 (272)
T ss_dssp             ----------HTCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCTTC
T ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHH---hCCcccCccchhheeeecccceeeccccceEEccCCcccccccc
Confidence                      34999999999999999999999   569999999999999999999999999999865422        


Q ss_pred             -----CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCC
Q 041830          540 -----TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN  577 (600)
Q Consensus       540 -----~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~  577 (600)
                           +.+||....  ..++.++|||||||+||||+||..|+.
T Consensus       171 ~gt~~y~APE~~~~--~~~~~~sDvwS~Gvvl~ellt~~~~~~  211 (272)
T d1qpca_         171 KFPIKWTAPEAINY--GTFTIKSDVWSFGILLTEIVTHGRIPY  211 (272)
T ss_dssp             CCCTTTSCHHHHHH--CEECHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred             CCcccccChHHHhC--CCCCchhhhhhhHHHHHHHHhCCCCCC
Confidence                 235565544  356888999999999999999655543

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-35  Score=305.45  Aligned_cols=175  Identities=22%  Similarity=0.335  Sum_probs=149.8

Q ss_pred             ceeEEEEEEEE--CCeEEEEEEcch----hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          389 RIEGAVYHGRL--NGKNLAIKRTEH----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       389 ~~~G~Vy~g~~--~g~~vAvK~~~~----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      |.+|.||+|+.  +|+.||+|+++.    .....+.+|+..+..++|||||++++++.++ ..+|+|||||++|+|.+++
T Consensus        17 G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-~~~~iVmEy~~gg~L~~~l   95 (322)
T d1s9ja_          17 GNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSD-GEISICMEHMDGGSLDQVL   95 (322)
T ss_dssp             CSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECS-SEEEEEEECCTTEEHHHHH
T ss_pred             CCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEEEcCCCCcHHHHH
Confidence            33499999998  689999998753    3345678899999999999999999998766 4899999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCcccc------
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV------  536 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~------  536 (600)
                      ++..            .+++.++..++.|++.||.|||+  ..+|+||||||+|||++.++.+||+|||+|+..      
T Consensus        96 ~~~~------------~l~~~~~~~~~~qil~aL~yLH~--~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~  161 (322)
T d1s9ja_          96 KKAG------------RIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMAN  161 (322)
T ss_dssp             HHHS------------SCCHHHHHHHHHHHHHHHHHHHH--HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHTC-
T ss_pred             hhcC------------CCCHHHHHHHHHHHHHHHHHHHH--hCCEEccccCHHHeeECCCCCEEEeeCCCccccCCCccc
Confidence            7543            38999999999999999999994  137999999999999999999999999999743      


Q ss_pred             ----CCCCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          537 ----NDDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       537 ----~~~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                          +..+.+||....  ..|+.++||||+||++|||++|+.||...+
T Consensus       162 ~~~GT~~Y~APEvl~~--~~y~~~~DiWSlGvil~ell~G~~Pf~~~~  207 (322)
T d1s9ja_         162 SFVGTRSYMSPERLQG--THYSVQSDIWSMGLSLVEMAVGRYPIPPPD  207 (322)
T ss_dssp             --CCSSCCCCHHHHHC--SCCCTTHHHHHHHHHHHHHHHSSCCSSCCC
T ss_pred             cccCCccccCchHHcC--CCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence                233457777765  458899999999999999999999997654

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-35  Score=292.26  Aligned_cols=175  Identities=22%  Similarity=0.403  Sum_probs=145.4

Q ss_pred             ceeEEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEecc---CCceEEEEeecCCCCH
Q 041830          389 RIEGAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTD---GPHSFLVFEYAKNGSL  458 (600)
Q Consensus       389 ~~~G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~---~~~~~LV~Ey~~~GsL  458 (600)
                      |.+|.||+|+.  +|+.||+|.+...     ..+.+++|+..+.+++|||||++++++...   ...+|+|||||++|+|
T Consensus        20 G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L   99 (270)
T d1t4ha_          20 GSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTL   99 (270)
T ss_dssp             CSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBH
T ss_pred             CcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcH
Confidence            33499999998  6889999987542     234678999999999999999999997642   3357999999999999


Q ss_pred             HHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC-CCCcEEEEeccCccccC
Q 041830          459 KDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLD-EEFNARVGNFGMARCVN  537 (600)
Q Consensus       459 ~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld-~~~~~kI~DFGla~~~~  537 (600)
                      .+++....            .+++.++..++.||+.||+|||+. .++|+||||||+|||++ +++.+||+|||+++...
T Consensus       100 ~~~l~~~~------------~~~~~~~~~~~~qi~~gl~yLH~~-~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~  166 (270)
T d1t4ha_         100 KTYLKRFK------------VMKIKVLRSWCRQILKGLQFLHTR-TPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR  166 (270)
T ss_dssp             HHHHHHHS------------SCCHHHHHHHHHHHHHHHHHHHTS-SSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC
T ss_pred             HHHHhccc------------cccHHHHHHHHHHHHHHHHHHHHC-CCCEEeCCcChhhceeeCCCCCEEEeecCcceecc
Confidence            99997542            389999999999999999999943 23499999999999996 57899999999997543


Q ss_pred             C----------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          538 D----------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       538 ~----------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                      .          .+.+||....   .++.++|||||||++|||++|+.||...
T Consensus       167 ~~~~~~~~GT~~Y~aPE~~~~---~~~~~~DIwSlGvilyel~~g~~Pf~~~  215 (270)
T d1t4ha_         167 ASFAKAVIGTPEFMAPEMYEE---KYDESVDVYAFGMCMLEMATSEYPYSEC  215 (270)
T ss_dssp             TTSBEESCSSCCCCCGGGGGT---CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred             CCccCCcccCccccCHHHhCC---CCCCcCchhhHHHHHHHHHHCCCCCCCc
Confidence            2          3356776643   4788999999999999999999999753

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-35  Score=297.35  Aligned_cols=171  Identities=25%  Similarity=0.468  Sum_probs=142.5

Q ss_pred             eeEEEEEEEE----CCeEEEEEEcchhH-----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          390 IEGAVYHGRL----NGKNLAIKRTEHEV-----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       390 ~~G~Vy~g~~----~g~~vAvK~~~~~~-----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      .+|.||+|.+    .++.||||+++.+.     .+.+.+|+..+.+++|||||+++|+|..  +..+||||||++|+|.+
T Consensus        19 ~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~--~~~~lvmE~~~~g~L~~   96 (277)
T d1xbba_          19 NFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA--ESWMLVMEMAELGPLNK   96 (277)
T ss_dssp             SSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES--SSEEEEEECCTTEEHHH
T ss_pred             CCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCCCCCCceEEEEecc--CCEEEEEEcCCCCcHHH
Confidence            3499999987    24679999986432     3467899999999999999999999853  36799999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-  539 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-  539 (600)
                      +++...            .++|.++++++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++..... 
T Consensus        97 ~l~~~~------------~l~~~~~~~i~~qi~~gl~ylH---~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~  161 (277)
T d1xbba_          97 YLQQNR------------HVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADE  161 (277)
T ss_dssp             HHHHCT------------TCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTC
T ss_pred             HHhhcc------------CCCHHHHHHHHHHHHHHHhhHH---hCCcccCCCcchhhcccccCcccccchhhhhhccccc
Confidence            997643            3999999999999999999999   568999999999999999999999999999865322 


Q ss_pred             --------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          540 --------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       540 --------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                                    +.+||....  ..++.++|||||||++|||+| |+.||...
T Consensus       162 ~~~~~~~~~~gt~~y~APE~l~~--~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~  214 (277)
T d1xbba_         162 NYYKAQTHGKWPVKWYAPECINY--YKFSSKSDVWSFGVLMWEAFSYGQKPYRGM  214 (277)
T ss_dssp             SEEEC----CCCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             cccccccccCCCceecCchhhcC--CCCCchhhhccchhhhhHHhhCCCCCCCCC
Confidence                          224554433  346788999999999999998 89999753

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.3e-35  Score=299.19  Aligned_cols=173  Identities=23%  Similarity=0.336  Sum_probs=147.3

Q ss_pred             eEEEEEEEE--CCeEEEEEEcch------hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEH------EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~------~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      +|.||+|+.  +|+.||||.++.      +..+.+.+|+..+..++|||||+++|++.++ +..|+|||||++|+|..++
T Consensus        28 fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-~~~~iv~E~~~~g~l~~~~  106 (309)
T d1u5ra_          28 FGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLRE-HTAWLVMEYCLGSASDLLE  106 (309)
T ss_dssp             SSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEEEEECCSEEHHHHHH
T ss_pred             CeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEEC-CEEEEEEEecCCCchHHHH
Confidence            499999998  789999998753      2234678899999999999999999998765 4899999999999998776


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC----
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND----  538 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~----  538 (600)
                      ....            .+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++....    
T Consensus       107 ~~~~------------~l~e~~~~~i~~qi~~aL~yLH---~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~  171 (309)
T d1u5ra_         107 VHKK------------PLQEVEIAAVTHGALQGLAYLH---SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSF  171 (309)
T ss_dssp             HHTS------------CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSBCCC
T ss_pred             HhCC------------CCCHHHHHHHHHHHHHHHHHHH---hCCEeccCCCcceEEECCCCCEEEeecccccccCCCCcc
Confidence            5432            3999999999999999999999   66999999999999999999999999999986543    


Q ss_pred             ----CCCCCcccccC-CCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 ----DTESPQFYSTN-PASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 ----~~~~pe~~~~~-~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                          .+.+||..... ...++.++|||||||++|||++|+.||...
T Consensus       172 ~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~  217 (309)
T d1u5ra_         172 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM  217 (309)
T ss_dssp             CSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred             ccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCC
Confidence                23467766542 345788999999999999999999999653

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.9e-35  Score=295.81  Aligned_cols=171  Identities=23%  Similarity=0.380  Sum_probs=146.7

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      +|.||+++.  +|+.||||.++...      ...+.+|+..+.+++|||||++++++.++ +..|+|||||++|+|.+++
T Consensus        21 fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~-~~~~ivmEy~~gg~L~~~~   99 (288)
T d1uu3a_          21 FSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDD-EKLYFGLSYAKNGELLKYI   99 (288)
T ss_dssp             SCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECS-SEEEEEECCCTTEEHHHHH
T ss_pred             CeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEEC-CEEEEEEEccCCCCHHHhh
Confidence            399999998  68999999986532      24578899999999999999999997655 5899999999999999998


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC----
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND----  538 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~----  538 (600)
                      ....            .+++.++..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++....    
T Consensus       100 ~~~~------------~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~  164 (288)
T d1uu3a_         100 RKIG------------SFDETCTRFYTAEIVSALEYLH---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQ  164 (288)
T ss_dssp             HHHS------------SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTSCEEECCCTTCEECC-----
T ss_pred             hccC------------CCCHHHHHHHHHHHHHHHHhhc---cccEEcCcCCccccccCCCceEEecccccceecccCCcc
Confidence            7543            3999999999999999999999   66999999999999999999999999999986532    


Q ss_pred             ----------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 ----------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 ----------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                .+.+||....  ..++.++|||||||+||||++|+.||...
T Consensus       165 ~~~~~~~GT~~Y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~  213 (288)
T d1uu3a_         165 ARANSFVGTAQYVSPELLTE--KSACKSSDLWALGCIIYQLVAGLPPFRAG  213 (288)
T ss_dssp             -----CCCCGGGCCHHHHHT--CCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             cccccccCCccccCceeecc--CCCCcccceehhhHHHHHHhhCCCCCCCc
Confidence                      1235666544  45788999999999999999999999754

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-35  Score=296.08  Aligned_cols=179  Identities=27%  Similarity=0.397  Sum_probs=139.7

Q ss_pred             eEEEEEEEE--CCeEEEEEEcch-----hHHHHHHHHHHHHHhCCCCceeeeeeEEecc-CCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEH-----EVITKLEMQLVQHATHHHPNIVRLLGTCLTD-GPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~-----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~-~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      +|.||+++.  +|+.||||.++.     ...+.+.+|+..+..++|||||++++++.+. +..+|+|||||++|+|.+++
T Consensus        17 fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i   96 (269)
T d2java1          17 YGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVI   96 (269)
T ss_dssp             SEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHH
T ss_pred             CeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHH
Confidence            399999998  689999998743     2234578899999999999999999998653 34689999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcC--CCCceecCCCCCCEEeCCCCcEEEEeccCccccCC--
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVM--NPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND--  538 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~--  538 (600)
                      ......        ...+++.+++.++.|++.||.|||+..  ..+|+||||||+|||++.++.+||+|||+++....  
T Consensus        97 ~~~~~~--------~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~  168 (269)
T d2java1          97 TKGTKE--------RQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT  168 (269)
T ss_dssp             HHHHHH--------TCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC----
T ss_pred             Hhcccc--------CCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCC
Confidence            653211        134999999999999999999999641  23599999999999999999999999999976532  


Q ss_pred             ----------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 ----------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 ----------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                .+.+||.+..  ..++.++|||||||++|||+||+.||...
T Consensus       169 ~~~~~~~gt~~Y~APE~l~~--~~~~~~~DIwSlGvilyel~tg~~Pf~~~  217 (269)
T d2java1         169 SFAKAFVGTPYYMSPEQMNR--MSYNEKSDIWSLGCLLYELCALMPPFTAF  217 (269)
T ss_dssp             -------CCCSCCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CccccCCCCcccCCHHHHcC--CCCChHHHHHhhCHHHHHHhhCCCCCCCC
Confidence                      2345666544  45788999999999999999999999753

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.7e-35  Score=297.26  Aligned_cols=177  Identities=23%  Similarity=0.338  Sum_probs=143.7

Q ss_pred             ceeEEEEEEEECCeEEEEEEcchhHHHH--HHHHHHHHHhCCCCceeeeeeEEeccCC---ceEEEEeecCCCCHHHHHh
Q 041830          389 RIEGAVYHGRLNGKNLAIKRTEHEVITK--LEMQLVQHATHHHPNIVRLLGTCLTDGP---HSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       389 ~~~G~Vy~g~~~g~~vAvK~~~~~~~~~--~e~ei~~~~~l~HpNIv~l~g~~~~~~~---~~~LV~Ey~~~GsL~~~L~  463 (600)
                      |.+|.||+|+++|+.||||+++.+....  .|.|+..+..++|||||+++|+|.+++.   .+|+|||||++|+|.++|+
T Consensus        14 G~fg~Vy~~~~~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~   93 (303)
T d1vjya_          14 GRFGEVWRGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLN   93 (303)
T ss_dssp             CSSSEEEEEEETTEEEEEEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHH
T ss_pred             CCCeEEEEEEECCEEEEEEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHh
Confidence            3348999999999999999987655443  4566666677899999999999986542   5799999999999999997


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhc-----CCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHV-----MNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND  538 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~  538 (600)
                      +.             .++|.++++++.|++.||+|||+.     .+++|+||||||+||||+.++.+||+|||+++....
T Consensus        94 ~~-------------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~  160 (303)
T d1vjya_          94 RY-------------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS  160 (303)
T ss_dssp             HC-------------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEET
T ss_pred             cC-------------CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccC
Confidence            53             289999999999999999999953     246999999999999999999999999999975532


Q ss_pred             C----------------CCCCcccccCCC----CCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          539 D----------------TESPQFYSTNPA----SWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       539 ~----------------~~~pe~~~~~~~----~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                      .                +.+||+......    .++.++|||||||+||||+||..||..
T Consensus       161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~  220 (303)
T d1vjya_         161 ATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGI  220 (303)
T ss_dssp             TTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTB
T ss_pred             CCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCc
Confidence            1                124555433211    246678999999999999999988754

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-34  Score=287.37  Aligned_cols=173  Identities=27%  Similarity=0.494  Sum_probs=146.8

Q ss_pred             eEEEEEEEE-CCeEEEEEEcchh--HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcC
Q 041830          391 EGAVYHGRL-NGKNLAIKRTEHE--VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLA  467 (600)
Q Consensus       391 ~G~Vy~g~~-~g~~vAvK~~~~~--~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~  467 (600)
                      +|.||+|++ +++.||||+++.+  ..+++.+|+..+..++|||||+++|+|.++ ...++||||+++|+|.+++.... 
T Consensus        17 fg~Vy~~~~~~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~-~~~~iv~Ey~~~g~l~~~~~~~~-   94 (258)
T d1k2pa_          17 FGVVKYGKWRGQYDVAIKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ-RPIFIITEYMANGCLLNYLREMR-   94 (258)
T ss_dssp             TEEEEEEEETTTEEEEEEEEESSSSCHHHHHHHHHHHHTCCCTTBCCEEEEECCS-SSEEEEEECCTTEEHHHHHHSGG-
T ss_pred             CeEEEEEEECCCCEEEEEEECcCcCCHHHHHHHHHHHHhcCCCceeeEEEEEeeC-CceEEEEEccCCCcHHHhhhccc-
Confidence            399999999 6778999998653  235788999999999999999999998665 48999999999999999986543 


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCCC-------
Q 041830          468 MKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDT-------  540 (600)
Q Consensus       468 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~~-------  540 (600)
                                ..++|..+++++.|+++||+|||   +.+|+||||||+|||+++++.+||+|||+++......       
T Consensus        95 ----------~~~~~~~~~~i~~qi~~gl~~LH---~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~  161 (258)
T d1k2pa_          95 ----------HRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS  161 (258)
T ss_dssp             ----------GCCCHHHHHHHHHHHHHHHHHHH---HTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCS
T ss_pred             ----------cCCcHHHHHHHHHHHHHHHHHHh---hcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeeccc
Confidence                      34899999999999999999999   5699999999999999999999999999997553221       


Q ss_pred             ------CCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCCC
Q 041830          541 ------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRPR  580 (600)
Q Consensus       541 ------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~~  580 (600)
                            .+||....  ..++.++|||||||++|||+| |+.||....
T Consensus       162 ~~t~~y~aPE~~~~--~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~  206 (258)
T d1k2pa_         162 KFPVRWSPPEVLMY--SKFSSKSDIWAFGVLMWEIYSLGKMPYERFT  206 (258)
T ss_dssp             CCCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred             CCCCCcCCcHHhcC--CCCCcceeecccchhhHhHHhcCCCCCCCCC
Confidence                  24555443  357889999999999999998 899997543

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-35  Score=293.09  Aligned_cols=174  Identities=28%  Similarity=0.501  Sum_probs=144.5

Q ss_pred             eEEEEEEEECCeEEEEEEcchhH-HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcCcc
Q 041830          391 EGAVYHGRLNGKNLAIKRTEHEV-ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLAMK  469 (600)
Q Consensus       391 ~G~Vy~g~~~g~~vAvK~~~~~~-~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~~~  469 (600)
                      +|.||+|+++|+.||||+++.+. .+.+.+|+..+.+++|||||+++|+|.++.+.+|+||||+++|+|.++|+....  
T Consensus        20 fg~Vy~~~~~~~~vAvK~i~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~--   97 (262)
T d1byga_          20 FGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR--   97 (262)
T ss_dssp             SCEEEEEEETTEEEEEEECCCCC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHH--
T ss_pred             CeEEEEEEECCeEEEEEEECcHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCC--
Confidence            39999999999999999997643 356889999999999999999999987655578999999999999999975331  


Q ss_pred             cccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC---------CC
Q 041830          470 NQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND---------DT  540 (600)
Q Consensus       470 ~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~---------~~  540 (600)
                              ..++|..+++|+.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++....         ..
T Consensus        98 --------~~l~~~~~~~i~~~i~~al~ylH---~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~~~~~~~~~y  166 (262)
T d1byga_          98 --------SVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVKW  166 (262)
T ss_dssp             --------HHCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTSCEEECCCCC------------CCTTT
T ss_pred             --------CCCCHHHHHHHHHHHHhhccccc---cCceeccccchHhheecCCCCEeecccccceecCCCCccccccccC
Confidence                    34899999999999999999999   66999999999999999999999999999986432         23


Q ss_pred             CCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          541 ESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       541 ~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                      .+||+...  ..++.++|||||||++|||+| |+.||...
T Consensus       167 ~aPE~l~~--~~~t~~sDIwSfG~il~el~t~~~~p~~~~  204 (262)
T d1byga_         167 TAPEALRE--KKFSTKSDVWSFGILLWEIYSFGRVPYPRI  204 (262)
T ss_dssp             SCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCTTS
T ss_pred             CChHHHhC--CCCChHHHHHhHHHHHHHHHHCCCCCCCCC
Confidence            46776654  457889999999999999998 68887653

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.2e-34  Score=292.84  Aligned_cols=171  Identities=28%  Similarity=0.483  Sum_probs=148.2

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||+++.  +|+.||||+++.+.      .+.+.+|+.++..++|||||++++++.++ ...|+|||||++|+|.+++
T Consensus        17 fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~ivmE~~~gg~l~~~~   95 (316)
T d1fota_          17 FGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDA-QQIFMIMDYIEGGELFSLL   95 (316)
T ss_dssp             SCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHH
T ss_pred             CcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeC-CeeeeEeeecCCccccccc
Confidence            489999998  69999999986543      24577899999999999999999998665 4899999999999999998


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC----
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND----  538 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~----  538 (600)
                      ....            .+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+|+....    
T Consensus        96 ~~~~------------~~~~~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~~~  160 (316)
T d1fota_          96 RKSQ------------RFPNPVAKFYAAEVCLALEYLH---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYT  160 (316)
T ss_dssp             HHTS------------SCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCBCC
T ss_pred             cccc------------cccccHHHHHHHHHHHhhhhhc---cCcEEccccCchheeEcCCCCEEEecCccceEecccccc
Confidence            7654            3788999999999999999999   77999999999999999999999999999986532    


Q ss_pred             -----CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 -----DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 -----~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                           .+.+||.+..  ..++.++|||||||+||||++|+.||...
T Consensus       161 ~~Gt~~Y~APE~l~~--~~y~~~~DiwSlGvilyemltG~~Pf~~~  204 (316)
T d1fota_         161 LCGTPDYIAPEVVST--KPYNKSIDWWSFGILIYEMLAGYTPFYDS  204 (316)
T ss_dssp             CCSCTTTCCHHHHTT--CCBCTTHHHHHHHHHHHHHHHSSCTTCCS
T ss_pred             ccCcccccCHHHHcC--CCCCchhhccccchhHHHHHhCCCCCCCc
Confidence                 2346776654  45788999999999999999999999754

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.1e-34  Score=293.86  Aligned_cols=172  Identities=24%  Similarity=0.352  Sum_probs=148.0

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .|.||+++.  +|+.||||+++...      ...+.+|+..+..++|||||++++++.++ +.+|+|||||++|+|.+++
T Consensus        18 fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~-~~~~iv~ey~~gg~L~~~~   96 (337)
T d1o6la_          18 FGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTH-DRLCFVMEYANGGELFFHL   96 (337)
T ss_dssp             SEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECS-SEEEEEEECCTTCBHHHHH
T ss_pred             CeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccc-cccccceeccCCCchhhhh
Confidence            499999998  79999999987543      24567899999999999999999997655 5899999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC---
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---  539 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~---  539 (600)
                      ....            .+++.+...++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+|+.....   
T Consensus        97 ~~~~------------~~~e~~~~~~~~qil~al~ylH---~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~  161 (337)
T d1o6la_          97 SRER------------VFTEERARFYGAEIVSALEYLH---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGAT  161 (337)
T ss_dssp             HHHS------------CCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCC
T ss_pred             hccc------------CCcHHHHHHHHHHHhhhhhhhh---hcCccccccCHHHeEecCCCCEEEeecccccccccCCcc
Confidence            7643            3899999999999999999999   679999999999999999999999999999865322   


Q ss_pred             ---------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 ---------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 ---------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                               +.+||....  ..++.++||||+||+||||++|+.||...+
T Consensus       162 ~~~~~GT~~Y~aPE~~~~--~~y~~~~DiwSlGvilyeml~G~~pf~~~~  209 (337)
T d1o6la_         162 MKTFCGTPEYLAPEVLED--NDYGRAVDWWGLGVVMYEMMCGRLPFYNQD  209 (337)
T ss_dssp             BCCCEECGGGCCGGGGSS--SCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cccceeCHHHhhhhhccC--CCCChhhcccchhhHHHHHHHCCCCCCCcC
Confidence                     235665554  457889999999999999999999997644

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.3e-34  Score=293.57  Aligned_cols=173  Identities=23%  Similarity=0.361  Sum_probs=139.0

Q ss_pred             ceeEEEEEEEE--CCeEEEEEEcchhH----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          389 RIEGAVYHGRL--NGKNLAIKRTEHEV----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       389 ~~~G~Vy~g~~--~g~~vAvK~~~~~~----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      |.+|.||+++.  +|+.||||.++...    ...+++|+..+..++|||||++++++.++ ...|||||||++|+|.++|
T Consensus        20 G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~-~~~~lvmE~~~gg~L~~~l   98 (307)
T d1a06a_          20 GAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESG-GHLYLIMQLVSGGELFDRI   98 (307)
T ss_dssp             GGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECS-SEEEEEECCCCSCBHHHHH
T ss_pred             ccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEEeccCCCcHHHhh
Confidence            34499999998  68999999986432    23567899999999999999999997655 5899999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC---CCCcEEEEeccCccccCC-
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLD---EEFNARVGNFGMARCVND-  538 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld---~~~~~kI~DFGla~~~~~-  538 (600)
                      ....            .+++.++..++.||+.||.|||   +.+|+||||||+|||+.   +++.+||+|||+++.... 
T Consensus        99 ~~~~------------~l~e~~~~~~~~qi~~al~ylH---~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~  163 (307)
T d1a06a_          99 VEKG------------FYTERDASRLIFQVLDAVKYLH---DLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG  163 (307)
T ss_dssp             HTCS------------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred             hccc------------CCCHHHHHHHHHHHHHHHHhhh---hceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence            7543            3999999999999999999999   66999999999999994   578999999999975432 


Q ss_pred             ----------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          539 ----------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       539 ----------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                .+.+||....  ..++.++|||||||+||||++|+.||...
T Consensus       164 ~~~~~~~GT~~y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~  212 (307)
T d1a06a_         164 SVLSTACGTPGYVAPEVLAQ--KPYSKAVDCWSIGVIAYILLCGYPPFYDE  212 (307)
T ss_dssp             ---------CTTSCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             CeeeeeeeCccccCcHHHcC--CCCCcHHHhhhhhHHHHHHHhCCCCCCCC
Confidence                      2346776654  45788999999999999999999999753

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=6.3e-34  Score=295.66  Aligned_cols=172  Identities=21%  Similarity=0.312  Sum_probs=146.4

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH---HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcC
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV---ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGG  465 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~---~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~  465 (600)
                      +|.||+++.  +|+.||||.++...   ...+++|+..+..++|||||++++++.++ ..+|||||||++|+|.+++...
T Consensus        42 fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-~~~~ivmE~~~gg~L~~~~~~~  120 (352)
T d1koba_          42 FGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDK-YEMVLILEFLSGGELFDRIAAE  120 (352)
T ss_dssp             TEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECS-SEEEEEEECCCCCBHHHHTTCT
T ss_pred             CeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEEEcCCCChHHHHHHhc
Confidence            399999998  69999999975422   34577899999999999999999997655 5899999999999999988654


Q ss_pred             cCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC--CCCcEEEEeccCccccCCCC---
Q 041830          466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLD--EEFNARVGNFGMARCVNDDT---  540 (600)
Q Consensus       466 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld--~~~~~kI~DFGla~~~~~~~---  540 (600)
                      .           ..|++.++..|+.||+.||.|||   +.+|+||||||+|||++  .++.+||+|||+|+......   
T Consensus       121 ~-----------~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~~  186 (352)
T d1koba_         121 D-----------YKMSEAEVINYMRQACEGLKHMH---EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVK  186 (352)
T ss_dssp             T-----------CCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCEE
T ss_pred             C-----------CCCCHHHHHHHHHHHHHHHHHHH---HCCeeecccccccccccccCCCeEEEeecccceecCCCCcee
Confidence            3           34899999999999999999999   66999999999999997  67899999999998765432   


Q ss_pred             --------CCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          541 --------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       541 --------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                              .+||....  ..++.++|||||||+||||+||+.||...
T Consensus       187 ~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvilyelltG~~Pf~~~  231 (352)
T d1koba_         187 VTTATAEFAAPEIVDR--EPVGFYTDMWAIGVLGYVLLSGLSPFAGE  231 (352)
T ss_dssp             EECSSGGGCCHHHHTT--CCBCHHHHHHHHHHHHHHHHHSCCSSCCS
T ss_pred             eccCcccccCHHHHcC--CCCCCccchHHHHHHHHHHHhCCCCCCCC
Confidence                    35665544  45788999999999999999999999753

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-34  Score=287.80  Aligned_cols=172  Identities=20%  Similarity=0.306  Sum_probs=145.9

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh---------HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE---------VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~---------~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~  459 (600)
                      +|.||+++.  +|+.||||+++..         ..+.+++|+..+..++|||||++++++.++ ...|||||||++|+|.
T Consensus        23 fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~iv~E~~~gg~L~  101 (293)
T d1jksa_          23 FAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENK-TDVILILELVAGGELF  101 (293)
T ss_dssp             SEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECS-SEEEEEEECCCSCBHH
T ss_pred             CeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEEEcCCCcccc
Confidence            399999998  6899999987532         235678999999999999999999998665 5899999999999999


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC----cEEEEeccCccc
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEF----NARVGNFGMARC  535 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~----~~kI~DFGla~~  535 (600)
                      +++....            .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++    .+||+|||+++.
T Consensus       102 ~~i~~~~------------~l~~~~~~~~~~qi~~al~yLH---~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~  166 (293)
T d1jksa_         102 DFLAEKE------------SLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK  166 (293)
T ss_dssp             HHHHHHS------------SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             chhcccc------------ccchhHHHHHHHHHHHHHHhhh---hcceeecccccceEEEecCCCcccceEecchhhhhh
Confidence            9997543            3999999999999999999999   66999999999999998776    599999999986


Q ss_pred             cCCC-----------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          536 VNDD-----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       536 ~~~~-----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                      ....           +.+||....  ..++.++|||||||+||||++|+.||...+
T Consensus       167 ~~~~~~~~~~~~t~~y~APE~~~~--~~~~~~~DiwSlGvilyell~g~~Pf~~~~  220 (293)
T d1jksa_         167 IDFGNEFKNIFGTPEFVAPEIVNY--EPLGLEADMWSIGVITYILLSGASPFLGDT  220 (293)
T ss_dssp             CTTSCBCSCCCCCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cCCCccccccCCCCcccCHHHHcC--CCCCCcccchhhhHHHHHHHcCCCCCCCCC
Confidence            5432           134555543  457889999999999999999999997543

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-34  Score=287.78  Aligned_cols=170  Identities=26%  Similarity=0.429  Sum_probs=138.5

Q ss_pred             eEEEEEEEECC------eEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          391 EGAVYHGRLNG------KNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       391 ~G~Vy~g~~~g------~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      +|.||+|++.+      ..||||+++..    ....+.+|+..+..++|||||+++|+|.+. ...++|||||.+|++.+
T Consensus        20 fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~-~~~~~v~e~~~~~~l~~   98 (283)
T d1mqba_          20 FGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKY-KPMMIITEYMENGALDK   98 (283)
T ss_dssp             SSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-SSEEEEEECCTTEEHHH
T ss_pred             CeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecC-CceEEEEEecccCcchh
Confidence            39999999832      36999997542    234678899999999999999999998665 48899999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-  539 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-  539 (600)
                      ++....           ..++|.++++++.||+.||+|||   +.+|+||||||+||||+.++.+||+|||+++..... 
T Consensus        99 ~~~~~~-----------~~~~~~~~~~i~~~i~~gl~~lH---~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~  164 (283)
T d1mqba_          99 FLREKD-----------GEFSVLQLVGMLRGIAAGMKYLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP  164 (283)
T ss_dssp             HHHHTT-----------TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC--------
T ss_pred             hhhccc-----------ccccHHHHHHHHHHHHHhhhhcc---ccccccCccccceEEECCCCeEEEcccchhhcccCCC
Confidence            887543           34999999999999999999999   669999999999999999999999999999864321 


Q ss_pred             --------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCC
Q 041830          540 --------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN  577 (600)
Q Consensus       540 --------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~  577 (600)
                                    +.+||....  ..++.++|||||||+||||++|..|+.
T Consensus       165 ~~~~~~~~~~gt~~Y~APE~l~~--~~~~~~sDI~S~Gvil~el~t~~~~~~  214 (283)
T d1mqba_         165 EATYTTSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMTYGERPY  214 (283)
T ss_dssp             ---------CCCGGGSCHHHHHS--CCCCHHHHHHHHHHHHHHHHTTSCCTT
T ss_pred             ccceEeccCCCCccccCHHHHcc--CCCCCcccccccHHHHHHHHhCCCCcc
Confidence                          235665544  467889999999999999999766654

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=1e-33  Score=293.89  Aligned_cols=172  Identities=19%  Similarity=0.304  Sum_probs=146.2

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh---HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcC
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE---VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGG  465 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~---~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~  465 (600)
                      +|.||+++.  +|+.||||++...   ..+.+++|+..+..++|||||++++++.++ +.+|||||||++|+|.+++...
T Consensus        39 fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~-~~~~ivmE~~~gg~L~~~l~~~  117 (350)
T d1koaa2          39 FGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDD-NEMVMIYEFMSGGELFEKVADE  117 (350)
T ss_dssp             TEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEET-TEEEEEECCCCSCBHHHHHTCT
T ss_pred             CeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEEC-CEEEEEEEcCCCCCHHHHHHhh
Confidence            399999998  6999999987542   234578899999999999999999998665 5899999999999999999653


Q ss_pred             cCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC--CCCcEEEEeccCccccCCC----
Q 041830          466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLD--EEFNARVGNFGMARCVNDD----  539 (600)
Q Consensus       466 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld--~~~~~kI~DFGla~~~~~~----  539 (600)
                      .           ..+++.++..|+.||+.||.|||   +.+|+||||||+|||++  .++.+||+|||+++.....    
T Consensus       118 ~-----------~~l~e~~~~~i~~qi~~aL~ylH---~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~~  183 (350)
T d1koaa2         118 H-----------NKMSEDEAVEYMRQVCKGLCHMH---ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVK  183 (350)
T ss_dssp             T-----------SCBCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCEE
T ss_pred             c-----------CCCCHHHHHHHHHHHHHHHHHHH---hcCCeeeeechhHeeeccCCCCeEEEeecchheecccccccc
Confidence            3           23899999999999999999999   66999999999999995  4678999999999865432    


Q ss_pred             -------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 -------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 -------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                             +.+||....  ..++.++|||||||++|||++|+.||...
T Consensus       184 ~~~gT~~Y~aPEv~~~--~~~~~~~DiwSlGvilyell~G~~Pf~~~  228 (350)
T d1koaa2         184 VTTGTAEFAAPEVAEG--KPVGYYTDMWSVGVLSYILLSGLSPFGGE  228 (350)
T ss_dssp             EECSCTTTCCHHHHHT--CCBCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             eecCcccccCHHHHcC--CCCChhHhhhhhhHHHHHHHhCCCCCCCC
Confidence                   345666654  45678899999999999999999999754

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-34  Score=289.09  Aligned_cols=170  Identities=24%  Similarity=0.444  Sum_probs=140.4

Q ss_pred             eEEEEEEEE-CCeEEEEEEcchhH--HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcC
Q 041830          391 EGAVYHGRL-NGKNLAIKRTEHEV--ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLA  467 (600)
Q Consensus       391 ~G~Vy~g~~-~g~~vAvK~~~~~~--~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~  467 (600)
                      +|.||+|++ +++.||||+++...  .+.+.+|+..+..++|||||+++|+|. ++ ..++|||||++|+|.+++.....
T Consensus        30 fg~Vy~~~~~~~~~vAiK~l~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~-~~~lv~Ey~~~g~l~~~~~~~~~  107 (285)
T d1fmka3          30 FGEVWMGTWNGTTRVAIKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EE-PIYIVTEYMSKGSLLDFLKGETG  107 (285)
T ss_dssp             SCEEEEEEETTTEEEEEEECCTTSSCHHHHHHHHHHHHHCCCTTBCCEEEEEC-SS-SCEEEECCCTTCBHHHHHSHHHH
T ss_pred             CeEEEEEEECCCCEEEEEEECcccCCHHHHHHHHHHHHhcccCCEeEEEEEEe-cC-CeEEEEEecCCCchhhhhhhccc
Confidence            389999999 56789999986543  356889999999999999999999974 43 68999999999999999875321


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--------
Q 041830          468 MKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--------  539 (600)
Q Consensus       468 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--------  539 (600)
                                ..++|.+++.|+.||+.||+|||   +.+|+||||||+|||||+++.+||+|||+++.....        
T Consensus       108 ----------~~l~~~~~~~i~~~i~~gl~~LH---~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~  174 (285)
T d1fmka3         108 ----------KYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGA  174 (285)
T ss_dssp             ----------TTCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEECCCCTTC-------------
T ss_pred             ----------ccchHHHHHHHHHHHHHHHHHHh---hhheecccccceEEEECCCCcEEEcccchhhhccCCCceeeccc
Confidence                      34999999999999999999999   568999999999999999999999999999765322        


Q ss_pred             -----CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCC
Q 041830          540 -----TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPIN  577 (600)
Q Consensus       540 -----~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~  577 (600)
                           +.+||....  ..++.++|||||||+||||++|+.|+.
T Consensus       175 ~gt~~y~aPE~~~~--~~~~~ksDI~S~Giil~el~t~~~p~~  215 (285)
T d1fmka3         175 KFPIKWTAPEAALY--GRFTIKSDVWSFGILLTELTTKGRVPY  215 (285)
T ss_dssp             -CCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred             cccccccChHHHhC--CCCCcHHhhhcchHHHHHHHhCCCCCC
Confidence                 124555544  456889999999999999999766654

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-34  Score=292.97  Aligned_cols=184  Identities=26%  Similarity=0.423  Sum_probs=143.0

Q ss_pred             eEEEEEEEECC-------eEEEEEEcchhH----HHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCCH
Q 041830          391 EGAVYHGRLNG-------KNLAIKRTEHEV----ITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSL  458 (600)
Q Consensus       391 ~G~Vy~g~~~g-------~~vAvK~~~~~~----~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL  458 (600)
                      +|.||+|++.+       ..||+|.+....    ...+.+|+..+.++ +|||||+++|+|.++ +..|+|||||++|+|
T Consensus        50 fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~-~~~~lv~Ey~~~g~L  128 (325)
T d1rjba_          50 FGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLS-GPIYLIFEYCCYGDL  128 (325)
T ss_dssp             SEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSCEEEEECCTTCBH
T ss_pred             CeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeC-CeEEEEEEcCCCCcH
Confidence            39999999832       369999875432    23567888888877 899999999998665 489999999999999


Q ss_pred             HHHHhcCcCccccc-----------ccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEE
Q 041830          459 KDWLHGGLAMKNQF-----------IASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARV  527 (600)
Q Consensus       459 ~~~L~~~~~~~~~~-----------~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI  527 (600)
                      .++|+..+......           .......++|.+++.++.||+.||+|||   +.+|+||||||+|||++.++.+||
T Consensus       129 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH---~~~IiHRDlKp~Nill~~~~~~Kl  205 (325)
T d1rjba_         129 LNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLE---FKSCVHRDLAARNVLVTHGKVVKI  205 (325)
T ss_dssp             HHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHH---HTTEEETTCSGGGEEEETTTEEEE
T ss_pred             HHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCchhccccccCCeEEE
Confidence            99997654210000           0001135899999999999999999999   569999999999999999999999


Q ss_pred             EeccCccccCCC--------------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCCC
Q 041830          528 GNFGMARCVNDD--------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRPR  580 (600)
Q Consensus       528 ~DFGla~~~~~~--------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~~  580 (600)
                      +|||+|+.....              +.+||....  ..++.++|||||||+||||+| |+.||....
T Consensus       206 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~  271 (325)
T d1rjba_         206 CDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFE--GIYTIKSDVWSYGILLWEIFSLGVNPYPGIP  271 (325)
T ss_dssp             CCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred             eeccccccccCCCceeeeccccCCCccCChHHHcC--CCCCcceeccchhHHHHHHHhCCCCCCCCCC
Confidence            999999754322              235665544  457889999999999999998 899997643

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=1.6e-33  Score=294.01  Aligned_cols=173  Identities=24%  Similarity=0.342  Sum_probs=142.4

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhHHH------HH---HHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEVIT------KL---EMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~~~------~~---e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~  459 (600)
                      +|.||+++.  +|+.||||.++.....      .+   ..++..+..++|||||++++++..+ +.+|+|||||++|+|.
T Consensus        17 fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~-~~~~ivmE~~~gg~L~   95 (364)
T d1omwa3          17 FGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP-DKLSFILDLMNGGDLH   95 (364)
T ss_dssp             SCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS-SEEEEEECCCCSCBHH
T ss_pred             CeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEEC-CEEEEEEEecCCCcHH
Confidence            499999998  6999999998653321      12   2335556667899999999997665 4899999999999999


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD  539 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~  539 (600)
                      ++|....            .+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+|+.....
T Consensus        96 ~~l~~~~------------~~~e~~~~~~~~qi~~aL~ylH---~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~  160 (364)
T d1omwa3          96 YHLSQHG------------VFSEADMRFYAAEIILGLEHMH---NRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  160 (364)
T ss_dssp             HHHHHHC------------SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS
T ss_pred             HHHHhcc------------cccHHHHHHHHHHHHHHHHHHH---HCCccceeeccceeEEcCCCcEEEeeeceeeecCCC
Confidence            9997543            3889999999999999999999   679999999999999999999999999999865432


Q ss_pred             ----------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 ----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 ----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                                +.+||.+.. ...++.++|||||||+||||+||+.||....
T Consensus       161 ~~~~~~GT~~y~APE~~~~-~~~~~~~~DiwSlGvilyemltG~~Pf~~~~  210 (364)
T d1omwa3         161 KPHASVGTHGYMAPEVLQK-GVAYDSSADWFSLGCMLFKLLRGHSPFRQHK  210 (364)
T ss_dssp             CCCSCCSCGGGCCHHHHST-TCCCCTHHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred             cccccccccccchhHHhhc-CCCCCcccchhHHHHHHHHHHhCCCCCCCCC
Confidence                      135665543 2457889999999999999999999997644

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=3.4e-33  Score=280.69  Aligned_cols=174  Identities=24%  Similarity=0.405  Sum_probs=145.8

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchh------------HHHHHHHHHHHHHhCC-CCceeeeeeEEeccCCceEEEEeecCC
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHE------------VITKLEMQLVQHATHH-HPNIVRLLGTCLTDGPHSFLVFEYAKN  455 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~------------~~~~~e~ei~~~~~l~-HpNIv~l~g~~~~~~~~~~LV~Ey~~~  455 (600)
                      .|.||+++.  +|+.||||+++..            ..+.+.+|+..+.++. |||||++++++.++ +..|||||||++
T Consensus        16 ~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~-~~~~ivmE~~~~   94 (277)
T d1phka_          16 SSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN-TFFFLVFDLMKK   94 (277)
T ss_dssp             SEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS-SEEEEEEECCTT
T ss_pred             CeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC-cceEEEEEcCCC
Confidence            499999998  7899999987432            1234678999999987 99999999997655 589999999999


Q ss_pred             CCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccc
Q 041830          456 GSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARC  535 (600)
Q Consensus       456 GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~  535 (600)
                      |+|.++|+...            .+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus        95 g~L~~~l~~~~------------~l~e~~~~~~~~qi~~al~~lH---~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~  159 (277)
T d1phka_          95 GELFDYLTEKV------------TLSEKETRKIMRALLEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ  159 (277)
T ss_dssp             CBHHHHHHHHS------------SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             chHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHH---HcCCcccccccceEEEcCCCCeEEccchheeE
Confidence            99999997532            3999999999999999999999   56999999999999999999999999999987


Q ss_pred             cCCCC-----------CCCccccc----CCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          536 VNDDT-----------ESPQFYST----NPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       536 ~~~~~-----------~~pe~~~~----~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                      .....           .+||....    ....++.++||||+||++|||++|+.||...+
T Consensus       160 ~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~  219 (277)
T d1phka_         160 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK  219 (277)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC
Confidence            65422           23444432    22346788999999999999999999997643

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.4e-33  Score=291.09  Aligned_cols=171  Identities=19%  Similarity=0.331  Sum_probs=147.6

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      +|.||+++.  +|+.||||+++.+.      .+.+.+|+.++..++|||||++++++... ...++||||+.+|+|.+++
T Consensus        54 fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-~~~~~v~e~~~~g~l~~~l  132 (350)
T d1rdqe_          54 FGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDN-SNLYMVMEYVAGGEMFSHL  132 (350)
T ss_dssp             SCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEEEECCTTCBHHHHH
T ss_pred             CcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccc-cccccccccccccchhhhH
Confidence            399999998  69999999986533      23567899999999999999999997655 4889999999999999999


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC---
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD---  539 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~---  539 (600)
                      ....            .+++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.....   
T Consensus       133 ~~~~------------~l~e~~~~~i~~qi~~aL~yLH---~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~~~~  197 (350)
T d1rdqe_         133 RRIG------------RFSEPHARFYAAQIVLTFEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTWT  197 (350)
T ss_dssp             HHHC------------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCBCC
T ss_pred             hhcC------------CCCHHHHHHHHHHHHHHHHHHH---hCCEecCcCCHHHcccCCCCCEEeeeceeeeeccccccc
Confidence            7543            3899999999999999999999   669999999999999999999999999999876433   


Q ss_pred             ------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 ------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 ------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                            +.+||.+..  ..++.++|||||||+||||+||+.||...
T Consensus       198 ~~Gt~~Y~APE~~~~--~~~~~~~DiwSlGvilyemltG~~Pf~~~  241 (350)
T d1rdqe_         198 LCGTPEALAPEIILS--KGYNKAVDWWALGVLIYEMAAGYPPFFAD  241 (350)
T ss_dssp             CEECGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccCccccCCHHHHcC--CCCCccccccchhHHHHHHHhCCCCCCCc
Confidence                  235666654  45788999999999999999999999753

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-33  Score=285.72  Aligned_cols=173  Identities=27%  Similarity=0.531  Sum_probs=143.5

Q ss_pred             eeEEEEEEEEC---C--eEEEEEEcch----hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          390 IEGAVYHGRLN---G--KNLAIKRTEH----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       390 ~~G~Vy~g~~~---g--~~vAvK~~~~----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      .+|+||+|++.   +  ..||||+++.    ...+.+.+|+..+.+++|||||+++|+|.......++|||||++|+|.+
T Consensus        39 ~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~  118 (311)
T d1r0pa_          39 HFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRN  118 (311)
T ss_dssp             TTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHH
T ss_pred             CCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhh
Confidence            34999999982   2  3589998753    2345788999999999999999999998765557899999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCCC
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDT  540 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~~  540 (600)
                      +++...           ..+++.++++++.|++.||.|||   +.+|+||||||+|||+++++.+||+|||+++......
T Consensus       119 ~~~~~~-----------~~~~~~~~~~i~~qia~gL~~lH---~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~  184 (311)
T d1r0pa_         119 FIRNET-----------HNPTVKDLIGFGLQVAKGMKFLA---SKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  184 (311)
T ss_dssp             HHHCTT-----------CCCBHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTT
T ss_pred             hhcccc-----------ccchHHHHHHHHHHHHHhhhhhc---ccCcccCCccHHhEeECCCCCEEEecccchhhccccc
Confidence            997644           34789999999999999999999   6699999999999999999999999999998653321


Q ss_pred             ----------------CCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          541 ----------------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       541 ----------------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                                      .+||....  ..++.++||||||++||||+||+.||..
T Consensus       185 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~ksDI~SfGivl~El~t~~~p~~~  236 (311)
T d1r0pa_         185 FDSVHNKTGAKLPVKWMALESLQT--QKFTTKSDVWSFGVLLWELMTRGAPPYP  236 (311)
T ss_dssp             CCCTTCTTCSSCCGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSCC
T ss_pred             cccceecccccccccccChHHHhc--CCCCChhHhhhhHHHHHHHHHCCCCCCC
Confidence                            23444333  3568889999999999999998888754

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.6e-33  Score=285.54  Aligned_cols=172  Identities=23%  Similarity=0.404  Sum_probs=142.6

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH------HHHHHHHHHHH-HhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV------ITKLEMQLVQH-ATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~------~~~~e~ei~~~-~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      +|.||+|+.  +|+.||||+++.+.      ...+..|...+ ..++|||||++++++.++ +..|||||||++|+|.++
T Consensus        15 fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~-~~~yivmEy~~~g~L~~~   93 (320)
T d1xjda_          15 FGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTK-ENLFFVMEYLNGGDLMYH   93 (320)
T ss_dssp             SSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECS-SEEEEEEECCTTCBHHHH
T ss_pred             CcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccC-CceeEEEeecCCCcHHHH
Confidence            399999999  79999999986532      12344555544 468999999999997655 589999999999999999


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--  539 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--  539 (600)
                      ++...            .+++.++..++.||+.||+|||   +.+|+||||||+|||+++++.+||+|||+++.....  
T Consensus        94 i~~~~------------~~~e~~~~~~~~qi~~al~ylH---~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~  158 (320)
T d1xjda_          94 IQSCH------------KFDLSRATFYAAEIILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA  158 (320)
T ss_dssp             HHHHS------------SCCHHHHHHHHHHHHHHHHHHH---HTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC
T ss_pred             hhccC------------CCCHHHHHHHHHHHHHHHHHHH---hCCeeeccCcccceeecCCCceeccccchhhhcccccc
Confidence            97543            3899999999999999999999   669999999999999999999999999999754321  


Q ss_pred             ----------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          540 ----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       540 ----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                                +.+||....  ..++.++|||||||++|||++|+.||...+
T Consensus       159 ~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlGvilyemltG~~PF~~~~  207 (320)
T d1xjda_         159 KTNTFCGTPDYIAPEILLG--QKYNHSVDWWSFGVLLYEMLIGQSPFHGQD  207 (320)
T ss_dssp             CBCCCCSCGGGCCHHHHTT--CCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             cccccCCCCCcCCHHHHcC--CCCCchhhhhhhhHHHHHHHhCCCCCCCCC
Confidence                      124555544  457889999999999999999999997543

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.2e-33  Score=285.34  Aligned_cols=175  Identities=19%  Similarity=0.268  Sum_probs=144.6

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhHH--HHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCc
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEVI--TKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGL  466 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~~--~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~  466 (600)
                      +|.||++..  +|+.||||.++....  ..+++|+..+..++|||||++++++.++ ..+|||||||++|+|.+++....
T Consensus        18 fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~-~~~~lvmE~~~gg~L~~~i~~~~   96 (321)
T d1tkia_          18 FGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESM-EELVMIFEFISGLDIFERINTSA   96 (321)
T ss_dssp             SEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSCCTTBCCEEEEEEET-TEEEEEECCCCCCBHHHHHTSSS
T ss_pred             CeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCCCCCCCeEEEEEEEC-CEEEEEEecCCCCcHHHHHHhcC
Confidence            499999998  689999999865432  3567899999999999999999997655 58999999999999999997543


Q ss_pred             CcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC--CCcEEEEeccCccccCCCC----
Q 041830          467 AMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE--EFNARVGNFGMARCVNDDT----  540 (600)
Q Consensus       467 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~--~~~~kI~DFGla~~~~~~~----  540 (600)
                                 ..+++.++..++.||+.||+|||   +.+|+||||||+|||++.  ...+||+|||+++......    
T Consensus        97 -----------~~l~e~~~~~i~~qi~~al~yLH---~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~~~  162 (321)
T d1tkia_          97 -----------FELNEREIVSYVHQVCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRL  162 (321)
T ss_dssp             -----------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEEEE
T ss_pred             -----------CCCCHHHHHHHHHHHHHHHHHHH---HcCCCcccccccceeecCCCceEEEEcccchhhccccCCcccc
Confidence                       23899999999999999999999   669999999999999985  4589999999998764332    


Q ss_pred             --CCCccccc---CCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          541 --ESPQFYST---NPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       541 --~~pe~~~~---~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                        ..|++..+   ....++.++||||+||++|||++|+.||...+
T Consensus       163 ~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~  207 (321)
T d1tkia_         163 LFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAET  207 (321)
T ss_dssp             EESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred             cccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCC
Confidence              12222222   12456788999999999999999999997644

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-33  Score=286.38  Aligned_cols=172  Identities=23%  Similarity=0.438  Sum_probs=142.5

Q ss_pred             eEEEEEEEE--CCe----EEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          391 EGAVYHGRL--NGK----NLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       391 ~G~Vy~g~~--~g~----~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      +|.||+|++  +|+    .||+|+++..    ..+.+.+|+..+.+++|||||+++|+|.++  ..++++||+.+|+|.+
T Consensus        22 fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~--~~~~v~e~~~~~~l~~   99 (317)
T d1xkka_          22 FGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS--TVQLITQLMPFGCLLD   99 (317)
T ss_dssp             SEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS--SEEEEEECCTTCBHHH
T ss_pred             CeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC--CeeEEEEeccCCcccc
Confidence            399999998  444    5899987542    235688999999999999999999998653  5789999999999999


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC--
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND--  538 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~--  538 (600)
                      ++....           ..++|.++++++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++....  
T Consensus       100 ~~~~~~-----------~~~~~~~~~~i~~qi~~gl~yLH---~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~  165 (317)
T d1xkka_         100 YVREHK-----------DNIGSQYLLNWCVQIAKGMNYLE---DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEE  165 (317)
T ss_dssp             HHHHTS-----------SSCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTC
T ss_pred             cccccc-----------cCCCHHHHHHHHHHHHHHHHHHH---HcCcccCcchhhcceeCCCCCeEeeccccceeccccc
Confidence            887653           34999999999999999999999   56999999999999999999999999999986432  


Q ss_pred             ------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCCC
Q 041830          539 ------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRPR  580 (600)
Q Consensus       539 ------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~~  580 (600)
                                  .+.+||....  ..++.++|||||||+||||+| |+.||....
T Consensus       166 ~~~~~~~~~gt~~y~APE~l~~--~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~  218 (317)
T d1xkka_         166 KEYHAEGGKVPIKWMALESILH--RIYTHQSDVWSYGVTVWELMTFGSKPYDGIP  218 (317)
T ss_dssp             C--------CCTTTSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCTTTTSC
T ss_pred             ccccccccccCccccChHHHhc--CCCChhhhhhhHHHHHHHHHHCCCCCCCCCC
Confidence                        2235665544  357889999999999999999 788987543

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=3e-33  Score=288.83  Aligned_cols=173  Identities=20%  Similarity=0.329  Sum_probs=141.2

Q ss_pred             eeEEEEEEEE--CCeEEEEEEcchhHHHHHHHHHHHHH-hCCCCceeeeeeEEec---cCCceEEEEeecCCCCHHHHHh
Q 041830          390 IEGAVYHGRL--NGKNLAIKRTEHEVITKLEMQLVQHA-THHHPNIVRLLGTCLT---DGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       390 ~~G~Vy~g~~--~g~~vAvK~~~~~~~~~~e~ei~~~~-~l~HpNIv~l~g~~~~---~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      .+|.||+++.  +|+.||||.++...  .+++|+..+. ..+|||||++++++.+   .+..+|+|||||++|+|.++|.
T Consensus        24 ~fg~Vy~a~~~~~~~~vAiK~i~~~~--~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~  101 (335)
T d2ozaa1          24 INGKVLQIFNKRTQEKFALKMLQDCP--KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQ  101 (335)
T ss_dssp             SSCEEEEEEETTTCCEEEEEEEECSH--HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHH
T ss_pred             cCeEEEEEEECCCCCEEEEEEECCcH--HHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHH
Confidence            3499999998  68999999987643  4566776654 4589999999998753   2346899999999999999997


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC---CCcEEEEeccCccccCCC-
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE---EFNARVGNFGMARCVNDD-  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~---~~~~kI~DFGla~~~~~~-  539 (600)
                      ....          ..|++.++..|+.||+.||+|||   +.+|+||||||+|||++.   ++.+||+|||+++..... 
T Consensus       102 ~~~~----------~~l~e~~~~~i~~qi~~al~ylH---~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~  168 (335)
T d2ozaa1         102 DRGD----------QAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN  168 (335)
T ss_dssp             SCSC----------CCEEHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC
T ss_pred             hcCC----------CCcCHHHHHHHHHHHHHHHHHHH---HcCCccccccccccccccccccccccccccceeeeccCCC
Confidence            5431          34899999999999999999999   679999999999999975   567999999999865332 


Q ss_pred             ----------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 ----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 ----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                +.+||....  ..++.++|||||||+||||+||+.||...
T Consensus       169 ~~~~~~gt~~y~aPE~~~~--~~y~~~~DiwSlGvily~lltg~~Pf~~~  216 (335)
T d2ozaa1         169 SLTTPCYTPYYVAPEVLGP--EKYDKSCDMWSLGVIMYILLCGYPPFYSN  216 (335)
T ss_dssp             CCCCCSCCCSSCCCCCCCG--GGGSHHHHHHHHHHHHHHHTTSSCSCEET
T ss_pred             ccccccCCcccCCcHHHcC--CCCCHHHHHHhhchhHHHHhhCCCCCCCC
Confidence                      234555543  35788999999999999999999999654

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=3.7e-33  Score=280.11  Aligned_cols=173  Identities=23%  Similarity=0.461  Sum_probs=136.3

Q ss_pred             eEEEEEEEEC-----CeEEEEEEcch----hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          391 EGAVYHGRLN-----GKNLAIKRTEH----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       391 ~G~Vy~g~~~-----g~~vAvK~~~~----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      +|.||+|++.     +..||||.++.    ...+.+.+|+..+..++|||||+++|++. + +..|+||||+++|+|.++
T Consensus        20 fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~-~~~~iv~E~~~~g~l~~~   97 (273)
T d1mp8a_          20 FGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-E-NPVWIIMELCTLGELRSF   97 (273)
T ss_dssp             SSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-S-SSCEEEEECCTTEEHHHH
T ss_pred             CcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-c-CeEEEEEEeccCCcHHhh
Confidence            3999999882     35689998753    23356789999999999999999999974 4 378999999999999998


Q ss_pred             HhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC--
Q 041830          462 LHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD--  539 (600)
Q Consensus       462 L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~--  539 (600)
                      +....           ..+++.+++.++.||++||.|||   +.+|+||||||+||++++++.+||+|||+++.....  
T Consensus        98 ~~~~~-----------~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~  163 (273)
T d1mp8a_          98 LQVRK-----------YSLDLASLILYAYQLSTALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY  163 (273)
T ss_dssp             HHHTT-----------TTSCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred             hhccC-----------CCCCHHHHHHHHHHHHHHhhhhc---ccCeeccccchhheeecCCCcEEEccchhheeccCCcc
Confidence            86543           34899999999999999999999   679999999999999999999999999999865322  


Q ss_pred             -----------CCCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCCCC
Q 041830          540 -----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRPRK  581 (600)
Q Consensus       540 -----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~~~  581 (600)
                                 +.+||....  ..++.++|||||||++|||+| |++||...+.
T Consensus       164 ~~~~~~~gt~~y~apE~l~~--~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~  215 (273)
T d1mp8a_         164 YKASKGKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEILMHGVKPFQGVKN  215 (273)
T ss_dssp             -------CCGGGCCHHHHHH--CCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred             eeccceecCcccchhhHhcc--CCCCCccccccchHHHHHHHhcCCCCCCCCCH
Confidence                       123444433  457888999999999999998 8999976443

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=2.7e-33  Score=284.83  Aligned_cols=172  Identities=23%  Similarity=0.324  Sum_probs=140.7

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhHH--------HHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEVI--------TKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKD  460 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~~--------~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~  460 (600)
                      +|.||+|+.  +|+.||||+++....        +.+.+|+..+..++|||||++++++..+ +..||||||+++|++..
T Consensus        11 fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~-~~~~ivmE~~~~~~~~~   89 (299)
T d1ua2a_          11 FATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHK-SNISLVFDFMETDLEVI   89 (299)
T ss_dssp             TEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCT-TCCEEEEECCSEEHHHH
T ss_pred             CeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccC-CceeehhhhhcchHHhh
Confidence            499999998  689999999764321        2467899999999999999999998655 48999999999887776


Q ss_pred             HHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-
Q 041830          461 WLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-  539 (600)
Q Consensus       461 ~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-  539 (600)
                      +....            ..+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+||+|||+++..... 
T Consensus        90 ~~~~~------------~~l~~~~~~~~~~qil~aL~~lH---~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~  154 (299)
T d1ua2a_          90 IKDNS------------LVLTPSHIKAYMLMTLQGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN  154 (299)
T ss_dssp             HTTCC------------SSCCSSHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC
T ss_pred             hhhcc------------cCCCHHHHHHHHHHHHHHHHHhh---ccceecccCCcceEEecCCCccccccCccccccCCCc
Confidence            65433            23889999999999999999999   679999999999999999999999999999765332 


Q ss_pred             -----------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 -----------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 -----------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                 +.+||.... ...++.++|||||||++|||++|+.||...
T Consensus       155 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~~DiwSlGvil~el~~g~~pf~~~  204 (299)
T d1ua2a_         155 RAYTHQVVTRWYRAPELLFG-ARMYGVGVDMWAVGCILAELLLRVPFLPGD  204 (299)
T ss_dssp             CCCCCSCCCCTTCCHHHHTT-CSCCCHHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred             ccccceecChhhccHHHHcc-CCCCChhhhhhhcchHHHHHHhCcCCCCCC
Confidence                       224554432 234688999999999999999999999754

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=99.98  E-value=9.2e-33  Score=277.76  Aligned_cols=172  Identities=26%  Similarity=0.407  Sum_probs=145.7

Q ss_pred             eEEEEEEEE--CCeEEEEEEcch------hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCC---ceEEEEeecCCCCHH
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEH------EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGP---HSFLVFEYAKNGSLK  459 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~------~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~---~~~LV~Ey~~~GsL~  459 (600)
                      +|.||+++.  +|+.||||.++.      +....+.+|+..+..++|||||++++++..++.   ..|||||||++|+|.
T Consensus        20 fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~   99 (277)
T d1o6ya_          20 MSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLR   99 (277)
T ss_dssp             SEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHH
T ss_pred             CeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEeh
Confidence            399999998  699999999753      223467889999999999999999999875432   378999999999999


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC--
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN--  537 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~--  537 (600)
                      +++....            .+++.+++.++.||+.||+|||   +.+|+||||||+|||++.++..+|+|||.++...  
T Consensus       100 ~~~~~~~------------~l~~~~~~~i~~qi~~al~~lH---~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~  164 (277)
T d1o6ya_         100 DIVHTEG------------PMTPKRAIEVIADACQALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADS  164 (277)
T ss_dssp             HHHHHHC------------SCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTSCEEECCCTTCEECC--
T ss_pred             hhhcccC------------CCCHHHHHHHHHHHHHHHHHHH---hCCccCccccCcccccCccccceeehhhhhhhhccc
Confidence            9986543            3999999999999999999999   6699999999999999999999999999876432  


Q ss_pred             -------------CCCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          538 -------------DDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       538 -------------~~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                                   ..+.+||....  ..++.++|||||||++|||+||+.||...
T Consensus       165 ~~~~~~~~~~~Gt~~Y~aPE~~~~--~~~~~~~DiwSlGvilyelltG~~Pf~~~  217 (277)
T d1o6ya_         165 GNSVTQTAAVIGTAQYLSPEQARG--DSVDARSDVYSLGCVLYEVLTGEPPFTGD  217 (277)
T ss_dssp             --------------TTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccccccCcccccCHHHHcC--CCCCcceecccchHHHHHHHhCCCCCCCc
Confidence                         22346776644  45788999999999999999999999754

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.98  E-value=3.9e-33  Score=279.76  Aligned_cols=173  Identities=26%  Similarity=0.447  Sum_probs=139.1

Q ss_pred             ceeEEEEEEEEC---C--eEEEEEEcchh------HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCC
Q 041830          389 RIEGAVYHGRLN---G--KNLAIKRTEHE------VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGS  457 (600)
Q Consensus       389 ~~~G~Vy~g~~~---g--~~vAvK~~~~~------~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~Gs  457 (600)
                      |.+|.||+|+++   +  ..||||+++.+      ..+.+.+|+..+..++|||||+++|+|.+  +..++|||||++|+
T Consensus        19 G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~--~~~~lv~e~~~~~~   96 (273)
T d1u46a_          19 GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT--PPMKMVTELAPLGS   96 (273)
T ss_dssp             ---CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS--SSCEEEEECCTTCB
T ss_pred             CCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee--cchheeeeeecCcc
Confidence            334999999872   2  36899987542      23567899999999999999999999854  36799999999999


Q ss_pred             HHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC
Q 041830          458 LKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN  537 (600)
Q Consensus       458 L~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~  537 (600)
                      |.+++....           ..++|.++++++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus        97 l~~~~~~~~-----------~~l~~~~~~~~~~qi~~gl~ylH---~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~  162 (273)
T d1u46a_          97 LLDRLRKHQ-----------GHFLLGTLSRYAVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALP  162 (273)
T ss_dssp             HHHHHHHHG-----------GGSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEEEETTEEEECCCTTCEECC
T ss_pred             hhhhhhccc-----------CCCCHHHHHHHHHHHHHHHHHhh---hCCEeeeeecHHHhccccccceeeccchhhhhcc
Confidence            999886533           34999999999999999999999   5689999999999999999999999999998763


Q ss_pred             CCC---------------CCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          538 DDT---------------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       538 ~~~---------------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                      ...               .+||....  ..++.++|||||||++|||+| |+.||...
T Consensus       163 ~~~~~~~~~~~~~~~~~~~aPE~~~~--~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~  218 (273)
T d1u46a_         163 QNDDHYVMQEHRKVPFAWCAPESLKT--RTFSHASDTWMFGVTLWEMFTYGQEPWIGL  218 (273)
T ss_dssp             C-CCEEEC-----CCGGGCCHHHHHH--CEEEHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred             cCCCcceecCccccCcccCCHHHHhC--CCCCcchhhhhhHHHHHHHHhCCCCCCCCc
Confidence            321               23444433  346778999999999999998 89999643

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.98  E-value=4.5e-33  Score=283.45  Aligned_cols=183  Identities=26%  Similarity=0.432  Sum_probs=144.5

Q ss_pred             eEEEEEEEEC-------CeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHH
Q 041830          391 EGAVYHGRLN-------GKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       391 ~G~Vy~g~~~-------g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~  459 (600)
                      +|.||+|++.       ++.||||+++.+    ..+++.+|+..+..++||||++++|+|... ...+++|||+++|+|.
T Consensus        26 fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-~~~~~v~e~~~~g~L~  104 (301)
T d1lufa_          26 FGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVG-KPMCLLFEYMAYGDLN  104 (301)
T ss_dssp             SCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSS-SSCEEEEECCTTCBHH
T ss_pred             CeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcCCCCcccceeeeccC-CceEEEEEecCCCcHH
Confidence            3999999974       368999998642    245688999999999999999999998655 4889999999999999


Q ss_pred             HHHhcCcCcccc------------cccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEE
Q 041830          460 DWLHGGLAMKNQ------------FIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARV  527 (600)
Q Consensus       460 ~~L~~~~~~~~~------------~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI  527 (600)
                      ++|+........            ........|+|.+++.|+.|++.||+|||   +.+++||||||+|||+|.++.+||
T Consensus       105 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH---~~~ivHrDlKp~NILld~~~~~Kl  181 (301)
T d1lufa_         105 EFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLS---ERKFVHRDLATRNCLVGENMVVKI  181 (301)
T ss_dssp             HHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECGGGCEEE
T ss_pred             HHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcc---cCCeEeeEEcccceEECCCCcEEE
Confidence            999753311000            00111245899999999999999999999   679999999999999999999999


Q ss_pred             EeccCccccCCC--------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCC-CCCCCC
Q 041830          528 GNFGMARCVNDD--------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQ-TPINRP  579 (600)
Q Consensus       528 ~DFGla~~~~~~--------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~-~Pf~~~  579 (600)
                      +|||+++.....              +.+||....  ..++.++|||||||+||||++|. +||...
T Consensus       182 ~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~--~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~  246 (301)
T d1lufa_         182 ADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFY--NRYTTESDVWAYGVVLWEIFSYGLQPYYGM  246 (301)
T ss_dssp             CCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCTTTTS
T ss_pred             ccchhheeccCCccccccCCCCcCcCcCCHHHHcc--CCCChhhhhccchhhHHHHHccCCCCCCCC
Confidence            999999754221              224555544  45788999999999999999985 567643

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.6e-32  Score=279.13  Aligned_cols=185  Identities=24%  Similarity=0.396  Sum_probs=133.1

Q ss_pred             eEEEEEEEE-------CCeEEEEEEcchhH----HHHHHHHHHHHHh-CCCCceeeeeeEEeccCCceEEEEeecCCCCH
Q 041830          391 EGAVYHGRL-------NGKNLAIKRTEHEV----ITKLEMQLVQHAT-HHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSL  458 (600)
Q Consensus       391 ~G~Vy~g~~-------~g~~vAvK~~~~~~----~~~~e~ei~~~~~-l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL  458 (600)
                      +|.||+|++       +++.||||+++...    ...+..|...+.+ .+|+|||++++++..++...++|||||++|+|
T Consensus        26 fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L  105 (299)
T d1ywna1          26 FGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL  105 (299)
T ss_dssp             SCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBH
T ss_pred             CeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcH
Confidence            399999987       23689999986422    2344455555554 46999999999987776678999999999999


Q ss_pred             HHHHhcCcCcccc----cccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCcc
Q 041830          459 KDWLHGGLAMKNQ----FIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR  534 (600)
Q Consensus       459 ~~~L~~~~~~~~~----~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~  534 (600)
                      .++|+........    ........++|.+++.++.||++||.|||   +.+|+||||||+||||++++.+||+|||+|+
T Consensus       106 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH---~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~  182 (299)
T d1ywna1         106 STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLAR  182 (299)
T ss_dssp             HHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECGGGCEEECC-----
T ss_pred             HHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHH---hCCCcCCcCCccceeECCCCcEEEccCcchh
Confidence            9999764321000    00001234899999999999999999999   6699999999999999999999999999997


Q ss_pred             ccCCC--------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhC-CCCCCCCC
Q 041830          535 CVNDD--------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSG-QTPINRPR  580 (600)
Q Consensus       535 ~~~~~--------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG-~~Pf~~~~  580 (600)
                      .....              +.+||....  ..++.++|||||||++|||+|| +.||....
T Consensus       183 ~~~~~~~~~~~~~~~gt~~y~APE~l~~--~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~  241 (299)
T d1ywna1         183 DIYKDPDYVRKGDARLPLKWMAPETIFD--RVYTIQSDVWSFGVLLWEIFSLGASPYPGVK  241 (299)
T ss_dssp             -CCSCTTSCCTTSCCCGGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred             hccccccccccCceeeCccccchhHhhc--CCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence            54321              124555443  4578899999999999999996 56776543

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.6e-32  Score=277.76  Aligned_cols=184  Identities=28%  Similarity=0.479  Sum_probs=143.4

Q ss_pred             ceeEEEEEEEE--CCe--EEEEEEcchh----HHHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCCHH
Q 041830          389 RIEGAVYHGRL--NGK--NLAIKRTEHE----VITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       389 ~~~G~Vy~g~~--~g~--~vAvK~~~~~----~~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~  459 (600)
                      |.+|.||+|++  +|.  .||||+++..    ..+.+.+|+..+.++ +|||||+++|+|.++ +..++||||+++|+|.
T Consensus        21 G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~-~~~~iV~ey~~~g~L~   99 (309)
T d1fvra_          21 GNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR-GYLYLAIEYAPHGNLL   99 (309)
T ss_dssp             GGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEET-TEEEEEECCCTTCBHH
T ss_pred             CCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC-CeeEEEEEecCCCcHH
Confidence            33499999998  454  5788887532    234678999999998 799999999998766 4899999999999999


Q ss_pred             HHHhcCcCcccc----cccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccc
Q 041830          460 DWLHGGLAMKNQ----FIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARC  535 (600)
Q Consensus       460 ~~L~~~~~~~~~----~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~  535 (600)
                      ++|+........    ........|+|.++++++.||+.||.|||   +.+|+||||||+|||++.++.+||+|||+++.
T Consensus       100 ~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH---~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~  176 (309)
T d1fvra_         100 DFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLS---QKQFIHRDLAARNILVGENYVAKIADFGLSRG  176 (309)
T ss_dssp             HHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEECGGGCEEECCTTCEES
T ss_pred             HHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhh---cCCccccccccceEEEcCCCceEEcccccccc
Confidence            999765311000    00111245999999999999999999999   66999999999999999999999999999875


Q ss_pred             cCC-----------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCC-CCCC
Q 041830          536 VND-----------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQT-PINR  578 (600)
Q Consensus       536 ~~~-----------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~-Pf~~  578 (600)
                      ...           ...+||....  ..++.++|||||||++|||++|.. ||..
T Consensus       177 ~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~sDvwSfGvil~ell~~~~~p~~~  229 (309)
T d1fvra_         177 QEVYVKKTMGRLPVRWMAIESLNY--SVYTTNSDVWSYGVLLWEIVSLGGTPYCG  229 (309)
T ss_dssp             SCEECCC----CCTTTCCHHHHHH--CEECHHHHHHHHHHHHHHHHTTSCCTTTT
T ss_pred             ccccccccceecCCcccchHHhcc--CCCCccceeehhHHHHHHHHhcCCCCCCC
Confidence            422           2234555543  456888999999999999999764 6653

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=4.6e-32  Score=275.54  Aligned_cols=173  Identities=22%  Similarity=0.409  Sum_probs=139.5

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH-----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV-----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~-----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      +|.||+|+.  +|+.||||+++.+.     ...+.+|+..++.++|||||++++++.++ ...|+||||+.+ ++.+++.
T Consensus        15 fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~-~~~~iv~e~~~~-~~~~~~~   92 (298)
T d1gz8a_          15 YGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTE-NKLYLVFEFLHQ-DLKKFMD   92 (298)
T ss_dssp             SSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEET-TEEEEEEECCSE-EHHHHHH
T ss_pred             CeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEEeccccccc-cceeEEEeecCC-chhhhhh
Confidence            499999998  69999999985432     24577899999999999999999998665 489999999975 4555554


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC----
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD----  539 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~----  539 (600)
                      ....          ..+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++.....    
T Consensus        93 ~~~~----------~~l~e~~~~~~~~qil~~L~yLH---~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~  159 (298)
T d1gz8a_          93 ASAL----------TGIPLPLIKSYLFQLLQGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTY  159 (298)
T ss_dssp             HTTT----------TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCT
T ss_pred             hhcc----------cCCCHHHHHHHHHHHHHHHHHhh---cCCEEccccCchheeecccCcceeccCCcceeccCCcccc
Confidence            3221          34999999999999999999999   668999999999999999999999999999755322    


Q ss_pred             --------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 --------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 --------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                              ..+||.... ...++.++|||||||++|||++|+.||...
T Consensus       160 ~~~~gt~~y~apE~~~~-~~~~~~~~DiwSlGvily~m~~G~~Pf~~~  206 (298)
T d1gz8a_         160 THEVVTLWYRAPEILLG-CKYYSTAVDIWSLGCIFAEMVTRRALFPGD  206 (298)
T ss_dssp             TCCBCCCTTCCHHHHTT-CSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             eeecccceeeehhhhcc-ccCCCccccccccchhhhHHhhCCCCCCCC
Confidence                    123443332 234577899999999999999999999754

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=4.8e-32  Score=276.65  Aligned_cols=180  Identities=22%  Similarity=0.411  Sum_probs=142.4

Q ss_pred             eEEEEEEEEC-------CeEEEEEEcchhH----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHH
Q 041830          391 EGAVYHGRLN-------GKNLAIKRTEHEV----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLK  459 (600)
Q Consensus       391 ~G~Vy~g~~~-------g~~vAvK~~~~~~----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~  459 (600)
                      +|.||+|++.       ++.||||+++...    ...+.+|+..+.+++|||||+++|+|..+ +..++|||||++|+|.
T Consensus        33 fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~-~~~~lv~e~~~~g~l~  111 (308)
T d1p4oa_          33 FGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG-QPTLVIMELMTRGDLK  111 (308)
T ss_dssp             SSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSS-SSCEEEEECCTTCBHH
T ss_pred             CeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecC-CceeEEEeecCCCCHH
Confidence            3999999874       4689999986422    23577899999999999999999998655 4889999999999999


Q ss_pred             HHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC
Q 041830          460 DWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD  539 (600)
Q Consensus       460 ~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~  539 (600)
                      ++++.......  .......++|.++++++.|+++||.|||   +.+|+||||||+|||+|+++.+||+|||+++.....
T Consensus       112 ~~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~ia~gl~~LH---~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~  186 (308)
T d1p4oa_         112 SYLRSLRPAMA--NNPVLAPPSLSKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET  186 (308)
T ss_dssp             HHHHHHHHHHH--HCTTCCCCCHHHHHHHHHHHHHHHHHHH---HTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGG
T ss_pred             HHHHhcccccc--cccccCCCCHHHHHHHHHHHHHHHHHHh---hCCeeeceEcCCceeecCCceEEEeecccceeccCC
Confidence            99975321100  0011134799999999999999999999   568999999999999999999999999999855322


Q ss_pred             --------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCC-CCCCC
Q 041830          540 --------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQ-TPINR  578 (600)
Q Consensus       540 --------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~-~Pf~~  578 (600)
                                    +.+||....  ..++.++||||||++||||+||. .||..
T Consensus       187 ~~~~~~~~~~~t~~y~aPe~l~~--~~~~~~~Dv~S~G~il~El~t~~~~p~~~  238 (308)
T d1p4oa_         187 DYYRKGGKGLLPVRWMSPESLKD--GVFTTYSDVWSFGVVLWEIATLAEQPYQG  238 (308)
T ss_dssp             GCEEGGGSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHHTSCCTTTT
T ss_pred             cceeeccceecccccCCHHHHcc--CCCCcccccccHHHHHHHHHhCCCCCCCC
Confidence                          123443333  34678899999999999999984 67754

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.2e-31  Score=270.67  Aligned_cols=185  Identities=21%  Similarity=0.401  Sum_probs=139.6

Q ss_pred             CceeEEEEEEEEC---------CeEEEEEEcchhH----HHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeec
Q 041830          388 NRIEGAVYHGRLN---------GKNLAIKRTEHEV----ITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYA  453 (600)
Q Consensus       388 ~~~~G~Vy~g~~~---------g~~vAvK~~~~~~----~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~  453 (600)
                      .|.+|.||+|+..         +..||||+++.+.    ..++.+|...+..+ +|||||+++|+|.++ ...++|||||
T Consensus        23 ~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~-~~~~~v~e~~  101 (299)
T d1fgka_          23 EGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD-GPLYVIVEYA  101 (299)
T ss_dssp             -----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSCEEEECCC
T ss_pred             ecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEecccccccC-CeEEEEEEcc
Confidence            3444999999862         2469999985532    23456666666665 799999999998765 4899999999


Q ss_pred             CCCCHHHHHhcCcCccc----ccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEe
Q 041830          454 KNGSLKDWLHGGLAMKN----QFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGN  529 (600)
Q Consensus       454 ~~GsL~~~L~~~~~~~~----~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~D  529 (600)
                      ++|+|.++|+.......    .........+++.++++++.||+.||+|||   +.+|+||||||+|||++.++.+||+|
T Consensus       102 ~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH---~~~ivHrDiKp~NiLl~~~~~~kl~d  178 (299)
T d1fgka_         102 SKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIAD  178 (299)
T ss_dssp             TTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEECTTCCEEECS
T ss_pred             CCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhh---hCCEEeeeecccceeecCCCCeEecc
Confidence            99999999976532100    001112245999999999999999999999   67999999999999999999999999


Q ss_pred             ccCccccCCCC--------------CCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCC
Q 041830          530 FGMARCVNDDT--------------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINR  578 (600)
Q Consensus       530 FGla~~~~~~~--------------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~  578 (600)
                      ||+++......              .+||....  ..++.++|||||||++|||++ |+.||..
T Consensus       179 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~--~~y~~k~DiwS~Gvvl~ell~~g~~p~~~  240 (299)
T d1fgka_         179 FGLARDIHHIDYYKKTTNGRLPVKWMAPEALFD--RIYTHQSDVWSFGVLLWEIFTLGGSPYPG  240 (299)
T ss_dssp             TTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred             chhhccccccccccccccCCCChhhhhhhHhcC--CCCCchhhhHHhHHHHHHhccCCCCCCCC
Confidence            99998653221              23444443  457889999999999999998 6888864

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=99.97  E-value=1.1e-31  Score=270.98  Aligned_cols=172  Identities=23%  Similarity=0.325  Sum_probs=142.2

Q ss_pred             eEEEEEEEE-CCeEEEEEEcchhH-----HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhc
Q 041830          391 EGAVYHGRL-NGKNLAIKRTEHEV-----ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHG  464 (600)
Q Consensus       391 ~G~Vy~g~~-~g~~vAvK~~~~~~-----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~  464 (600)
                      +|+||+|+. +|+.||||+++.+.     .+.+.+|+..+..++|||||++++++..+ +..++++||+.++.+..+.+.
T Consensus        15 fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~-~~~~i~~e~~~~~~~~~~~~~   93 (286)
T d1ob3a_          15 YGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTK-KRLVLVFEHLDQDLKKLLDVC   93 (286)
T ss_dssp             TEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECS-SCEEEEEECCSEEHHHHHHTS
T ss_pred             CcEEEEEEeCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCCCCcEEeeeeecccC-CceeEEEEeehhhhHHHHHhh
Confidence            399999998 78999999975432     24678899999999999999999998766 489999999988777666654


Q ss_pred             CcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCC-----
Q 041830          465 GLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDD-----  539 (600)
Q Consensus       465 ~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~-----  539 (600)
                      .            ..+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+|++|||++......     
T Consensus        94 ~------------~~l~~~~~~~i~~qi~~~L~~LH---~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~  158 (286)
T d1ob3a_          94 E------------GGLESVTAKSFLLQLLNGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT  158 (286)
T ss_dssp             T------------TCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             c------------CCcchhhhHHHHHHHHHHHHHhc---cCcEEecCCCCceeeEcCCCCEEecccccceecccCccccc
Confidence            3            23999999999999999999999   569999999999999999999999999998754322     


Q ss_pred             -------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          540 -------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       540 -------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                             ..+||.... ...++.++|||||||++|||++|+.||...
T Consensus       159 ~~~~~~~y~~pE~~~~-~~~~~~~~DiwslGv~l~el~~G~~pf~~~  204 (286)
T d1ob3a_         159 HEIVTLWYRAPDVLMG-SKKYSTTIDIWSVGCIFAEMVNGTPLFPGV  204 (286)
T ss_dssp             ---CCCTTCCHHHHTT-CCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             eecccchhhhHHHHhC-CCCCCcceeehhcCcHHHHHHHCCCCCCCC
Confidence                   123443332 245688999999999999999999999754

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.5e-31  Score=271.72  Aligned_cols=183  Identities=24%  Similarity=0.388  Sum_probs=141.7

Q ss_pred             eEEEEEEEE-------CCeEEEEEEcchh----HHHHHHHHHHHHHhC-CCCceeeeeeEEeccCCceEEEEeecCCCCH
Q 041830          391 EGAVYHGRL-------NGKNLAIKRTEHE----VITKLEMQLVQHATH-HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSL  458 (600)
Q Consensus       391 ~G~Vy~g~~-------~g~~vAvK~~~~~----~~~~~e~ei~~~~~l-~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL  458 (600)
                      +|.||+|++       +++.||||+++..    ....+.+|+..+..+ +|||||+++|+|.++ +..++|||||++|+|
T Consensus        36 fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~-~~~~lvmE~~~~g~l  114 (311)
T d1t46a_          36 FGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIG-GPTLVITEYCCYGDL  114 (311)
T ss_dssp             SEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS-SSCEEEEECCTTEEH
T ss_pred             CeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeC-CEEEEEEEcCCCCCH
Confidence            399999986       3468999998642    234567788888877 699999999998655 478999999999999


Q ss_pred             HHHHhcCcCcccc------cccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccC
Q 041830          459 KDWLHGGLAMKNQ------FIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGM  532 (600)
Q Consensus       459 ~~~L~~~~~~~~~------~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGl  532 (600)
                      .++|+........      ........+++.++++++.||++||+|||   +.+++||||||+|||++.++.+|++|||+
T Consensus       115 ~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH---~~~ivHrDLKp~NIl~~~~~~~ki~DfG~  191 (311)
T d1t46a_         115 LNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDFGL  191 (311)
T ss_dssp             HHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCSGGGEEEETTTEEEECCCGG
T ss_pred             HHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHH---hCCeeecccccccccccccCcccccccch
Confidence            9999865421100      00111245999999999999999999999   66999999999999999999999999999


Q ss_pred             ccccCCCC--------------CCCcccccCCCCCCccCchHHHHHHHHHHHh-CCCCCCCC
Q 041830          533 ARCVNDDT--------------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLS-GQTPINRP  579 (600)
Q Consensus       533 a~~~~~~~--------------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELlt-G~~Pf~~~  579 (600)
                      ++......              .+||....  ..++.++|||||||++|||+| |++||...
T Consensus       192 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DIwS~G~~l~ellt~g~p~~~~~  251 (311)
T d1t46a_         192 ARDIKNDSNYVVKGNARLPVKWMAPESIFN--CVYTFESDVWSYGIFLWELFSLGSSPYPGM  251 (311)
T ss_dssp             GSCTTSCTTSEECSSSEECGGGCCHHHHHH--CCCCHHHHHHHHHHHHHHHHTTTCCSSTTC
T ss_pred             heeccCCCcceEeeecccChHHcCHHHhcC--CCCCCcccccchHHHHHHHHhCCCCCCCCC
Confidence            98654322              23444433  457889999999999999999 55555443

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=1.1e-31  Score=269.21  Aligned_cols=171  Identities=23%  Similarity=0.356  Sum_probs=137.4

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhHH---------HHHHHHHHHHHhCC--CCceeeeeeEEeccCCceEEEEeecCC-C
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEVI---------TKLEMQLVQHATHH--HPNIVRLLGTCLTDGPHSFLVFEYAKN-G  456 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~~---------~~~e~ei~~~~~l~--HpNIv~l~g~~~~~~~~~~LV~Ey~~~-G  456 (600)
                      +|.||+|+.  +|+.||||+++.+..         .++.+|+..+..++  |||||++++++.++ +..|+||||+.+ +
T Consensus        17 fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~-~~~~lv~e~~~~~~   95 (273)
T d1xwsa_          17 FGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP-DSFVLILERPEPVQ   95 (273)
T ss_dssp             TEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS-SEEEEEEECCSSEE
T ss_pred             CeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC-CeEEEEEEeccCcc
Confidence            399999998  689999999865321         22456777776654  99999999997655 489999999975 6


Q ss_pred             CHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC-CCcEEEEeccCccc
Q 041830          457 SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE-EFNARVGNFGMARC  535 (600)
Q Consensus       457 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~-~~~~kI~DFGla~~  535 (600)
                      ++.+++....            .+++.++..++.|++.||+|||   +.+|+||||||+|||++. ++.+||+|||+++.
T Consensus        96 ~l~~~~~~~~------------~l~e~~~~~~~~qi~~al~~lH---~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~  160 (273)
T d1xwsa_          96 DLFDFITERG------------ALQEELARSFFWQVLEAVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGAL  160 (273)
T ss_dssp             EHHHHHHHHC------------SCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCSGGGEEEETTTTEEEECCCTTCEE
T ss_pred             hHHHHHhccC------------CCCHHHHHHHHHHHHHHHHHHH---HCCCccccCcccceEEecCCCeEEECcccccee
Confidence            8888886532            3899999999999999999999   679999999999999985 47999999999976


Q ss_pred             cCCCC----------CCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          536 VNDDT----------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       536 ~~~~~----------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                      .....          .+||..... ..++.++|||||||++|||++|+.||..
T Consensus       161 ~~~~~~~~~~GT~~y~aPE~~~~~-~~~~~~~DiwSlGvilyell~g~~Pf~~  212 (273)
T d1xwsa_         161 LKDTVYTDFDGTRVYSPPEWIRYH-RYHGRSAAVWSLGILLYDMVCGDIPFEH  212 (273)
T ss_dssp             CCSSCBCCCCSCGGGSCHHHHHHS-CBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred             cccccccccccCCCcCCHHHHcCC-CCCCcccccccceeeehhHhhCCCCCCC
Confidence            53321          245554432 2345678999999999999999999975

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=3.8e-31  Score=274.91  Aligned_cols=177  Identities=25%  Similarity=0.303  Sum_probs=139.2

Q ss_pred             eeEEEEEEEE--CCeEEEEEEcchhHHHHHHHHHHHHHhCCCCceeeeeeEEecc-----CCceEEEEeecCCCCHHHHH
Q 041830          390 IEGAVYHGRL--NGKNLAIKRTEHEVITKLEMQLVQHATHHHPNIVRLLGTCLTD-----GPHSFLVFEYAKNGSLKDWL  462 (600)
Q Consensus       390 ~~G~Vy~g~~--~g~~vAvK~~~~~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~-----~~~~~LV~Ey~~~GsL~~~L  462 (600)
                      .+|+||+++.  +|+.||||+++.+. ....+|+..+..++|||||++++++...     ...+|||||||++|.+..+.
T Consensus        32 ~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~  110 (350)
T d1q5ka_          32 SFGVVYQAKLCDSGELVAIKKVLQDK-RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVAR  110 (350)
T ss_dssp             TTEEEEEEEETTTCCEEEEEEEECCS-SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHH
T ss_pred             cCeEEEEEEECCCCCEEEEEEECccc-hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHH
Confidence            3499999999  68999999987654 3345788899999999999999998643     22478999999876444333


Q ss_pred             hcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC-cEEEEeccCccccCCCC-
Q 041830          463 HGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEF-NARVGNFGMARCVNDDT-  540 (600)
Q Consensus       463 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~-~~kI~DFGla~~~~~~~-  540 (600)
                      +....         ...+++.++..++.||+.||+|||   +.+|+||||||+|||++.++ .+||+|||+++...... 
T Consensus       111 ~~~~~---------~~~l~~~~~~~i~~qil~aL~yLH---~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~  178 (350)
T d1q5ka_         111 HYSRA---------KQTLPVIYVKLYMYQLFRSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP  178 (350)
T ss_dssp             HHHHT---------TCCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC
T ss_pred             hhhhc---------cCCCCHHHHHHHHHHHHHHHHHHH---hcCCcccCCCcceEEEecCCCceeEecccchhhccCCcc
Confidence            22111         134999999999999999999999   77999999999999999775 89999999998653321 


Q ss_pred             ----------CCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          541 ----------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       541 ----------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                                .+||.... ...++.++||||+||++|||++|+.||...+
T Consensus       179 ~~~~~gt~~y~aPE~~~~-~~~~~~~~DIwSlG~il~el~~g~~pf~~~~  227 (350)
T d1q5ka_         179 NVSYICSRYYRAPELIFG-ATDYTSSIDVWSAGCVLAELLLGQPIFPGDS  227 (350)
T ss_dssp             CCSCCSCTTSCCHHHHTT-CSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred             cccccccccccChHHhhc-ccCCCcceeecccceEEEehhhCCCCCCCCC
Confidence                      23443332 2457889999999999999999999997543

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=4e-31  Score=271.30  Aligned_cols=176  Identities=21%  Similarity=0.316  Sum_probs=142.4

Q ss_pred             eEEEEEEEE-----CCeEEEEEEcchh-------HHHHHHHHHHHHHhCCC-CceeeeeeEEeccCCceEEEEeecCCCC
Q 041830          391 EGAVYHGRL-----NGKNLAIKRTEHE-------VITKLEMQLVQHATHHH-PNIVRLLGTCLTDGPHSFLVFEYAKNGS  457 (600)
Q Consensus       391 ~G~Vy~g~~-----~g~~vAvK~~~~~-------~~~~~e~ei~~~~~l~H-pNIv~l~g~~~~~~~~~~LV~Ey~~~Gs  457 (600)
                      +|.||+++.     +|+.||||.++..       ..+.+.+|+..+.+++| |||+++++++... ...+++|||+.+|+
T Consensus        37 fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~-~~~~~v~e~~~~~~  115 (322)
T d1vzoa_          37 YGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE-TKLHLILDYINGGE  115 (322)
T ss_dssp             TEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEET-TEEEEEECCCCSCB
T ss_pred             CeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccC-CceeeeeecccccH
Confidence            399999986     4789999987532       22456678888888866 8999999997555 58999999999999


Q ss_pred             HHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC
Q 041830          458 LKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN  537 (600)
Q Consensus       458 L~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~  537 (600)
                      |.+++....            .+++.+...++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++...
T Consensus       116 L~~~i~~~~------------~~~e~~~~~~~~Qi~~al~~lH---~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~  180 (322)
T d1vzoa_         116 LFTHLSQRE------------RFTEHEVQIYVGEIVLALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFV  180 (322)
T ss_dssp             HHHHHHHHS------------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             HHHHHHhcc------------cccHHHHHHHHHHHHHHHHHhh---cCCEEeccCCccceeecCCCCEEEeeccchhhhc
Confidence            999997643            2788899999999999999999   6689999999999999999999999999997543


Q ss_pred             C-------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCCCC
Q 041830          538 D-------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRKK  582 (600)
Q Consensus       538 ~-------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~~  582 (600)
                      .             ...+||........++.++|||||||+||||++|+.||......
T Consensus       181 ~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~  238 (322)
T d1vzoa_         181 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK  238 (322)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC
T ss_pred             ccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence            2             12245555444455788899999999999999999999765544

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.97  E-value=2.5e-30  Score=268.17  Aligned_cols=176  Identities=19%  Similarity=0.300  Sum_probs=140.5

Q ss_pred             CceeEEEEEEEE--CCeEEEEEEcchh----HHHHHHHHHHHHHhCCCCceeeeeeEEeccCC---ceEEEEeecCCCCH
Q 041830          388 NRIEGAVYHGRL--NGKNLAIKRTEHE----VITKLEMQLVQHATHHHPNIVRLLGTCLTDGP---HSFLVFEYAKNGSL  458 (600)
Q Consensus       388 ~~~~G~Vy~g~~--~g~~vAvK~~~~~----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~---~~~LV~Ey~~~GsL  458 (600)
                      .|.+|+||+|+.  +|+.||||+++..    ..+.+.+|+.++..++||||+++++++..+..   ..++++||+.+|+|
T Consensus        18 ~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L   97 (345)
T d1pmea_          18 EGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADL   97 (345)
T ss_dssp             ---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEH
T ss_pred             eccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCch
Confidence            344499999988  6999999998532    23456789999999999999999999865421   23455567779999


Q ss_pred             HHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCC
Q 041830          459 KDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVND  538 (600)
Q Consensus       459 ~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~  538 (600)
                      .+++...             .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||+++....
T Consensus        98 ~~~l~~~-------------~l~~~~i~~i~~qil~al~yLH---~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~  161 (345)
T d1pmea_          98 YKLLKTQ-------------HLSNDHICYFLYQILRGLKYIH---SANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  161 (345)
T ss_dssp             HHHHHHC-------------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             hhhhhcC-------------CCCHHHHHHHHHHHHHHHHHHH---HCCCcCCCCCcceEEECCCCCEEEcccCceeeccC
Confidence            9999653             2899999999999999999999   66999999999999999999999999999875422


Q ss_pred             C---------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          539 D---------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       539 ~---------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                      .               ..+||.... ...++.++||||+||++|||++|+.||...+
T Consensus       162 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~~DiwSlG~il~eml~g~~pf~~~~  217 (345)
T d1pmea_         162 DHDHTGFLTEYVATRWYRAPEIMLN-SKGYTKSIDIWSVGCILAEMLSNRPIFPGKH  217 (345)
T ss_dssp             GGCBCCTTCCCCSCGGGCCGGGTTT-BCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred             CCccceeeccccccceechHHHhhc-CCCCCchhhhhccCceehHHhhCCCCCCCCC
Confidence            1               124554432 2346788999999999999999999997543

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=1.2e-30  Score=265.83  Aligned_cols=173  Identities=21%  Similarity=0.329  Sum_probs=136.6

Q ss_pred             eEEEEEEEE---CCeEEEEEEcchhH-----HHHHHHHHHHH---HhCCCCceeeeeeEEecc----CCceEEEEeecCC
Q 041830          391 EGAVYHGRL---NGKNLAIKRTEHEV-----ITKLEMQLVQH---ATHHHPNIVRLLGTCLTD----GPHSFLVFEYAKN  455 (600)
Q Consensus       391 ~G~Vy~g~~---~g~~vAvK~~~~~~-----~~~~e~ei~~~---~~l~HpNIv~l~g~~~~~----~~~~~LV~Ey~~~  455 (600)
                      +|.||+++.   +++.||||+++.+.     ...+.+|+..+   ...+||||+++++++...    ....+++|||+++
T Consensus        20 fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~   99 (305)
T d1blxa_          20 YGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ   99 (305)
T ss_dssp             TEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSC
T ss_pred             CeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccC
Confidence            399999997   36779999875321     12334555444   445899999999998532    2367999999998


Q ss_pred             CCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccc
Q 041830          456 GSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARC  535 (600)
Q Consensus       456 GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~  535 (600)
                      |++........           ..+++.++..++.|++.||+|||   +.+|+||||||+|||+++++.+||+|||+++.
T Consensus       100 ~~~~~~~~~~~-----------~~~~~~~~~~~~~qi~~aL~yLH---~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~  165 (305)
T d1blxa_         100 DLTTYLDKVPE-----------PGVPTETIKDMMFQLLRGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARI  165 (305)
T ss_dssp             BHHHHHHHSCT-----------TCSCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECSCCSCCC
T ss_pred             CchhhhhhccC-----------CCCCHHHHHHHHHHHHHHHHHHH---hCCEEecCCCccEEEEcCCCCeeecchhhhhh
Confidence            87765554332           34899999999999999999999   66999999999999999999999999999875


Q ss_pred             cC-----------CCCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          536 VN-----------DDTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       536 ~~-----------~~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                      ..           ..+.+||....  ..++.++||||+||++|||++|+.||...
T Consensus       166 ~~~~~~~~~~~gT~~Y~APE~~~~--~~y~~~~DiwSlG~il~ell~g~~pf~~~  218 (305)
T d1blxa_         166 YSFQMALTSVVVTLWYRAPEVLLQ--SSYATPVDLWSVGCIFAEMFRRKPLFRGS  218 (305)
T ss_dssp             CCGGGGGCCCCCCCTTCCHHHHTT--CCCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             hcccccCCCcccChhhcCcchhcC--CCCChhehhhchHHHHHHHHHCCCCCCCC
Confidence            42           23346776654  45789999999999999999999999754

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3e-30  Score=267.63  Aligned_cols=176  Identities=20%  Similarity=0.361  Sum_probs=142.0

Q ss_pred             CCceeEEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEeccC-----CceEEEEeecC
Q 041830          387 SNRIEGAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTDG-----PHSFLVFEYAK  454 (600)
Q Consensus       387 ~~~~~G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~-----~~~~LV~Ey~~  454 (600)
                      +.|.+|.||+++.  +|+.||||+++..     ..+.+.+|+..++.++|||||++++++...+     ..+|+||||+ 
T Consensus        27 G~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-  105 (346)
T d1cm8a_          27 GSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-  105 (346)
T ss_dssp             ------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-
T ss_pred             ecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-
Confidence            3444599999998  6999999998642     2346778999999999999999999986543     2469999999 


Q ss_pred             CCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCcc
Q 041830          455 NGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR  534 (600)
Q Consensus       455 ~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~  534 (600)
                      +++|..+++..             .|++.++..++.||+.||.|||   +.+|+||||||+|||++.++.+|++|||+++
T Consensus       106 ~~~l~~~~~~~-------------~l~~~~~~~~~~qi~~aL~~LH---~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~  169 (346)
T d1cm8a_         106 GTDLGKLMKHE-------------KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR  169 (346)
T ss_dssp             SEEHHHHHHHC-------------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTCCEEECCCTTCE
T ss_pred             cccHHHHHHhc-------------cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCcchhhccccccccccccccee
Confidence            56888877643             3999999999999999999999   6699999999999999999999999999998


Q ss_pred             ccCCCC---------CCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          535 CVNDDT---------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       535 ~~~~~~---------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                      ......         .+||.... ...++.++||||+||++|||++|+.||...+
T Consensus       170 ~~~~~~~~~~~t~~y~aPE~~~~-~~~~~~~~DiwSlGvil~ell~g~~pf~~~~  223 (346)
T d1cm8a_         170 QADSEMTGYVVTRWYRAPEVILN-WMRYTQTVDIWSVGCIMAEMITGKTLFKGSD  223 (346)
T ss_dssp             ECCSSCCSSCSCGGGCCTHHHHT-TTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccCCccccccccccccCHHHHcC-CCCCCccchhhcchHHHHHHHHCcCCCCCCC
Confidence            765432         24555433 2356888999999999999999999997643

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=99.96  E-value=2.7e-30  Score=265.93  Aligned_cols=173  Identities=20%  Similarity=0.309  Sum_probs=143.1

Q ss_pred             eeEEEEEEEE--CCeEEEEEEcchhHHHHHHHHHHHHHhCC-CCceeeeeeEEecc-CCceEEEEeecCCCCHHHHHhcC
Q 041830          390 IEGAVYHGRL--NGKNLAIKRTEHEVITKLEMQLVQHATHH-HPNIVRLLGTCLTD-GPHSFLVFEYAKNGSLKDWLHGG  465 (600)
Q Consensus       390 ~~G~Vy~g~~--~g~~vAvK~~~~~~~~~~e~ei~~~~~l~-HpNIv~l~g~~~~~-~~~~~LV~Ey~~~GsL~~~L~~~  465 (600)
                      .+|.||+|+.  +|+.||||+++....+++.+|+..+..+. ||||+++++++... ....++|||||++|+|.++.   
T Consensus        47 ~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~---  123 (328)
T d3bqca1          47 KYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---  123 (328)
T ss_dssp             SSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT---
T ss_pred             cCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh---
Confidence            3499999998  69999999998776677888999988885 99999999997643 34689999999999986543   


Q ss_pred             cCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC-cEEEEeccCccccCCCC----
Q 041830          466 LAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEF-NARVGNFGMARCVNDDT----  540 (600)
Q Consensus       466 ~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~-~~kI~DFGla~~~~~~~----  540 (600)
                                  ..+++.++..++.||+.||.|||   +.+|+||||||+|||++.++ .+||+|||+++......    
T Consensus       124 ------------~~l~e~~i~~i~~qil~aL~~LH---~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~  188 (328)
T d3bqca1         124 ------------QTLTDYDIRFYMYEILKALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV  188 (328)
T ss_dssp             ------------TSCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCCS
T ss_pred             ------------cCCCHHHHHHHHHHHHHHHHHHh---hcccccccccccceEEcCCCCeeeecccccceeccCCCcccc
Confidence                        23899999999999999999999   66999999999999998655 69999999998664322    


Q ss_pred             -------CCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCCC
Q 041830          541 -------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRK  581 (600)
Q Consensus       541 -------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~  581 (600)
                             .+||.... ...++.++||||+||++|||++|+.||....+
T Consensus       189 ~~~t~~y~aPE~~~~-~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~  235 (328)
T d3bqca1         189 RVASRYFKGPELLVD-YQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD  235 (328)
T ss_dssp             CCSCGGGCCHHHHTT-CCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred             cccCccccCcccccC-CCCCCcccchhhhhhhhHHhccCCCCCCCCch
Confidence                   24554433 23468889999999999999999999976543

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=6e-30  Score=258.61  Aligned_cols=171  Identities=22%  Similarity=0.321  Sum_probs=142.8

Q ss_pred             eEEEEEEEE--CCeEEEEEEcch-----hHHHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHh
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEH-----EVITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLH  463 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~-----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~  463 (600)
                      +|.||+|+.  +|+.||||+++.     .....+.+|+..+..++|||||++++++... ...++++|++.+++|..+++
T Consensus        15 fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~-~~~~iv~~~~~~~~l~~~~~   93 (292)
T d1unla_          15 YGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSD-KKLTLVFEFCDQDLKKYFDS   93 (292)
T ss_dssp             SSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECS-SEEEEEEECCSEEHHHHHHH
T ss_pred             CeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcCcCCEEeeccccccc-cceeEEeeeccccccccccc
Confidence            389999998  788999998743     2345678999999999999999999998665 48899999999999988886


Q ss_pred             cCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccCCCCC--
Q 041830          464 GGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVNDDTE--  541 (600)
Q Consensus       464 ~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~~~~~--  541 (600)
                      ...            .+++.++..++.|++.||+|||   +.+|+||||||+|||++.++.+||+|||.++.......  
T Consensus        94 ~~~------------~~~~~~~~~~~~q~~~aL~~lH---~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~  158 (292)
T d1unla_          94 CNG------------DLDPEIVKSFLFQLLKGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY  158 (292)
T ss_dssp             TTT------------CCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCC
T ss_pred             ccc------------ccchhHHHHHHHHHHHHHHHhh---cCCEeeecccCcccccccCCceeeeecchhhcccCCCccc
Confidence            543            3889999999999999999999   56999999999999999999999999999986643321  


Q ss_pred             ----------CCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          542 ----------SPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       542 ----------~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                                +||.... ...++.++|||||||++|||++|+.||..
T Consensus       159 ~~~~~~~~~~~pe~~~~-~~~~~~~~DiwSlG~il~ell~g~~p~~~  204 (292)
T d1unla_         159 SAEVVTLWYRPPDVLFG-AKLYSTSIDMWSAGCIFAELANAGRPLFP  204 (292)
T ss_dssp             CSCCSCGGGCCHHHHTT-CSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred             eeeccccchhhhhHhcc-CCCCCchhhccccchHHHHHhhCCCCCCC
Confidence                      2222222 23468889999999999999999999754

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=8.4e-30  Score=261.03  Aligned_cols=172  Identities=20%  Similarity=0.340  Sum_probs=136.7

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH-----HHHHHHHHHHHHhCCCCceeeeeeEEecc-------CCceEEEEeecCCC
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV-----ITKLEMQLVQHATHHHPNIVRLLGTCLTD-------GPHSFLVFEYAKNG  456 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~-----~~~~e~ei~~~~~l~HpNIv~l~g~~~~~-------~~~~~LV~Ey~~~G  456 (600)
                      +|+||+|+.  +|+.||||++..+.     ...+.+|+..+..++||||+++++++...       ....|+||||++++
T Consensus        23 fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~  102 (318)
T d3blha1          23 FGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHD  102 (318)
T ss_dssp             SSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEE
T ss_pred             CeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCC
Confidence            399999998  68999999875432     23567899999999999999999997542       13579999999987


Q ss_pred             CHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCcccc
Q 041830          457 SLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCV  536 (600)
Q Consensus       457 sL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~  536 (600)
                      .+..+....            ..+++.++..++.|++.||.|||   +.+|+||||||+|||++.++.+||+|||+++..
T Consensus       103 ~~~~~~~~~------------~~~~~~~~~~i~~qil~~l~~lH---~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~  167 (318)
T d3blha1         103 LAGLLSNVL------------VKFTLSEIKRVMQMLLNGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAF  167 (318)
T ss_dssp             HHHHHTCTT------------CCCCHHHHHHHHHHHHHHHHHHH---HTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             ccchhhhcc------------cccccHHHHHHHHHHHHHHHHhc---cCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence            766554332            23888999999999999999999   669999999999999999999999999999754


Q ss_pred             CCCC----------------CCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCC
Q 041830          537 NDDT----------------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINR  578 (600)
Q Consensus       537 ~~~~----------------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~  578 (600)
                      ....                .+||.... ...++.++|||||||++|||++|+.||..
T Consensus       168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~-~~~~~~k~DiwSlGvil~el~~g~~pf~~  224 (318)
T d3blha1         168 SLAKNSQPNRYTNRVVTLWYRPPELLLG-ERDYGPPIDLWGAGCIMAEMWTRSPIMQG  224 (318)
T ss_dssp             CC-----CCCCCSCCSCGGGCCHHHHTT-CSSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             ccccccccccccceecCHHHhhHHHHcC-CCCCCcHHHcccCCceeeeHhhCCCCCCC
Confidence            3211                23444332 23578899999999999999999999974

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=99.96  E-value=3.8e-29  Score=253.17  Aligned_cols=174  Identities=21%  Similarity=0.180  Sum_probs=140.9

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH-HHHHHHHHHHHHhCCC-CceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCc
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV-ITKLEMQLVQHATHHH-PNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGL  466 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~-~~~~e~ei~~~~~l~H-pNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~  466 (600)
                      +|.||+|+.  +|+.||||.++... ...+.+|+..+..+.| +|++.+++++..+ ...++||||+ +|+|.++++...
T Consensus        18 fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~-~~~~~vme~~-~~~l~~~~~~~~   95 (293)
T d1csna_          18 FGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEG-LHNVLVIDLL-GPSLEDLLDLCG   95 (293)
T ss_dssp             SCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEET-TEEEEEEECC-CCBHHHHHHHTT
T ss_pred             CeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecC-CccEEEEEec-CCCHHHHHHhhc
Confidence            399999998  68999999875432 2346777778877765 8999999987555 4889999999 689999987543


Q ss_pred             CcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCC-----CCcEEEEeccCccccCC---
Q 041830          467 AMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDE-----EFNARVGNFGMARCVND---  538 (600)
Q Consensus       467 ~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~-----~~~~kI~DFGla~~~~~---  538 (600)
                                 ..+++.++..++.|++.||+|||   +.+|+||||||+|||++.     ++.+||+|||+++....   
T Consensus        96 -----------~~~~~~~~~~i~~q~~~~l~~lH---~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~  161 (293)
T d1csna_          96 -----------RKFSVKTVAMAAKQMLARVQSIH---EKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT  161 (293)
T ss_dssp             -----------TCCCHHHHHHHHHHHHHHHHHHH---TTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred             -----------cchhhHHHHHHHHHHHHHHHHHH---HCCceeccCCccceeecCcccccCCceEEcccceeEEcccCcc
Confidence                       34899999999999999999999   779999999999999974     57899999999976432   


Q ss_pred             ----------------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCCCC
Q 041830          539 ----------------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRKK  582 (600)
Q Consensus       539 ----------------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~~  582 (600)
                                      .+.+||....  ..++.++|||||||++|||+||+.||......
T Consensus       162 ~~~~~~~~~~~~~GT~~y~aPE~~~~--~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~  219 (293)
T d1csna_         162 KQHIPYREKKNLSGTARYMSINTHLG--REQSRRDDLEALGHVFMYFLRGSLPWQGLKAA  219 (293)
T ss_dssp             CCBCCCCCCCCCCSCTTTCCHHHHTT--CCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC
T ss_pred             ccceeecccCceEEchhhcCHHHhcC--CCCChHHHHHHhhHHHHHHHhCCCcCCCccch
Confidence                            1234555443  45788899999999999999999999765433

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.96  E-value=2.7e-29  Score=254.98  Aligned_cols=174  Identities=20%  Similarity=0.236  Sum_probs=137.9

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH-HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEEEEeecCCCCHHHHHhcCcC
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV-ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDWLHGGLA  467 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~-~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~L~~~~~  467 (600)
                      +|.||+|+.  +|+.||||.+..+. ..++..|+..+..++|+|+|..++.|..+++..++||||+. |+|.+.+.... 
T Consensus        20 fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~-~~l~~~~~~~~-   97 (299)
T d1ckia_          20 FGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG-PSLEDLFNFCS-   97 (299)
T ss_dssp             SSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTT-
T ss_pred             CcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC-Cchhhhhhhcc-
Confidence            399999998  68999999865432 24567888889999888877777777666668899999995 57776665432 


Q ss_pred             cccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeC---CCCcEEEEeccCccccCCC-----
Q 041830          468 MKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLD---EEFNARVGNFGMARCVNDD-----  539 (600)
Q Consensus       468 ~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld---~~~~~kI~DFGla~~~~~~-----  539 (600)
                                ..+++.+++.++.|++.||+|||   +.+|+||||||+|||++   .+..+||+|||+|+.....     
T Consensus        98 ----------~~~~~~~~~~~~~qi~~~l~~lH---~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~  164 (299)
T d1ckia_          98 ----------RKFSLKTVLLLADQMISRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQH  164 (299)
T ss_dssp             ----------TCCCHHHHHHHHHHHHHHHHHHH---HTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCB
T ss_pred             ----------CCCcHHHHHHHHHHHHHHHHHHH---HCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccc
Confidence                      34899999999999999999999   67999999999999985   4567999999999865322     


Q ss_pred             --------------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCCC
Q 041830          540 --------------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPRK  581 (600)
Q Consensus       540 --------------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~~  581 (600)
                                    +.+||....  ..++.++|||||||++|||++|+.||.....
T Consensus       165 ~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~  218 (299)
T d1ckia_         165 IPYRENKNLTGTARYASINTHLG--IEQSRRDDLESLGYVLMYFNLGSLPWQGLKA  218 (299)
T ss_dssp             CCCCBCCSCCCCSSSCCHHHHTT--BCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred             eeccccCCcCCCccccCHHHHhC--CCCCChhhEEecCHHHHHHHhCCCcccccch
Confidence                          123444332  3468889999999999999999999976543

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.96  E-value=3.3e-29  Score=259.79  Aligned_cols=174  Identities=20%  Similarity=0.327  Sum_probs=138.8

Q ss_pred             ceeEEEEEEEE--CCeEEEEEEcchh-----HHHHHHHHHHHHHhCCCCceeeeeeEEecc----CCceEEEEeecCCCC
Q 041830          389 RIEGAVYHGRL--NGKNLAIKRTEHE-----VITKLEMQLVQHATHHHPNIVRLLGTCLTD----GPHSFLVFEYAKNGS  457 (600)
Q Consensus       389 ~~~G~Vy~g~~--~g~~vAvK~~~~~-----~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~----~~~~~LV~Ey~~~Gs  457 (600)
                      |.+|+||+++.  +|+.||||+++..     ..+.+.+|+..+..++|||||++++++...    ....++++||+.+|+
T Consensus        29 G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~  108 (348)
T d2gfsa1          29 GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGAD  108 (348)
T ss_dssp             GTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEE
T ss_pred             CCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCc
Confidence            33499999997  7999999998542     234567899999999999999999997532    123467778888999


Q ss_pred             HHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCccccC
Q 041830          458 LKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN  537 (600)
Q Consensus       458 L~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~  537 (600)
                      |.++++..             .+++.++..++.||+.||+|||   +.+|+||||||+|||++.++.+|++|||++....
T Consensus       109 L~~~~~~~-------------~l~e~~~~~i~~qil~aL~~LH---~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~  172 (348)
T d2gfsa1         109 LNNIVKCQ-------------KLTDDHVQFLIYQILRGLKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTD  172 (348)
T ss_dssp             HHHHHTTC-------------CCCHHHHHHHHHHHHHHHHHHH---HTTCCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred             hhhhcccc-------------cccHHHHHHHHHHHHHHHHHHH---hCCCcccccCCccccccccccccccccchhcccC
Confidence            99999643             2899999999999999999999   6699999999999999999999999999987553


Q ss_pred             CCC---------CCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCC
Q 041830          538 DDT---------ESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRP  579 (600)
Q Consensus       538 ~~~---------~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~  579 (600)
                      ...         .+||.... ...++.++|||||||++|||++|+.||...
T Consensus       173 ~~~~~~~g~~~y~apE~~~~-~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~  222 (348)
T d2gfsa1         173 DEMTGYVATRWYRAPEIMLN-WMHYNQTVDIWSVGCIMAELLTGRTLFPGT  222 (348)
T ss_dssp             GGGSSSCHHHHTSCHHHHTT-CSCCCTTHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred             cccccccccccccCchhhcC-CccCCcccchhhhhHHHHHHHhCCCCCCCC
Confidence            321         24554433 234678899999999999999999999754

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.95  E-value=1.1e-28  Score=256.70  Aligned_cols=174  Identities=19%  Similarity=0.302  Sum_probs=138.7

Q ss_pred             CCceeEEEEEEEE--CCeEEEEEEcch-----hHHHHHHHHHHHHHhCCCCceeeeeeEEecc-----CCceEEEEeecC
Q 041830          387 SNRIEGAVYHGRL--NGKNLAIKRTEH-----EVITKLEMQLVQHATHHHPNIVRLLGTCLTD-----GPHSFLVFEYAK  454 (600)
Q Consensus       387 ~~~~~G~Vy~g~~--~g~~vAvK~~~~-----~~~~~~e~ei~~~~~l~HpNIv~l~g~~~~~-----~~~~~LV~Ey~~  454 (600)
                      +.|.+|+||+|+.  +|+.||||+++.     .....+.+|+..+..++|||||++++++...     ....|+|||||.
T Consensus        26 G~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~  105 (355)
T d2b1pa1          26 GSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMD  105 (355)
T ss_dssp             SCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCS
T ss_pred             ecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccc
Confidence            4444599999998  699999999863     2334678899999999999999999997633     247899999997


Q ss_pred             CCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEEeccCcc
Q 041830          455 NGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVGNFGMAR  534 (600)
Q Consensus       455 ~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~DFGla~  534 (600)
                      ++ +.+.+.              ..+++.++..++.||+.||.|||   +.+|+||||||+|||++.++..|++|||+++
T Consensus       106 ~~-l~~~~~--------------~~~~~~~i~~~~~qil~gl~~LH---~~giiHrDlKP~Nil~~~~~~~kl~df~~~~  167 (355)
T d2b1pa1         106 AN-LCQVIQ--------------MELDHERMSYLLYQMLCGIKHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLAR  167 (355)
T ss_dssp             EE-HHHHHT--------------SCCCHHHHHHHHHHHHHHHHHHH---HTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred             hH-HHHhhh--------------cCCCHHHHHHHHHHHHHHHHHhh---hcccccccCCccccccccccceeeechhhhh
Confidence            65 444443              23899999999999999999999   6699999999999999999999999999987


Q ss_pred             ccCC-----------CCCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          535 CVND-----------DTESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       535 ~~~~-----------~~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                      ....           ...+||....  ..++.++||||+||++|||++|+.||...+
T Consensus       168 ~~~~~~~~~~~~~t~~y~aPE~l~~--~~~~~~~DiwSlG~~l~ell~g~~pF~~~~  222 (355)
T d2b1pa1         168 TAGTSFMMTPYVVTRYYRAPEVILG--MGYKENVDIWSVGCIMGEMVRHKILFPGRD  222 (355)
T ss_dssp             -------------CCTTCCHHHHTT--CCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred             ccccccccccccccccccChhhhcC--CCCCCCcccccccchHHHHhhCCCCCCCCC
Confidence            5432           2346776654  467889999999999999999999997543

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.90  E-value=4.4e-24  Score=221.86  Aligned_cols=176  Identities=18%  Similarity=0.291  Sum_probs=129.4

Q ss_pred             eEEEEEEEE--CCeEEEEEEcchhH--HHHHHHHHHHHHhCC-----------CCceeeeeeEEeccC-CceEEEEeecC
Q 041830          391 EGAVYHGRL--NGKNLAIKRTEHEV--ITKLEMQLVQHATHH-----------HPNIVRLLGTCLTDG-PHSFLVFEYAK  454 (600)
Q Consensus       391 ~G~Vy~g~~--~g~~vAvK~~~~~~--~~~~e~ei~~~~~l~-----------HpNIv~l~g~~~~~~-~~~~LV~Ey~~  454 (600)
                      +|.||+|+.  +|+.||||+++.+.  .+.+++|+..+..++           |+||+++++++...+ ...+++++++.
T Consensus        26 fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~  105 (362)
T d1q8ya_          26 FSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEV  105 (362)
T ss_dssp             SEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECC
T ss_pred             CeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeecc
Confidence            499999998  79999999987643  234566666655443           689999999875432 35567777766


Q ss_pred             CCC-HHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCC------cEEE
Q 041830          455 NGS-LKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEF------NARV  527 (600)
Q Consensus       455 ~Gs-L~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~------~~kI  527 (600)
                      .+. ..........          ..+++..+..++.||+.||+|||+  ..+|+||||||+|||++.++      .+|+
T Consensus       106 ~~~~~~~~~~~~~~----------~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~~kl  173 (362)
T d1q8ya_         106 LGENLLALIKKYEH----------RGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKI  173 (362)
T ss_dssp             CCEEHHHHHHHTTT----------SCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEEEEE
T ss_pred             cccccccccccccc----------cCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccceeeE
Confidence            544 3333322221          348899999999999999999995  35899999999999997654      4999


Q ss_pred             EeccCccccCCC---------CCCCcccccCCCCCCccCchHHHHHHHHHHHhCCCCCCCCC
Q 041830          528 GNFGMARCVNDD---------TESPQFYSTNPASWSMGIDIFAYGIVLLEVLSGQTPINRPR  580 (600)
Q Consensus       528 ~DFGla~~~~~~---------~~~pe~~~~~~~~~t~~sDVwSfGvvL~ELltG~~Pf~~~~  580 (600)
                      +|||.++.....         ..+||....  ..++.++||||+||+++||++|+.||...+
T Consensus       174 ~dfg~s~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~el~~g~~pF~~~~  233 (362)
T d1q8ya_         174 ADLGNACWYDEHYTNSIQTREYRSPEVLLG--APWGCGADIWSTACLIFELITGDFLFEPDE  233 (362)
T ss_dssp             CCCTTCEETTBCCCSCCSCGGGCCHHHHHT--CCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred             eecccccccccccccccccccccChhhccc--cCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence            999998754322         235665543  457889999999999999999999997543

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.72  E-value=1.4e-18  Score=163.42  Aligned_cols=145  Identities=11%  Similarity=0.061  Sum_probs=104.0

Q ss_pred             eEEEEEEEE-CCeEEEEEEcchhH---------------------HHHHHHHHHHHHhCCCCceeeeeeEEeccCCceEE
Q 041830          391 EGAVYHGRL-NGKNLAIKRTEHEV---------------------ITKLEMQLVQHATHHHPNIVRLLGTCLTDGPHSFL  448 (600)
Q Consensus       391 ~G~Vy~g~~-~g~~vAvK~~~~~~---------------------~~~~e~ei~~~~~l~HpNIv~l~g~~~~~~~~~~L  448 (600)
                      .|.||+|+. +|+.||||.++...                     ....+.|...+..+.|.+++..+++.     ..++
T Consensus        13 ~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~~-----~~~l   87 (191)
T d1zara2          13 ESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWE-----GNAV   87 (191)
T ss_dssp             SEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEE-----TTEE
T ss_pred             ceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEec-----CCEE
Confidence            399999997 89999999754211                     11235677778889999999987652     2379


Q ss_pred             EEeecCCCCHHHHHhcCcCcccccccccccCCCHHHHHHHHHHHHHHHHHHHhcCCCCceecCCCCCCEEeCCCCcEEEE
Q 041830          449 VFEYAKNGSLKDWLHGGLAMKNQFIASCYCFLTWSQRLRICLDVAMALQYMHHVMNPSYVHRNIKSRNIFLDEEFNARVG  528 (600)
Q Consensus       449 V~Ey~~~GsL~~~L~~~~~~~~~~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivHrDLk~~NILld~~~~~kI~  528 (600)
                      +|||++++.+.                   .+++....+++.|++.+|.|||   ..+|+||||||+|||++++ .++|+
T Consensus        88 vme~~~~~~~~-------------------~l~~~~~~~i~~ql~~~l~~lH---~~giiHrDiKP~NILv~~~-~~~li  144 (191)
T d1zara2          88 LMELIDAKELY-------------------RVRVENPDEVLDMILEEVAKFY---HRGIVHGDLSQYNVLVSEE-GIWII  144 (191)
T ss_dssp             EEECCCCEEGG-------------------GCCCSCHHHHHHHHHHHHHHHH---HTTEECSCCSTTSEEEETT-EEEEC
T ss_pred             EEEeecccccc-------------------chhhHHHHHHHHHHHHHHHHHh---hCCEEEccCChhheeeeCC-CEEEE
Confidence            99999875432                   1455556789999999999999   5699999999999999865 48899


Q ss_pred             eccCccccCCCCCCCccccc------C--CCCCCccCchHHHHH
Q 041830          529 NFGMARCVNDDTESPQFYST------N--PASWSMGIDIFAYGI  564 (600)
Q Consensus       529 DFGla~~~~~~~~~pe~~~~------~--~~~~t~~sDVwSfGv  564 (600)
                      |||+|+...... +.+++..      .  ...|..++|+||..-
T Consensus       145 DFG~a~~~~~~~-~~~~l~rd~~~~~~~f~r~y~~~~d~~s~~~  187 (191)
T d1zara2         145 DFPQSVEVGEEG-WREILERDVRNIITYFSRTYRTEKDINSAID  187 (191)
T ss_dssp             CCTTCEETTSTT-HHHHHHHHHHHHHHHHHHHHCCCCCHHHHHH
T ss_pred             ECCCcccCCCCC-cHHHHHHHHHHHHHHHcCCCCCcccHHHHHH
Confidence            999997664332 1122110      0  123566789998653

>d1e0ga_ d.7.1.1 (A:) Membrane-bound lytic murein transclycosylase D, MltD {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Membrane-bound lytic murein transclycosylase D, MltD
species: Escherichia coli [TaxId: 562]

Probab=99.28  E-value=8.1e-13  Score=92.88  Aligned_cols=46  Identities=22%  Similarity=0.265  Sum_probs=42.5

Q ss_pred             ceeeeecCCchhhHHHhcCCCchHHHHHhhCCCCCCCCCCCCCeEeeeee
Q 041830          127 LTKTTIKGESFYSIAQSLEGLTTCGAIKERNPSVSPWDLDDKARLQVPLR  176 (600)
Q Consensus       127 ~~y~v~~gdt~~~ia~~~~gl~t~~~l~~~N~~~~~~~l~~G~~l~vp~~  176 (600)
                      .+|+|++|||+|.||++|+  ++.++|++||++.  +.|++||+|.||++
T Consensus         3 v~y~V~~GDTl~~IA~~y~--vs~~~i~~~N~l~--~~l~~Gq~L~i~vk   48 (48)
T d1e0ga_           3 ITYRVRKGDSLSSIAKRHG--VNIKDVMRWNSDT--ANLQPGDKLTLFVK   48 (48)
T ss_dssp             CEEEECTTCCHHHHHHHHT--CCHHHHHHHCSCG--GGCCTTEEEECCCC
T ss_pred             EEEEECCCCCHHHHHHHHC--CCHHHHHHHcCCc--ccCcCCCEEEEEeC
Confidence            5799999999999999999  9999999999985  46999999999974

>d1y7ma2 d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-terminal domain {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Hypothetical protein YkuD, N-terminal domain
species: Bacillus subtilis [TaxId: 1423]

Probab=99.21  E-value=1.1e-12  Score=92.52  Aligned_cols=46  Identities=26%  Similarity=0.389  Sum_probs=42.5

Q ss_pred             ceeeeecCCchhhHHHhcCCCchHHHHHhhCCCCCCCCCCCCCeEeeee
Q 041830          127 LTKTTIKGESFYSIAQSLEGLTTCGAIKERNPSVSPWDLDDKARLQVPL  175 (600)
Q Consensus       127 ~~y~v~~gdt~~~ia~~~~gl~t~~~l~~~N~~~~~~~l~~G~~l~vp~  175 (600)
                      .+|+|++|||+|+||++|+  ++.++|+++|+..+ +.|++||+|.||.
T Consensus         2 i~y~V~~GDTL~~IA~~y~--v~~~~i~~~N~~~~-~~l~~Gq~L~IPg   47 (48)
T d1y7ma2           2 LTYQVKQGDTLNSIAADFR--ISTAALLQANPSLQ-AGLTAGQSIVIPG   47 (48)
T ss_dssp             EEEECCTTCCHHHHHHHTT--SCCCCCCCTSCTTC-SSCCTTCEEEETT
T ss_pred             EEEEECCCCCHHHHHHHhC--CCHHHHHHHcCCCC-CCCCCCCEEEeCC
Confidence            4799999999999999999  99999999999986 4699999999983

>d1y7ma2 d.7.1.1 (A:1-48) Hypothetical protein YkuD, N-terminal domain {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Hypothetical protein YkuD, N-terminal domain
species: Bacillus subtilis [TaxId: 1423]

Probab=98.83  E-value=6e-10  Score=78.22  Aligned_cols=45  Identities=16%  Similarity=0.153  Sum_probs=42.1

Q ss_pred             eeeecCCCCCChhhHHHhhCCChHHHHhhhCCCCCCCCCCCCCcEEEe
Q 041830           64 AILRTNSYYSSLFNLSFYLGLNRFVIARANGFSADTEFLPKDQPLLIP  111 (600)
Q Consensus        64 ~~y~~~~~~~~l~~ia~~~~~~~~~i~~~N~~~~~~~~i~~~~~l~vP  111 (600)
                      ++|+|++ ||||++||++|++++++|+++|++  .++.|++||.|.||
T Consensus         2 i~y~V~~-GDTL~~IA~~y~v~~~~i~~~N~~--~~~~l~~Gq~L~IP   46 (48)
T d1y7ma2           2 LTYQVKQ-GDTLNSIAADFRISTAALLQANPS--LQAGLTAGQSIVIP   46 (48)
T ss_dssp             EEEECCT-TCCHHHHHHHTTSCCCCCCCTSCT--TCSSCCTTCEEEET
T ss_pred             EEEEECC-CCCHHHHHHHhCCCHHHHHHHcCC--CCCCCCCCCEEEeC
Confidence            5799999 999999999999999999999999  45679999999999

>d1e0ga_ d.7.1.1 (A:) Membrane-bound lytic murein transclycosylase D, MltD {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: LysM domain
superfamily: LysM domain
family: LysM domain
domain: Membrane-bound lytic murein transclycosylase D, MltD
species: Escherichia coli [TaxId: 562]

Probab=98.82  E-value=9.9e-10  Score=76.81  Aligned_cols=45  Identities=20%  Similarity=0.118  Sum_probs=41.7

Q ss_pred             eeeecCCCCCChhhHHHhhCCChHHHHhhhCCCCCCCCCCCCCcEEEee
Q 041830           64 AILRTNSYYSSLFNLSFYLGLNRFVIARANGFSADTEFLPKDQPLLIPI  112 (600)
Q Consensus        64 ~~y~~~~~~~~l~~ia~~~~~~~~~i~~~N~~~~~~~~i~~~~~l~vP~  112 (600)
                      ++|+|++ ||||+.||++|++++.+|+++|+++  + .|++||.|.||+
T Consensus         3 v~y~V~~-GDTl~~IA~~y~vs~~~i~~~N~l~--~-~l~~Gq~L~i~v   47 (48)
T d1e0ga_           3 ITYRVRK-GDSLSSIAKRHGVNIKDVMRWNSDT--A-NLQPGDKLTLFV   47 (48)
T ss_dssp             CEEEECT-TCCHHHHHHHHTCCHHHHHHHCSCG--G-GCCTTEEEECCC
T ss_pred             EEEEECC-CCCHHHHHHHHCCCHHHHHHHcCCc--c-cCcCCCEEEEEe
Confidence            5799999 9999999999999999999999984  3 599999999997

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.68  E-value=5.7e-05  Score=71.90  Aligned_cols=69  Identities=17%  Similarity=0.029  Sum_probs=45.4

Q ss_pred             EEEEEEEECCeEEEEEEcchhHH---HHHHHHHHHHHhCC-CCceeeeeeEEeccCCceEEEEeecCCCCHHHH
Q 041830          392 GAVYHGRLNGKNLAIKRTEHEVI---TKLEMQLVQHATHH-HPNIVRLLGTCLTDGPHSFLVFEYAKNGSLKDW  461 (600)
Q Consensus       392 G~Vy~g~~~g~~vAvK~~~~~~~---~~~e~ei~~~~~l~-HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL~~~  461 (600)
                      ..||+...+++.+.+|+......   ..+++|...+..+. +--+-++++++..+ +..++|||++++.++.+.
T Consensus        28 ~~v~rv~~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~-~~~~lv~~~l~G~~~~~~  100 (263)
T d1j7la_          28 AKVYKLVGENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHD-GWSNLLMSEADGVLCSEE  100 (263)
T ss_dssp             SEEEEEECSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEET-TEEEEEEECCSSEEHHHH
T ss_pred             CcEEEEEeCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecC-CceEEEEEeccccccccc
Confidence            57999888888889998765331   23455655544332 22345666665444 478999999998877554

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.12  E-value=0.0002  Score=67.58  Aligned_cols=66  Identities=12%  Similarity=0.098  Sum_probs=41.7

Q ss_pred             EEEEEEEE-CCeEEEEEEcchhHHHHHHHHHHHHHhC--CCCceeeeeeEEeccCCceEEEEeecCCCCH
Q 041830          392 GAVYHGRL-NGKNLAIKRTEHEVITKLEMQLVQHATH--HHPNIVRLLGTCLTDGPHSFLVFEYAKNGSL  458 (600)
Q Consensus       392 G~Vy~g~~-~g~~vAvK~~~~~~~~~~e~ei~~~~~l--~HpNIv~l~g~~~~~~~~~~LV~Ey~~~GsL  458 (600)
                      ..||+... .|..+.+|..+......++.|...+..+  ..--+.++++++.++ ...++||||+++-++
T Consensus        25 ~~v~r~~~~~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~-~~~~~v~~~i~G~~~   93 (255)
T d1nd4a_          25 AAVFRLSAQGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEA-GRDWLLLGEVPGQDL   93 (255)
T ss_dssp             CEEEEEECTTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECS-SCEEEEEECCSSEET
T ss_pred             CeEEEEEeCCCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecccc-cceEEEEEeeecccc
Confidence            67898887 4556888987654434445555444433  223356677775444 478999999987543

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=95.11  E-value=0.058  Score=53.78  Aligned_cols=32  Identities=19%  Similarity=0.235  Sum_probs=26.8

Q ss_pred             CCceecCCCCCCEEeCCCCcEEEEeccCccccC
Q 041830          505 PSYVHRNIKSRNIFLDEEFNARVGNFGMARCVN  537 (600)
Q Consensus       505 ~~ivHrDLk~~NILld~~~~~kI~DFGla~~~~  537 (600)
                      ..++|+|+.+.|||++++. ++|.||..+....
T Consensus       223 ~~LiHGDl~~gNIlv~~~~-~~vID~E~a~~G~  254 (392)
T d2pula1         223 ETLIHGDLHTGSIFASEHE-TKVIDPEFAFYGP  254 (392)
T ss_dssp             CEEECSCCCGGGEEECSSC-EEECCCTTCEEEC
T ss_pred             cceeccCCcCCceeEcCCc-eEEechhhcccCC
Confidence            4689999999999998764 8999998876543

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=92.86  E-value=0.085  Score=50.95  Aligned_cols=29  Identities=17%  Similarity=0.181  Sum_probs=23.7

Q ss_pred             CCceecCCCCCCEEeCCCCcEEEEeccCccc
Q 041830          505 PSYVHRNIKSRNIFLDEEFNARVGNFGMARC  535 (600)
Q Consensus       505 ~~ivHrDLk~~NILld~~~~~kI~DFGla~~  535 (600)
                      ..++|+|+.+.|||++++  ..+.||+.+..
T Consensus       192 ~~liHgDlh~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         192 VLRLHGDCHAGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             CEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred             ceeecCCCCcccEEEeCC--ceEEechhccc
Confidence            468999999999999754  35789998764

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=92.15  E-value=0.27  Score=46.73  Aligned_cols=31  Identities=16%  Similarity=0.218  Sum_probs=27.5

Q ss_pred             CCCceecCCCCCCEEeCCCCcEEEEeccCcc
Q 041830          504 NPSYVHRNIKSRNIFLDEEFNARVGNFGMAR  534 (600)
Q Consensus       504 ~~~ivHrDLk~~NILld~~~~~kI~DFGla~  534 (600)
                      ..+++|+|+.+.||+++++...-|.||+.+.
T Consensus       182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         182 PAGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             CEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccccccCCcchhhhhcccccceeEecccccc
Confidence            4579999999999999998888899999874

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=86.47  E-value=0.36  Score=47.57  Aligned_cols=63  Identities=16%  Similarity=0.145  Sum_probs=33.1

Q ss_pred             eeEEEEEEEEC---------CeEEEEEEcch-hHHHHHHHHHHHHHhCC-CCceeeeeeEEeccCCceEEEEeecCCCC
Q 041830          390 IEGAVYHGRLN---------GKNLAIKRTEH-EVITKLEMQLVQHATHH-HPNIVRLLGTCLTDGPHSFLVFEYAKNGS  457 (600)
Q Consensus       390 ~~G~Vy~g~~~---------g~~vAvK~~~~-~~~~~~e~ei~~~~~l~-HpNIv~l~g~~~~~~~~~~LV~Ey~~~Gs  457 (600)
                      +.-.+|+....         .+.|.++..-. ......++|...+..+. +.=..++++++  ++   .+|+||+++..
T Consensus        54 ltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~--~~---g~I~efi~g~~  127 (395)
T d1nw1a_          54 MSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIF--SG---GRLEEYIPSRP  127 (395)
T ss_dssp             TTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEE--TT---EEEECCCCEEE
T ss_pred             cccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEc--CC---ceEEEEecccc
Confidence            33678888762         23466555321 11122345555444332 32234777775  22   58999998643